[["Diabetes mellitus may be present in patients with cystic fibrosis starting in the second decade of life.", {"entities": [[50, 65, "DISEASE"], [0, 17, "DISEASE"]]}], ["The prevalence increases rapidly with increasing age.", {"entities": []}], ["As life-expectancy increases in cystic fibrosis, cystic fibrosis related diabetes will be diagnosed more frequently in the future.", {"entities": [[32, 47, "DISEASE"], [49, 64, "DISEASE"]]}], ["Up to date, no data are available to answer the question if cystic fibrosis related diabetes should always initially be treated by insulin therapy.", {"entities": [[60, 75, "DISEASE"]]}], ["Missing data regarding oral antidiabetic treatment of newly diagnosed cystic fibrosis related diabetes are an important reason to recommend insulin treatment.", {"entities": [[70, 85, "DISEASE"]]}], ["Several centres report the successful management of cystic fibrosis related diabetes using oral anti-diabetic drugs at least for some years.", {"entities": [[52, 67, "DISEASE"]]}], ["Oral therapies would be less invasive for a patient group which is highly traumatized by a very demanding therapy.", {"entities": []}], ["Based on an initiative of the German Mukoviszidosis-Foundation, the present study tries to answer the question, whether oral therapy with repaglinide is as effective as insulin therapy in cystic fibrosis patients with early diagnosed diabetes mellitus.", {"entities": [[188, 203, "DISEASE"], [234, 251, "DISEASE"]]}], ["In all cystic fibrosis patients with an age of 10\u00a0years or older, an oral glucose tolerance test is recommended.", {"entities": [[7, 22, "DISEASE"]]}], ["The result of this test is classified according to the WHO cut off values.", {"entities": []}], ["It is required to have two diabetes positive oral glucose tolerance tests for the diagnosis of diabetes mellitus.", {"entities": [[95, 112, "DISEASE"]]}], ["This study is a multi-national, multicentre, open labelled, randomized and prospective controlled parallel group\u2019s trial, with 24\u00a0months treatment.", {"entities": []}], ["The primary objective of this trial is to compare the glycaemic control of oral therapy with Repaglinide with insulin injections in patients with cystic fibrosis related diabetes after 2\u00a0years of treatment.", {"entities": [[146, 161, "DISEASE"]]}], ["The trial should include 74 subjects showing cystic fibrosis related diabetes newly diagnosed by oral glucose tolerance test during annual screening for cystic fibrosis related diabetes.", {"entities": [[45, 60, "DISEASE"], [153, 168, "DISEASE"]]}], ["Patients are randomised by central fax randomisation.", {"entities": []}], ["Primary endpoint is mean HbA1c after 24\u00a0months of treatment.", {"entities": []}], ["Secondary endpoints are change in FEV1% predicted and change in BMI-Z-score.", {"entities": []}], ["There is only one prospective study comparing oral antidiabetic drugs to insulin in the treatment of CFRD without fasting hyperglycaemia.", {"entities": []}], ["The results regarding BMI after 6 months and 12 months showed an improvement for the insulin treated patients and were inconsistent for those treated with repaglinide.", {"entities": []}], ["HbA1c and lung function (FEV1%pred) were unchanged for either group.", {"entities": []}], ["The authors compared the changes -12 months to baseline and baseline to +12 months separately for each group.", {"entities": []}], ["Therefore a direct comparison of the effect of repaglinide versus insulin on BMI, HbA1c and FEV1%pred was not presented.", {"entities": []}], ["According to our protocol, we will directly compare treatment effects (HbA1c, BMI, FEV1%pred) in between both groups.", {"entities": []}], ["The actual Cochrane report regarding \u201cInsulin and oral agents for managing CFRD\u201d stated that further studies are needed to establish whether there is clear benefit for hypoglycemic agents.", {"entities": []}], ["We expect that the results of our study will help to address this clinical need.", {"entities": []}], ["ClinicalTrials.gov Identifier: NCT00662714", {"entities": []}], ["Epithelial cell extrusion is crucial for proper development and tissue homeostasis.", {"entities": []}], ["High-resolution 3D reconstruction and 4D imaging, combined with genetic analyis, have allowed us to reveal the highly-sterotyped morphogenetic events controlled by JAK/STAT signaling in a developmentally-programmed case of epithelial cell extrusion.", {"entities": []}], ["Specialized somatic cells, Polar Cells (PCs), are produced in excess and then undergo apoptotic elimination from the follicular epithelium in the Drosophila ovary.", {"entities": []}], ["We show that supernumerary PCs are first systematically enveloped by PC neighbors on all sides, first laterally, then apically in conjunction with highly-reinforced adherens junctions, and finally basally.", {"entities": [[69, 71, "GENE"]]}], ["The PC to be removed thus loses all contact with follicle cells, germline cells and the basement membrane in a process we have called cell \u2018monosis\u2019, for \u2018isolation\u2019 in Greek.", {"entities": [[4, 6, "GENE"]]}], ["PC monosis takes several hours, and always precedes, and is independent of, activation of apoptosis.", {"entities": [[0, 2, "GENE"]]}], ["JAK/STAT signaling is necessary within the surrounding follicular epithelium for PC monosis.", {"entities": [[81, 83, "GENE"]]}], ["Minutes after monosis is complete, PC apoptotic corpses are formed and extruded laterally within the epithelium, in contrast to the apical and basal extrusions described to date.", {"entities": [[35, 37, "GENE"]]}], ["These apoptotic corpses are engulfed and eliminated by surrounding follicle cells, which are thus acting as non-professional phagocytes.", {"entities": []}], ["This study therefore shows the non cell-autonomous impact of an epithelium, via JAK/STAT signaling activation, on cell morphogenesis events leading to apoptotic extrusion.", {"entities": []}], ["It is likely that the use of high-resolution 3D and 4D imaging, which allows for better spatio-temporal understanding of morphogenetic events, will reveal that cell monosis and lateral extrusion within an epithelium are pertinent for other cases of epithelial cell extrusion as well.", {"entities": []}], ["This is the second issue featuring a selected piece from the Yale Internal Medicine Residency Program's Writers' Workshop.", {"entities": []}], ["The annual workshop began in 2003.", {"entities": []}], ["Abraham Verghese and Richard Selzer, among the best known physician-writers in the United States, have served as workshop leaders, teaching the craft of writing to more than 35 residents.", {"entities": []}], ["In designing the workshop, Anna B. Reisman, assistant professor in the Department of Internal Medicine at the Yale University School of Medicine and VA Connecticut Health Care System, and Dr. Asghar Rastegar had the goal of making participants better physicians by providing a creative outlet for reflection.The stories and essays written by the Writers' Workshop participants present a range of experiences, real and imagined, and take readers deep into the minds of young doctors trying to make sense of what they do.", {"entities": []}], ["The interleukin-28B ( IL28B ) gene polymorphism is a strong baseline predictor of sustained virological response (SVR) in hepatitis C virus (HCV) treatment.", {"entities": [[122, 131, "DISEASE"], [22, 27, "GENE"]]}], ["The length of thymine\u2014adenine dinucleotide repeats, or (TA) n , in the regulatory region of IL28B can affect interferon transcription.", {"entities": [[92, 97, "GENE"]]}], ["In order to determine predictive values in HCV infection, we explored the correlation among factors including (TA) n genotypes, clinical features, interferon-\u03bb-3 (IFNL3) and interferon-\u03bb-4 (IFNL4) polymorphisms, and HCV treatment outcome.", {"entities": []}], ["Sera from 492 patients with chronic HCV infection, 101 individuals with spontaneous HCV clearance and 123 healthy blood donors (control group) were analyzed.", {"entities": []}], ["Genotyping of the (TA) n was performed by direct sequencing.", {"entities": []}], ["The rs12979860 (IFNL3) was identified using nested PCR and sequencing, while ss469415590 (IFNL4) was identified by real-time PCR.", {"entities": []}], ["The distribution of (TA) n was similar between individuals with spontaneous HCV clearance and chronic HCV infection, but differed significantly from healthy controls.", {"entities": []}], ["Individuals with both (TA) n alleles \u226512 had significantly higher SVR rate compared to individuals with at least one (TA) n <12 allele.", {"entities": []}], ["This strong correlation was seen for patients infected with HCV-1, HCV-3, and HCV-6.", {"entities": []}], ["The (TA) n genotypes were not associated with HCV viral load, ALT levels and liver stiffness, but were correlated with platelet counts ( p<0 .", {"entities": []}], ["In contrast, rs12979860 (CC) and ss469415590 (TT/TT) genotypes were associated with higher SVR rated only in patients with HCV-1.", {"entities": []}], ["The (TA) n genotypes were not associated with spontaneous clearance of HCV infection but associated with treatment response in patients infected with HCV-1, HCV-3 and HCV-6.", {"entities": []}], ["In contrast, IFNL3 and IFNL4 polymorphisms were predictive of treatment outcome only for patients infected with HCV-1.", {"entities": []}], ["Epidemiologic studies suggest that long term low dose celecoxib use significantly lowers breast cancer risk.", {"entities": [[89, 102, "DISEASE"], [96, 102, "DISEASE"]]}], ["We previously demonstrated that 400 mg celecoxib taken twice daily for 2 weeks lowered circulating plasma and breast nipple aspirate fluid (NAF) prostaglandin (PG)E 2 concentrations in post- but not premenopausal high risk women.", {"entities": []}], ["We hypothesized that circulating concentrations of celecoxib influenced PGE 2 response, and that plasma levels of the drug are influenced by menopausal status.", {"entities": []}], ["To address these hypotheses, the aims of the study were to determine: 1) if circulating plasma concentrations of celecoxib correlated with the change in plasma or NAF PGE 2 concentrations from baseline to end of treatment, and 2) whether menopausal status influenced circulating levels of celecoxib.", {"entities": []}], ["Matched NAF and plasma were collected from 46 high risk women who were administered celecoxib twice daily for two weeks, 20 subjects receiving 200 mg and 26 subjects 400 mg of the agent.", {"entities": []}], ["NAF and plasma samples were collected before and 2 weeks after taking celecoxib.", {"entities": []}], ["In women taking 400 mg bid celecoxib, plasma concentrations of the agent correlated inversely with the change in NAF PGE 2 levels from pre- to posttreatment.", {"entities": []}], ["Nonsignificant trends toward higher celecoxib levels were observed in post- compared to premenopausal women.", {"entities": []}], ["There was a significant decrease in NAF but not plasma PGE 2 concentrations in postmenopausal women who took 400 mg celecoxib (p = 0.03).", {"entities": []}], ["In high risk women taking 400 mg celecoxib twice daily, plasma concentrations of celecoxib correlated with downregulation of PGE 2 production by breast tissue.", {"entities": []}], ["Strategies synergistic with celecoxib to downregulate PGE 2 are of interest, in order to minimize the celecoxib dose required to have an effect.", {"entities": []}], ["Resting autoreactive T cells are present in the circulation of normal individuals without pathologic consequences.", {"entities": []}], ["In autoimmune animal models, stimulation of these self-reactive T cells in the presence of costimulatory molecules B7-1 results in T cell-mediated autoimmune disease, whereas B7-2 stimulation generates regulatory autoreactive T cells that abrogate disease severity.", {"entities": []}], ["Thus, reactivation in the brain of myelin-autoreactive T cells by antigen with costimulatory molecules may be a critical event in the pathophysiology of multiple sclerosis (MS), a putative autoimmune disease of central nervous system (CNS) myelin.", {"entities": [[153, 171, "DISEASE"], [189, 233, "DISEASE"]]}], ["We investigated the expression of cytokines and costimulatory molecules in a panel of 41 histologically characterized CNS specimens from 15 MS and 10 control cases using semiquantitative reverse transcriptase-polymerase chain reaction and immunocytochemistry.", {"entities": []}], ["In four cases, vascular CNS infarcts with inflammation were compared with MS plaques from the same brain.", {"entities": []}], ["We observed increased expression of B7- 1 and interleukin (IL) 12p40 in acute MS plaques, particularly from early disease cases but not in inflammatory infarcts.", {"entities": []}], ["B7-1 staining was localized predominantly to the lymphocytes in perivenular inflammatory cuffs but not the parenchyma.", {"entities": []}], ["In contrast, B7-2 was expressed predominantly on macrophages both in MS lesions of varied time duration and in inflammatory infarcts.", {"entities": []}], ["These findings indicate that an early event in the initiation of MS involves upregulation of B7-1 and IL-12, resulting in conditions that maximally stimulate T cell activation and induction of T helper 1-type immune responses.", {"entities": []}], ["Traditional gold mining is associated with mercury exposure.", {"entities": []}], ["Especially vulnerable to its neurotoxic effects is the developing nervous system of a child.", {"entities": []}], ["We aimed to investigate risk factors of mercury exposure among children in a rural mining town in Chile.", {"entities": []}], ["Using a validated questionnaire distributed to the parents of the children, a priori mercury risk factors, potential exposure pathways and demographics of the children were obtained.", {"entities": []}], ["Mercury levels were measured through analyzing fingernail samples.", {"entities": []}], ["Logistic regression modeling the effect of risk factors on mercury levels above the 75 The 288 children had a mean age of 9.6 years (SD\u200a=\u200a1.9).", {"entities": []}], ["The mean mercury level in the study population was 0.13 \u00b5g/g (SD 0.11, median 0.10, range 0.001\u20130.86 \u00b5g/g).", {"entities": []}], ["The strongest risk factor for children\u2019s odds of high mercury levels (>75 Mercury exposure through small-scale gold mining might affect children in their home environments.", {"entities": []}], ["These results may further help to convince the local population of banning mercury burning inside the households.", {"entities": []}], ["Duchenne muscular dystrophy (DMD), an incurable and a progressive muscle wasting disease, is caused by the absence of dystrophin protein, leading to recurrent muscle fiber damage during contraction.", {"entities": [[9, 27, "DISEASE"], [29, 32, "GENE"]]}], ["The inflammatory response to fiber damage is a compelling candidate mechanism for disease exacerbation.", {"entities": []}], ["The only established pharmacological treatment for DMD is corticosteroids to suppress muscle inflammation, however this treatment is limited by its insufficient therapeutic efficacy and considerable side effects.", {"entities": [[51, 54, "GENE"]]}], ["Recent reports show the therapeutic potential of inhibiting or enhancing pro- or anti-inflammatory factors released from DMD skeletal muscles, resulting in significant recovery from muscle atrophy and dysfunction.", {"entities": [[121, 124, "GENE"]]}], ["We discuss and review the recent findings of DMD inflammation and opportunities for drug development targeting specific releasing factors from skeletal muscles.", {"entities": [[45, 48, "GENE"]]}], ["It has been speculated that nonsteroidal anti-inflammatory drugs targeting specific inflammatory factors are more effective and have less side effects for DMD compared with steroidal drugs.", {"entities": [[155, 158, "GENE"]]}], ["For example, calcium channels, reactive oxygen species, and nuclear factor-\u03baB signaling factors are the most promising targets as master regulators of inflammatory response in DMD skeletal muscles.", {"entities": [[176, 179, "GENE"]]}], ["If they are combined with an oligonucleotide-based exon skipping therapy to restore dystrophin expression, the anti-inflammatory drug therapies may address the present therapeutic limitation of low efficiency for DMD.", {"entities": [[213, 216, "GENE"]]}], ["Type 2 diabetes mellitus (T2DM), by definition is a heterogeneous, multifactorial, polygenic syndrome which results from insulin receptor dysfunction.", {"entities": [[93, 101, "DISEASE"], [7, 24, "DISEASE"]]}], ["It is an outcome of oxidative stress caused by interactions of reactive metabolites (RMs) interactions with lipids, proteins and other mechanisms of human body.", {"entities": []}], ["Production of RMs mainly superoxide ( O 2 \u2212 ) has been found in a variety of predominating cellular enzyme systems including NAD(P)H oxidase, xanthine oxidase (XO), cyclooxygenase (COX), uncoupled endothelial nitric oxide synthase (eNOS) and myeloperoxidase (MPO).", {"entities": [[259, 262, "GENE"]]}], ["The four main RM related molecular mechanisms are: increased polyol pathway flux; increased advanced glycation end-product (AGE) formation; activation of protein kinase C (PKC) isoforms and increased hexosamine pathway flux which have been implicated in glucose-mediated vascular damage.", {"entities": []}], ["Superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione-S-transferase (GST), nitric oxide synthase (NOS) are antioxidant enzymes involved in scavenging RMs in normal individuals.", {"entities": []}], ["Functional polymorphisms of these antioxidant enzymes have been reported to be involved in pathogenesis of T2DM individuals.", {"entities": []}], ["The low levels of antioxidant enzymes or their non-functionality results in excessive RMs which initiate stress related pathways thereby leading to insulin resistance and T2DM.", {"entities": []}], ["An attempt has been made to review the role of RMs and antioxidant enzymes in oxidative stress resulting in T2DM.", {"entities": []}], ["\u2022 Four main molecular mechanisms are implicated in glucose-mediated vascular damage.", {"entities": []}], ["\u2022 Impaired antioxidant defense contributes to T2DM and related complications.", {"entities": []}], ["\u2022 SNPs in antioxidant enzymes are associated with pathogenesis of type 2 diabetes.", {"entities": []}], ["\u2022 Genotyping of gene variants in populations will help identify individuals at risk.", {"entities": []}], ["Four main molecular mechanisms are implicated in glucose-mediated vascular damage.", {"entities": []}], ["Impaired antioxidant defense contributes to T2DM and related complications.", {"entities": []}], ["SNPs in antioxidant enzymes are associated with pathogenesis of type 2 diabetes.", {"entities": []}], ["Genotyping of gene variants in populations will help identify individuals at risk.", {"entities": []}], ["Despite the development and dissemination of guidelines for the diagnosis and management of asthma, a gap remains between current recommendations and actual practice.", {"entities": [[92, 98, "DISEASE"]]}], ["To assess the physicians attitude towards asthma guidelines and their adherence to its recommendations.", {"entities": [[42, 48, "DISEASE"]]}], ["Three hundred and fifty two clinicians (101 General practitioners, 131 pediatric specialists, 35 pediatric consultants and 85 doctors did not report the qualification) engaged in direct childhood asthma care in Cairo, Egypt were subjected to a self-administered questionnaire with 35 questions of which most were multiple choices, aiming at assessment of three important aspects about the involved physicians; physician's knowledge, practice and attitude.", {"entities": [[196, 202, "DISEASE"]]}], ["165 of the clinicians were working in governmental hospitals, 68 clinicians work in private clinics and 119 clinicians work in both.", {"entities": []}], ["Agreement with asthma guidelines was present in 76.2% of the studied physicians, however those who not in agreement with the guidelines claimed that this was mainly due to patient factors, firstly the poor socioeconomic standard of the patient (18.1%) and secondly due to poor patient compliance (16%).", {"entities": [[15, 21, "DISEASE"]]}], ["Poor knowledge was found in 28.5%, poor practice was found in 43.6% and poor attitude was found in 14.4% of the studied physicians.", {"entities": []}], ["There was positive highly significant correlation between qualification and knowledge, (p < 0.01), positive highly significant correlation between qualification and practice, (p < 0.01), and positive highly significant correlation between qualification and attitude, (p < 0.01).", {"entities": []}], ["The attitude of the studied physicians revealed agreement of their majority with the guidelines, while the disagreement was mainly explained by the poor socioeconomic standard of the patients.", {"entities": []}], ["The degree of poor practice is more marked than that of poor knowledge or poor attitude reflecting resources limitations and applications obstacles in the physician's practice.", {"entities": []}], ["This study seeks to quantify variation in healthcare utilization and per capita costs using system-defined geographic regions based on enrollee residence within the Military Health System (MHS).", {"entities": []}], ["Data for fiscal years 2007 \u2013 2010 were obtained from the Military Health System under a data sharing agreement with the Defense Health Agency (DHA).", {"entities": []}], ["DHA manages all aspects of the Department of Defense Military Health System, including TRICARE.", {"entities": []}], ["Adjusted rates were calculated for per capita costs and for two procedures with high interest to the MHS- back surgery and Cesarean sections for TRICARE Prime and Plus enrollees.", {"entities": []}], ["Coefficients of variation (CoV) and interquartile ranges (IQR) were calculated and analyzed using residence catchment area as the geographic unit.", {"entities": []}], ["Catchment areas anchored by a Military Treatment Facility (MTF) were compared to catchment areas not anchored by a MTF.", {"entities": []}], ["Variation, as measured by CoV, was 0.37 for back surgery and 0.13 for C-sections in FY 2010- comparable to rates documented in other healthcare systems.", {"entities": []}], ["The 2010 CoV (and average cost) for per capita costs was 0.26 ($3,479.51).", {"entities": []}], ["Procedure rates were generally lower and CoVs higher in regions anchored by a MTF compared with regions not anchored by a MTF, based on both system-wide comparisons and comparisons of neighboring areas.", {"entities": []}], ["In spite of its centrally managed system and relatively healthy beneficiaries with very robust health benefits, the MHS is not immune to unexplained variation in utilization and cost of healthcare.", {"entities": []}], ["The clinical picture of the pandemic influenza A (H1N1)v ranges from a self-limiting afebrile infection to a rapidly progressive pneumonia.", {"entities": [[37, 46, "DISEASE"], [129, 138, "DISEASE"]]}], ["Prompt diagnosis and well-timed treatment are recommended.", {"entities": []}], ["Chest radiography (CRx) often fails to detect the early interstitial stage.", {"entities": [[19, 22, "GENE"]]}], ["The aim of this study was to evaluate the role of bedside chest ultrasonography (US) in the early management of the 2009 influenza A (H1N1)v infection.", {"entities": [[121, 130, "DISEASE"]]}], ["98 patients who arrived in the Emergency Department complaining of influenza-like symptoms were enrolled in the study.", {"entities": [[67, 76, "DISEASE"]]}], ["Patients not displaying symptoms of acute respiratory distress were discharged without further investigations.", {"entities": []}], ["Among patients with clinical suggestion of a community-acquired pneumonia, cases encountering other diagnoses or comorbidities were excluded from the study.", {"entities": [[64, 73, "DISEASE"]]}], ["Clinical history, laboratory tests, CRx, and computed tomography (CT) scan, if indicated, contributed to define the diagnosis of pneumonia in the remaining patients.", {"entities": [[129, 138, "DISEASE"], [36, 39, "GENE"]]}], ["Chest US was performed by an emergency physician, looking for presence of interstitial syndrome, alveolar consolidation, pleural line abnormalities, and pleural effusion, in 34 patients with a final diagnosis of pneumonia, in 16 having normal initial CRx, and in 33 without pneumonia, as controls.", {"entities": [[212, 221, "DISEASE"], [274, 283, "DISEASE"], [87, 95, "DISEASE"], [251, 254, "GENE"]]}], ["Chest US was carried out without discomfort in all subjects, requiring a relatively short time (9 minutes; range, 7 to 13 minutes).", {"entities": []}], ["An abnormal US pattern was detected in 32 of 34 patients with pneumonia (94.1%).", {"entities": [[62, 71, "DISEASE"]]}], ["A prevalent US pattern of interstitial syndrome was depicted in 15 of 16 patients with normal initial CRx, of whom 10 (62.5%) had a final diagnosis of viral (H1N1) pneumonia.", {"entities": [[164, 173, "DISEASE"], [39, 47, "DISEASE"], [102, 105, "GENE"]]}], ["Patients with pneumonia and abnormal initial CRx, of whom only four had a final diagnosis of viral (H1N1) pneumonia (22.2%; P < 0.05), mainly displayed an US pattern of alveolar consolidation.", {"entities": [[14, 23, "DISEASE"], [106, 115, "DISEASE"], [45, 48, "GENE"]]}], ["Finally, a positive US pattern of interstitial syndrome was found in five of 33 controls (15.1%).", {"entities": [[47, 55, "DISEASE"]]}], ["False negatives were found in two (5.9%) of 34 cases, and false positives, in five (15.1%) of 33 cases, with sensitivity of 94.1%, specificity of 84.8%, positive predictive value of 86.5%, and negative predictive value of 93.3%.", {"entities": []}], ["Bedside chest US represents an effective tool for diagnosing pneumonia in the Emergency Department.", {"entities": [[61, 70, "DISEASE"]]}], ["It can accurately provide early-stage detection of patients with (H1N1)v pneumonia having an initial normal CRx.", {"entities": [[73, 82, "DISEASE"], [108, 111, "GENE"]]}], ["Its routine integration into their clinical management is proposed.", {"entities": []}], ["Objective \u00a0To examine whether a very large effect (VLE; defined as a relative risk of \u22640.2 or \u22655) in a randomised trial could be an empirical marker that subsequent trials are unnecessary.", {"entities": []}], ["Design \u00a0Meta-epidemiological assessment of existing published data on randomised trials.", {"entities": []}], ["Data sources \u00a0Cochrane Database of Systematic Reviews (2010, issue 7) with data on subsequent large trials updated to 2015, issue 12.", {"entities": []}], ["Eligibility criteria \u00a0All binary outcome forest plots were selected, which contained an index randomised trial with a VLE that was nominally statistically significant (P<0.05), included a subsequent large randomised trial (\u2265200 events and \u2265200 non-events) for validation of the effect, assessed a primary outcome of the review, and was not a subgroup or sensitivity analysis.", {"entities": []}], ["Results \u00a0Of 3082 reviews yielding 85\u2009002 forest plots, only 44 (0.05%) satisfied the inclusion criteria.", {"entities": []}], ["Index trials were generally small, with a median sample of 99 (median 14 events).", {"entities": []}], ["Few index trials were rated at low risk of bias (9 of 44; 20%).", {"entities": []}], ["The relative risk was closer to the null in the subsequent large trials in 43 of 44 cases.", {"entities": []}], ["Subsequent large trial data failed to find a statistically significant (P<0.05) effect in the same direction in 19 cases (43%, 95% confidence interval 29% to 58%).", {"entities": []}], ["Even when the subsequent large trials did find a significant effect in the same direction, the additional primary outcomes in most of these trials would have to be considered before deciding in favour of using the intervention.", {"entities": []}], ["Subsequent large trial data found a statistically significant effect in the same direction in 19 of 21 cases when the index trial also had a value of P<0.001.", {"entities": []}], ["Conclusions \u00a0The frequency of VLEs followed by a large trial is vanishingly small, and where they occur they do not appear to be a reliable marker for a benefit that is reproducible and directly actionable.", {"entities": []}], ["An empirical rule using a VLE in a randomised controlled trial as a marker that further trials are unnecessary would be neither practical nor useful.", {"entities": []}], ["Caution should be taken when interpreting small studies with very large treatment effects.", {"entities": []}], ["Objectives .", {"entities": []}], ["Oxidative stress contributes to Parkinson's disease (PD) pathophysiology and progression.", {"entities": []}], ["The objective was to describe central and peripheral metabolites of redox metabolism and to describe correlations between glutathione (Glu) status, age, and disease severity.", {"entities": []}], ["58 otherwise healthy individuals with PD were examined during a single study visit.", {"entities": []}], ["Descriptive statistics and scatterplots were used to evaluate normality and distribution of this cross-sectional sample.", {"entities": []}], ["Blood tests and magnetic resonance spectroscopy (MRS) were used to collect biologic data.", {"entities": []}], ["Spearman's rank-order correlation coefficients were used to evaluate the strength and direction of the association.", {"entities": []}], ["The Unified PD Rating Scale (UPDRS) and the Patient-Reported Outcomes in PD (PRO-PD) were used to rate disease severity using regression analysis.", {"entities": []}], ["Blood measures of Glu decreased with age, although there was no age-related decline in MRS Glu.", {"entities": []}], ["The lower the blood Glu concentration, the more severe the UPDRS ( P = 0.02, 95% CI: \u221213.96, \u22121.14) and the PRO-PD ( P = 0.01, 95% CI: \u22120.83, \u22120.11) scores.", {"entities": []}], ["Discussion .", {"entities": []}], ["These data suggest whole blood Glu may have utility as a biomarker in PD.", {"entities": []}], ["Future studies should evaluate whether it is a modifiable risk factor for PD progression and whether Glu fortification improves PD outcomes.", {"entities": []}], ["Diet plays a crucial role in maintaining optimal immune function.", {"entities": []}], ["Research demonstrates the immunomodulatory properties and mechanisms of particular nutrients; however, these aspects are studied less in early life, when diet may exert an important role in the immune development of the neonate.", {"entities": []}], ["Besides the limited data from epidemiological and human interventional trials in early life, animal models hold the key to increase the current knowledge about this interaction in this particular period.", {"entities": []}], ["This paper reports the potential of the suckling rat as a model for immunonutrition studies in early life.", {"entities": []}], ["In particular, it describes the main changes in the systemic and mucosal immune system development during rat suckling and allows some of these elements to be established as target biomarkers for studying the influence of particular nutrients.", {"entities": []}], ["Different approaches to evaluate these immune effects, including the manipulation of the maternal diet during gestation and/or lactation or feeding the nutrient directly to the pups, are also described in detail.", {"entities": []}], ["In summary, this paper provides investigators with useful tools for better designing experimental approaches focused on nutrition in early life for programming and immune development by using the suckling rat as a model.", {"entities": []}], ["Graves disease (GD) is an organ-specific autoimmune disease characterized by hyperthyroidism, diffuse goiter, autoantibodies against thyroid-specific antigens, and dermopathy.", {"entities": [[102, 108, "DISEASE"], [77, 92, "DISEASE"]]}], ["Studies of GD have demonstrated the importance of the Th2 and Th17 immune responses in mediating disease progression.", {"entities": []}], ["In the present study, we investigated the role of a Th2 cytokine, thymic stromal lymphopoietin (TSLP), in GD and Th17 differentiation.", {"entities": [[96, 100, "GENE"]]}], ["In this study, we genotyped 470 patients with GD at 3 single nucleotide polymorphisms (SNPs) in TSLP .", {"entities": [[96, 100, "GENE"]]}], ["In addition, the serum concentrations of TSLP were determined in 432 patients and 272 controls.", {"entities": [[41, 45, "GENE"]]}], ["Ten patients and controls each were further screened using in vitro Th17 differentiation assays.", {"entities": []}], ["The SNPs were genotyped using ABI TaqMan\u00ae SNP genotyping assays.", {"entities": []}], ["For the Th17 differentiation assays, peripheral blood mononuclear cells (PBMCs) isolated from the patients and controls were placed into Th17 differentiation media, and interleukin 17 expression levels were determined.", {"entities": []}], ["Haplotype analysis indicated that patients with the Ht3 (TCC) haplotype have a 3.28-fold higher risk of developing GD ( p \u2009=\u20090.007), whereas those with the Ht5 (TCG) haplotype had a 0.03-fold, reduced risk of developing GD ( p \u2009=\u20091\u2009\u00d7\u200910 p \u2009=\u20090.007) was associated with female Graves ophthalmopathy (GO).", {"entities": []}], ["TSLP expression levels were higher in GD patients than in control subjects, and TLSP was also shown to promote the differentiation of Th17 cells in GD patients.", {"entities": [[0, 4, "GENE"]]}], ["These results suggest that polymorphisms in TSLP may be used as genetic markers for the diagnosis and prognosis of GD.", {"entities": [[44, 48, "GENE"]]}], ["Furthermore, TLSP may be a target for treating GD.", {"entities": []}], ["Oral glucocorticoids (steroids) are the mainstay of treatment for systemic lupus erythematosus (SLE), but their use is often associated with short- and long-term side effects.", {"entities": [[75, 94, "DISEASE"], [66, 94, "DISEASE"]]}], ["Following a literature review and discussions with patients with SLE, clinicians, and payers, a need was identified for a comprehensive SLE-specific tool that can be used to evaluate the side effects and benefits of steroids over time from a patient perspective.", {"entities": []}], ["The objective of this study was to develop a patient-reported outcome (PRO) measure to assess general impact (baseline burden), benefits, side effects, and impacts associated with the use of oral steroids in patients with SLE.", {"entities": []}], ["A qualitative research protocol was developed in which adults with SLE currently receiving or who had received steroids in the past year were recruited from six US rheumatology practices to participate in concept elicitation (CE) interviews.", {"entities": []}], ["The SLE Steroid Questionnaire (SSQ) was developed based on CE interview results and clinical input.", {"entities": []}], ["Cognitive debriefing interviews with a second group of patients with SLE evaluated the content, clarity, and relevance of the items.", {"entities": []}], ["The SSQ was refined using patient feedback, clinician review, and a translatability assessment.", {"entities": []}], ["The protocol received central independent review board approval.", {"entities": []}], ["Thirty-three patients (52% moderate disease severity; 58% currently receiving steroids, mean dose 8.7\u00a0mg/day) completed CE interviews.", {"entities": []}], ["Patients reported benefits, side effects, and impacts from steroids.", {"entities": []}], ["The refined SSQ contains 50 items assessing steroid dose/duration (4 items), general impact (baseline burden; 19 items), benefits (7 items), work/productivity (3 items), side effects (10 items), emotions (6 items), and overall satisfaction (1 item).", {"entities": []}], ["The SSQ is a unique PRO, developed using robust scientific methodology in accordance with the Food and Drug Administration PRO Guidance.", {"entities": []}], ["It was designed to comprehensively assess the patient experience with steroid therapy and better understand the benefits and burden of steroids for patients with SLE.", {"entities": []}], ["It is important to monitor health related quality of life in order to determine the efficacy of interventions and physical functioning of patients with cystic fibrosis in their daily activities.", {"entities": [[152, 167, "DISEASE"]]}], ["There is no a single-item global quality of life scale for routine clinical practice for adult patients with cystic fibrosis.", {"entities": [[109, 124, "DISEASE"]]}], ["We assessed the reliability and validity of a single-item global quality of life scale and compared with the Cystic Fibrosis Quality of Life Questionnaire (CF-QOL) for adult patients with cystic fibrosis.", {"entities": [[109, 124, "DISEASE"], [188, 203, "DISEASE"]]}], ["121 ( men = 66, women = 55) adult cystic fibrosis patients self-completed the CF-QOL, the Hospital Anxiety Depression Scale, and the single item global quality of life scale at the out patient clinic.", {"entities": [[34, 49, "DISEASE"]]}], ["33 (17 women) completed the repeat questionnaires at home within two weeks.", {"entities": []}], ["Socio-demographic characteristic and lung function data were extracted from the recent medical notes.", {"entities": []}], ["Mean (SD) age was 29.6 (8.9) years and mean (SD) forced expiratory volume in 1 second was 2.20 (0.94) litres.", {"entities": []}], ["The test-retest reproducibility using the intra-class correlation coefficient (ICC) for the CF-QOL was 0.83, 95% confidence interval 0.68 to 0.91.", {"entities": []}], ["The single item global quality of life ICC score was 0.78, 95% confidence interval 0.59 to 0.88.", {"entities": []}], ["Concurrent validity of the single-item global quality of life was examined in relation to all items of the CF-QOL, frequent episodes of readmission, anxiety and depression (all, p < 0.01) were moderately correlated.", {"entities": []}], ["The study provides preliminary evidence that the single-item quality of life scale is acceptable, valid and repeatable for adult patients with cystic fibrosis.", {"entities": [[143, 158, "DISEASE"]]}], ["It is a promising tool that can be easily incorporated into a routine clinical practice to assess patients' quality of life.", {"entities": []}], ["Accurate cervical intra-epithelial neoplasia (CIN) lesion grading is needed for effective patient management.", {"entities": []}], ["We applied computer-assisted scanning and analytic approaches to immuno-stained CIN lesion sections to more accurately delineate disease states and decipher cell proliferation impacts from HPV and smoking within individual epithelial layers.", {"entities": []}], ["A patient cohort undergoing cervical screening was identified (n\u200a=\u200a196) and biopsies of varying disease grades and with intact basement membranes and epithelial layers were obtained (n\u200a=\u200a261).", {"entities": []}], ["Specimens were sectioned, stained (Mib1), and scanned using a high-resolution imaging system.", {"entities": [[35, 39, "GENE"]]}], ["We achieved semi-automated delineation of proliferation status and epithelial cell layers using Otsu segmentation, manual image review, Voronoi tessellation, and immuno-staining.", {"entities": []}], ["Data were interrogated against known status for HPV infection, smoking, and disease grade.", {"entities": []}], ["We observed increased cell proliferation and decreased epithelial thickness with increased disease grade (when analyzing the epithelium at full thickness).", {"entities": []}], ["Analysis within individual cell layers showed a \u226550% increase in cell proliferation for CIN2 vs. CIN1 lesions in higher epithelial layers (with minimal differences seen in basal/parabasal layers).", {"entities": []}], ["Higher rates of proliferation for HPV-positive vs. -negative cases were seen in epithelial layers beyond the basal/parabasal layers in normal and CIN1 tissues.", {"entities": []}], ["Comparing smokers vs. non-smokers, we observed increased cell proliferation in parabasal (low and high grade lesions) and basal layers (high grade only).", {"entities": []}], ["In sum, we report CIN grade-specific differences in cell proliferation within individual epithelial layers.", {"entities": []}], ["We also show HPV and smoking impacts on cell layer-specific proliferation.", {"entities": []}], ["Our findings yield insight into CIN progression biology and demonstrate that rigorous, semi-automated imaging of histopathological specimens may be applied to improve disease grading accuracy.", {"entities": []}], ["Mobile health (mHealth) applications intended to support shared decision making in diagnostic and treatment decisions are increasingly available.", {"entities": []}], ["In this paper, we discuss some recent studies on mHealth applications with relevance to shared decision making.", {"entities": []}], ["We discuss the potential advantages and disadvantages of using mHealth in shared decision making in various contexts, and suggest some directions for future research in this quickly expanding field.", {"entities": []}], ["Lambda interferons (IFNLs) have immunomodulatory functions at epithelial barrier surfaces.", {"entities": []}], ["IFN-\u03bb4, a recent member of this family is expressed only in a subset of the population due to a frameshift-causing DNA polymorphism rs368234815.", {"entities": []}], ["We examined the association of this polymorphism with atopy (aeroallergen sensitization) and asthma in a Polish hospital-based case-control cohort comprising of well-characterized adult asthmatics (n\u2009=\u2009326) and healthy controls (n\u2009=\u2009111).", {"entities": [[93, 99, "DISEASE"]]}], ["In the combined cohort, we saw no association of the polymorphism with asthma and/or atopy.", {"entities": [[71, 77, "DISEASE"]]}], ["However, the IFN-\u03bb4-generating \u0394G allele protected older asthmatic women (>50\u2009yr of age) from atopic sensitization.", {"entities": []}], ["Further, \u0394G allele significantly associated with features of less-severe asthma including bronchodilator response and corticosteroid usage in older women in this Polish cohort.", {"entities": [[73, 79, "DISEASE"]]}], ["We tested the association of related IFNL locus polymorphisms (rs12979860 and rs8099917) with atopy, allergic rhinitis and presence/absence of asthma in three population-based cohorts from Europe, but saw no significant association of the polymorphisms with any of the phenotypes in older women.", {"entities": [[101, 118, "DISEASE"], [110, 118, "DISEASE"], [143, 149, "DISEASE"]]}], ["The polymorphisms associated marginally\u00a0with lower occurrence of asthma in men/older men after meta-analysis of data from all cohorts.", {"entities": [[65, 71, "DISEASE"]]}], ["Functional and well-designed replication studies may reveal the true positive nature of these results.", {"entities": []}], ["The multifunctional NS1 protein of influenza A viruses suppresses host cellular defense mechanisms and subverts other cellular functions.", {"entities": [[35, 44, "DISEASE"]]}], ["We report here on a new role for NS1 in modifying cell-cell signaling via the Hedgehog (Hh) pathway.", {"entities": []}], ["Genetic epistasis experiments and FRET-FLIM assays in Drosophila suggest that NS1 interacts directly with the transcriptional mediator, Ci/Gli1.", {"entities": []}], ["We further confirmed that Hh target genes are activated cell-autonomously in transfected human lung epithelial cells expressing NS1, and in infected mouse lungs.", {"entities": []}], ["We identified a point mutation in NS1, A122V, that modulates this activity in a context-dependent fashion.", {"entities": []}], ["When the A122V mutation was incorporated into a mouse-adapted influenza A virus, it cell-autonomously enhanced expression of some Hh targets in the mouse lung, including IL6, and hastened lethality.", {"entities": [[62, 71, "DISEASE"], [170, 173, "GENE"]]}], ["These results indicate that, in addition to its multiple intracellular functions, NS1 also modifies a highly conserved signaling pathway, at least in part via cell autonomous activities.", {"entities": []}], ["We discuss how this new Hh modulating function of NS1 may influence host lethality, possibly through controlling cytokine production, and how these new insights provide potential strategies for combating infection.", {"entities": []}], ["The NS1 protein produced by influenza A viruses alters host cellular defense mechanisms.", {"entities": [[28, 37, "DISEASE"]]}], ["We report here on a new role for NS1 in modifying cell-cell communication via the Hedgehog (Hh) signaling pathway.", {"entities": []}], ["Genetic and microscopy studies in flies indicate that NS1 alters the transcriptional read-out of Hh targets by interacting directly with the transcriptional effector, Ci/Gli.", {"entities": []}], ["Infected mouse lungs and human lung cells transfected with NS1 also revealed an upregulation of Hh target genes, including the non-canonical target IL6.", {"entities": [[148, 151, "GENE"]]}], ["We identified a point mutation in NS1 (A122V) that impairs this target activation in Drosophila .", {"entities": []}], ["The A122V mutation was incorporated into a mouse-adapted influenza A virus and was found to cell-autonomously increase expression of some Hh targets and hastened lethality in mice.", {"entities": [[57, 66, "DISEASE"]]}], ["NS1 also exhibited A122V-dependent effects on BMP target gene expression in a human lung cell line.", {"entities": []}], ["These results indicate that, in addition to its multiple intracellular functions, NS1 also modifies communication between host cells.", {"entities": []}], ["This new activity of NS1 appears to influence lethality caused by the virus and may facilitate viral dissemination by extending host survival.", {"entities": []}], ["Patient: Female, 36 Final Diagnosis: Pheochromocytoma Symptoms: Anxiety \u2022 depression Medication: \u2014 Clinical Procedure: \u2014 Specialty: Oncology \u2022 endocrinology Unusual clinical course, Mistake in diagnosis Pheochromocytoma is a rare catecholamine-producing neuroendocrine tumour with protean clinical manifestations, which can mimic a variety of conditions, often resulting in erroneous and delayed diagnosis.", {"entities": []}], ["A case of undiagnosed pheochromocytoma in a 36 year old female with a 15 year history of anxiety and depression is described.", {"entities": []}], ["The patient collapsed while on the phone to the next of kin and stopped breathing.", {"entities": []}], ["She was initially revived but suffered a cardiac arrest and died.", {"entities": []}], ["At autopsy an undiagnosed adrenal pheochromocytoma was found.", {"entities": []}], ["When considering a diagnosis of anxiety and depression, medical causes of the symptoms must be excluded.", {"entities": []}], ["Common conditions, such as thyroid disorders, stimulant abuse, asthma, cardiac arrhythmias, alcohol withdrawal and rarely pheochromocytoma, causing a similar spectrum of symptoms should be excluded by history and clinical examination.", {"entities": [[63, 69, "DISEASE"]]}], ["The purpose of this study was to investigate the association between asthma and invasive pneumococcal disease (IPD) in Korea.", {"entities": [[69, 75, "DISEASE"]]}], ["A retrospective population-based cohort study was conducted using the Korean Health Insurance Review and Assessment database 2010-2011.", {"entities": []}], ["The subjects included 935,106 (2010) and 952,295 (2011), of whom 398 (2010) and 428 (2011) patients with IPD were identified.", {"entities": []}], ["There was significant difference in the prevalence of IPD in patients with and without asthma (0.07% vs. 0.02% in 2010 and 0.08% vs. 0.01% in 2011; P <0.001).", {"entities": [[87, 93, "DISEASE"]]}], ["After adjusting for age and gender, patients with asthma showed over a three-fold increased risk of IPD compared with patients without asthma (adjusted odds ratio [aOR] 3.90, 95% confidence interval [CI] 3.02-5.03 in 2010 / aOR, 5.44; 95% CI, 4.10-7.22 in 2011; P <0.001).", {"entities": [[50, 56, "DISEASE"], [135, 141, "DISEASE"]]}], ["These findings were also significant in children (aOR, 2.08; 95% CI, 1.25-3.45 in 2010; P =0.005 / aOR, 3.26; 95% CI, 1.74-6.11 in 2011; P <0.001).", {"entities": []}], ["Although diabetes mellitus was also significantly associated with IPD, relatively low ORs compared with those of asthma were noted (aOR, 1.85; 95% CI, 1.35-2.54 in 2010 / aOR, 2.40; 95% CI, 1.78-3.24 in 2011; P <0.001).", {"entities": [[113, 119, "DISEASE"], [9, 26, "DISEASE"]]}], ["Both children and adults with asthma are at increased risk of developing IPD.", {"entities": [[30, 36, "DISEASE"]]}], ["We examined changes in the levels of eicosanoids in blood and pulmonary lymph of anesthetized sheep undergoing acute anaphylaxis.", {"entities": []}], ["Within 1-3 min of intravenous antigenic challenge of previously sensitized sheep, there were approximately 7-30-fold elevations in mean arterial plasma levels of thromboxane B2 and 6-ketoprostaglandin F1 alpha, respectively, as measured by RIA.", {"entities": []}], ["Negligible changes in levels of these cyclooxygenase products were found in both nonsensitized sheep and in sensitized sheep treated with indomethacin before antigenic challenge.", {"entities": []}], ["In contrast, no changes in levels of sulfidopeptide leukotrienes (SPLT) in pulmonary lymph were detectable by RIA during anaphylaxis in sensitized or nonsensitized sheep, but levels of SPLT in indomethacin- treated sensitized sheep increased more than fivefold above levels in lymph from both other groups of animals.", {"entities": []}], ["The immunoreactive SPLT in lymph from indomethacin-treated sheep was accounted for as LTE4, as demonstrated by mobility on HPLC and absorbance at 280 nm.", {"entities": []}], ["These results support the possibility that certain undesirable effects of nonsteroidal antiinflammatory drugs, such as cardiopulmonary reactions in aspirin-sensitive individuals, and impaired renal and cardiac function during therapy with these drugs, may be related in part to augmented synthesis of the 5-lipoxygenase pathway products, especially those of the sulfidopeptide class.", {"entities": []}], ["Increased LT production could also limit the antiinflammatory effectiveness of these drugs in many disease states.", {"entities": [[10, 12, "GENE"]]}], ["The objective of this study was to compare the efficacy, safety and tolerability of intravenous iron sucrose with that of oral ferrous fumarate in iron deficiency anemia during 14 to 34\u00a0weeks of pregnancy.", {"entities": [[152, 169, "DISEASE"], [147, 169, "DISEASE"], [163, 169, "DISEASE"]]}], ["A randomized controlled trial was performed involving 112 patients attending the antenatal clinic at Shri B.M.Patil Medical college Hospital, Bijapur from October 2011 to August 2012,with hemoglobin levels between 70-110\u00a0g/L and serum ferritin of\u2009<\u200915\u00a0ng/ml.", {"entities": []}], ["In the intravenous group,200\u00a0mg of iron sucrose was administered in 100\u00a0ml 0.9% sodium chloride per day.", {"entities": []}], ["Participants in the oral group were given 200\u00a0mg of ferrous fumarate per day.", {"entities": []}], ["The primary outcome measures for the trial, haemoglobin and serum ferritin levels were measured after 4\u00a0weeks.", {"entities": []}], ["Statistical significance was assessed using Student\u2019s t -test.", {"entities": []}], ["The change in haemoglobin in women receiving intravenous iron was higher than with oral ferrous fumarate 22\u2009\u00b1\u200911.5\u00a0g/L vs 12\u2009\u00b1\u20099\u00a0g/L (p\u2009<\u20090.0001).Similarly the change of serum ferritin was significantly higher in women receiving intravenous iron compared to oral iron.", {"entities": []}], ["55% participants in the intravenous group had an improvement in haemoglobin more than 20\u00a0g/L compared to only 11% of the oral therapy group.48% of patients in I.V group showed increase in ferritin level between 51 to 100\u00a0ng/ml in comparison to only 3.5% in oral group.", {"entities": []}], ["Intravenous iron sucrose is an effective in correction of anemia in pregnancy or iron store depletion.", {"entities": [[58, 64, "DISEASE"]]}], ["Intravenous iron sucrose is more effective than 200\u00a0mg a day ferrous fumarate in increasing maternal iron stores.", {"entities": []}], ["The trial registration number is CTRI/2016/12/007552 registered in Clinical Trial Registry India on 8/12/2016.", {"entities": []}], ["It is a retrospectively registered trial.", {"entities": []}], ["Controlled exposures of animals and humans to particulate matter (PM) or ozone air pollution cause an increase in plasma levels of endothelin-1, a potent vasoconstrictor that regulates pulmonary arterial pressure.", {"entities": []}], ["The primary objective of this field study was to determine whether Mexico City children, who are chronically exposed to levels of PM and O 3 that exceed the United States air quality standards, have elevated plasma endothelin-1 levels and pulmonary arterial pressures.", {"entities": []}], ["We conducted a study of 81 children, 7.9 \u00b1 1.3 years of age, lifelong residents of either northeast ( n = 19) or southwest ( n = 40) Mexico City or Polotitl\u00e1n ( n = 22), a control city with PM and O 3 levels below the U.S. air quality standards.", {"entities": []}], ["Clinical histories, physical examinations, and complete blood counts were done.", {"entities": []}], ["Plasma endothelin-1 concentrations were determined by immunoassay, and pulmonary arterial pressures were measured by Doppler echocardiography.", {"entities": []}], ["Mexico City children had higher plasma endothelin-1 concentrations compared with controls ( p < 0.001).", {"entities": []}], ["Mean pulmonary arterial pressure was elevated in children from both northeast ( p < 0.001) and southwest ( p < 0.05) Mexico City compared with controls.", {"entities": []}], ["Endothelin-1 levels in Mexico City children were positively correlated with daily outdoor hours ( p = 0.012), and 7-day cumulative levels of PM air pollution < 2.5 \u03bcm in aerodynamic diameter (PM 2.5 ) before endothelin-1 measurement ( p = 0.03).", {"entities": []}], ["Chronic exposure of children to PM 2.5 is associated with increased levels of circulating endothelin-1 and elevated mean pulmonary arterial pressure.", {"entities": []}], ["Preeclampsia is a complex disease in which several providers should interact continuously and in a coordinated manner to provide proper health care.", {"entities": []}], ["However, standardizing criteria to treat patients with preeclampsia is problematical and severe flaws have been observed in the management of the disease.", {"entities": []}], ["This paper describes a set of critical pathways (CPs) designed to provide uniform criteria for clinical decision-making at different levels of care of pregnant patients with preeclampsia or severe preeclampsia.", {"entities": []}], ["Clinicians and researchers from different countries participated in the construction of the CPs.", {"entities": []}], ["The CPs were developed using the following steps: a) Definition of the conceptual framework; b) Identification of potential users: primary care physicians and maternal and child health nurses in ambulatory settings; ob/gyn and intensive care physicians in secondary and tertiary care levels.", {"entities": []}], ["c) Structural development.", {"entities": []}], ["The CPs address the following care processes: 1.", {"entities": []}], ["Screening for preeclampsia, risk assessment and classification according to the level of risk.", {"entities": []}], ["Management of preeclampsia at primary care clinics.", {"entities": []}], ["Evaluation and management of preeclampsia at secondary and tertiary care hospitals: 4.", {"entities": []}], ["Criteria for clinical decision-making between conservative management and expedited delivery of patients with severe preeclampsia.", {"entities": []}], ["Since preeclampsia continues to be one of the primary causes of maternal deaths and morbidity worldwide, the expected impact of these CPs is the contribution to improving health care quality in both developed and developing countries.", {"entities": []}], ["The CPs are designed to be applied in a complex health care system, where different physicians and health providers at different levels of care should interact continuously and in a coordinated manner to provide care to all preeclamptic women.", {"entities": []}], ["Although the CPs were developed using evidence-based criteria, they could require careful evaluation and remodelling according to each system's demands.", {"entities": []}], ["Additionally, the CPs need to be tested in large-scale, multi-level studies in order to thoroughly examine and evaluate their efficacy and effectiveness.", {"entities": []}], ["Breathlessness is one of the core symptoms, particularly persistent and frequent, towards the end of life.", {"entities": []}], ["There is no evidence of how the experience of breathlessness differs across conditions.", {"entities": []}], ["This paper compares the experience of breathlessness in cancer, COPD, heart failure and MND, four conditions sharing heavy symptom burdens, poor prognoses, high breathlessness rates and palliative care needs.", {"entities": [[56, 62, "DISEASE"]]}], ["For this qualitative study a purposive sample of 48 patients was included with a diagnosis of cancer (10), COPD (18), heart failure (10) or MND (10) and experiencing daily problems of breathlessness.", {"entities": [[94, 100, "DISEASE"]]}], ["Patients were recruited from the respective clinics at the hospital; specialist nurses' ward rounds and consultations, and \"Breathe Easy\" service users meetings in the community.", {"entities": []}], ["Data were collected through semi-structured, in-depth interviews and participant observation.", {"entities": []}], ["Breathlessness was compared according to six components derived from explanatory models and symptom schemata, first within groups and then across groups.", {"entities": []}], ["Frequency counts were conducted to check the qualitative findings.", {"entities": []}], ["All conditions shared the disabling effects of breathlessness.", {"entities": []}], ["However there were differences between the four conditions, in the specific constraints of the illness and patients' experiences with the health care context and social environment.", {"entities": []}], ["In cancer, breathlessness signalled the (possible) presence of cancer, and functioned as a reminder of patients' mortality despite the hopes they put in surgery, therapies and new drugs.", {"entities": [[3, 9, "DISEASE"], [63, 69, "DISEASE"]]}], ["For COPD patients, breathlessness was perceived as a self-inflicted symptom.", {"entities": []}], ["Its insidious nature and response from services disaffirmed their experience and gradually led to greater disability in the course of illness.", {"entities": []}], ["Patients with heart failure perceived breathlessness as a contributing factor to the negative effects of other symptoms.", {"entities": []}], ["In MND breathlessness meant that the illness was a dangerous threat to patients' lives.", {"entities": []}], ["COPD and heart failure had similar experiences.", {"entities": []}], ["Integrated palliative care is needed, that makes use of all appropriate therapeutic options, collaborative efforts from health, social care professionals, patients and caregivers, and therapies that acknowledge the dynamic interrelation of the body, mind and spirit.", {"entities": []}], ["Bronchial thermoplasty is a novel procedure for patients with severe asthma showing a stable lung function.", {"entities": [[69, 75, "DISEASE"]]}], ["We herein report two cases with a deteriorating lung function.", {"entities": []}], ["The lung function tended to improve in one case, while the other case discontinued mepolizumab medication after the procedure.", {"entities": []}], ["Treatment was performed safely under general anesthesia in both cases.", {"entities": []}], ["The use of bronchial thermoplasty may therefore be useful for the treatment of patients with a deteriorating lung function.", {"entities": []}], ["Respiratory syncytial viral (RSV) infections are a frequent cause of chronic obstructive pulmonary disease (COPD) exacerbations, which are a major factor in disease progression and mortality.", {"entities": [[69, 106, "DISEASE"]]}], ["RSV is able to evade antiviral defenses to persist in the lungs of COPD patients.", {"entities": []}], ["Though RSV infection has been identified in COPD, its contribution to cigarette smoke-induced airway inflammation and lung tissue destruction has not been established.", {"entities": []}], ["Here we examine the long-term effects of cigarette smoke exposure, in combination with monthly RSV infections, on pulmonary inflammation, protease production and remodeling in mice.", {"entities": []}], ["RSV exposures enhanced the influx of macrophages, neutrophils and lymphocytes to the airways of cigarette smoke exposed C57BL/6J mice.", {"entities": []}], ["This infiltration of cells was most pronounced around the vasculature and bronchial airways.", {"entities": []}], ["By itself, RSV caused significant airspace enlargement and fibrosis in mice and these effects were accentuated with concomitant smoke exposure.", {"entities": []}], ["Combined stimulation with both smoke and RSV synergistically induced cytokine (IL-1\u03b1, IL-17, IFN-\u03b3, KC, IL-13, CXCL9, RANTES, MIF and GM-CSF) and protease (MMP-2, -8, -12, -13, -16 and cathepsins E, S, W and Z) expression.", {"entities": [[111, 116, "GENE"], [126, 129, "GENE"]]}], ["In addition, RSV exposure caused marked apoptosis within the airways of infected mice, which was augmented by cigarette smoke exposure.", {"entities": []}], ["RSV and smoke exposure also reduced protein phosphatase 2A (PP2A) and protein tyrosine phosphates (PTP1B) expression and activity.", {"entities": []}], ["This is significant as these phosphatases counter smoke-induced inflammation and protease expression.", {"entities": []}], ["Together, these findings show for the first time that recurrent RSV infection markedly enhances inflammation, apoptosis and tissue destruction in smoke-exposed mice.", {"entities": []}], ["Indeed, these results indicate that preventing RSV transmission and infection has the potential to significantly impact on COPD severity and progression.", {"entities": []}], ["This study investigated whether residence in Aberdeen, North Carolina, the location of the Aberdeen pesticides dumps site (a national priority list Superfund site containing organochlorine pesticides, volatile organic compounds, and metals), is associated with immune suppression as indicated by a higher incidence of herpes zoster and recent occurrences of other common infectious diseases.", {"entities": [[318, 331, "DISEASE"]]}], ["Study participants included 1,642 residents, 18-64 years of age, who responded to a telephone survey concerning potential occupational and recreational exposures to pesticides and other chemicals, lifetime history of herpes zoster (shingles), and the recent occurrence of other common infectious diseases.", {"entities": [[217, 230, "DISEASE"]]}], ["Stratified and logistic regression analyses were used to compare the cumulative incidence of herpes zoster among Aberdeen residents and residents of nearby communities.", {"entities": [[93, 106, "DISEASE"]]}], ["There was little evidence of an overall increased risk of herpes zoster among Aberdeen residents during the period 1951-1994 [relative risk (RR), 1.3; 95% confidence interval (CI), 0.8-2.1].", {"entities": [[58, 71, "DISEASE"]]}], ["However, an elevated risk of herpes zoster was noted consistently among Aberdeen residents of younger ages as compared to residents of the nearby communities.", {"entities": [[29, 42, "DISEASE"]]}], ["The RR was 2.0 (CI, 1.0-4.0) among those 18-40 years of age and was not affected by controlling for potential confounders.", {"entities": []}], ["The RR of herpes zoster was also consistently elevated in all age groups for the period before 1985.", {"entities": [[10, 23, "DISEASE"]]}], ["No differences were noted between residents of Aberdeen and those of the nearby communities with respect to the recent occurrence of other common infectious diseases.", {"entities": []}], ["These results support the plausibility of an association between exposure to the Aberdeen pesticides dumps site and immune suppression and the potential use of herpes zoster as a marker of immune suppression in studies of environmental chemical exposures.", {"entities": [[160, 173, "DISEASE"]]}], ["Cold-related mortality and morbidity remains an important public health problem in the UK and elsewhere.", {"entities": []}], ["Health burdens have often reported to be higher in the UK compared to other countries with colder climates, however such assessments are usually based on comparison of excess winter mortality indices, which are subject to biases.", {"entities": []}], ["Daily time-series regression or case-crossover studies provide the best evidence of the acute effects of cold exposure.", {"entities": []}], ["Such studies report a 6% increase in all-cause deaths in England & Wales for every 1\u00a0\u00b0C fall in daily mean temperature within the top 5% of the coldest days.", {"entities": []}], ["In major Scottish cities, a 1\u00a0\u00b0C reduction in mean temperature below 11\u00a0\u00b0C was associated with an increase in mortality of 2.9%, 3.4%, 4.8% and 1.7% from all-causes, cardiovascular, respiratory, and non-cardio-respiratory causes respectively.", {"entities": []}], ["In Northern Ireland, a 1\u00a0\u00b0C fall during winter months led to reductions of 4.5%, 3.9% and 11.2% for all-cause, cardiovascular and respiratory deaths respectively among adults.", {"entities": []}], ["Raised risks are also observed with morbidity outcomes.", {"entities": []}], ["Hip fractures among the elderly are only weakly associated with snow and ice conditions in the UK, with the majority of cases occurring indoors.", {"entities": []}], ["A person\u2019s susceptibility to cold weather is affected by both individual- and contextual-level risk factors.", {"entities": []}], ["Variations in the distributions of health, demographic, socio-economic and built-environment characteristics are likely to explain most differences in cold risk observed between UK regions.", {"entities": []}], ["Although cold-related health impacts reduced throughout much of the previous century in UK populations, there is little evidence on the contribution that milder winters due to climate change may have made to reductions in more recent decades.", {"entities": []}], ["Intervention measures designed to minimise cold exposure and reduce fuel poverty will likely play a key role in determining current and future health burdens associated with cold weather.", {"entities": []}], ["The online version of this article (10.1186/s12940-017-0323-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["To investigate the efficacy of oral moxifloxacin (MFLX) as a treatment for pneumonia in hemodialysis (HD) patients and the pharmacokinetic (PK) profile of MFLX after oral administration.", {"entities": [[75, 84, "DISEASE"]]}], ["Thirteen adult patients who required HD due to chronic renal failure were enrolled in the present study, which was performed to investigate the treatment of community-acquired pneumonia in HD patients.", {"entities": [[176, 185, "DISEASE"]]}], ["A standard dose of MFLX (400 mg, once daily) was administered.", {"entities": []}], ["The therapy was continued, discontinued, or switched to another antibiotic depending on the response of the pneumonia to MFLX.", {"entities": [[108, 117, "DISEASE"]]}], ["A population PK model was developed using the post-hoc method.", {"entities": []}], ["In total, 13 HD patients with pneumonia (male, n=7; female, n=6) were enrolled in the present study.", {"entities": [[30, 39, "DISEASE"]]}], ["The evaluation on the 3rd day showed that treatment was successful in 11 patients (84.6%) and that 10 patients were cured (76.9%).", {"entities": []}], ["In the one case in which MFLX treatment failed, the patient was cured by switching to ceftriaxone (CTRX) (2 g, intravenously) plus levofloxacin (LVFX) (250 mg, orally).", {"entities": []}], ["The causative bacterium in this male patient was P. aeruginosa .", {"entities": []}], ["It did not display resistance to fluoroquinolones.", {"entities": []}], ["One patient had liver dysfunction due to MFLX.", {"entities": []}], ["The estimated PK parameters of MFLX were as follows: AUC 0\u219224 , 61.04\u00b117.74 \u03bcg h/mL; C max , 5.25\u00b11.12 \u03bcg/mL; and C trough , 1.15\u00b10.45 \u03bcg/mL.", {"entities": [[87, 90, "GENE"]]}], ["The PK parameters of MFLX among the patients in whom adverse events occurred or in whom a cure was not achieved did not differ from those of the other patients to a statistically significant extent.", {"entities": []}], ["MFLX showed good efficacy and safety in HD patients with community-acquired pneumonia and the results of the PK analysis were favorable.", {"entities": [[76, 85, "DISEASE"]]}], ["Further prospective studies with larger numbers of patients will be needed to draw definitive conclusions.", {"entities": []}], ["New parameters in the 6-minute walk test (6MWT) are required for comprehensive analysis of exercise capacity in patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[126, 163, "DISEASE"]]}], ["The aim of the present study was to apply a novel index, the desaturation distance ratio (DDR), to clinical research on COPD as an estimate of exercise capacity and to examine whether DDR is a potential parameter for manifold analysis of exercise capacity in patients with COPD.", {"entities": []}], ["A total of 41 patients with COPD (median age [interquartile range] =75 [68\u201379] years; and body mass index [BMI] =22.3 [19.4\u201323.8] kg/m 2 ) values observed at each minute during the 6MWT.", {"entities": []}], ["Then the DDR was calculated as the ratio of the desaturation area to the 6-minute walk distance (6MWD).", {"entities": []}], ["The 6MWD was 370 (328\u2013445) m, and the decline in SpO 2 values (\u0394SpO 2 ) was \u22125.0% (\u22128.0% to \u22121.5%).", {"entities": []}], ["The DDR correlated modestly with baseline pulmonary function in patients with COPD (forced expiratory volume in 1 second [% of predicted value]: r =\u22120.658, P <0.001; and diffusing capacity of the lung for carbon monoxide [DL CO ]: r =\u22120.470, P =0.002), comparable with the findings of the 6MWD.", {"entities": []}], ["The DDR correlated well with \u0394SpO 2 ( r =\u22120.656, P <0.001) and with the increase in subjective sense of dyspnea during the 6MWT, as assessed by Borg scale scores (\u0394Borg) ( r =0.486, P =0.001), in contrast with the 6MWD, which was not significantly correlated with \u0394SpO 2 and \u0394Borg scale scores.", {"entities": []}], ["The DDR is more informative for manifold analysis of exercise capacity associated with oxygen desaturation and subsequent sense of dyspnea by exercise in patients with COPD.", {"entities": []}], ["For the last decade, mHealth has constantly expanded as a part of eHealth.", {"entities": []}], ["Mobile applications for health have the potential to target heterogeneous audiences and address specific needs in different situations, with diverse outcomes, and to complement highly developed health care technologies.", {"entities": []}], ["The market is rapidly evolving, making countless new mobile technologies potentially available to the health care system; however, systematic research on the impact of these technologies on health outcomes remains scarce.", {"entities": []}], ["To provide a comprehensive view of the field of mHealth research to date and to understand whether and how the new generation of smartphones has triggered research, since their introduction 5 years ago.", {"entities": []}], ["Specifically, we focused on studies aiming to evaluate the impact of mobile phones on health, and we sought to identify the main areas of health care delivery where mobile technologies can have an impact.", {"entities": []}], ["A systematic literature review was conducted on the impact of mobile phones and smartphones in health care.", {"entities": []}], ["Abstracts and articles were categorized using typologies that were partly adapted from existing literature and partly created inductively from publications included in the review.", {"entities": []}], ["The final sample consisted of 117 articles published between 2002 and 2012.", {"entities": []}], ["The majority of them were published in the second half of our observation period, with a clear upsurge between 2007 and 2008, when the number of articles almost doubled.", {"entities": []}], ["The articles were published in 77 different journals, mostly from the field of medicine or technology and medicine.", {"entities": []}], ["Although the range of health conditions addressed was very wide, a clear focus on chronic conditions was noted.", {"entities": []}], ["The research methodology of these studies was mostly clinical trials and pilot studies, but new designs were introduced in the second half of our observation period.", {"entities": []}], ["The size of the samples drawn to test mobile health applications also increased over time.", {"entities": []}], ["The majority of the studies tested basic mobile phone features (eg, text messaging), while only a few assessed the impact of smartphone apps.", {"entities": []}], ["Regarding the investigated outcomes, we observed a shift from assessment of the technology itself to assessment of its impact.", {"entities": []}], ["The outcome measures used in the studies were mostly clinical, including both self-reported and objective measures.", {"entities": []}], ["Research interest in mHealth is growing, together with an increasing complexity in research designs and aim specifications, as well as a diversification of the impact areas.", {"entities": []}], ["However, new opportunities offered by new mobile technologies do not seem to have been explored thus far.", {"entities": []}], ["Mapping the evolution of the field allows a better understanding of its strengths and weaknesses and can inform future developments.", {"entities": []}], ["Two devastating hurricanes ripped across the Gulf Coast of the United States during 2005.", {"entities": []}], ["The effects of Hurricane Katrina were especially severe: The human and environmental health impacts on New Orleans, Louisiana, and other Gulf Coast communities will be felt for decades to come.", {"entities": []}], ["The Federal Emergency Management Agency (FEMA) estimates that Katrina\u2019s destruction disrupted the lives of roughly 650,000 Americans.", {"entities": []}], ["Over 1,300 people died.", {"entities": []}], ["The projected economic costs for recovery and reconstruction are likely to exceed $125 billion.", {"entities": []}], ["The NIEHS (National Institute of Environmental Health Sciences) Portal aims to provide decision makers with the data, information, and the tools they need to a ) monitor human and environmental health impacts of disasters; b ) assess and reduce human exposures to contaminants; and c ) develop science-based remediation, rebuilding, and repopulation strategies.", {"entities": []}], ["The NIEHS Portal combines advances in geographic information systems (GIS), data mining/integration, and visualization technologies through new forms of grid-based (distributed, web-accessible) cyberinfrastructure.", {"entities": []}], ["The scale and complexity of the problems presented by Hurricane Katrina made it evident that no stakeholder alone could tackle them and that there is a need for greater collaboration.", {"entities": []}], ["The NIEHS Portal provides a collaboration-enabling, information-laden base necessary to respond to environmental health concerns in the Gulf Coast region while advancing integrative multidisciplinary research.", {"entities": []}], ["The NIEHS Portal is poised to serve as a national resource to track environmental hazards following natural and man-made disasters, focus medical and environmental response and recovery resources in areas of greatest need, and function as a test bed for technologies that will help advance environmental health sciences research into the modern scientific and computing era.", {"entities": []}], ["The clinical outcome of cardiovascular diseases as myocardial infarction and stroke are generally caused by rupture of an atherosclerotic plaque.", {"entities": [[51, 72, "DISEASE"]]}], ["However, the actual cause of a plaque to rupture is not yet established.", {"entities": []}], ["Interestingly, pathology studies have shown an increased presence of the mast cell, an important inflammatory effector cell in allergy and host defense, in (peri)vascular tissue during plaque progression, which may point towards a causal role for mast cells.", {"entities": []}], ["Very recent data in mouse models show that mast cells and derived mediators indeed can profoundly impact plaque progression, plaque stability and acute cardiovascular syndromes such as vascular aneurysm or myocardial infarction.", {"entities": [[206, 227, "DISEASE"]]}], ["In this review, we discuss recent evidence on the role of mast cells in the progression of cardiovascular disorders and give insight in the therapeutic potential of modulation of mast cell function in these processes to improve the resilience of a plaque to rupture.", {"entities": []}], ["Persistent eosinophil activation in both the upper and lower airway mucosa is a central feature of aspirin-exacerbated respiratory disease (AERD).", {"entities": []}], ["Eosinophil activation and survival are profoundly influenced by interleukin 5 (IL-5) and its receptor, IL-5R.", {"entities": []}], ["In patients susceptible to allergic disorders, IL-5 receptor \u03b1 ( IL5RA ) polymorphisms have been reported; however, an association with AERD remains unclear.", {"entities": [[65, 70, "GENE"]]}], ["We hypothesize that IL5RA polymorphisms may contribute to eosinophil activation in AERD patients.", {"entities": [[20, 25, "GENE"]]}], ["We recruited 139 AERD patients, 171 aspirin-tolerant asthma patients and 160 normal controls.", {"entities": [[53, 59, "DISEASE"]]}], ["IL5RA polymorphisms (\u22125993G>A, \u22125567C>G and \u22125091G>A) were genotyped and functional activity of polymorphism was assessed by luciferase reporter assay and electrophoretic mobility shift assay (EMSA).", {"entities": [[0, 5, "GENE"]]}], ["There was no significant difference in the genotype frequency of the three polymorphisms among the three groups.", {"entities": []}], ["AERD patients carrying the AA genotype at \u22125993G>A had a significantly higher presence of serum-specific immunoglobulin E (IgE) to staphylococcal enterotoxin A ( P =0.008) than those with the GG/GA genotype.", {"entities": []}], ["In vitro , the \u22125993A allele had a higher promoter activity compared with the \u22125993G allele in human mast cell (HMC-1; P =0.030) and human promyelocytic leukemia (HL-60; P =0.013) cells.", {"entities": [[153, 161, "DISEASE"]]}], ["In EMSA, a \u22125993A probe produced a specific shifted band than the \u22125993G had.", {"entities": []}], ["These findings suggest that a functional polymorphism in IL5RA may contribute to eosinophil and mast cell activation along with specific IgE responses to staphylococcal enterotoxin A in AERD patients.", {"entities": [[57, 62, "GENE"]]}], ["Following the 2013 USA release of the Influenza Virologic Surveillance Right Size Roadmap, the New York State Department of Health ( NYSDOH ) embarked on an evaluation of data sources for influenza virologic surveillance.", {"entities": [[38, 47, "DISEASE"], [188, 197, "DISEASE"]]}], ["To assess NYS data sources, additional to data generated by the state public health laboratory ( PHL ), which could enhance influenza surveillance at the state and national level.", {"entities": [[124, 133, "DISEASE"]]}], ["Potential sources of laboratory test data for influenza were analyzed for quantity and quality.", {"entities": [[46, 55, "DISEASE"]]}], ["Computer models, designed to assess sample sizes and the confidence of data for statistical representation of influenza activity, were used to compare PHL test data to results from clinical and commercial laboratories, reported between June 8, 2013 and May 31, 2014.", {"entities": [[110, 119, "DISEASE"]]}], ["Sample sizes tested for influenza at the state PHL were sufficient for situational awareness surveillance with optimal confidence levels, only during peak weeks of the influenza season.", {"entities": [[24, 33, "DISEASE"], [168, 177, "DISEASE"]]}], ["Influenza data pooled from NYS PHL s and clinical laboratories generated optimal confidence levels for situational awareness throughout the influenza season.", {"entities": [[0, 9, "DISEASE"], [140, 149, "DISEASE"]]}], ["For novel influenza virus detection in NYS , combined real\u2010time (rt) RT \u2010 PCR data from state and regional PHL s achieved \u226585% confidence during peak influenza activity, and \u226595% confidence for most of low season and all of off\u2010season.", {"entities": [[10, 19, "DISEASE"], [150, 159, "DISEASE"]]}], ["In NYS , combined data from clinical, commercial, and public health laboratories generated optimal influenza surveillance for situational awareness throughout the season.", {"entities": [[99, 108, "DISEASE"]]}], ["Statistical confidence for novel virus detection, which is reliant on only PHL data, was achieved for most of the year.", {"entities": []}], ["The Hygiene Hypothesis (HH) attributes the dramatic increase in autoimmune and allergic diseases observed in recent decades in Western countries to the reduced exposure to diverse immunoregulatory infectious agents.", {"entities": []}], ["This theory has since largely been supported by strong epidemiological and experimental evidence.", {"entities": []}], ["The analysis of these data along with the evolution of the Western world\u2019s microbiome enable us to obtain greater insight into microorganisms involved in the HH, as well as their regulatory mechanisms on the immune system.", {"entities": []}], ["Helminthes and their derivatives were shown to have a protective role.", {"entities": []}], ["Helminthes\u2019 broad immunomodulatory properties have already begun to be exploited in clinical trials of autoimmune diseases, including inflammatory bowel disease, multiple sclerosis, rheumatoid arthritis, and type-1 diabetes.", {"entities": [[134, 160, "DISEASE"], [162, 180, "DISEASE"], [182, 202, "DISEASE"], [193, 202, "DISEASE"]]}], ["In this review, we will dissect the microbial actors thought to be involved in the HH as well as their immunomodulatory mechanisms as emphasized by experimental studies, with a particular attention on parasites.", {"entities": []}], ["Thereafter, we will review the early clinical trials using helminthes\u2019 derivatives focusing on autoimmune diseases.", {"entities": []}], ["To evaluate the serological response in pregnant Danish women immunized during the 2009 pandemic by serologic infection or by vaccination with influenza A(H1N1) Pandemrix Observational cohort study.", {"entities": [[143, 152, "DISEASE"]]}], ["Department of Obstetrics, Aarhus University Hospital, Skejby, Denmark, October to December 2009.", {"entities": []}], ["Pregnant women and their offspring Serological analysis of antibodies to influenza A(H1N1)pdm09 by hemagglutination inhibition assay in 197 women and their offspring.", {"entities": [[73, 82, "DISEASE"]]}], ["Blood samples were collected consecutively at delivery from the mother and the umbilical cord.", {"entities": []}], ["In a subgroup of 124 of the 197 women, an additional blood sample from gestational weeks 9\u201312 was available for analysis.", {"entities": []}], ["Seroconversion, geometric mean titer, geometric mean\u2010fold rise and protective antibodies.", {"entities": []}], ["33 of the 124 subgroup women (27%) seroconverted during pregnancy, 79% after vaccination and 17% after serologic infection ( p \u00a0<\u00a00.001).", {"entities": []}], ["The geometric mean titer after delivery in non\u2010vaccinated, non\u2010serologically infected women was 17.1 (95% CI 15.7\u201318.6).", {"entities": []}], ["The geometric mean titer increased significantly after serologic infection with H1N1 [76.5 (95% CI 51.3\u2013113.9), p \u00a0<\u00a00.001] and after vaccination [589.6 (95% CI 339.3\u20131024.7), p \u00a0<\u00a00.001].", {"entities": []}], ["The geometric mean\u2010fold rise (mother at delivery/mother early pregnancy) was significantly higher after vaccination [2.23 (1.93\u20132.54)] than after serologic infection [1.73 (1.59\u20131.87), p \u00a0=\u00a00.013].", {"entities": []}], ["In newborns of vaccinated mothers, 89.5% had protective antibody levels compared with 15.8% in newborns of serologically infected mothers ( p \u00a0<\u00a00.001).", {"entities": []}], ["Influenza vaccination during pregnancy confers passive immunity to the newborn.", {"entities": [[0, 9, "DISEASE"]]}], ["O bjectives : We reported previously that 24-hr moving average ambient air pollution concentrations were positively associated with ventricular arrhythmias detected by implantable cardioverter defibrillators (ICDs).", {"entities": []}], ["ICDs also detect paroxysmal atrial fibrillation episodes (PAF) that result in rapid ventricular rates.", {"entities": []}], ["In this same cohort of ICD patients, we assessed the association between ambient air pollution and episodes of PAF.", {"entities": []}], ["D esign : We performed a case\u2013crossover study.", {"entities": []}], ["P articipants : Patients who lived in the Boston, Massachusetts, metropolitan area and who had ICDs implanted between June 1995 and December 1999 ( n = 203) were followed until July 2002.", {"entities": []}], ["E valuations /M easurements : We used conditional logistic regression to explore the association between community air pollution and 91 electrophysiologist-confirmed episodes of PAF among 29 subjects.", {"entities": []}], ["R esults : We found a statistically significant positive association between episodes of PAF and increased ozone concentration (22 ppb) in the hour before the arrhythmia (odds ratio = 2.08; 95% confidence interval = 1.22, 3.54; p = 0.001).", {"entities": []}], ["The risk estimate for a longer (24-hr) moving average was smaller, thus suggesting an immediate effect.", {"entities": []}], ["Positive but not statistically significant risks were associated with fine particles, nitrogen dioxide, and black carbon.", {"entities": []}], ["C onclusions : Increased ambient O 3 pollution was associated with increased risk of episodes of rapid ventricular response due to PAF, thereby suggesting that community air pollution may be a precipitant of these events.", {"entities": []}], ["Airway inflammation is key to the severity and persistence of asthma.", {"entities": [[62, 68, "DISEASE"]]}], ["Recent studies have revealed novel immune mechanisms that target dendritic cells, T helper 2 cytokines, regulatory T cells, and type 2 innate lymphoid cells in allergic inflammation, as well as novel approaches that target airway smooth muscle in asthma.", {"entities": [[247, 253, "DISEASE"]]}], ["These advances inform the development of new targeted treatments for allergic inflammation and asthma with the potential to provide therapeutic benefit.", {"entities": [[95, 101, "DISEASE"]]}], ["One of the main challenges in asthma control is adherence to pharmaceutical treatment.", {"entities": [[30, 36, "DISEASE"]]}], ["The aim of this study was to test the association between adherence to asthma medication, control and medical beliefs, cognitive and emotional perceptions using three different validated questionnaires.", {"entities": [[71, 77, "DISEASE"]]}], ["Beliefs about asthma medicine, cognitive and emotional factors were determined in a cross-sectional survey of patients attending outpatient pulmonologist practices in Latvia ( n \u2009=\u2009352).", {"entities": [[14, 20, "DISEASE"]]}], ["The validated Beliefs about Medicines Questionnaire and the Brief Illness Perception Questionnaire were used.", {"entities": []}], ["Adherence to asthma medication was assessed using the Morisky Medication Adherence Scale and two different versions of the Medication Adherence Reporting Scale.", {"entities": [[13, 19, "DISEASE"]]}], ["Several questions about necessity or concerns related to pharmaceutical treatment were able to predict poor adherence according to the Morisky scale.", {"entities": []}], ["If the patient felt that without the asthma medication his life would be impossible, his risk to have poor treatment adherence was 46% reduced (odds ratio 0.54; 95% confidence interval 0.33\u20130.89).", {"entities": [[37, 43, "DISEASE"]]}], ["Furthermore, asthma patients who were convinced that their health depends on the asthma treatment were less likely to have poor treatment adherence (odds ratio 0.56: 95% confidence interval 0.32\u20130.97).", {"entities": [[13, 19, "DISEASE"], [81, 87, "DISEASE"]]}], ["In case the patient was concerned by the need to constantly use asthma medication or sometimes concerned by long-term effects of asthma medication the odds of poor treatment adherence were 1.96 (95% confidence interval 1.19\u20133.24) and 2.43 (95% confidence interval 1.45\u20134.08), respectively.", {"entities": [[64, 70, "DISEASE"], [129, 135, "DISEASE"]]}], ["In conclusion, medication beliefs, particularly concerns and necessity of asthma treatment were associated with poor treatment adherence when assessed with the Morisky or 5-item Medication Adherence Reporting Scale.", {"entities": [[74, 80, "DISEASE"]]}], ["Concerns about treatment necessity and uses of asthma medication are key factors influencing poor treatment adherence in Latvia.", {"entities": [[47, 53, "DISEASE"]]}], ["There are multiple psychological and behavioral reasons why patients do not adhere to asthma treatment courses, including social and religious beliefs, and perceptions of chronic illness.", {"entities": [[86, 92, "DISEASE"]]}], ["Patient questionnaires and \u2018adherence scales\u2019 can help predict whether patients are likely to follow advice, but their efficacy differs for individual nations.", {"entities": []}], ["Dins Smits at Riga Stradins University, Latvia, and co-workers analyzed responses to three questionnaires completed by 352 asthma patients to assess treatment perceptions and the best questionnaire option for the Latvian population.", {"entities": [[123, 129, "DISEASE"]]}], ["Concerns about the use of asthma medication and beliefs about treatment necessity were key factors in poor adherence.", {"entities": [[26, 32, "DISEASE"]]}], ["These were picked up by the Morisky and MARS 5-item scales, which the authors recommend for future use.", {"entities": [[40, 44, "GENE"]]}], ["Hh/Gli signals are received by multiple pulmonary and immune cell types in response to allergen inhalation in vivo; this autocrine/paracrine activation enhances Th2 immune responses.", {"entities": []}], ["The pathophysiology of allergic asthma is driven by Th2 immune responses after aeroallergen inhalation.", {"entities": [[23, 38, "DISEASE"], [32, 38, "DISEASE"]]}], ["The mechanisms that initiate, potentiate, and regulate airway allergy are incompletely characterized.", {"entities": []}], ["We have shown that Hh signaling to T cells, via downstream Gli transcription factors, enhances T cell conversion to a Th2 phenotype.", {"entities": []}], ["In this study, we showed for the first time, to our knowledge, that Gli-dependent transcription is activated in T cells in vivo during murine AAD, a model for the immunopathology of asthma, and that genetic repression of Gli signaling in T cells decreases the differentiation and recruitment of Th2 cells to the lung.", {"entities": [[182, 188, "DISEASE"]]}], ["T cells were not the only cells that expressed activated Gli during AAD.", {"entities": []}], ["A substantial proportion of eosinophils and lung epithelial cells, both central mediators of the immunopathology of asthma, also underwent Hh/Gli signaling.", {"entities": [[116, 122, "DISEASE"]]}], ["Finally, Shh increased Il-4 expression in eosinophils.", {"entities": [[9, 12, "GENE"]]}], ["We therefore propose that Hh signaling during AAD is complex, involving multiple cell types, signaling in an auto- or paracrine fashion.", {"entities": []}], ["Improved understanding of the role of this major morphogenetic pathway in asthma may give rise to new drug targets for this chronic condition.", {"entities": [[74, 80, "DISEASE"]]}], ["Allergic asthma is characterized by airway hyperresponsiveness, eosinophilia, and mucus accumulation and is associated with increased IgE concentrations.", {"entities": [[64, 76, "DISEASE"], [9, 15, "DISEASE"]]}], ["We demonstrate here that peroxisome proliferator\u2013activated receptors (PPARs), PPAR-\u03b1 and PPAR-\u03b3, which have been shown recently to be involved in the regulation of various cell types within the immune system, decrease antigen-induced airway hyperresponsiveness, lung inflammation, eosinophilia, cytokine production, and GATA-3 expression as well as serum levels of antigen-specific IgE in a murine model of human asthma.", {"entities": [[281, 293, "DISEASE"], [413, 419, "DISEASE"]]}], ["In addition, we demonstrate that PPAR-\u03b1 and -\u03b3 are expressed in eosinophils and their activation inhibits in vitro chemotaxis and antibody-dependent cellular cytotoxicity.", {"entities": []}], ["Thus, PPAR-\u03b1 and -\u03b3 (co)agonists might be of therapeutic interest for the regulation of allergic or inflammatory reactions by targeting both regulatory and effector cells involved in the immune response.", {"entities": []}], ["The aim of our paper was to explore expressions of life choices and life chances (aspects of agency within structures) related to power and experiences of health among early unemployed adolescent young men during the transition period to adulthood.", {"entities": []}], ["These expressions of agency within structure were interpreted in the light of Cockerham\u2019s Health Lifestyles Theory.", {"entities": []}], ["Furthermore, social constructions of masculinities were addressed in our analysis.", {"entities": []}], ["Repeated interviews with ten young men in a cohort of school leavers were analyzed with qualitative content analysis.", {"entities": []}], ["Cockerham\u2019s model was useful for interpreting our findings and we found disposition to act to be a crucial theoretical tool to capture the will and intentions of participants in relation to health.", {"entities": []}], ["We developed the model in the following ways: structure and socialization were visualized as surrounding the whole model.", {"entities": []}], ["Analyses of what enhances or restricts power are important.", {"entities": []}], ["In addition to practices of health lifestyles, we added experiences of health as outcome as well as emotional aspects in disposition to act.", {"entities": []}], ["We interpret our findings as constructions of masculinities within certain structures, in relation to choices, habitus and practices.", {"entities": []}], ["Qualitative research could contribute to develop the understanding of the agency within structure relationships.", {"entities": []}], ["Future studies need to pay attention to experiences of health among young people at the margin of the labor market in various milieus \u2013 and to analyze these in relation to gender constructions and within the frame-work of agency within structure.", {"entities": []}], ["Myopia is a huge public health problem worldwide, reaching the highest incidence in Asia.", {"entities": [[0, 6, "DISEASE"]]}], ["Identification of susceptible genes is crucial for understanding the biological basis of myopia.", {"entities": [[89, 95, "DISEASE"]]}], ["In this paper, we have identified and characterized a functional myopia-associated gene using a specific mouse-knockout model.", {"entities": [[65, 71, "DISEASE"]]}], ["Mice lacking the muscarinic cholinergic receptor gene ( M 2 ; also known as Chrm2 ) were less susceptible to lens-induced myopia compared with wild-type mice, which showed significantly increased axial length and vitreous chamber depth when undergoing experimental induction of myopia.", {"entities": [[122, 128, "DISEASE"], [278, 284, "DISEASE"], [76, 81, "GENE"]]}], ["The key findings of this present study are that the sclera of M 2 mutant mice has higher expression of collagen type I and lower expression of collagen type V than do wild-type mice and mice that are mutant for other muscarinic subtypes, and, therefore, M 2 mutant mice were resistant to the development of experimental myopia.", {"entities": [[320, 326, "DISEASE"]]}], ["Pharmacological blockade of M 2 muscarinic receptor proteins retarded myopia progression in the mouse.", {"entities": [[70, 76, "DISEASE"]]}], ["These results suggest for the first time a role of M 2 in growth-related changes in extracellular matrix genes during myopia development in a mammalian model.", {"entities": [[118, 124, "DISEASE"]]}], ["M 2 receptor antagonists might thus provide a targeted therapeutic approach to the management of this refractive error.", {"entities": [[102, 118, "DISEASE"]]}], ["Many common clustering algorithms require a two-step process that limits their efficiency.", {"entities": []}], ["The algorithms need to be performed repetitively and need to be implemented together with a model selection criterion.", {"entities": []}], ["These two steps are needed in order to determine both the number of clusters present in the data and the corresponding cluster memberships.", {"entities": []}], ["As biomedical datasets increase in size and prevalence, there is a growing need for new methods that are more convenient to implement and are more computationally efficient.", {"entities": []}], ["In addition, it is often essential to obtain clusters of sufficient sample size to make the clustering result meaningful and interpretable for subsequent analysis.", {"entities": []}], ["We introduce Shrinkage Clustering , a novel clustering algorithm based on matrix factorization that simultaneously finds the optimal number of clusters while partitioning the data.", {"entities": []}], ["We report its performances across multiple simulated and actual datasets, and demonstrate its strength in accuracy and speed applied to subtyping cancer and brain tissues.", {"entities": [[146, 152, "DISEASE"]]}], ["In addition, the algorithm offers a straightforward solution to clustering with cluster size constraints.", {"entities": []}], ["Given its ease of implementation, computing efficiency and extensible structure, Shrinkage Clustering can be applied broadly to solve biomedical clustering tasks especially when dealing with large datasets.", {"entities": []}], ["Evidence is accumulating that perturbation of early life microbial colonization of the gut induces long-lasting adverse health effects in individuals.", {"entities": []}], ["Understanding the mechanisms behind these effects will facilitate modulation of intestinal health.", {"entities": []}], ["The objective of this study was to identify biological processes involved in these long lasting effects and the (molecular) factors that regulate them.", {"entities": []}], ["We used an antibiotic and the same antibiotic in combination with stress on piglets as an early life perturbation.", {"entities": []}], ["Then we used host gene expression data from the gut (jejunum) tissue and community-scale analysis of gut microbiota from the same location of the gut, at three different time-points to gauge the reaction to the perturbation.", {"entities": []}], ["We analysed the data by a new combination of existing tools.", {"entities": []}], ["First, we analysed the data in two dimensions, treatment and time, with quadratic regression analysis.", {"entities": []}], ["Then we applied network-based data integration approaches to find correlations between host gene expression and the resident microbial species.", {"entities": []}], ["The use of a new combination of data analysis tools allowed us to identify significant long-lasting differences in jejunal gene expression patterns resulting from the early life perturbations.", {"entities": []}], ["In addition, we were able to identify potential key gene regulators (hubs) for these long-lasting effects.", {"entities": []}], ["Furthermore, data integration also showed that there are a handful of bacterial groups that were associated with temporal changes in gene expression.", {"entities": []}], ["The applied systems-biology approach allowed us to take the first steps in unravelling biological processes involved in long lasting effects in the gut due to early life perturbations.", {"entities": []}], ["The observed data are consistent with the hypothesis that these long lasting effects are due to differences in the programming of the gut immune system as induced by the temporary early life changes in the composition and/or diversity of microbiota in the gut.", {"entities": []}], ["The online version of this article (doi:10.1186/s12864-015-1733-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The relationship between smoking and suicide remains controversial.", {"entities": []}], ["A total of 16 282 twin pairs born before 1958 in Finland and alive in 1974 were queried with detailed health and smoking questionnaires in 1975 and 1981, with response rates of 89% and 84%.", {"entities": []}], ["Smoking status and dose, marital, employment, and socio-economic status, and indicators of psychiatric and somatic illness were assessed at both time points.", {"entities": []}], ["Emergent psychiatric and medical illness and vital status, including suicide determined by forensic autopsy, were evaluated over 35-year follow-up through government registries.", {"entities": []}], ["The association between smoking and suicide was determined in competing risks hazard models.", {"entities": []}], ["In twin pairs discordant for smoking and suicide, the prospective association between smoking and suicide was determined using a matched case\u2013control design.", {"entities": []}], ["Smokers had a higher cumulative suicide incidence than former or never smokers.", {"entities": []}], ["Heavy smokers had significantly higher suicide risk [hazard ratio (HR) 3.47, 95% confidence interval (CI) 2.31\u20135.22] than light smokers (HR 2.30, 95% CI 1.61\u20133.23) ( p = 0.017).", {"entities": [[67, 69, "GENE"], [137, 139, "GENE"], [67, 69, "GENE"], [137, 139, "GENE"]]}], ["Compared with never smokers, smokers, but not former smokers, had increased suicide risk (HR 2.56, 95% CI 1.43\u20134.59), adjusting for depressive symptoms, alcohol and sedative\u2013hypnotic use, and excluding those who developed serious somatic or psychiatric illness.", {"entities": [[90, 92, "GENE"]]}], ["In twin pairs discordant for smoking and suicide, suicide was more likely in smokers [odds ratio (OR) 6.0, 95% CI 2.06\u201323.8].", {"entities": []}], ["Adults who smoked tobacco were more likely to die by suicide, with a large, dose-dependent effect.", {"entities": []}], ["This effect remained after consideration of many known predictors of suicide and shared familial effects, consistent with the hypothesis that exposure to tobacco smoke increases the risk of suicide.", {"entities": []}], ["Pain in trauma has a role similar to the double-edged sword.", {"entities": []}], ["On the one hand, pain is a good indicator to determine the severity and type of injury.", {"entities": []}], ["On the other hand, pain can induce sever complications and it may lead to further deterioration of the patient.", {"entities": []}], ["Therefore, knowing how to manage pain in trauma patients is an important part of systemic approach in trauma.", {"entities": []}], ["The aim of this manuscript is to provide information about pain management in trauma in the Emergency Room settings.", {"entities": []}], ["In this review we searched among electronic and manual documents covering a 15-yr period between 2000 and 2016.", {"entities": []}], ["Our electronic search included Pub Med, Google scholar, Web of Science, and Cochrane databases.", {"entities": []}], ["We looked for articles in English and in peer-reviewed journals using the following keywords: acute pain management, trauma, emergency room and injury.", {"entities": []}], ["More than 3200 documents were identified.", {"entities": []}], ["After screening based on the study inclusion criteria, 560 studies that had direct linkage to the study aim were considered for evaluation based World Health Organization (WHO) pain ladder chart.", {"entities": []}], ["To provide adequate pain management in trauma patients require: adequate assessment of age-specific pharmacologic pain management; identification of adequate analgesic to relieve moderate to severe pain; cognizance of serious adverse effects of pain medications and weighting medications against their benefits, and regularly reassessing patients and reevaluating their pain management regimen.", {"entities": []}], ["Patient-centered trauma care will also require having knowledge of barriers to pain management and discussing them with the patient and his/her family to identify solutions.", {"entities": []}], ["Lung fibrosis may be associated with Type-2 polarized inflammation.", {"entities": []}], ["Herein, we aim to investigate whether radiation can initiate a Type-2 immune response and contribute to the progression of pulmonary fibrosis in tumor-bearing animals.", {"entities": [[123, 141, "DISEASE"]]}], ["We developed a tumor-bearing mouse model with Lewis lung cancer to receive either radiation therapy alone or radiation combined with Th1 immunomodulator unmethylated cytosine-phosphorothioate-guanine containing oligodeoxynucleotide (CpG-ODN).", {"entities": [[52, 63, "DISEASE"], [57, 63, "DISEASE"]]}], ["The Type-2 immune phenotype in tumors and the histological grade of lung fibrosis were evaluated in mice sacrificed three weeks after irradiation.", {"entities": []}], ["Mouse lung tissues were analyzed for hydroxyproline and the expression of Type-1/Type-2 key transcription factors (T-bet/GATA-3).", {"entities": []}], ["The concentration of Type-1/Type-2 cytokines in serum was measured by cytometric bead array.", {"entities": []}], ["Lung fibrosis was observed to be more serious in tumor-bearing mice than in normal mice post-irradiation.", {"entities": []}], ["The fibrosis score in irradiated tumor-bearing mice on Day 21 was 4.33 \u00b1 0.82, which was higher than that of normal mice (2.00 \u00b1 0.63; P < 0.05).", {"entities": []}], ["Hydroxyproline and GATA-3 expression were increased in the lung tissues of tumor-bearing mice following irradiation.", {"entities": []}], ["CpG-ODN attenuated fibrosis by markedly decreasing GATA-3 expression.", {"entities": []}], ["Serum IL-13 and IL-5 were elevated, whereas INF-\u03b3 and IL-12 expression were decreased in irradiated tumor-bearing mice.", {"entities": []}], ["These changes were reversed after CpG-ODN treatment.", {"entities": []}], ["Thus, Type-2 immunity in tumors appeared to affect the outcome of radiation damage and might be of interest for future studies on developing approaches in which Type-1\u2013related immunotherapy and radiotherapy are used in combination.", {"entities": []}], ["The significance of the environment for health is increasingly being recognized.", {"entities": []}], ["There is a need for systematic approaches to assessment of environmental factors most relevant to health, health outcomes most influenced by the environment, and the relationships between them, as well as for approaches to representing the results of such assessments in policy deliberations.", {"entities": []}], ["As a step in the development of such methods, we used findings and data from the environmental protection and public health sectors to develop a set of measures representing topics relevant to children\u2019s environmental health.", {"entities": []}], ["We used a definition of the environment that emphasized contaminants and a process that involved both analytic and deliberative elements.", {"entities": []}], ["The steps in this process were to a ) develop a conceptual framework to depict relationships between environment and health with relevant types of data and information, b ) select topic areas of significance for children, c ) identify best available data sources and devise measures, d ) assess possible surrogate data sources and measures when needed, e ) design and implement metrics for computation of measures using specified data elements, f ) select graphical representations of measures, g ) identify related measures, and h ) identify data gaps.", {"entities": []}], ["Representatives of policy and stakeholder audiences participated in this process.", {"entities": []}], ["The measures are presented in three groups that reflect contaminants in the environment, contaminants in human tissues, and diseases and disorders.", {"entities": []}], ["The measures present scientifically based representations of data understandable to stakeholders and policy makers that integrate key information from the health and environment sectors in a consistent format.", {"entities": []}], ["The need for assessing noncancer risks for agents to which humans are routinely exposed indoors arises from the large amount of time spent indoors (i.e., employed persons spend about 60% of their time at home indoors, 30% at work indoors, and 5% in transit).", {"entities": []}], ["Sources of air pollutants include heating and cooling systems, combustion appliances, personal use products, furnishings, tobacco products, pesticides, bioeffluents from humans and animals, and other microbial contamination such as toxins from molds.", {"entities": []}], ["The purpose of this paper is to describe current dose-response assessment methods applicable to assessing risk following exposure to indoor air pollutants.", {"entities": []}], ["The role of structure-activity relationships in hazard identification is also described.", {"entities": []}], ["Risk assessments from exposure to indoor air pollutants require exposure assessments and dose-response assessments.", {"entities": []}], ["Dose-response assessment methodologies include the inhalation reference concentration (RfC), structure-activity relationships, dose-response models, and the decision analytic approach.", {"entities": []}], ["The RfC is an estimate (with uncertainty spanning perhaps an order of magnitude) of a daily exposure to the human population (including sensitive subgroups) that is likely to be without an appreciable risk of deleterious effects during a lifetime.", {"entities": []}], ["The current RfC method provides guidelines for making the necessary dosimetric adjustments for gases and aerosols.", {"entities": []}], ["Human equivalent concentrations for no-observed-adverse-effect levels in animals are determined by using mathematical relationships that adjust for regional deposition, solubility, ventilation rate, and blood:air partition coefficients.", {"entities": []}], ["The RfC methodology exists as an interim methodology.", {"entities": []}], ["Future scientific advancements are expected to further refine the approach.", {"entities": []}], ["Despite international guidelines, asthma control is short of the goal in different parts of the world.", {"entities": [[34, 40, "DISEASE"]]}], ["The objective of this study was to assess control of asthma in patients older than 14 years at the Chest Clinic of Jimma University Specialized Hospital/JUSH, South West Ethiopia.", {"entities": [[53, 59, "DISEASE"]]}], ["A cross-sectional hospital-based study was conducted on 234 physician-diagnosed asthmatic patients attending the chest follow up clinic from June 01 to July 31, 2012.", {"entities": []}], ["Asthma control was assessed using the GINA algorithm and the ACT questionnaire.", {"entities": [[0, 6, "DISEASE"]]}], ["Pulmonary function test was measured using a spirometer for 160 subjects.", {"entities": []}], ["Data were cleared, entered and analyzed using SPSS version 16 and independent variables were assessed for association with the level of asthma control using bivariate and multinomial analyses.", {"entities": [[136, 142, "DISEASE"]]}], ["Using the GINA based algorithm, 42 respondents (26.2%) were considered to have partly controlled asthma and the majority, 117 (76.1%), had uncontrolled asthma.", {"entities": [[97, 103, "DISEASE"], [152, 158, "DISEASE"]]}], ["Asthma was uncontrolled (ACT score <19) in 71.4% subjects and well-controlled (ACT score = 20\u201325) in 28.6%.", {"entities": [[0, 6, "DISEASE"]]}], ["Inhaled corticosteroids alone or in association with long-acting b-agonists, which are the prophylactic treatments recommended by GINA, were used by only 9 subjects (3.8%).", {"entities": []}], ["Factors associated independently with asthma control were individual patient's age group, unscheduled visit, frequency of SABA use, type of treatment and perceived rate of asthma control.", {"entities": [[38, 44, "DISEASE"], [172, 178, "DISEASE"]]}], ["Asthma control is unacceptably poor in Jimma, South West Ethiopia.", {"entities": [[0, 6, "DISEASE"]]}], ["This could be changed through improved appropriate treatment and frequent monitoring to achieve and maintain control.", {"entities": []}], ["Patients' non-adherence to medical treatment remains a persistent problem.", {"entities": []}], ["Many interventions to improve patient adherence are unsuccessful and sound theoretical foundations are lacking.", {"entities": []}], ["Innovations in theory and practice are badly needed.", {"entities": []}], ["A new and promising way could be to review the existing reviews of adherence to interventions and identify the underlying theories for effective interventions.", {"entities": []}], ["That is the aim of our study.", {"entities": []}], ["The study is a review of 38 systematic reviews of the effectiveness of adherence interventions published between 1990 and 2005.", {"entities": []}], ["Electronic literature searches were conducted in Medline, Psychinfo, Embase and the Cochrane Library.", {"entities": []}], ["Explicit inclusion and exclusion criteria were applied.", {"entities": []}], ["The scope of the study is patient adherence to medical treatment in the cure and care sector.", {"entities": []}], ["Significant differences in the effectiveness of adherence interventions were found in 23 of the 38 systematic reviews.", {"entities": []}], ["Effective interventions were found in each of four theoretical approaches to adherence interventions: technical, behavioural, educational and multi-faceted or complex interventions.", {"entities": []}], ["Technical solutions, such as a simplification of the regimen, were often found to be effective, although that does not count for every therapeutic regimen.", {"entities": []}], ["Overall, our results show that, firstly, there are effective adherence interventions without an explicit theoretical explanation of the operating mechanisms, for example technical solutions.", {"entities": []}], ["Secondly, there are effective adherence interventions, which clearly stem from the behavioural theories, for example incentives and reminders.", {"entities": []}], ["Thirdly, there are other theoretical models that seem plausible for explaining non-adherence, but not very effective in improving adherence behaviour.", {"entities": []}], ["Fourthly, effective components within promising theories could not be identified because of the complexity of many adherence interventions and the lack of studies that explicitly compare theoretical components.", {"entities": []}], ["There is a scarcity of comparative studies explicitly contrasting theoretical models or their components.", {"entities": []}], ["The relative weight of these theories and the effective components in the interventions designed to improve adherence, need to be assessed in future studies.", {"entities": []}], ["Osteopathic manipulative treatment (OMT) is a distinctive modality commonly used by osteopathic physicians to complement their conventional treatment of musculoskeletal disorders.", {"entities": []}], ["Previous reviews and meta-analyses of spinal manipulation for low back pain have not specifically addressed OMT and generally have focused on spinal manipulation as an alternative to conventional treatment.", {"entities": []}], ["The purpose of this study was to assess the efficacy of OMT as a complementary treatment for low back pain.", {"entities": []}], ["Computerized bibliographic searches of MEDLINE, EMBASE, MANTIS, OSTMED, and the Cochrane Central Register of Controlled Trials were supplemented with additional database and manual searches of the literature.", {"entities": []}], ["Six trials, involving eight OMT vs control treatment comparisons, were included because they were randomized controlled trials of OMT that involved blinded assessment of low back pain in ambulatory settings.", {"entities": []}], ["Data on trial methodology, OMT and control treatments, and low back pain outcomes were abstracted by two independent reviewers.", {"entities": []}], ["Effect sizes were computed using Cohen's d statistic and meta-analysis results were weighted by the inverse variance of individual comparisons.", {"entities": []}], ["In addition to the overall meta-analysis, stratified meta-analyses were performed according to control treatment, country where the trial was conducted, and duration of follow-up.", {"entities": []}], ["Sensitivity analyses were performed for both the overall and stratified meta-analyses.", {"entities": []}], ["Overall, OMT significantly reduced low back pain (effect size, -0.30; 95% confidence interval, -0.47 \u2013 -0.13; P = .001).", {"entities": []}], ["Stratified analyses demonstrated significant pain reductions in trials of OMT vs active treatment or placebo control and OMT vs no treatment control.", {"entities": []}], ["There were significant pain reductions with OMT regardless of whether trials were performed in the United Kingdom or the United States.", {"entities": []}], ["Significant pain reductions were also observed during short-, intermediate-, and long-term follow-up.", {"entities": []}], ["OMT significantly reduces low back pain.", {"entities": []}], ["The level of pain reduction is greater than expected from placebo effects alone and persists for at least three months.", {"entities": []}], ["Additional research is warranted to elucidate mechanistically how OMT exerts its effects, to determine if OMT benefits are long lasting, and to assess the cost-effectiveness of OMT as a complementary treatment for low back pain.", {"entities": []}], ["The response to exogenous epinephrine (Ep) is difficult to predict given the multitude of factors involved such as broad pharmacokinetic and pharmacodynamic between-subject variabilities, which may be more pronounced in children.", {"entities": []}], ["We investigated the pharmacokinetics and pharmacodynamics of Ep, co-administered with milrinone, in children who underwent open heart surgical repair for congenital defects following cardiopulmonary bypass, including associated variability factors.", {"entities": []}], ["Thirty-nine children with a high risk of low cardiac output syndrome were prospectively enrolled.", {"entities": [[60, 68, "DISEASE"]]}], ["Ep pharmacokinetics, hemodynamic and metabolic effects were analyzed using the non-linear mixed effects modeling software MONOLIX.", {"entities": []}], ["According to the final model, an Ep dosing simulation was suggested.", {"entities": []}], ["Ep dosing infusions ranged from 0.01 to 0.23\u00a0\u03bcg.kg CL x (BWi) q0 x (BWi ) According to this population analysis, the developmental effects of BW and age explained a part of the pharmacokinetic and pharmacodynamics between-subject variabilities of Ep administration in critically ill children.", {"entities": []}], ["This approach ultimately leads to a valuable Ep dosing simulation which should help clinicians to determine an appropriate a priori dosing regimen.", {"entities": []}], ["Premenstrual syndrome (PMS) occurs in women during their reproductive age with a quite negative impact on their daily lives.", {"entities": [[13, 21, "DISEASE"]]}], ["Women with PMS experience a wide range of physical or psychological symptoms and seek treatment for them.", {"entities": []}], ["Chinese herb medicine (CHM) is commonly used for PMS and the goal of this study is to investigate the prescription patterns of CHM for PMS by using a nationwide database.", {"entities": [[23, 26, "GENE"], [127, 130, "GENE"], [23, 26, "GENE"], [127, 130, "GENE"]]}], ["Prescriptions of CHM were obtained from two million beneficiaries randomly sampled from the National Health Insurance Research Database, a nationwide database in Taiwan.", {"entities": [[17, 20, "GENE"]]}], ["The ICD-9 code 625.4 was used to identify patients with PMS.", {"entities": []}], ["Association rule mining and social network analysis were used to explore both the combinations and the core treatments for PMS.", {"entities": []}], ["During 1998-2011, a total of 14,312 CHM prescriptions for PMS were provided.", {"entities": [[36, 39, "GENE"]]}], ["Jia-Wei-Xiao-Yao-San (JWXYS) was the CHM which had the highest prevalence (37.5% of all prescriptions) and also the core of prescription network for PMS.", {"entities": [[37, 40, "GENE"]]}], ["For combination of two CHM, JWXYS with Cyperus rotundus L. was prescribed most frequently, 7.7% of all prescriptions, followed by JWXYS with Leonurus heterophyllus Sweet, 5.9%, and Cyperus rotundus L. with Leonurus heterophyllus Sweet, 5.6%.", {"entities": [[23, 26, "GENE"]]}], ["JWXYS-centered CHM combinations were most commonly prescribed for PMS.", {"entities": [[15, 18, "GENE"]]}], ["To the best of our knowledge, this is the first pharmaco-epidemiological study to review CHM treatments for PMS.", {"entities": [[89, 92, "GENE"]]}], ["However, the efficacy and safety of these commonly used CHM were still lacking.", {"entities": [[56, 59, "GENE"]]}], ["The results of this study provide valuable references for further clinical trials and bench studies.", {"entities": []}], ["The prevalence of overweight is increasing globally and has become a serious health problem.", {"entities": []}], ["Low-grade chronic inflammation in overweight subjects is thought to play an important role in disease development.", {"entities": []}], ["Novel tools to understand these processes are needed.", {"entities": []}], ["Metabolic profiling is one such tool that can provide novel insights into the impact of treatments on metabolism.", {"entities": []}], ["To study the metabolic changes induced by a mild anti-inflammatory drug intervention, plasma metabolic profiling was applied in overweight human volunteers with elevated levels of the inflammatory plasma marker C-reactive protein.", {"entities": []}], ["Liquid and gas chromatography mass spectrometric methods were used to detect high and low abundant plasma metabolites both in fasted conditions and during an oral glucose tolerance test.", {"entities": []}], ["This is based on the concept that the resilience of the system can be assessed after perturbing a homeostatic situation.", {"entities": []}], ["Metabolic changes were subtle and were only detected using metabolic profiling in combination with an oral glucose tolerance test.", {"entities": []}], ["The repeated measurements during the oral glucose tolerance test increased statistical power, but the metabolic perturbation also revealed metabolites that respond differentially to the oral glucose tolerance test.", {"entities": []}], ["Specifically, multiple metabolic intermediates of the glutathione synthesis pathway showed time-dependent suppression in response to the glucose challenge test.", {"entities": []}], ["The fact that this is an insulin sensitive pathway suggests that inflammatory modulation may alter insulin signaling in overweight men.", {"entities": []}], ["In lung cancer, outcome measurement has been mostly limited to survival.", {"entities": [[3, 14, "DISEASE"], [8, 14, "DISEASE"]]}], ["Proper assessment of the value of lung cancer treatments, and the performance of institutions delivering care, requires more comprehensive measurement of standardised outcomes.", {"entities": [[34, 45, "DISEASE"], [39, 45, "DISEASE"]]}], ["The International Consortium for Health Outcomes Measurement convened an international, multidisciplinary working group of patient representatives, medical oncologists, surgeons, radiation oncologists, pulmonologists, palliative care specialists, registry experts and specialist nurses to review existing data and practices.", {"entities": []}], ["Using a modified Delphi method, the group developed a consensus recommendation (\u201cthe set\u201d) on the outcomes most essential to track for patients with lung cancer, along with baseline demographic, clinical and tumour characteristics (case-mix variables) for risk adjustment.", {"entities": [[149, 160, "DISEASE"], [154, 160, "DISEASE"]]}], ["The set applies to patients diagnosed with nonsmall cell lung cancer and small cell lung cancer.", {"entities": [[57, 68, "DISEASE"], [84, 95, "DISEASE"], [62, 68, "DISEASE"], [89, 95, "DISEASE"]]}], ["Our working group recommends the collection of the following outcomes: survival, complications during or within 6\u2005months of treatment and patient-reported domains of health-related quality of life including pain, fatigue, cough and dyspnoea.", {"entities": []}], ["Case-mix variables were defined to improve interpretation of comparisons.", {"entities": []}], ["We defined an international consensus recommendation of the most important outcomes for lung cancer patients, along with relevant case-mix variables, and are working to support adoption and reporting of these measures globally.", {"entities": [[88, 99, "DISEASE"], [93, 99, "DISEASE"]]}], ["#ICHOM Lung Cancer Standard Set of patient-centred outcomes: aligning global efforts to improve lung cancer care http://ow.ly/bFDR300EhY7", {"entities": [[7, 18, "DISEASE"], [96, 107, "DISEASE"], [12, 18, "DISEASE"], [101, 107, "DISEASE"]]}], ["This review describes current knowledge on the mechanisms that underlie glucocorticoid insufficiency in sepsis and the molecular action of glucocorticoids.", {"entities": []}], ["In patients with severe sepsis, numerous factors predispose to glucocorticoid insufficiency, including drugs, coagulation disorders and inflammatory mediators.", {"entities": []}], ["These factors may compromise the hypothalamic\u2013pituitary axis (i.e.", {"entities": []}], ["secondary adrenal insufficiency) or the adrenal glands (i.e.", {"entities": []}], ["primary adrenal failure), or may impair glucocorticoid access to target cells (i.e.", {"entities": []}], ["peripheral tissue resistance).", {"entities": []}], ["Irreversible anatomical damages to the hypothalamus, pituitary, or adrenal glands rarely occur.", {"entities": []}], ["Conversely, transient functional impairment in hormone synthesis may be a common complication of severe sepsis.", {"entities": []}], ["Glucocorticoids interact with a specific cytosolic glucocorticoid receptor, which undergoes conformational changes, sheds heat shock proteins and translocates to the nucleus.", {"entities": []}], ["Glucocorticoids may also interact with membrane binding sites at the surface of the cells.", {"entities": []}], ["The molecular action of glucocorticoids results in genomic and nongenomic effects.", {"entities": []}], ["Direct and indirect transcriptional and post-transcriptional effects related to the cytosolic glucocorticoid receptor account for the genomic effects.", {"entities": []}], ["Nongenomic effects are probably subsequent to cytosolic interaction between the glucocorticoid receptor and proteins, or to interaction between glucocorticoids and specific membrane binding sites.", {"entities": []}], ["Sputum induction is a non-invasive method for obtaining measurements of inflammation in the airways.", {"entities": []}], ["Whether spontaneously sampled sputum can be a valid surrogate is unknown.", {"entities": []}], ["The aim of this study was to compare levels of six inflammatory markers in sputum pairs consisting of induced and spontaneous sputum sampled on the same consultation either in a stable state or during exacerbations of chronic obstructive pulmonary disease (COPD).", {"entities": [[218, 255, "DISEASE"]]}], ["433 COPD patients aged 40\u201376, Global initiative for chronic Obstructive Lung Disease (GOLD) stage II-IV were enrolled in 2006/07 and followed every six months for three years.", {"entities": []}], ["356 patients were followed for potential exacerbations.", {"entities": []}], ["Interleukin-6, interleukin-8, interleukin-18, interferon gamma-inducible protein-10, monokine induced by gamma interferon and tumor necrosis factor-alpha (IL-6, IL-8, IL-18, IP-10, MIG and TNF-\u03b1) were measured by bead based multiplex immunoassay in 60 paired sputum samples from 45 patients.", {"entities": []}], ["Albumin was measured by enzyme immunoassay, for concentration correction.", {"entities": []}], ["Culturing for bacterial growth was performed on 24 samples.", {"entities": []}], ["Bland-Altman plots were used to assess agreement.", {"entities": []}], ["The paired non-parametric Wilcoxon signed-rank test, the non-parametric Spearman\u2019s rank correlation test and Kruskal-Wallis test were used for statistical analyses.", {"entities": []}], ["For all analyses, a p-value < 0.05 was considered significant.", {"entities": []}], ["Agreement between the two measurements was generally low for all six markers.", {"entities": []}], ["TNF-\u03b1 was significantly higher in spontaneous sputum at exacerbations (p = 0.002) and trending higher at the steady state (p = 0.06).", {"entities": []}], ["Correlation coefficients between the levels of markers in induced and spontaneous sputum varied between 0.58 (IL-18) to 0.83 (IP-10).", {"entities": []}], ["In spontaneous sputum IL-18 and MIG were higher in ex-smokers (p < 0.05).", {"entities": []}], ["The levels of all markers were higher in GOLD stage III & IV except for IL-6 in spontaneous sputum and IL-18 in induced sputum, compared with GOLD stage II, although not statistically significant.", {"entities": []}], ["In spontaneous sputum the levels of IL-6 were significantly higher if Haemophilus influenzae (HI) was not cultured.", {"entities": []}], ["We observed a low agreement and significant differences in inflammatory markers between induced and spontaneous sputum, both at steady state and exacerbations.", {"entities": []}], ["We recommend considering sampling method when reporting on inflammatory markers in sputum.", {"entities": []}], ["Dyslipidemia is a risk factor for cardiovascular disease, with elevated low-density lipoprotein cholesterol (LDL-C) and decreased high-density lipoprotein cholesterol (HDL-C) recognized as risk factors for acute coronary events.", {"entities": []}], ["Studies suggest an association between low cholesterol levels and poor outcomes in acute sepsis.", {"entities": []}], ["We sought to determine the relationship between baseline cholesterol levels and long-term rates of sepsis.", {"entities": []}], ["We used data from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort, a population-based cohort of 30,239 community-dwelling adults.", {"entities": []}], ["The primary outcome was first sepsis event, defined as hospitalization for an infection with the presence of \u22652 systemic inflammatory response syndrome criteria (abnormal temperature, heart rate, respiratory rate, white blood cell count) during the first 28\u00a0hours of hospitalization.", {"entities": [[143, 151, "DISEASE"]]}], ["Cox models assessed the association between quartiles of HDL-C or LDL-C and first sepsis event, adjusted for participant demographics, health behaviors, chronic medical conditions, and biomarkers.", {"entities": []}], ["We included 29,690 subjects with available baseline HDL-C and LDL-C.", {"entities": []}], ["There were 3423 hospitalizations for serious infections, with 1845 total sepsis events among 1526 individuals.", {"entities": []}], ["Serum HDL-C quartile was not associated with long-term rates of sepsis (hazard ratio (HR) (95% CI): Q1 (HDL-C 5\u201340\u00a0mg/dl), 1.08 (0.91\u20131.28); Q2 (HDL-C 41\u201349\u00a0mg/dl), 1.06 (0.90\u20131.26); Q3 (HDL-C 50\u201361\u00a0mg/dl), 1.04 (0.89\u20131.23); Q4, reference).", {"entities": [[86, 88, "GENE"]]}], ["However, compared with the highest quartile of LDL-C, low LDL-C was associated with higher rates of sepsis (Q1 (LDL-C 3\u201389\u00a0mg/dl), 1.30 (1.10\u20131.52); Q2 (LDL-C 90\u2013111\u00a0mg/dl), 1.24 (1.06\u20131.47); Q3 (LDL-C 112\u2013135\u00a0mg/dl), 1.07 (0.91\u20131.26); Q4, reference).", {"entities": []}], ["Low LDL-C was associated with higher long-terms rates of community-acquired sepsis.", {"entities": []}], ["HDL-C level was not associated with long-term sepsis rates.", {"entities": []}], ["The online version of this article (doi:10.1186/s13054-016-1579-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["An increasing prevalence of allergic diseases, such as atopic dermatitis, allergic rhinitis and bronchial asthma, has been noted worldwide.", {"entities": [[74, 91, "DISEASE"], [55, 72, "DISEASE"], [83, 91, "DISEASE"], [106, 112, "DISEASE"], [62, 72, "DISEASE"]]}], ["Allergic asthma strongly correlates with airway inflammation caused by the unregulated production of cytokines secreted by allergen-specific type-2 T helper (Th2) cells.", {"entities": [[0, 15, "DISEASE"], [9, 15, "DISEASE"]]}], ["This study aims to explore the therapeutic effect of the airway gene transfer of IL-12, IL-10 and TGF-\u03b2 on airway inflammation in a mouse model of allergic asthma.", {"entities": [[147, 162, "DISEASE"], [156, 162, "DISEASE"]]}], ["BALB/c mice were sensitized to ovalbumin (OVA) by intraperitoneal injections with OVA and challenged by nebulized OVA.", {"entities": []}], ["Different cytokine gene plasmids or non-coding vector plasmids were instilled daily into the trachea up to one day before the inhalatory OVA challenge phase.", {"entities": []}], ["Intratracheal administration of IL-10, IL-12 or TGF-\u03b2 can efficiently inhibit antigen-induced airway hyper-responsiveness and is able to largely significantly lower the number of eosinophils and neutrophils in bronchoalveolar lavage fluid of ovalbumin (OVA) sensitized and challenged mice during the effector phase.", {"entities": []}], ["Furthermore, the effect of IL-10 plasmids is more remarkable than any other cytokine gene plasmid.", {"entities": []}], ["On the other hand, local administration of IL-4 gene plasmids before antigen challenge can induce severe airway hyper-responsiveness (AHR) and airway eosinophilia.", {"entities": [[150, 162, "DISEASE"], [134, 137, "GENE"]]}], ["Our data demonstrated that anti- inflammatory cytokines, particularly IL-10, have the therapeutic potential for the alleviation of airway inflammation in murine model of asthma.", {"entities": [[170, 176, "DISEASE"]]}], ["Individuals with chronic obstructive pulmonary disease (COPD) are at a high risk of developing significant complications from infection with the influenza virus.", {"entities": [[145, 154, "DISEASE"], [17, 54, "DISEASE"]]}], ["It is therefore vital to ensure that prophylaxis with the influenza vaccine is effective in COPD.", {"entities": [[58, 67, "DISEASE"]]}], ["The aim of this study was to assess the immunogenicity of the 2010 trivalent influenza vaccine in persons with COPD compared to healthy subjects without lung disease, and to examine clinical factors associated with the serological response to the vaccine.", {"entities": [[77, 86, "DISEASE"], [153, 165, "DISEASE"]]}], ["In this observational study, 34 subjects (20 COPD, 14 healthy) received the 2010 influenza vaccine.", {"entities": [[81, 90, "DISEASE"]]}], ["Antibody titers at baseline and 28 days post-vaccination were measured using the hemagglutination inhibition assay (HAI) assay.", {"entities": []}], ["Primary endpoints included seroconversion (\u22654-fold increase in antibody titers from baseline) and the fold increase in antibody titer after vaccination.", {"entities": []}], ["Persons with COPD mounted a significantly lower humoral immune response to the influenza vaccine compared to healthy participants.", {"entities": [[79, 88, "DISEASE"]]}], ["Seroconversion occurred in 90% of healthy participants, but only in 43% of COPD patients ( P =0.036).", {"entities": []}], ["Increasing age and previous influenza vaccination were associated with lower antibody responses.", {"entities": [[28, 37, "DISEASE"]]}], ["Antibody titers did not vary significantly with cigarette smoking, presence of other comorbid diseases, or COPD severity.", {"entities": []}], ["The humoral immune response to the 2010 influenza vaccine was lower in persons with COPD compared to non-COPD controls.", {"entities": [[40, 49, "DISEASE"]]}], ["The antibody response also declined with increasing age and in those with a history of prior vaccination.", {"entities": []}], ["Background .", {"entities": []}], ["T2 inflammation of chronic rhinosinusitis with nasal polyps (CRSwNP) may be influenced by epithelial cytokines release (TSLP, IL-25, and IL-33).", {"entities": [[120, 124, "GENE"]]}], ["We investigated the release of TSLP, IL-25, and IL-33 by epithelial CRSwNP cells compared to epithelial sinus mucosa cells of patients with chronic rhinosinusitis without nasal polyps (CRSsNP).", {"entities": [[31, 35, "GENE"]]}], ["IL-25, IL-33, and TSLP were measured by ELISA in the supernatant of cell cultures derived by CRSwNP (9 patients, 6 atopic) and CRSsNP (7 patients, 2 atopic) in baseline condition and following stimulation with Dermatophagoides pteronyssinus (DP), Aspergillus fumigatus (AF), and poly(I:C).", {"entities": [[18, 22, "GENE"]]}], ["CRSwNP epithelial cells released increased levels of IL-25 (from 0.12 \u00b1 0.06\u2009pg/ml to 0.27 \u00b1 0.1\u2009pg/ml, p < 0.01) and TSLP (from 0.77 \u00b1 0.5\u2009pg/ml to 2.53 \u00b1 1.17\u2009pg/ml, p < 0.001) following poly(I:C) stimulation, while CRSsNP epithelial cells released increased levels of IL-25 and IL-33 following AF and DP stimulation, respectively (IL-25: from 0.18 \u00b1 0.07\u2009pg/ml to 0.51 \u00b1 0.1\u2009pg/ml, p < 0.001; IL-33: from 2.57 \u00b1 1.3\u2009pg/ml to 5.7 \u00b1 3.1\u2009pg/ml, p < 0.001).", {"entities": [[118, 122, "GENE"]]}], ["Conclusions .", {"entities": []}], ["CRSwNP epithelial cells release TSLP and IL-25 when stimulated by poly(I:C) but not by DP or AF, suggesting that viral infection may contribute to maintain and amplify the T2 immune response seen in CRSwNP.", {"entities": [[32, 36, "GENE"]]}], ["The early growth pattern, especially the age of peak growth, of broilers affects the time to market and slaughter weight, which in turn affect the profitability of the poultry industry.", {"entities": []}], ["However, the underlying mechanisms regulating chicken growth and development have rarely been studied.", {"entities": []}], ["This study aimed to identify candidate genes involved in chicken growth and investigated the potential regulatory mechanisms of early growth in chicken.", {"entities": []}], ["RNA sequencing was applied to compare the transcriptomes of chicken muscle tissues at three developmental stages during early growth.", {"entities": []}], ["In total, 978 differentially expressed genes (DEGs) (fold change \u2265 2; false discovery rate < 0.05) were detected by pairwise comparison.", {"entities": []}], ["Functional analysis showed that the DEGs are mainly involved in the processes of cell growth, muscle development, and cellular activities (such as junction, migration, assembly, differentiation, and proliferation).", {"entities": []}], ["Many of the DEGs are well known to be related to chicken growth, such as MYOD1 , GH , IGF2BP2 , IGFBP3 , SMYD1 , CEBPB , FGF2 , and IGFBP5 .", {"entities": [[73, 78, "GENE"], [86, 93, "GENE"], [96, 102, "GENE"], [105, 110, "GENE"], [113, 118, "GENE"], [121, 125, "GENE"], [132, 138, "GENE"]]}], ["KEGG pathway analysis identified that the DEGs were significantly enriched in five pathways (P < 0.1) related to growth and development: extracellular matrix\u2013receptor interaction, focal adhesion, tight junction, insulin signaling pathway, and regulation of the actin cytoskeleton.", {"entities": []}], ["A total of 42 DEGs assigned to these pathways are potential candidate genes inducing the difference in growth among the three developmental stages, such as MYH10 , FGF2 , FGF16 , FN1 , CFL2 , MAPK9 , IRS1 , PHKA1 , PHKB , and PHKG1 .", {"entities": [[156, 161, "GENE"], [164, 168, "GENE"], [171, 176, "GENE"], [179, 182, "GENE"], [185, 189, "GENE"], [192, 197, "GENE"], [200, 204, "GENE"], [207, 212, "GENE"], [215, 219, "GENE"], [226, 231, "GENE"]]}], ["Thus, our study identified a series of genes and several pathways that may participate in the regulation of early growth in chicken.", {"entities": []}], ["These results should serve as an important resource revealing the molecular basis of chicken growth and development.", {"entities": []}], ["Hydrogen sulfide is an essential catabolite that intervenes in the pathophysiology of several diseases from hypertension to stroke, diabetes and pancreatitis.", {"entities": [[108, 120, "DISEASE"], [145, 157, "DISEASE"]]}], ["It is endogenously synthesized mainly by two pyridoxal-5\u2032-phosphate-dependent enzymes involved in L-cysteine metabolism: cystathionine-\u00df-synthase (CBS) and cystathionine-\u03b3-lyase (CSE).", {"entities": [[147, 150, "GENE"]]}], ["Research in this field is currently impaired by the lack of pharmacological tools such as selective enzymatic inhibitors that could target specifically only one of these pathways.", {"entities": []}], ["We used a novel approach based on a hybrid method that includes drug design, synthetic biology, metabolomics and pharmacological assays to rationally design a new inhibitor selective for the CSE enzyme.", {"entities": []}], ["The identification of this compound opens new frontiers towards a better understanding of the role of CSE over CBS in the pathophysiology of diseases where a role for the H 2 S pathway has been proposed and the development of new lead compounds that could target the CSE enzyme.", {"entities": [[111, 114, "GENE"]]}], ["Modern high-throughput methods allow the investigation of biological functions across multiple \u2018omics\u2019 levels.", {"entities": []}], ["Levels include mRNA and protein expression profiling as well as additional knowledge on, for example, DNA methylation and microRNA regulation.", {"entities": []}], ["The reason for this interest in multi-omics is that actual cellular responses to different conditions are best explained mechanistically when taking all omics levels into account.", {"entities": []}], ["To map gene products to their biological functions, public ontologies like Gene Ontology are commonly used.", {"entities": []}], ["Many methods have been developed to identify terms in an ontology, overrepresented within a set of genes.", {"entities": []}], ["However, these methods are not able to appropriately deal with any combination of several data types.", {"entities": []}], ["Here, we propose a new method to analyse integrated data across multiple omics-levels to simultaneously assess their biological meaning.", {"entities": []}], ["We developed a model-based Bayesian method for inferring interpretable term probabilities in a modular framework.", {"entities": []}], ["Our Multi-level ONtology Analysis (MONA) algorithm performed significantly better than conventional analyses of individual levels and yields best results even for sophisticated models including mRNA fine-tuning by microRNAs.", {"entities": []}], ["The MONA framework is flexible enough to allow for different underlying regulatory motifs or ontologies.", {"entities": []}], ["It is ready-to-use for applied researchers and is available as a standalone application from http://icb.helmholtz-muenchen.de/mona .", {"entities": []}], ["Suhuang antitussive capsule (Suhuang), a traditional Chinese medication, is found effective in treating chronic cough and cough variant asthma (CVA).", {"entities": [[122, 142, "DISEASE"], [136, 142, "DISEASE"]]}], ["This study aimed to determine the possible effects and underlying mechanisms of Suhuang on chronic ovalbumin (OVA)-induced airway hyperresponsiveness (AHR), inflammation, and remodeling in mice.", {"entities": [[151, 154, "GENE"]]}], ["Mice were randomly assigned to six experimental groups: control, OVA model with or without Suhuang (low dose: 3.5\u2009g/kg, middle dose: 7.0\u2009g/kg, high dose: 14.0\u2009g/kg), or dexamethasone (2.5\u2009mg/kg).", {"entities": []}], ["AHR, inflammatory cells, cytokines in bronchoalveolar lavage fluid (BALF), lung pathology, mucus production, and airway remodeling were examined.", {"entities": [[0, 3, "GENE"]]}], ["We found Suhuang treated at lower doses effectively inhibited OVA-induced AHR, airway inflammation, mucus production and collagen deposition around the airway.", {"entities": [[74, 77, "GENE"]]}], ["High dose of Suhuang reduced most of the inflammatory hallmarks while exerted inconsiderable effects on the number of macrophages in BALF and AHR.", {"entities": [[142, 145, "GENE"]]}], ["At all doses, Suhuang significantly reduced the levels of interlukin (IL) -13 and transforming growth factor (TGF)-\u03b21, but had little effects on IL-4, IL-5, IL-17A and interferon (IFN)-\u03b3.", {"entities": []}], ["Thus, Suhuang administration alleviates the pathological changes of chronic asthma likely through inhibition of IL-13 and TGF-\u03b21.", {"entities": [[76, 82, "DISEASE"]]}], ["Suhuang might be a promising therapy for patients with allergic asthma in the future.", {"entities": [[55, 70, "DISEASE"], [64, 70, "DISEASE"]]}], ["Exposure to high altitude induces physiological responses due to hypoxia.", {"entities": []}], ["Lungs being at the first level to face the alterations in oxygen levels are critical to counter and balance these changes.", {"entities": []}], ["Studies have been done analysing pulmonary proteome alterations in response to exposure to hypobaric hypoxia.", {"entities": []}], ["However, such studies have reported the alterations at specific time points and do not reflect the gradual proteomic changes.", {"entities": []}], ["These studies also identify the various biochemical pathways and responses induced after immediate exposure and the resolution of these effects in challenge to hypobaric hypoxia.", {"entities": []}], ["In the present study, using 2-DE/MS approach, we attempt to resolve these shortcomings by analysing the proteome alterations in lungs in response to different durations of exposure to hypobaric hypoxia.", {"entities": []}], ["Our study thus highlights the gradual and dynamic changes in pulmonary proteome following hypobaric hypoxia.", {"entities": []}], ["For the first time, we also report the possible consideration of SULT1A1, as a biomarker for the diagnosis of high altitude pulmonary edema (HAPE).", {"entities": [[124, 139, "DISEASE"], [65, 72, "GENE"]]}], ["Higher SULT1A1 levels were observed in rats as well as in humans exposed to high altitude, when compared to sea-level controls.", {"entities": [[7, 14, "GENE"]]}], ["This study can thus form the basis for identifying biomarkers for diagnostic and prognostic purposes in responses to hypobaric hypoxia.", {"entities": []}], ["This meta-analysis showed trough concentrations of 0.5\u200amg/L to be the lower limit of voriconazole during treatment, whereas trough concentrations of 3.0\u200amg/L were associated with an increased risk of moderate to severe hepatotoxicity, particularly for the Asian population.", {"entities": []}], ["The optimum trough concentration of voriconazole for clinical response and safety is controversial.", {"entities": []}], ["The objective of this review was to determine the optimum trough concentration of voriconazole and evaluate its relationship with efficacy and safety.", {"entities": []}], ["MEDLINE, EMBASE, ClinicalTrials.gov, the Cochrane Library and three Chinese literature databases were searched.", {"entities": []}], ["Observational studies that compared clinical outcomes below and above the trough concentration cut-off value were included.", {"entities": []}], ["We set the trough concentration cut-off value for efficacy as 0.5, 1.0, 1.5, 2.0 and 3.0 mg/L and for safety as 3.0, 4.0, 5.0, 5.5 and 6.0 mg/L.", {"entities": []}], ["The efficacy outcomes were invasive fungal infection-related mortality, all-cause mortality, rate of successful treatment and rate of prophylaxis failure.", {"entities": []}], ["The safety outcomes included incidents of hepatotoxicity, neurotoxicity and visual disorders.", {"entities": []}], ["A total of 21 studies involving 1158 patients were included.", {"entities": []}], ["Compared with voriconazole trough concentrations of >0.5 mg/L, levels of <0.5 mg/L significantly decreased the rate of treatment success (risk ratio\u200a=\u200a0.46, 95% CI 0.29\u20130.74).", {"entities": []}], ["The incidence of hepatotoxicity was significantly increased with trough concentrations >3.0, >4.0, >5.5 and >6.0 mg/L.", {"entities": []}], ["The incidence of neurotoxicity was significantly increased with trough concentrations >4.0 and >5.5 mg/L.", {"entities": []}], ["A voriconazole level of 0.5 mg/L should be considered the lower threshold associated with efficacy.", {"entities": []}], ["A trough concentration >3.0 mg/L is associated with increased hepatotoxicity, particularly for the Asian population, and >4.0 mg/L is associated with increased neurotoxicity.", {"entities": []}], ["The aim of the study was to analyze the effect of preoperative patient characteristics on health outcomes 6\u00a0months after total hip replacement (THR), to support patient\u2019s decision making in daily practice with predicted health states and satisfaction thresholds.", {"entities": []}], ["By giving incremental effects for different patient subgroups, we support comparative effectiveness research (CER) on osteoarthritis interventions.", {"entities": [[118, 132, "DISEASE"]]}], ["In 2012, 321 patients participated in health state evaluation before and 6\u00a0months after THR.", {"entities": []}], ["Health-related quality of life (HRQoL) was measured with the EQ-5D questionnaire.", {"entities": []}], ["Hip-specific pain, function, and mobility were measured with the WOMAC in a prospective observation of a cohort.", {"entities": []}], ["The predictive capability of preoperative patient characteristics \u2013 classified according to socio-demographic factors, medical factors, and health state variables \u2013 for changes in health outcomes is tested by correlation analysis and multivariate linear regressions.", {"entities": []}], ["Related satisfaction thresholds were calculated with the patient acceptable symptom state (PASS) concept.", {"entities": []}], ["The mean WOMAC and EQ-5D scores before operation were 52 and 60 respectively (0 worst, 100 best).", {"entities": []}], ["At the 6-month follow-up, scores improved by 35 and 19 units.", {"entities": []}], ["On average, patients reported satisfaction with the operation if postoperative ( change ) WOMAC scores were higher than 85 ( 32 ) and postoperative ( change ) EQ-5D scores were higher than 79 ( 14 ).", {"entities": []}], ["Changes in WOMAC and EQ-5D scores can mainly be explained by preoperative scores.", {"entities": []}], ["The lower the preoperative WOMAC or EQ-5D scores, the higher the change in the scores.", {"entities": []}], ["Very good or very poor preoperative scores lower the probability of patient satisfaction with THR.", {"entities": []}], ["Shared decision making using a personalized risk assessment approach provides predicted health states and satisfaction thresholds.", {"entities": []}], ["The online version of this article (doi:10.1186/s12955-014-0108-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Studies show obesity decreases risk of tuberculosis (TB) disease.", {"entities": [[39, 51, "DISEASE"], [13, 20, "DISEASE"]]}], ["There is limited evidence on whether high body mass index also protects against TB infection; how very high body mass indices influence TB risk; or whether nutritional status predicts this risk in children.", {"entities": []}], ["We assessed the impact of body mass index on incident TB infection and disease among adults and children.", {"entities": []}], ["We conducted a prospective cohort study among household contacts of pulmonary TB cases in Lima, Peru.", {"entities": []}], ["We determined body mass index at baseline and followed participants for one year for TB infection and disease.", {"entities": []}], ["We used Cox proportional regression analyses to estimate hazard ratios for incident TB infection and disease.", {"entities": []}], ["We enrolled 14,044 household contacts, and among 6853 negative for TB infection and disease at baseline, 1787 (26.1%) became infected.", {"entities": []}], ["A total of 406 contacts developed secondary TB disease during follow-up.", {"entities": []}], ["Body mass index did not predict risk of TB infection but overweight household contacts had significantly decreased risk of TB disease (HR 0.48; 95% CI 0.37\u20130.64; p <0.001) compared to those with normal weight.", {"entities": [[135, 137, "GENE"]]}], ["Among adults, body mass index \u2265 35 kg/m High body mass index protects adults against TB disease even at levels \u2265 35 kg/m", {"entities": []}], ["A rigorous systematic review and meta-analysis focused on randomised controlled trials (RCTs) of non-individualised homeopathic treatment has not previously been reported.", {"entities": []}], ["We tested the null hypothesis that the main outcome of treatment using a non-individualised (standardised) homeopathic medicine is indistinguishable from that of placebo.", {"entities": []}], ["An additional aim was to quantify any condition-specific effects of non-individualised homeopathic treatment.", {"entities": []}], ["Literature search strategy, data extraction and statistical analysis all followed the methods described in a pre-published protocol.", {"entities": []}], ["A trial comprised \u2018reliable evidence\u2019 if its risk of bias was low or it was unclear in one specified domain of assessment.", {"entities": []}], ["\u2018Effect size\u2019 was reported as standardised mean difference (SMD), with arithmetic transformation for dichotomous data carried out as required; a negative SMD indicated an effect favouring homeopathy.", {"entities": []}], ["Forty-eight different clinical conditions were represented in 75 eligible RCTs.", {"entities": []}], ["Forty-nine trials were classed as \u2018high risk of bias\u2019 and 23 as \u2018uncertain risk of bias\u2019; the remaining three, clinically heterogeneous, trials displayed sufficiently low risk of bias to be designated reliable evidence.", {"entities": []}], ["Fifty-four trials had extractable data: pooled SMD was \u20130.33 (95% confidence interval (CI) \u20130.44, \u20130.21), which was attenuated to \u20130.16 (95% CI \u20130.31, \u20130.02) after adjustment for publication bias.", {"entities": []}], ["The three trials with reliable evidence yielded a non-significant pooled SMD: \u20130.18 (95% CI \u20130.46, 0.09).", {"entities": []}], ["There was no single clinical condition for which meta-analysis included reliable evidence.", {"entities": []}], ["The quality of the body of evidence is low.", {"entities": []}], ["A meta-analysis of all extractable data leads to rejection of our null hypothesis, but analysis of a small sub-group of reliable evidence does not support that rejection.", {"entities": []}], ["Reliable evidence is lacking in condition-specific meta-analyses, precluding relevant conclusions.", {"entities": []}], ["Better designed and more rigorous RCTs are needed in order to develop an evidence base that can decisively provide reliable effect estimates of non-individualised homeopathic treatment.", {"entities": []}], ["The online version of this article (doi:10.1186/s13643-017-0445-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Asthma is a disease of airway inflammation characterized by airway hyperresponsiveness, eosinophilic inflammation, and hypersecretion of mucus.", {"entities": []}], ["Ellagic acid, a compound derived from medicinal plants and fruits, has shown anti-inflammatory activity in several experimental disease models.", {"entities": []}], ["We used the classical experimental model, in BALB/c mice, of sensibilization with ovalbumin to determine the effect of ellagic acid (10\u2009mg/kg; oral route) in the resolution of allergic airways response.", {"entities": []}], ["Dexamethasone (1\u2009mg/kg; subcutaneous route) was used as a positive control.", {"entities": []}], ["The control group consisted of nonimmunized mice that received challenge with ovalbumin.", {"entities": []}], ["Ellagic acid and dexamethasone or vehicle (water) were administered before or after intranasal allergen challenge.", {"entities": []}], ["Ellagic acid accelerated the resolution of airways inflammation by decreasing total leukocytes and eosinophils numbers in the bronchoalveolar lavage fluid (BALF), the mucus production and lung inflammation in part by reducing IL-5 concentration, eosinophil peroxidase (EPO) activity, and P-selectin expression, but not activator protein 1 (AP-1) and nuclear factor kappa B (NF- \u03ba B) pathways.", {"entities": [[269, 272, "GENE"]]}], ["In addition, ellagic acid enhanced alveolar macrophage phagocytosis of IgG-OVA-coated beads ex vivo , a new proresolving mechanism for the clearance of allergen from the airways.", {"entities": []}], ["Together, these findings identify ellagic acid as a potential therapeutic agent for accelerating the resolution of allergic airways inflammation.", {"entities": []}], ["There is increasing recognition of the importance of early environmental exposures in the development of childhood asthma.", {"entities": [[115, 121, "DISEASE"]]}], ["Outdoor air pollution is a recognized asthma trigger, but it is unclear whether exposure influences incident disease.", {"entities": [[38, 44, "DISEASE"]]}], ["We investigated the effect of exposure to ambient air pollution in utero and during the first year of life on risk of subsequent asthma diagnosis in a population-based nested case\u2013control study.", {"entities": [[129, 135, "DISEASE"]]}], ["We assessed all children born in southwestern British Columbia in 1999 and 2000 ( n = 37,401) for incidence of asthma diagnosis up to 3\u20134 years of age using outpatient and hospitalization records.", {"entities": [[111, 117, "DISEASE"]]}], ["Asthma cases were age- and sex-matched to five randomly chosen controls from the eligible cohort.", {"entities": [[0, 6, "DISEASE"]]}], ["We estimated each individual\u2019s exposure to ambient air pollution for the gestational period and first year of life using high-resolution pollution surfaces derived from regulatory monitoring data as well as land use regression models adjusted for temporal variation.", {"entities": []}], ["We used logistic regression analyses to estimate effects of carbon monoxide, nitric oxide, nitrogen dioxide, particulate matter \u2264 10 \u03bcm and \u2264 2.5 \u03bcm in aerodynamic diameter (PM 10 and PM 2.5 ), ozone, sulfur dioxide, black carbon, woodsmoke, and proximity to roads and point sources on asthma diagnosis.", {"entities": [[286, 292, "DISEASE"]]}], ["A total of 3,482 children (9%) were classified as asthma cases.", {"entities": [[50, 56, "DISEASE"]]}], ["We observed a statistically significantly increased risk of asthma diagnosis with increased early life exposure to CO, NO, NO 2 , PM 10 , SO 2 , and black carbon and proximity to point sources.", {"entities": [[60, 66, "DISEASE"]]}], ["Traffic-related pollutants were associated with the highest risks: adjusted odds ratio = 1.08 (95% confidence interval, 1.04\u20131.12) for a 10-\u03bcg/m 2 , and 1.10 (1.06\u20131.13) for a 100-\u03bcg/m", {"entities": []}], ["IgG4 is the least abundant IgG subclass in human serum, representing less than 5\u00a0% of all IgG.", {"entities": []}], ["Increases in IgG4 occur following chronic exposure to antigen and are generally associated with states of immune tolerance.", {"entities": []}], ["In line with this, IgG4 is regarded as an anti-inflammatory antibody with a limited ability to elicit effective immune responses.", {"entities": []}], ["Furthermore, IgG4 attenuates allergic responses by inhibiting the activity of IgE.", {"entities": []}], ["The mechanism by which IgG4 inhibits IgE-mediated hypersensitivity has been investigated using a variety of model systems leading to two proposed mechanisms.", {"entities": []}], ["First by sequestering antigen, IgG4 can function as a blocking antibody, preventing cross-linking of receptor bound IgE.", {"entities": []}], ["Second IgG4 has been proposed to co-stimulate the inhibitory IgG receptor Fc\u03b3RIIb, which can negatively regulate Fc\u03b5RI signaling and in turn inhibit effector cell activation.", {"entities": []}], ["Recent advances in our understanding of the structural features of human IgG4 have shed light on the unique functional and immunologic properties of IgG4.", {"entities": []}], ["The aim of this review is to evaluate our current understanding of IgG4 biology and reassess the mechanisms by which IgG4 functions to inhibit IgE-mediated allergic responses.", {"entities": []}], ["A number of case reports on occupational asthma caused by herbal medicines have been issued, for example, on Sanyak, Chunkung, Banha, and Brazilian ginseng.", {"entities": [[41, 47, "DISEASE"]]}], ["Recently, cases of occupational asthma induced by Sanyak and Korean ginseng have been reported, but the pathogenic mechanisms involved are unknown.", {"entities": [[32, 38, "DISEASE"]]}], ["This study was carried out to evaluate the immunologic mechanism underlying Korean ginseng-induced occupational asthma.", {"entities": [[112, 118, "DISEASE"]]}], ["A patient engaged in Korean ginseng wholesale was referred for recurrent dyspnea, wheezing, and nasal symptoms, which were aggravated at work.", {"entities": []}], ["Allergen bronchial provocation testing to Korean ginseng extract showed a typical immediate response, and skin prick testing to Korean ginseng extract also showed a strong positive response.", {"entities": []}], ["Moreover, serum-specific IgE levels to Korean ginseng extract were significantly higher than in controls.", {"entities": []}], ["Enzyme-linked immunosorbent assay (ELISA) inhibition tests showed a dose-dependent inhibition by Korean ginseng, but not by Dermatophagoides farinae , wheat flour, or Chinese balloon flower.", {"entities": []}], ["Sodium dodecylsulfate-poly-acrylamide gel electrophoresis (SDS-PAGE) and immunoblotting revealed four specific Immunoglobulin E (IgE) binding components at 26, 30, 47, and 60 kDa, which were not bound by control sera.", {"entities": []}], ["These results strongly suggest that occupation asthma induced by Korean ginseng is induced via an IgE-mediated mechanism.", {"entities": [[47, 53, "DISEASE"]]}], ["Blinding is a cornerstone of treatment evaluation.", {"entities": []}], ["Blinding is more difficult to obtain in trials assessing nonpharmacological treatment and frequently relies on \u201ccreative\u201d (nonstandard) methods.", {"entities": []}], ["The purpose of this study was to systematically describe the strategies used to obtain blinding in a sample of randomized controlled trials of nonpharmacological treatment.", {"entities": []}], ["We systematically searched in Medline and the Cochrane Methodology Register for randomized controlled trials (RCTs) assessing nonpharmacological treatment with blinding, published during 2004 in high-impact-factor journals.", {"entities": []}], ["Data were extracted using a standardized extraction form.", {"entities": []}], ["We identified 145 articles, with the method of blinding described in 123 of the reports.", {"entities": []}], ["Methods of blinding of participants and/or health care providers and/or other caregivers concerned mainly use of sham procedures such as simulation of surgical procedures, similar attention-control interventions, or a placebo with a different mode of administration for rehabilitation or psychotherapy.", {"entities": []}], ["Trials assessing devices reported various placebo interventions such as use of sham prosthesis, identical apparatus (e.g., identical but inactivated machine or use of activated machine with a barrier to block the treatment), or simulation of using a device.", {"entities": []}], ["Blinding participants to the study hypothesis was also an important method of blinding.", {"entities": []}], ["The methods reported for blinding outcome assessors relied mainly on centralized assessment of paraclinical examinations, clinical examinations (i.e., use of video, audiotape, photography), or adjudications of clinical events.", {"entities": []}], ["This study classifies blinding methods and provides a detailed description of methods that could overcome some barriers of blinding in clinical trials assessing nonpharmacological treatment, and provides information for readers assessing the quality of results of such trials.", {"entities": []}], ["An assessment of blinding methods used in nonpharmacological trials published in one year in high-impact factor journals classifies methods used and describes methods that could overcome some barriers of blinding.", {"entities": []}], ["Well-conducted \u201crandomized controlled trials\u201d are generally considered to be the most reliable source of information about the effects of medical treatments.", {"entities": []}], ["In a randomized trial, the play of chance is used to decide whether each patient receives the treatment under investigation, or whether he/she is assigned to a \u201ccontrol\u201d group receiving the standard treatment for their condition.", {"entities": []}], ["This helps makes sure that the two groups of patients receiving the different treatments are equivalent at the start of the trial.", {"entities": []}], ["Proper randomization also prevents doctors from deciding which treatment individual patients are given, which could distort the results.", {"entities": []}], ["An additional technique used is \u201cblinding,\u201d which involves taking steps to prevent patients, doctors, or other people involved in the trial (e.g., those recording measurements) from finding out which patients have received which treatment.", {"entities": []}], ["Properly done, blinding should make sure the results of a trial are more accurate.", {"entities": []}], ["This is because in an unblinded study, participants may respond better if they know they have received a promising new treatment (or worse if they only got a placebo or an old drug).", {"entities": []}], ["In addition, doctors and others in the research team may \u201cwant\u201d a particular treatment to perform better in the trial, and unthinking bias could creep into their measurements or actions.", {"entities": []}], ["However, blinding is not a simple, single step; the people carrying out the trial often have to set up a variety of different procedures.", {"entities": []}], ["The authors of this study had already conducted research into the way in which blinding is done in trials involving drug (\u201cpharmacological\u201d) treatment.", {"entities": []}], ["Their work was published in October 2006 in PLoS Medicine .", {"entities": []}], ["However, concealing from patients the type of pill that they are being given is much easier than, for example, concealing whether or not they are having surgery or whether or not they are having psychotherapy.", {"entities": []}], ["The authors therefore set out to look at the methods that are in use for blinding in nonpharmacological trials.", {"entities": []}], ["They hoped that a better understanding of the different blinding methods would help people doing trials to design better trials in the future, and also help readers to interpret the quality of completed trials.", {"entities": []}], ["The authors systematically searched the published medical literature to find all randomized, blinded drug trials published in just one year (2004) in a number of different \u201chigh-impact\u201d journals (well-regarded journals whose articles are often mentioned in other articles).", {"entities": []}], ["Then, they classified information from the published trial reports.", {"entities": []}], ["They ended up with 145 trial reports, of which 123 described how blinding was done.", {"entities": []}], ["The trials covered a wide range of medical conditions and types of treatment.", {"entities": []}], ["The blinding methods used mainly involved the use of \u201csham\u201d procedures.", {"entities": []}], ["Thus, in 80% of the studies in which the treatment involved a medical device, a pretend device had been used to make patients in the control group think they were receiving treatment.", {"entities": []}], ["In many of the treatments involving surgery, researchers had devised elaborate ways of making patients think they had had an operation.", {"entities": []}], ["When the treatment involved manipulation (e.g.", {"entities": []}], ["physiotherapy or chiropractic), fake \u201chands-on\u201d techniques were given to the control patients.", {"entities": []}], ["The authors of this systematic review classify all the other techniques that were used to blind both the patients and members of the research teams.", {"entities": []}], ["They found that some highly innovative ideas have been successfully put into practice.", {"entities": []}], ["The authors have provided a detailed description of methods that could overcome some barriers of blinding in clinical trials assessing nonpharmacological treatment.", {"entities": []}], ["The classification of the techniques used will be useful for other researchers considering what sort of blinding they will use in their own research.", {"entities": []}], ["Please access these Web sites via the online version of this summary at http://dx.doi.org/10.1371/journal.pmed.0040061 .", {"entities": []}], ["The James Lind Library has been created to help patients and researchers understand fair tests of treatments in health care by illustrating how fair tests have developed over the centuries ClinicalTrials.gov, a trial registry created by the US National Institutes of Health, has an introduction to understanding clinical trials The UK National Health Service National Electronic Library for Health has an introduction to controlled clinical trials The CONSORT statement is intended to strengthen evidence-based reporting of clinical trials", {"entities": []}], ["Guanine protein-coupled receptors (GPCRs) constitute a eukaryotic transmembrane protein family and function as \u201cmolecular switches\u201d in the second messenger cascades and are found in all organisms between yeast and humans.", {"entities": []}], ["They form the single, biggest drug-target family due to their versatility of action and their role in several physiological functions, being active players in detecting the presence of light, a variety of smells and tastes, amino acids, nucleotides, lipids, chemicals etc.", {"entities": []}], ["in the environment of the cell.", {"entities": []}], ["Comparative genomic studies on model organisms provide information on target receptors in humans and their function.", {"entities": []}], ["The Japanese teleost Fugu has been identified as one of the smallest vertebrate genomes and a compact model to study the human genome, owing to the great similarity in its gene repertoire with that of human and other vertebrates.", {"entities": []}], ["Thus the characterization of the GPCRs of Fugu would provide insights to the evolution of the vertebrate genome.", {"entities": []}], ["We classified the GPCRs in the Fugu genome and our analysis of its 316 membrane-bound receptors, available on the public databases as well as from literature, detected 298 GPCRs that were grouped into five main families according to the GRAFS classification system (namely, Glutamate, Rhodopsin, Adhesion, Frizzled and Secretin).", {"entities": []}], ["We also identified 18 other GPCRs that could not be grouped under the GRAFS family and hence were classified as \u2018Other 7TM\u2019 receptors.", {"entities": []}], ["On comparison of the GPCR information from the Fugu genome with those in the human and chicken genomes, we detected 96.83% (306/316) and 96.51% (305/316) orthology in GPCRs among the Fugu-human genomes and Fugu-chicken genomes, respectively.", {"entities": []}], ["This study reveals the position of pisces in vertebrate evolution from the GPCR perspective.", {"entities": []}], ["Fugu can act as a reference model for the human genome for other protein families as well, going by the high orthology observed for GPCRs between Fugu and human.", {"entities": []}], ["The evolutionary comparison of GPCR sequences between key vertebrate classes of mammals, birds and fish will help in identifying key functional residues and motifs so as to fill in the blanks in the evolution of GPCRs in vertebrates.", {"entities": []}], ["Elevated levels of combustion-derived particulate matter (CDPM) are a risk factor for the development of lung diseases such as asthma.", {"entities": [[127, 133, "DISEASE"]]}], ["Studies have shown that CDPM exacerbates asthma, inducing acute lung dysfunction and inflammation; however, the impact of CDPM exposure on early immunological responses to allergens remains unclear.", {"entities": [[41, 47, "DISEASE"]]}], ["To determine the effects of early-life CDPM exposure on allergic asthma development in infants, we exposed infant mice to CDPM and then induced a mouse model of asthma using house dust mite (HDM) allergen.", {"entities": [[56, 71, "DISEASE"], [65, 71, "DISEASE"], [161, 167, "DISEASE"]]}], ["Mice exposed to CDPM+HDM failed to develop a typical asthma phenotype including airway hyperresponsiveness, Th2-inflammation, Muc5ac expression, eosinophilia, and HDM-specific Ig compared to HDM-exposed mice.", {"entities": [[145, 157, "DISEASE"], [53, 59, "DISEASE"]]}], ["Although HDM-specific IgE was attenuated, total IgE was two-fold higher in CDPM+HDM mice compared to HDM-mice.", {"entities": []}], ["We further demonstrate that CDPM exposure during early life induced an immunosuppressive environment in the lung, concurrent with increases in tolerogenic dendritic cells and Tregs, resulting in suppression of Th2 responses.", {"entities": []}], ["Despite having early immunosuppression, these mice develop severe allergic inflammation when challenged with allergen as adults.", {"entities": []}], ["These findings demonstrate a mechanism whereby CDPM exposure modulates adaptive immunity, inducing specific-antigen tolerance while amplifying total IgE, and leading to a predisposition to develop asthma upon rechallenge later in life.", {"entities": [[197, 203, "DISEASE"]]}], ["Patients with severe viral infections are often hospitalized in intensive care units (ICUs) and recent studies underline the frequency of viral detection in ICU patients.", {"entities": []}], ["Viral infections in the ICU often involve the respiratory or the central nervous system and can cause significant morbidity and mortality especially in immunocompromised patients.", {"entities": []}], ["The mainstay of therapy of viral infections is supportive care and antiviral therapy when available.", {"entities": []}], ["Increased understanding of the molecular mechanisms of viral infection has provided great potential for the discovery of new antiviral agents that target viral proteins or host proteins that regulate immunity and are involved in the viral life cycle.", {"entities": []}], ["These novel treatments need to be further validated in animal and human randomized controlled studies.", {"entities": []}], ["Genetic adaptation to different environmental conditions is expected to lead to large differences between populations at selected loci, thus providing a signature of positive selection.", {"entities": []}], ["Whereas balancing selection can maintain polymorphisms over long evolutionary periods and even geographic scale, thus leads to low levels of divergence between populations at selected loci.", {"entities": []}], ["However, little is known about the relative importance of these two selective forces in shaping genomic diversity, partly due to difficulties in recognizing balancing selection in species showing low levels of differentiation.", {"entities": []}], ["Here we address this problem by studying genomic diversity in the European common vole ( Microtus arvalis ) presenting high levels of differentiation between populations (average F ST \u200a=\u200a0.31).", {"entities": []}], ["We studied 3,839 Amplified Fragment Length Polymorphism (AFLP) markers genotyped in 444 individuals from 21 populations distributed across the European continent and hence over different environmental conditions.", {"entities": []}], ["Our statistical approach to detect markers under selection is based on a Bayesian method specifically developed for AFLP markers, which treats AFLPs as a nearly codominant marker system, and therefore has increased power to detect selection.", {"entities": []}], ["The high number of screened populations allowed us to detect the signature of balancing selection across a large geographic area.", {"entities": []}], ["We detected 33 markers potentially under balancing selection, hence strong evidence of stabilizing selection in 21 populations across Europe.", {"entities": []}], ["However, our analyses identified four-times more markers (138) being under positive selection, and geographical patterns suggest that some of these markers are probably associated with alpine regions, which seem to have environmental conditions that favour adaptation.", {"entities": []}], ["We conclude that despite favourable conditions in this study for the detection of balancing selection, this evolutionary force seems to play a relatively minor role in shaping the genomic diversity of the common vole, which is more influenced by positive selection and neutral processes like drift and demographic history.", {"entities": []}], ["Human disease genes differ significantly from their rodent orthologs with respect to their overall levels of conservation and their rates of evolutionary change.", {"entities": []}], ["Rodent orthologs of human trinucleotide repeat-expansion disease genes were also found to contain substantially fewer such repeats.", {"entities": []}], ["Model organisms have contributed substantially to our understanding of the etiology of human disease as well as having assisted with the development of new treatment modalities.", {"entities": []}], ["The availability of the human, mouse and, most recently, the rat genome sequences now permit the comprehensive investigation of the rodent orthologs of genes associated with human disease.", {"entities": []}], ["Here, we investigate whether human disease genes differ significantly from their rodent orthologs with respect to their overall levels of conservation and their rates of evolutionary change.", {"entities": []}], ["Human disease genes are unevenly distributed among human chromosomes and are highly represented (99.5%) among human-rodent ortholog sets.", {"entities": []}], ["Differences are revealed in evolutionary conservation and selection between different categories of human disease genes.", {"entities": []}], ["Although selection appears not to have greatly discriminated between disease and non-disease genes, synonymous substitution rates are significantly higher for disease genes.", {"entities": []}], ["In neurological and malformation syndrome disease systems, associated genes have evolved slowly whereas genes of the immune, hematological and pulmonary disease systems have changed more rapidly.", {"entities": [[33, 41, "DISEASE"]]}], ["Amino-acid substitutions associated with human inherited disease occur at sites that are more highly conserved than the average; nevertheless, 15 substituting amino acids associated with human disease were identified as wild-type amino acids in the rat.", {"entities": []}], ["Rodent orthologs of human trinucleotide repeat-expansion disease genes were found to contain substantially fewer of such repeats.", {"entities": []}], ["Six human genes that share the same characteristics as triplet repeat-expansion disease-associated genes were identified; although four of these genes are expressed in the brain, none is currently known to be associated with disease.", {"entities": []}], ["Most human disease genes have been retained in rodent genomes.", {"entities": []}], ["Synonymous nucleotide substitutions occur at a higher rate in disease genes, a finding that may reflect increased mutation rates in the chromosomal regions in which disease genes are found.", {"entities": []}], ["Rodent orthologs associated with neurological function exhibit the greatest evolutionary conservation; this suggests that rodent models of human neurological disease are likely to most faithfully represent human disease processes.", {"entities": []}], ["However, with regard to neurological triplet repeat expansion-associated human disease genes, the contraction, relative to human, of rodent trinucleotide repeats suggests that rodent loci may not achieve a 'critical repeat threshold' necessary to undergo spontaneous pathological repeat expansions.", {"entities": []}], ["The identification of six genes in this study that have multiple characteristics associated with repeat expansion-disease genes raises the possibility that not all human loci capable of facilitating neurological disease by repeat expansion have as yet been identified.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is a heterogeneous disease characterized by varying degrees of emphysematous lung destruction and small airway disease, each with distinct effects on clinical outcomes.", {"entities": []}], ["There is little known about how microRNAs contribute specifically to the emphysema phenotype.", {"entities": []}], ["We examined how genome-wide microRNA expression is altered with regional emphysema severity and how these microRNAs regulate disease-associated gene expression networks.", {"entities": []}], ["We profiled microRNAs in different regions of the lung with varying degrees of emphysema from 6 smokers with COPD and 2 controls (8 regions\u2009\u00d7\u20098 lungs\u2009=\u200964 samples).", {"entities": []}], ["Regional emphysema severity was quantified by mean linear intercept.", {"entities": []}], ["Whole genome microRNA and gene expression data were integrated in the same samples to build co-expression networks.", {"entities": []}], ["Candidate microRNAs were perturbed in human lung fibroblasts in order to validate these networks.", {"entities": []}], ["The expression levels of 63 microRNAs ( P \u2009<\u20090.05) were altered with regional emphysema.", {"entities": []}], ["A subset, including miR-638, miR-30c, and miR-181d, had expression levels that were associated with those of their predicted mRNA targets.", {"entities": [[20, 27, "GENE"], [29, 36, "GENE"], [42, 50, "GENE"]]}], ["Genes correlated with these microRNAs were enriched in pathways associated with emphysema pathophysiology (for example, oxidative stress and accelerated aging).", {"entities": []}], ["Inhibition of miR-638 expression in lung fibroblasts led to modulation of these same emphysema-related pathways.", {"entities": [[14, 21, "GENE"]]}], ["Gene targets of miR-638 in these pathways were amongst those negatively correlated with miR-638 expression in emphysema.", {"entities": [[16, 23, "GENE"], [88, 95, "GENE"], [16, 23, "GENE"], [88, 95, "GENE"]]}], ["Our findings demonstrate that microRNAs are altered with regional emphysema severity and modulate disease-associated gene expression networks.", {"entities": []}], ["Furthermore, miR-638 may regulate gene expression pathways related to the oxidative stress response and aging in emphysematous lung tissue and lung fibroblasts.", {"entities": [[13, 20, "GENE"]]}], ["Little is known about the role European patient organisations play in the process of deciding on reimbursement for medicines.", {"entities": []}], ["Therefore we explore the current role of patient organisations in the process of reimbursement for medicines in Western Europe.", {"entities": []}], ["We focus in particular on collaboration between patient organisations and the pharmaceutical industry in this respect.", {"entities": []}], ["Sixty-eight patient organisations representing seven medical conditions, from ten Western European countries, were asked to participate in the study.", {"entities": []}], ["The participating organisations reported their experiences in a web-based questionnaire.", {"entities": []}], ["Twenty-one patient organisations completed the questionnaire (response rate: 31%), of which ten (47.6%) demanded reimbursement for medicines.", {"entities": []}], ["Organisations demanding reimbursement were larger than those not demanding reimbursement.", {"entities": []}], ["The main aim of these organisations was to create better accessibility of medicines for patients.", {"entities": []}], ["Most organisations limited themselves to single actions.", {"entities": []}], ["Only two engaged in multiple actions.", {"entities": []}], ["Almost all organisations had general policies on cooperation with the pharmaceutical industry, with autonomy as the key feature.", {"entities": []}], ["The patient organisations said they were reasonably successful and almost always satisfied with their own role in the reimbursement process.", {"entities": []}], ["Our study has found that the role of European patient organisations in the reimbursement process still seems limited, especially for small patient organisations.", {"entities": []}], ["Background: Chronic arsenic exposure is a worldwide health problem.", {"entities": []}], ["How arsenic exposure promotes a variety of diseases is poorly understood, and specific relationships between experimental and human exposures are not established.", {"entities": []}], ["We propose phenotypic anchoring as a means to unify experimental observations and disease outcomes.", {"entities": []}], ["Objectives: We examined the use of phenotypic anchors to translate experimental data to human pathology and investigated research needs for which phenotypic anchors need to be developed.", {"entities": []}], ["Methods: During a workshop, we discussed experimental systems investigating arsenic dose/exposure and phenotypic expression relationships and human disease responses to chronic arsenic exposure and identified knowledge gaps.", {"entities": []}], ["In a literature review, we identified areas where data exist to support phenotypic anchoring of experimental results to pathologies from specific human exposures.", {"entities": []}], ["Discussion: Disease outcome is likely dependent on cell-type\u2013specific responses and interaction with individual genetics, other toxicants, and infectious agents.", {"entities": []}], ["Potential phenotypic anchors include target tissue dosimetry, gene expression and epigenetic profiles, and tissue biomarkers.", {"entities": []}], ["Conclusions: Translation to human populations requires more extensive profiling of human samples along with high-quality dosimetry.", {"entities": []}], ["Anchoring results by gene expression and epigenetic profiling has great promise for data unification.", {"entities": []}], ["Genetic predisposition of individuals affects disease outcome.", {"entities": []}], ["Interactions with infectious agents, particularly viruses, may explain some species-specific differences between human pathologies and experimental animal pathologies.", {"entities": []}], ["Invertebrate systems amenable to genetic manipulation offer potential for elaborating impacts of specific biochemical pathways.", {"entities": []}], ["Anchoring experimental results to specific human exposures will accelerate understanding \u2028of mechanisms of arsenic-induced human disease.", {"entities": []}], ["Infant body mass index (BMI) peak has proven to be a useful indicator for predicting childhood obesity risk in American and European populations.", {"entities": [[95, 102, "DISEASE"]]}], ["However, it has not been assessed in China.", {"entities": []}], ["We characterised infant BMI trajectories in a Chinese longitudinal cohort and evaluated whether BMI peak can predict overweight and obesity at age 2 years.", {"entities": [[132, 139, "DISEASE"]]}], ["Serial measurements (n=6\u201312) of weight and length were taken from healthy term infants (n=2073) in a birth cohort established in urban Shanghai.", {"entities": []}], ["Measurements were used to estimate BMI growth curves from birth to 13.5 months using a polynomial regression model.", {"entities": []}], ["BMI peak characteristics, including age (in months) and magnitude (BMI, in kg/m Mean age at peak BMI was 7.61 months, with a magnitude of 18.33\u2009kg/m We have shown that infant BMI peak is valuable for predicting early childhood overweight and obesity in urban Shanghai.", {"entities": [[242, 249, "DISEASE"]]}], ["Because this is the first Chinese community-based cohort study of this nature, future research is required to examine infant populations in other areas of China.", {"entities": []}], ["Exposure to secondhand smoke has immediate adverse respiratory and cardiovascular effects.", {"entities": []}], ["A growing body of literature examining health trends following the implementation of public smoking bans has demonstrated reductions in the rates of myocardial infarction and stroke, but there has been no extensive work examining asthma hospitalizations.", {"entities": [[149, 170, "DISEASE"], [230, 236, "DISEASE"]]}], ["The aim of this study was to determine the impact of the Michigan Smoke-Free Air Law (SFA law) on the rate of asthma hospitalizations among adults in Michigan and to determine any differential effects by race or sex.", {"entities": [[110, 116, "DISEASE"]]}], ["Data on adult asthma hospitalizations were obtained from the Michigan Inpatient Database (MIDB).", {"entities": [[14, 20, "DISEASE"]]}], ["Poisson regression was used to model relative risks for asthma hospitalization following the SFA law with adjustments for sex, race, age, insurance type, and month of year.", {"entities": [[56, 62, "DISEASE"]]}], ["Race-based and sex-based analyses were performed.", {"entities": []}], ["In the first year following implementation of the SFA law, adjusted adult asthma hospitalization rates decreased 8% (95% confidence interval [CI], 7%\u201310%; P < .001).", {"entities": [[74, 80, "DISEASE"]]}], ["While asthma hospitalization rates for both blacks and whites declined in the 12 months following implementation of the SFA law, blacks were 3% more likely to be hospitalized for asthma than whites (95% CI, 0%\u20137%; P = .04).", {"entities": [[6, 12, "DISEASE"], [179, 185, "DISEASE"]]}], ["The rate of decline in adult asthma hospitalizations did not differ by sex.", {"entities": [[29, 35, "DISEASE"]]}], ["The implementation of the SFA law was associated with a reduction in adult asthma hospitalization rates, with a greater decrease in hospitalization rates for whites compared with blacks.", {"entities": [[75, 81, "DISEASE"]]}], ["These results demonstrate that the SFA law is protecting the public\u2019s health and saving health care costs.", {"entities": []}], ["This study examined associations of abdominal adiposity with lung function, asthma symptoms and current doctor-diagnosed asthma and mediation by insulin resistance (IR) and sleep disordered breathing (SDB).", {"entities": [[76, 82, "DISEASE"], [121, 127, "DISEASE"]]}], ["A random sample of 2500 households was drawn from the community of Whyalla, South Australia (The Whyalla Intergenerational Study of Health, WISH February 2008 - July 2009).", {"entities": []}], ["Seven-hundred twenty-two randomly selected adults (\u226518\u2009years) completed clinical protocols (32.2% response rate).", {"entities": []}], ["Lung function was measured by spirometry.", {"entities": []}], ["Post-bronchodilator FEV 1 /FVC was used to measure airway obstruction and reversibility of FEV 1 was calculated.", {"entities": [[20, 23, "GENE"], [91, 94, "GENE"], [20, 23, "GENE"], [91, 94, "GENE"]]}], ["Current asthma was defined by self-reported doctor-diagnosis and evidence of currently active asthma.", {"entities": [[8, 14, "DISEASE"], [94, 100, "DISEASE"]]}], ["Symptom scores for asthma (CASS) and SDB were calculated.", {"entities": [[19, 25, "DISEASE"]]}], ["Intra-abdominal fat (IAF) was estimated using dual-energy x-ray absorptiometry (DXA).", {"entities": []}], ["IR was calculated from fasting glucose and insulin concentrations.", {"entities": []}], ["The prevalence of current doctor-diagnosed asthma was 19.9% (95% CI 16.7 \u2013 23.5%).", {"entities": [[43, 49, "DISEASE"]]}], ["The ratio of observed to expected cases given the age and sex distribution of the population was 2.4 (95%CI 2.1, 2.9).", {"entities": []}], ["IAF was not associated with current doctor-diagnosed asthma, FEV 1 /FVC or FEV 1 reversibility in men or women but was positively associated with CASS independent of IR and SDB in women.", {"entities": [[53, 59, "DISEASE"], [61, 64, "GENE"], [75, 78, "GENE"], [61, 64, "GENE"], [75, 78, "GENE"]]}], ["A 1% increase in IAF was associated with decreases of 12\u2009mL and 20\u2009mL in FEV 1 and FVC respectively in men, and 4\u2009mL and 7\u2009mL respectively in women.", {"entities": [[73, 76, "GENE"]]}], ["SDB mediated 12% and 26% of these associations respectively in men but had minimal effects in women.", {"entities": []}], ["In this population with an excess of doctor-diagnosed asthma, IAF was not a major factor in airway obstruction or doctor-diagnosed asthma, although women with higher IAF perceived more severe asthma symptoms which did not correlate with lower FEV 1 .", {"entities": [[54, 60, "DISEASE"], [131, 137, "DISEASE"], [192, 198, "DISEASE"], [243, 246, "GENE"]]}], ["Higher IAF was significantly associated with lower FEV 1 and FVC and in men SDB mechanisms may contribute up to one quarter of this association.", {"entities": [[51, 54, "GENE"]]}], ["Some of the environmental toxicants from air pollution include particulate matter (PM 10 ), fine particulate matter (PM 2.5 ), and ultrafine particles (UFP).", {"entities": []}], ["Both short- and long-term exposure could result in various degrees of respiratory health outcomes among exposed persons, which rely on the individuals' health status.", {"entities": []}], ["In this paper, we highlight a review of the studies that have used biomarkers to understand the association between air particles exposure and the development of respiratory problems resulting from the damage in the respiratory system.", {"entities": []}], ["Data from previous epidemiological studies relevant to the application of biomarkers in respiratory system damage reported from exposure to air particles are also summarized.", {"entities": []}], ["Based on these analyses, the findings agree with the hypothesis that biomarkers are relevant in linking harmful air particles concentrations to increased respiratory health effects.", {"entities": []}], ["Biomarkers are used in epidemiological studies to provide an understanding of the mechanisms that follow airborne particles exposure in the airway.", {"entities": []}], ["However, application of biomarkers in epidemiological studies of health effects caused by air particles in both environmental and occupational health is inchoate.", {"entities": []}], ["Conclusion .", {"entities": []}], ["Biomarkers unravel the complexity of the connection between exposure to air particles and respiratory health.", {"entities": []}], ["Coronary artery disease (CAD) is accountable for more than 7 million deaths each year according to the World Health Organization (WHO).", {"entities": []}], ["In a European population 80% of patients diagnosed with CAD are overweight and 31% are obese.", {"entities": []}], ["Physical inactivity and overweight are major risk factors in CAD, thus central strategies in secondary prevention are increased physical activity and weight loss.", {"entities": []}], ["In a randomized controlled trial 70 participants with stable CAD, age 45\u201375, body mass index 28\u201340\u00a0kg/m 2 peak 3 times weekly for 12\u00a0weeks followed by supervised AIT twice weekly for 40\u00a0weeks.", {"entities": []}], ["In the weight loss arm dieticians instruct the participants in a low energy diet (800\u20131000\u00a0kcal/day) for 12\u00a0weeks, followed by 40\u00a0weeks of weight maintenance combined with supervised AIT twice weekly.", {"entities": []}], ["The primary endpoint of the study is change in coronary flow reserve after the first 12\u00a0weeks\u2019 intervention.", {"entities": []}], ["Secondary endpoints include cardiovascular, metabolic, inflammatory and anthropometric measures.", {"entities": []}], ["The study will compare the short and long-term effects of a protocol consisting of AIT alone or a rapid weight loss followed by AIT.", {"entities": []}], ["Additionally, it will provide new insight in mechanisms behind the benefits of exercise and weight loss.", {"entities": []}], ["We wish to contribute to the creation of effective secondary prevention and sustainable rehabilitation strategies in the large population of overweight and obese patients diagnosed with CAD.", {"entities": []}], ["ClinicalTrials.gov: NCT01724567", {"entities": []}], ["Cell adhesion molecule 1 (CADM1), expressed by human lung mast cells (HLMCs), mediates their adhesion to airway smooth muscle (ASM), and contributes to ASM-dependent HLMC proliferation and survival.", {"entities": [[26, 31, "GENE"]]}], ["CADM1 is expressed in alternatively spliced isoforms, but those present in HLMCs and their function are not known.", {"entities": [[0, 5, "GENE"]]}], ["We cloned three functional and one cryptic non-functional isoform with alternative splicing between exons 7/11 and 1/2, respectively, from HLMCs and human MC lines (HMC-1 and LAD2).", {"entities": []}], ["Differentiated HLMCs and LAD2 cells expressed the functional isoform SP4 containing exons 7/8/11 (~80% of clones), as well as SP1 (exons 7/8/9/11) and a novel SP6 (exons 7/8/9/10/11).", {"entities": [[69, 72, "GENE"], [126, 129, "GENE"], [159, 162, "GENE"]]}], ["In contrast, immature HMC-1 cells expressed only functional SP4.", {"entities": [[60, 63, "GENE"]]}], ["SP4 overexpression in HMC-1 cells and HLMCs augmented homotypic adhesion to a greater extent than SP1 in various conditions.", {"entities": [[0, 3, "GENE"], [98, 101, "GENE"]]}], ["In contrast, CADM1 downregulation abolished homotypic adhesion, indicating that CADM1 is the sole receptor mediating mast cell aggregation.", {"entities": [[13, 18, "GENE"], [80, 85, "GENE"], [13, 18, "GENE"], [80, 85, "GENE"]]}], ["CADM1-mediated adhesion was enhanced by the presence of cell survival factors.", {"entities": []}], ["SP1 overexpression in HMC-1 cells compromised survival compared to SP4 overexpression or control.", {"entities": [[0, 3, "GENE"], [67, 70, "GENE"]]}], ["CADM1 downregulation resulted in reduced viability and decreased expression of the pro-survival protein Mcl-1 L , but not Blc-2 or Bcl-X L , and increased caspase-3/7 activity in both HMC-1 cells and HLMCs.", {"entities": [[0, 5, "GENE"]]}], ["This coincided with decreased basal Kit levels in HLMCs.", {"entities": []}], ["In summary, human MCs express multiple CADM1 isoforms which exhibit differential regulation of survival and homotypic adhesion.", {"entities": [[39, 44, "GENE"]]}], ["The most highly expressed SP4 isoform is likely to contribute to MC aggregation and longevity in mastocytosis, and augment the pathophysiology of allergic diseases.", {"entities": [[97, 109, "DISEASE"], [26, 29, "GENE"]]}], ["The online version of this article (doi:10.1007/s00018-012-0948-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Cattle are an important source of allergens in the working area of farmers.", {"entities": []}], ["Asthma caused by cow allergens is a significant occupational problem.", {"entities": [[0, 6, "DISEASE"]]}], ["Yet in allergological testing, the results of in vivo and in vitro diagnostic tests are often inconsistent even in cases with clearly cattle-related symptoms.", {"entities": []}], ["The aim of this study was to investigate four different commercial cow allergen extracts and to compare them with self prepared extracts of different cattle breeds by means of SDS-PAGE and immunoblotting using the sera of 42 German farmers with asthma and rhino-conjunctivitis caused by cattle contact.", {"entities": [[262, 276, "DISEASE"], [245, 251, "DISEASE"]]}], ["The commercial extracts investigated in this study showed only minor differences in protein pattern.", {"entities": []}], ["Using sera in immunoblotting experiments distinct bands were found for all symptomatic farmers, even in 13 farmers with a negative result in commercially available serological allergy tests.", {"entities": []}], ["Bands with molecular weights in the range between about 11 and 67\u00a0kDa were observed; reactivity with the major allergen Bos d 2 at about 20\u00a0kDa was detected in all farmers, although it was not the strongest band in all cases.", {"entities": []}], ["We demonstrate for the first time the allergenic relevance of additional proteins with molecular weights of 14, 30, 55 and approx.", {"entities": []}], ["67\u201397\u00a0kDa in more than 50% of farmers with cattle related symptoms.", {"entities": []}], ["One of our most striking results was that 32% of the investigated farmers with cattle related symptoms showed negative results with commercial serological tests but distinct reactions with cow allergen in immunoblotting experiments.", {"entities": []}], ["The Bos d 2 content in hair showed differences between certain breeds whereas German Brown and Simmental had particularly higher quantities of Bos d 2 in their hair than breeds such as Holstein-Friesian.", {"entities": []}], ["These results strongly support the following recommendation: test results with commercial extracts that are contradictory to the clinical symptoms should be supplemented by skin tests using extracts of the hair of the farmers\u2019 own cattle.", {"entities": []}], ["This study aimed to investigate how the impairment of the olfactory system influences interoception.", {"entities": []}], ["Interoception is known as the awareness of one\u2019s body or the sense of the condition of the body; more precisely, this construct is defined as the processing, representation, and perception of the internal physical state.", {"entities": []}], ["Interoceptive sensitivity and chemosensory performance were assessed in 77 subjects, including 43 functional anosmics, 18 hyposmics, and 16 healthy controls.", {"entities": []}], ["Interoceptive awareness was predicted by odor detection threshold, as well as the duration of olfactory loss in patients who suffered from reduced olfactory function\u2014the longer the olfactory impairment, the worse the perception of bodily signals.", {"entities": []}], ["The results of this study will significantly contribute to the basic understanding of the multifaceted effects of olfactory alterations.", {"entities": []}], ["Adherence to childhood immunization schedules is a function of various factors.", {"entities": []}], ["Given the increased use of technology as a strategy to increase immunization coverage, it is important to investigate how parents perceive different forms of communication, including traditional means and text-message reminders.", {"entities": []}], ["To examine current forms of communication about immunization information, parents\u2019 satisfaction levels with these communication modes, perceived barriers and benefits to using text messaging, and the ideal content of text messages for immunization reminders.", {"entities": []}], ["Structured interviews were developed and approved by two Institutional Review Boards.", {"entities": []}], ["A convenience sample of 50 parents was recruited from two local pediatric clinics.", {"entities": []}], ["The study included a demographics questionnaire, the shortened form of the Test of Functional Health Literacy for Adults (S-TOFHLA), questions regarding benefits and barriers of text communication from immunization providers, and preferred content for immunization reminders.", {"entities": []}], ["Content analyses were performed on responses to barriers, benefits, and preferred content (all Cohen\u2019s kappas > 0.70).", {"entities": []}], ["Respondents were mostly female (45/50, 90%), white non-Hispanic (31/50, 62%), between 20\u201341 years (mean = 29, SD 5), with one or two children (range 1\u20139).", {"entities": []}], ["Nearly all (48/50, 96%) had an S-TOFHLA score in the \u201cadequate\u201d range.", {"entities": []}], ["All parents (50/50, 100%) engaged in face-to-face contact with their child\u2019s physician at appointments, 74% (37/50) had contact via telephone, and none of the parents (0/50, 0%) used email or text messages.", {"entities": []}], ["Most parents were satisfied with the face-to-face (48/50, 96%) and telephone (28/50, 75%) communication.", {"entities": []}], ["Forty-nine of the 50 participants (98%) were interested in receiving immunization reminders by text message, and all parents (50/50, 100%) were willing to receive general appointment reminders by text message.", {"entities": []}], ["Parents made 200 comments regarding text-message reminders.", {"entities": []}], ["Benefits accounted for 63.5% of comments (127/200).", {"entities": []}], ["The remaining 37.5% (73/200) regarded barriers; however, no barriers could be identified by 26% of participants (13/50).", {"entities": []}], ["Parents made 172 comments regarding preferred content of text-message immunization reminders.", {"entities": []}], ["The most frequently discussed topics were date due (50/172, 29%), general reminder (26/172, 26%), and child\u2019s name (21/172, 12%).", {"entities": []}], ["Most parents were satisfied with traditional communication; however, few had experienced any alternative forms of communication regarding immunizations.", {"entities": []}], ["Benefits of receiving text messages for immunization reminders far outweighed the barriers identified by parents.", {"entities": []}], ["Few barriers identified were text specific.", {"entities": []}], ["Those that were, centered on cost if parents did not have unlimited texting plans.", {"entities": []}], ["Airway inflammation and mucus hyperproduction play the central role in the development of asthma, although the mechanisms remain unclear.", {"entities": [[90, 96, "DISEASE"]]}], ["The aquaporin (AQP)-5 may be involved in the process due to its contribution to the volume of liquid secreted from the airways.", {"entities": []}], ["The present study firstly found the overexpression of AQP5 in the airway epithelium and submucosal glands of asthmatics.", {"entities": [[54, 58, "GENE"]]}], ["Furthermore, we aimed at evaluating the role of AQP5 in airway inflammation and mucous hyperproductions during chronic allergic responses to house dust mite (HDM).", {"entities": [[48, 52, "GENE"]]}], ["Bronchoalveolar lavage levels of interleukin (IL)-2, IL-4, IL-10, interferon-\u03b3 and Mucin 5AC (MUC5AC), and number of peribronchial and perivascular cells were measured in AQP5 wild-type and AQP5 knockout (KO) mice.", {"entities": [[171, 175, "GENE"], [190, 194, "GENE"], [171, 175, "GENE"], [190, 194, "GENE"]]}], ["We found that HDM induced airway inflammation, lung Th2 cell accumulation and mucin hypersecretion in C57BL/6 mice rather than AQP5 KO mice.", {"entities": [[127, 131, "GENE"]]}], ["Expression of MUC5AC and MUC5B proteins and genes in the lung tissue was significantly lower in AQP5 KO mice.", {"entities": [[25, 30, "GENE"], [96, 100, "GENE"]]}], ["Thus, our results implicate involvement of AQP5 in the development of airway inflammation and mucous hyperproduction during chronic asthma.", {"entities": [[132, 138, "DISEASE"], [43, 47, "GENE"]]}], ["By-products of water disinfectants have been suggested to cause asthma, especially in atopic children.", {"entities": [[64, 70, "DISEASE"]]}], ["However, studies on indoor swimming pool attendance and asthma in children have presented conflicting results.", {"entities": [[56, 62, "DISEASE"]]}], ["The present study examined the relationship between indoor swimming pool attendance and asthma among sensitized and non-sensitized children aged 11-12 years.", {"entities": [[88, 94, "DISEASE"]]}], ["An extended ISAAC questionnaire was sent to the families of all children attending fifth or sixth grade, aged 11-12 years, in two municipalities in Northern Sweden in 2010.", {"entities": []}], ["A total of 1866 participated (96% of those invited) in the questionnaire study and 1652 (89%) also participated in skin prick testing for 10 standard airborne allergens.", {"entities": []}], ["Asthma was defined as physician-diagnosed asthma in combination with wheeze or use of asthma medication in the last 12\u00a0months.", {"entities": [[0, 6, "DISEASE"], [42, 48, "DISEASE"], [86, 92, "DISEASE"]]}], ["Current swimming pool attendance was reported as \u22651/week or <1/week.", {"entities": []}], ["Logistic regression models were used for data analysis.", {"entities": []}], ["The prevalence of current asthma was 8.9% (10.0% of boys; 7.9% of girls) and 14% had attended indoor pools \u22651/week.", {"entities": [[26, 32, "DISEASE"]]}], ["Children currently attending swimming pools \u22651/week had an increased risk of current asthma.", {"entities": [[85, 91, "DISEASE"]]}], ["Stratified analyses for allergic sensitization adjusted for sex, parental smoking, parental asthma, and damp housing, showed a statistically significant association for current asthma only among sensitized subjects (OR 95% CI 1.90 1.09-3.32).", {"entities": [[92, 98, "DISEASE"], [177, 183, "DISEASE"]]}], ["No association was found between current pool attendance and wheeze, sensitization, rhinitis or eczema.", {"entities": [[84, 92, "DISEASE"]]}], ["The present study supports the proposed link between indoor swimming pool attendance and asthma in sensitized children.", {"entities": [[89, 95, "DISEASE"]]}], ["Systematic reviews of the social and physical determinants of health provide metrics for evaluation of programs to mitigate health disparities.", {"entities": []}], ["Previous meta-analyses of the population health literature have identified several proximate social and physical determinants of population health in the circumpolar north including addiction, environmental exposures, diet/nutrition and global climate change.", {"entities": []}], ["Proximate health determinants are most amenable to early detection and modification or mitigation through disease prevention or health promotion interventions.", {"entities": []}], ["There is a need for research to replicate these findings based on the latest science.", {"entities": []}], ["This presentation describes a study applying Dahlgren and Whitehead's (1991) socio-ecological model of health determinants to identify the proximate social and physical determinants of health in the circumpolar north.", {"entities": []}], ["The study consisted of a systematic review of recent studies that link determinants of health with the leading causes of mortality and morbidity in Alaska.", {"entities": []}], ["Our search strategy employed a keyword search using the Circumpolar Health Bibliographic Database (CHBD) and 4 databases within the Web of Knowledge (WoK) data gateway.", {"entities": []}], ["Keywords included various terms for the arctic, all relevant nations and territories within the region, as well as leading health outcomes.", {"entities": []}], ["Studies meeting the following inclusion criteria were reviewed: original research within a circumpolar population, published in English during 2011, and involving a rigorous demonstration of a link between a social determinant and selected health outcomes.", {"entities": []}], ["Study conclusions includes a list of determinants identified, their associated outcomes and the study designs implemented to assess that association.", {"entities": []}], ["Organ-on-a-chip devices have gained attention in the field of in vitro modeling due to their superior ability in recapitulating tissue environments compared to traditional multiwell methods.", {"entities": []}], ["These constructed growth environments support tissue differentiation and mimic tissue\u2013tissue, tissue\u2013liquid, and tissue\u2013air interfaces in a variety of conditions.", {"entities": []}], ["By closely simulating the in vivo biochemical and biomechanical environment, it is possible to study human physiology in an organ-specific context and create more accurate models of healthy and diseased tissues, allowing for observations in disease progression and treatment.", {"entities": []}], ["These chip devices have the ability to help direct, and perhaps in the distant future even replace animal-based drug efficacy and toxicity studies, which have questionable relevance to human physiology.", {"entities": []}], ["Here, we review recent developments in the in vitro modeling of barrier tissue interfaces with a focus on the use of novel and complex microfluidic device platforms.", {"entities": []}], ["\u2022 Provide an introduction to chip technologies and their applications in drug discovery and disease modeling.", {"entities": []}], ["\u2022 Review of current organ-on-a-chip technologies in the in vitro modeling of barrier tissues.", {"entities": []}], ["\u2022 Highlight current chip technologies and address outstanding questions that need to be investigated prior to widespread use.", {"entities": []}], ["Provide an introduction to chip technologies and their applications in drug discovery and disease modeling.", {"entities": []}], ["Review of current organ-on-a-chip technologies in the in vitro modeling of barrier tissues.", {"entities": []}], ["Highlight current chip technologies and address outstanding questions that need to be investigated prior to widespread use.", {"entities": []}], ["Overuse of emergency rooms (ER) is a public health problem.", {"entities": []}], ["To investigate this issue, a cross-sectional survey was conducted at the ERs of King Abdul-Aziz Hospital, King Fahd Hospital, and Al-Thaghor Hospital in November 2013 with the aims of estimating emergency service utilization for non-urgent cases, identifying the predictors of ER utilization for non-urgent cases, and measuring patients\u2019 knowledge of primary healthcare centers (PHCCs).", {"entities": []}], ["Patients were interviewed using a structured questionnaire and the data were analyzed using the Statistical Package for the Social Sciences.", {"entities": []}], ["We recruited 300 patients; males comprised 50.7% of the sample.", {"entities": []}], ["A higher proportion of patients with non-urgent cases visited the ER three to four times a year (P=0.001).", {"entities": []}], ["A higher proportion of patients without emergencies had not attempted to visit an outpatient clinic before the ER (P=0.003).", {"entities": []}], ["Most patients without emergencies thought the ER was the first place to consult in case of illness.", {"entities": []}], ["Most patients who visited the ER were single, < 15 years, and had lower incomes.", {"entities": []}], ["Patients requested ER services for primary care-treatable conditions because of limited services and resources as well as limited working hours at PHCCs.", {"entities": []}], ["Most patients (90.0%) were knowledgeable about PHCCs, with those of lower education being more knowledgeable.", {"entities": []}], ["Patients reported long ER waiting times (\u2265 3 hours), no organization (85.9%), and lack of medical staff.", {"entities": []}], ["Overall, overuse of ER services is high at the Ministry of Health hospitals in Jeddah.", {"entities": []}], ["The risk factors for ER overuse are age < 15 years, singlehood, and low incomes.", {"entities": []}], ["Policy makers and health providers have a challenging task to control ER overuse.", {"entities": []}], ["We recommend developing strategies to implement policies aimed at reducing non-urgent ER use as well as making healthcare services more available to the population.", {"entities": []}], ["Genome-wide association studies (GWAS) have successfully identified a large number of genetic variants associated with complex traits, but these only explain a small proportion of the total heritability.", {"entities": []}], ["It has been recently proposed that rare variants can create \u2018synthetic association' signals in GWAS, by occurring more often in association with one of the alleles of a common tag single nucleotide polymorphism.", {"entities": []}], ["While the ultimate evaluation of this hypothesis will require the completion of large-scale sequencing studies, it is informative to place it in the broader context of what is known about the genetic architecture of complex disease.", {"entities": []}], ["In this review, we draw from empirical and theoretical data to summarize evidence showing that synthetic associations do not underlie many reported GWAS associations.", {"entities": []}], ["Respiratory disease can impose a significant burden on the health of rural populations.", {"entities": []}], ["The Saskatchewan Rural Health Study (SRHS) is a new large prospective cohort study of ages 6 and over currently being conducted in farming and non-farming communities to evaluate potential health determinants associated with respiratory outcomes in rural populations.", {"entities": []}], ["In this article, we describe the rationale and methodology for the adult component.", {"entities": []}], ["The study is being conducted over 5 years (2009\u201315) in two phases, baseline and longitudinal.", {"entities": []}], ["The baseline survey consists of two components, adults and children.", {"entities": []}], ["The adult component consists of a questionnaire-based evaluation of individual and contextual factors of importance to respiratory health in two sub populations (a Farm Cohort and a Small Town Cohort) of rural families in Saskatchewan Rural Municipalities (RMs).", {"entities": []}], ["Clinical studies of lung function and allergy tests are being conducted on selected sub-samples of the two cohorts based on the positive response to the last question on the baseline questionnaire: \u201cWould you be willing to be contacted about having breathing and/or allergy tests at a nearby location?\u201d.", {"entities": []}], ["We adopted existing population health theory to evaluate individual factors, contextual factors , and principal covariates on the outcomes of chronic bronchitis, chronic obstructive pulmonary disease, asthma and obstructive sleep apnea.", {"entities": [[162, 199, "DISEASE"], [201, 207, "DISEASE"], [150, 160, "DISEASE"]]}], ["Of the RMs selected to participate, 32 (89%) out of 36 RMs and 15 (94%) out of 16 small towns within the RMs agreed to participate.", {"entities": []}], ["Using the mail out survey method developed by Dillman, we obtained completed questionnaires from 4264 households (8261 individuals).", {"entities": []}], ["We obtained lung function measurements on 1609 adults, allergy skin test information on 1615 adults; both measurements were available on 1549 adults.", {"entities": []}], ["We observed differences between farm and non-farm rural residents with respect to individual, contextual factors and covariates.", {"entities": []}], ["There are differences between farm and non-farm rural residents with respect to individual and contextual factors and other variables of importance.", {"entities": []}], ["The findings of the SRHS will improve knowledge of respiratory disease etiology, assist in the development and targeting of prevention programs, and in planning health services with farm and small town populations.", {"entities": []}], ["Although there has been a rapid rise in the publication of meta-analyses of genetic association studies, little is known about their methodological quality.", {"entities": []}], ["The authors reviewed the quality of 120 randomly selected genetic meta-analyses published between 2005 and 2007.", {"entities": []}], ["Data extracted included issues of general relevance and other issues specific to genetic epidemiology.", {"entities": []}], ["Quality was markedly poorer in the 26% of the meta-analyses that accompanied a report on a primary study.", {"entities": []}], ["Such meta-analyses were predominantly published in specialist journals, and their quality was positively associated with the impact factor of the journal.", {"entities": []}], ["Among the meta-analyses that did not accompany a primary study, Human Genome Epidemiology reviews tended to score better than the others, although the comparison was limited by relatively small numbers.", {"entities": []}], ["Comparison of the overall quality with that of genetic meta-analyses published before 2000 showed improvement in both conduct and reporting.", {"entities": []}], ["However, the quality of the handling of specific genetic issues remains disappointingly low.", {"entities": []}], ["For a few key general quality issues, the authors compared their findings with findings in other fields of medicine and found that general quality was similar.", {"entities": []}], ["On the basis of this review, the authors provide practical recommendations for the conduct and reporting of genetic meta-analyses.", {"entities": []}], ["In low- and middle-income countries (LMIC), determinants of women\u2019s and children\u2019s health are complex and differential vulnerability may exist to risk factors of perinatal distress and preterm birth.", {"entities": []}], ["We examined the contribution of maternal perinatal distress on preterm birth and infant health in terms of infant survival and mother\u2013infant interaction.", {"entities": []}], ["A critical narrative and interpretive literature review was conducted.", {"entities": []}], ["Peer-reviewed electronic databases (MEDLINE, Embase, Global Health, CINHAL), grey literature, and reference lists were searched, followed by a consultation exercise.", {"entities": []}], ["The literature was predominantly from high-income countries.", {"entities": []}], ["We identify determinants of perinatal distress and explicate changes in the hypothalamic\u2013pituitary\u2013adrenal axis, sympathetic, immune and cardiovascular systems, and behavioral responses resulting in pathophysiological effects.", {"entities": []}], ["We suggest cultural\u2013neutral composite measures of allostatic mediators (i.e., several biomarkers) of maternal perinatal distress as objective indicators of dysregulation in body systems in pregnant women in LMIC.", {"entities": []}], ["Understanding causal links of maternal perinatal distress to preterm birth in women in LMIC should be a priority.", {"entities": []}], ["The roles of allostasis and allostatic load are considered within the context of the health of pregnant women and fetuses/newborns in LMIC with emphasis on identifying objective indicators of the level of perinatal distress and protective factors or processes contributing to resilience while facing toxic stress.", {"entities": []}], ["We propose a prospective study design with multiple measures across pregnancy and postpartum requiring complex statistical modeling.", {"entities": []}], ["Building research capacity through partnering researchers in high-income countries and LMIC and reflecting on unique ethical challenges will be important to generating new knowledge in LMIC.", {"entities": []}], ["\u25ba Allergen-specific immunotherapy is based on therapeutic vaccination with allergens.", {"entities": []}], ["\u25ba The genes encoding allergen molecules and their structures have been identified.", {"entities": []}], ["\u25ba Detailed knowledge of allergen structures and epitopes allows engineering new vaccines.", {"entities": []}], ["\u25ba These vaccines target different mechanisms of the allergic immune response.", {"entities": []}], ["\u25ba New allergy vaccines will increase safety, efficacy and convenience of immunotherapy and are currently tested in immunotherapy trials.", {"entities": []}], ["Vaccines aim to establish or strengthen immune responses but are also effective for the treatment of allergy.", {"entities": []}], ["The latter is surprising because allergy represents a hyper-immune response based on immunoglobulin E production against harmless environmental antigens, i.e., allergens.", {"entities": []}], ["Nevertheless, vaccination with allergens, termed allergen-specific immunotherapy is the only disease-modifying therapy of allergy with long-lasting effects.", {"entities": []}], ["New forms of allergy diagnosis and allergy vaccines based on recombinant allergen-derivatives, peptides and allergen genes have emerged through molecular allergen characterization.", {"entities": []}], ["The molecular allergy vaccines allow sophisticated targeting of the immune system and may eliminate side effects which so far have limited the use of traditional allergen extract-based vaccines.", {"entities": []}], ["Successful clinical trials performed with the new vaccines indicate that broad allergy vaccination is on the horizon and may help to control the allergy pandemic.", {"entities": []}], ["The use of herbal medicinal products and supplements has increased during last decades.", {"entities": []}], ["At present, some herbs are used to enhance muscle strength and body mass.", {"entities": []}], ["Emergent evidence suggests that the health benefits from plants are attributed to their bioactive compounds such as Polyphenols, Terpenoids, and Alkaloids which have several physiological effects on the human body.", {"entities": []}], ["At times, manufacturers launch numerous products with banned ingredient inside with inappropriate amounts or fake supplement inducing harmful side effect.", {"entities": []}], ["Unfortunately up to date, there is no guarantee that herbal supplements are safe for anyone to use and it has not helped to clear the confusion surrounding the herbal use in sport field especially.", {"entities": []}], ["Hence, the purpose of this review is to provide guidance on the efficacy and side effect of most used plants in sport.", {"entities": []}], ["We have identified plants according to the following categories: Ginseng, alkaloids, and other purported herbal ergogenics such as Tribulus Terrestris , Cordyceps Sinensis.", {"entities": []}], ["We found that most herbal supplement effects are likely due to activation of the central nervous system via stimulation of catecholamines.", {"entities": []}], ["Ginseng was used as an endurance performance enhancer, while alkaloids supplementation resulted in improvements in sprint and cycling intense exercises.", {"entities": []}], ["Despite it is prohibited, small amount of ephedrine was usually used in combination with caffeine to enhance muscle strength in trained individuals.", {"entities": []}], ["Some other alkaloids such as green tea extracts have been used to improve body mass and composition in athletes.", {"entities": []}], ["Other herb (i.e.", {"entities": []}], ["Rhodiola, Astragalus) help relieve muscle and joint pain, but results about their effects on exercise performance are missing.", {"entities": []}], ["This study was aimed to evaluate the prevalence of soy protein hypersensitivity in cow's milk protein-sensitive children in Korea.", {"entities": []}], ["A total of 1,363 patients with atopic dermatitis, urticaria, enterocolitis syndrome, bronchial asthma or allergic rhinitis were recruited.", {"entities": [[105, 122, "DISEASE"], [50, 59, "DISEASE"], [31, 48, "DISEASE"], [114, 122, "DISEASE"], [75, 83, "DISEASE"], [95, 101, "DISEASE"], [38, 48, "DISEASE"]]}], ["First, we estimated the prevalence of sensitization to soy in children sensitized to cow's milk.", {"entities": []}], ["Specific IgE levels > 0.7 kU/L by CAP assay were considered positive.", {"entities": []}], ["Next, the prevalence of soy allergy in cow's milk allergy (CMA) patients was investigated.", {"entities": []}], ["Those children whose parents agreed to participate the open challenge test with soy had a convincing history of allergic reactions elicited by cow's milk and these symptoms were relieved by elimination.", {"entities": []}], ["All of them had negative soy-specific IgE.", {"entities": []}], ["Patients with positive soy-specific IgE accounted for 18.3% of 224 children sensitized to cow's milk protein.", {"entities": []}], ["The prevalence of sensitization to soy decreased with age (36.8% in the first year of life, 16.4% in the second year, and 13.7% in the third year).", {"entities": []}], ["Of 21 CMA patients, 42.9% (n=9) were determined to have soy allergy (mean age 10.3 months).", {"entities": []}], ["Our results suggest that soy protein formula should be carefully used as a substitute for cow's milk in CMA patients, especially during infancy.", {"entities": []}], ["Thus far, no algorithms have been developed to automatically extract patients who meet Asthma Predictive Index (API) criteria from the Electronic health records (EHR) yet.", {"entities": [[87, 93, "DISEASE"]]}], ["Our objective is to develop and validate a natural language processing (NLP) algorithm to identify patients that meet API criteria.", {"entities": []}], ["This is a cross-sectional study nested in a birth cohort study in Olmsted County, MN.", {"entities": []}], ["Asthma status ascertained by manual chart review based on API criteria served as gold standard.", {"entities": [[0, 6, "DISEASE"]]}], ["NLP-API was developed on a training cohort ( n \u2009=\u200987) and validated on a test cohort ( n \u2009=\u2009427).", {"entities": []}], ["Criterion validity was measured by sensitivity, specificity, positive predictive value and negative predictive value of the NLP algorithm against manual chart review for asthma status.", {"entities": [[170, 176, "DISEASE"]]}], ["Construct validity was determined by associations of asthma status defined by NLP-API with known risk factors for asthma.", {"entities": [[53, 59, "DISEASE"], [114, 120, "DISEASE"]]}], ["Among the eligible 427 subjects of the test cohort, 48% were males and 74% were White.", {"entities": []}], ["Median age was 5.3\u00a0years (interquartile range 3.6\u20136.8).", {"entities": []}], ["35 (8%) had a history of asthma by NLP-API vs. 36 (8%) by abstractor with 31 by both approaches.", {"entities": [[25, 31, "DISEASE"]]}], ["NLP-API predicted asthma status with sensitivity 86%, specificity 98%, positive predictive value 88%, negative predictive value 98%.", {"entities": [[18, 24, "DISEASE"]]}], ["Asthma status by both NLP and manual chart review were significantly associated with the known asthma risk factors, such as history of allergic rhinitis, eczema, family history of asthma, and maternal history of smoking during pregnancy ( p value <\u20090.05).", {"entities": [[135, 152, "DISEASE"], [144, 152, "DISEASE"], [0, 6, "DISEASE"], [95, 101, "DISEASE"], [180, 186, "DISEASE"]]}], ["Maternal smoking [odds ratio: 4.4, 95% confidence interval 1.8\u201310.7] was associated with asthma status determined by NLP-API and abstractor, and the effect sizes were similar between the reviews with 4.4 vs 4.2 respectively.", {"entities": [[89, 95, "DISEASE"]]}], ["NLP-API was able to ascertain asthma status in children mining from EHR and has a potential to enhance asthma care and research through population management and large-scale studies when identifying children who meet API criteria.", {"entities": [[30, 36, "DISEASE"], [103, 109, "DISEASE"]]}], ["Upper respiratory infections (URI) and their complications are a major healthcare burden for pediatric populations.", {"entities": []}], ["Although the microbiology of the nasopharynx is an important determinant of the complications of URI, little is known of the nasopharyngeal (NP) microbiota of children, the factors that affect its composition, and its precise relationship with URI.", {"entities": []}], ["Healthy children ( n \u2009=\u200947) aged 49\u201384\u00a0months from a prospective cohort study based in Wisconsin, USA, were examined.", {"entities": []}], ["Demographic and clinical\u00a0data and NP swab samples were obtained from participants upon entry to the study.", {"entities": []}], ["All NP samples\u00a0were profiled for bacterial microbiota using a phylogenetic microarray, and these data were related to demographic characteristics and upper respiratory health outcomes.", {"entities": []}], ["The composition of the NP bacterial community of children was significantly related prior to the history of acute sinusitis ( R P \u2009<\u20090.009).", {"entities": [[114, 123, "DISEASE"]]}], ["History of acute sinusitis was associated with significant depletion in relative abundance of taxa including Faecalibacterium prausnitzii and Akkermansia spp.", {"entities": [[17, 26, "DISEASE"]]}], ["and enrichment of Moraxella nonliquefaciens .", {"entities": []}], ["Enrichment of M. nonliquefaciens was also a characteristic of baseline NP samples of children who subsequently developed acute sinusitis over the 1-year study period.", {"entities": [[127, 136, "DISEASE"]]}], ["Time to develop URI was significantly positively correlated with NP diversity, and children who experienced more frequent URIs exhibited significantly diminished NP microbiota diversity ( P \u2009\u2264\u20090.05).", {"entities": []}], ["These preliminary data suggest that previous history of acute sinusitis influences the composition of the NP microbiota, characterized by a depletion in relative abundance of specific taxa.", {"entities": [[62, 71, "DISEASE"]]}], ["Diminished diversity was associated with more frequent URIs.", {"entities": []}], ["The online version of this article (doi:10.1186/s40168-016-0179-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Studies examining the cellular mechanisms of inflammation and protease production in the lung tissue and airways of COPD patients have shed light on the important role of kinase-based signaling cascades.", {"entities": []}], ["These pathways can be activated by environmental stimuli such as tobacco smoke, and by endogenous signals such as cytokines, growth factors, and inflammation-derived oxidants.", {"entities": []}], ["The three most widely characterized cascades are those directed by the classical mitogen activated protein (MAP) kinase (ERK1/2), stress activated protein kinase/c-Jun N-terminal protein kinase, and p38 enzymes.", {"entities": []}], ["These phosphorylation cascades transmit and amplify extracellular, receptor-mediated signals through the cytoplasm of the cell to activate nuclear transcription factors which bind and induce expression of target genes.", {"entities": []}], ["The result is tight control of diverse cellular events, and rapid responses to external stimuli.", {"entities": []}], ["However, recent research suggests that constitutive or aberrant activation of MAP kinases contributes to several COPD-associated phenotypes, including mucus overproduction and secretion, inflammation, cytokine expression, apoptosis, T cell activation, matrix metalloproteinase production, and fibrosis.", {"entities": []}], ["This review explores the biological functions of the MAP kinase pathways in the pathogenesis of COPD, their activation by cigarette smoke, and discusses the potential role of MAP kinase inhibitors in COPD therapy.", {"entities": []}], ["Lung cancer is one of the most frequent types of cancer worldwide.", {"entities": [[0, 11, "DISEASE"], [5, 11, "DISEASE"], [49, 55, "DISEASE"]]}], ["Most patients are diagnosed at advanced stage and thus have poor prognosis.", {"entities": []}], ["Smoking is a risk factor for lung cancer, however most smokers do not develop lung cancer while 20% of women with lung adenocarcinoma are non-smokers.", {"entities": [[119, 133, "DISEASE"], [29, 40, "DISEASE"], [78, 89, "DISEASE"], [114, 133, "DISEASE"], [34, 40, "DISEASE"], [83, 89, "DISEASE"]]}], ["Therefore, it is possible that these two groups present differences besides the smoking status, including differences in their gene expression signature.", {"entities": []}], ["The altered expression patterns of non-coding RNAs in complex diseases make them potential biomarkers for diagnosis and treatment.", {"entities": []}], ["We analyzed data from differentially and constitutively expressed PIWI-interacting RNAs and small nucleolar RNAs from publicly available small RNA high-throughput sequencing data in search of an expression pattern of non-coding RNA that could differentiate these two groups.", {"entities": []}], ["Here, we report two sets of differentially expressed small non-coding RNAs identified in normal and tumoral tissues of women with lung adenocarcinoma, that discriminate between smokers and non-smokers.", {"entities": [[135, 149, "DISEASE"], [130, 149, "DISEASE"]]}], ["Our findings may offer new insights on metabolic alterations caused by tobacco and may be used for early diagnosis of lung cancer.", {"entities": [[118, 129, "DISEASE"], [123, 129, "DISEASE"]]}], ["Pesticides, in particular folpet, have been found in rural and urban air in France in the past few years.", {"entities": []}], ["Folpet is a contact fungicide and has been widely used for the past 50 years in vineyards in France.", {"entities": []}], ["Slightly water-soluble and mostly present as particles in the environment, it has been measured at average concentration of 40.1 \u03bcg/m in vitro on respiratory cells.", {"entities": []}], ["Granulometry of two commercial forms of folpet (Folpan 80WG 50 ) on human bronchial epithelial cells (16HBE14o-) was found to be between 2.89 and 5.11 \u03bcg/cm These results show that the particles of commercial forms of folpet are relatively stable over time.", {"entities": []}], ["Particles could be easily inhaled by humans, could reach the conducting airways and are cytotoxic to respiratory cells in vitro.", {"entities": []}], ["Folpet particles may mediate its toxicity directly or indirectly through ROS-mediated alterations.", {"entities": []}], ["These data constitute the first step towards the risk assessment of folpet particles by inhalation for human health.", {"entities": []}], ["This work confirms the need for further studies on the effect of environmental pesticides on the respiratory system.", {"entities": []}], ["Real-time PCR array for rapid detection of multiple viral pathogens should be highly useful in cases where the sample volume and the time of testing are limited, i.e.", {"entities": []}], ["in the eligibility testing of tissue and organ donors.", {"entities": []}], ["We developed a real-time PCR array capable of simultaneously detecting eight human viral pathogens: human immunodeficiency virus types 1 and 2 (HIV-1 and -2), hepatitis B virus (HBV), hepatitis C virus (HCV), human T-cell leukemia virus-1 and -2 (HTLV-1 and -2), vaccinia virus (VACV) and West Nile virus (WNV).", {"entities": [[159, 168, "DISEASE"], [184, 193, "DISEASE"], [222, 230, "DISEASE"], [263, 271, "DISEASE"]]}], ["One hundred twenty (120) primers were designed using a combination of bioinformatics approaches, and, after experimental testing, 24 primer sets targeting eight viral pathogens were selected to set up the array with SYBR Green chemistry.", {"entities": []}], ["The specificity and sensitivity of the virus-specific primer sets selected for the array were evaluated using analytical panels with known amounts of viruses spiked into human plasma.", {"entities": []}], ["The array detected: 10 genome equivalents (geq)/ml of HIV-2 and HCV, 50 geq of HIV-1 (subtype B), HBV (genotype A) and WNV.", {"entities": []}], ["It detected 100\u20131,000 geq/ml of plasma of HIV-1 subtypes (A \u2013 G), group N and CRF (AE and AG) isolates.", {"entities": []}], ["Further evaluation with a panel consisting of 28 HIV-1 and HIV-2 clinical isolates revealed no cross-reactivity of HIV-1 or HIV-2 specific primers with another type of HIV.", {"entities": []}], ["All 28 viral isolates were identified with specific primer sets targeting the most conserved genome areas.", {"entities": []}], ["The PCR array correctly identified viral infections in a panel of 17 previously quantified clinical plasma samples positive for HIV-1, HCV or HBV at as low as several geq per PCR reaction.", {"entities": []}], ["The viral array described here demonstrated adequate performance in the testing of donors\u2019 clinical samples.", {"entities": []}], ["Further improvement in its sensitivity for the broad spectrum of HIV-1 subtypes is under development.", {"entities": []}], ["A synopsis of new clinical research highlights important aspects of one study in a brief structured format.", {"entities": []}], ["When delivered as email alerts, synopses enable clinicians to become aware of new developments relevant for practice.", {"entities": []}], ["Once read, a synopsis can become a known item of clinical information.", {"entities": []}], ["In time-pressured situations, remembering a known item may facilitate information retrieval by the clinician.", {"entities": []}], ["However, exactly how synopses first delivered as email alerts influence retrieval at some later time is not known.", {"entities": []}], ["We examined searches for clinical information in which a synopsis previously read as an email alert was retrieved (defined as a dyad ).", {"entities": []}], ["Our study objectives were to (1) examine whether family physicians retrieved synopses they previously read as email alerts and then to (2) explore whether family physicians purposefully retrieved these synopses.", {"entities": []}], ["We conducted a mixed-methods study in which a qualitative multiple case study explored the retrieval of email alerts within a prospective longitudinal cohort of practicing family physicians.", {"entities": []}], ["Reading of research-based synopses was tracked in two contexts: (1) push, meaning to read on email and (2) pull, meaning to read after retrieval from one electronic knowledge resource.", {"entities": []}], ["Dyads, defined as synopses first read as email alerts and subsequently retrieved in a search of a knowledge resource, were prospectively identified.", {"entities": []}], ["Participants were interviewed about all of their dyads.", {"entities": []}], ["Outcomes were the total number of dyads and their type.", {"entities": []}], ["Over a period of 341 days, 194 unique synopses delivered to 41 participants resulted in 4937 synopsis readings.", {"entities": []}], ["In all, 1205 synopses were retrieved over an average of 320 days.", {"entities": []}], ["Of the 1205 retrieved synopses, 21 (1.7%) were dyads made by 17 family physicians.", {"entities": []}], ["Of the 1205 retrieved synopses, 6 (0.5%) were known item type dyads.", {"entities": []}], ["However, dyads also occurred serendipitously.", {"entities": []}], ["In the single knowledge resource we studied, email alerts containing research-based synopses were rarely retrieved.", {"entities": []}], ["Our findings help us to better understand the effect of push on pull and to improve the integration of research-based information within electronic resources for clinicians.", {"entities": []}], ["Mobile phone technology is a novel way of delivering health care and improving health outcomes.", {"entities": []}], ["This trial investigates the use of motivational mobile phone text messages (SMS) to improve adherence to antiretroviral therapy (ART) over six months.", {"entities": [[76, 79, "GENE"]]}], ["CAMPS was a single-site randomized two-arm parallel design trial in Yaound\u00e9, Cameroon.", {"entities": []}], ["We enrolled and randomized HIV-positive adults on ART, aged 21 years and above to receive a weekly standardized motivational text message versus usual care alone.", {"entities": []}], ["The primary outcome was adherence measured using a visual analogue scale (VAS), number of doses missed (in the week preceding the interview) and pharmacy refill data.", {"entities": []}], ["Outcomes were measured at 3 and 6 months.", {"entities": []}], ["Service providers and outcome assessors were blinded to allocation.", {"entities": []}], ["Analysis was by intention-to-treat.", {"entities": []}], ["Between November and December 2010, 200 participants were randomized, with 101 in the intervention group and 99 in the control group.", {"entities": []}], ["At 6 months, overall retention was 81.5%.", {"entities": []}], ["We found no significant effect on adherence by VAS>95% (risk ratio [RR] 1.06, 95% confidence interval [CI] 0.89, 1.29; p\u200a=\u200a0.542; reported missed doses (RR 1.01, 95% CI 0.87, 1.16; p>0.999) or number of pharmacy refills (mean difference [MD] 0.1, 95% CI: 0.23, 0.43; p\u200a=\u200a0.617.", {"entities": []}], ["One participant in the intervention arm reported a possible disclosure of status.", {"entities": []}], ["Standardized motivational mobile phone text messages did not significantly improve adherence to ART in this study.", {"entities": []}], ["Other types of messaging or longer term studies are recommended.", {"entities": []}], ["Pan-African Clinical Trials Registry; PACTR201011000261458 2.", {"entities": []}], ["Clinicaltrials.gov; NCT01247181", {"entities": []}], ["Approximately 210 million people are estimated to have chronic obstructive pulmonary disease [COPD] worldwide.", {"entities": [[55, 92, "DISEASE"]]}], ["The burden of disease is known to be high, though less is known about those of a younger age.", {"entities": []}], ["The aim of this study was to investigate the wider personal, economic and societal burden of COPD on a cross country working-age cohort.", {"entities": []}], ["A cross-country [Brazil, China, Germany, Turkey, US, UK] cross-sectional survey methodology was utilised to answer the research questions.", {"entities": []}], ["2426 participants aged 45-67 recruited via a number of recruitment methods specific to each country completed the full survey.", {"entities": []}], ["Inclusion criteria were a recalled physician diagnosis of COPD, a smoking history of > 10 pack years and the use of COPD medications in the previous 3 months prior to questioning.", {"entities": []}], ["The survey included items from the validated Work Productivity and Activity Impairment [WPAI] scale and the EuroQoL 5 Dimension [EQ-5D] scale.", {"entities": []}], ["Disease severity was measured using the 5-point MRC [Medical Research Council] dyspnoea scale as a surrogate measure.", {"entities": []}], ["64% had either moderate [n = 1012] or severe [n = 521] COPD, although this varied by country.", {"entities": []}], ["75% of the cohort reported at least one comorbid condition.", {"entities": []}], ["Quality of life declined with severity of illness [mild, mean EQ-5D score = 0.84; moderate 0.58; severe 0.41].", {"entities": []}], ["The annual cost of healthcare utilisation [excluding treatment costs and diagnostic tests] per individual was estimated to be $2,364 [\u00a31,500].", {"entities": []}], ["For those remaining in active employment [n: 677]: lost time from work cost the individual an average of $880 [\u00a3556] per annum and lifetime losses of $7,365 [\u00a34,661] amounting to $596,000 [\u00a3377,000] for the cohort.", {"entities": []}], ["447 [~40%] of the working population had retired prematurely because of COPD incurring individual estimated lifetime income losses of $316,000 [\u00a3200,000] or a combined total of $141 m [\u00a389.6 m].", {"entities": []}], ["As the mean age of retirees was 58.3 and average time since retirement was 4 years, this suggests the average age of retirement is around 54.", {"entities": []}], ["This would mean a high societal and economic impact in all study countries, particularly where typical state retirement ages are higher, for example in Brazil, Germany and the UK [65] and the US [65,66,67], compared to Turkey [58 for women, 60 for men] and China [60].", {"entities": []}], ["Although generalisation across a broader COPD population is limited due to the varied participant recruitment methods, these data nevertheless suggest that COPD has significant personal, economic and societal burden on working age people.", {"entities": []}], ["Further efforts to improve COPD diagnosis and management are required.", {"entities": []}], ["Several organizations representing pharmacy and other health professions stress the importance of teaching public health topics as part of training future practitioners.", {"entities": []}], ["The objective of our study was to assess the number of U.S. pharmacy schools that incorporate lifestyle modification topics into their curricula.", {"entities": []}], ["We developed an electronic survey on lifestyle modification topics and sent it to each of the 89 pharmacy schools in the United States.", {"entities": []}], ["The survey defined lifestyle modification topics as topics that address nutrition, exercise, weight loss, smoking cessation, and alcohol use.", {"entities": []}], ["Of 89 pharmacy schools contacted, 50 (56%) responded to the survey.", {"entities": []}], ["Of the 50, four offer at least one required course in a lifestyle modification topic, seven offer at least one elective course, and one offers a required course that incorporates more than one lifestyle modification topic.", {"entities": []}], ["Five required and nine elective courses were identified from the responses.", {"entities": []}], ["Nutrition was the most commonly offered required course topic, followed by smoking cessation, exercise, weight loss, and alcohol use.", {"entities": []}], ["Few pharmacy schools are addressing recommendations to promote public health education through formalized didactic courses.", {"entities": []}], ["More courses on lifestyle modification topics should be offered to pharmacy students, who will be highly accessible to the public as pharmacists and will be able to offer education to enhance public health focused on the prevention of chronic diseases.", {"entities": []}], ["Taking the advan tage of high-throughput single nucleotide polymorphism (SNP) genotyping technology, large genome-wide association studies (GWASs) have been considered to hold promise for unravelling complex relationships between genotype and phenotype.", {"entities": []}], ["At present, traditional single-locus-based methods are insufficient to detect interactions consisting of multiple-locus, which are broadly existing in complex traits.", {"entities": []}], ["In addition, statistic tests for high order epistatic interactions with more than 2 SNPs propose computational and analytical challenges because the computation increases exponentially as the cardinality of SNPs combinations gets larger.", {"entities": []}], ["In this paper, we provide a simple, fast and powerful method using dynamic clustering and cloud computing to detect genome-wide multi-locus epistatic interactions.", {"entities": []}], ["We have constructed systematic experiments to compare powers performance against some recently proposed algorithms, including TEAM, SNPRuler, EDCF and BOOST.", {"entities": []}], ["Furthermore, we have applied our method on two real GWAS datasets, Age-related macular degeneration (AMD) and Rheumatoid arthritis (RA) datasets, where we find some novel potential disease-related genetic factors which are not shown up in detections of 2-loci epistatic interactions.", {"entities": [[121, 130, "DISEASE"], [79, 99, "DISEASE"]]}], ["Experimental results on simulated data demonstrate that our method is more powerful than some recently proposed methods on both two- and three-locus disease models.", {"entities": []}], ["Our method has discovered many novel high-order associations that are significantly enriched in cases from two real GWAS datasets.", {"entities": []}], ["Moreover, the running time of the cloud implementation for our method on AMD dataset and RA dataset are roughly 2 hours and 50 hours on a cluster with forty small virtual machines for detecting two-locus interactions, respectively.", {"entities": []}], ["Therefore, we believe that our method is suitable and effective for the full-scale analysis of multiple-locus epistatic interactions in GWAS.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is associated with significant morbidity, places substantial time and cost burden on the health care system, and is now the third leading cause of death in the US.", {"entities": []}], ["Many interventions are available to appropriately manage patients with COPD; however, fully implementing these strategies to help improve outcomes may be difficult.", {"entities": []}], ["Collaboration between an interprofessional team of health care professionals (which includes physicians, nurses, respiratory therapists, physical therapists, dietitians, pharmacists, and many others) and COPD patients and caregivers is necessary to optimally manage these patients and to truly impact outcomes in this devastating disease.", {"entities": []}], ["Prescribing evidence-based non-pharmacological and pharmacological therapies is an important start, but a true team-based approach is critical to successfully implement comprehensive care in patients with COPD.", {"entities": []}], ["The goal of this review is to employ a case-based approach to provide practical information regarding the roles of the interprofessional team in implementing strategies to optimally manage COPD patients.", {"entities": []}], ["In regions with a high infectious disease burden, concerns have been raised about the safety of iron supplementation because higher iron concentrations in the gut lumen may increase risk of enteropathogen infection.", {"entities": []}], ["The aim of this study was to investigate interactions of the enteropathogen Salmonella enterica ssp.", {"entities": []}], ["enterica Typhimurium with intestinal cells under different iron concentrations encountered in the gut lumen during iron deficiency and supplementation using an in vitro colonic fermentation system inoculated with immobilized child gut microbiota combined with Caco-2/HT29-MTX co-culture monolayers.", {"entities": []}], ["Colonic fermentation effluents obtained during normal, low (chelation by 2,2'-dipyridyl) and high iron (26.5 mg iron/L) fermentation conditions containing Salmonella or pure Salmonella cultures with similar iron conditions were applied to cellular monolayers.", {"entities": []}], ["Salmonella adhesion and invasion capacity, cellular integrity and immune response were assessed.", {"entities": []}], ["Under high iron conditions in pure culture, Salmonella adhesion was 8-fold increased compared to normal iron conditions while invasion was not affected leading to decreased invasion efficiency (\u221286%).", {"entities": []}], ["Moreover, cellular cytokines IL-1\u03b2, IL-6, IL-8 and TNF-\u03b1 secretion as well as NF-\u03baB activation in THP-1 cells were attenuated under high iron conditions.", {"entities": []}], ["Low iron conditions in pure culture increased Salmonella invasion correlating with an increase in IL-8 release.", {"entities": []}], ["In fermentation effluents, Salmonella adhesion was 12-fold and invasion was 428-fold reduced compared to pure culture.", {"entities": []}], ["Salmonella in high iron fermentation effluents had decreased invasion efficiency (\u221277.1%) and cellular TNF-\u03b1 release compared to normal iron effluent.", {"entities": []}], ["The presence of commensal microbiota and bacterial metabolites in fermentation effluents reduced adhesion and invasion of Salmonella compared to pure culture highlighting the importance of the gut microbiota as a barrier during pathogen invasion.", {"entities": []}], ["High iron concentrations as encountered in the gut lumen during iron supplementation attenuated Salmonella invasion efficiency and cellular immune response suggesting that high iron concentrations alone may not lead to an increased Salmonella invasion.", {"entities": []}], ["Phthalates, ubiquitous environmental pollutants that may disturb the endocrine system, are used primarily as plasticizers of polyvinyl chloride and as additives in consumer and personal care products.", {"entities": []}], ["In this study, we examined the association between urinary concentrations of nine phthalate metabolites and breast cancer (BC) in Mexican women.", {"entities": [[108, 121, "DISEASE"], [115, 121, "DISEASE"]]}], ["We age-matched 233 BC cases to 221 women residing in northern Mexico.", {"entities": []}], ["Sociodemographic and reproductive characteristics were obtained by direct interviews.", {"entities": []}], ["Phthalates were determined in urine samples (collected pretreatment from the cases) by isotope dilution/high-performance liquid chromatography coupled to tandem mass spectrometry.", {"entities": []}], ["Phthalate metabolites were detected in at least 82% of women.", {"entities": []}], ["The geometric mean concentrations of monoethyl phthalate (MEP) were higher in cases than in controls (169.58 vs. 106.78 \u03bcg/g creatinine).", {"entities": []}], ["Controls showed significantly higher concentrations of mono- n -butyl phthalate, mono(2-ethyl-5-oxohexyl) phthalate, and mono(3-carboxypropyl) phthalate (MCPP) than did the cases.", {"entities": []}], ["After adjusting for risk factors and other phthalates, MEP urinary concentrations were positively associated with BC [odds ratio (OR), highest vs. lowest tertile = 2.20; 95% confidence interval (CI), 1.33\u20133.63; p for trend < 0.01].", {"entities": []}], ["This association became stronger when estimated for premenopausal women (OR, highest vs. lowest tertile = 4.13; 95% CI, 1.60\u201310.70; p for trend < 0.01).", {"entities": []}], ["In contrast, we observed significant negative associations for monobenzyl phthalate (MBzP) and MCPP.", {"entities": []}], ["We show for the first time that exposure to diethyl phthalate, the parent compound of MEP, may be associated with increased risk of BC, whereas exposure to the parent phthalates of MBzP and MCPP might be negatively associated.", {"entities": []}], ["These findings require confirmation.", {"entities": []}], ["In this study, we investigated the mechanisms through which microRNAs (miRNAs or miRs) regulate lung development after birth, as well as the role of miRNAs in the development of bronchopulmonary dysplasia (BPD).", {"entities": []}], ["For this purpose, a total of 90 neonatal Wistar rats were randomly and equally assigned to either a model group or a control group.", {"entities": []}], ["On postnatal days 3, 7 and 14, the lung tissues were collected for histological analysis to determine morphological changes.", {"entities": []}], ["The expression levels of proliferating cell nuclear antigen (PCNA) and platelet endothelial cell adhesion molecule-1 (PECAM-1, also known as CD31) were measured by RT-qPCR and western blot analysis.", {"entities": [[61, 65, "GENE"]]}], ["A miRCURY\u2122 LNA array was employed to screen for differentially expressed miRNAs, and the possible target genes of those miRNAs were predicted.", {"entities": []}], ["Our results revealed that, compared with the control group, the following changes induced by hyperoxia were observed in the model group over time: a decrease in the number, but an increase in the size of the alveoli, and a decrease in the number of secondary septa formed.", {"entities": []}], ["In the model group, from postnatal days 3\u201314, the mRNA and protein expression levels of PCNA and CD31 were significantly lower than those in the control group.", {"entities": [[88, 92, "GENE"]]}], ["The differentially expressed miRNAs between the 2 groups were identified on days 3, 7 and 14 after birth.", {"entities": []}], ["Possible target genes were identified for 32 differentially expressed miRNAs.", {"entities": []}], ["Taken together, these findings suggest that during the development of BPD, an alveolarization disorder with microvascular dysplasia co-exists with the differential expression of certain miRNAs during the different stages of alveolar development in a neonatal rat model of hyperoxia-induced BPD.", {"entities": []}], ["This indicates that miRNAs may participate in the occurrence and development of BPD.", {"entities": []}], ["The term asthma\u2013COPD overlap syndrome (ACOS) is one of multiple terms used to describe patients with characteristics of both COPD and asthma, representing ~20% of patients with obstructive airway diseases.", {"entities": [[29, 37, "DISEASE"], [9, 15, "DISEASE"], [134, 140, "DISEASE"]]}], ["The recognition of both sets of morbidities in patients is important to guide practical treatment decisions.", {"entities": []}], ["It is widely recognized that patients with COPD and coexisting asthma present with a higher disease burden, despite the conceptual expectation that the \u201creversible\u201d or \u201ctreatable\u201d component of asthma would allow for more effective management and better outcomes.", {"entities": [[63, 69, "DISEASE"], [193, 199, "DISEASE"]]}], ["However, subcategorization into terms such as ACOS is complicated by the vast spectrum of heterogeneity that is encapsulated by asthma and COPD, resulting in different clinical clusters.", {"entities": [[128, 134, "DISEASE"]]}], ["In this review, we discuss the possibility that these different clusters are suboptimally described by the umbrella term \u201cACOS\u201d, as this additional categorization may lead to clinical confusion and potential inappropriate use of resources.", {"entities": []}], ["We suggest that a more clinically relevant approach would be to recognize the extreme variability and the numerous phenotypes encompassed within obstructive airway diseases, with various degrees of overlapping in individual patients.", {"entities": []}], ["In addition, we discuss some of the evidence to be considered when making practical decisions on the treatment of patients with overlapping characteristics between COPD and asthma, as well as the potential options for phenotype and biomarker-driven management of airway disease with the aim of providing more personalized treatment for patients.", {"entities": [[173, 179, "DISEASE"]]}], ["Finally, we highlight the need for more evidence in patients with overlapping disease characteristics and to facilitate better characterization of potential treatment responders.", {"entities": []}], ["The airway surface liquid (ASL) is the thin layer of fluid coating the luminal surface of airway epithelial cells at an air interface.", {"entities": [[27, 30, "GENE"]]}], ["Its composition and osmolality are thought to be important in normal airway physiology and in airway diseases such as asthma and cystic fibrosis.", {"entities": [[129, 144, "DISEASE"], [118, 124, "DISEASE"]]}], ["The determinants of ASL osmolality include epithelial cell solute and water transport properties, evaporative water loss, and the composition of secreted fluids.", {"entities": [[20, 23, "GENE"]]}], ["We developed a noninvasive approach to measure ASL osmolality using osmotically sensitive 400-nm-diam liposomes composed of phosphatidylcholine/cholesterol/polyethylene glycol-phosphatidylcholine (1:0.3:0.08 molar ratio).", {"entities": [[47, 50, "GENE"]]}], ["Calcein was encapsulated in the liposomes at self-quenching concentrations (30 mM) as a volume-sensitive marker, together with sulforhodamine 101 (2 mM) as a volume-insensitive reference.", {"entities": []}], ["Liposome calcein/sulforhodamine 101 fluorescence ratios responded rapidly (<0.2 s) and stably to changes in solution osmolality.", {"entities": []}], ["ASL osmolality was determined from calcein/sulforhodamine 101 fluorescence ratios after addition of microliter quantities of liposome suspensions to the ASL.", {"entities": [[0, 3, "GENE"], [153, 156, "GENE"], [0, 3, "GENE"], [153, 156, "GENE"]]}], ["In bovine airway epithelial cells cultured on porous supports at an air\u2013liquid interface, ASL thickness (by confocal microscopy) was 22 \u03bcm and osmolality was 325 \u00b1 12 mOsm.", {"entities": [[90, 93, "GENE"]]}], ["In anesthetized mice in which a transparent window was created in the trachea, ASL thickness was 55 \u03bcm and osmolality was 330 \u00b1 36 mOsm.", {"entities": [[79, 82, "GENE"]]}], ["ASL osmolality was not affected by pharmacological inhibition of CFTR in airway cell cultures or by genetic deletion of CFTR in knockout mice.", {"entities": [[0, 3, "GENE"], [65, 69, "GENE"], [120, 124, "GENE"], [65, 69, "GENE"], [120, 124, "GENE"]]}], ["ASL osmolality could be increased substantially to >400 mOsm by exposure of the epithelium to dry air; the data were modeled mathematically using measured rates of osmosis and evaporative water loss.", {"entities": [[0, 3, "GENE"]]}], ["These results establish a ratio imaging method to map osmolality in biological compartments.", {"entities": []}], ["ASL fluid is approximately isosmolar under normal physiological conditions, but can become hyperosmolar when exposed to dry air, which may induce cough and airway reactivity in some patients.", {"entities": [[0, 3, "GENE"]]}], ["Allergy has been an increasing problem in several parts of the world.", {"entities": []}], ["Prenatal exposure to allergen and microbial components may affect the development of allergies in childhood, as indicated by epidemiological and experimental studies.", {"entities": []}], ["We investigated the capacity for allergic sensitisation in offspring after induction of a Th1- or a Th2-polarised immune response to the same allergen in mothers during pregnancy.", {"entities": []}], ["During pregnancy, mice were immunised with ovalbumin (OVA) given with either one of the Th2-adjuvants pertussis toxin (PT) or Al(OH) 3 (aluminium hydroxide), or with the Th1 adjuvant CpG.", {"entities": [[102, 111, "DISEASE"]]}], ["Offspring were immunised with OVA in Al(OH) 3 as young adults.", {"entities": []}], ["Serum and supernatants from ex vivo stimulated or non-stimulated spleen cells from mothers and offspring were analysed for OVA-specific antibodies and cytokines, respectively.", {"entities": []}], ["Mothers immunised with OVA together with either Al(OH) 3 or PT had increased levels of OVA-specific IgE and IgG1 compared to naive mothers, whereas mothers immunised with OVA together with CpG had increased levels of OVA-specific IgG2a compared to naive mothers.", {"entities": []}], ["In general the highest levels of IL-5, IL-10, and IFN\u03b3 were observed in spleen cells from mothers immunised with PT and OVA.", {"entities": []}], ["Upon immunisation, offspring from mothers immunised with OVA and either PT or Al(OH) 3 showed reduced levels of OVA-specific IgE and IgG1 and increased levels of OVA-specific IgG2a antibodies compared to offspring from naive mothers.", {"entities": []}], ["Maternal immunisation with CpG and OVA did not affect antibody responses in offspring.", {"entities": []}], ["Allergic sensitisation in the offspring was affected by the type of adjuvant used for immunisation of the mothers with the same allergen.", {"entities": []}], ["Th2 polarisation of the immune response in the mothers was found to give reduced IgE levels upon sensitisation of the offspring, whereas no reduction was achieved with Th1 polarisation in the mothers.", {"entities": []}], ["Objective and background .", {"entities": []}], ["Pulmonary aneurysms and thrombosis constitute a significant cause of morbidity and mortality in Beh\u00e7et's disease (BD).", {"entities": []}], ["Various factors have been studied to explore the pathogenesis of vascular involvement in BD.", {"entities": []}], ["As endothelin (ET) is known for its potent vasoconstrictor and proinflammatory properties, we supposed that it is involved during the inflammatory process of BD pulmonary vasculitis.", {"entities": [[171, 181, "DISEASE"]]}], ["To investigate the role of ET in BD, ET-1 concentrations were measured in bronchoalveolar lavage fluid (BALF) of 18 nonsmoking BD patients with pulmonary manifestations and 12 control subjects.", {"entities": []}], ["Immunoreactivity of ET-1 was also evaluated in alveolar macrophages (AMs) cytoplasm.", {"entities": []}], ["ET-1 levels in BD-BALF were significantly higher than those of controls.", {"entities": []}], ["ET-1 levels were correlated with the number of alveolar macrophages, but not with BAL-CD4/CD8 ratio.", {"entities": []}], ["ET-1-immunoreactivity was found mainly in AM of BD-BAL.", {"entities": []}], ["Conclusions .", {"entities": []}], ["Increased ET-1 production from AM is associated with pulmonary BD manifestations.", {"entities": []}], ["Aging is a universal process to all life forms.", {"entities": []}], ["The most current and widely accepted definition for aging in humans is that there is a progressive loss of function and energy production that is accompanied by decreasing fertility and increasing mortality with advancing age.", {"entities": []}], ["The most obvious and commonly recognised consequence of aging and energy decline is a decrease in skeletal muscle function which affects every aspect of human life from the ability to play games, walk and run to chew, swallow and digest food.", {"entities": []}], ["There is hence a recognised overall decline of an individuals\u2019 fitness for the environment that they occupy.", {"entities": []}], ["In Westernised countries this decline is gradual and the signs become mostly noticeable after the 5th decade of life and henceforth, where the individual slowly progresses to death over the next three to four decades.", {"entities": []}], ["Given that the aging process is slow and gradual, it presents with opportunities and options that may ameliorate and improve the overall functional capacity of the organism.", {"entities": []}], ["Small changes in function may be more amenable and likely to further slow down and possibly reverse some of the deleterious effects of aging, rather, than when the incremental changes are large.", {"entities": []}], ["This overall effect may then translate into a significant compression of the deleterious aspects of human aging with a resultant increase in human life expectancy.", {"entities": []}], ["Internet-based self-management (IBSM) support cost-effectively improves asthma control, asthma related quality of life, number of symptom-free days, and lung function in patients with mild to moderate persistent asthma.", {"entities": [[72, 78, "DISEASE"], [88, 94, "DISEASE"], [212, 218, "DISEASE"]]}], ["The current challenge is to implement IBSM in clinical practice.", {"entities": []}], ["This study is a three-arm cluster randomized trial with a cluster pre-randomisation design and 12\u2009months follow-up per practice comparing the following three IBSM implementation strategies: minimum strategy (MS): dissemination of the IBSM program; intermediate strategy (IS): MS + start-up support for professionals ( i.e.", {"entities": []}], [", support in selection of the appropriate population and training of professionals); and extended strategy (ES): IS + additional training and ongoing support for professionals.", {"entities": []}], ["Because the implementation strategies (interventions) are primarily targeted at general practices, randomisation will occur at practice level.", {"entities": []}], ["In this study, we aim to evaluate 14 primary care practices per strategy in the Leiden-The Hague region, involving 140 patients per arm.", {"entities": []}], ["Patients aged 18 to 50\u2009years, with a physician diagnosis of asthma, prescription of inhaled corticosteroids, and/or montelukast for \u22653\u2009months in the previous year are eligible to participate.", {"entities": [[60, 66, "DISEASE"]]}], ["Primary outcome measures are the proportion of referred patients that participate in IBSM, and the proportion of patients that have clinically relevant improvement in the asthma-related quality of life.", {"entities": [[171, 177, "DISEASE"]]}], ["The secondary effect measures are clinical outcomes (asthma control, lung function, usage of airway treatment, and presence of exacerbations); self-management related outcomes (health education impact , medication adherence, and illness perceptions); and patient utilities.", {"entities": [[53, 59, "DISEASE"]]}], ["Process measures are the proportion of practices that participate in IBSM and adherence of professionals to implementation strategies.", {"entities": []}], ["Cost-effective measurements are medical costs and healthcare consumption.", {"entities": []}], ["Follow-up is six months per patient.", {"entities": []}], ["This study provides insight in the amount of support that is required by general practices for cost-effective implementation of IBSM.", {"entities": []}], ["Additionally, design and results can be beneficial for implementation of other self-management initiatives in clinical practice.", {"entities": []}], ["the Netherlands National Trial Register NTR2970", {"entities": []}], ["The Together for Agricultural Safety project is a community-based social marketing project working to reduce the adverse health effects of pesticide exposure among fernery and nursery workers in Florida.", {"entities": []}], ["In 3 years, the collaboration between university and community researchers has embodied many of the principles of community-based research while completing multiple stages of formative data collection required for a social marketing project.", {"entities": []}], ["This hybrid approach to developing a health intervention for a minority community has been successful in its early stages because the community partners are organized, empowered, and motivated to execute research activities with the assistance of academic partners.", {"entities": []}], ["However, this work has also been labor intensive and costly.", {"entities": []}], ["This article describes the lessons learned by project partners and considers the limitations of this approach for agricultural health research.", {"entities": []}], ["Errors in consuming drugs are associated with significant morbidity and mortality, besides an impact on the already overburdened health-care system.", {"entities": []}], ["Misunderstanding drug labels and prescriptions plays an important role in contributing to adverse drug events.", {"entities": []}], ["To evaluate abilities to understand prescriptions and drug labels among patients attending tertiary care hospital in Karachi.", {"entities": []}], ["A cross sectional study was conducted at the Aga Khan University Hospital (AKUH), from January to March 2009.", {"entities": []}], ["After informed consent, 181 adult patients and their healthy attendants were interviewed at AKUH using a standardized questionnaire, which ascertained patient demographics, factors that might increase exposure to health-care personnel as well as the basic knowledge and understanding of prescriptions and drug labels.", {"entities": []}], ["Out of 181, majority 137(76%) had received graduate or post-graduate degrees.", {"entities": []}], ["16 (9%) had received no formal education; of which all were females and 89(84%) of the total females were housewives.", {"entities": []}], ["Overall, 130(72%) followed only a single doctor\u2019s prescription.", {"entities": []}], ["Majority failed to understand various medical terminologies related to dosage.", {"entities": []}], ["In the high literacy group, 45(33%) understood once daily OD (p\u200a=\u200a0.003), 27(20%) thrice daily TID (p\u200a=\u200a0.05), 29(21%) twice daily BD (p\u200a=\u200a0.01), 31(23%) thrice daily TDS (p\u200a=\u200a0.002) and 43(31%) as needed SOS (p\u200a=\u200a0.003) as compared to the group with no formal education, who were unable to comprehend the terms.", {"entities": []}], ["The most common reason for using more than one prescription was decreased satisfaction with the doctor in 19(39%) and multiple co-morbids as responded by 17(35%) of patients.", {"entities": []}], ["Knowledge regarding various medical terminologies used for dosage and routes of drug administration were also understood more frequently among the English medium respondents.", {"entities": []}], ["The elderly identified medicine through color (47%, p<0.001), and were less likely to understand drug indications (p\u200a=\u200a0.05) compared to younger subjects.", {"entities": []}], ["Understanding of drug prescriptions is alarmingly low in the community, even amongst the educated.", {"entities": []}], ["Care givers need to revisit this often ignored aspect of patient care.", {"entities": []}], ["Mechanical ventilation of severe acute asthma is still considered a challenging issue, mainly because of the gas trapping phenomenon with the potential for life-threatening barotraumatic pulmonary complications.", {"entities": [[39, 45, "DISEASE"]]}], ["Herein, we describe 2 consecutive cases of near-fatal asthma for whom the recommended protective mechanical ventilation approach using low tidal volume of 6\u200amL/kg and small levels of PEEP was rapidly compromised by giant pneumomediastinum with extensive subcutaneousemphysema.", {"entities": [[54, 60, "DISEASE"]]}], ["Near fatal asthma.", {"entities": [[11, 17, "DISEASE"]]}], ["A rescue therapeutic strategy combining extracorporeal CO 2 removal membrane with ultra-protective extremely low tidal volume (3\u200amL/kg) ventilation was applied.", {"entities": []}], ["Both patients survived hospital discharge.", {"entities": []}], ["These 2 cases indicate that ECCO 2 R associated with ultra-protective ventilation could be an alternative to surgery in case of life-threatening barotrauma occurring under mechanical ventilation.", {"entities": []}], ["The relationship between lower urinary tract symptoms (LUTS) and common mental health disorders such as depression and anxiety in men remains unclear.", {"entities": []}], ["Inflammation has recently been identified as an independent risk factor for LUTS and depression.", {"entities": []}], ["This study aimed to assess the association between depression, anxiety and LUTS, and the moderating influence of systemic inflammation, in the presence of other biopsychosocial confounders.", {"entities": []}], ["Participants were randomly-selected from urban, community-dwelling males aged 35\u201380 years at recruitment (n = 1195; sample response rate:67.8%).", {"entities": []}], ["Of these, 730 men who attended baseline (2002\u20135) and follow-up clinic visits (2007\u201310), with complete outcome measures, and without prostate or bladder cancer and/or surgery, neurodegenerative conditions, or antipsychotic medications use, were selected for the present study.", {"entities": [[152, 158, "DISEASE"]]}], ["Unadjusted and multi-adjusted regression models of incident storage and voiding LUTS and incident depression and anxiety were combined with serum inflammatory markers (high-sensitive C-reactive protein (hsCRP), tumor necrosis factor-alpha (TNF-\u03b1), interleukin\u20136 (IL\u20136), myeloperoxidase (MPO), soluble e-selectin (e-Sel)) and socio-demographic, lifestyle, and health-related factors.", {"entities": [[287, 290, "GENE"]]}], ["Hierarchical multiple regression was used to assessed the moderating effect of inflammatory markers.", {"entities": []}], ["The incidence of storage, voiding LUTS, depression and anxiety was 16.3% (n = 108), 12.1% (n = 88), 14.5% (n = 108), and 12.2% (n = 107).", {"entities": []}], ["Regression models demonstrated that men with depression and anxiety at baseline were more likely to have incident storage, but not voiding LUTS (OR: 1.26, 99%CI: 1.01\u20134.02; and OR:1.74; 99%CI:1.05\u20132.21, respectively).", {"entities": []}], ["Men with anxiety and storage LUTS at baseline were more likely to have incident depression (OR: 2.77, 99%CI: 1.65\u20137.89; and OR:1.45; 99%CI:1.05\u20132.36, respectively), while men with depression and voiding LUTS were more likely to have anxiety at follow-up (OR: 5.06, 99%CI: 2.81\u20139.11; and OR:2.40; 99%CI:1.16\u20134.98, respectively).", {"entities": []}], ["CRP, TNF-\u03b1, and e-Sel were found to have significant moderating effects on the development of storage LUTS (1.06, 0.91\u20131.96, R There is a bidirectional relationship between storage, but not voiding, LUTS and both depression and anxiety.", {"entities": [[0, 3, "GENE"]]}], ["We observed variable moderation effects for selected inflammatory markers on the development of depression, anxiety and storage LUTS.", {"entities": []}], ["This report presents a review of the efficacy and safety of peramivir, a neuraminidase inhibitor that was granted Emergency Use Authorization by the US Food and Drug Administration (FDA) from October 23, 2009 to June 23, 2010 during the 2009 H1N1 pandemic.", {"entities": []}], ["Literature was accessed via PubMed (January 2000\u2013April 2014) using several search terms: peramivir; BCX-1812; RWJ 270201; H1N1, influenza; antivirals; and neuraminidase inhibitors.", {"entities": [[128, 137, "DISEASE"]]}], ["The peramivir manufacturers, Shionogi and Co Ltd and BioCryst Pharmaceuticals, were contacted to obtain unpublished data and information presented at recent scientific meetings.", {"entities": []}], ["Information was obtained from the Centers for Disease Control and Prevention (CDC) and from US FDA websites.", {"entities": []}], ["English-language and Japanese-language reports in the literature were reviewed and selected based on relevance, along with information from the CDC, US FDA, and the drug manufacturers.", {"entities": []}], ["We obtained eleven clinical trial reports of intravenous peramivir, two of which described comparisons with oseltamivir.", {"entities": []}], ["Seven of nine other recently reported published studies was a dose\u2013response study.", {"entities": []}], ["Clinical reports of critically ill patients and pediatric patients infected with pandemic H1N1 described that early treatment significantly decreased mortality.", {"entities": []}], ["Peramivir administered at 300 mg once daily in adult patients with influenza significantly reduces the time to alleviation of symptoms or fever compared to placebo.", {"entities": [[67, 76, "DISEASE"]]}], ["It is likely to be as effective as other neuraminidase inhibitors.", {"entities": []}], ["Although peramivir shows efficacy for the treatment of seasonal and pH1N1 influenza, it has not received US FDA approval.", {"entities": [[74, 83, "DISEASE"]]}], ["Peramivir is used safely and efficiently in hospitalized adult and pediatric patients with suspected or laboratory-confirmed influenza.", {"entities": [[125, 134, "DISEASE"]]}], ["Peramivir might be a beneficial alternative antiviral treatment for many patients, including those unable to receive inhaled or oral neuraminidase inhibitors, or those requiring nonintravenous drug delivery.", {"entities": []}], ["Currently is not feasible using conventional spirometry as a screening method in Primary Care especially among smoking population to detect chronic obstructive pulmonary disease in early stages.", {"entities": [[140, 177, "DISEASE"]]}], ["Therefore, the FUMEPOC study protocol intends to analyze the validity and reliability of Vitalograph COPD-6 spirometer as simpler tool to aid screening and diagnosis of this disease in early stages in primary care surgery.", {"entities": []}], ["Study design: An observational, descriptive study of diagnostic tests, undertaken in Primary Care and Pneumology Outpatient Care Centre at San Juan Hospital and Elda Hospital.", {"entities": []}], ["All smokers attending the primary care surgery and consent to participate in the study will undergo a test with Vitalograph COPD-6 spirometer.", {"entities": []}], ["Subsequently, a conventional spirometry will be performed in the hospital and the results will be compared with those of the Vitalograph COPD-6 test.", {"entities": []}], ["It is difficult to use the spirometry as screening for early diagnose test in real conditions of primary care clinical practice.", {"entities": []}], ["The use of a simpler tool, Vitalograph COPD-6 spirometer, can help in the early diagnose and therefore, it could improve the clinical management of the disease.", {"entities": []}], ["The relation between early-life rhinovirus (RV) wheezing illness and later onset of wheezing/asthma remains a subject of debate.", {"entities": [[93, 99, "DISEASE"]]}], ["Therefore, we conducted this meta-analysis to evaluate the association between RV wheezing illness in the first 3\u2005years of life and the subsequent development of wheezing/asthma.", {"entities": [[171, 177, "DISEASE"]]}], ["Systematic review and meta-analysis.", {"entities": []}], ["The PubMed, EMBASE, Web of Science, Chinese National Knowledge Infrastructure (CNKI) and Wanfang databases were systematically searched for studies published between 1988 and February 2017, and additional studies were found by searching reference lists of relevant articles.", {"entities": []}], ["2 reviewers independently extracted data and assessed the quality of each study.", {"entities": []}], ["Results were pooled using fixed-effect models or random-effects models as appropriate.", {"entities": []}], ["The meta-analysis included 15 original articles which met the criteria, while 10 articles reported the results of 4 longitudinal cohort studies with different follow-up periods.", {"entities": []}], ["RV wheezing illness in the first 3\u2005years of life was associated with an increased risk of wheezing/asthma in later life (relative risk (RR)=2.00, 95% CI 1.62 to 2.49, p<0.001).", {"entities": [[99, 105, "DISEASE"]]}], ["In subgroup analysis by age at follow-up, the association still remained significant in <10\u2005years (RR=2.02, 95% CI 1.70 to 2.39, p<0.001) and \u226510\u2005years (RR=1.92, 95% CI 1.36 to 2.72, p<0.001).", {"entities": []}], ["The meta-analysis suggests an association between RV-induced wheezing in the first 3\u2005years of life and the subsequent development of wheezing/asthma.", {"entities": [[142, 148, "DISEASE"]]}], ["Large-scale and well-designed studies that adequately address concerns for potential confounding factors are required to validate the risk identified in the current meta-analysis.", {"entities": []}], ["Wolfram Syndrome (WFS:OMIM 222300) is an autosomal recessive, progressive, neurologic and endocrinologic degenerative disorder caused by mutations in the WFS1 gene, encoding the endoplasmic reticulum (ER) protein wolframin, thought to be involved in the regulation of ER stress.", {"entities": [[154, 158, "GENE"]]}], ["This paper reports a cross section of data from the Washington University WFS Research Clinic, a longitudinal study to collect detailed phenotypic data on a group of young subjects in preparation for studies of therapeutic interventions.", {"entities": []}], ["Eighteen subjects (ages 5.9\u201325.8, mean 14.2\u00a0years) with genetically confirmed WFS were identified through the Washington University International Wolfram Registry.", {"entities": []}], ["Examinations included: general medical, neurologic, ophthalmologic, audiologic, vestibular, and urologic exams, cognitive testing and neuroimaging.", {"entities": []}], ["Seventeen (94%) had diabetes mellitus with the average age of diabetes onset of 6.3\u2009\u00b1\u20093.5\u00a0years.", {"entities": [[20, 37, "DISEASE"]]}], ["Diabetes insipidus was diagnosed in 13 (72%) at an average age of 10.6\u2009\u00b1\u20093.3\u00a0years.", {"entities": []}], ["Seventeen (94%) had optic disc pallor and defects in color vision, 14 (78%) had hearing loss and 13 (72%) had olfactory defects, eight (44%) had impaired vibration sensation.", {"entities": []}], ["Enuresis was reported by four (22%) and nocturia by three (17%).", {"entities": []}], ["Of the 11 tested for bladder emptying, five (45%) had elevated post-void residual bladder volume.", {"entities": []}], ["WFS causes multiple endocrine and neurologic deficits detectable on exam, even early in the course of the disease.", {"entities": []}], ["Defects in olfaction have been underappreciated.", {"entities": []}], ["The proposed mechanism of these deficits in WFS is ER stress-induced damage to neuronal and hormone-producing cells.", {"entities": []}], ["This group of subjects with detailed clinical phenotyping provides a pool for testing proposed treatments for ER stress.", {"entities": []}], ["Longitudinal follow-up is necessary for establishing the natural history and identifying potential biomarkers of progression.", {"entities": []}], ["Urinary 11\u2010dehydro\u2010thromboxane ( TX )B 2 has been described as a potential predictive biomarker of major adverse cardiovascular events ( MACE s) in high cardiac risk patients.", {"entities": []}], ["This part of LTIMI (Leukotrienes and Thromboxane In Myocardial Infarction) study aimed to evaluate the relationship between 11\u2010dehydro\u2010 TXB 2 and MACE s in patients with acute myocardial infarction ( AMI ).", {"entities": [[52, 73, "DISEASE"], [176, 197, "DISEASE"], [170, 197, "DISEASE"]]}], ["LTIMI was an observational, prospective study in 180 consecutive patients with AMI type 1 referred for primary percutaneous coronary intervention.", {"entities": []}], ["On admission and at follow\u2010up visits (1 month, 1 year), 11\u2010dehydro\u2010 TXB 2 was measured in urinary samples by using high\u2010performance liquid chromatography\u2013tandem mass spectrometry.", {"entities": []}], ["The primary outcome was occurrence of composite MACE s during 1\u2010year after AMI .", {"entities": []}], ["Left ventricular ejection fraction was assessed in echocardiography on admission and at 1\u2010year follow\u2010up.", {"entities": []}], ["Analyses of 11\u2010dehydro\u2010 TXB 2 (pg/mg creatinine) were performed on log\u2010transformed data and expressed as median with IQR (Q1\u2013Q3).", {"entities": []}], ["11\u2010Dehydro\u2010 TXB 2 level on admission was 7.39 (6.85\u20138.01) and decreased at 1 month (6.73, 6.27\u20137.12; P <0.001) and 1\u2010year follow\u2010up (6.37, 5.91\u20136.94; P <0.001).", {"entities": []}], ["In univariate analysis, baseline 11\u2010dehydro\u2010 TXB 2 was higher in patients with MACE s (n=60; 7.73, 7.07\u20138.60) compared with those without MACE s (n=119; 7.28, 6.68\u20137.79; P =0.002).", {"entities": []}], ["In multivariate regression model, 11\u2010dehydro\u2010 TXB 2 and 3 other variables (diabetes, multivessel disease, and left ventricular ejection fraction) were found to be best 1\u2010year cumulative MACE predictors with odds ratio for 11\u2010dehydro\u2010 TXB 2 of 1.58 (95% CI 1.095\u20132.33; P =0.017) and area under the curve (in receiver operating characteristic analysis of 0.8).", {"entities": []}], ["Baseline 11\u2010dehydro\u2010 TXB 2 negatively correlated with both left ventricular ejection fraction on admission ( R =\u22120.21; P =0.006) and after 1 year ( R =\u22120.346; P <0.001).", {"entities": []}], ["11\u2010Dehydro\u2010 TXB 2 predicts 1\u2010year cumulative MACE s in AMI patients and provides prognostic information on the left ventricular performance.", {"entities": []}], ["The New York City Department of Health and Mental Hygiene has operated an emergency department syndromic surveillance system since 2001, using temporal and spatial scan statistics run on a daily basis for cluster detection.", {"entities": []}], ["Since the system was originally implemented, a number of new methods have been proposed for use in cluster detection.", {"entities": []}], ["We evaluated six temporal and four spatial/spatio-temporal detection methods using syndromic surveillance data spiked with simulated injections.", {"entities": []}], ["The algorithms were compared on several metrics, including sensitivity, specificity, positive predictive value, coherence, and timeliness.", {"entities": []}], ["We also evaluated each method\u2019s implementation, programming time, run time, and the ease of use.", {"entities": []}], ["Among the temporal methods, at a set specificity of 95%, a Holt-Winters exponential smoother performed the best, detecting 19% of the simulated injects across all shapes and sizes, followed by an autoregressive moving average model (16%), a generalized linear model (15%), a modified version of the Early Aberration Reporting System\u2019s C2 algorithm (13%), a temporal scan statistic (11%), and a cumulative sum control chart (<2%).", {"entities": [[335, 337, "GENE"]]}], ["Of the spatial/spatio-temporal methods we tested, a spatial scan statistic detected 3% of all injects, a Bayes regression found 2%, and a generalized linear mixed model and a space-time permutation scan statistic detected none at a specificity of 95%.", {"entities": []}], ["Positive predictive value was low (<7%) for all methods.", {"entities": []}], ["Overall, the detection methods we tested did not perform well in identifying the temporal and spatial clusters of cases in the inject dataset.", {"entities": []}], ["The spatial scan statistic, our current method for spatial cluster detection, performed slightly better than the other tested methods across different inject magnitudes and types.", {"entities": []}], ["Furthermore, we found the scan statistics, as applied in the SaTScan software package, to be the easiest to program and implement for daily data analysis.", {"entities": []}], ["Different parts of the medicinal plant Zanthoxylum budrunga Wall enjoy a variety of uses in ethnobotanical practice in Bangladesh.", {"entities": []}], ["In the present study, a number of phytochemical and pharmacological investigations were done on the ethanol extract of Z. budrunga seeds (ZBSE) to evaluate its antinociceptive and antioxidant potential.", {"entities": []}], ["ZBSE was also subjected to HPLC analysis to detect the presence of some common antioxidants.", {"entities": []}], ["In acetic acid induced writhing test in mice, ZBSE showed 65.28 and 74.30% inhibition of writhing at the doses of 250 and 500\u2009mg/kg and the results were statistically significant ( P < 0.001).", {"entities": []}], ["In hot-plate test, ZBSE raised the pain threshold significantly ( P < 0.001) throughout the entire observation period.", {"entities": []}], ["In DPPH scavenging assay, the IC 50 of ZBSE was observed at 82.60\u2009 \u03bc g/mL.", {"entities": []}], ["The phenolic content was found to be 338.77\u2009mg GAE/100\u2009g of dried plant material.", {"entities": []}], ["In reducing power assay, ZBSE showed a concentration dependent reducing ability.", {"entities": []}], ["HPLC analysis indicated the presence of caffeic acid with a concentration of 75.45\u2009mg/100\u2009g ZBSE.", {"entities": []}], ["Present investigation supported the use of Zanthoxylum budrunga seed in traditional medicine for pain management.", {"entities": []}], ["Constituents including caffeic acid and other phenolics might have some role in the observed activity.", {"entities": []}], ["A deletion polymorphism in glutathione S-transferase Mu-1 (GSTM1-null) has previously been implicated to play a role in rheumatoid arthritis (RA) risk and progression, although no prior investigations have examined its associations with anticitrullinated protein antibody (ACPA) positivity.", {"entities": [[120, 140, "DISEASE"], [131, 140, "DISEASE"]]}], ["The purpose of this study was to examine the associations of GSTM1-null with ACPA positivity in RA and to assess for evidence of interaction between GSTM1 and HLA-DRB1 shared epitope (SE) .", {"entities": [[61, 66, "GENE"], [149, 154, "GENE"], [159, 167, "GENE"]]}], ["Associations of GSTM1-null with ACPA positivity were examined separately in two RA cohorts, the Veterans Affairs Rheumatoid Arthritis (VARA) registry ( n = 703) and the Study of New-Onset RA (SONORA; n = 610).", {"entities": [[113, 133, "DISEASE"], [124, 133, "DISEASE"]]}], ["Interactions were examined by calculating an attributable proportion (AP) due to interaction.", {"entities": []}], ["A majority of patients in the VARA registry (76%) and SONORA (69%) were positive for ACPA with a similar frequency of GSTM1-null (53% and 52%, respectively) and HLA-DRB1 SE positivity (76% and 71%, respectively).", {"entities": [[161, 169, "GENE"]]}], ["The parameter of patients who had ever smoked was more common in the VARA registry (80%) than in SONORA (65%).", {"entities": []}], ["GSTM1-null was significantly associated with ACPA positivity in the VARA registry (odds ratio (OR), 1.45; 95% confidence interval (CI), 1.02 to 2.05), but not in SONORA (OR, 1.00; 95% CI, 0.71 to 1.42).", {"entities": []}], ["There were significant additive interactions between GSTM1 and HLA-DRB1 SE in the VARA registry (AP, 0.49; 95% CI, 0.21 to 0.77; P < 0.001) in ACPA positivity, an interaction replicated in SONORA (AP, 0.38; 95% CI, 0.00 to 0.76; P = 0.050).", {"entities": [[53, 58, "GENE"], [63, 71, "GENE"]]}], ["This study is the first to show that the GSTM1-null genotype, a common genetic variant, exerts significant additive interaction with HLA-DRB1 SE on the risk of ACPA positivity in RA.", {"entities": [[133, 141, "GENE"]]}], ["Since GSTM1 has known antioxidant functions, these data suggest that oxidative stress may be important in the development of RA-specific autoimmunity in genetically susceptible individuals.", {"entities": [[6, 11, "GENE"]]}], ["Seasonal variation may influence the development and exacerbation of inflammatory bowel disease (IBD).", {"entities": [[69, 95, "DISEASE"]]}], ["However, most epidemiologic studies on this topic have been conducted in Western countries.", {"entities": []}], ["The purpose of this study was to determine whether birth dates and symptom flares follow a seasonal pattern in Korean patients with IBD.", {"entities": []}], ["Patients with a diagnosis of IBD established between January 2003 and December 2010 were investigated at six university hospitals in Korea.", {"entities": []}], ["The expected births and flares, with a uniform distribution during the year and considering differences in the number of days in the months of 1 year, were calculated.", {"entities": []}], ["A total of 411 patients with ulcerative colitis (UC) and 316 patients with Crohn disease (CD) were included in the study.", {"entities": [[29, 47, "DISEASE"]]}], ["Birth during the winter period, and especially in January and February, was associated with an increased risk of IBD, especially in UC patients.", {"entities": []}], ["The symptom flares of CD patients occurred most frequently in the spring, with a nadir in the autumn.", {"entities": []}], ["However, no disease flare seasonality was noted for UC patients.", {"entities": []}], ["Our data suggest that seasonally varying environmental factors during pregnancy and the postpartum period are associated with a susceptibility to IBD later in life and that exacerbations of CD are influenced by seasonal factors.", {"entities": []}], ["Klippel-Feil syndrome (KFS) is characterized by the developmental failure of the cervical spine and has two dominantly inherited subtypes.", {"entities": [[13, 21, "DISEASE"]]}], ["Affected individuals who are the children of a consanguineous marriage are extremely rare in the medical literature, but the gene responsible for this recessive trait subtype of KFS has recently been reported.", {"entities": []}], ["We identified a family with the KFS phenotype in which their parents have a consanguineous marriage.", {"entities": []}], ["Radiological examinations revealed that they carry fusion defects and numerical abnormalities in the cervical spine, scoliosis, malformations of the cranial base, and Sprengel\u2019s deformity.", {"entities": []}], ["We applied whole genome linkage and whole-exome sequencing analysis to identify the chromosomal locus and gene mutated in this family.", {"entities": []}], ["Whole genome linkage analysis revealed a significant linkage to chromosome 17q12 - q33 with a LOD score of 4.2.", {"entities": []}], ["Exome sequencing identified the G\u2009>\u2009A p.Q84X mutation in the MEOX1 gene, which is segregated based on pedigree status.", {"entities": [[61, 66, "GENE"]]}], ["Homozygous MEOX1 mutations have reportedly caused a similar phenotype in knockout mice.", {"entities": [[11, 16, "GENE"]]}], ["Here, we report a truncating mutation in the MEOX1 gene in a KFS family with an autosomal recessive trait.", {"entities": [[45, 50, "GENE"]]}], ["Together with another recently reported study and the knockout mouse model, our results suggest that mutations in MEOX1 cause a recessive KFS phenotype in humans.", {"entities": [[114, 119, "GENE"]]}], ["Assessment of the periodontium has relied exclusively on a variety of physical measurements (e.g., attachment level, probing depth, bone loss, mobility, recession, degree of inflammation, etc.)", {"entities": []}], ["in relation to various case definitions of periodontal disease.", {"entities": [[43, 62, "DISEASE"]]}], ["Periodontal health was often an afterthought and was simply defined as the absence of the signs and symptoms of a periodontal disease.", {"entities": [[114, 133, "DISEASE"]]}], ["Accordingly, these strict and sometimes disparate definitions of periodontal disease have resulted in an idealistic requirement of a pristine periodontium for periodontal health, which makes us all diseased in one way or another.", {"entities": [[65, 84, "DISEASE"]]}], ["Furthermore, the consequence of not having a realistic definition of health has resulted in potentially questionable recommendations .", {"entities": []}], ["The aim of this manuscript was to assess the biological, environmental, sociological, economic, educational and psychological relationships that are germane to constructing a paradigm that defines periodontal health using a modified wellness model.", {"entities": []}], ["The paradigm includes four cardinal characteristics, i.e., 1) a functional dentition, 2) the painless function of a dentition, 3) the stability of the periodontal attachment apparatus, and 4) the psychological and social well-being of the individual.", {"entities": []}], ["Finally, strategies and policies that advocate periodontal health were appraised.", {"entities": []}], ["I'm not sick but I'm not well, and it's a sin to live so well.", {"entities": []}], ["Flagpole Sitta, Harvey Danger", {"entities": []}], ["It is a high priority that health care providers have effective communication skills.", {"entities": []}], ["It has been well documented that the doctor-patient relationship is central to the delivery of high quality medical care, and it has been shown to affect patient satisfaction, to decrease the use of pain killers, to shorten hospital stays, to improve recovery from surgery and a variety of other biological, psychological and social outcomes.", {"entities": []}], ["This study sought to quantify the current knowledge of interns in Iran about communication skills.", {"entities": []}], ["A cross-sectional study using a self-report questionnaire was conducted among interns.", {"entities": []}], ["Data analysis was based on 223 questionnaires.", {"entities": []}], ["The internal consistency of the items was 0.8979.", {"entities": []}], ["Overall, knowledge levels were unsatisfactory.", {"entities": []}], ["Results indicated that interns had a limited knowledge of communication skills, including identification of communication skills.", {"entities": []}], ["In addition, there was a significant difference between the mean scores of interns on breaking bad news and sex education.", {"entities": []}], ["The confidence of males about their communication skills was significantly higher than for females.", {"entities": []}], ["Analysis of the total scores by age and sex showed that there was a statistically significant main effect for sex and the interaction with age was statistically significant.", {"entities": []}], ["Free response comments of the interns are also discussed.", {"entities": []}], ["It is argued that there is a real need for integrating a communication skills course, which is linked to the various different ethnic and religious backgrounds of interns, into Iranian medical curricula.", {"entities": []}], ["Some recommendations are made and the limitations of the study are discussed.", {"entities": []}], ["Symptoms of sleep-disordered breathing, especially obstructive sleep apnea syndrome (OSAS), are common in asthma patients and have been associated with asthma severity.", {"entities": [[75, 83, "DISEASE"], [106, 112, "DISEASE"], [152, 158, "DISEASE"]]}], ["It is known that asthma symptoms tend to be more severe at night and that asthma-related deaths are most likely to occur during the night or early morning.", {"entities": [[17, 23, "DISEASE"], [74, 80, "DISEASE"]]}], ["Nocturnal symptoms occur in 60-74% of asthma patients and are markers of inadequate control of the disease.", {"entities": [[38, 44, "DISEASE"]]}], ["Various pathophysiological mechanisms are related to the worsening of asthma symptoms, OSAS being one of the most important factors.", {"entities": [[70, 76, "DISEASE"]]}], ["In patients with asthma, OSAS should be investigated whenever there is inadequate control of symptoms of nocturnal asthma despite the treatment recommended by guidelines having been administered.", {"entities": [[17, 23, "DISEASE"], [115, 121, "DISEASE"]]}], ["There is evidence in the literature that the use of continuous positive airway pressure contributes to asthma control in asthma patients with obstructive sleep apnea and uncontrolled asthma.", {"entities": [[103, 109, "DISEASE"], [121, 127, "DISEASE"], [183, 189, "DISEASE"]]}], ["Tem-se observado que sintomas dos dist\u00farbios respirat\u00f3rios do sono, especialmente a s\u00edndrome da apneia obstrutiva do sono (SAOS), s\u00e3o comuns em asm\u00e1ticos; al\u00e9m disso, associam-se com a gravidade da asma.", {"entities": []}], ["Sabe-se que durante a noite tende a haver maior gravidade dos sintomas da asma, assim como uma maior propor\u00e7\u00e3o de mortalidade durante a noite e as primeiras horas da manh\u00e3.", {"entities": []}], ["Sintomas noturnos ocorrem entre 60-74% dos pacientes com asma e s\u00e3o marcadores de controle inadequado da doen\u00e7a.", {"entities": []}], ["V\u00e1rios mecanismos fisiopatol\u00f3gicos s\u00e3o relacionados a esse agravamento.", {"entities": []}], ["A SAOS est\u00e1 inclu\u00edda entre os fatores mais importantes.", {"entities": []}], ["A investiga\u00e7\u00e3o da SAOS em pacientes com asma deve ser realizada sempre que n\u00e3o houver um controle adequado dos sintomas noturnos da asma com o tratamento recomendado por diretrizes.", {"entities": [[166, 169, "GENE"]]}], ["H\u00e1 evid\u00eancias da literatura que sugerem que o uso de press\u00e3o positiva cont\u00ednua nas vias a\u00e9reas pode contribuir para o controle da asma, quando o paciente asm\u00e1tico tem apneia obstrutiva do sono e sua asma n\u00e3o est\u00e1 controlada.", {"entities": []}], ["To facilitate efficient selection and the prioritization of candidate complex disease susceptibility genes for association analysis, increasingly comprehensive annotation tools are essential to integrate, visualize and analyze vast quantities of disparate data generated by genomic screens, public human genome sequence annotation and ancillary biological databases.", {"entities": []}], ["We have developed a plug-in package for Ensembl called \"Statistical Viewer\" that facilitates the analysis of genomic features and annotation in the regions of interest defined by linkage analysis.", {"entities": []}], ["Statistical Viewer is an add-on package to the open-source Ensembl Genome Browser and Annotation System that displays disease study-specific linkage and/or association data as 2 dimensional plots in new panels in the context of Ensembl's Contig View and Cyto View pages.", {"entities": []}], ["An enhanced upload server facilitates the upload of statistical data, as well as additional feature annotation to be displayed in DAS tracts, in the form of Excel Files.", {"entities": []}], ["The Statistical View panel, drawn directly under the ideogram, illustrates lod score values for markers from a study of interest that are plotted against their position in base pairs.", {"entities": []}], ["A module called \"Get Map\" easily converts the genetic locations of markers to genomic coordinates.", {"entities": []}], ["The graph is placed under the corresponding ideogram features a synchronized vertical sliding selection box that is seamlessly integrated into Ensembl's Contig- and Cyto- View pages to choose the region to be displayed in Ensembl's \"Overview\" and \"Detailed View\" panels.", {"entities": []}], ["To resolve Association and Fine mapping data plots, a \"Detailed Statistic View\" plot corresponding to the \"Detailed View\" may be displayed underneath.", {"entities": []}], ["Features mapping to regions of linkage are accentuated when Statistic View is used in conjunction with the Distributed Annotation System (DAS) to display supplemental laboratory information such as differentially expressed disease genes in private data tracks.", {"entities": []}], ["Statistic View is a novel and powerful visual feature that enhances Ensembl's utility as valuable resource for integrative genomic-based approaches to the identification of candidate disease susceptibility genes.", {"entities": []}], ["At present there are no other tools that provide for the visualization of 2-dimensional plots of quantitative data scores against genomic coordinates in the context of a primary public genome annotation browser.", {"entities": []}], ["In respiratory disorders, patient- and physician-perceived satisfaction with the maintenance inhaler device is an important factor driving treatment compliance and outcomes.", {"entities": []}], ["We examine inhaler preferences in asthma and COPD from patient and physician perspectives, particularly focusing on the relative importance of individual device attributes and patient characteristics guiding inhaler choice.", {"entities": [[34, 40, "DISEASE"]]}], ["Real-world data from >7,300 patients with asthma, COPD, or asthma\u2013COPD overlap syndrome (ACOS) consulting for routine care were derived from respiratory Disease Specific Programs conducted in Europe, USA, Japan, and China.", {"entities": [[79, 87, "DISEASE"], [42, 48, "DISEASE"], [59, 65, "DISEASE"]]}], ["Outcome variables included current pattern of inhaled maintenance therapy and device type, physician preference, patient-reported device attribute importance, and satisfaction.", {"entities": []}], ["The most commonly prescribed inhalers for maintenance therapy of asthma, COPD, and ACOS were dry powder inhalers (62.8%\u201388.5% of patients) and pressurized metered dose inhalers (18.9%\u201335.3% of patients).", {"entities": [[65, 71, "DISEASE"]]}], ["One-third of physicians stated no preference for maintenance device when prescribing treatment, and less than one-third of patients reported being \u201cextremely satisfied\u201d with any attribute of their device.", {"entities": []}], ["Instructions being \u201csimple and easy to follow\u201d was the inhaler attribute most commonly selected as important.", {"entities": []}], ["For approximately one-third of patients across all groups, \u201cease of use/suitability of inhaler device\u201d was a reason for the prescribing decision, as stated by the physician.", {"entities": []}], ["Device characteristics were more likely to impact the prescribing decision in older patients (in asthma and COPD; P <0.01) and those with worse disease severity (in COPD; P <0.001).", {"entities": [[97, 103, "DISEASE"]]}], ["A relatively high proportion of physicians had no preference for inhaler type across asthma, COPD, and ACOS.", {"entities": [[85, 91, "DISEASE"]]}], ["Simplicity of use was the most important inhaler attribute from a patient\u2019s perspective.", {"entities": []}], ["Physicians appeared to place most importance on ease of use and device suitability when selecting inhalers for older patients and those with more severe disease, particularly in COPD.", {"entities": []}], ["There is controversy about chronic health consequences of tick-borne infections, especially Lyme borreliosis.", {"entities": []}], ["This study aims to assess whether general function, physical fitness and subjective health complaints are associated with tick bites or antibodies to Borrelia burgdorferi sensu lato in blood donors.", {"entities": []}], ["Sera from 1,213 blood donors at four different blood banks in Sogn and Fjordane county in western Norway were obtained during January to June 2010, and analysed for specific IgG and IgM antibodies.", {"entities": []}], ["A questionnaire including questions on tick bites, subjective health complaints, general function and physical fitness was completed.", {"entities": []}], ["Tick bites had been experienced by 65.7 % of the study population.", {"entities": []}], ["78 (6.4 %) were positive for IgG (9.7 % in men, 2.4 % in women), and 69 (5.7 %) for IgM (6.1 % in men, 5.1 % in women), verified by immunoblot.", {"entities": []}], ["No association between number of experienced tick bites or seropositivity for Borrelia antibodies and subjective health complaints, reduced general function or reduced physical fitness was found.", {"entities": []}], ["The results do not support any association between tick bites or Borrelia antibodies and subjective health complaints in blood donors in an endemic area for Lyme borreliosis.", {"entities": []}], ["The online version of this article (doi:10.1186/s12889-015-2026-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Searching for associations between genetic variants and complex diseases has been a very active area of research for over two decades.", {"entities": []}], ["More than 51,000 potential associations have been studied and published, a figure that keeps increasing, especially with the recent explosion of array-based Genome-Wide Association Studies.", {"entities": []}], ["Even if the number of true associations described so far is high, many of the putative risk variants detected so far have failed to be consistently replicated and are widely considered false positives.", {"entities": []}], ["Here, we focus on the world-wide patterns of replicability of published association studies.", {"entities": []}], ["We report three main findings.", {"entities": []}], ["First, contrary to previous results, genes associated to complex diseases present lower degrees of genetic differentiation among human populations than average genome-wide levels.", {"entities": []}], ["Second, also contrary to previous results, the differences in replicability of disease associated-loci between Europeans and East Asians are highly correlated with genetic differentiation between these populations.", {"entities": []}], ["Finally, highly replicated genes present increased levels of high-frequency derived alleles in European and Asian populations when compared to African populations.", {"entities": []}], ["Our findings highlight the heterogeneous nature of the genetic etiology of complex disease, confirm the importance of the recent evolutionary history of our species in current patterns of disease susceptibility and could cast doubts on the status as false positives of some associations that have failed to replicate across populations.", {"entities": []}], ["Heart rate (HR) is an emerging risk factor in coronary artery disease (CAD).", {"entities": [[12, 14, "GENE"]]}], ["However, there is little contemporary data regarding HR and the use of HR-lowering medications, particularly beta-blockers, among patients with stable CAD in routine clinical practice.", {"entities": [[53, 55, "GENE"], [71, 73, "GENE"]]}], ["The goal of the present analysis was to describe HR in such patients, overall and in relation to beta-blocker use, and to describe the determinants of HR.", {"entities": [[49, 51, "GENE"], [151, 153, "GENE"], [49, 51, "GENE"], [151, 153, "GENE"]]}], ["CLARIFY is an international, prospective, observational, longitudinal registry of outpatients with stable CAD, defined as prior myocardial infarction or revascularization procedure, evidence of coronary stenosis of >50%, or chest pain associated with proven myocardial ischemia.", {"entities": [[194, 211, "DISEASE"], [269, 277, "DISEASE"], [128, 149, "DISEASE"]]}], ["A total of 33,438 patients from 45 countries in Europe, the Americas, Africa, Middle East, and Asia/Pacific were enrolled between November 2009 and July 2010.", {"entities": []}], ["Most of the 33,177 patients included in this analysis were men (77.5%).", {"entities": []}], ["Mean (SD) age was 64.2 (10.5) years, HR by pulse was 68.3 (10.6) bpm, and by electrocardiogram was 67.2 (11.4) bpm.", {"entities": [[37, 39, "GENE"]]}], ["Overall, 44.0% had HR\u226570 bpm.", {"entities": []}], ["Beta-blockers were used in 75.1% of patients and another 14.4% had intolerance or contraindications to beta-blocker therapy.", {"entities": []}], ["Among 24,910 patients on beta-blockers, 41.1% had HR\u226570 bpm.", {"entities": []}], ["HR\u226570 bpm was independently associated with higher prevalence and severity of angina, more frequent evidence of myocardial ischemia, and lack of use of HR-lowering agents.", {"entities": [[123, 131, "DISEASE"]]}], ["Despite a high rate of use of beta-blockers, stable CAD patients often have resting HR\u226570 bpm, which was associated with an overall worse health status, more frequent angina and ischemia.", {"entities": [[178, 186, "DISEASE"]]}], ["Further HR lowering is possible in many patients with CAD.", {"entities": [[8, 10, "GENE"]]}], ["Whether it will improve symptoms and outcomes is being tested.", {"entities": []}], ["Controlled-Trials.com ISRCTN43070564", {"entities": []}], ["Sulfur mustard (SM) is a chemical warfare agent and a terrorism choice that targets various organs and tissues, especially lung tissues.", {"entities": []}], ["Its toxic effects are tightly associated with oxidative stress.", {"entities": []}], ["The signaling molecule hydrogen sulfide (H 2 S) protects the lungs against oxidative stress and activates the NF-E2 p45-related factor 2 (Nrf2) pathway.", {"entities": []}], ["Here, we sought to establish whether endogenous H 2 S plays a role in SM induced lesion in mouse lungs and lung cells and whether endogenous H 2 S plays the role through Nrf2 pathway to protect against SM-induced oxidative damage.", {"entities": []}], ["Furthermore, we also explored whether activation of Nrf2 by H 2 S involves sulfhydration of Kelch-like ECH-associated protein-1 (Keap1).", {"entities": [[129, 134, "GENE"]]}], ["Using a mouse model of SM-induced lung injury, we demonstrated that SM-induced attenuation of the sulfide concentration was prevented by NaHS.", {"entities": []}], ["Concomitantly, NaHS attenuates SM-induced oxidative stress.", {"entities": []}], ["We also found that H 2 S enhanced Nrf2 nuclear translocation, and stimulated expression of Nrf2-targeted downstream protein and mRNA levels.", {"entities": []}], ["Incubation of the lung cells with NaHS decreased SM-induced ROS production.", {"entities": []}], ["Furthermore, we also found that H 2 S S-sulfhydrated Keap1, which induced Nrf2 dissociation from Keap1, and enhanced Nrf2 nuclear translocation.", {"entities": [[53, 58, "GENE"], [97, 102, "GENE"], [53, 58, "GENE"], [97, 102, "GENE"]]}], ["Our data indicate that H 2 S is a critical, however, being long neglected signal molecule in SM-induced lung injury.", {"entities": []}], ["Germline polymorphisms in both model organisms and humans influence susceptibility to complex trait diseases such as inflammation and cancer Mus spretus species are resistant to tumor development, and crosses between Mus spretus and susceptible Mus musculus strains have been used to map locations of genetic variants that contribute to skin cancer susceptibility musculus x spretus backcross to generate a network view of the gene expression architecture of mouse skin.", {"entities": [[337, 348, "DISEASE"], [134, 140, "DISEASE"], [342, 348, "DISEASE"]]}], ["Here we demonstrate how this approach identifies expression motifs that contribute to tissue organization and biological functions related to inflammation, hematopoiesis, cell cycle control and tumor susceptibility.", {"entities": []}], ["Motifs associated with inflammation, epidermal barrier function and proliferation are differentially regulated in backcross mice susceptible or resistant to tumor development.", {"entities": []}], ["The intestinal stem cell marker Lgr5 is identified as a candidate master regulator of the hair follicle, and the Vitamin D receptor ( Vdr) is linked to coordinated control of epidermal barrier function, inflammation, and tumor susceptibility.", {"entities": [[32, 36, "GENE"], [134, 137, "GENE"]]}], ["Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare, autoimmune small and medium vessel vasculitis.", {"entities": [[99, 109, "DISEASE"]]}], ["EGPA is accompanied by asthma and involves mainly the blood vessels of the lungs, gastrointestinal system, and peripheral nerves; however, the skin, kidneys, and heart may be also affected.", {"entities": [[23, 29, "DISEASE"]]}], ["To investigate if patients with EGPA experience reduced health-related quality of life (HRQOL), and the effect of this parameter on their own perception of future health outlook.", {"entities": []}], ["Twenty-six EGPA patients are in disease remission and completed a custom-designed questionnaire and the Medical Outcomes Study Short Form 36 (SF-36).", {"entities": []}], ["Using the RAND method, eight HRQOL dimensions were calculated: general health, physical functioning, emotional role limitations, physical role limitations, social functioning, mental health, bodily pain, and vitality.", {"entities": []}], ["Using norm-based scores, the HRQOL of patients was compared with that of the general population.", {"entities": []}], ["EGPA patients had decreased HRQOL across all eight dimensions of the SF-36.", {"entities": []}], ["Patients with higher mental component score felt more positive about their future health, while patients with low physical component score were likely not to feel negatively about their future health.", {"entities": []}], ["Also, 36\u00a0% of older patients (>50\u00a0years) had a positive outlook compared to 47\u00a0% of younger patients (<50\u00a0years) and patients with a longer disease course were much less likely to have a positive outlook (30\u00a0% positive) than those with a shorter course (50\u00a0% positive).", {"entities": []}], ["Although not statistically significant, these correlations warrant further investigation with a larger patient population.", {"entities": []}], ["Despite being in disease remission, EGPA patients had decreased quality of life, which in turn influenced their perception of their future health outlook.", {"entities": []}], ["High-risk neuroblastoma is an aggressive malignancy with high rates of treatment failure.", {"entities": [[10, 23, "DISEASE"]]}], ["We evaluated genetic variants associated with in vitro sensitivity to two derivatives of cyclophosphamide for association with clinical response in a separate replication cohort of neuroblastoma patients (n=2,709).", {"entities": [[181, 194, "DISEASE"]]}], ["Lymphoblastoid cell lines (LCLs) were exposed to increasing concentrations of 4-hydroperoxycyclophosphamide [4HC n=422] and phosphoramide mustard [PM n=428] to determine sensitivity.", {"entities": []}], ["Genome-wide association studies (GWAS) were performed to identify single nucleotide polymorphisms (SNPs) associated with 4HC and PM sensitivity.", {"entities": []}], ["SNPs consistently associated with LCL sensitivity were analyzed for associations with event-free survival in patients.", {"entities": []}], ["Two linked SNPs, rs9908694 and rs1453560, were found to be associated with PM sensitivity in LCLs across populations and were associated with event-free survival in all patients ( P =0.01) and within the high-risk subset ( P =0.05).", {"entities": []}], ["Our study highlights the value of cell-based models to identify candidate variants that may predict response to treatment in patients with cancer.", {"entities": [[139, 145, "DISEASE"]]}], ["Experience with the macrophage electrophoretic mobility (MEM) test of Field and Caspary in subjects with malignant and non-malignant disease is reported.", {"entities": []}], ["There was some discrimination between groups of patients with benign and malignant lesions but there was no clear separation between the groups.", {"entities": []}], ["A trial of the Cardiff modification of the test failed to discriminate between groups of patients with benign and malignant chest disease.", {"entities": []}], ["In the view of the authors the MEM test in its present form is not sufficiently reproducible to warrant more general clinical application as an in vitro test for cancer.", {"entities": [[162, 168, "DISEASE"]]}], ["Increasing numbers of survivors of preterm birth are growing into adulthood today.", {"entities": []}], ["Long-term health-effects of prematurity are still poorly understood, but include increased risk for diabetes, obesity and cardiovascular diseases in adult life.", {"entities": [[110, 117, "DISEASE"]]}], ["To test if reduced physical fitness may be a link in the causal chain of preterm birth and diseases in later life, the association of preterm birth and adult exercise capacity was investigated.", {"entities": []}], ["The hypothesis was that preterm birth contributes independently of other risk factors to lower physical fitness in adulthood.", {"entities": []}], ["Population-based national cohort study of all males conscripting for military service in 1993\u20132001 and born in Sweden 1973\u20131983, n\u200a=\u200a218,820.", {"entities": []}], ["Data were retrieved from the Swedish Conscript Register, the Medical Birth Register and the Population and Housing Census 1990.", {"entities": []}], ["Primary outcome was the results from maximal exercise test (W max in Watt) performed at conscription.", {"entities": [[62, 65, "GENE"]]}], ["Association to perinatal and socioeconomic risk factors, other co-variates and confounders were analysed.", {"entities": []}], ["General linear modelling showed that preterm birth predicted low W max in a dose-response related pattern, with 25 Watt reduction in W max for the lowest gestational ages, those born \u226427 weeks.", {"entities": [[67, 70, "GENE"], [135, 138, "GENE"], [67, 70, "GENE"], [135, 138, "GENE"]]}], ["Low birth weight for gestational age also independently predicted low W max compared to normal and high birth weight (32 Watt reduction for those with a birth weight Standard Deviation Score <2).", {"entities": [[72, 75, "GENE"]]}], ["Low parental education was significantly associated with reduced W max (range 17 Watt), as well as both low and high current BMI, with severe obesity resulting in a 16 Watt deficit compared to W max top performance.", {"entities": [[142, 149, "DISEASE"], [67, 70, "GENE"], [195, 198, "GENE"], [67, 70, "GENE"], [195, 198, "GENE"]]}], ["Being born preterm as well as being born small for gestational age predicts low exercise capacity in otherwise healthy young men.", {"entities": []}], ["The effect size of being born preterm equal or exceed that of other known risk factors for unfitness in adults, such as low parental education and overweight.", {"entities": []}], ["We report the case of a patient with Churg-Strauss syndrome with eighth cranial nerve palsy.", {"entities": [[72, 91, "DISEASE"], [51, 59, "DISEASE"]]}], ["Vestibulocochlear nerve palsy is extremely rare in Churg-Strauss syndrome.", {"entities": [[65, 73, "DISEASE"]]}], ["To the best of our knowledge, only one case of complicated neuropathy of the eighth cranial nerve has been described in a previous report presenting an aggregate calculation, but no differentiation between polyarteritis nodosa and Churg-Strauss syndrome was made.", {"entities": [[59, 69, "DISEASE"], [245, 253, "DISEASE"], [206, 226, "DISEASE"]]}], ["High-dose immunoglobulin was administered to our patient, and her neuropathy of the eighth cranial nerve showed improvement.", {"entities": [[66, 76, "DISEASE"]]}], ["At the age of 46, a Japanese woman developed Churg-Strauss syndrome that later became stable with low-dose prednisolone treatment.", {"entities": [[59, 67, "DISEASE"]]}], ["At the age of 52, she developed sudden difficulty of hearing in her left ear, persistent severe rotary vertigo, and mononeuritis multiplex.", {"entities": [[116, 128, "DISEASE"], [116, 138, "DISEASE"]]}], ["At admission, bilateral perceptive deafness of about 80dB and eosinophilia of 4123/\u03bcL in peripheral blood were found.", {"entities": [[62, 74, "DISEASE"]]}], ["A diagnosis of cranial neuropathy of the eighth cranial nerve associated with exacerbated Churg-Strauss syndrome was made.", {"entities": [[23, 33, "DISEASE"], [104, 112, "DISEASE"]]}], ["Although high doses of steroid therapy alleviated the inflammatory symptoms and markers, the vertigo and bilateral hearing loss remained.", {"entities": []}], ["Addition of a high-dose immunoglobulin finally resulted in marked alleviation of the symptoms associated with neuropathy of the eighth cranial nerve.", {"entities": [[110, 120, "DISEASE"]]}], ["A high dose of immunoglobulin therapy shows favorable effects in neuropathy of the eighth cranial nerve, but no reports regarding its efficacy in cranial neuropathy have been published.", {"entities": [[65, 75, "DISEASE"], [154, 164, "DISEASE"]]}], ["Detection algorithm using proxy data for a bioterrorism agent release and historical data for influenza was effective.", {"entities": [[94, 103, "DISEASE"]]}], ["Conventional disease surveillance mechanisms that rely on passive reporting may be too slow and insensitive to rapidly detect a large-scale infectious disease outbreak; the reporting time from a patient's initial symptoms to specific disease diagnosis takes days to weeks.", {"entities": []}], ["To meet this need, new surveillance methods are being developed.", {"entities": []}], ["Referred to as nontraditional or syndromic surveillance, these new systems typically rely on prediagnostic data to rapidly detect infectious disease outbreaks, such as those caused by bioterrorism.", {"entities": []}], ["Using data from a large health maintenance organization, we discuss the development, implementation, and evaluation of a time-series syndromic surveillance detection algorithm for influenzalike illness in Minnesota.", {"entities": []}], ["This review gives an overview of different yeast strains and enzyme classes involved in yeast whole-cell biotransformations.", {"entities": []}], ["A focus was put on the synthesis of compounds for fine chemical and API (= active pharmaceutical ingredient) production employing single or only few-step enzymatic reactions.", {"entities": []}], ["Accounting for recent success stories in metabolic engineering, the construction and use of synthetic pathways was also highlighted.", {"entities": []}], ["Examples from academia and industry and advances in the field of designed yeast strain construction demonstrate the broad significance of yeast whole-cell applications.", {"entities": []}], ["In addition to Saccharomyces cerevisiae , alternative yeast whole-cell biocatalysts are discussed such as Candida sp., Cryptococcu s sp., Geotrichum sp., Issatchenkia sp., Kloeckera sp., Kluyveromyces sp., Pichia sp.", {"entities": []}], ["(including Hansenula polymorpha = P. angusta ), Rhodotorula sp., Rhodosporidium sp., alternative Saccharomyces sp., Schizosaccharomyces pombe , Torulopsis sp., Trichosporon sp., Trigonopsis variabilis , Yarrowia lipolytica and Zygosaccharomyces rouxii .", {"entities": []}], ["Objective To test the hypothesis that people taking anxiolytic and hypnotic drugs are at increased risk of premature mortality, using primary care prescription records and after adjusting for a wide range of potential confounders.", {"entities": []}], ["Design Retrospective cohort study.", {"entities": []}], ["Setting 273 UK primary care practices contributing data to the General Practice Research Database.", {"entities": []}], ["Participants 34\u2009727 patients aged 16 years and older first prescribed anxiolytic or hypnotic drugs, or both, between 1998 and 2001, and 69\u2009418 patients with no prescriptions for such drugs (controls) matched by age, sex, and practice.", {"entities": []}], ["Patients were followed-up for a mean of 7.6 years (range 0.1-13.4 years).", {"entities": []}], ["Main outcome All cause mortality ascertained from practice records.", {"entities": []}], ["Results Physical and psychiatric comorbidities and prescribing of non-study drugs were significantly more prevalent among those prescribed study drugs than among controls.", {"entities": []}], ["The age adjusted hazard ratio for mortality during the whole follow-up period for use of any study drug in the first year after recruitment was 3.46 (95% confidence interval 3.34 to 3.59) and 3.32 (3.19 to 3.45) after adjusting for other potential confounders.", {"entities": []}], ["Dose-response associations were found for all three classes of study drugs (benzodiazepines, Z drugs (zaleplon, zolpidem, and zopiclone), and other drugs).", {"entities": []}], ["After excluding deaths in the first year, there were approximately four excess deaths linked to drug use per 100 people followed for an average of 7.6 years after their first prescription.", {"entities": []}], ["Conclusions In this large cohort of patients attending UK primary care, anxiolytic and hypnotic drugs were associated with significantly increased risk of mortality over a seven year period, after adjusting for a range of potential confounders.", {"entities": []}], ["As with all observational findings, however, these results are prone to bias arising from unmeasured and residual confounding.", {"entities": []}], ["Causality assessment is crucial to post-marketing pharmacovigilance and helps optimize safe and appropriate use of medicines by patients in the real world.", {"entities": []}], ["Self-reported olfactory and gustatory dysfunction are common in the general population as well as in patients with allergic rhinitis and nasal polyposis.", {"entities": [[115, 132, "DISEASE"], [124, 132, "DISEASE"]]}], ["Intranasal corticosteroids, including intranasal fluticasone propionate (INFP), are amongst the most effective drugs indicated in the treatment of allergic rhinitis and nasal polyposis.", {"entities": [[147, 164, "DISEASE"], [156, 164, "DISEASE"]]}], ["While intranasal corticosteroids are associated with olfactory and gustatory dysfunction and are currently labeled for these adverse events, causality assessment has not been performed to date.", {"entities": []}], ["Although there is no single widely accepted method to assess causality in pharmacovigilance, the Bradford Hill criteria offer a robust and comprehensive approach because nine distinct aspects of an observed potential drug\u2013event association are assessed.", {"entities": []}], ["In this literature-based narrative review, Hill\u2019s criteria were applied to determine causal inference between INFP and olfactory and gustatory dysfunction.", {"entities": []}], ["To evaluate the role of oral ketotifen and topical antibiotic therapy in the management of pruritus in prurigo nodularis (PN) patients.", {"entities": []}], ["Twenty-seven patients with PN and a history of atopy with raised IgE were included in this study in a dermatology clinic.", {"entities": []}], ["All patients had positive growth of Staphylococcus aureus on the lesional skin swab.", {"entities": []}], ["All patients received topical halobetasol and oral hydroxyzine for 4 weeks.", {"entities": []}], ["In addition, all patients in the study group received oral ketotifen and topical antibiotic therapy for 4 weeks.", {"entities": []}], ["Randomization was performed by using a table of random numbers, and the participants were randomly allocated to one of the two groups in the study.", {"entities": []}], ["The study was a single-blind study, and the blinding was done by the investigator.", {"entities": []}], ["Of the 14 patients in the study group, 9 had complete relief from pruritus by the end of first week, which was maintained till the end of 4 weeks.", {"entities": []}], ["In the control group, mild to moderate reduction in the intensity of pruritus in the PN lesions of all patients were noted by the end of the first week.", {"entities": []}], ["No further improvement in the level of pruritus was noted in the participants during the trial period.", {"entities": []}], ["The treatment was well tolerated by the patients, and the adverse reactions of drugs were minimal in both groups.", {"entities": []}], ["This study showed that oral ketotifen and topical antibiotic therapy can be helpful in the management of pruritus in PN patients.", {"entities": []}], ["The loss of skeletal muscle mass (MM) or muscle function (MF) alone increases the risk for losing physical independence in older adults.", {"entities": []}], ["We aimed to examine the independent and synergic associations of low MM and low MF, both criteria of sarcopenia, with the risk for losing projected physical independence in later life (+90\u2009years old).", {"entities": []}], ["Cross\u2010sectional analyses were conducted in 3493 non\u2010institutionalized older adults (1166 males).", {"entities": []}], ["Physical independence was assessed with a 12\u2010item composite physical function scale.", {"entities": []}], ["Logistic regression was used to estimate the odds\u2010ratio (OR) for being at risk for losing physical independence.", {"entities": []}], ["Approximately 30% of the participants were at risk for losing physical independence at 90\u2009years of age.", {"entities": []}], ["Independent analysis demonstrated that participants with low MM had 1.65 (95%CI: 1.27\u20132.31) increased odds for being at risk for losing physical independence and participants with low MF had 6.19 (95%CI 5.08\u20137.53) increased odds for being at risk.", {"entities": []}], ["Jointly, having a low MM and a low MF increased the risk for losing physical independence to 12.28 (95%CI 7.95 to 18.96).", {"entities": []}], ["Although low MM represents a risk factor for losing physical independence, low MF seems to play a more dominant role in this relationship, with the presence of both sarcopenia criteria representing a substantial risk for losing physical independence in later life.", {"entities": []}], ["Some previous studies have postulated an association between migraine and excessive daytime sleepiness (EDS).", {"entities": [[61, 69, "DISEASE"]]}], ["This study evaluated the association of EDS with migraine and headache frequency in a general population, after adjusting for potential confounding variables.", {"entities": [[49, 57, "DISEASE"]]}], ["The study was a postal survey of a random age and gender-stratified sample of 40,000 persons aged 20 to 80\u00a0years old drawn by the National Population Register in Norway.", {"entities": []}], ["The questionnaire included questions about migraine, headache, the Epworth sleepiness scale (ESS) and various comorbidities.", {"entities": [[43, 51, "DISEASE"]]}], ["EDS was defined as ESS\u2009>\u200910.", {"entities": []}], ["The association of EDS and migraine/headache were analysed by bivariate and multivariable logistic regression analyses.", {"entities": [[27, 35, "DISEASE"]]}], ["A total of 21,177 persons responded to the ESS and were included in the analyses.", {"entities": []}], ["The odds ratio (OR) for EDS was increased for migraineurs (1.42 (95% CI 1.31\u25001.54), p\u2009< \u20090.001) compared to non-migraineurs; however, this finding was not significant after adjustment for a number of possible confounders.", {"entities": []}], ["EDS increased with increasing headache frequency, with an OR of 2.74 (95% CI 2.05\u25003.65), p\u2009< \u20090.001) for those with headache on >179\u00a0days per year compared to those without headache in multivariable analysis.", {"entities": []}], ["In a general population, the odds for EDS increased significantly with the headache frequency, irrespective of migraine status.", {"entities": [[111, 119, "DISEASE"]]}], ["EDS was not associated with reported migraine in multivariable analysis.", {"entities": [[37, 45, "DISEASE"]]}], ["For asthma and psychological morbidity, it is well established that higher prevalence among males in childhood is replaced by higher prevalence among females by adolescence.", {"entities": [[4, 10, "DISEASE"]]}], ["This review investigates whether there is evidence for a similar emerging female \u2018excess\u2019 in relation to a broad range of physical morbidity measures.", {"entities": []}], ["Establishing whether this pattern is generalised or health outcome-specific will further understandings of the aetiology of gender differences in health.", {"entities": []}], ["Databases (Medline; Embase; CINAHL; PsycINFO; ERIC) were searched for English language studies (published 1992\u20132010) presenting physical morbidity prevalence data for males and females, for at least two age-bands within the age-range 4\u201317 years.", {"entities": []}], ["A three-stage screening process (initial sifting; detailed inspection; extraction of full papers), was followed by study quality appraisals.", {"entities": []}], ["Of 11\u00a0245 identified studies, 41 met the inclusion criteria.", {"entities": []}], ["Most ( n \u00a0=\u00a031) presented self-report survey data (five longitudinal, 26 cross-sectional); 10 presented routinely collected data (GP/hospital statistics).", {"entities": []}], ["Extracted data, supplemented by additional data obtained from authors of the included studies, were used to calculate odds ratios of a female excess, or female:male incident rate ratios as appropriate.", {"entities": []}], ["To test whether these changed with age, the values were logged and regressed on age in random effects meta-regressions.", {"entities": []}], ["These showed strongest evidence of an emerging/increasing female excess for self-reported measures of headache, abdominal pain, tiredness, migraine and self-assessed health.", {"entities": [[139, 147, "DISEASE"]]}], ["Type 1 diabetes and epilepsy, based on routinely collected data, did not show a significant emerging/increasing female excess.", {"entities": []}], ["For most physical morbidity measures reviewed, the evidence broadly points towards an emerging/increasing female excess during the transition to adolescence, although results varied by morbidity measure and study design, and suggest that this may occur at a younger age than previously thought.", {"entities": []}], ["\u25ba Review of international evidence of gender-by-age differences in child and adolescent physical morbidity.", {"entities": []}], ["\u25ba Meta-regressions show an emerging/increasing female excess for several measures.", {"entities": []}], ["\u25ba An emerging/increasing male excess was seen for type 1 diabetes only.", {"entities": []}], ["\u25ba Findings suggest female excess physical morbidity emerges in mid-late childhood.", {"entities": []}], ["\u25ba Longitudinal studies commencing in childhood are needed to understand gender patterning of health.", {"entities": []}], ["Endogenously produced lipid autacoids are locally acting small molecule mediators that play a central role in the regulation of inflammation and tissue homeostasis.", {"entities": []}], ["A well-studied group of autacoids are the products of arachidonic acid metabolism, among which the prostaglandins and leukotrienes are the best known.", {"entities": []}], ["They are generated by two pathways controlled by the enzyme systems cyclooxygenase and lipoxygenase, respectively.", {"entities": []}], ["However, arachidonic acid is also substrate for a third enzymatic pathway, the cytochrome P450 (CYP) system.", {"entities": []}], ["This third eicosanoid pathway consists of two main branches: \u03c9-hydroxylases convert arachidonic acid to hydroxyeicosatetraenoic acids (HETEs) and epoxygenases convert it to epoxyeicosatrienoic acids (EETs).", {"entities": []}], ["This third CYP pathway was originally studied in conjunction with inflammatory and cardiovascular disease.", {"entities": []}], ["Arachidonic acid and its metabolites have recently stimulated great interest in cancer biology; but, unlike prostaglandins and leukotrienes the link between cytochome P450 metabolites and cancer has received little attention.", {"entities": [[80, 86, "DISEASE"], [188, 194, "DISEASE"]]}], ["In this review, the emerging role in cancer of cytochrome P450 metabolites, notably 20-HETE and EETs, are discussed.", {"entities": [[37, 43, "DISEASE"]]}], ["It has been increasingly recognized that non-adherence is an important factor that determines the outcome of peritoneal dialysis (PD) therapy.", {"entities": []}], ["There is therefore a need to establish the levels of non-adherence to different aspects of the PD regimen (dialysis procedures, medications, and dietary/fluid restrictions).", {"entities": []}], ["A systematic review of peer-reviewed literature was performed in PubMed, PsycINFO and CINAHL databases using PRISMA guidelines in May 2013.", {"entities": []}], ["Publications on non-adherence in PD were selected by two reviewers independently according to predefined inclusion and exclusion criteria.", {"entities": []}], ["Relevant data on patient characteristics, measures, rates and factors associated with non-adherence were extracted.", {"entities": []}], ["The quality of studies was also evaluated independently by two reviewers according to a revised version of the Effective Public Health Practice Project assessment tool.", {"entities": []}], ["The search retrieved 204 studies, of which a total of 25 studies met inclusion criteria.", {"entities": []}], ["Reported rates of non-adherence varied across studies: 2.6\u201353% for dialysis exchanges, 3.9\u201385% for medication, and 14.4\u201367% for diet/fluid restrictions.", {"entities": []}], ["Methodological differences in measurement and definition of non-adherence underlie the observed variation.", {"entities": []}], ["Factors associated with non-adherence that showed a degree of consistency were mostly socio-demographical, such as age, employment status, ethnicity, sex, and time period on PD treatment.", {"entities": []}], ["Non-adherence to different dimensions of the dialysis regimen appears to be prevalent in PD patients.", {"entities": []}], ["There is a need for further, high-quality research to explore these factors in more detail, with the aim of informing intervention designs to facilitate adherence in this patient population.", {"entities": []}], ["Non-communicable diseases (NCDs) are the largest cause of premature death worldwide.", {"entities": []}], ["Socioeconomic inequalities contribute to a disparity in the burden of NCDs among disadvantaged and advantaged populations in low (LIC), middle (MIC), and high income countries (HIC).", {"entities": []}], ["We conducted an overview of systematic reviews to systematically and objectively assess the available evidence on socioeconomic inequalities in relation to morbidity and mortality of NCDs and their risk factors.", {"entities": []}], ["We searched PubMed, The Cochrane Library, EMBASE, SCOPUS, Global Health, and Business Source Complete for relevant systematic reviews published between 2003 and December 2013.", {"entities": []}], ["Two authors independently screened abstracts and full-text publications and determined the risk of bias of the included systematic reviews.", {"entities": []}], ["We screened 3302 abstracts, 173 full-text publications and ultimately included 22 systematic reviews.", {"entities": []}], ["Most reviews had major methodological shortcomings; however, our synthesis showed that having low socioeconomic status (SES) and/or living in low and middle income countries (LMIC) increased the risk of developing cardiovascular diseases (CVD), lung and gastric cancer, type 2 diabetes, and chronic obstructive pulmonary disease (COPD).", {"entities": [[291, 328, "DISEASE"], [262, 268, "DISEASE"]]}], ["Furthermore, low SES increased the risk of mortality from lung cancer, COPD, and reduced breast cancer survival in HIC.", {"entities": [[58, 69, "DISEASE"], [89, 102, "DISEASE"], [63, 69, "DISEASE"], [96, 102, "DISEASE"]]}], ["Reviews included here indicated that lower SES is a risk factor for obesity in HIC, but this association varied by SES measure.", {"entities": [[68, 75, "DISEASE"]]}], ["Early case fatalities of stroke were lower and survival of retinoblastoma was higher in MIC compared to LIC.", {"entities": [[59, 73, "DISEASE"]]}], ["The current evidence supports an association between socioeconomic inequalities and NCDs and risk factors for NCDs.", {"entities": []}], ["However, this evidence is incomplete and limited by the fairly low methodological quality of the systematic reviews, including shortcomings in the study selection and quality assessment process.", {"entities": []}], ["The online version of this article (doi:10.1186/s12889-015-2227-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The aim of this study was to assess the experiences of patients with chronic obstructive pulmonary disease (COPD) while they were completing the St. George\u2019s Respiratory Questionnaire for COPD patients (SGRQ-C), using qualitative research methods.", {"entities": [[69, 106, "DISEASE"]]}], ["Twenty Dutch COPD patients were recruited through pulmonary physicians [13 women; mean age\u00a0=\u00a063.3\u00a0years (SD\u00a0=\u00a011.4)].", {"entities": []}], ["A trained interviewer applied the Three-Step Test Interview which allowed the interviewer to follow the thought process of the patient filling out the SGRQ-C.", {"entities": []}], ["The official Dutch translation of the SGRQ-C was used.", {"entities": []}], ["Patients missed a recall period for the Symptoms subscale; were uncertain how to interpret specific words and phrases like \u201cgood days\u201d, \u201cgames\u201d, and \u201chousework\u201d; were confused by long-item stems that included a list of activities; and were frustrated by the dichotomous format used for the majority of SGRQ-C items (true/false).", {"entities": []}], ["Overall, patients were satisfied with the SGRQ-C.", {"entities": []}], ["Nevertheless, making minor adjustments could further increase its quality.", {"entities": []}], ["This includes reintroducing a recall period in the first set of items such as used in the previous version and splitting up items consisting of multiple activities.", {"entities": []}], ["Furthermore, we recommend using the same response format (4 or 5 response categories) for all items.", {"entities": []}], ["A multi-dimensional strategy to tackle the global obesity epidemic requires an in-depth understanding of the mechanisms that underlie this complex condition.", {"entities": [[50, 57, "DISEASE"]]}], ["Much of the current mechanistic knowledge has arisen from preclinical research performed mostly, but not exclusively, in laboratory mouse and rat strains.", {"entities": []}], ["These experimental models mimic certain aspects of the human condition and its root causes, particularly the over-consumption of calories and unbalanced diets.", {"entities": []}], ["As with human obesity, obesity in rodents is the result of complex gene\u2013environment interactions.", {"entities": [[14, 21, "DISEASE"], [23, 30, "DISEASE"]]}], ["Here, we review the traditional monogenic models of obesity, their contemporary optogenetic and chemogenetic successors, and the use of dietary manipulations and meal-feeding regimes to recapitulate the complexity of human obesity.", {"entities": [[52, 59, "DISEASE"], [223, 230, "DISEASE"]]}], ["We critically appraise the strengths and weaknesses of these different models to explore the underlying mechanisms, including the neural circuits that drive behaviours such as appetite control.", {"entities": []}], ["We also discuss the use of these models for testing and screening anti-obesity drugs, beneficial bio-actives, and nutritional strategies, with the goal of ultimately translating these findings for the treatment of human obesity.", {"entities": [[71, 78, "DISEASE"], [220, 227, "DISEASE"]]}], ["Summary: We review genetic models of obesity, their optogenetic and chemogenetic successors, and the use of dietary manipulations and meal-feeding regimes.", {"entities": [[37, 44, "DISEASE"]]}], ["Genome-wide association studies (GWAS) for quantitative traits and disease in humans and other species have shown that there are many loci that contribute to the observed resemblance between relatives.", {"entities": []}], ["GWAS to date have mostly focussed on discovery of genes or regulatory regions habouring causative polymorphisms, using single SNP analyses and setting stringent type-I error rates.", {"entities": []}], ["Genome-wide marker data can also be used to predict genetic values and therefore predict phenotypes.", {"entities": []}], ["Here, we propose a Bayesian method that utilises all marker data simultaneously to predict phenotypes.", {"entities": []}], ["We apply the method to three traits: coat colour, %CD8 cells, and mean cell haemoglobin, measured in a heterogeneous stock mouse population.", {"entities": []}], ["We find that a model that contains both additive and dominance effects, estimated from genome-wide marker data, is successful in predicting unobserved phenotypes and is significantly better than a prediction based upon the phenotypes of close relatives.", {"entities": []}], ["Correlations between predicted and actual phenotypes were in the range of 0.4 to 0.9 when half of the number of families was used to estimate effects and the other half for prediction.", {"entities": []}], ["Posterior probabilities of SNPs being associated with coat colour were high for regions that are known to contain loci for this trait.", {"entities": []}], ["The prediction of phenotypes using large samples, high-density SNP data, and appropriate statistical methodology is feasible and can be applied in human medicine, forensics, or artificial selection programs.", {"entities": []}], ["Results from recent genome-wide association studies indicate that for most complex traits, there are many loci that contribute to variation in observed phenotype and that the effect of a single variant (single nucleotide polymorphism, SNP) on a phenotype is small.", {"entities": []}], ["Here, we propose a method that combines the effects of multiple SNPs to make a prediction of a phenotype that has not been observed.", {"entities": []}], ["We apply the method to data on mice, using phenotypic and genomic data from some individuals to predict phenotypes in other, either related or unrelated, individuals.", {"entities": []}], ["We find that correlations between predicted and actual phenotypes are in the range of 0.4 to 0.9.", {"entities": []}], ["The method also shows that the SNPs used in the prediction appear in regions that are known to contain genes associated with the traits studied.", {"entities": []}], ["The prediction of unobserved phenotypes from high-density SNP data and appropriate statistical methodology is feasible and can be applied in human medicine, forensics, or artificial breeding programs.", {"entities": []}], ["Frailty is a common problem among older people and it is associated with an increased risk of death and long-term institutional care.", {"entities": []}], ["Early identification of frailty is necessary to prevent a further decline in the health status of home care clients.", {"entities": []}], ["The aims of the present study were to determine the prevalence of frailty and associated factors among 75-year-old or older home care clients.", {"entities": []}], ["The study participants were 75-year-old or older home care clients living in three cities in Eastern and Central Finland.", {"entities": []}], ["Home care clients who had completed the abbreviated Comprehensive Geriatric Assessment (aCGA) for frailty ( n \u2009=\u2009257) were included in the present study.", {"entities": []}], ["Baseline data were obtained on functional status, cognitive status, depressive symptoms, self-rated health, ability to walk 400\u00a0m, nutritional status, drug use and comorbidities.", {"entities": []}], ["Most of the home care clients (90%) were screened for frailty using the aCGA.", {"entities": []}], ["Multivariate analysis showed that the risk of malnutrition or malnutrition (OR\u2009=\u20094.27, 95% CI\u2009=\u20091.56, 11.68) and a low level of education (OR\u2009=\u20091.14, 95% CI\u2009=\u20091.07, 1.23) were associated with frailty.", {"entities": []}], ["Frailty is a prevalent problem among home care clients.", {"entities": []}], ["The risk of malnutrition or malnourishment and a lower level of education increase the risk of frailty.", {"entities": []}], ["Screening for frailty should be done to detect the most vulnerable older people for further intervention to prevent adverse health problems.", {"entities": []}], ["ClinicalTrials.gov: NCT02214758 .", {"entities": []}], ["Patient enablement can be defined as the extent to which a patient is capable of understanding and coping with his or her health issues.", {"entities": []}], ["This concept is linked to a number of health outcomes such as self-management of chronic diseases and quality of life.", {"entities": []}], ["The Patient Enablement Instrument (PEI) was designed to measure this concept after a medical consultation.", {"entities": []}], ["The instrument, in its original form and its translations into several languages, has proven to be reliable and valid.", {"entities": []}], ["The purpose of this study was to evaluate the reliability of the French version of the PEI (PEI-Fv) in a family practice setting.", {"entities": []}], ["One hundred and ten participants were recruited in a family medicine clinic in the Saguenay region of Quebec (Canada).", {"entities": []}], ["The PEI-Fv was completed twice, immediately after consultation with a physician (T1) and 2 weeks after the consultation (T2).", {"entities": []}], ["The internal consistency of the tool was assessed with Cronbach's \u03b1 and test-retest reliability by intraclass correlation coefficient.", {"entities": []}], ["The mean score for the PEI-Fv was 5.06 \u00b1 3.97 (95% confidence interval [CI]: 4.30-5.81) at T1 and 4.63 \u00b1 3.90 (95% CI: 3.82-5.44) at T2.", {"entities": []}], ["Cronbach's \u03b1 was high at T1 (\u03b1 1 = 0.93; 95% CI: 0.91-0.95) and T2 (\u03b1 2 = 0.93; 95% CI: 0.91-0.95).", {"entities": []}], ["The intraclass correlation coefficient was 0.62 (95% CI: 0.48-0.74), indicating a moderate test-retest reliability.", {"entities": []}], ["The internal consistency of the PEI-Fv is excellent.", {"entities": []}], ["Test-retest reliability was moderate to good.", {"entities": []}], ["Test-retest reliability should be examined in further studies at a less than 2-week interval to reduce maturation bias.", {"entities": []}], ["This instrument can be used to measure enablement after consultation in a French-speaking family practice setting.", {"entities": []}], ["Combined methylmalonic acidemia (MMA) and homocysteinemia are a group of autosomal recessive disorders caused by inborn errors of cobalamin metabolism, including CblC, D, F, and J, with cblC being the most common subtype.", {"entities": [[9, 31, "DISEASE"]]}], ["The clinical manifestations of combined MMA and homocysteinemia vary, but typically include neurologic, developmental and hematologic abnormalities.", {"entities": []}], ["We report 4 children with combined MMA and homocysteinemia who presented predominantly with late-onset diffuse lung diseases (DLD).", {"entities": [[126, 129, "GENE"]]}], ["Of these, 3 accompanied by pulmonary arterial hypertension (PAH), 1 accompanied by hypertension, and 2 accompanied by renal thrombotic microangiopathy (TMA), which was confirmed by renal biopsy.", {"entities": [[46, 58, "DISEASE"], [83, 95, "DISEASE"]]}], ["This confirms combined MMA and homocysteinemia should be considered in the differential diagnosis of DLD with or without PAH or renal TMA.", {"entities": [[101, 104, "GENE"]]}], ["Dysfunctional pulmonary homeostasis and repair, including diseases such as pulmonary fibrosis (PF), chronic obstructive pulmonary disease (COPD), and tumorigenesis have been increasing over the past decade, a fact that heavily implicates environmental influences.", {"entities": [[100, 137, "DISEASE"], [75, 93, "DISEASE"]]}], ["Several investigations have suggested that in response to increased transforming growth factor - beta (TGF\u03b2) signaling, the alveolar type II (ATII) epithelial cell undergoes phenotypic changes that may contribute to the complex pathobiology of PF.", {"entities": []}], ["We have previously demonstrated that increased tissue stiffness associated with PF is a potent extracellular matrix (ECM) signal for epithelial cell activation of TGF\u03b2.", {"entities": []}], ["The work reported here explores the relationship between tissue stiffness and exposure to environmental stimuli in the activation of TGF\u03b2.", {"entities": []}], ["We hypothesized that exposure of ATII cells to fine particulate matter (PM2.5) will result in enhanced cell contractility, TGF\u03b2 activation, and subsequent changes to ATII cell phenotype.", {"entities": []}], ["ATII cells were cultured on increasingly stiff substrates with or without addition of PM2.5.", {"entities": []}], ["Exposure to PM2.5 resulted in increased activation of TGF\u03b2, increased cell contractility, and elongation of ATII cells.", {"entities": []}], ["Most notably, on 8 kPa substrates, a stiffness greater than normal but less than established fibrotic lung, addition of PM2.5 resulted in increased cortical cell stiffness, enhanced actin staining and cell elongation; a result not seen in the absence of PM2.5.", {"entities": []}], ["Our work suggests that PM2.5 exposure additionally enhances the existing interaction between ECM stiffness and TGF\u03b2 that has been previously reported.", {"entities": []}], ["Furthermore, we show that this additional enhancement is likely a consequence of intracellular reactive oxygen species (ROS) leading to increased TGF\u03b2 signaling events.", {"entities": []}], ["These results highlight the importance of both the micromechanical and biochemical environment in lung disease initiation and suggest that individuals in early stages of lung remodeling during fibrosis may be more susceptible than healthy individuals when exposed to environmental injury adjuvants.", {"entities": [[98, 110, "DISEASE"]]}], ["Despite the prevalence of Aspergillus -related disease in immune suppressed lung transplant patients, little is known of the host-pathogen interaction.", {"entities": []}], ["Because of the mould\u2019s angiotropic nature and because of its capacity to thrive in hypoxic conditions, we hypothesized that the degree of Aspergillus invasion would increase with progressive rejection-mediated ischemia of the allograft.", {"entities": [[210, 218, "DISEASE"]]}], ["To study this relationship, we utilized a novel orthotopic tracheal transplant model of Aspergillus infection, in which it was possible to assess the effects of tissue hypoxia and ischemia on airway infectivity.", {"entities": [[180, 188, "DISEASE"]]}], ["Laser Doppler flowmetry and FITC-lectin were used to determine blood perfusion, and a fiber optic microsensor was used to measure airway tissue oxygen tension.", {"entities": []}], ["Fungal burden and depth of invasion were graded using histopathology.", {"entities": []}], ["We demonstrated a high efficacy (80%) for producing a localized fungal tracheal infection with the majority of infection occurring at the donor-recipient anastomosis; Aspergillus was more invasive in allogeneic compared to syngeneic groups.", {"entities": []}], ["During the study period, the overall kinetics of both non-infected and infected allografts was similar, demonstrating a progressive loss of perfusion and oxygenation, which reached a nadir by days 10-12 post-transplantation.", {"entities": []}], ["The extent of Aspergillus invasion directly correlated with the degree of graft hypoxia and ischemia.", {"entities": [[92, 100, "DISEASE"]]}], ["Compared to the midtrachea, the donor-recipient anastomotic site exhibited lower perfusion and more invasive disease; a finding consistent with clinical experience.", {"entities": []}], ["For the first time, we identify ischemia as a putative risk factor for Aspergillus invasion.", {"entities": [[32, 40, "DISEASE"]]}], ["Therapeutic approaches focused on preserving vascular health may play an important role in limiting Aspergillus infections.", {"entities": []}], ["The relationship between extensively drug-resistant tuberculosis (XDR-TB) and multidrug-resistant Gram-negative bacilli (MDR-GNB) is unclear.", {"entities": [[52, 64, "DISEASE"]]}], ["Identification of the relationship between XDR-TB and MDR-GNB would have important implications for patient care.", {"entities": []}], ["We conducted a retrospective study reviewing the records of patients admitted with a confirmed pulmonary TB from 2011 to 2014.", {"entities": []}], ["To identify the relationship between XDR-TB and MDR-GNB, univariable comparison and multivariable logistic regression were performed.", {"entities": []}], ["Among 2962 pulmonary TB patients, 45(1.5%) patients had a diagnosis of XDR-TB.", {"entities": []}], ["A total of 165 MDR-GNB strains were detected in 143 (4.8%) pulmonary TB patients.", {"entities": []}], ["XDR-TB patients had a significantly higher occurrence of MDR-GNB than non-XDR-TB patients (24.4% vs. 4.5%; P<0.001).", {"entities": []}], ["Age (OR 1.02, 95% CI 1.01\u20131.03), hypoalbuminemia (OR 1.48, 95% CI 1.18\u20131.85), chronic renal failure (OR 6.67, 95% CI 1.42\u201331.47), chronic hepatic insufficiency (OR 1.99, 95% CI 1.15\u20133.43), presence of XDR-TB (OR 6.56, 95% CI 1.61\u201326.69), and duration of TB diagnostic delay (OR 1.01, 95% CI 1.00\u20131.02) were the independent risk factors for MDR-GNB infection.", {"entities": []}], ["Patients with XDR-TB have a significantly higher risk of being affected by MDR-GNB pathogen.", {"entities": []}], ["The underlying mechanism association warrant further studies.", {"entities": []}], ["Low tidal volume (V T ) ventilation is recommended in patients with acute respiratory distress syndrome (ARDS).", {"entities": [[95, 103, "DISEASE"]]}], ["This may increase arterial carbon dioxide tension (PaCO 2 ), decrease pH, and augment pulmonary vascular resistance (PVR).", {"entities": [[117, 120, "GENE"]]}], ["We hypothesized that Tris(hydroxymethyl)aminomethane (THAM), a pure proton acceptor, would dampen these effects, preventing the increase in PVR.", {"entities": [[140, 143, "GENE"]]}], ["A one-hit injury ARDS model was established by repeated lung lavages in 18 piglets.", {"entities": []}], ["After ventilation with V T of 6 ml/kg to maintain normocapnia, V T was reduced to 3 ml/kg to induce hypercapnia.", {"entities": []}], ["Six animals received THAM for 1 h, six for 3 h, and six serving as controls received no THAM.", {"entities": []}], ["In all, the experiment continued for 6 h. The THAM dosage was calculated to normalize pH and exhibit a lasting effect.", {"entities": []}], ["Gas exchange, pulmonary, and systemic hemodynamics were tracked.", {"entities": []}], ["Inflammatory markers were obtained at the end of the experiment.", {"entities": []}], ["In the controls, the decrease in V T from 6 to 3 ml/kg increased PaCO 2 from 6.0\u00b10.5 to 13.8\u00b11.5 kPa and lowered pH from 7.40\u00b10.01 to 7.12\u00b10.06, whereas base excess (BE) remained stable at 2.7\u00b12.3 mEq/L to 3.4\u00b13.2 mEq/L.", {"entities": []}], ["In the THAM groups, PaCO 2 decreased and pH increased above 7.4 during the infusions.", {"entities": []}], ["After discontinuing the infusions, PaCO 2 increased above the corresponding level of the controls (15.2\u00b11.7 kPa and 22.6\u00b13.3 kPa for 1-h and 3-h THAM infusions, respectively).", {"entities": []}], ["Despite a marked increase in BE (13.8\u00b13.5 and 31.2\u00b12.2 for 1-h and 3-h THAM infusions, respectively), pH became similar to the corresponding levels of the controls.", {"entities": []}], ["PVR was lower in the THAM groups (at 6 h, 329\u00b177 dyn\u2219s/m The pH in the THAM groups was similar to pH in the controls at 6 h, despite a marked increase in BE.", {"entities": [[0, 3, "GENE"]]}], ["This was due to an increase in PaCO 2 after stopping the THAM infusion, possibly by intracellular release of CO 2 .", {"entities": []}], ["Pulmonary arterial pressure and PVR were lower in the THAM-treated animals, indicating that THAM may be an option to reduce PVR in acute hypercapnia.", {"entities": [[32, 35, "GENE"], [124, 127, "GENE"], [32, 35, "GENE"], [124, 127, "GENE"]]}], ["Acute respiratory distress syndrome (ARDS) has a substantial mortality rate and annually affects more than 140,000 people in the USA alone.", {"entities": [[27, 35, "DISEASE"]]}], ["Standard management includes lung protective ventilation but this impairs carbon dioxide clearance and may lead to right heart dysfunction or increased intracranial pressure.", {"entities": []}], ["Extracorporeal carbon dioxide removal has the potential to optimize lung protective ventilation by uncoupling oxygenation and carbon dioxide clearance.", {"entities": []}], ["The aim of this article is to review the carbon dioxide removal strategies that are likely to be widely available in the near future.", {"entities": []}], ["Relevant published literature was identified using PubMed and Medline searches.", {"entities": []}], ["Queries were performed by using the search terms ECCOR, AVCO2R, VVCO2R, respiratory dialysis, and by combining carbon dioxide removal and ARDS.", {"entities": []}], ["The only search limitation imposed was English language.", {"entities": []}], ["Additional articles were identified from reference lists in the studies that were reviewed.", {"entities": []}], ["Several novel strategies to achieve carbon dioxide removal were identified, some of which are already commercially available whereas others are in advanced stages of development.", {"entities": []}], ["Symptomatic peripheral arterial disease (PAD) is associated with impaired walking endurance in patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[109, 146, "DISEASE"]]}], ["However, it is unknown whether asymptomatic PAD is associated with impaired walking endurance in patients with COPD.", {"entities": []}], ["This prospective cross-sectional study enrolled 200 COPD patients (mean age: 70.9 years) who volunteered to perform ankle-brachial index (ABI) and 6-minute walk test (6MWT) consecutively.", {"entities": []}], ["Demographic data, lung function, dyspnea scales, and cardiovascular risk factors were recorded.", {"entities": []}], ["The ABI was used to detect PAD (ABI <0.90).", {"entities": []}], ["All patients were free of PAD symptoms at enrollment.", {"entities": []}], ["Of the 200 COPD patients, 17 (8.5%) were diagnosed with asymptomatic PAD.", {"entities": []}], ["The COPD patients without asymptomatic PAD did not walk significantly further on the 6MWT than the COPD patients with asymptomatic PAD (439\u00b186 m vs 408\u00b174 m, P =0.159).", {"entities": []}], ["The strongest correlation with the distance walked on the 6MWT was Medical Research Council dyspnea scale ( r P <0.001), followed by oxygen-cost diagram ( r P <0.001) and forced expiratory volume in 1 second ( r P <0.001).", {"entities": []}], ["In multivariate linear regression analysis, only age, forced expiratory volume in 1 second, and baseline pulse oximetry were independently correlated with the distance covered on the 6MWT ( P <0.05).", {"entities": []}], ["However, body mass index, baseline heart rate, and ABI were not correlated with the distance covered on the 6MWT.", {"entities": []}], ["Asymptomatic PAD is not associated with walking endurance in patients with COPD.", {"entities": []}], ["Therefore, it is important to detect and treat asymptomatic PAD early so that COPD patients do not progress to become exercise intolerant.", {"entities": []}], ["Limited by the small sample size and predominantly male (99%) population in the study, further large-scale prospective studies are needed to verify the results.", {"entities": []}], ["Surveillance of univariate syndromic data as a means of potential indicator of developing public health conditions has been used extensively.", {"entities": []}], ["This paper aims to improve the performance of detecting outbreaks by using a background forecasting algorithm based on the adaptive recursive least squares method combined with a novel treatment of the Day of the Week effect.", {"entities": []}], ["Previous work by the first author has suggested that univariate recursive least squares analysis of syndromic data can be used to characterize the background upon which a prediction and detection component of a biosurvellance system may be built.", {"entities": []}], ["An adaptive implementation is used to deal with data non-stationarity.", {"entities": []}], ["In this paper we develop and implement the RLS method for background estimation of univariate data.", {"entities": []}], ["The distinctly dissimilar distribution of data for different days of the week, however, can affect filter implementations adversely, and so a novel procedure based on linear transformations of the sorted values of the daily counts is introduced.", {"entities": []}], ["Seven-days ahead daily predicted counts are used as background estimates.", {"entities": []}], ["A signal injection procedure is used to examine the integrated algorithm's ability to detect synthetic anomalies in real syndromic time series.", {"entities": []}], ["We compare the method to a baseline CDC forecasting algorithm known as the W2 method.", {"entities": []}], ["We present detection results in the form of Receiver Operating Characteristic curve values for four different injected signal to noise ratios using 16 sets of syndromic data.", {"entities": []}], ["We find improvements in the false alarm probabilities when compared to the baseline W2 background forecasts.", {"entities": []}], ["The current paper introduces a prediction approach for city-level biosurveillance data streams such as time series of outpatient clinic visits and sales of over-the-counter remedies.", {"entities": []}], ["This approach uses RLS filters modified by a correction for the weekly patterns often seen in these data series, and a threshold detection algorithm from the residuals of the RLS forecasts.", {"entities": []}], ["We compare the detection performance of this algorithm to the W2 method recently implemented at CDC.", {"entities": []}], ["The modified RLS method gives consistently better sensitivity at multiple background alert rates, and we recommend that it should be considered for routine application in bio-surveillance systems.", {"entities": []}], ["Oral health-related quality of life (OHRQoL) has been used to describe the consequences of oral health conditions and treatments in children.", {"entities": []}], ["A better understanding of OHRQoL and its relationship with dental fear and previous dental experience is necessary to improve children\u2019s oral health status.", {"entities": []}], ["The aim of this study was to investigate the association of dental history and experience with dental fear and the OHRQoL of children aged 11 to 14\u00a0years.", {"entities": []}], ["A cross-sectional study was conducted using a multi-stage stratified sample of 1,312 middle school children.", {"entities": []}], ["Information regarding OHRQoL was collected from the children using the Child Perceptions Questionnaire (CPQ 11\u201314 ), and information regarding dental fear was collected using the Children\u2019s Fear Survey Schedule-Dental Subscale (CFSS-DS).", {"entities": []}], ["Information on past dental experiences and sociodemographic data were collected from the parents using self-administered questionnaires.", {"entities": []}], ["Dental examinations were performed to assess caries experience.", {"entities": []}], ["The multivariable model indicated that dental fear was the strongest predictor of OHRQoL as the fearful children had on average CPQ 11\u201314 scores that were 10 units higher than those of the non-fearful children.", {"entities": []}], ["Regarding past dental experience, pain as the reason for the most recent dental visit was associated with poor OHRQoL, while receiving a filling during the previous dental visits was significantly associated with better OHRQoL.", {"entities": []}], ["In addition, a larger number of siblings, a lower family income, a lower paternal education level, health problems and prior hospitalization were significantly associated with poor OHRQoL.", {"entities": []}], ["This study identified that dental fear and some factors related to previous dental experience are associated with OHRQoL.", {"entities": []}], ["In dental practice, children with dental fear should be identified, guided and treated early to avoid deterioration of their OHRQoL.", {"entities": []}], ["The online version of this article (doi:10.1186/s12903-017-0338-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The assorted and multidimensional concerns that give rise to the issue of environmental justice have proved to be intellectually daunting and highly resistant to positive change.", {"entities": []}], ["Low-income, people of color, and tribal communities confronting environmental stressors are beset by stressors in both the physical and social environments.", {"entities": []}], ["For this reason, while the bifurcation of the public health and environmental fields taking place over the past several decades has yielded generally negative impacts in areas of public health, environment, and planning, the consequences for low-income and disadvantaged communities have been especially grievous.", {"entities": []}], ["This commentary builds on the recent Institute of Medicine workshop titled \"Rebuilding the Unity of Health and the Environment: A New Vision of Environmental Health for the 21st Century.\"", {"entities": []}], ["The workshop organizers posited that only by thinking about environmental health on multiple levels will it be possible to merge various strategies to protect both the environment and health.", {"entities": []}], ["In this commentary we examine how such a new vision of uniting public health and the environment can contribute to attaining environmental justice for all populations.", {"entities": []}], ["Background: The cardiopulmonary effects of the individual criteria air pollutants have been well investigated, but little is known about the cardiopulmonary effects of inhaled multipollutant mixtures that more realistically represent environmental exposures.", {"entities": []}], ["Objectives: We assessed the cardiopulmonary effects of exposure to photochemically altered particle-free multipollutant mixtures.", {"entities": []}], ["Methods: We exposed mice to filtered air (FA), multipollutant mixtures, or ozone (O 3 ) for 4 hr in a photochemical reaction chamber.", {"entities": [[94, 96, "GENE"]]}], ["Eight hours after exposure, we assessed cardiac responses using a Langendorff preparation in a protocol consisting of 20 min of global ischemia followed by 2 hr of reperfusion.", {"entities": [[135, 143, "DISEASE"], [158, 160, "GENE"]]}], ["Cardiac function was assessed by measuring the index of left-ventricular developed pressure (LVDP) and contractility (dP/dt) before ischemia.", {"entities": [[132, 140, "DISEASE"]]}], ["On reperfusion after ischemia, recovery of postischemic LVDP and size of infarct were examined.", {"entities": [[21, 29, "DISEASE"]]}], ["We used bronchoalveolar lavage (BAL) cell counts to assess lung inflammation.", {"entities": []}], ["Results: Exposure to the multipollutant mixtures decreased LVDP, baseline rate of left ventricular contraction (dP/dt maximum ), and baseline rate of left ventricular relaxation (dP/dt minimum ) compared with exposure to FA.", {"entities": []}], ["Exposure to O 3 also decreased heart rate and dP/dt minimum .", {"entities": []}], ["Time to ischemic contracture was prolonged in the multipollutant-mixture group relative to that in the FA group.", {"entities": []}], ["Mice in the multipollutant-mixture group had better recovery of postischemic LVDP and smaller infarct size.", {"entities": []}], ["Exposure to multipollutant mixtures and to O 3 exposure increased numbers of macrophages in the BAL fluid.", {"entities": []}], ["Conclusions: Exposure to photochemically altered urban air pollution appears to affect cardiac mechanics in isolated perfused hearts.", {"entities": []}], ["Inhalation of acute multipollutant mixtures decreases LVDP and cardiac contractility in isolated non-ischemic murine hearts, prolongs ischemic contracture, increases postischemic recovery of LVDP, and reduces infarct size.", {"entities": []}], ["Citation: McIntosh-Kastrinsky R, Diaz-Sanchez D, Sexton KG, Jania CM, Zavala J, Tilley SL, Jaspers I, Gilmour MI, Devlin RB, Cascio WE, Tong H. 2013.", {"entities": []}], ["Photochemically altered air pollution mixtures and contractile parameters in isolated murine hearts before and after ischemia.", {"entities": [[117, 125, "DISEASE"]]}], ["Environ Health Perspect 121:1344\u20131348;\u2002 http://dx.doi.org/10.1289/ehp.1306609", {"entities": []}], ["Preeclampsia (PE) is an obstetric disorder with high morbidity and mortality rates but without clear pathogeny.", {"entities": []}], ["The dysfunction of the blood coagulation-fibrinolysis system is a salient characteristic of PE that varies in severity, and necessitates different treatments.", {"entities": []}], ["Therefore, it is necessary to find suitable predictors for the onset and severity of PE.", {"entities": []}], ["We aimed to evaluate blood coagulation parameters and platelet indices as potential predictors for the onset and severity of PE.", {"entities": []}], ["Blood samples from 3 groups of subjects, normal pregnant women (n\u200a=\u200a79), mild preeclampsia (mPE) (n\u200a=\u200a53) and severe preeclampsia (sPE) (n\u200a=\u200a42), were collected during early and late pregnancy.", {"entities": []}], ["The levels of coagulative parameters and platelet indices were measured and compared among the groups.", {"entities": []}], ["The receiver-operating characteristic (ROC) curves of these indices were generated, and the area under the curve (AUC) was calculated.", {"entities": []}], ["The predictive values of the selected potential parameters were examined in binary regression analysis.", {"entities": []}], ["During late pregnancy in the normal pregnancy group, the activated partial thromboplastin time (APTT), prothrombin time (PT), thrombin time (TT) and platelet count decreased, while the fibrinogen level and mean platelet volume (MPV) increased compared to early pregnancy ( p <0.05).", {"entities": []}], ["However, the PE patients presented with increased APTT, TT, MPV and D-dimer (DD) during the third trimester.", {"entities": []}], ["In the analysis of subjects with and without PE, TT showed the largest AUC (0.743) and high predictive value.", {"entities": []}], ["In PE patients with different severities, MPV showed the largest AUC (0.671) and ideal predictive efficiency.", {"entities": []}], ["Normal pregnancy causes a maternal physiological hypercoagulable state in late pregnancy.", {"entities": []}], ["PE may trigger complex disorders in the endogenous coagulative pathways and consume platelets and FIB, subsequently activating thrombopoiesis and fibrinolysis.", {"entities": []}], ["Thrombin time and MPV may serve as early monitoring markers for the onset and severity of PE, respectively.", {"entities": []}], ["Signal transduction is a process required to conduct information from a receptor to the nucleus.", {"entities": []}], ["This process is vital for the control of cellular function and fate.", {"entities": []}], ["The dynamics of signaling activation and inhibition determine processes such as apoptosis, proliferation, and differentiation.", {"entities": []}], ["Thus, it is important to understand the factors modulating transient and sustained response.", {"entities": []}], ["To address this question, by applying mathematical approach we have studied the factors which can alter the activation nature of downstream signaling molecules.", {"entities": []}], ["The factors which we have investigated are loops (feed forward and feedback loops), cross-talk of signal transduction pathways, and the change in the concentration of the signaling molecules.", {"entities": []}], ["Based on our results we conclude that among these factors feedback loop and the cross-talks which directly inhibit the target protein dominantly controls the transient cellular response.", {"entities": []}], ["Enaminones are synthetic compounds with an established role in the prevention of various forms of seizures.", {"entities": []}], ["Recent evidence suggests potent anti-tussive, bronchodilation and anti-inflammatory properties.", {"entities": []}], ["Pre-treatment with particularly E121 compound resulted in a decrease in leukocyte recruitment in the ovalbumin induced-model of asthma, immune cell proliferation and cytokine release in vitro .", {"entities": [[128, 134, "DISEASE"]]}], ["We hypothesize that E121 might serve as a therapeutic potential in intestinal inflammation through modulating immune cell functions.", {"entities": []}], ["Colitis was induced by daily dextran sulfate sodium (DSS) administration for 5 days, and its severity was determined by gross and histological assessments.", {"entities": []}], ["The plasma level of various cytokines was measured using flow cytometry-based assay.", {"entities": []}], ["The colonic expression/ phosphorylation level of various molecules was determined by immunofluorescence and western blotting.", {"entities": []}], ["The effects of E121 treatment on in vitro neutrophil chemotaxis (under-agarose assay), superoxide release (luminol oxidation assay) and apoptosis (annexin V/7AAD) were also determined.", {"entities": []}], ["DSS-induced colitis in mice was significantly reduced by daily E121 treatment (30\u2013100 mg/kg) at gross and histological levels.", {"entities": []}], ["This effect was due to modulated plasma levels of interleukin (IL-2) and colonic expression levels of various signaling molecules and proteins involved in apoptosis.", {"entities": []}], ["In vitro neutrophil survival, chemotaxis, and superoxide release were also reduced by E121 treatment.", {"entities": []}], ["Our results indicate important anti-inflammatory actions of E121 in the pathogenesis of IBD.", {"entities": []}], ["The use of neuraminidase-inhibiting anti-viral medication to treat influenza is relatively infrequent.", {"entities": [[67, 76, "DISEASE"]]}], ["Rapid, cost-effective methods for diagnosing influenza are needed to enable appropriate prescribing.", {"entities": [[45, 54, "DISEASE"]]}], ["Multi-viral respiratory panels using reverse transcription polymerase chain reaction (PCR) assays to diagnose influenza are accurate but expensive and more time-consuming than low sensitivity rapid influenza tests.", {"entities": [[110, 119, "DISEASE"], [198, 207, "DISEASE"]]}], ["Influenza clinical decision algorithms are both rapid and inexpensive, but most are based on regression analyses that do not account for higher order interactions.", {"entities": [[0, 9, "DISEASE"]]}], ["This study used classification and regression trees (CART) modeling to estimate probabilities of influenza.", {"entities": [[97, 106, "DISEASE"]]}], ["Eligible enrollees\u2009\u2265\u20095\u00a0years old ( n \u2009=\u20094,173) who presented at ambulatory centers for treatment of acute respiratory illness (\u22647\u00a0days) with cough or fever in 2011\u20132012, provided nasal and pharyngeal swabs for PCR testing for influenza, information on demographics, symptoms, personal characteristics and self-reported influenza vaccination status.", {"entities": [[226, 235, "DISEASE"], [319, 328, "DISEASE"]]}], ["Antiviral medication was prescribed for just 15\u00a0% of those with PCR-confirmed influenza.", {"entities": [[78, 87, "DISEASE"]]}], ["An algorithm that included fever, cough, and fatigue had sensitivity of 84\u00a0%, specificity of 48\u00a0%, positive predictive value (PPV) of 23\u00a0% and negative predictive value (NPV) of 94\u00a0% for the development sample.", {"entities": []}], ["The CART algorithm has good sensitivity and high NPV, but low PPV for identifying influenza among outpatients \u22655\u00a0years.", {"entities": [[82, 91, "DISEASE"]]}], ["Thus, it is good at identifying a group who do not need testing or antivirals and had fair to good predictive performance for influenza.", {"entities": [[126, 135, "DISEASE"]]}], ["Further testing of the algorithm in other influenza seasons would help to optimize decisions for lab testing or treatment.", {"entities": [[42, 51, "DISEASE"]]}], ["Deepening of the upper eyelid sulcus (DUES) is a common complication of prostaglandin F2\u03b1 analog treatment, which causes cosmetic problems.", {"entities": []}], ["However, identifying this condition using photographs is difficult due to such problems as the camera flash effects, blepharoptosis or wide-open eyes.", {"entities": []}], ["We investigated the association between a DUES-like appearance and wide-open eyes regarding the presence of wide-open eyes as a cause for overestimating the incidence of DUES.", {"entities": []}], ["One eye and the forehead in 100 subjects (31 younger subjects, 30 older subjects and 39 patients with blepharoptosis) were evaluated in the present study.", {"entities": []}], ["Digital photographs of the subjects with natural open and wide-open eyes were taken with a flash.", {"entities": []}], ["Five signs (a puffy eyelid, the presence/absence of the upper eyelid sulcus (UES), wrinkles on the forehead with natural open eyes and an increase in the number of wrinkles on the forehead and a DUES-like appearance with wide-open eyes) were judged to be negative or positive by three independent observers.", {"entities": []}], ["Univariate and multivariate logistic regression analyses were performed to determine the independent predictor(s) of a DUES-like appearance with wide-open eyes.", {"entities": []}], ["Fourteen subjects (four young, three old and seven subjects with blepharoptosis) were judged to have a DUES-like appearance with wide-open eyes (14%).", {"entities": []}], ["The only predictive factor was the presence of UES in the patients with natural open eyes (odds ratio\u200a=\u200a17.244, 95% confidence interval: 3.447\u201386.270, P<0.001).", {"entities": []}], ["Among the 12 UES-positive subjects, six (50%) exhibited a DUES-like appearance with wide-open eyes.", {"entities": []}], ["The presence of wide-open eyes can thus cause a DUES-like appearance.", {"entities": []}], ["Blepharoptosis itself is not a predictive factor; however, care should be taken not to overestimate the incidence of DUES, especially in patients with UES with natural open eyes, as a DUES-like appearance can be caused by wide-open eyes, even in treatment-na\u00efve patients.", {"entities": []}], ["UMIN000010500", {"entities": []}], ["A rich civic infrastructure of community-based organizations (CBOs) can help generate, diffuse and maintain a culture of engagement and health that benefits marginalized populations most at risk for illness, disability, and poor health.", {"entities": []}], ["Attention to CBOs advances \u201cmeso-level\u201d frameworks for understanding health cultures and outcomes by going beyond attention to social networks and social identities.", {"entities": []}], ["We focus on three mechanisms: CBOs can (1) empower individuals by developing civic capacity and personal efficacy; (2) foster solidarity by building networks, social identities and a shared commitment to collective well-being; and (3) mobilize people to have a voice in health-related policies and programming, thereby affecting community well-being.", {"entities": []}], ["We draw on theory and research in sociology, political science and psychology, and we illustrate the utility of a CBO approach by examining survey and semi-structured interview data from participants in youth civic groups in 13 low-income, predominantly immigrant communities in California.", {"entities": []}], ["Interview data illustrate the ways in which CBOs enhance members' civic capacities, provide a sense of empowerment and efficacy to engage in healthy behaviors, develop solidarity among diverse participants, and elaborate networks among those committed to community well-being.", {"entities": []}], ["We also discuss CBO-led campaigns in which youth mobilized for change in policies and practices of local institutions to illustrate possible community-wide health consequences of CBO engagement.", {"entities": []}], ["CBOs can thus generate individual-level well-being effects, and reduce structural barriers to good health through changes in the broader environment.", {"entities": []}], ["\u2022 Civic groups can function as meso-level determinants of health and well-being.", {"entities": []}], ["\u2022 Civic groups can empower individuals, build solidarity and facilitate policy change.", {"entities": []}], ["\u2022 We illustrate with indepth interviews and surveys of minority youth in California.", {"entities": []}], ["\u2022 We discuss cases of community-based organizations' health-related initiatives.", {"entities": []}], ["Civic groups can function as meso-level determinants of health and well-being.", {"entities": []}], ["Civic groups can empower individuals, build solidarity and facilitate policy change.", {"entities": []}], ["We illustrate with indepth interviews and surveys of minority youth in California.", {"entities": []}], ["We discuss cases of community-based organizations' health-related initiatives.", {"entities": []}], ["PM 2.5 has gradually become a major environmental problem of China with its rapid economic development, urbanization, and increasing of motor vehicles.", {"entities": []}], ["Findings and awareness of serious PM 2.5 pollution make the PM 2.5 a new criterion pollutant of the Chinese National Ambient Air Quality Standard (NAAQS) revised in 2012.", {"entities": []}], ["The 2012 NAAQS sets the PM 2.5 concentrate limitation with the 24-hour average value and the annual mean value.", {"entities": []}], ["Wuhan is quite typical among central and southern China in climate, economy, development level, and energy consumption.", {"entities": []}], ["The data are cited from the official website of Wuhan Environmental Protection Bureau and cover the period from 1 January to 30 June 2013.", {"entities": []}], ["The data definitely confirm the existence of serious PM 2.5 pollution in Wuhan and indicate that the addition of PM 2.5 as a criterion pollutant significantly brings down the attainment rate of air quality.", {"entities": []}], ["The example of Wuhan reveals that local governments should take measures to reduce the emission of PM 2.5 if it affects the attainment rate and the performance evaluation value of air quality.", {"entities": []}], ["The main contribution of 2012 NAAQS is that it brings down the attainment rate of the air quality and forces local governmental officials to take the measures accordingly.", {"entities": []}], ["Humidification of inspired gas is important for patients receiving respiratory support.", {"entities": []}], ["High-flow nasal cannula (HFNC) effectively provides temperature and humidity-controlled gas to the airway.", {"entities": []}], ["We hypothesized that various levels of gas humidification would have differential effects on airway epithelial monolayers.", {"entities": []}], ["Calu-3 monolayers were placed in environmental chambers at 37\u00b0C with relative humidity (RH) < 20% (dry), 69% (noninterventional comparator), and >90% (HFNC) for 4 and 8 hours with 10\u2009L/min of room air.", {"entities": []}], ["At 4 and 8 hours, cell viability and transepithelial resistance measurements were performed, apical surface fluid was collected and assayed for indices of cell inflammation and function, and cells were harvested for histology ( n = 6/condition).", {"entities": []}], ["Transepithelial resistance and cell viability decreased over time ( P < 0.001) between HFNC and dry groups ( P < 0.001).", {"entities": []}], ["Total protein secretion increased at 8 hours in the dry group ( P < 0.001).", {"entities": []}], ["Secretion of interleukin (IL)-6 and IL-8 in the dry group was greater than the other groups at 8 hours ( P < 0.001).", {"entities": []}], ["Histological analysis showed increasing injury over time for the dry group.", {"entities": []}], ["These data demonstrate that exposure to low humidity results in reduced epithelial cell function and increased inflammation.", {"entities": []}], ["Oxidative stress is known to be involved in the pathogenesis of chronic obstructive pulmonary disease (COPD).", {"entities": [[64, 101, "DISEASE"]]}], ["Evidence suggests that leukocytes mitochondria DNA (mtDNA) is susceptible to undergo mutations, insertions, or depletion in response to reactive oxidative stress (ROS).", {"entities": []}], ["We hypothesize that mtDNA copy number is associated with the development of COPD.", {"entities": []}], ["Relative mtDNA copy number was measured by a quantitative real-time PCR assay using DNA extracted from peripheral leukocytes.", {"entities": []}], ["MtDNA copy number of peripheral leukocytes in the COPD group (n = 86) is significantly decreased compared with non-smoker group (n = 77) (250.3\u00b1 21.5 VS. 464.2\u00b1 49.9, P<0.001).", {"entities": []}], ["MtDNA copy number in the COPD group was less than that in the healthy smoking group, but P value nearly achieved significance (250.3\u00b1 21.5 VS. 404.0\u00b1 76.7, P = 0.08) MtDNA copy number has no significance with age, gender, body mass index, current smoking, and pack-years in COPD group, healthy smoker group and no smoker group, respectively.", {"entities": []}], ["Serum glutathione level in the COPD group is significantly decreased compared with healthy smoker and non-smoker groups (4.5\u00b1 1.3 VS. 6.2\u00b1 1.9 and 4.5\u00b1 1.3 VS. 7.1\u00b11.1 mU/mL; P<0.001 respectively).", {"entities": []}], ["Pearson correlation test shows a significant liner correlation between mtDNA copy number and serum glutathione level (R = 0.2, P = 0.009).", {"entities": []}], ["COPD is associated with decreased leukocyte mtDNA copy number and serum glutathione.", {"entities": []}], ["COPD is a regulatory disorder of leukocytes mitochondria.", {"entities": []}], ["However, further studies are needed to determine the real mechanisms about the gene and the function of mitochondria.", {"entities": []}], ["Allergy is often accompanied by infections and lower levels of antimicrobial peptides (AMPs).", {"entities": []}], ["Vitamin D has been shown to increase expression of selected AMPs.", {"entities": []}], ["In this study we investigated whether antimicrobial peptide levels in nasal secretions of allergic asthma patients are lower than in healthy controls, and whether administration of the active form of vitamin D (1,25(OH) 2 D3) affects these antimicrobial peptide levels.", {"entities": [[90, 105, "DISEASE"], [99, 105, "DISEASE"]]}], ["The levels of antimicrobial peptides in nasal secretions were compared between 19 allergic asthma patients and 23 healthy controls.", {"entities": [[82, 97, "DISEASE"], [91, 97, "DISEASE"]]}], ["The effect of seven days daily oral treatment with 2 \u03bcg 1,25(OH) 2 D3 on antimicrobial peptides in nasal secretions was assessed in a placebo-controlled cross-over clinical study.", {"entities": []}], ["Levels of neutrophil \u03b1-defensins (human neutrophil peptides 1\u20133; HNP1-3) and lipocalin 2 (LCN2; also known as NGAL) were significantly lower in asthmatics, but no differences in LL-37 and SLPI were detected.", {"entities": [[90, 94, "GENE"], [188, 192, "GENE"]]}], ["Treatment with a short-term 1,25(OH) 2 D3 caused a small increase in HNP1-3, but not when the asthma and control groups were analyzed separately.", {"entities": [[94, 100, "DISEASE"]]}], ["LL-37, LCN2 and SLPI did not change after treatment with 1,25(OH) 2 D3.", {"entities": [[7, 11, "GENE"], [16, 20, "GENE"]]}], ["Levels of the antimicrobial peptides HNP1-3 and LCN2 are lower in nasal secretions in asthmatics and are not substantially affected by a short-term treatment with active vitamin D.", {"entities": [[48, 52, "GENE"]]}], ["Adverse drug events are a frequent cause of emergency department presentations.", {"entities": []}], ["Administrative data could be used to identify patients presenting with adverse drug events for post-market surveillance, and to conduct research in patient safety and in drug safety and effectiveness.", {"entities": []}], ["However, such data sources have not been evaluated for their completeness with regard to adverse drug event reporting.", {"entities": []}], ["Our objective was to determine the proportion of adverse drug events to outpatient medications diagnosed at the point-of-care in emergency departments that were documented in administrative data.", {"entities": []}], ["We linked the records of patients enrolled in a prospective observational cohort study on adverse drug events conducted in two Canadian tertiary care emergency departments to their administrative data.", {"entities": []}], ["We compared the number of adverse drug events diagnosed and recorded at the point-of-care in the prospective study with the number of adverse drug events recorded in the administrative data.", {"entities": []}], ["Among 1574 emergency department visits, 221 were identified as adverse drug event-related in the prospective database.", {"entities": []}], ["We found 15 adverse drug events documented in administrative records with ICD-10 codes clearly indicating an adverse drug event, indicating a sensitivity of 6.8% (95% CI 4.0\u201311.2%) of this code set.", {"entities": []}], ["When the ICD-10 code categories were broadened to include codes indicating a very likely, likely or possible adverse event to a medication, 62 of 221 events were identifiable in administrative data, corresponding to a sensitivity of 28.1% (95% CI 22.3-34.6%).", {"entities": []}], ["Adverse drug events to outpatient medications were underreported in emergency department administrative data compared to the number of adverse drug events diagnosed and recorded at the point-of-care.", {"entities": []}], ["Measurement of internal thoracic impedance (ITI) is sensitive and accurate in detecting acute pulmonary edema even at its preclinical stage.", {"entities": [[94, 109, "DISEASE"]]}], ["We evaluated the suitability of the highly sensitive and noninvasive RS-207 monitor for detecting pleural effusion and for demonstrating increased ITI during its resolution.", {"entities": []}], ["This prospective controlled study was performed in a single department of internal medicine of a university-affiliated hospital between 2012-2013.", {"entities": []}], ["One-hundred patients aged 25\u201396 years were included, of whom 50 had bilateral or right pleural effusion of any etiology (study group) and 50 had no pleural effusion (controls).", {"entities": []}], ["ITI, the main component of which is lung impedance, was continuously measured by the RS-207 monitor.", {"entities": []}], ["The predictive value of ITI monitoring was determined by 8 measurements taken every 8 hours.", {"entities": []}], ["Pleural effusion was diagnosed according to well-accepted clinical and roentgenological criteria.", {"entities": []}], ["During treatment, the ITI of the study group increased from 32.9\u00b14.2 ohm to 42.8\u00b13.8 ohm ( p <0.0001) compared to non-significant changes in the control group (59.6\u00b16.6 ohm, p = 0.24).", {"entities": []}], ["Prominent changes were observed in the respiratory rate of the study group: there was a decrease from 31.2\u00b14.0 to 19.5\u00b12.4 ohm (35.2%) compared to no change for the controls, and a mean increase from 83.6\u00b15.3%-92.5\u00b11.6% (13.2%) in O2 saturation compared to 94.2\u00b11.7% for the controls.", {"entities": []}], ["Determination of ITI for the detection and monitoring of treatment of patients with pleural effusion enables earlier diagnosis and more effective therapy, and can prevent hospitalization and serious complications, such as respiratory distress, and the need for mechanical ventilation.", {"entities": []}], ["The study is registered at ClinicalTrials.gov NCT01601444", {"entities": []}], ["Assess the impact of using the recently published WHO growth standard, based on healthy, breastfed infants in multiple countries that excluded prematurely-born infants, versus the Infant Health Development Program (IHDP) growth reference constructed from premature infants, on the interpretation of the growth of premature infants after hospital discharge.", {"entities": []}], ["A retrospective cohort was constructed of infants born at gestational age \u2264 35 weeks who initially presented for care at one of 32 outpatient sites between 2006 and 2008 (N=2297).", {"entities": []}], ["Kappa statistics measured overall agreement and agreement in ever classifying infants < 5 The WHO and IHDP growth curves showed moderate agreement for all measurements (\u03ba 0.40-0.52).", {"entities": []}], ["When the curves disagreed on whether an infant was < 5 Choice of growth curve affects the assessment of growth and the classification of underweight status.", {"entities": []}], ["Longitudinal studies are needed to determine which assessment identifies the greatest number of premature infants at risk for long-term growth issues.", {"entities": []}], ["Adenosine is a potent extracellular messenger that is produced in high concentrations under metabolically unfavourable conditions.", {"entities": []}], ["Tissue hypoxia, consequent to a compromised cellular energy status, is followed by the enhanced breakdown of ATP leading to the release of adenosine.", {"entities": []}], ["Through the interaction with A 2 and A 3 membrane receptors, adenosine is devoted to the restoration of tissue homeostasis, acting as a retaliatory metabolite.", {"entities": []}], ["Several aspects of the immune response have to be taken into consideration and even though in general it is very important to dampen inflammation, in some circumstances, such as the case of cancer, it is also necessary to increase the activity of immune cells against pathogens.", {"entities": [[190, 196, "DISEASE"]]}], ["Therefore, adenosine receptors that are defined as \u2018sensors\u2013of metabolic changes in the local tissue environment may be very important targets for modulation of immune responses and drugs devoted to regulating the adenosinergic system are promising in different clinical situations.", {"entities": []}], ["A fundamental issue in biology and medicine is illustration of the overall drug impact which is always the consequence of changes in local regions of metabolic pathways (subpathways).", {"entities": []}], ["To gain insights into the global relationship between drugs and their affected metabolic subpathways, we constructed a drug\u2013metabolic subpathway network (DRSN).", {"entities": []}], ["This network included 3925 significant drug\u2013metabolic subpathway associations representing drug dual effects.", {"entities": []}], ["Through analyses based on network biology, we found that if drugs were linked to the same subpathways in the DRSN, they tended to share the same indications and side effects.", {"entities": []}], ["Furthermore, if drugs shared more subpathways, they tended to share more side effects.", {"entities": []}], ["We then calculated the association score by integrating drug-affected subpathways and disease-related subpathways to quantify the extent of the associations between each drug class and disease class.", {"entities": []}], ["The results showed some close drug\u2013disease associations such as sex hormone drugs and cancer suggesting drug dual effects.", {"entities": [[86, 92, "DISEASE"]]}], ["Surprisingly, most drugs displayed close associations with their side effects rather than their indications.", {"entities": []}], ["To further investigate the mechanism of drug dual effects, we classified all the subpathways in the DRSN into therapeutic and non-therapeutic subpathways representing drug therapeutic effects and side effects.", {"entities": []}], ["Compared to drug side effects, the therapeutic effects tended to work through tissue-specific genes and these genes tend to be expressed in the adrenal gland, liver and kidney; while drug side effects always occurred in the liver, bone marrow and trachea.", {"entities": []}], ["Taken together, the DRSN could provide great insights into understanding the global relationship between drugs and metabolic subpathways.", {"entities": []}], ["A number of subjects, especially the very young and the elderly, are unable to cooperate and to perform forced expiratory manoeuvres in the evaluation of bronchial hyperresponsiveness (BHR).", {"entities": []}], ["The objective of our study was to investigate the use of the interrupter technique as a method to measure the response to provocation and to compare it with the conventional PD 20 FEV 1 .", {"entities": [[180, 183, "GENE"]]}], ["We studied 170 normal subjects, 100 male and 70 female (mean \u00b1 SD age, 38 \u00b1 8.5 and 35 \u00b1 7.5 years, respectively), non-smoking from healthy families.", {"entities": []}], ["These subjects had no respiratory symptoms, rhinitis or atopic history.", {"entities": [[44, 52, "DISEASE"]]}], ["A dosimetric cumulative inhalation of methacholine was used and the response was measured by the dose which increases baseline end interruption resistance by 100% (PD 100 Rint, EI) as well as by percent dose response ratio (DRR).", {"entities": []}], ["BHR at a cut-off level of 0.8 mg methacholine exhibited 31 (18%) of the subjects (specificity 81.2%), 21 male and 10 female, while 3% showed a response in the asthmatic range.", {"entities": []}], ["The method was reproducible and showed good correlation with PD 20 FEV 1 (r = 0.76, p < 0.005), with relatively narrow limits of agreement at -1.39 \u03bcmol and 1.27 \u03bcmol methacholine, respectively, but the interrupter methodology proved more sensitive than FEV 1 in terms of reactivity (DRR).", {"entities": [[67, 70, "GENE"], [254, 257, "GENE"], [67, 70, "GENE"], [254, 257, "GENE"]]}], ["Interrupter methodology is clinically useful and may be used to evaluate bronchial responsiveness in normal subjects and in situations when forced expirations cannot be performed.", {"entities": []}], ["The glucocorticoid receptor (GR) is a transcription factor of which the underlying gene regulatory mechanisms are complex and incompletely understood.", {"entities": []}], ["The non-steroidal anti-inflammatory Compound A (CpdA), a selective GR modulating compound in various cell models, has been shown to favour GR-mediated gene repression but not GR-mediated gene activation.", {"entities": []}], ["Shifting balances towards only a particular subset of GR gene regulatory events may be of benefit in the treatment of inflammatory diseases.", {"entities": []}], ["We present evidence to support that the combination of CpdA with Dexamethasone (DEX), a classic steroidal GR ligand, can shape GR function towards a unique gene regulatory profile in a cell type-dependent manner.", {"entities": []}], ["The molecular basis hereof is a changed GR phosphorylation status concomitant with a change in the GR cofactor recruitment profile.", {"entities": []}], ["We subsequently identified and confirmed the orphan nuclear receptor SHP as a coregulator that is specifically enriched at GR when CpdA and DEX are combined.", {"entities": []}], ["Combining CpdA with DEX not only leads to stronger suppression of pro-inflammatory gene expression, but also enhanced anti-inflammatory GR target gene expression in epithelial cells, making ligand combination strategies in future a potentially attractive alternative manner of skewing and fine-tuning GR effects towards an improved therapeutic benefit.", {"entities": []}], ["OBJECTIVES: Combined coronary artery bypass grafting and valve surgery requires a prolonged period of cardioplegic arrest (CA) predisposing to myocardial injury and postoperative cardiac-specific complications.", {"entities": []}], ["The aim of this trial was to reduce the CA time in patients undergoing combined coronary artery bypass grafting and valve surgery and assess if this was associated with less myocardial injury and related complications.", {"entities": []}], ["METHODS: Participants were randomized to (i) coronary artery bypass grafting performed on the beating heart with cardiopulmonary bypass support followed by CA for the valve procedure (hybrid) or (ii) both procedures under CA (conventional).", {"entities": []}], ["To assess complications related to myocardial injury, we used the composite of death, myocardial infarction, arrhythmia, need for pacing or inotropes for\u2009>12\u2009h. To assess myocardial injury, we used serial plasma troponin T and markers of metabolic stress in myocardial biopsies.", {"entities": [[86, 107, "DISEASE"]]}], ["RESULTS: Hundred and sixty patients (80 hybrid and 80 conventional) were randomized.", {"entities": []}], ["Mean age was 66.5 years and 74% were male.", {"entities": []}], ["Valve procedures included aortic (61.8%) and mitral (33.1%) alone or in combination (5.1%).", {"entities": []}], ["CA time was 16% lower in the hybrid group [median 98 vs 89\u2009min, geometric mean ratio (GMR) 0.84, 95% confidence interval (CI) 0.77\u20130.93, P \u2009=\u20090.0004].", {"entities": []}], ["Complications related to myocardial injury occurred in 131/160 patients (64/80 conventional, 67/80 hybrid), odds ratio 1.24, 95% CI 0.54\u20132.86, P \u2009=\u20090.61.", {"entities": []}], ["Release of troponin T was similar between groups (GMR 1.04, 95% CI 0.87\u20131.24, P \u2009=\u20090.68).", {"entities": []}], ["Adenosine monophosphate was 28% lower in the hybrid group (GMR 0.72, 95% CI 0.51\u20131.02, P \u2009=\u20090.056).", {"entities": []}], ["CONCLUSIONS: The hybrid procedure reduced the CA time but myocardial injury outcomes were not superior to conventional approach.", {"entities": []}], ["TRIAL REGISTRATION: ISRCTN65770930.", {"entities": []}], ["Erlotinib is an orally administered tyrosine kinase inhibitor used for treatment of non-small cell lung cancer.", {"entities": [[99, 110, "DISEASE"], [104, 110, "DISEASE"]]}], ["Understanding actual use of medication is essential for optimizing treatment conditions.", {"entities": []}], ["In this multicentre prospective observational study, patients starting erlotinib treatment were followed for 4\u00a0months.", {"entities": []}], ["Adherence was assessed using a medication event monitoring system (MEMS).", {"entities": []}], ["Area under the curve (AUC) was determined after 1, 2 and 4\u00a0months.", {"entities": []}], ["Before start and at monthly intervals, patients filled out questionnaires about attitude towards medication and disease, quality of life, symptoms and use in daily practice.", {"entities": []}], ["Sixty-two patients (median age 63.5\u00a0years, 53\u00a0% male) were included of whom 15 were still on treatment after 4\u00a0months.", {"entities": []}], ["MEMS data of 55 patients revealed a mean adherence of 96.8\u00a0\u00b1\u00a04.0\u00a0%.", {"entities": []}], ["Over one-third of patients had an adherence rate <95\u00a0%.", {"entities": []}], ["At 1\u00a0month, 21\u00a0% of patients did not always correctly take erlotinib without food.", {"entities": []}], ["Associated risk factors were older age, suboptimal adherence, ocular symptoms and stomatitis (all p \u00a0<\u00a00.05).", {"entities": [[82, 92, "DISEASE"]]}], ["After 1\u00a0month of treatment, fatigue (91\u00a0%) and rash (86\u00a0%) were the most common symptoms reported.", {"entities": []}], ["AUC ss of erlotinib was higher in patients with rash and patients with moderate\u2013severe anorexia (both p \u00a0<\u00a00.05).", {"entities": []}], ["Though adherence to erlotinib treatment is generally high, non-adherence might be an issue in a considerable number of patients.", {"entities": []}], ["To support optimal erlotinib intake, clinicians need to take adequate measures to ameliorate symptoms and to address adherence and correct intake without food.", {"entities": []}], ["Especially older patients and those who experience stomatitis may need extra attention.", {"entities": [[51, 61, "DISEASE"]]}], ["Climate change has been recognized as both one of the biggest threats and the biggest opportunities for global health in the 21st century.", {"entities": []}], ["This trend review seeks to assess and characterize the amount and type of scientific literature on the link between climate change and human health.", {"entities": []}], ["We tracked the use of climate-related terms and their co-occurrence with health terms during the 25 years since the first Intergovernmental Panel on Climate Change (IPCC) report, from 1990 to 2014, in two scientific databases and in the IPCC reports.", {"entities": []}], ["We investigated the trends in the number of publications about health and climate change through time, by nature of the health impact under study, and by geographic area.", {"entities": []}], ["We compared the scientific production in the health field with that of other sectors on which climate change has an impact.", {"entities": []}], ["The number of publications was extremely low in both databases from 1990 (325 and 1,004, respectively) until around 2006 (1,332 and 4,319, respectively), which has since then increased exponentially in recent years (6,079 and 17,395, respectively, in 2014).", {"entities": []}], ["However, the number of climate change papers regarding health is still about half that of other sectors.", {"entities": []}], ["Certain health impacts, particularly malnutrition and non-communicable diseases (NCDs), remain substantially understudied.", {"entities": []}], ["Approximately two-thirds of all published studies were carried out in OECD countries (Organization for Economic Cooperation and Development), predominantly in Europe and North America.", {"entities": []}], ["There is a clear need for further research on the links between climate change and health.", {"entities": []}], ["This pertains particularly to research in and by those countries in which health will be mostly affected and capacity to adapt is least.", {"entities": []}], ["Specific undertreated topics such as NCDs, malnutrition, and mental health should gain the priority they deserve.", {"entities": []}], ["Funding agencies are invited to take note of and establish calls for proposals accordingly.", {"entities": []}], ["Raising the interest in this research area in young scientists remains a challenge and should lead to innovative courses for large audiences, such as Massive Open Online Courses.", {"entities": []}], ["One hundred and sixty women admitted for breast tumour biopsy to the King's College Hospital group have been followed sequentially for 2 years.", {"entities": []}], ["Sixty-nine women had early operable breast cancer and 91 had benign breast disease.", {"entities": [[68, 82, "DISEASE"], [36, 49, "DISEASE"], [43, 49, "DISEASE"]]}], ["All these women had serum immunoglobulin IgG, IgA, IgM and IgE levels measured preoperatively and postoperatively at 3 months, 1 year and 2 years.", {"entities": []}], ["No differences were found in any of the serum immunoglobulin levels between the two groups at any time.", {"entities": []}], ["There was, however, a positive correlation between the extent of metastatic breast cancer and the serum level of various immunoglobulins, particularly IgA.", {"entities": [[76, 89, "DISEASE"], [83, 89, "DISEASE"]]}], ["There was no evidence that routine postoperative radiotherapy influenced the levels of serum immunoglobulins.", {"entities": []}], ["The findings suggest a secondary defence reaction against increasing tumour load, and do not support the theory of an early immune defect in immunoglobulin metabolism which could play a part in the pathogenesis of breast cancer.", {"entities": [[214, 227, "DISEASE"], [221, 227, "DISEASE"]]}], ["Although there is no diagnostic value in measuring the levels of serum immunoglobulins in patients with breast tumours, there may be some value in following the levels in cancer patients, as a guide to subclinical spread of the disease.", {"entities": [[171, 177, "DISEASE"]]}], ["Recent research conducted by investigators at the National Center for Chronic Disease Prevention and Health Promotion\u2014a division of the US Centers for Disease Control and Prevention (CDC)\u2014found that 'Regular-Soda Intake, Independent of Weight Status, is Associated with Asthma among US High School Students.'", {"entities": [[270, 276, "DISEASE"]]}], ["On the basis of their review of prior studies, researchers hypothesized that the association may be due to high intake of sodium benzoate, a commonly used preservative in US soft drinks.", {"entities": []}], ["But a closer look at these prior research studies suggests that there is no strong scientific evidence that the preservatives in US soft drinks are associated with asthma.", {"entities": [[164, 170, "DISEASE"]]}], ["Importantly, other recent research suggests that the association may be with the unpaired (excess free) fructose in high fructose corn syrup.", {"entities": []}], ["A quinazolinedione-derived screening hit 2 was discovered with cellular antiviral activity against respiratory syncytial virus (CPE EC 50 = 2.1 \u03bcM), moderate efficacy in reducing viral progeny (4.2 log at 10 \u03bcM), and marginal cytotoxic liability (selectivity index, SI \u223c 24).", {"entities": [[128, 131, "GENE"]]}], ["Scaffold optimization delivered analogs with improved potency and selectivity profiles.", {"entities": []}], ["Most notable were compounds 15 and 19 (EC 50 = 300\u2013500 nM, CC 50 > 50 \u03bcM, SI > 100), which significantly reduced viral titer (>400,000-fold), and several analogs were shown to block the activity of the RNA-dependent RNA-polymerase complex of RSV.", {"entities": []}], ["Allergen recognition by dendritic cells (DCs) is a key event in the allergic cascade leading to production of IgE antibodies.", {"entities": []}], ["C-type lectins, such as the mannose receptor and DC-SIGN, were recently shown to play an important role in the uptake of the house dust mite glycoallergen Der p 1 by DCs.", {"entities": []}], ["In addition to mannose receptor (MR) and DC-SIGN the high and low affinity IgE receptors, namely Fc\u03f5RI and Fc\u03f5RII (CD23), respectively, have been shown to be involved in allergen uptake and presentation by DCs.", {"entities": []}], ["This study aims at understanding the extent to which IgE- and IgG-facilitated Der p 1 uptake by DCs influence T cell polarisation and in particular potential bias in favour of Th2.", {"entities": []}], ["We have addressed this issue by using two chimaeric monoclonal antibodies produced in our laboratory and directed against a previously defined epitope on Der p 1, namely human IgE 2C7 and IgG1 2C7.", {"entities": []}], ["Flow cytometry was used to establish the expression patterns of IgE (Fc\u03f5RI and Fc\u03f5RII) and IgG (Fc\u03b3RI) receptors in relation to MR on DCs.", {"entities": []}], ["The impact of Fc\u03f5RI, Fc\u03f5RII, Fc\u03b3RI and mannose receptor mediated allergen uptake on Th1/Th2 cell differentiation was investigated using DC/T cell co-culture experiments.", {"entities": []}], ["Myeloid DCs showed high levels of Fc\u03f5RI and Fc\u03b3RI expression, but low levels of CD23 and MR, and this has therefore enabled us to assess the role of IgE and IgG-facilitated allergen presentation in T cell polarisation with minimal interference by CD23 and MR. Our data demonstrate that DCs that have taken up Der p 1 via surface IgE support a Th2 response.", {"entities": []}], ["However, no such effect was demonstrable via surface IgG.", {"entities": []}], ["IgE bound to its high affinity receptor plays an important role in Der p 1 uptake and processing by peripheral blood DCs and in Th2 polarisation of T cells.", {"entities": []}], ["Atherosclerotic lesions are characterized by the accumulation of oxidized LDL (OxLDL) and the infiltration of macrophages and T cells.", {"entities": []}], ["Cytokine expression in the microenvironment of evolving lesions can profoundly contribute to plaque development.", {"entities": []}], ["While the pro-atherogenic effect of T helper (Th) 1 cytokines, such as IFN-\u03b3, is well established, the role of Th2 cytokines is less clear.", {"entities": []}], ["Therefore, we characterized the role of the Th2 cytokine interleukin (IL)-13 in murine atherosclerosis.", {"entities": [[87, 102, "DISEASE"]]}], ["Here, we report that IL-13 administration favourably modulated the morphology of already established atherosclerotic lesions by increasing lesional collagen content and reducing vascular cell adhesion molecule-1 (VCAM-1)-dependent monocyte recruitment, resulting in decreased plaque macrophage content.", {"entities": []}], ["This was accompanied by the induction of alternatively activated (M2) macrophages, which exhibited increased clearance of OxLDL compared to IFN-\u03b3-activated (M1) macrophages in vitro .", {"entities": []}], ["Importantly, deficiency of IL-13 results in accelerated atherosclerosis in LDLR", {"entities": [[56, 71, "DISEASE"], [75, 79, "GENE"]]}], ["Ascites is one of the most common complications of liver diseases, even though in 15% of the cases it is related to extrahepatic diseases; 3% are of cardiac nature and they appear associated with signs and symptoms of heart failure.", {"entities": []}], ["A 70 year old man was admitted with more than one year history of abdominal distension and a weight gain of 10 kilograms.", {"entities": []}], ["He is asymptomatic and walks 2000\u20133000 meters a day without angor or dyspnea.", {"entities": []}], ["The physical examination shows moderate abdominal distension, with no hepatosplenomegaly or edema, and there is mild jugular vein distension.", {"entities": []}], ["The studies performed (complete laboratory work up, paracentesis, liver biopsy, echocardiogram, intrahepatic pressure measurements, etc.)", {"entities": []}], ["showed a chylous ascites related to portal hypertension, and left ventricular dysfunction was the only probable cause found.", {"entities": [[43, 55, "DISEASE"], [36, 55, "DISEASE"]]}], ["Asymptomatic heart dysfunction can mimic liver disease and should be kept in mind as a cause of chylous ascites.", {"entities": [[41, 54, "DISEASE"]]}], ["Weevils can devastate food legumes in developing countries, but genetically modified peas ( Pisum sativum ), chickpeas and cowpeas expressing the gene for alpha-amylase inhibitor-1 (\u03b1AI) from the common bean ( Phaseolus vulgaris ) are completely protected from weevil destruction.", {"entities": []}], ["\u03b1AI is seed-specific, accumulated at high levels and undergoes post-translational modification as it traverses the seed endomembrane system.", {"entities": []}], ["This modification was thought to be responsible for the reported allergenicity in mice of the transgenic pea but not the bean.", {"entities": []}], ["Here, we observed that transgenic \u03b1AI peas, chickpeas and cowpeas as well as non-transgenic beans were all allergenic in BALB/c mice.", {"entities": []}], ["Even consuming non-transgenic peas lacking \u03b1AI led to an anti-\u03b1AI response due to a cross-reactive response to pea lectin.", {"entities": []}], ["Our data demonstrate that \u03b1AI transgenic peas are not more allergenic than beans or non-transgenic peas in mice.", {"entities": []}], ["This study illustrates the importance of repeat experiments in independent laboratories and the potential for unexpected cross-reactive allergic responses upon consumption of plant products in mice.", {"entities": []}], ["Transforming growth factor-\u03b21 (TGF-\u03b21) is related to the degree of atrial fibrosis and plays critical roles in the induction and perpetuation of atrial fibrillation (AF).", {"entities": []}], ["To investigate the association of the common promoter polymorphism rs1800469 in the TGF-\u03b21 gene ( TGFB1 ) with the risk of AF in Chinese Han population, we carried out a case-control study of two hospital-based independent populations: Southeast Chinese population (581 patients with AF and 723 controls), and Northeast Chinese population (308 AF patients and 292 controls).", {"entities": [[98, 103, "GENE"]]}], ["Two hundred and seventy-eight cases of AF were lone AF and 334 cases of AF were diagnosed as paroxysmal AF.", {"entities": []}], ["In both populations, AF patients had larger left atrial diameters than the controls did.", {"entities": []}], ["The rs1800469 genotypes in the TGFB1 gene were determined by polymerase chain reaction-restriction fragment length polymorphism.", {"entities": [[31, 36, "GENE"]]}], ["The genotype and allele frequencies of rs1800469 were not different between AF patients and controls of the Southeast Chinese population, Northeast Chinese population, and total Study Population.", {"entities": []}], ["After adjustment for age, sex, hypertension and LAD, there was no association between the rs1800469 polymorphism and the risk of AF under the dominant, recessive and additive genetic models.", {"entities": [[31, 43, "DISEASE"]]}], ["Similar results were obtained from subanalysis of the lone and paroxymal AF subgroups.", {"entities": []}], ["Our results do not support the role of the TGFB1 rs1800469 functional gene variant in the development of AF in the Chinese Han population.", {"entities": [[43, 48, "GENE"]]}], ["Air pollution by diesel exhaust particles is associated with elevated mortality and increased hospital admissions in individuals with respiratory diseases such as asthma and chronic obstructive pulmonary disease.", {"entities": [[174, 211, "DISEASE"], [163, 169, "DISEASE"]]}], ["During active inflammation monocytes are recruited to the airways and can replace resident alveolar macrophages.", {"entities": []}], ["We therefore investigated whether chronic fourteen day exposure to low concentrations of diesel exhaust particles can alter the phenotype and function of monocytes from healthy individuals and those with chronic obstructive pulmonary disease.", {"entities": [[204, 241, "DISEASE"]]}], ["Monocytes were purified from the blood of healthy individuals and people with a diagnosis of chronic obstructive pulmonary disease.", {"entities": [[93, 130, "DISEASE"]]}], ["Monocyte-derived macrophages were generated in the presence or absence of diesel exhaust particles and their phenotypes studied through investigation of their lifespan, cytokine generation in response to Toll like receptor agonists and heat killed bacteria, and expression of surface markers.", {"entities": []}], ["Chronic fourteen day exposure of monocyte-derived macrophages to concentrations of diesel exhaust particles >10 \u00b5g/ml caused mitochondrial and lysosomal dysfunction, and a gradual loss of cells over time both in healthy and chronic obstructive pulmonary disease individuals.", {"entities": [[224, 261, "DISEASE"]]}], ["Chronic exposure to lower concentrations of diesel exhaust particles impaired CXCL8 cytokine responses to lipopolysaccharide and heat killed E. coli , and this phenotype was associated with a reduction in CD14 and CD11b expression.", {"entities": [[205, 209, "GENE"]]}], ["Chronic diesel exhaust particle exposure may therefore alter both numbers and function of lung macrophages differentiating from locally recruited monocytes in the lungs of healthy people and patients with chronic obstructive pulmonary disease.", {"entities": [[205, 242, "DISEASE"]]}], ["Delivery arrangements include changes in who receives care and when, who provides care, the working conditions of those who provide care, coordination of care amongst different providers, where care is provided, the use of information and communication technology to deliver care, and quality and safety systems.", {"entities": []}], ["How services are delivered can have impacts on the effectiveness, efficiency and equity of health systems.", {"entities": []}], ["This broad overview of the findings of systematic reviews can help policymakers and other stakeholders identify strategies for addressing problems and improve the delivery of services.", {"entities": []}], ["To provide an overview of the available evidence from up-to-date systematic reviews about the effects of delivery arrangements for health systems in low-income countries.", {"entities": []}], ["Secondary objectives include identifying needs and priorities for future evaluations and systematic reviews on delivery arrangements and informing refinements of the framework for delivery arrangements outlined in the review.", {"entities": []}], ["We searched Health Systems Evidence in November 2010 and PDQ-Evidence up to 17 December 2016 for systematic reviews.", {"entities": []}], ["We did not apply any date, language or publication status limitations in the searches.", {"entities": []}], ["We included well-conducted systematic reviews of studies that assessed the effects of delivery arrangements on patient outcomes (health and health behaviours), the quality or utilisation of healthcare services, resource use, healthcare provider outcomes (such as sick leave), or social outcomes (such as poverty or employment) and that were published after April 2005.", {"entities": []}], ["We excluded reviews with limitations important enough to compromise the reliability of the findings.", {"entities": []}], ["Two overview authors independently screened reviews, extracted data, and assessed the certainty of evidence using GRADE.", {"entities": []}], ["We prepared SUPPORT Summaries for eligible reviews, including key messages, 'Summary of findings' tables (using GRADE to assess the certainty of the evidence), and assessments of the relevance of findings to low-income countries.", {"entities": []}], ["We identified 7272 systematic reviews and included 51 of them in this overview.", {"entities": []}], ["We judged 6 of the 51 reviews to have important methodological limitations and the other 45 to have only minor limitations.", {"entities": []}], ["We grouped delivery arrangements into eight categories.", {"entities": []}], ["Some reviews provided more than one comparison and were in more than one category.", {"entities": []}], ["Across these categories, the following intervention were effective; that is, they have desirable effects on at least one outcome with moderate- or high-certainty evidence and no moderate- or high-certainty evidence of undesirable effects.", {"entities": []}], ["Who receives care and when : queuing strategies and antenatal care to groups of mothers.", {"entities": []}], ["Who provides care : lay health workers for caring for people with hypertension, lay health workers to deliver care for mothers and children or infectious diseases, lay health workers to deliver community-based neonatal care packages, midlevel health professionals for abortion care, social support to pregnant women at risk, midwife-led care for childbearing women, non-specialist providers in mental health and neurology, and physician-nurse substitution.", {"entities": [[66, 78, "DISEASE"]]}], ["Coordination of care : hospital clinical pathways, case management for people living with HIV and AIDS, interactive communication between primary care doctors and specialists, hospital discharge planning, adding a service to an existing service and integrating delivery models, referral from primary to secondary care, physician-led versus nurse-led triage in emergency departments, and team midwifery.", {"entities": []}], ["Where care is provided : high-volume institutions, home-based care (with or without multidisciplinary team) for people living with HIV and AIDS, home-based management of malaria, home care for children with acute physical conditions, community-based interventions for childhood diarrhoea and pneumonia, out-of-facility HIV and reproductive health services for youth, and decentralised HIV care.", {"entities": [[292, 301, "DISEASE"], [170, 177, "DISEASE"]]}], ["Information and communication technology : mobile phone messaging for patients with long-term illnesses, mobile phone messaging reminders for attendance at healthcare appointments, mobile phone messaging to promote adherence to antiretroviral therapy, women carrying their own case notes in pregnancy, interventions to improve childhood vaccination.", {"entities": []}], ["Quality and safety systems : decision support with clinical information systems for people living with HIV/AIDS.", {"entities": []}], ["Complex interventions (cutting across delivery categories and other health system arrangements): emergency obstetric referral interventions.", {"entities": []}], ["A wide range of strategies have been evaluated for improving delivery arrangements in low-income countries, using sound systematic review methods in both Cochrane and non-Cochrane reviews.", {"entities": []}], ["These reviews have assessed a range of outcomes.", {"entities": []}], ["Most of the available evidence focuses on who provides care, where care is provided and coordination of care.", {"entities": []}], ["For all the main categories of delivery arrangements, we identified gaps in primary research related to uncertainty about the applicability of the evidence to low-income countries, low- or very low-certainty evidence or a lack of studies.", {"entities": []}], ["What is the aim of this overview?", {"entities": []}], ["The aim of this Cochrane Overview is to provide a broad summary of what is known about the effects of delivery arrangements for health systems in low-income countries.", {"entities": []}], ["This overview is based on 51 systematic reviews.", {"entities": []}], ["These systematic reviews searched for studies that evaluated different types of delivery arrangements.", {"entities": []}], ["The reviews included a total of 850 studies.", {"entities": []}], ["This overview is one of a series of four Cochrane Overviews that evaluate health system arrangements.", {"entities": []}], ["What was studied in the overview?", {"entities": []}], ["Delivery arrangements include changes in who receives care and when, who provides care, the working conditions of those who provide care, coordination of care amongst different health care providers, where care is provided, the use of information and communication technology to deliver care, and quality and safety systems.", {"entities": []}], ["How services are delivered can have impacts on the effectiveness, efficiency and equity of health systems.", {"entities": []}], ["This overview can help policymakers and other stakeholders to identify evidence-informed strategies to improve the delivery of services.", {"entities": []}], ["What are the main results of the overview?", {"entities": []}], ["When focusing only on evidence assessed as high to moderate certainty, the overview points to a number of delivery arrangements that had at least one desirable outcome and no evidence of any undesirable outcomes.", {"entities": []}], ["These include the following: Who receives care and when - Queuing strategies - Group antenatal care Who provides care \u2013 role expansion or task shifting - Lay or community health workers supporting the care of people with hypertension - Community-based neonatal packages that include additional training of outreach workers - Lay health workers to deliver care for mothers and children or for infectious diseases - Mid-level, non-physician providers for abortion care - Health workers providing social support during at-risk pregnancies - Midwife-led care for childbearing women and their infants - Non-specialist health workers or other professionals with health roles to help people with mental, neurological and substance-abuse disorders - Nurses substituting for physicians in providing care Coordination of care - Structured multidisciplinary care plans (care pathways) used by health care providers in hospitals to detail essential steps in the care of people with a specific clinical problem - Interactive communication between collaborating primary care physicians and specialist physicians in outpatient care - Planning to facilitate patients\u2019 discharge from hospital to home - Adding a new health service to an existing service and integrating services in health care delivery - Integrating vaccination with other healthcare services - Using physicians rather than nurses to lead triage in emergency departments - Groups or teams of midwives providing care for a group of women during pregnancy and childbirth and after childbirth Where care is provided \u2013 site of service delivery - Clinics or hospitals that manage a high volume of people living with HIV and AIDS rather than smaller volumes - Intensive home-based care for people living with HIV and AIDS - Home-based management of malaria in children - Providing care closer to home for children with long-term health conditions - Community-based interventions using lay health workers for childhood diarrhoea and pneumonia - Youth HIV and reproductive health services provided outside of health facilities - Decentralising care for initiation and maintenance of HIV and AIDS medicine treatment to peripheral health centres or lower levels of healthcare Information and communication technology - Mobile phone messaging for people with long-term illnesses - Mobile phone messaging reminders for attendance at healthcare appointments - Mobile phone messaging to promote adherence to antiretroviral therapy - Women carrying their own case notes in pregnancy - Information and communication interventions to improve childhood vaccination coverage Quality and safety systems - Establishing clinical information systems to organize patient data for people living with HIV and AIDS Packages that include multiple interventions - Interventions to improve referral for emergency care during pregnancy and childbirth How up to date is this overview?", {"entities": [[221, 233, "DISEASE"], [1976, 1985, "DISEASE"], [1793, 1800, "DISEASE"]]}], ["The overview authors searched for systematic reviews that had been published up to 17 December 2016.", {"entities": []}], ["The rapid increase in metabolic diseases, which occurred in the last three decades in both industrialized and developing countries, has been related to the rise in sugar-added foods and sweetened beverages consumption.", {"entities": []}], ["An emerging topic in the pathogenesis of metabolic diseases related to modern nutrition is the role of Advanced Glycation Endproducts (AGEs).", {"entities": []}], ["AGEs can be ingested with high temperature processed foods, but also endogenously formed as a consequence of a high dietary sugar intake.", {"entities": []}], ["Animal models of high sugar consumption, in particular fructose, have reported AGE accumulation in different tissues in association with peripheral insulin resistance and lipid metabolism alterations.", {"entities": []}], ["The in vitro observation that fructose is one of the most rapid and effective glycating agents when compared to other sugars has prompted the investigation of the in vivo fructose-induced glycation.", {"entities": []}], ["In particular, the widespread employment of fructose as sweetener has been ascribed by many experimental and observational studies for the enhancement of lipogenesis and intracellular lipid deposition.", {"entities": []}], ["Indeed, diet-derived AGEs have been demonstrated to interfere with many cell functions such as lipid synthesis, inflammation, antioxidant defences, and mitochondrial metabolism.", {"entities": []}], ["Moreover, emerging evidence also in humans suggest that this impact of dietary AGEs on different signalling pathways can contribute to the onset of organ damage in liver, skeletal and cardiac muscle, and the brain, affecting not only metabolic control, but global health.", {"entities": []}], ["Indeed, the most recent reports on the effects of high sugar consumption and diet-derived AGEs on human health reviewed here suggest the need to limit the dietary sources of AGEs, including added sugars, to prevent the development of metabolic diseases and related comorbidities.", {"entities": []}], ["Immunization offers the best protection from influenza infection.", {"entities": [[45, 54, "DISEASE"]]}], ["Little evidence describes disparities in immunization uptake among low-income individuals.", {"entities": []}], ["Higher rates of chronic disease put this population at increased risk of influenza-related complications.", {"entities": [[73, 82, "DISEASE"]]}], ["This analysis examines if the type of main source of household income in low-income groups affects influenza immunization uptake.", {"entities": [[99, 108, "DISEASE"]]}], ["We hypothesized that individuals on social assistance have less access to immunization compared to those with employment earnings or seniors\u2019 benefits.", {"entities": []}], ["Data was obtained from the Canadian Community Health Survey annual component 2009-2010.", {"entities": []}], ["A total of 10,373 low-income respondents (<20,000$ Canadian per annum) were included.", {"entities": []}], ["Logistic regression, stratified according to type of provincial publicly funded immunization program, was used to examine the association between influenza immunization (in the last 12 months) and main source of household income (employment earnings; social assistance as a combination of employment insurance or worker\u2019s compensation or welfare; or seniors\u2019 benefits).", {"entities": [[146, 155, "DISEASE"]]}], ["Overall, 32.5% of respondents reported receiving influenza immunization.", {"entities": [[49, 58, "DISEASE"]]}], ["In multivariable analysis of universal publicly funded influenza immunization programs, those reporting social assistance (AOR 1.24, 95% CI 1.02-1.51) or seniors\u2019 benefits (AOR 1.56, 95% CI 1.23-1.98) were more likely to be immunized compared to those reporting employment earnings.", {"entities": [[55, 64, "DISEASE"]]}], ["Similar results were observed for high-risk programs.", {"entities": []}], ["Among the low-income sample, overall influenza immunization coverage is low.", {"entities": [[37, 46, "DISEASE"]]}], ["Those receiving social assistance or seniors\u2019 benefits may have been targeted due to higher rates of chronic disease.", {"entities": []}], ["Programs reaching the workforce may be important to attain broader coverage.", {"entities": []}], ["However, CCHS data was collected during the H1N1 pandemic influenza, thus results may not be generalizable to influenza immunization in non-pandemic years.", {"entities": [[58, 67, "DISEASE"], [110, 119, "DISEASE"]]}], ["Julian Little and colleagues present the STREGA recommendations, which are aimed at improving the reporting of genetic association studies.", {"entities": []}], ["Inhibitors of vascular endothelial growth factor and its receptors (VEGFRs) are attractive therapeutic candidates for cancer treatment.", {"entities": [[118, 124, "DISEASE"]]}], ["One such small molecule VEGFR inhibitor, SU5416, limits angiogenesis in vivo and is widely used for investigating VEGFR signaling in tumor pathophysiology.", {"entities": []}], ["Herein, we describe novel actions of SU5416 on the immune system.", {"entities": []}], ["Treatment of mice with SU5416 for 3 days induced significant reductions in size and cellularity of peripheral lymph nodes.", {"entities": []}], ["Interestingly, SU5416 did not affect initial lymphocyte localization to peripheral lymph nodes but did reduce lymphocyte accumulation during long-term migration assays.", {"entities": []}], ["Treatment with SU5416 also induced severe loss of double-positive thymocytes resulting in thymic atrophy and a reduction in peripheral B cells.", {"entities": []}], ["Furthermore, immune responses following immunization were reduced in mice treated with SU5416.", {"entities": []}], ["Findings of thymic atrophy and reduced weight gain during SU5416 treatment suggested elevated corticosterone levels.", {"entities": []}], ["Indeed, a significant 5-fold increase in serum corticosterone was found 4 hours after treatment with SU5416.", {"entities": []}], ["Importantly, adrenalectomy negated the effects of SU5416 treatment on primary immune tissues, and partial reversal of SU5416-induced changes was observed following blockade of glucocorticoid receptors.", {"entities": []}], ["SU5416 has been reported to inhibit the activation of latent transforming growth factor (TGF)-\u03b2, a cytokine involved in the regulation of glucocorticoid release by the adrenal glands.", {"entities": []}], ["Interestingly, treatment with a TGF-\u03b2 receptor inhibitor, showed a similar phenotype as SU5416 treatment, including elevated serum corticosterone levels and thymic atrophy.", {"entities": []}], ["Therefore, these results suggest that SU5416 induces glucocorticoid release directly from the adrenal glands, possibly by inhibition of TGF-\u03b2 activation.", {"entities": []}], ["In this study, we tested the hypothesis that exposure to diesel exhaust particles (DEP) may increase susceptibility of the host to pulmonary infection.", {"entities": []}], ["Male Sprague-Dawley rats received a single dose of DEP (5 mg/kg), carbon black (CB, 5 mg/kg), or saline intratracheally.", {"entities": []}], ["Three days later, the rats were inoculated intratracheally with approximately 5,000 Listeria monocytogenes and sacrificed at 3, 5, and 7 days postinfection, and we determined the number of viable Listeria in the left lobe of lungs.", {"entities": []}], ["The remaining lungs underwent bronchoalveolar lavage (BAL) and the retrieved BAL cells were identified and counted.", {"entities": []}], ["Luminol-dependent chemiluminescence, a measure of reactive oxygen species (ROS) formation, generated by BAL cells was monitored and the levels of nitric oxide and tumor necrosis factor (TNF)-[alpha] produced by macrophages in culture were determined.", {"entities": [[186, 189, "GENE"]]}], ["At 7 days postinfection, we excised the lung-draining lymph nodes and phenotyped the lymphocyte subpopulations.", {"entities": []}], ["Exposure of rats to DEP, but not to CB, decreased the clearance of Listeria from the lungs.", {"entities": []}], ["Listeria-induced generation of luminol-dependent chemiluminescence by pulmonary phagocytes decreased by exposure to DEP but not CB.", {"entities": []}], ["Similarly, Listeria-induced production of NO by alveolar macrophages was negated at 3, 5, and 7 days after inoculation in DEP-exposed rats.", {"entities": []}], ["In contrast, CB exposure had no effect on Listeria-induced NO production at 3 days after infection and had a substantially smaller effect than DEP at later days.", {"entities": []}], ["Exposure to DEP or CB resulted in enlarged lung-draining lymph nodes and increased the number and percentage of CD4(+) and CD8(+) T cells.", {"entities": [[112, 115, "GENE"]]}], ["These results showed that exposure to DEP decreased the ability of macrophages to produce antimicrobial oxidants in response to Listeria, which may play a role in the increased susceptibility of rats to pulmonary infection.", {"entities": []}], ["This DEP-induced suppression is caused partially by chemicals adsorbed onto the carbon core of DEP, because impaired macrophage function and decreased Listeria clearance were not observed following exposure to CB.", {"entities": []}], ["Past studies reported evidence of associations between air pollution and respiratory symptoms and morbidity for children.", {"entities": []}], ["Few studies examined associations between air pollution and emergency room (ER) visits for wheezing, and even fewer for gastroenteric illness.", {"entities": []}], ["We conducted a multicity analysis of the relationship between air pollution and ER visits for wheezing and gastroenteric disorder in children 0\u20132 years of age.", {"entities": []}], ["We obtained ER visit records for wheezing and gastroenteric disorder from six Italian cities.", {"entities": []}], ["A city-specific case\u2013crossover analysis was applied to estimate effects of particulate matter (PM), nitrogen dioxide, sulfur dioxide, ozone, and carbon monoxide, adjusting for immediate and delayed effects of temperature.", {"entities": []}], ["Lagged effects of air pollutants up to 6 prior days were examined.", {"entities": []}], ["The city-specific results were combined using a random-effect meta-analysis.", {"entities": []}], ["CO and SO 2 were most strongly associated with wheezing, with a 2.7% increase [95% confidence interval (CI), 0.5\u20134.9] for a 1.04-\u03bcg/m 2 .", {"entities": []}], ["Positive associations were also found for PM with aerodynamic diameter \u2264 10 \u03bcg and NO 2 .", {"entities": []}], ["We found a significant association between the 3-day moving average CO and gastroenteric disorders [3.8% increase (95% CI, 1.0\u20136.8)].", {"entities": []}], ["When data were stratified by season, the associations were stronger in summer for wheezing and in winter for gastroenteric disorders.", {"entities": []}], ["Air pollution is associated with triggering of wheezing and gastroenteric disorders in children 0\u20132 years of age; more work is needed to understand the mechanisms to help prevent wheezing in children.", {"entities": []}], ["Somatic disorders occur more often in adult psychiatric patients than in the general adult population.", {"entities": []}], ["However, in child and adolescent psychiatry this association is unclear, mainly due to a lack of integration of existing data.", {"entities": []}], ["To address this issue, we here present a systematic review on medical comorbidity in the two major developmental disorders autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) and formulate clinical recommendations.", {"entities": [[158, 198, "DISEASE"], [123, 147, "DISEASE"]]}], ["The literature was searched using the PubMed and PsycINFO databases (2000\u20131 May 2016) with the keywords \u201c[((child and adolescent) AND (Autism OR Attention Deficit Hyperactivity Disorder* OR ADHD)) AND (\u201cCardiovascular Diseases\u201d [Mesh] OR \u201cEndocrine System Diseases\u201d [Mesh] OR \u201cImmune System Diseases\u201d [Mesh] OR \u201cNeurobehavioral Manifestations\u201d [Mesh] OR \u201cGastrointestinal Disorders\u201d [Mesh] OR Somatic OR Autoimmune disease OR Nervous system disease OR Infection OR Infectious disease)].", {"entities": [[145, 185, "DISEASE"]]}], ["Two raters independently assessed the quality of the eligible studies.", {"entities": []}], ["The initial search identified 5278 articles.", {"entities": []}], ["Based on inclusion and exclusion criteria 104 papers were selected and subsequently subjected to a quality control.", {"entities": []}], ["This quality was assessed according to a standardized and validated set of criteria and yielded 29 studies for inclusion.", {"entities": []}], ["This thorough literature search provides an overview of relevant articles on medical comorbidity in ADHD and/or ASD, and shows that medical disorders in these children and adolescents appear to be widespread.", {"entities": []}], ["Those who work with children with ASD and/or ADHD should be well aware of this and actively promote routine medical assessment.", {"entities": []}], ["Additionally, case\u2013control studies and population-based studies are needed to provide reliable prevalence estimates.", {"entities": []}], ["Future studies should furthermore focus on a broader evaluation of medical disorders in children and adolescents with ADHD and/or ASD to improve treatment algorithm in this vulnerable group.", {"entities": []}], ["We spend most of our lives in indoor environments and are exposed to microbes present in these environments.", {"entities": []}], ["Hence, knowledge about this exposure is important for understanding how it impacts on human health.", {"entities": []}], ["However, the bacterial flora in indoor environments has been only fragmentarily explored and mostly using culture methods.", {"entities": []}], ["The application of molecular methods previously utilised in other environments has resulted in a substantial increase in our awareness of microbial diversity.", {"entities": []}], ["The composition and dynamics of indoor dust bacterial flora were investigated in two buildings over a period of one year.", {"entities": []}], ["Four samples were taken in each building, corresponding to the four seasons, and 16S rDNA libraries were constructed.", {"entities": []}], ["A total of 893 clones were analysed and 283 distinct operational taxonomic units (OTUs) detected among them using 97% sequence similarity as the criterion.", {"entities": []}], ["All libraries were dominated by Gram-positive sequences, with the most abundant phylum being Firmicutes .", {"entities": []}], ["Four OTUs having high similarity to Corynebacterium -, Propionibacterium -, Streptococcus - and Staphylococcus - sequences were present in all samples.", {"entities": []}], ["The most abundant of the Gram-negative OTUs were members of the family Sphingomonadaceae , followed by Oxalobacteraceae , Comamonadaceae , Neisseriaceae and Rhizobiaceae .", {"entities": []}], ["The relative abundance of alpha- and betaproteobacteria increased slightly towards summer at the expense of firmicutes.", {"entities": []}], ["The proportion of firmicutes and gammaproteobacteria of the total diversity was highest in winter and that of actinobacteria, alpha- and betaproteobacteria in spring or summer, whereas the diversity of bacteroidetes peaked in fall.", {"entities": []}], ["A statistical comparison of the libraries revealed that the bacterial flora of the two buildings differed during all seasons except spring, but differences between seasons within one building were not that clear, indicating that differences between the buildings were greater than the differences between seasons.", {"entities": []}], ["This work demonstrated that the bacterial flora of indoor dust is complex and dominated by Gram-positive species.", {"entities": []}], ["The dominant phylotypes most probably originated from users of the building.", {"entities": []}], ["Seasonal variation was observed as proportional changes of the phyla and at the species level.", {"entities": []}], ["The microflora of the two buildings investigated differed statistically and differences between the buildings were more pronounced than differences between seasons.", {"entities": []}], ["FTY720, a new chemical substance derived from the ascomycete Isaria sinclairii , is used for treating multiple sclerosis, renal cancer, and asthma.", {"entities": [[102, 120, "DISEASE"], [140, 146, "DISEASE"], [128, 134, "DISEASE"]]}], ["Sphingosine 1-phosphate (S1P) is a bioactive sphingolipid metabolite and exists in red blood cells.", {"entities": []}], ["FTY720 is a synthetic S1P analog which can block S1P evoking physiological effects.", {"entities": []}], ["Recently studies show that S1P was participating in activated inflammation cells induced renal injury.", {"entities": []}], ["The objective of this study was to assess the protective effect of FTY720 on kidney damage and the potential mechanism of FTY720 which alleviate podocyte injury in chronic kidney disease.", {"entities": [[172, 186, "DISEASE"]]}], ["In this study, we selected 40 patients with IgA nephropathy and examined their clinical characteristics.", {"entities": []}], ["Ang II-infusion rat renal injury model was established to evaluate the glomeruli and tubulointerstitial lesion.", {"entities": [[0, 3, "GENE"]]}], ["The result showed that the concentration of S1P in serum and urine was positively correlated with IgA nephropathy patients' renal injury.", {"entities": []}], ["FTY720 could reduce renal histological lesions induced by Ang II-infusion in rats.", {"entities": [[58, 61, "GENE"]]}], ["Moreover, FTY720 decreased S1P synthesis in Ang II-infusion rats via downregulation of inflammatory cytokines including TNF- \u03b1 and IL-6.", {"entities": [[44, 47, "GENE"]]}], ["In addition, FTY720 alleviated exogenous S1P-induced podocyte damage.", {"entities": []}], ["In conclusion, FTY720 is able to attenuate S1P-induced podocyte damage via reducing inflammatory cytokines.", {"entities": []}], ["Human interleukin-26 induces Th17 cells, is over-expressed in rheumatoid arthritis, and is thus a promising therapeutic target in chronic inflammatory disease.", {"entities": [[62, 82, "DISEASE"], [73, 82, "DISEASE"]]}], ["Interleukin-26 (IL-26), a member of the IL-10 cytokine family, induces the production of proinflammatory cytokines by epithelial cells.", {"entities": []}], ["IL-26 has been also reported overexpressed in Crohn's disease, suggesting that it may be involved in the physiopathology of chronic inflammatory disorders.", {"entities": []}], ["Here, we have analyzed the expression and role of IL-26 in rheumatoid arthritis (RA), a chronic inflammatory disorder characterized by joint synovial inflammation.", {"entities": [[59, 79, "DISEASE"], [70, 79, "DISEASE"]]}], ["We report that the concentrations of IL-26 are higher in the serums of RA patients than of healthy subjects and dramatically elevated in RA synovial fluids compared to RA serums.", {"entities": []}], ["Immunohistochemistry reveals that synoviolin", {"entities": []}], ["\"It is not the death of GERD that I seek, but that it turns from its evil ways and follows the path of righteousness.\"", {"entities": []}], ["The reflux world is fully aware of what GERD is and what GERD does.", {"entities": []}], ["What the world does not know, however, is the answer to the most important yet least asked question surrounding GERD's raison-d'etre: Why is GERD here and why do we have it?", {"entities": []}], ["What GERD is: abnormal gastric reflux into the esophagus that causes any type of mischief.", {"entities": []}], ["What GERD does: causes discomfort and/or pain with or without destroying the mucosa; causes stricture or stenosis, preventing food from being swallowed; sets the stage for the development of esophageal adenocarcinoma; invades the surrounding lands to harass the peaceful oropharyngeal, laryngeal and broncho-pulmonary territories; reminds us that we are not only human, but that we are dust and ashes.", {"entities": [[202, 216, "DISEASE"]]}], ["Why GERD is here: We propose three separate and distinct etiologies of GERD, and we offer the following three hypotheses to explain why, after 1.5 million years of standing erect, we have evolved into a species (specifically Homosapiens sapiens) that is destined to live with the scourge of GERD.", {"entities": []}], ["Hypothesis 1: congenital.", {"entities": []}], ["The antireflux barrier, comprising the smooth-muscled lower esophageal sphincter, the skeletal-muscled right crural diaphragm and the phreno-esophageal ligament does not completely develop due to a developmental anomaly or incomplete gestation.", {"entities": []}], ["Hypothesis 2: acute trauma: The antireflux barrier in adults suffering acute traumatic injury to the abdomen or chest is permanently disrupted by unexpected forces, such as motor vehicle accidents (with steering wheel crush impact), blows to the abdomen (from activities such as boxing, etc.", {"entities": []}], ["), heavy lifting or moving (e.g., pianos, refrigerators) or stress positions (e.g., hand stands on parallel gym bars).", {"entities": []}], ["The trauma creates a hiatal hernia that renders the antireflux mechanism useless and incapable of preventing GERD.", {"entities": []}], ["Hypothesis 3: chronic trauma: The antireflux barrier in children and adults is gradually weakened over time as a result of chronic straining to defecate and straining in an unphysiologic position, both of which stem from our modern day habits of eating a low-fiber diet and living on the high-seated toilet.", {"entities": []}], ["We suggest that the chronic traumatic hiatal hernia is (a) the cause of more than 90 percent of the GERD that stalks the Western world; (b) is a direct result of abandoning the popular and worldwide practice of squatting to socialize, eat and defecate; and (c) is our just reward for adopting the \"civilized\" high sitting position on chairs and modern toilets.", {"entities": []}], ["Inflammation increases during exacerbations of COPD, but only a few studies systematically assessed these changes.", {"entities": []}], ["Better identification of these changes will increase our knowledge and potentially guide therapy, for instance by helping with quicker distinction of bacterially induced exacerbations from other causes.", {"entities": []}], ["To identify which inflammatory parameters increase during COPD exacerbations compared to stable disease, and to compare bacterial and non-bacterial exacerbations.", {"entities": []}], ["In 45 COPD patients (37 male/8 female, 21 current smokers, mean age 65, FEV 1 52% predicted, pack years 38) sputum was collected during a stable phase and subsequently during an exacerbation.", {"entities": [[72, 75, "GENE"]]}], ["Sputum total cell counts (9.0 versus 7.9 \u00d7 10 Sputum eosinophil, neutrophil, and lymphocyte counts increase during COPD exacerbations.", {"entities": []}], ["The increase in systemic inflammation during exacerbations seems to be limited to exacerbations caused by bacterial infections of the lower airways.", {"entities": []}], ["Sputum TNF-\u03b1 is a candidate marker for predicting airway bacterial infection.", {"entities": []}], ["Recent epidemiological data suggest the relation between hearing difficulty and depression is more evident in younger and middle-aged populations than in older adults.", {"entities": []}], ["There are also suggestions that the relation may be more evident in specific subgroups; that is, other factors may influence a relationship between hearing and depression in different subgroups.", {"entities": []}], ["Using cross-sectional data from the UK Biobank on 134,357 community-dwelling people and structural equation modelling, this study examined the potential mediating influence of social isolation and unemployment and the confounding influence of physical illness and cardiovascular conditions on the relation between a latent hearing variable and both a latent depressive episodes variable and a latent depressive symptoms variable.", {"entities": []}], ["The models were stratified by age (40s, 50s, and 60s) and gender and further controlled for physical illness and professional support in associations involving social isolation and unemployment.", {"entities": []}], ["The latent hearing variable was primarily defined by reported hearing difficulty in noise.", {"entities": []}], ["For all subgroups, poor hearing was significantly related to both more depressive episodes and more depressive symptoms.", {"entities": []}], ["In all models, the direct and generally small association exceeded the indirect associations via physical health and social interaction.", {"entities": []}], ["Significant (depressive episodes) and near significant (depressive symptoms) higher direct associations were estimated for males in their 40s and 50s than for males in their 60s.", {"entities": []}], ["There was at each age-group no significant difference in estimated associations across gender.", {"entities": []}], ["Irrespective of the temporal order of variables, findings suggest that audiological services should facilitate psychosocial counselling.", {"entities": []}], ["\u201cCo-production\u201d is becoming an increasingly popular term in policymaking, governance, and research.", {"entities": []}], ["While the shift from engagement and involvement to co-production in health care holds the promise of revolutionising health services and research, it is not always evident what counts as co-production: what is being produced, under what circumstances, and with what implications for participants.", {"entities": []}], ["We discuss these questions and propose that co-production can be understood as an exploratory space and a generative process that leads to different, and sometimes unexpected, forms of knowledge, values, and social relations.", {"entities": []}], ["By opening up this discussion, we hope to stimulate future debates on co-production as well as draw out ways of thinking differently about collaboration and participation in health care and research.", {"entities": []}], ["Part of the title of this article is inspired by the book \u201cThe Social Construction of What?\u201d by Ian Hacking (Cambridge, MA: Harvard University Press; 2000).", {"entities": []}], ["Risk stratification methods developed on the basis of predicting illness severity are often used to prioritise patients on the basis of urgency.", {"entities": []}], ["Illness severity and urgency may not be interchangeable.", {"entities": []}], ["Severe illness places patients at risk of adverse outcome, but treatment is only urgent if adverse outcome can be prevented by time-sensitive treatment.", {"entities": []}], ["We aimed to develop a score to identify patients in need of urgent treatment, on the basis of potential to benefit from time-sensitive intervention, and to compare this with a severity score identifying patients at high risk of death.", {"entities": []}], ["A sequential cohort of adults presenting to one Emergency Department by ambulance and admitted to hospital was prospectively collected (2437 derivation, 2322 validation).", {"entities": []}], ["Data on outcomes representing potential to benefit was collected retrospectively on a random subset (398 derivation, 227 validation).", {"entities": []}], ["Logistic regression identified variables predictive of death and potential to benefit from urgent treatment.", {"entities": []}], ["Death was predicted using age, respiratory rate, diastolic blood pressure, oxygen saturations, temperature, GCS and respiratory disease (AUROC 0.84 (95\u00a0% CI 0.8\u20130.89) derivation and 0.74 (0.69\u20130.81) validation), while potential to benefit was predicted by pulse, systolic blood pressure and GCS (AUROC 0.74 (0.67\u20130.80) derivation and 0.71 (0.59\u20130.82) validation).", {"entities": []}], ["A score developed to predict the need for urgent treatment has a different composition to a score developed to predict illness severity, suggesting that triage methods based on predicting severity could lead to inappropriate prioritisation on the intended basis of urgency.", {"entities": []}], ["The online version of this article (doi:10.1186/s13049-015-0150-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The efficacy of low-dose medicine (LDM) in childhood mild/moderate eczema is not known.", {"entities": []}], ["We conducted a double-blind, two-stage, randomized, placebo-controlled clinical trial, lasting 23 months, to address this issue.", {"entities": []}], ["Eighty children with chronic mild/moderate eczema were randomly allocated to Group A (placebo) or Group B (treatment group; Galium-Heel\u00ae, a low-dose multicomponent medicine based upon natural substances; Guna-Interleukin 12 and Guna-Interferon-\u03b3 administered twice a day for six non-consecutive months for each stage).", {"entities": []}], ["LDM is characterized by the use of biological molecules, such as cytokines, neuropeptides, growth factors, hormones at very low concentrations, which correspond to physiological levels within the human body.", {"entities": []}], ["The dosage of the cytokines used in this trial (IFN-\u03b3 and IL-12) is 10 fg/ml.", {"entities": []}], ["The SCORAD index was evaluated by the same operator: subjects with a SCORAD index below 20 were considered to have mild eczema (61/80; mean: 10.79), whereas a SCORAD index between 20\u201350 indicated moderate eczema (19/80; mean: 26.84).", {"entities": []}], ["The data of 66/80 children were analyzed in stage 1 and those of 62/66 children in stage 2.", {"entities": []}], ["The primary outcome measure was reduction of eczema severity assessed by the SCORAD index.", {"entities": []}], ["Secondary outcomes were disease-free interval, and treatment safety and tolerability.", {"entities": []}], ["The decrease in disease severity was greater in Group B than in Group A already in stage 1 (a decrease 63.9% versus 53.2%), but the difference was not significant ( p = 0.16).", {"entities": []}], ["Moreover, subjective symptoms (itching and sleep disturbances) initially decreased and then worsened in Group A, whereas itching decreased linearly and sleep disturbances decreased significantly ( p =0.049) in Group B.", {"entities": []}], ["Preliminary evidence suggests potential benefit, but further work is needed to validate this approach.", {"entities": []}], ["The trial was registered with EudraCT number 2010\u2013018640-13 through the database of the National Clinical Trials Monitoring Centre Database (Osservatorio delle Sperimentazioni Cliniche, OsSC) of the Italian Medicines Agency.", {"entities": []}], ["Activation of receptors for growth factors on lung epithelial cells is essential for transformation into tumor cells, supporting their viability and proliferation.", {"entities": []}], ["In most lung cancer patients, EGFR is constitutively activated without evidence of mutation.", {"entities": [[8, 19, "DISEASE"], [13, 19, "DISEASE"], [30, 34, "GENE"]]}], ["Defining mechanisms for constitutive activation of EGFR could elucidate additional targets for therapy of lung cancers.", {"entities": [[51, 55, "GENE"]]}], ["The approach was to identify lung cancer cell lines with constitutively activated EGFR and use systematic selection of inhibitors to evaluate their effects on specific EGFR phosphorylations and downstream signaling pathways.", {"entities": [[29, 40, "DISEASE"], [34, 40, "DISEASE"], [82, 86, "GENE"], [168, 172, "GENE"], [82, 86, "GENE"], [168, 172, "GENE"]]}], ["Interactions between receptors, kinases, and scaffolding proteins were investigated by co-immunoprecipitation plus Western blotting.", {"entities": []}], ["The results revealed a dependence on Src family of tyrosine kinases for downstream signaling and cell growth.", {"entities": [[37, 40, "GENE"]]}], ["Lyn, a Src family kinase functional in normal and malignant B-lymphocytes, was a defining signal transducer required for EGFR signaling in Calu3 cell line.", {"entities": [[0, 3, "GENE"], [7, 10, "GENE"], [121, 125, "GENE"]]}], ["Src family kinase activation in turn, was dependent on PKC\u00dfII.", {"entities": [[0, 3, "GENE"]]}], ["Lyn and PKC exist in membrane complexes of RACK1 and in association with EGFR which pairs with other receptor partners.", {"entities": [[0, 3, "GENE"], [73, 77, "GENE"]]}], ["Silencing of Lyn expression with interfering siRNA decreased EGFR activation and cell viability.", {"entities": [[13, 16, "GENE"], [61, 65, "GENE"]]}], ["The importance of Src family kinases and PKC\u00dfII in the initiation of the EGFR signaling pathway in lung tumor cells was demonstrated.", {"entities": [[18, 21, "GENE"], [73, 77, "GENE"]]}], ["We conclude that phosphorylation of EGFR is mediated through PKC\u00dfII regulation of Lyn activation, and occurs in association with RACK1 and Cbp/PAG proteins.", {"entities": [[36, 40, "GENE"], [82, 85, "GENE"]]}], ["We suggest that protein complexes in cell membranes, including lipid rafts, may serve as novel targets for combination therapies with EGFR and Src Family Kinase inhibitors in lung cancer.", {"entities": [[175, 186, "DISEASE"], [180, 186, "DISEASE"], [134, 138, "GENE"], [143, 146, "GENE"]]}], ["Recently, the importance of the lung microbiota during health and disease has been examined in humans and in small animal models.", {"entities": []}], ["Whilst sheep have been proposed as an appropriate large animal model for studying the pathophysiology of a number of important human respiratory diseases, it is clearly important to continually define the limits of agreement between these systems as new concepts emerge.", {"entities": []}], ["In humans, it has recently been established that the lung microbiota is seeded by microbes from the oral cavity.", {"entities": []}], ["We sought to determine whether the same was true in sheep.", {"entities": []}], ["We took lung fluid and upper aerodigestive tract (oropharyngeal) swab samples from 40 lambs (7\u00a0weeks old).", {"entities": []}], ["DNA extraction was performed, and the V2-V3 region of the 16S rRNA gene was amplified by PCR then sequenced via Illumina Miseq.", {"entities": []}], ["Oropharyngeal swabs were either dominated by bacteria commonly associated with the rumen or by bacteria commonly associated with the upper aerodigestive tract.", {"entities": []}], ["Lung microbiota samples did not resemble either the upper aerodigestive tract samples or reagent-only controls.", {"entities": []}], ["Some rumen-associated bacteria were found in lung fluids, indicating that inhalation of ruminal bacteria does occur.", {"entities": []}], ["We also identified several bacteria which were significantly more abundant in lung fluids than in the upper aerodigestive tract swabs, the most predominant of which was classified as Staphylococcus equorum .", {"entities": []}], ["In contrast to humans, we found that the lung microbiota of lambs is dissimilar to that of the upper aerodigestive tract, and we suggest that this may be related to physiological and anatomical differences between sheep and humans.", {"entities": []}], ["Understanding the comparative physiology and anatomy underlying differences in lung microbiota between species will provide a foundation upon which to interpret changes associated with disease and/or environment.", {"entities": []}], ["The online version of this article (10.1186/s40168-017-0364-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Rhinovirus (RV) is the most prevalent human respiratory virus and is responsible for at least half of all common colds.", {"entities": []}], ["RV infections may result in a broad spectrum of effects that range from asymptomatic infections to severe lower respiratory illnesses.", {"entities": []}], ["The basis for inter-individual variation in the response to RV infection is not well understood.", {"entities": []}], ["In this study, we explored whether host genetic variation is associated with variation in gene expression response to RV infections between individuals.", {"entities": []}], ["To do so, we obtained genome-wide genotype and gene expression data in uninfected and RV-infected peripheral blood mononuclear cells (PBMCs) from 98 individuals.", {"entities": []}], ["We mapped local and distant genetic variation that is associated with inter-individual differences in gene expression levels (eQTLs) in both uninfected and RV-infected cells.", {"entities": []}], ["We focused specifically on response eQTLs (reQTLs), namely, genetic associations with inter-individual variation in gene expression response to RV infection.", {"entities": []}], ["We identified local reQTLs for 38 genes, including genes with known functions in viral response ( UBA7 , OAS1 , IRF5 ) and genes that have been associated with immune and RV-related diseases (e.g., ITGA2 , MSR1 , GSTM3 ).", {"entities": [[98, 102, "GENE"], [105, 109, "GENE"], [112, 116, "GENE"], [198, 203, "GENE"], [206, 210, "GENE"], [213, 218, "GENE"]]}], ["The putative regulatory regions of genes with reQTLs were enriched for binding sites of virus-activated STAT2, highlighting the role of condition-specific transcription factors in genotype-by-environment interactions.", {"entities": [[104, 109, "GENE"]]}], ["Overall, we suggest that the 38 loci associated with inter-individual variation in gene expression response to RV-infection represent promising candidates for affecting immune and RV-related respiratory diseases.", {"entities": []}], ["Rhinovirus (RV) is the predominant cause of the common cold.", {"entities": [[48, 59, "DISEASE"]]}], ["However, infections with RV result in a broad spectrum of effects ranging from asymptomatic infections to severe lower respiratory illnesses.", {"entities": []}], ["We hypothesized that diversity in response to RV-infections is, at least in part, due to variation in the host genome.", {"entities": []}], ["To address this, we mapped the genetic variations that are associated with gene expression response (reQTLs) to RV-infection in PBMCs.", {"entities": []}], ["Here, we report local reQTLs for 38 genes including those with known functions in viral response such as UBA7 , OAS1 , IRF5 and those that have been previously associated with immune and RV-related diseases (e.g., ITGA2 , MSR1 , GSTM3 ).", {"entities": [[105, 109, "GENE"], [112, 116, "GENE"], [119, 123, "GENE"], [214, 219, "GENE"], [222, 226, "GENE"], [229, 234, "GENE"]]}], ["We also show that reQTL regions are enriched for binding sites of the virus-activated STAT2 transcription factor, suggesting a potential mechanism of action for five of the reQTLs identified.", {"entities": [[86, 91, "GENE"]]}], ["Overall, the reQTLs we identified represent promising candidates to affect individual\u2019s immune response to RV infections and further targeted studies of the reQTL regions might lead to improved control and treatment of RV-associated immune and respiratory diseases.", {"entities": []}], ["The SNP309 polymorphism (T-G) in the promoter of MDM2 gene has been reported to be associated with enhanced MDM2 expression and tumor development.", {"entities": [[49, 53, "GENE"], [108, 112, "GENE"], [49, 53, "GENE"], [108, 112, "GENE"]]}], ["Studies investigating the association between MDM2 SNP309 polymorphism and endometrial cancer risk reported conflicting results.", {"entities": [[75, 93, "DISEASE"], [87, 93, "DISEASE"], [46, 50, "GENE"]]}], ["We performed a meta-analysis of all available studies to explore this association.", {"entities": []}], ["All studies published up to August 2013 on the association between MDM2 SNP309 polymorphism and endometrial cancer risk were identified by searching electronic databases PubMed, Web of Science, EMBASE, and Chinese Biomedical Literature database (CBM).", {"entities": [[96, 114, "DISEASE"], [108, 114, "DISEASE"], [67, 71, "GENE"]]}], ["The association between the MDM2 SNP309 polymorphism and endometrial cancer risk was assessed by odds ratios (ORs) together with their 95% confidence intervals (CIs).", {"entities": [[57, 75, "DISEASE"], [69, 75, "DISEASE"], [28, 32, "GENE"]]}], ["Eight case\u2013control studies with 2069 endometrial cancer cases and 4546 controls were identified.", {"entities": [[37, 55, "DISEASE"], [49, 55, "DISEASE"]]}], ["Overall, significant increase of endometrial cancer risk was found when all studies were pooled in the meta-analysis (GG vs. TT: OR\u2009=\u20091.464, 95% CI 1.246\u20131.721, P \u2009<\u20090.001; GG vs. TG\u2009+\u2009TT: OR\u2009=\u20091.726, 95% CI 1.251\u20132.380, P \u2009=\u20090.001; GG\u2009+\u2009TG vs. TT: OR\u2009=\u20091.169, 95% CI 1.048\u20131.304, P \u2009=\u20090.005).", {"entities": [[33, 51, "DISEASE"], [45, 51, "DISEASE"], [180, 182, "GENE"], [238, 240, "GENE"], [180, 182, "GENE"], [238, 240, "GENE"]]}], ["In subgroup analysis by ethnicity and HWE in controls, significant increase of endometrial cancer risks were observed in Caucasians and studies consistent with HWE.", {"entities": [[79, 97, "DISEASE"], [91, 97, "DISEASE"]]}], ["In subgroup analysis according to study quality, significant associations were observed in both high quality studies and low quality studies.", {"entities": []}], ["This meta-analysis suggests that MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility, especially in Caucasian populations.", {"entities": [[73, 91, "DISEASE"], [85, 91, "DISEASE"], [33, 37, "GENE"]]}], ["Further large and well-designed studies are needed to confirm this association.", {"entities": []}], ["Understanding chemokine interactions with glycosaminoglycans (GAG) is critical as these interactions have been linked to a number of inflammatory medical conditions, such as arthritis and asthma.", {"entities": [[174, 183, "DISEASE"], [188, 194, "DISEASE"]]}], ["To better characterize in vivo protein function, comprehensive knowledge of multimeric species, formed by chemokines under native conditions, is necessary.", {"entities": []}], ["Herein is the first report of a tetrameric assembly of the human chemokine CCL11, which was shown bound to the GAG Arixtra\u2122.", {"entities": [[75, 80, "GENE"]]}], ["Isothermal titration calorimetry data indicated that CCL11 interacts with Arixtra, and ion mobility mass spectrometry (IM-MS) was used to identify ions corresponding to the CCL11 tetrameric species bound to Arixtra.", {"entities": [[53, 58, "GENE"], [173, 178, "GENE"], [53, 58, "GENE"], [173, 178, "GENE"]]}], ["Collisional cross sections (CCS) of the CCL11 tetramer-Arixtra noncovalent complex were compared to theoretical CCS values calculated using a preliminary structure of the complex deduced using X-ray crystallography.", {"entities": [[28, 31, "GENE"], [112, 115, "GENE"], [40, 45, "GENE"], [28, 31, "GENE"], [112, 115, "GENE"]]}], ["Experimental CCS values were in agreement with theoretical values, strengthening the IM-MS evidence for the formation of the noncovalent complex.", {"entities": [[13, 16, "GENE"]]}], ["Tandem mass spectrometry data of the complex indicated that the tetramer-GAG complex dissociates into a monomer and a trimer-GAG species, suggesting that two CC-like dimers are bridged by Arixtra.", {"entities": []}], ["As development of chemokine inhibitors is of utmost importance to treatment of medical inflammatory conditions, these results provide vital insights into chemokine-GAG interactions.", {"entities": []}], ["Fibromyalgia, a potentially debilitating chronic pain syndrome of unknown etiology, may be characterized by inflammation.", {"entities": [[54, 62, "DISEASE"]]}], ["In this study, we investigated the relation of FMS to serum C-reactive protein (CRP) in a large population of adults (18+) and investigated the influence of other factors on this relationship, including BMI, comorbidities, as well as mood and sleep disturbance.", {"entities": [[80, 83, "GENE"]]}], ["Participants were 52,535 Ohio Valley residents (Fibromyalgia n \u00a0=\u00a01125).", {"entities": []}], ["All participants completed a comprehensive health survey (2005\u20132006) part of the C8 Health Project; serum levels of CRP were obtained, as was history of Fibromyalgia physician diagnosis.", {"entities": [[116, 119, "GENE"]]}], ["Logistic and linear regressions were used for this cross-sectional analysis.", {"entities": []}], ["Mean CRP was higher among participants reporting Fibromyalgia than those without (5.54\u00a0\u00b1\u00a09.8 vs.3.75\u00a0\u00b1\u00a07.2\u00a0mg/L, p \u00a0<\u00a0.0001)).", {"entities": [[5, 8, "GENE"]]}], ["CRP level showed a strong, positive association with FMS (unadjusted odds ratio (OR) for highest vs. lowest quartile\u00a0=\u00a02.5 (CI 2.1,3.0;p for trend\u00a0<\u00a0.0001)); adjustment for demographic and lifestyle factors attenuated but did not eliminate this association (AOR for highest vs. lowest quartile\u00a0=\u00a01.4 (CI 1.1,1.6;p for trend\u00a0<\u00a0.0001)).", {"entities": [[0, 3, "GENE"]]}], ["Further addition of body mass index (BMI) and comorbidities to the model markedly weakened this relationship (AORs, respectively, for highest vs lowest CRP quartile\u00a0=\u00a01.2 (CI 1.0,1.4) and 1.1 (CI 0.9,1.3).", {"entities": [[152, 155, "GENE"]]}], ["In contrast, inclusion of mood and sleep impairment only modestly reduced the adjusted risk estimate (AORs for highest vs. lowest quartile\u00a0=\u00a01.3 (CI 1.1,1.5) for each)).", {"entities": []}], ["Findings from this large cross-sectional study indicate a significant positive cross-sectional association of Fibromyalgia to serum C-reactive protein may be explained, in part, by BMI and comorbidity.", {"entities": []}], ["Prospective research is needed to confirm this, and clarify the potential mediating influence of obesity and comorbid conditions on this relationship.", {"entities": [[97, 104, "DISEASE"]]}], ["Rosacea is a common, chronic inflammatory skin disease that can present with a variety of signs and symptoms.", {"entities": [[0, 7, "DISEASE"], [42, 54, "DISEASE"]]}], ["The potentially simultaneous occurrence of different signs and symptoms is due to different underlying inflammatory pathways, emphasizing the need for complementary treatment approaches.", {"entities": []}], ["Topical ivermectin cream (10\u00a0mg/g) and systemic, oral anti-inflammatory doxycycline (40 mg modified-release) are both approved for the treatment of papulopustular rosacea (PPR).", {"entities": [[163, 170, "DISEASE"]]}], ["Whether or not a combined therapeutic approach may be more beneficial than monotherapy for patients with PPR remains to be tested.", {"entities": []}], ["Here, we summarize underlying inflammatory pathways implicated in rosacea and clarify the impact of these two agents on selective pathways during inflammation, due to specific characteristics of their individual mechanisms of action (MoA).", {"entities": [[66, 73, "DISEASE"]]}], ["Based on the complementary MoA of doxycycline modified-release and ivermectin, a scientific rationale for a combined therapy targeting inflammatory lesions in rosacea is given.", {"entities": [[159, 166, "DISEASE"]]}], ["We propose that topical ivermectin cream is a promising new candidate as first-line treatment to target the inflammatory lesions of rosacea, which can be used in combination with systemic doxycycline modified-release to provide an optimal treatment approach considering all inflammatory pathways involved in PPR.", {"entities": [[132, 139, "DISEASE"]]}], ["Funding Galderma.", {"entities": []}], ["South Asians (Asian Indians and Pakistanis) are the second fastest growing ethnic group in the United States (U.S.) and have an increased risk of atherosclerotic cardiovascular disease (ASCVD).", {"entities": []}], ["This pilot study evaluated a culturally-salient, community-based healthy lifestyle intervention to reduce ASCVD risk among South Asians.", {"entities": []}], ["Through an academic-community partnership, medically underserved South Asian immigrants at risk for ASCVD were randomized into the South Asian Heart Lifestyle Intervention (SAHELI) study.", {"entities": []}], ["The intervention group attended 6 interactive group classes focused on increasing physical activity, healthful diet, weight, and stress management.", {"entities": []}], ["They also received follow-up telephone support calls.", {"entities": []}], ["The control group received translated print education materials about ASCVD and healthy behaviors.", {"entities": []}], ["Primary outcomes were feasibility and initial efficacy, measured as change in moderate/vigorous physical activity and dietary saturated fat intake at 3- and 6-months.", {"entities": []}], ["Secondary clinical and psychosocial outcomes were also measured.", {"entities": []}], ["Participants\u2019 ( n \u2009=\u200963) average age was 50 (SD\u2009=\u20098) years, 63 % were female, 27 % had less than or equal to a high school education, one-third were limited English proficient, and mean BMI was 30 kg/m2 (SD\u2009\u00b1\u20095).", {"entities": []}], ["There were no significant differences in change in physical activity or saturated fat intake between the intervention and control group.", {"entities": []}], ["Compared to the control group, the intervention group showed significant weight loss (\u22121.5 kg, p -value\u2009=\u20090.04) and had a greater sex-adjusted decrease in hemoglobin A1C (\u22120.43 %, p -value <0.01) at 6 months.", {"entities": []}], ["Study retention was 100 %.", {"entities": []}], ["This pilot study suggests that a culturally-salient, community-based lifestyle intervention was feasible for engaging medically underserved South Asian immigrants and more effective at addressing ASCVD risk factors than print health education materials.", {"entities": []}], ["NCT01647438 , Date of Trial Registration: July 19, 2012 The online version of this article (doi:10.1186/s12889-015-2401-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["This review scopes the evidence on the effectiveness and cost-effectiveness of interventions to improve suboptimal use of medicines in order to determine the evidence gaps and help inform research priorities.", {"entities": []}], ["Systematic searches of the National Health Service (NHS) Economic Evaluation Database, the Cochrane Database of Systematic Reviews and the Database of Abstracts of Reviews of Effects.", {"entities": [[52, 55, "GENE"]]}], ["The majority of the studies evaluated interventions to improve adherence, inappropriate prescribing and prescribing errors.", {"entities": []}], ["Interventions tend to be specific to a particular stage of the pathway and/or to a particular disease and have mostly been evaluated for their effect on intermediate or process outcomes.", {"entities": []}], ["Medicines optimization offers an opportunity to improve health outcomes and efficiency of healthcare.", {"entities": []}], ["The available evidence is insufficient to assess the effectiveness and cost-effectiveness of interventions to address suboptimal medicine use in the UK NHS.", {"entities": [[152, 155, "GENE"]]}], ["Decision modelling, evidence synthesis and elicitation have the potential to address the evidence gaps and help prioritize research.", {"entities": []}], ["The glucocorticoid receptor (GR) is a ligand-regulated transcription factor that controls the expression of extensive gene networks, driving both up- and down-regulation.", {"entities": []}], ["GR utilizes multiple DNA-binding-dependent and -independent mechanisms to achieve context-specific transcriptional outcomes.", {"entities": []}], ["The DNA-binding-independent mechanism involves tethering of GR to the pro-inflammatory transcription factor activator protein-1 (AP-1) through protein-protein interactions.", {"entities": []}], ["This mechanism has served as the predominant model of GR-mediated transrepression of inflammatory genes.", {"entities": []}], ["However, ChIP-seq data have consistently shown GR to occupy AP-1 response elements (TREs), even in the absence of AP-1.", {"entities": []}], ["Therefore, the current model is insufficient to explain GR action at these sites.", {"entities": []}], ["Here, we show that GR regulates a subset of inflammatory genes in a DNA-binding-dependent manner.", {"entities": []}], ["Using structural biology and biochemical approaches, we show that GR binds directly to TREs via sequence-specific contacts to a GR-binding sequence (GBS) half-site found embedded within the TRE motif.", {"entities": []}], ["Furthermore, we show that GR-mediated transrepression observed at TRE sites to be DNA-binding-dependent.", {"entities": []}], ["This represents a paradigm shift in the field, showing that GR uses multiple mechanisms to suppress inflammatory gene expression.", {"entities": []}], ["This work further expands our understanding of this complex multifaceted transcription factor.", {"entities": []}], ["Diabetes is a growing health concern in developing countries, with Cameroon population having an estimated 6% affected.", {"entities": []}], ["Of note, hospital attendees appear to be increasing all over the country, with fluctuating numbers throughout the annual calendar.", {"entities": []}], ["The aim of the study was to investigate the relationship between diabete hospitalization admission rates and climate variations in Yaounde.", {"entities": []}], ["A retrospectively designed study was conducted in four health facilities of Yaounde (Central Hospital, University teaching hospital, Biyem-Assi and Djoungolo District Hospitals), using medical records from 2000 to 2008.", {"entities": []}], ["A relationship between diabetes (newly diagnosed diabetes patients or decompensated diabetics) hospitalization admissions and climate variations was determined using the \u201c2000\u20132008\u201d national meteorological database (precipitation and temperature).", {"entities": []}], ["The monthly medians of precipitation and temperature were 154mm and 25 \u00b0C, respectively.", {"entities": []}], ["The month of October received 239mm of precipitation.", {"entities": []}], ["The monthly medians of diabetic admissions rates (newly diagnosed or decompensated diabetes patients) were 262 and 72 respectively.", {"entities": []}], ["October received 366 newly diagnosed diabetics and 99 decompensated diabetics.", {"entities": []}], ["Interestingly, diabetic hospitalization admissions rates were higher during the rainy (51 %, 1633/3232) than the dry season, though the difference was non-significant.", {"entities": []}], ["The wettest month (October) reported the highest cases (10 %, 336/3232) corresponding to the month with the highest precipitation level (239mm).", {"entities": []}], ["Diabetes hospitalization admissions rates varied across health facilities [from 6 % (189/3232) in 2000 to 15 % (474/3232) in 2008].", {"entities": []}], ["Diabetes is an important epidemiological disease in the city of Yaounde.", {"entities": []}], ["The variation in the prevalence of diabetes is almost superimposed to that of precipitation; and the prevalence seems increasing during raining seasons in Yaound\u00e9.", {"entities": []}], ["The pre-nodal afferent lymph is the fluid which directly derives from the extracellular milieu from every parenchymal organ and, as it continues to circulate between the cells, it collects products deriving from the organ metabolism/catabolism.", {"entities": []}], ["A comprehensive qualitative and quantitative investigation of the self-antigenic repertoire transported by the human lymph is still missing.", {"entities": []}], ["A major difference between lymph and plasma could be visualized by FPLC and 2D gel in the amount of low molecular weight products corresponding to peptide fragments.", {"entities": []}], ["Naturally processed peptides in normal pre-nodal human lymph were then fractionated by HPLC and characterized by multidimensional mass spectrometry.", {"entities": []}], ["Analysis of more then 300 sequences identified self-peptides derived from both intracellular and extracellular proteins revealing the variety of catabolic products transported by human lymph.", {"entities": []}], ["Quantitative analysis established that at least some of these peptides are present in the circulating lymph in nanomolar concentration.", {"entities": []}], ["The peptidome, generated by physiological tissue catabolism and transported by the pre-nodal lymph, is in addition to the self-peptidome generated in endosomal compartment.", {"entities": []}], ["Unlike self antigen processed by local or nodal APC, which mostly produce epitopes constrained by the endosomal processing activity, self antigens present in the lymph could derived from a wider variety of processing pathways; including caspases, involved in cellular apoptosis, and ADAM and other metalloproteinases involved in surface receptor editing, cytokines processing and matrix remodeling.", {"entities": [[48, 51, "GENE"]]}], ["Altogether, expanding the tissue-specific self-repertoire available for the maintenance of immunological tolerance.", {"entities": []}], ["IL\u201033 plays an important role in the initiation of type\u20102 immune responses, as well as the enhancement of type 2 effector functions.", {"entities": []}], ["Engagement of the IL\u201033 receptor on macrophages facilitates polarization to an alternative activation state by amplifying IL\u20104 and IL\u201013 signaling to IL\u20104R\u03b1.", {"entities": []}], ["IL\u20104 and IL\u201013 also induce macrophage proliferation but IL\u201033 involvement in this process has not been rigorously evaluated.", {"entities": []}], ["As expected, in vivo delivery of IL\u201033 induced IL\u20104R\u03b1\u2010dependent alternative macrophage activation in the serous cavities.", {"entities": []}], ["IL\u201033 delivery also induced macrophages to proliferate but, unexpectedly, this was independent of IL\u20104R\u03b1 signaling.", {"entities": []}], ["In a filarial nematode infection model in which IL\u20104R\u03b1\u2010dependent alternative activation and proliferation in the pleural cavity is well described, IL\u201033R was essential for alternative activation but not macrophage proliferation.", {"entities": []}], ["Similarly, during Alternaria alternata induced airway inflammation, which provokes strong IL\u201033 responses, we observed that both IL\u20104R\u03b1 and IL\u201033R were required for alternative activation, while macrophage proliferation in the pleural cavity was still evident in the absence of either receptor alone.", {"entities": []}], ["Our data show that IL\u201033R and IL\u20104R\u03b1 promote macrophage proliferation independently of each other, but both are essential for induction of alternative activation.", {"entities": []}], ["Arctium lappa L. (Asteraceae), burdock, is a medicinal plant that is popularly used for treating hypertension, gout, hepatitis, and other inflammatory disorders.", {"entities": [[97, 109, "DISEASE"], [117, 126, "DISEASE"], [111, 115, "DISEASE"]]}], ["This study was performed to test the effect of ethanol extract of Arctium lappa L. (EAL) seeds on vascular reactivity and inflammatory factors in rats fed a high fat/cholesterol diet (HFCD).", {"entities": []}], ["EAL-I (100 mg\u00b7kg Treatment with low or high doses of EAL markedly attenuated plasma levels of triglycerides and augmented plasma levels of high-density lipoprotein (HDL) in HFCD-fed rats.", {"entities": []}], ["Chronic treatment with EAL markedly reduced impairments of acetylcholine (ACh)-induced relaxation of aortic rings.", {"entities": []}], ["Furthermore, chronic treatment with EAL significantly lowered systolic blood pressure (SBP) and maintained smooth and flexible intimal endothelial layers in HFCD-fed rats.", {"entities": []}], ["Chronic treatment with EAL suppressed upregulation of intercellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1, and E-selectin in the aorta.", {"entities": []}], ["Chronic treatment with EAL also suppressed increases in matrix metalloproteinase (MMP)-2 expression.", {"entities": []}], ["These results suggested that EAL can inhibit HFCD-induced vascular inflammation in the rat model.", {"entities": []}], ["The present study provides evidence that EAL ameliorates HFCD-induced vascular dysfunction through protection of vascular relaxation and suppression of vascular inflammation.", {"entities": []}], ["With regard to the use of rituximab for patients with steroid-dependent nephrotic syndrome and frequently relapsing nephrotic syndrome, not only has the regimen not been clinically verified but also there is a lack of health economics evidence.", {"entities": [[72, 90, "DISEASE"], [116, 134, "DISEASE"], [82, 90, "DISEASE"], [126, 134, "DISEASE"]]}], ["Therefore, we conducted a prospective clinical study on 30 patients before (with steroids and immunosuppressants) and after introducing rituximab therapy.", {"entities": []}], ["Relapse rates and total invoiced medical expenses were selected as the primary endpoints for treatment effectiveness and treatment costs, respectively.", {"entities": []}], ["As secondary endpoints, cost-effectiveness was compared before and after administering rituximab in relation to previous pharmacotherapy.", {"entities": []}], ["The observation period was 24 months before and after the initiation of rituximab.", {"entities": []}], ["We showed that there was a statistically significant improvement in the relapse rate from a mean of 4.30 events before administration to a mean of 0.27 events after administration and that there was a significantly better prognosis in the cumulative avoidance of relapse rate by Kaplan\u2013Meier analysis ( p \u2009<\u20090.01).", {"entities": []}], ["Finally, the total medical costs decreased from 2,923\u2009USD to 1,280\u2009USD per month, and the pre\u2013post cost-effectiveness was confirmed as dominant.", {"entities": []}], ["We, therefore, conclude that treatment with rituximab was possibly superior to previous pharmacological treatments from a health economics perspective.", {"entities": []}], ["The epithelium regulates the interaction between the noxious xenogenous, as well as the microbial environment and the immune system, not only by providing a barrier but also by expressing a number of immunoregulatory membrane receptors, and intracellular danger sensors and their downstream effectors.", {"entities": []}], ["Amongst these are a number of inflammasome sensor subtypes, which have been initially characterized in myeloid cells and described to be activated upon assembly into multiprotein complexes by microbial and environmental triggers.", {"entities": []}], ["This review compiles a vast amount of literature that supports a pivotal role for inflammasomes in the various epithelial barriers of the human body as essential factors maintaining immune signaling and homeostasis.", {"entities": []}], ["Altered maternal inflammatory responses play a role in the development of preeclampsia and the hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome.", {"entities": [[155, 163, "DISEASE"]]}], ["We examined whether allelic variants of the innate immune receptors Toll-like receptor 4 (TLR4) and nucleotide-binding oligomerization domain 2 (NOD2), that impair the inflammatory response to endotoxin, are related to preeclampsia and HELLP syndrome.", {"entities": [[242, 250, "DISEASE"], [90, 94, "GENE"], [145, 149, "GENE"]]}], ["We determined five common mutations in TLR4 (D299G and T399I) and NOD2 (R702W, G908R and L1007fs) in 340 primiparous women with a history of early-onset preeclampsia, of whom 177 women developed HELLP syndrome and in 113 women with a history of only uneventful pregnancies as controls.", {"entities": [[201, 209, "DISEASE"], [39, 43, "GENE"], [66, 70, "GENE"]]}], ["In addition, we assessed plasma levels of pro-inflammatory biomarkers C-reactive protein, interleukin-6, soluble intercellular adhesion molecule-1, fibrinogen and von Willebrand factor in a subset of 214 women included at least six months after delivery.", {"entities": []}], ["After adjustment for maternal age and chronic hypertension, attenuating allelic variants of TLR4 were more common in women with a history of early-onset preeclampsia than in controls (OR 2.9 [95% CI 1.2\u20136.7]).", {"entities": [[46, 58, "DISEASE"], [92, 96, "GENE"]]}], ["Highest frequencies for TLR4 variants were observed in women who developed HELLP syndrome (adjusted OR 4.1 [95% CI 1.7\u20139.8]).", {"entities": [[81, 89, "DISEASE"], [24, 28, "GENE"]]}], ["In addition, high levels of interleukin-6 and fibrinogen were associated with a history of early-onset preeclampsia.", {"entities": []}], ["Combined positivity for any of the TLR4 and NOD2 allelic variants and high levels of interleukin-6 was 6.9-fold more common in women with a history of early-onset preeclampsia (95% CI 2.1\u201323.2) compared to controls.", {"entities": [[35, 39, "GENE"], [44, 48, "GENE"]]}], ["We observed an association of common TLR4 and NOD2 gene variants, and pro-inflammatory phenotype with a history of early-onset preeclampsia and HELLP syndrome.", {"entities": [[150, 158, "DISEASE"], [37, 41, "GENE"], [46, 50, "GENE"]]}], ["These findings suggest involvement of the maternal innate immune system in severe hypertensive disorders of pregnancy.", {"entities": []}], ["To explore contemporary practices and clinical recommendations regarding the use of acupuncture for infants by Traditional Chinese Medicine (TCM) practitioners in Shanghai.", {"entities": []}], ["A qualitative study consisting of four field visits between February 2014 and March 2015.", {"entities": []}], ["Data was collected using participant observation, focus group interview, in-depth interview, textbook page analysis and informant validation.", {"entities": []}], ["14 Shanghainese professionals, including interpreters and TCM practitioners, of which seven were acupuncturists.", {"entities": []}], ["The Longhua Hospital (paediatric, acupuncture and Tui na departments) in southern Shanghai and the campus of the Shanghai University of Traditional Chinese Medicine.", {"entities": []}], ["The Longhua Hospital outpatient acupuncture clinic receives 400 consultations on average per day.", {"entities": []}], ["Children, including patients from the paediatric department, are referred to this clinic.", {"entities": []}], ["During 3\u2005days of participant observations at this department, we saw two children.", {"entities": []}], ["No infants.", {"entities": []}], ["During 3\u2005days at the paediatric department and 1\u2005day at the Tui na department we saw no referrals.", {"entities": []}], ["Formal interviews and informal conversations with acupuncturists and other TCM professionals revealed that acupuncture was neither routinely practiced nor recommended for infants and small children.", {"entities": []}], ["Acupuncture was considered potentially painful for this young patient population.", {"entities": []}], ["Alternative treatment options such as herbal treatments or medical massage were widely available and preferred.", {"entities": []}], ["Western medical diagnostics and treatment were also used, recommended, and trusted.", {"entities": []}], ["Acupuncture for infants is not a preferred therapeutic method among TCM practitioners working in contemporary Shanghai.", {"entities": []}], ["Acupuncture on broad indications in infants appears to be a Western practice with little basis in TCM modern-day practice.", {"entities": []}], ["Bronchopulmonary dysplasia (BPD) is currently the most common severe complication in premature infants and is characterized by the arrest of alveolar and vascular growth.", {"entities": []}], ["Alveolar type II cells play an important role in the pathological foundation of BPD.", {"entities": []}], ["An association of BPD with epithelial-to-mesenchymal transition (EMT) in type II cells exposed to hyperoxia was previously identified.", {"entities": []}], ["SOX4, a transcription factor that is indispensable to embryogenesis, including lung development, participates in regulating EMT and cell survival, affecting tumorigenesis.", {"entities": [[0, 4, "GENE"]]}], ["The aim of the present study was to investigate the involvement of SOX4 in the occurrence of BPD, which, to the best of our knowledge, has not been previously determined.", {"entities": [[67, 71, "GENE"]]}], ["For this purpose, newborn rats were randomly divided into two treatment groups: The model group was exposed to hyperoxia (80\u201385% O 2 ), while the control group was kept under normoxic conditions (21% O 2 ).", {"entities": []}], ["Lung tissues were collected on postnatal days 1, 3, 7, 14 and 21 and morphological changes in the lungs were examined by hematoxylin and eosin staining.", {"entities": []}], ["The location of SOX4 in type II cells was detected by double immunofluorescence.", {"entities": [[16, 20, "GENE"]]}], ["The expression of SOX4 and enhancer of zeste homolog 2 (EZH2) in type II cells and lung tissues were detected by immunochemistry, western blotting and quantitative polymerase chain reaction analysis.", {"entities": [[18, 22, "GENE"], [56, 60, "GENE"]]}], ["The results demonstrated that, compared with the control group, the radial alveolar count decreased rapidly in the model group, accompanied by increased mean alveolar diameter and alveolar septal thickness.", {"entities": []}], ["SOX4 and EZH2 were highly expressed in type II cells exposed to hyperoxia.", {"entities": [[0, 4, "GENE"], [9, 13, "GENE"]]}], ["However, in total lung tissues, SOX4 and EZH2 expression was profoundly decreased in the early stages and increased in the late stages following exposure to hyperoxia.", {"entities": [[32, 36, "GENE"], [41, 45, "GENE"]]}], ["The expression of the EZH2 protein was positively correlated with that of the SOX4 protein.", {"entities": [[22, 26, "GENE"], [78, 82, "GENE"]]}], ["In conclusion, at the alveolar stage, which is a critical period after birth for lung development, hyperoxia induced dysregulation of SOX4 and EZH2 in rat lungs, indicating that SOX4 may contribute to the disruption of lung development in BPD by regulating EZH2 expression.", {"entities": [[134, 138, "GENE"], [178, 182, "GENE"], [143, 147, "GENE"], [257, 261, "GENE"], [134, 138, "GENE"], [178, 182, "GENE"], [143, 147, "GENE"], [257, 261, "GENE"]]}], ["Endobroncheal tuberculosis is defined as tuberculous infection of the tracheobronchial tree with microbial and histopathological evidence.", {"entities": [[14, 26, "DISEASE"]]}], ["The disease is usually mistaken for other lung diseases including lung cancer.", {"entities": [[66, 77, "DISEASE"], [71, 77, "DISEASE"]]}], ["Bronchial stenosis is a common complication of this type of tuberculosis despite the use of effective anti-tuberculous chemotherapy.", {"entities": [[60, 72, "DISEASE"]]}], ["We are presenting a case of endobronchial tuberculosis that simulated lung cancer and healed without residual bronchial stenosis.", {"entities": [[70, 81, "DISEASE"], [42, 54, "DISEASE"], [75, 81, "DISEASE"]]}], ["Recent studies demonstrated that nasal polyps (NP) patients in China and other Asian regions possessed distinct Th17-dominant inflammation and enhanced tissue remodeling.", {"entities": []}], ["However, the mechanism underlying these observations is not fully understood.", {"entities": []}], ["This study sought to evaluate the association of interleukin (IL)-17A with MUC5AC expression and goblet cell hyperplasia in Chinese NP patients and to characterize the signaling pathway underlying IL-17A-induced MUC5AC expression in vitro .", {"entities": []}], ["We enrolled 25 NP patients and 22 normal controls and examined the expression of IL-17A, MUC5AC and act1 in polyp tissues by immunohistochemical (IHC) staining, quantitative polymerase chain reaction (qPCR) and western blot.", {"entities": []}], ["Moreover, by using an in vitro culture system of polyp epithelial cells (PECs), IL-17A-induced gene expression was screened in cultured PECs by DNA microarray.", {"entities": []}], ["The expression of IL-17RA, IL-17RC, act1 and MUC5AC and the activation of the MAPK pathway (ERK, p38 and JNK), were further examined in cultured PECs and NCI-H292 cells by qPCR and western blotting, respectively.", {"entities": []}], ["We found that increased IL-17A production was significantly correlated with MUC5AC and act1 expression and goblet cell hyperplasia in polyp tissues ( p <0.05).", {"entities": []}], ["IL-17A significantly stimulated the expression of IL-17RA, IL-17RC, act1 and MUC5AC, and the activation of the MAPK pathway in cultured PECs and NCI-H292 cells ( p <0.05).", {"entities": []}], ["In addition, IL-17RA, IL-17RC and act1 siRNA significantly blocked IL-17A-induced MUC5AC production in vitro ( p <0.05).", {"entities": []}], ["Our results suggest that IL-17A plays a crucial role in stimulating the production of MUC5AC and goblet cell hyperplasia through the act1-mediated signaling pathway and may suggest a promising strategy for the management of Th17-dominant NP patients.", {"entities": []}], ["Ambient bioaerosols are ubiquitous in the daily environment and can affect health in various ways.", {"entities": []}], ["However, few studies have been conducted to comprehensively evaluate personal bioaerosol exposure in occupational and indoor environments because of the complex composition of bioaerosols and the lack of standardized sampling/analysis methods.", {"entities": []}], ["We conducted a study to determine the most efficient collection/analysis method for the personal exposure assessment of multiple bioaerosols.", {"entities": []}], ["The sampling efficiencies of three filters and four samplers were compared.", {"entities": []}], ["According to our results, polycarbonate (PC) filters had the highest relative efficiency, particularly for bacteria.", {"entities": [[41, 43, "GENE"]]}], ["Side-by-side sampling was conducted to evaluate the three filter samplers (with PC filters) and the NIOSH Personal Bioaerosol Cyclone Sampler.", {"entities": [[80, 82, "GENE"]]}], ["According to the results, the Button Aerosol Sampler and the IOM Inhalable Dust Sampler had the highest relative efficiencies for fungi and bacteria, followed by the NIOSH sampler.", {"entities": []}], ["Personal sampling was performed in a pig farm to assess occupational bioaerosol exposure and to evaluate the sampling/analysis methods.", {"entities": []}], ["The Button and IOM samplers yielded a similar performance for personal bioaerosol sampling at the pig farm.", {"entities": []}], ["However, the Button sampler is more likely to be clogged at high airborne dust concentrations because of its higher flow rate (4 L/min).", {"entities": []}], ["Therefore, the IOM sampler is a more appropriate choice for performing personal sampling in environments with high dust levels.", {"entities": []}], ["In summary, the Button and IOM samplers with PC filters are efficient sampling/analysis methods for the personal exposure assessment of multiple bioaerosols.", {"entities": [[45, 47, "GENE"]]}], ["Delivery of bronchodilators with a metered-dose inhaler (MDI) and a spacer device in mechanically ventilated patients has become a widespread practice.", {"entities": []}], ["However, except for the short-acting \u03b22-agonist salbutamol, the duration of action of other bronchodilators, including long-acting \u03b22-agonists, delivered with this technique is not well established.", {"entities": []}], ["The purpose of this study was to examine the duration of bronchodilation induced by the long-acting \u03b22-agonist salmeterol administered with an MDI and a spacer in a group of mechanically ventilated patients with exacerbation of chronic obstructive pulmonary disease (COPD).", {"entities": [[228, 265, "DISEASE"]]}], ["Ten mechanically ventilated patients with acute exacerbation of COPD received four puffs of salmeterol (25 \u03bcg/puff).", {"entities": []}], ["Salmeterol was administered with an MDI adapted to the inspiratory limb of the ventilator circuit using an aerosol cloud enhance spacer.", {"entities": []}], ["Static and dynamic airway pressures, minimum (R int ) and maximum (Rrs) inspiratory resistance, and the difference between Rrs and R int (\u0394R) were measured before and at 15, 30, and 60 minutes as well as at 2, 3, 4, 6, 8, 10, and 12 hours after salmeterol administration.", {"entities": []}], ["The overall effects of salmeterol on respiratory system mechanics and heart rate during the 12-hour study period were analyzed by nonparametric Wilcoxon signed rank test.", {"entities": []}], ["Salmeterol caused a significant decrease in dynamic and static airway pressures, R int , and Rrs.", {"entities": []}], ["These changes were evident at 30 minutes and remained significant for 8 hours after salmeterol administration.", {"entities": []}], ["The duration of bronchodilation varied significantly among patients, lasting in some patients more than 10 hours and wearing off in others in less than 6 hours.", {"entities": []}], ["It is concluded that four puffs of salmeterol delivered with an MDI and a spacer device induces significant bronchodilation in mechanically ventilated patients with COPD exacerbation, the duration of which is highly variable, precluding definite conclusions in regard to optimum dosing schedules.", {"entities": []}], ["The aim was to assess and compare reported sleep disturbances and objectively measured sleep in men and women with COPD compared with controls and also explore sex differences.", {"entities": []}], ["A total of 96 patients with COPD and 90 age- and sex-matched controls answered a sleep questionnaire, underwent ambulatory polysomnography, a post-bronchodilatory spirometry, and blood sampling.", {"entities": []}], ["Of the patients with COPD, 51% reported sleep disturbances as compared with 31% in controls ( P =0.008).", {"entities": []}], ["Sleep disturbances were significantly more prevalent in males with COPD compared with controls, whereas there was no significant difference in females.", {"entities": []}], ["The use of hypnotics was more common among patients with COPD compared with controls, both in men (15% vs 0%, P =0.009) and women (36% vs 16%, P =0.03).", {"entities": []}], ["The men with COPD had significantly longer recorded sleep latency than the male control group (23 vs 9.3 minutes, P <0.001), while no corresponding difference was found in women.", {"entities": []}], ["In men with COPD, those with reported sleep disturbances had lower forced vital capacity, higher C-reactive protein, myeloperoxidase, and higher prevalence of chronic bronchitis.", {"entities": [[167, 177, "DISEASE"]]}], ["The COPD was associated with impaired sleep in men while the association was less clear in women.", {"entities": []}], ["This was also confirmed by recorded longer sleep latency in male subjects with COPD compared with controls.", {"entities": []}], ["The nonreceptor tyrosine kinase c-Abl has a role in regulating smooth muscle cell proliferation, which contributes to the development of airway remodeling in chronic asthma.", {"entities": [[166, 172, "DISEASE"]]}], ["MicroRNAs (miRs) are small noncoding RNA molecules that regulate gene expression by binding to complementary sequences in the 3\u2032 untranslated regions (3\u2032 UTR) of target mRNAs.", {"entities": []}], ["Previous analysis suggests that miR-203 is able to bind to the 3\u2032 UTR of human c-Abl mRNA.", {"entities": [[32, 39, "GENE"]]}], ["In this report, treatment with miR-203 attenuated the expression of c-Abl mRNA and protein in human airway smooth muscle (HASM) cells.", {"entities": [[31, 38, "GENE"]]}], ["Furthermore, transfection with an miR-203 inhibitor enhanced the expression of c-Abl at mRNA and protein levels in HASM cells.", {"entities": [[34, 41, "GENE"]]}], ["Treatment with platelet-derived growth factor (PDGF) induced the proliferation and ERK1/2 phosphorylation in HASM cells.", {"entities": []}], ["Exposure to miR-203 attenuated the PDGF-stimulated proliferation and ERK1/2 phosphorylation in HASM cells.", {"entities": [[12, 19, "GENE"]]}], ["The expression of c-Abl at protein and mRNA levels was higher in asthmatic HASM cells, whereas the level of miR-203 was reduced in asthmatic HASM cells as compared to control HASM cells.", {"entities": [[108, 115, "GENE"]]}], ["Taken together, our present results suggest that miR-203 is a negative regulator of c-Abl expression in smooth muscle cells.", {"entities": [[49, 56, "GENE"]]}], ["miR-203 regulates smooth muscle cell proliferation by controlling c-Abl expression, which in turn modulates the activation of ERK1/2.", {"entities": [[0, 7, "GENE"]]}], ["Vitamin D deficiency is common and predisposes to many serious diseases, yet often goes unrecognized.", {"entities": []}], ["We describe a case of severe vitamin D deficiency with osteomalacia in a patient resident in a psychiatric hospital for more than 35 years, and discuss causes and complications.", {"entities": [[55, 67, "DISEASE"]]}], ["We assayed the serum 25-hydroxyvitamin D levels of all patients under our care on one old-age psychiatry rehabilitation unit.", {"entities": []}], ["Ten of twelve (83%) of patients had vitamin D deficiency, and 92% had suboptimal vitamin D levels.", {"entities": []}], ["Vitamin D status was strongly predicted by dietary supplementation.", {"entities": []}], ["Of those not on vitamin D supplements, 100% had vitamin D deficiency, with vitamin D levels significantly below those of historical controls.", {"entities": []}], ["Age, sex, and duration of admission did not predict vitamin D status in this group.", {"entities": []}], ["We advocate vitamin D screening in all patients admitted to psychogeriatric units, and discuss treatment options given the current problems affecting high-dose vitamin D supply to the United Kingdom.", {"entities": []}], ["The ankle blood pressure is commonly used as a ratio to the brachial blood pressure, called ankle-brachial index (ABI).", {"entities": []}], ["Very few studies have considered the independent value of the ankle blood pressure without indexing it to the brachial blood pressure.", {"entities": []}], ["We examined the value of ankle blood pressure, together with the exercise blood pressure, as a predictor of cardiovascular (CVD) and total mortality.", {"entities": []}], ["A prospective follow-up study of 3,858 consecutive ambulatory patients (mean age 51 years, 65,9% male) referred to a symptom-limited exercise test between August 1989 and December 1995.", {"entities": []}], ["The cohort was followed up for all-cause and CVD mortality until December 31, 2004, by record linkage with the National Causes-of-Death Register.", {"entities": []}], ["The independent value of ankle blood pressure as a predictor of cardiovascular and total mortality was assessed using Cox proportional hazards modelling.", {"entities": []}], ["The average follow-up time was 14 years, during which 346 persons died, 108 of them due to CVD.", {"entities": []}], ["Persons with normal (<140 mmHg) resting brachial blood pressure, ankle blood pressure < 175 mmHg and exercise blood pressure at moderate exercise level \u2264215 mmHg at baseline investigation, had the best prognosis and were taken as the reference category.", {"entities": []}], ["Among persons with elevated ankle blood pressure (\u2265175 mmHg) but normal or borderline resting brachial pressure and normal exercise blood pressure (\u2264215 mmHg) at moderate exercise level the multivariate-adjusted hazard ratios (HR, 95% confidence interval) for CVD and total mortality were 2.70 (1.52 \u2013 4.80) and 2.13 (1.58 \u2013 2.85), respectively.", {"entities": [[227, 229, "GENE"]]}], ["Similar and equally significant HRs were observed in persons with both elevated ankle blood pressure and elevated exercise blood pressure, as well as in those persons with elevated exercise blood pressure but ankle blood pressure < 175 mmHg.", {"entities": []}], ["These results suggest that the ankle blood pressure has an independent value as a marker of arterial stiffness or subclinical atherosclerosis and a risk of future mortality in middle-aged, asymptomatic persons.", {"entities": [[126, 141, "DISEASE"]]}], ["YKL-40 is an extracellular matrix glycoprotein with a significant role in tissue inflammation and remodeling.", {"entities": []}], ["MIP-1a has chemotactic and pro-inflammatory properties, and is induced by YKL-40 in several lung disorders.", {"entities": []}], ["The aim of this study was to determine the levels of YKL-40 and MIP-1a in blood serum and pleural fluids of various pulmonary diseases, and to evaluate their potential role as differential diagnosis biomarkers.", {"entities": []}], ["We recruited 60 patients (age: 62.5\u2009\u00b1\u200920.6\u00a0years) with pleural effusions: 49 exudates and 11 transudates (T).", {"entities": []}], ["Exudates were further classified based on the underlying disease: ten with tuberculosis (TB), 13 with lung cancer (LCa), 15 with metastatic cancer (MCa) of non-lung origin and 11 with parapneumonic (PN) effusions.", {"entities": [[102, 113, "DISEASE"], [75, 87, "DISEASE"], [107, 113, "DISEASE"], [140, 146, "DISEASE"]]}], ["YKL-40 and MIP-1a levels were measured by ELISA.", {"entities": []}], ["Pleural YKL-40 levels (ng/ml) were similar among all patient groups (TB: 399\u2009\u00b1\u200936, LCa: 401\u2009\u00b1\u2009112, MCa: 416\u2009\u00b1\u200934, PN: 401\u2009\u00b1\u200950, T: 399\u2009\u00b1\u200942, p \u2009=\u20090.92).", {"entities": []}], ["On the contrary, YKL-40 was significantly lower in the serum of TB patients (TB: 58\u2009\u00b1\u200922, LCa: 212\u2009\u00b1\u2009106, MCa: 254\u2009\u00b1\u2009140, PN: 265\u2009\u00b1\u2009140, T: 229\u2009\u00b1\u2009123, p \u2009<\u20090.001).", {"entities": []}], ["Pleural MIP-1a protein levels (ng/ml) were statistically lower only in patients with LCa (TB: 25.0\u2009\u00b1\u200920.2, LCa: 7.3\u2009\u00b1\u20096.0, MCa: 16.1\u2009\u00b1\u200914.9, PN: 25.4\u2009\u00b1\u200927.9, T: 18.5\u2009\u00b1\u20097.9, p \u2009=\u20090.012), a finding also observed in serum MIP-1a levels (TB: 17.1\u2009\u00b1\u20097.6, LCa: 9.4\u2009\u00b1\u20097.0, MCa: 28.7\u2009\u00b1\u200928.7, PN: 33.3\u2009\u00b1\u200924.0, T: 22.9\u2009\u00b1\u20098.7, p \u2009=\u20090.003).", {"entities": []}], ["Our data suggest that both YKL-40 and MIP-1a, particularly in serum, could prove useful for the differentiation of pleural effusions in clinical practice, especially of TB or LCa origin.", {"entities": []}], ["However, large-scale studies are needed to validate these findings.", {"entities": []}], ["Dietary supplementation with oligosaccharides has been proven to be beneficial for health in several mammalian species.", {"entities": []}], ["Next to prebiotic effects resulting in a modulation of gut micro biota, immunomodulatory effects of oligosaccharides have been documented in vivo .", {"entities": []}], ["Supplementation with defined oligosaccharide fractions has been shown to attenuate allergic responses and enhance defensive immune responses.", {"entities": []}], ["Despite the accumulating evidence for immunomodulatory effects, very limited information is available regarding the direct mechanism of action of oligosaccharides.", {"entities": []}], ["This study aims to elucidate the effects of selected oligosaccharide fractions on the lipopolysaccharide (LPS) induced inflammatory response in equine peripheral blood mononuclear cells (PBMCs).", {"entities": []}], ["We investigated three different products containing either galacto-oligosaccharides (GOS) alone, a combination of GOS with fructo-oligosaccharides (FOS), and a triple combination of GOS and FOS with acidic oligosaccharides (AOS), at different concentrations.", {"entities": [[148, 151, "GENE"], [190, 193, "GENE"], [148, 151, "GENE"], [190, 193, "GENE"]]}], ["These products have been used in an identical composition in various previously published in vivo experiments.", {"entities": []}], ["As the selected oligosaccharide fractions were derived from natural products, the fractions contained defined amounts of mono- and disaccharides and minor amounts of endotoxin, which was taken into account in the design of the study and the analysis of data.", {"entities": []}], ["Acquired data were analysed in a Bayesian hierarchical linear regression model, accounting for variation between horses.", {"entities": []}], ["Exposing cultured PBMCs to either GOS or GOS/FOS fractions resulted in a substantial dose-dependent increase of tumour necrosis factor-\u03b1 (TNF-\u03b1) production in LPS challenged PBMCs.", {"entities": []}], ["In contrast, incubation with GOS/FOS/AOS resulted in a dose-dependent reduction of both TNF-\u03b1 and interleukin-10 production following LPS challenge.", {"entities": []}], ["In addition, incubation with GOS/FOS/AOS significantly increased the apparent PBMC viability, indicating a protective or mitogenic effect.", {"entities": []}], ["Furthermore, mono- and disaccharide control fractions significantly stimulated the inflammatory response in LPS challenged PBMCs as well, though to a lesser extent than GOS and GOS/FOS fractions.", {"entities": []}], ["We found distinct immunomodulating effects of the investigated standardised oligosaccharide fractions, which either stimulated or suppressed the LPS induced inflammatory response in PBMCs.", {"entities": []}], ["Both scenarios require additional investigation, to elucidate underlying modulatory mechanisms, and to translate this knowledge into the clinical application of oligosaccharide supplements in foals and other neonates.", {"entities": []}], ["Background and Purpose .", {"entities": []}], ["Contrast media (CM) for magnetic resonance imaging (MRI) may determine the development of acute adverse reactions.", {"entities": []}], ["Objective was to retrospectively assess the frequency and severity of adverse reactions associated with gadolinium-based contrast agents (GBCAs) injection in patients who underwent MRI.", {"entities": []}], ["Material and Methods .", {"entities": []}], ["At our center 10608 MRI examinations with CM were performed using five different GBCAs: Gd-BOPTA (MultiHance), Gd-DTPA (Magnevist), Gd-EOBDTPA (Primovist), Gd-DOTA (Dotarem), and Gd-BTDO3A (Gadovist).", {"entities": []}], ["32 acute adverse reactions occurred, accounting for 0.3% of all administration.", {"entities": []}], ["Twelve reactions were associated with Gd-DOTA injection (0.11%), 9 with Gd-BOPTA injection (0.08%), 6 with Gd-BTDO3A (0.056%), 3 with Gd-EOB-DTPA (0.028%), and 2 with Gd-DTPA (0.018%).", {"entities": []}], ["Twenty-four reactions (75.0%) were mild, four (12.5%) moderate, and four (12.5%) severe.", {"entities": []}], ["The most severe reactions were seen associated with use of Gd-BOPTA, with 3 severe reactions in 32 total reactions.", {"entities": []}], ["Conclusion .", {"entities": []}], ["Acute adverse reactions are generally rare with the overall adverse reaction rate of 0.3%.", {"entities": []}], ["The most common adverse reactions were not severe, consisting in skin rash and hives.", {"entities": []}], ["Multimorbidity is common in advanced age, and is usually associated with negative \u2013 yet to some extent preventable \u2013 health outcomes.", {"entities": []}], ["Detecting comorbid conditions is especially difficult in individuals with dementia, as they might not always be able to sufficiently express discomfort.", {"entities": [[74, 82, "DISEASE"]]}], ["This study compares relevant comorbidity complexes in elderly people with and without dementia, with a particular look at gender- and living environment-specific differences.", {"entities": [[86, 94, "DISEASE"]]}], ["Moreover, associations between selected comorbid conditions and dementia are reviewed more closely.", {"entities": [[64, 72, "DISEASE"]]}], ["Using 2006 claims data from a large German Statutory Health Insurance fund, 9,139 individuals with dementia and 28,614 age- and gender-matched control subjects aged 65 years and older were identified.", {"entities": [[99, 107, "DISEASE"]]}], ["A total of 30 comorbidity complexes were defined based on ICD-10 codes.", {"entities": []}], ["Corresponding prevalence rates were calculated, and the association between a distinct condition and dementia was evaluated via logistic regression in the overall sample as well as in analyses stratified by gender and living environment.", {"entities": [[101, 109, "DISEASE"]]}], ["Individuals with dementia were more likely to be diagnosed with 15 comorbidity complexes, including Parkinson\u2019s, stroke, diabetes, atherosclerosis (supposed dementia risk factors) or fluids and electrolyte disorders, insomnia, incontinence, pneumonia, fractures and injuries (supposed sequelae).", {"entities": [[131, 146, "DISEASE"], [17, 25, "DISEASE"], [157, 165, "DISEASE"], [241, 250, "DISEASE"]]}], ["In contrast, they were less likely to be diagnosed with 11 other conditions, which included vision and hearing problems, diseases of the musculoskeletal system, lipoprotein disorders and hypertension.", {"entities": [[187, 199, "DISEASE"]]}], ["In a gender-stratified analysis, the patterns remained largely the same, but a bigger comorbidity gap between cases and control subjects emerged in the male population.", {"entities": []}], ["Restricting the analysis to community-living individuals did not lead to any substantial changes.", {"entities": []}], ["Besides strengthening the evidence on accepted dementia risk factors and sequelae, the analyses point to particular conditions that are likely to remain untreated or even undiagnosed.", {"entities": [[47, 55, "DISEASE"]]}], ["This issue seems to affect male and female individuals with dementia to varying degrees.", {"entities": [[60, 68, "DISEASE"]]}], ["Raising awareness of these conditions is important to possibly preventing comorbidity-associated complications and disease progression in dementia patients.", {"entities": [[138, 146, "DISEASE"]]}], ["To more comprehensively understand the mutual interactions between dementia and comorbidity, further research on diagnostic and treatment attitudes regarding comorbidity in dementia patients and on their gender-specific health-seeking behaviour seems to be required.", {"entities": [[67, 75, "DISEASE"], [173, 181, "DISEASE"]]}], ["The performance of ultrasound (US) in the diagnosis of acute gouty (MSU) arthritis and calcium pyrophosphate (CPP) arthritis is not yet well defined.", {"entities": [[73, 82, "DISEASE"], [115, 124, "DISEASE"]]}], ["Most studies evaluated US as the basis for diagnosing crystal arthritis in already diagnosed cases of gout and few prospective studies have been performed.", {"entities": [[62, 71, "DISEASE"], [102, 106, "DISEASE"]]}], ["One hundred nine consecutive patients who presented an acute arthritis of suspected microcrystalline arthritis were prospectively included.", {"entities": [[61, 70, "DISEASE"], [101, 110, "DISEASE"]]}], ["All underwent an US of the symptomatic joints(s) and of knees, ankles and 1 Fifty-one patients had MSU, 28 CPP and 9 had both crystals by microscopic analysis.", {"entities": []}], ["No crystals were detected in 21.", {"entities": []}], ["One had septic arthritis.", {"entities": [[8, 24, "DISEASE"], [15, 24, "DISEASE"]]}], ["Based on US signs in the symptomatic joint, the sensitivity of US for both gout and CPP was low (60\u00a0% for both).", {"entities": [[75, 79, "DISEASE"]]}], ["In gout, the presence of US signs in the symptomatic joint was highly predictive of the diagnosis (PPV\u2009=\u200992\u00a0%).", {"entities": [[3, 7, "DISEASE"]]}], ["When US diagnosis was based on an examination of multiple joints, the sensitivity for both gout and CPP rose significantly but the specificity and the PPV decreased.", {"entities": [[91, 95, "DISEASE"]]}], ["In the absence of US signs in all the joints studied, CPP arthritis was unlikely (NPV\u2009=\u200987\u00a0%) particularly in patients with no previous crisis (NPV\u2009=\u200994\u00a0%).", {"entities": [[58, 67, "DISEASE"]]}], ["X-ray of the symptomatic joints was confirmed to be not useful in diagnosing gout and was equally sensitive or specific as US in CPP arthritis.", {"entities": [[133, 142, "DISEASE"], [77, 81, "DISEASE"]]}], ["Arthrocenthesis remains the key investigation for the diagnosis of microcrystalline acute arthritis.", {"entities": [[90, 99, "DISEASE"]]}], ["Although US can help in the diagnostic process, its diagnostic performance is only moderate.", {"entities": []}], ["US should not be limited to the symptomatic joint.", {"entities": []}], ["Examination of multiple joints gives a better diagnostic sensitivity but lower specificity.", {"entities": []}], ["The online version of this article (doi:10.1186/s13075-015-0701-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["A major obstacle for effective utilization of therapeutic oligonucleotides such as siRNA, antisense, antimiRs etc.", {"entities": []}], ["is to deliver them specifically to the target tissues.", {"entities": []}], ["Toward this goal, nucleic acid aptamers are re-emerging as a prominent class of biomolecules capable of delivering target specific therapy and therapeutic monitoring by various molecular imaging modalities.", {"entities": []}], ["This class of short oligonucleotide ligands with high affinity and specificity are selected from a large nucleic acid pool against a molecular target of choice.", {"entities": []}], ["Poor cellular uptake of therapeutic oligonucleotides impedes gene-targeting efficacy in vitro and in vivo .", {"entities": []}], ["In contrast, aptamer-oligonucleotide chimeras have shown the capacity to deliver siRNA, antimiRs, small molecule drugs etc.", {"entities": []}], ["toward various targets and showed very promising results in various studies on different diseases models.", {"entities": []}], ["However, to further improve the bio-stability of such chimeric conjugates, it is important to introduce chemically-modified nucleic acid analogs.", {"entities": []}], ["In this review, we highlight the applications of nucleic acid aptamers for target specific delivery of therapeutic oligonucleotides.", {"entities": []}], ["Airway smooth muscle contraction is critical for maintenance of appropriate airway tone, and has been implicated in asthma pathogenesis.", {"entities": [[116, 122, "DISEASE"]]}], ["Smooth muscle contraction requires an \u201cengine\u201d (myosin activation) and a \u201ctransmission system\u201d (actin cytoskeletal remodeling).", {"entities": []}], ["However, the mechanisms that control actin remodeling in smooth muscle are not fully elucidated.", {"entities": []}], ["The adapter protein Crk-associated substrate (CAS) regulates actin dynamics and the contraction in smooth muscle.", {"entities": []}], ["In addition, profilin-1 (Pfn-1) and Abelson tyrosine kinase (c-Abl) are also involved in smooth muscle contraction.", {"entities": []}], ["The interplays among CAS, Pfn-1 and c-Abl in smooth muscle have not been previously investigated.", {"entities": []}], ["The association of CAS with Pfn-1 in mouse tracheal rings was evaluated by co-immunoprecipitation.", {"entities": []}], ["Tracheal rings from c-Abl conditional knockout mice were used to assess the roles of c-Abl in the protein-protein interaction and smooth muscle contraction.", {"entities": []}], ["Decoy peptides were utilized to evaluate the importance of CAS/Pfn-1 coupling in smooth muscle contraction.", {"entities": []}], ["Stimulation with acetylcholine (ACh) increased the interaction of CAS with Pfn-1 in smooth muscle, which was regulated by CAS tyrosine phosphorylation and c-Abl.", {"entities": []}], ["The CAS/Pfn-1 coupling was also modified by the phosphorylation of cortactin (a protein implicated in Pfn-1 activation).", {"entities": []}], ["In addition, ACh activation promoted the spatial redistribution of CAS and Pfn-1 in smooth muscle cells, which was reduced by c-Abl knockdown.", {"entities": []}], ["Inhibition of CAS/Pfn-1 interaction by a decoy peptide attenuated the ACh-induced actin polymerization and contraction without affecting myosin light chain phosphorylation.", {"entities": []}], ["Furthermore, treatment with the Src inhibitor PP2 and the actin polymerization inhibitor latrunculin A attenuated the ACh-induced c-Abl tyrosine phosphorylation (an indication of c-Abl activation).", {"entities": [[32, 35, "GENE"]]}], ["Our results suggest a novel activation loop in airway smooth muscle: c-Abl promotes the CAS/Pfn-1 coupling and actin polymerization, which conversely facilitates c-Abl activation.", {"entities": []}], ["The positive feedback may render c-Abl in active state after contractile stimulation.", {"entities": []}], ["Aspirin reduces mortality for men and women with coronary heart disease (CHD).", {"entities": [[58, 71, "DISEASE"], [49, 71, "DISEASE"]]}], ["Previous research suggests women with acute coronary syndromes receive less aggressive care, including less frequent early administration of aspirin.", {"entities": []}], ["The presence of gender differences in aspirin use for secondary prevention is less clear.", {"entities": []}], ["To determine if a gender difference exists in the use of aspirin for secondary prevention among individuals with CHD.", {"entities": []}], ["We analyzed data from the nationally representative 2000\u20132002 Medical Expenditure Panel Surveys to determine the prevalence of regular aspirin use among men and women with CHD.", {"entities": []}], ["Participants, 1,869, 40\u00a0years and older who reported CHD or prior myocardial infarction.", {"entities": [[66, 87, "DISEASE"]]}], ["Women were less likely than men to use aspirin regularly (62.4% vs 75.6%, p \u2009<\u2009.001) even after adjusting for demographic, socioeconomic and clinical characteristics (adjusted OR\u2009=\u20090.62, 95% CI, 0.48\u20130.79).", {"entities": []}], ["This difference narrowed but remained significant when the analysis was limited to those without self-reported contraindications to aspirin (79.8% vs 86.4%, P \u2009=\u2009.002, adjusted OR\u2009=\u20090.68, 95% CI, 0.48\u20130.97).", {"entities": []}], ["Women were more likely than men to report contraindications (20.5% vs 12.5%, P \u2009<\u2009.001).", {"entities": []}], ["Differences in aspirin use were greater between women and men with private health insurance (61.8% vs 79.0%, P \u2009<\u2009.001, adjusted OR\u2009=\u20090.48, 95% CI, 0.35\u20130.67) than among those with public coverage (62.5% vs 70.7%, P \u2009=\u2009.04, adjusted OR\u2009=\u20090.74, 95% CI, 0.50\u20131.11) ( P \u2009<\u2009.001 for gender\u2013insurance interaction).", {"entities": []}], ["We found a gender difference in aspirin use among patients with CHD not fully explained by differences in patient characteristics or reported contraindications.", {"entities": []}], ["These findings suggest a need for improved secondary prevention of cardiovascular events for women with CHD.", {"entities": []}], ["Epigenetic changes could mediate the association of maternal pre-pregnancy body mass index (BMI) and gestational weight gain (GWG) with adverse offspring outcomes.", {"entities": []}], ["However, studies in humans are lacking.", {"entities": []}], ["Here, we examined the association of maternal pre-pregnancy BMI and GWG in different periods of pregnancy with cytosine-guanine (CpG) dinucleotide site methylation differences in newborn cord blood DNA from 88 participants in the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort using the Illumina GoldenGate Panel I. Pyrosequencing was used for validation of the top associated locus and for replication in 170 non-overlapping mother-offspring pairs from the ALSPAC cohort.", {"entities": []}], ["After correction for multiple testing greater GWG in early pregnancy (between 0 to 18\u00a0weeks of gestation) was associated with increased DNA methylation levels in four CpG sites at MMP7 , KCNK4 , TRPM5 and NFKB1 genes (difference in methylation >5% per 400\u00a0g/week greater GWG) (q values 0.023 -0.065).", {"entities": [[180, 184, "GENE"], [187, 192, "GENE"], [195, 200, "GENE"], [205, 210, "GENE"]]}], ["Pre-pregnancy BMI and GWG in mid- or late pregnancy were not associated with differential DNA methylation at any CpG site.", {"entities": []}], ["Pyrosequencing showed that greater GWG in early pregnancy was associated with increased DNA methylation levels at the top associated CpG site at MMP7 , although association did not reach statistical significance (p\u2009=\u20090.302).", {"entities": [[145, 149, "GENE"]]}], ["Greater GWG in mid- (p\u2009=\u20090.167) and late-pregnancy (p\u2009=\u20090.037) were also associated with increased DNA methylation levels at the MMP7 CpG site.", {"entities": [[129, 133, "GENE"]]}], ["In addition, newborns of mothers who exceeded the IoM-recommended GWG had higher DNA methylation levels at the MMP7 CpG site than those of mothers with IoM-recommended GWG (p\u2009=\u20090.080).", {"entities": [[111, 115, "GENE"]]}], ["We failed to replicate findings.", {"entities": []}], ["Greater GWG in early pregnancy was associated with increased methylation at CpG sites at MMP7 , KCNK4 , TRPM5 and NFKB1 genes in offspring cord blood DNA.", {"entities": [[89, 93, "GENE"], [96, 101, "GENE"], [104, 109, "GENE"], [114, 119, "GENE"]]}], ["The specific association of GWG in early pregnancy with the top associated CpG site at MMP7 was not validated using Pyrosequencing and it did not replicate.", {"entities": [[87, 91, "GENE"]]}], ["However, given the potential functional relevancy of the four identified loci, we advocate further exploration of them in larger studies.", {"entities": []}], ["Gut microbial colonization and development of immune competence are intertwined and are influenced by early-life nutritional, environmental, and management factors.", {"entities": []}], ["Perturbation of the gut microbiome at young age affects the crosstalk between intestinal bacteria and host cells of the intestinal mucosa.", {"entities": []}], ["We investigated the effect of a perturbation of the normal early life microbial colonization of the jejunum in 1-day old chickens.", {"entities": []}], ["Perturbation was induced by administering 0.8\u00a0mg amoxicillin per bird per day) via the drinking water for a period of 24\u00a0h. Effects of the perturbation were measured by 16S rRNA profiling of the microbiome and whole genome gene expression analysis.", {"entities": []}], ["In parallel to what has been observed for other animal species, we hypothesized that such an intervention may have negative impact on immune development.", {"entities": []}], ["Trends were observed in changes of the composition and diversity of the microbiome when comparing antibiotic treated birds with their controls.", {"entities": []}], ["in the jejunum, the expression of numerous genes changed, which potentially leads to changes in biological activities of the small intestinal mucosa.", {"entities": []}], ["Validation of the predicted functional changes was performed by staining immune cells in the small intestinal mucosa and a reduction in the number of macrophage-like (KUL01 These results underscore the importance of early life microbial colonization of the gut in relation to immune development and the necessity to explore the capabilities of a variety of early life dietary and/or environmental factors to modulate the programming for immune competence in broilers.", {"entities": []}], ["The online version of this article (doi:10.1186/s12864-017-3625-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Ultraviolet radiation (UVR) exposure and family history are major associated risk factors for the development of non-melanoma skin cancer (NMSC).", {"entities": [[126, 137, "DISEASE"], [117, 125, "DISEASE"], [131, 137, "DISEASE"]]}], ["The objective of this study was to develop and validate a multi-parameterized artificial neural network based on available personal health information for early detection of NMSC with high sensitivity and specificity, even in the absence of known UVR exposure and family history.", {"entities": []}], ["The 1997\u20132015 NHIS adult survey data used to train and validate our neural network (NN) comprised of 2,056 NMSC and 460,574 non-cancer cases.", {"entities": [[128, 134, "DISEASE"]]}], ["We extracted 13 parameters for our NN: gender, age, BMI, diabetic status, smoking status, emphysema, asthma, race, Hispanic ethnicity, hypertension, heart diseases, vigorous exercise habits, and history of stroke.", {"entities": [[135, 147, "DISEASE"], [101, 107, "DISEASE"]]}], ["This study yielded an area under the ROC curve of 0.81 and 0.81 for training and validation, respectively.", {"entities": []}], ["Our results (training sensitivity 88.5% and specificity 62.2%, validation sensitivity 86.2% and specificity 62.7%) were comparable to a previous study of basal and squamous cell carcinoma prediction that also included UVR exposure and family history information.", {"entities": [[178, 187, "DISEASE"], [164, 187, "DISEASE"]]}], ["These results indicate that our NN is robust enough to make predictions, suggesting that we have identified novel associations and potential predictive parameters of NMSC.", {"entities": []}], ["The global burden of disease has shifted from communicable diseases in children to chronic diseases in adults.", {"entities": []}], ["This epidemiologic shift varies greatly by region, but in Europe, chronic conditions account for 86% of all deaths, 77% of the disease burden, and up to 80% of health care expenditures.", {"entities": []}], ["A number of risk factors have been implicated in chronic diseases, such as exposure to infectious agents.", {"entities": []}], ["A number of associations have been well established while others remain uncertain.", {"entities": []}], ["We assessed the body of evidence regarding the infectious aetiology of chronic diseases in the peer-reviewed literature over the last decade.", {"entities": []}], ["Causality was assessed with three different criteria: First, the total number of associations documented in the literature between each infectious agent and chronic condition; second, the epidemiologic study design (quality of the study); third, evidence for the number of Hill's criteria and Koch's postulates that linked the pathogen with the chronic condition.", {"entities": []}], ["We identified 3136 publications, of which 148 were included in the analysis.", {"entities": []}], ["There were a total of 75 different infectious agents and 122 chronic conditions.", {"entities": []}], ["The evidence was strong for five pathogens, based on study type, strength and number of associations; they accounted for 60% of the associations documented in the literature.", {"entities": []}], ["They were human immunodeficiency virus, hepatitis C virus, Helicobacter pylori , hepatitis B virus, and Chlamydia pneumoniae and were collectively implicated in the aetiology of 37 different chronic conditions.", {"entities": [[40, 49, "DISEASE"], [81, 90, "DISEASE"]]}], ["Other pathogens examined were only associated with very few chronic conditions (\u22643) and when applying the three different criteria of evidence the strength of the causality was weak.", {"entities": []}], ["Prevention and treatment of these five pathogens lend themselves as effective public health intervention entry points.", {"entities": []}], ["By concentrating research efforts on these promising areas, the human, economic, and societal burden arising from chronic conditions can be reduced.", {"entities": []}], ["A decrease in blood lactate levels (Lac) >10% during the first hours of resuscitation in sepsis is associated with better outcomes, but the mechanisms are unclear.", {"entities": []}], ["Our objective was to investigate the relationship between the time course of Lac, inflammatory response, and mitochondrial respiration during experimental sepsis.", {"entities": []}], ["Original data from two previously published studies were reanalyzed.", {"entities": []}], ["In cohort 1, pigs were randomized to be resuscitated for 48\u00a0h starting at 6, 12, and 24\u00a0h, respectively, after fecal peritonitis induction ( n \u2009=\u20098 each).", {"entities": [[117, 128, "DISEASE"]]}], ["Animals were categorized according to the decrease in Lac during the first 6\u00a0h of resuscitation (early if \u226510% [Lac \u226510%] or late if <10% or increased [Lac <10%]), and systemic hemodynamics, inflammatory parameters, and mitochondrial function were compared between groups.", {"entities": []}], ["In a second group of animals with fecal peritonitis and 24\u00a0h of resuscitation ( n \u2009=\u200916, cohort 2), abdominal regional Lac exchange was measured, and animals were categorized according to the decrease in Lac as in cohort 1.", {"entities": [[40, 51, "DISEASE"]]}], ["Overall mortality was 20% (4 of 20) in the Lac \u226510% group and 60% (12 of 20) in the Lac <10% group ( p \u2009=\u20090.022).", {"entities": []}], ["In cohort 1, systemic hemodynamics were similar in the Lac \u226510% ( n \u2009=\u200913) and Lac <10% ( n \u2009=\u200911) groups.", {"entities": []}], ["Plasma interleukin-6 levels increased during unresuscitated sepsis and decreased during resusciation in both groups, but they were lower at study end in the Lac \u226510% group ( p \u2009=\u20090.047).", {"entities": []}], ["Complexes I and II maximal (state 3) and resting (state 4) isolated brain mitochondrial respiration at study end was higher in the Lac \u226510% group than in the Lac <10% group, whereas hepatic, myocardial, and skeletal muscle mitochondrial respiration was similar in both groups.", {"entities": []}], ["In cohort 2, mesenteric, total hepatic, and renal blood flow at study end was higher in the Lac \u226510% group ( n \u2009=\u20097) than in the Lac <10% group ( n \u2009=\u20099), despite similar cardiac output.", {"entities": []}], ["Hepatic lactate influx and uptake in the Lac \u226510% group were approximately 1.5 and 3 times higher, respectively, than in the Lac <10% group ( p \u2009=\u20090.066 for both).", {"entities": []}], ["A decrease in Lac >10% during early resuscitation (6\u00a0h) after abdominal sepsis is associated with lower levels of plasma interleukin-6 and improved brain but not hepatic or muscle mitochondrial respiration.", {"entities": []}], ["Blood flow redistribution to abdominal organs in animals with early decrease in Lac concentrations increases the potential to both deliver and extract Lac.", {"entities": []}], ["The online version of this article (doi:10.1186/s13054-017-1691-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["We investigated the diversity and distribution of fungi in nine different sites inside 30 residential dishwashers.", {"entities": []}], ["In total, 503 fungal strains were isolated, which belong to 10 genera and 84 species.", {"entities": []}], ["Irrespective of the sampled site, 83% of the dishwashers were positive for fungi.", {"entities": []}], ["The most frequent opportunistic pathogenic species were Exophiala dermatitidis , Candida parapsilosis sensu stricto , Exophiala phaeomuriformis , Fusarium dimerum , and the Saprochaete/Magnusiomyces clade.", {"entities": []}], ["The black yeast E .", {"entities": []}], ["dermatitidis was detected in 47% of the dishwashers, primarily at the dishwasher rubber seals, at up to 10 F .", {"entities": []}], ["dimerum was isolated from washed dishes, while dishwasher waste water contained E .", {"entities": []}], ["dermatitidis , Exophiala oligosperma and Sarocladium killiense .", {"entities": []}], ["Plumbing systems supplying water to household appliances represent the most probable route for contamination of dishwashers, as the fungi that represented the core dishwasher mycobiota were also detected in the tap water.", {"entities": []}], ["Hot aerosols from dishwashers contained the human opportunistic yeast C .", {"entities": []}], ["parapsilosis , Rhodotorula mucilaginosa and E .", {"entities": []}], ["dermatitidis (as well as common air-borne genera such as Aspergillus , Penicillium , Trichoderma and Cladosporium ).", {"entities": []}], ["Comparison of fungal contamination of kitchens without and with dishwashers revealed that virtually all were contaminated with fungi.", {"entities": []}], ["In both cases, the most contaminated sites were the kitchen drain and the dish drying rack.", {"entities": []}], ["The most important difference was higher prevalence of black yeasts ( E .", {"entities": []}], ["dermatitidis in particular) in kitchens with dishwashers.", {"entities": []}], ["In kitchens without dishwashers, C .", {"entities": []}], ["parapsilosis strongly prevailed with negligible occurrence of E .", {"entities": []}], ["dermatitidis .", {"entities": []}], ["dimerum was isolated only from kitchens with dishwashers, while Saprochaete/Magnusiomyces isolates were only found within dishwashers.", {"entities": []}], ["We conclude that dishwashers represent a reservoir of enriched opportunistic pathogenic species that can spread from the dishwasher into the indoor biome.", {"entities": []}], ["Nutritional supplements are popular among athletes to improve performance and physical recovery.", {"entities": []}], ["Protein supplements fulfill this function by improving performance and increasing muscle mass; however, their effect on other organs or systems is less well known.", {"entities": []}], ["Diet alterations can induce gut microbiota imbalance, with beneficial or deleterious consequences for the host.", {"entities": []}], ["To test this, we performed a randomized pilot study in cross-country runners whose diets were complemented with a protein supplement (whey isolate and beef hydrolysate) ( n = 12) or maltodextrin (control) ( n = 12) for 10 weeks.", {"entities": []}], ["Microbiota, water content, pH, ammonia, and short-chain fatty acids (SCFAs) were analyzed in fecal samples, whereas malondialdehyde levels (oxidative stress marker) were determined in plasma and urine.", {"entities": []}], ["Fecal pH, water content, ammonia, and SCFA concentrations did not change, indicating that protein supplementation did not increase the presence of these fermentation-derived metabolites.", {"entities": []}], ["Similarly, it had no impact on plasma or urine malondialdehyde levels; however, it increased the abundance of the Bacteroidetes phylum and decreased the presence of health-related taxa including Roseburia , Blautia , and Bifidobacterium longum .", {"entities": []}], ["Thus, long-term protein supplementation may have a negative impact on gut microbiota.", {"entities": []}], ["Further research is needed to establish the impact of protein supplements on gut microbiota.", {"entities": []}], ["It is common in asthma and allergy clinics to see patients presenting with upper and lower airway symptoms that are induced by chemicals and scents and not explained by allergic or asthmatic reactions.", {"entities": [[16, 22, "DISEASE"]]}], ["Previous studies have shown that these patients often have increased cough sensitivity to inhaled capsaicin; such sensitivity is known to reflect the airway sensory reactivity.", {"entities": []}], ["The aim of this study was to evaluate the duration of symptoms induced by chemicals and scents and to measure health-related quality of life (HRQL) in patients with chemically induced airway symptoms.", {"entities": []}], ["We also wished to determine and compare repeatability of the cough response to capsaicin inhalation, and to evaluate the patients\u2019 airway sensory reactivity in a long-term perspective.", {"entities": []}], ["Seventeen patients with a history of at least 12 months of airway symptoms induced by chemicals and scents were followed over 5 years with repeated questionnaires, measurements of HRQL, and capsaicin inhalation tests.", {"entities": []}], ["The symptoms persisted and did not change significantly over time, and the patients had a reduced HRQL that did not change during the 5-year period.", {"entities": []}], ["The capsaicin sensitivity was increased at the start of the study, the cough sensitivity was long-lasting, and the repeatability of the capsaicin inhalation test was considered to be good in a long-term perspective.", {"entities": []}], ["Upper and lower airway symptoms induced by chemicals and scents represent an entity of chronic diseases, different from asthma or chronic obstructive pulmonary disease, with persistent symptoms, a reduced HRQL, and unchanged sensory hyperreactivity.", {"entities": [[130, 167, "DISEASE"], [120, 126, "DISEASE"]]}], ["Inflammation is a comprehensive array of physiological response to a foreign organism, including human pathogens, dust particles, and viruses.", {"entities": []}], ["Inflammations are mainly divided into acute and chronic inflammation depending on various inflammatory processes and cellular mechanisms.", {"entities": []}], ["Recent investigations have clarified that inflammation is a major factor for the progression of various chronic diseases/disorders, including diabetes, cancer, cardiovascular diseases, eye disorders, arthritis, obesity, autoimmune diseases, and inflammatory bowel disease.", {"entities": [[245, 271, "DISEASE"], [211, 218, "DISEASE"], [200, 209, "DISEASE"], [152, 158, "DISEASE"]]}], ["Free radical productions from different biological and environmental sources are due to an imbalance of natural antioxidants which further leads to various inflammatory associated diseases.", {"entities": []}], ["In this review article, we have outlined the inflammatory process and its cellular mechanisms involved in the progression of various chronic modern human diseases.", {"entities": []}], ["In addition, we have discussed the role of free radicals-induced tissue damage, antioxidant defence, and molecular mechanisms in chronic inflammatory diseases/disorders.", {"entities": []}], ["The systematic knowledge regarding the role of inflammation and its associated adverse effects can provide a clear understanding in the development of innovative therapeutic targets from natural sources that are intended for suppression of various chronic inflammations associated diseases.", {"entities": []}], ["To undertake a process evaluation of pharmacists' recommendations arising in the context of a complex IT-enabled pharmacist-delivered randomised controlled trial (PINCER trial) to reduce the risk of hazardous medicines management in general practices.", {"entities": []}], ["PINCER pharmacists manually recorded patients' demographics, details of interventions recommended, actions undertaken by practice staff and time taken to manage individual cases of hazardous medicines management.", {"entities": []}], ["Data were coded, double-entered into SPSS version 15 and then summarised using percentages for categorical data (with 95% confidence interval (CI)) and, as appropriate, means (\u00b1 standard deviation) or medians (interquartile range) for continuous data.", {"entities": []}], ["Pharmacists spent a median of 20\u00a0min (interquartile range 10, 30) reviewing medical records, recommending interventions and completing actions in each case of hazardous medicines management.", {"entities": []}], ["Pharmacists judged 72% (95% CI 70, 74; 1463/2026) of cases of hazardous medicines management to be clinically relevant.", {"entities": []}], ["Pharmacists recommended 2105 interventions in 74% (95% CI 73, 76; 1516/2038) of cases and 1685 actions were taken in 61% (95% CI 59, 63; 1246/2038) of cases; 66% (95% CI 64, 68; 1383/2105) of interventions recommended by pharmacists were completed and 5% (95% CI 4, 6; 104/2105) of recommendations were accepted by general practitioners (GPs), but not completed at the end of the pharmacists' placement; the remaining recommendations were rejected or considered not relevant by GPs.", {"entities": []}], ["The outcome measures were used to target pharmacist activity in general practice towards patients at risk from hazardous medicines management.", {"entities": []}], ["Recommendations from trained PINCER pharmacists were found to be broadly acceptable to GPs and led to ameliorative action in the majority of cases.", {"entities": []}], ["It seems likely that the approach used by the PINCER pharmacists could be employed by other practice pharmacists following appropriate training.", {"entities": []}], ["To understand and predict chronic obstructive pulmonary disease (COPD), a biomarker that reflects disease severity is needed.", {"entities": [[26, 63, "DISEASE"]]}], ["Data from 10269 adults aged over 40 years of age were retrieved from the Korea National Health and Nutrition Examination Survey (KNHANES), and 1302 patients met the criteria for COPD.", {"entities": []}], ["The association between values of vitamin D and parathyroid hormone (PTH), and COPD severity including lung function and quality of life, were analyzed.", {"entities": [[69, 72, "GENE"]]}], ["In COPD patients, lung function was inversely related to PTH values ( P = 0.02 for FVC [% predicted]; P < 0.001 for FEV 1 [% predicted]); however, the association of lung function with vitamin D levels was not statistically significant in a multivariable analysis.", {"entities": [[57, 60, "GENE"], [116, 119, "GENE"]]}], ["Value of PTH was independently associated with EQ5D-index ( P = 0.04), but vitamin D level showed no significant relationship with EQ5D-index ( P = 0.59) or EQ5D-VAS ( P = 0.81).", {"entities": [[9, 12, "GENE"]]}], ["Elevation of PTH, unlike vitamin D, is independently associated with COPD severity, and may be a better biomarker for COPD.", {"entities": [[13, 16, "GENE"]]}], ["This study was performed to determine the changes in pulmonary function in patients randomised to receive treatment with four cycles of bleomycin, etoposide and cisplatin (BEP) (27 patients) or with four cycles of etoposide and cisplatin (EP) (27 patients) for disseminated non-seminomatous testicular cancer.", {"entities": [[291, 308, "DISEASE"], [302, 308, "DISEASE"]]}], ["This enabled us to establish whether effects other than those due to bleomycin determined the detrimental effects of BEP on lung function assessments.", {"entities": []}], ["Slow inspiratory vital capacity (VC), the transfer factor of the lungs for carbon monoxide (TLCO), the diffusing capacity of the alveolo-capillary membrane (Dm), the pulmonary capillary blood volume (Vc) and the transfer factor of the lungs for carbon monoxide per unit alveolar volume (KCO) were determined before and at 3 week intervals during chemotherapy.", {"entities": []}], ["Both groups, similar in terms of factors that may influence pulmonary function, showed during therapy a significant decrease in TLCO compared with the pretreatment value.", {"entities": []}], ["Only at the end of the therapy was a significant difference in TLCO between both groups observed.", {"entities": []}], ["Dm diminished also significantly in both groups during treatment, but differences between both groups were not seen.", {"entities": []}], ["VC and Vc decreased in patients receiving BEP but remained constant during treatment with EP.", {"entities": []}], ["It can be concluded that the Dm, KCO, and the widely used TLCO are not suitable parameters to monitor specifically pulmonary toxicity induced by bleomycin as part of a multidrug regimen.", {"entities": []}], ["However, VC and Vc appear to be proper lung function assessments which reflect specifically alterations induced by bleomycin.", {"entities": []}], ["Ongoing growth in health care expenditures and changing patterns in the demand for health care challenge societies worldwide.", {"entities": []}], ["The Chronic Care Model (CCM), combined with classification for care needs based on Kaiser Permanente (KP) Triangle, may offer a suitable framework for change.", {"entities": []}], ["The aim of the present study is to investigate the effectiveness of Embrace, a population-based model for integrated elderly care, regarding patient outcomes, service use, costs, and quality of care.", {"entities": []}], ["The CCM and the KP Triangle were translated to the Dutch setting and adapted to the full elderly population living in the community.", {"entities": []}], ["A randomized controlled trial with balanced allocation was designed to test the effectiveness of Embrace.", {"entities": []}], ["Eligible elderly persons are 75 years and older and enrolled with one of the participating general practitioner practices.", {"entities": []}], ["Based on scores on the INTERMED-Elderly Self-Assessment and Groningen Frailty Indicator, participants will be stratified into one of three strata: (A) robust; (B) frail; and (C) complex care needs.", {"entities": []}], ["Next, participants will be randomized per stratum to Embrace or care as usual.", {"entities": []}], ["Embrace encompasses an Elderly Care Team per general practitioner practice, an Electronic Elderly Record System, decision support instruments, and a self-management support and prevention program \u2013 combined with care and support intensity levels increasing from stratum A to stratum C. Primary outcome variables are patient outcomes, service use, costs, and quality of care.", {"entities": []}], ["Data will be collected at baseline, twelve months after starting date, and during the intervention period.", {"entities": []}], ["This study could provide evidence for the effectiveness of Embrace.", {"entities": []}], ["The Netherlands National Trial Register NTR3039", {"entities": []}], ["Chronic obstructive pulmonary disease is associated with significant morbidity and mortality.", {"entities": [[0, 37, "DISEASE"]]}], ["Trials of maintenance chronic obstructive pulmonary disease treatments focus on improvement in lung function and reductions in exacerbations, while patients are much more concerned about symptoms and health status.", {"entities": [[22, 59, "DISEASE"]]}], ["Our aim was to investigate the effects of tiotropium\u2009+\u2009olodaterol on patient-reported health outcomes, breathlessness and night-time rescue medication use in patients with chronic obstructive pulmonary disease, compared to placebo, tiotropium or olodaterol monotherapy.", {"entities": [[172, 209, "DISEASE"]]}], ["Two pairs of replicate, phase III studies of 12 (OTEMTO 1\u2009+\u20092) and 52 weeks\u2019 (TONADO 1\u2009+\u20092) duration were evaluated, in which patients received either tiotropium\u2009+\u2009olodaterol 2.5/5 or 5/5\u2009\u03bcg, tiotropium 2.5 or 5\u2009\u03bcg, olodaterol 5\u2009\u03bcg or placebo, all delivered once daily via Respimat inhaler.", {"entities": []}], ["Patient-reported outcomes included breathlessness assessed by transition dyspnoea index focal score, health status assessed by St George\u2019s Respiratory Questionnaire total score and night-time rescue medication use at 12 or 24 weeks.", {"entities": []}], ["Outcomes from the pooled study data are reported.", {"entities": []}], ["Overall, 1621 and 5162 patients were treated in the OTEMTO and TONADO trials, respectively.", {"entities": []}], ["Significantly larger improvements in St George\u2019s Respiratory Questionnaire and transition dyspnoea index focal scores were observed and a greater proportion of patients were responders to therapy (based on minimum clinically important differences in St George\u2019s Respiratory Questionnaire and transition dyspnoea index) with tiotropium\u2009+\u2009olodaterol compared to either monotherapy or to placebo.", {"entities": []}], ["Tiotropium\u2009+\u2009olodaterol 5/5\u2009\u00b5g significantly reduced night-time rescue medication usage.", {"entities": []}], ["Results from four in-depth studies show that a combined inhaler is very effective for treatment of moderate to severe chronic lung disease.", {"entities": [[126, 138, "DISEASE"]]}], ["Alleviating the symptoms of chronic obstructive pulmonary disease (COPD), particularly sleep disturbance, is crucial to enhancing patients\u2019 quality of life.", {"entities": [[28, 65, "DISEASE"]]}], ["Gary Ferguson at the Pulmonary Research Institute of Southeast Michigan, together with other scientists across the USA and Germany, analysed data from four large-scale studies to evaluate the efficacy of STIOLTO Respimat, a combination of two bronchodilators\u2014tiotropium, and olodaterol, which tackle airway obstruction and breathlessness, improving long-term lung function.", {"entities": []}], ["They found that the new drug combination triggered significant improvements in patients\u2019 quality of life and levels of breathlessness.", {"entities": []}], ["Use of night-time rescue medication in patients on STIOLTO Respimat was considerably reduced.", {"entities": []}], ["A greater number of patients responded positively to the combined inhaler than to monotherapy.", {"entities": []}], ["To investigate access to weight management interventions for overweight and obese patients in primary care.", {"entities": []}], ["UK primary care electronic health records.", {"entities": []}], ["A cohort of 91\u2005413 overweight and obese patients aged 30\u2013100\u2005years was sampled from the Clinical Practice Research Datalink (CPRD).", {"entities": []}], ["Patients with body mass index (BMI) values \u226525\u2005kg/m Interventions for body weight management, including advice, referrals and prescription of antiobesity drugs, were evaluated.", {"entities": []}], ["The rate of body weight management interventions and time to intervention were the main outcomes.", {"entities": []}], ["Data were analysed for 91\u2005413 patients, mean age 56\u2005years, including 55\u2005094 (60%) overweight and 36\u2005319 (40%) obese, including 4099 (5%) with morbid obesity.", {"entities": [[149, 156, "DISEASE"], [142, 156, "DISEASE"]]}], ["During the study period, 90% of overweight patients had no weight management intervention recorded.", {"entities": []}], ["Intervention was more frequent among obese patients, but 59% of patients with morbid obesity had no intervention recorded.", {"entities": [[85, 92, "DISEASE"], [78, 92, "DISEASE"]]}], ["Rates of intervention increased with BMI category.", {"entities": []}], ["In morbid obesity, rates of intervention per 1000 patient years were: advice, 60.2 (95% CI 51.8 to 70.4); referral, 75.7 (95% CI 69.5 to 82.6) and antiobesity drugs 89.9 (95% CI 85.0 to 95.2).", {"entities": [[10, 17, "DISEASE"], [3, 17, "DISEASE"]]}], ["Weight management interventions were more often accessed by women, older patients, those with comorbidity and those in deprivation.", {"entities": []}], ["Follow-up of body weight subsequent to interventions was infrequent.", {"entities": []}], ["Limited evidence of weight management interventions in primary care electronic health records may result from poor recording of advice given, but may indicate a lack of patient access to appropriate body weight management interventions in primary care.", {"entities": []}], ["Postoperative pulmonary complications (PPCs) are major causes of morbidity, mortality, and prolonged hospital stay in patients after surgery.", {"entities": [[39, 43, "GENE"]]}], ["Using effective strategies to prevent its occurrence is essential to improve outcome.", {"entities": []}], ["However, despite various efforts, the incidence of PPCs remains elevated in high-risk patients.", {"entities": [[51, 55, "GENE"]]}], ["Anticholinergic inhalation is used to reduce high airway resistance and improve pulmonary function; it may be helpful to decrease the risk of PPCs.", {"entities": [[142, 146, "GENE"]]}], ["Penehyclidine is a long-acting anticholinergic agent which selectively blocks M1 and M3 receptors.", {"entities": []}], ["We hypothesize that, in high-risk patients, prophylactic penehyclidine inhalation may decrease the incidence of PPCs.", {"entities": [[112, 116, "GENE"]]}], ["This is a randomized, double-blind, placebo-controlled trial with two parallel arms.", {"entities": []}], ["A total of 864 patients at high risk of PPCs will be enrolled and randomized to receive prophylactic inhalation of either penehyclidine or placebo (water for injection).", {"entities": [[40, 44, "GENE"]]}], ["Study drug inhalation will be administered from the night (7\u00a0pm) before surgery until the second day after surgery, in an interval of every 12\u00a0hours.", {"entities": []}], ["The primary outcome is the incidence of PPCs within 30\u00a0days after surgery.", {"entities": [[40, 44, "GENE"]]}], ["Secondary outcomes include the time to onset of PPCs (from end of surgery to first diagnosis of PPCs), the number of PPCs (indicates the number of diagnosed individual PPCs), the incidence of postoperative extrapulmonary complications, the length of stay in hospital after surgery, and the 30-day all-cause mortality.", {"entities": [[48, 52, "GENE"], [96, 100, "GENE"], [117, 121, "GENE"], [168, 172, "GENE"], [48, 52, "GENE"], [96, 100, "GENE"], [117, 121, "GENE"], [168, 172, "GENE"], [48, 52, "GENE"], [96, 100, "GENE"], [117, 121, "GENE"], [168, 172, "GENE"], [48, 52, "GENE"], [96, 100, "GENE"], [117, 121, "GENE"], [168, 172, "GENE"]]}], ["Results of the present study will provide evidence to guide clinical practice in using prophylactic inhalation of an anticholinergic to prevent PPCs in high-risk patients.", {"entities": [[144, 148, "GENE"]]}], ["The study was registered prospectively in Chinese Clinical Trial Registry ( www.chictr.org.cn , ChiCTR-IPC-15006603 ) on 14 May 2015 and retrospectively in ClinicalTrials.gov ( NCT02644876 ) on 30 December 2015.", {"entities": []}], ["The online version of this article (doi:10.1186/s13063-017-2315-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Mycoplasmas are fastidious slow growing organisms lacking a cell wall and mostly isolated from the mucosal surfaces of the respiratory and genitourinary tracts.", {"entities": []}], ["There is a dearth of information regarding clinical Mycoplasma spp.", {"entities": []}], ["isolates among Egyptian patients.", {"entities": []}], ["A total of 170 samples were collected from patients and apparently healthy personnel in local public hospitals in Cairo, Egypt.", {"entities": []}], ["Isolation of Mycoplasma spp.", {"entities": []}], ["was carried out using appropriate culture media and further identification was carried out by biochemical tests followed by serotyping using specific antisera.", {"entities": []}], ["Confirmation was done by PCR for detection of different Mycoplasma spp.", {"entities": []}], ["using genus-specific primers targeting 16S ribosomal RNA gene.", {"entities": []}], ["Characterization of the antibiotic resistance and sensitivity pattern against different antimicrobials was carried out using disc diffusion test.", {"entities": []}], ["The results indicated the presence of six Mycoplasma spp.", {"entities": []}], ["in 22.94% of the samples.", {"entities": []}], ["Mycoplasmas were detected more frequently in throat swabs than sputum.", {"entities": []}], ["Mycoplasma pneumoniae was highly sensitive to macrolides and quinolones but less sensitive to aminoglycosides and tetracyclines.", {"entities": []}], ["Molecular techniques were found to be of more rapid, highly sensitive, able to detect nonviable organisms, and cost effective.", {"entities": []}], ["These results shed light on difficulties of Mycoplasma detection and the superiority of molecular techniques over culture.", {"entities": []}], ["Given the relative abundance and toxic potential of acrolein in inhaled cigarette smoke, it is surprising how little is known about the pulmonary and systemic effects of acrolein.", {"entities": []}], ["Here we test the hypothesis whether systemic administration of acrolein could cause endoplasmic reticulum (ER) stress, and lung cell apoptosis, leading to the enlargement of the alveolar air spaces in rats.", {"entities": []}], ["Acute and chronic effects of intraperitoneally administered acrolein were tested.", {"entities": []}], ["Mean alveolar airspace area was measured by using light microscopy and imaging system software.", {"entities": []}], ["TUNEL staining and immunohistochemistry (IHC) for active caspase 3 and Western blot analysis for active caspase 3, and caspase 12 were performed to detect apoptosis.", {"entities": []}], ["The ER-stress related gene expression in the lungs was determined by Quantitative real-time PCR analysis.", {"entities": []}], ["Acrolein-protein adducts in the lung tissue were detected by IHC.", {"entities": []}], ["Acute administration of acrolein caused a significant elevation of activated caspase 3, upregulation of VEGF expression and induced ER stress proteins in the lung tissue.", {"entities": []}], ["The chronic administration of acrolein in rats led to emphysematous lung tissue remodeling.", {"entities": []}], ["TUNEL staining and IHC for cleaved caspase 3 showed a large number of apoptotic septal cells in the acrolein-treated rat lungs.", {"entities": []}], ["Chronic acrolein administration cause the endoplasmic reticulum stress response manifested by significant upregulation of ATF4, CHOP and GADd34 expression.", {"entities": [[122, 126, "GENE"]]}], ["In smokers with COPD there was a considerable accumulation of acrolein-protein adducts in the inflammatory, airway and vascular cells.", {"entities": []}], ["Systemic administration of acrolein causes endoplasmic reticulum stress response, lung cell apoptosis, and chronic administration leads to the enlargement of the alveolar air spaces and emphysema in rats.", {"entities": []}], ["The substantial accumulation of acrolein-protein adducts in the lungs of COPD patients suggest a role of acrolein in the pathogenesis of emphysema.", {"entities": []}], ["Human rhinovirus (HRV) infections are major contributors to the healthcare burden associated with acute exacerbations of chronic airway disease, such as chronic obstructive pulmonary disease and asthma.", {"entities": [[153, 190, "DISEASE"], [195, 201, "DISEASE"]]}], ["Cellular responses to HRV are mediated through pattern recognition receptors that may in part signal from membrane microdomains.", {"entities": []}], ["We previously found Toll-like receptor signaling is reduced, by targeting membrane microdomains with a specific liposomal phosphatidylserine species, 1-stearoyl-2-arachidonoyl- sn -glycero-3-phospho- L -serine (SAPS).", {"entities": []}], ["Here we explored the ability of this approach to target a clinically important pathogen.", {"entities": []}], ["We determined the biochemical and biophysical properties and stability of SAPS liposomes and studied their ability to modulate rhinovirus-induced inflammation, measured by cytokine production, and rhinovirus replication in both immortalized and normal primary bronchial epithelial cells.", {"entities": []}], ["SAPS liposomes rapidly partitioned throughout the plasma membrane and internal cellular membranes of epithelial cells.", {"entities": []}], ["Uptake of liposomes did not cause cell death, but was associated with markedly reduced inflammatory responses to rhinovirus, at the expense of only modest non-significant increases in viral replication, and without impairment of interferon receptor signaling.", {"entities": []}], ["Thus using liposomes of phosphatidylserine to target membrane microdomains is a feasible mechanism for modulating rhinovirus-induced signaling, and potentially a prototypic new therapy for viral-mediated inflammation.", {"entities": []}], ["AIRNET was a thematic network project (2002\u20132004) initiated to stimulate the interaction between researchers in air pollution and health in Europe.", {"entities": []}], ["As part of AIRNET\u2019s communication strategy, a standardized workshop model was developed to organize national meetings on air pollution and health (AIRNET network days).", {"entities": []}], ["Emphasis was given to tailor the national workshop information and related activities to the specific needs of a wider range of stakeholders (e.g., policy makers, nongovernmental organizations, industry representatives).", {"entities": []}], ["In this report we present an overview of the results of four workshops held in western, northern, central/eastern, and southern regions of Europe in 2004.", {"entities": []}], ["Overall, workshop experiences indicated that by actively involving participants in the planning of each meeting, AIRNET helped create an event that addressed participants\u2019 needs and interests.", {"entities": []}], ["A wide range of communication formats used to discuss air pollution and health also helped stimulate active interaction among participants.", {"entities": []}], ["Overall, the national workshops held by AIRNET offered a way to improve communication among the different stakeholders.", {"entities": []}], ["Because a broad stakeholder involvement in decision making can positively affect the development of widely supported policies, such meetings should be continued for Europe and elsewhere.", {"entities": []}], ["Supplemental Digital Content is available in the text HIV-infected individuals on antiretroviral therapy (ART) are at increased risk of cardiovascular disease (CVD).", {"entities": []}], ["Given the relationship between innate immune activation and CVD, we investigated the association of single-nucleotide polymorphisms (SNPs) in TLR4 and CD14 and carotid intima-media thickness (cIMT), a surrogate measurement for CVD, in HIV-infected individuals on ART and HIV-uninfected controls as a cross-sectional, case-control study.", {"entities": [[142, 146, "GENE"], [151, 155, "GENE"]]}], ["We quantified the frequency of monocyte subsets (CD14, CD16), markers of monocyte activation (CD38, HLA-DR), and endothelial adhesion (CCR2, CX3CR1, CD11b) by flow cytometry.", {"entities": [[49, 53, "GENE"], [94, 98, "GENE"], [135, 139, "GENE"], [141, 147, "GENE"]]}], ["Plasma levels of lipopolysaccharide, sCD163, sCD14, sCX3CL1, and sCCL2, were measured by ELISA.", {"entities": []}], ["Genotyping of TLR4 and CD14 SNPs was also performed.", {"entities": [[14, 18, "GENE"], [23, 27, "GENE"]]}], ["The TT genotype for CD14 /\u2212260SNP but not the CC/CT genotype was associated with elevated plasma sCD14, and increased frequency of CD11b+CD14+ monocytes in HIV-infected individuals.", {"entities": [[20, 24, "GENE"], [137, 141, "GENE"]]}], ["The TT genotype was associated with lower cIMT in HIV-infected patients (n\u200a=\u200a47) but not in HIV-uninfected controls (n\u200a=\u200a37).", {"entities": []}], ["The AG genotype for TLR4 / +896 was associated with increased CX3CR1 expression on total monocytes among HIV-infected individuals and increased sCCL2 and fibrinogen levels in HIV-uninfected controls.", {"entities": [[20, 24, "GENE"], [62, 68, "GENE"]]}], ["SNPs in CD14 /\u2212 260 and TLR4 / +896 were significantly associated with different markers of systemic and monocyte activation and cIMT that differed between HIV-infected participants on ART and HIV-uninfected controls.", {"entities": [[8, 12, "GENE"], [24, 28, "GENE"]]}], ["Further investigation on the relationship of these SNPs with a clinical endpoint of CVD is warranted in HIV-infected patients on ART.", {"entities": []}], ["The hypothalamic-pituitary-adrenal (HPA) axis plays an important role in regulating and controlling immune responses.", {"entities": []}], ["Dysfunction of the HPA axis has been implicated in the pathogenesis of rheumatoid arthritis (RA) and other rheumatic diseases.", {"entities": [[71, 91, "DISEASE"], [82, 91, "DISEASE"]]}], ["The impact of glucocorticoid (GC) therapy on HPA axis function also remains a matter of concern, particularly for longer treatment duration.", {"entities": [[30, 32, "GENE"]]}], ["Knowledge of circadian rhythms and the influence of GC in rheumatology is important: on the one hand we aim for optimal treatment of the daily undulating inflammatory symptoms, for example morning stiffness and swelling; on the other, we wish to disturb the HPA axis as little as possible.", {"entities": [[52, 54, "GENE"]]}], ["This review describes circadian rhythms in RA and other chronic inflammatory diseases, dysfunction of the HPA axis in RA and other rheumatic diseases and the recent concept of the hepato-hypothalamic-pituitary-adrenal-renal axis, the problem of adrenal suppression by GC therapy and how it can be avoided, and evidence that chronotherapy with modified release prednisone effective at 02:00 a.m. can inhibit proinflammatory sequelae of nocturnal inflammation better compared with GC administration in the morning but does not increase the risk of HPA axis insufficiency in RA.", {"entities": [[268, 270, "GENE"], [479, 481, "GENE"], [268, 270, "GENE"], [479, 481, "GENE"]]}], ["Patients with obstructive sleep apnea (OSA) have been described to have increased levels of inflammatory cytokines (particularly TNF-\u03b1) and have severely disturbed sleep architecture.", {"entities": []}], ["Serum inflammatory markers, even in normal individuals, have been associated with abnormal sleep architecture.", {"entities": []}], ["Not much is known about the role the TNF receptor plays in the inflammation of OSA nor if it is associated with changes in sleep architecture or arousals during the night.", {"entities": [[37, 40, "GENE"]]}], ["We hypothesized that the TNF receptor might play an important role in the inflammation as well as sleep architecture changes in patients with OSA.", {"entities": [[25, 28, "GENE"]]}], ["Thirty-six patients with diagnosed (AHI\u2009>\u200915) but untreated OSA were enrolled in this study.", {"entities": []}], ["Baseline polysomnograms as well as TNF-\u03b1 and soluble TNF receptor I (sTNF-RI) serum levels were obtained on all patients.", {"entities": [[35, 38, "GENE"], [53, 56, "GENE"]]}], ["We evaluated the association between serum levels of TNF-\u03b1 and sTNF-RI with various polysomongraphic characteristics, including sleep stages and EEG arousals.", {"entities": []}], ["sTNF-RI levels were significantly correlated with snore arousals ( r value 0.449, p value 0.009), spontaneous movement arousals ( r value 0.378, p value 0.025), and periodic limb movement arousals ( r value 0.460, p value 0.008).", {"entities": []}], ["No statistically significant correlations were observed with TNF-\u03b1 to any polysomnographic variables.", {"entities": []}], ["To control for statistical significance with multiple comparisons, a MANOVA was performed with TNF-\u03b1 and sTNF-RI as dependent variables and sleep architecture measures and arousals as independent variables.", {"entities": []}], ["The model for sTNF-RI was statistically significant ( F value 2.604, p value 0.03), whereas the model for TNF-\u03b1 was not, suggesting sleep quality significantly affects sTNF-RI.", {"entities": []}], ["Hierarchal linear regression analysis demonstrated that sTNF-RI was independently associated with spontaneous movement arousal index scores after controlling for age, body mass index, and sleep apnea severity.", {"entities": []}], ["These findings suggest that sTNF-RI is associated with arousals during sleep, but not with other measures in patients with OSA.", {"entities": []}], ["Leukotriene B 4 (LTB 4 ) is a potent lipid mediator of inflammation, and its biological effects are mediated primarily through the high affinity LTB 4 receptor BLT1.", {"entities": [[17, 20, "GENE"], [145, 148, "GENE"], [17, 20, "GENE"], [145, 148, "GENE"]]}], ["Although numerous studies have reported that LTB 4 -BLT1 signaling is involved in inflammatory diseases, the role of BLT1 signaling in pain remains undefined.", {"entities": [[45, 48, "GENE"]]}], ["To clarify the role of LTB 4 -BLT1 signaling in acute inflammatory pain induced by tissue injury, we performed pain behavioral analysis and assessment of local inflammation induced by peripheral formalin injections in BLT1 knockout mice.", {"entities": [[23, 26, "GENE"]]}], ["We examined the phosphorylation of cAMP response element-binding protein (CREB) in the spinal cord both in wild-type and BLT1 knockout mice because phosphorylation of CREB in spinal cord neurons is important for nociceptive sensitization following peripheral injury.", {"entities": []}], ["We also examined the effect of a BLT1 antagonist on formalin-induced pain responses in mice.", {"entities": []}], ["BLT1 knockout mice exhibited markedly attenuated nociceptive responses induced by intraplantar formalin injections.", {"entities": []}], ["Edema formation and neutrophil infiltration in the paw were significantly decreased in BLT1 knockout mice compared with wild-type mice.", {"entities": []}], ["Phosphorylation of CREB in the spinal cord after the intraplantar formalin injection was decreased in BLT1 knockout mice.", {"entities": []}], ["In addition, mice pretreated with a BLT1 antagonist showed reduced nociception and attenuated CREB phosphorylation in the spinal cord after the formalin injection.", {"entities": []}], ["Our data suggest that LTB 4 -BLT1 axis contributes not only to the peripheral inflammation but also to the neuronal activation in the spinal cord induced by intraplantar formalin injections.", {"entities": [[22, 25, "GENE"]]}], ["Thus, LTB 4 -BLT1 signaling is a potential target for therapeutic intervention of acute and persistent pain induced by tissue injury.", {"entities": [[6, 9, "GENE"]]}], ["the addition of oligosaccharides to infant formula has been shown to mimic some of the beneficial effects of human milk.", {"entities": []}], ["The aim of the study was to assess the tolerance and safety of a formula containing an innovative mixture of oligosaccharides in early infancy.", {"entities": []}], ["this study was performed as a multi-center, randomized, double-blind, placebo-controlled trial including healthy term infants.", {"entities": []}], ["Infants were recruited before the age of 8 weeks, either having started with formula feeding or being fully breast-fed (breastfeeding group).", {"entities": []}], ["Formula-fed infants were randomized to feeding with a regular formula containing a mixture of neutral oligosaccharides and pectin-derived acidic oligosaccharides (prebiotic formula group) or regular formula without oligosaccharides (control formula group).", {"entities": []}], ["Growth, tolerance and adverse events were assessed at 8, 16, 24 and 52 weeks of age.", {"entities": []}], ["The prebiotic and control groups showed similar mean weight, length and head circumference, skin fold thicknesses, arm circumference gains and stool frequency at each study point.", {"entities": []}], ["As far as the anthropometric parameters are concerned, the prebiotic group and the control group did not attain the values shown by the breastfeeding group at any study point.", {"entities": []}], ["The skin fold thicknesses assessed in the breastfeeding group at 8 weeks were strikingly larger than those in formula fed infants, whereas at 52 weeks were strikingly smaller.", {"entities": []}], ["The stool consistency in the prebiotic group was softer than in the control group at 8, 16 and 24 weeks (p<0.001) and closer to that of the breastfeeding group.", {"entities": []}], ["There was no difference in the incidence of adverse events between the two formula groups.", {"entities": []}], ["our findings demonstrate the tolerability and the long term safety of a formula containing an innovative mixture of oligosaccharides in a large cohort of healthy infants.", {"entities": []}], ["drks-neu.uniklinik-freiburg.de DRKS 00000201", {"entities": []}], ["Obesity and overeating are among the most prevalent health concerns worldwide and individuals are increasingly using performance and image-enhancing drugs (PIEDs) as an easy and fast way to control their weight.", {"entities": []}], ["Among these, herbal weight-loss products (HWLPs) often attract users due to their health claims, assumed safety, easy availability, affordable price, extensive marketing, and the perceived lack of need for professional oversight.", {"entities": []}], ["Reports suggest that certain HWLPs may lead to onset or exacerbation of psychiatric disturbances.", {"entities": []}], ["Here we review the available evidence on psychiatric adverse effects of HWLPs due to their intrinsic toxicity and potential for interaction with psychiatric medications.", {"entities": []}], ["The objective of this study was to design and test the feasibility and impact of a community health worker (CHW) intervention for comorbid asthma and obesity.", {"entities": [[150, 157, "DISEASE"], [139, 145, "DISEASE"]]}], ["Using a proof of concept study design, we collected pre/post outcomes from a single intervention cohort of urban low-income in a single community area.", {"entities": []}], ["A community-based participatory research approach was employed.", {"entities": []}], ["Forty-six children and their caregivers were recruited.", {"entities": []}], ["Children were 5\u201312 years old with physician-diagnosed asthma and body mass index (BMI)\u2009>\u200985%.", {"entities": [[54, 60, "DISEASE"]]}], ["Families were offered 12 home visits from CHWs that integrated asthma and obesity core curriculums.", {"entities": [[74, 81, "DISEASE"], [63, 69, "DISEASE"]]}], ["The primary asthma outcome was asthma control, measured via the Childhood Asthma Control Test (cACT).", {"entities": [[12, 18, "DISEASE"], [31, 37, "DISEASE"], [74, 80, "DISEASE"]]}], ["The primary obesity outcome was child body mass index (BMI).", {"entities": [[12, 19, "DISEASE"]]}], ["Families received a median of 10 out of the 12 home visits over 1 year.", {"entities": []}], ["At 1 year, there was a significant improvement in the number of children with controlled asthma as measured via cACT (85.7% at 1 year compared to 61.9% at baseline, p \u2009=\u20090.01).", {"entities": [[89, 95, "DISEASE"]]}], ["Activity limitations and emergency utilization were reduced while inhaler technique improved ( p \u2009<\u20090.01 for all).", {"entities": []}], ["Child BMI z-score was reduced: mean\u2009=\u20091.97 (SD 0.79) at 1 year compared to mean\u2009=\u20092.13 (SD 0.40) at baseline, p \u2009<\u20090.01.", {"entities": []}], ["No association was seen between change in child BMI and change in asthma control.", {"entities": [[66, 72, "DISEASE"]]}], ["Worse baseline child depression scores were associated with less improvement in asthma control ( p \u2009=\u20090.003) and higher baseline caregiver post-traumatic stress disorder scores were associated with increased child BMI ( p \u2009=\u20090.012).", {"entities": [[139, 169, "DISEASE"], [80, 86, "DISEASE"]]}], ["The CHW intervention has promise for improving asthma and weight outcomes in high-risk children with comorbid asthma and obesity; this model warrants further development and investigation.", {"entities": [[121, 128, "DISEASE"], [47, 53, "DISEASE"], [110, 116, "DISEASE"]]}], ["REALISE Asia\u2014an online questionnaire-based study of Asian asthma patients\u2014identified five patient clusters defined in terms of their control status and attitude towards their asthma (categorised as: \u2018Well-adjusted and at least partly controlled\u2019; \u2018In denial about symptoms\u2019; \u2018Tolerating with poor control\u2019; \u2018Adrift and poorly controlled\u2019; \u2018Worried with multiple symptoms\u2019).", {"entities": [[58, 64, "DISEASE"], [175, 181, "DISEASE"]]}], ["We developed consensus recommendations for tailoring management of these attitudinal\u2013control clusters.", {"entities": []}], ["An expert panel undertook a three-round electronic Delphi (e-Delphi): Round 1: panellists received descriptions of the attitudinal\u2013control clusters and provided free text recommendations for their assessment and management.", {"entities": []}], ["Round 2: panellists prioritised Round 1 recommendations and met (or joined a teleconference) to consolidate the recommendations.", {"entities": []}], ["Round 3: panellists voted and prioritised the remaining recommendations.", {"entities": []}], ["Consensus was defined as Round 3 recommendations endorsed by >50% of panellists.", {"entities": []}], ["Highest priority recommendations were those receiving the highest score.", {"entities": []}], ["The multidisciplinary panellists (9 clinicians, 1 pharmacist and 1 health social scientist; 7 from Asia) identified consensus recommendations for all clusters.", {"entities": []}], ["Recommended pharmacological (e.g., step-up/down; self-management; simplified regimen) and non-pharmacological approaches (e.g., trigger management, education, social support; inhaler technique) varied substantially according to each cluster\u2019s attitude to asthma and associated psychosocial drivers of behaviour.", {"entities": [[255, 261, "DISEASE"]]}], ["The attitudinal\u2013control clusters defined by REALISE Asia resonated with the international panel.", {"entities": []}], ["Consensus was reached on appropriate tailored management approaches for all clusters.", {"entities": []}], ["Summarised and incorporated into a structured management pathway, these recommendations could facilitate personalised care.", {"entities": []}], ["Generalisability of these patient clusters should be assessed in other socio-economic, cultural and literacy groups and nationalities in Asia.", {"entities": []}], ["The trillions of microbes living in the gut\u2014the gut microbiota\u2014play an important role in human biology and disease.", {"entities": []}], ["While much has been done to explore its diversity, a full understanding of our microbiomes demands an evolutionary perspective.", {"entities": []}], ["In this review, we compare microbiomes from human populations, placing them in the context of microbes from humanity\u2019s near and distant animal relatives.", {"entities": []}], ["We discuss potential mechanisms to generate host-specific microbiome configurations and the consequences of disrupting those configurations.", {"entities": []}], ["Finally, we propose that this broader phylogenetic perspective is useful for understanding the mechanisms underlying human\u2013microbiome interactions.", {"entities": []}], ["The incidence of early childhood acute respiratory infections (ARIs) has been associated with aspects of the indoor environment.", {"entities": []}], ["In recent years, public awareness about some of these environmental issues has increased, including new laws and subsequent changes in occupant behaviours.", {"entities": []}], ["This New Zealand study investigated current exposures to specific risk factors in the home during the first five years of life and provided updated evidence on the links between the home environment and childhood ARI hospitalisation.", {"entities": []}], ["Pregnant women ( n \u2009=\u20096822) were recruited in 2009 and 2010, and their 6853 children created a child cohort that was representative of New Zealand births from 2007-10.", {"entities": []}], ["Longitudinal data were collected through face-to-face interviews and linkage to routinely collected national datasets.", {"entities": []}], ["Incidence rates with Poisson distribution confidence intervals were computed and Cox regression modelling for repeated events was performed.", {"entities": []}], ["Living in a rented dwelling (48%), household crowding (22%) or dampness (20%); and, in the child\u2019s room, heavy condensation (20%) or mould or mildew on walls or ceilings (13%) were prevalent.", {"entities": []}], ["In 14% of the households, the mother smoked cigarettes and in 30%, other household members smoked.", {"entities": []}], ["Electric heaters were commonly used, followed by wood, flued gas and unflued portable gas heaters.", {"entities": []}], ["The incidence of ARI hospitalisation before age five years was 33/1000 person-years.", {"entities": []}], ["The risk of ARI hospitalisation was higher for children living in households where there was a gas heater in the child\u2019s bedroom: hazard ratio for flued gas heater 1.69 (95% CI: 1.21-2.36); and for unflued gas heater 1.68 (95% CI: 1.12-2.53); and where a gas heater was the sole type of household heating (hazard ratio: 1.64 (95% CI: 1.29-2.09)).", {"entities": []}], ["The risk was reduced in households that used electric heaters (Hazard ratio: 0.74 (95% CI: 0.61-0.89)) or wood burners (hazard ratio: 0.79 (95% CI: 0.66-0.93)) as a form of household heating.", {"entities": []}], ["The associations with other risk factors were not significant.", {"entities": []}], ["The risk of early childhood ARI hospitalisation is increased by gas heater usage, specifically in the child\u2019s bedroom.", {"entities": []}], ["Use of non-gas forms of heating may reduce the risk of early childhood ARI hospitalisation.", {"entities": []}], ["The online version of this article (doi:10.1186/s12940-016-0207-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Background: Laboratory studies suggest that fine particulate matter (\u2264 2.5 \u00b5m in diameter; PM 2.5 ) can activate pathophysiological responses that may induce insulin resistance and type 2 diabetes.", {"entities": []}], ["However, epidemiological evidence relating PM 2.5 and diabetes is sparse, particularly for incident diabetes.", {"entities": []}], ["Objectives: We conducted a population-based cohort study to determine whether long-term exposure to ambient PM 2.5 is associated with incident diabetes.", {"entities": []}], ["Methods: We assembled a cohort of 62,012 nondiabetic adults who lived in Ontario, Canada, and completed one of five population-based health surveys between 1996 and 2005.", {"entities": []}], ["Follow-up extended until 31 December 2010.", {"entities": []}], ["Incident diabetes diagnosed between 1996 and 2010 was ascertained using the Ontario Diabetes Database, a validated registry of persons diagnosed with diabetes (sensitivity = 86%, specificity = 97%).", {"entities": []}], ["Six-year average concentrations of PM 2.5 at the postal codes of baseline residences were derived from satellite observations.", {"entities": []}], ["We used Cox proportional hazards models to estimate the associations, adjusting for various individual-level risk factors and contextual covariates such as smoking, body mass index, physical activity, and neighborhood-level household income.", {"entities": []}], ["We also conducted multiple sensitivity analyses.", {"entities": []}], ["In addition, we examined effect modification for selected comorbidities and sociodemographic characteristics.", {"entities": []}], ["Results: There were 6,310 incident cases of diabetes over 484,644 total person-years of follow-up.", {"entities": []}], ["The adjusted hazard ratio for a 10-\u00b5g/m 2.5 was 1.11 (95% CI: 1.02, 1.21).", {"entities": []}], ["Estimated associations were comparable among all sensitivity analyses.", {"entities": []}], ["We did not find strong evidence of effect modification by comorbidities or sociodemographic covariates.", {"entities": []}], ["Conclusions: This study suggests that long-term exposure to PM 2.5 may contribute to the development of diabetes.", {"entities": []}], ["We have previously shown that underground railway particulate matter (PM) is rich in iron and other transition metals across coarse (PM 10\u20132.5 ), fine (PM 2.5 ), and quasi-ultrafine (PM 0.18 ) fractions and is able to generate reactive oxygen species (ROS).", {"entities": []}], ["However, there is little knowledge of whether the metal-rich nature of such particles exerts toxic effects in mucus-covered airway epithelial cell cultures or whether there is an increased risk posed by the ultrafine fraction.", {"entities": []}], ["Monolayer and mucociliary air-liquid interface (ALI) cultures of primary bronchial epithelial cells (PBECs) were exposed to size-fractionated underground railway PM (1.1\u201311.1\u2009\u00b5g/cm", {"entities": []}], ["A substantial fraction of UK general practitioners' salaries is now intended to reflect the quality of care provided.", {"entities": []}], ["This performance-related pay system has probably improved aspects of primary health care but, using the observational data available, disentangling the impacts of different types of targets set within this unique payment system is challenging.", {"entities": []}], ["Financial incentives undoubtedly influence GPs' activities, however, those aimed at encouraging GPs' delivery of health promotion counselling may not always have the effects intended.", {"entities": []}], ["There is strong, observational evidence that targets and incentives intended to increase smoking cessation counselling by GPs have merely increased their propensity to record this activity in patients' medical records.", {"entities": []}], ["The limitations of using financial incentives to stimulate the delivery of counselling in primary care are discussed and a re-appraisal of their use within UK GPs' performance-related pay system is argued for.", {"entities": []}], ["The utility of targets employed by the system for UK General Practitioners' performance related pay may be inappropriate for encouraging the delivery of health promotion counselling interventions.", {"entities": []}], ["An evaluation of these targets is essential before they are further developed or added to.", {"entities": []}], ["Both short and long-term exposure to traffic-related air pollutants have been associated with asthma and reduced lung function.", {"entities": [[94, 100, "DISEASE"]]}], ["We hypothesized that short-term indoor exposure to fine particulate matter <2.5\u00a0\u03bcm (PM 2.5 ) and vanadium (V) would be associated with altered buccal cell DNA methylation of targeted asthma genes and decreased lung function among urban children in a nested subcohort of African American and Dominican children.", {"entities": [[183, 189, "DISEASE"]]}], ["Six day integrated levels of air pollutants were measured from children\u2019s homes (age 9\u201314; n \u2009=\u2009163), repeated 6\u00a0months later ( n \u2009=\u200998).", {"entities": []}], ["Buccal samples were collected repeatedly during visits.", {"entities": []}], ["CpG promoter loci of asthma genes (i.e., interleukin 4 (IL4), interferon gamma (IFN\u03b3), inducible nitric oxide synthase (NOS2A), arginase 2 (ARG2)) were pyrosequenced and lung function was assessed.", {"entities": [[21, 27, "DISEASE"], [56, 59, "GENE"], [140, 144, "GENE"]]}], ["Exposure to V, but not PM 2.5 , was associated with lower DNA methylation of IL4 and IFN\u03b3.", {"entities": [[77, 80, "GENE"]]}], ["In exploratory analyses, V levels were associated with lower methylation of the proinflammatory NOS2A-CpG 2.5 , but not V, appeared associated with lower lung function (i.e., reduced z -scores for forced expiratory volume in one second (FEV 1 , FEV 1 / forced vital capacity [FEV 1 /FVC] and forced expiratory flow at 25\u201375% of FVC [FEF 25\u201375 ]).", {"entities": [[237, 240, "GENE"], [245, 248, "GENE"], [276, 279, "GENE"], [237, 240, "GENE"], [245, 248, "GENE"], [276, 279, "GENE"], [237, 240, "GENE"], [245, 248, "GENE"], [276, 279, "GENE"]]}], ["Exposure to V was associated with altered DNA methylation of allergic and proinflammatory asthma genes implicated in air pollution related asthma.", {"entities": [[90, 96, "DISEASE"], [139, 145, "DISEASE"]]}], ["However, short-term exposure to PM 2.5, but not V, appeared associated with decrements in lung function among urban children.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-017-0550-9) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Cysteinyl leukotrienes (cys-LTs), LTC 4 , LTD 4 , LTE 4 are potent inflammatory lipid mediators that act through two distinct G-protein-coupled receptors, CysLT 1 R and CysLT 2 R. Although cys-LTs are shown to induce vascular leakage and atherosclerosis, the molecular mechanism by which cys-LTs modulate endothelial function is not known.", {"entities": [[238, 253, "DISEASE"]]}], ["Here, we show that cys-LTs (LTC 4 and LTD 4 ) induce robust calcium influx in human umbilical vein endothelial cells (HUVECs) through CysLT 2 R, but not CysLT 1 R. Further, cys-LT treatment induced endothelial cell (EC) contraction leading to monolayer disruption via CysLT 2 R/Rho kinase dependent pathway.", {"entities": []}], ["Furthermore, stimulation with cys-LTs potentiated TNF\u03b1-induced VCAM-1 expression and leukocyte recruitment to ECs through CysLT 2 R. In contrast, we found that both LTC 4 and LTD 4 stimulated EC proliferation through CysLT 1 R. Taken together, these results suggest that cys-LTs induce endothelial inflammation and proliferation via CysLT 2 R/Rho kinase and CysLT 1 R/Erk dependent pathways, respectively, which play critical role in the etiology of cardiovascular diseases such as atherosclerosis and myocardial infarction.", {"entities": [[482, 497, "DISEASE"], [502, 523, "DISEASE"]]}], ["Growing evidence is showing a role of neurogenic inflammation in allergic reactions, with sensory and autonomic nerve fibers releasing neuromediators, which may actively participate in the allergic inflammatory cascade.", {"entities": []}], ["Although the cornea is the most densely innervated tissue of the human body, little is known on the role of neuromediators at the ocular surface.", {"entities": []}], ["In this study, we aimed at evaluating the role of substance P (SP), calcitonine gene related peptide (CGRP), neuropeptide Y (NPY) and vasoactive intestinal peptide (VIP) in allergic reactions of the ocular surface.", {"entities": [[125, 128, "GENE"], [165, 168, "GENE"]]}], ["Fifteen patients with allergic conjunctivitis (6 female, 9 male, mean age 30\u00b18 years) in non-active phase, and 10 age-matched healthy subjects were included in this study.", {"entities": [[22, 45, "DISEASE"], [31, 45, "DISEASE"]]}], ["The conjunctival provocation test (CPT) with allergen was performed in all allergic patients and in 5 healthy subjects.", {"entities": []}], ["Tear samples were collected and the tear content of VIP, NPY, CGRP, and SP was measured by ELISA at baseline and after CPT.", {"entities": [[52, 55, "GENE"], [57, 60, "GENE"]]}], ["The Mann\u2013Whitney U-test and Wilcoxon test were used to compare neuromediator tear levels.", {"entities": []}], ["No significant differences in neuropeptide tear levels were observed between healthy and allergic patients in non-active phase.", {"entities": []}], ["CPT induced conjunctival hyperemia and itching in all allergic patients, while no reaction was observed in the control eyes and in healthy subjects.", {"entities": []}], ["In allergic patients SP, CGRP, and VIP, but not NPY, were significantly higher after CPT as compared to baseline (SP: 3.9\u00b11.3 ng/ml versus 5.8\u00b11.1 ng/ml, p=0.011; CGRP: 5.5\u00b12.3 ng/ml versus 7.3\u00b12.7 ng/ml; p=0.002; VIP: 4\u00b10.9 ng/ml versus 5.1\u00b11.5 ng/ml, p=0.007).", {"entities": [[35, 38, "GENE"], [214, 217, "GENE"], [48, 51, "GENE"], [35, 38, "GENE"], [214, 217, "GENE"]]}], ["No significant changes were observed in the control eyes of allergic patients challenged with diluent and in healthy subjects after allergen provocation.", {"entities": []}], ["Locally-released neuromediators may participate in modulating the allergic response of the ocular surface.", {"entities": []}], ["Asthma, a chronic respiratory disease, can be aggravated by exposure to certain chemical irritants.", {"entities": [[0, 6, "DISEASE"]]}], ["The objectives were first to investigate the extent to which experimental observations on asthmatic subjects are taken into consideration in connection with the registration process under the EU REACH regulation, and second, to determine whether asthmatics are provided adequate protection by the derived no\u2010effect levels (DNELs) for acute inhalation exposure.", {"entities": []}], ["We identified substances for which experimental data on the pulmonary functions of asthmatics exposed to chemicals under controlled conditions are available.", {"entities": []}], ["The effect concentrations were then compared with DNELs and other guideline and limit values.", {"entities": []}], ["As of April 2015, only 2.6% of 269 classified irritants had available experimental data on asthmatics.", {"entities": []}], ["Fourteen of the 22 identified substances with available data were fully registered under REACH and we retrieved 114 reliable studies related to these.", {"entities": []}], ["Sixty\u2010three of these studies, involving nine of the 14 substances, were cited by the REACH registrants.", {"entities": []}], ["However, only 17 of the 114 studies, involving four substances, were regarded as key studies.", {"entities": []}], ["Furthermore, many of the DNELs for acute inhalation were higher than estimated effect levels for asthmatics, i.e., lowest observed adverse effect concentrations or no\u2010observed adverse effect concentrations, indicating low or no safety margin.", {"entities": []}], ["We conclude that REACH registrants tend to disregard findings on asthmatics when deriving these DNELs.", {"entities": []}], ["In addition, we found examples of DNELs, particularly among those derived for workers, which likely do not provide adequate protection for asthmatics.", {"entities": []}], ["Copyright \u00a9 2016 The Authors Journal of Applied Toxicology Published by John Wiley & Sons Ltd. We investigate the extent to which experimental observations on asthmatic subjects are taken into consideration by REACH registrants and determine whether asthmatics are provided adequate protection by the acute inhalation Derived No\u2010Effect Levels.", {"entities": []}], ["Of 114 studies concerning 14 substances fulfilling our inclusion criteria, 63 studies, involving nine substances, were cited by the REACH registrants.", {"entities": []}], ["However, only 17 of the 114 studies, involving four substances, were regarded as key studies.", {"entities": []}], ["Furthermore, many of the Derived No\u2010Effect Levels were higher than Lowest\u2010 or No\u2010Observed Adverse Effect Concentrations values from these studies.", {"entities": []}], ["Epigenetics is the term used to describe heritable changes in gene expression that are not coded in the DNA sequence itself but by post-translational modifications in DNA and histone proteins.", {"entities": []}], ["These modifications include histone acetylation, methylation, ubiquitination, sumoylation and phosphorylation.", {"entities": []}], ["Epigenetic regulation is not only critical for generating diversity of cell types during mammalian development, but it is also important for maintaining the stability and integrity of the expression profiles of different cell types.", {"entities": []}], ["Until recently, the study of human disease has focused on genetic mechanisms rather than on non-coding events.", {"entities": []}], ["However, it is becoming increasingly clear that disruption of epigenetic processes can lead to several major pathologies, including cancer, syndromes involving chromosomal instabilities, and mental retardation.", {"entities": [[132, 138, "DISEASE"]]}], ["Furthermore, the expression and activity of enzymes that regulate these epigenetic modifications have been reported to be abnormal in the airways of patients with respiratory disease.", {"entities": []}], ["The development of new diagnostic tools might reveal other diseases that are caused by epigenetic alterations.", {"entities": []}], ["These changes, despite being heritable and stably maintained, are also potentially reversible and there is scope for the development of 'epigenetic therapies' for disease.", {"entities": []}], ["Scoparone (6,7-dimethoxycoumarin) is the representative ingredient of Yinchenhao ( Artemisia capillaris Thunb.)", {"entities": []}], ["which is a famous Chinese medicinal herb and shows favorable efficacy for all kinds of liver disease, specifically for the treatment of Yanghuang syndrome (YHS).", {"entities": [[87, 100, "DISEASE"], [146, 154, "DISEASE"]]}], ["The precise molecular mechanism concerning the action of scoparone on YHS is yet to be fully elucidated.", {"entities": []}], ["The aim of the present study was to determine the mechanism of scoparone and evaluate its efficacy on metabolite levels.", {"entities": []}], ["The differential expression of metabolites responsible for the pharmacological effects of scoparone was characterized and the protection effect of scoparone against this disease.", {"entities": []}], ["Using multivariate statistical analysis, 33 biomarkers were identified using precise MS/MS and play an important role in the regulation of key metabolic pathways associated with liver disease.", {"entities": [[178, 191, "DISEASE"]]}], ["In addition, pathological results also showed consistent changes in the YHS model group and after treatment with scoparone, both the metabolic profile and histopathology resembled that of normal level, which suggesting favorable efficacy over the observed time period.", {"entities": []}], ["The present work indicated that a metabolomics platform provided a new insight into understanding the mechanisms of action of natural medicines such as scoparone.", {"entities": []}], ["Epidemiologic studies associate childhood exposure to traffic-related air pollution with increased respiratory infections and asthmatic and allergic symptoms.", {"entities": []}], ["The strongest associations between traffic exposure and negative health impacts are observed in individuals with respiratory inflammation.", {"entities": []}], ["We hypothesized that interactions between nitric oxide (NO), increased during lung inflammatory responses, and reactive oxygen species (ROS), increased as a consequence of traffic exposure \u2500 played a key role in the increased susceptibility of these at-risk populations to traffic emissions.", {"entities": []}], ["Diesel exhaust particles (DEP) were used as surrogates for traffic particles.", {"entities": []}], ["Murine lung epithelial (LA-4) cells and BALB/c mice were treated with a cytokine mixture (cytomix: TNF\u03b1, IL-1\u03b2, and IFN\u03b3) to induce a generic inflammatory state.", {"entities": []}], ["Cells were exposed to saline or DEP (25 \u03bcg/cm Cytomix treatment significantly increased LA-4 cell NO production though iNOS activation.", {"entities": []}], ["Cytomix\u2009+\u2009 DEP-exposed cells incurred the greatest intracellular ROS production, with commensurate cytotoxicity, as these cells were unable to maintain redox balance.", {"entities": []}], ["By contrast, saline\u2009+\u2009DEP-exposed cells were able to mount effective antioxidant responses.", {"entities": []}], ["DEP effects were mediated by: (1) increased ROS including superoxide anion (O 2 \u02d9 2 \u02d9 reduced by superoxide dismutase (SOD) supplementation or by blocking iNOS induction.", {"entities": []}], ["In mice, cytomix\u2009+\u2009 DEP-exposure resulted in greater ROS production in lung phagocytes.", {"entities": []}], ["Phagocyte and epithelial effects were, by and large, prevented by treatment with FeTMPyP, which accelerates peroxynitrite catalysis.", {"entities": []}], ["During inflammation, due to interactions of NO and O 2 \u02d9 at increased risk for exposure to traffic-dominated urban air pollution.", {"entities": []}], ["Several pharmacological treatments used in internal medicine can induce psychiatric side effects (PSEs) that mimic diagnoses seen in psychiatry.", {"entities": []}], ["PSEs may occur upon withdrawal or intoxication, and also at usual therapeutic doses.", {"entities": []}], ["Drugs that may lead to depressive, anxious, or psychotic syndromes include corticosteroids, isotretinoin, levo-dopar mefloquine, interferon-a, and anabolic steroids, as well as some over-the-counter medications.", {"entities": []}], ["PSEs are often difficult to diagnose and can be very harmful to patients.", {"entities": []}], ["PSEs are discussed in this review, as well as diagnostic clues to facilitate their identification.", {"entities": []}], ["Cardamom is a well-known spice in Indian subcontinent, used in culinary and traditional medicine practices since ancient times.", {"entities": []}], ["The current investigation was untaken to evaluate the potential benefit of cardamom powder supplementation in high carbohydrate high fat (HCHF) diet induced obese rats.", {"entities": []}], ["Male Wistar rats (28 rats) were divided into four different groups such as Control, Control\u00a0+\u00a0cardamom, HCHF, HCHF\u00a0+\u00a0cardamom.", {"entities": []}], ["High carbohydrate and high fat (HCHF) diet was prepared in our laboratory.", {"entities": []}], ["Oral glucose tolerance test, organs wet weight measurements and oxidative stress parameters analysis as well as liver marker enzymes such as alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP) activities were assayed on the tissues collected from the rats.", {"entities": []}], ["Plasma lipids profiles were also measured in all groups of animals.", {"entities": []}], ["Moreover, histological staining was also performed to evaluate inflammatory cells infiltration and fibrosis in liver.", {"entities": []}], ["The current investigation showed that, HCHF diet feeding in rats developed glucose intolerance and increased peritoneal fat deposition compared to control rats.", {"entities": [[75, 94, "DISEASE"]]}], ["Cardamom powder supplementation improved the glucose intolerance significantly ( p \u00a0>\u00a00.05) and prevented the abdominal fat deposition in HCHF diet fed rats.", {"entities": [[45, 64, "DISEASE"]]}], ["HCHF diet feeding in rats also developed dyslipidemia, increased fat deposition and inflammation in liver compared to control rats.", {"entities": []}], ["Cardamom powder supplementation significantly prevented the rise of lipid parameters ( p \u00a0>\u00a00.05) in HCHF diet fed rats.", {"entities": []}], ["Histological assessments confirmed that HCHF diet increased the fat deposition and inflammatory cells infiltration in liver which was normalized by cardamom powder supplementation in HCHF diet fed rats.", {"entities": []}], ["Furthermore, HCHF diet increased lipid peroxidation, decreased antioxidant enzymes activities and increased advanced protein oxidation product level significantly ( p \u00a0>\u00a00.05) both in plasma and liver tissue which were modulated by cardamom powder supplementation in HCHF diet fed rats.", {"entities": []}], ["HCHF diet feeding in rats also increased the ALT, AST and ALP enzyme activities in plasma which were also normalized by cardamom powder supplementation in HCHF diet fed rats.", {"entities": []}], ["Moreover, cardamom powder supplementation ameliorated the fibrosis in liver of HCHF diet fed rats.", {"entities": []}], ["This study suggests that, cardamom powder supplementation can prevent dyslipidemia, oxidative stress and hepatic damage in HCHF diet fed rats.", {"entities": []}], ["According to the hygiene hypothesis, infections in early life protect from allergic diseases.", {"entities": []}], ["However, in earlier studies surrogate measures of infection rather than clinical infections were associated with decreased frequencies of atopic diseases.", {"entities": []}], ["Exposure to infection indicating sub-clinical infection rather than clinical infection might protect from atopic diseases.", {"entities": []}], ["Objective: to investigate whether exposure to acute respiratory infections within pregnancy and the first year of life is associated with atopic conditions at age 5\u201314 years and to explore when within pregnancy and the first year of life this exposure is most likely to be protective.", {"entities": []}], ["Historical cohort study: Population level data on acute respiratory infections from the routine reporting system of the former German Democratic Republic were linked with individual data from consecutive surveys on atopic diseases in the same region (n = 4672).", {"entities": []}], ["Statistical analyses included multivariate logistic regression analysis and polynomial distributed lag models.", {"entities": []}], ["High exposure to acute respiratory infection between pregnancy and age one year was associated with overall reduced odds of asthma, eczema, hay fever, atopic sensitization and total IgE.", {"entities": [[124, 130, "DISEASE"]]}], ["Exposure in the first 9 months of life showed the most pronounced effect.", {"entities": []}], ["Adjusted odds ratio's for asthma, hay fever, inhalant sensitization and total IgE were statistical significantly reduced up to around half.", {"entities": [[26, 32, "DISEASE"]]}], ["Exposure to respiratory infection (most likely indicating sub-clinical infection) within pregnancy and the first year of life may be protective in atopic diseases development.", {"entities": []}], ["The post-natal period thereby seems to be particularly important.", {"entities": []}], ["In pre-school children a diagnosis of asthma is not easily made and only a minority of wheezing children will develop persistent atopic asthma.", {"entities": [[38, 44, "DISEASE"], [136, 142, "DISEASE"]]}], ["According to the general consensus a diagnosis of asthma becomes more certain with increasing age.", {"entities": [[50, 56, "DISEASE"]]}], ["Therefore the congruence between asthma medication use and doctor-diagnosed asthma is expected to increase with age.", {"entities": [[33, 39, "DISEASE"], [76, 82, "DISEASE"]]}], ["The aim of this study is to evaluate the relationship between prescribing of asthma medication and doctor-diagnosed asthma in children age 0\u201317.", {"entities": [[77, 83, "DISEASE"], [116, 122, "DISEASE"]]}], ["We studied all 74,580 children below 18 years of age, belonging to 95 GP practices within the second Dutch national survey of general practice (DNSGP-2), in which GPs registered all physician-patient contacts during the year 2001.", {"entities": []}], ["Status on prescribing of asthma medication (at least one prescription for beta2-agonists, inhaled corticosteroids, cromones or montelukast) and doctor-diagnosed asthma (coded according to the International Classification of Primary Care) was determined.", {"entities": [[25, 31, "DISEASE"], [161, 167, "DISEASE"]]}], ["In total 7.5% of children received asthma medication and 4.1% had a diagnosis of asthma.", {"entities": [[35, 41, "DISEASE"], [81, 87, "DISEASE"]]}], ["Only 49% of all children receiving asthma medication was diagnosed as an asthmatic.", {"entities": [[35, 41, "DISEASE"]]}], ["Subgroup analyses on age, gender and therapy groups showed that the Positive Predictive Value (PPV) differs significantly between therapy groups only.", {"entities": []}], ["The likelihood of having doctor-diagnosed asthma increased when a child received combination therapy of short acting beta2-agonists and inhaled corticosteroids (PPV = 0.64) and with the number of prescriptions (3 prescriptions or more, PPV = 0.66).", {"entities": [[42, 48, "DISEASE"]]}], ["Both prescribing of asthma medication and doctor-diagnosed asthma declined with age but the congruence between the two measures did not increase with age.", {"entities": [[20, 26, "DISEASE"], [59, 65, "DISEASE"]]}], ["In this study, less than half of all children receiving asthma medication had a registered diagnosis of asthma.", {"entities": [[56, 62, "DISEASE"], [104, 110, "DISEASE"]]}], ["Detailed subgroup analyses show that a diagnosis of asthma was present in at most 66%, even in groups of children treated intensively with asthma medication.", {"entities": [[52, 58, "DISEASE"], [139, 145, "DISEASE"]]}], ["Although age strongly influences the chance of being treated, remarkably, the congruence between prescribing of asthma medication and doctor-diagnosed asthma does not increase with age.", {"entities": [[112, 118, "DISEASE"], [151, 157, "DISEASE"]]}], ["The Psychosocial Assessment Tool (PAT) is a brief family screener, identifying families at universal or elevated risk for psychosocial problems.", {"entities": []}], ["This study aimed to determine the feasibility and usability of the electronic PAT (ePAT) in pediatric cancer care.", {"entities": [[102, 108, "DISEASE"]]}], ["Eighty-six parents of newly diagnosed children with cancer (0\u201318\u00a0years) agreed to participate and registered at the website www.hetklikt.nu (58%).", {"entities": [[52, 58, "DISEASE"]]}], ["Seventy-five families completed the ePAT at approximately 1\u00a0month post-diagnosis.", {"entities": []}], ["Answers were transformed into an electronic PROfile (PAT ePROfile) and fed back to the psychosocial team.", {"entities": []}], ["Team members completed a semi-structured evaluation questionnaire.", {"entities": []}], ["Feasibility was measured as the percentage of website registrations, completed ePATs, and PAT ePROfiles reviewed or discussed by the team.", {"entities": []}], ["Usability\u00a0included perceived match of the PAT ePROfile with the team\u2019s own risk estimation, perceived added value, and perceived actions undertaken as a result of the PAT ePROfile.", {"entities": []}], ["Feasibility was 70% for website registration, 87% for completed ePATs, 85% for PAT ePROfile reviewing, and 67% for ePROfile discussion.", {"entities": []}], ["Team members reported that the PAT ePROfile matched with their own risk estimation ( M\u00a0= \u00a07.92, SD \u00a0=\u00a01.88) and did not provide additional information ( M\u00a0= \u00a02.18, SD \u00a0=\u00a02.30).", {"entities": []}], ["According to the team, actions were undertaken for 25% of the families as a result of the PAT ePROfile.", {"entities": []}], ["More actions were undertaken for families with elevated risk scores compared to universal risk scores ( p\u00a0= \u00a0.007).", {"entities": []}], ["Implementation of the ePAT seems generally feasible, but it is not always clear how this screener adds to current clinical practice.", {"entities": []}], ["Strategies should be developed together with team members to improve quick exchange of ePAT results and allocate care according to the needs of the families.", {"entities": []}], ["To determine semen quality and reproductive hormone levels in young Faroese men.", {"entities": []}], ["Descriptive cross-sectional study of Faroese men compared with Danish men.", {"entities": []}], ["Faroese one-centre study.", {"entities": []}], ["481 men born from 1981 to 1987 and investigated from 2007 to 2010.", {"entities": []}], ["Sperm concentration, semen volume, total sperm count, sperm motility, sperm morphology and reproductive hormone levels.", {"entities": []}], ["Sperm concentrations for the Faroese men were lower than for the Danish men (crude median 40 vs 48 mill/ml, p<0.0005).", {"entities": []}], ["Semen volume was higher, and thus the total sperm counts did not differ (159 vs 151 mill, p=0.2).", {"entities": []}], ["Motility and morphology did not differ between the Faroese and Danes.", {"entities": []}], ["The inhibin B/follicle-stimulating hormone ratios for the Faroese men were lower than for the Danes (64 vs 76, p=0.001).", {"entities": []}], ["Similarly, lower total testosterone/luteinising hormone (LH) ratio (4.6 vs 6.0, p<0.0005) and lower calculated free-testosterone/LH ratio (94 vs 134, p<0.0005) were detected for the Faroese men.", {"entities": []}], ["Semen quality among the Faroese men is at the same low level as reported for Danish men, and the reproductive hormone levels furthermore indicated a lower Leydig cell capacity for testosterone production.", {"entities": []}], ["The influence of environmental exposure and genetic factors on semen quality has to be studied further.", {"entities": []}], ["The T helper cell subsets Th1, Th2, Th17, and Treg play an important role in immune cell homeostasis, in host defense, and in immunological disorders.", {"entities": []}], ["Recently, much attention has been paid to Th17 cells which seem to play an important role in the early phase of the adoptive immune response and autoimmune disease.", {"entities": []}], ["When generating Th17 cells under in vitro conditions the amount of IL-17A producing cells hardly exceeds 20% while the nature of the remaining T cells is poorly characterized.", {"entities": []}], ["As engagement of the aryl hydrocarbon receptor (AHR) has also been postulated to modulate the differentiation of T helper cells into Th17 cells with regard to the IL-17A expression we ask how far do Th17 polarizing conditions in combination with ligand induced AHR activation have an effect on the production of other T helper cell cytokines.", {"entities": [[48, 51, "GENE"], [261, 264, "GENE"], [48, 51, "GENE"], [261, 264, "GENE"]]}], ["We found that a high proportion of T helper cells cultured under Th17 polarizing conditions are IL-8 and IL-9 single producing cells and that AHR activation results in an upregulation of IL-8 and a downregulation of IL-9 production.", {"entities": [[142, 145, "GENE"]]}], ["Thus, we have identified IL-8 and IL-9 producing T helper cells which are subject to regulation by the engagement of the AHR.", {"entities": [[121, 124, "GENE"]]}], ["The major house dust mite allergen, Der p 1, is a papain-like cysteine protease expressed as an inactive precursor, proDer p 1, carrying an N-terminal propeptide with a unique structure.", {"entities": []}], ["The maturation of the zymogen into an enzymatically-active form of Der p 1 is a multistep autocatalytic process initiated under acidic conditions through conformational changes of the propeptide, leading to the loss of its inhibitory ability and its subsequent gradual cleavage.", {"entities": []}], ["The aims of this study were to characterize the residues present in the Der p 1 propeptide involved in the initiation of the zymogen maturation process, but also to assess the impact of acidic pH on the propeptide structure, the activity of Der p 1 and the fate of the propeptide.", {"entities": []}], ["Using various complementary enzymatic and structural approaches, we demonstrated that a structural triad K17p-D51p-Y19p within the N-terminal domain of the propeptide is essential for its stabilization and the sensing of pH changes.", {"entities": []}], ["Particularly, the protonation of D51p under acidic conditions unfolds the propeptide through disruption of the K17p-D51p salt bridge, reduces its inhibition capacity and unmasks the buried residues K17p and Y19p constituting the first maturation cleavage site of the zymogen.", {"entities": []}], ["Our results also evidenced that this triad acts in a cooperative manner with other propeptide pH-responsive elements, including residues E56p and E80p, to promote the propeptide unfolding and/or to facilitate its proteolysis.", {"entities": []}], ["Furthermore, we showed that acidic conditions modify Der p 1 proteolytic specificity and confirmed that the formation of the first intermediate represents the limiting step of the in vitro Der p 1 maturation process.", {"entities": []}], ["Altogether, our results provide new insights into the early events of the mechanism of proDer p 1 maturation and identify a unique structural triad acting as a stabilizing and a pH-sensing regulatory element.", {"entities": []}], ["Asthma prevalence has increased world-wide especially in children; thus there is a need to develop new therapies that are safe and effective especially for patients with severe/refractory asthma.", {"entities": [[0, 6, "DISEASE"], [188, 194, "DISEASE"]]}], ["CD4 Mice (wild type, CD4 CD4 Our data suggests the involvement of TRPV1 in allergic asthma and thus we feel this target merits further investigation.", {"entities": [[75, 90, "DISEASE"], [84, 90, "DISEASE"], [0, 3, "GENE"], [21, 24, "GENE"], [25, 28, "GENE"], [0, 3, "GENE"], [21, 24, "GENE"], [25, 28, "GENE"], [0, 3, "GENE"], [21, 24, "GENE"], [25, 28, "GENE"], [66, 71, "GENE"]]}], ["Like many developing countries, Serbia is facing a growing burden of chronic diseases.", {"entities": []}], ["Within such public health issue, multi-morbidity requires a special attention.", {"entities": []}], ["This study investigated the prevalence of multi-morbidity in the Serbia population and assessed the co-occurrence of chronic diseases by age and gender.", {"entities": []}], ["We analyzed data from the 2013 National Health Survey, which included 13,103 individuals \u2265 20 years old.", {"entities": []}], ["Multi-morbidity patterns were identified by exploratory factor analysis of data on self-reported chronic diseases, as well as data on measured body weight and height.", {"entities": []}], ["The analysis was stratified by age and gender.", {"entities": []}], ["Multi-morbidity was present in nearly one-third of respondents (26.9%) and existed in all age groups, with the highest prevalence among individuals aged 65 years and older (47.2% of men and 65.0% of women).", {"entities": []}], ["Six patterns of multi-morbidity were identified: non-communicable, cardio-metabolic, respiratory, cardiovascular, aggregate, and mechanical/mental/metabolic.", {"entities": []}], ["The non-communicable pattern was observed in both genders but only in the 20\u201344 years age group, while the aggregate pattern occurred only in middle-aged men.", {"entities": []}], ["Cardio-metabolic and respiratory patterns were present in all age groups.", {"entities": []}], ["Cardiovascular and mechanical/mental/metabolic patterns showed similar presentation in both men and women.", {"entities": []}], ["Multi-morbidity is a common occurrence among adults in Serbia, especially in the elderly.", {"entities": []}], ["While several patterns may be explained by underlying pathophysiologies, some require further investigation and follow-up.", {"entities": []}], ["Recognizing the complexity of multi-morbidity in Serbia is of great importance from both clinical and preventive perspectives given that it affects one-third of the population and may require adjustment of the healthcare system to address the needs of affected individuals.", {"entities": []}], ["New approaches are often introduced to the neonatal intensive care unit (NICU) and other areas of the health service in either a haphazard or cataclysmic fashion.", {"entities": []}], ["The needs of staff education are often addressed incompletely or too late.", {"entities": []}], ["Rarely is education assessed after the introduction of a major change.", {"entities": []}], ["We changed the basis of our NICU respiratory support.", {"entities": []}], ["We conducted a major educational and support program before this intervention.", {"entities": []}], ["This study documented and assessed the educational components of this change in our health service provision.", {"entities": []}], ["Senior medical and nursing staff attended training abroad and an education program was applied for one year prior to the change.", {"entities": []}], ["Multidisciplinary educational support for doctors, nurses and allied health was continued after the change.", {"entities": []}], ["Assessment was by anonymous questionnaire, prior to change, at one and at nine months.", {"entities": []}], ["Our hypothesis was that dissatisfaction with education would be greatest at one month.", {"entities": []}], ["Both theory education and practical education aspects of the new approach were rated as good to very good and this did not change with time.", {"entities": []}], ["Difficulty of applying the technique was rated as ambivalent initially but decreased significantly over 9 months until it was rated easy to very easy (p < 0.001).", {"entities": []}], ["Over all, the change was rated by staff as beneficial, both at the end of the education period and at nine months, with no decrease at one month.", {"entities": []}], ["If education and training reaches all staff, with a system of mutual and continued support, even large changes in clinical practice can be achieved without the dissatisfaction with the educational process that is often otherwise seen.", {"entities": []}], ["Mutations in the SLC26A4 gene are a common cause of human hereditary hearing impairment worldwide.", {"entities": [[17, 24, "GENE"]]}], ["Previous studies have demonstrated that different SLC26A4 mutations have different pathogenetic mechanisms.", {"entities": [[50, 57, "GENE"]]}], ["By using a genotype-driven approach, we established a knock-in mouse model (i.e., Slc26a4 mice) homozygous for the common p.H723R mutation in the East Asian population.", {"entities": [[82, 89, "GENE"]]}], ["To verify the pathogenicity of the p.H723R allele in mice, we further generated mice with compound heterozygous mutations (i.e., Slc26a4 ) by intercrossing Slc26a4 mice with Slc26a4 mice, which segregated the c.919-2A>G mutation with an abolished Slc26a4 function.", {"entities": [[129, 136, "GENE"], [156, 163, "GENE"], [174, 181, "GENE"], [247, 254, "GENE"], [129, 136, "GENE"], [156, 163, "GENE"], [174, 181, "GENE"], [247, 254, "GENE"], [129, 136, "GENE"], [156, 163, "GENE"], [174, 181, "GENE"], [247, 254, "GENE"], [129, 136, "GENE"], [156, 163, "GENE"], [174, 181, "GENE"], [247, 254, "GENE"]]}], ["Mice were then subjected to audiologic assessments, a battery of vestibular evaluations, inner ear morphological studies, and noise exposure experiments.", {"entities": []}], ["The results were unexpected; both Slc26a4 and Slc26a4 mice showed normal audiovestibular phenotypes and inner ear morphology, and they did not show significantly higher shifts in hearing thresholds after noise exposure than the wild-type mice.", {"entities": [[34, 41, "GENE"], [46, 53, "GENE"], [34, 41, "GENE"], [46, 53, "GENE"]]}], ["The results indicated not only the p.H723R allele was non-pathogenic in mice, but also a single p.H723R allele was sufficient to maintain normal inner ear physiology in heterozygous compound mice.", {"entities": []}], ["There might be discrepancies in the pathogenicity of specific SLC26A4 mutations in humans and mice; therefore, precautions should be taken when extrapolating the results of animal studies to humans.", {"entities": [[62, 69, "GENE"]]}], ["The zinc-dependent mammalian histone deacetylase (HDAC) family comprises 11 enzymes, which have specific and critical functions in development and tissue homeostasis.", {"entities": []}], ["Mounting evidence points to a link between misregulated HDAC activity and many oncologic and nononcologic diseases.", {"entities": []}], ["Thus the development of HDAC inhibitors for therapeutic treatment garners a lot of interest from academic researchers and biotechnology entrepreneurs.", {"entities": []}], ["Numerous studies of HDAC inhibitor specificities and molecular mechanisms of action are ongoing.", {"entities": []}], ["In one of these studies, mass spectrometry was used to characterize the affinities and selectivities of HDAC inhibitors toward native HDAC multiprotein complexes in cell extracts.", {"entities": []}], ["Such a novel approach reproduces in vivo molecular interactions more accurately than standard studies using purified proteins or protein domains as targets and could be very useful in the isolation of inhibitors with superior clinical efficacy and decreased toxicity compared to the ones presently tested or approved.", {"entities": []}], ["HDAC inhibitor induced-transcriptional reprogramming, believed to contribute largely to their therapeutic benefits, is achieved through various and complex mechanisms not fully understood, including histone deacetylation, transcription factor or regulator (including HDAC1) deacetylation followed by chromatin remodeling and positive or negative outcome regarding transcription initiation.", {"entities": [[267, 272, "GENE"]]}], ["Although only a very low percentage of protein-coding genes are affected by the action of HDAC inhibitors, about 40% of noncoding microRNAs are upregulated or downregulated.", {"entities": []}], ["Moreover, a whole new world of long noncoding RNAs is emerging, revealing a new class of potential targets for HDAC inhibition.", {"entities": []}], ["HDAC inhibitors might also regulate transcription elongation and have been shown to impinge on alternative splicing.", {"entities": []}], ["Mutations of the von Hippel\u2013Lindau ( VHL) gene are associated with pheochromocytomas and paragangliomas, but the role of VHL in sympathoadrenal homeostasis is unknown.", {"entities": [[37, 40, "GENE"], [121, 124, "GENE"], [37, 40, "GENE"], [121, 124, "GENE"]]}], ["We generated mice lacking Vhl in catecholaminergic cells.", {"entities": [[26, 29, "GENE"]]}], ["They exhibited atrophy of the carotid body (CB), adrenal medulla, and sympathetic ganglia.", {"entities": []}], ["Vhl -null animals had an increased number of adult CB stem cells, although the survival of newly generated neuron-like glomus cells was severely compromised.", {"entities": [[0, 3, "GENE"]]}], ["The effects of Vhl deficiency were neither prevented by pharmacological inhibition of prolyl hydroxylases or selective genetic down-regulation of prolyl hydroxylase-3, nor phenocopied by hypoxia inducible factor overexpression.", {"entities": [[15, 18, "GENE"]]}], ["Vhl-deficient animals appeared normal in normoxia but survived for only a few days in hypoxia, presenting with pronounced erythrocytosis, pulmonary edema, and right cardiac hypertrophy.", {"entities": [[138, 153, "DISEASE"]]}], ["Therefore, in the normal sympathoadrenal setting, Vhl deletion does not give rise to tumors but impairs development and plasticity of the peripheral O 2 -sensing system required for survival in hypoxic conditions.", {"entities": [[50, 53, "GENE"]]}], ["Complex diseases are often difficult to diagnose, treat and study due to the multi-factorial nature of the underlying etiology.", {"entities": []}], ["Large data sets are now widely available that can be used to define novel, mechanistically distinct disease subtypes (endotypes) in a completely data-driven manner.", {"entities": []}], ["However, significant challenges exist with regard to how to segregate individuals into suitable subtypes of the disease and understand the distinct biological mechanisms of each when the goal is to maximize the discovery potential of these data sets.", {"entities": []}], ["A multi-step decision tree-based method is described for defining endotypes based on gene expression, clinical covariates, and disease indicators using childhood asthma as a case study.", {"entities": [[162, 168, "DISEASE"]]}], ["We attempted to use alternative approaches such as the Student\u2019s t-test, single data domain clustering and the Modk-prototypes algorithm, which incorporates multiple data domains into a single analysis and none performed as well as the novel multi-step decision tree method.", {"entities": []}], ["This new method gave the best segregation of asthmatics and non-asthmatics, and it provides easy access to all genes and clinical covariates that distinguish the groups.", {"entities": []}], ["The multi-step decision tree method described here will lead to better understanding of complex disease in general by allowing purely data-driven disease endotypes to facilitate the discovery of new mechanisms underlying these diseases.", {"entities": []}], ["This application should be considered a complement to ongoing efforts to better define and diagnose known endotypes.", {"entities": []}], ["When coupled with existing methods developed to determine the genetics of gene expression, these methods provide a mechanism for linking genetics and exposomics data and thereby accounting for both major determinants of disease.", {"entities": []}], ["In acute dyspnoeic children, assessment of dyspnoea severity and treatment response is frequently based on clinical dyspnoea scores.", {"entities": []}], ["Our study aim was to validate five commonly used paediatric dyspnoea scores.", {"entities": []}], ["Fifty children aged 0\u20138 years with acute dyspnoea were clinically assessed before and after bronchodilator treatment, a subset of 27 children were videotaped and assessed twice by nine observers.", {"entities": []}], ["The observers scored clinical signs necessary to calculate the Asthma Score (AS), Asthma Severity Score (ASS), Clinical Asthma Evaluation Score 2 (CAES-2), Pediatric Respiratory Assessment Measure (PRAM) and respiratory rate, accessory muscle use, decreased breath sounds (RAD).", {"entities": []}], ["A total of 1120 observations were used to assess fourteen measurement properties within domains of validity, reliability and utility.", {"entities": []}], ["All five dyspnoea scores showed overall poor results, scoring insufficiently on more than half of the quality criteria for measurement properties.", {"entities": []}], ["The AS and PRAM were the most valid with good values on six and moderate values on three properties.", {"entities": []}], ["Poor results were mainly due to insufficient measurement properties in the validity and reliability domains whereas utility properties were moderate to good in all scores.", {"entities": []}], ["This study shows that commonly used dyspnoea scores show insufficient validity and reliability to allow for clinical use without caution.", {"entities": []}], ["Approximately sixty per cent of ovarian cancer patients die within the first five years of diagnosis due to recurrence associated with chemoresistance.", {"entities": [[32, 46, "DISEASE"], [40, 46, "DISEASE"]]}], ["The metzincin family of metalloproteinases is enzymes involved in matrix remodeling in response to normal physiological changes and diseased states.", {"entities": []}], ["Recently, there has been a mounting awareness of these proteinases and their endogenous inhibitors, the tissue inhibitors of metalloproteinases (TIMPs), as superb modulators of cellular communication and signaling regulating key biological processes in cancer progression.", {"entities": [[253, 259, "DISEASE"]]}], ["This review investigates the role of metzincins and their inhibitors in ovarian cancer.", {"entities": [[72, 86, "DISEASE"], [80, 86, "DISEASE"]]}], ["We propose that understanding the metzincins and TIMP biology in ovarian cancer may provide valuable insights in combating ovarian cancer progression and chemoresistance-mediated recurrence in patients.", {"entities": [[65, 79, "DISEASE"], [123, 137, "DISEASE"], [73, 79, "DISEASE"], [131, 137, "DISEASE"]]}], ["Unintentional injuries cause much of the global mortality burden, with the workplace being a common accident setting.", {"entities": []}], ["Even in high-income economies, occupational injury figures remain remarkably high.", {"entities": []}], ["Because risk factors for occupational injuries are prone to confounding, the present research takes a comprehensive approach.", {"entities": []}], ["To better understand the occurrence of occupational injuries, sociodemographic factors and work- and health-related factors are tested simultaneously.", {"entities": []}], ["Thus, the present analysis aims to develop a comprehensive epidemiological model that facilitates the explanation of varying injury rates in the workplace.", {"entities": []}], ["The representative phone survey German Health Update 2010 provides information on medically treated occupational injuries sustained in the year prior to the interview.", {"entities": []}], ["Data were collected on sociodemographics, occupation, working conditions, health-related behaviors, and chronic diseases.", {"entities": []}], ["For the economically active population (18\u201370 years, n = 14,041), the 12-month prevalence of occupational injuries was calculated with a 95% confidence interval (CI).", {"entities": []}], ["Blockwise multiple logistic regression was applied to successively include different groups of variables.", {"entities": []}], ["Overall, 2.8% (95% CI 2.4\u20133.2) of the gainfully employed population report at least one occupational injury (women: 0.9%; 95% CI 0.7\u20131.2; men: 4.3%; 95% CI 3.7\u20135.0).", {"entities": []}], ["In the fully adjusted model, male gender (OR 3.16) and age 18\u201329 (OR 1.54), as well as agricultural (OR 5.40), technical (OR 3.41), skilled service (OR 4.24) or manual (OR 5.12), and unskilled service (OR 3.13) or manual (OR 4.97) occupations are associated with higher chances of occupational injuries.", {"entities": []}], ["The same holds for frequent stressors such as heavy carrying (OR 1.78), working in awkward postures (OR 1.46), environmental stress (OR 1.48), and working under pressure (OR 1.41).", {"entities": []}], ["Among health-related variables, physical inactivity (OR 1.47) and obesity (OR 1.73) present a significantly higher chance of occupational injuries.", {"entities": [[66, 73, "DISEASE"]]}], ["While the odds for most work-related factors were as expected, the associations for health-related factors such as smoking, drinking, and chronic diseases were rather weak.", {"entities": []}], ["In part, this may be due to context-specific factors such as safety and workplace regulations in high-income countries like Germany.", {"entities": []}], ["This assumption could guide further research, taking a multi-level approach to international comparisons.", {"entities": []}], ["Bronchiectasis is a chronic lung disease characterised by recurrent infection, inflammation, persistent cough and sputum production.", {"entities": [[0, 14, "DISEASE"], [28, 40, "DISEASE"]]}], ["The disease is increasing in prevalence, requiring a greater awareness of the disease across primary and secondary care.", {"entities": []}], ["Mild and moderate cases of bronchiectasis in adults can often be managed by primary care clinicians.", {"entities": [[27, 41, "DISEASE"]]}], ["Initial assessments and long-term treatment plans that include both pharmacological and non-pharmacological treatments, however, should be undertaken in collaboration with a secondary care team that includes physiotherapists and specialists in respiratory medicine.", {"entities": []}], ["Bronchiectasis is often identified in patients with other lung diseases, such as chronic obstructive pulmonary disease, asthma, and in a lesser but not insignificant number of patients with other inflammatory diseases, such as rheumatoid arthritis and inflammatory bowel disease.", {"entities": [[252, 278, "DISEASE"], [227, 247, "DISEASE"], [81, 118, "DISEASE"], [0, 14, "DISEASE"], [238, 247, "DISEASE"], [120, 126, "DISEASE"]]}], ["Overall goals of therapy are to prevent exacerbations, improve symptoms, improve quality of life and preserve lung function.", {"entities": []}], ["Prompt treatment of exacerbations with antibiotic therapy is important to limit the impact of exacerbations on quality of life and lung function decline.", {"entities": []}], ["Patient education and cooperation with health-care providers to implement treatment plans are key to successful disease management.", {"entities": []}], ["It is important for the primary care provider to work with secondary care providers to develop an individualised treatment plan to optimise care with the goal to delay disease progression.", {"entities": []}], ["Here, we review the diagnosis and treatment of bronchiectasis with a focus on practical considerations that will be useful to primary care.", {"entities": [[47, 61, "DISEASE"]]}], ["The liver is crucial for human life, and the health of this organ often mirrors the health of the individual.", {"entities": []}], ["The liver can be the target of several diseases, the most prevalent of which, as a consequence of development and changes in human lifestyles, is the nonalcoholic fatty liver disease (NAFLD).", {"entities": [[163, 182, "DISEASE"], [169, 182, "DISEASE"]]}], ["NAFLD is a multifactorial disease that embraces many histo-pathologic conditions and is highly linked to metabolic derangements.", {"entities": []}], ["Technological progress and industrialization have also had the consequence of releasing pollutants in the environment, for instance pesticides or solvents, as well as by-products of discharge, such as the particulate matter.", {"entities": []}], ["In the last decade, a growing body of evidence has emerged, shedding light on the potential impact of environmental pollutants on liver health and, in particular, on NAFLD occurrence.", {"entities": []}], ["These contaminants have a great steatogenic potential and need to be considered as tangible NAFLD risk factors.", {"entities": []}], ["There is an urgent need for a deeper comprehension of their molecular mechanisms of action, as well as for new lines of intervention to reduce their worldwide diffusion.", {"entities": []}], ["This review wishes to sensitize the community to the effects of several environmental pollutants on liver health.", {"entities": []}], ["Ciguatoxins and brevetoxins are neurotoxic cyclic polyether compounds produced by dinoflagellates, which are responsible for ciguatera and neurotoxic shellfish poisoning (NSP) respectively.", {"entities": []}], ["Recently, brevenal, a natural compound was found to specifically inhibit brevetoxin action and to have a beneficial effect in NSP.", {"entities": []}], ["Considering that brevetoxin and ciguatoxin specifically activate voltage-sensitive Na", {"entities": []}], ["The aim of this analysis is to examine the longitudinal impact of symptoms of depression/anxiety on treatment response, long-term disease activity and physical disability in RA.", {"entities": []}], ["Secondary analysis of clinical trial data was performed.", {"entities": []}], ["Data were collected at baseline and at 6-monthly intervals for 2 years.", {"entities": []}], ["The EuroQoL (EQ-5D Results.", {"entities": []}], ["Data from 379 patients were included.", {"entities": []}], ["After adjusting for covariates, baseline depression/anxiety symptoms were associated with increased DAS-28 outcomes and increased tender joint counts.", {"entities": []}], ["Persistent depression/anxiety symptoms were associated with increased DAS-28 scores, HAQ scores, tender joint counts and patient global assessment of disease activity, and reduced odds of reaching clinical remission.", {"entities": []}], ["Patients with symptoms of depression/anxiety at baseline also showed a 50% reduction in prednisolone treatment effect, in comparison with patients with no symptoms of depression/anxiety at baseline.", {"entities": []}], ["Conclusion.", {"entities": []}], ["Baseline and persistent symptoms of depression/anxiety are associated with poorer health outcomes over time, as well as reduced treatment response.", {"entities": []}], ["Mental health should be routinely measured both in clinical practice and in research, and managed alongside rheumatological disease to optimize health outcomes.", {"entities": []}], ["Further research is required to examine whether treatment of mental disorders can improve rheumatological outcomes.", {"entities": []}], ["Forced Vital Capacity (FVC) is an important predictor of all-cause mortality in the absence of chronic respiratory conditions.", {"entities": []}], ["Epidemiological evidence highlights the role of early life factors on adult FVC, pointing to environmental exposures and genes affecting lung development as risk factors for low FVC later in life.", {"entities": []}], ["Although highly heritable, a small number of genes have been found associated with FVC, and we aimed at identifying further genetic variants by focusing on lung development genes.", {"entities": []}], ["Per-allele effects of 24,728 SNPs in 403 genes involved in lung development were tested in 7,749 adults from three studies (NFBC1966, ECRHS, EGEA).", {"entities": []}], ["The most significant SNP for the top 25 genes was followed-up in 46,103 adults (CHARGE and SpiroMeta consortia) and 5,062 children (ALSPAC).", {"entities": []}], ["Associations were considered replicated if the replication p-value survived Bonferroni correction ( p <0.002; 0.05/25), with a nominal p-value considered as suggestive evidence.", {"entities": []}], ["For SNPs with evidence of replication, effects on the expression levels of nearby genes in lung tissue were tested in 1,111 lung samples (Lung eQTL consortium), with further functional investigation performed using public epigenomic profiling data (ENCODE).", {"entities": []}], ["NCOR2 -rs12708369 showed strong replication in children (p = 0.0002), with replication unavailable in adults due to low imputation quality.", {"entities": [[0, 5, "GENE"]]}], ["This intronic variant is in a strong transcriptional enhancer element in lung fibroblasts, but its eQTL effects could not be tested due to low imputation quality in the eQTL dataset.", {"entities": []}], ["SERPINE2 -rs6754561 replicated at nominal level in both adults (p = 0.036) and children (p = 0.045), while WNT16- rs2707469 replicated at nominal level only in adults (p = 0.026).", {"entities": [[0, 8, "GENE"]]}], ["The eQTL analyses showed association of WNT16- rs2707469 with expression levels of the nearby gene CPED1 .", {"entities": []}], ["We found no statistically significant eQTL effects for SERPINE2 -rs6754561.", {"entities": [[55, 63, "GENE"]]}], ["We have identified a new gene, NCOR2 , in the retinoic acid signalling pathway pointing to a role of vitamin A metabolism in the regulation of FVC.", {"entities": [[31, 36, "GENE"]]}], ["Our findings also support SERPINE2 , a COPD gene with weak previous evidence of association with FVC, and suggest WNT16 as a further promising candidate.", {"entities": [[26, 34, "GENE"], [114, 119, "GENE"]]}], ["Hepatitis C virus (HCV) accounts for 15,000 deaths in the United States yearly because people living with HCV are not identified in time to seek treatment, are ineligible for or refuse treatment, or face structural impediments to obtaining treatment such as lack of access to health care or lack of insurance.", {"entities": []}], ["People who inject drugs (PWID) comprise a large proportion\u2014estimates of up to 60\u201370\u00a0%\u2014of current and new HCV infected individuals and face many barriers to completing HCV treatment.", {"entities": []}], ["We conducted 30 qualitative semi-structured interviews of current and former PWID seeking HCV treatment at an opioid-agonist treatment facility in New York City.", {"entities": []}], ["We used thematic analysis, informed by grounded theory, to examine perceptions of HCV and decisions to initiate HCV treatment.", {"entities": []}], ["We analyzed the themes that emerged via the common sense model (CSM) of illness perception theoretical framework.", {"entities": []}], ["Using thematic analyses, two major themes emerged related to engagement in HCV treatment.", {"entities": []}], ["First, participants independently compared HCV to HIV, and in so doing, emphasized the potential fatality of HCV and the need for treatment.", {"entities": []}], ["Second, participants described witnessing others suffer or die from untreated HCV and expressed how these recollections impacted their desire to undergo treatment themselves.", {"entities": []}], ["Together, these themes contributed to the way participants perceived HCV and informed their decisions to initiate treatment.", {"entities": []}], ["Both themes reflect the CSM\u2019s \u201cself-regulation\u201d process, which posits that understanding the causes and consequences of an illness impacts one\u2019s ability to seek treatment to overcome this illness state.", {"entities": []}], ["This paper offers insight into how clinicians can better understand and utilize HCV illness perceptions to evaluate willingness to engage in HCV treatment among PWID considering antiviral treatment modalities.", {"entities": []}], ["Statins are 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors that alter the synthesis of cholesterol.", {"entities": []}], ["Some studies have shown a significant association of statins with improved respiratory health outcomes of patients with asthma, chronic obstructive pulmonary disease and lung cancer.", {"entities": [[170, 181, "DISEASE"], [128, 165, "DISEASE"], [120, 126, "DISEASE"], [175, 181, "DISEASE"]]}], ["Here we hypothesize that statins impact gene expression in human lungs and may reveal the pleiotropic effects of statins that are taking place directly in lung tissues.", {"entities": []}], ["Human lung tissues were obtained from patients who underwent lung resection or transplantation.", {"entities": []}], ["Gene expression was measured on a custom Affymetrix array in a discovery cohort (n = 408) and two replication sets (n = 341 and 282).", {"entities": []}], ["Gene expression was evaluated by linear regression between statin users and non-users, adjusting for age, gender, smoking status, and other covariables.", {"entities": []}], ["The results of each cohort were combined in a meta-analysis and biological pathways were studied using Gene Set Enrichment Analysis.", {"entities": []}], ["The discovery set included 141 statin users.", {"entities": []}], ["The lung mRNA expression levels of eighteen and three genes were up-regulated and down-regulated in statin users (FDR < 0.05), respectively.", {"entities": []}], ["Twelve of the up-regulated genes were replicated in the first replication set, but none in the second (p-value < 0.05).", {"entities": []}], ["Combining the discovery and replication sets into a meta-analysis improved the significance of the 12 up-regulated genes, which includes genes encoding enzymes and membrane proteins involved in cholesterol biosynthesis.", {"entities": []}], ["Canonical biological pathways altered by statins in the lung include cholesterol, steroid, and terpenoid backbone biosynthesis.", {"entities": []}], ["No genes encoding inflammatory, proteases, pro-fibrotic or growth factors were altered by statins, suggesting that the direct effect of statin in the lung do not go beyond its antilipidemic action.", {"entities": []}], ["Although more studies are needed with specific lung cell types and different classes and doses of statins, the improved health outcomes and survival observed in statin users with chronic lung diseases do not seem to be mediated through direct regulation of gene expression in the lung.", {"entities": []}], ["Tight junctions are the most apically localized part of the epithelial junctional complex.", {"entities": []}], ["They regulate the permeability and polarity of cell layers and create compartments in cell membranes.", {"entities": []}], ["Claudins are structural molecules of tight junctions.", {"entities": []}], ["There are 27 claudins known, and expression of different claudins is responsible for changes in the electrolyte and solute permeability in cells layers.", {"entities": []}], ["Studies have shown that claudins and tight junctions also protect multicellular organisms from infections and that some infectious agents may use claudins as targets to invade and weaken the host's defense.", {"entities": []}], ["In neoplastic diseases, claudin expression may be up- or downregulated.", {"entities": []}], ["Since their expression is associated with specific tumor types or with specific locations of tumors to a certain degree, they can, in a restricted sense, also be used as tumor markers.", {"entities": []}], ["However, the regulation of claudin expression is complex involving growth factors and integrins, protein kinases, proto-oncogens and transcription factors.", {"entities": []}], ["In this review, the significance of claudins is discussed in lung disease and development.", {"entities": [[61, 73, "DISEASE"]]}], ["In a recent National Research Council document, new strategies for risk assessment were described to enable more accurate and quicker assessments.", {"entities": []}], ["The systems biology approach evaluates the integration of biological processes and how disruption of these processes by chemicals or other hazards affects disease outcomes.", {"entities": []}], ["This type of approach could provide information used in delineating the mode of action of the response or toxicity, and may be useful to define the low adverse and no adverse effect levels.", {"entities": []}], ["Biomarkers of effect are changes measured in biological systems and are considered to be preclinical in nature.", {"entities": []}], ["Advances in computational methods and experimental -omics methods that allow the simultaneous measurement of families of macromolecules such as DNA, RNA, and proteins in a single analysis have made these systems approaches feasible for broad application.", {"entities": []}], ["The utility of the information for risk assessments from -omics approaches has shown promise and can provide information on mode of action and dose-response relationships.", {"entities": []}], ["As these techniques evolve, estimation of internal dose and response biomarkers will be a critical test of these new technologies for application in risk assessment strategies.", {"entities": []}], ["While proof of concept studies have been conducted that provide evidence of their value, challenges with standardization and harmonization still need to be overcome before these methods are used routinely.", {"entities": []}], ["Inner-city children have high rates of asthma.", {"entities": [[39, 45, "DISEASE"]]}], ["Exposures to particles, including allergens, may cause or exacerbate asthma symptoms.", {"entities": [[69, 75, "DISEASE"]]}], ["As part of an epidemiologic study of inner-city children with asthma, continuous (10-min average) measurements of particle concentrations were made for 2-week periods in 294 homes drawn from seven cities.", {"entities": [[62, 68, "DISEASE"]]}], ["Measurements were made using an optical scattering device that is most sensitive to fine particles.", {"entities": []}], ["The concentrations recorded by these devices were corrected to agree with colocated outdoor gravimetric PM2.5 monitors.", {"entities": []}], ["Indoor concentrations in the homes averaged 27.7 (standard deviation = 35.9) micro g/m3, compared with concurrent outdoor concentrations of 13.6 (7.5) micro g/m3.", {"entities": []}], ["A multivariate model indicated that outdoor particles penetrated indoors with an efficiency of 0.48 and were therefore responsible for only 25% of the mean indoor concentration.", {"entities": []}], ["The major indoor source was smoking, which elevated indoor concentrations by 37 micro g/m3 in the 101 homes with smokers.", {"entities": []}], ["Other significant sources included frying, smoky cooking events, use of incense, and apartment housing, although the increases due to these events ranged only from 3 to 6 micro g/m3.", {"entities": []}], ["The 10-min averaging time allowed calculation of an average diurnal variation, showing large increases in the evening due to smoking and smaller increases at meal times due to cooking.", {"entities": []}], ["Most of the observed variance in indoor concentrations was day to day, with roughly similar contributions to the variance from visit to visit and home to home within a city and only a small contribution made by variance among cities.", {"entities": []}], ["The small variation among cities and the similarity across cities of the observed indoor air particle distributions suggest that sources of indoor concentrations do not vary considerably from one city to the next, and thus that simple models can predict indoor air concentrations in cities having only outdoor measurements.", {"entities": []}], ["Uridine diphosphate glycosyltransferases (UGTs) are pivotal in the process of glycosylation for decorating natural products with sugars.", {"entities": []}], ["It is one of the versatile mechanisms in determining chemical complexity and diversity for the production of suite of pharmacologically active plant natural products.", {"entities": []}], ["Picrorhiza kurrooa is a highly reputed medicinal herb known for its hepato-protective properties which are attributed to a novel group of iridoid glycosides known as picrosides.", {"entities": []}], ["Although the plant is well studied in terms of its pharmacological properties, very little is known about the biosynthesis of these important secondary metabolites.", {"entities": []}], ["In this study, we identified two family-1 glucosyltransferases from P. kurrooa .", {"entities": []}], ["The full length cDNAs of UGT94F4 and UGT86C4 contained open reading frames of 1455 and 1422 nucleotides, encoding polypeptides of 484 and 473 amino acids respectively.", {"entities": []}], ["UGT94F2 and UGT86C4 showed differential expression pattern in leaves, rhizomes and inflorescence.", {"entities": []}], ["To elucidate whether the differential expression pattern of the two Picrorhiza UGTs correlate with transcriptional regulation via their promoters and to identify elements that could be recognized by known iridoid-specific transcription factors, upstream regions of each gene were isolated and scanned for putative cis -regulatory elements.", {"entities": []}], ["Interestingly, the presence of cis -regulatory elements within the promoter regions of each gene correlated positively with their expression profiles in response to different phytohormones.", {"entities": []}], ["HPLC analysis of picrosides extracted from different tissues and elicitor-treated samples showed a significant increase in picroside levels, corroborating well with the expression profile of UGT94F2 possibly indicating its implication in picroside biosynthesis.", {"entities": []}], ["Using homology modeling and molecular docking studies, we provide an insight into the donor and acceptor specificities of both UGTs identified in this study.", {"entities": []}], ["UGT94F2 was predicted to be an iridoid-specific glucosyltransferase having maximum binding affinity towards 7-deoxyloganetin while as UGT86C4 was predicted to be a kaempferol-specific glucosyltransferase.", {"entities": []}], ["These are the first UGTs being reported from P. kurrooa.", {"entities": []}], ["The Trial of Early Aggressive Therapy in Juvenile Idiopathic Arthritis (TREAT trial) was accompanied by a once-in-a-generation sample collection for translational research.", {"entities": [[61, 70, "DISEASE"]]}], ["In this paper, we report the results of whole blood gene expression analyses and genomic data-mining designed to cast light on the immunopathogenesis of polyarticular juvenile idiopathic arthritis (JIA).", {"entities": [[187, 196, "DISEASE"]]}], ["TREAT samples and samples from an independent cohort were analyzed on Affymetrix microarrays and compared to healthy controls.", {"entities": []}], ["Data from the independent cohort were used to validate the TREAT data.", {"entities": []}], ["Pathways analysis was used to characterize gene expression profiles.", {"entities": []}], ["Furthermore, we correlated differential gene expression with new information about functional regulatory elements within the genome to develop models of aberrant gene expression in JIA.", {"entities": []}], ["There was a strong concordance in gene expression between TREAT samples and the independent cohort.", {"entities": []}], ["In addition, rheumatoid factor (RF)-positive and RF-negative patients showed only small differences on whole blood expression profiles.", {"entities": []}], ["Analysis of the combined samples showed 158 genes represented by 176 probes that showed differential expression between TREAT subjects at baseline and healthy controls.", {"entities": []}], ["None of the differentially expressed genes were encoded within linkage disequilibrium blocks containing single nucleotide polymorphisms known to be associated with risk for JIA.", {"entities": []}], ["Functional analysis of these genes showed functional associations with multiple processes associated with innate and adaptive immunity, and appeared to reflect overall suppression of STAT1\u20133/interferon response factor-mediated pathways.", {"entities": []}], ["Despite their limitations, whole blood expression profiles clearly distinguish children with polyarticular JIA from healthy controls.", {"entities": []}], ["Whole blood expression profiles identify several immunologic pathways of biologic relevance that will need to be pursued in homogeneous cell populations in order to clarify mechanisms of pathogenesis.", {"entities": []}], ["ClinicalTrials.gov registry #NCT00443430 , originally registered 2 March 2007 and last updated 30 May 2013.", {"entities": []}], ["Bronchial epithelial cell death and airway inflammation induced by cigarette smoke (CS) have been involved in the pathogenesis of COPD.", {"entities": [[84, 86, "GENE"]]}], ["GRP78, belonging to heat shock protein 70 family, has been implicated in cell death and inflammation, while little is known about its roles in COPD.", {"entities": []}], ["Here, we demonstrate that GRP78 regulates CS-induced necroptosis and injury in bronchial epithelial cells.", {"entities": []}], ["GRP78 and necroptosis markers were examined in human bronchial epithelial (HBE) cell line, primary mouse tracheal epithelial cells, and mouse lungs.", {"entities": []}], ["siRNA targeting GRP78 gene and necroptosis inhibitor were used.", {"entities": []}], ["Expression of inflammatory cytokines, mucin MUC5AC, and related signaling pathways were detected.", {"entities": []}], ["Exposure to CS significantly increased the expression of GRP78 and necroptosis markers in HBE cell line, primary mouse tracheal epithelial cells, and mouse lungs.", {"entities": [[12, 14, "GENE"]]}], ["Inhibition of GRP78 significantly suppressed CS extract (CSE)-induced necroptosis.", {"entities": [[45, 47, "GENE"]]}], ["Furthermore, GRP78\u2013necroptosis cooperatively regulated CSE-induced inflammatory cytokines such as interleukin 6 (IL6), IL8, and mucin MUC5AC in HBE cells, likely through the activation of nuclear factor (NF-\u03baB) and activator protein 1 (AP-1) pathways, respectively.", {"entities": [[113, 116, "GENE"], [119, 122, "GENE"]]}], ["Taken together, our results demonstrate that GRP78 promotes CSE-induced inflammatory response and mucus hyperproduction in airway epithelial cells, likely through upregulation of necroptosis and subsequent activation of NF-\u03baB and AP-1 pathways.", {"entities": []}], ["Thus, inhibition of GRP78 and/or inhibition of necroptosis could be the effective therapeutic approaches for the treatment of COPD.", {"entities": []}], ["Background: Weight and health behaviours are known to affect physical disability; however the evidence exploring the impact of changes to these lifestyle factors over the life course on disability is inconsistent.", {"entities": []}], ["We aimed to explore the roles of weight and activity change between mid and later life on physical disability.", {"entities": []}], ["Methods: Baseline and 20-year clinical follow-up data were collected from1418 men and women, aged 58\u201388 years at follow-up, as part of a population-based observational study based in north-west London.", {"entities": []}], ["At clinic, behavioural data were collected by questionnaire and anthropometry measured.", {"entities": []}], ["Disability was assessed using a performance-based locomotor function test and self-reported questionnaires on functional limitation and basic activities of daily living (ADLs).", {"entities": []}], ["Results: At follow-up, 39% experienced a locomotor dysfunction, 24% a functional limitation and 17% an impairment of ADLs.", {"entities": []}], ["Weight gain of 10\u201320% or >20% of baseline, but not weight loss, were associated with increased odds of a functional limitation [odds ratio (OR) 1.69, 95% confidence interval (CI) 1.14-2.49 and OR 2.74, 1.55-4.83, respectively], after full adjustment for covariates.", {"entities": []}], ["The same patterns were seen for the other disability outcomes.", {"entities": []}], ["Increased physical activity reduced, and decreased physical activity enhanced the likelihood of disability, independent of baseline behaviours and adiposity.", {"entities": []}], ["The adverse effects of weight gain appeared to be lessened in the presence of increased later-life physical activity.", {"entities": []}], ["Conclusion: Weight and activity changes between mid and later life have strong implications for physical functioning in older groups.", {"entities": []}], ["These findings reinforce the importance of the maintenance of healthy weight and behaviour throughout the life course, and the need to promote healthy lifestyles across population groups.", {"entities": []}], ["Bronchial hyperresponsiveness (BHR) elevates the risk for development of respiratory symptoms and accelerates the decline in forced expiratory volume in the first second (FEV 1 ).", {"entities": [[171, 174, "GENE"]]}], ["We thus aimed to assess the prevalence, determinants and quantity of BHR in Helsinki.", {"entities": []}], ["This study involved 292 randomly selected subjects age 26\u201366 years, women comprising 58%.", {"entities": []}], ["Following a structured interview, a spirometry, a bronchodilation test, and a skin-prick test, we assessed a bronchial challenge test with inhaled histamine using a dosimetric tidal breathing method.", {"entities": []}], ["Results included the provocative dose inducing a decrease in FEV 1 by 15% (PD 15 FEV 1 ) and the dose-response slope.", {"entities": [[61, 64, "GENE"], [81, 84, "GENE"], [61, 64, "GENE"], [81, 84, "GENE"]]}], ["For statistical risk factor-analyses, the severity of BHR was considered; PD 15 values \u22641.6 mg (BHR) and \u22640.4 mg [moderate or severe BHR (BHR ms )] served as cut-off levels.", {"entities": []}], ["BHR presented in 21.2% and BHR ms in 6.2% of the subjects.", {"entities": []}], ["FEV 1 < 80% of predicted [odds ratio (OR) 4.09], airway obstruction (FEV 1 /forced vital capacity < 88% of predicted) (OR 4.33) and history of respiratory infection at age <5 (OR 2.65) yielded an increased risk for BHR as ORs in multivariate analysis.", {"entities": [[0, 3, "GENE"], [69, 72, "GENE"], [0, 3, "GENE"], [69, 72, "GENE"]]}], ["For BHR ms , the determinants were decreased FEV 1 below 80% of predicted (OR 27.18) and airway obstruction (OR 6.16).", {"entities": [[45, 48, "GENE"]]}], ["Respiratory symptoms and asthma medication showed a significant association with BHR.", {"entities": [[25, 31, "DISEASE"]]}], ["Of the adult population of Helsinki, 21% showed BHR to inhaled histamine.", {"entities": []}], ["The main determinants were decreased FEV 1 and airway obstruction.", {"entities": [[37, 40, "GENE"]]}], ["Quantitative assessment of BHR by different cut-off levels provides a tool for characterization of phenotypes of airway disorders in epidemiologic and clinical studies.", {"entities": []}], ["Please cite this paper as: Juusela M, Pallasaho P, Sarna S, Piiril\u00e4 P, Lundb\u00e4ck B and Sovij\u00e4rvi A.", {"entities": []}], ["Bronchial hyperresponsiveness in an adult population in Helsinki: decreased FEV 1 , the main determinant.", {"entities": [[76, 79, "GENE"]]}], ["Clin Respir J 2013; 7: 34\u201344.", {"entities": []}], ["The demographic characteristics of pandemic influenza decedents among middle and low-income tropical countries are poorly understood.", {"entities": [[44, 53, "DISEASE"]]}], ["We explored the demographics of persons who died with influenza A (H1N1)pdm09 infection during 2009\u20132010, in seven countries in the American tropics.", {"entities": [[54, 63, "DISEASE"]]}], ["We used hospital-based surveillance to identify laboratory-confirmed influenza deaths in Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama and Dominican Republic.", {"entities": [[69, 78, "DISEASE"]]}], ["An influenza death was defined as a person who died within two weeks of a severe acute respiratory infection (SARI) defined as sudden onset of fever >38 \u00b0C, cough or sore-throat, and shortness of breath, or difficulty breathing requiring hospitalization, and who tested positive for influenza A (H1N1)pdm09 virus by real time polymerase chain reaction.", {"entities": [[3, 12, "DISEASE"], [283, 292, "DISEASE"]]}], ["We abstracted the demographic and clinical characteristics of the deceased from their medical records.", {"entities": []}], ["During May 2009-June 2010, we identified 183 influenza deaths.", {"entities": [[45, 54, "DISEASE"]]}], ["Their median age was 32\u00a0years (IQR 18\u201346 years).", {"entities": []}], ["One-hundred and one (55\u00a0%) were female of which 20 (20\u00a0%) were pregnant and 7 (7\u00a0%) were in postpartum.", {"entities": []}], ["One-hundred and twelve decedents (61\u00a0%) had pre-existing medical conditions, (15\u00a0% had obesity, 13\u00a0% diabetes, 11\u00a0% asthma, 8\u00a0% metabolic disorders, 5\u00a0% chronic obstructive pulmonary disease, and 10\u00a0% neurological disorders).", {"entities": [[153, 190, "DISEASE"], [87, 94, "DISEASE"], [116, 122, "DISEASE"]]}], ["65 % received oseltamivir but only 5\u00a0% received it within 48\u00a0h of symptoms onset.", {"entities": []}], ["The pandemic killed young adults, pregnant women and those with pre-existing medical conditions.", {"entities": []}], ["Most sought care too late to fully benefit from oseltamivir.", {"entities": []}], ["We recommend countries review antiviral treatment policies for people at high risk of developing complications.", {"entities": []}], ["The online version of this article (doi:10.1186/s12889-015-2064-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Advances in medicine and health policy have resulted in growing of older population, with a concurrent rise in multimorbidity, particularly in Iran, as a country transitioning to a western lifestyle, and in which the percent of the population over the age of 60 years is increasing.", {"entities": []}], ["This study aims to assess multimorbidity and the associated risk factors in Iran.", {"entities": []}], ["We used data from 50,045 participants (age 40\u201375 y) in the Golestan Cohort Study, including data on demographics, lifestyle habits, socioeconomic status, and anthropometric indices.", {"entities": []}], ["Multimorbidity was defined as the presence of 2 or more out of 8 self-reported chronic conditions, including cardiovascular diseases, diabetes, chronic obstructive pulmonary disease, chronic kidney disease, liver disease, gastroesophageal reflux disease, tuberculosis, and cancer.", {"entities": [[191, 205, "DISEASE"], [207, 220, "DISEASE"], [144, 181, "DISEASE"], [255, 267, "DISEASE"], [222, 253, "DISEASE"], [273, 279, "DISEASE"]]}], ["Multivariate logistic regression models were used to examine the associations between multiple different factors and the risk factors.", {"entities": []}], ["Multimorbidity prevalence was 19.4%, with the most common chronic diseases being gastroesophageal reflux disease (76.7%), cardiovascular diseases (72.7%), diabetes (25.3%), and chronic obstructive pulmonary disease (21.9%).", {"entities": [[177, 214, "DISEASE"], [81, 112, "DISEASE"]]}], ["The odds of multimorbidity was 2.56-fold higher at the age of >60 years compared with that at <50 years ( P \u200a<\u200a0.001), and 2.11-fold higher in women than in men ( P \u200a<\u200a0.001).", {"entities": []}], ["Other factors associated with higher risk of multimorbidity included non-Turkmen ethnicity, low education, unemployment, low socioeconomic status, physical inactivity, overweight, obesity, former smoking, opium and alcohol use, and poor oral health.", {"entities": [[180, 187, "DISEASE"]]}], ["Apart from advanced age and female sex, the most important potentially modifiable lifestyle factors, including excess body weight and opium use, and opium user, are associated with multimorbidity.", {"entities": []}], ["Policies aiming at controlling multimorbidity will require a multidimensional approach to reduce modifiable risk factors in the younger population in developing countries alongside adopting efficient strategies to improve life quality in the older population.", {"entities": []}], ["Medicinal plants are important elements of indigenous medical system that have persisted in developing countries.", {"entities": []}], ["Many of the botanical chemo-preventions currently used as potent anticancer agents.", {"entities": []}], ["However, some important anticancer agents are still extracted from plants because they cannot be synthesized chemically on a commercial scale due to their complex structures that often contain several chiral centers.", {"entities": []}], ["The aim of this study was to test different extracts from the Moringa oleifera leaves (ML), its PLGA-CS-PEG nanocomposites (MLn), as well as root core (Rc) and outer (Ro) parts for activity against hepatocarcinoma HepG2, breast MCF7, and colorectal HCT 116/ Caco-2 cells in vitro.", {"entities": [[124, 127, "GENE"]]}], ["Nano-composites were prepared and characterized.", {"entities": []}], ["Then, the nanocomposites and the free counterparts were screened on different propagated cancer cell lines.", {"entities": [[89, 95, "DISEASE"]]}], ["The underlying cytotoxic impact was followed using apoptosis measurements.", {"entities": []}], ["All extracts kill the different cancer cells with different ratios, but intriguingly, the root core extract could kill the majority of cancer cells (approximately 70-80%), while sparing normal BHK-21 cells with minimal inhibitory effect (approximately 30-40%).", {"entities": [[32, 38, "DISEASE"], [135, 141, "DISEASE"]]}], ["Apoptotic cell increment came to confirm the cytotoxic effects of these extracts on HCT 116 cells (Rc: 212% and Ro: 180%, respectively) and HepG2 cells (ML: 567.5% and MLn: 608%, respectively) compared to control (100%) mechanistically wise.", {"entities": [[168, 171, "GENE"]]}], ["Moringa oleifera nanocomposites may have potential for use as a natural source of anti-cancer compounds.", {"entities": [[87, 93, "DISEASE"]]}], ["Sepsis caused by Neisseria meningitidis (meningococcus) is a rapidly progressing, life-threatening disease.", {"entities": []}], ["Because its initial symptoms are rather unspecific, medical attention is often sought too late, i.e., when the systemic inflammatory response is already unleashed.", {"entities": []}], ["This in turn limits the success of antibiotic treatment.", {"entities": []}], ["The complement system is generally accepted as the most important innate immune determinant against invasive meningococcal disease since it protects the host through the bactericidal membrane attack complex.", {"entities": []}], ["However, complement activation concomitantly liberates the C5a peptide, and it remains unclear whether this potent anaphylatoxin contributes to protection and/or drives the rapidly progressing immunopathogenesis associated with meningococcal disease.", {"entities": []}], ["Here, we dissected the specific contribution of C5a receptor 1 (C5aR1), the canonical receptor for C5a, using a mouse model of meningococcal sepsis.", {"entities": [[64, 69, "GENE"]]}], ["Mice lacking C3 or C5 displayed susceptibility that was enhanced by >1,000-fold or 100-fold, respectively, consistent with the contribution of these components to protection.", {"entities": [[13, 15, "GENE"], [19, 21, "GENE"]]}], ["In clear contrast, C5ar1 N. meningitidis more rapidly than wild-type (WT) animals.", {"entities": [[19, 24, "GENE"]]}], ["This favorable outcome stemmed from an ameliorated inflammatory cytokine response to N. meningitidis in C5ar1 in vivo and ex vivo whole-blood infections.", {"entities": [[104, 109, "GENE"]]}], ["In addition, inhibition of C5aR1 signaling without interference with the complement bactericidal activity reduced the inflammatory response also in human whole blood.", {"entities": [[27, 32, "GENE"]]}], ["Enticingly, pharmacologic C5aR1 blockade enhanced mouse survival and lowered meningococcal burden even when the treatment was administered after sepsis induction.", {"entities": [[26, 31, "GENE"]]}], ["Together, our findings demonstrate that C5aR1 drives the pathophysiology associated with meningococcal sepsis and provides a promising target for adjunctive therapy.", {"entities": [[40, 45, "GENE"]]}], ["The devastating consequences of N. meningitidis sepsis arise due to the rapidly arising and self-propagating inflammatory response that mobilizes antibacterial defenses but also drives the immunopathology associated with meningococcemia.", {"entities": []}], ["The complement cascade provides innate broad-spectrum protection against infection by directly damaging the envelope of pathogenic microbes through the membrane attack complex and triggers an inflammatory response via the C5a peptide and its receptor C5aR1 aimed at mobilizing cellular effectors of immunity.", {"entities": [[251, 256, "GENE"]]}], ["Here, we consider the potential of separating the bactericidal activities of the complement cascade from its immune activating function to improve outcome of N. meningitidis sepsis.", {"entities": []}], ["Our findings demonstrate that the specific genetic or pharmacological disruption of C5aR1 rapidly ameliorates disease by suppressing the pathogenic inflammatory response and, surprisingly, allows faster clearance of the bacterial infection.", {"entities": [[84, 89, "GENE"]]}], ["This outcome provides a clear demonstration of the therapeutic benefit of the use of C5aR1-specific inhibitors to improve the outcome of invasive meningococcal disease.", {"entities": []}], ["Factors predicting prescriptions of triple therapy were investigated in a large group of general practitioners in Italy.", {"entities": []}], ["In the population treated by identified general practitioners, a cohort of newly diagnosed chronic obstructive pulmonary disease patients was extracted from IMS Health Longitudinal Database during the period 2010\u20132013.", {"entities": [[91, 128, "DISEASE"]]}], ["From the diagnosis, 1-year follow-up was evaluated.", {"entities": []}], ["Thirty-two thousand forty-six newly diagnosed chronic obstructive pulmonary disease patients were evaluated (57.7% male, mean age 67 years).", {"entities": [[46, 83, "DISEASE"]]}], ["During 2 years prior to diagnosis less than 13% of patients were requested with a pulmonology evaluation and less than 5% with a spirometry; 65.1% cases were prescribed with a respiratory drug, which in 9.6% of cases was inhaled corticosteroid/long-acting \u03b2 2 -agonist fixed-dose combination.", {"entities": []}], ["Two thousand and twenty eight patients (6.3% of the newly diagnosed chronic obstructive pulmonary disease patients) were treated with triple therapy during the first year of follow-up, whose 858 (42.3%) starting immediately, and 762 (37.6%) following an initial treatment with inhaled corticosteroid/long-acting \u03b2 2 -agonist fixed-dose combination.", {"entities": [[68, 105, "DISEASE"]]}], ["Being older, being requested with pulmonologist evaluation or spirometry, being prescribed with a inhaled corticosteroid/long-acting \u03b2 2 -agonist fixed-dose combination at diagnosis resulted independent predictors of triple therapy use.", {"entities": []}], ["An improved education program for doctors promoting correct use of medication for chronic lung disease is needed in Italy.", {"entities": [[90, 102, "DISEASE"]]}], ["Current guidelines state that inhaled corticosteroids (ICSs) should be reserved for patients with severe chronic obstructive pulmonary disease (COPD), but it appears that doctors do not always follow this advice.", {"entities": [[105, 142, "DISEASE"]]}], ["Fabiano Di Marco, at San Paolo Hospital\u2014Universit\u00e0 degli Studi di Milano, and co-workers analyzed data from 32,046 COPD patients newly-diagnosed by family doctors in Italy between 2010 and 2013.", {"entities": []}], ["When the researchers followed up on patients after 1 year, 2028 (6.3%) of newly-diagnosed patients were being treated with triple inhaled therapy incorporating ICSs\u201442% of these patients had started triple therapy immediately upon diagnosis.", {"entities": []}], ["Being an older male and having been prescribed with a ICS/LABA FDC at diagnosis were strong predictors of triple therapy use within 1 year from the diagnosis.", {"entities": []}], ["Objective \u00a0To determine the risk of venous thromboembolism associated with use of testosterone treatment in men, focusing particularly on the timing of the risk.", {"entities": []}], ["Design \u00a0Population based case-control study Setting \u00a0370 general practices in UK primary care with linked hospital discharge diagnoses and in-hospital procedures and information on all cause mortality.", {"entities": []}], ["Participants \u00a019\u2009215 patients with confirmed venous thromboembolism (comprising deep venous thrombosis and pulmonary embolism) and 909\u2009530 age matched controls from source population including more than 2.22 million men between January 2001 and May 2013.", {"entities": [[107, 125, "DISEASE"]]}], ["Exposure of interest \u00a0Three mutually exclusive testosterone exposure groups were identified: current treatment, recent (but not current) treatment, and no treatment in the previous two years.", {"entities": []}], ["Current treatment was subdivided into duration of more or less than six months.", {"entities": []}], ["Main outcome measure \u00a0Rate ratios of venous thromboembolism in association with current testosterone treatment compared with no treatment were estimated using conditional logistic regression and adjusted for comorbidities and all matching factors.", {"entities": []}], ["Results \u00a0The adjusted rate ratio of venous thromboembolism was 1.25 (95% confidence interval 0.94 to 1.66) for current versus no testosterone treatment.", {"entities": []}], ["In the first six months of testosterone treatment, the rate ratio of venous thromboembolism was 1.63 (1.12 to 2.37), corresponding to 10.0 (1.9 to 21.6) additional venous thromboembolisms above the base rate of 15.8 per 10\u2009000 person years.", {"entities": []}], ["The rate ratio after more than six months\u2019 treatment was 1.00 (0.68 to 1.47), and after treatment cessation it was 0.68 (0.43 to 1.07).", {"entities": []}], ["Increased rate ratios within the first six months of treatment were observed in all strata: the rate ratio was 1.52 (0.94 to 2.46) for patients with pathological hypogonadism and 1.88 (1.02 to 3.45) for those without it, and 1.41 (0.82 to 2.41) for those with a known risk factor for venous thromboembolism and 1.91 (1.13 to 3.23) for those without one.", {"entities": [[162, 174, "DISEASE"]]}], ["Conclusions \u00a0Starting testosterone treatment was associated with an increased risk of venous thromboembolism, which peaked within six months and declined thereafter.", {"entities": []}], ["The production and dissemination of spores by members of the fungal kingdom is a major reason for the success of this eukaryotic lineage in colonizing most terrestrial ecosystems.", {"entities": []}], ["Ballistospores are a type of spore produced by basidiomycete fungi, such as the mushrooms and plant pathogenic rusts.", {"entities": []}], ["These spores are forcefully discharged through a unique liquid-drop fusion mechanism, enabling the aerosolization of these particles that can contribute to plant disease and human allergies.", {"entities": []}], ["The genes responsible for this process are unknown due to technical challenges in studying many of the fungi that produce ballistospores.", {"entities": []}], ["Here, we applied newly-developed techniques in a forward genetic screen to identify genes required for ballistospore formation or function in a tractable red yeast, a species of Sporobolomyces .", {"entities": []}], ["One strain bearing a mutation in the PHS1 gene was identified as a mirror mutant.", {"entities": []}], ["PHS1 encodes 3-hydroxyacyl-CoA dehydratase required for the third step in very long chain fatty acid biosynthesis.", {"entities": []}], ["The Sporobolomyces PHS1 gene complements the essential functions of a S. cerevisiae phs1 mutant.", {"entities": []}], ["The Sporobolomyces phs1 mutant strain has less dehydratase activity and a reduction in very long chain fatty acids compared to wild type.", {"entities": []}], ["The mutant strain also exhibits sensitivity to cell wall stress agents and loss of shooting due to a delay in ballistospore formation, indicating that the role of Phs1 in spore dissemination may be primarily in cellular integrity.", {"entities": []}], ["The 2009 H1N1 influenza virus (formerly known as swine flu) first appeared in Mexico and the United States in March and April 2009 and has swept the globe with unprecedented speed as a result of airline travel.", {"entities": [[14, 23, "DISEASE"]]}], ["On June 11, 2009, the World Health Organization raised its pandemic level to the highest level, Phase 6, indicating widespread community transmission on at least two continents.", {"entities": []}], ["The 2009 H1N1 virus contains a unique combination of gene segments from human, swine and avian influenza A viruses.", {"entities": [[95, 104, "DISEASE"], [89, 104, "DISEASE"]]}], ["Children and young adults appear to be the most affected, perhaps reflecting protection in the elderly owing to exposure to H1N1 strains before 1957.", {"entities": []}], ["Most clinical disease is relatively mild but complications leading to hospitalization, with the need for intensive care, can occur, especially in very young children, during pregnancy, in morbid obesity, and in those with underlying medical conditions such as chronic lung and cardiac diseases, diabetes, and immunosuppression.", {"entities": [[195, 202, "DISEASE"], [188, 202, "DISEASE"]]}], ["Bacterial coinfection has played a significant role in fatal cases.", {"entities": []}], ["The case of fatality has been estimated at around 0.4%.", {"entities": []}], ["Mathematical modeling suggests that the effect of novel influenza virus can be reduced by immunization, but the question remains: can we produce enough H1N1 vaccine to beat the pandemic?", {"entities": [[56, 65, "DISEASE"]]}], ["Allograft vasculopathy (AV) remains one of the major challenges to the long-term functioning of solid organ transplants.", {"entities": []}], ["Although its exact pathogenesis remains unclear, AV is characterized by both fibromuscular proliferation and infiltration of CD4", {"entities": [[125, 128, "GENE"]]}], ["Studies have identified associations between household secondhand tobacco smoke (SHS) exposure and induction of childhood asthma.", {"entities": [[122, 128, "DISEASE"]]}], ["However, the true nature and strength of this association remains confounded in many studies, producing inconsistent evidence.", {"entities": []}], ["To look for sources of potential bias and try to uncover consistent patterns of relative risk estimates (RRs), we conducted a meta-analysis of studies published between 1970 and 2005.", {"entities": []}], ["Through an extensive literature search, we identified 38 epidemiologic studies of SHS exposure and the development of childhood asthma (that also controlled for atopy history) from 300 potentially relevant articles.", {"entities": [[128, 134, "DISEASE"]]}], ["We observed substantial heterogeneity within initial summary RRs of 1.48 [95% confidence interval (CI), 1.32\u20131.65], 1.25 (1.21\u20131.30), and 1.21 (1.08\u20131.36), for ever, current, and incident asthma, respectively.", {"entities": [[188, 194, "DISEASE"]]}], ["Lack of control for type of atopy history (familial or child) and child\u2019s own smoking status within studies and age category altered summary RRs in separate meta-regressions.", {"entities": []}], ["After adjusting for these confounding characteristics, consistent patterns of association emerged between SHS exposure and childhood asthma induction.", {"entities": [[133, 139, "DISEASE"]]}], ["Our summary RR of 1.33 (95% CI, 1.14\u20131.56) from studies of incident asthma among older children (6\u201318 years of age) is 1.27 times the estimate from studies of younger children and higher than estimates reported in earlier meta-analyses.", {"entities": [[68, 74, "DISEASE"]]}], ["This new finding indicates that exposure duration may be a more important factor in the induction of asthma than previously understood, and suggests that SHS could be a more fundamental and widespread cause of childhood asthma than some previous meta-analyses have indicated.", {"entities": [[101, 107, "DISEASE"], [220, 226, "DISEASE"]]}], ["Self-reported health is a widely used measure of health status across individuals.", {"entities": []}], ["As the ageing population increases, the health of the elderly also becomes of growing concern.", {"entities": []}], ["The elderly go through life facing social, economic and financial hardships.", {"entities": []}], ["These hardships are known to affect the health status of people as they age.", {"entities": []}], ["The purpose of this study is to assess social and health related factors of self-reported health among the elderly in Ghana.", {"entities": []}], ["A multivariate regression analysis in form of a binary and ordinal logistic regression were used to determine the association between socioeconomic, demographic and health related factors, on self-reported health.", {"entities": []}], ["The data used for this study was drawn from the World Health Organization (WHO) Study on Global Ageing and Adult Health (SAGE) Wave 1.", {"entities": []}], ["In total, out of 2613 respondent, 579 (20.1%) rated their health status as poor and 2034 (79.9%) as good.", {"entities": []}], ["The results showed that the odds of reporting poor health was 2.5 times higher among the old-old compared to the young old.", {"entities": []}], ["The elderly with one or more than one chronic condition had the odds of 1.6 times and 2 times respectively, of reporting poor health.", {"entities": []}], ["Engaging in mild to moderate exercise increased the chances of reporting poor health by 1.8 times.", {"entities": []}], ["The elderly who had never worked in a lifetime were 2 times more likely to report poor health.", {"entities": []}], ["In the same way, residents of Eastern and Western parts of Ghana were 2 times more likely to report poor health compared to those in the Upper West region.", {"entities": []}], ["Respondents with functional limitations and disabilities were 3.6 times and 2.4 times respectively, more likely to report poor health.", {"entities": []}], ["On the other hand, the odds of reporting poor health was 29, 36 and 27% less among respondents in the highest income quintiles, former users of tobacco and those satisfied with certain aspects of life respectively.", {"entities": []}], ["Also, current alcohol users were 41% less likely to report poor health.", {"entities": []}], ["The health status of the elderly is to an extent determined by the circumstances in which they are born, grow and live.", {"entities": []}], ["The findings suggest that addressing social issues faced by individuals in youthful age will go a long way to achieving good health in the future.", {"entities": []}], ["People with physical limitations and disabilities are most vulnerable to unmet healthcare needs and support system from government, policy makers and family.", {"entities": []}], ["Asthma is the result of a complex interaction between environmental factors and genetic variants that confer susceptibility.", {"entities": [[0, 6, "DISEASE"]]}], ["The glutathione S-transferases (GSTT1 and GSTM1) are phase II enzymes thought to protect the airways from oxidative stress.", {"entities": [[32, 37, "GENE"], [42, 47, "GENE"]]}], ["Few and contradictory data are available on the association between asthma development and GSTT1 and GSTM1 polymorphisms in different ethnic groups.", {"entities": [[68, 74, "DISEASE"], [91, 96, "GENE"], [101, 106, "GENE"]]}], ["The current study aimed to investigate whether these polymorphisms are associated with asthma development in the Egyptian population.", {"entities": [[87, 93, "DISEASE"]]}], ["The cross-sectional study was performed on 94 asthmatic children 6 -12\u00a0yrs and 90 matched healthy controls.", {"entities": []}], ["Candidates were subjected to clinical evaluation and measurement of absolute blood eosinophilic count, total serum IgE, and GSTT1 and GSTM1 genotype by multiplex PCR technique.", {"entities": [[124, 129, "GENE"], [134, 139, "GENE"]]}], ["The results for GSTT1 null genotype were 87.2% and 97.2% for asthmatic children and controls respectively and showed to be significantly more in controls (P =0.007, OR:0.683, CI: 0.034 -0.715).", {"entities": [[16, 21, "GENE"]]}], ["The results for GSTM1 null genotype were 50% and 61.1% for asthmatic children and controls respectively and showed to be nonsignificant (p\u2009=\u20090.130, OR: 1.000, CI: 0.54- 1.86).", {"entities": [[16, 21, "GENE"]]}], ["Also, no association was detected between GSTT1 and GSTM1 polymorphisms and atopic conditions or asthma severity.", {"entities": [[97, 103, "DISEASE"], [42, 47, "GENE"], [52, 57, "GENE"]]}], ["The significant detection o f GSTT1 null genotype more in controls than in asthmatics with no association with other atopic manifestations or asthma severity and the lack of association detected between GSTM1 polymorphism in relation to asthma, atopy or asthma severity confirm the uncertain role of those genes in the development of asthma.", {"entities": [[142, 148, "DISEASE"], [237, 243, "DISEASE"], [254, 260, "DISEASE"], [334, 340, "DISEASE"], [30, 35, "GENE"], [203, 208, "GENE"]]}], ["Nuclear Factor kappa B (NF-\u03baB) is a transcription factor family critical in the activation of pro- inflammatory responses.", {"entities": []}], ["The NF-\u03baB pathway is regulated by oxidant-induced post-translational modifications.", {"entities": []}], ["Protein S-glutathionylation, or the conjugation of the antioxidant molecule, glutathione to reactive cysteines inhibits the activity of inhibitory kappa B kinase beta (IKK\u03b2), among other NF-\u03baB proteins.", {"entities": []}], ["Glutathione S-transferase Pi (GSTP) is an enzyme that has been shown to catalyze protein S-glutathionylation (PSSG) under conditions of oxidative stress.", {"entities": []}], ["The objective of the present study was to determine whether GSTP regulates NF-\u03baB signaling, S-glutathionylation of IKK, and subsequent pro-inflammatory signaling.", {"entities": []}], ["We demonstrated that, in unstimulated cells, GSTP associated with the inhibitor of NF-\u03baB, I\u03baB\u03b1.", {"entities": []}], ["However, exposure to LPS resulted in a rapid loss of association between I\u03baB\u03b1 and GSTP, and instead led to a protracted association between IKK\u03b2 and GSTP.", {"entities": []}], ["LPS exposure also led to increases in the S-glutathionylation of IKK\u03b2.", {"entities": []}], ["SiRNA-mediated knockdown of GSTP decreased IKK\u03b2-SSG, and enhanced NF-\u03baB nuclear translocation, transcriptional activity, and pro-inflammatory cytokine production in response to lipopolysaccharide (LPS).", {"entities": []}], ["TLK117, an isotype-selective inhibitor of GSTP, also enhanced LPS-induced NF-\u03baB transcriptional activity and pro-inflammatory cytokine production, suggesting that the catalytic activity of GSTP is important in repressing NF-\u03baB activation.", {"entities": []}], ["Expression of both wild-type and catalytically-inactive Y7F mutant GSTP significantly attenuated LPS- or IKK\u03b2-induced production of GM-CSF.", {"entities": []}], ["These studies indicate a complex role for GSTP in modulating NF-\u03baB, which may involve S-glutathionylation of IKK proteins, and interaction with NF-\u03baB family members.", {"entities": []}], ["Our findings suggest that targeting GSTP is a potential avenue for regulating the activity of this prominent pro-inflammatory and immunomodulatory transcription factor.", {"entities": []}], ["fx1 \u2022 LPS-induced S-glutathionylation of IKK\u03b2 is dependent on GSTP.", {"entities": []}], ["\u2022 NF-\u03baB regulation by GSTP is dependent on multiple mechanisms.", {"entities": []}], ["\u2022 GSTP modulates NF-\u03baB activation and production of pro-inflammatory mediators.", {"entities": []}], ["LPS-induced S-glutathionylation of IKK\u03b2 is dependent on GSTP.", {"entities": []}], ["NF-\u03baB regulation by GSTP is dependent on multiple mechanisms.", {"entities": []}], ["GSTP modulates NF-\u03baB activation and production of pro-inflammatory mediators.", {"entities": []}], ["The identification and appropriate management of those at highest risk for life-threatening anaphylaxis remains a clinical enigma.", {"entities": []}], ["The most widely used criteria for such patients were developed in a symposium convened by National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network.", {"entities": []}], ["In this paper we review the current literature on the diagnosis of acute allergic reactions as well as atypical presentations that clinicians should recognize.", {"entities": []}], ["Review of case series reveals significant variability in definition and approach to this common and potentially life-threatening condition.", {"entities": []}], ["Series on fatal cases of anaphylaxis indicate that mucocutaneous signs and symptoms occur less frequently than in milder cases.", {"entities": []}], ["Of biomarkers studied to aid in the work-up of possible anaphylaxis, drawing blood during the initial six hours of an acute reaction for analysis of serum tryptase has been recommended in atypical cases.", {"entities": []}], ["This can provide valuable information when a definitive diagnosis cannot be made by history and physical exam.", {"entities": []}], ["Reduced gas transfer in patients with pulmonary arterial hypertension (PAH) is traditionally attributed to remodeling and progressive loss of pulmonary arterial vasculature that results in decreased capillary blood volume available for gas exchange.", {"entities": [[57, 69, "DISEASE"]]}], ["We tested this hypothesis by determination of lung diffusing capacity (DL) and its components, the alveolar capillary membrane diffusing capacity (D m ) and lung capillary blood volume (V c ) in 28 individuals with PAH in comparison to 41 healthy individuals, and in 19 PAH patients over time.", {"entities": []}], ["Using single breath simultaneous measure of diffusion of carbon monoxide (DL CO ) and nitric oxide (DL NO ), DL and D m were respectively determined, and V c calculated.", {"entities": []}], ["D m and V c were evaluated over time in relation to standard clinical indicators of disease severity, including brain natriuretic peptide (BNP), 6-minute walk distance (6MWD) and right ventricular systolic pressure (RVSP) by echocardiography.", {"entities": []}], ["Both DL CO and DL NO were reduced in PAH as compared to controls and the lower DL in PAH was due to loss of both D m and V c (all p\u2009<\u20090.01).", {"entities": []}], ["While DL CO of PAH patients did not change over time, DL NO decreased by 24 ml/min/mmHg/year (p\u2009=\u20090.01).", {"entities": []}], ["Consequently, D m decreased and V c tended to increase over time, which led to deterioration of the D m /V c ratio, a measure of alveolar-capillary membrane functional efficiency without changes in clinical markers.", {"entities": []}], ["The findings indicate that lower than normal gas transfer in PAH is due to loss of both D m and V c , but that deterioration of D m /V c over time is related to worsening membrane diffusion.", {"entities": []}], ["The immunoproteasome subunit \u03b25i has been shown to play an important role in Th1/Th17 driven models of colitis and arthritis.", {"entities": [[115, 124, "DISEASE"]]}], ["However, the function of \u03b25i in Th2 dependent diseases remains enigmatic.", {"entities": []}], ["To study the role of \u03b25i in Th2-driven pathology, \u03b25i knockout (KO) and control mice were tested in different models of experimental allergic asthma.", {"entities": [[133, 148, "DISEASE"], [142, 148, "DISEASE"]]}], ["\u03b25i-deficient mice showed reduced OVA/Alum- and subcutaneous/OVA-induced acute asthma with decreased eosinophilia in the bronchoalveolar lavage (BAL), low OVA-specific IgG1 and reduced local and systemic Th2 cytokines.", {"entities": [[101, 113, "DISEASE"], [79, 85, "DISEASE"]]}], ["While Th2 cells in the lungs were reduced, Tregs and Th1 cells were not affected.", {"entities": []}], ["Attenuated asthma in \u03b25i KO mice could not be attributed to defects in OVA uptake or maturation of dendritic cells in the lung.", {"entities": [[11, 17, "DISEASE"]]}], ["Surprisingly, \u03b25i deficient mice developed HDM asthma which was comparable to control mice.", {"entities": [[47, 53, "DISEASE"]]}], ["Here, we present novel evidence for the requirement of the \u03b25i immunosubunit to generate a strong Th2 response during OVA- but not HDM-induced acute asthma.", {"entities": [[149, 155, "DISEASE"]]}], ["The unexpected role of \u03b25i in OVA asthma remains to be clarified.", {"entities": [[34, 40, "DISEASE"]]}], ["In contrast to resident constitutive mast cells (CMCs), mucosal MCs (MMCs) appear in lung and trachea of sensitized mice only following inhalation challenge.", {"entities": []}], ["We monitored the influx and maturation of MCs by their expression of Kit, Fc\u03b5RI, \u03b27 integrin and side scatter (SSC) by flow cytometry.", {"entities": []}], ["Influx of MC progenitors (MCps) (Fc\u03b5RI", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is considered a multisystem disease, in which comorbidities feature prominently.", {"entities": []}], ["COPD guidelines recommend holistic assessment and management of relevant comorbid diseases but there is limited information as to how this is best achieved.", {"entities": []}], ["This pilot study aimed to explore the views of stakeholders, including patients and the healthcare team, on the feasibility, acceptability and barriers to a collaborative, multidisciplinary team-based care intervention (\u2018TEAMcare\u2019) to improve health outcomes in COPD patients, within the context of a local hospital outpatient clinic.", {"entities": []}], ["A mixed methods study design was used.", {"entities": []}], ["A COPD care algorithm was developed based on the Australasian guidelines, COPDX.", {"entities": []}], ["COPD participants were consecutively recruited from an outer metropolitan hospital\u2019s respiratory clinic.", {"entities": []}], ["Participants attended for follow up visits at 5 and 10\u00a0months to ascertain clinical status, algorithm compliance and to review and revise management recommendations.", {"entities": []}], ["The intervention was conducted using existing resources, involving collaboration with general practice and the publicly-funded local chronic disease management programme (Medicare Local).", {"entities": []}], ["Stakeholders provided qualitative feedback about the intervention in terms of feasibility, acceptability and barriers via structured and semi-structured interviews.", {"entities": []}], ["All interviews were recorded, transcribed verbatim and analysed using qualitative thematic analysis to identify key concepts and themes.", {"entities": []}], ["The study protocol was abandoned prematurely due to clear lack of feasibility.", {"entities": []}], ["Of 12 participants, 4 withdrew and none completed pulmonary rehabilitation (PR).", {"entities": []}], ["The main reasons for non-participation or study withdrawal related to reluctance to attend PR (6 of 16) and the burden of increased appointments (4 of 16).", {"entities": []}], ["PR conflicted with employment hours, which presented problems for some participants.", {"entities": []}], ["Similarly, themes that emerged from qualitative data indicate healthcare provider perception of deficiencies in funding (for infrastructure and staffing).", {"entities": []}], ["Health literacy, motivation, organisation and functional impairment were issues for patients.", {"entities": []}], ["Available data from this small pilot provided valuable insights to inform future design and implementation strategies.", {"entities": []}], ["Delivering structured team-based care to COPD patients presents challenges.", {"entities": []}], ["In addition to enhancing health resources for engaging COPD patients, a focus on health literacy and improving health service access, including colocalisation and access outside business hours, may be required.", {"entities": []}], ["ACTRN12616000342415 ; 16/03/2016.", {"entities": []}], ["The online version of this article (doi:10.1186/s12913-016-1592-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Mesenchymal stem cells (MSCs) are multipotent cells that differentiate into the mesenchymal lineages of adipocytes, osteocytes and chondrocytes.", {"entities": []}], ["MSCs can also transdifferentiate and thereby cross lineage barriers, differentiating for example into neurons under certain experimental conditions.", {"entities": []}], ["MSCs have anti-proliferative, anti-inflammatory and anti-apoptotic effects on neurons.", {"entities": []}], ["Therefore, MSCs were tested in experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis (MS), for their effectiveness in modulating the pathogenic process in EAE to develop effective therapies for MS.", {"entities": [[99, 117, "DISEASE"], [55, 72, "DISEASE"]]}], ["The data in the literature have shown that MSCs can inhibit the functions of autoreactive T cells in EAE and that this immunomodulation can be neuroprotective.", {"entities": []}], ["In addition, MSCs can rescue neural cells via a mechanism that is mediated by soluble factors, which provide a suitable environment for neuron regeneration, remyelination and cerebral blood flow improvement.", {"entities": []}], ["In this review, we discuss the effectiveness of MSCs in modulating the immunopathogenic process and in providing neuroprotection in EAE.", {"entities": []}], ["Eosinophils play a central role in asthma.", {"entities": [[35, 41, "DISEASE"]]}], ["The present study was performed to investigate the effect of tumour necrosis factor-\u03b1 (TNF-\u03b1) on longevity of isolated human eosinophils.", {"entities": []}], ["In contrast to Fas, TNF-\u03b1 inhibited eosinophil apoptosis as evidenced by a combination of flow cytometry, DNA fragmentation assay and morphological analyses.", {"entities": [[15, 18, "GENE"]]}], ["The effect of TNF-\u03b1 on eosinophil apoptosis was reversed by a TNF-\u03b1 neutralising antibody.", {"entities": []}], ["The anti-apoptotic effect of TNF-\u03b1 was not due to autocrine release of known survival-prolonging cytokines interleukins 3 and 5 or granulocyte-macrophage-colony-stimulating factor as their neutralisation did not affect the effect of TNF-\u03b1.", {"entities": []}], ["The anti-apoptotic signal was mediated mainly by the TNF-receptor 1.", {"entities": []}], ["TNF-\u03b1 induced phosphorylation and degradation of I\u03baB and an increase in NF-\u03baB DNA-binding activity.", {"entities": []}], ["The survival-prolonging effect of TNF-\u03b1 was reversed by inhibitors of NF-\u03baB pyrrolidinedithiocarbamate and gliotoxin and by an inhibitor of I\u03baB kinase, BMS-345541.", {"entities": []}], ["TNF-\u03b1 induced also an increase in AP-1 DNA-binding activity and the antiapoptotic effect of TNF-\u03b1 was potentiated by inhibitors of AP-1, SR 11302 and tanshinone IIA and by an inhibitor of c-jun- N -terminal kinase, SP600125, which is an upstream kinase activating AP-1.", {"entities": []}], ["Our results thus suggest that TNF-\u03b1 delays human eosinophil apoptosis via TNF-receptor 1 and the resulting changes in longevity depend on yin-yang balance between activation of NF-\u03baB and AP-1.", {"entities": []}], ["From June of 2009 to August of 2010 the influenza subtype H1N1pdm09 caused a worldwide pandemic.", {"entities": [[40, 49, "DISEASE"]]}], ["The impact on populations and health care systems around the globe evolved differently.", {"entities": []}], ["Substantial data come from the German national surveillance network in an outpatient and private practice setting, while information on hospitalized patients in Germany is rather limited.", {"entities": []}], ["Data from the Federal Statistics Office comprising health insurance claims of the entire nationwide inpatient sample from 2005 to 2012 were used to identify patients who were hospitalized for laboratory-confirmed influenza and to analyse demographical aspects, comorbidities, hospitalization duration, outcomes and ventilator use during the pandemic and seasonal waves of influenza.", {"entities": [[213, 222, "DISEASE"], [372, 381, "DISEASE"]]}], ["A number of 34,493 admissions for laboratory-confirmed influenza occurred during waves between 2005 and 2012.", {"entities": [[55, 64, "DISEASE"]]}], ["During the pandemic seasonal waves, the number of hospitalizations vastly surpassed the level that was seen in any of the seasonal waves.", {"entities": []}], ["A major demographic shift was seen with respect to patient age, as younger patients (< 60 years old) were more frequently hospitalized.", {"entities": []}], ["Mean length of stay was shorter (149 vs. 193 hours), mean time on ventilation tended to be shorter (261 vs. 305 hours) in young children (< 4 years old) and longer (393 vs. 339 hours) in the elderly (> 60 years old).", {"entities": []}], ["Time to ventilation was shorter in non-fatal cases (328 vs. 349 hours) and longer in fatal cases (419 vs. 358 hours).", {"entities": []}], ["Logistic regression was used to show the impact of comorbidities and co-diagnoses on mortality and the need for ventilation, as well as differences between pandemic and seasonal influenza.", {"entities": [[178, 187, "DISEASE"]]}], ["Inpatient data suggest differences in patient populations during pandemic and seasonal influenza.", {"entities": [[87, 96, "DISEASE"]]}], ["Younger patients were more frequently hospitalized.", {"entities": []}], ["Differences with respect to the presence of certain comorbidities and co-diagnoses, length of stay, time to ventilation and ventilation time could be identified.", {"entities": []}], ["It has become increasingly recognized that skeletal muscle dysfunction is common in patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[98, 135, "DISEASE"]]}], ["Muscle strength and endurance are decreased, whereas muscle fatigability is increased.", {"entities": []}], ["There is a reduced proportion of type I fibers and an increase in type II fibers.", {"entities": []}], ["Muscle atrophy occurs with a reduction in fiber cross-sectional area.", {"entities": []}], ["Oxidative enzyme activity is decreased, and measurement of muscle bioenergetics during exercise reveals a reduced aerobic capacity.", {"entities": []}], ["Deconditioning is probably very important mechanistically.", {"entities": []}], ["Other mechanisms that may be of varying importance in individual patients include chronic hypercapnia and/or hypoxia, nutritional depletion, steroid usage, and oxidative stress.", {"entities": []}], ["Potential therapies include exercise training, oxygen supplementation, nutritional repletion, and administration of anabolic hormones.", {"entities": []}], ["Human eosinophil derived neurotoxin (EDN), a granule protein secreted by activated eosinophils, is a biomarker for asthma in children.", {"entities": [[115, 121, "DISEASE"]]}], ["EDN belongs to the human RNase A superfamily possessing both ribonucleolytic and antiviral activities.", {"entities": []}], ["EDN interacts with heparin oligosaccharides and heparin sulfate proteoglycans on bronchial epithelial Beas-2B cells.", {"entities": []}], ["In this study, we demonstrate that the binding of EDN to cells requires cell surface glycosaminoglycans (GAGs), and the binding strength between EDN and GAGs depends on the sulfation levels of GAGs.", {"entities": []}], ["Furthermore, in silico computer modeling and in vitro binding assays suggest critical roles for the following basic amino acids located within heparin binding regions (HBRs) of EDN", {"entities": []}], ["It has been suggested that statins can both stimulate and suppress the immune system, and thereby, may influence autoimmune diseases.", {"entities": []}], ["Therefore, we studied effects of statins on innate and adaptive immunity, and self-tolerance by measuring serological levels of C-reactive protein (CRP), neopterin, immunoglobulin E (IgE) antibodies and the presence of autoantibodies (antinuclear antibodies (ANA) and IgM rheumatoid factor (RF)) in the general population.", {"entities": [[148, 151, "GENE"]]}], ["We conducted a nested case-control study within the population-based Doetinchem cohort.", {"entities": []}], ["Data from health questionnaires, serological measurements and information on medication from linkage to pharmacy-dispensing records were available.", {"entities": []}], ["We selected 332 statin users (cases) and 331 non-users (controls), matched by age, sex, date of serum collection, history of cardiovascular diseases, diabetes mellitus type II and stroke.", {"entities": [[150, 167, "DISEASE"]]}], ["Multivariate regression analyses were performed to estimate effect of statins on the immune system.", {"entities": []}], ["The median level of CRP in statin users (1.28 mg/L, interquartile range (IQR): 0.59-2.79) was lower than in non-users (1.62 mg/L, IQR: 0.79-3.35), which after adjustment was estimated to be a 28% lower level.", {"entities": [[20, 23, "GENE"]]}], ["We observed an inverse association between duration of statin use and CRP levels.", {"entities": [[70, 73, "GENE"]]}], ["Elevated levels of IgE (>100 IU/mL) were more prevalent in statin users compared to non-users.", {"entities": []}], ["A trend towards increased levels of IgE antibodies in statin users was observed, whereas no associations were found between statin use and levels of neopterin or the presence of autoantibodies.", {"entities": []}], ["In this general population sub-sample, we observed an anti-inflammatory effect of statin use and a trend towards an increase of IgE levels, an surrogate marker for Th (helper) 2 responses without a decrease in neopterin levels, a surrogate marker for Th1 response and/or self-tolerance.", {"entities": []}], ["We postulate that the observed decreased inflammatory response during statin therapy may be important but is insufficient to induce loss of self-tolerance.", {"entities": []}], ["The parents of a 3-year old boy are anxious about their son who has recurring episodes of wheezing.", {"entities": []}], ["They are frustrated that no one seems to be able to give them answers to their questions and would like a referral to a specialist.", {"entities": []}], ["Does their son have asthma and what is the prognosis; how can the recurrent wheezing be managed and can the risk of asthma be reduced; are there lifestyle changes that could improve the environment and avoid triggers?", {"entities": [[20, 26, "DISEASE"], [116, 122, "DISEASE"]]}], ["Communication and support from the family practice team were essential.", {"entities": []}], ["Listening to the parents\u2019 concerns, explaining the diagnostic uncertainty, being realistic about what drug treatments could achieve, and providing practical advice on inhaler use and trigger avoidance reassured the parents that there was a strategy for managing their son\u2019s wheeze.", {"entities": []}], ["The specialist referral was postponed.", {"entities": []}], ["Only a minority of patients at high risk for osteoporotic fracture receive treatment.", {"entities": []}], ["Study patients\u2019 and physicians\u2019 views regarding postmenopausal osteoporosis (PMO) to identify impediments to good care.", {"entities": [[63, 75, "DISEASE"]]}], ["A qualitative study involving 18 physicians and 37 women (age 57\u201387) with PMO.", {"entities": []}], ["All women interviewed considered PMO to be somewhat normal wear-and-tear associated with old age.", {"entities": []}], ["The women identified a large number of \"causes\" for osteoporosis but finally viewed it as chance.", {"entities": [[52, 64, "DISEASE"]]}], ["They all described its progression as slow.", {"entities": []}], ["Three representations of PMO severity were identified: some women tended to interpreted it as benign (21), others tended to dramatize it (11), and the rest were uncertain (5).", {"entities": []}], ["These representations did not appear linked to age or fracture.", {"entities": []}], ["Even the women who associated fracture and PMO were uncertain of the link between them.", {"entities": []}], ["Fractures were considered to be random events, independent of osteoporosis.", {"entities": [[62, 74, "DISEASE"]]}], ["Women received general life-style recommendations from their physicians positively, but did not connect them specifically to osteoporosis.", {"entities": [[125, 137, "DISEASE"]]}], ["Indeed, these recommendations, along with the fear of side effects, the absence of tangible results of treatments, the view of PMO as a natural process, and the representations of PMO severity are factors that may deter treatments and impact compliance.", {"entities": []}], ["As for the physicians, they identified eight risk factors, recognizing menopause as central to PMO and recognized the link between risk of fracture and PMO.", {"entities": []}], ["However, some considered the impact of fractures to be limited in time, and viewed PMO as a \"benign\" disease.", {"entities": []}], ["Seeing the progression of PMO as slow and inevitable reduced their urgency to diagnose and treat it as compared to other diseases.", {"entities": []}], ["Some physicians acknowledged limited mastery of the existing therapeutic arsenal and unsuccessful handling of patient compliance.", {"entities": []}], ["Women\u2019s and physicians\u2019 perspectives on PMO converged to trivialize postmenopausal osteoporosis and thus disqualify it as a legitimate disease.", {"entities": [[83, 95, "DISEASE"]]}], ["A better understanding of women\u2019s and physicians\u2019 views, practices, and concerns related to PMO can improve osteoporosis management.", {"entities": [[108, 120, "DISEASE"]]}], ["Allergic rhinitis (AR) and rhinosinusitis (RS) negatively impact psychological well-being and health-related quality of life (HRQoL).", {"entities": [[9, 17, "DISEASE"]]}], ["However, few population-based studies have investigated the effects of these conditions on mental health and HRQoL.", {"entities": []}], ["To explore independent associations of AR and/or RS with mental health and HRQoL using data from the 2013\u20132015 Korea National Health and Nutrition Examination Survey (KNHANES).", {"entities": []}], ["The KNHANES is a nationwide cross-sectional survey of the non-institutionalized population of Korea.", {"entities": []}], ["A total of 15,441 adults completed the clinical examination and the health questionnaire.", {"entities": []}], ["We divided all participants into four groups: AR-/RS-, AR-/RS+, AR+/RS-, and AR+/RS+.", {"entities": []}], ["Logistic regression analyses were performed after adjustment for sociodemographic characteristics, general health behaviors, and other comorbidities.", {"entities": []}], ["The AR+/RS+ group contained the highest proportion of subjects with perceived stress and depressed mood.", {"entities": []}], ["Subjects with AR+/RS+ also had more frequent problems in terms of pain/discomfort and anxiety/depression.", {"entities": []}], ["After adjusting for all confounders, the odds ratios (ORs) were 2.96 (p = 0.009) for depressed mood and 3.17 (p = 0.013) for suicidal ideation in the AR+/RS+ group compared with in the AR-/RS- group.", {"entities": []}], ["The AR+/RS- group reported more perceived stress (OR, 1.56, p = 0.003) and depression (OR, 1.72, p = 0.024) compared with the AR-/RS- group.", {"entities": []}], ["In terms of the ORs for HRQoL, the AR+/RS+ group reported more problems in terms of self-care (OR, 3.73, p = 0.038) and more pain/discomfort (OR 2.19, p = 0.006) compared with the AR-/RS- group.", {"entities": []}], ["In the Korean population, AR and RS exerted a synergistic negative impact on mental health and HRQoL, especially suicidal ideation.", {"entities": []}], ["Most patients seek help from clinicians for impaired HRQoL.", {"entities": []}], ["Therefore, clinicians should consider the underlying mental health and HRQoL of patients with AR and/or RS, as these may be impaired by their conditions.", {"entities": []}], ["Candidate gene case-control studies have identified several single nucleotide polymorphisms (SNPs) that are associated with asthma susceptibility.", {"entities": [[124, 130, "DISEASE"]]}], ["Most of these studies have been restricted to evaluations of specific SNPs within a single gene and within populations from European ancestry.", {"entities": []}], ["Recently, there is increasing interest in understanding racial differences in genetic risk associated with childhood asthma.", {"entities": [[117, 123, "DISEASE"]]}], ["Our aim was to compare association patterns of asthma candidate genes between children of European and African ancestry.", {"entities": [[47, 53, "DISEASE"]]}], ["Using a custom-designed Illumina SNP array, we genotyped 1,485 children within the Greater Cincinnati Pediatric Clinic Repository and Cincinnati Genomic Control Cohort for 259 SNPs in 28 genes and evaluated their associations with asthma.", {"entities": [[231, 237, "DISEASE"]]}], ["We identified 14 SNPs located in 6 genes that were significantly associated (p-values <0.05) with childhood asthma in African Americans.", {"entities": [[108, 114, "DISEASE"]]}], ["Among Caucasians, 13 SNPs in 5 genes were associated with childhood asthma.", {"entities": [[68, 74, "DISEASE"]]}], ["Two SNPs in IL4 were associated with asthma in both races (p-values <0.05).", {"entities": [[37, 43, "DISEASE"], [12, 15, "GENE"]]}], ["Gene-gene interaction studies identified race specific sets of genes that best discriminate between asthmatic children and non-allergic controls.", {"entities": []}], ["We identified IL4 as having a role in asthma susceptibility in both African American and Caucasian children.", {"entities": [[38, 44, "DISEASE"], [14, 17, "GENE"]]}], ["However, while IL4 SNPs were associated with asthma in asthmatic children with European and African ancestry, the relative contributions of the most replicated asthma-associated SNPs varied by ancestry.", {"entities": [[45, 51, "DISEASE"], [160, 166, "DISEASE"], [15, 18, "GENE"]]}], ["These data provides valuable insights into the pathways that may predispose to asthma in individuals with European vs. African ancestry.", {"entities": [[79, 85, "DISEASE"]]}], ["The activation and infiltration of polymorphonuclear neutrophils (PMN) are critical key steps in inflammation.", {"entities": []}], ["PMN-mediated inflammation is limited by anti-inflammatory and pro-resolving mechanisms, including specialized pro-resolving lipid mediators (SPM).", {"entities": []}], ["We examined the effects of 15-epi-LXA 4 on inflammation and the biosynthesis of pro-inflammatory mediators, such as prostaglandins, leukotriene B 4 and various hydroxyeicosatetraenoic acids and SPM, in an oxazolone (OXA)-induced hypersensitivity model for dermal inflammation.", {"entities": []}], ["15-epi-LXA 4 (100 \u03bcM, 5 \u03bcL subcutaneously injected) significantly (P < 0.05) reduced inflammation in skin, 24 hours after the OXA challenge, as compared to skin treated with vehicle.", {"entities": []}], ["No significant influence on the biosynthesis of prostaglandins or leukotriene B 4 was observed, whereas the level of 15S-hydroxy-eicosatetraenoic acid was significantly (P < 0.05) lower in the skin areas treated with 15-epi-LXA 4 .", {"entities": []}], ["In spite of the use of a fully validated analytical procedure, no SPM were detected in the biological samples.", {"entities": []}], ["To investigate the reason for the lack of analytical signal, we tried to mimic the production of SPM (lipoxins, resolvins, maresin and protectin) by injecting them subcutaneously into the skin of mice and studying the in vivo availability and distribution of the compounds.", {"entities": []}], ["All analytes showed very little lateral distribution in skin tissue and their levels were markedly decreased (> 95%) 2 hours after injection.", {"entities": []}], ["However, docosahexaenoic acid derivatives were biologically more stable than SPM derived from arachidonic acid or eicosapentaenoic acid.", {"entities": []}], ["The presentation of new influenza A(H1N1) is broad and evolving as it continues to affect different geographic locations and populations.", {"entities": [[24, 33, "DISEASE"]]}], ["To improve the accuracy of predicting influenza infection in an outpatient setting, we undertook a comparative analysis of H1N1(2009), seasonal influenza, and persons with acute respiratory illness (ARI) in an outpatient setting.", {"entities": [[38, 47, "DISEASE"], [144, 153, "DISEASE"]]}], ["Comparative analyses of one hundred non-matched cases each of PCR confirmed H1N1(2009), seasonal influenza, and ARI cases.", {"entities": [[97, 106, "DISEASE"]]}], ["Multivariate analysis was performed to look for predictors of influenza infection.", {"entities": [[62, 71, "DISEASE"]]}], ["Receiver operating characteristic curves were constructed for various combinations of clinical and laboratory case definitions.", {"entities": []}], ["The initial clinical and laboratory features of H1N1(2009) and seasonal influenza were similar.", {"entities": [[72, 81, "DISEASE"]]}], ["Among ARI cases, fever, cough, headache, rhinorrhea, the absence of leukocytosis, and a normal chest radiograph positively predict for both PCR-confirmed H1N1-2009 and seasonal influenza infection.", {"entities": [[177, 186, "DISEASE"]]}], ["The sensitivity and specificity of current WHO and CDC influenza-like illness (ILI) criteria were modest in predicting influenza infection.", {"entities": [[55, 64, "DISEASE"], [119, 128, "DISEASE"]]}], ["However, the combination of WHO ILI criteria with the absence of leukocytosis greatly improved the accuracy of diagnosing H1N1(2009) and seasonal influenza (positive LR of 7.8 (95%CI 3.5\u201317.5) and 9.2 (95%CI 4.1\u201320.3) respectively).", {"entities": [[146, 155, "DISEASE"]]}], ["The clinical presentation of H1N1(2009) infection is largely indistinguishable from that of seasonal influenza.", {"entities": [[101, 110, "DISEASE"]]}], ["Among patients with acute respiratory illness, features such as a temperature greater than 38\u00b0C, rhinorrhea, a normal chest radiograph, and the absence of leukocytosis or significant gastrointestinal symptoms were all positively associated with H1N1(2009) and seasonal influenza infection.", {"entities": [[269, 278, "DISEASE"]]}], ["An enhanced ILI criteria that combines both a symptom complex with the absence of leukocytosis on testing can improve the accuracy of predicting both seasonal and H1N1-2009 influenza infection.", {"entities": [[173, 182, "DISEASE"]]}], ["Suboptimal nutrition among children remains a problem among South Asian (SA) families.", {"entities": []}], ["Appropriate complementary feeding (CF) practices can greatly reduce this risk.", {"entities": []}], ["Thus, we undertook a systematic review of studies assessing CF (timing, dietary diversity, meal frequency and influencing factors) in children aged <2 years in Pakistan.", {"entities": []}], ["Searches between January 2000 and June 2016 in MEDLINE, EMBASE, Global Health, Web of Science, OVID Maternity & Infant Care, CINAHL, Cochrane Library, BanglaJOL, POPLINE and WHO Global Health Library.", {"entities": []}], ["Eligibility criteria: primary research on CF practices in SA children aged 0\u20132 years and/or their families.", {"entities": []}], ["Search terms: \u2018children\u2019, \u2018feeding\u2019 and \u2018Asians\u2019 with their derivatives.", {"entities": []}], ["Two researchers undertook study selection, data extraction and quality appraisal (EPPI-Centre Weight of Evidence).", {"entities": []}], ["From 45 712 results, seventeen studies were included.", {"entities": []}], ["Despite adopting the WHO Infant and Young Child Feeding guidelines, suboptimal CF was found in all studies.", {"entities": []}], ["Nine of fifteen studies assessing timing recorded CF introduced between 6 and 9 months.", {"entities": []}], ["Five of nine observed dietary diversity across four of seven food groups; and two of four, minimum meal frequency in over 50 % of participants.", {"entities": []}], ["Influencing factors included lack of CF knowledge, low maternal education, socio-economic status and cultural beliefs.", {"entities": []}], ["This is the first systematic review to evaluate CF practices in Pakistan.", {"entities": []}], ["Campaigns to change health and nutrition behaviour are needed to meet the substantial unmet needs of these children.", {"entities": []}], ["In chronic disease management, patients are increasingly called upon to undertake a new role as lay tutors within self-management training programmes.", {"entities": []}], ["The internet constitutes an increasingly significant healthcare setting and a key arena for self-management support and communication.", {"entities": []}], ["This study evaluates how a new quasi-professional health workforce \u2013 volunteer tutors \u2013 engage, guide and attempt to manage people with long-term conditions in the ways of 'good' self-management within the context of an online self-management course.", {"entities": []}], ["A qualitative analysis of postings to the discussion centre of 11 online classes (purposively selected from 27) run as part of the Expert Patients Programme.", {"entities": []}], ["Facilitators (term for tutors online) and participants posted questions, comments and solutions related to self-management of long-term conditions; these were subjected to a textual and discursive analysis to explore: a) how facilitators, through the internet, engaged participants in issues related to self-management; b) how participants responded to and interacted with facilitators.", {"entities": []}], ["Emergent themes included: techniques and mechanisms used to engage people with self-management; the process facilitators followed \u2013 'sharing', 'modelling' and 'confirming'; and the emergence of a policing role regarding online disclosure.", {"entities": []}], ["Whilst exchanging medical advice was discouraged, facilitators often professed to understand and give advice on psychological aspects of behaviour.", {"entities": []}], ["The study gave an insight into the roles tutors adopt \u2013 one being their ability to 'police' subjective management of long-term conditions and another being to attempt to enhance the psychological capabilities of participants.", {"entities": []}], ["Interleukin-12 (IL-12), a heterodimeric cytokine composed of p35 and p40 subunits, has been thought to play an important role in the pathogenesis of malaria.", {"entities": [[149, 156, "DISEASE"]]}], ["The IL-12p40 subunit is encoded by the IL12B gene.", {"entities": [[39, 44, "GENE"]]}], ["An IL12B promoter allele, CTCTAA, at rs17860508 has been reported to be associated with susceptibility to cerebral malaria in African populations.", {"entities": [[106, 122, "DISEASE"], [115, 122, "DISEASE"], [3, 8, "GENE"]]}], ["However, this association has not so far been replicated in non-African populations.", {"entities": []}], ["To examine whether the CTCTAA allele is associated with susceptibility to cerebral malaria in Asian populations, 303 Thai patients with Plasmodium falciparum malaria (109 cerebral malaria and 194 mild malaria patients) were genotyped for rs17860508 by PCR-direct sequencing.", {"entities": [[74, 90, "DISEASE"], [171, 187, "DISEASE"], [83, 90, "DISEASE"], [158, 165, "DISEASE"], [180, 187, "DISEASE"], [201, 208, "DISEASE"]]}], ["The CTCTAA allele showed a significant association with susceptibility to cerebral malaria in the Thai population (allelic OR = 1.37; one sided P -value = 0.030).", {"entities": [[74, 90, "DISEASE"], [83, 90, "DISEASE"]]}], ["The existence of a significant association between the CTCTAA allele and susceptibility to cerebral malaria was confirmed in Southeast Asian population, which was previously reported in African populations.", {"entities": [[91, 107, "DISEASE"], [100, 107, "DISEASE"]]}], ["This study assessed the presence of influenza virus among young children and the coverage of vaccination from 2010 to 2012 in S\u00e3o Paulo, Brazil.", {"entities": [[36, 45, "DISEASE"]]}], ["Our results demonstrated a lower rate of influenza detection and a predominance of influenza B.", {"entities": [[41, 50, "DISEASE"], [83, 92, "DISEASE"]]}], ["A decrease of coverage vaccination through the surveillance periods was observed.", {"entities": []}], ["Background .", {"entities": []}], ["There is a growing controversy about the use of oronasal masks (ONM) or total facemask (TFM) in noninvasive positive pressure ventilation (NPPV), so we designed a trial to compare the uses of these two masks in terms of effectiveness and comfort.", {"entities": []}], ["Between February and November 2014, a total of 48 patients with respiratory failure were studied.", {"entities": [[64, 83, "DISEASE"]]}], ["Patients were randomized to receive NPPV via ONM or TFM.", {"entities": []}], ["Data were recorded at 60 minutes and six and 24 hours after intervention.", {"entities": []}], ["Patient comfort was assessed using a questionnaire.", {"entities": []}], ["Data were analyzed using t -test and chi-square test.", {"entities": []}], ["Repeated measures ANOVA and Mann\u2013Whitney U test were used to compare clinical and laboratory data.", {"entities": []}], ["There were no differences in venous blood gas (VBG) values between the two groups ( P > 0.05).", {"entities": []}], ["However, at six hours, TFM was much more effective in reducing the partial pressure of carbon dioxide (PCO2) ( P = 0.04).", {"entities": []}], ["Patient comfort and acceptance were statistically similar in both groups ( P > 0.05).", {"entities": []}], ["Total time of NPPV was also similar in the two groups ( P > 0.05).", {"entities": []}], ["Conclusions .", {"entities": []}], ["TFM was superior to ONM in acute phase of respiratory failure but not once the patients were out of acute phase.", {"entities": [[42, 61, "DISEASE"]]}], ["Although urinary concentrations of phthalate metabolites are frequently used as biomarkers in epidemiologic studies, variability during pregnancy has not been characterized.", {"entities": []}], ["We measured phthalate metabolite concentrations in spot urine samples collected from 246 pregnant Dominican and African-American women.", {"entities": []}], ["Twenty-eight women had repeat urine samples collected over a 6-week period.", {"entities": []}], ["We also analyzed 48-hr personal air samples ( n = 96 women) and repeated indoor air samples ( n = 32 homes) for five phthalate diesters.", {"entities": []}], ["Mixed-effects models were fit to evaluate reproducibility via intraclass correlation coefficients (ICC).", {"entities": []}], ["We evaluated the sensitivity and specificity of using a single specimen versus repeat samples to classify a woman\u2019s exposure in the low or high category.", {"entities": []}], ["Phthalates were detected in 85\u2013100% of air and urine samples.", {"entities": []}], ["ICCs for the unadjusted urinary metabolite concentrations ranged from 0.30 for mono-ethyl phthalate to 0.66 for monobenzyl phthalate.", {"entities": []}], ["For indoor air, ICCs ranged from 0.48 [di-2-ethylhexyl phthalate (DEHP)] to 0.83 [butylbenzyl phthalate (BBzP)].", {"entities": []}], ["Air levels of phthalate diesters correlated with their respective urinary metabolite concentrations for BBzP ( r = 0.71), di-isobutyl phthalate ( r = 0.44), and diethyl phthalate (DEP; r = 0.39).", {"entities": []}], ["In women sampled late in pregnancy, specific gravity appeared to be more effective than creatinine in adjusting for urine dilution.", {"entities": []}], ["Urinary concentrations of DEP and DEHP metabolites in pregnant women showed lower reproducibility than metabolites for di- n -butyl phthalate and BBzP.", {"entities": []}], ["A single indoor air sample may be sufficient to characterize phthalate exposure in the home, whereas urinary phthalate biomarkers should be sampled longitudinally during pregnancy to minimize exposure misclassification.", {"entities": []}], ["Carbamylation is a non-enzymatic post-translational modification induced upon exposure of free amino groups to urea-derived cyanate leading to irreversible changes of protein charge, structure and function.", {"entities": []}], ["Levels of carbamylated proteins increase significantly in chronic kidney disease and carbamylated albumin is considered as an important biomarker indicating mortality risk.", {"entities": [[66, 80, "DISEASE"]]}], ["High plasma concentrations and long half-life make fibrinogen a prime target for carbamylation.", {"entities": []}], ["As aggregation and cross-linking of fibrin monomers rely on lysine residues, it is likely that carbamylation impacts fibrinogen processing.", {"entities": []}], ["In this study we investigated carbamylation levels of fibrinogen from kidney disease patients as well as the impact of carbamylation on fibrinogen cleavage by thrombin, fibrin polymerisation and cross-linking in vitro .", {"entities": [[70, 84, "DISEASE"]]}], ["In conjunction, all these factors determine clot structure and stability and thus control biochemical and mechanical properties.", {"entities": []}], ["LC-MS/MS analyses revealed significantly higher homocitrulline levels in patient fibrinogen than in fibrinogen isolated from control plasma.", {"entities": []}], ["In our in vitro studies we found that although carbamylation does not affect thrombin cleavage per se, it alters fibrin polymerisation kinetics and impairs cross-linking and clot degradation.", {"entities": []}], ["In addition, carbamylated fibrin clots had reduced fiber size and porosity associated with decreased mechanical stability.", {"entities": []}], ["Using mass spectroscopy, we discovered that N-terminally carbamylated fibrinopeptide A was generated in this process and acted as a strong neutrophil chemoattractant potentially mediating recruitment of inflammatory cells to sites of fibrin(ogen) turnover.", {"entities": []}], ["Taken together, carbamylation of fibrinogen seems to play a role in aberrant fibrin clot formation and might be involved in haemostatic disorders associated with chronic inflammatory diseases.", {"entities": []}], ["Genome-Wide Association Study (GWAS) meta-analyses have identified a strong association signal for lung function, which maps to a region on 4q24 containing two oppositely transcribed genes: glutathione S-transferase, C-terminal domain containing ( GSTCD ) and integrator complex subunit 12 ( INTS12 ).", {"entities": [[248, 253, "GENE"], [292, 298, "GENE"]]}], ["Both genes were found to be expressed in a range of human airway cell types.", {"entities": []}], ["The promoter regions and transcription start sites were determined in mRNA from human lung and a novel splice variant was identified for each gene.", {"entities": []}], ["We obtained the following evidence for GSTCD and INTS12 co-regulation and expression: (i) correlated mRNA expression was observed both via Q-PCR and in a lung expression quantitative trait loci (eQTL) study, (ii) induction of both GSTCD and INTS12 mRNA expression in human airway smooth muscle cells was seen in response to TGF\u03b21, (iii) a lung eQTL study revealed that both GSTCD and INTS12 mRNA levels positively correlate with percent predicted FEV 1 , and (iv) FEV 1 GWAS associated SNPs in 4q24 were found to act as an eQTL for INTS12 in a number of tissues.", {"entities": [[39, 44, "GENE"], [231, 236, "GENE"], [374, 379, "GENE"], [49, 55, "GENE"], [241, 247, "GENE"], [384, 390, "GENE"], [532, 538, "GENE"], [39, 44, "GENE"], [231, 236, "GENE"], [374, 379, "GENE"], [49, 55, "GENE"], [241, 247, "GENE"], [384, 390, "GENE"], [532, 538, "GENE"], [39, 44, "GENE"], [231, 236, "GENE"], [374, 379, "GENE"], [49, 55, "GENE"], [241, 247, "GENE"], [384, 390, "GENE"], [532, 538, "GENE"], [447, 450, "GENE"], [464, 467, "GENE"], [447, 450, "GENE"], [464, 467, "GENE"], [49, 55, "GENE"], [241, 247, "GENE"], [384, 390, "GENE"], [532, 538, "GENE"]]}], ["In fixed sections of human lung tissue, GSTCD protein expression was ubiquitous, whereas INTS12 expression was predominantly in epithelial cells and pneumocytes.", {"entities": [[40, 45, "GENE"], [89, 95, "GENE"]]}], ["During human fetal lung development, GSTCD protein expression was observed to be highest at the earlier pseudoglandular stage (10-12 weeks) compared with the later canalicular stage (17-19 weeks), whereas INTS12 expression levels did not alter throughout these stages.", {"entities": [[37, 42, "GENE"], [205, 211, "GENE"]]}], ["Knowledge of the transcriptional and translational regulation and expression of GSTCD and INTS12 provides important insights into the potential role of these genes in determining lung function.", {"entities": [[80, 85, "GENE"], [90, 96, "GENE"]]}], ["Future work is warranted to fully define the functions of INTS12 and GSTCD .", {"entities": [[58, 64, "GENE"], [69, 74, "GENE"]]}], ["Vesicular stomatitis virus (VSV) based recombinant viruses (such as VSV-\u0394M51) are effective oncolytic viruses (OVs) against a majority of pancreatic ductal adenocarcinoma (PDAC) cell lines.", {"entities": [[156, 170, "DISEASE"], [10, 20, "DISEASE"], [138, 170, "DISEASE"]]}], ["However, some PDAC cell lines are highly resistant to VSV-\u0394M51.", {"entities": []}], ["We recently showed that treatment of VSV-resistant PDAC cells with ruxolitinib (JAK1/2 inhibitor) or TPCA-1 (IKK-\u03b2 inhibitor) breaks their resistance to VSV-\u0394M51.", {"entities": []}], ["Here we compared the global effect of ruxolitinib or TPCA-1 treatment on cellular gene expression in PDAC cell lines highly resistant to VSV-\u0394M51.", {"entities": []}], ["Our study identified a distinct subset of 22 interferon-stimulated genes (ISGs) downregulated by both ruxolitinib and TPCA-1.", {"entities": []}], ["Further RNA and protein analyses demonstrated that 4 of these genes (MX1, EPSTI1, XAF1, and GBP1) are constitutively co-expressed in VSV-resistant, but not in VSV-permissive PDACs, thus serving as potential biomarkers to predict OV therapy success.", {"entities": [[69, 72, "GENE"], [74, 80, "GENE"], [82, 86, "GENE"], [92, 96, "GENE"]]}], ["Moreover, shRNA-mediated knockdown of one of such ISG, MX1, showed a positive effect on VSV-\u0394M51 replication in resistant PDAC cells, suggesting that at least some of the identified ISGs contribute to resistance of PDACs to VSV-\u0394M51.", {"entities": [[55, 58, "GENE"]]}], ["As certain oncogene and tumor suppressor gene variants are often associated with increased tropism of OVs to cancer cells, we also analyzed genomic DNA in a set of PDAC cell lines for frequently occurring cancer associated mutations.", {"entities": [[109, 115, "DISEASE"], [205, 211, "DISEASE"]]}], ["While no clear correlation was found between such mutations and resistance of PDACs to VSV-\u0394M51, the analysis generated valuable genotypic data for future studies.", {"entities": []}], ["Currently, there is much interest in measuring fractional exhaled nitric oxide ( FE NO ) in populations.", {"entities": []}], ["We evaluated the reproducibility of FE NO in healthy subjects and determined the number of subjects necessary to carry out a longitudinal survey of FE NO in a population containing smokers and non-smokers, based on the assessed reproducibility.", {"entities": []}], ["The reproducibility of FE NO was examined in 18 healthy smokers and 21 non-smokers.", {"entities": []}], ["FE NO was assessed once at 9 AM on five consecutive days; in the last day this measurement was repeated at 2 PM.", {"entities": []}], ["Respiratory symptoms and medical history were assessed by questionnaire.", {"entities": []}], ["The within- and between-session repeatability of FE NO and log-transformed FE NO was described.", {"entities": []}], ["The power of a longitudinal study based on a relative increase in FE NO was estimated using a bilateral t-test of the log-transformed FE NO using the between-session variance of the assay.", {"entities": []}], ["FE NO measurements were highly reproducible throughout the study.", {"entities": []}], ["FE NO was significantly higher in males than females regardless of smoking status.", {"entities": []}], ["FE NO was positively associated with height (p < 0.001), gender (p < 0.034), smoking (p < 0.0001) and percent FEV 1 /FVC (p < 0.001) but not with age (p = 0.987).", {"entities": [[110, 113, "GENE"]]}], ["The between-session standard deviation was roughly constant on the log scale.", {"entities": []}], ["Assuming the between-session standard deviation is equal to its longitudinal equivalent, either 111 or 29 subjects would be necessary to achieve an 80% power in detecting a 3% or a 10% increase in FE NO respectively.", {"entities": []}], ["The good reproducibility of FE NO is not influenced by gender or smoking habits.", {"entities": []}], ["In a well controlled, longitudinal study it should allow detecting even small increases in FE NO with a reasonable population size.", {"entities": []}], ["Probiotics are ingested live microbes that can modify intestinal microbial populations in a way that benefits the host.", {"entities": []}], ["The interest in probiotic preventative/therapeutic potential in allergic diseases stemmed from the fact that probiotics have been shown to improve intestinal dysbiosis and permeability and to reduce inflammatory cytokines in human and murine experimental models.", {"entities": []}], ["Enhanced presence of probiotic bacteria in the intestinal microbiota is found to correlate with protection against allergy.", {"entities": []}], ["Therefore, many studies have been recently designed to examine the efficacy of probiotics, but the literature on the allergic skin disorders is still very scarce.", {"entities": []}], ["Here, our objective is to summarize and evaluate the available knowledge from randomized or nonrandomized controlled trials of probiotic use in allergic skin conditions.", {"entities": []}], ["Clinical improvement especially in IgE-sensitized eczema and experimental models such as atopic dermatitis-like lesions (trinitrochlorobenzene and picryl chloride sensitizations) and allergic contact dermatitis (dinitrofluorobenzene sensitization) has been reported.", {"entities": [[192, 210, "DISEASE"], [89, 106, "DISEASE"], [183, 210, "DISEASE"], [96, 106, "DISEASE"], [200, 210, "DISEASE"]]}], ["Although there is a very promising evidence to recommend the addition of probiotics into foods, probiotics do not have a proven role in the prevention or the therapy of allergic skin disorders.", {"entities": []}], ["Thus, being aware of possible measures, such as probiotics use, to prevent/heal atopic diseases is essential for the practicing allergy specialist.", {"entities": []}], ["In order to begin to address the burden of non-communicable diseases (NCDs) in sub-Saharan Africa, high quality community-based epidemiological studies from the region are urgently needed.", {"entities": []}], ["Cluster-designed sampling methods may be most efficient, but designing such studies requires assumptions about the clustering of the outcomes of interest.", {"entities": []}], ["Currently, few studies from Sub-Saharan Africa have been published that describe the clustering of NCDs.", {"entities": []}], ["Therefore, we report the neighborhood clustering of several NCDs from a community-based study in Northern Tanzania.", {"entities": []}], ["We conducted a cluster-designed cross-sectional household survey between January and June 2014.", {"entities": []}], ["We used a three-stage cluster probability sampling method to select thirty-seven sampling areas from twenty-nine neighborhood clusters, stratified by urban and rural.", {"entities": []}], ["Households were then randomly selected from each of the sampling areas, and eligible participants were tested for chronic kidney disease (CKD), glucose impairment including diabetes, hypertension, and obesity as part of the CKD-AFRiKA study.", {"entities": [[183, 195, "DISEASE"], [122, 136, "DISEASE"], [201, 208, "DISEASE"]]}], ["We used linear mixed models to explore clustering across each of the samplings units, and we estimated absolute-agreement intra-cluster correlation (ICC) coefficients ( \u03c1 ) for the neighborhood clusters.", {"entities": []}], ["We enrolled 481 participants from 346 urban and rural households.", {"entities": []}], ["Neighborhood cluster sizes ranged from 6 to 49 participants (median: 13.0; 25th\u201375th percentiles: 9\u201321).", {"entities": []}], ["Clustering varied across neighborhoods and differed by urban or rural setting.", {"entities": []}], ["Among NCDs, hypertension ( \u03c1 \u2009=\u20090.075) exhibited the strongest clustering within neighborhoods followed by CKD ( \u03c1 \u2009=\u20090.440), obesity ( \u03c1 \u2009=\u20090.040), and glucose impairment ( \u03c1 \u2009=\u20090.039).", {"entities": [[12, 24, "DISEASE"], [126, 133, "DISEASE"]]}], ["The neighborhood clustering was substantial enough to contribute to a design effect for NCD outcomes including hypertension, CKD, obesity, and glucose impairment, and it may also highlight NCD risk factors that vary by setting.", {"entities": [[111, 123, "DISEASE"], [130, 137, "DISEASE"]]}], ["These results may help inform the design of future community-based studies or randomized controlled trials examining NCDs in the region particularly those that use cluster-sampling methods.", {"entities": []}], ["The health and economic implications of new imaging technologies are increasingly relevant policy issues.", {"entities": []}], ["Cardiac magnetic resonance imaging (CMR) is currently not or not sufficiently reimbursed in a number of countries including Germany, presumably because of a limited evidence base.", {"entities": []}], ["It is unknown, however, whether it can be effectively used to facilitate medical decision-making and reduce costs by serving as a gatekeeper to invasive coronary angiography.", {"entities": []}], ["We investigated whether the application of CMR in patients suspected of having coronary artery disease (CAD) reduces costs by averting referrals to cardiac catheterization.", {"entities": []}], ["We used propensity score methods to match 218 patients from a CMR registry to a previously studied cohort in which CMR was demonstrated to reliably identify patients who were low-risk for major cardiac events.", {"entities": []}], ["Covariates over which patients were matched included comorbidity profiles, demographics, CAD-related symptoms, and CAD risk as measured by Morise scores.", {"entities": []}], ["We determined the proportion of patients for whom cardiac catheterization was deferred based upon CMR findings.", {"entities": []}], ["We then calculated the economic effects of practice pattern changes using data on cardiac catheterization and CMR costs.", {"entities": []}], ["CMR reduced the utilization of cardiac catheterization by 62.4%.", {"entities": []}], ["Based on estimated catheterization costs of \u20ac 619, the utilization of CMR as a gatekeeper reduced per-patient costs by a mean of \u20ac 90.", {"entities": []}], ["Savings were realized until CMR costs exceeded \u20ac 386.", {"entities": []}], ["Cost savings were greatest for patients at low-risk for CAD, as measured by baseline Morise scores, but were present for all Morise subgroups with the exception of patients at the highest risk of CAD.", {"entities": []}], ["CMR significantly reduces the utilization of cardiac catheterization in patients suspected of having CAD.", {"entities": []}], ["Per-patient savings range from \u20ac 323 in patients at lowest risk of CAD to \u20ac 58 in patients at high-risk but not in the highest risk stratum.", {"entities": []}], ["Because a negative CMR evaluation has high negative predictive value, its application as a gatekeeper to cardiac catheterization should be further explored as a treatment option.", {"entities": []}], ["Concentrations of ambient fine particles (PM 10 : particles with an aerodynamic diameter \u2264 10 \u00b5m) are still exceeding current air quality standards in many European cities.", {"entities": []}], ["In Munich (Germany), low emission zone and transit bans for heavy-duty vehicles were introduced in 2008 aiming at reduction of traffic emissions contribution to PM 10 .", {"entities": []}], ["The effects of those measures on PM 10 mass concentrations in Munich were investigated with a semiparametric regression model for modeling PM 10 levels adjusted for time, background pollution, public holidays and wind direction.", {"entities": []}], ["The reduction of PM 10 concentration after the introduction of the measures was larger at a traffic monitoring site (13.0 %, 19.6 % in summer, and 6.8 % in winter) and smaller in urban background (4.5 %, 5.7 % in summer, and 3.2 % in winter).", {"entities": []}], ["The effect was most pronounced on Fridays and on the weekends in summer.", {"entities": []}], ["Since quinine was first isolated, animals, plants and microorganisms producing a wide variety of quinolone compounds have been discovered, several of which possess medicinally interesting properties ranging from antiallergenic and anticancer to antimicrobial activities.", {"entities": []}], ["Over the years, these have served in the development of many synthetic drugs, including the successful fluoroquinolone antibiotics.", {"entities": []}], ["Pseudomonas aeruginosa and related bacteria produce a number of 2-alkyl-4(1 H )-quinolones, some of which exhibit antimicrobial activity.", {"entities": []}], ["However, quinolones such as the Pseudomonas quinolone signal and 2-heptyl-4-hydroxyquinoline act as quorum-sensing signal molecules, controlling the expression of many virulence genes as a function of cell population density.", {"entities": []}], ["Here, we review selectively this extensive family of bicyclic compounds, from natural and synthetic antimicrobials to signalling molecules, with a special emphasis on the biology of P. aeruginosa .", {"entities": []}], ["In particular, we review their nomenclature and biochemistry, their multiple properties as membrane-interacting compounds, inhibitors of the cytochrome bc 1 complex and iron chelators, as well as the regulation of their biosynthesis and their integration into the intricate quorum-sensing regulatory networks governing virulence and secondary metabolite gene expression.", {"entities": []}], ["We report the progress of an ongoing effort by the Air Resources Laboratory, NOAA to build a prototype regional Chemical Analysis System (ARLCAS).", {"entities": []}], ["The ARLCAS focuses on providing long-term analysis of the three dimensional (3D) air-pollutant concentration fields over the continental U.S.", {"entities": []}], ["It leverages expertise from the NASA Earth Science Division-sponsored Air Quality Applied Science Team (AQAST) for the state-of-science knowledge in atmospheric and data assimilation sciences.", {"entities": []}], ["The ARLCAS complies with national operational center requirement protocols and aims to have the modeling system to be maintained by a national center.", {"entities": []}], ["Meteorology and chemistry observations consist of land-, air- and space-based observed and quality-assured data.", {"entities": []}], ["We develop modularized testing to investigate the efficacies of the various components of the ARLCAS.", {"entities": []}], ["The sensitivity testing of data assimilation schemes showed that with the increment of additional observational data sets, the accuracy of the analysis chemical fields also increased incrementally in varying margins.", {"entities": []}], ["The benefit is especially noted for additional data sets based on a different platform and/or a different retrieval algorithm.", {"entities": []}], ["We also described a plan to apply the analysis chemical fields in environmental surveillance at the Centers for Disease Control and Prevention.", {"entities": []}], ["Chronic lung diseases represent a major public health problem with only limited therapeutic options.", {"entities": []}], ["An important unmet need is to identify compounds and drugs that target key molecular pathways involved in the pathogenesis of chronic lung diseases.", {"entities": []}], ["Over the last decade, there has been extensive interest in investigating Wingless/integrase-1 (WNT) signalling pathways; and WNT signal alterations have been linked to pulmonary disease pathogenesis and progression.", {"entities": []}], ["Here, we comprehensively review the cumulative evidence for WNT pathway alterations in chronic lung pathologies, including idiopathic pulmonary fibrosis, pulmonary arterial hypertension, asthma and COPD.", {"entities": [[173, 185, "DISEASE"], [134, 152, "DISEASE"], [187, 193, "DISEASE"], [123, 152, "DISEASE"]]}], ["While many studies have focused on the canonical WNT/\u03b2-catenin signalling pathway, recent reports highlight that non-canonical WNT signalling may also significantly contribute to chronic lung pathologies; these studies will be particularly featured in this review.", {"entities": []}], ["We further discuss recent advances uncovering the role of WNT signalling early in life, the potential of pharmaceutically modulating WNT signalling pathways and highlight (pre)clinical studies describing promising new therapies for chronic lung diseases.", {"entities": []}], ["The role of mast cells (MCs) in Toxoplasma gondii infection is poorly known.", {"entities": []}], ["Kunming outbred mice were infected intraperitoneally with RH strain T. gondii , either treated with compound 48/80 (C48/80, MC activator) or disodium cromoglycate (DSCG, MC inhibitor).", {"entities": []}], ["Compared with infected controls, infected mice treated with C48/80 exhibited significantly increased inflammation in the liver ( P \u00a0<\u00a00.01), spleen ( P \u00a0<\u00a00.05), and mesentery ( P \u00a0<\u00a00.05) tissues, higher parasite burden in the peritoneal lavage fluids ( P \u00a0<\u00a00.01), and increased levels of mRNA transcripts of T. gondii tachyzoite surface antigen 1 (SAG1) gene in the spleen and liver tissues ( P \u00a0<\u00a00.01), accompanied with significantly increased Th1 cytokine (IFN-\u03b3, IL-12p40, and TNF-\u03b1) ( P \u00a0<\u00a00.01) and decreased IL-10 ( P \u00a0<\u00a00.01) mRNA expressions in the liver, and increased IFN-\u03b3 ( P \u00a0<\u00a00.01) and IL-12p40 ( P \u00a0<\u00a00.01) but decreased TNF-\u03b1 ( P \u00a0<\u00a00.01) and IL-4 ( P \u00a0<\u00a00.01) in the spleens of infected mice treated with C48/80 at day 9-10 p.i.", {"entities": []}], ["Whereas mice treated with DSCG had significantly decreased tissue lesions ( P \u00a0<\u00a00.01), lower parasite burden in the peritoneal lavage fluids ( P \u00a0<\u00a00.01) and decreased SAG1 expressions in the spleen and liver tissues ( P \u00a0<\u00a00.01), accompanied with significantly increased IFN-\u03b3 ( P \u00a0<\u00a00.01) and IL-12p40 ( P \u00a0<\u00a00.05) in the liver, and decreased IFN-\u03b3 ( P \u00a0<\u00a00.05) and TNF-\u03b1 ( P \u00a0<\u00a00.01) in the spleens; IL-4 and IL-10 expressions in both the spleen and liver were significantly increased ( P \u00a0<\u00a00.01) in the infected mice treated with DSCG.", {"entities": []}], ["These findings suggest that mediators associated with the MC activation may play an important role in modulating acute inflammatory pathogenesis and parasite clearance during T. gondii infection in this strain of mice.", {"entities": []}], ["Thus,\u00a0MC\u00a0activation/inhibition mechanisms are potential novel targets for the prevention and control of T. gondii infection.", {"entities": []}], ["Nasopharyngeal carcinoma (NPC) is a common epithelial neoplasm among the Chinese populations in Southern China and South East Asia.", {"entities": [[15, 24, "DISEASE"]]}], ["Epstein-Barr virus (EBV) is known to be an important etiologic agent of NPC and the viral gene products are frequently detected in NPC tissues along with elevated antibody titres to the viral proteins (VCA and EA) in a majority of patients.", {"entities": []}], ["Elevated plasma EBV DNA load is regarded as an important marker for the presence of the disease and for the monitoring of disease progression.", {"entities": []}], ["However, other serum/plasma parameters such as the levels of certain interleukins and growth factors have also been implicated in NPC.", {"entities": []}], ["The objectives of the present study are, 1) to investigate the correlations between plasma EBV DNA load and the levels of interleukin (IL)-6, IL-10, TGF-\u03b21 and SCF (steel factor) and 2) to relate these parameters to the stages of NPC and the effect of treatment.", {"entities": []}], ["A total of 78 untreated NPC patients were enrolled in this study.", {"entities": []}], ["Of these, 51 were followed-up after treatment.", {"entities": []}], ["The remaining patients had irregular or were lost to follow-up.", {"entities": []}], ["Plasma EBV DNA was quantified using real-time quantitative PCR.", {"entities": []}], ["The levels of plasma interleukins and growth factors were quantified using ELISA.", {"entities": []}], ["A significant decrease in EBV DNA load was detected in plasma of untreated NPC patients (1669 \u00b1 637 copies/mL; n = 51) following treatment (57 \u00b1 37 copies/mL, p < 0.05); n = 51).", {"entities": []}], ["Plasma EBV DNA load was shown to be a good prognosticator for disease progression and clinical outcome in five of the follow-up patients.", {"entities": []}], ["A significant difference in IL-6 levels was noted between the untreated patients (164 \u00b1 37 pg/mL; n = 51) and following treatment (58 \u00b1 16 pg/mL, p < 0.05; n = 51).", {"entities": []}], ["Positive correlations between EBV DNA load and IL-10 ( r (49) = 0.535, p < 0.01), between IL6 and IL-10 ( r (49) = 0.474, p < 0.01) and between TGF and SCF ( r (49) = 0.464, p < 0.01) were observed in patients following treatment.", {"entities": [[90, 93, "GENE"]]}], ["None of the parameters tested including IgA-VCA were associated with tumour stages.", {"entities": []}], ["We conclude that among the parameters investigated, EBV DNA load and IL-6 levels were promising markers for the presence of NPC and for the assessment of treatment outcome.", {"entities": []}], ["Recent studies have suggested that the long-acting muscarinic receptor antagonist tiotropium, a drug widely prescribed for its bronchodilator activity in patients with chronic obstructive pulmonary disease and asthma, improves symptoms and attenuates cough in preclinical and clinical tussive agent challenge studies.", {"entities": [[168, 205, "DISEASE"], [210, 216, "DISEASE"]]}], ["The mechanism by which tiotropium modifies tussive responses is not clear, but an inhibition of vagal tone and a consequent reduction in mucus production from submucosal glands and bronchodilation have been proposed.", {"entities": []}], ["The aim of this study was to investigate whether tiotropium can directly modulate airway sensory nerve activity and thereby the cough reflex.", {"entities": []}], ["We used a conscious cough model in guinea pigs, isolated vagal sensory nerve and isolated airway neuron tissue\u2013\u00a0and cell-based assays, and in\u00a0vivo single-fiber recording electrophysiologic techniques.", {"entities": []}], ["Inhaled tiotropium blocked cough and single C-fiber firing in the guinea pig to the transient receptor potential (TRP) V1 agonist capsaicin, a clinically relevant tussive stimulant.", {"entities": []}], ["Tiotropium and ipratropium, a structurally similar muscarinic antagonist, inhibited capsaicin responses in isolated guinea pig vagal tissue, but glycopyrrolate and atropine did not.", {"entities": []}], ["Tiotropium failed to modulate other TRP channel\u2013mediated responses.", {"entities": []}], ["Complementary data were generated in airway-specific primary ganglion neurons, demonstrating that tiotropium inhibited capsaicin-induced, but not TRPA1-induced, calcium movement and voltage changes.", {"entities": []}], ["For the first time, we have shown that tiotropium inhibits neuronal TRPV1-mediated effects through a mechanism unrelated to its anticholinergic activity.", {"entities": []}], ["We speculate that some of the clinical benefit associated with taking tiotropium (eg, in symptom control) could be explained through this proposed mechanism of action.", {"entities": []}], ["COPD is a complex disease with multiple pathological components, which we unfortunately tend to ignore when spirometry is used as the only method to evaluate the disorder.", {"entities": []}], ["Additional measures are needed to allow a more complete and clinically relevant assessment of COPD.", {"entities": []}], ["The earliest potential risk factors of disease in COPD are variations in the genetic background.", {"entities": []}], ["Genetic variations are present from conception and can determine lifelong changes in enzyme activities and protein concentrations.", {"entities": []}], ["In contrast, measurements in blood, sputum, exhaled breath, broncho-alveolar lavage, and lung biopsies may vary substantially over time.", {"entities": []}], ["This review explores potential markers of early disease and prognosis in COPD by examining genetic markers in the \u03b1 1 -antitrypsin, cystic fibrosis transmembrane conductance regulator (CFTR), and MBL-2 genes, and by examining the biochemical markers fibrinogen and C-reactive protein (CRP), which correlate with degree of pulmonary inflammation during stable conditions of COPD.", {"entities": [[132, 147, "DISEASE"], [185, 189, "GENE"], [285, 288, "GENE"]]}], ["Chronic lung inflammation appears to contribute to the pathogenesis of COPD, and markers of this process have promising predictive value in COPD.", {"entities": []}], ["To implement markers for COPD in clinical practice, besides those already established for the \u03b1 1 -antitrypsin gene, further research and validation studies are needed.", {"entities": []}], ["Dermal vascular smooth muscle cells (DVSMCs) are important for vascular wall fibrosis in microangiopathy of systemic sclerosis (SSc).", {"entities": []}], ["T helper 17 cell-associated cytokines, particularly interleukin-17A (IL-17A), have been demonstrated to play a role in the pathogenesis of SSc.", {"entities": []}], ["However, the effect of IL-17A on the DVSMCs in microangiopathy of SSc has not been established.", {"entities": []}], ["In the present study, we investigated the effect of IL-17A on the SSc patient-derived DVSMCs.", {"entities": []}], ["DVSMCs from patients with SSc and healthy subjects were incubated using IL-17A or serum derived from patients with SSc.", {"entities": []}], ["Subsequently, the proliferation, collagen synthesis and secretion, and migration of DVSMCs were analysed using a cell counting kit-8 (CCK-8), dual-luciferase reporter assay, real-time reverse transcription-polymerase chain reaction (RT-PCR), Western blot, enzyme-linked immunosorbent assay (ELISA) and transwell assay.", {"entities": []}], ["The protein phosphorylation of signalling pathways in the process of IL-17A-mediated DVSMC activation was investigated and validated by specific signalling pathway inhibitor.", {"entities": []}], ["IL-17A and serum from patients with SSc could promote the proliferation, collagen synthesis and secretion, and migration of DVSMCs.", {"entities": []}], ["IL-17A neutralising antibody could inhibit the IL-17A-induced activation of DVSMCs.", {"entities": []}], ["Additionally, IL-17A induced the activation of extracellular-regulated protein kinases 1/2 (ERK1/2) in DVSMCs, and ERK1/2 inhibitor could block the IL-17A-elicited activation of DVSMCs.", {"entities": []}], ["Our results suggested that IL-17A derived from patients with SSc might induce the proliferation, collagen synthesis and secretion, and migration of DVSMCs via ERK1/2 signalling pathway, raising the likelihood that IL-17A and ERK1/2 might be promising therapeutic targets for the treatment of SSc-related vasculopathy.", {"entities": []}], ["The online version of this article (doi:10.1186/s13075-014-0512-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Cysteinyl leukotrienes (CysLTs) and lipoxins (LXs) are lipid mediators that control inflammation, with the former inducing and the latter inhibiting this process.", {"entities": []}], ["Because the role played by these mediators in paracoccidioidomycosis was not investigated, we aimed to characterize the role of CysLT in the pulmonary infection developed by resistant (A/J) and susceptible (B10.A) mice.", {"entities": [[46, 68, "DISEASE"]]}], ["48\u2009h after infection, elevated levels of pulmonary LTC 4 and LXA 4 were produced by both mouse strains, but higher levels were found in the lungs of susceptible mice.", {"entities": []}], ["Blocking the CysLTs receptor by MTL reduced fungal loads in B10.A, but not in A/J mice.", {"entities": []}], ["In susceptible mice, MLT treatment led to reduced influx of PMN leukocytes, increased recruitment of monocytes, predominant synthesis of anti-inflammatory cytokines, and augmented expression of 5- and 15-lipoxygenase mRNA, suggesting a prevalent LXA 4 activity.", {"entities": []}], ["In agreement, MTL-treated macrophages showed reduced fungal burdens associated with decreased ingestion of fungal cells.", {"entities": []}], ["Furthermore, the addition of exogenous LX reduced, and the specific blockade of the LX receptor increased the fungal loads of B10.A macrophages.", {"entities": []}], ["This study showed for the first time that inhibition of CysLTs signaling results in less severe pulmonary paracoccidioidomycosis that occurs in parallel with elevated LX activity and reduced infection of macrophages.", {"entities": [[106, 128, "DISEASE"]]}], ["The prokaryote Mycoplasma pneumoniae is a major cause of respiratory disease in humans, accounting for 20% of all community-acquired pneumonia and the leading cause of pneumonia in older children and young adults.", {"entities": [[133, 142, "DISEASE"], [168, 177, "DISEASE"]]}], ["The limitations of existing options for mycoplasma diagnosis highlight a critical need for a new detection platform with high sensitivity, specificity, and expediency.", {"entities": []}], ["Here we evaluated silver nanorod arrays (NA) as a biosensing platform for detection and differentiation of M. pneumoniae in culture and in spiked and true clinical throat swab samples by surface-enhanced Raman spectroscopy (SERS).", {"entities": []}], ["Three M. pneumoniae strains were reproducibly differentiated by NA-SERS with 95%\u2013100% specificity and 94\u2013100% sensitivity, and with a lower detection limit exceeding standard PCR.", {"entities": []}], ["Analysis of throat swab samples spiked with M. pneumoniae yielded detection in a complex, clinically relevant background with >90% accuracy and high sensitivity.", {"entities": []}], ["In addition, NA-SERS correctly classified with >97% accuracy, ten true clinical throat swab samples previously established by real-time PCR and culture to be positive or negative for M. pneumoniae .", {"entities": []}], ["Our findings suggest that the unique biochemical specificity of Raman spectroscopy, combined with reproducible spectral enhancement by silver NA, holds great promise as a superior platform for rapid and sensitive detection and identification of M. pneumoniae , with potential for point-of-care application.", {"entities": []}], ["Biomass fuel smoke is thought to contribute to chronic obstructive pulmonary disease, which is characterized by mucous cell metaplasia and enhanced mucus secretion.", {"entities": [[47, 84, "DISEASE"]]}], ["We investigated the effect of particulate matter (PM) with a diameter <2.5 \u03bcm (PM2.5) from wood smoke (WSPM2.5) on the expression of the most prominent secreted mucin, MUC5AC.", {"entities": []}], ["Wood smoke was able to induce MUC5AC expression in the rat respiratory tract after 3 months of exposure.", {"entities": []}], ["WSPM2.5 could induce MUC5AC production in both primary human airway epithelial cells and the NCI-H292 cell line.", {"entities": []}], ["This induction process was mediated by activation of epithelial growth factor receptor (EGFR)-extracellular signal-regulated kinase (ERK) signaling through an EGFR ligand-dependent mechanism.", {"entities": [[88, 92, "GENE"], [159, 163, "GENE"], [88, 92, "GENE"], [159, 163, "GENE"]]}], ["Amphiregulin (AR) was identified as the major ligand responsible for EGFR-ERK signaling activation and MUC5AC expression.", {"entities": []}], ["In turn, EGFR-ERK pathway activation was found to contribute to the de novo synthesis of AR.", {"entities": []}], ["This positive feedback loop might play an important role in a sustained mucus hypersecretion response.", {"entities": []}], ["Non-compliance with medication is a major health problem.", {"entities": []}], ["Cultural differences may explain different compliance patterns.", {"entities": []}], ["The size of the compliance burden and the impact of socio-demographic and socio-economic status within and across countries in Europe have, however, never been analysed in one survey.", {"entities": []}], ["The aim of this study was to analyse 1) medical drug compliance in different European countries with respect to socio-demographic and socio-economic factors, and to examine 2) whether cross-national differences could be explained by these factors.", {"entities": []}], ["A multi-country interview survey European Social Survey, Round 2 was conducted in 2004/05 comprising questions about compliance with last prescribed drug.", {"entities": []}], ["Non-compliance was classified as primary and secondary, depending whether the drug was purchased or not.", {"entities": []}], ["Statistical weighting allowed for adjustment for national differences in sample mechanisms.", {"entities": []}], ["A multiple imputation strategy was used to compensate for missing values.", {"entities": []}], ["The analytical approach included multivariate and multilevel analyses.", {"entities": []}], ["The survey comprised 45,678 participants.", {"entities": []}], ["Response rate was 62.5% (range 43.6\u201379.1%).", {"entities": []}], ["Reported compliance was generally high (82%) but the pattern of non-compliance showed large variation between countries.", {"entities": []}], ["Some 3.2% did not purchase the most recently prescribed medicine, and 13.6% did not take the medicine as prescribed.", {"entities": []}], ["Multiple regression analyses showed that each variable had very different and in some cases opposite impact on compliance within countries.", {"entities": []}], ["The multilevel analysis showed that the variation between countries did not change significantly when adjusted for increasing numbers of covariates.", {"entities": []}], ["Reported compliance was generally high but showed wide variation between countries.", {"entities": []}], ["Cross-national differences could, however, not be explained by the socio-demographic and socio-economic variables measured.", {"entities": []}], ["Most persons in drug treatment smoke cigarettes.", {"entities": []}], ["Until drug treatment facilities systematically treat their patients' tobacco use, millions will flow through the drug treatment system, overcome their primary drug of abuse, but die prematurely from tobacco-related illnesses.", {"entities": []}], ["This paper reviews the literature on the health benefits of quitting smoking for drug treatment patients, whether smoking causes relapse to other drug or alcohol abuse, the treatment of tobacco dependence, and good and bad times for quitting smoking among drug treatment patients.", {"entities": [[154, 167, "DISEASE"]]}], ["It also presents a conceptual model and recommendations for treating tobacco in substance abuse treatment, and provides references to internet and paper-copy tools and information for treating tobacco dependence.", {"entities": [[80, 95, "DISEASE"]]}], ["At present, research on tobacco treatment in drug treatment is in its infancy.", {"entities": []}], ["Although few drug treatment programs currently offer formal services, many more will likely begin to treat nicotine dependence as external forces and patient demand for these services increases.", {"entities": [[107, 126, "DISEASE"]]}], ["In the absence of clear guidelines and attention to quality of care, drug treatment programs may adopt smoking cessation services based on cost, convenience, or selection criteria other than efficacy.", {"entities": []}], ["Because research in this field is relatively new, substance abuse treatment professionals should adhere to the standards of care for the general population, but be prepared to update their practices with emerging interventions that have proven to be effective for patients in drug treatment.", {"entities": [[50, 65, "DISEASE"]]}], ["Depression is predicted to become one of the two most burdensome diseases worldwide by 2020 and is common in people with chronic physical conditions.", {"entities": []}], ["However, depression is relatively uncommon in Asia.", {"entities": []}], ["Family support is an important Asian cultural value that we hypothesized could protect people with chronic physical conditions from developing depression.", {"entities": []}], ["We investigated depressive symptom prevalence and risk factors in a Chinese sample with chronic medical conditions, focusing on the possible protective role of family relationships.", {"entities": []}], ["Data were obtained from the Hong Kong Jockey Club FAMILY Project cohort study in 2009\u20132011, which included 6,195 participants (age \u226515) with self-reported chronic conditions.", {"entities": []}], ["Depressive symptoms were recorded using the Patient Health Questionnaire-9 (PHQ-9).", {"entities": []}], ["Demographic and lifestyle variables, stressful life events, perceived family support and neighborhood cohesion were assessed.", {"entities": []}], ["Factors associated with a non-somatic (PHQ-6) depression score were also examined.", {"entities": []}], ["The prevalence of depressive symptoms (PHQ-9 scores \u22655) was 17% in those with one or more chronic conditions, and was more prevalent in women than in men (19.7% vs .", {"entities": []}], ["13.9%; p \u2009<\u20090.001).", {"entities": []}], ["In multilevel analyses, life stress, number of chronic conditions and satisfaction with family support explained 43% of the variance in PHQ-9 scores (standardized regression coefficients of 0.46, 0.15, and \u22120.12 respectively, all p <0.001).", {"entities": []}], ["Body mass index, problem alcohol drinking, physical activity, and unmarried status were significantly associated with PHQ-9 scores, although these associations were weak.", {"entities": []}], ["Variables associated with depression explained 35% of the variance in non-somatic (PHQ-6) depression scores.", {"entities": []}], ["Satisfaction with family support played a stronger protective role against depressive symptoms (both PHQ-9 and PHQ-6 scores) among women than men ( p \u2009<\u20090.05).", {"entities": []}], ["Acute life stress and the number of chronic conditions, together with socio-demographic factors, explain most variance in depressive symptoms among chronically ill Chinese individuals.", {"entities": []}], ["Somatic items in the PHQ-9 increased the depression scores but they did not alter the pattern of predictors.", {"entities": []}], ["Family support appears to be an important protective factor in Chinese cultures for individuals with chronic conditions.", {"entities": []}], ["Mucosal antibodies harboring various antiviral activities may best protect mucosal surfaces against early HIV-1 entry at mucosal sites and they should be ideally induced by prophylactic HIV-1 vaccines for optimal prevention of sexually transmitted HIV-1.", {"entities": []}], ["A phase I, double-blind, randomized, placebo-controlled trial was conducted in twenty-four healthy HIV-uninfected young women.", {"entities": []}], ["The study objectives were to assess the safety, tolerability and immunogenicity of virosomes harboring surface HIV-1 gp41-derived P1 lipidated peptides (MYM-V101).", {"entities": []}], ["Participants received placebo or MYM-V101 vaccine at 10 \u03bcg/dose or 50 \u03bcg/dose intramuscularly at week 0 and 8, and intranasally at week 16 and 24.", {"entities": []}], ["MYM-V101 was safe and well-tolerated at both doses administered by the intramuscular and intranasal routes, with the majority of subjects remaining free of local and general symptoms.", {"entities": []}], ["P1-specific serum IgGs and IgAs were induced in all high dose recipients after the first injection.", {"entities": []}], ["After the last vaccination, vaginal and rectal P1-specific IgGs could be detected in all high dose recipients.", {"entities": []}], ["Approximately 63% and 43% of the low and high dose recipients were respectively tested positive for vaginal P1-IgAs, while 29% of the subjects from the high dose group tested positive for rectal IgAs.", {"entities": []}], ["Serum samples had total specific IgG and IgA antibody concentrations \u22650.4 \u03bcg/mL, while mucosal samples were usually below 0.01 \u03bcg/mL.", {"entities": []}], ["Vaginal secretions from MYM-V101 vaccinated subjects were inhibiting HIV-1 transcytosis but had no detectable neutralizing activity.", {"entities": []}], ["P1-specific Th1 responses could not be detected on PBMC.", {"entities": []}], ["This study demonstrates the excellent safety and tolerability of MYM-V101, eliciting systemic and mucosal antibodies in the majority of subjects.", {"entities": []}], ["Vaccine-induced mucosal anti-gp41 antibodies toward conserved gp41 motifs were harboring HIV-1 transcytosis inhibition activity and may contribute to reduce sexually-transmitted HIV-1.", {"entities": []}], ["ClinicalTrials.gov NCT01084343", {"entities": []}], ["This paper sought to provide normative values for grip strength among older adults across different age groups in northwest Russia and to investigate their predictive value for adverse events.", {"entities": []}], ["A population-based prospective cohort study of 611 community-dwelling individuals 65+.", {"entities": []}], ["Grip strength was measured using the standard protocol applied in the Groningen Elderly Tests.", {"entities": []}], ["The cut-off thresholds for grip strength were defined separately for men and women of different ages using a weighted polynomial regression.", {"entities": []}], ["A Cox regression analysis, the c-statistic, a risk reclassification analysis, and bootstrapping techniques were used to analyze the data.", {"entities": []}], ["The outcomes were the 5-year mortality rate, the loss of autonomy and mental decline.", {"entities": []}], ["We determined the age-related reference intervals of grip strength for older adults.", {"entities": []}], ["The 5 This study presents age- and sex-specific reference values for grip strength in the 65+ Russian population derived from a prospective cohort study.", {"entities": []}], ["The norms can be used in clinical practice to identify patients at increased risk for adverse outcomes.", {"entities": []}], ["Previous studies conducted in various geographical and ethnical populations have shown that Alpha-1-antitrypsin ( Alpha-1-AT ) expression affects the occurrence and progression of chronic obstructive pulmonary disease (COPD).", {"entities": [[180, 217, "DISEASE"]]}], ["We aimed to explore the associations of rs9944155AG, rs1051052AG, and rs1243166AG polymorphisms in the Alpha-1-AT gene with the risk of COPD in Uygur population in the Kashgar region.", {"entities": []}], ["From March 2013 to December 2015, a total of 225 Uygur COPD patients and 198 healthy people were recruited as cases and controls, respectively, in Kashgar region.", {"entities": []}], ["DNA was extracted according to the protocol of the DNA genome kit, and Sequenom MassARRAY single-nucleotide polymorphism technology was used for genotype determination.", {"entities": []}], ["Serum concentration of Alpha-1-AT was detected by enzyme-linked immunosorbent assay.", {"entities": []}], ["A logistic regression model was used to estimate the associations of polymorphisms with COPD.", {"entities": []}], ["The rs1243166-G allele was associated with a higher risk of COPD (odds ratio [ OR ] = 2.039, 95% confidence interval [ CI ]: 1.116\u20133.725, P = 0.019).", {"entities": []}], ["In cases, Alpha-1-AT levels were the highest among participants carrying rs1243166 AG genotype, followed by AA and GG genotype ( \u03c7 11.89, P = 0.003).", {"entities": []}], ["Similarly, the rs1051052-G allele was associated with a higher risk of COPD ( OR = 19.433, 95% CI : 8.783\u201343.00, P < 0.001).", {"entities": []}], ["The highest Alpha-1-AT levels were observed in cases carrying rs1051052 AA genotype, followed by cases with AG and GG genotypes ( \u03c7 P < 0.001).", {"entities": []}], ["However, individuals with rs9944155-G allele exhibited a lower risk of COPD than those carrying the rs9944155-A allele ( OR = 0.121, 95% CI : 0.070\u20130.209, P < 0.001).", {"entities": []}], ["In both cases and controls, no significant difference in Alpha-1-AT levels was observed among various rs9944115 genotypes.", {"entities": []}], ["rs1243166, rs9944155, and rs1051052 sites of Alpha-1-AT may be associated with the COPD morbidity in Uygur population.", {"entities": []}], ["While rs1243166-G allele and rs1051052-G allele are associated with an increased risk of developing COPD, rs9944155-G allele is a protect locus in Uygur population.", {"entities": []}], ["Alpha-1-AT levels in Uygur COPD patients were lower than those in healthy people and differed among patients with different rs1051052 AG and rs1243166 AG genotypes.", {"entities": []}], ["Policies for allocating deceased donor kidneys have recently shifted from allocation based on Human Leucocyte Antigen (HLA) tissue matching in the UK and USA.", {"entities": [[119, 122, "GENE"]]}], ["Newer allocation algorithms incorporate waiting time as a primary factor, and in the UK, young adults are also favoured.", {"entities": []}], ["However, there is little contemporary UK research on the views of stakeholders in the transplant process to inform future allocation policy.", {"entities": []}], ["This research project aimed to address this issue.", {"entities": []}], ["Discrete Choice Experiment (DCE) questionnaires were used to establish priorities for kidney transplantation among different stakeholder groups in the UK.", {"entities": []}], ["Questionnaires were targeted at patients, carers, donors / relatives of deceased donors, and healthcare professionals.", {"entities": []}], ["Attributes considered included: waiting time; donor-recipient HLA match; whether a recipient had dependents; diseases affecting life expectancy; and diseases affecting quality of life.", {"entities": [[62, 65, "GENE"]]}], ["Responses were obtained from 908 patients (including 98 ethnic minorities); 41 carers; 48 donors / relatives of deceased donors; and 113 healthcare professionals.", {"entities": []}], ["The patient group demonstrated statistically different preferences for every attribute (i.e.", {"entities": []}], ["significantly different from zero) so implying that changes in given attributes affected preferences, except when prioritizing those with no rather than moderate diseases affecting quality of life.", {"entities": []}], ["The attributes valued highly related to waiting time, tissue match, prioritizing those with dependents, and prioritizing those with moderate rather than severe diseases affecting life expectancy.", {"entities": []}], ["Some preferences differed between healthcare professionals and patients, and ethnic minority and non-ethnic minority patients.", {"entities": []}], ["Only non-ethnic minority patients and healthcare professionals clearly prioritized those with better tissue matches.", {"entities": []}], ["Our econometric results are broadly supportive of the 2006 shift in UK transplant policy which emphasized prioritizing the young and long waiters.", {"entities": []}], ["However, our findings suggest the need for a further review in the light of observed differences in preferences amongst ethnic minorities, and also because those with dependents may be a further priority.", {"entities": []}], ["Dendritic cells (DCs) are major orchestrators of immune responses and inflammation.", {"entities": []}], ["They are migratory cells, which may play a role in Alzheimer\u2019s disease (AD), as suggested by prior in vitro studies.", {"entities": []}], ["With the intent to investigate the clinical relevance of DC modifications in vivo, the present study was aimed to evaluate the levels of blood DCs in AD patients, in relation to the progression of the disease, the severity of its symptoms, and the treatment with acetylcholinesterase inhibitors (AChEIs), a class of drugs used to improve cognitive functioning\u00a0in people with dementia.", {"entities": [[375, 383, "DISEASE"]]}], ["The two main subpopulations of immature blood DCs, namely myeloid (mDCs) and plasmacytoid (pDCs) cells, were evaluated by flow cytometry analysis in 106 AD patients, in comparison with the same cells from 65 individuals with mild cognitive impairment (MCI) and 73 healthy control subjects (HC).", {"entities": []}], ["The relationship between blood DC levels and symptom severity was also assessed in AD patients, and their blood DC frequency was considered both in the absence or presence of treatment with AChEIs.", {"entities": []}], ["A significant depletion in blood mDCs was observed in AD patients, as compared to HC and MCI subjects.", {"entities": []}], ["At variance, pDC levels were comparable among the three groups of subjects.", {"entities": [[13, 16, "GENE"]]}], ["The mDC decrease was evident only after the emergence of AD clinical symptoms, as confirmed by the follow-up analysis of a subgroup of MCI subjects who exhibited a significant decline in mDCs after their conversion to AD.", {"entities": []}], ["Notably, the mDC decline was inversely correlated in AD patients with the frequency and severity of depressive symptoms.", {"entities": []}], ["Eventually, the mDC depletion was not observable in patients treated with AChEIs.", {"entities": []}], ["Our results provide the first evidence that blood mDC levels are dysregulated in AD.", {"entities": []}], ["This phenomenon appears mainly linked to AD progression, associated with stronger severity of AD-related symptoms, and influenced by AChEI treatment.", {"entities": []}], ["Taken all together, these data suggest that blood mDCs may serve as a cell source to test disease-induced and treatment-related changes and support the innovative notion that DCs play a role in AD, as ultimate evidence of the immune system participation in disease progression.", {"entities": []}], ["The Bacillus Calmette-Gu\u00e9rin vaccine (BCG) against tuberculosis is administered intradermally, and vaccination is often followed by a scar at the injection site.", {"entities": [[51, 63, "DISEASE"]]}], ["Among BCG-vaccinated individuals, having a scar has been associated with lower mortality.", {"entities": []}], ["We aimed to examine the impact of vaccination technique for scarring in a high income setting, by assessing the associations between the post injection reaction, the wheal size, and the probability of developing a scar, and scar size.", {"entities": []}], ["This study was nested within a clinical multicenter study randomizing 4262 infants to either BCG vaccination (BCG 1331 SSI) or no intervention.", {"entities": []}], ["In this substudy, including 492 vaccinated infants, the immediate post BCG vaccination reaction was registered as either wheal (a raised, blanched papule at the injection site), bulge (a palpable element at the injection site), or no reaction.", {"entities": []}], ["The presence or absence of a BCG scar and the size the scar was measured at 13\u00a0months of age.", {"entities": []}], ["Of 492 infants included, 87% had a wheal after vaccination, 11% had a bulge, and 2% had no reaction.", {"entities": []}], ["The mean wheal size was 3.8\u00a0mm (95% confidence interval 3.7\u20133.9).", {"entities": []}], ["Overall, 95% (442/466, 26 lost to follow-up) of BCG-vaccinated infants had a scar at 13\u00a0months of age.", {"entities": []}], ["In infants with a wheal, the probability of developing a scar was 96%, declining to 87% in the case of a bulge, and to 56% in the case of no reaction (p for same probability\u00a0=\u00a00.03).", {"entities": []}], ["Wheal size was positively correlated with the probability of getting a scar and scar size.", {"entities": []}], ["Scarring after BCG vaccination has been associated with lower infant mortality.", {"entities": []}], ["In a high-income setting, we found that correct injection technique is highly important for the development of a BCG scar and that registration of the category of BCG skin reaction (as wheal, bulge, or no reaction) may be used to identify infants at risk of scar failure.", {"entities": []}], ["Finally, the wheal size was positively associated with both the probability of getting a scar and scar size.", {"entities": []}], ["The study was registered at www.ClinicalTrials.gov with trial registration number NCT01694108 .", {"entities": []}], ["The online version of this article (doi:10.1186/s12879-017-2641-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Perfluorooctanoate (PFOA) and perfluorooctane sulfonate (PFOS) are persistent environmental contaminants that affect metabolic regulation, inflammation, and other factors implicated in the development and progression of colorectal cancer (CRC).", {"entities": [[220, 237, "DISEASE"], [231, 237, "DISEASE"]]}], ["However, the link between these compounds and CRC remains unknown.", {"entities": []}], ["In this cross-sectional study, we investigated the association of CRC diagnosis to PFOA and PFOS blood levels in a large Appalachian population.", {"entities": []}], ["Participants were 47,359 adults\u2009\u2265\u200921\u00a0years of age and residing in six PFOA-contaminated water districts in the mid-Ohio Valley (N\u2009=\u200947,151 cancer-free adults, 208 cases of primary CRC).", {"entities": [[139, 145, "DISEASE"]]}], ["All participants completed a comprehensive health survey between 2005 and 2006; serum levels of PFOA, PFOS, and a range of other blood markers were also measured.", {"entities": []}], ["Medical history was assessed via self report and cancer diagnosis confirmed via chart review.", {"entities": [[49, 55, "DISEASE"]]}], ["CRC showed a strong inverse, dose\u2013response association with PFOS serum levels (odds ratio (OR) adjusted for potential confounders\u2009=\u20090.2, 95% confidence interval (CI) 0.2,0.3) for highest vs. lowest quartile of PFOS, P -trend\u2009<\u20090.00001) and a significant, but more modest inverse association with PFOA (adjusted OR\u2009=\u20090.6 (CI 0.4, 0.9) for highest vs. lowest quartile, P -trend\u2009=\u20090.001).", {"entities": []}], ["These inverse associations were stronger in those diagnosed within the previous 6\u00a0years and resident in the same water district for a minimum of 10\u201315\u00a0years preceding assessment.", {"entities": []}], ["The relationship between PFOA and CRC was also more pronounced in men and leaner adults, and showed a stronger linear trend at lower exposure levels.", {"entities": []}], ["In this large cross-sectional study, we found a strong, inverse association between PFOS and likelihood of CRC diagnosis and a significant, although more modest inverse association between PFOA and CRC.", {"entities": []}], ["If confirmed in prospective investigations, these findings may aid in identifying new strategies for CRC prevention and treatment and inform future studies regarding mechanisms underlying CRC pathogenesis.", {"entities": []}], ["The aim was to evaluate the effects of traditional Chinese medicine (TCM) as a combination medication with adjuvant chemotherapy on postoperative early stage non-small cell lung cancer (NSCLC) patients.", {"entities": [[173, 184, "DISEASE"], [178, 184, "DISEASE"]]}], ["The 314 patients with completely resected stage IB, II or IIIA cancers were assigned into vinorelbine plus cisplatin/carboplatin (NP/NC) (control, n \u2009=\u2009158) and NP/NC with additional TCM (intervention, n \u2009=\u2009156) groups.", {"entities": []}], ["The primary endpoint was QOL scores; secondary endpoints were the toxicity and safety of the regimens.", {"entities": []}], ["The NP/NC regimen caused mild (grade 1 or 2) non-hematologic toxic effects in the patients comprising vomiting (43.6%), fatigue (36.9%), pain (23%), dry mouth (27.6%) and diarrhea (7.9%).", {"entities": [[171, 179, "DISEASE"]]}], ["The incidence of adverse events was significantly lower in the intervention group than in the control group (0.57% vs 4.02%, P \u2009=\u20090.037).", {"entities": []}], ["Transient severe (grade 3 or 4) hematological toxic effects occurred less often (hemoglobin reduction (11.9 vs 22.5 percent) and total bilirubin increased (to 42.1 vs 46.2%) in the intervention compared to the control group during the 2nd chemotherapy cycle.", {"entities": []}], ["When combined with adjuvant chemotherapy, TCM led to partial relief of symptoms in addition to a reduction of side-effects and adverse events caused by the NP/NC regimens.", {"entities": []}], ["The present study aimed to investigate the distribution of total serum immunoglobulin E (IgE) levels in Korean schoolchildren and to evaluate its utility in the prediction of atopy and allergic diseases.", {"entities": []}], ["A nationwide, cross-sectional survey was conducted in first grade students from randomly selected elementary and middle schools.", {"entities": []}], ["Total IgE levels were measured by ImmunoCAP.", {"entities": []}], ["Skin prick tests were performed for 18 common inhalant allergens to determine the presence of atopy.", {"entities": []}], ["Children aged 12\u201313 years and parents of children aged 6\u20137 years were asked to complete questionnaire assessing allergic diseases.", {"entities": []}], ["The cut-off levels of total IgE were determined by analyzing receiver operating characteristic curves.", {"entities": []}], ["The median total IgE level was 86.7 kU/L (range: 1.5\u20134,523.1) in 3,753 children aged 6\u20137 years and 94.7 kU/L (range: 1.5\u20133,000.0) in 3,930 children aged 12\u201313 years.", {"entities": []}], ["Total IgE concentrations were higher in children with atopy or allergic diseases than in those without (all P < 0.001).", {"entities": []}], ["At the cut-off value of 127.7 kU/L, sensitivity, specificity, and positive and negative predictive values (PPV and NPV) were 67.1%, 75.4%, 65.4%, and 76.7%, respectively, in elementary schoolchildren.", {"entities": []}], ["At the cut-off value of 63.0 kU/L, sensitivity, specificity, PPV, and NPV were 81.9%, 66.6%, 75.0%, and 75.1%, respectively, in middle schoolchildren.", {"entities": []}], ["PPV and NPV were \u2265 70% when cut-offs of 258.8 kU/L and 38.4 kU/L were used for the diagnosis of atopy in 6\u20137 year-olds and 12\u201313 year-olds, respectively.", {"entities": []}], ["This nationwide population-based study provided the first normal reference ranges of total IgE in Korean schoolchildren.", {"entities": []}], ["Intramuscular vitamin A supplementation decreases the risk of bronchopulmonary dysplasia (BPD) in very-low-birth-weight preterm infants without significant adverse effects.", {"entities": []}], ["However, intramuscular vitamin A supplementation is not widely accepted because of the discomfort and risk of trauma associated with repeated injections.", {"entities": []}], ["Enteral vitamin A supplementation has not been studied adequately in the clinical trials.", {"entities": []}], ["Enterally administered water-soluble vitamin A is absorbed better than the fat-soluble form.", {"entities": []}], ["We hypothesised that enteral administration of a water-soluble vitamin A preparation will decrease severity of BPD compared with a control group receiving placebo.", {"entities": []}], ["We plan a double-blind randomised placebo-controlled trial at a tertiary neonatal-perinatal intensive care unit.", {"entities": []}], ["Eligibility criteria include infants born at less than 28\u00a0weeks\u2019 gestational age and less than 72\u00a0h of life.", {"entities": []}], ["Infants with major congenital gastrointestinal or respiratory tract abnormalities will be excluded.", {"entities": []}], ["After parental consent, infants will be randomized to receive either enteral water-soluble vitamin A (5000\u00a0IU once a day) or placebo.", {"entities": []}], ["The intervention will be started within 24\u00a0h of introduction of feeds and continued until 34\u00a0weeks\u2019 post-menstrual age (PMA).", {"entities": []}], ["The primary outcome is severity of BPD at 36\u00a0weeks\u2019 PMA.", {"entities": []}], ["Severity of BPD will be assessed objectively from the right-shift of the peripheral oxyhaemoglobin saturation versus partial pressure of inspired oxygen (SpO 2 -PiO 2 ) curve.", {"entities": []}], ["We require 188 infants for 80% power and 5% significance level based on an expected 20% decrease in the right shift of the SpO 2 -PiO 2 curve in the vitamin A group (primary outcome) compared with control group at 36\u00a0weeks\u2019 PMA, and a 20% attrition rate.", {"entities": []}], ["Secondary outcomes will be plasma and salivary concentrations of vitamin A on day 28 of the trial (first 30 infants), lung and diaphragm function, clinical outcomes at 36\u00a0week\u2019 PMA or before discharge/death, and safety of vitamin A. BPD poses a significant economic burden on the health-care system.", {"entities": []}], ["If our study shows that enteral supplementation of water-soluble vitamin A is safe and effective for decreasing the severity of BPD, it will provide the opportunity to further evaluate a simple, globally acceptable preventive therapy for BPD.", {"entities": []}], ["ANZCTR; ACTRN12616000408482 (30th March 2016).", {"entities": []}], ["The online version of this article (10.1186/s12887-017-0958-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The aim of the present study was to determine whether aerobic exercise involving an active video game system improved asthma control, airway inflammation and exercise capacity in children with moderate to severe asthma.", {"entities": [[118, 124, "DISEASE"], [212, 218, "DISEASE"]]}], ["A randomized, controlled, single-blinded clinical trial was carried out.", {"entities": []}], ["Thirty-six children with moderate to severe asthma were randomly allocated to either a video game group (VGG; N = 20) or a treadmill group (TG; n = 16).", {"entities": [[44, 50, "DISEASE"], [140, 142, "GENE"]]}], ["Both groups completed an eight-week supervised program with two weekly 40-minute sessions.", {"entities": []}], ["Pre-training and post-training evaluations involved the Asthma Control Questionnaire, exhaled nitric oxide levels (FeNO), maximum exercise testing (Bruce protocol) and lung function.", {"entities": [[56, 62, "DISEASE"]]}], ["No differences between the VGG and TG were found at the baseline.", {"entities": [[35, 37, "GENE"]]}], ["Improvements occurred in both groups with regard to asthma control and exercise capacity.", {"entities": [[52, 58, "DISEASE"]]}], ["Moreover, a significant reduction in FeNO was found in the VGG (p < 0.05).", {"entities": []}], ["Although the mean energy expenditure at rest and during exercise training was similar for both groups, the maximum energy expenditure was higher in the VGG.", {"entities": []}], ["The present findings strongly suggest that aerobic training promoted by an active video game had a positive impact on children with asthma in terms of clinical control, improvementin their exercise capacity and a reductionin pulmonary inflammation.", {"entities": [[132, 138, "DISEASE"]]}], ["Clinicaltrials.gov NCT01438294", {"entities": []}], ["Airway eosinophilia is considered a central event in the pathogenesis of asthma.", {"entities": [[7, 19, "DISEASE"], [73, 79, "DISEASE"]]}], ["Eotaxin plays a key role in selective eosinophil accumulation in the airways and, subsequently, their activation and degranulation.", {"entities": []}], ["The study was undertaken to evaluate eotaxin-1 levels in the exhaled breath condensate (EBC) of asthmatics with different degrees of asthma severity and to establish the possible correlation of these measurements with other recognized parameters of airway inflammation.", {"entities": [[133, 139, "DISEASE"]]}], ["EBC was collected from 46 patients with allergic asthma (14 with steroid-na\u00efve asthma, 16 with ICS-treated, stable asthma, 16 with ICS-treated unstable asthma) and 12 healthy volunteers.", {"entities": [[40, 55, "DISEASE"], [49, 55, "DISEASE"], [79, 85, "DISEASE"], [115, 121, "DISEASE"], [152, 158, "DISEASE"]]}], ["Concentrations of eotaxin-1 were measured by ELISA.", {"entities": []}], ["In the three groups of asthmatics, eotaxin-1 concentrations in EBC were significantly higher compared with healthy volunteers (steroid-na\u00efve asthma: 9.70 pg/ml \u00b1 1.70, stable ICS-treated asthma: 10.45 \u00b1 2.00, unstable ICS-treated asthma: 17.97 \u00b1 3.60, healthy volunteers: 6.24 \u00b1 0.70).", {"entities": [[141, 147, "DISEASE"], [187, 193, "DISEASE"], [230, 236, "DISEASE"]]}], ["Eotaxin-1 levels were significantly higher in patients with unstable asthma than in the two groups with stable disease.", {"entities": [[69, 75, "DISEASE"]]}], ["We observed statistically significant correlations between the concentrations of eotaxin-1 in EBC and exhaled nitric oxide (F ENO ) or serum eosinophil cationic protein (ECP) in the three studied groups of asthmatics.", {"entities": []}], ["We also discovered a significantly positive correlation between eotaxin-1 in EBC and blood eosinophil count in the groups of patients with unstable asthma and steroid-na\u00efve asthma.", {"entities": [[148, 154, "DISEASE"], [173, 179, "DISEASE"]]}], ["Measurements of eotaxin-1 in the EBC of asthma patients may provide another useful diagnostic tool for detecting and monitoring airway inflammation and disease severity.", {"entities": [[40, 46, "DISEASE"]]}], ["The emergence and pandemic spread of a new strain of influenza A (H1N1) virus in 2009 resulted in a serious alarm in clinical and public health services all over the world.", {"entities": [[53, 62, "DISEASE"]]}], ["One distinguishing feature of this new influenza pandemic was the different profile of hospitalized patients compared to those from traditional seasonal influenza infections.", {"entities": [[39, 48, "DISEASE"], [153, 162, "DISEASE"]]}], ["Our goal was to analyze sociodemographic and clinical factors associated to hospitalization following infection by influenza A(H1N1) virus.", {"entities": [[115, 124, "DISEASE"]]}], ["We report the results of a Spanish nationwide study with laboratory confirmed infection by the new pandemic virus in a case-control design based on hospitalized patients.", {"entities": []}], ["The main risk factors for hospitalization of influenza A (H1N1) 2009 were determined to be obesity (BMI\u226540, with an odds-ratio [OR] 14.27), hematological neoplasia (OR 10.71), chronic heart disease, COPD (OR 5.16) and neurological disease, among the clinical conditions, whereas low education level and some ethnic backgrounds (Gypsies and Amerinds) were the sociodemographic variables found associated to hospitalization.", {"entities": [[45, 54, "DISEASE"], [184, 197, "DISEASE"], [91, 98, "DISEASE"]]}], ["The presence of any clinical condition of moderate risk almost triples the risk of hospitalization (OR 2.88) and high risk conditions raise this value markedly (OR 6.43).", {"entities": []}], ["The risk of hospitalization increased proportionally when for two (OR 2.08) or for three or more (OR 4.86) risk factors were simultaneously present in the same patient.", {"entities": []}], ["These findings should be considered when a new influenza virus appears in the human population.", {"entities": [[47, 56, "DISEASE"]]}], ["Inflammasomes are intracellular multiprotein complexes of the innate immune system.", {"entities": []}], ["Upon an inflammatory insult, such as infection or intracellular damage, a nucleotide-binding oligomerization domain-like receptor (NLR) sensor protein and the adaptor protein ASC (apoptosis-associated speck-like protein containing a caspase activation and recruitment domain) are assembled to activate protease procaspase-1.", {"entities": []}], ["This protease processes pro-IL-1\u03b2 and pro-IL-18 cytokines, which are released to induce the inflammatory response.", {"entities": []}], ["De-regulation of inflammasome contributes to the progression of several diseases, such as Alzheimer\u2019s disease, diabetes, cancer, inflammatory and autoimmune disorders.", {"entities": [[121, 127, "DISEASE"]]}], ["We herein describe the identification of methylergometrine (MEM), a drug currently used as a smooth muscle constrictor during postpartum hemorrhage, as an inhibitor of the inflammasome complex in ASC-mediated procaspase-1 activation screening.", {"entities": []}], ["MEM inhibits the activation of the nucleotide-binding oligomerization domain-like receptor protein 1 (NLRP1) and nucleotide-binding oligomerization domain-like receptor protein 3 (NLRP3) inflammasomes in cellular models upon different pro-inflammatory stimuli.", {"entities": [[102, 107, "GENE"], [180, 185, "GENE"]]}], ["Our results suggest that MEM has the potential to reposition in the treatment of inflammatory diseases with the advantages of established safety and clinical data.", {"entities": []}], ["The online version of this article (doi:10.1007/s10495-017-1405-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["In October 2014, the United States began actively monitoring all persons who had traveled from Guinea, Liberia, and Sierra Leone in the previous 21 days.", {"entities": []}], ["State public health departments were responsible for monitoring all travelers; Minnesota has the largest Liberian population in the United States.", {"entities": []}], ["The MDH Ebola Clinical Team (ECT) was established to assess travelers with symptoms of concern for Ebola virus disease (EVD), coordinate access to healthcare at appropriate facilities including Ebola Assessment and Treatment Units (EATU), and provide guidance to clinicians.", {"entities": []}], ["Minnesota Department of Health (MDH) began receiving traveler information collected by U.S. Customs and Border Control and Centers for Disease Control and Prevention staff on October 21, 2014 via encrypted electronic communication.", {"entities": []}], ["All travelers returning from Liberia, Sierra Leone, and Guinea during 10/21/14\u20135/15/15 were monitored by MDH staff in the manner recommended by CDC based on the traveler\u2019s risk categorization as \u201clow (but not zero)\u201d, \u201csome\u201d and \u201chigh\u201d risk.", {"entities": []}], ["When a traveler reported symptoms or a temperature \u2265100.4\u00b0 F at any time during their 21-day monitoring period, an ECT member would speak to the traveler and perform a clinical assessment by telephone or via video-chat.", {"entities": []}], ["Based on the assessment the ECT member would recommend 1) continued clinical monitoring while at home with frequent telephone follow-up by the ECT member, 2) outpatient clinical evaluation at an outpatient site agreed upon by all parties, or 3) inpatient clinical evaluation at one of four Minnesota EATUs.", {"entities": []}], ["ECT members assessed and approved testing for Ebola virus infection at MDH.", {"entities": []}], ["Traveler data, calls to the ECT and clinical outcomes were logged on a secure server at MDH.", {"entities": []}], ["During 10/21/14\u20135/15/15, a total of 783 travelers were monitored; 729 (93%) traveled from Liberia, 30 (4%) Sierra Leone, and 24 (3%) Guinea.", {"entities": []}], ["The median number monitored per week was 59 (range 45\u2013143).", {"entities": []}], ["The median age was 35 years; 136 (17%) were aged <18 years.", {"entities": []}], ["Thirteen of 256 women of reproductive age (5%) were pregnant.", {"entities": []}], ["The country of passport issuance was known for 720 of the travelers.", {"entities": []}], ["The majority of monitored travelers (478 [66%]) used a non-U.S. passport including 442 (61%) Liberian nationals.", {"entities": []}], ["A total of 772 (99%) travelers were \u201clow (but not zero)\u201d risk; 11 (1%) were \u201csome\u201d risk.", {"entities": []}], ["Among monitored travelers, 43 (5%) experienced illness symptoms; 29 (67%) had a symptom consistent with EVD.", {"entities": []}], ["Two were tested for Ebola virus disease and had negative results.", {"entities": []}], ["Most frequently reported symptoms were fever (20/43, 47%) and abdominal pain (12/43, 28%).", {"entities": []}], ["During evaluation, 16 (37%) of 43 travelers reported their symptoms began prior to travel; chronic health conditions in 24 travelers including tumors/cancer, pregnancy, and orthopedic conditions were most common.", {"entities": [[150, 156, "DISEASE"]]}], ["Infectious causes in 19 travelers included upper respiratory infection, malaria, and gastrointestinal infections.", {"entities": [[72, 79, "DISEASE"]]}], ["Prior to 2014, no similar active monitoring program for travelers had been performed in Minnesota; assessment and management of symptomatic travelers was a new activity for MDH.", {"entities": []}], ["Ensuring safe entrance into healthcare was particularly challenging for children, and pregnant women, as well as those without an established connection to healthcare.", {"entities": []}], ["Unnecessary inpatient evaluations were successfully avoided by close clinical follow-up by phone.", {"entities": []}], ["Before similar monitoring programs are considered in the future, careful thought must be given to necessary resources and the impact on affected populations, public health, and the healthcare system.", {"entities": []}], ["In implementing new programs of care, such as person-centered care, there is a risk that the focus will be at an organizational level, instead of a level that describes what happens in the personal development among staff.", {"entities": []}], ["The aim of this study was to describe experiences of the implementation process of a learning supporting model designed to increase patient involvement and autonomy in care.", {"entities": []}], ["The project, which lasted 2\u00a0years, involved training sessions, supervision and reflective meetings.", {"entities": []}], ["Over the period, the staff who participated focused on developing their dialogues with patients to make the patients aware of their own capabilities and to encourage them to be fully involved in the treatment.", {"entities": []}], ["A reflective lifeworld approach was used.", {"entities": []}], ["Data were collected through interviews, notes and written stories, and analyzed using hermeneutic analysis with a focus on meanings.", {"entities": []}], ["At the beginning of the project, the participants perceived the model as abstract and difficult to understand but supervision and reflection sessions enabled understanding and changed the participants\u2019 approach to caring.", {"entities": []}], ["The participants described the model as an approach used in challenging patients to become involved in their care and to take charge of their lives when living with a chronic life-threatening disease.", {"entities": []}], ["The participants\u2019 experience of implementing the model has not been easy but has led to increased self-confidence and feelings of improved competence in dialogue with patients.", {"entities": []}], ["Using the PARISH model when critically examining the results shows that in the implementation process there were some difficulties, e.g.", {"entities": []}], ["the context was supportive and facilitating but there was no appointed facilitator.", {"entities": []}], ["By making participation in improvement work voluntary, the impact of such work becomes less efficient, less cost-effective and probably less sustainable.", {"entities": []}], ["Furthermore, implementation needs encouragement since changing approaches takes time and requires patience.", {"entities": []}], ["Group supervision sessions seem an appropriate way to translate research into practice; systematic scheduled and mandatory group supervision sessions would, therefore, probably make implementation more robust and sustainable.", {"entities": []}], ["In addition, a well-trained facilitator would be able to motivate staff to undertake daily reflection and participate in group supervision sessions.", {"entities": []}], ["Reflection seems to be a key component in the personal learning necessary to change work routines and approaches.", {"entities": []}], ["Heme oxygenase-1 (HO-1), an inducible stress protein, confers cytoprotection against oxidative stress in vitro and in vivo.", {"entities": []}], ["In addition to its physiological role in heme degradation, HO-1 may influence a number of cellular processes, including growth, inflammation, and apoptosis.", {"entities": []}], ["By virtue of anti-inflammatory effects, HO-1 limits tissue damage in response to proinflammatory stimuli and prevents allograft rejection after transplantation.", {"entities": []}], ["The transcriptional upregulation of HO-1 responds to many agents, such as hypoxia, bacterial lipopolysaccharide, and reactive oxygen/nitrogen species.", {"entities": []}], ["HO-1 and its constitutively expressed isozyme, heme oxygenase-2, catalyze the rate-limiting step in the conversion of heme to its metabolites, bilirubin IX\u03b1, ferrous iron, and carbon monoxide (CO).", {"entities": []}], ["The mechanisms by which HO-1 provides protection most likely involve its enzymatic reaction products.", {"entities": []}], ["Remarkably, administration of CO at low concentrations can substitute for HO-1 with respect to anti-inflammatory and anti-apoptotic effects, suggesting a role for CO as a key mediator of HO-1 function.", {"entities": []}], ["Chronic, low-level, exogenous exposure to CO from cigarette smoking contributes to the importance of CO in pulmonary medicine.", {"entities": []}], ["The implications of the HO-1/CO system in pulmonary diseases will be discussed in this review, with an emphasis on inflammatory states.", {"entities": []}], ["Apparently balanced chromosomal rearrangements can be associated with an abnormal phenotype, including intellectual disability and autism spectrum disorder (ASD).", {"entities": [[103, 126, "DISEASE"], [131, 155, "DISEASE"]]}], ["Genome-wide microarrays reveal cryptic genomic imbalances, related or not to the breakpoints, in 25% to 50% of patients with an abnormal phenotype carrying a microscopically balanced chromosomal rearrangement.", {"entities": []}], ["Here we performed microarray analysis of 18 patients with ASD carrying balanced chromosomal abnormalities to identify submicroscopic imbalances implicated in abnormal neurodevelopment.", {"entities": []}], ["Eighteen patients with ASD carrying apparently balanced chromosomal abnormalities were screened using single nucleotide polymorphism (SNP) arrays.", {"entities": []}], ["Nine rearrangements were de novo , seven inherited, and two of unknown inheritance.", {"entities": []}], ["Genomic imbalances were confirmed by fluorescence in situ hybridization and quantitative PCR.", {"entities": []}], ["We detected clinically significant de novo copy number variants in four patients (22%), including three with de novo rearrangements and one with an inherited abnormality.", {"entities": []}], ["The sizes ranged from 3.3 to 4.9\u00a0Mb; three were related to the breakpoint regions and one occurred elsewhere.", {"entities": [[33, 35, "GENE"]]}], ["We report a patient with a duplication of the Wolf-Hirschhorn syndrome critical region, contributing to the delineation of this rare genomic disorder.", {"entities": [[62, 70, "DISEASE"]]}], ["The patient has a chromosome 4p inverted duplication deletion, with a 0.5\u00a0Mb deletion of terminal 4p and a 4.2\u00a0Mb duplication of 4p16.2p16.3.", {"entities": [[74, 76, "GENE"], [111, 113, "GENE"], [74, 76, "GENE"], [111, 113, "GENE"]]}], ["The other cases included an apparently balanced de novo translocation t(5;18)(q12;p11.2) with a 4.2\u00a0Mb deletion at the 18p breakpoint, a subject with de novo pericentric inversion inv(11)(p14q23.2) in whom the array revealed a de novo 4.9\u00a0Mb deletion in 7q21.3q22.1, and a patient with a maternal inv(2)(q14.2q37.3) with a de novo 3.3\u00a0Mb terminal 2q deletion and a 4.2\u00a0Mb duplication at the proximal breakpoint.", {"entities": [[100, 102, "GENE"], [239, 241, "GENE"], [335, 337, "GENE"], [369, 371, "GENE"], [100, 102, "GENE"], [239, 241, "GENE"], [335, 337, "GENE"], [369, 371, "GENE"], [100, 102, "GENE"], [239, 241, "GENE"], [335, 337, "GENE"], [369, 371, "GENE"], [100, 102, "GENE"], [239, 241, "GENE"], [335, 337, "GENE"], [369, 371, "GENE"]]}], ["In addition, we identified a rare de novo deletion of unknown significance on a chromosome unrelated to the initial rearrangement, disrupting a single gene, RFX3 .", {"entities": [[157, 161, "GENE"]]}], ["These findings underscore the utility of SNP arrays for investigating apparently balanced chromosomal abnormalities in subjects with ASD or related neurodevelopmental disorders in both clinical and research settings.", {"entities": []}], ["To develop a complex intervention for community pharmacy staff to promote uptake of smoking cessation services and to increase quit rates.", {"entities": []}], ["Following the Medical Research Council framework, we used a mixed-methods approach to develop, pilot and then refine the intervention.", {"entities": []}], ["Phase I : We used information from qualitative studies in pharmacies, systematic literature reviews and the Capability, Opportunity, Motivation\u2014Behaviour framework to inform design of the initial version of the intervention.", {"entities": []}], ["Phase II : We then tested the acceptability of this intervention with smoking cessation advisers and assessed fidelity using actors who visited pharmacies posing as smokers, in a pilot study.", {"entities": []}], ["Phase III : We reviewed the content and associated theory underpinning our intervention, taking account of the results of the earlier studies and a realist analysis of published literature.", {"entities": []}], ["We then confirmed a logic model describing the intended operation of the intervention and used this model to refine the intervention and associated materials.", {"entities": []}], ["Eight community pharmacies in three inner east London boroughs.", {"entities": []}], ["12 Stop Smoking Advisers.", {"entities": []}], ["Two, 150\u2009min, skills-based training sessions focused on communication and behaviour change skills with between session practice.", {"entities": []}], ["The pilot study confirmed acceptability of the intervention and showed preliminary evidence of benefit; however, organisational barriers tended to limit effective operation.", {"entities": []}], ["The pilot data and realist review pointed to additional use of Diffusion of Innovations Theory to seat the intervention in the wider organisational context.", {"entities": []}], ["We have developed and refined an intervention to promote smoking cessation services in community pharmacies, which we now plan to evaluate in a randomised controlled trial.", {"entities": []}], ["UKCRN ID 18446, Pilot.", {"entities": []}], ["Morphology, composition, and mixing state of individual particles emitted from crop residue, wood, and solid waste combustion in a residential stove were analyzed using transmission electron microscopy (TEM).", {"entities": []}], ["Our study showed that particles from crop residue and apple wood combustion were mainly organic matter (OM) in smoldering phase, whereas soot-OM internally mixed with K in flaming phase.", {"entities": []}], ["Wild grass combustion in flaming phase released some Cl-rich-OM/soot particles and cardboard combustion released OM and S-rich particles.", {"entities": []}], ["Interestingly, particles from hardwood (pear wood and bamboo) and softwood (cypress and pine wood) combustion were mainly soot and OM in the flaming phase, respectively.", {"entities": []}], ["The combustion of foam boxes, rubber tires, and plastic bottles/bags in the flaming phase released large amounts of soot internally mixed with a small amount of OM, whereas the combustion of printed circuit boards and copper-core cables emitted large amounts of OM with Br-rich inclusions.", {"entities": []}], ["In addition, the printed circuit board combustion released toxic metals containing Pb, Zn, Sn, and Sb.", {"entities": []}], ["The results are important to document properties of primary particles from combustion sources, which can be used to trace the sources of ambient particles and to know their potential impacts in human health and radiative forcing in the air.", {"entities": []}], ["Myoclonus may occur after hypoxia.", {"entities": []}], ["In 1963, Lance and Adams described persistent myoclonus with other features after hypoxia.", {"entities": []}], ["However, myoclonus occurring immediately after hypoxia may demonstrate different syndromic features from classic Lance\u2013Adams syndrome (LAS).", {"entities": [[125, 133, "DISEASE"]]}], ["The aim of this review is to provide up-to-date information about the spectrum of myoclonus occurring after hypoxia with emphasis on neurophysiological features.", {"entities": []}], ["A literature search was performed on PubMed database from 1960 to 2015.", {"entities": []}], ["The following search terms were used: \u201cmyoclonus,\u201d \u201cpost anoxic myoclonus,\u201d \u201cpost hypoxic myoclonus,\u201d and \u201cLance Adams syndrome.\u201d The articles describing clinical features, neurophysiology, management, and prognosis of post-hypoxic myoclonus cases were included for review.", {"entities": [[119, 127, "DISEASE"]]}], ["Several reports in the literature were separated clinically into \u201cacute post-hypoxic myoclonus,\u201d which occurred within hours of severe hypoxia, and \u201cchronic post-hypoxic myoclonus,\u201d which occurred with some recovery of mental status as the LAS.", {"entities": []}], ["Acute post-hypoxic myoclonus was generalized in the setting of coma.", {"entities": []}], ["Chronic post-hypoxic myoclonus presented as multifocal cortical action myoclonus that was significantly disabling.", {"entities": []}], ["There was overlap of neurophysiological findings for these two syndromes but also different features.", {"entities": []}], ["Treatment options for these two distinct clinical\u2013neurophysiologic post-hypoxic myoclonus syndromes were approached differently.", {"entities": []}], ["The review of clinical and neurophysiological findings suggests that myoclonus after hypoxia manifests in one or a combination of distinct syndromes: acute and/or chronic myoclonus.", {"entities": []}], ["The mechanism of post-hypoxic myoclonus may arise either from cortical and/or subcortical structures.", {"entities": []}], ["More research is needed to clarify mechanisms and treatment of post-hypoxic myoclonus.", {"entities": []}], ["The participation of minors in biobank research can offer great benefits for science and health care.", {"entities": []}], ["However, as minors are a vulnerable population they are also in need of adequate protective measures when they are enrolled in research.", {"entities": []}], ["Research using biobanked biological samples from children poses additional ethical issues to those raised by research using adult biobanks.", {"entities": []}], ["For example, small children have only limited capacity, if any, to understand the meaning and implications of the research and to give a documented agreement to it.", {"entities": []}], ["Older minors are gradually acquiring this capacity.", {"entities": []}], ["We describe principles for good practice related to the inclusion of minors in biobank research, focusing on issues related to benefits and subsidiarity, consent, proportionality and return of results.", {"entities": []}], ["Some of these issues are currently heavily debated, and we conclude by providing principles for good practice for policy makers of biobanks, researchers and anyone involved in dealing with stored tissue samples from children.", {"entities": []}], ["Actual implementation of the principles will vary according to different jurisdictions.", {"entities": []}], ["Objective .", {"entities": []}], ["Impulse oscillometry (IOS) is an evolving technology for the diagnosis and followup of patients with asthma.", {"entities": [[101, 107, "DISEASE"]]}], ["Our objective is to review the findings on patients who underwent both spirometry and IOS during clinical evaluations of their asthma.", {"entities": [[127, 133, "DISEASE"]]}], ["The goal was to retrospectively evaluate IOS during the initial diagnosis and followup of patients with asthma in comparison with spirometry.", {"entities": [[104, 110, "DISEASE"]]}], ["We routinely perform IOS and spirometry evaluation in patients with suspected asthma during baseline visits and at followup.", {"entities": [[78, 84, "DISEASE"]]}], ["We reviewed the data on 39 patients over the age of 13 with asthma at baseline and following treatment with inhaled corticosteroids.", {"entities": [[60, 66, "DISEASE"]]}], ["IOS and spirometry were both done at baseline, following short acting bronchodilator administration, and at followup after at least three months of inhaled corticosteroid treatment.", {"entities": []}], ["IOS showed improvement in airway function both initially, following short acting bronchodilator introduction, and later after initiation of long term inhaled corticosteroid treatment, even when the spirometry did not reveal improvement.", {"entities": []}], ["We noted the IOS improvement in the reactance or AX as well as the resistance in smaller airways or R5.", {"entities": []}], ["Conclusion .", {"entities": []}], ["IOS may provide a useful measure towards identifying an asthma diagnosis and followup without inducing the extra respiratory effort spirometry requires.", {"entities": [[56, 62, "DISEASE"]]}], ["Osteoarthritis (OA) typically generates pain, reduced mobility and reduced quality of life.", {"entities": [[0, 14, "DISEASE"]]}], ["Most conventional treatments for osteoarthritis, such as non-steroidal anti-inflammatory drugs (NSAIDs) and simple analgesics, have side effects.", {"entities": [[33, 47, "DISEASE"]]}], ["PCSO-524\u2122, a non polar lipid extract from the New Zealand Green Lipped Mussel, is rich in omega-3 fatty acids and has been shown to reduce inflammation in both animal studies and patient trials.", {"entities": []}], ["This OA trial examined pain relief changes in relation to quality of life and safety of use for OA patients who took PCSO-524\u2122 compared with patients who took fish oil (containing an industry standard EPA-18% and DHA-12% blend).", {"entities": []}], ["PCSO-524\u2122 patients showed a statistically significant improvement compared with patients who took fish oil.", {"entities": []}], ["There was an 89% decrease in their pain symptoms and 91% reported an improved quality of life.", {"entities": []}], ["Patients treated with fish oil showed significantly less improvement and a greater level of physical discomfort during the study.", {"entities": []}], ["These results suggest that PCSO-524\u2122 might offer a potential alternative complementary therapy with no side effects for OA patients.", {"entities": []}], ["The need for new options for chronic lung diseases promotes the research on stem cells for lung repair.", {"entities": []}], ["Bone marrow-derived mesenchymal stem cells (MSCs) can modulate lung inflammation, but the data on cellular processes involved in early airway remodeling and the potential involvement of neuropeptides are scarce.", {"entities": []}], ["To elucidate the mechanisms by which local administration of MSCs interferes with pathophysiological features of airway hyperresponsiveness in an animal model.", {"entities": []}], ["GFP-tagged mouse MSCs were intratracheally delivered in the ovalbumin mouse model with subsequent functional tests, the analysis of cytokine levels, neuropeptide expression and histological evaluation of MSCs fate and airway pathology.", {"entities": []}], ["Additionally, MSCs were exposed to pro-inflammatory factors in vitro .", {"entities": []}], ["Functional improvement was observed after MSC administration.", {"entities": [[42, 45, "GENE"]]}], ["Although MSCs did not adopt lung cell phenotypes, cell therapy positively affected airway remodeling reducing the hyperplastic phase of the gain in bronchial smooth muscle mass, decreasing the proliferation of epithelium in which mucus metaplasia was also lowered.", {"entities": []}], ["Decrease of interleukin-4, interleukin-5, interleukin-13 and increase of interleukin-10 in bronchoalveolar lavage was also observed.", {"entities": []}], ["Exposed to pro-inflammatory cytokines, MSCs upregulated indoleamine 2,3-dioxygenase.", {"entities": []}], ["Moreover, asthma-related in vivo upregulation of pro-inflammatory neurokinin 1 and neurokinin 2 receptors was counteracted by MSCs that also determined a partial restoration of VIP, a neuropeptide with anti-inflammatory properties.", {"entities": [[10, 16, "DISEASE"], [177, 180, "GENE"]]}], ["Intratracheally administered MSCs positively modulate airway remodeling, reduce inflammation and improve function, demonstrating their ability to promote tissue homeostasis in the course of experimental allergic asthma.", {"entities": [[203, 218, "DISEASE"], [212, 218, "DISEASE"]]}], ["Because of a limited tissue retention, the functional impact of MSCs may be attributed to their immunomodulatory response combined with the interference of neuropeptide system activation and tissue remodeling.", {"entities": []}], ["Cigarette smoke is the leading risk factor for the development of chronic obstructive pulmonary disease (COPD) an inflammatory condition characterised by neutrophilic inflammation and release of proinflammatory mediators such as interleukin-8 (IL-8).", {"entities": [[66, 103, "DISEASE"]]}], ["Human airway smooth muscle cells (HASMC) are a source of proinflammatory cytokines and chemokines.", {"entities": []}], ["We investigated whether cigarette smoke could directly induce the release of chemokines from HASMC.", {"entities": []}], ["HASMC in primary culture were exposed to cigarette smoke extract (CSE) with or without TNF\u03b1.", {"entities": []}], ["Chemokines were measured by enzyme-linked immunosorbent assay (ELISA) and gene expression by real time polymerase chain reaction (PCR).", {"entities": []}], ["Data were analysed using one-way analysis of variance (ANOVA) followed by Bonferroni's t test CSE (5, 10 and 15%) induced IL-8 release and expression without effect on eotaxin or RANTES release.", {"entities": []}], ["At 20%, there was less IL-8 release.", {"entities": []}], ["TNF\u03b1 enhanced CSE-induced IL-8 release and expression.", {"entities": []}], ["However, CSE (5\u201330%) inhibited TNF\u03b1-induced eotaxin and RANTES production.", {"entities": []}], ["The effects of CSE on IL-8 release were inhibited by glutathione (GSH) and associated with the induction of the oxidant sensing protein, heme oxygenase-1.", {"entities": []}], ["Cigarette smoke may directly cause the release of IL-8 from HASMC, an effect enhanced by TNF-\u03b1 which is overexpressed in COPD.", {"entities": []}], ["Inhibition of eotaxin and RANTES by cigarette smoke is consistent with the predominant neutrophilic but not eosinophilic inflammation found in COPD.", {"entities": []}], ["Osteoporosis, which is now recognized as a major comorbidity of chronic obstructive pulmonary disease (COPD), must be diagnosed by appropriate methods.", {"entities": [[64, 101, "DISEASE"], [0, 12, "DISEASE"]]}], ["The aims of this study were to clarify the relationships between bone mineral density (BMD) and COPD-related clinical variables and to explore the association of BMD with the updated Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification in men.", {"entities": []}], ["We enrolled 50 Japanese men with clinically stable COPD who underwent dual-energy X-ray absorptiometry (DEXA), pulmonary function testing, and computerized tomography (CT) and who had completed a questionnaire (COPD assessment test [CAT]).", {"entities": []}], ["We determined the association between the T-score and other tested parameters and compared the BMD of patients in each GOLD category.", {"entities": []}], ["Twenty-three of the 50 patients (46.0%) were diagnosed with osteopenia, and 7 (14.0%) were diagnosed with osteoporosis.", {"entities": [[106, 118, "DISEASE"]]}], ["The BMD findings were significantly correlated with the CAT score, forced expiratory volume in 1 second percentage predicted (FEV 1 % predicted), low attenuation volume percentage (LAV%), and percentage of cross-sectional area of small pulmonary vessels (%CSA) on CT images.", {"entities": [[126, 129, "GENE"]]}], ["Notably, the median T-score of the GOLD category D participants was significantly lower than that of the participants in each of the other categories (A [-0.98], B [-1.06], C [-1.05], and D [-2.19], p<0.05).", {"entities": []}], ["Reduced BMD was associated with airflow limitation, extent of radiographic findings, and a poor quality of life (QOL) in patients with COPD.", {"entities": []}], ["The BMD of GOLD category D patients was the lowest of all of the patients evaluated, and category D patients may benefit from active intervention for osteoporosis.", {"entities": [[150, 162, "DISEASE"]]}], ["Thymic stromal lymphopoietin (TSLP) is a cytokine known to mature dendritics cells, lower pro-inflammatory IL-12 secretion, induce differentiation of anti-inflammatory FoxP3+ regulatory T cells (Treg).", {"entities": [[30, 34, "GENE"]]}], ["Moreover, Crohn\u2019s disease patients have shown a reduction of intestinal TSLP expression.", {"entities": [[72, 76, "GENE"]]}], ["To understand the role of TSLP in inflammation, we constructed Lactococcus lactis strain producing TSLP (LL-TSLP) and investigated the effect of its administration on dextran sulfate sodium (DSS)-induced colitis model in mice.", {"entities": [[26, 30, "GENE"], [99, 103, "GENE"], [108, 112, "GENE"], [26, 30, "GENE"], [99, 103, "GENE"], [108, 112, "GENE"]]}], ["LL-TSLP secrete an active molecule which lowers secretion of IL-12 by dendritic cells.", {"entities": []}], ["Treatment with LL-TSLP, increases the amount of TGF-\u03b2 secreted by T cells in Mesenteric Lymph Node in healthy mice.", {"entities": []}], ["In acute DSS-induced colitis, LL-TSLP delayed the Disease Activity Index and lowered histological score and colonic INF-\u03b3 production.", {"entities": []}], ["In a DSS-recovery model, LL-TSLP induced a better protective effect if the strain was administered at the beginning of the colitis.", {"entities": []}], ["At Day 4 of colitis we observed an induction of Treg by LL-TSLP.", {"entities": []}], ["TSLP showed an anti-inflammatory protective role in DSS-induced colitis.", {"entities": [[0, 4, "GENE"]]}], ["We have demonstrated that a short and early administration of LL-TSLP is more efficient than a long lasting treatment.", {"entities": []}], ["The use of oral food challenges (OFCs) in clinics is limited because they are complicated and associated with anaphylactic symptoms.", {"entities": []}], ["To increase their use, it is necessary to develop novel, effective, and safe methods.", {"entities": []}], ["However, the effectiveness of different OFCs has not been compared.", {"entities": []}], ["To investigate the effect of ingestion methods on wheat allergy symptoms and treatment during OFCs.", {"entities": []}], ["Without changing the total challenge dose, we changed the administration method from a 5-installment dose titration every 15 min (15-min interval method) to 3 installments every 30 min (30-min interval method).", {"entities": []}], ["We retrospectively reviewed and compared the results of 65 positive 15-min interval wheat challenge tests conducted between July 2005 and February 2008 and 87 positive 30-min interval tests conducted between March 2008 and December 2009.", {"entities": []}], ["A history of immediate symptoms was more common for the 30-min interval method; however, no difference between methods was observed in other background parameters.", {"entities": []}], ["Switching from the 15-min to the 30-min interval method did not increase symptoms or require treatment.", {"entities": []}], ["The rate of cardiovascular symptoms ( p = 0.032), and adrenaline use ( p = 0.017) was significantly lower with the 30-min interval method.", {"entities": []}], ["The results did not change after adjusting for the effects of immediate symptom history in multivariate analysis.", {"entities": []}], ["This study suggests that the 30-min interval method reduces the risk of adverse events, compared to the 15-min interval method.", {"entities": []}], ["The Enterovirus (EV) and Parechovirus genera of the picornavirus family include many important human pathogens, including poliovirus, rhinovirus, EV-A71, EV-D68, and human parechoviruses (HPeV).", {"entities": []}], ["They cause a wide variety of diseases, ranging from a simple common cold to life-threatening diseases such as encephalitis and myocarditis.", {"entities": [[127, 138, "DISEASE"], [61, 72, "DISEASE"], [110, 122, "DISEASE"]]}], ["At the moment, no antiviral therapy is available against these viruses and it is not feasible to develop vaccines against all EVs and HPeVs due to the great number of serotypes.", {"entities": []}], ["Therefore, a lot of effort is being invested in the development of antiviral drugs.", {"entities": []}], ["Both viral proteins and host proteins essential for virus replication can be used as targets for virus inhibitors.", {"entities": []}], ["As such, a good understanding of the complex process of virus replication is pivotal in the design of antiviral strategies goes hand in hand with a good understanding of the complex process of virus replication.", {"entities": []}], ["In this review, we will give an overview of the current state of knowledge of EV and HPeV replication and how this can be inhibited by small-molecule inhibitors.", {"entities": []}], ["Hypertension and hyperlipidemia are major cardiovascular disease risk factors.", {"entities": [[0, 12, "DISEASE"]]}], ["To modify them, patients often need to adopt healthier lifestyles and adhere to prescribed medications.", {"entities": []}], ["However, patients\u2019 adherence to recommended treatments has been suboptimal.", {"entities": []}], ["Reducing out-of-pocket costs (ROPC) to patients may improve medication adherence and consequently improve health outcomes.", {"entities": []}], ["This Community Guide systematic review examined the effectiveness of ROPC for medications prescribed for patients with hypertension and hyperlipidemia.", {"entities": [[119, 131, "DISEASE"]]}], ["We assessed effectiveness and economics of ROPC for medications to treat hypertension, hyperlipidemia, or both.", {"entities": [[73, 85, "DISEASE"]]}], ["Per Community Guide review methods, reviewers identified, evaluated, and summarized available evidence published from January 1980 through July 2015.", {"entities": []}], ["Eighteen studies were included in the analysis.", {"entities": []}], ["ROPC interventions resulted in increased medication adherence for patients taking blood pressure and cholesterol medications by a median of 3.0 percentage points; proportion achieving 80% adherence to medication increased by 5.1 percentage points.", {"entities": []}], ["Blood pressure and cholesterol outcomes also improved.", {"entities": []}], ["Nine studies were included in the economic review, with a median intervention cost of $172 per person per year and a median change in health care cost of \u2212$127 per person per year.", {"entities": []}], ["ROPC for medications to treat hypertension and hyperlipidemia is effective in increasing medication adherence, and, thus, improving blood pressure and cholesterol outcomes.", {"entities": [[30, 42, "DISEASE"]]}], ["Most ROPC interventions are implemented in combination with evidence-based health care interventions such as team-based care with medication counseling.", {"entities": []}], ["An overall conclusion about the economics of the intervention could not be reached with the small body of inconsistent cost-benefit evidence.", {"entities": []}], ["Living in communities with more vegetation during pregnancy has been associated with higher birth weights, but fewer studies have evaluated other birth outcomes, and only one has been conducted in the Eastern United States, in regions with a broad range, including high levels, of greenness.", {"entities": []}], ["We evaluated associations between prenatal residential greenness and birth outcomes (term birth weight, small for gestational age, preterm birth, and low 5 min Apgar score) across a range of community types using electronic health record data from 2006\u20132013 from the Geisinger Health System in Pennsylvania.", {"entities": []}], ["We assigned greenness based on mother\u2019s geocoded address using the normalized difference vegetation index from satellite imagery.", {"entities": []}], ["We used propensity scores to restrict the study population to comparable groups among those living in green vs. less-green areas.", {"entities": []}], ["Analyses were adjusted for demographic, clinical, and environmental covariates, and stratified by community type (city, borough, and township).", {"entities": []}], ["In cities, higher greenness (tertiles 2\u20133 vs. 1) was protective for both preterm (OR = 0.78, 95% CI: 0.61\u20130.99) and small for gestational age birth (OR = 0.73, 95% CI: 0.58\u20130.97), but not birth weight or Apgar score.", {"entities": []}], ["We did not observe associations between greenness and birth outcomes in adjusted models in boroughs or townships.", {"entities": []}], ["These results add to the evidence that greener cities might be healthier cities.", {"entities": []}], ["The Rpd3-like members of the class I lysine deacetylase family are important regulators of chromatin structure and gene expression and have pivotal functions in the control of proliferation, differentiation and development.", {"entities": []}], ["The highly related class I deacetylases HDAC1 and HDAC2 have partially overlapping but also isoform-specific roles in diverse biological processes, whereas HDAC3 and HDAC8 have unique functions.", {"entities": [[40, 45, "GENE"], [50, 55, "GENE"], [156, 161, "GENE"], [166, 171, "GENE"]]}], ["This review describes the role of class I KDACs in the regulation of transcription as well as their non-transcriptional functions, in particular their contributions to splicing, mitosis/meiosis, replication and DNA repair.", {"entities": []}], ["During the past years, a number of mouse loss-of-function studies provided new insights into the individual roles of class I deacetylases in cell cycle control, differentiation and tumorigenesis.", {"entities": []}], ["Simultaneous ablation of HDAC1 and HDAC2 or single deletion of Hdac3 severely impairs cell cycle progression in all proliferating cell types indicating that these class I deacetylases are promising targets for small molecule inhibitors as anti-tumor drugs.", {"entities": [[25, 30, "GENE"], [35, 40, "GENE"], [63, 68, "GENE"]]}], ["During treatment of patients with Chronic Diseases (CD) the therapist-patient interaction is often intense, and the strategies used during treatment require physiotherapists to assume a coaching role.", {"entities": []}], ["Uncovering therapist factors that explain inter-therapist variation might provide tools to improve treatment outcome and to train future therapists.", {"entities": []}], ["The purpose of this study was to explore the so-called \u2018therapist-effect\u2019, by looking at the influence of intrinsic therapist factors, specifically personality traits, on treatment outcome in patients with CD.", {"entities": []}], ["A cohort study was performed using data from the NIVEL Primary Care Database (NPCD) in 2011\u20132012 and an additional questionnaire.", {"entities": []}], ["Patients with CD ( n \u2009=\u2009393) treated by Dutch physiotherapists working in outpatient practices ( n \u2009=\u200939) were included.", {"entities": []}], ["Patient and treatment outcome variables were extracted from NPCD.", {"entities": []}], ["The course of complaint was measured using the Numeric Rating Scale.", {"entities": []}], ["Therapist variables were measured using a questionnaire consisting of demographics and the Big Five traits: Extraversion, Neuroticism, Agreeableness, Conscientiousness and Openness to experiences.", {"entities": []}], ["Data were analysed using multilevel linear regression.", {"entities": []}], ["Only Neuroticism was found to be significant (Neuroticism F\u2009=\u20090.71, P \u2009=\u20090.01; therapist gender F\u2009=\u20090.72, P \u2009=\u20090.03; life events F\u2009=\u2009\u22120.54, P \u2009=\u20090.09; patient gender F\u2009=\u2009\u22120.43, P \u2009=\u20090.10; patient age F\u2009=\u20090.01, P \u2009=\u20090.27).", {"entities": []}], ["Subgroup analyses of 180 patients with Osteoarthritis and 30 therapists showed similar results.", {"entities": []}], ["There are indications that patients with CD who are treated by therapists who tend to be calmer, more relaxed, secure and resilient have a greater reduction in severity of complaints compared to patients treated by therapists who show less of these traits.", {"entities": []}], ["Being a male therapist and having experienced life events influence outcome positively.", {"entities": []}], ["However, more extensive research is needed to validate the current findings.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is a progressive condition characterized by airflow limitation associated with an abnormal inflammatory response of the lungs to noxious particles and gases, caused primarily by cigarette smoking.", {"entities": []}], ["Increased oxidative burden plays an important role in the pathogenesis of COPD.", {"entities": []}], ["There is a delicate balance between the toxicity of oxidants and the protective function of the intracellular and extracellular antioxidant defense systems, which is critically important for the maintenance of normal pulmonary functions.", {"entities": []}], ["Several biomarkers of oxidative stress are available and have been evaluated in COPD.", {"entities": []}], ["In this review, we summarize the main literature findings about circulating oxidative stress biomarkers, grouped according to their method of detection, measured in COPD subjects.", {"entities": []}], ["U1-snRNA is an integral part of the U1 ribonucleoprotein pivotal for pre-mRNA splicing.", {"entities": []}], ["Toll-like receptor (TLR) signaling has recently been associated with immunoregulatory capacities of U1-snRNA.", {"entities": []}], ["Using lung A549 epithelial/carcinoma cells, we report for the first time on interferon regulatory factor (IRF)-3 activation initiated by endosomally delivered U1-snRNA.", {"entities": [[27, 36, "DISEASE"]]}], ["This was associated with expression of the IRF3-inducible genes interferon-\u03b2 (IFN-\u03b2), CXCL10/IP-10 and indoleamine 2,3-dioxygenase.", {"entities": []}], ["Mutational analysis of the U1-snRNA-activated IFN-\u03b2 promoter confirmed the crucial role of the PRDIII element, previously proven pivotal for promoter activation by IRF3.", {"entities": [[164, 168, "GENE"]]}], ["Notably, expression of these parameters was suppressed by bafilomycin A 1 , an inhibitor of endosomal acidification, implicating endosomal TLR activation.", {"entities": []}], ["Since resiquimod, an agonist of TLR7/8, failed to stimulate A549 cells, data suggest TLR3 to be of prime relevance for cellular activation.", {"entities": [[85, 89, "GENE"]]}], ["To assess the overall regulatory potential of U1-snRNA-activated epithelial cells on cytokine production, co-cultivation with peripheral blood mononuclear cells (PBMC) was performed.", {"entities": []}], ["Interestingly, A549 cells activated by U1-snRNA reinforced phytohemagglutinin-induced interleukin-10 release by PBMC but suppressed that of tumor necrosis factor-\u03b1, indicating an anti-inflammatory potential of U1-snRNA.", {"entities": []}], ["Since U1-snRNA is enriched in apoptotic bodies and epithelial cells are capable of performing efferocytosis, the present data in particular connect to immunobiological aspects of apoptosis at host/environment interfaces.", {"entities": []}], ["The main goals of prophylactic treatment for migraine are to decrease headache attack frequency, length and intensity, to improve the efficacy of symptomatic drugs, to reduce their need, and to prevent pain chronicization.", {"entities": [[45, 53, "DISEASE"]]}], ["Therefore, the choice of a prophylactic drug and the modality of treatment is not easy and often not adequately supported by literature data nor by current national and international guidelines.", {"entities": []}], ["Moreover, the response of the migraine patient to treatment is often unforeseeable.", {"entities": [[30, 38, "DISEASE"]]}], ["The aim of this short review is to provide some practical suggestions to the physician regarding how to decide when to begin a migraine prophylactic treatment and how to apply the specific guidelines of the Italian Society for the Study of Headache.", {"entities": [[127, 135, "DISEASE"]]}], ["Low levels of 25-OH vitamin D are associated with respiratory tract infection (RTI).", {"entities": []}], ["However, results from randomized controlled trials are inconclusive.", {"entities": []}], ["Therefore, we performed a systematic review and meta-analysis to assess the preventive effect of vitamin D supplementation on RTI.", {"entities": []}], ["Randomized, controlled trials of vitamin D for prevention of RTI were used for the analysis.", {"entities": []}], ["The risks of within-trial and publication bias were assessed.", {"entities": []}], ["Odds ratios of RTI were pooled using a random-effects model.", {"entities": []}], ["Heterogeneity was assessed using Cochran's Q and I Of 1137 citations retrieved, 11 placebo-controlled studies of 5660 patients were included in the meta-analysis.", {"entities": []}], ["Overall, vitamin D showed a protective effect against RTI (OR, 0.64; 95% CI, 0.49 to 0.84).", {"entities": []}], ["There was significant heterogeneity among studies (Cohran's Q p<0.0001, I Results indicate that vitamin D has a protective effect against RTI, and dosing once-daily seems most effective.", {"entities": []}], ["Due to heterogeneity of included studies and possible publication bias in the field, these results should be interpreted with caution.", {"entities": []}], ["Hospitalizations for persons with chronic obstructive pulmonary disease (COPD) result in significant health care resource use and excess expenditures.", {"entities": [[34, 71, "DISEASE"]]}], ["Despite well-documented sociodemographic disparities in COPD outcomes, no study has characterized geographic variations in COPD hospitalization across the US.", {"entities": []}], ["Almost 3.8 million COPD hospitalization records were extracted from Medicare claims for 1995\u20132006, and the total population of eligible Medicare beneficiaries was extracted from the Medicare enrollment records to calculate COPD hospitalization rates by Health Service Area (HSA), (n = 949).", {"entities": []}], ["Spatial cluster analysis and Bayesian hierarchical spatial modeling were used to characterize the geography of COPD hospitalizations.", {"entities": []}], ["The overall COPD hospitalization rate was 11.30 per 1,000 beneficiaries for the aggregated period 1995\u20132006.", {"entities": []}], ["HSA-level COPD hospitalization rates had a median of 11.7 and a range of 3.0 (Cache, UT) to 76.3 (Pike, KY).", {"entities": [[104, 106, "GENE"]]}], ["Excessive hospitalization risk was concentrated in Appalachia, the southern Great Lakes, the Mississippi Delta, the Deep South, and west Texas.", {"entities": []}], ["In the Bayesian spatial mixture model, 73% of variability of COPD hospitalization relative risk was attributed to unidentified regional social and physical environments shared by HSAs rather than to unique local HSA factors (27%).", {"entities": []}], ["We discovered distinct geographic patterns in COPD hospitalization rates and risks attributed to both regionally-shared environmental risk factors and HSA-unique environmental contexts.", {"entities": []}], ["The correlates of these geographic patterns remain to be determined.", {"entities": []}], ["Geographic comparisons of COPD hospitalization risk provide insights for better public health practice, policies, and programs for COPD prevention.", {"entities": []}], ["The latest scientific reports raise concerns about the rapidly increasing burden of chronic diseases in the state of Qatar.", {"entities": []}], ["Pregnant Qatari women often confront complications during pregnancy including gestational diabetes, hypertension, abortion and stillbirth.", {"entities": [[100, 112, "DISEASE"], [78, 98, "DISEASE"]]}], ["The investigation of early life environmental, genetic, nutritional and social factors that may affect lifelong health is of great importance.", {"entities": []}], ["Birth cohort studies offer a great opportunity to address early life hazards and their possible long lasting effects on health.", {"entities": []}], ["The Qatari Birth Cohort study is the first mother-child cohort study in the Middle East Area that aims to assess the synergetic role of environmental exposure and genetic factors in the development of chronic disease and monitor woman and child health and/or obstetric characteristics with high prevalence.", {"entities": []}], ["The present manuscript describes the recruitment phase of the study (duration: 2\u00a0years; expected number: 3000 families), where the pregnant Qatari women and their husbands are being contacted before the 15th week of gestation at the Primary Health Care Centers.", {"entities": []}], ["The consented participants are interviewed to obtain information on several factors (sociodemographic characteristics, dietary habits, occupational/environmental exposure) and maternal characteristics are assessed based on anthropometric measurements, spirometry, and blood pressure.", {"entities": []}], ["Pregnant women are invited to provide biological samples (blood and urine) in each trimester of their pregnancy, as well as cord blood at delivery.", {"entities": []}], ["Fathers are also asked to provide biological samples.", {"entities": []}], ["The present study provides invaluable insights into a wide range of early life factors affecting human health.", {"entities": []}], ["With a geographical focus on the Middle East, it will be a resource for information to the wider scientific community and will allow the formulation of effective policies with a primary focus on public health interventions for maternal and child health.", {"entities": []}], ["This work reports the recent results achieved at the SENSOR Lab, Brescia (Italy) to address the selectivity of metal oxide based gas sensors.", {"entities": []}], ["In particular, two main strategies are being developed for this purpose: (i) investigating different sensing mechanisms featuring different response spectra that may be potentially integrated in a single device; (ii) exploiting the electronic nose (EN) approach.", {"entities": []}], ["The former has been addressed only recently and activities are mainly focused on determining the most suitable configuration and measurements to exploit the novel mechanism.", {"entities": []}], ["Devices suitable to exploit optical (photoluminescence), magnetic (magneto-optical Kerr effect) and surface ionization in addition to the traditional chemiresistor device are here discussed together with the sensing performance measured so far.", {"entities": []}], ["The electronic nose is a much more consolidated technology, and results are shown concerning its suitability to respond to industrial and societal needs in the fields of food quality control and detection of microbial activity in human sweat.", {"entities": []}], ["Studies into the regulation of interleukin-10 (IL-10), have focused only on the molecular or single-cell level.", {"entities": []}], ["The cues that induce IL-10 in the context of cell-to-cell communication are scarce.", {"entities": []}], ["To fill this gap, this study elucidates the cell-to-cell interaction dependent regulation of IL-10.", {"entities": []}], ["The simultaneous activation of CD4 These findings are of prominence as CD3/CD28/CpG treatment can induce the anti-inflammatory cytokines IL-10 and IL-30, and the activation or inhibition of the CD40/CD154 acts as molecular rheostat of the expression of IL-10 or IL-30.", {"entities": [[31, 34, "GENE"]]}], ["More importantly, this not only serves as an example of IL-10 regulation at the cellular via coordination of two signals from two cell types, but these findings also lay the molecular and cellular groundwork for future studies to investigate how to manipulate IL-10 or IL-30 production during inflammation, cancer, or autoimmune diseases.", {"entities": [[307, 313, "DISEASE"]]}], ["Immunoglobulin G4-related disease (IgG4-RD) is a newly recognized fibro-inflammatory condition.", {"entities": []}], ["Forty-two cases with immunoglobulin G4-related sialadenitis (IgG4-RS) confirmed by histopathological and immunohistochemical assessment were studied to clarify the clinicopathologic characteristics of the salivary glands involved in IgG4-RS, especially the relationship between the histopathologic features and function of salivary glands or serum levels of IgG4.", {"entities": [[47, 59, "DISEASE"]]}], ["Clinical, serologic, imaging and histopathological data of these cases were analyzed.", {"entities": []}], ["CT volumes of submandibular, parotid, and lacrimal glands were calculated.", {"entities": []}], ["The saliva flow rate was measured.", {"entities": []}], ["Scintigraphy with 99mTc-pertechnetate was undertaken in 31 cases, and the concentration index (CI) and secretion index (SI) was calculated.", {"entities": []}], ["Relationships between fibrosis severity and salivary gland function or serum IgG4 levels were analyzed.", {"entities": []}], ["The first symptom was swelling of bilateral submandibular or lacrimal glands.", {"entities": []}], ["Physical examination showed multiple bilateral major salivary glands (including sublingual and accessory parotid glands) and lacrimal glands were enlarged in IgG4 RS.", {"entities": []}], ["Multiple enlarged cervical lymph nodes were noted in 30 patients.", {"entities": []}], ["Saliva flow at rest was lower than normal in 34 cases; stimulated saliva flow was lower than normal in 15 cases.", {"entities": []}], ["Secretory function was reduced more severely in the submandibular glands than in the parotid glands.", {"entities": []}], ["Serum levels of IgG4 were elevated in 95.2% of cases and 78.6% patients had increased IgE levels.", {"entities": []}], ["Serum IgG4 level was higher and saliva secretion lower as glandular fibrosis increased.", {"entities": []}], ["Prominent changes in the morphology, histology, immunohistochemistry and secretion of the major salivary glands of IgG4-RS patients were accompanied by involvement of the lacrimal glands and cervical lymph nodes.", {"entities": []}], ["Elevated IgE, allergic history, eosinophil infiltration suggest allergic reactions as a potential pathogenesis of IgG4-RS.", {"entities": []}], ["Severity of glandular fibrosis correlated with salivary function and serum levels of IgG4.", {"entities": []}], ["Stroke has a major impact on survivors.", {"entities": []}], ["Our study was designed to describe the mental status and health-related quality of life (HRQoL) in long-term survivors of TIA or minor ischaemic stroke (MIS) and evaluate associations of mental and physical factors with HR-QoL.", {"entities": []}], ["A random sample of the 10-year survivors of the Dutch TIA Trial (DTT) and the dutch participants of the European Atrial Fibrillation Trial (EAFT) were interviewed by postal questionnaire (n = 468) and at home (n = 198).", {"entities": []}], ["Demographic data, mental health status (depression (CES-D), cognition (CAMCOG)), and health perception (SF-36 and Euroqol) were measured.", {"entities": []}], ["198 long-term survivors were included; mean age was 72.5 (SD 8.7 years), 22% was depressed (CES-D \u2265 16) and 15% had cognitive dysfunction (CAMCOG < 80).", {"entities": []}], ["The overall HR-QoL did not differ much from the norm population.", {"entities": []}], ["Physical disability, occurrence of a major stroke and comorbidity of locomotion or the heart were independently associated with a low health perception.", {"entities": []}], ["Despite varying amounts of disability, the majority of long-term survivors of a TIA or MIS rated their quality of life as rather good.", {"entities": []}], ["Physical factors, rather than mental status were independently related to a decrease in perceived health.", {"entities": []}], ["Aspirin-intolerant asthma (AIA) is a rare condition that is characterized by the development of bronchoconstriction in asthmatic patients after ingestion of non-steroidal anti-inflammatory drugs including aspirin.", {"entities": [[19, 25, "DISEASE"]]}], ["However, the underlying mechanisms of AIA occurrence are still not fully understood.", {"entities": []}], ["To identify the genetic variations associated with aspirin intolerance in asthmatics, the first stage of genome-wide association study with 109,365 single nucleotide polymorphisms (SNPs) was undertaken in a Korean AIA (n\u200a=\u200a80) cohort and aspirin-tolerant asthma (ATA, n\u200a=\u200a100) subjects as controls.", {"entities": [[255, 261, "DISEASE"]]}], ["For the second stage of follow-up study, 150 common SNPs from 11 candidate genes were genotyped in 163 AIA patients including intermediate AIA (AIA-I) subjects and 429 ATA controls.", {"entities": []}], ["Among 11 candidate genes, multivariate logistic analyses showed that SNPs of CEP68 gene showed the most significant association with aspirin intolerance ( P values of co-dominant for CEP68 , 6.0\u00d710 CEP68 gene showed linkage disequilibrium (LD), and the haplotype of CEP68_ht4 (T-G-A-A-A-C-G) showed a highly significant association with aspirin intolerance (OR \u200a=\u200a2.63; 95% CI \u200a=\u200a1.64\u20134.21; P \u200a=\u200a6.0\u00d710 CEP68 rs7572857G>A variant that replaces glycine with serine showed a higher decline of forced expiratory volume in 1s (FEV 1 ) by aspirin provocation than other variants ( P \u200a=\u200a3.0\u00d710 CEP68 could be a susceptible gene for aspirin intolerance in asthmatics, suggesting that the nonsynonymous Gly74Ser could affect the polarity of the protein structure.", {"entities": [[77, 82, "GENE"], [183, 188, "GENE"], [198, 203, "GENE"], [403, 408, "GENE"], [588, 593, "GENE"], [77, 82, "GENE"], [183, 188, "GENE"], [198, 203, "GENE"], [403, 408, "GENE"], [588, 593, "GENE"], [77, 82, "GENE"], [183, 188, "GENE"], [198, 203, "GENE"], [403, 408, "GENE"], [588, 593, "GENE"], [77, 82, "GENE"], [183, 188, "GENE"], [198, 203, "GENE"], [403, 408, "GENE"], [588, 593, "GENE"], [523, 526, "GENE"], [77, 82, "GENE"], [183, 188, "GENE"], [198, 203, "GENE"], [403, 408, "GENE"], [588, 593, "GENE"]]}], ["The Appraisal of Guidelines for Research & Evaluation (AGREE) II instrument is the most commonly used guideline appraisal tool.", {"entities": []}], ["It includes 23 appraisal criteria (items) organized within 6 domains and 2 overall assessments (1. overall guideline quality; 2. recommendation for use).", {"entities": []}], ["The aim of this systematic review was twofold.", {"entities": []}], ["Firstly, to investigate how often AGREE II users conduct the 2 overall assessments.", {"entities": []}], ["Secondly, to investigate the influence of the 6 domain scores on each of the 2 overall assessments.", {"entities": []}], ["A systematic bibliographic search was conducted for publications reporting guideline appraisals with AGREE II.", {"entities": []}], ["The impact of the 6 domain scores on the overall assessment of guideline quality was examined using a multiple linear regression model.", {"entities": []}], ["Their impact on the recommendation for use (possible answers: \u201cyes\u201d, \u201cyes, with modifications\u201d, \u201cno\u201d) was examined using a multinomial regression model.", {"entities": []}], ["118 relevant publications including 1453 guidelines were identified.", {"entities": []}], ["77.1% of the publications reported results for at least one overall assessment, but only 32.2% reported results for both overall assessments.", {"entities": []}], ["The results of the regression analyses showed a statistically significant influence of all domains on overall guideline quality, with Domain 3 (rigour of development) having the strongest influence.", {"entities": []}], ["For the recommendation for use, the results showed a significant influence of Domains 3 to 5 (\u201cyes\u201d vs. \u201cno\u201d) and Domains 3 and 5 (\u201cyes, with modifications\u201d vs. \u201cno\u201d).", {"entities": []}], ["The 2 overall assessments of AGREE II are underreported by guideline assessors.", {"entities": []}], ["Domains 3 and 5 have the strongest influence on the results of the 2 overall assessments, while the other domains have a varying influence.", {"entities": []}], ["Within a normative approach, our findings could be used as guidance for weighting individual domains in AGREE II to make the overall assessments more objective.", {"entities": []}], ["Alternatively, a stronger content analysis of the individual domains could clarify their importance in terms of guideline quality.", {"entities": []}], ["Moreover, AGREE II should require users to transparently present how they conducted the assessments.", {"entities": []}], ["Interleukin 17A (IL-17), a mediator implicated in chronic and severe inflammatory diseases, enhances the production of pro-inflammatory mediators by attenuating decay of the encoding mRNAs.", {"entities": []}], ["The decay of many of these mRNAs depends on proteins (AUBps) that target AU-rich elements in the 3\u2032-untranslated region of mRNAs and facilitate either mRNA decay or stabilization.", {"entities": []}], ["Here we show that AUBps and the target mRNA assemble in a novel ribonucleoprotein complex in the presence of microRNA16 (miR16), which leads to the degradation of the target mRNA.", {"entities": []}], ["Notably, IL-17 attenuates miR16 expression and promotes the binding of stabilizing AUBps over that of destabilizing AUBps, reducing mRNA decay.", {"entities": []}], ["These findings indicate that miR16 independently of a seed sequence, directs the competition between degrading and stabilizing AUBps for target mRNAs.", {"entities": []}], ["Since AUBps affect expression of about 8% of the human transcriptome and miR16 is ubiquitously expressed, IL-17 may in addition to inflammation affect many other cellular processes.", {"entities": []}], ["Inflammation is driven by inflammatory mediators.", {"entities": []}], ["Interleukin 17A (IL-17) is implicated in chronic and severe inflammation and exaggerates production of inflammatory mediators.", {"entities": []}], ["This is due, at least in part, to the IL-17-attenuated degradation of mRNAs encoding these inflammatory mediators, but the underlying mechanism has remained elusive.", {"entities": []}], ["Most of these mRNAs contain AU-rich elements in their 3\u2032-untranslated region and are targeted by AU-binding proteins (AUBps) that promote either mRNA degradation or stabilization.", {"entities": []}], ["Here we show that IL-17 directs the AU-mediated mRNA degradation (AMD pathway) by modulating the interaction of degrading and stabilizing AUBps via microRNA16 (miR16).", {"entities": []}], ["Whereas microRNAs target mRNAs to the RISC pathway for degradation by binding to a seed sequence, miR16 drives degradation by the AMD pathway without an apparent seed sequence.", {"entities": []}], ["Transcriptome analyses have revealed that the expression of 8% of all eukaryotic transcripts is dependent on the AMD pathway.", {"entities": []}], ["Therefore, the impact of IL-17 on inflammatory diseases may extend beyond the production of inflammatory mediators to processes like tissue repair, cell cycle, etc.", {"entities": []}], ["In addition, targeting AUBp and/or miR16 may provide a novel therapeutic option to combat the IL-17 axis of inflammation.", {"entities": []}], ["To determine the underdiagnosis rate in new COPD cases at the end of a nine-year follow-up period-in the study designated \" Projeto Latino-Americano de Investiga\u00e7\u00e3o em Obstru\u00e7\u00e3o Pulmonar \" (PLATINO, Latin-American Pulmonary Obstruction Investigation Project)-and compare that with the underdiagnosis rate during the initial phase of the study, as well as to identify the clinical features exhibited by the subjects who were not diagnosed until the end of the follow-up phase.", {"entities": []}], ["The study population comprised the 1,000 residents of the city of S\u00e3o Paulo, Brazil, who took part in the PLATINO study.", {"entities": []}], ["Of those, 613 participated in the follow-up phase, during which the subjects were assessed with the same instruments and equipment employed in the initial phase of the study.", {"entities": []}], ["We used the chi-square test or the independent sample t-test to analyze the underdiagnosis rate and to identify the characteristics of the subjects who were not diagnosed until the end of the follow-up phase.", {"entities": []}], ["The underdiagnosis rate for new COPD cases at the end of the nine-year follow-up period was 70.0%.", {"entities": []}], ["The underdiagnosis rate during the follow-up phase was 17.5% lower than that reported for the initial phase of the study.", {"entities": []}], ["The subjects who were not diagnosed until the end of the follow-up phase presented with fewer respiratory symptoms, better pulmonary function, and less severe disease than did those previously diagnosed with COPD.", {"entities": []}], ["The underdiagnosis rate for new COPD cases was lower in the follow-up phase of the study than in the initial phase.", {"entities": []}], ["The subjects who were not diagnosed until the end of the follow-up phase of the PLATINO study presented with the same clinical profile as did those who were not diagnosed in the initial phase.", {"entities": []}], ["These findings underscore the need for spirometry in order to confirm the diagnosis of COPD and provide early intervention.", {"entities": []}], ["Determinar a taxa de subdiagn\u00f3stico em novos casos de DPOC em uma amostra de pacientes ap\u00f3s nove anos de seguimento do estudo \"Projeto Latino-Americano de Investiga\u00e7\u00e3o em Obstru\u00e7\u00e3o Pulmonar\" (PLATINO) e compar\u00e1-la \u00e0 taxa de subdiagn\u00f3stico obtida na fase inicial do estudo, assim como identificar as caracter\u00edsticas cl\u00ednicas dos indiv\u00edduos subdiagnosticados na fase de seguimento.", {"entities": []}], ["A popula\u00e7\u00e3o desse estudo foi composta por 1.000 residentes na cidade de S\u00e3o Paulo que fizeram parte do estudo PLATINO.", {"entities": [[38, 41, "GENE"]]}], ["Desses, 613 indiv\u00edduos participaram da fase de seguimento.", {"entities": []}], ["Os indiv\u00edduos foram avaliados utilizando-se os mesmos instrumentos e equipamentos na fase inicial do estudo.", {"entities": []}], ["O teste do qui-quadrado ou o teste t para amostras independentes foi utilizado para analisar a taxa de subdiagn\u00f3stico e identificar as caracter\u00edsticas dos indiv\u00edduos subdiagnosticados durante a fase de seguimento.", {"entities": []}], ["A taxa de subdiagn\u00f3stico para novos casos da DPOC ap\u00f3s nove anos de acompanhamento foi de 70,0%.", {"entities": []}], ["A taxa de subdiagn\u00f3stico na fase de seguimento foi 17,5% menor que a da fase inicial do estudo.", {"entities": []}], ["Os indiv\u00edduos subdiagnosticados na fase de seguimento apresentavam poucos sintomas respirat\u00f3rios, fun\u00e7\u00e3o pulmonar mais preservada e menor gravidade da doen\u00e7a do que aqueles previamente diagnosticados com DPOC.", {"entities": []}], ["A taxa de subdiagn\u00f3stico na fase de seguimento foi menor que a da fase inicial do estudo.", {"entities": []}], ["Os indiv\u00edduos subdiagnosticados na fase de seguimento do estudo PLATINO apresentavam o mesmo perfil cl\u00ednico daqueles subdiagnosticados na fase inicial.", {"entities": []}], ["Esses achados refor\u00e7am a necessidade da utiliza\u00e7\u00e3o da espirometria para o diagn\u00f3stico de DPOC e possibilitar a interven\u00e7\u00e3o precoce.", {"entities": []}], ["Diabetes is strongly associated with systemic inflammation and oxidative stress, but its effect on pulmonary vascular disease and lung function has often been disregarded.", {"entities": [[109, 125, "DISEASE"]]}], ["Several studies identified restrictive lung disease and fibrotic changes in diabetic patients and in animal models of diabetes.", {"entities": [[39, 51, "DISEASE"]]}], ["While microvascular dysfunction is a well-known complication of diabetes, the mechanisms leading to diabetes-induced lung injury have largely been disregarded.", {"entities": []}], ["We described the potential involvement of diabetes-induced platelet-endothelial interactions in perpetuating vascular inflammation and oxidative injury leading to fibrotic changes in the lung.", {"entities": []}], ["Changes in nitric oxide synthase (NOS) activation and decreased NO bioavailability in the diabetic lung increase platelet activation and vascular injury and may account for platelet hyperreactivity reported in diabetic patients.", {"entities": []}], ["Additionally, the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway has been reported to mediate pancreatic islet damage, and is implicated in the onset of diabetes, inflammation and vascular injury.", {"entities": []}], ["Many growth factors and diabetes-induced agonists act via the JAK/STAT pathway.", {"entities": []}], ["Other studies reported the contribution of the JAK/STAT pathway to the regulation of the pulmonary fibrotic process but the role of this pathway in the development of diabetic lung fibrosis has not been considered.", {"entities": []}], ["These observations may open new therapeutic perspectives for modulating multiple pathways to mitigate diabetes onset or its pulmonary consequences.", {"entities": []}], ["Human metapneumovirus (HMPV) is one of the most important respiratory viral pathogens affecting infants and children worldwide.", {"entities": []}], ["Our study describes the epidemiological and clinical characteristics of HMPV present in patients hospitalised with acute respiratory illness (ARI) in Guangzhou, Southern China.", {"entities": []}], ["A cross-sectional study.", {"entities": []}], ["Two tertiary hospitals in Guangzhou.", {"entities": []}], ["Throat swabs were collected over a 3-year period from 5133 paediatric patients (\u226414 years) hospitalised with ARI.", {"entities": []}], ["Patients who are HMPV positive with clinical presentations (101/103) were recorded for further analysis.", {"entities": []}], ["Of the 5133 patients included in the study, 103 (2.0%) were positive for HMPV.", {"entities": []}], ["HMPV was more prevalent in children \u22645 years (2.2%, 98/4399) compared with older children (>5\u201314 years) (0.7%, 5/734) (P = 0.004).", {"entities": []}], ["Two seasonal HMPV peaks were observed each year and mainly occurred in spring and early summer.", {"entities": []}], ["Overall, 18.4% (19/103) of patients who are HMPV positive were codetected with other pathogens, most frequently respiratory syncytial virus (36.8%, 7/19).", {"entities": []}], ["Patients who are HMPV positive presented with a wide spectrum of clinical features, including cough (100.0%, 101/101), abnormal pulmonary breath sound (91.1%, 92/101), fever (88.1%, 89/101), expectoration (77.2%, 78/101), coryza (50.5%, 51/101) and wheezing (46.5%, 47/101).", {"entities": []}], ["The main diagnosis of patients who are HMPV positive was bronchopneumonia (66.7%, 56/84).", {"entities": [[57, 73, "DISEASE"]]}], ["Fever (\u226538\u02daC) (91.6%, 76/83) was detected more often in patients with only HMPV detected than in patients with HMPV plus other pathogen(s) detected (72.2%, 13/18) (P=0.037), whereas diarrhoea was more common in patients with HMPV plus other pathogen(s) detected (22.2%, 4/18), compared with patients with HMPV only (3.6%, 3/83) (P=0.018).", {"entities": []}], ["HMPV is an important respiratory pathogen in children with ARI in Guangzhou, particularly in children \u22645 years old.", {"entities": []}], ["HMPV has a seasonal variation.", {"entities": []}], ["Bronchopneumonia is a major diagnosis in patients who are HMPV positive.", {"entities": [[0, 16, "DISEASE"]]}], ["Insampaedok-san (ren-shen-bai-du-san in Chinese) is a traditional herbal formula widely used for the treatment of respiratory diseases in Korea and China.", {"entities": []}], ["In this study, we investigated the acute oral toxicity of an Insampaedok-san water extract (ISSE) in rats and the antiasthmatic effects of ISSE and its mechanism in a model of asthma induced by ovalbumin (OVA) in mice.", {"entities": [[176, 182, "DISEASE"]]}], ["In a safety study, ISSE was administrated orally to rats of both sexes at single doses of 0 and 5000\u00a0mg/kg.", {"entities": []}], ["We observed body weight changes, mortality, clinical signs, and gross pathological findings.", {"entities": []}], ["In vitro antioxidant activity of ISSE was measured using 2,2-diphenyl-2-picrylhydrazyl and 2,2-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid radical scavenging methods.", {"entities": []}], ["A model of asthma was established in mice by sensitization and challenge with OVA.", {"entities": [[11, 17, "DISEASE"]]}], ["We assessed the levels of type 2\u00a0T-helper cytokines, chemokines, and immunoglobulin levels, using enzyme-linked immunosorbent assays, and superoxide dismutase (SOD) activity using a kit.", {"entities": []}], ["No adverse effects were observed in the acute ISSE toxicity study.", {"entities": []}], ["ISSE showed potent free radical scavenging activity and inhibited the recruitment of inflammatory cells into the lung and mucus hypersecretion in OVA-challenged mice.", {"entities": []}], ["ISSE significantly decreased levels of interleukin (IL)-4, IL-5, eotaxin, and OVA-specific immunoglobulin (Ig)E, and increased SOD activity.", {"entities": []}], ["These results indicate that ISSE is safe for human consumption and its antiasthmatic effect is associated with the ability of ISSE to attenuate inflammation and oxidative stress.", {"entities": []}], ["In a world where resources are scarce and urban areas consume the vast majority of these resources, it is vital to make cities greener and more sustainable.", {"entities": []}], ["Advanced systems to improve and automate processes within a city will play a leading role in smart cities.", {"entities": []}], ["From smart design of buildings, which capture rain water for later use, to intelligent control systems, which can monitor infrastructures autonomously, the possible improvements enabled by sensing technologies are immense.", {"entities": []}], ["Ubiquitous sensing poses numerous challenges, which are of a technological or social nature.", {"entities": []}], ["This paper presents an overview of the state of the art with regards to sensing in smart cities.", {"entities": []}], ["Topics include sensing applications in smart cities, sensing platforms and technical challenges associated with these technologies.", {"entities": []}], ["In an effort to provide a holistic view of how sensing technologies play a role in smart cities, a range of applications and technical challenges associated with these applications are discussed.", {"entities": []}], ["As some of these applications and technologies belong to different disciplines, the material presented in this paper attempts to bridge these to provide a broad overview, which can be of help to researchers and developers in understanding how advanced sensing can play a role in smart cities.", {"entities": []}], ["Epidemiologic studies demonstrate that infection, specifically pneumonia, contributes substantially to the increased morbidity and mortality among elderly individuals following exposure to ambient particulate matter (PM).", {"entities": [[63, 72, "DISEASE"]]}], ["This laboratory has previously demonstrated that a single inhalation exposure of Streptococcus pneumoniae-infected rats to concentrated ambient PM(2.5) (particulate matter with aerodynamic diameter < or =2.5 microm) from New York City (NYC) air exacerbates the infection process and alters pulmonary and systemic immunity.", {"entities": []}], ["Although these results provide some basis for explaining the epidemiologic findings, the identity of specific PM constituents that might have been responsible for the worsening pneumonia in exposed hosts remains unclear.", {"entities": [[177, 186, "DISEASE"]]}], ["Thus, studies were performed to correlate the physicochemical attributes of ambient PM(2.5) with its in vivo immunotoxicity to identify and characterize the role of constitutive transition metals in exacerbating an ongoing streptococcal infection.", {"entities": []}], ["Uninfected or previously infected rats were exposed in the laboratory to soluble divalent Fe, Mn, or Ni chloride salts.", {"entities": []}], ["After exposure, uninfected rats were sacrificed and their lungs were lavaged.", {"entities": []}], ["Lungs from infected hosts were used to evaluate changes in bacterial clearance and effects of exposure on the extent/severity of infection.", {"entities": []}], ["Results demonstrated that inhalation of Fe altered innate and adaptive immunity in uninfected hosts, and both Fe and Ni reduced pulmonary bacterial clearance in previously infected rats.", {"entities": []}], ["The effects on clearance produced in infected Fe-exposed rats were similar to those seen in infected rats exposed to ambient NYC PM.", {"entities": []}], ["Taken together, these studies demonstrate that inhaled ambient PM can worsen the outcome of an ongoing pulmonary infection and that associated Fe may play some role in the immunotoxicity.", {"entities": []}], ["Changes in self-concept are an important potential outcome for many interventions for people with long-term conditions.", {"entities": []}], ["This study sought to identify and evaluate outcome questionnaires suitable for quantifying changes in self-concept in people with long-term conditions, in the context of treatment with acupuncture and Chinese medicine.", {"entities": []}], ["A literature search was followed by an evaluation of three questionnaires: The Wellbeing Questionnaire W-BQ12, the Patient Enablement Instrument (PEI), and the Arizona Integrative Outcome Scale (AIOS).", {"entities": []}], ["A convenience sample of 23 people completed the questionnaires on two occasions and were interviewed about their experience and their questionnaire responses.", {"entities": []}], ["All acupuncturists were interviewed.", {"entities": []}], ["Changes in self-concept were common and emerged over time.", {"entities": []}], ["The three questionnaires had different strengths and weaknesses in relation to measuring changes in self-concept.", {"entities": []}], ["The generic AIOS had face validity and was sensitive to changes in self-concept over time, but it lacked specificity.", {"entities": []}], ["The PEI was sensitive and specific in measuring these changes but had lower acceptability.", {"entities": []}], ["The sensitivity of the W-BQ12 was affected by initial high scores (ceiling effect) and a shorter timescale but was acceptable and is suitable for repeated administration.", {"entities": []}], ["The PEI and W-BQ12 questionnaires worked well in combination.", {"entities": []}], ["Changes in self-concept are important outcomes of complex interventions for people with long-term illness and their measurement requires carefully evaluated tools and long-term follow-up.", {"entities": []}], ["The literature review and the analysis of the strengths and weaknesses of the questionnaires is a resource for other researchers.", {"entities": []}], ["The W-BQ12 and the PEI both proved useful for this population and a larger quantitative study is planned.", {"entities": []}], ["Each year, around 50.000 children in Sweden experience a separation between their parents.", {"entities": []}], ["Joint physical custody (JPC), where the child alternates homes between the parents for about equal amount of time, has become a common living arrangement after parental separation.", {"entities": []}], ["Children in two homes could benefit from everyday contact with both parents and access to both parents\u2019 financial resources.", {"entities": []}], ["However, children could experience stress from being constantly moving and potentially exposed to parental conflicts.", {"entities": []}], ["Still, studies on JPC and biological functioning related to stress, are lacking.", {"entities": []}], ["The aim of this study was to investigate how living arrangements (intact family/JPC) relate to HPA-axis activity and recurrent pain in mid-adolescents.", {"entities": []}], ["Mid-adolescents (106 girls and 51 boys) provided demographic details, self-reports of recurrent pain (headache, stomachache, neck/shoulder and back pain) and salivary samples.", {"entities": []}], ["Salivary cortisol samples were collected: 1) immediately at awakening, 2) +30\u00a0minutes, 3) +60\u00a0minutes, and 4) at 8\u00a0p.m.", {"entities": []}], ["The cortisol awakening response (CAR) was computed using an established formula.", {"entities": []}], ["Additionally, the diurnal decline between the waking and 8\u00a0p.m. samples was computed.", {"entities": []}], ["Hierarchical multiple regressions showed that living arrangements (intact family/JPC) was not associated with morning cortisol (CAR), the diurnal cortisol decline or with recurrent pain.", {"entities": []}], ["However, sex was a significant predictor of both cortisol measures and recurrent pain with girls exhibiting a higher cortisol awakening response and a greater diurnal decline value as well as reporting more recurrent pain than did boys.", {"entities": []}], ["Living arrangements were not associated with HPA-axis activity or recurrent pain in this group of well-functioning mid-adolescents.", {"entities": []}], ["Although this study is the first to investigate how living arrangements relate to HPA-axis functioning and additional studies are needed, the tentative findings suggest that these mid-adolescents have adapted to their living arrangements and that other factors play a more pertinent role for HPA-functioning and subjective health.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) has been classically divided into blue bloaters and pink puffers.", {"entities": []}], ["The utility of these clinical subtypes is unclear.", {"entities": []}], ["However, the broader distinction between airway-predominant and emphysema-predominant COPD may be clinically relevant.", {"entities": []}], ["The objective was to define clinical features of emphysema-predominant and non-emphysematous COPD patients.", {"entities": []}], ["Current and former smokers from the Genetic Epidemiology of COPD Study (COPDGene) had chest computed tomography (CT) scans with quantitative image analysis.", {"entities": []}], ["Emphysema-predominant COPD was defined by low attenuation area at -950 Hounsfield Units (LAA -950 ) \u226510%.", {"entities": []}], ["Non-emphysematous COPD was defined by airflow obstruction with minimal to no emphysema (LAA -950 \u2009<\u20095%).", {"entities": []}], ["Out of 4197 COPD subjects, 1687 were classified as emphysema-predominant and 1817 as non-emphysematous; 693 had LAA -950 between 5\u201310% and were not categorized.", {"entities": []}], ["Subjects with emphysema-predominant COPD were older (65.6 vs 60.6\u00a0years, p\u2009<\u20090.0001) with more severe COPD based on airflow obstruction (FEV 1 44.5 vs 68.4%, p\u2009<\u20090.0001), greater exercise limitation (6-minute walk distance 1138 vs 1331\u00a0ft, p\u2009<\u20090.0001) and reduced quality of life (St. George\u2019s Respiratory Questionnaire score 43 vs 31, p\u2009<\u20090.0001).", {"entities": [[137, 140, "GENE"]]}], ["Self-reported diabetes was more frequent in non-emphysematous COPD (OR 2.13, p\u2009<\u20090.001), which was also confirmed using a strict definition of diabetes based on medication use.", {"entities": []}], ["The association between diabetes and non-emphysematous COPD was replicated in the ECLIPSE study.", {"entities": []}], ["Non-emphysematous COPD, defined by airflow obstruction with a paucity of emphysema on chest CT scan, is associated with an increased risk of diabetes.", {"entities": []}], ["COPD patients without emphysema may warrant closer monitoring for diabetes, hypertension, and hyperlipidemia and vice versa.", {"entities": [[76, 88, "DISEASE"]]}], ["Clinicaltrials.gov identifiers: COPDGene NCT00608764 , ECLIPSE NCT00292552 .", {"entities": []}], ["The online version of this article (doi:10.1186/1471-2466-14-164) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The classical form of \u03b11-antitrypsin deficiency (ATD) is an autosomal co-dominant disorder that affects ~1 in 3000 live births and is an important genetic cause of lung and liver disease.", {"entities": [[173, 186, "DISEASE"]]}], ["The protein affected, \u03b11-antitrypsin (AT), is predominantly derived from the liver and has the function of inhibiting neutrophil elastase and several other destructive neutrophil proteinases.", {"entities": []}], ["The genetic defect is a point mutation that leads to misfolding of the mutant protein, which is referred to as \u03b11-antitrypsin Z (ATZ).", {"entities": []}], ["Because of its misfolding, ATZ is unable to efficiently traverse the secretory pathway.", {"entities": []}], ["Accumulation of ATZ in the endoplasmic reticulum of liver cells has a gain-of-function proteotoxic effect on the liver, resulting in fibrosis, cirrhosis and/or hepatocellular carcinoma in some individuals.", {"entities": [[160, 184, "DISEASE"], [175, 184, "DISEASE"]]}], ["Moreover, because of reduced secretion, there is a lack of anti-proteinase activity in the lung, which allows neutrophil proteases to destroy the connective tissue matrix and cause chronic obstructive pulmonary disease (COPD) by loss of function.", {"entities": [[181, 218, "DISEASE"]]}], ["Wide variation in the incidence and severity of liver and lung disease among individuals with ATD has made this disease one of the most challenging of the rare genetic disorders to diagnose and treat.", {"entities": [[58, 70, "DISEASE"]]}], ["Other than cigarette smoking, which worsens COPD in ATD, genetic and environmental modifiers that determine this phenotypic variability are unknown.", {"entities": []}], ["A limited number of therapeutic strategies are currently available, and liver transplantation is the only treatment for severe liver disease.", {"entities": [[127, 140, "DISEASE"]]}], ["Although replacement therapy with purified AT corrects the loss of anti-proteinase function, COPD progresses in a substantial number of individuals with ATD and some undergo lung transplantation.", {"entities": []}], ["Nevertheless, advances in understanding the variability in clinical phenotype and in developing novel therapeutic concepts is beginning to address the major clinical challenges of this mysterious disorder.", {"entities": []}], ["Searching the Web for documents using information retrieval systems plays an important part in clinicians\u2019 practice of evidence-based medicine.", {"entities": []}], ["While much research focuses on the design of methods to retrieve documents, there has been little examination of the way different search engine capabilities influence clinician search behaviors.", {"entities": []}], ["Previous studies have shown that use of task-based search engines allows for faster searches with no loss of decision accuracy compared with resource-based engines.", {"entities": []}], ["We hypothesized that changes in search behaviors may explain these differences.", {"entities": []}], ["In all, 75 clinicians (44 doctors and 31 clinical nurse consultants) were randomized to use either a resource-based or a task-based version of a clinical information retrieval system to answer questions about 8 clinical scenarios in a controlled setting in a university computer laboratory.", {"entities": []}], ["Clinicians using the resource-based system could select 1 of 6 resources, such as PubMed; clinicians using the task-based system could select 1 of 6 clinical tasks, such as diagnosis.", {"entities": []}], ["Clinicians in both systems could reformulate search queries.", {"entities": []}], ["System logs unobtrusively capturing clinicians\u2019 interactions with the systems were coded and analyzed for clinicians\u2019 search actions and query reformulation strategies.", {"entities": []}], ["The most frequent search action of clinicians using the resource-based system was to explore a new resource with the same query, that is, these clinicians exhibited a \u201cbreadth-first\u201d search behaviour.", {"entities": []}], ["Of 1398 search actions, clinicians using the resource-based system conducted 401 (28.7%, 95% confidence interval [CI] 26.37-31.11) in this way.", {"entities": []}], ["In contrast, the majority of clinicians using the task-based system exhibited a \u201cdepth-first\u201d search behavior in which they reformulated query keywords while keeping to the same task profiles.", {"entities": []}], ["Of 585 search actions conducted by clinicians using the task-based system, 379 (64.8%, 95% CI 60.83-68.55) were conducted in this way.", {"entities": []}], ["This study provides evidence that different search engine designs are associated with different user search behaviors.", {"entities": []}], ["Trichinella spiralis has the unique ability to make itself \u201cat home\u201d by creating and hiding in a new type of cell in the host body that is the nurse cell.", {"entities": []}], ["From this immunologically privileged place, the parasite orchestrates a long-lasting molecular cross talk with the host through muscle larvae excretory-secretory products (ES L1).", {"entities": []}], ["Those products can successfully modulate parasite-specific immune responses as well as responses to unrelated antigens (either self or nonself in origin), providing an anti-inflammatory milieu and maintaining homeostasis.", {"entities": []}], ["It is clear, based on the findings from animal model studies, that T. spiralis and its products induce an immunomodulatory network (which encompasses Th2- and Treg-type responses) that may allow the host to deal with various hyperimmune-associated disorders as well as tumor growth, although the latter still remains unclear.", {"entities": []}], ["This review focuses on studies of the molecules released by T. spiralis , their interaction with pattern recognition receptors on antigen presenting cells, and subsequently provoked responses.", {"entities": []}], ["This paper also addresses the immunomodulatory properties of ES L1 molecules and how the induced immunomodulation influences the course of different experimental inflammatory and malignant diseases.", {"entities": []}], ["To evaluate effectiveness and safety of titrated oral misoprostol solution (OMS) in comparison with vaginal dinoprostone for cervix ripening and labor induction in term pregnant women.", {"entities": []}], ["A multicenter randomized controlled trial of women with term singleton pregnancy with indications for labor induction; 481 participants were allocated to receive titrated OMS with different doses by hourly administration according to the procedure or insert vaginal dinoprostone for cervix ripening and labor induction to compare maternal outcomes including indication of labor induction, mode of outcome of delivery, maternal morbidity, and neonatal outcomes between two groups for evaluating the efficacy and safety of titrated oral misoprostol induction.", {"entities": []}], ["Proportion of delivery within 12\u00a0h of titrated oral misoprostol is significantly less than vaginal dinoprostone ( p \u00a0=\u00a00.03), but no difference of total vaginal delivery rate ( p \u00a0=\u00a00.93); the mean time of first treatment to vaginal delivery was longer in OMS group (21.3\u00a0\u00b1\u00a014.5\u00a0h) compared with the vaginal dinoprostone group (15.7\u00a0\u00b1\u00a09.6\u00a0h).", {"entities": []}], ["Although the proportion of cesarean section between the two groups showed no statistically significant difference, OMS group showed significantly lower frequency of uterine hyperstimulation, hypertonus, partus precipitatus and non-reassuring fetal heart rate than dinoprostone group.", {"entities": []}], ["Neonatal outcomes were similar evaluating from Apgar score and NICU admission.", {"entities": []}], ["Our study also showed that labor induction of women with cervix Bishop score \u22643 needed increased dosage of misoprostol solution.", {"entities": []}], ["Titrated OMS is as effective as vaginal dinoprostone in labor induction for term pregnant women, with safer effect for its lower rate of adverse effect for women.", {"entities": []}], ["We performed a literature review to investigate how epidemiological studies have been used to assess the health consequences of living in the vicinity of industries.", {"entities": []}], ["77 papers on the chronic effects of air pollution around major industrial areas were reviewed.", {"entities": []}], ["Major health themes were cancers (27 studies), morbidity (25 studies), mortality (7 studies), and birth outcome (7 studies).", {"entities": []}], ["Only 3 studies investigated mental health.", {"entities": []}], ["While studies were available from many different countries, a majority of papers came from the United Kingdom, Italy, and Spain.", {"entities": []}], ["Several studies were motivated by concerns from the population or by previous observations of an overincidence of cases.", {"entities": []}], ["Geographical ecological designs were largely used for studying cancer and mortality, including statistical designs to quantify a relationship between health indicators and exposure.", {"entities": [[63, 69, "DISEASE"]]}], ["Morbidity was frequently investigated through cross-sectional surveys on the respiratory health of children.", {"entities": []}], ["Few multicenter studies were performed.", {"entities": []}], ["In a majority of papers, exposed areas were defined based on the distance to the industry and were located from <2\u2009km to >20\u2009km from the plants.", {"entities": []}], ["Improving the exposure assessment would be an asset to future studies.", {"entities": []}], ["Criteria to include industries in multicenter studies should be defined.", {"entities": []}], ["Falls are a serious problem in the elderly, and have recently been described as cardiovascular-mediated side effects of beta-blocker eye drops.", {"entities": []}], ["Therefore, we investigated the possible association between the long-term use of beta-blockers, prostaglandins and their combinations in eye drops, and falls, dizziness and orthostatic hypotension in older patients.", {"entities": []}], ["All participants were long-term users of eye drops containing beta-blockers, prostaglandins or their combinations.", {"entities": []}], ["They underwent a structured falls interview and blood pressure measurement for testing of orthostatic hypotension.", {"entities": []}], ["The odds ratio for presence of orthostatic hypotension or a positive falls history according to use of beta-blocker eye drops was calculated with a binary logistic regression analysis.", {"entities": []}], ["The main outcome measures were a positive falls history and the presence of orthostatic hypotension.", {"entities": []}], ["In total, 148 of 286 subjects participated.", {"entities": []}], ["After adjustment for age, gender, and use of fall-risk-increasing drugs other than beta-blocker eye drops, we found no significant difference in fall risk [odds ratio (OR): 0.60; 95% confidence interval (CI): 0.268\u20131.327] between patients using ophthalmic beta-blockers or a combination of ophthalmic beta-blockers and prostaglandins, and patients using ophthalmic prostaglandins only.", {"entities": []}], ["Although prevalence of orthostatic hypotension was higher in the beta-blocker group (OR: 1.67; 95% CI: 0.731\u20133.793) compared to the prostaglandin group, this was a non-significant difference.", {"entities": []}], ["In our study, we did not find a significant association between long-term use of beta-blockers eye drops and falls, dizziness or orthostatic hypotension in older ophthalmic outpatients, compared to long-term use of prostaglandin eye drops.", {"entities": []}], ["This study was designed to explore the impact of Yoga and Meditation based lifestyle intervention (YMLI) on cellular aging in apparently healthy individuals.", {"entities": []}], ["During this 12-week prospective, open-label, single arm exploratory study, 96 apparently healthy individuals were enrolled to receive YMLI.", {"entities": []}], ["The primary endpoints were assessment of the change in levels of cardinal biomarkers of cellular aging in blood from baseline to week 12, which included DNA damage marker 8-hydroxy-2\u2032-deoxyguanosine (8-OH2dG), oxidative stress markers reactive oxygen species (ROS), and total antioxidant capacity (TAC), and telomere attrition markers telomere length and telomerase activity.", {"entities": []}], ["The secondary endpoints were assessment of metabotrophic blood biomarkers associated with cellular aging, which included cortisol, \u03b2 -endorphin, IL-6, BDNF, and sirtuin-1.", {"entities": [[151, 155, "GENE"]]}], ["After 12 weeks of YMLI, there were significant improvements in both the cardinal biomarkers of cellular aging and the metabotrophic biomarkers influencing cellular aging compared to baseline values.", {"entities": []}], ["The mean levels of 8-OH2dG, ROS, cortisol, and IL-6 were significantly lower and mean levels of TAC, telomerase activity, \u03b2 -endorphin, BDNF, and sirtuin-1 were significantly increased (all values p < 0.05) post-YMLI.", {"entities": [[136, 140, "GENE"]]}], ["The mean level of telomere length was increased but the finding was not significant ( p = 0.069).", {"entities": []}], ["YMLI significantly reduced the rate of cellular aging in apparently healthy population.", {"entities": []}], ["Helminth infections and allergy have evolutionary and clinical links.", {"entities": []}], ["Infection with the nematode Ascaris lumbricoides induces IgE against several molecules including invertebrate pan-allergens.", {"entities": []}], ["These antibodies influence the pathogenesis and diagnosis of allergy; therefore, studying parasitic and non-parasitic allergens is essential to understand both helminth immunity and allergy.", {"entities": []}], ["Glutathione transferases (GSTs) from cockroach and house dust mites are clinically relevant allergens and comparative studies between them and the GST from A. lumbricoides (GSTA) are necessary to evaluate their allergenicity.", {"entities": []}], ["We sought to analyze the allergenic potential of GSTA in connection with the IgE response to non-parasitic GSTs.", {"entities": []}], ["IgE to purified GSTs from Ascaris (nGSTA and rGSTA), house dust mites (rDer p 8, nBlo t 8 and rBlo t 8), and cockroach (rBla g 5) was measured by ELISA in subjects from Cartagena, Colombia.", {"entities": []}], ["Also, multidimensional proteomic approaches were used to study the extract of A. lumbricoides and investigate the existence of GST isoforms.", {"entities": []}], ["We found that among asthmatics, the strength of IgE levels to GSTA was significantly higher than to mite and cockroach GSTs, and there was a strong positive correlation between IgE levels to these molecules.", {"entities": []}], ["Specific IgE to GSTA was found in 13.2% of controls and 19.5% of asthmatics.", {"entities": []}], ["In addition nGSTA induced wheal and flare in skin of sensitized asthmatics indicating that it might be of clinical relevance for some patients.", {"entities": []}], ["Frequency and IgE levels to GSTA were higher in childhood and declined with age.", {"entities": []}], ["At least six GST isoforms in A. lumbricoides bind human IgE.", {"entities": []}], ["Four isoforms were the most abundant and several amino acid substitutions were found, mainly on the N-terminal domain.", {"entities": []}], ["In conclusion, a new allergenic component of Ascaris has been discovered; it could have clinical impact in allergic patients and influence the diagnosis of mite and cockroach allergy in tropical environments.", {"entities": []}], ["Multipotent mesenchymal stromal cells (MSC) can be recovered from a variety of tissues in the body.", {"entities": [[39, 42, "GENE"]]}], ["Yet, their functional properties were shown to vary depending on tissue origin.", {"entities": []}], ["While MSC have emerged as a favoured cell type for tendon regenerative therapies, very little is known about the influence of the MSC source on their properties relevant to tendon regeneration.", {"entities": [[6, 9, "GENE"], [130, 133, "GENE"], [6, 9, "GENE"], [130, 133, "GENE"]]}], ["The aim of this study was to assess and compare the expression of tendon extracellular matrix proteins and tendon differentiation markers in MSC derived from different sources as well as in native tendon tissue.", {"entities": [[141, 144, "GENE"]]}], ["MSC isolated from equine bone marrow, adipose tissue, umbilical cord tissue, umbilical cord blood and tendon tissue were characterized and then subjected to mRNA analysis by real-time polymerase chain reaction.", {"entities": [[0, 3, "GENE"]]}], ["MSC derived from adipose tissue displayed the highest expression of collagen 1A2, collagen 3A1 and decorin compared to MSC from all other sources and native tendon tissue (p <\u20090.01).", {"entities": [[0, 3, "GENE"], [119, 122, "GENE"], [0, 3, "GENE"], [119, 122, "GENE"]]}], ["Tenascin-C and scleraxis expressions were highest in MSC derived from cord blood compared to MSC derived from other sources, though both tenascin-C and scleraxis were expressed at significantly lower levels in all MSC compared to native tendon tissue (p <\u20090.01).", {"entities": [[53, 56, "GENE"], [93, 96, "GENE"], [214, 217, "GENE"], [53, 56, "GENE"], [93, 96, "GENE"], [214, 217, "GENE"], [53, 56, "GENE"], [93, 96, "GENE"], [214, 217, "GENE"]]}], ["These findings demonstrate that the MSC source impacts the cell properties relevant to tendon regeneration.", {"entities": [[36, 39, "GENE"]]}], ["Adipose derived MSC might be superior regarding their potential to positively influence tendon matrix reorganization.", {"entities": [[16, 19, "GENE"]]}], ["The online version of this article (doi:10.1186/1756-0500-7-826) contains supplementary material, which is available to authorized users.", {"entities": []}], ["We have examined sensitivity and specificity of pseudocontinuous arterial spin labeling (PCASL) to detect global and regional changes in cerebral blood flow (CBF) in response to two different psychoactive drugs.", {"entities": []}], ["We tested alcohol and morphine in a placebo-controlled, double-blind randomized study in 12 healthy young men.", {"entities": []}], ["Drugs were administered intravenously.", {"entities": []}], ["Validated pharmacokinetic protocols achieved minimal intersubject and intrasubject variance in plasma drug concentration.", {"entities": []}], ["Permutation-based statistical testing of a mixed effect repeated measures model revealed a widespread increase in absolute CBF because of both morphine and alcohol.", {"entities": []}], ["Conjunction analysis revealed overlapping effects of morphine and alcohol on absolute CBF in the left anterior cingulate, right hippocampus, right insula, and left primary sensorimotor areas.", {"entities": []}], ["Effects of morphine and alcohol on relative CBF (obtained from z-normalization of absolute CBF maps) were significantly different in the left putamen, left frontoparietal network, cerebellum, and the brainstem.", {"entities": []}], ["Corroborating previous PET results, our findings suggest that PCASL is a promising tool for central nervous system drug research.", {"entities": []}], ["Mobile text messages are a widely recognized communication method in societies, as the global penetration of the technology approaches 100% worldwide.", {"entities": []}], ["Systematic knowledge is still lacking on how the mobile telephone text messaging (short message service, SMS) has been used in health care services.", {"entities": [[105, 108, "GENE"]]}], ["This study aims to review the literature on the use of mobile phone text message reminders in health care.", {"entities": []}], ["We conducted a systematic literature review of studies on mobile telephone text message reminders.", {"entities": []}], ["The data sources used were PubMed (MEDLINE), CINAHL, Proquest Databases/ PsycINFO, EMBASE, Cochrane Library, Scopus, and hand searching since 2003.", {"entities": []}], ["Studies reporting the use of SMS intended to remind patients in health services were included.", {"entities": [[29, 32, "GENE"]]}], ["Given the heterogeneity in the studies, descriptive characteristics, purpose of the study, response rates, description of the intervention, dose and timing, instruments, outcome measures, and outcome data from the studies were synthesized using a narrative approach.", {"entities": []}], ["From 911 initial citations, 60 studies were included in the review.", {"entities": []}], ["The studies reported a variety of use for SMS.", {"entities": [[42, 45, "GENE"]]}], ["Mobile telephone text message reminders were used as the only intervention in 73% (44/60) of the studies, and in 27% (16/60) of the remaining studies, SMS was connected to another comprehensive health intervention system.", {"entities": [[151, 154, "GENE"]]}], ["SMS reminders were sent to different patient groups: patients with HIV/AIDS (15%, 9/60) and diabetes (13%, 8/60) being the most common groups.", {"entities": [[0, 3, "GENE"]]}], ["The response rates of the studies varied from 22-100%.", {"entities": []}], ["Typically, the text message reminders were sent daily.", {"entities": []}], ["The time before the specific intervention to be rendered varied from 10 minutes (eg, medication taken) to 2 weeks (eg, scheduled appointment).", {"entities": []}], ["A wide range of different evaluation methods and outcomes were used to assess the impact of SMS varying from existing databases (eg, attendance rate based on medical records), questionnaires, and physiological measures.", {"entities": [[92, 95, "GENE"]]}], ["About three quarters of the studies (77%, 46/60) reported improved outcomes: adherence to medication or to treatment reportedly improved in 40% (24/60) of the studies, appointment attendance in 18% (11/60) of the studies, and non-attendance rates decreased in 18% (11/60) of the studies.", {"entities": []}], ["Other positive impacts were decreased amount of missed medication doses, more positive attitudes towards medication, and reductions in treatment interruptions.", {"entities": []}], ["We can conclude that although SMS reminders are used with different patient groups in health care, SMS is less systematically studied with randomized controlled trial study design.", {"entities": [[30, 33, "GENE"], [99, 102, "GENE"], [30, 33, "GENE"], [99, 102, "GENE"]]}], ["Although the amount of evidence for SMS application recommendations is still limited, having 77% (46/60) of the studies showing improved outcomes may indicate its use in health care settings.", {"entities": [[36, 39, "GENE"]]}], ["However, more well-conducted SMS studies are still needed.", {"entities": [[29, 32, "GENE"]]}], ["Chemokines are a large family of small cytokines and generally have low molecular weight ranging from 7 to 15kDa.", {"entities": []}], ["Chemokines and their receptors are able to control the migration and residence of all immune cells.", {"entities": []}], ["Some chemokines are considered pro-inflammatory, and their release can be induced during an immune response at a site of infection, while others are considered homeostatic and are involved in controlling of cells migration during tissue development or maintenance.", {"entities": []}], ["The physiologic importance of this family of mediators is resulting from their specificity \u2212 members of the chemokine family induce recruitment of well-defined leukocyte subsets.", {"entities": []}], ["There are two major chemokine sub-families based upon cysteine residues position: CXC and CC.", {"entities": []}], ["As a general rule, members of the CXC chemokines are chemotactic for neutrophils, and CC chemokines are chemotactic for monocytes and sub-set of lymphocytes, although there are some exceptions.", {"entities": []}], ["This review discusses the potential role of chemokines in inflammation focusing on the two best-characterized chemokines: monocyte chemoattractant protein-1, a CC chemokine, and interleukin-8, a member of the CXC chemokine sub-family.", {"entities": []}], ["Quimiocinas s\u00e3o uma grande fam\u00edlia de pequenas citocinas e seu peso molecular varia de 7 a 15kDa.", {"entities": []}], ["As quimiocinas e seus receptores s\u00e3o capazes de controlar a migra\u00e7\u00e3o e a resid\u00eancia de c\u00e9lulas imunes.", {"entities": []}], ["Algumas quimiocinas s\u00e3o consideradas pr\u00f3-inflamat\u00f3rias e podem ser induzidas durante a resposta imune no s\u00edtio de infec\u00e7\u00e3o, enquanto outras s\u00e3o consideradas homeost\u00e1ticas e est\u00e3o envolvidas no controle da migra\u00e7\u00e3o celular durante o desenvolvimento ou a manuten\u00e7\u00e3o dos tecidos.", {"entities": []}], ["A import\u00e2ncia fisiol\u00f3gica dessa fam\u00edlia de mediadores \u00e9 resultado de sua especificidade \u2212 os membros da fam\u00edlia de quimiocinas induzem ao recrutamento de subtipos bem definidos de leuc\u00f3citos.", {"entities": []}], ["Existem duas grandes subfam\u00edlias de quimiocinas baseadas na posi\u00e7\u00e3o dos res\u00edduos de ciste\u00ednas: CXC e CC.", {"entities": []}], ["Como regra geral, membros da fam\u00edlia de quimiocinas CXC s\u00e3o quimiot\u00e1ticos de neutr\u00f3filos, e as quimiocinas CC s\u00e3o quimiot\u00e1ticos de mon\u00f3citos e subtipos de linf\u00f3citos, apesar de existirem algumas exce\u00e7\u00f5es.", {"entities": []}], ["Esta revis\u00e3o discute o potencial papel das quimiocinas na inflama\u00e7\u00e3o focando nas duas quimiocinas mais bem caracterizadas: a prote\u00edna quimioatraente de mon\u00f3citos-1, uma quimiocina CC, e a interleucina 8, uma quimiocina membro da subfam\u00edlia CXC.", {"entities": []}], ["Mast cell-derived prostaglandin D 2 (PGD 2 ) is the major prostanoid found within the airway of asthmatics immediately following allergen challenge.", {"entities": [[37, 40, "GENE"]]}], ["PGD 2 has been shown to have chemokinetic effects on eosinophils and T helper type 2 (Th2) cells in vitro .", {"entities": [[0, 3, "GENE"]]}], ["This occurs through the interaction of PGD 2 with the G-protein-coupled chemokine receptor homologous molecule expressed on Th2 lymphocytes (CRTH2).", {"entities": [[39, 42, "GENE"]]}], ["The expression of CRTH2 has been shown to be highly selective for Th2 cells.", {"entities": []}], ["Using flow cytometry we have studied the expression of CRTH2 on T cells in blood and bronchoalveolar lavage fluid in asthmatics and normal subjects.", {"entities": []}], ["CRTH2 expression was confined to a small percentage of blood T cells in asthmatics (1\u00b78% \u00b1 0\u00b72) and normal (1\u00b76% \u00b1 0\u00b72) subjects.", {"entities": []}], ["CRTH2 was enriched significantly on interleukin (IL)-4 P < 0\u00b7001).", {"entities": []}], ["There was a small population of CRTH2 P < 0\u00b705).", {"entities": []}], ["There were similar amounts of PGD 2 in the BAL of asthma and normal subjects.", {"entities": [[50, 56, "DISEASE"], [30, 33, "GENE"]]}], ["Within paired blood\u2013BAL samples from the same subject there was no increase in CRTH2 P < 0\u00b7001).", {"entities": []}], ["CRTH2 is expressed preferentially by IL-4", {"entities": []}], ["Adherence to anti-osteoporosis treatments is poor, exposing treated women to increased fracture risk.", {"entities": [[18, 30, "DISEASE"]]}], ["Determinants of poor adherence are poorly understood.", {"entities": []}], ["The study aims to determine physician- and patient- rated treatment compliance with osteoporosis treatments and to evaluate factors influencing compliance.", {"entities": [[84, 96, "DISEASE"]]}], ["This was an observational, cross-sectional pharmacoepidemiological study with a randomly-selected sample of 420 GPs, 154 rheumatologists and 110 gynaecologists practicing in France.", {"entities": []}], ["Investigators included post-menopausal women with a diagnosis of osteoporosis and a treatment initiated in the previous six months.", {"entities": [[65, 77, "DISEASE"]]}], ["Investigators completed a questionnaire on clinical features, treatments and medical history, and on patient compliance.", {"entities": []}], ["Patients completed a questionnaire on sociodemographic features, lifestyle, attitudes and knowledge about osteoporosis, treatment compliance, treatment satisfaction and quality of life.", {"entities": [[106, 118, "DISEASE"]]}], ["Treatment compliance was evaluated with the Morisky Medication-taking Adherence Scale.", {"entities": []}], ["Variables collected in the questionnaires were evaluated for association with compliance using multivariate logistic regression analysis.", {"entities": []}], ["785 women were evaluated.", {"entities": []}], ["Physicians considered 95.4% of the sample to be compliant, but only 65.5% of women considered themselves compliant.", {"entities": []}], ["The correlation between patient and physician perceptions of compliance was low (\u03ba: 0.11 [95% CI: 0.06 to 0.16]).", {"entities": []}], ["Patient-rated compliance was highest for monthly bisphosphonates (79.7%) and lowest for hormone substitution therapy (50.0%).", {"entities": []}], ["Six variables were associated with compliance: treatment administration frequency, perceptions of long-term treatment acceptability, perceptions of health consequences of osteoporosis, perceptions of knowledge about osteoporosis, exercise and mental quality of life.", {"entities": [[171, 183, "DISEASE"], [216, 228, "DISEASE"]]}], ["Compliance to anti-osteoporosis treatments is poor.", {"entities": [[19, 31, "DISEASE"]]}], ["Reduction of dosing regimen frequency and patient education may be useful ways of improving compliance.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) and benign prostatic hyperplasia (BPH) are common disorders in ageing male populations.", {"entities": []}], ["Nevertheless, the relationship between the two diseases has rarely been explored.", {"entities": []}], ["The objective of this study was to examine whether patients with COPD are at an increased risk of BPH.", {"entities": []}], ["Retrospective nationwide cohort study.", {"entities": []}], ["Data retrieved from the Taiwan National Health Insurance Research Database.", {"entities": []}], ["Overall, 19 959 male patients aged 40 years and over with newly diagnosed COPD between 2000 and 2006 were included as the COPD group, and 19 959 sex-matched and age-matched enrollees without COPD were included as the non-COPD group.", {"entities": []}], ["Both groups were followed-up until the end of 2011.", {"entities": []}], ["A Cox proportional hazards regression model was used to compute the risk of BPH in patients with COPD compared with enrollees without COPD.", {"entities": []}], ["The overall incidence rate of BPH was 1.53 times higher in the COPD group than that in the non-COPD group (44.7 vs 25.7 per 1000 person-years, 95% CI 1.46 to 1.60) after adjusting for covariates.", {"entities": []}], ["An additional stratified analysis revealed that this increased risk of BPH in patients with COPD remained significantly higher than that in enrollees without COPD in all men aged 40 years and over.", {"entities": []}], ["After adjustment for covariates, male patients with COPD were found to be at a higher risk of BPH.", {"entities": []}], ["We suggest that clinicians should be cautious about the increased risk of BPH in male patients with COPD.", {"entities": []}], ["In skeletal muscle, excitation leads to increased [Na i , loss of K o , depolarization, and Cl o by 28 \u00b1 12 mM, sufficient to cause severe loss of excitability as the result of inactivation of Na o by 71 \u00b1 22 mM and 73 \u00b1 15 mM, respectively.", {"entities": []}], ["In spite of this, excitability may be maintained by the rapid and marked stimulation of the electrogenic Na o to 40\u201380 mM augmented intracellular", {"entities": []}], ["Exosomes are nanovesicles released by different cell types, such as dendritic cells (DCs), mast cells (MCs), and tumor cells.", {"entities": []}], ["Exosomes of different origin play a role in antigen presentation and modulation of immune response to infectious disease.", {"entities": []}], ["In this study, we demonstrate that mast cells and CD4", {"entities": [[50, 53, "GENE"]]}], ["Rural and regional Australians have a higher likelihood of mental illness throughout their lifetime than people living in major cities, although the underlying reasons are not yet well defined.", {"entities": []}], ["Additionally, rural populations experience more lifestyle associated co-morbidities including obesity, diabetes and cardiovascular disease.", {"entities": [[94, 101, "DISEASE"]]}], ["Research conducted by the National Centre for Farmer Health between 2004 and 2009 revealed a positive correlation between obesity and psychological distress among the farming community.", {"entities": [[122, 129, "DISEASE"]]}], ["Chronic stress is known to overstimulate the regulation of the hypothalamic-pituitary-adrenal (HPA) axis and cortisol secretion which are associated with abdominal adiposity.", {"entities": []}], ["Increasing physical activity may normalise cortisol secretion and thereby positively impact both physical and mental health.", {"entities": []}], ["This paper assesses the effects of increasing physical activity on obesity, health behaviors and mental health in Victorian farming men and women.", {"entities": [[67, 74, "DISEASE"]]}], ["Farming Fit was a six month quasi-experimental (convenience sample) longitudinal design control-intervention study.", {"entities": []}], ["Overweight or obese (BMI \u226525\u00a0kg/m n \u2009=\u200943) and women ( n \u2009=\u200929) were recruited with demographic, health behaviors, anthropometric, blood pressure and biochemistry data collected at baseline and at a six months.", {"entities": []}], ["Salivary cortisol and depression anxiety stress scale results were collected at baseline, three and six months.", {"entities": []}], ["The intervention group ( n \u2009=\u200937) received a personalized exercise program and regular phone coaching to promote physical activity.", {"entities": []}], ["The intervention group showed significant reductions in body weight and waist circumference.", {"entities": []}], ["Results indicated that following the six month exercise program, the intervention group were 2.64\u2009\u00b1\u20090.65\u00a0kg lighter ( p \u2009<\u20090.001), had reduced waist circumference by 2.01\u2009\u00b1\u20090.86\u00a0cm ( p \u2009=\u20090.02) and BMI by 0.97\u2009\u00b1\u20090.22\u00a0kg/m p\u2009< \u20090.001) relative to the control group.", {"entities": []}], ["Increasing physical activity altered measures of obesity in farm men and women but did not affect mental health measures or cortisol secretion levels.", {"entities": [[49, 56, "DISEASE"]]}], ["ACTRN12610000827033", {"entities": []}], ["The pathophysiology of chronic obstructive pulmonary disease (COPD) includes persistent airflow limitation, altered gas exchange, and enhanced chronic inflammatory response.", {"entities": [[23, 60, "DISEASE"]]}], ["According to disease severity in individual patients, exacerbations and comorbidities frequently occur.", {"entities": []}], ["The overall nocturnal and daily symptoms have a strong impact on patient quality of life and clinical outcomes.", {"entities": []}], ["Bronchodilators, by targeting two important aspects of COPD pathophysiology, ie, bronchoconstriction and lung hyperinflation, are the mainstay of therapy for COPD.", {"entities": []}], ["Aclidinium bromide in particular is an anticholinergic molecule, approved for maintenance bronchodilator treatment of stable COPD, that combines high antimuscarinic activity with strong kinetic selectivity for the M3 receptor subtype.", {"entities": []}], ["Moreover, the elevated plasma clearance of aclidinium has been related to low systemic bioavailability and low incidence of anticholinergic adverse events, whereas the reduced residence time at M2 receptors provides good cardiovascular safety.", {"entities": []}], ["Altogether, these characteristics result in a high safety and tolerability profile.", {"entities": []}], ["This review aims to reappraise the contribution of symptoms and of the level of quality of life determinants on COPD severity and to evaluate how therapeutic strategies with aclidinium may positively impact on these specific determinants of disease severity.", {"entities": []}], ["Although various theories describe mechanisms leading to differential parenting of boys and girls, there is no consensus about the extent to which parents do treat their sons and daughters differently.", {"entities": []}], ["The last meta-analyses on the subject were conducted more than fifteen years ago, and changes in gender-specific child rearing in the past decade are quite plausible.", {"entities": []}], ["In the current set of meta-analyses, based on 126 observational studies (15,034 families), we examined mothers\u2019 and fathers\u2019 differential use of autonomy-supportive and controlling strategies with boys and girls, and the role of moderators related to the decade in which the study was conducted, the observational context, and sample characteristics.", {"entities": []}], ["Databases of Web of Science, ERIC, PsychInfo, Online Contents, Picarta, and Proquest were searched for studies examining differences in observed parental control of boys and girls between the ages of 0 and 18 years.", {"entities": []}], ["Few differences were found in parents\u2019 use of control with boys and girls.", {"entities": []}], ["Parents were slightly more controlling with boys than with girls, but the effect size was negligible ( d = 0.08).", {"entities": []}], ["The effect was larger, but still small, in normative groups and in samples with younger children.", {"entities": []}], ["No overall effect for gender-differentiated autonomy-supportive strategies was found (d = 0.03).", {"entities": []}], ["A significant effect of time emerged: studies published in the 1970s and 1980s reported more autonomy-supportive strategies with boys than toward girls, but from 1990 onwards parents showed somewhat more autonomy-supportive strategies with girls than toward boys.", {"entities": []}], ["Taking into account parents\u2019 gender stereotypes might uncover subgroups of families where gender-differentiated control is salient, but based on our systematic review of the currently available large data base we conclude that in general the differences between parenting of boys versus girls are minimal.", {"entities": []}], ["Lobular capillary hemangioma (LCH) of the tracheobronchial tree is a rare benign tumor, whose characteristics and treatments remain relatively unknown.", {"entities": [[8, 28, "DISEASE"], [18, 28, "DISEASE"]]}], ["A 39-year-old man with hemoptysis caused by neoplasm in the bronchus intermedius was admitted to our hospital.", {"entities": []}], ["The patient was diagnosed with LCH.", {"entities": []}], ["The lesions were removed with biopsy forceps, and cryotherapy was performed.", {"entities": []}], ["After follow up for more than 2 years, no recurrence was found.", {"entities": []}], ["Airway LCH can be treated by excisional biopsy, cryotherapy, APC, laser, radiotherapy, and surgery.", {"entities": [[61, 64, "GENE"]]}], ["Cryotherapy is worthy of recommendation.", {"entities": []}], ["Local reaction to allergen-specific immunotherapy (SIT) usually appears within 30 minutes, but cases with exercise-induced urticaria at the SIT site 2\u20133 weeks after the last allergen injection have been reported.", {"entities": [[123, 132, "DISEASE"]]}], ["A 28-year-old man was treated with house dust mite-SIT for 5 years, due to asthma when he was an 11-year-old boy.", {"entities": [[75, 81, "DISEASE"]]}], ["On a treadmill exercise test for 50 minutes, erythema, swelling, and pruritus occurred at the SIT site, which lasted for one hour.", {"entities": []}], ["There was no evidence of complement activation, and the skin biopsy specimens showed no apparent difference between the lesion and normal sites in the distribution of inflammatory cells and in mast cell degranulation.", {"entities": []}], ["However, the morphine, but not the histamine, skin test responses were increased after the exercise.", {"entities": []}], ["There must be a remaining long-term sequela of the SIT, including an increased releasability of mast cells, even after more than 10 years.", {"entities": []}], ["Promyelocytic leukemia protein (PML) is a tumor suppressor that is highly expressed in endothelial cells nonetheless its role in endothelial cell biology remains elusive.", {"entities": [[14, 22, "DISEASE"], [32, 35, "GENE"]]}], ["Tumor necrosis factor alpha (TNF \u03b1 ) is an important cytokine associated with many inflammation-related diseases.", {"entities": [[29, 32, "GENE"]]}], ["We have previously demonstrated that TNF \u03b1 induces PML protein accumulation.", {"entities": [[37, 40, "GENE"], [51, 54, "GENE"]]}], ["We hypothesized that PML may play a role in TNF \u03b1 signaling pathway.", {"entities": [[21, 24, "GENE"], [44, 47, "GENE"]]}], ["To identify potential PML target genes and investigate the putative crosstalk between PML\u2019s function and TNF \u03b1 signaling in endothelial cells, we carried out a microarray analysis in human primary umbilical endothelial cells (HUVECs).", {"entities": [[22, 25, "GENE"], [86, 89, "GENE"], [22, 25, "GENE"], [86, 89, "GENE"], [105, 108, "GENE"]]}], ["We found that PML and TNF \u03b1 regulate common and distinct genes involved in a similar spectrum of biological processes, pathways and human diseases.", {"entities": [[14, 17, "GENE"], [22, 25, "GENE"]]}], ["More importantly, we found that PML is required for fine-tuning of TNF \u03b1 -mediated immune and inflammatory responses.", {"entities": [[32, 35, "GENE"], [67, 70, "GENE"]]}], ["Furthermore, our data suggest that PML and TNF \u03b1 synergistically regulate cell adhesion by engaging multiple molecular mechanisms.", {"entities": [[35, 38, "GENE"], [43, 46, "GENE"]]}], ["Our biological functional assays exemplified that adhesion of U937 human leukocytes to HUVECs is co-regulated by PML and TNF \u03b1 signaling.", {"entities": [[113, 116, "GENE"], [121, 124, "GENE"]]}], ["Together, our study identified PML as an essential regulator of TNF \u03b1 signaling by revealing the crosstalk between PML knockdown-mediated effects and TNF \u03b1 -elicited signaling, thereby providing novel insights into TNF \u03b1 signaling in endothelial cells.", {"entities": [[31, 34, "GENE"], [115, 118, "GENE"], [64, 67, "GENE"], [150, 153, "GENE"], [215, 218, "GENE"], [31, 34, "GENE"], [115, 118, "GENE"], [64, 67, "GENE"], [150, 153, "GENE"], [215, 218, "GENE"], [64, 67, "GENE"], [150, 153, "GENE"], [215, 218, "GENE"]]}], ["Immunoglobulin A nephropathy (IgAN) is the most common form of primary glomerulonephritis worldwide and an important cause of kidney disease in young adults.", {"entities": [[71, 89, "DISEASE"], [126, 140, "DISEASE"]]}], ["Highly variable clinical presentation and outcome of IgAN suggest that this diagnosis may encompass multiple subsets of disease that are not distinguishable by currently available clinical tools.", {"entities": []}], ["Marked differences in disease prevalence between individuals of European, Asian, and African ancestry suggest the existence of susceptibility genes that are present at variable frequencies in these populations.", {"entities": []}], ["Familial forms of IgAN have also been reported throughout the world but are probably underrecognized because associated urinary abnormalities are often intermittent in affected family members.", {"entities": []}], ["Of the many pathogenic mechanisms reported, defects in IgA1 glycosylation that lead to formation of immune complexes have been consistently demonstrated.", {"entities": []}], ["Recent data indicates that these IgA1 glycosylation defects are inherited and constitute a heritable risk factor for IgAN.", {"entities": []}], ["Because of the complex genetic architecture of IgAN, the efforts to map disease susceptibility genes have been difficult, and no causative mutations have yet been identified.", {"entities": []}], ["Linkage-based approaches have been hindered by disease heterogeneity and lack of a reliable noninvasive diagnostic test for screening family members at risk of IgAN.", {"entities": []}], ["Many candidate-gene association studies have been published, but most suffer from small sample size and methodological problems, and none of the results have been convincingly validated.", {"entities": []}], ["New genomic approaches, including genome-wide association studies currently under way, offer promising tools for elucidating the genetic basis of IgAN.", {"entities": []}], ["The online version of this article (doi:10.1007/s00467-010-1500-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["For schizophrenia, bipolar disorder, and autism, clinical descriptions are precise and reliable, but there is great overlap among diagnoses in associated genetic polymorphisms and rare variants, treatment response, and other phenomenological findings such as brain imaging.", {"entities": [[4, 17, "DISEASE"], [19, 35, "DISEASE"]]}], ["It is widely hoped that new diagnostic categories can be developed which are more precise and predictive of important features of illness, particularly response to pharmacological agents.", {"entities": []}], ["It is the intent of this paper to describe the diagnostic implications of some current genetic findings, and to describe how the genetic associations with diagnosis may be teased apart into new associations with biologically coherent diagnostic entities and scales, based on the various functional aspects of the associated genes and functional genomic data.", {"entities": []}], ["Verifying the proteins that are targeted by compounds of natural herbs will be helpful to select natural herb-based drug candidates.", {"entities": []}], ["However, this entails a great deal of effort to clarify the interaction throughout in vitro or in vivo experiments.", {"entities": []}], ["In this light, in silico prediction of the interactions between compounds and target proteins can help ease the efforts.", {"entities": []}], ["In this study, we performed in silico predictions of herbal compound target identification.", {"entities": []}], ["First, data related to compounds, target proteins, and interactions between them are taken from the DrugBank database.", {"entities": []}], ["Then we characterized six classes of compound-target interaction in humans including G-protein-coupled receptors (GPCRs), ion channel, enzymes, receptors, transporters, and other proteins.", {"entities": []}], ["Also, classification-prediction models that predict the interactions between compounds and target proteins through a machine learning method were constructed using these matrices.", {"entities": []}], ["As a result, AUC values of six classes are 0.94, 0.93, 0.90, 0.89, 0.91, and 0.76 respectively.", {"entities": []}], ["Finally, the interactions of compounds from natural products were predicted using the constructed classification models.", {"entities": []}], ["Furthermore, from our predicted results, we confirmed that several important disease related proteins were predicted as targets of natural herbal compounds.", {"entities": []}], ["We constructed classification-prediction models that predict the interactions between compounds and target proteins.", {"entities": []}], ["The constructed models showed good prediction performances, and numbers of potential natural compounds target proteins were predicted from our results.", {"entities": []}], ["Porphyromonas gingivalis ( P. gingivalis ) is considered to be involved in the development of atherosclerosis.", {"entities": [[94, 109, "DISEASE"]]}], ["However, the role of different virulence factors produced by P. gingivalis in this process is still uncertain.", {"entities": []}], ["The aim of this study was to investigate the transcriptional profiling of human aortic smooth muscle cells (AoSMCs) infected with wild type, gingipain mutants or fimbriae mutants of P. gingivalis .", {"entities": []}], ["AoSMCs were exposed to wild type (W50 and 381), gingipain mutants (E8 and K1A), or fimbriae mutants (DPG-3 and KRX-178) of P. gingivalis.", {"entities": []}], ["We observed that wild type P. gingivalis changes the expression of a considerable larger number of genes in AoSMCs compare to gingipain and fimbriae mutants, respectively.", {"entities": []}], ["The results from pathway analysis revealed that the common differentially expressed genes for AoSMCs infected by 3 different wild type P. gingivalis strains were enriched in pathways of cancer, cytokine-cytokine receptor interaction, regulation of the actin cytoskeleton, focal adhesion, and MAPK signaling pathway.", {"entities": [[186, 192, "DISEASE"]]}], ["Disease ontology analysis showed that various strains of P. gingivalis were associated with different disease profilings.", {"entities": []}], ["Our results suggest that gingipains and fimbriae, especially arginine-specific gingipain, produced by P. gingivalis play important roles in the association between periodontitis and other inflammatory diseases, including atherosclerosis.", {"entities": [[221, 236, "DISEASE"], [164, 177, "DISEASE"]]}], ["Major basic protein (MBP), the predominant cationic protein of human eosinophil specific granules, is stored within crystalloid cores of these granules.", {"entities": [[21, 24, "GENE"]]}], ["Secretion of MBP contributes to the immunopathogenesis of varied diseases.", {"entities": [[13, 16, "GENE"]]}], ["Prior electron microscopy (EM) of eosinophils in sites of inflammation noted losses of granule cores in the absence of granule exocytosis and suggested that eosinophil granule proteins might be released through piecemeal degranulation (PMD), a secretory process mediated by transport vesicles.", {"entities": []}], ["Because release of eosinophil granule-derived MBP through PMD has not been studied, we evaluated secretion of this cationic protein by human eosinophils.", {"entities": [[46, 49, "GENE"]]}], ["Intracellular localizations of MBP were studied within non-stimulated and eotaxin-stimulated human eosinophils by both immunofluorescence and a pre-embedding immunonanogold electron microscopy (EM) method which enables optimal epitope preservation and antigen access to membrane microdomains.", {"entities": [[31, 34, "GENE"]]}], ["In parallel, quantification of transport vesicles was assessed in eosinophils from a patient with hypereosinophilic syndrome (HES).", {"entities": [[116, 124, "DISEASE"]]}], ["Our data demonstrate vesicular trafficking of MBP within eotaxin-stimulated eosinophils.", {"entities": [[46, 49, "GENE"]]}], ["Vesicular compartments, previously implicated in transport from granules to the plasma membrane, including large vesiculotubular carriers termed eosinophil sombrero vesicles (EoSVs), were found to contain MBP.", {"entities": [[205, 208, "GENE"]]}], ["These secretory compartments were significantly increased in numbers within HES eosinophils.", {"entities": []}], ["Moreover, in addition to granule-stored MBP, even unstimulated eosinophils contained appreciable amounts of MBP within secretory vesicles, as evidenced by immunonanogold EM and immunofluorescent co-localizations of MBP and CD63.", {"entities": [[40, 43, "GENE"], [108, 111, "GENE"], [215, 218, "GENE"], [40, 43, "GENE"], [108, 111, "GENE"], [215, 218, "GENE"], [40, 43, "GENE"], [108, 111, "GENE"], [215, 218, "GENE"], [223, 227, "GENE"]]}], ["These data suggest that eosinophil MBP, with its multiple extracellular activities, can be mobilized from granules via PMD into secretory vesicles and both granule- and secretory vesicle-stored pools of MBP are available for agonist-elicited secretion of MBP from human eosinophils.", {"entities": [[35, 38, "GENE"], [203, 206, "GENE"], [255, 258, "GENE"], [35, 38, "GENE"], [203, 206, "GENE"], [255, 258, "GENE"], [35, 38, "GENE"], [203, 206, "GENE"], [255, 258, "GENE"]]}], ["The recognition of PMD as a secretory process to release MBP is important to understand the pathological basis of allergic and other eosinophil-associated inflammatory diseases.", {"entities": [[57, 60, "GENE"]]}], ["The increased expression of placental growth factor (PlGF) in chronic obstructive pulmonary disease and allergy-related asthma suggests its role in the pathogenesis of these diseases.", {"entities": [[62, 99, "DISEASE"], [120, 126, "DISEASE"]]}], ["In asthmatic smokers, airway remodelling is accompanied by an accelerated decline in lung function.", {"entities": []}], ["However, whether PlGF contributes to the persistent airflow obstruction and vascular remodelling typically seen in asthmatic smokers is unknown.", {"entities": []}], ["In this study we measured lung function, airway-wall thickening, and PlGF levels in serum and induced sputum in 74 asthmatic and 42 healthy smokers and never-smokers.", {"entities": []}], ["Using human lung microvascular endothelial cells (HLMECs), we evaluated the in vitro effects of PlGF on each step of vascular remodelling, including proliferation, migration, stress-fibre expression, and tubule formation.", {"entities": []}], ["Our data showed significantly higher serum and sputum PlGF levels in asthma patients, especially asthmatic smokers, than in healthy controls.", {"entities": [[69, 75, "DISEASE"]]}], ["Serum and sputum PlGF levels correlated negatively with post-bronchodilator forced expiratory volume in 1\u2009s (FEV 1 ) and the FEV 1 /forced vital capacity, but positively with airway-wall thickening.", {"entities": [[109, 112, "GENE"], [125, 128, "GENE"], [109, 112, "GENE"], [125, 128, "GENE"]]}], ["Stimulation of HLMECs with rhPlGF promoted all of the steps of airway-microvascular remodelling.", {"entities": []}], ["These findings provide insights into the influence of cigarette smoking on the structural changes in the airways of asthmatics and the important pathogenic role played by PlGF.", {"entities": []}], ["The impact of \u2009lipoxin A 4 (LXA 4 ) and aspirin-triggered lipoxins (ATLs) was investigated in tumor necrosis factor (TNF)-\u03b1\u2013initiated neutrophil (polymorphonuclear leukocyte) responses in vitro and in vivo using metabolically stable LX analogues.", {"entities": [[117, 120, "GENE"]]}], ["At concentrations as low as 1\u201310 nM, the LXA 4 and ATL analogues each inhibited TNF-\u03b1\u2013stimulated superoxide anion generation and IL-1\u03b2 release by human polymorphonuclear leukocytes.", {"entities": []}], ["These LXA 4 -ATL actions were time and concentration dependent and proved selective for TNF-\u03b1, as these responses were not altered with either GM-CSF\u2013 or zymosan-stimulated cells.", {"entities": []}], ["TNF-\u03b1\u2013induced IL-1\u03b2 gene expression was also regulated by both anti-LXA 4 receptor antibodies and LXA 4 -ATL analogues.", {"entities": []}], ["In murine air pouches, 15 R/S -methyl-LXA 4 dramatically inhibited TNF-\u03b1\u2013stimulated leukocyte trafficking, as well as the appearance of both macrophage inflammatory peptide 2 and IL-1\u03b2, while concomitantly stimulating IL-4 in pouch exudates.", {"entities": []}], ["Together, these results indicate that both LXA 4 and ATL regulate TNF-\u03b1\u2013directed neutrophil actions in vitro and in vivo and stimulate IL-4 in exudates, playing a pivotal role in immune responses.", {"entities": []}], ["The combination of cromolyn and ibuprofen is being investigated as a treatment for early Alzheimer\u2019s disease (AD).", {"entities": []}], ["This study investigated the pharmacokinetics, safety, and tolerability of cromolyn and ibuprofen co-administration in healthy elderly adult volunteers.", {"entities": []}], ["In this open-labeled study, 26 subjects, aged 55\u201375\u00a0years, received co-administration of inhaled cromolyn (single dose 17.1\u00a0mg; double dose 34.2\u00a0mg total) and oral ibuprofen (single dose 10 mg; double dose 20\u00a0mg total).", {"entities": []}], ["Blood sampling was performed for 6\u00a0h after co-administration in all subjects; cerebrospinal fluid (CSF) was collected in three to four subjects per cohort for 4\u00a0h following co-administration.", {"entities": []}], ["Safety parameters, including adverse events (AEs), were monitored throughout the study.", {"entities": []}], ["For cromolyn, the mean (\u00b1SD) maximum observed concentration ( C max ) in plasma was 46.69 \u00b1 32.97 and 96.75 \u00b1 46.22\u00a0ng/ml after single- and double-dose inhalation, respectively [time to C max ( t max ) ~22\u00a0min for each; terminal elimination half-life ( t \u00bd ) ~1.8\u00a0h for each].", {"entities": [[64, 67, "GENE"], [188, 191, "GENE"], [196, 199, "GENE"], [64, 67, "GENE"], [188, 191, "GENE"], [196, 199, "GENE"], [64, 67, "GENE"], [188, 191, "GENE"], [196, 199, "GENE"]]}], ["For ibuprofen, the plasma C max was 1090.98 \u00b1 474.64\u00a0ng/ml and 2062.96 \u00b1 655.13 ng/ml after single- and double-dose oral administration, respectively ( t max ~1.6\u20131.8 h; t \u00bd ~1.9\u00a0h for each).", {"entities": [[28, 31, "GENE"], [154, 157, "GENE"], [28, 31, "GENE"], [154, 157, "GENE"]]}], ["For cromolyn, the CSF C max was 0.24 \u00b1 0.08\u00a0ng/ml at 3.72 \u00b1 0.70\u00a0h after single-dose administration and 0.34 \u00b1 0.17\u00a0ng/ml at 3.45 \u00b1 0.95\u00a0h after double-dose administration, and for ibuprofen, the CSF C max was 3.94 \u00b1 1.29\u00a0ng/ml at 2.55 \u00b1 0.96\u00a0h after single-dose administration and 8.93 \u00b1 3.29\u00a0ng/ml at 3.15 \u00b1 1.05\u00a0h after double-dose administration.", {"entities": [[24, 27, "GENE"], [202, 205, "GENE"], [24, 27, "GENE"], [202, 205, "GENE"]]}], ["Three (12%) subjects reported mild or moderate AEs which were unlikely to be related to study drug.", {"entities": []}], ["The combination of cromolyn and ibuprofen was safe and well tolerated.", {"entities": []}], ["The concentrations of cromolyn and ibuprofen observed in the CSF are considered sufficient to titrate the estimated daily amyloid production and the associated inflammatory response in patients with AD.", {"entities": []}], ["The online version of this article (doi:10.1007/s40261-017-0549-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Chitosan and Agaricus blazei Murill (ABM) extracts possess antitumor activities.", {"entities": []}], ["The aim of the present study was to investigate whether chitosan, ABM extract or the two in combination were effective against tumors in tumor-bearing mice.", {"entities": []}], ["The mice were subcutaneously injected with SK-Hep 1 cells and were then were divided into the following six groups: Group 1, control group; group 2, chitosan 5 mg/kg/day; group 3, chitosan 20 mg/kg/day; group 4, ABM (246 mg/kg/day) and chitosan (5 mg/kg/day) combined; group 5, ABM (984 mg/kg/day) and chitosan (20 mg/kg/day) combined; and group 6, ABM (984 mg/kg/day).", {"entities": []}], ["The mice were treated with the different concentrations of chitosan, ABM or combinations of the two for 6 weeks.", {"entities": []}], ["The levels of glutamic oxaloacetic transaminase (GOT), glutamic pyruvic transaminase (GPT) and vascular endothelial growth factor (VEGF), and tissue histopathological features were examined in the surviving animals.", {"entities": [[86, 89, "GENE"]]}], ["Based on the results of the investigation, the treatments performed in groups 2, 3 and 4 were identified as being capable of reducing the weights of the tumors, however, group 4, which was treated with chitosan (5 mg/kg/day) in combination with ABM (246 mg/kg/day) was able to reduce the levels of GOT and VEGF.", {"entities": []}], ["As a result, treatment with chitosan in combination with ABM may offer potential in cancer therapy and requires further investigation.", {"entities": [[84, 90, "DISEASE"]]}], ["The primary objective of this study was to identify the existence of chronic disease multimorbidity patterns in the primary care population, describing their clinical components and analysing how these patterns change and evolve over time both in women and men.", {"entities": []}], ["The secondary objective of this study was to generate evidence regarding the pathophysiological processes underlying multimorbidity and to understand the interactions and synergies among the various diseases.", {"entities": []}], ["This observational, retrospective, multicentre study utilised information from the electronic medical records of 19 primary care centres from 2008.", {"entities": []}], ["To identify multimorbidity patterns, an exploratory factor analysis was carried out based on the tetra-choric correlations between the diagnostic information of 275,682 patients who were over 14 years of age.", {"entities": []}], ["The analysis was stratified by age group and sex.", {"entities": []}], ["Multimorbidity was found in all age groups, and its prevalence ranged from 13% in the 15 to 44 year age group to 67% in those 65 years of age or older.", {"entities": []}], ["Goodness-of-fit indicators revealed sample values between 0.50 and 0.71.", {"entities": []}], ["We identified five patterns of multimorbidity: cardio-metabolic, psychiatric-substance abuse, mechanical-obesity-thyroidal, psychogeriatric and depressive.", {"entities": [[77, 92, "DISEASE"], [105, 112, "DISEASE"]]}], ["Some of these patterns were found to evolve with age, and there were differences between men and women.", {"entities": []}], ["Non-random associations between chronic diseases result in clinically consistent multimorbidity patterns affecting a significant proportion of the population.", {"entities": []}], ["Underlying pathophysiological phenomena were observed upon which action can be taken both from a clinical, individual-level perspective and from a public health or population-level perspective.", {"entities": []}], ["Our microbial companions (the \u201cmicrobiota\u201d) are extremely important for the preservation of human health.", {"entities": []}], ["Although changes in bacterial communities (dysbiosis) are commonly associated with disease, such changes have also been described in healthy pregnancies, where the microbiome plays an essential role in maternal and child health outcomes, including normal immune and metabolic function in later life.", {"entities": []}], ["Nevertheless, this new understanding of the importance of the microbiome has not yet influenced contemporary clinical practice regarding antibiotic use during pregnancy.", {"entities": []}], ["Antibiotic treatment during pregnancy is widespread in Western countries, and accounts for 80\u00a0% of prescribed medications in pregnancy.", {"entities": []}], ["However, antibiotic treatment, while at times lifesaving, can also have detrimental consequences.", {"entities": []}], ["A single course of antibiotics perturbs bacterial communities, with evidence that the microbial ecosystem does not return completely to baseline following treatment.", {"entities": []}], ["Antibiotics in pregnancy should be used only when indicated, choosing those with the narrowest range possible.", {"entities": []}], ["Bacteria are essential for normal human development and, while antibiotic treatment during pregnancy has an important role in controlling and preventing infections, it may have undesired effects regarding the maternal and fetoplacental microbiomes.", {"entities": []}], ["We expect that microbiota manipulation in pregnancy, through the use of probiotics and fecal microbiota transplantation, will be the subject of increasing clinical interest.", {"entities": []}], ["To compare the diagnostic accuracy and time expenditure of screening models based on glycated hemoglobin (HbA 1c ) level and psychometric measures for mood disorder (MD) among children with type 1 diabetes.", {"entities": [[151, 164, "DISEASE"]]}], ["With semistructured clinical interviews (Schedule for Affective Disorders and Schizophrenia for Children\u2013Present and Lifetime version, 120 min/patient) as a reference for diagnosing MD, including major depressive disorder (MDD), we tested 163 subjects, aged 8 to 18 years, with type 1 diabetes.", {"entities": [[196, 221, "DISEASE"]]}], ["We evaluated four screening approaches: 1 ) Children\u2019s Depression Inventory (CDI) at 30 min/patient, 2 ) HbA 1c level, 3 ) HbA 1c level plus CDI, and 4 ) HbA 1c level plus Children's Depression Rating Scale (CDRS) at 40 min/patient.", {"entities": []}], ["These tests were conducted with all participants, and the total time expenditure for all four approaches was calculated as the total time needed to implement successfully the screening for MD or MDD in the center.", {"entities": []}], ["HbA 1c performed on par with individual psychometric tests in diagnosing MD or MDD.", {"entities": []}], ["The HbA 1c plus CDRS model was the best screening procedure for both MD and MDD, with diagnostic thresholds for HbA 1c established at 8.7% and 9.0%, respectively.", {"entities": []}], ["Cutoff points for CDRS assessed after filtering by HbA 1c were 26 (MD) and 30 (MDD) points.", {"entities": []}], ["Center-wide application of this procedure would result in an 83% reduction of the examination time necessary for the psychiatrist for MD screening and a 91% reduction for MDD screening, as compared with standard screening with CDI.", {"entities": []}], ["Use of HbA 1c level followed by CDRS is a time-efficient procedure to screen for MD in children with type 1 diabetes.", {"entities": []}], ["Volcanic ash contributed significantly to particulate matter (PM) in Iceland following the eruptions in Eyjafjallaj\u00f6kull 2010 and Gr\u00edmsv\u00f6tn 2011.", {"entities": []}], ["This study aimed to investigate the association between different PM sources and emergency hospital visits for cardiorespiratory causes from 2007 to 2012.", {"entities": []}], ["Indicators of PM 10 sources; \u201cvolcanic ash\u201d, \u201cdust storms\u201d, or \u201cother sources\u201d (traffic, fireworks, and re-suspension) on days when PM 10 exceeded the daily air quality guideline value of 50 \u00b5g/m 10 exceeded the air quality guideline value 115 out of 2191 days; 20 days due to volcanic ash, 14 due to dust storms (two days had both dust storm and ash contribution) and 83 due to other sources.", {"entities": []}], ["High PM 10 levels from volcanic ash tended to be significantly associated with the emergency hospital visits; estimates ranged from 4.8% (95% Confidence Interval (CI): 0.6, 9.2%) per day of exposure in unadjusted models to 7.3% (95% CI: \u22120.4, 15.5%) in adjusted models.", {"entities": []}], ["Dust storms were not consistently associated with daily emergency hospital visits and other sources tended to show a negative association.", {"entities": []}], ["We found some evidence indicating that volcanic ash particles were more harmful than particles from other sources, but the results were inconclusive and should be interpreted with caution.", {"entities": []}], ["Cystic fibrosis is characterized by recurring pulmonary exacerbations that lead to the deterioration of lung function and eventual lung failure.", {"entities": []}], ["Excessive inflammatory responses by airway epithelia have been linked to the overproduction of the inflammatory cytokine IL-6 and IL-8.", {"entities": []}], ["The mechanism by which this occurs is not fully understood, but normal IL-1\u03b2 mediated activation of the production of these cytokines occurs via H 2 O 2 dependent signaling.", {"entities": []}], ["Therefore, we speculated that CFTR dysfunction causes alterations in the regulation of steady state H 2 O 2 .", {"entities": [[30, 34, "GENE"]]}], ["We found significantly elevated levels of H 2 O 2 in three cultured epithelial cell models of CF, one primary and two immortalized.", {"entities": []}], ["Increases in H 2 O 2 heavily contributed to the excessive IL-6 and IL-8 production in CF epithelia.", {"entities": []}], ["Proteomic analysis of three in vitro and two in vivo models revealed a decrease in antioxidant proteins that regulate H 2 O 2 processing, by \u22652 fold in CF vs. matched normal controls.", {"entities": []}], ["When cells are stimulated, differential expression in CF versus normal is enhanced; corresponding to an increase in H 2 O 2 mediated production of IL-6 and IL-8.", {"entities": []}], ["The cause of this redox imbalance is a decrease by \u223c70% in CF cells versus normal in the expression and activity of the transcription factor Nrf-2.", {"entities": []}], ["Inhibition of CFTR function in normal cells produced this phenotype, while N-acetyl cysteine, selenium, an activator of Nrf-2, and the overexpression of Nrf-2 all normalized H 2 O 2 processing and decreased IL-6 and IL-8 to normal levels, in CF cells.", {"entities": [[14, 18, "GENE"]]}], ["We conclude that a paradoxical decrease in Nrf-2 driven antioxidant responses in CF epithelia results in an increase in steady state H 2 O 2 , which in turn contributes to the overproduction of the pro-inflammatory cytokines IL-6 and IL-8.", {"entities": []}], ["Treatment with antioxidants can ameliorate exaggerated cytokine production without affecting normal responses.", {"entities": []}], ["Pulmonary emphysema is characterized by alveolar destruction and persistent inflammation of the airways.", {"entities": [[0, 19, "DISEASE"]]}], ["Although IL-17A contributes to many chronic inflammatory diseases, it\u2019s role in the inflammatory response of elastase-induced emphysema remains unclear.", {"entities": []}], ["In a model of elastase-induced pulmonary emphysema we examined the response of IL-17A-deficient mice, monitoring airway inflammation, static compliance, lung histology and levels of neutrophil-related chemokine and pro-inflammatory cytokines in bronchoalveolar lavage (BAL) fluid.", {"entities": [[31, 50, "DISEASE"]]}], ["Wild-type mice developed emphysematous changes in the lung tissue on day 21 after elastase treatment, whereas emphysematous changes were decreased in IL-17A-deficient mice compared to wild-type mice.", {"entities": []}], ["Neutrophilia in BAL fluid, seen in elastase-treated wild-type mice, was reduced in elastase-treated IL-17A-deficient mice on day 4, associated with decreased levels of KC, MIP-2 and IL-1 beta.", {"entities": []}], ["Elastase-treated wild-type mice showed increased IL-17A levels as well as increased numbers of IL-17A+ CD4 T cells in the lung in the initial period following elastase treatment.", {"entities": [[103, 106, "GENE"]]}], ["These data identify the important contribution of IL-17A in the development of elastase-induced pulmonary inflammation and emphysema.", {"entities": []}], ["Targeting IL-17A in emphysema may be a potential therapeutic strategy for delaying disease progression.", {"entities": []}], ["Air pollution and climate change are potential drivers for the increasing burden of allergic diseases.", {"entities": []}], ["The molecular mechanisms by which air pollutants and climate parameters may influence allergic diseases, however, are complex and elusive.", {"entities": []}], ["This article provides an overview of physical, chemical and biological interactions between air pollution, climate change, allergens, adjuvants and the immune system, addressing how these interactions may promote the development of allergies.", {"entities": []}], ["We reviewed and synthesized key findings from atmospheric, climate, and biomedical research.", {"entities": []}], ["The current state of knowledge, open questions, and future research perspectives are outlined and discussed.", {"entities": []}], ["The Anthropocene, as the present era of globally pervasive anthropogenic influence on planet Earth and, thus, on the human environment, is characterized by a strong increase of carbon dioxide, ozone, nitrogen oxides, and combustion- or traffic-related particulate matter in the atmosphere.", {"entities": []}], ["These environmental factors can enhance the abundance and induce chemical modifications of allergens, increase oxidative stress in the human body, and skew the immune system toward allergic reactions.", {"entities": []}], ["In particular, air pollutants can act as adjuvants and alter the immunogenicity of allergenic proteins, while climate change affects the atmospheric abundance and human exposure to bioaerosols and aeroallergens.", {"entities": []}], ["To fully understand and effectively mitigate the adverse effects of air pollution and climate change on allergic diseases, several challenges remain to be resolved.", {"entities": []}], ["Among these are the identification and quantification of immunochemical reaction pathways involving allergens and adjuvants under relevant environmental and physiological conditions.", {"entities": []}], ["When the immune system encounters incoming infectious agents, this generally leads to immunity.", {"entities": []}], ["The evoked immune response is usually robust, but can be severely perturbed by potentially harmful environmental agents such as chemicals, pharmaceuticals and allergens.", {"entities": []}], ["Immunosuppression, hypersensitivity and autoimmunity may occur due to changed immune activity.", {"entities": []}], ["Evaluation of the immunotoxic potency of agents as part of risk assessment is currently established in vivo with animal models and in vitro with cell lines or primary cells.", {"entities": []}], ["Although in vivo testing is usually the most relevant situation for many agents, more and more in vitro models are being developed for assessment of immunotoxicity.", {"entities": []}], ["In this context, hypersensitivity and immunosuppression are considered to be a primary focus for developing in vitro methods.", {"entities": []}], ["Three-dimensional organotypic tissue models are also part of current research in immunotoxicology.", {"entities": []}], ["In recent years, there has been a revival of interest in organotypic tissue models.", {"entities": []}], ["In the context of immunotoxicity testing, precision-cut lung slices in particular have been intensively studied.", {"entities": []}], ["Therefore, this review is very much focused on pulmonary immunotoxicology.", {"entities": []}], ["Respiratory hypersensitivity and inflammation are further highlighted aspects of this review.", {"entities": []}], ["Immunotoxicity assessment currently is of limited use in other tissue models, which are therefore described only briefly within this review.", {"entities": []}], ["While asthma presentation is heterogeneous, current asthma management guidelines in primary care are quite homogeneous.", {"entities": [[6, 12, "DISEASE"], [52, 58, "DISEASE"]]}], ["In this study we aim to cluster patients together into different phenotypes, that may aid the general practitioner in individualised asthma management.", {"entities": [[133, 139, "DISEASE"]]}], ["We analysed data from the ACCURATE trial, containing 611 adult asthmatics, 18\u201350 year-old, treated in primary care, with one year follow-up.", {"entities": []}], ["Variables obtained at baseline ( n \u2009=\u200914), were assessed by cluster analysis.", {"entities": []}], ["Subsequently, established phenotypes were assessed separately on important asthma outcomes after one year follow-up: asthma control (Asthma Control Questionnaire (ACQ)), quality of life (Asthma Quality of Life Questionnaire (AQLQ)), exacerbation-rate and medication-usage.", {"entities": [[75, 81, "DISEASE"], [117, 123, "DISEASE"], [133, 139, "DISEASE"], [187, 193, "DISEASE"]]}], ["Five distinct phenotypes were identified.", {"entities": []}], ["The first phenotype was predominantly defined by their early onset atopic form of asthma.", {"entities": [[82, 88, "DISEASE"]]}], ["The second phenotype mainly consisted of female patients with a late onset asthma.", {"entities": [[75, 81, "DISEASE"]]}], ["The third phenotype were patients with high reversibility rates after bronchodilator usage.", {"entities": []}], ["The fourth phenotype were smokers and the final phenotype were frequent exacerbators.", {"entities": []}], ["The exacerbators phenotype had the worst outcomes for asthma control and quality of life and experienced the highest exacerbation-rate, despite using the most medication.", {"entities": [[54, 60, "DISEASE"]]}], ["The early onset phenotype patients were relatively well controlled and their medication dosage was low.", {"entities": []}], ["Asthma patients should be characterised according to their individual asthma type to ensure more targeted treatment.", {"entities": [[0, 6, "DISEASE"], [70, 76, "DISEASE"]]}], ["Even though asthma manifests itself in a wide variety of forms with differing degrees of severity, treatment of the disease often takes a broad, one-size-fits-all approach.", {"entities": [[12, 18, "DISEASE"]]}], ["To determine if asthma can indeed be split into distinct phenotypes, Rishi Khusial\u00a0at the Leiden University Medical Center and co-workers across the Netherlands analysed data from 611 adult asthmatics treated in primary care, and followed them up after one year.", {"entities": [[16, 22, "DISEASE"]]}], ["The team identified five phenotypes in the primary care cohort, including one group with early onset asthma, another whose asthma responded well to bronchodilators, and a group classed as frequent exacerbators.", {"entities": [[101, 107, "DISEASE"], [123, 129, "DISEASE"]]}], ["Further analysis of long-term asthma outcomes showed clear differences between phenotypes, particularly in terms of asthma control and quality of life.", {"entities": [[30, 36, "DISEASE"], [116, 122, "DISEASE"]]}], ["To estimate the prevalence and factors associated with functional disability in adults in Brazil.", {"entities": []}], ["We used information from the health supplement of the National Household Sample Survey in 2008.", {"entities": []}], ["The dependent variable was the functional disability among adults of 18 to 65 years, measured by the difficulty of walking about 100 meters; independent variables were: health plan membership, region of residence, state of domicile, education level, household income, economic activity, self-perception of health, hospitalization, chronic diseases, age group, sex, and color.", {"entities": []}], ["We calculated the gross odds ratios (OR), and their respective confidence intervals (95%), and adjusted them for variables of study by ordinal logistic regression, following hierarchical model.", {"entities": []}], ["Sample weights were considered in all calculations.", {"entities": []}], ["We included 18,745 subjects, 74.0% of whom were women.", {"entities": []}], ["More than a third of adults reported having functional disability.", {"entities": []}], ["The disability was significantly higher among men (OR = 1.17; 95%CI 1.09;1.27), people from 35 to 49 years (OR = 1.30; 95%CI 1.17;1.45) and 50 to 65 years (OR = 1.38; 95%CI 1.24;1.54); economically inactive individuals (OR = 2.21; 95%CI 1.65;2.96); adults who reported heart disease (OR = 1.13; 95%CI 1.03;1.24), diabetes mellitus (OR = 1.16; 95%CI 1.05;1.29), arterial systemic hypertension (OR = 1.10; 95%CI 1.02;1.18), and arthritis/rheumatism (OR = 1.24; 95%CI 1.15;1.34); and participants who were admitted in the last 12 months (OR = 2.35; 95%CI 1.73;3.2).", {"entities": [[379, 391, "DISEASE"], [269, 282, "DISEASE"], [426, 435, "DISEASE"], [313, 330, "DISEASE"]]}], ["Functional disability is common among Brazilian adults.", {"entities": []}], ["Hospitalization is the most strongly associated factor, followed by economic activity, and chronic diseases.", {"entities": []}], ["Sex, age, education, and income are also associated.", {"entities": []}], ["Results indicate specific targets for actions that address the main factors associated with functional disabilities and contribute to the projection of interventions for the improvement of the well-being and promotion of adults\u2019 quality of life.", {"entities": []}], ["Estimar a preval\u00eancia e os fatores associados \u00e0 incapacidade funcional em adultos do Brasil.", {"entities": []}], ["Foram utilizadas as informa\u00e7\u00f5es do suplemento sa\u00fade da Pesquisa Nacional por Amostra de Domic\u00edlios de 2008.", {"entities": [[73, 76, "GENE"]]}], ["A vari\u00e1vel dependente foi a incapacidade funcional entre adultos de 18 a 65 anos, mensurada pela dificuldade para caminhar cerca de 100 metros e as vari\u00e1veis independentes foram filia\u00e7\u00e3o a plano de sa\u00fade, regi\u00e3o de resid\u00eancia, situa\u00e7\u00e3o de domic\u00edlio, n\u00edvel de escolaridade, renda familiar, atividade econ\u00f4mica, autopercep\u00e7\u00e3o de sa\u00fade, interna\u00e7\u00e3o hospitalar, doen\u00e7as cr\u00f4nicas, faixa et\u00e1ria, sexo e cor.", {"entities": []}], ["Foram calculados os odds ratios (OR) brutos e seus respectivos intervalos de confian\u00e7a (IC95%) e ajustados para vari\u00e1veis do estudo por meio de regress\u00e3o log\u00edstica ordinal seguindo modelo hierarquizado.", {"entities": [[132, 135, "GENE"]]}], ["Os pesos amostrais foram considerados em todos os c\u00e1lculos.", {"entities": []}], ["Foram inclu\u00eddos 18.745 sujeitos, 74,0% dos quais constitu\u00edram mulheres.", {"entities": []}], ["Mais de um ter\u00e7o dos adultos relataram ter incapacidade funcional.", {"entities": []}], ["A incapacidade foi significativamente maior entre os homens (OR = 1,17; IC95% 1,09;1,27), pessoas de 35 a 49 anos (OR = 1,30; IC95% 1,17;1,45) e 50 a 65 anos (OR = 1,38; IC95% 1,24;1,54); indiv\u00edduos inativos economicamente (OR = 2,21; IC95% 1,65;2,96); adultos que reportaram ter doen\u00e7as cardiovasculares (OR = 1,13; IC95% 1,03;1,24), diabetes mellitus (OR = 1,16; IC95% 1,05;1,29), hipertens\u00e3o arterial sist\u00eamica (OR = 1,10; IC95% 1,02;1,18), e artrite/reumatismo (OR = 1,24; IC95% 1,15;1,34); e participantes que estiveram internados nos \u00faltimos 12 meses (OR = 2,35; IC95% 1,73;3,2).", {"entities": [[335, 352, "DISEASE"]]}], ["Incapacidade funcional \u00e9 comum entre os adultos brasileiros.", {"entities": []}], ["A interna\u00e7\u00e3o hospitalar \u00e9 o fator mais fortemente associado, seguida de atividade econ\u00f4mica e doen\u00e7as cr\u00f4nicas.", {"entities": []}], ["Sexo, idade, escolaridade e renda tamb\u00e9m s\u00e3o associados.", {"entities": []}], ["Os resultados indicam alvos espec\u00edficos para a\u00e7\u00f5es que abordem os principais fatores associados \u00e0 incapacidade funcional e contribuem na proje\u00e7\u00e3o de interven\u00e7\u00f5es para a melhora do bem-estar e promo\u00e7\u00e3o da qualidade de vida dos adultos brasileiros.", {"entities": []}], ["DNase autoantibodies (Abs) can be found in the blood of patients with several autoimmune diseases, while the blood of healthy donors or patients with diseases with insignificant disturbances of the immune status does not contain the DNase Abs.", {"entities": []}], ["Here we have analysed for the first time the DNase activity in the patients with diseases caused by several bacterial infections.", {"entities": []}], ["Several rigid criteria have been applied to show that the DNase activity is an intrinsic property of IgGs from the sera of patients with bacterial diseases but not from healthy donors.", {"entities": []}], ["The relative activity of IgGs has been shown to vary extensively between the diseases analysed and from patient to patient, but most of the preparations had detectable levels of the DNase activity.", {"entities": []}], ["On average, the catalytic activities were significantly lower than in patients with autoimmune pathologies and increased in the following order: streptococcal infection (erysipelas) < urogenital chlamydiosis associated with arthritis (Reiter\u2019s disease) < meningococcal meningitis < shigellosis < suppurative surgical infections caused by Staphylococcus aureus < suppurative surgical infections caused by epidermal staphylococci < urogenital ureaplasmosis associated with reactive arthritis.", {"entities": [[471, 489, "DISEASE"], [282, 293, "DISEASE"], [170, 180, "DISEASE"], [269, 279, "DISEASE"], [224, 233, "DISEASE"], [480, 489, "DISEASE"]]}], ["While intact IgGs possessed this catalytic activity, separated light chains of polyclonal Abs appeared to be even more active in the hydrolysis of DNA.", {"entities": []}], ["To protect residents from tobacco smoke exposure (TSE), the Boston Housing Authority (BHA) prohibited smoking in BHA-owned apartments beginning in 2012.", {"entities": []}], ["Our goal was to determine if the smoke-free policy reduced TSE for non-smoking BHA residents.", {"entities": []}], ["We compared TSE before the smoke-free policy (2012) and one year later among BHA residents as well as residents of the neighboring Cambridge Housing Authority (CHA) where no such policy was in place.", {"entities": []}], ["Participants were a convenience sample of adult non-smoking BHA and CHA residents cohabitating with only non-smokers.", {"entities": []}], ["Main outcomes were 7-day airborne nicotine in participants\u2019 apartments; residents\u2019 saliva cotinine; and residents\u2019 self-reported TSE.", {"entities": []}], ["We enrolled 287 confirmed non-smokers (192 BHA, 95 CHA).", {"entities": []}], ["Seventy-nine percent (229) were assessed at follow-up.", {"entities": []}], ["At baseline, apartment and resident TSE were high in both housing authorities (detectable airborne nicotine: 46% BHA, 48% CHA; detectable saliva cotinine: 49% BHA, 70% CHA).", {"entities": []}], ["At follow-up there were significant but similar declines in nicotine in both sites (detectable: -33% BHA, -39% CHA, p = 0.40).", {"entities": []}], ["Detectable cotinine rose among BHA residents while declining among CHA participants (+17% BHA vs. -13% CHA, p = 0.002).", {"entities": []}], ["Resident self-reported TSE within and outside of the housing environment decreased similarly for both BHA and CHA residents.", {"entities": []}], ["Apartment air nicotine decreased after the introduction of the smoke-free policy, though the decline may not have resulted from the policy.", {"entities": []}], ["The BHA policy did not result in reduced individual-level TSE.", {"entities": []}], ["Unmeasured sources of non-residential TSE may have contributed to BHA residents\u2019 cotinine levels.", {"entities": []}], ["Fstl1, a secreted protein of the BMP antagonist class, has been implicated in the regulation of lung development and alveolar maturation.", {"entities": [[0, 5, "GENE"]]}], ["Here we generated a Fstl1-lacZ reporter mouse line as well as a Fstl1 knockout allele.", {"entities": [[20, 25, "GENE"], [64, 69, "GENE"]]}], ["We localized Fstl1 transcript in lung smooth muscle cells and identified Fstl1 as essential regulator of lung smooth muscle formation.", {"entities": [[13, 18, "GENE"], [73, 78, "GENE"], [13, 18, "GENE"], [73, 78, "GENE"]]}], ["Deletion of Fstl1 in mice led to postnatal death as a result of respiratory failure due to multiple defects in lung development.", {"entities": [[64, 83, "DISEASE"], [12, 17, "GENE"]]}], ["Analysis of the mutant phenotype showed impaired airway smooth muscle (SM) manifested as smaller SM line in trachea and discontinued SM surrounding bronchi, which were associated with decreased transcriptional factors myocardin/serum response factor (SRF) and impaired differentiation of SM cells.", {"entities": [[251, 254, "GENE"]]}], ["Fstl1 knockout mice also displayed abnormal vasculature SM manifested as hyperplasia SM in pulmonary artery.", {"entities": [[0, 5, "GENE"]]}], ["This study indicates a pivotal role for Fstl1 in early stage of lung airway smooth muscle development.", {"entities": [[40, 45, "GENE"]]}], ["Following the 2005-6 chikungunya outbreak, a project to strengthen regional Public Health preparedness in the Indian Ocean was implemented.", {"entities": [[21, 32, "DISEASE"]]}], ["It includes the Comoros, Madagascar, Mauritius, Reunion (France) and Seychelles.", {"entities": []}], ["A Field Epidemiology Training Programme (FETP-OI) was started in 2011 to develop a pool of well-trained intervention epidemiologists.", {"entities": []}], ["The FETP-OI consists of two years of supervised, learning-by-doing, on-the-job training at national sites involved in disease surveillance and response.", {"entities": []}], ["It includes work placements at the Madagascar Pasteur Institute and the French regional epidemiology unit in Reunion and up to three training courses per year.", {"entities": []}], ["Training objectives include epidemiological surveillance, outbreak investigations, research studies, scientific communication and transfer of competencies.", {"entities": []}], ["In four years, two cohorts of in total 15 fellows originating from four countries followed the FETP-OI.", {"entities": []}], ["They led 42 surveillance projects (71% routine management, 14% evaluations, 12% setup, 3% other) and investigated 36 outbreak alerts, 58% of them in Madagascar; most investigations (72%) concerned foodborne pathogens, plague or malaria.", {"entities": [[218, 224, "DISEASE"], [228, 235, "DISEASE"]]}], ["Fellows performed 18 studies (44% descriptive analyses, 22% disease risk factors, and 34% on other subjects), and presented results during regional and international conferences through 26 oral and 15 poster presentations.", {"entities": []}], ["Four articles were published in regional Public Health bulletins and several scientific manuscripts are in process.", {"entities": []}], ["The FETP-OI has created a regional force of intervention consisting of field epidemiologists and trained supervisors using the same technical language and epidemiological methods.", {"entities": []}], ["The third cohort is now ongoing.", {"entities": []}], ["Technically and financially sustainable FETP-OI projects help addressing public health priorities of the Indian Ocean.", {"entities": []}], ["In models of diabetic retinopathy, insulin-like growth factor binding protein-3 (IGFBP-3) is protective to the retina, especially retinal microvascular endothelial cells (RECs), but the underlying mechanisms are unclear.", {"entities": [[13, 33, "DISEASE"]]}], ["For this study, we hypothesized that IGFBP-3 may reduce vascular endothelial growth factor (VEGF) levels through reduced endothelial nitric oxide synthase (eNOS) activity, which may be protective against macular edema.", {"entities": []}], ["To test this hypothesis, we grew primary human retinal endothelial cells in normal glucose (5 mM) or high glucose (25 mM) for three days, treated with IGFBP-3 NB plasmid (a plasmid of IGFBP-3 that cannot bind IGF-1), followed by western blotting for eNOS, protein kinase C zeta (PKCzeta), and VEGF.", {"entities": []}], ["Additionally, we treated some cells with recombinant eNOS or PKCzeta, after IGFBP-3 NB plasmid transfection to validate that these pathways regulate VEGF levels.", {"entities": []}], ["Immunoprecipitation experiments were done with the eNOS antibody, followed by western blotting for PKCzeta, to determine if eNOS and PKCzeta interact directly.", {"entities": []}], ["Our results suggest that 1) IGFBP-3 inhibits the endothelial nitric oxide synthase (eNOS) and protein kinase C zeta (PKCzeta) pathway, which in turn inhibits VEGF production, and 2) that eNOS plays a role in activating PKCzeta to increase VEGF levels in diabetic retinopathy.", {"entities": [[254, 274, "DISEASE"]]}], ["In conclusion, IGFBP-3 may be a novel treatment for macular edema through the inhibition of eNOS and PKCzeta activation, leading to reduced VEGF levels.", {"entities": []}], ["Contaminants encountered in many households, such as environmental tobacco smoke, house dust mite, cockroach, cat and dog dander, and mold, are risk factors in asthma.", {"entities": [[160, 166, "DISEASE"]]}], ["Young children are a particularly vulnerable subpopulation for environmentally mediated asthma, and the economic burden associated with this disease is substantial.", {"entities": [[88, 94, "DISEASE"]]}], ["Certain mechanical interventions are effective both in reducing allergen loads in the home and in improving asthmatic children\u2019s respiratory health.", {"entities": []}], ["Combinations of interventions including the use of dust mite-impermeable bedding covers, improved cleaning practices, high-efficiency particulate air vacuum cleaners, mechanical ventilation, and parental education are associated with both asthma trigger reduction and improved health outcomes for asthmatic children.", {"entities": [[239, 245, "DISEASE"]]}], ["Compared with valuated health benefits, these combinations of interventions have proven cost effective in studies that have employed them.", {"entities": []}], ["Education alone has not proven effective in changing parental behaviors such as smoking in the home.", {"entities": []}], ["Future research should focus on improving the effectiveness of education on home asthma triggers, and understanding long-term children\u2019s health effects of the interventions that have proven effective in reducing asthma triggers.", {"entities": [[81, 87, "DISEASE"], [212, 218, "DISEASE"]]}], ["Exercise training is recommended for non-cystic fibrosis (CF) bronchiectasis, but the long-term effects are unclear.", {"entities": [[62, 76, "DISEASE"], [41, 56, "DISEASE"]]}], ["This randomised controlled trial aimed to determine the effects of exercise training and review of airway clearance therapy (ACT) on exercise capacity, health related quality of life (HRQOL) and the incidence of acute exacerbations in people with non-CF bronchiectasis.", {"entities": [[254, 268, "DISEASE"]]}], ["Participants were randomly allocated to 8\u00a0weeks of supervised exercise training and review of ACT, or control.", {"entities": []}], ["Primary outcomes of exercise capacity and HRQOL (Chronic respiratory disease questionnaire) and secondary outcomes of cough-related QOL (Leicester cough questionnaire) and psychological symptoms (Hospital anxiety and depression scale) were measured at baseline, following completion of the intervention period and at 6 and 12\u00a0months follow up.", {"entities": []}], ["Secondary outcomes of the exacerbation rate and time to first exacerbation were analysed over 12\u00a0months.", {"entities": []}], ["Eighty-five participants (mean FEV 1 74% predicted; median Modified Medical Research Council Dyspnoea grade of 1 (IQR [1\u20133]) were included.", {"entities": [[31, 34, "GENE"]]}], ["Exercise training increased the incremental shuttle walk distance (mean difference to control 62\u00a0m, 95% CI 24 to 101\u00a0m) and the 6-minute walking distance (mean difference to control 41\u00a0m, 95% CI 19 to 63\u00a0m), but these improvements were not sustained at 6 or 12\u00a0months.", {"entities": []}], ["Exercise training reduced dyspnoea (p\u2009=\u20090.009) and fatigue (p\u2009=\u20090.01) but did not impact on cough-related QOL or mood.", {"entities": []}], ["Exercise training reduced the frequency of acute exacerbations (median 1[IQR 1\u20133]) compared to the control group (2[1\u20133]) over 12\u00a0months follow up (p\u2009=\u20090.012), with a longer time to first exacerbation with exercise training of 8\u00a0months (95% CI 7 to 9\u00a0months) compared to the control group (6\u00a0months [95% CI 5 to 7\u00a0months], p\u2009=\u20090.047).", {"entities": []}], ["Exercise training in bronchiectasis is associated with short term improvement in exercise capacity, dyspnoea and fatigue and fewer exacerbations over 12\u00a0months.", {"entities": [[21, 35, "DISEASE"]]}], ["ClinicalTrials.gov ( NCT00885521 ).", {"entities": []}], ["The traditional markets in southern Ecuador and within the Andean region are especially important for plant resource trading among local people, even since before Spanish colonization; therefore, ethnobotanical studies are currently necessary and important.", {"entities": []}], ["These strategic spaces persist for the traditional medicine cultural value reflected in the higher consumption of medicinal plants, which span all socioeconomic levels of rural and urban people.", {"entities": []}], ["The purpose of this study includes the following: 1) to create a novel list of medicinal plants sold at 33 traditional markets; 2) to establish medicinal plant use agreement amongst vendors with the Factor of Informant Consensus (FIC); and 3) to determine the most sold medicinal plant species using the Fidelity Level (FL).", {"entities": []}], ["This study focus on traditional markets ethnobotany utilizes the largest sample of medicinal plants market vendors up to date in Ecuador, interviewing them at 33 traditional markets, located within the Loja province.", {"entities": []}], ["In order to determine the most sold medicinal plants and their ethnobotanical information, structured questionnaires and personal conversations were conducted with 196 medicinal plant vendors, and voucher specimens were created.", {"entities": []}], ["Agreement among vendors about the therapeutic use of medicinal plants was measured using the FIC, and the most sold medicinal plant species were assessed with the FL.", {"entities": []}], ["This research registered 160 medicinal plant species, grouped in 126 genera and 57 families that were sold in 33 traditional markets.", {"entities": []}], ["The uses of medicinal plants in southern Ecuador are related to a long history of traditional medicine health practices that has persisted until today as well as high plant diversity.", {"entities": []}], ["The 53 therapeutic uses recorded were grouped into 12 medical categories that were adapted from the World Health Organization.", {"entities": []}], ["Three medical categories shared the highest value for FIC\u2009=\u20090.92, which showed a high level of agreement of market vendors for 57 medicinal plant species sold to treat ailments related with digestive, dermatological, and sensorial systems.", {"entities": []}], ["The FL index determined 11 culturally important medicinal plant species based on the reported uses by 40 or more market vendors.", {"entities": []}], ["Two medicinal plant species had an FL\u2009=\u2009100\u00a0%, Matricaria recutita and Gaiadendrum punctatum , used to treat digestive and respiratory systems ailments.", {"entities": []}], ["In the Loja province, people continue to consume medicinal plant species sold at local markets to treat somatic and/or psychosomatic health ailments because sociocultural customs are strongly expressed in ancestral practices of wellbeing.", {"entities": []}], ["When the largest values of FL (60.5\u00a0%\u2013100\u00a0%) and FIC (0.81\u20130.92) indexes are combined, they demonstrated agreement among 196 market vendors in the use of seven medicinal plant species that were most sold for the 12 medical categories.", {"entities": []}], ["This study stresses how important public policies are for the trade and quality of medicinal plant resources, particularly for local people practicing auto-medication.", {"entities": []}], ["Reasons for the maintenance of traditional markets in southern Ecuador include lower cost of medicinal plants, confidence in traditional medicine, and/or sociocultural environment.", {"entities": []}], ["In Ecuador, the sustainable management of wild medicinal plants diversity, particularly the most sold, is crucial for its conservation in nature.", {"entities": []}], ["The aim of this study was to investigate the prevalence of human coronavirus (HCoV)-NL63, human metapneumovirus (hMPV), human bocavirus (Boca), human polyomavirus KI (KIV) and human polyomavirus WU (WUV) in respiratory tract infections (RTI) in Kuwait.", {"entities": []}], ["Respiratory samples from 735 hospitalized patients with RTI from September 2010 to April 2013 were evaluated for the presence of HCoV-NL63, hMPV, Boca, KIV and WUV using molecular assays, polymerase chain reaction (PCR) and reverse-transcription PCR.", {"entities": []}], ["Of the 735 patients, 285 (38.8%) were diagnosed with viral RTI.", {"entities": []}], ["The distribution of respiratory viruses was hMPV: 15 (5.3%), Boca: 14 (4.9%), WUV: 10 (3.5%) and KIV: 4 (1.4%).", {"entities": []}], ["HCoV-NL63 was not detected in any of the samples.", {"entities": []}], ["These newly discovered viruses were associated with the development of RTI in Kuwait.", {"entities": []}], ["The rapid identification of these viral infections could aid in the control of nosocomial transmission, reduce the use of antibiotics and improve treatment and management strategies.", {"entities": []}], ["Inhibitory molecules of the B7/CD28 family play a key role in the induction of immune tolerance in the tumor microenvironment.", {"entities": []}], ["The programmed death-1 receptor (PD-1), with its ligands PD-L1 and PD-L2, constitutes an important member of these inhibitory pathways.", {"entities": []}], ["The relevance of the PD-1/PD-L1 pathway in cancer has been extensively studied and therapeutic approaches targeting PD-1 and PD-L1 have been developed and are undergoing human clinical testing.", {"entities": [[43, 49, "DISEASE"]]}], ["However, PD-L2 has not received as much attention and its role in modulating tumor immunity is less clear.", {"entities": []}], ["Here, we review the literature on the immunobiology of PD-L2, particularly on its possible roles in cancer-induced immune suppression and we discuss the results of recent studies targeting PD-L2 in cancer.", {"entities": [[100, 106, "DISEASE"], [198, 204, "DISEASE"]]}], ["Eosinophilic inflammation and remodeling of the airways including subepithelial fibrosis and myofibroblast hyperplasia are characteristic pathological findings of bronchial asthma.", {"entities": [[173, 179, "DISEASE"]]}], ["Epithelial to mesenchymal transition (EMT) plays a critical role in airway remodelling.", {"entities": []}], ["In this study, we hypothesized that infiltrating eosinophils promote airway remodelling in bronchial asthma.", {"entities": [[101, 107, "DISEASE"]]}], ["To demonstrate this hypothesis we evaluated the effect of eosinophils on EMT by in vitro and in vivo studies.", {"entities": []}], ["EMT was assessed in mice that received intra-tracheal instillation of mouse bone marrow derived eosinophils and in human bronchial epithelial cells co-cultured with eosinophils freshly purified from healthy individuals or with eosinophilic leukemia cell lines.", {"entities": [[240, 248, "DISEASE"]]}], ["Intra-tracheal instillation of eosinophils was associated with enhanced bronchial inflammation and fibrosis and increased lung concentration of growth factors.", {"entities": []}], ["Mice instilled with eosinophils pre-treated with transforming growth factor(TGF)-\u03b21 siRNA had decreased bronchial wall fibrosis compared to controls.", {"entities": []}], ["EMT was induced in bronchial epithelial cells co-cultured with human eosinophils and it was associated with increased expression of TGF-\u03b21 and Smad3 phosphorylation in the bronchial epithelial cells.", {"entities": [[143, 148, "GENE"]]}], ["Treatment with anti-TGF-\u03b21 antibody blocked EMT in bronchial epithelial cells.", {"entities": []}], ["Eosinophils induced EMT in bronchial epithelial cells, suggesting their contribution to the pathogenesis of airway remodelling.", {"entities": []}], ["Surveys of patient satisfaction and their willingness to return can be used for the optimization of processes, improving their quality, and increasing the satisfaction and loyalty in customers.", {"entities": []}], ["This study looked at the factors significantly associated with patient satisfaction after primary total hip replacement (THR), and which affect the patients\u2019 willingness to return to the same hospital for future treatment, even when unrelated to their THR.", {"entities": []}], ["Data for the study was collected by written survey from 810 patients of 43 hospitals following their THR.", {"entities": []}], ["Satisfaction and willingness to return were measured using a validated, multidimensional questionnaire, primarily based on six-point scales, which were then evaluated together with routine hospital data, according to bivariate and multivariate analyses.", {"entities": []}], ["The bivariate analysis showed a strong correlation between satisfaction or willingness to return and the health condition before hospitalization as well as the perceived length of stay.", {"entities": []}], ["In contrast, the patient\u2019s gender and the number of inpatient cases in a hospital with THR had no influence.", {"entities": []}], ["The binary logistic regression analyses identified three predictors associated with overall satisfaction and seven predictors associated with willingness to return.", {"entities": []}], ["The strongest factor for both dependent variables was the perceived length of stay, and the weakest factor for satisfaction was the treatment outcome.", {"entities": []}], ["Overall, with all of the medical and service-related issues considered, high levels of satisfaction were reached.", {"entities": []}], ["Despite the high satisfaction scores, probable causes for declining the willingness to return were identified.", {"entities": []}], ["The results provide incentives for hospitals and medical professionals to attain a high satisfaction levels in their THR patients.", {"entities": []}], ["To investigate whether daily diet provides adequate selenium intake in healthy men and women living in Tehran, Iran.", {"entities": []}], ["Serum level of selenium was determined in 184 healthy individuals of both genders.", {"entities": []}], ["The samples were divided into two age groups, adults and children, for analysis.", {"entities": []}], ["The serum level of selenium was determined using hydride generation and flame atomic absorption spectroscopy.", {"entities": []}], ["The mean and standard deviation of serum selenium levels in children (1\u201316 years) was 84.3 \u00b1 11 \u03bcg/l and there was no significant difference between genders in this group.", {"entities": []}], ["In adults (older than 16 years) the mean serum selenium level was 100.6 \u00b1 13 SD \u03bcg/l; among women the mean was 93.9 \u00b1 14 SD \u03bcg/l and among men it was 102.2 \u00b1 12 SD \u03bcg/l.", {"entities": []}], ["The mean selenium level in men was higher than in women and data analysis showed a significant difference between them (p < 0.005).", {"entities": []}], ["There was also a positive correlation between higher selenium serum concentration and age in men (P < 0.001).", {"entities": []}], ["Daily intake of selenium in men and women was calculated to be 67 \u03bcg and 62.1 \u03bcg respectively.", {"entities": []}], ["Our results show that the serum concentration of selenium in an Iranian population is similar to other nationalities in the Middle East, particularly Saudi Arabia.", {"entities": []}], ["Heliotropium strigosum is used in traditional medicine to manage gastrointestinal pain, respiratory distress and vascular disorders.", {"entities": []}], ["The present study was undertaken to provide scientific evidences for these folkloric uses by in vitro experimental settings.", {"entities": []}], ["A crude methanol extract of the Heliotropium strigosum (Hs.Cr) was tested in vitro on isolated rabbit jejunum preparations to detect the possible presence of spasmolytic activity.", {"entities": []}], ["Moreover, isolated rabbit tracheal and aorta preparations were used to ascertain the relaxant effects of the extract.", {"entities": []}], ["The Hs.Cr exhibited relaxant effects in rabbit jejunum in a concentration dependent manner (0.01-3.0\u00a0mg/ml).", {"entities": []}], ["The Hs.Cr also relaxed K The Hs.Cr was found to exhibit spasmolytic, bronchodilator and vasorelaxant activities on isolated rabbit jejunum, trachea and aorta preparations, likely mediated through Ca", {"entities": []}], ["Conventional C-reactive protein assays have been used to detect or guide the treatment of acute sepsis.", {"entities": []}], ["The objective of this study was to determine the association between elevated baseline high-sensitivity C-reactive protein (hsCRP) and the risk of future sepsis events.", {"entities": []}], ["We studied data from 30,239 community dwelling, black and white individuals, age \u226545 years old enrolled in the RE asons for G eographic a nd R acial D ifferences in S troke (REGARDS) cohort.", {"entities": []}], ["Baseline hsCRP and participant characteristics were determined at the start of the study.", {"entities": []}], ["We identified sepsis events through review of hospital records.", {"entities": []}], ["Elevated hsCRP was defined as values >3.0 mg/L.", {"entities": []}], ["Using Cox regression, we determined the association between elevated hsCRP and first sepsis event, adjusting for sociodemographic factors (age, sex, race, region, education, income), health behaviors (tobacco and alcohol use), chronic medical conditions (coronary artery disease, diabetes, dyslipidemia, hypertension, chronic kidney disease, chronic lung disease) and statin use.", {"entities": [[304, 316, "DISEASE"], [326, 340, "DISEASE"], [350, 362, "DISEASE"]]}], ["Over the mean observation time of 5.7 years (IQR 4.5\u20137.1), 974 individuals experienced a sepsis event, and 11,447 (37.9%) had elevated baseline hsCRP (>3.0 mg/L).", {"entities": []}], ["Elevated baseline hsCRP was independently associated with subsequent sepsis (adjusted HR 1.56; 95% CI 1.36\u20131.79), adjusted for sociodemographics, health behaviors, chronic medical conditions and statin use.", {"entities": [[86, 88, "GENE"]]}], ["Elevated baseline hsCRP was associated with increased risk of future sepsis events.", {"entities": []}], ["hsCRP may help to identify individuals at increased risk for sepsis.", {"entities": []}], ["Involvement of the Interferon Regulatory Factor 1 (IRF-1) gene in regulation of cell differentiation and proliferation made it a potential target in cancer research.", {"entities": [[149, 155, "DISEASE"]]}], ["IRF-1 acts as a tumor suppressor gene, and is inactivated in chronic (CML) and non-chronic myelogenous leukemia (non-CML).", {"entities": [[103, 111, "DISEASE"]]}], ["In the light of numerous reports on genetic changes in the noncoding region of the IRF-1 gene, this study aimed to explore possible genomic changes in coding and non-coding regions of IRF-1 in a random sample of leukemic Saudi patients, in order to obtain insights into potential impact of genetic changes on clinicopathological characteristics.", {"entities": []}], ["Patients were classified into two major leukemia subtypes: CML (8 cases; 36.4%) and non-CML (14 cases; 63.6%).", {"entities": [[40, 48, "DISEASE"]]}], ["Sequencing results revealed two novel mutations in the coding area of the IRF-1 gene likely to influence the IRF-1/DNA binding affinity.", {"entities": []}], ["In addition, three mutational sites in the non-coding region between exon 5&6 (8985(T>G), 8,990(T>G) and 8995(A>G) were identified.", {"entities": []}], ["In conclusion, a larger representative study might help provide better understanding of the possible contribution of the identified genetic changes in IRF-1 to disease prognosis and outcomes in leukemic patients.", {"entities": []}], ["The purposes of this study were to investigate whether reduced lung function is associated with metabolic syndrome (MS) and diabetes (DM) in American Indians (AIs) and to determine whether lower pulmonary function presents before the development of DM or MS.", {"entities": [[106, 114, "DISEASE"]]}], ["The Strong Heart Study (SHS) is a multicenter, prospective study of cardiovascular disease (CVD) and its risk factors among AI adults.", {"entities": []}], ["The present analysis used lung function assessment by standard spirometry at the SHS second examination (1993\u20131995) in 2,396 adults free of overt lung disease or CVD, with or without DM or MS.", {"entities": [[146, 158, "DISEASE"]]}], ["Among MS-free/DM-free participants, the development of MS/DM at the SHS third examination (1996\u20131999) was investigated.", {"entities": []}], ["Significantly lower pulmonary function was observed for AIs with MS or DM.", {"entities": []}], ["Impaired pulmonary function was associated with MS and DM after adjustment for age, sex, abdominal obesity, current smoking status, physical activity index, hypertension, and SHS field center.", {"entities": [[157, 169, "DISEASE"], [99, 106, "DISEASE"]]}], ["Both forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV1) were negatively associated with insulin resistance or DM severity and with serum markers of inflammation ( P < 0.05).", {"entities": []}], ["FVC and FEV1-to-FVC ratio both predicted DM in unadjusted analyses but not when adjusted for covariates, including waist circumference.", {"entities": []}], ["In the adjusted model, abdominal obesity predicted both MS and DM.", {"entities": [[33, 40, "DISEASE"]]}], ["Reduced lung function is independently associated with MS and with DM, and impaired lung function presents before the development of MS or DM; these associations may result from the effects of obesity and inflammation.", {"entities": [[193, 200, "DISEASE"]]}], ["The benefit of corticosteroids as adjunctive treatment in patients with severe community-acquired pneumonia (CAP) requiring hospital admission remains unclear.", {"entities": [[98, 107, "DISEASE"]]}], ["This study aimed to evaluate the impact of corticosteroid treatment on outcomes in patients with CAP.", {"entities": []}], ["This was a prospective, double-blind and randomized study.", {"entities": []}], ["All patients received treatment with ceftriaxone plus levofloxacin and methyl-prednisolone (MPDN) administered randomly and blindly as an initial bolus, followed by a tapering regimen, or placebo.", {"entities": []}], ["Of the 56 patients included in the study, 28 (50%) were treated with concomitant corticosteroids.", {"entities": []}], ["Patients included in the MPDN group show a more favourable evolution of the pO2/FiO2 ratio and faster decrease of fever, as well as greater radiological improvement at seven days.", {"entities": []}], ["The time to resolution of morbidity was also significantly shorter in this group.", {"entities": []}], ["Six patients met the criteria for mechanical ventilation (MV): five in the placebo group (22.7%) and one in the MPDN group (4.3%).", {"entities": []}], ["The duration of MV was 13 days (interquartile range 7 to 26 days) for the placebo group and three days for the only case in the MPDN group.", {"entities": []}], ["The differences did not reach statistical significance.", {"entities": []}], ["Interleukin (IL)-6 and C-reactive protein (CRP) showed a significantly quicker decrease after 24 h of treatment among patients treated with MPDN.", {"entities": [[43, 46, "GENE"]]}], ["No differences in mortality were found among groups.", {"entities": []}], ["MPDN treatment, in combination with antibiotics, improves respiratory failure and accelerates the timing of clinical resolution of severe CAP needing hospital admission.", {"entities": [[58, 77, "DISEASE"]]}], ["International Standard Randomized Controlled Trials Register, ISRCTN22426306 .", {"entities": []}], ["The implementation of a home smoking ban (HSB) is associated with tobacco use cessation.", {"entities": []}], ["We identified which quitline callers were most likely to report 30-day cessation among those who implemented complete HSBs after enrollment.", {"entities": []}], ["Our sample consisted of callers to the Arizona Smokers\u2019 Helpline who enrolled from January 1, 2011, through July 26, 2015, and who reported no HSB at enrollment and a complete HSB by 7-month follow-up.", {"entities": []}], ["We used logistic regression to estimate associations between no use of tobacco in the previous 30 days (30-day quit) at 7-month follow-up and demographic characteristics, health conditions, tobacco use, and cessation strategies.", {"entities": []}], ["At 7-month follow-up, 65.4% of 399 callers who implemented a complete HSB reported 30-day quit.", {"entities": []}], ["Lower odds of tobacco use cessation were associated with having a chronic health condition (odds ratio [OR], 0.31; 95% confidence interval [CI], 0.18\u20130.56) and living with other smokers (OR, 0.46; 95% CI, 0.29\u20130.73).", {"entities": []}], ["Higher odds of tobacco cessation were associated with completing 5 or more telephone coaching sessions (OR, 2.48; 95% CI, 1.54\u20133.98) and having confidence to quit (OR, 2.05; 95% CI, 1.05\u20133.99).", {"entities": []}], ["However, confidence to quit was not significant in the sensitivity analysis.", {"entities": []}], ["Implementing an HSB after enrolling in quitline services increases the likelihood of cessation among some tobacco users.", {"entities": []}], ["Individuals with complete HSBs were more likely to quit if they did not have a chronic health condition, did not live with another smoker, and were actively engaged in coaching services.", {"entities": []}], ["These findings may be used by quitlines to develop HSB intervention protocols primarily targeting tobacco users most likely to benefit from them.", {"entities": []}], ["Respiratory syncytial virus is the most important pathogen in lower respiratory tract infection in infants and young children.", {"entities": []}], ["In high-risk populations it may develop severe, sometimes fatal, lower respiratory tract infections.", {"entities": []}], ["A proportion of these infants require admission to intensive care units due to the severity of the condition and the level of care needed.", {"entities": []}], ["Furthermore, we must consider the possible increased risk of asthma following RSV infection in infancy.", {"entities": [[61, 67, "DISEASE"]]}], ["The aim of this work is to show how we strictly coordinated, during the 2008-2009 RSV season, the delivery of prophylaxis while minimising drug cost through vial sharing and cohorting infants with a software performed through Visual Basic programming system.", {"entities": []}], ["By using this method we have been able to obtain a saving of the 29.2% compared to the theoretical amount.", {"entities": []}], ["No infant requested hospitalisation for a RSV infection.", {"entities": []}], ["Such a model ensures all patients to receive appropriate immunization and thus positively influencing the cost-benefit of palivizumab prophylaxis.", {"entities": []}], ["We hope that our model of care delivery will be of use to other hospitals.", {"entities": []}], ["Previous studies suggested an association between chronic obstructive pulmonary disease (COPD) and cognitive impairment, mostly in developed countries.", {"entities": [[50, 87, "DISEASE"]]}], ["There is no evidence available on the association between these two common chronic disorders in the elderly people in People\u2019s Republic of China where the population is aging rapidly.", {"entities": []}], ["The study population was randomly selected from a nationally representative Disease Surveillance Point System in People\u2019s Republic of China.", {"entities": []}], ["A standardized questionnaire was administered by trained interviewers during a face-to-face interview in the field survey conducted in 2010\u20132011.", {"entities": []}], ["Cognitive function was assessed using the Mini-Mental State Examination.", {"entities": []}], ["COPD was measured by self-report and the Medical Research Council respiratory questionnaire was used to assess respiratory symptoms.", {"entities": []}], ["A multivariate logistic regression model was applied to examine the association between COPD and cognitive impairment with adjustment for potential confounding factors.", {"entities": []}], ["A total of 16,629 subjects aged over 60 years were included in the study.", {"entities": []}], ["The prevalence of cognitive impairment was 9.4% (95% confidence interval [CI] 7.7, 11.1).", {"entities": []}], ["Chronic phlegm was associated with significantly higher prevalence of cognitive impairment in models adjusted for age, sex, marital status, geographic region, urban/rural, education, smoking status, alcohol drinking, and indoor air pollution (odds ratio [OR] 1.46, 95% CI 1.11, 1.93).", {"entities": []}], ["Chronic respiratory symptoms and self-reported COPD were strongly related to cognitive impairment in urban areas.", {"entities": []}], ["There were no significant effect modifications for sex, regions, educational level, smoking status, and alcohol drinking.", {"entities": []}], ["There was strong association between COPD and cognitive impairment in urban Chinese elderly population.", {"entities": []}], ["Objective The trade-off between the speed and simplicity of dictionary-based term recognition and the richer linguistic information provided by more advanced natural language processing (NLP) is an area of active discussion in clinical informatics.", {"entities": []}], ["In this paper, we quantify this trade-off among text processing systems that make different trade-offs between speed and linguistic understanding.", {"entities": []}], ["We tested both types of systems in three clinical research tasks: phase IV safety profiling of a drug, learning adverse drug\u2013drug interactions, and learning used-to-treat relationships between drugs and indications.", {"entities": []}], ["Materials We first benchmarked the accuracy of the NCBO Annotator and REVEAL in a manually annotated, publically available dataset from the 2008 i2b2 Obesity Challenge.", {"entities": []}], ["We then applied the NCBO Annotator and REVEAL to 9 million clinical notes from the Stanford Translational Research Integrated Database Environment (STRIDE) and used the resulting data for three research tasks.", {"entities": []}], ["Results There is no significant difference between using the NCBO Annotator and REVEAL in the results of the three research tasks when using large datasets.", {"entities": []}], ["In one subtask, REVEAL achieved higher sensitivity with smaller datasets.", {"entities": []}], ["Conclusions For a variety of tasks, employing simple term recognition methods instead of advanced NLP methods results in little or no impact on accuracy when using large datasets.", {"entities": []}], ["Simpler dictionary-based methods have the advantage of scaling well to very large datasets.", {"entities": []}], ["Promoting the use of simple, dictionary-based methods for population level analyses can advance adoption of NLP in practice.", {"entities": []}], ["We have shown that intravenous adenosine in normal subjects does not cause bronchospasm, but causes dyspnea, most likely by an effect on vagal C fibers in the lungs [Burki et al.", {"entities": []}], ["J Appl Physiol 2005; 98:180-5].", {"entities": []}], ["Since airways inflammation and bronchial hyperreactivity are features of asthma, it is possible that intravenous adenosine may be associated with an increased intensity of dyspnea, and may cause bronchospasm, as noted anecdotally in previous reports.", {"entities": [[73, 79, "DISEASE"]]}], ["We compared the effects of placebo and 10 mg intravenous adenosine, in 6 normal and 6 asthmatic subjects.", {"entities": []}], ["Placebo injection had no significant (p > 0.05) effect on the forced expiratory spirogram, heart rate, minute ventilation (Ve), or respiratory sensation.", {"entities": []}], ["Similarly, adenosine injection caused no significant changes (p > 0.05) in the forced expiratory spirogram; however, there was a rapid development of dyspnea as signified visually on a modified Borg scale, and a significant (p < 0.05) tachycardia in each subject (Asthmatics +18%, Normals + 34%), and a significant (p < 0.05) increase in Ve (Asthmatics +93%, Normals +130%).", {"entities": []}], ["The intensity of dyspnea was significantly greater (p < 0.05) in the asthmatic subjects.", {"entities": []}], ["These data indicate that intravenous adenosine does not cause bronchospasm in asthmatic subjects, and supports the concept that adenosine-induced dyspnea is most likely secondary to stimulation of vagal C fibers in the lungs.", {"entities": []}], ["The increased intensity of adenosine-induced dyspnea in the asthmatic subjects suggests that airways inflammation may have sensitized the vagal C fibers.", {"entities": []}], ["Chemoprevention represents the possibility to prevent, stop or reverse the cancerogenetic process.", {"entities": []}], ["In this context the interest towards natural extracts and botanical drugs has constantly grown due to their phytochemical content.", {"entities": []}], ["Castanea sativa Mill.", {"entities": []}], ["(CSM) extracts showed to exert positive effect in the prevention/counteraction of chronic/degenerative diseases, therefore, we evaluated the potential chemopreventive effect of CSM bark extract.", {"entities": []}], ["Flow cytometry (FCM) analyses of Jurkat cells treated with CSM bark extract (0\u2013500\u00a0\u03bcg\u00b7mL CSM bark extract induced apoptosis in Jurkat cells in a dose- and time- dependent manner activating the extrinsic pathways as evidenced by the increase of activated caspase-8 positive cells.", {"entities": []}], ["Moreover, IC 50 calculated after 24\u00a0h treatment resulted 304 and 128\u00a0\u03bcg\u00b7mL Our data suggest that CSM bark extract might be considered an interesting potential anti-cancer agent, since it induces apoptosis in cancer cells without appreciable cytotoxic effects on non-transformed cells.", {"entities": [[164, 170, "DISEASE"], [208, 214, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12906-017-1756-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Hospitalizations for ambulatory care sensitive (ACS) conditions are established indicators for the availability and quality of ambulatory care.", {"entities": []}], ["We aimed to assess the differences between asylum-seeking children and children of the general population in a German city with respect to (i) the prevalence of ACS hospitalizations, and (ii) the utilization of emergency outpatient services for ACS conditions.", {"entities": []}], ["Using anonymous account data, all children admitted to the University Hospital Heidelberg in 2015 were included in our study.", {"entities": []}], ["A unique cost unit distinguished asylum seekers residing in a nearby reception center (exposed) from the children of the general population.", {"entities": []}], ["We adapted international lists of ACS conditions and calculated the prevalence of ACS hospitalizations and the utilization of emergency outpatient services for ACS conditions, attributable fractions among the exposed (Afe) and the population attributable fraction among total admissions (PAF) for each outcome.", {"entities": []}], ["Differences in the prevalence of each outcome between exposed and controls were analyzed in logistic regression models adjusted for sex, age group and quarterly admission.", {"entities": []}], ["Of the 32,015 admissions in 2015, 19.9% (6287) were from inpatient and 80.1% (25,638) from outpatient care.", {"entities": []}], ["In inpatient care, 9.8% (622) of all admissions were hospitalizations for ACS conditions.", {"entities": []}], ["The Afe of ACS hospitalizations was 46.57%, the PAF was 1.12%.", {"entities": []}], ["Emergency service use for ACS conditions could be identified in 8.3% (3088) of all admissions (Afe: 79.57%, PAF: 5.08%).", {"entities": []}], ["The odds ratio (OR) of asylum-seeking children being hospitalized for ACS conditions in comparison to the control group was 1.81 [95% confidence interval, CI: 1.02; 3.2].", {"entities": []}], ["The OR of the asylumseeking population compared to the general population for the utilization of emergency service use for ACS conditions was 4.93 [95% CI: 4.11; 5.91].", {"entities": []}], ["Asylum-seeking children had significantly higher odds of ACS hospitalization and of utilization of emergency outpatient services for ACS conditions.", {"entities": []}], ["Using the concept of ACS conditions allowed measuring the strength of primary care provided to this local asylum-seeking population.", {"entities": []}], ["This approach could help to compare the strength of primary care provision in different locations, and allow an objective.", {"entities": []}], ["Few monogenic causes for severe manifestations of common allergic diseases have been identified.", {"entities": []}], ["Via next generation sequencing on a cohort of patients with severe atopic dermatitis, some with comorbid infections, we found 8 individuals from 4 families with novel heterozygous mutations in CARD11, a scaffolding protein involved in lymphocyte receptor signaling.", {"entities": [[67, 84, "DISEASE"], [74, 84, "DISEASE"], [193, 199, "GENE"]]}], ["Disease improved over time in most patients.", {"entities": []}], ["Transfection of mutant expression constructs into T cell lines demonstrated both loss of function and dominant interfering activity upon antigen receptor-induced NF-\u03baB and mTORC1 activation.", {"entities": []}], ["Patient T-cells had similar defects, as well as diminished IFN-\u03b3 cytokine production.", {"entities": []}], ["The mTORC1 and IFN-\u03b3 production defects could be partially rescued by supplementing with glutamine, which requires CARD11 for import into T cells.", {"entities": [[115, 121, "GENE"]]}], ["Our findings indicate a single hypomorphic gene mutation in CARD11 can cause potentially correctable cellular defects that lead to atopic dermatitis.", {"entities": [[131, 148, "DISEASE"], [138, 148, "DISEASE"], [60, 66, "GENE"]]}], ["Systematic reviews and meta-analyses of randomized trials that include patient-reported outcomes (PROs) often provide crucial information for patients and clinicians facing challenging health care decisions.", {"entities": []}], ["Based on emerging methods, guidance on combining PROs in meta-analysis is likely to enhance their usefulness.", {"entities": []}], ["The objectives of this paper are: i) to describe PROs and why they are important for health care decision-making, ii) illustrate the key risk of bias issues that systematic reviewers should consider and, iii) address outcome characteristics of PROs and provide guidance for combining outcomes.", {"entities": []}], ["We suggest a step-by-step approach to addressing issues of PROs in meta-analyses.", {"entities": []}], ["Systematic reviewers should begin by asking themselves if trials have addressed all the important effects of treatment on patients\u2019 quality of life.", {"entities": []}], ["If the trials have addressed PROs, have investigators chosen the appropriate instruments?", {"entities": []}], ["In particular, does evidence suggest the PROs used are valid and responsive, and is the review free of outcome reporting bias?", {"entities": []}], ["Systematic reviewers must then decide how to categorize PROs and when to pool results.", {"entities": []}], ["Autoimmune type 1 diabetes (T1D) is thought to be caused by a defective immune regulation with regulatory T (Treg) cells playing a fundamental role in this process.", {"entities": []}], ["Tolerance mechanisms depend on tunable responses that are sensitive to minor perturbations in the expression of molecules that can be carried out by multiple epigenetic mechanisms, including regulation by microRNAs.", {"entities": []}], ["In this study, microRNA expression profile was investigated in Treg cells isolated from peripheral blood (PB) and from pancreatic draining lymph nodes (PLN) of T1D patients and non-diabetic subjects.", {"entities": [[152, 155, "GENE"]]}], ["Among 72 microRNAs analyzed, miR-125a-5p resulted specifically hyper-expressed in Treg cells purified from PLN of T1D patients.", {"entities": [[29, 40, "GENE"], [107, 110, "GENE"]]}], ["TNFR2 and CCR2 were identified as miR-125a-5p target genes.", {"entities": [[10, 14, "GENE"], [34, 45, "GENE"]]}], ["Elevated miR-125a-5p was detected in Treg cells isolated from PLN but not from PB of donors with T1D and was associated with reduced CCR2 expression.", {"entities": [[9, 20, "GENE"], [62, 65, "GENE"], [133, 137, "GENE"]]}], ["A specific beta-cell expression of the CCR2-ligand (CCL2) was observed in the pancreata of cadaveric donors, suggesting that beta-cells are prone to attract CCR2", {"entities": [[52, 56, "GENE"], [39, 43, "GENE"], [157, 161, "GENE"]]}], ["The aim of this study was to investigate the health-related quality of life (HRQOL) in 2\u22127-year-old children diagnosed with recurrent respiratory tract infections (RRTIs) and the impact of RRTIs on affected families.", {"entities": []}], ["This was a cross-sectional case-control study evaluating 2\u22127-year-old children with RRTIs (n\u200a=\u200a352), 2\u22127-year-old healthy children (n\u200a=\u200a376), and associated caregivers (parents and/or grandparents).", {"entities": []}], ["A Chinese version of the PedsQL\u2122 4.0 Generic Core Scale was used to assess childhood HRQOL, and a Chinese version of the Family Impact Module (FIM) was used to assess the impact of RRTIs on family members.", {"entities": []}], ["HRQOL scores were compared between children with RRTIs and healthy children.", {"entities": []}], ["In addition, a multiple step-wise regression with demographic variables of children and their caregivers, family economic status, and caregiver\u2019s HRQOL as independent variables determined factors that influenced HRQOL in children with RRTIs.", {"entities": []}], ["Children with RRTIs showed significantly lower physical, emotional, social, and school functioning scores than healthy children ( p <0.05).", {"entities": []}], ["Caregivers for children with RRTIs also scored significantly lower than caregivers for healthy children on physical, emotional, social, cognitive, and communication functioning ( p <0.05).", {"entities": []}], ["Caregivers for RRTIs affected children also reported significantly higher levels of worry.", {"entities": []}], ["Multivariate analyses showed that children\u2019s age, children\u2019s relation with caregivers, the frequency of respiratory tract infections in the preceding year, caregiver\u2019s educational level, and caregiver\u2019s own HRQOL influenced HRQOL in children with RRTIs.", {"entities": []}], ["The current data demonstrated that RRTIs were associated with lower HRQOL in both children and their caregivers and negatively influenced family functioning.", {"entities": []}], ["In addition, caregivers\u2019 social characteristics also significantly affected HRQOL in children with RRTIs.", {"entities": []}], ["Prior studies of patients leaving hospital against medical advice (AMA) have been limited by not being population-based or assessing only one type of patient.", {"entities": []}], ["We used administrative data at the Manitoba Centre for Health Policy to evaluate all adult residents of Manitoba, Canada discharged alive from acute care hospitals between April 1, 1990 and February 28, 2009.", {"entities": []}], ["We identified the rate of leaving AMA, and used multivariable logistic regression to identify socio-demographic and diagnostic variables associated with leaving AMA.", {"entities": []}], ["Of 1 916 104 live hospital discharges, 21 417 (1.11%) ended with the patient leaving AMA.", {"entities": []}], ["The cohort contained 610 187 individuals, of whom 12 588 (2.06%) left AMA once and another 2 986 (0.49%) left AMA more than once.", {"entities": []}], ["The proportion of AMA discharges did not change over time.", {"entities": []}], ["Alcohol and drug abuse was the diagnostic group with the highest proportion of AMA discharges, at 11.71%.", {"entities": []}], ["Having left AMA previously had the strongest association with leaving AMA (odds ratio 170, 95% confidence interval 156\u2013185).", {"entities": []}], ["Leaving AMA was more common among men, those with lower average household incomes, histories of alcohol or drug abuse or HIV/AIDS.", {"entities": []}], ["Major surgical procedures were associated with a much lower chance of leaving the hospital AMA.", {"entities": []}], ["The rate of leaving hospital AMA did not systematically change over time, but did vary based on patient and illness characteristics.", {"entities": []}], ["Having left AMA in the past was highly predictive of subsequent AMA events.", {"entities": []}], ["Increasing incidence and substantial morbidity and mortality of respiratory diseases requires the development of new human-specific anti-inflammatory and disease-modifying therapeutics.", {"entities": []}], ["Therefore, new predictive animal models that closely reflect human lung pathology are needed.", {"entities": []}], ["In the current study, a tiered acute lipopolysaccharide (LPS)-induced inflammation model was established in marmoset monkeys ( Callithrix jacchus) to reflect crucial features of inflammatory lung diseases.", {"entities": []}], ["Firstly, in an ex vivo approach marmoset and, for the purposes of comparison, human precision-cut lung slices (PCLS) were stimulated with LPS in the presence or absence of the phosphodiesterase-4 (PDE4) inhibitor roflumilast.", {"entities": []}], ["Pro-inflammatory cytokines including tumor necrosis factor-alpha (TNF-\u03b1) and macrophage inflammatory protein-1 beta (MIP-1\u03b2) were measured.", {"entities": []}], ["The corticosteroid dexamethasone was used as treatment control.", {"entities": []}], ["Secondly, in an in vivo approach marmosets were pre-treated with roflumilast or dexamethasone and unilaterally challenged with LPS.", {"entities": []}], ["Ipsilateral bronchoalveolar lavage (BAL) was conducted 18 hours after LPS challenge.", {"entities": []}], ["BAL fluid was processed and analyzed for neutrophils, TNF-\u03b1, and MIP-1\u03b2.", {"entities": []}], ["TNF-\u03b1 release in marmoset PCLS correlated significantly with human PCLS.", {"entities": []}], ["Roflumilast treatment significantly reduced TNF-\u03b1 secretion ex vivo in both species, with comparable half maximal inhibitory concentration (IC 50 ).", {"entities": []}], ["LPS instillation into marmoset lungs caused a profound inflammation as shown by neutrophilic influx and increased TNF-\u03b1 and MIP-1\u03b2 levels in BAL fluid.", {"entities": []}], ["This inflammatory response was significantly suppressed by roflumilast and dexamethasone.", {"entities": []}], ["The close similarity of marmoset and human lungs regarding LPS-induced inflammation and the significant anti-inflammatory effect of approved pharmaceuticals assess the suitability of marmoset monkeys to serve as a promising model for studying anti-inflammatory drugs.", {"entities": []}], ["Chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by both a chronic inflammation and tissue remodelling; as indicated by extracellular matrix protein deposition, basement membrane thickening, goblet cell hyperplasia and subepithelial edema, with reduced vessels and glands.", {"entities": []}], ["Although remodelling is generally considered to be consequence of persistent inflammation, the chronological order and relationship between inflammation and remodelling in polyp development is still not clear.", {"entities": []}], ["The aim of our study was therefore to investigate the pathological features prevalent in the development of nasal polyps and to elucidate the chronological order and relationship between inflammation and remodelling, by comparing specific markers of inflammation and remodelling in early stage nasal polyps confined to the middle turbinate (refer to as middle turbinate CRSwNP) obtained from 5 CRSwNP patients with bilateral polyposis, mature ethmoidal polyps from 6 CRSwNP patients, and normal nasal mucosal tissue from 6 control subjects.", {"entities": []}], ["Middle turbinate CRSwNP demonstrated significantly more severe epithelial loss compared to mature ethmoidal polyps and normal nasal mucosa.", {"entities": []}], ["The epithelial cell junction molecules E-cadherin, ZO-1 and occludin were also expressed in significantly lower amounts in mature ethmoidal polyps compared to healthy mucosa.", {"entities": []}], ["Middle turbinate CRSwNP were further characterized by significantly increased numbers of subepithelial eosinophils and M2 type macrophages, with a distinct lack of collagen and deposition of fibronectin in polyp part.", {"entities": []}], ["In contrast, the turbinate area of the middle turbinate CRSwNP was characterized by an increase in TGF-\u03b2 activated myofibroblasts expressing \u03b1-SMA and vimentin, an increase in the number of pSmad2 positive cells, as well as increased deposition of collagen.", {"entities": []}], ["These findings suggest a complex network of processes in the formation of CRSwNP; including gross epithelial damage and repair reactions, eosinophil and macrophage cell infiltration, and tissue remodelling.", {"entities": []}], ["Furthermore, remodelling appears to occur in parallel, rather than subsequent to inflammation.", {"entities": []}], ["Consistent estimation of the burden of chronic obstructive pulmonary disease (COPD) has been hindered by differences in methods, including different spirometric cut-offs for impaired lung function.", {"entities": [[39, 76, "DISEASE"]]}], ["The impact of different definitions on the prevalence of potential airflow obstruction, and its associations with key risk factors, is evaluated using cross-sectional data from two nationally representative population surveys.", {"entities": []}], ["Pooled cross-sectional analysis of Wave 2 of the UK Household Longitudinal Survey and the Health Survey for England 2010, including 7879 participants, aged 40\u201395\u2005years, who lived in England and Wales, without diagnosed asthma and with good-quality spirometry data.", {"entities": [[219, 225, "DISEASE"]]}], ["Potential airflow obstruction was defined using self-reported physician-diagnosed COPD; a fixed threshold (FT) forced expiratory volume in 1\u2005s/forced vital capacity (FEV 1 /FVC) ratio <0.7 and an age-specific, sex-specific, height-specific and ethnic-specific lower limit of normal (LLN).", {"entities": [[166, 169, "GENE"]]}], ["Standardised questions elicited self-reported information on demography, smoking history, ethnicity, occupation, respiratory symptoms and cardiovascular disease.", {"entities": []}], ["Consistent across definitions, participants classed with obstructed airflow were more likely to be older, currently smoke, have higher pack-years of smoking and be engaged in routine occupations.", {"entities": []}], ["The prevalence of airflow obstruction was 2.8% (95% CI 2.3% to 3.2%), 22.2% (21.2% to 23.2%) and 13.1% (12.2% to 13.9%) according to diagnosed COPD, FT and LLN, respectively.", {"entities": []}], ["The gap in prevalence between FT and LLN increased in older age groups.", {"entities": []}], ["Sex differences in the risk of obstruction, after adjustment for key risk factors, was sensitive to the choice of spirometric cut-off, being significantly higher in men when using FT, compared with no significant difference using LLN.", {"entities": []}], ["Applying FT or LLN spirometric cut-offs gives a different picture of the size and distribution of the disease burden.", {"entities": []}], ["Longitudinal studies examining differences in unscheduled hospital admissions and risk of death between FT and LLN may inform the choice as to the best way to include spirometry in assessments of airflow obstruction.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) includes pulmonary components with increased comorbidity rates, as well as being a systemic disease.", {"entities": []}], ["Comorbidities may frequently occur in COPD patients over 40 yr old.", {"entities": []}], ["We report the comorbidities of patients with COPD, diagnosed by spirometry, in a population-based epidemiologic survey in Korea.", {"entities": []}], ["Data were derived from the fourth Korean Health and Nutrition Examination Survey in 2008, a stratified multistage clustered probability design survey of a sample representing the entire population of Korea.", {"entities": []}], ["Results of spirometry and various health-related questionnaires were analyzed in 2,177 subjects aged \u2265 40 yr.", {"entities": []}], ["The prevalence of COPD (FEV 1 /FVC < 0.7) in subjects \u2265 40 yr of age was 14.1%.", {"entities": [[24, 27, "GENE"]]}], ["Multivariate analysis showed that underweight (odds ratio [OR] 3.07, 95% confidence interval [CI] 1.05-8.98), coronary heart disease (OR, 0.43; 95% CI, 0.20-0.93) and dyslipidemia (OR, 0.61; 95% CI, 0.45-0.82) were significantly associated with COPD, whereas allergic rhinitis, anemia, arthritis, chronic renal failure, depression, diabetes mellitus, hypertension, gastrointestinal ulcer, and osteoporosis were not.", {"entities": [[351, 363, "DISEASE"], [259, 276, "DISEASE"], [119, 132, "DISEASE"], [110, 132, "DISEASE"], [268, 276, "DISEASE"], [393, 405, "DISEASE"], [286, 295, "DISEASE"], [278, 284, "DISEASE"], [332, 349, "DISEASE"]]}], ["Underweight might be more prevalent but coronary heart disease and dyslipidemia are less prevalent in Koreans with than without COPD in population setting.", {"entities": [[49, 62, "DISEASE"], [40, 62, "DISEASE"]]}], ["Recent studies suggest an important role for neurotransmitters as modulators of inflammation.", {"entities": []}], ["Neuroinflammatory mediators such as cytokines and molecules of the arachidonic acid pathway are generated and released by microglia.", {"entities": []}], ["The monoamine norepinephrine reduces the production of cytokines by activated microglia in vitro .", {"entities": []}], ["However, little is known about the effects of norepinephrine on prostanoid synthesis.", {"entities": []}], ["In the present study, we investigate the role of norepinephrine on cyclooxygenase- (COX-)2 expression/synthesis and prostaglandin (PG)E 2 production in rat primary microglia.", {"entities": []}], ["Interestingly, norepinephrine increased COX-2 mRNA, but not protein expression.", {"entities": []}], ["Norepinephrine strongly enhanced COX-2 expression and PGE 2 production induced by lipopolysaccharide (LPS).", {"entities": []}], ["This effect is likely to be mediated by \u03b2-adrenoreceptors, since \u03b2-, but not \u03b1-adrenoreceptor agonists produced similar results.", {"entities": []}], ["Furthermore, \u03b2-adrenoreceptor antagonists blocked the enhancement of COX-2 levels induced by norepinephrine and \u03b2-adrenoreceptor agonists.", {"entities": []}], ["Considering that PGE 2 displays different roles in neuroinflammatory and neurodegenerative disorders, norepinephrine may play an important function in the modulation of these processes in pathophysiological conditions.", {"entities": []}], ["Smoking during pregnancy increases the risk of bronchopulmonary dysplasia (BPD) and, in mice, gestational exposure to sidestream cigarette smoke (SS) induces BPD-like condition characterized by alveolar simplification, impaired angiogenesis, and suppressed surfactant protein production.", {"entities": []}], ["Normal fetal development occurs in a hypoxic environment and nicotinic acetylcholine receptors (nAChRs) regulate the hypoxia-inducible factor (HIF)-1\u03b1 that controls apoptosis and angiogenesis.", {"entities": []}], ["To understand SS-induced BPD, we hypothesized that gestational SS affected alveolar development through HIF-1\u03b1.", {"entities": []}], ["Pregnant BALB/c mice were exposed to air (control) or SS throughout the gestational period and the 7-day-old lungs of the progeny were examined.", {"entities": []}], ["Gestational SS increased apoptosis of alveolar and airway epithelial cells.", {"entities": []}], ["This response was associated with increased alveolar volumes, higher levels of proapoptotic factors (FOXO3a, HIPK2, p53, BIM, BIK, and BAX) and the antiangiogenic factor (GAX), and lower levels of antiapoptotic factors (Akt-PI3K, NF-\u03baB, HIF-1\u03b1, and Bcl-2) in the lung.", {"entities": [[109, 114, "GENE"], [126, 129, "GENE"], [135, 138, "GENE"]]}], ["Although gestational SS increased the cells containing the proangiogenic bombesin-like-peptide, it markedly decreased the expression of its receptor GRPR in the lung.", {"entities": [[149, 153, "GENE"]]}], ["The effects of SS on apoptosis were attenuated by the nAChR antagonist mecamylamine.", {"entities": []}], ["Gestational SS-induced BPD is potentially regulated by nAChRs and associated with downregulation of HIF-1\u03b1, increased apoptosis of epithelial cells, and increased alveolar volumes.", {"entities": []}], ["Thus, in mice, exposure to sidestream tobacco smoke during pregnancy promotes BPD-like condition that is potentially mediated through the nAChR/HIF-1\u03b1 pathway.", {"entities": []}], ["This 9-month open-label extension of the Circadian Administration of Prednisone in Rheumatoid Arthritis Study (CAPRA 1) investigated the long-term safety and efficacy of prednisone chronotherapy with a novel modified-release (MR) prednisone for up to 12 months.", {"entities": [[83, 103, "DISEASE"], [94, 103, "DISEASE"]]}], ["Of 288 patients with rheumatoid arthritis originally randomised to MR or immediate-release (IR) prednisone, 249 continued with prednisone chronotherapy (2\u201310 mg/day) in the 9-month open-label extension.", {"entities": [[21, 41, "DISEASE"], [32, 41, "DISEASE"]]}], ["Duration of morning stiffness of the joints (MS), disease activity scores (DAS28), American College of Rheumatology (ACR20) responses and plasma levels of interleukin 6 (IL-6) were assessed.", {"entities": []}], ["Safety was analysed from adverse event reports and laboratory investigations.", {"entities": []}], ["During the 3-month double-blind phase, patients in the MR group achieved a reduction in MS of 33.1% while no change was observed in the IR group.", {"entities": []}], ["After 6 months of treatment, MS was reduced in the IR/MR group by 54% and in the MR/MR group by 56%.", {"entities": []}], ["MS reduction after 12 months was 45% (IR/MR group) and 55% (MR/MR group).", {"entities": []}], ["Plasma levels of IL-6 declined on MR treatment.", {"entities": []}], ["DAS28 was reduced from 5.8 to 4.8 (MR/MR group) and 4.9 (IR/MR group), respectively.", {"entities": []}], ["37% of the 219 patients who completed the 12-month study achieved improvement according to the ACR20 criteria.", {"entities": []}], ["Adverse events did not differ from the known profile of low-dose prednisone.", {"entities": []}], ["Prednisone chronotherapy with the MR tablet was safe and well tolerated and provided a sustained improvement which resulted in a better benefit to risk ratio of low-dose glucocorticoid treatment for at least 12 months.", {"entities": []}], ["Increased levels of IFN-\u03b3 are routinely observed in the respiratory tract following influenza virus infection, yet its potential role remains unclear.", {"entities": [[84, 93, "DISEASE"]]}], ["We now demonstrate that influenza-induced IFN-\u03b3 restricts protective innate lymphoid cell group II (ILC2) function in the lung following challenge with the pandemic H1N1 A/CA/04/2009 influenza virus.", {"entities": [[24, 33, "DISEASE"], [183, 192, "DISEASE"]]}], ["Specifically, IFN-\u03b3 deficiency resulted in enhanced ILC2 activity, characterized by increased production of IL-5 and amphiregulin, and improved tissue integrity, yet no change in ILC2 numbers, viral load or clearance.", {"entities": []}], ["We further found that IFN-\u03b3-deficient mice, as well as wild-type animals treated with neutralizing anti-IFN-\u03b3 antibody, exhibited decreased susceptibility to lethal infection with H1N1 A/CA/04/2009 influenza virus, and moreover that survival was dependent on the presence of IL-5.", {"entities": [[198, 207, "DISEASE"]]}], ["The beneficial effects of IFN-\u03b3 neutralization were not observed in ILC2-deficient animals.", {"entities": []}], ["These data support the novel concept that IFN-\u03b3 can play a detrimental role in the pathogenesis of influenza through a restriction in ILC2 activity.", {"entities": [[99, 108, "DISEASE"]]}], ["Thus, regulation of ILC2 activity is a potential target for post-infection therapy of influenza.", {"entities": [[86, 95, "DISEASE"]]}], ["Thousands of rescue and recovery workers descended on the World Trade Center (WTC) in the wake of the terrorist attack of September 11, 2001 (9/11).", {"entities": []}], ["Recent studies show that respiratory illness and post-traumatic stress disorder (PTSD) are the hallmark health problems, but relationships between them are poorly understood.", {"entities": [[49, 79, "DISEASE"]]}], ["The current study examined this link and evaluated contributions of WTC exposures.", {"entities": []}], ["Participants were 8508 police and 12 333 non-traditional responders examined at the WTC Medical Monitoring and Treatment Program (WTC-MMTP), a clinic network in the New York area established by the National Institute for Occupational Safety and Health (NIOSH).", {"entities": []}], ["We used structural equation modeling (SEM) to explore patterns of association among exposures, other risk factors, probable WTC-related PTSD [based on the PTSD Checklist (PCL)], physician-assessed respiratory symptoms arising after 9/11 and present at examination, and abnormal pulmonary functioning defined by low forced vital capacity (FVC).", {"entities": []}], ["Fewer police than non-traditional responders had probable PTSD (5.9% v .", {"entities": []}], ["23.0%) and respiratory symptoms (22.5% v .", {"entities": []}], ["28.4%), whereas pulmonary function was similar.", {"entities": []}], ["PTSD and respiratory symptoms were moderately correlated ( r =0.28 for police and 0.27 for non-traditional responders).", {"entities": []}], ["Exposure was more strongly associated with respiratory symptoms than with PTSD or lung function.", {"entities": []}], ["The SEM model that best fit the data in both groups suggested that PTSD statistically mediated the association of exposure with respiratory symptoms.", {"entities": []}], ["Although longitudinal data are needed to confirm the mediation hypothesis, the link between PTSD and respiratory symptoms is noteworthy and calls for further investigation.", {"entities": []}], ["The findings also support the value of integrated medical and psychiatric treatment for disaster responders.", {"entities": []}], ["In this multi-country cluster-randomized behavioural intervention trial promoting exclusive breastfeeding (EBF) in Africa, we compared growth of infants up to 6\u00a0months of age living in communities where peer counsellors promoted EBF with growth in those infants living in control communities.", {"entities": []}], ["A total of 82 clusters in Burkina Faso, Uganda and South Africa were randomised to either the intervention or the control arm.", {"entities": []}], ["Feeding data and anthropometric measurements were collected at visits scheduled 3, 6, 12 and 24\u00a0weeks post-partum.", {"entities": []}], ["We calculated weight-for-length (WLZ), length-for-age (LAZ) and weight-for-age (WAZ) z-scores.", {"entities": []}], ["Country specific adjusted Least Squares Means with 95% confidence intervals (CI) based on a longitudinal analysis are reported.", {"entities": []}], ["Prevalence ratios (PR) for the association between peer counselling for EBF and wasting (WLZ\u2009<\u2009\u22122), stunting (LAZ\u2009<\u2009\u22122) and underweight (WAZ\u2009<\u2009\u22122) were calculated at each data collection point.", {"entities": []}], ["The study included a total of 2,579 children.", {"entities": []}], ["Adjusting for socio-economic status, the mean WLZ at 24\u00a0weeks were in Burkina Faso \u22120.20 (95% CI \u22120.39 to \u22120.01) and in Uganda \u22120.23 (95% CI \u22120.43 to \u22120.03) lower in the intervention than in the control arm.", {"entities": []}], ["In South Africa the mean WLZ at 24\u00a0weeks was 0.23 (95% CI 0.03 to 0.43) greater in the intervention than in the control arm.", {"entities": []}], ["Differences in LAZ between the study arms were small and not statistically significant.", {"entities": []}], ["In Uganda, infants in the intervention arm were more likely to be wasted compared to those in the control arm at 24\u00a0weeks (PR 2.36; 95% CI 1.11 to 5.00).", {"entities": []}], ["Differences in wasting in South Africa and Burkina Faso and stunting and underweight in all three countries were small and not significantly different.", {"entities": []}], ["There were small differences in mean anthropometric indicators between the intervention and control arms in the study, but in Uganda and Burkina Faso, a tendency to slightly lower ponderal growth (weight-for-length z-scores) was found in the intervention arms.", {"entities": []}], ["ClinicalTrials.gov: NCT00397150", {"entities": []}], ["Otosclerosis is a common disorder that leads to conductive hearing loss.", {"entities": [[0, 12, "DISEASE"]]}], ["Most patients with otosclerosis also have tinnitus, and surgical treatment is known to improve hearing as well as tinnitus.", {"entities": [[19, 31, "DISEASE"]]}], ["Some patients however experience worsening of tinnitus after the operation, but there are no known factors that allow surgeons to predict who will be at risk.", {"entities": []}], ["In this prospective observational study on 133 patients undergoing stapedotomy, we show that postoperative air conduction thresholds at very high stimulus frequencies predict improvement of tinnitus, as assessed with proportional odds logistic regression models.", {"entities": []}], ["Young patients were significantly more likely to experience reduction of tinnitus and patients whose tinnitus became better were also more satisfied with the outcome of the operation.", {"entities": []}], ["These findings have practical importance for patients and their surgeons.", {"entities": []}], ["Young patients can be advised that surgery is likely to be beneficial for their tinnitus, but a less positive message should be conveyed to older patients.", {"entities": []}], ["The aim of this study was to explore the choice of modality for diagnosis, treatments, and consequences of anastomotic leakage.", {"entities": []}], ["This is a retrospective study of consecutive patients who underwent surgery that included a colorectal anastomosis due to colorectal cancer, diverticulitis, inflammatory bowel disease (IBD), or benign polyps.", {"entities": [[157, 183, "DISEASE"], [141, 155, "DISEASE"], [122, 139, "DISEASE"], [133, 139, "DISEASE"]]}], ["A total of 600 patients were included during 2010\u20132012, and 60 (10%) had an anastomotic leakage.", {"entities": []}], ["It took in mean 8.8\u00a0days (range 2\u201342) until the anastomotic leakage was diagnosed.", {"entities": []}], ["A total of 44/60 of the patients with a leakage had a CT scan of the abdomen; 11 (25%) were initially negative for anastomotic leakage.", {"entities": []}], ["Among all leakages, the anastomosis was taken down in 45 patients (76.3%).", {"entities": []}], ["All patients with a grade B leakage ( n \u00a0=\u00a06) were treated with antibiotics, and two also received transanal drainage.", {"entities": []}], ["The overall complication rate was also significantly higher in those with leakage (93.3 vs. 28.5%, p \u00a0<\u00a00.001), and it was more common with more than three complications (70 vs. 1.5%, p \u00a0<\u00a00.001).", {"entities": []}], ["There was a higher mortality in the leakage group.", {"entities": []}], ["This study demonstrated that one fourth of the CT scans that were executed were initially negative for leakage.", {"entities": []}], ["Most patients with a grade C leakage will not have an intact anastomosis.", {"entities": []}], ["An anastomotic leakage leads to significantly more severe postoperative complications, higher rate of reoperations, and higher mortality.", {"entities": []}], ["An earlier relaparotomy instead of a CT scan and improved postoperative surveillance could possibly reduce the consequences of the anastomotic leakage.", {"entities": []}], ["Type 2 diabetes mellitus (T2DM) is associated with reduced myocardial glucose uptake (GU) and increased free fatty acid uptake (FFAU).", {"entities": [[7, 24, "DISEASE"]]}], ["Sprint interval training (SIT) improves physical exercise capacity and metabolic biomarkers, but effects of SIT on cardiac function and energy substrate metabolism in diabetic subjects are unknown.", {"entities": []}], ["We tested the hypothesis that SIT is more effective than moderate-intensity continuous training (MICT) on adaptations in left and right ventricle (LV and RV) glucose and fatty acid metabolism in diabetic subjects.", {"entities": []}], ["Twenty-six untrained men and women with T2DM or prediabetes were randomized into two-week-long SIT (n\u2009=\u200913) and MICT (n\u2009=\u200913) interventions.", {"entities": []}], ["Insulin-stimulated myocardial GU and fasted state FFAU were measured by positron emission tomography and changes in LV and RV structure and function by cardiac magnetic resonance.", {"entities": []}], ["In contrast to our hypothesis, SIT significantly decreased GU compared to MICT in LV.", {"entities": []}], ["FFAU of both ventricles remained unchanged by training.", {"entities": []}], ["RV end-diastolic volume (EDV) and RV mass increased only after MICT, whereas LV EDV, LV mass, and RV and LV end-systolic volumes increased similarly after both training modes.", {"entities": []}], ["As SIT decreases myocardial insulin-stimulated GU compared to MICT which may already be reduced in T2DM, SIT may be metabolically less beneficial than MICT for a diabetic heart.", {"entities": []}], ["Cough is one of the most common symptoms that doctor faces in working with pediatric population, and according to some characteristics of cough, doctors can often conclude localization, and sometimes even the nature of the disease that causes it.", {"entities": []}], ["Cough is not only the physiological defense reaction, but a symptom of a disease.", {"entities": []}], ["According to duration it can be acute, chronic and recidivist, recurrent and persistent, strong or discreet, caused by changes in body position and changes in outside temperature.", {"entities": []}], ["Pathoanatomically it is divided into lobar, lobular, alveolar and interstitial, pathogenetically to bronchogenic and hematogenous, as well as in immuno competent and immunocompromised, and clinically on the local and inpatient (72 hours after hospital admission).", {"entities": []}], ["Considering the contents, cough can be productive\u2013with secretion from the respiratory tract, and unproductive-dry, without secretion.", {"entities": []}], ["By auscultation bronchial breathing, rattle and crepitus can be heard.", {"entities": []}], ["The primary diagnostics is radiological, posterior to anterior (P-A) and lateral footage of the chest.", {"entities": []}], ["Laboratory findings in typical pneumonia, are characterized by leukocytosis, neutrophilia and shift of blood image to the left.", {"entities": [[31, 40, "DISEASE"]]}], ["Sedimentation is accelerated and C-reactive protein is elevated.", {"entities": []}], ["The basic bacteriological diagnosis is sputum Gram\u2019s stain and culture of sputum.", {"entities": []}], ["In atypical pneumonia, leukocytes are usually in the normal range, and it is necessary to do serological tests (IgM and IgG antibodies).", {"entities": [[12, 21, "DISEASE"]]}], ["The role of doctors in primary health care is auscultation differentiation of murmurs with confirmation of doubt if there is pathological findings by laboratory tests and treatment, depending on the type of cough.", {"entities": []}], ["Treatment is essentially pharmacological, with irrefutable importance of non-pharmacological measures.", {"entities": []}], ["Leukotrienes are derived from arachidonic acid and serve as mediators of inflammation and immediate hypersensitivity.", {"entities": []}], ["Leukotriene B 4 (LTB 4 ) and leukotriene C 4 (LTC 4 ) act through G protein\u2013coupled receptors LTB 4 receptor (BLTR) and Cys-LTR, respectively.", {"entities": [[17, 20, "GENE"], [94, 97, "GENE"], [17, 20, "GENE"], [94, 97, "GENE"]]}], ["To investigate the physiological role of BLTR, we produced mice with a targeted disruption of the BLTR gene.", {"entities": []}], ["Mice deficient for BLTR (BLTR 4 for calcium mobilization or chemotaxis.", {"entities": []}], ["Additionally, LTB 4 elicited peritoneal neutrophil influx in control but not in BLTR 4 -induced inflammation in mice.", {"entities": [[14, 17, "GENE"]]}], ["Neutrophil influx in a peritonitis model and acute ear inflammation in response to arachidonic acid was significantly reduced in BLTR P = 0.002) relative to male (1 of 11) mice of PAF-induced anaphylaxis.", {"entities": [[23, 34, "DISEASE"]]}], ["These results demonstrate the role of BLTR in leukotriene-mediated acute inflammation and an unexpected sex-related involvement in PAF-induced anaphylaxis.", {"entities": []}], ["Patients with chronic obstructive pulmonary disease (COPD) often have multiple hospitalisations because of exacerbation.", {"entities": [[14, 51, "DISEASE"]]}], ["Evidence shows disease management programmes are one of the most cost-effective measures to prevent re-hospitalisation for COPD exacerbation, but lack implementation and economic appraisal in China.", {"entities": []}], ["The aims of the proposed study are to determine whether a hospital outreach invention programme for disease management can decrease hospitalisations and medical costs in patients with COPD in China.", {"entities": []}], ["Economic appraisal of the programme will also be carried out.", {"entities": []}], ["A randomised single-blinded controlled trial will be conducted.", {"entities": []}], ["220 COPD patients with exacerbations will be recruited from the Third Xiangya Hospital, Central South University, China.", {"entities": []}], ["After hospital discharge they will be randomly allocated into an intervention or a control group.", {"entities": []}], ["Participants in the intervention group will attend a 3-month hospital-based pulmonary rehabilitation intervention and then receive a home-based programme.", {"entities": []}], ["Both groups will receive identical usual discharge care before discharge from hospital.", {"entities": []}], ["The primary outcomes will include rate of hospitalisation and medical cost, while secondary outcomes will include mortality, self-efficacy, self-management, health status, quality of life, exercise tolerance and pulmonary function, which will be evaluated at baseline and at 3, 12 and 24\u2005months after the intervention.", {"entities": []}], ["Cost-effectiveness analysis will be employed for economic appraisal.", {"entities": []}], ["The study has been approved by the institutional review board (IRB) of the Third Xiangya Hospital, Central South University (IRB2014-S159).", {"entities": []}], ["Findings will be shared widely through conference presentations and peer-reviewed publications.", {"entities": []}], ["Furthermore, the results of the programme will be submitted to health authorities and policy reform will be recommended.", {"entities": []}], ["Chi CTR-TRC-14005108; Pre-results.", {"entities": []}], ["A thorough analysis of continuous adventitious sounds (CAS) can provide distinct and complementary information about bronchodilator response (BDR), beyond that provided by spirometry.", {"entities": []}], ["Nevertheless, previous approaches to CAS analysis were limited by certain methodology issues.", {"entities": []}], ["The aim of this study is to propose a new integrated approach to CAS analysis that contributes to improving the assessment of BDR in clinical practice for asthma patients.", {"entities": [[155, 161, "DISEASE"]]}], ["Respiratory sounds and flow were recorded in 25 subjects, including 7 asthma patients with positive BDR (BDR+), assessed by spirometry, 13 asthma patients with negative BDR (BDR-), and 5 controls.", {"entities": [[70, 76, "DISEASE"], [139, 145, "DISEASE"]]}], ["A total of 5149 acoustic components were characterized using the Hilbert spectrum, and used to train and validate a support vector machine classifier, which distinguished acoustic components corresponding to CAS from those corresponding to other sounds.", {"entities": []}], ["Once the method was validated, BDR was assessed in all participants by CAS analysis, and compared to BDR assessed by spirometry.", {"entities": []}], ["BDR+ patients had a homogenous high change in the number of CAS after bronchodilation, which agreed with the positive BDR by spirometry, indicating high reversibility of airway obstruction.", {"entities": []}], ["Nevertheless, we also found an appreciable change in the number of CAS in many BDR- patients, revealing alterations in airway obstruction that were not detected by spirometry.", {"entities": []}], ["We propose a categorization for the change in the number of CAS, which allowed us to stratify BDR- patients into three consistent groups.", {"entities": []}], ["From the 13 BDR- patients, 6 had a high response, similar to BDR+ patients, 4 had a noteworthy medium response, and 1 had a low response.", {"entities": []}], ["In this study, a new non-invasive and integrated approach to CAS analysis is proposed as a high-sensitive tool for assessing BDR in terms of acoustic parameters which, together with spirometry parameters, contribute to improving the stratification of BDR levels in patients with obstructive pulmonary diseases.", {"entities": []}], ["Clark Freifeld and colleagues discuss mobile applications, including their own smartphone application, that show promise for health monitoring and information sharing.", {"entities": []}], ["The UK government's response to the obesity epidemic calls for action in communities to improve people's health behaviour.", {"entities": [[36, 43, "DISEASE"]]}], ["This study evaluated the effects of a community intervention on dietary quality and levels of physical activity of women from disadvantaged backgrounds.", {"entities": []}], ["Non-randomised controlled evaluation of a complex public health intervention.", {"entities": []}], ["527 women attending Sure Start Children's Centres (SSCC) in Southampton (intervention) and 495 women attending SSCCs in Gosport and Havant (control).", {"entities": []}], ["Training SSCC staff in behaviour change skills that would empower women to change their health behaviours.", {"entities": []}], ["Main outcomes dietary quality and physical activity.", {"entities": []}], ["Intermediate outcomes self-efficacy and sense of control.", {"entities": []}], ["1-year post-training, intervention staff used skills to support behaviour change significantly more than control staff.", {"entities": []}], ["There were statistically significant reductions of 0.1 SD in the dietary quality of all women between baseline and follow-up and reductions in self-efficacy and sense of control.", {"entities": []}], ["The decline in self-efficacy and control was significantly smaller in women in the intervention group than in women in the control group (adjusted differences in self-efficacy and control, respectively, 0.26 (95% CI 0.001 to 0.50) and 0.35 (0.05 to 0.65)).", {"entities": []}], ["A lower decline in control was associated with higher levels of exposure in women in the intervention group.", {"entities": []}], ["There was a statistically significant improvement in physical activity in the intervention group, with 22.9% of women reporting the highest level of physical activity compared with 12.4% at baseline, and a smaller improvement in the control group.", {"entities": []}], ["The difference in change in physical activity level between the groups was not statistically significant (adjusted difference 1.02 (0.74 to 1.41)).", {"entities": []}], ["While the intervention did not improve women's diets and physical activity levels, it had a protective effect on intermediate factors\u2014control and self-efficacy\u2014suggesting that a more prolonged exposure to the intervention might improve health behaviour.", {"entities": []}], ["Further evaluation in a more controlled setting is justified.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is a major burden for the health care system, but the exact costs are difficult to estimate and there are insufficient data available on past and future time trends of COPD-related costs.", {"entities": []}], ["The aim of the study was to calculate COPD-related costs in Finland during the years 1996\u20132006 and estimate future costs for the years 2007\u20132030.", {"entities": []}], ["COPD-related direct and indirect costs in the public health care sector of the whole of Finland during the years 1996\u20132006 were retrieved from national registers.", {"entities": []}], ["In addition, we made a mathematical prediction model on COPD costs for the years 2007\u20132030 on the basis of population projection and changes in smoking habits.", {"entities": []}], ["The total annual COPD-related costs amounted to about 100\u2013110 million Euros in 1996\u20132006, with no obvious change, but there was a slight decrease in direct costs and an increase in indirect costs during these years.", {"entities": []}], ["The estimation model predicted a 60% increase up to 166 million Euros in COPD-related annual costs by the year 2030.", {"entities": []}], ["This is caused almost entirely by an increase in direct health care costs that reflect the predicted ageing of the Finnish population, as older age is a significant factor that increases the need for hospitalisation.", {"entities": []}], ["The total annual COPD-related costs in Finland have been stable during the years 1996\u20132006, but if management strategies are not changed a significant increase in direct costs is expected by the year 2030 due to ageing of the population.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) has become a major public health problem worldwide because of its high and increasing prevalence, morbidity, and mortality.", {"entities": []}], ["Little attention has been paid to earlier stages of COPD or before it has developed.", {"entities": []}], ["Reportedly, TCM may have some advantages in relieving symptoms and reducing the incidence of COPD exacerbations.", {"entities": []}], ["We postulate that patients with COPD will benefit from therapy with TCM treatment according to syndrome differentiation.", {"entities": [[95, 103, "DISEASE"]]}], ["A prospective, multi-center, double-blinded and randomized controlled method will be used to test the therapeutic effects of TCM treatment according to syndrome differentiation.", {"entities": [[152, 160, "DISEASE"]]}], ["A total of 504 patients will be enrolled into this study with 252 in each treatment group.", {"entities": []}], ["Patients will receive medication according to their assigned group.", {"entities": []}], ["TCM for COPD will be administered twice daily over 52\u2009weeks, and all patients will follow the treatment program for 52\u2009weeks.", {"entities": []}], ["The FEV 1 and exacerbations will be used as the primary outcome measures.", {"entities": [[4, 7, "GENE"]]}], ["The quality of life and the Modified Medical Research Council (MMRC) Dyspnea Scale, and the 6-min walk test (6MWD) will be used as the secondary outcome measures.", {"entities": []}], ["We postulate that patients with COPD will benefit from therapy with TCM treatment according to syndrome differentiation.", {"entities": [[95, 103, "DISEASE"]]}], ["This study is registered at ClinicalTrials.gov, NCT01486186", {"entities": []}], ["Objective To estimate the percentage reduction in incidence of dementia that would be obtained if specific risk factors were eliminated.", {"entities": [[63, 71, "DISEASE"]]}], ["Design Prospective seven year cohort study.", {"entities": []}], ["Setting General population, Montpellier, France.", {"entities": []}], ["Participants 1433 people aged over 65 with a mean baseline age of 72.5 (SD 5.1) years.", {"entities": []}], ["Main outcome measures Diagnosis of mild cognitive impairment or dementia established by a standardised neurological examination.", {"entities": [[64, 72, "DISEASE"]]}], ["Results Cox models were constructed to derive hazard ratios and determine confounding and interaction effects for potentially modifiable risk factors for dementia.", {"entities": [[154, 162, "DISEASE"]]}], ["Mean percentage population attributable fractions were calculated with 95% confidence intervals derived from bootstrapping for seven year incidence of mild cognitive impairment or dementia.", {"entities": [[180, 188, "DISEASE"]]}], ["The final model retained crystallised intelligence (population attributable fraction 18.11%, 95% confidence interval 10.91% to 25.42%), depression (10.31%, 3.66% to 17.17%), fruit and vegetable consumption (6.46%, 0.15% to 13.06%), diabetes (4.88%, 1.87% to 7.98%), and apolipoprotein E \u03b54 allele (7.11%, 2.44% to 11.98%).", {"entities": []}], ["Conclusions Increasing crystallised intelligence and fruit and vegetable consumption and eliminating depression and diabetes are likely to have the biggest impact on reducing the incidence of dementia, outweighing even the effect of removing the principal known genetic risk factor.", {"entities": [[192, 200, "DISEASE"]]}], ["Although causal relations cannot be concluded with certainty, the study suggests priorities that may inform public health programmes.", {"entities": []}], ["Growing evidence indicates that B cells are not the only source of immunoglobulin (Ig).", {"entities": []}], ["To investigate this discovery further, we used \u03bcMT mice, which have a disruption of the first transmembrane exon of the \u03bc heavy chain and do not express the membrane form of IgM.", {"entities": []}], ["These mice lack mature B cells and thus serve as a good model to explore Ig expression by liver epithelial cells.", {"entities": []}], ["We found that Ig heavy chains (\u03bc, \u03b4, \u03b3 and \u03b1) and light chains (\u03ba and \u03bb) were expressed in sorted liver epithelial cells of \u03bcMT mice.", {"entities": []}], ["Surprisingly, each heavy chain class showed its respective variable region sequence characteristics in their variable region, instead of sharing the same VDJ usage, which suggests that class switching does not occur in liver epithelial cells.", {"entities": []}], ["Moreover, the \u03b3 and \u03b1 chains, but not the \u03bc and \u03b4 chains, showed mutations in the variable region, thus indicating that different classes of Ig have different activities.", {"entities": []}], ["Our findings support the concept that non-B cells, liver epithelial cells here, can produce different classes of Ig.", {"entities": []}], ["In order to get a better understanding of the role of protease-activated receptor 2 (PAR2) in type 2 helper T (Th2) cell responses against Trichinella spiralis infection, we analyzed Th2 responses in T. spiralis -infected PAR2 knockout (KO) mice.", {"entities": []}], ["The levels of the Th2 cell-secreted cytokines, IL-4, IL-5, and IL-13 were markedly reduced in the PAR2 KO mice as compared to the wild type mice following infection with T. spiralis .", {"entities": []}], ["The serum levels of parasite-specific IgE increased significantly in the wild type mice as the result of T. spiralis infection, but this level was not significantly increased in PAR2 KO mice.", {"entities": []}], ["The expression level of thymic stromal lymphopoietin, IL-25, and eotaxin gene (the genes were recently known as Th2 response initiators) of mouse intestinal epithelial cells were increased as the result of treatment with T. spiralis excretory-secretory proteins.", {"entities": []}], ["However, the expression of these chemokine genes was inhibited by protease inhibitor treatments.", {"entities": []}], ["In conclusion, PAR2 might involve in Th2 responses against T. spiralis infection.", {"entities": []}], ["To demonstrate that preoperative treatment for 28 days with topical dorzolamide/timolol is non-inferior (\u0394 = 4 mm Hg) to oral acetazolamide and topical dexamethasone (standard therapy) in terms of intraocular pressure (IOP) reduction 3 and 6 months after trabeculectomy in glaucoma patients.", {"entities": [[273, 281, "DISEASE"]]}], ["Sixty-two eyes undergoing trabeculectomy with mitomycin C were included in this monocentric prospective randomized controlled study.", {"entities": []}], ["IOP change between baseline and 3 months post-op was defined as the primary efficacy variable.", {"entities": []}], ["Secondary efficacy variables included the number of 5-fluorouracil (5-FU) injections, needlings, suture lyses, preoperative IOP change, hypertension rate and change of conjunctival redness 3 and 6 months post-op.", {"entities": [[136, 148, "DISEASE"]]}], ["Safety was assessed based on the documentation of adverse events.", {"entities": []}], ["Preoperative treatment with topical dorzolamide/timolol was non-inferior to oral acetazolamide and topical dexamethasone in terms of IOP reduction 3 months after trabeculectomy (adjusted means -8.12 mmHg versus -8.30 mmHg; Difference: 0.18; 95% CI -1.91 to 2.26, p = 0.8662).", {"entities": []}], ["Similar results were found 6 months after trabeculectomy (-9.13 mmHg versus -9.06 mmHg; p = 0.9401).", {"entities": []}], ["Comparable results were also shown for both groups concerning the classification of the filtering bleb, corneal staining, and numbers of treatments with 5-FU, needlings and suture lyses.", {"entities": []}], ["More patients reported AEs in the acetazolamide/dexamethasone group than in the dorzolamide/timolol group.", {"entities": []}], ["Preoperative, preservative-free, fixed-dose dorzolamide/timolol seems to be equally effective as preoperative acetazolamide and dexamethasone and has a favourable safety profile.", {"entities": []}], ["Oxidative stress and inflammation are two critical factors that drive the formation of plaques in atherosclerosis.", {"entities": [[98, 113, "DISEASE"]]}], ["Nrf2 is a redox-sensitive transcription factor that upregulates a battery of antioxidative genes and cytoprotective enzymes that constitute the cellular response to oxidative stress.", {"entities": []}], ["Our previous studies have shown that disruption of Nrf2 in mice ( Nrf2 Nrf2 in mice causes increased atherosclerosis.", {"entities": [[101, 116, "DISEASE"]]}], ["To investigate the role of Nrf2 in the development of atherosclerosis, we crossed Nrf2 ApoE ApoE ApoE Nrf2 ApoE Nrf2 ApoE ApoE Nrf2 ApoE Nrf2 ApoE Nrf2 Nrf2 is pro-atherogenic in mice, despite its antioxidative function.", {"entities": [[54, 69, "DISEASE"], [87, 91, "GENE"], [92, 96, "GENE"], [97, 101, "GENE"], [107, 111, "GENE"], [117, 121, "GENE"], [122, 126, "GENE"], [132, 136, "GENE"], [142, 146, "GENE"], [87, 91, "GENE"], [92, 96, "GENE"], [97, 101, "GENE"], [107, 111, "GENE"], [117, 121, "GENE"], [122, 126, "GENE"], [132, 136, "GENE"], [142, 146, "GENE"], [87, 91, "GENE"], [92, 96, "GENE"], [97, 101, "GENE"], [107, 111, "GENE"], [117, 121, "GENE"], [122, 126, "GENE"], [132, 136, "GENE"], [142, 146, "GENE"], [87, 91, "GENE"], [92, 96, "GENE"], [97, 101, "GENE"], [107, 111, "GENE"], [117, 121, "GENE"], [122, 126, "GENE"], [132, 136, "GENE"], [142, 146, "GENE"], [87, 91, "GENE"], [92, 96, "GENE"], [97, 101, "GENE"], [107, 111, "GENE"], [117, 121, "GENE"], [122, 126, "GENE"], [132, 136, "GENE"], [142, 146, "GENE"], [87, 91, "GENE"], [92, 96, "GENE"], [97, 101, "GENE"], [107, 111, "GENE"], [117, 121, "GENE"], [122, 126, "GENE"], [132, 136, "GENE"], [142, 146, "GENE"], [87, 91, "GENE"], [92, 96, "GENE"], [97, 101, "GENE"], [107, 111, "GENE"], [117, 121, "GENE"], [122, 126, "GENE"], [132, 136, "GENE"], [142, 146, "GENE"], [87, 91, "GENE"], [92, 96, "GENE"], [97, 101, "GENE"], [107, 111, "GENE"], [117, 121, "GENE"], [122, 126, "GENE"], [132, 136, "GENE"], [142, 146, "GENE"]]}], ["The net pro-atherogenic effect of Nrf2 may be mediated via positive regulation of CD36.", {"entities": [[82, 86, "GENE"]]}], ["Our data demonstrates that the potential effects of Nrf2-targeted therapies on cardiovascular disease need to be investigated.", {"entities": []}], ["C-reactive protein (CRP) measurement has proven valuable for detecting exacerbations, but its usefulness in predicting etiology remains controversial.", {"entities": [[20, 23, "GENE"]]}], ["Likewise, its potential value as a marker of severity, which is well established in patients with pneumonia, remains unproven in chronic obstructive pulmonary disease (COPD) exacerbations.", {"entities": [[98, 107, "DISEASE"], [129, 166, "DISEASE"]]}], ["A cohort study of 118 patients with severe COPD and acute infectious exacerbations were included and followed up over 1 year.", {"entities": []}], ["Episodes of exacerbations meeting Anthonisen\u2019s criteria type I\u2013II were evaluated, analyzing the etiology and inflammatory response as measured by CRP in blood.", {"entities": [[146, 149, "GENE"]]}], ["A total of 380 episodes were recorded.", {"entities": []}], ["Full microbiological analysis was available in 265 samples.", {"entities": []}], ["Haemophilus influenzae was the most commonly isolated bacteria and rhinovirus the most common virus.", {"entities": []}], ["Median CRP levels from the 265 episodes were higher in the cases with positive cultures for bacteria (58.30 mg/L, interquartile range [IQR] 21.0\u201328.2) than in episodes only positive for viruses (37.3 mg/L, IQR 18.6\u201379.1) and cases negative for any microorganism (36.4 mg/L, IQR 10.8\u201393.7) ( P <0.014).", {"entities": [[7, 10, "GENE"]]}], ["H. influenzae and Streptococcus pneumoniae reached the highest CRP levels of 74.5 mg/L (IQR 23.9\u2013167.9) and 74.1 mg/L (IQR 42.0\u2013220.7), respectively.", {"entities": [[63, 66, "GENE"]]}], ["In the 380 exacerbations studied, 227 (~60%) were community-managed, while 153 (~40%) required hospital admission.", {"entities": []}], ["In the multivariate analysis to assess the influence of inflammatory response on exacerbation severity, baseline hypercapnia (odds ratio [OR]: 2.70, 95% confidence interval [CI]: 1.46\u20134.9) and CRP levels >100 mg/L (OR: 4.23, 95% CI: 2.12\u20138.44) were independent predictors after adjustment for baseline characteristics.", {"entities": [[193, 196, "GENE"]]}], ["CRP level was higher in bacterial infections, especially when H. influenzae and S. pneumoniae were isolated.", {"entities": [[0, 3, "GENE"]]}], ["CRP values >100 mg/L were associated with a fourfold increased risk of hospital admission.", {"entities": [[0, 3, "GENE"]]}], ["Therefore, CRP blood levels may be a useful biomarker in the management of exacerbations appearing in patients with severe disease.", {"entities": [[11, 14, "GENE"]]}], ["Patient-reported outcome measures (PROMs) are measures of the outcome of treatment(s) reported directly by the patient or carer.", {"entities": []}], ["There is increasing international policy interest in using these to assess the impact of clinical care.", {"entities": []}], ["To identify suitably validated PROMs for asthma and examine their potential for use in clinical settings.", {"entities": [[41, 47, "DISEASE"]]}], ["We systematically searched MEDLINE, EMBASE and Web of Science databases from 1990 onwards to identify PROMs for asthma.", {"entities": [[112, 118, "DISEASE"]]}], ["These were critically appraised, then narratively synthesised.", {"entities": []}], ["We also identified the generic PROMs commonly used alongside asthma-specific PROMs.", {"entities": [[61, 67, "DISEASE"]]}], ["We identified 68 PROMs for asthma, 13 of which were selected through screening as being adequately developed to warrant full-quality appraisal: 8 for adults, 4 for children and 1 for a child\u2019s caregiver.", {"entities": [[27, 33, "DISEASE"]]}], ["The PROMs found to be sufficiently well validated to offer promise for use in clinical settings were the Asthma Quality of Life Questionnaire (AQLQ) and mini-AQLQ for adults, and Pediatric Asthma Quality of Life Questionnaire for children.", {"entities": [[105, 111, "DISEASE"], [189, 195, "DISEASE"]]}], ["Rhinasthma was considered promising in simultaneously assessing the impact of asthma and rhinitis in those with coexistent disease.", {"entities": [[89, 97, "DISEASE"], [78, 84, "DISEASE"]]}], ["We identified 28 generic PROMs commonly used in conjunction with asthma-specific instruments.", {"entities": [[65, 71, "DISEASE"]]}], ["We identified asthma PROMs that offer the greatest potential for use in clinical settings.", {"entities": [[14, 20, "DISEASE"]]}], ["Further work is needed to assess whether these are fit-for-purpose for use in clinical practice with individual patients.", {"entities": []}], ["In particular, there is a need to ensure these are validated for use in clinical settings, acceptable to patients, caregivers and clinicians, and yield meaningful outcomes.", {"entities": []}], ["Chronic obstructive lung disease (COPD) is characterized by matrix deposition in the small airways but matrix loss from the parenchyma, phenomena which must depend on the ability of local fibroblasts to produce matrix after smoke exposure.", {"entities": [[8, 32, "DISEASE"], [20, 32, "DISEASE"]]}], ["To investigate this idea, we exposed C57Bl/6 mice once to cigarette smoke or to air (control) and prepared primary cultures of lung fibroblasts by microdissecting large airways (trachea, LAF), medium size airways (major bronchi, MAF) and parenchyma (PF).", {"entities": [[229, 232, "GENE"]]}], ["Control PF showed the lowest rate of wound closure and wound closure was depressed in all lines by a single in vivo smoke exposure.", {"entities": []}], ["Gene expression of matrix proteins differed considerably among the sites; decorin, which may sequester TGF\u03b2, was markedly higher in PF.", {"entities": []}], ["PF showed higher intrinsic ratios of pSmad2/Smad2.", {"entities": []}], ["Smoke caused much greater increases in secreted and matrix deposited collagens 1 and 3 in PF than in LAF or MAF.", {"entities": [[108, 111, "GENE"]]}], ["Expression of Thy-1, a gene that suppresses myofibroblast differentiation, was increased by smoke in PF.", {"entities": []}], ["We conclude that there is considerable regional heterogeneity in murine lung fibroblasts in terms of matrix production, either basally or after in vivo smoke exposure; that PF have lower ability to repair wounds and higher intrinsic TGF\u03b2 signaling; and that a single exposure to smoke produces lasting changes in the pattern of matrix production and wound repair, changes that may be mediated in part by smoke-induced release of TGF\u03b2.", {"entities": []}], ["However, PF still retain the ability to repair by producing new matrix after a single in vivo smoke exposure.", {"entities": []}], ["Although adaptation and proper biological functioning require developmental programming, pollutant interference can cause developmental toxicity or DT.", {"entities": []}], ["This commentary assesses whether it is ethical for citizens/physicians/scientists to allow avoidable DT.", {"entities": []}], ["Using conceptual, economic, ethical, and logical analysis, the commentary assesses what major ethical theories and objectors would say regarding the defensibility of allowing avoidable DT.", {"entities": []}], ["The commentary argues that (1) none of the four major ethical theories (based, respectively, on virtue, natural law, utility, or equity) can consistently defend avoidable DT because it unjustifiably harms, respectively, individual human flourishing, human life, the greatest good, and equality.", {"entities": []}], ["(2) Justice also requires leaving \u201cas much and as good\u201d biological resources for all, including future generations possibly harmed if epigenetic change is heritable.", {"entities": []}], ["(3) Scientists/physicians have greater justice-based duties, than ordinary/average citizens, to help stop DT because they help cause it and have greater professional abilities/opportunities to help stop it.", {"entities": []}], ["(4) Scientists/physicians likewise have greater justice-based duties, than ordinary/average citizens, to help stop DT because they benefit more from it, given their relatively greater education/consumption/income.", {"entities": []}], ["The paper shows that major objections to (3)-(4) fail on logical, ethical, or scientific grounds, then closes with practical suggestions for implementing its proposals.", {"entities": []}], ["Because allowing avoidable DT is ethically indefensible, citizens---and especially physicians/scientists---have justice-based duties to help stop DT.", {"entities": []}], ["In this paper, we present an RIP module with the features of supporting multiple inductive sensors, no variable frequency LC oscillator, low power consumption, and automatic gain adjustment for each channel.", {"entities": []}], ["Based on the method of inductance measurement without using a variable frequency LC oscillator, we further integrate pulse amplitude modulation and time division multiplexing scheme into a module to support multiple RIP sensors.", {"entities": []}], ["All inductive sensors are excited by a high-frequency electric current periodically and momentarily, and the inductance of each sensor is measured during the time when the electric current is fed to it.", {"entities": []}], ["To improve the amplitude response of the RIP sensors, we optimize the sensing unit with a matching capacitor parallel with each RIP sensor forming a frequency selection filter.", {"entities": []}], ["Performance tests on the linearity of the output with cross-sectional area and the accuracy of respiratory volume estimation demonstrate good linearity and accurate lung volume estimation.", {"entities": []}], ["Power consumption of this new RIP module with two sensors is very low.", {"entities": []}], ["The performance of respiration measurement during movement is also evaluated.", {"entities": []}], ["This RIP module is especially desirable for wearable systems with multiple RIP sensors for long-term respiration monitoring.", {"entities": []}], ["A thorough evaluation of headache in children and adolescents is necessary to make the correct diagnosis and initiate treatment.", {"entities": []}], ["In part 1 of this article (\u00d6zge et al.", {"entities": []}], ["in J Headache Pain,", {"entities": []}], ["The effective dose of irradiation to control pest mites in quarantine has been studied extensively, but the molecular mechanisms underlying the effects of the irradiation on mites are largely unknown.", {"entities": []}], ["In this study, exposure to 400 Gy of \u03b3 rays had significant ( p < 0.05) effects on the adult survival, fecundity and egg viability of Panonychus citri .", {"entities": []}], ["The irradiation caused the degradation of the DNA of P. citri adults and damaged the plasma membrane system of the egg, which led to condensed nucleoli and gathered yolk.", {"entities": []}], ["Additionally, the transcriptomes and gene expression profiles between irradiated and non-irradiated mites were compared, and three digital gene expression libraries were assembled and analyzed.", {"entities": []}], ["The differentially expressed genes were putatively involved in apoptosis, cell death and the cell cycle.", {"entities": []}], ["Finally, the expression profiles of some related genes were studied using quantitative real-time PCR.", {"entities": []}], ["Our study provides valuable information on the changes in the transcriptome of irradiated P. citri , which will facilitate a better understanding of the molecular mechanisms that cause the sterility induced by irradiation.", {"entities": []}], ["The quest for the right combination of bronchodilators with different mechanisms of action such as long-acting muscarinic antagonists and long-acting \u03b2-agonists in the management of stable moderate-to-severe chronic obstructive pulmonary disease (COPD) is a topic of intense research activity currently, given the rising morbidity and mortality due to this disease.", {"entities": [[208, 245, "DISEASE"]]}], ["The fixed-dose combination of aclidinium bromide and formoterol fumarate in a single inhaler seems to offer superior advantages over either drugs given alone or as separate inhalers concurrently.", {"entities": []}], ["Since the fixed-dose combination needs to be given twice daily, it is likely to achieve control of symptoms most crucial to the quality of life in COPD, namely, the morning hours.", {"entities": []}], ["This is reflected in significant trough FEV 1 (forced expiratory volume in 1 second) improvements after the dose.", {"entities": [[40, 43, "GENE"]]}], ["This paper reviews the various studies related to this combination put in the perspective of its safety and efficacy and potential benefits over other therapeutic options.", {"entities": []}], ["However, there is a dearth of data on the long-term safety and efficacy in terms of improvement in lung function.", {"entities": []}], ["This combination could emerge as an excellent option in the management of stable COPD if data on exacerbation rates and patient-reported outcomes become available from longer-term studies.", {"entities": []}], ["Moreover, we need some more studies to define the ideal phenotype of COPD best suited for the use of this combination.", {"entities": []}], ["There is, to date, no medical therapy that modifies the decline in lung function that occurs in COPD.", {"entities": []}], ["As the disease becomes more severe, exacerbations of COPD become increasingly common, affecting patient quality of life and increasing health care costs.", {"entities": []}], ["Mucolytic agents, through their actions on inflammatory and oxidative pathways, have potential benefits in COPD.", {"entities": []}], ["This paper reviews the randomized controlled trial (RCT) evidence for the effectiveness of at least 2 months of daily therapy with oral mucolytics in COPD.", {"entities": []}], ["Based on evidence from 26 RCTs, mucolytics reduce exacerbations by up to 0.8 exacerbations per year, with a greater effect in patients with more severe COPD.", {"entities": []}], ["This effect appears to be of a similar magnitude to the reduction in exacerbations seen with tiotropium and inhaled corticosteroids (ICS), but RCTs that compared the agents would be required to confirm this.", {"entities": []}], ["Mucolytics do not affect the rate of lung function decline, but they do not have any significant adverse effects.", {"entities": []}], ["Mucolytic treatment should be considered in: patients with more severe COPD who have frequent or prolonged exacerbations; those who are repeatedly admitted to hospital; or in those patients with frequent exacerbations who are unable to take tiotropium or ICS.", {"entities": []}], ["Primary care needs to be strengthened in order to address the many societal challenges.", {"entities": []}], ["Group practices in primary care foster collaboration with other health care providers, which encourages care co-ordination and leads to a higher quality of primary care.", {"entities": []}], ["Nursing roles and responsibilities expanded over time and nurses have been found to often provide equal high-quality chronic patient care compared to physicians, even with higher patient satisfaction.", {"entities": []}], ["Inter-professional collaboration between primary care physicians and nurses is a possible strategy to achieve the desired quality outcomes in a strengthened primary care system.", {"entities": []}], ["The objective of this research is to synthesize the evidence presented in literature on the impact of collaboration between physicians and nurses on patient outcomes in primary care or in comparable care settings.", {"entities": []}], ["A systematic review of peer-reviewed reviews was performed in four databases: COCHRANE, MEDLINE, EMBASE and CINAHL.", {"entities": []}], ["All studies from 1970 until May 22 2016 were included in the search strategy.", {"entities": []}], ["Titles, abstracts and full texts were respectively reviewed.", {"entities": []}], ["At least two of the three authors independently reviewed each of the 277 abstracts and 58 full texts retrieved in the searches to identify those which contained all the inclusion criteria.", {"entities": []}], ["Two authors independently appraised the methodological quality of the reviews, using the AMSTAR quality appraisal tool.", {"entities": []}], ["A total of eleven systematic reviews met all the inclusion criteria and almost fifty different patient outcomes were described.", {"entities": []}], ["In most reviews, it was concluded that nurses do have added value.", {"entities": []}], ["Blood pressure, patient satisfaction and hospitalization are patient outcomes where three or more systematic reviews concluded better results when physicians and nurses collaborated, compared to usual care.", {"entities": []}], ["Colorectal screening, hospital length of stay and health-related quality of life are outcomes where collaboration appeared not to be effective.", {"entities": []}], ["Collaboration between physicians and nurses may have a positive impact on a number of patient outcomes and on a variety of pathologies.", {"entities": []}], ["To address future challenges of primary care, there is a need for more integrated inter-professional collaboration care models with sufficiently educated nurses.", {"entities": []}], ["The online version of this article (10.1186/s12875-017-0698-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Sulfonylureas, a commonly-used class of medication used to treat type 2 diabetes, have been associated with an increased risk of cardiovascular disease.", {"entities": []}], ["Their effects on QT interval duration and related electrocardiographic phenotypes are potential mechanisms for this adverse effect.", {"entities": []}], ["In eleven ethnically diverse cohorts that included 71 857 European, African American, and Hispanic/Latino ancestry individuals with repeated measures of medication use and electrocardiogram (ECG) measurements, we conducted a pharmacogenomic genome-wide association study of sulfonylurea use and three ECG phenotypes: QT, JT, and QRS intervals.", {"entities": []}], ["In ancestry-specific meta-analyses, 8 novel pharmacogenomic loci met the threshold for genome-wide significance (P < 5 x 10 CYP2C9 (rs1057910) that has been associated with sulfonylurea-related treatment effects and other adverse drug reactions in previous studies was replicated.", {"entities": [[124, 130, "GENE"]]}], ["Additional research is needed to replicate the novel findings and to understand their biological basis.", {"entities": []}], ["Today patients can consult with their treating physician by cell phone or e-mail.", {"entities": []}], ["These means of communication enhance the quality of medical care and increase patient satisfaction, but they can also impinge on physicians\u2019 free time and their patient schedule while at work.", {"entities": []}], ["The objective of this study is to assess the attitudes and practice of patients on obtaining the cell phone number or e-mail address of their physician for the purpose of medical consultation.", {"entities": []}], ["Personal interviews with patients, 18\u2009years of age or above, selected by random sampling from the roster of adults insured by Clalit Health Services, Southern Division.", {"entities": []}], ["The total response rate was 41%.", {"entities": []}], ["The questionnaire included questions on the attitude and practice of patients towards obtaining their physician\u2019s cell phone number or e-mail address.", {"entities": []}], ["Comparisons were performed using Chi-square tests to analyze statistically significant differences of categorical variables.", {"entities": []}], ["Two-tailed p values less than 0.05 were considered statistically significant, with a power of 0.8.", {"entities": []}], ["The study sample included 200 patients with a mean age of 46.6\u2009\u00b1\u200917.1, of whom 110 were women (55%).", {"entities": []}], ["Ninety-three (46.5%) responded that they would be very interested in obtaining their physician\u2019s cell phone number, and an additional 83 (41.5%) would not object to obtaining it.", {"entities": []}], ["Of the 171 patients (85.5%) who had e-mail addresses, 25 (14.6%) said they would be very interested in obtaining their physician\u2019s e-mail address, 85 (49.7%) said they would not object to getting it, and 61 (35.7%) were not interested.", {"entities": []}], ["In practice only one patient had requested the physician\u2019s e-mail address and none actually had it.", {"entities": []}], ["Patients favored cell phones over e-mail for consulting with their treating physicians.", {"entities": []}], ["With new technologies such as cell phones and e-mail in common use, it is important to determine how they can be best used and how they should be integrated into the flow of clinical practice.", {"entities": []}], ["Silybin is one of the main flavonoids produced by milk thistle, which has been used in the treatment of liver diseases.", {"entities": []}], ["In this study, we examined the protective effects and possible mechanisms of action of silybin in lipopolysaccharide (LPS)-induced lung injury and inflammation.", {"entities": []}], ["Pre-treatment of mice with silybin significantly inhibited LPS-induced airway inflammatory cell recruitment, including macrophages, T cells and neutrophils.", {"entities": []}], ["The production of cytokines, such as interleukin-1\u03b2 (IL-1\u03b2) and tumor necrosis factor-\u03b1 (TNF-\u03b1) in bronchoalveolar fluid and serum was also decreased following treatment with silybin.", {"entities": []}], ["Elevated cytokine mRNA levels induced by LPS in lung tissue were all suppressed by silybin and lung histological alterations were also improved.", {"entities": []}], ["In addition, experiments using cells indicated that silybin significantly decreased the mRNA levels and secretion of IL-1\u03b2 and TNF-\u03b1 in THP-1 cells.", {"entities": []}], ["Moreover, the mechanisms responsible for these effects were attributed to the inhibitory effect of silybin on nuclear factor-\u03baB (NF-\u03baB) signaling and NLR family pyrin domain containing 3 (NLRP3) inflammasome activation.", {"entities": [[188, 193, "GENE"]]}], ["The data form our study thus support the utility of silybin as a potential medicine for the treatment of acute lung injury-associated inflammation and pathological changes.", {"entities": []}], ["Silybin exerts protective effects against lung injury by regulating NF-\u03baB signaling and the NLRP3 inflammasome activation.", {"entities": [[92, 97, "GENE"]]}], ["Inflammation, which is directly regulated by interleukin-6 (IL-6) signaling, is implicated in the etiology of several chronic diseases.", {"entities": []}], ["Although a common, non-synonymous variant in the IL-6 receptor gene ( IL6R Asp358Ala; rs2228145 A>C) is associated with the risk of several common diseases, with the 358Ala allele conferring protection from coronary heart disease (CHD), rheumatoid arthritis (RA), atrial fibrillation (AF), abdominal aortic aneurysm (AAA), and increased susceptibility to asthma, the variant's effect on IL-6 signaling is not known.", {"entities": [[290, 315, "DISEASE"], [216, 229, "DISEASE"], [207, 229, "DISEASE"], [237, 257, "DISEASE"], [300, 315, "DISEASE"], [248, 257, "DISEASE"], [355, 361, "DISEASE"], [70, 74, "GENE"]]}], ["Here we provide evidence for the association of this non-synonymous variant with the risk of type 1 diabetes (T1D) in two independent populations and confirm that rs2228145 is the major determinant of the concentration of circulating soluble IL-6R (sIL-6R) levels (34.6% increase in sIL-6R per copy of the minor allele 358Ala; rs2228145 [C]).", {"entities": []}], ["To further investigate the molecular mechanism of this variant, we analyzed expression of IL-6R in peripheral blood mononuclear cells (PBMCs) in 128 volunteers from the Cambridge BioResource.", {"entities": []}], ["We demonstrate that, although 358Ala increases transcription of the soluble IL6R isoform ( P \u200a=\u200a8.3\u00d710 P \u22645.6\u00d710 P \u22645.2\u00d710 IL6R variant.", {"entities": [[76, 80, "GENE"], [123, 127, "GENE"], [76, 80, "GENE"], [123, 127, "GENE"]]}], ["Interleukin-6 (IL-6) is a complex cytokine, which plays a critical role in the regulation of inflammatory responses.", {"entities": []}], ["Genetic variation in the IL-6 receptor gene is associated with the risk of several human diseases with an inflammatory component, including coronary heart disease, rheumatoid arthritis, and asthma.", {"entities": [[149, 162, "DISEASE"], [140, 162, "DISEASE"], [164, 184, "DISEASE"], [175, 184, "DISEASE"], [190, 196, "DISEASE"]]}], ["A common non-synonymous single nucleotide polymorphism in this gene (Asp358Ala) has been suggested to be the causal variant in this region by affecting the circulatory concentrations of soluble IL-6R (sIL-6R).", {"entities": []}], ["In this study we extend the genetic association of this variant to type 1 diabetes and provide evidence that this variant exerts its functional mechanism by regulating the balance between sIL-6R (generated through cleavage of the surface receptor and by alternative splicing of a soluble IL6R isoform) and membrane-bound IL-6R.", {"entities": [[288, 292, "GENE"]]}], ["These data show for the first time that the minor allele of this non-synonymous variant (Ala358) directly controls the surface levels of IL-6R on individual immune cells and that these differences in protein levels translate into a functional impairment in IL-6R signaling.", {"entities": []}], ["These findings may have implications for clinical trials targeting inflammatory mechanisms involving IL-6R signaling and may provide tools for identifying patients with specific benefit from therapeutic intervention in the IL-6R signaling pathway.", {"entities": []}], ["We herein describe the first known case of diffuse alveolar hemorrhage (DAH) associated with the administration of Makyo-kanseki-to, a Chinese herbal drug.", {"entities": []}], ["A 64-year-old man with bronchial asthma presented with persistent cough.", {"entities": [[33, 39, "DISEASE"]]}], ["Makyo-kanseki-to was prescribed as an adjunctive treatment for bronchial asthma.", {"entities": [[73, 79, "DISEASE"]]}], ["Immediately after drug ingestion, the patient expectorated bloody sputum.", {"entities": []}], ["DAH was diagnosed based on the presence of bilateral ground-glass opacity which was identified on chest computed tomography and bloody bronchoalveolar lavage fluid.", {"entities": []}], ["We diagnosed that the administration of Makyo-kanseki-to was the responsible medication because the hemorrhage developed immediately after drug ingestion and resolved after the cessation of such medication with no subsequent recurrence.", {"entities": []}], ["The burden of chronic conditions and multimorbidity is a growing health problem in developed countries.", {"entities": []}], ["The study aimed to determine the estimated prevalence and patterns of multimorbidity in urban areas of Catalonia, stratified by sex and adult age groups, and to assess whether socioeconomic status and use of primary health care services were associated with multimorbidity.", {"entities": []}], ["A cross-sectional study was conducted in Catalonia.", {"entities": []}], ["Participants were adults (19+ years) living in urban areas, assigned to 251 primary care teams.", {"entities": []}], ["Main outcome: multimorbidity (\u22652 chronic conditions).", {"entities": []}], ["Other variables: sex (male/female), age (19\u201324; 25\u201344; 45\u201364; 65\u201379; 80+ years), socioeconomic status (quintiles), number of health care visits during the study.", {"entities": []}], ["We included 1,356,761 patients; mean age, 47.4\u00a0years (SD: 17.8), 51.0% women.", {"entities": []}], ["Multimorbidity was present in 47.6% (95% CI 47.5-47.7) of the sample, increasing with age in both sexes but significantly higher in women (53.3%) than in men (41.7%).", {"entities": []}], ["Prevalence of multimorbidity in each quintile of the deprivation index was higher in women than in men (except oldest group).", {"entities": []}], ["In women, multimorbidity prevalence increased with quintile of the deprivation index.", {"entities": []}], ["Overall, the median (interquartile range) number of primary care visits was 8 (4\u201314) in multimorbidity vs 1 (0\u20134) in non-multimorbidity patients.", {"entities": []}], ["The most prevalent multimorbidity pattern beyond 45\u00a0years of age was uncomplicated hypertension and lipid disorder.", {"entities": [[83, 95, "DISEASE"]]}], ["Compared with the least deprived group, women in other quintiles of the deprivation index were more likely to have multimorbidity than men until 65\u00a0years of age.", {"entities": []}], ["The odds of multimorbidity increased with number of visits in all strata.", {"entities": []}], ["When all chronic conditions were included in the analysis, almost 50% of the adult urban population had multimorbidity.", {"entities": []}], ["The prevalence of multimorbidity differed by sex, age group and socioeconomic status.", {"entities": []}], ["Multimorbidity patterns varied by life-stage and sex; however, circulatory-endocrine-metabolic patterns were the most prevalent multimorbidity pattern after 45\u00a0years of age.", {"entities": []}], ["Women younger than 80\u00a0years had greater prevalence of multimorbidity than men, and women\u2019s multimorbidity prevalence increased as socioeconomic status declined in all age groups.", {"entities": []}], ["Identifying multimorbidity patterns associated with specific age-related life-stages allows health systems to prioritize and to adapt clinical management efforts by age group.", {"entities": []}], ["Rodent infestations are a public health problem in poor urban communities.", {"entities": []}], ["The use of illegal street pesticides to control rodent infestations with resulting poisonings is an additional public health concern receiving limited attention in many developing countries, including South Africa.", {"entities": []}], ["Participants in a household intervention in two poor urban areas of Cape Town, South Africa, received two high quality rat traps.", {"entities": []}], ["Reported in this article are the results of a follow-up survey conducted six months after distribution to assess community perceived acceptability of using rat traps instead of toxic pesticides (N\u2009=\u2009175).", {"entities": []}], ["Of the 175 respondents that were followed up, 88% used the traps and only 35% continued using pesticides after the intervention.", {"entities": []}], ["The analysis identified perceived effectiveness of the traps (prevalence odds ratio 18.00, 95% confidence interval 4.62 to 70.14), being male (prevalence odds ratio 8.86, 95% confidence interval 1.73 to 45.19), and the willingness to buy traps from an informal market (prevalence odds ratio 17.75, 95% confidence interval 4.22 to 74.57) as significantly associated with the acceptance of trap use.", {"entities": []}], ["Rat traps, when introduced to poor urban communities, are acceptable as an alternative to toxic pesticides for rodent control.", {"entities": []}], ["Sustainability of trap use, however, needs to be researched, especially cost and cost-benefit.", {"entities": []}], ["Patients with chronic obstructive pulmonary disease (COPD) are at higher risk of stroke than those without COPD.", {"entities": [[14, 51, "DISEASE"]]}], ["This study aims to explore the impact of inhaled pharmacotherapy on stroke risk in COPD patients during a three-year follow-up, using a nationwide, population-based study and a matched cohort design.", {"entities": []}], ["The study cohort comprised 10,413 patients who had received COPD treatment between 2004 and 2006; 41,652 randomly selected subjects comprised the comparison cohort.", {"entities": []}], ["Cox proportional hazard regressions and two-stage propensity score calibration were performed to determine the impact of various inhaled therapies including short-acting muscarinic antagonists, long-acting muscarinic antagonists, short-acting \u03b2-agonists (SABAs), long-acting \u03b2-agonists (LABAs), and LABA plus inhaled corticosteroid (ICS), on the risk after adjustment for patient demographic characteristics and comorbid disorders.", {"entities": []}], ["Of the 52,065 sampled patients, 2,689 (5.2%) developed stroke during follow-up, including 727 (7.0%) from the COPD cohort and 1,962 (4.7%) from the comparison cohort ( p < 0.001).", {"entities": []}], ["Treatment with SABA was associated with 1.67-fold (95% CI 1.45\u20131.91; p < 0.001) increased risk of stroke in COPD patients.", {"entities": []}], ["By contrast, the cumulative incidence of stroke was significantly lower in those treated with LABA plus ICS than those treated without (adjusted hazard ratio 0.75, 95% CI 0.60\u20130.94, p = 0.014).", {"entities": []}], ["Among COPD patients, the use of inhaled SABA is associated with an increased risk of stroke, and combination treatment with inhaled LABA and ICS relates to a risk reduction.", {"entities": []}], ["Further prospective research is needed to verify whether LABA plus ICS confers protection against stroke in patients with COPD.", {"entities": []}], ["Recurrent airway obstruction ( RAO ), an asthma\u2010like disease, is 1 of the most common allergic diseases in horses in the northern hemisphere.", {"entities": [[41, 47, "DISEASE"]]}], ["Hypersensitivity reactions to environmental antigens cause an allergic inflammatory response in the equine airways.", {"entities": []}], ["Cytosine\u2010phosphate\u2010guanosine\u2010oligodeoxynucleotides (CpG\u2010 ODN ) are known to direct the immune system toward a Th1\u2010pathway, and away from the pro\u2010allergic Th2\u2010line (Th2/Th1\u2010shift).", {"entities": []}], ["Gelatin nanoparticles ( GNP s) are biocompatible and biodegradable immunological inert drug delivery systems that protect CpG\u2010 ODN against nuclease degeneration.", {"entities": []}], ["Preliminary studies on the inhalation of GNP \u2010bound CpG\u2010 ODN in RAO \u2010affected horses have shown promising results.", {"entities": []}], ["The aim of this study was to evaluate the clinical and immunological effects of GNP \u2010bound CpG\u2010 ODN in a double\u2010blinded, placebo\u2010controlled, prospective, randomized clinical trial and to verify a sustained effect post\u2010treatment.", {"entities": []}], ["Twenty\u2010four RAO \u2010affected horses received 1 inhalation every 2\u00a0days for 5 consecutive administrations.", {"entities": []}], ["Horses were examined for clinical, endoscopic, cytological, and blood biochemical variables before the inhalation regimen (I), immediately afterwards ( II ), and 4\u00a0weeks post\u2010treatment ( III ).", {"entities": []}], ["At time points I and II , administration of treatment rather than placebo corresponded to a statistically significant decrease in respiratory effort, nasal discharge, tracheal secretion, and viscosity, Aa DO 2 and neutrophil percentage, and an increase in arterial oxygen pressure.", {"entities": []}], ["Administration of a GNP \u2010bound CpG\u2010 ODN formulation caused a potent and persistent effect on allergic and inflammatory\u2010induced clinical variables in RAO \u2010affected horses.", {"entities": []}], ["This treatment, therefore, provides an innovative, promising, and well\u2010tolerated strategy beyond conventional symptomatic long\u2010term therapy and could serve as a model for asthma treatment in humans.", {"entities": [[171, 177, "DISEASE"]]}], ["It remains unknown whether chronic circadian disturbance (CCD) during pregnancy can lead to mood disorders in the offspring.", {"entities": []}], ["Here we show that pregnant mice in the F0 generation that were exposed to CCD stress displayed depression-like behaviors, and produced offspring in the F1 and F2 generations that also exhibited mood-associated behavioral phenotypes despite the lack of direct stressful experiences during their postnatal or adult period.", {"entities": [[159, 161, "GENE"]]}], ["Prenatal CCD stress was correlated with the elevation of plasma corticosterone levels in F1 mice.", {"entities": []}], ["Furthermore, the diurnal expression profiles of core circadian clock genes were disrupted in the suprachiasmatic nucleus of F1 mice.", {"entities": []}], ["Proteomics analysis revealed that prenatal CCD stress resulted in distinct changes in protein expression in the hypothalamus of female F1 mice, in particular proteins that were associated with cellular activities, metabolism, development and diseases.", {"entities": []}], ["Sex-specific differences in melanocortin 4 receptor expression were apparent in the CCD F1 generation.", {"entities": []}], ["We conclude that maternal exposure to chronic circadian disturbance during pregnancy can lead to sex-specific mood disorders that persist for at least two filial generations.", {"entities": []}], ["The underlying mechanisms may depend on transgenerational changes in plasma corticosterone levels, circadian pacemaking, and hypothalamic protein expression.", {"entities": []}], ["A cross-sectional study was performed to investigate the relationships between physical, psychosocial, and individual characteristics and different endpoints of low back, neck, shoulder, hand/wrist and knee musculoskeletal complaints among cosmetologists in Athens, Greece.", {"entities": []}], ["The study population consisted of 95 female and seven male beauty therapists (response rate 90%) with a mean age and duration of employment of 38 and 16 years, respectively.", {"entities": []}], ["Neck pain was the most prevalent musculoskeletal complaint, reported by 58% of the subjects, while hand/wrist and low back complaints resulted more frequently in self-reported consequences (chronicity, care seeking and absenteeism).", {"entities": []}], ["Significant relationships were found between self-reported physical risk factors like prolonged sitting, use of vibrating tools, reaching far and awkward body postures and the occurrence of musculoskeletal disorders at various body sites.", {"entities": []}], ["Among psychosocial variables co-worker support and skill discretion seem to be the most important reflecting organizational problems and cognitive-behavioral aspects.", {"entities": []}], ["The study results also suggest that effective intervention strategies most likely have to take into account both ergonomic improvements and organizational aspects.", {"entities": []}], ["Health care utilization in many developing countries, Tanzania included, is mainly through the use of traditional medicine (TRM) and its practitioners despite the presence of the conventional medicine.", {"entities": []}], ["This article presents findings on the study that aimed to get an experience of health care utilization from both urban and rural areas of seven administrative regions in Tanzania.", {"entities": []}], ["A total of 33 health facility managers were interviewed on health care provision and availability of supplies including drugs, in their respective areas.", {"entities": []}], ["The findings revealed that the health facilities were overburden with higher population to serve than it was planned.", {"entities": []}], ["Consequently essential drugs and other health supplies were available only in the first two weeks of the month.", {"entities": []}], ["Conventional health practitioners considered traditional health practitioners to be more competent in mental health management, and overall, they were considered to handle more HIV/AIDS cases knowingly or unknowingly due to shear need of healthcare by this group.", {"entities": []}], ["In general conventional health practitioners were positive towards traditional medicine utilization; and some of them admitted using traditional medicines.", {"entities": []}], ["Traditional medicines like other medical health systems worldwide have side effects and some contentious ethical issues that need serious consideration and policy direction.", {"entities": []}], ["Since many people will continue using traditional/alternative medicine, there is an urgent need to collaborate with traditional/alternative health practitioners through the institutionalization of basic training including hygiene in order to improved healthcare in the community and attain the Millennium Development Goals by 2015.", {"entities": []}], ["The biggest barrier to treatment of common mental disorders in primary care settings is low recognition among health care providers.", {"entities": []}], ["This study attempts to explore the explanatory models of common mental disorders (CMD) with the goal of identifying how they could help in improving the recognition, leading to effective treatment in primary care.", {"entities": []}], ["The paper describes findings of a cross sectional qualitative study nested within a large randomized controlled trial (the Manas trial).", {"entities": []}], ["Semi structured interviews were conducted with 117 primary health care attendees (30 males and 87 females) suffering from CMD.", {"entities": []}], ["Main findings of the study are that somatic phenomena were by far the most frequent presenting problems; however, psychological phenomena were relatively easily elicited on probing.", {"entities": []}], ["Somatic phenomena were located within a biopsychosocial framework, and a substantial proportion of informants used the psychological construct of \u2018tension\u2019 or \u2018worry\u2019 to label their illness, but did not consider themselves as suffering from a \u2018mental disorder\u2019.", {"entities": []}], ["Very few gender differences were observed in the descriptions of symptoms but at the same time the pattern of adverse life events and social difficulties varied across gender.", {"entities": []}], ["Our study demonstrates how people present their illness through somatic complaints but clearly link their illness to their psychosocial world.", {"entities": []}], ["However they do not associate their illness to a \u2018mental disorder\u2019 and this is an important phenomenon that needs to be recognized in management of CMD in primary settings.", {"entities": []}], ["Our study also elicits important gender differences in the experience of CMD.", {"entities": []}], ["Biological samples are an important part of investigating toxic exposures and disease outcomes.", {"entities": []}], ["However, blood, urine, saliva, or hair can only reflect relatively recent exposures.", {"entities": []}], ["Alternatively, deciduous teeth have served as a biomarker of early developmental exposure to heavy metals, but little has been done to assess organic toxic exposures such as pesticides, plastics, or medications.", {"entities": []}], ["The purpose of our study was to determine if organic chemicals previously detected in a sample of typically developing children could be detected in teeth from a sample of children with autism.", {"entities": []}], ["Eighty-three deciduous teeth from children with autism spectrum disorders (ASD) were chosen from our tooth repository.", {"entities": []}], ["Organic compounds were assessed using liquid chromatography tandem mass spectrometry and gas chromatography methods.", {"entities": []}], ["Consistent with a prior report from Camann et al., (2013), we have demonstrated that specific semivolatile organic chemicals relevant to autism etiology can be detected in deciduous teeth.", {"entities": []}], ["This report provides evidence that teeth can be useful biomarkers of early life exposure for use in epidemiologic case-control studies seeking to identify differential unbiased exposures during development between those with and without specific disorders such as autism.", {"entities": []}], ["Despite their notorious diversity, biological cells are mechanically well characterized by only a few robust and universal laws.", {"entities": []}], ["Intriguingly, the law characterizing the nonlinear response to stretch appears self-contradictory.", {"entities": []}], ["Various cell types have been reported to both stiffen and soften, or \u201cfluidize\u201d upon stretch.", {"entities": []}], ["Within the classical paradigm of cells as viscoelastic bodies, this constitutes a paradox.", {"entities": []}], ["Our measurements reveal that minimalistic reconstituted cytoskeletal networks (F-actin/HMM) exhibit a similarly peculiar response.", {"entities": []}], ["A mathematical model of transiently crosslinked polymer networks, the so-called inelastic glassy wormlike chain (iG wlc ) model, can simulate the data and resolve the apparent contradiction.", {"entities": []}], ["It explains the observations in terms of two antagonistic physical mechanisms, the nonlinear viscoelastic resistance of biopolymers to stretch, and the breaking of weak transient bonds between them.", {"entities": []}], ["Our results imply that the classical paradigm of cells as viscoelastic bodies has to be replaced by such an inelastic mechanical model.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is characterised by chronic inflammation of the airways and progressive destruction of lung parenchyma, a process that in most cases is initiated by cigarette smoking.", {"entities": []}], ["Several mechanisms are involved in the development of the disease: influx of inflammatory cells into the lung (leading to chronic inflammation of the airways), imbalance between proteolytic and anti-proteolytic activity (resulting in the destruction of healthy lung tissue) and oxidative stress.", {"entities": []}], ["Recently, an increasing number of data suggest a fourth important mechanism involved in the development of COPD: apoptosis of structural cells in the lung might possibly be an important upstream event in the pathogenesis of COPD.", {"entities": []}], ["There is an increase in apoptotic alveolar epithelial and endothelial cells in the lungs of COPD patients.", {"entities": []}], ["Since this is not counterbalanced by an increase in proliferation of these structural cells, the net result is destruction of lung tissue and the development of emphysema.", {"entities": []}], ["Data from animal models suggest a role for Vascular Endothelial Growth Factor (VEGF) in the induction of apoptosis of structural cells in the lung.", {"entities": []}], ["Other mediators of apoptosis, such as caspase-3 and ceramide, could be interesting targets to prevent apoptosis and the development of emphysema.", {"entities": []}], ["In this review, recent data on the role of apoptosis in COPD from both animal models as well as from studies on human subjects will be discussed.", {"entities": []}], ["The aim is to provide an up to date summary on the increasing knowledge on the role of apoptosis in COPD and pulmonary emphysema.", {"entities": [[109, 128, "DISEASE"]]}], ["Using the systematic evolution of ligands by exponential enrichment (SELEX) method, we identified oligonucleotides that bind to the first extracellular domain of the Orai1 protein with high affinities and high specificities.", {"entities": [[166, 171, "GENE"]]}], ["These ligands were isolated from a random single-strand DNA (ssDNA) library with 40 randomized sequence positions, using synthesized peptides with amino acid sequences identical to the first extracellular domain of the Orai1 protein as the targets for SELEX selection.", {"entities": [[219, 224, "GENE"]]}], ["Seven aptamers were obtained after 12 rounds of SELEX.", {"entities": []}], ["An enzyme-linked oligonucleotide assay (ELONA) was performed to determine the affinities of the aptamers.", {"entities": []}], ["Aptamer Y1 had the highest affinity (Kd = 1.72\u00d710", {"entities": []}], ["Incidence and prevalence of ulcerative colitis follow a north\u2013south (latitudinal) gradient and increases northwards at the northern hemisphere or southwards at the southern hemisphere.", {"entities": [[28, 46, "DISEASE"]]}], ["The disease has increased during the last decades.", {"entities": []}], ["The temporal trend has been explained by the hygiene hypothesis, but few parallel explanations exist for the spatial variability.", {"entities": []}], ["Many factors are linked to latitude such as climate.", {"entities": []}], ["Our purpose was to investigate the association between variables governing the climate and prospectively identified patients.", {"entities": []}], ["In this study, we used a subset of the population-based Cohort of Norway (n\u2009=\u200980412) where 370 prevalent cases of ulcerative colitis were identified through self-reported medication.", {"entities": [[114, 132, "DISEASE"]]}], ["The meteorological and climatic variables temperature, precipitation, and altitude were recorded from weather stations of the Norwegian Meteorological Institute.", {"entities": []}], ["Summer temperature was used to capture environmental temperature.", {"entities": []}], ["Summer temperature was significantly related to the prevalence of ulcerative colitis.", {"entities": [[66, 84, "DISEASE"]]}], ["For each one-degree increase in temperature the odds for ulcerative colitis decreased with about 9% (95% CI: 3%-15%).", {"entities": [[57, 75, "DISEASE"]]}], ["None of the other climatic factors were significantly associated to the risk of ulcerative colitis.", {"entities": [[80, 98, "DISEASE"]]}], ["Contextual variables did not change the association to the prevalence of ulcerative colitis.", {"entities": [[73, 91, "DISEASE"]]}], ["The present results show that the prevalence of ulcerative colitis is associated to summer temperature.", {"entities": [[48, 66, "DISEASE"]]}], ["Our speculation is that summer temperature works as an instrumental variable for the effect of microbial species richness on the development of ulcerative colitis.", {"entities": [[144, 162, "DISEASE"]]}], ["Environmental temperature is one of the main forces governing microbial species richness and the microbial composition of the commensal gut flora is known to be an important part in the process leading to ulcerative colitis.", {"entities": [[205, 223, "DISEASE"]]}], ["The aim of this study was to determine whether long-term intermittent azithromycin therapy reduces the frequency of exacerbation in severe chronic obstructive pulmonary disease (COPD).", {"entities": [[139, 176, "DISEASE"]]}], ["We retrospectively investigated the clinical benefits of long-term azithromycin (500 mg orally three times per week) over 12 months in patients with severe COPD and a minimum of four acute exacerbations (AECOPD) per year or chronic bronchial colonization by Pseudomonas aeruginosa , comparing the number of AECOPD, hospitalizations due to respiratory disease, days of hospital stay, and bacterial infections during azithromycin treatment and in the year prior to this therapy.", {"entities": []}], ["Twenty patients who completed the 12-month treatment period were analyzed.", {"entities": []}], ["No clinically significant adverse events were observed during azithromycin treatment.", {"entities": []}], ["Compared with baseline data, azithromycin therapy significantly reduced the number of AECOPD (2.8 \u00b1 2.5 versus 6.8 \u00b1 2.8, P < 0.001), hospitalizations (1.4 \u00b1 1.5 versus 3.6 \u00b1 1.4, P < 0.001), and cumulative annual days of hospital stay (25 \u00b1 32.2 versus 43.7 \u00b1 21.4, P = 0.01).", {"entities": []}], ["The improvement was particularly significant in patients with exacerbations caused by common potentially pathogenic microorganisms, who had 70% fewer AECOPD and hospitalizations.", {"entities": []}], ["Patients colonized by P. aeruginosa had reductions of 43% in AECOPD and 47% in hospitalizations.", {"entities": []}], ["Long-term azithromycin is well tolerated and associated with significant reductions in AECOPD, hospitalizations, and length of hospital stay in patients with severe COPD.", {"entities": []}], ["The persistent administration of \u03b2 2 -adrenergic (\u03b2 2 AR) agonists has been demonstrated to increase the risk of severe asthma, partly due to the induction of tolerance to bronchoprotection via undefined mechanisms.", {"entities": [[120, 126, "DISEASE"]]}], ["The present study investigated the potential effect of the long-acting \u03b2 2 -adrenergic agonist, formoterol, on the expression of muscarinic M3 receptor (M 3 R) in rat airway smooth muscle cells (ASMCs).", {"entities": []}], ["Primary rat ASMCs were isolated and characterized following immunostaining with anti-\u03b1-smooth muscle actin antibodies.", {"entities": []}], ["The protein expression levels of M 3 R and phospholipase C-\u03b2 1 (PLC\u03b2 1 ) were characterized by western blot analysis and the production of inositol 1,4,5-trisphosphate (IP 3 ) was determined using an enzyme-linked immunosorbent assay.", {"entities": []}], ["Formoterol increased the protein expression of M 3 R in rat ASMCs in a time- and dose-dependent manner, which was significantly inhibited by the \u03b2 2 AR antagonist, ICI118,551 and the cyclic adenosine monophosphate (cAMP) inhibitor, SQ22,536.", {"entities": []}], ["The increased protein expression of M 3 R was positively correlated with increased production of PLC\u03b2 1 and IP 3 .", {"entities": []}], ["Furthermore, treatment with the glucocorticoid, budesonide, and the PLC inhibitor, U73,122, significantly suppressed the formoterol-induced upregulated protein expression levels of M 3 R and PLC\u03b2 1 and production of IP 3 .", {"entities": []}], ["The present study demonstrated that formoterol mediated the upregulation of M 3 R in the rat ASMCs by activating the \u03b2 2 AR-cAMP signaling pathway, resulting in increased expression levels of PLC\u03b2 1 and IP 3 , which are key to inducing bronchoprotection tolerance.", {"entities": []}], ["Administration of glucocorticoids or a PLC antagonist prevented formoterol-induced bronchoprotection tolerance by suppressing the protein expression of M 3 R.", {"entities": []}], ["Fluticasone furoate/vilanterol (FF/VI) is a novel, once-daily, inhaled corticosteroid/long-acting \u03b2 2 -agonist combination approved for the treatment of COPD and asthma.", {"entities": [[162, 168, "DISEASE"]]}], ["We compared the safety and efficacy of FF/VI and tiotropium (TIO) in subjects with moderate-to-severe COPD with greater risk for comorbid cardiovascular disease (CVD).", {"entities": []}], ["This randomized, blinded, double-dummy, parallel-group study compared a once-daily morning dose of FF/VI 100/25 mcg delivered via ELLIPTA\u2122 with TIO 18 mcg via HandiHaler 1 ) 30%\u201370% predicted, and CVD or CVD risk.", {"entities": []}], ["The primary endpoint was change from baseline in 24-hour weighted mean FEV 1 on Day 84.", {"entities": [[71, 74, "GENE"]]}], ["Other efficacy endpoints included time to onset of bronchodilation, trough FEV 1 , other spirometry measures, rescue medication use, symptoms, quality of life (St George\u2019s Respiratory Questionnaire-COPD [SGRQ-C]), and health status (COPD Assessment Tests [CAT]) measures.", {"entities": [[75, 78, "GENE"]]}], ["Safety endpoints included cardiovascular monitoring, cortisol excretion, COPD exacerbations, and adverse events, including prespecified drug effects.", {"entities": []}], ["Both FF/VI and TIO improved the 24-hour weighted mean FEV 1 from baseline after 12 weeks with no significant difference between treatments.", {"entities": [[54, 57, "GENE"]]}], ["Other endpoints favored FF/VI for time to onset of bronchodilation, rescue medication use, dyspnea, SGRQ-C and CAT scores, or favored TIO for change from baseline in forced vital capacity and inspiratory capacity.", {"entities": []}], ["Pneumonia occurred more frequently in the FF/VI group, and two TIO-treated subjects died following cardiovascular events.", {"entities": []}], ["Other safety measures were similar between groups, and cardiovascular monitoring did not reveal increased CVD risk.", {"entities": []}], ["Both FF/VI and TIO were efficacious in improving lung function in subjects with COPD and comorbid CVD or CVD risk factors, with minor differences in efficacy and safety profiles.", {"entities": []}], ["Group 3 pulmonary hypertension (PH) is a common complication of chronic lung disease (CLD), including chronic obstructive pulmonary disease (COPD), interstitial lung disease, and sleep-disordered breathing.", {"entities": [[18, 30, "DISEASE"], [102, 139, "DISEASE"], [148, 173, "DISEASE"], [8, 30, "DISEASE"], [72, 84, "DISEASE"], [161, 173, "DISEASE"]]}], ["Development of PH is associated with poor prognosis and may progress to right heart failure, however, in the majority of the patients with CLD, PH is mild to moderate and only a small number of patients develop severe PH.", {"entities": []}], ["The pathophysiology of PH in CLD is multifactorial and includes hypoxic pulmonary vasoconstriction, pulmonary vascular remodeling, small vessel destruction, and fibrosis.", {"entities": []}], ["The effects of PH on the right ventricle (RV) range between early RV remodeling, hypertrophy, dilatation, and eventual failure with associated increased mortality.", {"entities": []}], ["The golden standard for diagnosis of PH is right heart catheterization, however, evidence of PH can be appreciated on clinical examination, serology, radiological imaging, and Doppler echocardiography.", {"entities": []}], ["Treatment of PH in CLD focuses on management of the underlying lung disorder and hypoxia.", {"entities": []}], ["There is, however, limited evidence to suggest that PH-specific vasodilators such as phosphodiesterase-type 5 inhibitors, endothelin receptor antagonists, and prostanoids may have a role in the treatment of patients with CLD and moderate-to-severe PH.", {"entities": []}], ["Allostatic load (AL) is a cumulative measure of physiological deregulation and is influenced by multiple factors including nutrition.", {"entities": []}], ["The objectives of the study were to assess AL among adolescent boys (15-19 yr) and delineate its association with psychological stress and micronutrient status.", {"entities": []}], ["A cross-sectional, school-based study was conducted among 370 adolescent boys of five higher secondary schools from Hyderabad, India.", {"entities": []}], ["Perceived stress, adolescent life event stress (ALES), psychological morbidity and coping were measured.", {"entities": []}], ["Biomarkers of AL included dehydroepiandrosterone sulphate, 12-h urinary cortisol, interleukin-6, C-reactive protein, lipid profile, body mass index and blood pressure.", {"entities": []}], ["Micronutrient status with respect to iron (haemoglobin, ferritin, hepcidin, soluble transferrin receptor), folate, vitamins B12, C and A were analyzed in a sub-sample of 146 boys.", {"entities": []}], ["AL score \u22653 was calculated from eight biomarkers.", {"entities": []}], ["Fourteen per cent participants had no AL but 34.3 per cent had AL score of \u2265 3.", {"entities": []}], ["Unadjusted means of ALES scores were significantly different ( P = 0.045) among participants with low [mean, 95% confidence interval (CI): 580, 531-629] and high (663, 605-721) AL.", {"entities": []}], ["After controlling for confounders, the means were significantly different for controllable life event sub-scale of ALES ( P = 0.048).", {"entities": []}], ["Adjusted hepcidin concentrations were significantly higher among participants with high AL (means, 95% CI, 27.2, 24.0-30.8 for high AL; 22.1, 20.2-24.2 \u03bcg/l for low AL, P = 0.014).", {"entities": []}], ["Build-up of AL was found in adolescent boys and was positively associated with life event stress.", {"entities": []}], ["Iron nutrition and stress exhibited a positive association through hepcidin.", {"entities": []}], ["The study provides a link between iron nutrition, physiological deregulation and stress.", {"entities": []}], ["The study of genetic polymorphisms has touched every aspect of pulmonary and critical care medicine.", {"entities": []}], ["We review recent progress made using genetic polymorphisms to define pathophysiology, to identify persons at risk for pulmonary disease and to predict treatment response.", {"entities": []}], ["Several pitfalls are commonly encountered in studying genetic polymorphisms, and this article points out criteria that should be applied to design high-quality genetic polymorphism studies.", {"entities": []}], ["Clinical observations suggest that the rate of metastatic development and long-term mortality following surgery in breast cancer patients is influenced by the menstrual phase during which surgery is conducted.", {"entities": [[115, 128, "DISEASE"], [122, 128, "DISEASE"]]}], ["The menstrual cycle is known to modulate various physiological responses and medical conditions that involve adrenergic mechanisms (e.g., asthma).", {"entities": [[138, 144, "DISEASE"]]}], ["Natural killer activity (NKA), an immune function controlling metastasis, is suppressed following surgery, and in vitro by adrenaline.", {"entities": []}], ["We therefore hypothesize that the clinical observation may be partly attributable to surgery-induced adrenergic suppression of NK-dependent resistance to metastasis, a suppression that depends on menstrual phase during surgery.", {"entities": []}], ["To test this hypothesis in rats, 140 F344 females at different phases of their oestrous cycle were injected with a \u03b2-adrenergic agonist, metaproterenol (MP) (0.4 or 0.8\u2009mg kg n = 36).", {"entities": []}], ["Finally, the effects of stress on the number and activity of NK cells were assessed along the oestrous cycle ( n = 71).", {"entities": []}], ["The findings indicate that the suppressive effects of MP on resistance to metastasis and on NKA, are significantly greater during the oestrous phase characterized by high oestradiol levels (D3/proestrus/oestrus).", {"entities": []}], ["Similarly, NKA per cell was suppressed by stress only during this phase.", {"entities": []}], ["In untreated animals, in which inadvertent stress was minimized, no effects of the oestrous cycle on NKA or on resistance to metastasis were evident.", {"entities": []}], ["These findings indicate that the oestrous cycle modulates adrenergic suppression of NKA and of resistance to metastasis.", {"entities": []}], ["The relevance of these findings to the above clinical observation, as well as that of our related findings in women from a parallel study, is discussed.", {"entities": []}], ["\u00a9 2000 Cancer Research Campaign http://www.bjcancer.com", {"entities": [[7, 13, "DISEASE"]]}], ["Vascular Endothelial Growth Factor-A (VEGF-A) can be generated as multiple isoforms by alternative splicing.", {"entities": []}], ["Two families of isoforms have been described in humans, pro-angiogenic isoforms typified by VEGF-A 165 a, and anti-angiogenic isoforms typified by VEGF-A 165 b.", {"entities": []}], ["The practical determination of expression levels of alternative isoforms of the same gene may be complicated by experimental protocols that favour one isoform over another, and the use of specific positive and negative controls is essential for the interpretation of findings on expression of the isoforms.", {"entities": []}], ["Here we address some of the difficulties in experimental design when investigating alternative splicing of VEGF isoforms, and discuss the use of appropriate control paradigms.", {"entities": []}], ["We demonstrate why use of specific control experiments can prevent assumptions that VEGF-A 165 b is not present, when in fact it is.", {"entities": []}], ["We reiterate, and confirm previously published experimental design protocols that demonstrate the importance of using positive controls.", {"entities": []}], ["These include using known target sequences to show that the experimental conditions are suitable for PCR amplification of VEGF-A 165 b mRNA for both q-PCR and RT-PCR and to ensure that mispriming does not occur.", {"entities": []}], ["We also provide evidence that demonstrates that detection of VEGF-A 165 b protein in mice needs to be tightly controlled to prevent detection of mouse IgG by a secondary antibody.", {"entities": []}], ["We also show that human VEGF 165 b protein can be immunoprecipitated from cultured human cells and that immunoprecipitating VEGF-A results in protein that is detected by VEGF-A 165 b antibody.", {"entities": []}], ["These findings support the conclusion that more information on the biology of VEGF-A 165 b isoforms is required, and confirm the importance of the experimental design in such investigations, including the use of specific positive and negative controls.", {"entities": []}], ["In this pilot study, we examined associations between local interleukin (IL)-26, disease severity and biomarkers of Th2-mediated inflammation in a well-defined cohort of pediatric patients (14\u00a0years median age, 41\u00a0% females) with controlled ( n \u2009=\u200928) or uncontrolled ( n \u2009=\u200948) asthma.", {"entities": [[279, 285, "DISEASE"]]}], ["Sputum IL-26 protein concentrations (ELISA) reflected disease control in patients without local (low exhaled nitric oxide) or systemic (low blood eosinophils) signs of eosinophilic inflammation.", {"entities": []}], ["Moreover, sputum-IL-26 concentrations correlated with those of blood neutrophils.", {"entities": []}], ["Our study indicates that IL-26 is a potential biomarker of disease severity in pediatric asthma without signs of Th2-mediated inflammation.", {"entities": [[89, 95, "DISEASE"]]}], ["Aldose Reductase (AR) is implicated in the development of secondary complications of diabetes, providing an interesting target for therapeutic intervention.", {"entities": []}], ["Extracts of Rauvolfia serpentina , a medicinal plant endemic to the Himalayan mountain range, have been known to be effective in alleviating diabetes and its complications.", {"entities": []}], ["In this study, we aim to prospect for novel plant-derived inhibitors from R. serpentina and to understand structural basis of their interactions.", {"entities": []}], ["An extensive library of R. serpentina molecules was compiled and computationally screened for inhibitory action against AR.", {"entities": []}], ["The stability of complexes, with docked leads, was verified using molecular dynamics simulations.", {"entities": []}], ["Two structurally distinct plant-derived leads were identified as inhibitors: indobine and indobinine.", {"entities": []}], ["Further, using these two leads as templates, 16 more leads were identified through ligand-based screening of their structural analogs, from a small molecules database.", {"entities": []}], ["Thus, we obtained plant-derived indole alkaloids, and their structural analogs, as potential AR inhibitors from a manually curated dataset of R. serpentina molecules.", {"entities": []}], ["Indole alkaloids reported herein, as a novel structural class unreported hitherto, may provide better insights for designing potential AR inhibitors with improved efficacy and fewer side effects.", {"entities": []}], ["Impaired lung function and innate immunity have both attracted growing interest as a potentially novel risk factor for glucose intolerance, insulin resistance, and type 2 diabetes.", {"entities": [[119, 138, "DISEASE"]]}], ["We aimed to evaluate whether surfactant protein D (SP-D), a lung-derived innate immune protein, was behind these associations.", {"entities": []}], ["Serum SP-D was evaluated in four different cohorts.", {"entities": []}], ["The cross-sectional associations between SP-D and metabolic and inflammatory parameters were evaluated in two cohorts, the cross-sectional relationship with lung function in one cohort, and the longitudinal effects of weight loss on fasting and circadian rhythm of serum SP-D and cortisol concentrations in one prospective cohort.", {"entities": []}], ["In the cross-sectional studies, serum SP-D concentration was significantly decreased in subjects with obesity and type 2 diabetes ( P = 0.005) and was negatively associated with fasting and postload serum glucose.", {"entities": [[102, 109, "DISEASE"]]}], ["SP-D was also associated with A1C, serum lipids, insulin sensitivity, inflammatory parameters, and plasma insulinase activity.", {"entities": []}], ["Smoking subjects with normal glucose tolerance, but not smoking patients with type 2 diabetes, showed significantly higher serum SP-D concentration than nonsmokers.", {"entities": []}], ["Serum SP-D concentration correlated positively with end-tidal carbon dioxide tension ( r = 0.54, P = 0.034).", {"entities": []}], ["In the longitudinal study, fasting serum SP-D concentration decreased significantly after weight loss ( P = 0.02).", {"entities": []}], ["Moreover, the main components of cortisol and SP-D rhythms became synchronous after weight loss.", {"entities": []}], ["These findings suggest that lung innate immunity, as inferred from circulating SP-D concentrations, is at the cross-roads of inflammation, obesity, and insulin resistance.", {"entities": [[139, 146, "DISEASE"]]}], ["To evaluate the role of serum cytokines in the pathogenesis of respiratory syncytial virus (RSV) infection in infants with low birth weight (LBW).", {"entities": []}], ["A prospective observational study was performed, and hospitalized children with lower respiratory tract infection (LRTI) were recruited.", {"entities": []}], ["Three hundred fifty-eight patients <\u20091\u00a0year met the inclusion criteria: 116 patients had only RSV infection (RSV group); 242 patients had no RSV or other specific pathogen (non-RSV group).", {"entities": []}], ["Serum interleukin-2 (IL-2), IL-4, IL-6, IL-10, tumor necrosis factor-\u03b1 (TNF-\u03b1), and interferon-\u03b3 (IFN-\u03b3) were detected through flow cytometry.", {"entities": []}], ["No significant differences in serum IL-2, 4, 6, 10, and IFN-\u03b3 levels were observed between the RSV and non-RSV groups.", {"entities": []}], ["For RSV infected infants with or without wheezing, delivery mode had no obvious effect on the changes of serum cytokine levels.", {"entities": []}], ["However, the level of IL-6 in the RSV-infected infants with LBW was significantly higher than that in infants with normal birth weight.", {"entities": []}], ["Serum IL-6 level was significantly increased in RSV infected infants with LBW.", {"entities": []}], ["It is likely that the specific serum cytokine pattern will contribute to our understanding of the pathogenesis of RSV infections, especially in RSV-infected infants with LBW.", {"entities": []}], ["Overall obesity, as measured by body mass index (BMI), has been associated with a low level of health-related quality of life (HRQOL), but little is known about abdominal obesity.", {"entities": [[8, 15, "DISEASE"], [171, 178, "DISEASE"]]}], ["This cross-sectional study aimed to determine whether abdominal obesity, as measured by waist circumference (WC), would be significantly associated with HRQOL independent of overall obesity, and if so, whether the association would differ by gender among the Korean population.", {"entities": [[64, 71, "DISEASE"], [182, 189, "DISEASE"]]}], ["Cross-sectional study.", {"entities": []}], ["South Korea.", {"entities": []}], ["Using data from the 2007\u20132009 Korea National Health and Nutrition Examination Survey, a total of 13\u2005754 men and women aged 19\u201365\u2005years were selected, and information about height (cm), weight (kg), WC (cm) and the EuroQOL-5 Dimensions (EQ-5D) scores for HRQOL were taken.", {"entities": []}], ["Not only an overall obesity (as categorised into obese, overweight or non-overweight groups based on BMI) but also an abdominal obesity (defined by WC \u226590\u2005cm for men and \u226585\u2005cm for women) was significantly associated with lower EQ-5D scores, after adjusting for age, gender, socioeconomic variables and a number of comorbidities.", {"entities": [[20, 27, "DISEASE"], [128, 135, "DISEASE"]]}], ["Even after adjusting BMI effect, the association between abdominal obesity and lower EQ-5D scores remained significant for women, but not for men.", {"entities": [[67, 74, "DISEASE"]]}], ["Among the Korean population aged 19\u201365\u2005years, abdominal obesity was associated with impaired HRQOL, independently of overall obesity.", {"entities": [[56, 63, "DISEASE"], [125, 132, "DISEASE"]]}], ["Furthermore, this association differed by gender, being significant only for women.", {"entities": []}], ["Therefore, primary healthcare professionals should pay attention to gender differences in the impact of obesity on HRQOL when evaluating population-based health programmes.", {"entities": [[104, 111, "DISEASE"]]}], ["Alzheimer\u2019s disease (AD) is an age-dependent neurodegenerative disorder and the most common cause of dementia.", {"entities": [[101, 109, "DISEASE"]]}], ["The early stages of AD are characterized by short-term memory loss.", {"entities": []}], ["Once the disease progresses, patients experience difficulties in sense of direction, oral communication, calculation, ability to learn, and cognitive thinking.", {"entities": []}], ["The median duration of the disease is 10 years.", {"entities": []}], ["The pathology is characterized by deposition of amyloid beta peptide (so-called senile plaques) and tau protein in the form of neurofibrillary tangles.", {"entities": []}], ["Currently, two classes of drugs are licensed by the European Medicines Agency for the treatment of AD, ie, acetylcholinesterase inhibitors for mild to moderate AD, and memantine, an N-methyl-D-aspartate receptor antagonist, for moderate and severe AD.", {"entities": []}], ["Treatment with acetylcholinesterase inhibitors or memantine aims at slowing progression and controlling symptoms, whereas drugs under development are intended to modify the pathologic steps leading to AD.", {"entities": []}], ["Herein, we review the clinical features, pharmacologic properties, and cost-effectiveness of the available acetylcholinesterase inhibitors and memantine, and focus on disease-modifying drugs aiming to interfere with the amyloid beta peptide, including vaccination, passive immunization, and tau deposition.", {"entities": []}], ["A wide prevalence of socio-religious and cultural practices in the Asian subcontinent often leads to multitude of skin diseases which may be missed by the dermatologists because of a lack of awareness.", {"entities": []}], ["\u2018Henna\u2019 use causes IgE-mediated hypersensitivity reactions and contact dermatitis.", {"entities": [[63, 81, "DISEASE"], [71, 81, "DISEASE"]]}], ["\u2018Kumkum\u2019 application can result in pigmented contact dermatitis and lichen planus pigmentosus.", {"entities": [[45, 63, "DISEASE"], [68, 81, "DISEASE"], [53, 63, "DISEASE"]]}], ["Sticker \u2018bindis\u2019 and \u2018alta\u2019 induce contact leukoderma.", {"entities": []}], ["Irritant and allergic contact dermatitis occurs after playing with \u2018Holi\u2019 colors.", {"entities": [[22, 40, "DISEASE"], [13, 40, "DISEASE"], [30, 40, "DISEASE"]]}], ["Threading and drawstring dermatitis lead to koebnerization of pre-existing dermatoses, infections and even squamous cell carcinoma of skin.", {"entities": [[121, 130, "DISEASE"], [107, 130, "DISEASE"], [25, 35, "DISEASE"]]}], ["Mild irritant reactions and contact sensitization occur secondary to balm and hair oil use.", {"entities": []}], ["\u2018Mudichood\u2019 represents the comedogenic effect of hair oils combined with occlusion and humidity.", {"entities": []}], ["Aromatherapy oils can cause contact dermatitis and photosensitive reactions.", {"entities": [[28, 46, "DISEASE"], [36, 46, "DISEASE"]]}], ["Heavy metal and steroid toxicity along with severe cutaneous adverse effects like erythroderma can occur as a consequent to the use of alternative medicines.", {"entities": []}], ["Squamous cell carcinoma due to chronic heat exposure from the heating device \u201c kangri \u201d is seen in Kashmiris.", {"entities": [[14, 23, "DISEASE"], [0, 23, "DISEASE"]]}], ["Prayer nodules in Muslims and traction alopecia in Sikhs illustrate how religious practices can negatively affect the skin.", {"entities": [[39, 47, "DISEASE"]]}], ["With increasing globalization and migration, the practice of indigenous customs and traditions is no longer limited to regional territories, making it imperative for the dermatologists to be acquainted with the cutaneous side effects they can cause.", {"entities": []}], ["Background.", {"entities": []}], ["Proteinases play a key role in emphysema.", {"entities": []}], ["Bauhinia bauhinioides cruzipain inhibitor (BbCI) is a serine-cysteine proteinase inhibitor.", {"entities": []}], ["We evaluated BbCI treatment in elastase-induced pulmonary alterations.", {"entities": []}], ["C57BL / 6 mice received intratracheal elastase (ELA group) or saline (SAL group).", {"entities": []}], ["One group of mice was treated with BbCI (days 1, 15, and 21 after elastase instillation, ELABC group).", {"entities": []}], ["Controls received saline and BbCI (SALBC group).", {"entities": []}], ["After 28 days, we evaluated respiratory mechanics, exhaled nitric oxide, and bronchoalveolar lavage fluid.", {"entities": []}], ["In lung tissue we measured airspace enlargement, quantified neutrophils, TNF \u03b1 -, MMP-9-, MMP-12-, TIMP-1-, iNOS-, and eNOS-positive cells, 8-iso-PGF2 \u03b1 , collagen, and elastic fibers in alveolar septa and airways.", {"entities": [[73, 76, "GENE"]]}], ["MUC-5-positive cells were quantified only in airways.", {"entities": []}], ["BbCI reduced elastase-induced changes in pulmonary mechanics, airspace enlargement and elastase-induced increases in total cells, and neutrophils in BALF.", {"entities": []}], ["BbCI reduced macrophages and neutrophils positive cells in alveolar septa and neutrophils and TNF \u03b1 -positive cells in airways.", {"entities": [[94, 97, "GENE"]]}], ["BbCI attenuated elastic and collagen fibers, MMP-9- and MMP-12-positive cells, and isoprostane and iNOS-positive cells in alveolar septa and airways.", {"entities": []}], ["BbCI reduced MUC5ac-positive cells in airways.", {"entities": []}], ["Conclusions.", {"entities": []}], ["BbCI improved lung mechanics and reduced lung inflammation and airspace enlargement and increased oxidative stress levels induced by elastase.", {"entities": []}], ["BbCI may have therapeutic potential in chronic obstructive pulmonary disease.", {"entities": [[39, 76, "DISEASE"]]}], ["Many evidences show the inverse correlation between helminth infection and allergic or autoimmune diseases.", {"entities": []}], ["Identification and characterization of the active helminth-derived products responsible for the beneficial effects on allergic or inflammatory diseases will provide another feasible approach to treat these diseases.", {"entities": []}], ["Colitis was induced in C57BL/6 mice by giving 3% DSS orally for 7 days.", {"entities": []}], ["During this period, the mice were treated daily with the excretory/secretory products from T. spiralis adult worms (AES) intraperitoneally.", {"entities": []}], ["The severity of colitis was monitored by measuring body weight, stool consistency or bleeding, colon length and inflammation.", {"entities": []}], ["To determine the T. spiralis AES product-induced immunological response, Th1, Th2, Th17 and regulatory cytokine profiles were measured in lymphocytes isolated from colon, mesenteric lymph nodes (MLN), and the spleen of treated mice.", {"entities": [[195, 198, "GENE"]]}], ["The CD4 Our results provide direct evidences that T. spiralis AES have a therapeutic potential for alleviating inflammatory colitis in mice.", {"entities": [[4, 7, "GENE"]]}], ["This effect is possibly mediated by the immunomodulation of regulatory T cells to produce regulatory and anti-inflammatory cytokines and inhibit pro-inflammatory cytokines.", {"entities": []}], ["Sudden cardiac death (SCD) is a sudden unexpected event, from a cardiac cause, that occurs in less than one hour after the symptoms onset, in a person without any previous condition that would seem fatal or who was seen without any symptoms 24 hours before found dead.", {"entities": [[22, 25, "GENE"]]}], ["Although it is a relatively frequent event, there are only few reliable data in underdeveloped countries.", {"entities": []}], ["We aimed to describe the features of SCD in Ribeir\u00e3o Preto, Brazil (600,000 residents) according to Coroners\u2019 Office autopsy reports.", {"entities": [[37, 40, "GENE"]]}], ["We retrospectively reviewed 4501 autopsy reports between 2006 and 2010, to identify cases of SCD.", {"entities": [[93, 96, "GENE"]]}], ["Specific cause of death as well as demographic information, date, location and time of the event, comorbidities and whether cardiopulmonary resuscitation (CPR) was attempted were collected.", {"entities": []}], ["We identified 899 cases of SCD (20%); the rate was 30/100000 residents per year.", {"entities": [[27, 30, "GENE"]]}], ["The vast majority of cases of SCD involved a coronary artery disease (CAD) (64%) and occurred in men (67%), between the 6 The majority of victims of SCD were men, in their sixties and seventies and the main cause of death was CAD.", {"entities": [[30, 33, "GENE"], [149, 152, "GENE"], [30, 33, "GENE"], [149, 152, "GENE"]]}], ["Chagas\u2019 disease, an important public health problem in Latin America, was found in about 5.5% of the cases.", {"entities": []}], ["The objective of this study was to determine the epidemiology of hospitalized pediatric sepsis in Brazil (1992\u20132006) and to compare mortality caused by sepsis to that caused by other major childhood diseases.", {"entities": []}], ["We performed a retrospective descriptive study of hospital admissions using a government database of all hospital affiliated with the Brazilian health system.", {"entities": []}], ["We studied all hospitalizations in children from 28 days through 19 years with diagnosis of bacterial sepsis defined by the criteria of the International Classification of Diseases (ICD), ( We concluded that sepsis remains an important health problem in children in Brazil.", {"entities": []}], ["The institution of universal primary care programs has been associated with substantially reduced sepsis incidence and therefore deaths ; however, hospital mortality rates in children with sepsis remain unchanged.", {"entities": []}], ["Implementation of additional health initiatives to reduce sepsis mortality in hospitalized patients could have great impact on childhood mortality rates in Brazil.", {"entities": []}], ["Although maternal serum alpha-fetoprotein (AFP), human chorionic gonandotrophin (hCG), and estriol play important roles in immunomodulation and immunoregulation during pregnancy, their relationship to the development of bronchopulmonary dysplasia (BPD) in young infants is unknown despite BPD being associated with pre- and postnatal inflammatory factors.", {"entities": [[43, 46, "GENE"]]}], ["The objective of this population-based study was to examine whether second trimester levels of AFP, hCG, and unconjugated estriol (uE3) were associated with an increased risk of BPD.", {"entities": [[95, 98, "GENE"]]}], ["We found that these serum biomarkers were associated with an increased risk of BPD.", {"entities": []}], ["Risks were especially high when AFP and/or hCG levels were above the 95", {"entities": [[32, 35, "GENE"]]}], ["Mitochondria-derived reactive oxygen species (ROS) play important roles in the development of cardiovascular disease highlighting the need for novel targeted therapies.", {"entities": []}], ["This study assessed the potential therapeutic benefit of combining the mitochondria-specific antioxidant, MitoQ 10 , with the low-dose angiotensin receptor blocker (ARB), losartan, on attenuation of hypertension and left ventricular hypertrophy.", {"entities": [[199, 211, "DISEASE"]]}], ["In parallel, we investigated the impact of MitoQ 10 on cardiac hypertrophy in a neonatal cardiomyocyte cell line.", {"entities": []}], ["Eight-week-old male stroke-prone spontaneously hypertensive rats (SHRSPs, n \u200a=\u200a8\u201311) were treated with low-dose losartan (2.5\u200amg/kg per day); MitoQ 10 (500\u200a\u03bcmol/l); a combination of MitoQ 10 and losartan (M\u200a+\u200aL); or vehicle for 8 weeks.", {"entities": []}], ["Systolic pressure and pulse pressure were significantly lower in M\u200a+\u200aL rats (167.1\u200a\u00b1\u200a2.9\u200ammHg; 50.2\u200a\u00b1\u200a2.05\u200ammHg) than in untreated SHRSP (206.6\u200a\u00b1\u200a9\u200ammHg, P \u200a<\u200a0.001; 63.7\u200a\u00b1\u200a2.7\u200ammHg, P \u200a=\u200a0.001) and demonstrated greater improvement than MitoQ 10 or low-dose losartan alone, as measured by radiotelemetry.", {"entities": []}], ["Left ventricular mass index was significantly reduced from 22.8\u200a\u00b1\u200a0.74 to 20.1\u200a\u00b1\u200a0.61\u200amg/mm in the combination group ( P \u200a<\u200a0.05).", {"entities": []}], ["Picrosirius red staining showed significantly reduced cardiac fibrosis in M\u200a+\u200aL rats (0.82\u200a\u00b1\u200a0.22\u200aA.U.)", {"entities": []}], ["compared with control (5.94\u200a\u00b1\u200a1.35\u200aA.U., P \u200a<\u200a0.01).", {"entities": []}], ["In H9c2 neonatal rat cardiomyocytes, MitoQ 10 significantly inhibited angiotensin II mediated hypertrophy in a dose-dependent manner (500\u200anmol/l MitoQ 10 153.7\u200a\u00b1\u200a3.1\u200amicrons vs. angiotensin II 200.1\u200a\u00b1\u200a3.6\u200amicrons, P \u200a<\u200a0.001).", {"entities": []}], ["Combining MitoQ 10 and low-dose losartan provides additive therapeutic benefit, significantly attenuating development of hypertension and reducing left ventricular hypertrophy.", {"entities": [[121, 133, "DISEASE"]]}], ["In addition, MitoQ 10 mediates a direct antihypertrophic effect on rat cardiomyocytes in vitro .", {"entities": []}], ["MitoQ 10 has potential as a novel therapeutic intervention in conjunction with current antihypertensive drugs.", {"entities": []}], ["Chronic Obstructive Pulmonary Disease (COPD) is a chronic inflammatory disease, primarily affecting the airways.", {"entities": []}], ["Stable biomarkers characterizing the inflammatory phenotype of the disease, relevant for disease activity and suited to predict disease progression are needed to monitor the efficacy and safety of drug interventions.", {"entities": []}], ["We therefore analyzed a large panel of markers in bronchoalveolar lavage, bronchial biopsies, serum and induced sputum of 23 healthy smokers and 24 smoking COPD patients (GOLD II) matched for age and gender.", {"entities": []}], ["Sample collection was performed twice within a period of 6 weeks.", {"entities": []}], ["Assays for over 100 different markers were validated for the respective matrices prior to analysis.", {"entities": []}], ["In our study, we found 51 markers with a sufficient repeatability (intraclass correlation coefficient >0.6), most of these in serum.", {"entities": []}], ["Differences between groups were observed for markers from all compartments, which extends (von-Willebrand-factor) and confirms (e.g.", {"entities": []}], ["C-reactive-protein, interleukin-6) previous findings.", {"entities": []}], ["No correlations between lung and serum markers were observed, including A1AT.", {"entities": []}], ["Airway inflammation defined by sputum neutrophils showed only a moderate repeatability.", {"entities": []}], ["This could be improved, when a combination of neutrophils and four sputum fluid phase markers was used to define the inflammatory phenotype.In summary, our study provides comprehensive information on the repeatability and interrelationship of pulmonary and systemic COPD-related markers.", {"entities": []}], ["These results are relevant for ongoing large clinical trials and future COPD research.", {"entities": []}], ["While serum markers can discriminate between smokers with and without COPD, they do not seem to sufficiently reflect the disease-associated inflammatory processes within the airways.", {"entities": []}], ["Incense burning is a popular cultural and religious practice, but whether exposure to incense smoke has effects on lung function is unclear.", {"entities": []}], ["We investigated association between lung function and incense burning exposure and other household exposures in adolescents who participated in a mass asthma\u2010screening program.", {"entities": [[151, 157, "DISEASE"]]}], ["Information on asthmatic status and associated factors was obtained from parent\u2010completed questionnaires and student\u2010completed video questionnaires.", {"entities": []}], ["Approximately 10% of students received lung function examinations.", {"entities": []}], ["Valid lung function data of 5010 students aged 14\u201016\u00a0years in northern Taiwan were analyzed.", {"entities": []}], ["Forced vital capacity ( FVC ) and forced expiratory flow in 1\u00a0second ( FEV 1 ) were compared by incense burning status and other types of exposures for adolescents.", {"entities": [[71, 74, "GENE"]]}], ["Overall, 70.6% of students were exposed to incense smoke at home.", {"entities": []}], ["The mean FVC and FEV 1 measures were lower among adolescents with daily exposure to incense burning than those without such exposure ( P <.05).", {"entities": [[17, 20, "GENE"]]}], ["Sharing bedroom was also associated with decreased FVC and FEV 1 .", {"entities": [[59, 62, "GENE"]]}], ["After controlling for confounding factors, multivariable linear regression analysis with generalized estimation equation showed that FVC was negatively associated with daily exposure to incense burning, sharing a bedroom, and living in a house adjacent to a traffic road.", {"entities": []}], ["Such associations were also observed in FEV 1 .", {"entities": [[40, 43, "GENE"]]}], ["Daily exposure to incense burning is associated with impaired adolescent lung function.", {"entities": []}], ["The diagnosis of chronic obstructive pulmonary disease (COPD) is often delayed until later stages of the disease.", {"entities": [[17, 54, "DISEASE"]]}], ["The purpose of the present study was to determine the prevalence of COPD among adults on treatment for systemic arterial hypertension independently of the presence of respiratory symptoms.", {"entities": [[121, 133, "DISEASE"]]}], ["This cross-sectional study included adults aged \u226540 years with tobacco/occupational exposure and systemic arterial hypertension diagnosed at three Primary Health Care facilities in Goiania, Brazil.", {"entities": [[115, 127, "DISEASE"]]}], ["Patients were evaluated using a standardized respiratory questionnaire and spirometry.", {"entities": []}], ["COPD prevalence was measured considering the value of forced vital capacity and/or forced expiratory volume in 1 second <0.70.", {"entities": []}], ["Of a total of 570 subjects, 316 (55%) met inclusion criteria and were invited to participate.", {"entities": []}], ["Two hundred and thirty-three (73.7%) patients with arterial hypertension reported at least one respiratory symptom, while 83 (26.3%) reported no respiratory symptoms; 41 (17.6%) patients with arterial hypertension and at least one respiratory symptom, and 10 (12%) patients with arterial hypertension but no respiratory symptoms were diagnosed with COPD ( P =0.24).", {"entities": [[60, 72, "DISEASE"], [201, 213, "DISEASE"], [288, 300, "DISEASE"]]}], ["The prevalence of COPD in people with no previous COPD diagnosis was greater among those with no respiratory symptoms (100%) than among those with respiratory symptoms (56.1%) ( P =0.01).", {"entities": []}], ["Our findings suggest that regardless of the presence of respiratory symptoms, individuals aged \u226540 years with tobacco/occupational exposure and arterial hypertension may benefit from spirometric evaluation.", {"entities": [[153, 165, "DISEASE"]]}], ["Systemic autoimmune rheumatic diseases (SARDs) are a group of debilitating autoimmune diseases, including systemic lupus erythematosus and related disorders.", {"entities": [[115, 134, "DISEASE"], [106, 134, "DISEASE"]]}], ["Assessing the healthcare and economic burden of SARDs has been challenging: while administrative databases can be used to determine healthcare utilisation and costs with minimal selection and recall bias, other health, sociodemographic and economic data have typically been sourced from highly selected, clinic-based cohorts.", {"entities": []}], ["To address these gaps, we are collecting self-reported survey data from a general population-based cohort of individuals with and without SARDs and linking it to their longitudinal administrative health data.", {"entities": []}], ["Using administrative data from the province of British Columbia (BC), Canada, we established a population-based cohort of all BC adults receiving care for SARDs during 1996\u20132010 (n=20\u2009729) and non-SARD individuals randomly selected from the general population.", {"entities": []}], ["BC Ministry of Health granted us contact information for 12 000 SARD and non-SARD individuals, who were recruited to complete the surveys by mail or online.", {"entities": []}], ["Four hundred individuals were initially invited to participate, with 135 (34%) consenting and 127 (94%) submitting the first survey (72% completed online).", {"entities": []}], ["Sixty-three (49.6%) reported \u22651\u2009SARD diagnosis.", {"entities": []}], ["The non-SARDs group (n=64) was 92% female with mean age 57.0\u00b111.6 years.", {"entities": []}], ["The SARDs group (n=63) was 94% female with mean age 56.5\u00b113.1 years.", {"entities": []}], ["Forty-eight per cent of those with SARDs were current-or-former smokers (mean 10.6\u00b116.2 pack-years), and 33% were overweight or obese (mean body mass index of 24.4\u00b15.3).", {"entities": []}], ["Health and productivity data collected from the surveys will be linked to participants\u2019 administrative health data from the years 1990\u20132013, allowing us to determine the healthcare and lost productivity costs of SARDs, and assess the impact of patient-reported variables on utilisation, costs, disability and clinical outcomes.", {"entities": []}], ["Findings will be disseminated through scientific conferences and peer-reviewed journals.", {"entities": []}], ["The purpose of this study was to define the prevalence of undiagnosed airflow obstruction (AO) among subjects with a history of smoking but no previous diagnosis of chronic lung disease.", {"entities": [[173, 185, "DISEASE"]]}], ["The finding of AO likely represents diagnosis of chronic obstructive pulmonary disease.", {"entities": [[49, 86, "DISEASE"]]}], ["People aged \u226530 years with a history of smoking who attended public outpatient clinics for primary care services were included in this study.", {"entities": []}], ["A cross-sectional survey in five clinics in Hong Kong using the Breathlessness, Cough, and Sputum Scale, the Lung Function Questionnaire, and office spirometry was conducted.", {"entities": []}], ["In total, 731 subjects (response rate =97.9%) completed the questionnaires and spirometry tests.", {"entities": []}], ["Most of the subjects were men (92.5%) in the older age group (mean age =62.2 years; standard deviation =11.7).", {"entities": []}], ["Of the 731 subjects, 107 had AO, giving a prevalence of 14.6% (95% confidence interval =12.1\u201317.2); 45 subjects with AO underwent a postbronchodilator test.", {"entities": []}], ["By classifying the severity of chronic obstructive pulmonary disease using the Global Initiative for Chronic Obstructive Lung Disease, 27 (60%) were considered to be in mild category and 18 (40%) in moderate category.", {"entities": [[31, 68, "DISEASE"], [121, 133, "DISEASE"]]}], ["None of them belonged to the severe or very severe category.", {"entities": []}], ["The total score of Lung Function Questionnaire showed that majority of the subjects with AO also had chronic cough, wheezing attack, or breathlessness, although most did not show any acute respiratory symptoms in accordance with the Breathlessness, Cough, and Sputum Scale.", {"entities": []}], ["Diagnosis of AO was positively associated with the number of years of smoking (odds ratio =1.044, P =0.035) and being normal or underweight (odds ratio =1.605, P =0.046).", {"entities": []}], ["It was negatively associated with a history of hypertension (odds ratio =0.491, P =0.003).", {"entities": [[47, 59, "DISEASE"]]}], ["One-seventh of smokers have undiagnosed AO.", {"entities": []}], ["Spirometry screening of smokers should be considered in order to diagnose AO at an early stage, with an emphasis on smoking cessation.", {"entities": []}], ["Alcohol consumption is known to lead to gene expression changes in the brain.", {"entities": []}], ["After performing weighted gene co-expression network analyses (WGCNA) on genome-wide mRNA and microRNA (miRNA) expression in Nucleus Accumbens (NAc) of subjects with alcohol dependence (AD; N = 18) and of matched controls (N = 18), six mRNA and three miRNA modules significantly correlated with AD were identified (Bonferoni-adj.", {"entities": [[166, 184, "DISEASE"]]}], ["Cell-type-specific transcriptome analyses revealed two of the mRNA modules to be enriched for neuronal specific marker genes and downregulated in AD, whereas the remaining four mRNA modules were enriched for astrocyte and microglial specific marker genes and upregulated in AD.", {"entities": []}], ["Gene set enrichment analysis demonstrated that neuronal specific modules were enriched for genes involved in oxidative phosphorylation, mitochondrial dysfunction and MAPK signaling.", {"entities": []}], ["Glial-specific modules were predominantly enriched for genes involved in processes related to immune functions, i.e.", {"entities": []}], ["cytokine signaling (all adj.", {"entities": []}], ["In mRNA and miRNA modules, 461 and 25 candidate hub genes were identified, respectively.", {"entities": []}], ["In contrast to the expected biological functions of miRNAs, correlation analyses between mRNA and miRNA hub genes revealed a higher number of positive than negative correlations (\u03c7", {"entities": []}], ["There is no malaria vaccine currently available, and the most advanced candidate has recently reported a modest 30% efficacy against clinical malaria.", {"entities": [[12, 19, "DISEASE"], [142, 149, "DISEASE"]]}], ["Although many efforts have been dedicated to achieve this goal, the research was mainly directed to identify antigenic targets.", {"entities": []}], ["Nevertheless, the latest progresses on understanding how immune system works and the data recovered from vaccination studies have conferred to the vaccine formulation its deserved relevance.", {"entities": []}], ["Additionally to the antigen nature, the manner in which it is presented (delivery adjuvants) as well as the immunostimulatory effect of the formulation components (immunostimulants) modulates the immune response elicited.", {"entities": []}], ["Protective immunity against malaria requires the induction of humoral, antibody-dependent cellular inhibition (ADCI) and effector and memory cell responses.", {"entities": [[28, 35, "DISEASE"]]}], ["This review summarizes the status of adjuvants that have been or are being employed in the malaria vaccine development, focusing on the pharmaceutical and immunological aspects, as well as on their immunization outcomings at clinical and preclinical stages.", {"entities": [[91, 98, "DISEASE"]]}], ["A number of related changes have evolved over the past 25\u00a0years: the development of a truly national disaster mental health service in Israel; progress in the science of risk, resilience and evidence base care for those suffering from traumatic stress related disorders; and the development of conceptual models of population level disaster mental health response in the context of emergency management systems such as the Incident Command System.", {"entities": []}], ["In a recent IJHPR article, Bodas, et al.", {"entities": []}], ["report on the dynamic history of disaster mental health response in Israel, which informed by the all too numerous real world events affecting the region.", {"entities": []}], ["What is most striking is that the system now in place reflects true \u201clessons learned\u201d in that problems and issues identified in incidents informed deliberative planning, and the current system reflects many iterations of \u201clessons observed and learned\u201d.", {"entities": []}], ["There appears to be commitment across sectors of government in Israel that the mental health consequences of disasters and terrorism are important and a priority.", {"entities": []}], ["This is advanced thinking and sound policy.", {"entities": []}], ["As the system in Israel continues to evolve, additional possibilities are offered for further consideration, based on the author\u2019s US-centric experience, to advance emergency response systems in Israel, the Middle East and around the world.", {"entities": []}], ["Current therapy for relieving bronchoconstriction may be ineffective in severe asthma, particularly in the small airways.", {"entities": [[79, 85, "DISEASE"]]}], ["The aim of this study was to further characterise responses to the recently identified novel bronchodilators rosiglitazone (RGZ) and chloroquine (CQ) under conditions where \u03b2-adrenoceptor agonist efficacy was limited or impaired in mouse small airways within lung slices.", {"entities": []}], ["Relaxation to RGZ and CQ was assessed following submaximal methacholine (MCh) pre-contraction, in slices treated overnight with either RGZ, CQ or albuterol (ALB) (to induce \u03b2-adrenoceptor desensitization), and in slices treated with caffeine/ryanodine in which contraction is associated with increases in Ca RGZ and CQ, but not ALB or ISO, elicited complete relaxation with increasing MCh pre-contraction and maintained their potency and efficacy following \u03b2-adrenoceptor desensitization.", {"entities": []}], ["RGZ, CQ and ALB maintained efficacy following overnight incubation with RGZ or CQ.", {"entities": []}], ["Relaxation responses to all dilators were generally maintained but delayed after caffeine/ryanodine.", {"entities": []}], ["Pre-treatment with RGZ, but not CQ, ALB or ISO, reduced MCh potency.", {"entities": []}], ["This study demonstrates the superior effectiveness of RGZ in comparison to CQ and \u03b2-adrenoceptor agonists as a dilator of mouse small airways.", {"entities": []}], ["Further investigation of the mechanisms underlying the relatively greater efficacy of RGZ under these conditions are warranted and should be extended to include studies in human asthmatic airways.", {"entities": []}], ["Bronchiectasis is characterized by an irreversible dilatation of bronchi and is associated with lung fibrosis.", {"entities": [[0, 14, "DISEASE"]]}], ["MMP-1 polymorphism may alter its transcriptional activity, and differentially modulate bronchial destruction and lung fibrosis.", {"entities": []}], ["To investigate the association of MMP-1 polymorphisms with disease severity in non-cystic fibrosis (CF) bronchiectasis patients, 51 normal subjects and 113 patients with bronchiectasis were studied.", {"entities": [[104, 118, "DISEASE"], [170, 184, "DISEASE"], [83, 98, "DISEASE"]]}], ["The associations between MMP-1 polymorphisms, lung function, and disease severity evaluated by high resolution computed tomography (HRCT) were analyzed.", {"entities": []}], ["The frequency of MMP-1 (-1607G) allele was significantly higher in patients with bronchiectasis than normal subjects (70.8% vs 45.1%, p<0.01).", {"entities": [[81, 95, "DISEASE"]]}], ["Forced expiratory volume in 1 second (FEV1) was decreased in bronchiectasis patients with 1G/1G (1.2\u00b10.1 L, n\u200a=\u200a14) and 1G/2G (1.3\u00b10.1 L, n\u200a=\u200a66) genotypes compared to the 2G/2G genotype (1.7\u00b10.1 L, n\u200a=\u200a33, p<0.01).", {"entities": [[61, 75, "DISEASE"]]}], ["Six minute walking distance was decreased in bronchiectasis patients with 1G/1G and 1G/2G compared to that of 2G/2G genotype.", {"entities": [[45, 59, "DISEASE"]]}], ["Disease severity evaluated by HRCT score significantly increased in bronchiectasis patients with 1G/1G and 1G/2G genotypes compared to that of 2G/2G genotype.", {"entities": [[68, 82, "DISEASE"]]}], ["Bronchiectasis patients with at least one MMP-1 (-1607G) allele showed increased tendency for hospitalization.", {"entities": [[0, 14, "DISEASE"]]}], ["Serum levels of pro-MMP-1, active MMP-1 and TGF-\u03b21 were significantly increased in patients with bronchiectasis with 1G/1G and 1G/2G genotype compared with 2G/2G genotype or normal subjects.", {"entities": [[97, 111, "DISEASE"]]}], ["Under IL-1\u03b2 stimulation, peripheral blood monocytes from subjects with 1G/2G or 1G/1G genotype secreted higher levels of TGF-\u03b21compared to subjects with 2G/2G genotype.", {"entities": []}], ["This is the first report to address the influence of MMP-1 polymorphisms on lung function and airway destruction in non-CF bronchiectasis patients.", {"entities": [[123, 137, "DISEASE"]]}], ["Bronchiectasis patients with MMP-1 (-1607G) polymorphism may be more vulnerable to permanent lung fibrosis or airway destruction due to the enhanced MMP-1 and TGF-\u03b21 activity.", {"entities": [[0, 14, "DISEASE"]]}], ["Upregulated MMP-1 activity results in proteolytic destruction of matrix, and leads to subsequent fibrosis.", {"entities": []}], ["The importance of n -3 long chain polyunsaturated fatty acids (LC-PUFAs) for human health has received more focus the last decades, and the global consumption of n -3 LC-PUFA has increased.", {"entities": []}], ["Seafood, the natural n -3 LC-PUFA source, is harvested beyond a sustainable capacity, and it is therefore imperative to develop alternative n -3 LC-PUFA sources for both eicosapentaenoic acid (EPA, 20:5 n -3) and docosahexaenoic acid (DHA, 22:6 n -3).", {"entities": []}], ["Genera of algae such as Nannochloropsis , Schizochytrium , Isochrysis and Phaedactylum within the kingdom Chromista have received attention due to their ability to produce n -3 LC-PUFAs.", {"entities": []}], ["Knowledge of LC-PUFA synthesis and its regulation in algae at the molecular level is fragmentary and represents a bottleneck for attempts to enhance the n -3 LC-PUFA levels for industrial production.", {"entities": []}], ["In the present review, Phaeodactylum tricornutum has been used to exemplify the synthesis and compartmentalization of n -3 LC-PUFAs.", {"entities": []}], ["Based on recent transcriptome data a co-expression network of 106 genes involved in lipid metabolism has been created.", {"entities": []}], ["Together with recent molecular biological and metabolic studies, a model pathway for n -3 LC-PUFA synthesis in P. tricornutum has been proposed, and is compared to industrialized species of Chromista.", {"entities": []}], ["Limitations of the n -3 LC-PUFA synthesis by enzymes such as thioesterases, elongases, acyl-CoA synthetases and acyltransferases are discussed and metabolic bottlenecks are hypothesized such as the supply of the acetyl-CoA and NADPH.", {"entities": []}], ["A future industrialization will depend on optimization of chemical compositions and increased biomass production, which can be achieved by exploitation of the physiological potential, by selective breeding and by genetic engineering.", {"entities": []}], ["Dyspnea, or shortness of breath, is a common symptom in patients with advanced cancer.", {"entities": [[79, 85, "DISEASE"]]}], ["Pharmacologic management is of proven benefit, but it does not help all patients.", {"entities": []}], ["Preliminary data suggest that acupuncture can relieve dyspnea in a variety of populations, including cancer patients.", {"entities": [[101, 107, "DISEASE"]]}], ["We conducted a pilot study (ISRCTN89462491) preparatory to a fully powered randomized, placebo-controlled trial to determine whether acupuncture reduces dyspnea in patients with lung or breast cancer.", {"entities": [[186, 199, "DISEASE"], [193, 199, "DISEASE"]]}], ["The study sample was comprised of forty-seven patients with lung or breast cancer presenting with dyspnea.", {"entities": [[68, 81, "DISEASE"], [75, 81, "DISEASE"]]}], ["Patients receiving symptomatic treatments were not excluded as long as no changes in management were planned during the trial.", {"entities": []}], ["Patients were randomized to receive a single session of true or placebo acupuncture in addition to their existing dyspnea treatments.", {"entities": []}], ["Semi-permanent acupuncture \"studs\" were then inserted: patients applied pressure to these studs twice a day to provide ongoing stimulation to acupuncture points.", {"entities": []}], ["The subjective sensation of dyspnea was assessed with a 0 \u2013 10 numerical rating scale immediately before and after acupuncture treatment and daily for a week thereafter.", {"entities": []}], ["All but two of 47 randomized patients provided follow-up data.", {"entities": []}], ["Dyspnea scores were slightly higher for patients receiving true versus placebo acupuncture, for both the period immediately following acupuncture treatment and for the daily one week follow-up (differences between means of 0.34, 95% C.I.", {"entities": []}], ["-0.33, 1.02 and 0.56, 95% C.I.", {"entities": []}], ["-0.39, 1.51).", {"entities": []}], ["The 95% confidence interval excludes the prespecified minimum clinically significant difference of a 20% greater improvement in dyspnea for patients receiving acupuncture.", {"entities": []}], ["The acupuncture technique used in this trial is unlikely to have effects on dyspnea importantly larger than placebo for patients with advanced cancer.", {"entities": [[143, 149, "DISEASE"]]}], ["The chronic impact of ambient air pollutants on lung function in adults is not fully understood.", {"entities": []}], ["The objective of this study was to investigate the association of long-term exposure to ambient air pollution with lung function in adult participants from five cohorts in the European Study of Cohorts for Air Pollution Effects (ESCAPE).", {"entities": []}], ["Residential exposure to nitrogen oxides (NO 2 , NO x ) and particulate matter (PM) was modelled and traffic indicators were assessed in a standardised manner.", {"entities": []}], ["The spirometric parameters forced expiratory volume in 1 s (FEV 1 ) and forced vital capacity (FVC) from 7613 subjects were considered as outcomes.", {"entities": [[60, 63, "GENE"]]}], ["Cohort-specific results were combined using meta-analysis.", {"entities": []}], ["We did not observe an association of air pollution with longitudinal change in lung function, but we observed that a 10 \u03bcg\u00b7m 2 exposure was associated with lower levels of FEV 1 (\u221214.0 mL, 95% CI \u221225.8 to \u22122.1) and FVC (\u221214.9 mL, 95% CI \u221228.7 to \u22121.1).", {"entities": [[172, 175, "GENE"]]}], ["An increase of 10 \u03bcg\u00b7m 10 , but not other PM metrics (PM 2.5 , coarse fraction of PM, PM absorbance), was associated with a lower level of FEV 1 (\u221244.6 mL, 95% CI \u221285.4 to \u22123.8) and FVC (\u221259.0 mL, 95% CI \u2212112.3 to \u22125.6).", {"entities": [[139, 142, "GENE"]]}], ["The associations were particularly strong in obese persons.", {"entities": []}], ["This study adds to the evidence for an adverse association of ambient air pollution with lung function in adults at very low levels in Europe.", {"entities": []}], ["The ESCAPE study finds that, even at very low levels, air pollution has adverse effects on lung function in adults http://ow.ly/A1ssB", {"entities": []}], ["Environmental tobacco smoke (ETS) contaminates indoor air in homes and workplaces.", {"entities": []}], ["Although the adverse effects of active cigarette smoking on the respiratory tract have been extensively characterized, the effects of ETS exposure on adult asthma have not yet been investigated extensively and the available data are limited.", {"entities": [[156, 162, "DISEASE"]]}], ["This article examines the evidence for ETS exposure as a cause of asthma and asthma exacerbation in adults, and for ETS exposure in the workplace specifically as contributing to these health effects.", {"entities": [[66, 72, "DISEASE"], [77, 83, "DISEASE"]]}], ["It addresses methodological barriers that limit the available data and evaluates the adequacy of the data for risk assessment.", {"entities": []}], ["Aspirin has been considered to be beneficial in preventing cardiovascular diseases and cancer.", {"entities": [[87, 93, "DISEASE"]]}], ["Several pharmaco-epidemiology cohort studies have shown protective effects of aspirin on diseases using various statistical methods, with the Cox regression model being the most commonly used approach.", {"entities": []}], ["However, there are some inherent limitations to the conventional Cox regression approach such as guarantee-time bias, resulting in an overestimation of the drug effect.", {"entities": []}], ["To overcome such limitations, alternative approaches, such as the time-dependent Cox model and landmark methods have been proposed.", {"entities": []}], ["This study aimed to compare the performance of three methods: Cox regression, time-dependent Cox model and landmark method with different landmark times in order to address the problem of guarantee-time bias.", {"entities": []}], ["Through statistical modeling and simulation studies, the performance of the above three methods were assessed in terms of type I error, bias, power, and mean squared error (MSE).", {"entities": []}], ["In addition, the three statistical approaches were applied to a real data example from the Korean National Health Insurance Database.", {"entities": []}], ["Effect of cumulative rosiglitazone dose on the risk of hepatocellular carcinoma was used as an example for illustration.", {"entities": [[55, 79, "DISEASE"], [70, 79, "DISEASE"]]}], ["In the simulated data, time-dependent Cox regression outperformed the landmark method in terms of bias and mean squared error but the type I error rates were similar.", {"entities": []}], ["The results from real-data example showed the same patterns as the simulation findings.", {"entities": []}], ["While both time-dependent Cox regression model and landmark analysis are useful in resolving the problem of guarantee-time bias, time-dependent Cox regression is the most appropriate method for analyzing cumulative dose effects in pharmaco-epidemiological studies.", {"entities": []}], ["Atopic dermatitis (atopic eczema) is a chronic inflammatory skin disease that has reached epidemic proportions in children worldwide and is increasing in prevalence.", {"entities": [[0, 17, "DISEASE"], [60, 72, "DISEASE"], [7, 17, "DISEASE"]]}], ["Because of the significant socioeconomic effect of atopic dermatitis and its effect on the quality of life of children and families, there have been decades of research focused on disease prevention, with limited success.", {"entities": [[51, 68, "DISEASE"], [58, 68, "DISEASE"]]}], ["Recent advances in cutaneous biology suggest skin barrier defects might be key initiators of atopic dermatitis and possibly allergic sensitization.", {"entities": [[93, 110, "DISEASE"], [100, 110, "DISEASE"]]}], ["Our objective was to test whether skin barrier enhancement from birth represents a feasible strategy for reducing the incidence of atopic dermatitis in high-risk neonates.", {"entities": [[131, 148, "DISEASE"], [138, 148, "DISEASE"]]}], ["We performed a randomized controlled trial in the United States and United Kingdom of 124 neonates at high risk for atopic dermatitis.", {"entities": [[116, 133, "DISEASE"], [123, 133, "DISEASE"]]}], ["Parents in the intervention arm were instructed to apply full-body emollient therapy at least once per day starting within 3 weeks of birth.", {"entities": []}], ["Parents in the control arm were asked to use no emollients.", {"entities": []}], ["The primary feasibility outcome was the percentage of families willing to be randomized.", {"entities": []}], ["The primary clinical outcome was the cumulative incidence of atopic dermatitis at 6 months, as assessed by a trained investigator.", {"entities": [[61, 78, "DISEASE"], [68, 78, "DISEASE"]]}], ["Forty-two percent of eligible families agreed to be randomized into the trial.", {"entities": []}], ["All participating families in the intervention arm found the intervention acceptable.", {"entities": []}], ["A\u00a0statistically significant protective effect was found with the use of daily emollient on the cumulative incidence of atopic dermatitis with a relative risk reduction of 50% (relative risk, 0.50; 95% CI, 0.28-0.9; P \u00a0= .017).", {"entities": [[119, 136, "DISEASE"], [126, 136, "DISEASE"]]}], ["There were no emollient-related adverse events and no differences in adverse events between groups.", {"entities": []}], ["The results of this trial demonstrate that emollient therapy from birth represents a feasible, safe, and effective approach for atopic dermatitis prevention.", {"entities": [[128, 145, "DISEASE"], [135, 145, "DISEASE"]]}], ["If confirmed in larger trials, emollient therapy from birth would be a simple and low-cost intervention that could reduce the global burden of allergic diseases.", {"entities": []}], ["We examined whether systemic cytokine signaling via interleukin (IL)-17 and growth-related oncogene-\u03b1 (GRO-\u03b1) is impaired in smokers with obstructive pulmonary disease including chronic bronchitis (OPD-CB).", {"entities": [[186, 196, "DISEASE"]]}], ["We also examined how this systemic cytokine signaling relates to bacterial colonization in the airways of the smokers with OPD-CB.", {"entities": []}], ["Currently smoking OPD-CB patients (n=60, corresponding to Global initiative for chronic Obstructive Lung Disease [GOLD] stage I\u2013IV) underwent recurrent blood and sputum sampling over 60 weeks, during stable conditions and at exacerbations.", {"entities": []}], ["We characterized cytokine protein concentrations in blood and bacterial growth in sputum.", {"entities": []}], ["Asymptomatic smokers (n=10) and never-smokers (n=10) were included as control groups.", {"entities": []}], ["During stable clinical conditions, the protein concentrations of IL-17 and GRO-\u03b1 were markedly lower among OPD-CB patients compared with never-smoker controls, whereas the asymptomatic smoker controls displayed intermediate concentrations.", {"entities": []}], ["Notably, among OPD-CB patients, colonization by opportunistic pathogens was associated with markedly lower IL-17 and GRO-\u03b1, compared with colonization by common respiratory pathogens or oropharyngeal flora.", {"entities": []}], ["During exacerbations in the OPD-CB patients, GRO-\u03b1 and neutrophil concentrations were increased, whereas protein concentrations and messenger RNA for IL-17 were not detectable in a reproducible manner.", {"entities": []}], ["In smokers with OPD-CB, systemic cytokine signaling via IL-17 and GRO-\u03b1 is impaired and this alteration may be linked to colonization by opportunistic pathogens in the airways.", {"entities": []}], ["Given the potential pathogenic and therapeutic implications, these findings deserve to be validated in new and larger patient cohorts.", {"entities": []}], ["Findings of randomized controlled trials and robust quasi-experimental and epidemiological studies suggest likely benefits of influenza vaccination for persons with asthma, with reductions in influenza infection, respiratory illness, asthma attacks, and emergency department visits and hospitalizations for influenza-related asthma complications.", {"entities": [[126, 135, "DISEASE"], [192, 201, "DISEASE"], [307, 316, "DISEASE"], [165, 171, "DISEASE"], [234, 240, "DISEASE"], [325, 331, "DISEASE"]]}], ["There is uncertainty about the effectiveness of influenza vaccination in persons with asthma and its impact on asthma outcomes, which may contribute to the suboptimal vaccination rates in persons with asthma.", {"entities": [[48, 57, "DISEASE"], [86, 92, "DISEASE"], [111, 117, "DISEASE"], [201, 207, "DISEASE"]]}], ["This systematic review and meta-analysis involved searching 12 international databases for randomized controlled trials (RCTs) and high-quality quasi-experimental and epidemiological studies (1970\u20132016).", {"entities": []}], ["The risk of bias was low for 3 included RCTs.", {"entities": []}], ["The quality of 3 included observational studies was moderate.", {"entities": []}], ["The quality of evidence was very low for all study outcomes.", {"entities": []}], ["Pooled vaccine effectiveness in 1825 persons with asthma from 2 test-negative design case-control studies was 45% (95% confidence interval [CI], 31%\u201356%) for laboratory-confirmed influenza.", {"entities": [[179, 188, "DISEASE"], [50, 56, "DISEASE"]]}], ["Pooled efficacy of live vaccines in reducing influenza was 81% (95% CI, 33%\u2013 94%).", {"entities": [[45, 54, "DISEASE"]]}], ["Live vaccine reduced febrile illness by 72% (95% CI, 20%\u201390%).", {"entities": []}], ["Influenza vaccine prevented 59%\u201378% of asthma attacks leading to emergency visits and/or hospitalizations.", {"entities": [[0, 9, "DISEASE"], [39, 45, "DISEASE"]]}], ["For persons with asthma, influenza vaccination may be effective in both reducing influenza infection and asthma attacks.", {"entities": [[25, 34, "DISEASE"], [81, 90, "DISEASE"], [17, 23, "DISEASE"], [105, 111, "DISEASE"]]}], ["This overview of the published epidemiological evidence of migraine helps to identify the size of the public\u2013health problem that migraine represents.", {"entities": [[59, 67, "DISEASE"], [129, 137, "DISEASE"]]}], ["It also highlights the need for further epidemiological studies in many parts of the world to gain full understanding of the scale of clinical, economic and humanistic burdens attributable to it.", {"entities": []}], ["This paper presents some of the work on migraine undertaken by the World Health Organization (WHO) in the Global Burden of Disease study conducted in 2000 and reported in the World Health Report 2001 .", {"entities": [[40, 48, "DISEASE"]]}], ["Migraine was not included in the first Global Burden of Disease 1990.", {"entities": [[0, 8, "DISEASE"]]}], ["The paper also discussed the measurement of disability attributable to headache disorders using WHO ICF Classification.", {"entities": []}], ["Using disabilityadjusted life years (DALYs) as a summary measure of population health (which adds disability to mortality), WHO have shown that mental and neurological disorders collectively account for 30.8% of all years of healthy life lost to disability (YLDs) whilst migraine, one amongst these, alone accounts for 1.4% and is in the top 20 causes of disability worldwide.", {"entities": [[271, 279, "DISEASE"]]}], ["This information is combined with the increasingly widely accepted belief that disability and functioning are relevant parameters for monitoring the health of nations and that there is an increasing need to measure them.", {"entities": []}], ["WHO's Classification of Functioning, Disability and Health (ICF) provides a model of human functioning and disability, as well as a classification system, that allows us to highlight and measure all dimensions of disability.", {"entities": []}], ["ICF applied to headache disorders allows comparability with other health conditions as well as evaluation of the role of the environment as a cause of disability amongst people with headache.", {"entities": []}], ["Migraine causes a large propotion of the non\u2013fatal disease\u2013related burden worldwide.Our kowledge of headache related burden is incomplete and it is necessary to add to it epidemiological studies in many parts of the world and to combine this with measurements of disability using both DALYs and WHO \u2018s ICF Classification.", {"entities": [[0, 8, "DISEASE"]]}], ["The work described here has been the base for the Global Campaign against Headache disorders: \"Lifting the Burden\", launched in 2004 jointly by WHO, IHS (International Headache Society), WHA (World Headache Alliance) and EHF (European Headache Federation).", {"entities": [[221, 224, "GENE"]]}], ["Although DDT [1,1,1-trichloro-2,2-bis(4-chlorophenyl)ethane] has been banned in many countries since the 1970s, it may still pose a risk to human respiratory health.", {"entities": []}], ["In agriculture, DDT exposures have been associated with asthma and chronic bronchitis.", {"entities": [[56, 62, "DISEASE"], [75, 85, "DISEASE"]]}], ["However, little is known about the effect of DDT on lung function.", {"entities": []}], ["We used data on 1,696 participants 20\u201379 years of age from the Canadian Health Measures Survey (CHMS) and conducted multiple regression analysis to estimate associations between plasma p,p\u00b4 -DDT/DDE and lung function.", {"entities": []}], ["Almost all participants (> 99.0%) had detectable concentrations of plasma p,p\u00b4 -DDE, but only 10.0% had detectable p,p\u00b4 -DDT.", {"entities": []}], ["Participants with detectable p,p\u00b4 -DDT had significantly lower mean FVC (difference = 311 mL; 95% CI: \u2013492, \u2013130; p = 0.003) and FEV 1 (difference = 232 mL; 95% CI: \u2013408, \u201355; p = 0.015) than those without.", {"entities": [[129, 132, "GENE"]]}], ["A 100-ng/g lipid increase in plasma p,p\u00b4 -DDE was associated with an 18.8-mL decrease in mean FVC (95% CI: \u201329, \u20139) and an 11.8-mL decrease in mean FEV 1 (95% CI: \u201321, \u20133).", {"entities": [[148, 151, "GENE"]]}], ["Neither exposure was associated with FEV 1 /FVC ratio or FEF 25%\u201375% .", {"entities": [[37, 40, "GENE"]]}], ["DDT exposures, which may have occurred decades ago, were still detectable among Canadians.", {"entities": []}], ["Plasma DDT and DDE were negatively associated with lung function parameters.", {"entities": []}], ["Additional research on the potential effects of DDT use on lung function is warranted.", {"entities": []}], ["Ye M, Beach J, Martin JW, Senthilselvan A.", {"entities": []}], ["Association between lung function in adults and plasma DDT and DDE levels: results from the Canadian Health Measures Survey.", {"entities": []}], ["Environ Health Perspect 123:422\u2013427;\u2002 http://dx.doi.org/10.1289/ehp.1408217", {"entities": []}], ["Recently, claim-data-based comorbidity-adjusted methods such as the Charlson index and the Elixhauser comorbidity measures have been widely used among researchers.", {"entities": []}], ["At the same time, there have been an increasing number of attempts to improve the predictability of comorbidity-adjusted models.", {"entities": []}], ["We tried to improve the predictability of models using the Charlson and Elixhauser indices by using medication data; specifically, we used medication data to estimate omitted comorbidities in the claim data.", {"entities": []}], ["We selected twelve major diseases (other than malignancies) that caused large numbers of in-hospital mortalities during 2008 in hospitals with 700 or more beds in South Korea.", {"entities": []}], ["Then, we constructed prediction models for in-hospital mortality using the Charlson index and Elixhauser comorbidity measures, respectively.", {"entities": []}], ["Inferring missed comorbidities using medication data, we built enhanced Charlson and Elixhauser comorbidity-measures-based prediction models, which included comorbidities inferred from medication data.", {"entities": []}], ["We then compared the c-statistics of each model.", {"entities": []}], ["247,712 admission cases were enrolled.", {"entities": []}], ["55 generic drugs were used to infer 8 out of 17 Charlson comorbidities, and 106 generic drugs were used to infer 14 out of 31 Elixhauser comorbidities.", {"entities": []}], ["Before the inclusion of comorbidities inferred from medication data, the c-statistics of models using the Charlson index were 0.633-0.882 and those of the Elixhauser index were 0.699-0.917.", {"entities": []}], ["After the inclusion of comorbidities inferred from medication data, 9 of 12 models using the Charlson index and all of the models using the Elixhauser comorbidity measures were improved in predictability but, the differences were relatively small.", {"entities": []}], ["Prediction models using Charlson index or Elixhauser comorbidity measures might be improved by including comorbidities inferred from medication data.", {"entities": []}], ["Fluctuations of estradiol and progesterone levels caused by the menstrual cycle worsen asthma symptoms.", {"entities": [[87, 93, "DISEASE"]]}], ["Conflicting data are reported in literature regarding pro and anti-inflammatory properties of estradiol and progesterone.", {"entities": []}], ["Female Wistar rats were ovalbumin (OVA) sensitized 1 day after resection of the ovaries (OVx).", {"entities": []}], ["Control group consisted of sensitized-rats with intact ovaries (Sham-OVx).", {"entities": []}], ["Allergic challenge was performed by aerosol (OVA 1%, 15 min) two weeks later.", {"entities": []}], ["Twenty four hours after challenge, BAL, bone marrow and total blood cells were counted.", {"entities": []}], ["Lung tissues were used as explants, for expontaneous cytokine secretion in vitro or for immunostaining of E-selectin.", {"entities": []}], ["We observed an exacerbated cell recruitment into the lungs of OVx rats, reduced blood leukocytes counting and increased the number of bone marrow cells.", {"entities": []}], ["Estradiol-treated OVx allergic rats reduced, and those treated with progesterone increased, respectively, the number of cells in the BAL and bone marrow.", {"entities": []}], ["Lungs of OVx allergic rats significantly increased the E-selectin expression, an effect prevented by estradiol but not by progesterone treatment.", {"entities": []}], ["Systemically, estradiol treatment increased the number of peripheral blood leukocytes in OVx allergic rats when compared to non treated-OVx allergic rats.", {"entities": []}], ["Cultured-BAL cells of OVx allergic rats released elevated amounts of LTB 4 and nitrites while bone marrow cells increased the release of TNF-\u03b1 and nitrites.", {"entities": [[69, 72, "GENE"]]}], ["Estradiol treatment of OVx allergic rats was associated with a decreased release of TNF-\u03b1, IL-10, LTB 4 and nitrites by bone marrow cells incubates.", {"entities": [[98, 101, "GENE"]]}], ["In contrast, estradiol caused an increase in IL-10 and NO release by cultured-BAL cells.", {"entities": []}], ["Progesterone significantly increased TNF- \u03b1 by cultured BAL cells and bone marrow cells.", {"entities": []}], ["Data presented here suggest that upon hormonal oscillations the immune sensitization might trigger an allergic lung inflammation whose phenotype is under control of estradiol.", {"entities": []}], ["Our data could contribute to the understanding of the protective role of estradiol in some cases of asthma symptoms in fertile ans post-menopausal women clinically observed.", {"entities": [[100, 106, "DISEASE"]]}], ["Previous studies have demonstrated that integrins are involved in the aetiology of asthma.", {"entities": [[83, 89, "DISEASE"]]}], ["Several single-nucleotide polymorphisms (SNPs) in the integrin \u03b23 (ITGB3) gene are significantly associated with asthma in Western populations.", {"entities": [[113, 119, "DISEASE"], [67, 72, "GENE"]]}], ["Given the important roles of environmental exposures in the development of asthma, we evaluated the associations between six SNPs in ITGB3 and asthma in Chinese Han children.", {"entities": [[75, 81, "DISEASE"], [143, 149, "DISEASE"], [133, 138, "GENE"]]}], ["A total of 321 unrelated Chinese children with asthma and 315 healthy children were recruited for the study.", {"entities": [[47, 53, "DISEASE"]]}], ["SNP genotyping was performed by high-resolution melting analysis (HRM).", {"entities": []}], ["The selected SNPs were well genotyped by HRM, and SNP rs3809865 in the 3\u2032 untranslated region (3\u2032UTR) of ITGB3 was found to be strongly associated with asthma (adjusted p \u200a=\u200a0.004).", {"entities": [[152, 158, "DISEASE"], [105, 110, "GENE"]]}], ["The minor allele of rs3809865 showed a protective effect against asthma (OR: 0.59; 95% CI: 0.43\u20130.8).", {"entities": [[65, 71, "DISEASE"]]}], ["The seed regions of two miRNAs (hsa-mir-124 and hsa-mir-506) were predicted to bind to the sequence containing rs3809865 by TargetScan and PITA.", {"entities": []}], ["Luciferase reporter assays demonstrated that the T allele of rs3809865 was more efficiently targeted by hsa-mir-124 than was the A allele, which suggested that rs3809865 could affect the binding of hsa-mir-124 to ITGB3.", {"entities": [[213, 218, "GENE"]]}], ["Furthermore, the transfection of A549 cells with hsa-mir-124 resulted in the downregulation of ITGB3 expression.", {"entities": [[95, 100, "GENE"]]}], ["Our results revealed that rs3809865 was significantly associated with asthma due to its effect on the binding of hsa-mir-124 to ITGB3.", {"entities": [[70, 76, "DISEASE"], [128, 133, "GENE"]]}], ["This study used selected lambs that varied in their resistance to the gastrointestinal parasite Teladorsagia circumcincta .", {"entities": []}], ["Infection over 12 weeks identified susceptible (high adult worm count, AWC; high fecal egg count, FEC; low body weight, BW; low IgA) and resistant sheep (no/low AWC and FEC, high BW and high IgA).", {"entities": []}], ["Resistance is mediated largely by a Th2 response and IgA and IgE antibodies, and is a heritable characteristic.", {"entities": []}], ["The polarization of T cells and the development of appropriate immune responses is controlled by the master regulators, T-bet ( TBX21 ), GATA-3 ( GATA3 ), ROR\u03b3t ( RORC2 ) and ROR\u03b1 ( RORA ); and several inflammatory diseases of humans and mice are associated with allelic or transcript variants of these transcription factors.", {"entities": [[128, 133, "GENE"], [146, 151, "GENE"], [182, 186, "GENE"]]}], ["This study tested the hypothesis that resistance of sheep to T .", {"entities": []}], ["circumcincta is associated with variations in the structure, sequence or expression levels of individual master regulator transcripts.", {"entities": []}], ["We have identified and sequenced one variant of sheep TBX21 , two variants of GATA3 and RORC2 and five variants of RORA from lymph node mRNA.", {"entities": [[54, 59, "GENE"], [78, 83, "GENE"], [115, 119, "GENE"]]}], ["Relative RT-qPCR analysis showed that TBX21 , GATA3 and RORC2 were not significantly differentially-expressed between the nine most resistant (AWC, 0; FEC, 0) and the nine most susceptible sheep (AWC, mean 6078; FEC, mean 350).", {"entities": [[38, 43, "GENE"], [46, 51, "GENE"]]}], ["Absolute RT-qPCR on all 45 animals identified RORVv5 as being significantly differentially-expressed (p = 0.038) between resistant, intermediate and susceptible groups; RORCv2 was not differentially-expressed (p = 0.77).", {"entities": []}], ["Spearman\u2019s rank analysis showed that RORAv5 transcript copy number was significantly negatively correlated with parameters of susceptibility, AWC and FEC; and was positively correlated with BW.", {"entities": []}], ["RORCv2 was not correlated with AWC, FEC or BW but was significantly negatively correlated with IgA antibody levels.", {"entities": []}], ["This study identifies the full length RORA variant ( RORAv5 ) as important in controlling the protective immune response to T .", {"entities": [[38, 42, "GENE"]]}], ["circumcincta infection in sheep.", {"entities": []}], ["Chronic bronchitis is thought to occur in elderly patients, and smoking seems to be an important risk factor.", {"entities": [[8, 18, "DISEASE"]]}], ["The outcomes related to the age of onset in patients with chronic bronchitis are still unclear.", {"entities": [[66, 76, "DISEASE"]]}], ["A retrospective study was conducted on deceased patients whose diagnosis included bronchitis from 2010 to 2016.", {"entities": [[82, 92, "DISEASE"]]}], ["Patients were separated into two groups according to the age of onset (Group I, age \u226450 years old; Group II, age >50 years old).", {"entities": []}], ["Information regarding disease course, smoking history, death age, number of admissions per year, Hugh Jones Index, and self-reported comorbidities of the patients was recorded.", {"entities": []}], ["The courses of chronic cough and sputum were 33.38\u00b17.73 years and 14.44\u00b18.60 years in Group I and Group II, respectively ( p <0.05).", {"entities": []}], ["The death ages of Group I and Group II were 77.65\u00b17.87 years and 84.69\u00b16.67 years, respectively ( p <0.05).", {"entities": []}], ["There was a significant negative correlation between the number of hospital admissions per year and the age of onset.", {"entities": []}], ["The age of onset was negatively associated with daily smoking count ( r =\u22120.210) and total smoking count ( r =\u22120.146).", {"entities": []}], ["In Group I, there were fewer cases of coronary heart disease (OR =0.41 [0.24\u20130.71]), neurological diseases (OR =0.48 [0.24\u20130.97]), and total comorbidities (OR =0.67 [0.54\u20130.85]) than in Group II.", {"entities": [[47, 60, "DISEASE"], [38, 60, "DISEASE"]]}], ["Patients with early onset chronic bronchitis had a longer history, younger death age, poorer health status, and lower incidence of comorbidities.", {"entities": [[34, 44, "DISEASE"]]}], ["Helicobacter pylori (HP) infection is associated with reduced lung function and systemic inflammation in chronic obstructive pulmonary disease (COPD) patients.", {"entities": [[105, 142, "DISEASE"], [21, 23, "GENE"]]}], ["Azithromycin (AZ) is active against HP and reduces the risk of COPD exacerbation.", {"entities": [[36, 38, "GENE"]]}], ["We determined whether HP infection status modifies the effects of AZ in COPD patients.", {"entities": [[22, 24, "GENE"]]}], ["Plasma samples from 1018 subjects with COPD who participated in the Macrolide Azithromycin (MACRO) in COPD Study were used to determine the HP infection status at baseline and 12\u00a0months of follow-up using a serologic assay.", {"entities": [[140, 142, "GENE"]]}], ["Based on HP infection status and randomization to either AZ or placebo (PL), the subjects were divided into 4 groups: HP+/AZ, HP-/AZ, HP+/PL, and HP-/PL.", {"entities": [[9, 11, "GENE"], [118, 120, "GENE"], [126, 128, "GENE"], [134, 136, "GENE"], [146, 148, "GENE"]]}], ["Time to first exacerbation was compared across the 4 groups using Kaplan-Meier survival analysis and a Cox proportional hazards model.", {"entities": []}], ["The rates of exacerbation were compared using both the Kruskal-Wallis test and negative binomial analysis.", {"entities": []}], ["Blood biomarkers at enrolment and at follow-up visits 3, 12, and 13 (1\u00a0month after treatment was stopped) months were measured.", {"entities": []}], ["One hundred eighty one (17.8%) patients were seropositive to HP.", {"entities": [[61, 63, "GENE"]]}], ["Non-Caucasian participants were nearly three times more likely to be HP seropositive than Caucasian participants (37.4% vs 13.6%; p \u2009<\u20090.001).", {"entities": [[69, 71, "GENE"]]}], ["The median time to first exacerbation was significantly different across the four groups ( p \u2009=\u20090.001) with the longest time in the HP+/AZ group (11.2\u00a0months, 95% CI; 8.4\u201312.5+) followed by the HP-/AZ group (8.0\u00a0months, 95% CI; 6.7\u20139.7).", {"entities": []}], ["Hazard ratio (HR) for exacerbations was lowest in the HP+/AZ group after adjustment for age, sex, smoking status, ethnicity, history of peptic ulcer, dyspnea, previous hospital admission, GOLD grade of severity, and forced vital capacity (HR, 0.612; 95% CI, 0.442\u20130.846 vs HR, 0.789; 95% CI, 0.663\u20130.938 in the HP-/AZ group).", {"entities": [[136, 148, "DISEASE"], [14, 16, "GENE"], [239, 241, "GENE"], [273, 275, "GENE"], [14, 16, "GENE"], [239, 241, "GENE"], [273, 275, "GENE"], [14, 16, "GENE"], [239, 241, "GENE"], [273, 275, "GENE"]]}], ["Circulating levels of soluble tumor necrosis factor receptor-75 were reduced only in the HP+/AZ group after 3\u00a0months of AZ treatment (\u22120.87\u2009\u00b1\u20090.31\u00a0\u03bcg/L; p \u2009=\u20090.002); levels returned to baseline after discontinuing AZ.", {"entities": []}], ["AZ is effective in preventing COPD exacerbations in patients with HP seropositivity, possibly by modulating TNF pathways related to HP infection.", {"entities": [[66, 68, "GENE"], [132, 134, "GENE"], [108, 111, "GENE"], [66, 68, "GENE"], [132, 134, "GENE"]]}], ["The online version of this article (doi:10.1186/s12931-017-0594-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Monoclonal antibodies are essential therapeutics and diagnostics in a large number of diseases.", {"entities": []}], ["Moreover, they are essential tools in all sectors of life sciences.", {"entities": []}], ["Although the great majority of monoclonal antibodies currently in use are of mouse origin, the use of human B cells to generate monoclonal antibodies is increasing as new techniques to tap the human B cell repertoire are rapidly emerging.", {"entities": []}], ["Cloned lines of immortalized human B cells are ideal sources of monoclonal antibodies.", {"entities": []}], ["In this review, we summarize our studies to the regulation of the replicative life span, differentiation, and maturation of B cells that led to the development of a platform that uses immortalization of human B cells by in vitro genetic modification for antibody development.", {"entities": []}], ["We describe a number of human antibodies that were isolated using this platform and the application of the technique in other species.", {"entities": []}], ["We also discuss the use of immortalized B cells as antigen\u2010presenting cells for the discovery of tumor neoantigens.", {"entities": []}], ["Despite the public health significance of annual influenza outbreaks, the literature comparing the epidemiology of influenza A and B infections is limited and dated and may not reflect recent trends.", {"entities": [[49, 58, "DISEASE"], [115, 124, "DISEASE"]]}], ["In Canada, the relative contribution of influenza A and B to the burden of morbidity is not well understood.", {"entities": [[40, 49, "DISEASE"]]}], ["We examined rates of laboratory-confirmed cases of influenza A and B (LCI-A and LCI-B) in the Canadian province of Manitoba between 1993 and 2008 and compared cases of the two types in terms of socio-demographic and clinical characteristics.", {"entities": [[51, 60, "DISEASE"]]}], ["Laboratory-confirmed cases of influenza A and B in Manitoba between 1993 and 2008 were identified from the Cadham Provincial Laboratory (CPL) Database and linked to de-identified provincial administrative health records.", {"entities": [[30, 39, "DISEASE"]]}], ["Crude and age-adjusted incidence rates of LCI-A and LCI-B were calculated.", {"entities": []}], ["Demographic characteristics, health status, health service use, and vaccination history were compared by influenza type.", {"entities": [[105, 114, "DISEASE"]]}], ["Over the study period, 1,404 of LCI-A and 445 cases of LCI-B were diagnosed, corresponding to an annual age-standardized rate of 7.2 (95% CI: 6.5-7.9) for LCI-A and 2.2 (CI: 1.5 \u2013 3.0) per 100,000 person-years for LCI-B.", {"entities": []}], ["Annual rates fluctuated widely but there was less variation in the LCI-B rates.", {"entities": []}], ["For LCI-A, but not LCI-B, incidence was inversely related to household income.", {"entities": []}], ["Older age, urban residence and past hospitalization were associated with increased detection of LCI-A whereas receipt of the influenza vaccine was associated with decreased LCI-A detection.", {"entities": [[125, 134, "DISEASE"]]}], ["Once socio-demographic variables were controlled, having a pre-existing chronic disease or immune suppression was not related to influenza type.", {"entities": [[129, 138, "DISEASE"]]}], ["Influenza A and B affected different segments of the population.", {"entities": [[0, 9, "DISEASE"]]}], ["Older age was associated with increased LCI-A detection, but not with pre-existing chronic diseases.", {"entities": []}], ["This information may be useful to public health professionals in planning and evaluating new and existing seasonal influenza vaccines.", {"entities": [[115, 124, "DISEASE"]]}], ["Cells are constantly exposed to a large variety of lipids.", {"entities": []}], ["Traditionally, these molecules were thought to serve as simple energy storing molecules.", {"entities": []}], ["More recently it has been realized that they can also initiate and regulate signaling events that will decisively influence development, cellular differentiation, metabolism and related functions through the regulation of gene expression.", {"entities": []}], ["Multicellular organisms dedicate a large family of nuclear receptors to these tasks.", {"entities": []}], ["These proteins combine the defining features of both transcription factors and receptor molecules, and therefore have the unique ability of being able to bind lipid signaling molecules and transduce the appropriate signals derived from lipid environment to the level of gene expression.", {"entities": []}], ["Intriguingly, the members of a subfamily of the nuclear receptors, the peroxisome proliferator-activated receptors (PPARs) are able to sense and interpret fatty acid signals derived from dietary lipids, pathogenic lipoproteins or essential fatty acid metabolites.", {"entities": []}], ["Not surprisingly, Peroxisome proliferator-activated receptors were found to be key regulators of lipid and carbohydrate metabolism.", {"entities": []}], ["Unexpectedly, later studies revealed that Peroxisome proliferator-activated receptors are also able to modulate inflammatory responses.", {"entities": []}], ["Here we summarize our understanding on how these transcription factors/receptors connect lipid metabolism to inflammation and some of the novel regulatory mechanisms by which they contribute to homeostasis and certain pathological conditions.", {"entities": []}], ["This article is part of a Special Issue entitled: Translating nuclear receptors from health to disease.", {"entities": []}], ["\u25ba PPARs and lipid environment form a regulatory circuit.", {"entities": []}], ["\u25ba Fatty acid derived molecules can regulate inflammation through PPARs.", {"entities": []}], ["\u25ba PPARs have anti-inflammatory roles in a number of inflammatory diseases.", {"entities": []}], ["\u25ba A number of outstanding questions about the biology of PPARs are still unanswered.", {"entities": []}], ["Growing knowledge about cellular interactions in the immune system, including the central role of cytokine networks, has lead to new treatments using monoclonal antibodies that block specific components of the immune system.", {"entities": []}], ["Systemic cytokine concentrations can serve as surrogate outcome parameters of these interventions to study inflammatory pathways operative in patients in vivo .", {"entities": []}], ["This is now possible due to novel technologies such as multiplex immunoassays (MIA) that allows detection of multiple cytokines in a single sample.", {"entities": [[79, 82, "GENE"]]}], ["However, apparently trivial underappreciated processes, (sample handling and storage, interference of endogenous plasma proteins) can greatly impact the reliability and reproducibility of cytokine detection.", {"entities": []}], ["Therefore we set out to investigate several processes that might impact cytokine profiles such as blood collecting tubes, duration of storage, and number of freeze thawing cycles.", {"entities": []}], ["Since under physiological conditions cytokine concentrations normally are low or undetectable we spiked cytokines in the various plasma and serum samples.", {"entities": []}], ["Overall recoveries ranged between 80-120%.", {"entities": []}], ["Long time storage showed cytokines are stable for a period up to 2 years of storage at -80\u00b0C.", {"entities": []}], ["After 4 years several cytokines (IL-1\u03b1, IL-1\u03b2, IL-10, IL-15 and CXCL8) degraded up to 75% or less of baseline values.", {"entities": []}], ["Furthermore we show that only 2 out of 15 cytokines remained stable after several freeze-thawing cycles.", {"entities": []}], ["We also demonstrate implementation of an internal control for multiplex cytokine immunoassays.", {"entities": []}], ["All together we show parameters which are essential for measurement of cytokines in the context of clinical trials.", {"entities": []}], ["The immune system is a complex adaptive system of cells and molecules that are interwoven in a highly organized communication network.", {"entities": []}], ["Primary immune deficiencies are disorders in which essential parts of the immune system are absent or do not function according to plan.", {"entities": []}], ["X-linked agammaglobulinemia is a B-lymphocyte maturation disorder in which the production of immunoglobulin is prohibited by a genetic defect.", {"entities": [[9, 27, "DISEASE"]]}], ["Patients have to be put on life-long immunoglobulin substitution therapy in order to prevent recurrent and persistent opportunistic infections.", {"entities": []}], ["We formulate an immune response model in terms of stochastic differential equations and perform a systematic analysis of empirical therapy protocols that differ in the treatment frequency.", {"entities": []}], ["The model accounts for the immunoglobulin reduction by natural degradation and by antigenic consumption, as well as for the periodic immunoglobulin replenishment that gives rise to an inhomogeneous distribution of immunoglobulin specificities in the shape space.", {"entities": []}], ["Results are obtained from computer simulations and from analytical calculations within the framework of the Fokker-Planck formalism, which enables us to derive closed expressions for undetermined model parameters such as the infection clearance rate.", {"entities": []}], ["We find that the critical value of the clearance rate, below which a chronic infection develops, is strongly dependent on the strength of fluctuations in the administered immunoglobulin dose per treatment and is an increasing function of the treatment frequency.", {"entities": []}], ["The comparative analysis of therapy protocols with regard to the treatment frequency yields quantitative predictions of therapeutic relevance, where the choice of the optimal treatment frequency reveals a conflict of competing interests: In order to diminish immunomodulatory effects and to make good economic sense, therapeutic immunoglobulin levels should be kept close to physiological levels, implying high treatment frequencies.", {"entities": []}], ["However, clearing infections without additional medication is more reliably achieved by substitution therapies with low treatment frequencies.", {"entities": []}], ["Our immune response model predicts that the compromise solution of immunoglobulin substitution therapy has a treatment frequency in the range from one infusion per week to one infusion per two weeks.", {"entities": []}], ["The study investigated the association between community proximity to mine dumps, and current wheeze, rhinoconjunctivitis, and asthma among adolescents.", {"entities": [[127, 133, "DISEASE"]]}], ["This study was conducted during May\u2013November 2012 around five mine dumps in South Africa.", {"entities": []}], ["Communities in close proximity to mine dumps had an increased likelihood of current wheeze OR 1.38 (95\u2009% CI: 1.10\u20131.71), rhinoconjunctivitis OR 1.54 (95\u2009% CI: 1.29\u20131.82), and a protective association with asthma OR 0.29 (95\u2009% CI: 0.23\u20130.35).", {"entities": [[205, 211, "DISEASE"]]}], ["Factors associated with health outcomes included other indoor and outdoor pollution sources.", {"entities": []}], ["Wheeze and rhinoconjunctivitis appear to be a public health problem in these communities.", {"entities": []}], ["The findings of this study serve as a base for further detailed epidemiological studies for communities in close proximity to the mine dumps e.g.", {"entities": []}], ["a planned birth cohort study.", {"entities": []}], ["Fluticasone furoate (FF) is a novel long-acting inhaled corticosteroid (ICS).", {"entities": []}], ["This double-blind, placebo-controlled randomized study evaluated the efficacy and safety of FF 200 mcg or 400 mcg once daily, either in the morning or in the evening, and FF 200 mcg twice daily (morning and evening), for 8 weeks in patients with persistent asthma.", {"entities": [[257, 263, "DISEASE"]]}], ["Asthma patients maintained on ICS for \u2265 3 months with baseline morning forced expiratory volume in one second (FEV 1 ) 50-80% of predicted normal value and FEV 1 reversibility of \u2265 12% and \u2265 200 ml were eligible.", {"entities": [[0, 6, "DISEASE"], [111, 114, "GENE"], [156, 159, "GENE"], [111, 114, "GENE"], [156, 159, "GENE"]]}], ["The primary endpoint was mean change from baseline FEV 1 at week 8 in pre-dose (morning or evening [depending on regimen], pre-rescue bronchodilator) FEV 1 .", {"entities": [[51, 54, "GENE"], [150, 153, "GENE"], [51, 54, "GENE"], [150, 153, "GENE"]]}], ["A total of 545 patients received one of five FF treatment groups and 101 patients received placebo (intent-to-treat population).", {"entities": []}], ["Each of the five FF treatment groups produced a statistically significant improvement in pre-dose FEV 1 compared with placebo (p < 0.05).", {"entities": [[98, 101, "GENE"]]}], ["FF 400 mcg once daily in the evening and FF 200 mcg twice daily produced similar placebo-adjusted improvements in evening pre-dose FEV 1 at week 8 (240 ml vs. 235 ml).", {"entities": [[131, 134, "GENE"]]}], ["FF 400 mcg once daily in the morning, although effective, resulted in a smaller improvement in morning pre-dose FEV 1 than FF 200 mcg twice daily at week 8 (315 ml vs. 202 ml).", {"entities": [[112, 115, "GENE"]]}], ["The incidence of oral candidiasis was low (0-4%) and UC excretion was comparable with placebo for all FF groups.", {"entities": [[17, 33, "DISEASE"], [22, 33, "DISEASE"]]}], ["FF at total daily doses of 200 mcg or 400 mcg was significantly more effective than placebo.", {"entities": []}], ["FF 400 mcg once daily in the evening had similar efficacy to FF 200 mcg twice daily and all FF regimens had a safety tolerability profile generally similar to placebo.", {"entities": []}], ["This indicates that inhaled FF is an effective and well tolerated once-daily treatment for mild-to-moderate asthma.", {"entities": [[108, 114, "DISEASE"]]}], ["NCT00398645", {"entities": []}], ["More than 90% of pregnant women take prescription or non-prescription drugs at some time during pregnancy.", {"entities": []}], ["In general, unless absolutely necessary, drugs should not be used during pregnancy because many of them are harmful to the fetus.", {"entities": []}], ["Appropriate dispensing is one of the steps for rational drug use; so, it is necessary that drug dispensers should have relevant and updated knowledge and skills regarding drug use in pregnancy.", {"entities": []}], ["To assess the knowledge of drug dispensers and pregnant women regarding drug use in pregnancy, focusing on four commonly used drugs that are teratogenic or cause unwanted effects to the fetus and babies.", {"entities": []}], ["The study was conducted in two parts: consumers\u2032 perception and providers\u2032 practice.", {"entities": []}], ["It was a cross-sectional study involving visits to 200 private retail community pharmacies (as simulated client) within Temeke, Ilala and Kinondoni municipals in Dar es Salaam, Tanzania.", {"entities": []}], ["The second part of the study was conducted at the antenatal clinics of the three municipal hospitals in Dar es Salaam.", {"entities": []}], ["A semi-structured questionnaire was used to gather information from pregnant women.", {"entities": []}], ["In total, 200 pregnant women were interviewed.", {"entities": []}], ["Out of 200 drug dispensers, 86 (43%) were willing to dispense artemether-lumefantrine (regardless of the age of pregnancy), 56 (29%) were willing to dispense sodium valproate, 104 (52%) were willing to dispense captopril and 50 (25%) were willing to dispense tetracycline.", {"entities": []}], ["One hundred and thirty-three (66.5%) pregnant women reported that they hesitated to take medications without consulting their physicians, 47 (23.5%) indicated that it was safe to take medications during pregnancy, while 123 (61.5%) mentioned that it was best to consult a doctor, while 30 (15%) did not have any preference.", {"entities": []}], ["Sixty-three (31.5%) women reported that they were aware of certain drugs that are contraindicated during pregnancy.", {"entities": []}], ["It is evident that most drug dispensers have low knowledge regarding the harmful effects of drugs during pregnancy.", {"entities": []}], ["Drug dispensing personnel should be considered part of the therapeutic chain and, if appropriately trained, they will play a very important role in promoting rational use of medicines.", {"entities": []}], ["Mobile Health (mHealth) proposes health care delivering anytime and anywhere.", {"entities": []}], ["It aims to answer several emerging problems in health services, including the increasing number of chronic diseases, high costs on national health services, and the need to provide direct access to health services, regardless of time and place.", {"entities": []}], ["mHealth systems include the use of mobile devices and apps that interact with patients and caretakers.", {"entities": []}], ["However, mobile devices present several constraints, such as processor, energy, and storage resource limitations.", {"entities": []}], ["The constant mobility and often-required Internet connectivity also exposes and compromises the privacy and confidentiality of health information.", {"entities": []}], ["This paper presents a proposal, construction, performance evaluation, and validation of a data encryption solution for mobile health apps (DE4MHA), considering a novel and early-proposed cooperation strategy.", {"entities": []}], ["The goal was to present a robust solution based on encryption algorithms that guarantee the best confidentiality, integrity, and authenticity of users health information.", {"entities": []}], ["In this paper, we presented, explained, evaluated the performance, and discussed the cooperation mechanisms and the proposed encryption solution for mHealth apps.", {"entities": []}], ["First, we designed and deployed the DE4MHA.", {"entities": []}], ["Then two studies were performed: (1) study and comparison of symmetric and asymmetric encryption/decryption algorithms in an mHealth app under a cooperation environment, and (2) performance evaluation of the DE4MHA.", {"entities": [[133, 136, "GENE"]]}], ["Its performance was evaluated through a prototype using an mHealth app for obesity prevention and cares, called SapoFit.", {"entities": [[75, 82, "DISEASE"], [67, 70, "GENE"]]}], ["We then conducted an evaluation study of the mHealth app with cooperation mechanisms and the DE4MHA using real users and a real cooperation scenario.", {"entities": [[53, 56, "GENE"]]}], ["In 5 days, 5 different groups of 7 students selected randomly agreed to use and experiment the SapoFit app using the 7 devices available for trials.", {"entities": [[103, 106, "GENE"]]}], ["There were 35 users of SapoFit that participated in this study.", {"entities": []}], ["The performance evaluation of the app was done using 7 real mobile devices in 5 different days.", {"entities": [[34, 37, "GENE"]]}], ["The results showed that confidentiality and protection of the users\u2019 health information was guaranteed and SapoFit users were able to use the mHealth app with satisfactory quality.", {"entities": [[150, 153, "GENE"]]}], ["Results also showed that the app with the DE4MHA presented nearly the same results as the app without the DE4MHA.", {"entities": [[29, 32, "GENE"], [90, 93, "GENE"], [29, 32, "GENE"], [90, 93, "GENE"]]}], ["The performance evaluation results considered the probability that a request was successfully answered as a function of the number of uncooperative nodes in the network.", {"entities": []}], ["The service delivery probability decreased with the increase of uncooperative mobile nodes.", {"entities": []}], ["Using DE4MHA, it was observed that performance presented a slightly worse result.", {"entities": []}], ["The service average was also slightly worse but practically insignificantly different than with DE4MHA, being considered negligible.", {"entities": []}], ["This paper proposed a data encryption solution for mobile health apps, called DE4MHA.", {"entities": []}], ["The data encryption algorithm DE4MHA with cooperation mechanisms in mobile health allow users to safely obtain health information with the data being carried securely.", {"entities": []}], ["These security mechanisms did not deteriorate the overall network performance and the app, maintaining similar performance levels as without the encryption.", {"entities": [[86, 89, "GENE"]]}], ["More importantly, it offers a robust and reliable increase of privacy, confidentiality, integrity, and authenticity of their health information.", {"entities": []}], ["Although it was experimented on a specific mHealth app, SapoFit, both DE4MHA and the cooperation strategy can be deployed in other mHealth apps.", {"entities": [[51, 54, "GENE"]]}], ["Metal oxide nanoparticles (NPs) have been widely used in industry, cosmetics, and biomedicine.", {"entities": [[27, 30, "GENE"]]}], ["We examined hazards of several well-characterized high production volume NPs because of increasing concern about occupational exposure via inhalation.", {"entities": [[73, 76, "GENE"]]}], ["A panel of well-characterized NPs [cerium oxide (CeO 2 NP), titanium dioxide (TiO 2 NP), carbon black (CBNP), silicon dioxide (SiO 2 NP), nickel oxide (NiONP), zinc oxide (ZnONP), copper oxide (CuONP), and amine-modified polystyrene beads] was instilled into lungs of rats.", {"entities": [[30, 33, "GENE"]]}], ["We evaluated the inflammation potencies of these NPs 24 hr and 4 weeks postinstillation.", {"entities": [[49, 52, "GENE"], [56, 58, "GENE"]]}], ["For NPs that caused significant inflammation at 24 hr, we then investigated the characteristics of the inflammation.", {"entities": [[4, 7, "GENE"], [51, 53, "GENE"]]}], ["All exposures were carried out at equal-surface-area doses.", {"entities": []}], ["Only CeO 2 NP, NiONP, ZnONP, and CuONP were inflammogenic to the lungs of rats at the high doses used.", {"entities": []}], ["Strikingly, each of these induced a unique inflammatory footprint both acutely (24 hr) and chronically (4 weeks).", {"entities": [[83, 85, "GENE"]]}], ["Acutely, patterns of neutrophil and eosinophil infiltrates differed after CeO 2 NP, NiONP, ZnONP, and CuONP treatment.", {"entities": []}], ["Chronic inflammatory responses also differed after 4 weeks, with neutrophilic, neutrophilic/lymphocytic, eosinophilic/fibrotic/granulomatous, and fibrotic/granulomatous inflammation being caused respectively by CeO 2 NP, NiONP, ZnONP, and CuONP.", {"entities": []}], ["Different types of inflammation imply different hazards in terms of pathology, risks, and risk severity.", {"entities": []}], ["In vitro testing could not have differentiated these complex hazard outcomes, and this has important implications for the global strategy for NP hazard assessment.", {"entities": []}], ["Our results demonstrate that NPs cannot be viewed as a single hazard entity and that risk assessment should be performed separately and with caution for different NPs.", {"entities": [[29, 32, "GENE"], [163, 166, "GENE"], [29, 32, "GENE"], [163, 166, "GENE"]]}], ["The aim of this study was to characterize the evolution of lung function and -structure in elastase-induced emphysema in adult mice and the effect of mesenchymal stromal cell (MSC) administration on these parameters.", {"entities": [[176, 179, "GENE"]]}], ["Adult mice were treated with intratracheal (4.8 units/100\u00a0g bodyweight) elastase to induce emphysema.", {"entities": []}], ["MSCs were administered intratracheally or intravenously, before or after elastase injection.", {"entities": []}], ["Lung function measurements, histological and morphometric analysis of lung tissue were performed at 3 weeks, 5 and 10 months after elastase and at 19, 20 and 21\u00a0days following MSC administration.", {"entities": [[176, 179, "GENE"]]}], ["Elastase-treated mice showed increased dynamic compliance and total lung capacity, and reduced tissue-specific elastance and forced expiratory flows at 3 weeks after elastase, which persisted during 10 months follow-up.", {"entities": []}], ["Histology showed heterogeneous alveolar destruction which also persisted during long-term follow-up.", {"entities": []}], ["Jugular vein injection of MSCs before elastase inhibited deterioration of lung function but had no effects on histology.", {"entities": []}], ["Intratracheal MSC treatment did not modify lung function or histology.", {"entities": [[14, 17, "GENE"]]}], ["In conclusion, elastase-treated mice displayed persistent characteristics of pulmonary emphysema.", {"entities": [[77, 96, "DISEASE"]]}], ["Jugular vein injection of MSCs prior to elastase reduced deterioration of lung function.", {"entities": []}], ["Intratracheal MSC treatment had no effect on lung function or histology.", {"entities": [[14, 17, "GENE"]]}], ["Physicians in Canadian emergency departments (EDs) annually treat 185,000 alert and stable trauma victims who are at risk for cervical spine (C-spine) injury.", {"entities": []}], ["However, only 0.9% of these patients have suffered a cervical spine fracture.", {"entities": []}], ["Current use of radiography is not efficient.", {"entities": []}], ["The Canadian C-Spine Rule is designed to allow physicians to be more selective and accurate in ordering C-spine radiography, and to rapidly clear the C-spine without the need for radiography in many patients.", {"entities": []}], ["The goal of this phase III study is to evaluate the effectiveness of an active strategy to implement the Canadian C-Spine Rule into physician practice.", {"entities": []}], ["Specific objectives are to: 1) determine clinical impact, 2) determine sustainability, 3) evaluate performance, and 4) conduct an economic evaluation.", {"entities": []}], ["We propose a matched-pair cluster design study that compares outcomes during three consecutive 12-months \"before,\" \"after,\" and \"decay\" periods at six pairs of \"intervention\" and \"control\" sites.", {"entities": []}], ["These 12 hospital ED sites will be stratified as \"teaching\" or \"community\" hospitals, matched according to baseline C-spine radiography ordering rates, and then allocated within each pair to either intervention or control groups.", {"entities": []}], ["During the \"after\" period at the intervention sites, simple and inexpensive strategies will be employed to actively implement the Canadian C-Spine Rule.", {"entities": []}], ["The following outcomes will be assessed: 1) measures of clinical impact, 2) performance of the Canadian C-Spine Rule, and 3) economic measures.", {"entities": []}], ["During the 12-month \"decay\" period, implementation strategies will continue, allowing us to evaluate the sustainability of the effect.", {"entities": []}], ["We estimate a sample size of 4,800 patients in each period in order to have adequate power to evaluate the main outcomes.", {"entities": []}], ["Phase I successfully derived the Canadian C-Spine Rule and phase II confirmed the accuracy and safety of the rule, hence, the potential for physicians to improve care.", {"entities": []}], ["What remains unknown is the actual change in clinical behaviors that can be affected by implementation of the Canadian C-Spine Rule, and whether implementation can be achieved with simple and inexpensive measures.", {"entities": []}], ["We believe that the Canadian C-Spine Rule has the potential to significantly reduce health care costs and improve the efficiency of patient flow in busy Canadian EDs.", {"entities": []}], ["Exosomes, endosome-derived membrane microvesicles, contain specific RNA transcripts that are thought to be involved in cell-cell communication.", {"entities": []}], ["These RNA transcripts have great potential as disease biomarkers.", {"entities": []}], ["To characterize exosomal RNA profiles systemically, we performed RNA sequencing analysis using three human plasma samples and evaluated the efficacies of small RNA library preparation protocols from three manufacturers.", {"entities": []}], ["In all we evaluated 14 libraries (7 replicates).", {"entities": []}], ["From the 14 size-selected sequencing libraries, we obtained a total of 101.8 million raw single-end reads, an average of about 7.27 million reads per library.", {"entities": []}], ["Sequence analysis showed that there was a diverse collection of the exosomal RNA species among which microRNAs (miRNAs) were the most abundant, making up over 42.32% of all raw reads and 76.20% of all mappable reads.", {"entities": []}], ["At the current read depth, 593 miRNAs were detectable.", {"entities": []}], ["The five most common miRNAs (miR-99a-5p, miR-128, miR-124-3p, miR-22-3p, and miR-99b-5p) collectively accounted for 48.99% of all mappable miRNA sequences.", {"entities": [[41, 48, "GENE"]]}], ["MiRNA target gene enrichment analysis suggested that the highly abundant miRNAs may play an important role in biological functions such as protein phosphorylation, RNA splicing, chromosomal abnormality, and angiogenesis.", {"entities": []}], ["From the unknown RNA sequences, we predicted 185 potential miRNA candidates.", {"entities": []}], ["Furthermore, we detected significant fractions of other RNA species including ribosomal RNA (9.16% of all mappable counts), long non-coding RNA (3.36%), piwi-interacting RNA (1.31%), transfer RNA (1.24%), small nuclear RNA (0.18%), and small nucleolar RNA (0.01%); fragments of coding sequence (1.36%), 5 This study demonstrated that a wide variety of RNA species are embedded in the circulating vesicles.", {"entities": []}], ["To our knowledge, this is the first report that applied deep sequencing to discover and characterize profiles of plasma-derived exosomal RNAs.", {"entities": []}], ["Further characterization of these extracellular RNAs in diverse human populations will provide reference profiles and open new doors for the development of blood-based biomarkers for human diseases.", {"entities": []}], ["Chronic rhinosinusitis (CRS) is a heterogeneous disease characterized by persistent sinonasal inflammation and sinus microbiome dysbiosis.", {"entities": []}], ["The basis of this heterogeneity is poorly understood.", {"entities": []}], ["We sought to address the hypothesis that a limited number of compositionally distinct pathogenic bacterial microbiota exist in CRS patients and invoke discrete immune responses and clinical phenotypes in CRS patients.", {"entities": []}], ["Sinus brushings from patients with CRS ( n \u2009=\u200959) and healthy individuals ( n \u2009=\u200910) collected during endoscopic sinus surgery were analyzed using 16S rRNA gene sequencing, predicted metagenomics, and RNA profiling of the mucosal immune response.", {"entities": []}], ["We show that CRS patients cluster into distinct sub-groups (DSI-III), each defined by specific pattern of bacterial co-colonization (permutational multivariate analysis of variance (PERMANOVA); p \u2009=\u20090.001, r Streptococcaceae (DSI), Pseudomonadaceae (DSII), Corynebacteriaceae [DSIII(a)], or Staphylococcaceae [DSIII(b)] .", {"entities": []}], ["Each pathogenic microbiota was predicted to be functionally distinct (PERMANOVA; p \u2009=\u20090.005, r H 1 responses, while DSIII(a), which exhibited significantly increased incidence of nasal polyps (Fisher\u2019s exact; p \u2009=\u20090.034, relative risk\u2009=\u20092.16), primarily induced IL-5 expression (Kruskal Wallis; q \u2009=\u20090.045).", {"entities": []}], ["A large proportion of CRS patient heterogeneity may be explained by the composition of their sinus bacterial microbiota and related host immune response\u2014features which may inform strategies for tailored therapy in this patient population.", {"entities": []}], ["The online version of this article (doi:10.1186/s40168-017-0266-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["To determine whether initial reactive oxygen species (ROS)-induced endothelial cell injury is involved in early death after paraquat intoxication and concentrations of angiopoietin-1 (Ang-1), angiopoietin-2 (Ang-2), and von Willebrand factor (VWF) reflecting endothelial cell injury, we investigated the initial endothelial cell injury marker involved in the pathogenesis of death within 5 days after paraquat ingestion.", {"entities": [[243, 246, "GENE"]]}], ["Sixty patients with paraquat poisoning were prospectively enrolled.", {"entities": []}], ["Plasma samples were collected at admission.", {"entities": []}], ["Plasma concentrations of Ang-1, Ang-2, and VWF were measured by enzyme-linked immunosorbent assay.", {"entities": [[43, 46, "GENE"]]}], ["The patients were classified into 3 categories: survivors, early death (died within 5 days after ingestion), and late death (died more than 5 days after ingestion).", {"entities": []}], ["The baseline concentration of Ang-2 and the Ang-2: Ang-1 ratio were significantly higher in patients who died (Ang-2 [pg/mL], 1012.75\u00b1468.02 vs. 1986.07\u00b11675.37 [p=0.002]; Ang-2: Ang-1, 0.90\u00b10.49 vs. 2.16\u00b12.28 [p=0.002]).", {"entities": []}], ["The Ang-2: Ang-1 ratio was significantly higher in the early death group (2.41\u00b12.54) than in the survivors (0.90\u00b10.49) and the late death group (1.33\u00b10.64).", {"entities": []}], ["The Ang-2: Ang-1 ratio was significantly associated with early death (OR, 2.602; 95% CI, 1.106\u20136.117; p=0.028) after adjusting for plasma levels of paraquat, age, PCO 2 , and creatinine.", {"entities": []}], ["VWF did not predict mortality.", {"entities": [[0, 3, "GENE"]]}], ["Endothelial cell damage could be involved in the pathogenesis of early death following paraquat ingestion.", {"entities": []}], ["Transforming growth factor (TGF)-\u03b2 inhibits T cell proliferation and differentiation.", {"entities": []}], ["TGF-\u03b2 has been shown to inhibit the expression of transcription factors such as GATA-3 and T-bet that play important roles in T cell differentiation.", {"entities": []}], ["Here we show that TGF-\u03b2 inhibits T cell differentiation at a more proximal step.", {"entities": []}], ["An early event during T cell activation is increased intracellular calcium levels.", {"entities": []}], ["Calcium influx in activated T cells and the subsequent activation of transcription factors such as NFATc, events essential for T cell differentiation, are modulated by the Tec kinases that are downstream of the T cell receptor and CD28.", {"entities": [[231, 235, "GENE"]]}], ["We show that in stimulated CD4", {"entities": [[27, 30, "GENE"]]}], ["Neutrophil elastase level/activity is elevated in a variety of diseases such as atherosclerosis, systolic hypertension and obstructive pulmonary disease.", {"entities": [[106, 118, "DISEASE"], [80, 95, "DISEASE"]]}], ["It is unknown whether obese individuals with prehypertension also have elevated neutrophil elastase, and if so, whether it has a deleterious effect on pulmonary function.", {"entities": []}], ["Objectives: To determine neutrophil elastase levels in obese prehypertensive women and investigate correlations with pulmonary function tests.", {"entities": []}], ["Thirty obese prehypertensive women were compared with 30 obese normotensive subjects and 30 healthy controls.", {"entities": []}], ["The study groups were matched for age.", {"entities": []}], ["Measurements: The following were determined: body mass index, waist circumference, blood pressure, lipid profile, high sensitivity C-reactive protein, serum neutrophil elastase, and pulmonary function tests including forced expiratory volume in one second (FEV 1 ), forced vital capacity (FVC) and FEV 1 /FVC ratio.", {"entities": [[257, 260, "GENE"], [298, 301, "GENE"], [257, 260, "GENE"], [298, 301, "GENE"]]}], ["Serum neutrophil elastase concentration was significantly higher in both prehypertensive (405.8 \u00b1 111.6 ng/ml) and normotensive (336.5 \u00b1 81.5 ng/ml) obese women than in control non-obese women (243.9 \u00b1 23.9 ng/ml); the level was significantly higher in the prehypertensive than the normotensive obese women.", {"entities": []}], ["FEV1, FVC and FEV1/FVC ratio in both prehypertensive and normotensive obese women were significantly lower than in normal controls, but there was no statistically significant difference between the prehypertensive and normotensive obese women.", {"entities": []}], ["In prehypertensive obese women, there were significant positive correlations between neutrophil elastase and body mass index, waist circumference, systolic blood pressure, diastolic blood pressure, total cholesterol, triglyceride, low density lipoprotein cholesterol, high sensitivity C-reactive protein and negative correlations with high density lipoprotein cholesterol, FEV1, FVC and FEV1/FVC.", {"entities": []}], ["Neutrophil elastase concentration is elevated in obese prehypertensive women along with an increase in high sensitivity C-reactive protein which may account for dyslipidemia and airflow dysfunction in the present study population.", {"entities": []}], ["We investigated whether an acute bout of moderate intensity exercise in the postprandial period attenuates the triglyceride and airway inflammatory response to a high-fat meal (HFM) compared to remaining inactive in the postprandial period.", {"entities": []}], ["Seventeen (11\u2009M/6\u2009F) physically active (\u2265150\u2009min/week of moderate-vigorous physical activity (MVPA)) subjects were randomly assigned to an exercise (EX; 60% VO 2peak ) or sedentary (CON) condition after a HFM (10\u2009kcal/kg, 63% fat).", {"entities": []}], ["Blood analytes and airway inflammation via exhaled nitric oxide (eNO) were measured at baseline, and 2 and 4 hours after HFM.", {"entities": []}], ["Airway inflammation was assessed with induced sputum and cell differentials at baseline and 4 hours after HFM.", {"entities": []}], ["Triglycerides doubled in the postprandial period (~113 \u00b1 18%, P < 0.05), but the increase did not differ between EX and CON.", {"entities": []}], ["Percentage of neutrophils was increased 4 hours after HFM (~17%), but the increase did not differ between EX and CON.", {"entities": []}], ["Exhaled nitric oxide changed nonlinearly from baseline to 2 and 4 hours after HFM ( P < 0.05, \u2009 \u03b7", {"entities": []}], ["Healthcare management is oriented toward single diseases, yet multimorbidity is nevertheless the rule and there is a tendency for certain diseases to occur in clusters.", {"entities": []}], ["This study sought to identify comorbidity patterns in patients with chronic diseases, by reference to number of comorbidities, age and sex, in a population receiving medical care from 129 general practitioners in Spain, in 2007.", {"entities": []}], ["A cross-sectional study was conducted in a health-area setting of the Madrid Autonomous Region ( Comunidad Aut\u00f3noma ), covering a population of 198,670 individuals aged over 14 years.", {"entities": []}], ["Multiple correspondences were analyzed to identify the clustering patterns of the conditions targeted.", {"entities": []}], ["Forty-two percent (95% confidence interval [CI]: 41.8\u201342.2) of the registered population had at least one chronic condition.", {"entities": []}], ["In all, 24.5% (95% CI: 24.3\u201324.6) of the population presented with multimorbidity.", {"entities": []}], ["In the correspondence analysis, 98.3% of the total information was accounted for by three dimensions.", {"entities": []}], ["The following four, age- and sex-related comorbidity patterns were identified: pattern B, showing a high comorbidity rate; pattern C, showing a low comorbidity rate; and two patterns, A and D, showing intermediate comorbidity rates.", {"entities": []}], ["Four comorbidity patterns could be identified which grouped diseases as follows: one showing diseases with a high comorbidity burden; one showing diseases with a low comorbidity burden; and two showing diseases with an intermediate comorbidity burden.", {"entities": []}], ["The purpose of this study was to investigate the profile of histone deacetylase (HDAC) expression in the synovial tissue of rheumatoid arthritis (RA) compared with that of normal control and osteoarthritis (OA), and to examine whether there is a link between HDAC activity and synovial inflammation.", {"entities": [[124, 144, "DISEASE"], [135, 144, "DISEASE"], [191, 205, "DISEASE"]]}], ["HDAC activity and histone acetyltransferase (HAT) activity were determined in nuclear extracts of total synovial tissue surgically obtained from normal, OA and RA joints.", {"entities": []}], ["The level of cytoplasmic tumor necrosis factor a (TNF\u03b1) fraction was measured by ELISA.", {"entities": []}], ["Total RNA of synovial tissue was used for RT-PCR of HDAC1-8.", {"entities": []}], ["In synovial fibroblasts from RA (RASFs), the effects of TNF\u03b1 on nuclear HDAC activity and class I HDACs (1, 2, 3, 8) mRNA expressions were examined by quantitative real-time PCR.", {"entities": []}], ["The protein expression and distribution of class I HDACs were examined by Western blotting.", {"entities": []}], ["Nuclear HDAC activity was significantly higher in RA than in OA and normal controls and correlated with the amount of cytoplasmic TNF\u03b1.", {"entities": []}], ["The mRNA expression of HDAC1 in RA synovial tissue was higher than in OA and normal controls, and showed positive correlation with TNF\u03b1 mRNA expression.", {"entities": [[23, 28, "GENE"]]}], ["The protein level of nuclear HDAC1 was higher in RA synovial tissue compared with OA synovial tissue.", {"entities": [[29, 34, "GENE"]]}], ["Stimulation with TNF\u03b1 significantly increased the nuclear HDAC activity and HDAC1 mRNA expression at 24 hours and HDAC1 protein expression at 48 hours in RASFs.", {"entities": [[76, 81, "GENE"], [114, 119, "GENE"], [76, 81, "GENE"], [114, 119, "GENE"]]}], ["Our results showed nuclear HDAC activity and expression of HDAC1 were significantly higher in RA than in OA synovial tissues, and they were upregulated by TNF\u03b1 stimulation in RASFs.", {"entities": [[59, 64, "GENE"]]}], ["These data might provide important clues for the development of specific small molecule HDAC inhibitors.", {"entities": []}], ["Biological particles deposit on air handling system filters as they process air.", {"entities": []}], ["This study reports and interprets abundance and diversity information regarding biomass accumulation on ordinarily used filters acquired from several locations in a university environment.", {"entities": []}], ["DNA-based analysis was applied both to quantify (via DNA fluorometry and qPCR) and to characterize (via high-throughput sequencing) the microbial material on filters, which mainly processed recirculated indoor air.", {"entities": []}], ["Results were interpreted in relation to building occupancy and ventilation system operational parameters.", {"entities": []}], ["Based on accumulated biomass, average DNA concentrations per AHU filter surface area across nine indoor locations after twelve weeks of filter use were in the respective ranges 1.1 to 41 ng per cm Clostridium , Streptophyta , Bacillus , Acinetobacter and Ktedonobacter for bacteria and Aspergillus , Cladosporium , Nigrospora , Rigidoporus and Lentinus for fungi.", {"entities": []}], ["Conditional indoor airborne DNA concentrations (median (range)) were estimated to be 13 (2.6\u2013107) pg/m Conditional airborne concentrations and the relative abundances of selected groups of genera correlate well with occupancy level.", {"entities": []}], ["Bacterial DNA was found to be more responsive than fungal DNA to differences in occupancy level and indoor environmental conditions.", {"entities": []}], ["The pollution in the air is a complex mixture of chemical substances of varying toxicity of which the sulfur oxides are a principal component.", {"entities": []}], ["Those components which pose the primary hazards to human health have not yet been fully identified, nor have their respective contributions to human disease been fully determined.", {"entities": []}], ["Efficient and effective control strategies are dependent upon the identification and understanding of these toxic components.", {"entities": []}], ["Ultimately, the goal of standard-setting should be the development of composite pollution indices rather than control of individual pollutants.", {"entities": []}], ["Concentrations of SO 2 in the ambient air twice the current standards are associated with adverse health effects.", {"entities": []}], ["A considerable body of evidence suggests that there may be discernible human health effects from exposure to concentrations approximating the current standards.", {"entities": []}], ["There is therefore no basis for relaxation of the present standards for sulfur oxides at this time.", {"entities": []}], ["Since the scientific basis for this judgment is incomplete, further scientific information will be required either to validate the present standards or to justify alteration of these standards.", {"entities": []}], ["The association between cholelithiasis and depression remains unclear.", {"entities": [[24, 38, "DISEASE"]]}], ["We examined the risk of depression in patients with cholelithiasis.", {"entities": [[52, 66, "DISEASE"]]}], ["From the National Health Insurance population claims data of Taiwan, we identified 14071 newly diagnosed cholelithiasis patients (4969 symptomatic and 9102 asymptomatic) from 2000 to 2010.", {"entities": [[105, 119, "DISEASE"]]}], ["For each cholelithiasis patient, 4 persons without cholelithiasis were randomly selected in the control cohort from the general population frequency matched by age, sex, and diagnosis year.", {"entities": [[9, 23, "DISEASE"], [51, 65, "DISEASE"]]}], ["Both cohorts were followed up until the end of 2011 to monitor the occurrence of depression.", {"entities": []}], ["Adjusted hazard ratios (aHRs) of depression were estimated using the Cox proportional hazards model after controlling for age, sex and comorbidities.", {"entities": []}], ["The overall incidence rates of depression were 1.87- and 1.83-fold greater in the symptomatic and asymptomatic cholelithiasis subcohorts than in the control cohort (incidence, 10.1 and 9.96 vs 5.43 per 1000 person-years, respectively).", {"entities": [[111, 125, "DISEASE"]]}], ["The multivariable Cox proportional hazards regression analysis revealed higher variable-specific aHRs in women than in men, in younger patients than in older patients, and in those without comorbidities than in those with any comorbidity.", {"entities": []}], ["Cholecystectomy reduced the hazard of developing depression with aHRs of 0.79 (95% confidence interval [CI] 0.62\u20130.99) for symptomatic cholelithiasis patients and 0.76 (95% CI 0.60\u20130.96) for asymptomatic patients.", {"entities": [[135, 149, "DISEASE"]]}], ["Patients with cholelithiasis are at a higher risk of developing depression than the general population.", {"entities": [[14, 28, "DISEASE"]]}], ["Patients could be benefited from cholecystectomy and have the hazard of developing depression significantly reduced.", {"entities": []}], ["The mammalian epidermis is a continually renewing structure that provides the interface between the organism and an innately hostile environment.", {"entities": []}], ["The keratinocyte is its principal cell.", {"entities": []}], ["Keratinocyte proteins form a physical epithelial barrier, protect against microbial damage, and prepare immune responses to danger.", {"entities": []}], ["Epithelial immunity is disordered in many common diseases and disordered epithelial differentiation underlies many cancers.", {"entities": []}], ["In order to identify the genes that mediate epithelial development we used a tissue model of the skin derived from primary human keratinocytes.", {"entities": []}], ["We measured global gene expression in triplicate at five times over the ten days that the keratinocytes took to fully differentiate.", {"entities": []}], ["We identified 1282 gene transcripts that significantly changed during differentiation (false discovery rate <0.01%).", {"entities": []}], ["We robustly grouped these transcripts by K-means clustering into modules with distinct temporal expression patterns, shared regulatory motifs, and biological functions.", {"entities": []}], ["We found a striking cluster of late expressed genes that form the structural and innate immune defences of the epithelial barrier.", {"entities": []}], ["Gene Ontology analyses showed that undifferentiated keratinocytes were characterised by genes for motility and the adaptive immune response.", {"entities": []}], ["We systematically identified calcium-binding genes, which may operate with the epidermal calcium gradient to control keratinocyte division during skin repair.", {"entities": []}], ["The results provide multiple novel insights into keratinocyte biology, in particular providing a comprehensive list of known and previously unrecognised major components of the epidermal barrier.", {"entities": []}], ["The findings provide a reference for subsequent understanding of how the barrier functions in health and disease.", {"entities": []}], ["Exposure to synthetic glucocorticoids during development can result in later cardiovascular and renal disease in sheep and rats.", {"entities": []}], ["Although prenatal glucocorticoid exposure is associated with impaired renal development, less is known about effects on the developing heart.", {"entities": []}], ["This study aimed to examine the effects of a short-term exposure to dexamethasone (60 hours from embryonic day 12.5) on the developing mouse heart, and cardiovascular function in adult male offspring.", {"entities": []}], ["Dexamethasone (DEX) exposed fetuses were growth restricted compared to saline treated controls (SAL) at E14.5, but there was no difference between groups at E17.5.", {"entities": []}], ["Heart weights of the DEX fetuses also tended to be smaller at E14.5, but not different at E17.5.", {"entities": []}], ["Cardiac AT 1a R, Bax, and IGF-1 mRNA expression was significantly increased by DEX compared to SAL at E17.5.", {"entities": [[17, 20, "GENE"]]}], ["In 12-month-old offspring DEX exposure caused an increase in basal blood pressure of \u223c3 mmHg.", {"entities": []}], ["In addition, DEX exposed mice had a widened pulse pressure compared to SAL.", {"entities": []}], ["DEX exposed males at 12 months had an approximate 25% reduction in nephron number compared to SAL, but no difference in cardiomyocyte number.", {"entities": []}], ["Exposure to DEX in utero appears to adversely impact on nephrogenesis and heart growth but is not associated with a cardiomyocyte deficit in male mice in adulthood, possibly due to compensatory growth of the myocardium following the initial insult.", {"entities": []}], ["However, the widened pulse pressure may be indicative of altered vascular compliance.", {"entities": []}], ["Limited data exist on the impact of living kidney donation on the donor-recipient relationship.", {"entities": []}], ["Purpose of this study was to explore motivations to donate or accept a (living donor) kidney, whether expected relationship changes influence decision making and whether relationship changes are actually experienced.", {"entities": []}], ["We conducted 6 focus groups in 47 of 114 invited individuals (41%), asking retrospectively about motivations and decision making around transplantation.", {"entities": []}], ["We used qualitative and quantitative methods to analyze the focus group transcripts.", {"entities": []}], ["Most deceased donor kidney recipients had a potential living donor available which they refused or did not want.", {"entities": []}], ["They mostly waited for a deceased donor because of concern for the donor\u2019s health (75%).", {"entities": []}], ["They more often expected negative relationship changes than living donor kidney recipients (75% vs. 27%, p\u2009=\u20090.01) who also expected positive changes.", {"entities": []}], ["Living donor kidney recipients mostly accepted the kidney to improve their own quality of life (47%).", {"entities": []}], ["Donors mostly donated a kidney because transplantation would make the recipient less dependent (25%).", {"entities": []}], ["After transplantation both positive and negative relationship changes are experienced.", {"entities": []}], ["Expected relationship changes and concerns about the donor\u2019s health lead some kidney patients to wait for a deceased donor, despite having a potential living donor available.", {"entities": []}], ["Further research is needed to assess whether this concerns a selected group.", {"entities": []}], ["Enhancing antiviral host defense responses through nutritional supplementation would be an attractive strategy in the fight against influenza.", {"entities": [[132, 141, "DISEASE"]]}], ["Using inoculation with live attenuated influenza virus (LAIV) as an infection model, we have recently shown that ingestion of sulforaphane-containing broccoli sprout homogenates (BSH) reduces markers of viral load in the nose.", {"entities": [[39, 48, "DISEASE"]]}], ["To investigate the systemic effects of short-term BSH supplementation in the context of LAIV-inoculation, we examined peripheral blood immune cell populations in non-smoking subjects from this study, with a particular focus on NK cells.", {"entities": []}], ["We carried out a randomized, double-blinded, placebo-controlled study measuring the effects of BSH (N = 13) or placebo (alfalfa sprout homogenate, ASH; N = 16) on peripheral blood mononuclear cell responses to a standard nasal vaccine dose of LAIV in healthy volunteers.", {"entities": []}], ["Blood was drawn prior to (day-1) and post (day2, day21) LAIV inoculation and analyzed for neutrophils, monocytes, macrophages, T cells, NKT cells, and NK cells.", {"entities": []}], ["In addition, NK cells were enriched, stimulated, and assessed for surface markers, intracellular markers, and cytotoxic potential by flow cytometry.", {"entities": []}], ["Overall, LAIV significantly reduced NKT (day2 and day21) and T cell (day2) populations.", {"entities": []}], ["LAIV decreased NK cell CD56 and CD158b expression, while significantly increasing CD16 expression and cytotoxic potential (on day2).", {"entities": []}], ["BSH supplementation further increased LAIV-induced granzyme B production (day2) in NK cells compared to ASH and in the BSH group granzyme B levels appeared to be negatively associated with influenza RNA levels in nasal lavage fluid cells.", {"entities": [[189, 198, "DISEASE"]]}], ["We conclude that nasal influenza infection may induce complex changes in peripheral blood NK cell activation, and that BSH increases virus-induced peripheral blood NK cell granzyme B production, an effect that may be important for enhanced antiviral defense responses.", {"entities": [[23, 32, "DISEASE"]]}], ["Trial Registration : ClinicalTrials.gov NCT01269723", {"entities": []}], ["The use of Complementary and Alternative Medicine (CAM) in Inflammatory Bowel Disease (IBD) is increasing.", {"entities": []}], ["Although CAM often improves patients\u2019 well-being, it can also lead to side-effects and interactions with conventional medications.", {"entities": []}], ["Research on patients with IBD in Sweden who have experiences of CAM is sparse.", {"entities": []}], ["More studies are needed to enhance awareness of and improve communication about CAM.", {"entities": []}], ["The aim of this study was to describe experiences of CAM in the healthcare context reported by patients with IBD.", {"entities": []}], ["Fifteen patients with IBD, eight with Crohn\u2019s disease (CD) and seven with ulcerative colitis (UC), were recruited.", {"entities": [[74, 92, "DISEASE"]]}], ["Semi-structured qualitative interviews were conducted and qualitative content analysis was performed.", {"entities": []}], ["The analysis revealed the theme Knowledge and communication lead to participation in the area of CAM based on three categories; CAM use, Communication and Self-care.", {"entities": []}], ["Patients with IBD wanted to be asked about CAM to be able to start a dialogue, as some perceived being treated in a disparaging manner and not taken seriously when raising the subject.", {"entities": []}], ["Healthcare professionals (HCPs) need to be aware of this in order to meet and understand patient needs.", {"entities": []}], ["Patients with IBD found it easier to communicate about CAM with the IBD nurses than physicians and dietary changes was one important CAM treatment.", {"entities": []}], ["The finding that it was easier to discuss CAM with nurses than physicians emphasizes the important role of the IBD nurse in communication and monitoring patients\u2019 CAM use.", {"entities": []}], ["Patients wanted to be asked about CAM to be able to start a dialogue, as some perceived not taken seriously when raising the subject.", {"entities": []}], ["Furthermore, HCPs need to understand that many patients with IBD regard dietary changes as an important part of CAM treatment.", {"entities": []}], ["Further research in these areas is needed.", {"entities": []}], ["The performance of daily activities is a major challenge for people with chronic obstructive pulmonary disease (COPD).", {"entities": [[73, 110, "DISEASE"]]}], ["The Functional Performance Inventory (FPI) was developed based on an analytical framework of functional status and qualitative interviews with COPD patients describing these difficulties.", {"entities": []}], ["The 65-item FPI was reduced to a 32-item short form (SF) through a systematic process of qualitative and quantitative item reduction and formatted for greater clarity and ease of use.", {"entities": []}], ["This study examined the content validity of the reduced, reformatted form of the instrument, the FPI-SF.", {"entities": []}], ["Qualitative cognitive interviews were conducted with COPD patients recruited from three geographically diverse pulmonary clinics in the United States.", {"entities": []}], ["Interviews were designed to assess respondent interpretation of the instrument, evaluate clarity and ease of completion, and identify any new activities participants found important and difficult to perform that were not represented by the existing items.", {"entities": []}], ["Twenty subjects comprised the sample; 12 (60%) were male, 14 (70%) were Caucasian, the mean age was 63.0 \u00b1 11.3 years, 12 (60%) were retired, the mean forced expiratory volume in 1 second (FEV 1 ) was 1.5 \u00b1 0.5 L, and the mean percent predicted FEV 1 was 48.4% \u00b1 13.1%.", {"entities": [[189, 192, "GENE"], [245, 248, "GENE"], [189, 192, "GENE"], [245, 248, "GENE"]]}], ["Participants understood the FPI-SF as intended, including instructions, items, and response options.", {"entities": []}], ["Two minor formatting changes were suggested to improve clarity of presentation.", {"entities": []}], ["Participants found the content of the FPI-SF to be comprehensive, with items covering activities they felt were important and often difficult to perform.", {"entities": []}], ["These results, together with its development history and previously tested quantitative properties, suggest that the FPI-SF is content valid for use in clinical studies of COPD.", {"entities": []}], ["The oral selective phosphodiesterase-4 inhibitor roflumilast (ROF) reduces exacerbations in patients with severe COPD.", {"entities": []}], ["Adverse events (AEs) can cause early ROF discontinuation.", {"entities": []}], ["Alternative dosing strategies may help patients continue their therapy.", {"entities": []}], ["In this multicenter, double-blind trial, 1,321 patients with severe COPD were randomized 1:1:1 to 4 weeks\u2019 treatment with ROF 250 \u00b5g once daily (OD), 500 \u00b5g every other day (EOD), or 500 \u00b5g OD, each followed by ROF 500 \u00b5g OD for 8 weeks, plus standard therapy.", {"entities": []}], ["The primary end point was the percentage of patients prematurely discontinuing study treatment.", {"entities": []}], ["Patients in the 250 \u00b5g OD/500 \u00b5g OD group had significantly fewer treatment discontinuations (odds ratio [OR] 0.66 [95% CI 0.47\u20130.93], p =0.017) and lower rates of AEs of interest such as diarrhea, nausea, headache, decreased appetite, insomnia and abdominal pain (OR 0.63 [95% CI 0.47\u20130.83], p =0.001) compared with those in the 500 \u00b5g OD group.", {"entities": [[188, 196, "DISEASE"]]}], ["Although rates of discontinuation and AEs of interest were numerically lower with ROF 500 \u00b5g EOD/500 \u00b5g OD, the difference was not significant (OR 0.76, p =0.114, and OR 0.78, p =0.091, respectively) compared with ROF 500 \u00b5g OD.", {"entities": []}], ["A dose of ROF 250 \u00b5g OD for 4 weeks before escalation to the approved maintenance dose of 500 \u00b5g OD resulted in reduced treatment discontinuation and improved tolerability.", {"entities": []}], ["The International Circumpolar Surveillance network is a population-based surveillance system that collects data on invasive pneumococcal disease (IPD) in Northern Canada.", {"entities": []}], ["A 7-valent pneumococcal conjugate vaccine was first introduced in some regions of Northern Canada in 2002, followed by 10-valent (2009) and 13-valent (PCV-13) vaccines (2010).", {"entities": []}], ["A 23-valent polysaccharide (PPV-23) vaccine was first introduced in 1988 for special populations and adults aged 65 years and older.", {"entities": []}], ["To describe the epidemiology in the context of pneumococcal vaccination programs, we analysed surveillance data from Northern Canada from 1999 to 2010.", {"entities": []}], ["A standardized case report form capturing demographic and clinical information was completed for all IPD cases in Northern Canada meeting the national case definition.", {"entities": []}], ["Isolates were sent to a reference laboratory for confirmation, serotyping and antimicrobial resistance testing.", {"entities": []}], ["Both laboratory and epidemiological data were sent to the Public Health Agency of Canada for analysis.", {"entities": []}], ["Population denominators were obtained from Statistics Canada.", {"entities": []}], ["From 1999 to 2010, 433 IPD cases were reported (average 36 cases per year).", {"entities": []}], ["Incidence was greatest among infants aged <2 years and among those aged 65 years and older, with an average annual incidence of 133 and 67 cases per 100,000 population, respectively.", {"entities": []}], ["After a peak in incidence in 2008, rates among infants have declined.", {"entities": []}], ["Incidence rates varied from 2 to 16 times greater, depending on the year, among Aboriginals compared to non-Aboriginals.", {"entities": []}], ["Hospitalization was reported in 89% of all cases and the case fatality ratio was 6.0%.", {"entities": []}], ["Clinical manifestations varied, with some patients reporting >1 manifestation.", {"entities": []}], ["Pneumonia was the most common (70%), followed by bacteremia/septicaemia (30%) and meningitis (8%).", {"entities": [[82, 92, "DISEASE"]]}], ["Approximately, 42% of cases aged <2 years in 2009 and 2010 had serotypes covered by the PCV-13.", {"entities": []}], ["In addition, the majority (89%) of serotypes isolated in cases aged 65 years and older were included in the PPV-23 vaccine.", {"entities": []}], ["IPD continues to be a major cause of disease in Northern Canadian populations, with particularly high rates among infants and Aboriginals.", {"entities": []}], ["Continued surveillance is needed to determine the impact of conjugate pneumococcal vaccine programs.", {"entities": []}], ["Additional studies investigating factors that predispose infants and Aboriginal peoples would also be beneficial.", {"entities": []}], ["Mozambique is located on the East Coast of Africa bordering South Africa, Zimbabwe, Zambia, Malawi and Tanzania and is one of the poorest countries in the world.", {"entities": []}], ["Currently NCDs account for 28% of deaths in Mozambique.", {"entities": []}], ["Risk factors such as tobacco and alcohol use and poor diet are present in both urban and rural settings.", {"entities": []}], ["Diseases such as hypertension and diabetes affect large proportions of the population, but people are often unaware of their condition or poorly managed.", {"entities": [[17, 29, "DISEASE"]]}], ["Data from studies on diabetes highlight the financial burden for NCD management in Mozambique for both the individual and health system.", {"entities": []}], ["The National Strategic Plan for the prevention and control of NCDs in Mozambique has as its aim to create a positive environment to minimise or eliminate the exposure to risk factors and guarantee access to care.", {"entities": []}], ["The plan has as its overall objective to reduce exposure to risk factors and morbidity and mortality due to NCDs and has 4 areas of intervention: 1) Prevention and health education with regards to NCDs; 2) Access to quality care, treatment and follow-up; 3) Prevention of disability and premature mortality and 4) Surveillance, research, monitoring and evaluation and advocacy for NCDs.", {"entities": []}], ["The Ministry of Health developed projects for diabetes and hypertension and used these as key lessons that could then be applied to other NCDs.", {"entities": [[59, 71, "DISEASE"]]}], ["Mozambique, through political commitment from the Ministry of Health and the dedication of local champions, has been able to garner international support to improve care for people with diabetes and then use this to develop its National Plan for NCDs.", {"entities": []}], ["Despite this increase in attention resources available do not match the challenge of NCDs in Mozambique.", {"entities": []}], ["Mozambique\u2019s experience provides a practical example of actions that can be undertaken in a resource poor country to tackle the emerging burden of NCDs.", {"entities": []}], ["Microarray studies related to cystic fibrosis (CF) airway gene expression have gone some way in clarifying the complex molecular background of CF lung diseases, but have made little progress in defining a robust \u201cmolecular signature\u201d associated with mutant CFTR expression.", {"entities": [[30, 45, "DISEASE"], [257, 261, "GENE"]]}], ["Disparate methodological and statistical analyses complicate comparisons between independent studies of the CF transcriptome, and although each study may be valid in isolation, the conclusions reached differ widely.", {"entities": []}], ["We carried out a small-scale whole genome microarray study of gene expression in human native nasal epithelial cells from F508del-CFTR homozygotes in comparison to non-CF controls.", {"entities": []}], ["We performed superficial comparisons with other microarray datasets in an attempt to identify a subset of regulated genes that could act as a signature of F508del-CFTR expression in native airway tissue samples.", {"entities": []}], ["Among the alterations detected in CF, up-regulation of genes involved in cell proliferation, and down-regulation of cilia genes were the most notable.", {"entities": []}], ["Other changes involved gene expression changes in calcium and membrane pathways, inflammation, defence response, wound healing and the involvement of estrogen signalling.", {"entities": []}], ["Comparison of our data set with previously published studies allowed us to assess the consistency of independent microarray data sets, and shed light on the limitations of such snapshot studies in measuring a system as subtle and dynamic as the transcriptome.", {"entities": []}], ["Comparison of in-vivo studies nevertheless yielded a small molecular CF signature worthy of future investigation.", {"entities": []}], ["Despite the variability among the independent studies, the current CF transcriptome meta-analysis identified subsets of differentially expressed genes in native airway tissues which provide both interesting clues to CF pathogenesis and a possible CF biomarker.", {"entities": []}], ["John R. Paul, Professor of Preventive Medicine at the Yale University School of Medicine, wrote numerous monographs and papers defining and delimiting the field of preventive medicine and its fundamental science, clinical epidemiology.", {"entities": []}], ["For Dr. Paul, preventive medicine was part of the continuum of clinical medicine; others believed that it was a separate entity deserving of departmental status.", {"entities": []}], ["This paper discusses Dr. Paul's definition and philosophy of preventive medicine in contrast to other disciplines, such as social medicine and public health.", {"entities": []}], ["S-nitrosoglutathione (GSNO) serves as a reservoir for nitric oxide (NO) and thus is a key homeostatic regulator of airway smooth muscle tone and inflammation.", {"entities": []}], ["Decreased levels of GSNO in the lungs of asthmatics have been attributed to increased GSNO catabolism via GSNO reductase (GSNOR) leading to loss of GSNO- and NO- mediated bronchodilatory and anti-inflammatory actions.", {"entities": []}], ["GSNOR inhibition with the novel small molecule, N6022, was explored as a therapeutic approach in an experimental model of asthma.", {"entities": [[122, 128, "DISEASE"]]}], ["Female BALB/c mice were sensitized and subsequently challenged with ovalbumin (OVA).", {"entities": []}], ["Efficacy was determined by measuring both airway hyper-responsiveness (AHR) upon methacholine (MCh) challenge using whole body plethysmography and pulmonary eosinophilia by quantifying the numbers of these cells in the bronchoalveolar lavage fluid (BALF).", {"entities": [[157, 169, "DISEASE"], [147, 169, "DISEASE"], [71, 74, "GENE"]]}], ["Several other potential biomarkers of GSNOR inhibition were measured including levels of nitrite, cyclic guanosine monophosphate (cGMP), and inflammatory cytokines, as well as DNA binding activity of nuclear factor kappa B (NF\u03baB).", {"entities": []}], ["The dose response, onset of action, and duration of action of a single intravenous dose of N6022 given from 30\u00a0min to 48\u00a0h prior to MCh challenge were determined and compared to effects in mice not sensitized to OVA.", {"entities": []}], ["The direct effect of N6022 on airway smooth muscle tone also was assessed in isolated rat tracheal rings.", {"entities": []}], ["N6022 attenuated AHR (ED 50 of 0.015\u2009\u00b1\u20090.002\u00a0mg/kg; Mean\u2009\u00b1\u2009SEM) and eosinophilia.", {"entities": [[68, 80, "DISEASE"], [17, 20, "GENE"]]}], ["Effects were observed from 30\u00a0min to 48\u00a0h after treatment and were comparable to those achieved with three inhaled doses of ipratropium plus albuterol used as the positive control.", {"entities": []}], ["N6022 increased BALF nitrite and plasma cGMP, while restoring BALF and plasma inflammatory markers toward baseline values.", {"entities": []}], ["N6022 treatment also attenuated the OVA-induced increase in NF\u03baB activation.", {"entities": []}], ["In rat tracheal rings, N6022 decreased contractile responses to MCh.", {"entities": []}], ["The significant bronchodilatory and anti-inflammatory actions of N6022 in the airways are consistent with restoration of GSNO levels through GSNOR inhibition.", {"entities": []}], ["GSNOR inhibition may offer a therapeutic approach for the treatment of asthma and other inflammatory lung diseases.", {"entities": [[71, 77, "DISEASE"]]}], ["N6022 is currently being evaluated in clinical trials for the treatment of inflammatory lung disease.", {"entities": [[88, 100, "DISEASE"]]}], ["To determine the quality of prescribing in hypertension in primary and secondary health care settings using the Prescription Quality Index (PQI) tool and to assess the reliability of this tool.", {"entities": [[43, 55, "DISEASE"]]}], ["An observational cross-sectional study was carried out for 6 months in order to assess quality of prescribing of antihypertensive drugs using Prescription Quality Index (PQI) at four primary (PHC) and two secondary (SHC) health care facilities.", {"entities": []}], ["Patients attending these facilities for at least 3 months were included.", {"entities": []}], ["Complete medical history and prescriptions received were noted.", {"entities": []}], ["Total and criteria wise PQI scores were derived for each prescription.", {"entities": []}], ["Prescriptions were categorized as poor (score of \u226431), medium (score 32-33) and high quality (score 34-43) based on PQI total score.", {"entities": []}], ["Psychometric analysis using factor analysis was carried out to assess reliability and validity.", {"entities": []}], ["Total 73 hypertensive patients were included.", {"entities": []}], ["Mean age was 61.2 \u00b1 11 years with 35 (48%) patients above 65 years of age.", {"entities": []}], ["Total PQI score was 26 \u00b1 11.", {"entities": []}], ["There was a significant difference in PQI score between PHC and SHC ( P < 0.05) Out of 73 prescriptions, 43 (59%) were of poor quality with PQI score <31.", {"entities": []}], ["The value of Cronbach's \u03b1 for the entire 22 criteria of PQI was 0.71 suggesting good reliability of PQI tool in our setting.", {"entities": []}], ["Based on PQI scores, quality of prescribing in hypertensive patients was poor, somewhat better in primary as compared to secondary health care facility.", {"entities": []}], ["PQI is reliable for measuring prescribing quality in hypertension in Indian set up.", {"entities": [[53, 65, "DISEASE"]]}], ["Since forced expiratory volume in 1 second (FEV 1 ) shows a weak correlation with patients\u2019 symptoms in COPD, some volume parameters may better reflect the change in dyspnea symptoms after treatment.", {"entities": [[44, 47, "GENE"]]}], ["In this article, we investigated the role of inspiratory capacity (IC) on dyspnea evaluation among COPD patients with or without emphysematous lesions.", {"entities": []}], ["In this prospective study, 124 patients with stable COPD were recruited.", {"entities": []}], ["During the baseline visit, patients performed pulmonary function tests and dyspnea evaluation using the modified Medical Research Council (mMRC) scale.", {"entities": []}], ["Partial patients underwent quantitative computerized tomography scans under physicians\u2019 recommendations, and emphysematous changes were assessed using the emphysema index (EI; low attenuation area [LAA]% \u2212950).", {"entities": []}], ["These subjects were then divided into the emphysema-predominant group (LAA% \u2212950\u22659.9%) and the non-emphysema-predominant group (LAA% \u2212950<9.9%).", {"entities": []}], ["After treatment for ~1 month, subjects returned for reevaluation of both pulmonary function parameters and dyspnea severity.", {"entities": []}], ["Correlation analysis between the change in IC (\u0394IC) and dyspnea (\u0394mMRC) was performed.", {"entities": []}], ["Correlation analysis revealed that \u0394IC was negatively correlated with \u0394mMRC (correlation coefficient [cc], \u22120.490, P <0.001) in the total study population, which was stronger than that between \u0394FEV 1 and \u0394mMRC (cc, \u22120.305, P =0.001).", {"entities": []}], ["Patients with absolute \u0394mMRC >1 were more likely to exhibit a marked increase in IC (\u2265300 mL) than those with absolute \u0394mMRC \u22641 (74.36% versus 35.29%; odds ratio [OR], 5.317; P <0.001).", {"entities": []}], ["In the emphysema-predominant group, only \u0394IC strongly correlated with \u0394mMRC (cc, \u22120.459, P =0.005), while \u0394FEV 1 did not ( P >0.05).", {"entities": []}], ["IC could serve as an effective complement to FEV 1 in COPD patients undergoing dyspnea evaluation after treatment.", {"entities": [[45, 48, "GENE"]]}], ["For COPD patients with predominant emphysematous lesions, an increase in IC is particularly more suitable for explaining dyspnea relief than FEV 1 .", {"entities": [[141, 144, "GENE"]]}], ["We aimed to analyze the global scientific output of regulatory T-cell (Treg) research and built a model to qualitatively and quantitatively evaluate publications from 2000 to 2015.", {"entities": []}], ["Data were obtained from the Web of Science Core Collection (WoSCC) of Thomson Reuters on January 1, 2016.", {"entities": []}], ["The bibliometric method and Citespace III were used to analyze authors, journals, publication outputs, institutions, countries, research areas, research hotspots, and trends.", {"entities": []}], ["In total, we identified 35,741 publications on Treg research from 2000 to 2015, and observed that the annual publication rate increased with time.", {"entities": []}], ["The Journal of Immunology published the highest number of articles, the leading country was the USA, and the leading institute was Harvard University.", {"entities": []}], ["Sakaguchi, Hori, Fontenot, and Wang were the top authors in Treg research.", {"entities": []}], ["Immunology accounted for the highest number of publications, followed by oncology, experimental medicine, cell biology, and hematology.", {"entities": []}], ["Keyword analysis indicated that autoimmunity, inflammation, cytokine, gene expression, foxp3, and immunotherapy were the research hotspots, whereas autoimmune inflammation, gene therapy, granzyme B, ROR\u03b3t, and th17 were the frontiers of Treg research.", {"entities": [[87, 92, "GENE"]]}], ["This bibliometric analysis revealed that Treg-related studies are still research hotspots, and that Treg-related clinical therapies are the research frontiers; however, further study and collaborations are needed worldwide.", {"entities": []}], ["Overall, our findings provide valuable information for the editors of immunology journals to identify new perspectives and shape future research directions.", {"entities": []}], ["Muscarinic receptors are expressed by most cell types and mediate cellular signaling of their natural ligand acetylcholine.", {"entities": []}], ["Thereby, they control numerous central and peripheral physiological organ responses to neuronal activity.", {"entities": []}], ["In the human lung, muscarinic receptors are predominantly expressed by smooth muscle cells, epithelial cells, and fibroblasts.", {"entities": []}], ["Antimuscarinic agents are used for the treatment of chronic obstructive pulmonary disease and to a lesser extent for asthma.", {"entities": [[52, 89, "DISEASE"], [117, 123, "DISEASE"]]}], ["They are primarily used as bronchodilators, but it is now accepted that they are also associated with anti-inflammatory, antiproliferative, and antiremodeling effects.", {"entities": []}], ["Remodeling of the small airways is a major pathology in COPD and impairs lung function through changes of the extracellular matrix.", {"entities": []}], ["Glycosaminoglycans, particularly hyaluronic acid, and matrix metalloproteases are among extracellular matrix molecules that have been associated with tissue inflammation and remodeling in lung diseases, including chronic obstructive pulmonary disease and asthma.", {"entities": [[213, 250, "DISEASE"], [255, 261, "DISEASE"]]}], ["Since muscarinic receptors have been shown to influence the homeostasis of glycosaminoglycans and matrix metalloproteases, these molecules may be proved valuable endpoint targets in clinical studies for the pharmacological exploitation of the anti-inflammatory and antiremodeling effects of muscarinic inhibitors in the treatment of chronic obstructive pulmonary disease and asthma.", {"entities": [[333, 370, "DISEASE"], [375, 381, "DISEASE"]]}], ["Patient: Male, 61 Final Diagnosis: Strongyloides stercolaris-associated diarrhea Symptoms: Diarrhea \u2022 epigastric pain \u2022 nausea \u2022 weight loss Medication: Ivermectin Clinical Procedure: Colonic biopsies Specialty: Infectious Diseases Rare disease Strongyloides stercoralis infection is endemic in subtropical and tropical regions but is reported rather sporadically in temperate countries.", {"entities": [[72, 80, "DISEASE"], [91, 99, "DISEASE"]]}], ["In the USA, the highest rates of infection are from the southeastern states, predominantly among immigrants.", {"entities": []}], ["There is paucity of case reports on S. stercoralis infection among HIV-infected patients who were born and raised in the USA.", {"entities": []}], ["A 61-year-old male with known HIV infection (CD4 count: 235 cells/uL, undetectable HIV RNA, on antiretroviral therapy) presented with a 3-month history of diarrhea.", {"entities": [[155, 163, "DISEASE"], [45, 48, "GENE"]]}], ["He was initially diagnosed to have diarrhea secondary to norovirus and later with Escherichia coli .", {"entities": [[35, 43, "DISEASE"]]}], ["He was treated with levofloxacin but the diarrhea persisted.", {"entities": [[41, 49, "DISEASE"]]}], ["Stool PCR, Clostridium difficile enzyme-linked immunoassay, cryptosporidium and giardia antigen, cyclospora and isospora smear, and fecal microscopy were all negative.", {"entities": []}], ["Peripheral blood eosinophil count was 1,000 eosinophils/mcL.", {"entities": []}], ["Colonic biopsies revealed fragments of S. stercoralis larvae within the crypts.", {"entities": []}], ["The patient was treated with ivermectin with improvement of symptoms.", {"entities": []}], ["Social history revealed that he was born and raised in the northeastern USA.", {"entities": []}], ["He was a daily methamphetamine user and engaged in anal sex with men.", {"entities": []}], ["He denied travel to endemic areas, except for a visit to Japan more than 30 years ago.", {"entities": []}], ["Our case highlights that S. stercoralis may be an underdiagnosed/under-reported cause of chronic diarrhea among HIV-infected patients.", {"entities": [[97, 105, "DISEASE"]]}], ["What makes this case peculiar is that the patient was born and raised in the continental USA, absence of recent travel to endemic areas, and relatively high CD4 counts.", {"entities": [[157, 160, "GENE"]]}], ["Parasitic infections, such as S. stercoralis, should be considered among HIV-infected patients with persistent diarrhea and eosinophilia regardless of ethnicity or recent travel history.", {"entities": [[111, 119, "DISEASE"], [124, 136, "DISEASE"]]}], ["One of the national mortality databases in the U.S. is the Beneficiary Identification and Record Locator Subsystem (BIRLS) Death File that contains death dates of those who have received any benefits from the Department of Veterans Affairs (VA).", {"entities": []}], ["The completeness of this database was shown to vary widely from cohort to cohort in previous studies.", {"entities": []}], ["Three other sources of death dates are available in the VA that can complement the BIRLS Death File.", {"entities": []}], ["The objective of this study is to evaluate the completeness and accuracy of death dates in the four sources available in the VA and to examine whether these four sources can be combined into a database with improved completeness and accuracy.", {"entities": []}], ["A random sample of 3,000 was drawn from 8.3 million veterans who received benefits from the VA between 1997 and 1999 and were alive on January 1, 1999 according to at least one source.", {"entities": []}], ["Death dates found in BIRLS Death File, Medical SAS Inpatient Datasets, Medicare Vital Status, and Social Security Administration (SSA) Death Master File were compared with dates obtained from the National Death Index.", {"entities": []}], ["A combined dataset from these sources was also compared with National Death Index dates.", {"entities": []}], ["Compared with the National Death Index, sensitivity (or the percentage of death dates correctly recorded in a source) was 77.4% for BIRLS Death File, 12.0% for Medical SAS Inpatient Datasets, 83.2% for Medicare Vital Status, and 92.1% for SSA Death Master File.", {"entities": []}], ["Over 95% of death dates in these sources agreed exactly with dates from the National Death Index.", {"entities": []}], ["Death dates in the combined dataset demonstrated 98.3% sensitivity and 97.6% exact agreement with dates from the National Death Index.", {"entities": []}], ["The BIRLS Death File is not an adequate source of mortality data for the VA population due to incompleteness.", {"entities": []}], ["When the four sources of mortality data are carefully combined, the resulting dataset can provide more timely data for death ascertainment than the National Death Index and has comparable accuracy and completeness.", {"entities": []}], ["Lack of human data on influenza virus aerosol shedding fuels debate over the importance of airborne transmission.", {"entities": [[22, 31, "DISEASE"]]}], ["We provide overwhelming evidence that humans generate infectious aerosols and quantitative data to improve mathematical models of transmission and public health interventions.", {"entities": []}], ["We show that sneezing is rare and not important for\u2014and that coughing is not required for\u2014influenza virus aerosolization.", {"entities": [[90, 99, "DISEASE"]]}], ["Our findings, that upper and lower airway infection are independent and that fine-particle exhaled aerosols reflect infection in the lung, opened a pathway for a deeper understanding of the human biology of influenza infection and transmission.", {"entities": [[207, 216, "DISEASE"]]}], ["Our observation of an association between repeated vaccination and increased viral aerosol generation demonstrated the power of our method, but needs confirmation.", {"entities": []}], ["Little is known about the amount and infectiousness of influenza virus shed into exhaled breath.", {"entities": [[55, 64, "DISEASE"]]}], ["This contributes to uncertainty about the importance of airborne influenza transmission.", {"entities": [[65, 74, "DISEASE"]]}], ["We screened 355 symptomatic volunteers with acute respiratory illness and report 142 cases with confirmed influenza infection who provided 218 paired nasopharyngeal (NP) and 30-minute breath samples (coarse >5-\u00b5m and fine \u22645-\u00b5m fractions) on days 1\u20133 after symptom onset.", {"entities": [[106, 115, "DISEASE"]]}], ["We assessed viral RNA copy number for all samples and cultured NP swabs and fine aerosols.", {"entities": []}], ["We recovered infectious virus from 52 (39%) of the fine aerosols and 150 (89%) of the NP swabs with valid cultures.", {"entities": []}], ["The geometric mean RNA copy numbers were 3.8 \u00d7 10", {"entities": []}], ["Many edible plants are used in Cameroon since ancient time to control microbial infections.", {"entities": []}], ["This study was designed at evaluating the antibacterial activities of the methanol extracts of ten Cameroonian vegetables against a panel of twenty nine Gram negative bacteria including multi-drug resistant (MDR) strains.", {"entities": []}], ["The broth microdilution method was used to determine the Minimal Inhibitory Concentrations (MIC) and the Minimal Bactericidal Concentrations (MBC) of the studied extracts.", {"entities": []}], ["When chloramphenicol was used as a reference antibiotic, the MICs were also determined in the presence of Phenylalanine-Arginine \u03b2- Naphtylamide (PA\u03b2N), an efflux pumps inhibitor (EPI).", {"entities": []}], ["The phytochemical screening of the extracts was performed using standard methods.", {"entities": []}], ["All tested extracts exhibited antibacterial activities, with the MIC values varying from 128 to 1024 mg/L.", {"entities": []}], ["The studied extracts showed large spectra of action, those from L. sativa, S. edule , C. pepo and S. nigrum being active on all the 29 bacterial strains tested meanwhile those from Amaranthus hybridus, Vernonia hymenolepsis , Lactuca.carpensis and Manihot esculenta were active on 96.55% of the strains used.", {"entities": []}], ["The plant extracts were assessed for the presence of large classes of secondary metabolites: alkaloids, anthocyanins, anthraquinones, flavonoids, phenols, saponins, steroids, tannins and triterpenes.", {"entities": []}], ["Each studied plant extract was found to contain compounds belonging to at least two of the above mentioned classes.", {"entities": []}], ["These results confirm the traditional claims and provide promising baseline information for the potential use of the tested vegetables in the fight against bacterial infections involving MDR phenotypes.", {"entities": []}], ["Clefts of the lip, alveolus, and palate (CLPs) rank among the most frequent and significant congenital malformations.", {"entities": [[41, 45, "GENE"]]}], ["Leu10Pro and Arg25Pro polymorphisms in the precursor region and Thr263Ile polymorphism in the prodomain of the transforming growth factor \u03b21 (TGF-\u03b21) gene have proved to be crucial to predisposition of several disorders.", {"entities": []}], ["In this study, polymorphism analysis was performed by real-time polymerase chain reaction (LightCycler) and TGF-\u03b21 levels determined by enzyme-linked immunosorbent assay.", {"entities": []}], ["Only 2/60 Caucasian non-syndromic patients with CLP (3.3%) carried the Arg25Pro and another 2/60 patients (3.3%) the Thr263Ile genotypes, whereas, in a control group of 60 healthy Caucasian blood donors, these heterozygous genotypes were more frequent 16.7% having Arg25Pro (10/60; p < 0.035) and 10,0% having Thr263Ile (6/60), respectively.", {"entities": []}], ["TGF-\u03b21 levels in platelet-poor plasma of heterozygous Arg25Pro individuals were lower than those of homozygous members (Arg25Arg) in the latter group, but this discrepancy narrowly failed to be significant.", {"entities": []}], ["Although polymorphisms in codon 10 and 25 were associated with each other, no difference was found between patients and controls concerning the Leu10Pro polymorphism.", {"entities": []}], ["The genetic differences in codons 25 and 263 suggest that TGF-\u03b21 could play an important role in occurrence of CLP, however, functional experiments will be required to confirm the mechanisms of disturbed development.", {"entities": []}], ["It is well known that a variety of inflammatory diseases are accompanied by hypercoagulability, and a number of more-or-less longer-term signalling pathways have been shown to be involved.", {"entities": []}], ["In recent work, we have suggested a direct and primary role for bacterial lipopolysaccharide (LPS) in this hypercoagulability, but it seems never to have been tested directly.", {"entities": []}], ["Here, we show that the addition of tiny concentrations (0.2 ng l in vivo represents a molecular amplification by the LPS of more than 10", {"entities": []}], ["To determine the impact of intimate partner violence on women\u2019s mental and physical health over a 16 year period and across three generations.", {"entities": []}], ["Participants were from the Australian Longitudinal study on Women\u2019s Health, a broadly representative national sample of women comprised of three birth cohorts 1973\u201378, 1946\u201351 and 1921\u201326 who were randomly selected from the Australian Medicare (i.e.", {"entities": []}], ["national health insurer) database in 1996 to participate in the longitudinal health and wellbeing survey.", {"entities": []}], ["Since baseline, six waves of survey data have been collected.", {"entities": []}], ["Women from each cohort who had returned all six surveys and had a baseline measure (Survey 1) for intimate partner violence were eligible for the current study.", {"entities": []}], ["The main outcome of interest was women\u2019s physical and mental health, measured using the Medical Outcome Study Short-Form (SF-36).", {"entities": []}], ["The experience of intimate partner violence was measured using the survey item \u2018Have you ever been in a violent relationship with a partner/spouse?\u2019 Sociodemographic information was also collected.", {"entities": []}], ["For all cohorts, women who had lived with intimate partner violence were more likely to report poorer mental health, physical function and general health, and higher levels of bodily pain.", {"entities": []}], ["Some generational differences existed.", {"entities": []}], ["Younger women showed a reduction in health associated with the onset of intimate partner violence, which was not apparent for women in the older two groups.", {"entities": []}], ["In addition, the physical health differences between women born 1921\u201326 who had and had not experienced intimate partner violence tapered off overtime, whereas these differences remained constant for women born 1973\u201378 and 1946\u201351.", {"entities": []}], ["Despite generational differences, intimate partner violence adversely impacted on mental and physical health over the 16 year study period and across generations.", {"entities": []}], ["Studies on exercise-induced bronchoconstriction (EIB) in team sports are lacking.", {"entities": []}], ["The aim of this study was to screen for EIB among amateur teenage football players in Tunisia and to compare EIB prevalence between regions.", {"entities": []}], ["One hundred ninety-six male football players (mean age [SD], 13.5 [0.5] yrs), practicing in three different cities of Tunisia (Tunis, Sousse and Sfax), underwent an outdoor free run of 7 minutes.", {"entities": []}], ["Forced expiratory volume in one second (FEV 1 ) was recorded prior to and at 0, 3, 5, 10, 15, 20 and 30 minutes after the run.", {"entities": [[40, 43, "GENE"]]}], ["Players were screened for EIB positivity defined as a greater than 10% decline in FEV 1 from the resting value at any timepoint.", {"entities": [[82, 85, "GENE"]]}], ["FEV 1 decreased more than 10% in 30% of the players.", {"entities": [[0, 3, "GENE"]]}], ["EIB positivity was more common in Sfax (15.8%) than in Tunis (7.7%) ( P =.03).", {"entities": []}], ["Air humidity during the study was higher in Tunis.", {"entities": []}], ["EIB is prevalent among amateur teenage football players in Tunisia.", {"entities": []}], ["The prevalence differs between regions and seems to be dependent on air humidity levels.", {"entities": []}], ["Several reports have indicated that hypoxia, GLI, and connective tissue growth factor (CTGF) contribute to pulmonary fibrosis in idiopathic pulmonary fibrosis.", {"entities": [[107, 125, "DISEASE"], [140, 158, "DISEASE"], [129, 158, "DISEASE"], [87, 91, "GENE"]]}], ["We investigated the participation of mitogen-activated protein kinase kinase (MEK) kinase 1 (MEKK1)/MEK1/ERK1/GLI-1/2 and activator protein-1 (AP-1) signaling in hypoxia-induced CTGF expression in human lung fibroblasts.", {"entities": [[178, 182, "GENE"]]}], ["Hypoxia time-dependently increased CTGF expression, which was attenuated by the small interfering RNA (siRNA) of GLI-1 (GLI-1 siRNA) and GLI-2 (GLI-2 siRNA) in both human lung fibroblast cell line (WI-38) and primary human lung fibroblasts (NHLFs).", {"entities": [[35, 39, "GENE"]]}], ["Moreover, GLI-1 siRNA and GLI-2 siRNA attenuated hypoxia-induced CTGF-luciferase activity, and the treatment of cells with hypoxia induced GLI-1 and GLI-2 translocation.", {"entities": []}], ["Furthermore, hypoxia-induced CTGF expression was reduced by an MEK inhibitor (PD98059), MEK1 siRNA, ERK inhibitor (U0126), ERK1 siRNA, and MEKK1 siRNA.", {"entities": [[29, 33, "GENE"]]}], ["Both PD98059 and U0126 significantly attenuated hypoxia-induced CTGF-luciferase activity.", {"entities": []}], ["Hypoxia time-dependently increased MEKK1, ERK, and p38 MAPK phosphorylation.", {"entities": []}], ["Moreover, SB203580 (a p38 MAPK inhibitor) also apparently inhibited hypoxia-induced CTGF expression.", {"entities": [[84, 88, "GENE"]]}], ["The treatment of cells with hypoxia induced ERK, GLI-1, or GLI-2 complex formation.", {"entities": []}], ["Hypoxia-induced GLI-1 and GLI-2 translocation into the nucleus was significantly attenuated by U0126.", {"entities": []}], ["In addition, hypoxia-induced ERK Tyr204 phosphorylation was impeded by MEKK1 siRNA.", {"entities": []}], ["Moreover, hypoxia-induced CTGF-luciferase activity was attenuated by cells transfected with AP-1 site mutation in a CTGF construct.", {"entities": [[26, 30, "GENE"], [116, 120, "GENE"]]}], ["Exposure to hypoxia caused a time-dependent phosphorylation of c-Jun, but not of c-Fos.", {"entities": []}], ["Chromatin immunoprecipitation (ChIP) revealed that hypoxia induced the recruitment of c-Jun, GLI-1, and GLI-2 to the AP-1 promoter region of CTGF.", {"entities": [[141, 145, "GENE"]]}], ["Hypoxia-treated cells exhibited an increase in \u03b1-smooth muscle actin (\u03b1-SMA) and collagen production, which was blocked by GLI-1 siRNA and GLI-2 siRNA.", {"entities": []}], ["Overall, these data implied that the MEKK1/MEK1/ERK1/GLI-1/GLI-2, and AP-1 pathways mediated hypoxia-induced CTGF expression in human lung fibroblasts.", {"entities": [[109, 113, "GENE"]]}], ["Furthermore, GLI-1 and GLI-2 found to be involved in hypoxia-induced \u03b1-SMA and collagen expression.", {"entities": []}], ["Telehealth has the potential to improve asthma management through regular monitoring of lung function and/or asthma symptoms by health professionals in conjunction with feedback to patients.", {"entities": [[40, 46, "DISEASE"], [109, 115, "DISEASE"]]}], ["Although the benefits of telehealth for improving asthma management have been extensively studied, the feasibility of telehealth for supporting asthma management in pregnant women has not been investigated.", {"entities": [[50, 56, "DISEASE"], [144, 150, "DISEASE"]]}], ["This study aims to evaluate the use of telehealth for remotely monitoring lung function and optimising asthma control during pregnancy.", {"entities": [[103, 109, "DISEASE"]]}], ["A randomised controlled trial comparing usual care with a telehealth program (MASTERY Breathe-easy 1 , FEV 6 ) twice daily, and recording asthma symptoms and medication usage weekly; and a written asthma action plan (WAAP).", {"entities": [[138, 144, "DISEASE"], [197, 203, "DISEASE"], [103, 106, "GENE"]]}], ["The primary outcome measure is change in asthma control measured using the Asthma Control Questionnaire (ACQ).", {"entities": [[41, 47, "DISEASE"], [75, 81, "DISEASE"]]}], ["Secondary outcomes include changes in mini-Asthma Quality of Life Questionnaire (mAQLQ) score, lung function, asthma-related health visits, days off work/study, and oral corticosteroid use.", {"entities": [[43, 49, "DISEASE"], [110, 116, "DISEASE"]]}], ["Outcome data were collected at baseline, 3\u00a0months and 6\u00a0months by a research assistant masked to group allocation.", {"entities": []}], ["Maternal and neonatal outcomes were also collected post-partum.", {"entities": []}], ["This is the first study to evaluate the application of telehealth to optimize asthma management in pregnant women.", {"entities": [[78, 84, "DISEASE"]]}], ["If effective, this telehealth program could improve asthma self-management by pregnant women which may reduce the maternal and fetal risks of poorly controlled asthma during pregnancy.", {"entities": [[52, 58, "DISEASE"], [160, 166, "DISEASE"]]}], ["Australian New Zealand Clinical Trials Registry ( ACTRN 12613000800729 ) 17 July 2013 The online version of this article (doi:10.1186/s12890-015-0082-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Guidelines are the foundation for healthcare planning, delivery and quality improvement but are not consistently implemented.", {"entities": []}], ["Few guidelines are accompanied by guideline implementation tools (GItools).", {"entities": []}], ["Users have requested GItools, and developers have requested guidance on how to develop GItools.", {"entities": []}], ["First it is necessary to characterize GItools.", {"entities": []}], ["The purpose of this research was to generate a framework of desirable features of GItools.", {"entities": []}], ["Items representing desirable GItool features were generated by a cross-sectional survey of the international guideline community.", {"entities": []}], ["Items were confirmed by 31 guideline developers, implementers and researchers in a two-round Delphi survey administered on the Internet.", {"entities": []}], ["The resulting GItool framework was applied with a sample of GItools accompanying guidelines identified in the National Guideline Clearinghouse.", {"entities": []}], ["The cross-sectional survey was completed by 96 respondents from Australia, Canada, the United Kingdom, the United States, The Netherlands, and various other countries.", {"entities": []}], ["Seven of nine items were rated by the majority as desirable.", {"entities": []}], ["A total of 31 panelists from 10 countries including Australia, Canada, Germany, New Zealand, Peru, Saudi Arabia, Spain, the United Kingdom, and the United States took part in a two-round Delphi survey.", {"entities": []}], ["Ten items achieved consensus as desirable GItool features in round #1, and two additional items in round #2.", {"entities": []}], ["A total of 13 GItools for Resource Planning, Implementation and Evaluation were identified among 149 guidelines on a variety of clinical topics (8.7%).", {"entities": []}], ["Many GItools did not possess features considered desirable.", {"entities": []}], ["Inclusion of higher quality GItools in guidelines is needed to support user adoption of guidelines.", {"entities": []}], ["The GItool framework can serve as the basis for evaluating and adapting existing GItools, or developing new GItools.", {"entities": []}], ["Further research is needed to validate the framework, develop and implement instruments by which developers can apply the framework, and specify which guidelines should be accompanied by GItools.", {"entities": []}], ["Data were extracted from the case records of UK patients admitted with laboratory-confirmed influenza A(H1N1)pdm09.", {"entities": [[92, 101, "DISEASE"]]}], ["White and non-White patients were characterized by age, sex, socioeconomic status, pandemic wave and indicators of pre-morbid health status.", {"entities": []}], ["Logistic regression examined differences by ethnicity in patient characteristics, care pathway and clinical outcomes; multivariable models controlled for potential confounders.", {"entities": []}], ["Whites ( n \u00a0=\u00a0630) and non-Whites ( n \u00a0=\u00a0510) differed by age, socioeconomic status, pandemic wave of admission, pregnancy, recorded obesity, previous and current smoking, and presence of chronic obstructive pulmonary disease.", {"entities": [[188, 225, "DISEASE"], [133, 140, "DISEASE"]]}], ["After adjustment for a priori confounders non-Whites were less likely to have received pre-admission antibiotics [adjusted odds ratio (aOR) 0\u00b743, 95% confidence interval (CI) 0\u00b728\u20130\u00b768, P \u00a0<\u00a00\u00b7001) but more likely to receive antiviral drugs as in-patients (aOR 1\u00b753, 95% CI 1\u00b708\u20132\u00b718, P \u00a0=\u00a00\u00b7018).", {"entities": []}], ["However, there were no significant differences by ethnicity in delayed admission, severity at presentation for admission, or likelihood of severe outcome.", {"entities": []}], ["The use of biomedical SNP markers of diseases can improve effectiveness of treatment.", {"entities": []}], ["Genotyping of patients with subsequent searching for SNPs more frequent than in norm is the only commonly accepted method for identification of SNP markers within the framework of translational research.", {"entities": []}], ["The bioinformatics applications aimed at millions of unannotated SNPs of the \u201c1000 Genomes\u201d can make this search for SNP markers more focused and less expensive.", {"entities": []}], ["We used our Web service involving Fisher's Z -score for candidate SNP markers to find a significant change in a gene's expression.", {"entities": []}], ["Here we analyzed the change caused by SNPs in the gene's promoter via a change in affinity of the TATA-binding protein for this promoter.", {"entities": []}], ["We provide examples and discuss how to use this bioinformatics application in the course of practical analysis of unannotated SNPs from the \u201c1000 Genomes\u201d project.", {"entities": []}], ["Using known biomedical SNP markers, we identified 17 novel candidate SNP markers nearby: rs549858786 (rheumatoid arthritis); rs72661131 (cardiovascular events in rheumatoid arthritis); rs562962093 (stroke); rs563558831 (cyclophosphamide bioactivation); rs55878706 (malaria resistance, leukopenia), rs572527200 (asthma, systemic sclerosis, and psoriasis), rs371045754 (hemophilia B), rs587745372 (cardiovascular events); rs372329931, rs200209906, rs367732974, and rs549591993 (all four: cancer); rs17231520 and rs569033466 (both: atherosclerosis); rs63750953, rs281864525, and rs34166473 (all three: malaria resistance, thalassemia).", {"entities": [[529, 544, "DISEASE"], [619, 630, "DISEASE"], [285, 295, "DISEASE"], [102, 122, "DISEASE"], [162, 182, "DISEASE"], [343, 352, "DISEASE"], [265, 272, "DISEASE"], [599, 606, "DISEASE"], [113, 122, "DISEASE"], [173, 182, "DISEASE"], [311, 317, "DISEASE"], [486, 492, "DISEASE"]]}], ["The present study explored which underlying motivations induced people to participate in a television exercise program called \u201cThe Netherlands on the Move!-television\u201d (NOM-tv).", {"entities": []}], ["A cross-sectional study was carried out among 1,349 viewers of NOM-tv.", {"entities": []}], ["The respondents completed the intrinsic motivation inventory (IMI), assessing their levels of intrinsic motivation towards participating in the NOM-tv exercises.", {"entities": []}], ["The results showed that higher levels of intrinsic motivation (i.e.", {"entities": []}], ["enjoying the NOM-tv exercises, feeling competent to perform this activity, and willingness to put effort into the exercises) were the most important predictive factors of more frequent participation in the NOM-tv exercises.", {"entities": []}], ["Future screen-based interventions to reduce sedentary behavior should aim especially at encouraging people's intrinsic orientations towards physical activity in an autonomy-supportive way.", {"entities": []}], ["Many children with asthma do not have sufficient asthma control, which leads to increased healthcare costs and productivity loss of parents.", {"entities": [[19, 25, "DISEASE"], [49, 55, "DISEASE"]]}], ["One of the causative factors are adherence problems.", {"entities": []}], ["Effective interventions improving medication adherence may therefore improve asthma control and reduce costs.", {"entities": [[77, 83, "DISEASE"]]}], ["A promising solution is sending real time text-messages via the mobile phone network, when a medicine is about to be forgotten.", {"entities": []}], ["As the effect of real time text-messages in children with asthma is unknown, the primary aim of this study is to determine the effect of a Real Time Medication Monitoring system (RTMM) with text-messages on adherence to inhaled corticosteroids (ICS).", {"entities": [[58, 64, "DISEASE"]]}], ["The secondary objective is to study the effects of RTMM on asthma control, quality of life and cost-effectiveness of treatment.", {"entities": [[59, 65, "DISEASE"]]}], ["A multicenter, randomized controlled trial involving 220 children (4\u201311\u2009years) using ICS for asthma.", {"entities": [[93, 99, "DISEASE"]]}], ["All children receive an RTMM-device for one year, which registers time and date of ICS doses.", {"entities": []}], ["Children in the intervention group also receive tailored text-messages, sent only when a dose is at risk of omission.", {"entities": []}], ["Primary outcome measure is the proportion of ICS dosages taken within the individually predefined time-interval.", {"entities": []}], ["Secondary outcome measures include asthma control (monthly Asthma Control Tests), asthma exacerbations, healthcare use (collected from hospital records, patient reports and pharmacy record data), and disease-specific quality of life (PAQLQ questionnaire).", {"entities": [[35, 41, "DISEASE"], [59, 65, "DISEASE"], [82, 88, "DISEASE"]]}], ["Parental and children\u2019s acceptance of RTMM is evaluated with online focus groups and patient questionnaires.", {"entities": []}], ["An economic evaluation is performed adopting a societal perspective, including relevant healthcare costs and parental productivity loss.", {"entities": []}], ["Furthermore, a decision-analytic model is developed in which different levels of adherence are associated with clinical and financial outcomes.", {"entities": []}], ["Also, sensitivity analyses are carried out on different price levels for RTMM.", {"entities": []}], ["If RTMM with tailored text-message reminders proves to be effective, this technique can be used in daily practice, which would support children with suboptimal adherence in their asthma (self)management and in achieving better asthma control and better quality of life.", {"entities": [[179, 185, "DISEASE"], [227, 233, "DISEASE"]]}], ["Netherlands Trial Register NTR2583 .", {"entities": []}], ["Voice change is one of the earliest features of Parkinson\u2019s disease.", {"entities": []}], ["However, quantitative studies of vocal fold dynamics which are needed to provide insight into disease biology, aid diagnosis, or track progression, are few.", {"entities": []}], ["We therefore quantified arytenoid cartilage movements and glottic area during repeated phonation in 15 patients with Parkinson\u2019s disease (symptom duration < 6 years) and 19 controls, with 320-slice computerised tomography (CT).", {"entities": []}], ["We related these measures to perceptual voice evaluations and spirometry.", {"entities": []}], ["We hypothesised that Parkinson\u2019s disease patients have a smaller inter-arytenoid distance, a preserved or larger glottic area because vocal cord bowing has previously been reported, less variability in loudness, more voice dysdiadochokinesis and breathiness and a shortened phonation time because of arytenoid hypokinesis relative to glottic area.", {"entities": []}], ["Inter-arytenoid distance in Parkinson\u2019s disease patients was moderately smaller (Mdn = 0.106, IQR = 0.091\u20130.116) than in controls (Mdn = 0.132, IQR = 0.116\u20130.166) (W = 212, P = 0.015, r = \u22120.42), normalised for anatomical and other inter-subject variance, analysed with two-tailed Wilcoxon\u2019s rank sum test.", {"entities": []}], ["This finding was confirmed in a linear mixed model analysis\u2014Parkinson\u2019s disease significantly predicted a reduction in the dependent variable, inter-arytenoid distance (b = \u22120.87, SEb = 0.39, 95% CI [\u22121.66, \u22120.08], t(31) = \u22122.24, P = 0.032).", {"entities": []}], ["There was no difference in glottic area.", {"entities": []}], ["On perceptual voice evaluation, patients had more breathiness and dysdiadochokinesis, a shorter maximum phonation time, and less variability in loudness than controls.", {"entities": []}], ["There was no difference in spirometry after adjustment for smoking history.", {"entities": []}], ["As predicted, vocal fold adduction movements are reduced in Parkinson\u2019s disease on repeated phonation but glottic area is maintained.", {"entities": []}], ["Some perceptual characteristics of Parkinsonian speech reflect these changes.", {"entities": []}], ["We are the first to use 320-slice CT to study laryngeal motion.", {"entities": []}], ["Our findings indicate how Parkinson\u2019s disease affects intrinsic laryngeal muscle position and excursion.", {"entities": []}], ["Asthma is a genetically heterogeneous disease.", {"entities": [[0, 6, "DISEASE"]]}], ["Polymorphisms of genes encoding components of the vitamin D pathway have been reported to associate with the risk of asthma.", {"entities": [[117, 123, "DISEASE"]]}], ["We have previously demonstrated that vitamin D status was associated with lung function in Chinese asthma patients.", {"entities": [[99, 105, "DISEASE"]]}], ["In this study, we tested whether polymorphisms of genes encoding for vitamin D receptor ( VDR ), vitamin D 25-hydroxylase ( CYP2R1 ) and vitamin D binding protein ( GC ) were associated with asthma in the Chinese Han population.", {"entities": [[191, 197, "DISEASE"], [90, 93, "GENE"], [124, 130, "GENE"], [165, 167, "GENE"]]}], ["We sequenced all 8 exons of VDR and all 5 exons of CYP2R1 in a Chinese case-control cohort of asthma consisting of 467 cases and 288 unrelated healthy controls.", {"entities": [[94, 100, "DISEASE"], [28, 31, "GENE"], [51, 57, "GENE"]]}], ["Two mutations were identified in these regions.", {"entities": []}], ["These variants were specified as rs2228570 in exon 2 of VDR and rs12794714 in exon 1 of CYP2R1 .", {"entities": [[56, 59, "GENE"], [88, 94, "GENE"]]}], ["We also genotyped two common polymorphisms in GC gene (rs4588 and rs7041) by a PCR-restriction fragment length polymorphism (RFLP) method.", {"entities": [[46, 48, "GENE"]]}], ["We analyzed the association between these 4 polymorphisms and asthma susceptibility and asthma-related traits.", {"entities": [[62, 68, "DISEASE"], [88, 94, "DISEASE"]]}], ["Polymorphic markers in VDR and CYP2R1 were not associated with asthma in the Chinese Han cohort.", {"entities": [[63, 69, "DISEASE"], [23, 26, "GENE"], [31, 37, "GENE"]]}], ["Importantly, variants in GC gene, which give rise to the two most common electrophoretic isoforms of the vitamin D binding protein, were associated with asthma susceptibility.", {"entities": [[153, 159, "DISEASE"], [25, 27, "GENE"]]}], ["Compared with isoform Gc1, Gc2 was significantly associated with the risk of asthma (OR = 1.35, 95% CI = 1.01-1.78 p = 0.006).", {"entities": [[77, 83, "DISEASE"]]}], ["The results provide supporting evidence for association between GC variants and asthma susceptibility in the Chinese Han population.", {"entities": [[80, 86, "DISEASE"], [64, 66, "GENE"]]}], ["Obesity is a serious public health issue affecting both children and adults.", {"entities": [[0, 7, "DISEASE"]]}], ["Prevention and management of obesity is proposed to begin in childhood when environmental factors exert a long-term effect on the risk for obesity in adulthood.", {"entities": [[29, 36, "DISEASE"], [139, 146, "DISEASE"]]}], ["Thus, identifying modifiable factors may help to reduce this risk.", {"entities": []}], ["Recent evidence suggests that gut microbiota is involved in the control of body weight, energy homeostasis and inflammation and thus, plays a role in the pathophysiology of obesity.", {"entities": [[173, 180, "DISEASE"]]}], ["Prebiotics and probiotics are of interest because they have been shown to alter the composition of gut microbiota and to affect food intake and appetite, body weight and composition and metabolic functions through gastrointestinal pathways and modulation of the gut bacterial community.", {"entities": []}], ["As shown in this review, prebiotics and probiotics have physiologic functions that contribute to changes in the composition of gut microbiota, maintenance of a healthy body weight and control of factors associated with childhood obesity through their effects on mechanisms controlling food intake, fat storage and alterations in gut microbiota.", {"entities": [[229, 236, "DISEASE"]]}], ["Health-related quality of life (HRQOL) may be associated with the longevity of patients; yet it is not clear whether this association holds in a general population, especially in low- and middle-income countries.", {"entities": []}], ["The objective of this study was to determine whether baseline HRQOL was associated with 10-year all-cause mortality in a Chinese general population.", {"entities": []}], ["A prospective cohort study was conducted from 2002 to 2012 on 1739 participants in 11 villages of Beijing.", {"entities": []}], ["Baseline data on six domains of HRQOL, chronic diseases and cardiovascular risk factors were collected in either 2002 (n\u200a=\u200a1290) or 2005 (n\u200a=\u200a449).", {"entities": []}], ["Subjects were followed through the end of the study period, or until they were censored due to death or loss to follow-up, whichever came first.", {"entities": []}], ["A multivariable Cox model estimated that Total HRQOL score (bottom 50% versus top 50%) was associated with a 44% increase in all-cause mortality (Hazard Ratio [HR]\u200a=\u200a1.44; 95% confidence interval [CI]: 1.00-2.06), after adjusting for sex, age, education levels, occupation, marital status, smoking status, fruit intake, vegetable intake, physical exercise, hypertension, history of a stroke, myocardial infarction, chronic respiratory disease, and kidney disease.", {"entities": [[357, 369, "DISEASE"], [448, 462, "DISEASE"], [392, 413, "DISEASE"], [160, 162, "GENE"]]}], ["Among the six HRQOL domains, the Independence domain had the largest fully adjusted HR (HR\u200a=\u200a1.66; 95% CI: 1.13-2.42), followed by Psychological (HR\u200a=\u200a1.47; 95% CI: 1.03-2.09), Environmental (HR\u200a=\u200a1.43, 95% CI: 1.003-2.03), Physical (HR\u200a=\u200a1.38; 95% CI: 0.97-1.95), General (HR\u200a=\u200a1.37; 95% CI: 0.97-1.94), and the Social domain (HR\u200a=\u200a1.15; 95% CI: 0.81-1.65).", {"entities": [[84, 86, "GENE"], [88, 90, "GENE"], [146, 148, "GENE"], [192, 194, "GENE"], [234, 236, "GENE"], [274, 276, "GENE"], [328, 330, "GENE"], [84, 86, "GENE"], [88, 90, "GENE"], [146, 148, "GENE"], [192, 194, "GENE"], [234, 236, "GENE"], [274, 276, "GENE"], [328, 330, "GENE"], [84, 86, "GENE"], [88, 90, "GENE"], [146, 148, "GENE"], [192, 194, "GENE"], [234, 236, "GENE"], [274, 276, "GENE"], [328, 330, "GENE"], [84, 86, "GENE"], [88, 90, "GENE"], [146, 148, "GENE"], [192, 194, "GENE"], [234, 236, "GENE"], [274, 276, "GENE"], [328, 330, "GENE"], [84, 86, "GENE"], [88, 90, "GENE"], [146, 148, "GENE"], [192, 194, "GENE"], [234, 236, "GENE"], [274, 276, "GENE"], [328, 330, "GENE"], [84, 86, "GENE"], [88, 90, "GENE"], [146, 148, "GENE"], [192, 194, "GENE"], [234, 236, "GENE"], [274, 276, "GENE"], [328, 330, "GENE"], [84, 86, "GENE"], [88, 90, "GENE"], [146, 148, "GENE"], [192, 194, "GENE"], [234, 236, "GENE"], [274, 276, "GENE"], [328, 330, "GENE"]]}], ["Lower HRQOL, especially the inability to live independently, was associated with a significantly increased risk of 10-year all-cause mortality.", {"entities": []}], ["The inclusion of HRQOL measures in clinical assessment may improve diagnostic accuracy to improve clinical outcomes and better target public health promotions.", {"entities": []}], ["The use of supra-physiological, exogenous corticosteroids in pregnancy may lead to neonatal adrenal suppression.", {"entities": []}], ["We report on a single-center, case series study carried out between 2006 and 2014, which included all newborns ( n \u00a0=\u00a016) of mothers using prednisolone \u226510\u00a0mg/day during pregnancy.", {"entities": []}], ["Newborns were routinely assessed according to hospital protocol, with follow-up until 6\u00a0weeks after birth.", {"entities": []}], ["We investigated the clinical symptoms and biochemical findings of adrenal suppression occurring in the newborns.", {"entities": []}], ["Mean dose of maternal prednisolone was 29.7\u00a0\u00b1\u00a016.1\u00a0mg/day with a mean duration of 18.4\u00a0\u00b1\u00a015.4\u00a0weeks.", {"entities": []}], ["Five newborns showed hypoglycemia with normal serum cortisol concentrations and urinary steroid profiles.", {"entities": [[21, 33, "DISEASE"]]}], ["Two newborns had abnormal urinary steroid profiles, probably the result of prematurity, but with adequate adrenal stress response during clinical sepsis.", {"entities": []}], ["Conclusion : In this retrospective case series, we found no evidence of prolonged effects of maternal prednisolone use during pregnancy on the neonatal hypothalamic-pituitary-adrenal axis.", {"entities": []}], ["Pay-for-performance (P4P) is increasingly implemented in the healthcare system to encourage improvements in healthcare quality.", {"entities": []}], ["P4P is a payment model that rewards healthcare providers for meeting pre-established targets for delivery of healthcare services by financial incentives.", {"entities": []}], ["Based on their performance, healthcare providers receive either additional or reduced payment.", {"entities": []}], ["Currently, little is known about P4P schemes intending to improve delivery of chronic care through disease management.", {"entities": []}], ["The objectives of this paper are therefore to provide an overview of P4P schemes used to stimulate delivery of chronic care through disease management and to provide insight into their effects on healthcare quality and costs.", {"entities": []}], ["A systematic PubMed search was performed for English language papers published between 2000 and 2010 describing P4P schemes related to the implementation of disease management.", {"entities": []}], ["Wagner's chronic care model was used to make disease management operational.", {"entities": []}], ["Eight P4P schemes were identified, introduced in the USA (n = 6), Germany (n = 1), and Australia (n = 1).", {"entities": []}], ["Five P4P schemes were part of a larger scheme of interventions to improve quality of care, whereas three P4P schemes were solely implemented.", {"entities": []}], ["Most financial incentives were rewards, selective, and granted on the basis of absolute performance.", {"entities": []}], ["More variation was found in incented entities and the basis for providing incentives.", {"entities": []}], ["Information about motivation, certainty, size, frequency, and duration of the financial incentives was generally limited.", {"entities": []}], ["Five studies were identified that evaluated the effects of P4P on healthcare quality.", {"entities": []}], ["Most studies showed positive effects of P4P on healthcare quality.", {"entities": []}], ["No studies were found that evaluated the effects of P4P on healthcare costs.", {"entities": []}], ["The number of P4P schemes to encourage disease management is limited.", {"entities": []}], ["Hardly any information is available about the effects of such schemes on healthcare quality and costs.", {"entities": []}], ["Bone marrow transplantation offers great promise for treating a number of disease states.", {"entities": []}], ["However, the widespread application of this approach is dependent upon the development of less toxic methods to establish chimerism and avoid graft-versus-host disease (GVHD).", {"entities": []}], ["Immunosuppressive drugs are used in the treatment of inflammatory and autoimmune diseases, as well as in transplantation.", {"entities": []}], ["Frequently prescribed in young people, these treatments may have deleterious effects on fertility, pregnancy outcomes and the unborn child.", {"entities": []}], ["This review aims to summarize the main gonadal side effects of immunosuppressants, to detail the effects on fertility and pregnancy of each class of drug, and to provide recommendations on the management of patients who are seen prior to starting or who are already receiving immunosuppressive treatment, allowing them in due course to bear children.", {"entities": []}], ["The recommendations for use are established with a rather low level of proof, which needs to be taken into account in the patient management.", {"entities": []}], ["Methotrexate, mycophenolate, and le- and teri-flunomide, cyclophosphamide, mitoxanthrone are contraindicated if pregnancy is desired due to their teratogenic effects, as well as gonadotoxic effects in the case of cyclophosphamide.", {"entities": []}], ["Anti-TNF-alpha and mTOR-inhibitors are to be used cautiously if pregnancy is desired, since experience using these drugs is still relatively scarce.", {"entities": []}], ["Azathioprine, glucocorticoids, mesalazine, anticalcineurins such as cyclosporine and tacrolimus, \u00df-interferon, glatiramer-acetate and chloroquine can be used during pregnancy, bearing in mind however that side effects may still occur.", {"entities": []}], ["Experience is limited concerning natalizumab, fingolimod, dimethyl-fumarate and induction treatments.", {"entities": []}], ["Conclusion: At the time of prescription, patients must be informed of the possible consequences of immunosuppressants on fertility and of the need for contraception.", {"entities": []}], ["Pregnancy must be planned and the treatment modified if necessary in a pre-conception time period adapted to the half-life of the drug, imperatively in relation with the prescriber of the immunosuppressive drugs.", {"entities": []}], ["Mesothelin and calretinin are blood-based markers for malignant mesothelioma.", {"entities": [[54, 76, "DISEASE"]]}], ["The objective of this study was to analyse the markers in plasma samples from cancer-free men and to identify factors influencing their concentrations to minimise false-positive test results when using these markers for the early detection of malignant mesothelioma.", {"entities": [[78, 84, "DISEASE"], [243, 265, "DISEASE"]]}], ["The present analyses used data and archived blood samples of the population-based Heinz Nixdorf Recall Study among elderly people collected from 2011 to 2014.", {"entities": []}], ["A total of 569 men (median age 70\u2009years) without a malignant disease at the time of blood sampling were selected for these analyses.", {"entities": []}], ["Mesothelin and calretinin concentration in plasma samples.", {"entities": []}], ["We observed 24 mesothelin concentrations \u22651.5\u2009nM (specificity 95.8%, 95%\u2009CI 93.8% to 97.2%) and 34 calretinin concentrations \u22651.0\u2009ng/mL (specificity 94.0%, 95%\u2009CI 91.7% to 95.7%).", {"entities": []}], ["Only five men had both markers above these cut-offs.", {"entities": []}], ["Renal dysfunction and hypertension were major predictors of elevated mesothelin in addition to age.", {"entities": [[22, 34, "DISEASE"]]}], ["Regarding calretinin, the effect of renal dysfunction was slightly weaker and hypertension was not associated with increased concentrations.", {"entities": [[78, 90, "DISEASE"]]}], ["However, a diagnosis of cancer after blood collection and bronchial asthma were associated with positive calretinin results.", {"entities": [[68, 74, "DISEASE"], [24, 30, "DISEASE"]]}], ["The combined determination of mesothelin and calretinin results in only few false-positive marker tests.", {"entities": []}], ["Both markers are mainly influenced by renal dysfunction.", {"entities": []}], ["The determination of cystatin C concentrations may be informative when interpreting the test results.", {"entities": []}], ["Ethnic disparities in lung function have been linked mainly to anthropometric factors but have not been fully explained.", {"entities": []}], ["We conducted a cross-sectional pilot study to investigate how best to study ethnic differences in lung function in young adults and evaluate whether these could be explained by birth weight and socio-economic factors.", {"entities": []}], ["We recruited 112 university students of White and South Asian British ethnicity, measured post-bronchodilator lung function, obtained information on respiratory symptoms and socio-economic factors through questionnaires, and acquired birth weight through data linkage.", {"entities": []}], ["We regressed lung function against ethnicity and candidate predictors defined a priori using linear regression, and used penalised regression to examine a wider range of factors.", {"entities": []}], ["We reviewed the implications of our findings for the feasibility of a larger study.", {"entities": []}], ["There was a similar parental socio-economic environment and no difference in birth weight between the two ethnic groups, but the ethnic difference in FVC adjusted for sex, age, height, demi-span, father\u2019s occupation, birth weight, maternal educational attainment and maternal upbringing was 0.81L (95%CI: -1.01 to -0.54L).", {"entities": []}], ["Difference in body proportions did not explain the ethnic differences although parental immigration was an important predictor of FVC independent of ethnic group.", {"entities": []}], ["Participants were comfortable with study procedures and we were able to link birth weight data to clinical measurements.", {"entities": []}], ["Studies of ethnic disparities in lung function among young adults are feasible.", {"entities": []}], ["Future studies should recruit a socially more diverse sample and investigate the role of markers of acculturation in explaining such differences.", {"entities": []}], ["Human genome variation may cause differences in traits and disease risks.", {"entities": []}], ["Disease-causal/susceptible genes and variants for both common and rare diseases can be detected by comprehensive whole-genome analyses, such as whole-genome sequencing (WGS), using next-generation sequencing (NGS) technology and genome-wide association studies (GWAS).", {"entities": []}], ["Here, in addition to the application of an NGS as a whole-genome analysis method, we summarize approaches for the identification of functional disease-causal/susceptible variants from abundant genetic variants in the human genome and methods for evaluating their functional effects in human diseases, using an NGS and in silico and in vitro functional analyses.", {"entities": []}], ["We also discuss the clinical applications of the functional disease causal/susceptible variants to personalized medicine.", {"entities": []}], ["Despite several lines of evidence from preclinical and post-mortem studies suggesting that inflammation is involved in Multiple System Atrophy (MSA), no previous studies have measured peripheral indices of inflammation in MSA patients.", {"entities": []}], ["We measured C-reactive protein, interleukin (IL)-6, soluble IL-2 receptor and tumor necrosis factor (TNF)-\u03b1 in blood samples from MSA patients (n\u200a=\u200a14) and healthy controls (n\u200a=\u200a40).", {"entities": [[101, 104, "GENE"]]}], ["IL-6 and TNF-\u03b1 were significantly elevated in MSA patients compared to healthy controls.", {"entities": []}], ["After controlling for the potentially confounding effects of age, gender, and somatic co-morbidities, a diagnosis of MSA was still significantly associated with high levels of TNF-\u03b1.", {"entities": []}], ["Higher TNF-\u03b1 levels were associated with less severe motor symptoms and earlier disease stage.", {"entities": []}], ["Our findings are in line with the hypothesis that inflammation might be involved at an early stage of MSA pathophysiology.", {"entities": []}], ["In Central America, the traditional temazcales or wood-fired steam baths, commonly used by many Native American populations, are often heated by wood fires with little ventilation, and this use results in high wood smoke exposure.", {"entities": []}], ["Urinary mutagenicity has been previously employed as a non-invasive biomarker of human exposure to combustion emissions.", {"entities": []}], ["This study examined the urinary mutagenicity in 19 indigenous Mayan families from the highlands of Guatemala who regularly use temazcales ( N = 32), as well as control (unexposed) individuals from the same population ( N = 9).", {"entities": []}], ["Urine samples collected before and after temazcal exposure were enzymatically deconjugated and extracted using solid-phase extraction.", {"entities": []}], ["The creatinine-adjusted mutagenic potency of urine extracts was assessed using the plate-incorporation version of the Salmonella mutagenicity assay with strain YG1041 in the presence of exogenous metabolic activation.", {"entities": []}], ["The post-exposure mutagenic potency of urine extracts were, on average, 1.7-fold higher than pre-exposure samples ( P < 0.005) and also significantly more mutagenic than the control samples ( P < 0.05).", {"entities": []}], ["Exhaled carbon monoxide (CO) was ~10 times higher following temazcal use ( P < 0.0001), and both CO level and time spent in temazcal were positively associated with urinary mutagenic potency (i.e.", {"entities": []}], ["P < 0.0001 and P = 0.01, respectively).", {"entities": []}], ["Thus, the wood smoke exposure associated with temazcal use contributes to increased excretion of conjugated mutagenic metabolites.", {"entities": []}], ["Moreover, urinary mutagenic potency is correlated with other metrics of exposure (i.e.", {"entities": []}], ["exhaled CO, duration of exposure).", {"entities": []}], ["Since urinary mutagenicity is a biomarker associated with genetic damage, temazcal use may therefore be expected to contribute to an increased risk of DNA damage and mutation, effects associated with the initiation of cancer.", {"entities": [[218, 224, "DISEASE"]]}], ["Surgical resection is a standard component of treatment in the clinical management of patients with glioblastoma multiforme (GBM).", {"entities": [[100, 112, "DISEASE"]]}], ["However, experimental therapies are rarely investigated in the context of tumor debulking in preclinical models.", {"entities": []}], ["Here, a surgical debulking GBM xenograft model was developed in nude rats, and was used in combination with CD47 blocking immunotherapy, a novel treatment strategy that triggers phagocytosis of tumor cells by macrophages in diverse cancer types including GBM.", {"entities": [[232, 238, "DISEASE"], [108, 112, "GENE"]]}], ["Orthotopic patient\u2013derived xenograft tumors expressing CD47 were resected at 4 weeks after implantation and immediately thereafter treated with anti-CD47 or control antibodies injected into the cavity.", {"entities": [[55, 59, "GENE"], [149, 153, "GENE"]]}], ["Debulking prolonged survival (median survival, 68.5 vs 42.5 days, debulking and non-debulking survival times, respectively; n = 6 animals/group; P = 0.0005).", {"entities": []}], ["Survival was further improved in animals that underwent combination treatment with anti-CD47 mAbs (median survival, 81.5 days vs 69 days, debulking + anti-CD47 vs debulking + control IgG, respectively; P = 0.0007).", {"entities": []}], ["Immunohistochemistical staining of tumor sections revealed an increase in recruitment of cells positive for CD68, a marker for macrophages/immune cell types, to the surgical site (50% vs 10%, debulking vs non-debulking, respectively).", {"entities": [[108, 112, "GENE"]]}], ["Finally, analysis of tumor protein lysates on antibody microarrays demonstrated an increase in pro-inflammatory cytokines, such as CXCL10, and a decrease in angiogenic proteins in debulking + anti-CD47 vs non-debulking + IgG tumors.", {"entities": [[131, 137, "GENE"]]}], ["The results indicated that surgical resection combined with anti-CD47 blocking immunotherapy promoted an inflammatory response and prolonged survival in animals, and is therefore an attractive strategy for clinical translation.", {"entities": []}], ["Nontuberculous mycobacteria are human pathogens with increasing incidence and prevalence worldwide.", {"entities": []}], ["Mycobacterium shimoidei is a rare cause of pulmonary disease, with only 15 cases previously reported.", {"entities": []}], ["This series documents an additional 23 cases of M. shimoidei from Queensland, Australia, and highlights the pathogenicity and clinical role of this species.", {"entities": []}], ["Latin Americans are highly heterogeneous regarding the type of Native American ancestry.", {"entities": []}], ["Consideration of specific associations with common diseases may lead to substantial advances in unraveling of disease etiology and disease prevention.", {"entities": []}], ["Here we investigate possible associations between the type of Native American ancestry and leading causes of death.", {"entities": []}], ["After an aggregate-data study based on genome-wide genotype data from 1805 admixed Chileans and 639,789 deaths, we validate an identified association with gallbladder cancer relying on individual data from 64 gallbladder cancer patients, with and without a family history, and 170 healthy controls.", {"entities": [[155, 173, "DISEASE"], [209, 227, "DISEASE"], [167, 173, "DISEASE"], [221, 227, "DISEASE"]]}], ["Native American proportions were markedly underestimated when the two main types of Native American ancestry in Chile, originated from the Mapuche and Aymara indigenous peoples, were combined together.", {"entities": []}], ["Consideration of the type of Native American ancestry was crucial to identify disease associations.", {"entities": []}], ["Native American ancestry showed no association with gallbladder cancer mortality (P = 0.26).", {"entities": [[52, 70, "DISEASE"], [64, 70, "DISEASE"]]}], ["By contrast, each 1% increase in the Mapuche proportion represented a 3.7% increased mortality risk by gallbladder cancer (95%CI 3.1\u20134.3%, P = 6\u00d710 A lot of attention has been paid to Latino heterogeneity related to individual proportions of Native American, European and African ancestry.", {"entities": [[103, 121, "DISEASE"], [115, 121, "DISEASE"]]}], ["The importance of the type of Native American ancestry for health, however, has hardly been studied.", {"entities": []}], ["Here we examined genetic data from 2,039 admixed Chileans to investigate possible associations between top causes of death and the two major types of Native American ancestry in Chile.", {"entities": []}], ["Our findings demonstrate the necessity of suitable surrogates for ancestry estimation which mirror the actual composition of the study population, and the advantage of considering fine-scale Latino heterogeneity for unraveling of disease etiology and personalized healthcare.", {"entities": []}], ["Propylthiouracil (PTU) is known to be a potential cause of antineutrophil cytoplasmic antibody (ANCA) positive small vessel vasculitis, resulting in glomerulonephritis and diffuse alveolar hemorrhage (DAH).", {"entities": [[149, 167, "DISEASE"], [124, 134, "DISEASE"]]}], ["Herein, we describe a 25-year-old pregnant woman who developed a perinulcear ANCA (p-ANCA) and myeloperoxidase ANCA (MPO-ANCA) positive DAH during PTU therapy.", {"entities": []}], ["The patient improved after corticosteroid therapy and discontinuation of the PTU.", {"entities": []}], ["Methimazole was prescribed in spite of the risk of recurrence of DAH because of the pregnancy.", {"entities": []}], ["The patient is currently free from pulmonary problems.", {"entities": []}], ["Our case shows that the alternative agent, methimazole, can be used to treat hyperthyroidism in a pregnant patient with PTU associated DAH.", {"entities": [[77, 92, "DISEASE"]]}], ["Newborn screening, which identifies inherited disorders and sometimes carrier status, will increasingly involve health professionals in the provision of appropriate information and support to children and their families.", {"entities": []}], ["The ability to understand carrier results relies on an understanding of probabilistic terms.", {"entities": []}], ["However, little is known about how best to convey probabilistic medical information to children.", {"entities": []}], ["Research with adult populations suggests information format significantly affects comprehension.", {"entities": []}], ["This study aimed to explore which presentation format is most effective in conveying probabilistic information to children.", {"entities": []}], ["A probabilistic task based on the cup game was used to measure which of five different formats was associated with greatest understanding in children aged 7\u201311 years old (n = 106).", {"entities": []}], ["Formats used were verbal labels (e.g.", {"entities": []}], ["rarely, sometimes), percentages, proportion-word (e.g.", {"entities": []}], ["1 in X), proportion-notation (e.g.", {"entities": []}], ["1:X) and pie charts.", {"entities": []}], ["There was also an additional mixed format condition.", {"entities": []}], ["In each trial a picture was presented of three cups, each with a different probability depicted beneath it, and the child was asked to select which cup was most likely to contain the ball.", {"entities": []}], ["Three trials were presented per format.", {"entities": []}], ["Children also rated how certain they were that they had answered correctly.", {"entities": []}], ["There was a significant relationship between format and comprehension scores.", {"entities": []}], ["Post hoc tests showed children performed significantly better when probability was presented as a pie chart, in comparison to percentages, proportion \u2013 notation, proportion-word and mixed format trials.", {"entities": []}], ["Furthermore, most children (84%) got all trials correct for this format and children were significantly more certain that their response was correct in the pie chart trials compared to all the other formats (p < 0.001).", {"entities": []}], ["Significant positive correlations were found between self-ratings of certainty and comprehension of verbal labels, percentages and pie charts.", {"entities": []}], ["Older age was also associated with better performance on all formats except percentages.", {"entities": []}], ["Overall comprehension was calculated by summing the scores for the individual trials and this was independently associated with older age and higher IQ.", {"entities": []}], ["The results suggest that 7\u201311 year olds can understand probability information, but that the format used will significantly affect the accuracy and confidence with which children in this age group make judgements about the likelihood of an event.", {"entities": []}], ["Of the formats studied, pie charts appear to be the optimal method of presenting probabilistic information to children in this age group.", {"entities": []}], ["Health professionals and designers of health messages should be cognisant of this when communicating medical information to children aged 7\u201311 years old.", {"entities": []}], ["Health care providers are an important target audience for public health emergency preparedness, response and recovery communications.", {"entities": []}], ["Short Message Service or text messaging to cell phones may be a promising supplemental or alternative technique for reaching health care providers with time-sensitive public health information.", {"entities": []}], ["However, studies to date have yet to investigate the message content and formatting requirements of providers with respect to public health alerts and advisories or sought to understand how to meet these needs using Short Message Service technology.", {"entities": []}], ["Data collection was completed using a two-part online survey.", {"entities": []}], ["In the first part, health care providers identified their use of different technologies for receiving information and provided input on the message components most important in a public health message.", {"entities": []}], ["In the second part, health care providers participated in an exercise in which they shortened three public health emergency messages, ranging from 2024\u20132828 characters per message, to meet the 160-character limitation for text delivery.", {"entities": []}], ["Results were analyzed to determine associations between provider types, age ranges, gender, access to various media (text, email, fax, social media, etc.", {"entities": []}], ["), and smart phone ownership.", {"entities": []}], ["The following components were most frequently selected as essential for a public health message: Topic, Recommendation, Geographic Location, Signs & Symptoms, Population Affected, and Link to Additional Information.", {"entities": []}], ["There was no statistically significant association between message component selection and provider type, age ranges, or gender.", {"entities": []}], ["In the message conversion exercise, we found a statistically significant association between providers who reported receiving information by SMS and/or smart phone ownership and including a link to additional information in the converted message, ranging from 61% to over 72% on a per message analysis.", {"entities": [[141, 144, "GENE"]]}], ["A substantive recommendation derived from this study is that public health agencies include a link to additional website information when sending messages in SMS format.", {"entities": [[158, 161, "GENE"]]}], ["SMS could be a useful public health tool for communicating with health care providers but further investigation of how to effectively use SMS and other mobile technologies is needed to inform public health decisions regarding adoption of messaging systems utilizing these newer technologies.", {"entities": [[0, 3, "GENE"], [138, 141, "GENE"], [0, 3, "GENE"], [138, 141, "GENE"]]}], ["Exacerbations of chronic obstructive pulmonary disease (COPD) are acute events of worsened respiratory symptoms that may increase the risk of cardiovascular disease (CVD), a leading cause of mortality amongst COPD patients.", {"entities": [[17, 54, "DISEASE"]]}], ["The utility of lung-specific inflammatory mediators such as club cell protein-16 (CC-16) and surfactant protein D (SPD) and that of a novel marker of CV outcomes in COPD- RelB- in predicting adverse cardiovascular events during exacerbation is not known.", {"entities": []}], ["Thirty-eight subjects with COPD admitted to the hospital for severe exacerbation were included in this analysis.", {"entities": []}], ["Clinical, physiological and arterial stiffness measurements were performed within 72 hours of admission; this was followed by measurements taken every 3 days until hospital discharge, then once a week until 30 days after discharge, and then again at 90 and 180 days.", {"entities": []}], ["Plasma concentrations of inflammatory mediators were measured from peripheral venous blood taken at admission, and at days 15, 30, 90 and 180.", {"entities": []}], ["CC-16 and RelB concentrations were increased at day 15 of exacerbations whereas SPD concentrations were decreased.", {"entities": [[10, 14, "GENE"]]}], ["The course of change in CC-16 and RelB levels over time was inversely associated with that of carotid-femoral pulse wave velocity, the gold-standard measure of arterial stiffness.", {"entities": [[34, 38, "GENE"]]}], ["Increases in CC-16 could predict a decreased number of subsequent exacerbations during follow-up.", {"entities": []}], ["Lung-specific (CC-16) and novel (RelB) biomarkers are associated with systemic cardiovascular changes over time.", {"entities": [[33, 37, "GENE"]]}], ["CC-16 can predict subsequent exacerbations in subjects with severe COPD and may be an important biomarker of pulmonary and systemic stress in COPD.", {"entities": []}], ["Altered Toll-like receptor (TLR) signaling has been implicated in the pathogenesis of systemic lupus erythematosus (SLE).", {"entities": [[95, 114, "DISEASE"], [86, 114, "DISEASE"]]}], ["The present study was undertaken to characterize responses of B cells from SLE patients to TLR7 and TLR9 stimulation and to explore the potential role of single immunoglobulin interleukin-1 receptor related molecule (SIGIRR) in the regulation of TLR-mediated responses of SLE B cells.", {"entities": [[91, 95, "GENE"], [100, 104, "GENE"], [217, 223, "GENE"]]}], ["Peripheral blood mononuclear cells (PBMC) were isolated from 64 patients with SLE and 37 healthy donors.", {"entities": []}], ["CD19+ B cells purified using microbeads were cultured with TLR7 or TLR9 agonists.", {"entities": [[59, 63, "GENE"], [67, 71, "GENE"]]}], ["Cell proliferation was measured by thymine incorporation and the frequency of antibody-secreting cells was determined by ELISPOT assay.", {"entities": []}], ["SIGIRR expression in PBMCs and B cells was analyzed using flow cytometry analysis.", {"entities": [[0, 6, "GENE"]]}], ["In contrast to the enhanced proliferation following B cell receptor (BCR) engagement, B cells from SLE patients exhibited a virtually normal proliferative response to TLR7 or TLR9 stimulation.", {"entities": [[69, 72, "GENE"], [167, 171, "GENE"], [175, 179, "GENE"]]}], ["Moreover, B cells from SLE patients and healthy donors were almost equally competent to differentiate into antibody-secreting cells upon TLR engagement except for a reduction in the generation of IgG-secreting cells by TLR9-stimulated lupus B cells.", {"entities": []}], ["In line with these somehow unexpected observations, SLE B cells were found to express a significantly higher level of SIGIRR than normal B cells.", {"entities": [[118, 124, "GENE"]]}], ["Despite the reported upregulation of TLR7 and TLR9 expression in B cell from SLE patients, their responses to TLR stimulation were largely normal.", {"entities": [[37, 41, "GENE"], [46, 50, "GENE"]]}], ["The increased expression of the negative regulator SIGIRR may be partly responsible for the \u201cbalance of terror\u201d.", {"entities": [[51, 57, "GENE"]]}], ["Chronic rhinosinusitis (CRS) is a chronic inflammatory disease of the sinonasal mucosa either accompanied by polyp formation (CRSwNP) or without polyps (CRSsNP).", {"entities": []}], ["CRSsNP accounts for the majority of CRS cases and is characterized by fibrosis and neutrophilic inflammation.", {"entities": []}], ["However, the pathogenesis of CRS, especially CRSsNP, remains unclear.", {"entities": []}], ["Immunohistochemistry of CRSsNP specimens in the present study showed that the submucosa, perivascular areas, and the mucous glands were abundant in fibroblasts.", {"entities": []}], ["Therefore, we investigated the effects bradykinin (BK), an autacoid known to participate in inflammation, on human CRSsNP nasal mucosa-derived fibroblasts (NMDFs).", {"entities": []}], ["BK increased CXCL1 and -8 secretion and mRNA expression with EC 50 ranging from 0.15~0.35 \u03bcM.", {"entities": [[13, 18, "GENE"]]}], ["Moreover, BK enhanced cell proliferation and upregulated the expressions of proinflammatory molecules, including cell adhesion molecules (CAMs) and cyclooxygenase (COX)-1 and -2.", {"entities": []}], ["These functionally caused an increase in monocyte adhesion to fibroblast monolayer.", {"entities": []}], ["Using pharmacological intervention and BKR siRNA knockdown, we demonstrated that the BK-induced CXCL chemokine release, cell proliferation and COX and CAM expressions were mainly through the B2 receptor (B2R).", {"entities": []}], ["Accordingly, the B2R was preferentially expressed in the NMDFs than B1R.", {"entities": []}], ["The B2R was highly expressed in the CRSsNP than the control specimens, while the B1R and kininogen (KNG)/BK expression slightly increased in the CRSsNP mucosa.", {"entities": []}], ["Collectively, we report here for the first time that fibroblasts, KNG/BK, and BKRs are overexpressed in CRSsNP mucosa and BK upregulates chemokine expression, proliferation, and proinflammatory molecule expression in NMDFs via B2R activation, which lead to a functional increase in monocyte-fibroblast interaction.", {"entities": []}], ["Our findings reveal a critical role of fibroblast, KNG/BK, and BKRs in the development of CRSsNP.", {"entities": []}], ["Despite the feasibility and safety of bariatric procedures nowadays, high-risk patients with vast obesity and severe comorbidities demonstrate relatively high perioperative morbidity and mortality rates and, therefore, form a distinguished challenge for the bariatric surgeons.", {"entities": [[98, 105, "DISEASE"]]}], ["We retrospectively analyzed high-risk patients, who underwent bariatric surgery in University Hospital Leipzig between May 2012 and December 2016.", {"entities": []}], ["High-risk patients were defined when (Bergeat et al., 2016) at least one of the following risk factors was met: age\u2009\u2265\u200970 years, body mass index (BMI)\u2009>\u200970\u2009kg/m A total of 25 high-risk obese patients were identified.", {"entities": []}], ["All patients had a standardized postoperative management with a mean length of hospital stay of 4\u2009\u00b1\u20091.4 days.", {"entities": []}], ["One patient required an operative revision due to a stapler line leak after sleeve gastrectomy.", {"entities": []}], ["No other major postoperative complications occurred.", {"entities": []}], ["Bariatric surgery for severe high-risk patients can be performed safely in high-volume centers following standardized procedures.", {"entities": []}], ["The association between aspirin use and lung cancer risk in women was examined in a case\u2013control study nested in the New York University Women's Health Study, a large cohort in New York.", {"entities": [[40, 51, "DISEASE"], [45, 51, "DISEASE"]]}], ["Case subjects were all the 81 incident lung cancer cases who had provided information about aspirin use at enrollment and during the 1994\u20131996 follow up.", {"entities": [[39, 50, "DISEASE"], [44, 50, "DISEASE"]]}], ["Ten controls per case were randomly selected from among study participants who matched a case by age, menopausal status, and dates of enrollment and follow-up.", {"entities": []}], ["Relative to no aspirin use, the odds ratio for lung cancer (all histological sub-types combined) among subjects who reported aspirin use three or more times per week for at least 6 months was 0.66 (95% confidence interval 0.34\u20131.28), after adjustment for smoking and education.", {"entities": [[47, 58, "DISEASE"], [52, 58, "DISEASE"]]}], ["A stronger inverse association was observed in analyses restricted to non-small cell lung cancer (adjusted odds ratio 0.39, 95% confidence interval 0.16\u20130.96).", {"entities": [[85, 96, "DISEASE"], [90, 96, "DISEASE"]]}], ["These results suggest that regular aspirin use might be inversely associated with risk of lung cancer in women, particularly the non-small cell sub-type.", {"entities": [[90, 101, "DISEASE"], [95, 101, "DISEASE"]]}], ["British Journal of Cancer (2002) 87 , 49\u201353.", {"entities": [[19, 25, "DISEASE"]]}], ["doi: 10.1038/sj.bjc.6600370 www.bjcancer.com \u00a9 2002 Cancer Research UK", {"entities": [[52, 58, "DISEASE"]]}], ["The Hokkaido Study on Environment and Children\u2019s Health is an ongoing study consisting of two birth cohorts of different population sizes: the Sapporo cohort and the Hokkaido cohort.", {"entities": []}], ["Our primary study goals are (1) to examine the effects of low-level environmental chemical exposures on birth outcomes, including birth defects and growth retardation; (2) to follow the development of allergies, infectious diseases, and neurobehavioral developmental disorders and perform a longitudinal observation of child development; (3) to identify high-risk groups based on genetic susceptibility to environmental chemicals; and (4) to identify the additive effects of various chemicals, including tobacco smoking.", {"entities": []}], ["The purpose of this report is to update the progress of the Hokkaido Study, to summarize the recent results, and to suggest future directions.", {"entities": []}], ["In particular, this report provides the basic characteristics of the cohort populations, discusses the population remaining in the cohorts and those who were lost to follow-up at birth, and introduces the newly added follow-up studies and case-cohort study design.", {"entities": []}], ["In the Sapporo cohort of 514 enrolled pregnant women, various specimens, including maternal and cord blood, maternal hair, and breast milk, were collected for the assessment of exposures to dioxins, polychlorinated biphenyls, organochlorine pesticides, perfluoroalkyl substances, phthalates, bisphenol A, and methylmercury.", {"entities": []}], ["As follow-ups, face-to-face neurobehavioral developmental tests were conducted at several different ages.", {"entities": []}], ["In the Hokkaido cohort of 20,926 enrolled pregnant women, the prevalence of complicated pregnancies and birth outcomes, such as miscarriage, stillbirth, low birth weight, preterm birth, and small for gestational age were examined.", {"entities": []}], ["The levels of exposure to environmental chemicals were relatively low in these study populations compared to those reported previously.", {"entities": []}], ["We also studied environmental chemical exposure in association with health outcomes, including birth size, neonatal hormone levels, neurobehavioral development, asthma, allergies, and infectious diseases.", {"entities": [[161, 167, "DISEASE"]]}], ["In addition, genetic and epigenetic analyses were conducted.", {"entities": []}], ["The results of this study demonstrate the effects of environmental chemical exposures on genetically susceptible populations and on DNA methylation.", {"entities": []}], ["Further study and continuous follow-up are necessary to elucidate the combined effects of chemical exposure on health outcomes.", {"entities": []}], ["Many claims are made that the use of traditional medicine is a substantial and growing part of healthcare behavior around the world.", {"entities": []}], ["In Bhutan traditional medical practice is one of the country's tangible heritages.", {"entities": []}], ["The country hosts two forms of traditional medicines: local healing practices and the official traditional medical system known as sowa rigpa , meaning \"the science of healing\".", {"entities": []}], ["This paper explores the attitudes on sowa rigpa among Bhutanese living in Thimphu, the capital of Bhutan.", {"entities": []}], ["This study was conducted from May to September 2009.", {"entities": []}], ["In total, 155 people coming from diverse social backgrounds were randomly selected for the study.", {"entities": []}], ["The study made use of qualitative as well as quantitative approaches, involving the administration of questionnaires and conducting in-depth interviews.", {"entities": []}], ["From the 155 respondents 99% have heard about sowa rigpa , mainly from their friends or relatives.", {"entities": []}], ["The study showed that sowa rigpa is popular among the respondents since more than half (51%) have said that they have been treated by sowa rigpa doctors.", {"entities": []}], ["The data revealed that the majority (83%) of the respondents are satisfied with the treatment received.", {"entities": []}], ["The Bhutanese healthcare system that integrates sowa rigpa and modern medicine offers an opportunity for active healthcare decision-making by the patients.", {"entities": []}], ["The improved understanding of the knowledge, attitudes and treatment seeking practices of the participants in the study provides useful information for health practitioners and policy makers to plan health activities.", {"entities": []}], ["The present preliminary study represents only people living in the capital city of Bhutan.", {"entities": []}], ["Therefore, a further nationwide study is planned to better understand the role sowa rigpa plays also in rural Bhutan.", {"entities": []}], ["DNA methylation may regulate gene expression by restricting the access of transcription factors.", {"entities": []}], ["We have previously demonstrated that GATA-1 regulates the transcription of the CCR3 gene by dynamically interacting with both positively and negatively acting GATA elements of high affinity binding in the proximal promoter region including exon 1.", {"entities": [[79, 83, "GENE"]]}], ["Exon 1 has three CpG sites, two of which are positioned at the negatively acting GATA elements.", {"entities": []}], ["We hypothesized that the methylation of these two CpGs sites might preclude GATA-1 binding to the negatively acting GATA elements and, as a result, increase the availability of GATA-1 to the positively acting GATA element, thereby contributing to an increase in GATA-1-mediated transcription of the gene.", {"entities": []}], ["To this end, we determined the methylation of the three CpG sites by bisulfate pyrosequencing in peripheral blood eosinophils, cord blood (CB)-derived eosinophils, PBMCs, and cell lines that vary in CCR3 mRNA expression.", {"entities": [[199, 203, "GENE"]]}], ["Our results demonstrated that methylation of CpG sites at the negatively acting GATA elements severely reduced GATA-1 binding and augmented transcription activity in vitro .", {"entities": []}], ["In agreement, methylation of these CpG sites positively correlated with CCR3 mRNA expression in the primary cells and cell lines examined.", {"entities": [[72, 76, "GENE"]]}], ["Interestingly, methylation patterns of these three CpG sites in CB-derived eosinophils mostly resembled those in peripheral blood eosinophils.", {"entities": []}], ["These results suggest that methylation of CpG sites at the GATA elements in the regulatory regions fine-tunes CCR3 transcription.", {"entities": [[110, 114, "GENE"]]}], ["Responding to a request by corrections agency management, we investigated coccidioidomycosis in prison employees in central California, a coccidioidomycosis-endemic area.", {"entities": [[74, 92, "DISEASE"], [138, 156, "DISEASE"]]}], ["We identified 103 cases of coccidioidomycosis that occurred over 4.5 years.", {"entities": [[27, 45, "DISEASE"]]}], ["As a result, we recommended training and other steps to reduce dust exposure among employees and thus potential exposure to Coccidioides .", {"entities": []}], ["Metabolomics has opened new avenues for studying metabolic alterations in type 2 diabetes.", {"entities": []}], ["While many urine and blood metabolites have been associated individually with diabetes, a complete systems view analysis of metabolic dysregulations across multiple biofluids and over varying timescales of glycaemic control is still lacking.", {"entities": []}], ["Here we report a broad metabolomics study in a clinical setting, covering 2,178 metabolite measures in saliva, blood plasma and urine from 188 individuals with diabetes and 181 controls of Arab and Asian descent.", {"entities": []}], ["Using multivariate linear regression we identified metabolites associated with diabetes and markers of acute, short-term and long-term glycaemic control.", {"entities": []}], ["Ninety-four metabolite associations with diabetes were identified at a Bonferroni level of significance ( p\u2009< \u20092.3\u2009\u00d7\u200910 Our study reveals a complex network of biochemical dysregulation involving metabolites from different pathways of diabetes pathology, and provides a reference framework for future diabetes studies with metabolic endpoints.", {"entities": []}], ["The online version of this article (doi:10.1007/s00125-015-3636-2) contains peer-reviewed but unedited supplementary material, which is available to authorised users.", {"entities": []}], ["Interferon gamma is a major macrophage-activating cytokine during infection with Mycobacterium tuberculosis , the causative pathogen of tuberculosis, and its role has been well established in animal models and in humans.", {"entities": [[95, 107, "DISEASE"], [136, 148, "DISEASE"]]}], ["This cytokine is produced by activated T helper 1 cells, which can best deal with intracellular pathogens such as M. tuberculosis .", {"entities": [[117, 129, "DISEASE"]]}], ["Based on the hypothesis that genes which regulate interferon gamma may influence tuberculosis susceptibility, we investigated polymorphisms in eight candidate genes.", {"entities": [[81, 93, "DISEASE"]]}], ["Fifty-four polymorphisms in eight candidate genes were genotyped in over 800 tuberculosis cases and healthy controls in a population-based case-control association study in a South African population.", {"entities": [[77, 89, "DISEASE"]]}], ["Genotyping methods used included the SNPlex Genotyping System\u2122, capillary electrophoresis of fluorescently labelled PCR products, TaqMan A haplotype in interleukin 12B was nominally associated with tuberculosis (p = 0.02), but after permutation testing, done to assess the significance for the entire analysis, this was not globally significant.", {"entities": [[198, 210, "DISEASE"]]}], ["In addition a novel allele was found for the interleukin 12B D5S2941 microsatellite.", {"entities": []}], ["This study highlights the importance of using larger sample sizes when attempting validation of previously reported genetic associations.", {"entities": []}], ["Initial studies may be false positives or may propose a stronger genetic effect than subsequently found to be the case.", {"entities": []}], ["The prime objective of this study is to examine the trends of disease and age pattern of hospitalisation and associated costs in India during 1995\u20132014.", {"entities": []}], ["Present study used nationally representative data on morbidity and healthcare from the 52nd (1995) and 71st (2014) rounds of the National Sample Survey.", {"entities": []}], ["A total of 120\u2009942 and 65\u2009932 households were surveyed in 1995 and 2014, respectively.", {"entities": []}], ["Descriptive statistics, logistic regression analyses and decomposition analyses were used in examining the changes in patterns of hospitalisation and associated costs.", {"entities": []}], ["Hospitalisation rates and costs per hospitalisation (out-of-pocket expenditure) were estimated for selected diseases and in four broad categories: communicable diseases, non-communicable diseases (NCDs), injuries and others.", {"entities": []}], ["All the costs are presented at 2014 prices in US$.", {"entities": []}], ["Hospitalisation rate in India has increased from 1661 in 1995 to 3699 in 2014 (per 100\u2009000 population).", {"entities": []}], ["It has more than doubled across all age groups.", {"entities": []}], ["Hospitalisation among children was primarily because of communicable diseases, while NCDs were the leading cause of hospitalisation for the 40+ population.", {"entities": []}], ["Costs per hospitalisation have increased from US$177 in 1995 to US$316 in 2014 (an increase of 79%).", {"entities": []}], ["Costs per hospitalisation for NCDs in 2014 were US$471 compared with US$175 for communicable diseases.", {"entities": []}], ["It was highest for cancer inpatients (US$942) followed by heart diseases (US$674).", {"entities": [[19, 25, "DISEASE"]]}], ["Age is the significant predictor of hospitalisation for all the selected diseases.", {"entities": []}], ["Decomposition results showed that about three-fifth of the increase in unconditional costs per hospitalisation was due to increase in mean hospital costs, and the other two-fifth was due to increase in hospitalisation rates.", {"entities": []}], ["There has been more than twofold increase in hospitalisation rates in India during the last two decades, and significantly higher rates were observed among infants and older adults.", {"entities": []}], ["Increasing hospitalisation rates and costs per hospitalisation are contributing substantially to the rising healthcare costs in India.", {"entities": []}], ["The emergence of transfusion transmitted infection (TTI) especially HIV/AIDS has created a huge obstacle in ensuring blood safety.", {"entities": []}], ["To assess the situation in Eritrea, we carried out a retrospective study of 29,501 blood donors for the prevalence of TTI's i.e.", {"entities": []}], ["HIV, HBV, HCV and Syphilis.", {"entities": []}], ["The study population included all donors who donated blood from January 2006 to November 2009.", {"entities": []}], ["The data was collected from the National Blood Transfusion Services (NTBS) of Eritrea and includes category of donor and result for TTI markers.", {"entities": []}], ["A total of 29,501 units of blood were collected from 23,385(79%) voluntary blood donors and the rest 6,116(21%) units were collected from family replacement donors.", {"entities": []}], ["The over all prevalence of TTI's were 3.8% with 3.5% in voluntary blood donors and 5.1% in family replacement donors.", {"entities": []}], ["The sero-prevalence for TTI markers were 0.18% HIV, 2.58% HBV, 0.57% HCV and 0.49% Syphilis.", {"entities": []}], ["In conclusion, even if the TTI prevalence rate among Eritrean blood donors is low, ensuring blood safety has a long way to go.", {"entities": []}], ["Common variable immunodeficiency (CVID) and immunoglobulin (Ig) G subclass deficiency (IgGSD) are heterogeneous disorders characterized by respiratory tract infections, selective Ig isotype deficiencies, and impaired antibody responses to polysaccharide antigens.", {"entities": []}], ["Using univariable analyses, we compared observations in 34 CVID and 398 IgGSD adult index patients (81.9% women) referred to a hematology/oncology practice.", {"entities": []}], ["Similarities included specialties of referring physicians, mean ages, proportions of women, reactivity to Pneumovax, median serum IgG3 and IgG4 levels, median blood CD56+/CD16+ lymphocyte levels, positivity for HLA-A and -B types, and frequencies of selected HLA-A, -B haplotypes.", {"entities": [[211, 216, "GENE"], [259, 264, "GENE"], [211, 216, "GENE"], [259, 264, "GENE"]]}], ["Dissimilarities included greater prevalence of autoimmune conditions, lower median IgG, IgA, and IgM, and lower median CD19+, CD3+/CD4+, and CD3+/CD8+ blood lymphocytes in CVID patients.", {"entities": []}], ["Prevalence of Sj\u00f6gren's syndrome and hypothyroidism was significantly greater in CVID patients.", {"entities": [[37, 51, "DISEASE"], [24, 32, "DISEASE"]]}], ["Combined subnormal IgG1/IgG3 occurred in 59% and 29% of CVID and IgGSD patients, respectively.", {"entities": []}], ["Isolated subnormal IgG3 occurred in 121 IgGSD patients (88% women).", {"entities": []}], ["Logistic regression on CVID (versus IgGSD) revealed a significant positive association with autoimmune conditions and significant negative associations with IgG1, IgG3, and IgA and CD56+/CD16+ lymphocyte levels, but the odds ratio was increased for autoimmune conditions alone (6.9 (95% CI 1.3, 35.5)).", {"entities": []}], ["Influenza causes seasonal infections worldwide that can lead to complications and deaths in every age group.", {"entities": [[0, 9, "DISEASE"]]}], ["The most effective and cheapest way to combat influenza is through vaccination.", {"entities": [[46, 55, "DISEASE"]]}], ["In many countries, including Poland, for each age group, the rate of vaccination against influenza is still at a very low level, which generates high social costs, not infrequently family tragedies in the case of irreversible complications of influenza, or death of a loved one.", {"entities": [[89, 98, "DISEASE"], [243, 252, "DISEASE"]]}], ["Regular vaccination should be part of good medical practice, as well as an individual\u2019s engagement in their own health and in that of their family.", {"entities": []}], ["Based on numerous studies, it is estimated that the effectiveness of current inactivated influenza vaccine in reducing morbidity and mortality in high-risk groups ranges from 50\u201370%.", {"entities": [[89, 98, "DISEASE"]]}], ["According to data from the National Institute of Public Health-National Institute of Hygiene, the rate of vaccination in children in 2008 in Poland was very low.", {"entities": []}], ["In the group of children aged from 6 months to 14 years, only 1.1\u20131.6% were vaccinated.", {"entities": []}], ["Although influenza vaccination for people aged over 65 years was free of charge in many provinces in this group, only 13.4% of this population was immunized, while in the case of people with chronic diseases, only 11.1% were immunized.", {"entities": [[9, 18, "DISEASE"]]}], ["The vaccination rate among health care employees is an embarrassing 6.4%.", {"entities": []}], ["More educational activities addressed to both medical professionals and patients are required in order to increase influenza vaccine coverage in Poland.", {"entities": [[115, 124, "DISEASE"]]}], ["The selenoprotein glutathione peroxidase 2 (GPx2) is expressed in the epithelium of the gastrointestinal tract, where it is thought to be involved in maintaining mucosal homeostasis.", {"entities": [[44, 48, "GENE"]]}], ["To gain novel insights into the role of GPx2, proteomic profiles of colonic tissues either derived from wild type (WT) or GPx2 knockout (KO) mice, maintained under selenium (Se) deficiency or adequate Se supplementation conditions were established and analyzed.", {"entities": [[40, 44, "GENE"], [122, 126, "GENE"], [40, 44, "GENE"], [122, 126, "GENE"]]}], ["Amongst the panel of differentially expressed proteins, the calcium-activated chloride channel regulator 1 (CLCA1) was significantly down-regulated in GPx2 KO versus WT mice regardless of the given Se status.", {"entities": [[108, 113, "GENE"], [151, 155, "GENE"]]}], ["Moreover, transcript levels of the isoforms CLCA2 and CLCA3 showed a similar expression pattern.", {"entities": [[44, 49, "GENE"]]}], ["In the intestine, CLCA1 is usually restricted to mucin-producing goblet cells.", {"entities": [[18, 23, "GENE"]]}], ["However, although -SeKO mice had the highest numbers of goblet cells as confirmed by significantly enhanced mRNA expression levels of the goblet cell marker mucin-2, the observed expression pattern suggests that GPx2 KO goblet cells might be limited in synthesizing CLCA1.", {"entities": [[212, 216, "GENE"], [266, 271, "GENE"]]}], ["Furthermore, transcript levels of differentiation markers such as chromogranin-1 (Chga) for enteroendocrine cells and leucine-rich repeat-containing G-protein coupled receptor 5 (Lgr5) for stem cells were also downregulated in GPx2 KO mice.", {"entities": [[82, 86, "GENE"], [179, 183, "GENE"], [227, 231, "GENE"]]}], ["Moreover, this was accompanied by a downregulation of the mRNA expression levels of the intestinal hormones glucagon-like peptide 1 (Glp1), ghrelin (Ghrl) and somatostatin (Sst).", {"entities": [[149, 153, "GENE"], [173, 176, "GENE"]]}], ["Thus, it seems that GPx2 might be important for the modulation of cell fate decisions in the murine intestinal epithelium.", {"entities": [[20, 24, "GENE"]]}], ["Eosinophilic otitis media (EOM) is a relatively rare, intractable, middle ear disease with extremely viscous mucoid effusion containing eosinophils.", {"entities": [[67, 85, "DISEASE"], [13, 25, "DISEASE"]]}], ["EOM is associated with adult bronchial asthma and nasal allergies.", {"entities": [[39, 45, "DISEASE"]]}], ["Conventional treatments for otitis media with effusion (OME) or for chronic otitis media (COM), like tympanoplasty or mastoidectomy, when performed for the treatment of EOM, can induce severe complications such as deafness.", {"entities": [[28, 40, "DISEASE"], [76, 88, "DISEASE"]]}], ["Therefore, it should be differentiated from the usual type of OME or COM.", {"entities": []}], ["To our knowledge, the clinical and imaging findings of EOM of temporal bone are not well-known to radiologists.", {"entities": []}], ["We report here the CT and MRI findings of two EOM cases and review the clinical and histopathologic findings of this recently described disease entity.", {"entities": []}], ["Silibinin is the major active molecule of silymarin, the mixture of flavonolignans extracted from Cirsium japonicum .", {"entities": []}], ["It has been used for the treatment of hepatitis and inflammation-related diseases.", {"entities": [[38, 47, "DISEASE"]]}], ["In the present study, the effects of silibinin on allergic inflammation and its signaling were investigated in the induced human mast cells.", {"entities": []}], ["Cell growth inhibition induced by silibinin was measured by MTS assay.", {"entities": []}], ["Histamine release was measured by enzyme immunoassay.", {"entities": []}], ["The tumor necrosis factor-\u03b1 (TNF-\u03b1), interleukin-6 (IL-6), and interleukin-8 (IL-8) secreted protein levels and mRNA levels were measured by the ELISA assay and RT-PCR, respectively.", {"entities": []}], ["The NF-\u03baB promoter activity was examined by a luciferase assay.", {"entities": []}], ["Silibinin suppressed the growth of HMC-1 cells and also reduced the production and mRNA expression of pro-inflammatory cytokines such as TNF-\u03b1, IL-6, and IL-8.", {"entities": []}], ["Moreover, silibinin inhibited the nuclear translocation of nuclear factor (NF)-\u03baB through inhibition of the phosphorylation of I\u03baB\u03b1 and suppressed NF-\u03baB transcriptional activity in stimulated HMC-1 cells.", {"entities": []}], ["Taken together, these results indicate that silibinin inhibits the production of pro-inflammatory cytokines through inhibition of NF-\u03baB signaling pathway in HMC-1 human mast cells, suggesting that silibinin could be used for the treatment of mast cell-derived allergic inflammatory diseases.", {"entities": []}], ["Air pollution has become a severe environmental problem due to urbanization and heavy traffic.", {"entities": []}], ["Monitoring street-level air quality is an important issue, but most official monitoring stations are installed to monitor large-scale air quality conditions, and their limited spatial resolution cannot reflect the detailed variations in air quality that may be induced by traffic jams.", {"entities": []}], ["By deploying wireless sensors on crossroads and main roads, this study established a pilot framework for a wireless sensor network (WSN)-based real-time monitoring system to understand street-level spatial-temporal changes of carbon monoxide (CO) in urban settings.", {"entities": []}], ["The system consists of two major components.", {"entities": []}], ["The first component is the deployment of wireless sensors.", {"entities": []}], ["We deployed 44 sensor nodes, 40 transmitter nodes and four gateway nodes in this study.", {"entities": []}], ["Each sensor node includes a signal processing module, a CO sensor and a wireless communication module.", {"entities": []}], ["In order to capture realistic human exposure to traffic pollutants, all sensors were deployed at a height of 1.5 m on lampposts and traffic signs.", {"entities": []}], ["The study area covers a total length of 1.5 km of Keelung Road in Taipei City.", {"entities": []}], ["The other component is a map-based monitoring platform for sensor data visualization and manipulation in time and space.", {"entities": []}], ["Using intensive real-time street-level monitoring framework, we compared the spatial-temporal patterns of air pollution in different time periods.", {"entities": []}], ["Our results capture four CO concentration peaks throughout the day at the location, which was located along an arterial and nearby traffic sign.", {"entities": []}], ["The hourly average could reach 5.3 ppm from 5:00 pm to 7:00 pm due to the traffic congestion.", {"entities": []}], ["The proposed WSN-based framework captures detailed ground information and potential risk of human exposure to traffic-related air pollution.", {"entities": []}], ["It also provides street-level insights into real-time monitoring for further early warning of air pollution and urban environmental management.", {"entities": []}], ["Gut under severe insult is considered to have an important role in promoting infection and multiple organ dysfunction syndrome from the viewpoint of altered intestinal epithelium, immune system and commensal bacteria.", {"entities": [[118, 126, "DISEASE"]]}], ["There are few reports, however, about the relationship between gut flora and septic complications.", {"entities": []}], ["We analyzed gut flora in patients with systemic inflammatory response syndrome (SIRS) and evaluated key bacteria and their cutoff values for infectious complications and mortality by using classification and regression trees (CART).", {"entities": [[70, 78, "DISEASE"]]}], ["Eighty-one SIRS patients with a serum C-reactive protein level higher than 10\u00a0mg/dL treated in the intensive care unit (ICU) for more than 2\u00a0days were included for the study.", {"entities": []}], ["We quantitatively evaluated nine types of bacteria in fecal samples by plate or tube technique.", {"entities": []}], ["Two hundred seventy-one samples were analyzed using CART and logistic regression.", {"entities": []}], ["The dominant factors for complication of enteritis were the minimum number of total obligate anaerobes and the maximum number of Staphylococcus and Enterococcus .", {"entities": []}], ["The dominant factors for complication of bacteremia were the minimum numbers of total obligate anaerobes and total facultative anaerobes.", {"entities": []}], ["The dominant factors for mortality were the numbers of total obligate anaerobes and total facultative anaerobes and age.", {"entities": []}], ["A decrease in total obligate anaerobes and an increase in pathogenic bacteria in the gut are associated with septic complications and mortality in patients with SIRS.", {"entities": []}], ["The altered gut flora may be a potential prognostic marker in SIRS patients.", {"entities": []}], ["Breathlessness in chronic obstructive pulmonary disease (COPD) is often discordant with airway pathophysiology (\u201cover-perception\u201d).", {"entities": [[18, 55, "DISEASE"]]}], ["Pulmonary rehabilitation profoundly affects breathlessness, without influencing lung function.", {"entities": []}], ["Learned associations influence brain mechanisms of sensory perception.", {"entities": []}], ["We hypothesised that improvements in breathlessness with pulmonary rehabilitation may be explained by changing neural representations of learned associations.", {"entities": []}], ["In 31 patients with COPD, we tested how pulmonary rehabilitation altered the relationship between brain activity during a breathlessness-related word-cue task (using functional magnetic resonance imaging), and clinical and psychological measures of breathlessness.", {"entities": []}], ["Changes in ratings of breathlessness word cues positively correlated with changes in activity in the insula and anterior cingulate cortex.", {"entities": []}], ["Changes in ratings of breathlessness-anxiety negatively correlated with activations in attention regulation and motor networks.", {"entities": []}], ["Baseline activity in the insula, anterior cingulate cortex and prefrontal cortex correlated with improvements in breathlessness and breathlessness-anxiety.", {"entities": []}], ["Pulmonary rehabilitation is associated with altered neural responses related to learned breathlessness associations, which can ultimately influence breathlessness perception.", {"entities": []}], ["These findings highlight the importance of targeting learned associations within treatments for COPD, demonstrating how neuroimaging may contribute to patient stratification and more successful personalised therapy.", {"entities": []}], ["Pulmonary rehabilitation improves breathlessness by recalibrating the brain's sensory perception networks http://ow.ly/crhy30cQerx", {"entities": []}], ["A key focus in the field of drug discovery has been motivated by the neuroprotection of natural compounds.", {"entities": []}], ["Cerebral ischemia is a multifaceted pathological process with a series of mechanisms, and a perspective for the development of neuroprotectants from traditional herbal medicine or natural products is a promising treatment for this disease.", {"entities": [[9, 17, "DISEASE"]]}], ["Natural compounds with the effects of anti-oxidation, anti-inflammation, anti-apoptosis, and neurofunctional regulation exhibit therapeutic effects on experimental ischemic brain injury.", {"entities": []}], ["Conferring to the pharmacological mechanisms underlying neuroprotection, a study found that androgapholide, a diterpene lactone compound, exhibits varying degrees of neuroprotective activities in both in vitro and in vivo experimental models of stroke.", {"entities": []}], ["The neuroprotective mechanisms of andrographolide are suggested as: (I) increasing nuclear factor E2-related factor 2-heme oxygenase (Nrf2-HO-1) expression through p38-mitogen activated protein kinase (MAPK) regulation, (II) inducing cerebral endothelial cells (CEC) apoptosis and caspase-3 activation, (III) down regulating Bax, inducible nitric oxide synthase (iNOS), and (IV) inhibiting hydroxyl radical (OH", {"entities": [[325, 328, "GENE"]]}], ["In idiopathic pulmonary fibrosis loss of alveolar epithelium induces inflammation of the pulmonary tissue followed by accumulation of pathogenic myofibroblasts leading eventually to respiratory failures.", {"entities": [[14, 32, "DISEASE"], [3, 32, "DISEASE"]]}], ["In animal models inflammatory and resident cells have been demonstrated to contribute to pulmonary fibrosis.", {"entities": [[89, 107, "DISEASE"]]}], ["Regenerative potential of pulmonary and extra-pulmonary stem and progenitor cells raised the hope for successful treatment option against pulmonary fibrosis.", {"entities": [[138, 156, "DISEASE"]]}], ["Herein, we addressed the contribution of lung microenvironment and prominin-1 Prominin-1 in vitro by cytokines and growth factors.", {"entities": []}], ["Pulmonary fibrosis was induced in C57Bl/6 mice by intratracheal instillation of bleomycin.", {"entities": [[0, 18, "DISEASE"]]}], ["Prominin-1 Prominin-1 The microenvironment of inflamed lung impairs the regenerative capacity of bone marrow-derived prominin-1", {"entities": []}], ["The transition from hospital to home can expose patients to adverse events during the post discharge period.", {"entities": []}], ["Post discharge care including phone calls may provide support for patients returning home but the impact on care transitions is unknown.", {"entities": []}], ["To examine the effect of a 72-hour post discharge phone call on the patient's transition of care experience.", {"entities": []}], ["Cluster-randomized control trial.", {"entities": []}], ["Urban, academic medical center.", {"entities": []}], ["General medical patients age 18 and older discharged home after hospitalization.", {"entities": []}], ["Primary outcome measure was the Care Transition Measure (CTM-3) score, a validated measure of the quality of care transitions.", {"entities": []}], ["Secondary measures included self-reported adherence to medication and follow up plans, and 30-day composite of emergency department (ED) visits and hospital readmission.", {"entities": []}], ["328 patients were included in the study over an 6-month period.", {"entities": []}], ["114 (69%) received a post discharge phone call, and 214 of all patients in the study completed the follow outcome survey (65% response rate).", {"entities": []}], ["A small difference in CTM-3 scores was observed between the intervention and control groups (1.87 points, 95% CI 0.47\u20133.27, p\u200a=\u200a0.01).", {"entities": []}], ["Self-reported adherence to treatment plans, ED visits, and emergency readmission rates were similar between the two groups (odds ratio 0.57, 95% CI 0.13\u20132.45, 1.20, 95% CI 0.61\u20132.37, and 1.18, 95% CI 0.53\u20132.61, respectively).", {"entities": []}], ["A single post discharge phone call had a small impact on the quality of care transitions and no effect on hospital utilization.", {"entities": []}], ["Higher intensity post discharge support may be required to improve the patient experience upon returning home.", {"entities": []}], ["ClinicalTrials.gov NCT01580774", {"entities": []}], ["Adipose tissue (AT) dysfunction, characterized by loss of its homeostatic functions, is a hallmark of non-communicable diseases.", {"entities": []}], ["It is characterized by chronic low-grade inflammation and is observed in obesity, metabolic disorders such as insulin resistance and diabetes.", {"entities": [[73, 80, "DISEASE"]]}], ["While classically it has been identified by increased cytokine or chemokine expression, such as increased MCP-1, RANTES, IL-6, interferon (IFN) gamma or TNF\u03b1, mechanistically, immune cell infiltration is a prominent feature of the dysfunctional AT.", {"entities": []}], ["These immune cells include M1 and M2 macrophages, effector and memory T cells, IL-10 producing FoxP3+\u2009T regulatory cells, natural killer and NKT cells and granulocytes.", {"entities": []}], ["Immune composition varies, depending on the stage and the type of pathology.", {"entities": []}], ["Infiltrating immune cells not only produce cytokines but also metalloproteinases, reactive oxygen species, and chemokines that participate in tissue remodelling, cell signalling, and regulation of immunity.", {"entities": []}], ["The presence of inflammatory cells in AT affects adjacent tissues and organs.", {"entities": []}], ["In blood vessels, perivascular AT inflammation leads to vascular remodelling, superoxide production, endothelial dysfunction with loss of nitric oxide (NO) bioavailability, contributing to vascular disease, atherosclerosis, and plaque instability.", {"entities": [[207, 222, "DISEASE"], [189, 205, "DISEASE"]]}], ["Dysfunctional AT also releases adipokines such as leptin, resistin, and visfatin that promote metabolic dysfunction, alter systemic homeostasis, sympathetic outflow, glucose handling, and insulin sensitivity.", {"entities": []}], ["Anti-inflammatory and protective adiponectin is reduced.", {"entities": []}], ["AT may also serve as an important reservoir and possible site of activation in autoimmune-mediated and inflammatory diseases.", {"entities": []}], ["Thus, reciprocal regulation between immune cell infiltration and AT dysfunction is a promising future therapeutic target.", {"entities": []}], ["Nicotine modulates multiple inflammatory responses in the lung through the nicotinic acetylcholine receptor subtype alpha7 (\u03b17).", {"entities": []}], ["Previously we reported that \u03b17 modulates both the hematopoietic and epithelium responses in the lung to the bacterial inflammogen, lipopolysaccharide (LPS).", {"entities": []}], ["Here we apply immunohistochemistry, flow cytometry and RNA-Seq analysis of isolated distal lung epithelium to further define \u03b17-expression and function in this tissue.", {"entities": []}], ["Mouse lines were used that co-express a bicistronic tau-green fluorescent protein (tGFP) as a reporter of \u03b17 (\u03b17", {"entities": []}], ["There is great interest in the identification of genetic factors that differentiate psoriatic arthritis (PsA) from psoriasis vulgaris (PsV), as such discoveries could lead to the identification of distinct underlying aetiological pathways.", {"entities": [[115, 124, "DISEASE"], [94, 103, "DISEASE"], [84, 103, "DISEASE"]]}], ["Recent studies identified single nucleotide polymorphisms (SNPs) in the interleukin 13 ( IL-13 ) gene region as risk factors for PsV.", {"entities": []}], ["Further investigations in one of these studies found the effect to be primarily restricted to PsA, thus suggesting the discovery of a specific genetic risk factor for PsA.", {"entities": []}], ["Given this intriguing evidence, association to this gene was investigated in large collections of PsA and PsV patients and healthy controls.", {"entities": []}], ["Two SNPs (rs20541 and rs1800925) mapping to the IL-13 gene were genotyped in 1057 PsA and 778 type I PsV patients using the Sequenom genotyping platform.", {"entities": []}], ["Genotype frequencies were compared to those of 5575 healthy controls.", {"entities": []}], ["Additional analyses were performed in phenotypic subgroups of PsA (type I or II PsV and in those seronegative for rheumatoid factor).", {"entities": []}], ["Both SNPs were found to be highly associated with susceptibility to PsA (rs1800925 ptrend = 6.1\u00d710 This study confirms that the effect of IL-13 risk locus is specific for PsA, thus highlighting a key biological pathway that differentiates PsA from PsV.", {"entities": []}], ["The identification of markers that differentiate the two diseases raises the possibility in future of allowing screening of PsV patients to identify those at risk of developing PsA.", {"entities": []}], ["The bacteria inhabiting the mammalian gastrointestinal (GI) tract play a vital role in normal digestion and immune function.", {"entities": []}], ["In a healthy host, the immune system is tolerant to gut bacteria and does not mount an effector response to bacteria-derived antigens.", {"entities": []}], ["Loss of tolerance to intestinal microflora has been associated with inflammatory bowel disease (IBD) in both mice and humans.", {"entities": [[68, 94, "DISEASE"]]}], ["Mice lacking Ndfip1, an adaptor protein for E3 ubiquitin ligases of the Nedd4-family, in T cells (Ndfip1-cKO) develop a disease resembling IBD.", {"entities": [[13, 19, "GENE"], [98, 104, "GENE"]]}], ["Inflammation in these mice is characterized by increased activation of peripheral T cells, infiltration of eosinophils into the GI tract, and epithelial hypertrophy in the esophagus.", {"entities": []}], ["We hypothesized that this intestinal inflammation in Ndfip1-cKO mice is caused by a loss of T-cell tolerance to bacterial antigens.", {"entities": []}], ["Here, we show that treatment of Ndfip1-cKO mice with broad-spectrum antibiotics drastically reduced bacterial load in stool but had little effect on T-cell activation and did not affect eosinophil infiltration into the GI tract or epithelial hypertrophy in the esophagus.", {"entities": []}], ["Thus, inflammation in Ndfip1-cKO mice is not caused by a loss of tolerance to intestinal microbiota.", {"entities": []}], ["Rather, T cell activation and eosinophilia may instead be triggered by other environmental antigens.", {"entities": [[30, 42, "DISEASE"]]}], ["Cough is a common symptom for which patients seek medical care and is defined as chronic if it has lasted for more than 8\u00a0weeks.", {"entities": []}], ["The Hull Airway Reflux Questionnaire (HARQ) was developed with the aim of eliciting the major component of chronic cough.", {"entities": []}], ["It comprises 14 items with a maximum total score of 70.", {"entities": []}], ["A Swedish version (HARQ-S) has previously been developed but not yet formally validated.", {"entities": []}], ["The aim of the present study was to validate the HARQ-S in terms of instrumental reliability and concurrent validity.", {"entities": []}], ["A total of 67 consecutively selected non-smoking patients with chronic cough and 91 non-smoking allegedly healthy controls were asked to answer two questionnaires, the HARQ-S and a local questionnaire, at two occasions about 3\u00a0weeks apart.", {"entities": []}], ["The HARQ-S showed good psychometric properties.", {"entities": []}], ["The patients had significantly higher total scores ( p \u00a0<\u00a00.001) compared to the controls, and the questionnaire showed outstanding discrimination ability to distinguish between patients and controls, with an area under the receiver operating characteristic curve of 0.99.", {"entities": []}], ["Fifty patients and 77 controls completed the HARQ-S twice, showing good test\u2013retest agreement in all items as well as in the total scores in both groups, and without any significant differences over time.", {"entities": []}], ["The Swedish version of the HARQ is a valid and reliable questionnaire with good agreement between the two measurements in both patients and controls.", {"entities": []}], ["The HARQ-S has good reliability and validity and can be used as a diagnostic tool in Swedish-speaking patients with chronic cough.", {"entities": []}], ["Recent data suggest that corneal somatosensory dysfunction may be the underlying cause of severe dry eye symptoms in the absence of ocular surface pathology seen in a subset of patients diagnosed with \u201cdry eye syndrome.\u201d This subset of patients tends to demonstrate a unique constellation of symptoms that are persistent, more severe, and generally respond poorly to current dry eye therapies targeting inadequate or dysfunctional tears.", {"entities": [[202, 218, "DISEASE"], [210, 218, "DISEASE"]]}], ["A growing body of literature suggests that symptoms in these patients may be better characterized as neuropathic ocular pain rather than dry eye.", {"entities": []}], ["In these patients, dry eye symptoms are often associated with numerous comorbid pain conditions and evidence of central pain processing abnormalities, where eye pain is just one of multiple overlapping peripheral manifestations.", {"entities": []}], ["In this review, we discuss the concept and potential mechanisms of chronic overlapping pain conditions as well as evidence for considering neuropathic ocular pain as one of these overlapping pain conditions.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is a major but neglected public health problem.", {"entities": []}], ["Currently 1.4% of the England population has a clinical diagnosis of COPD, but the true burden of the disease has not been known with certainty, as many cases remain undiagnosed.", {"entities": []}], ["A mathematical model based on cross sectional data from a representative sample of the population in England (the Heath Survey for England 2001, n = 10,750) was developed allowing estimates on the prevalence of COPD (defined based on the presence of airflow obstruction) to be obtained.", {"entities": []}], ["Logistic regression analysis was used to investigate and choose risk factors for inclusion in the model and to derive the prevalence estimates based on the strength of association between selected risk factors and the outcome COPD.", {"entities": []}], ["The model allows the prevalence to be estimated in populations at national level and also at regional and large local areas, based on their compositions according to age, sex, smoking and ethnicity, and on area degrees of urbanisation and deprivation.", {"entities": []}], ["We applied the model to measure the prevalence of COPD in England and in some sub-groups of the population within the country.", {"entities": []}], ["The prevalence of COPD in England is estimated as 3.1% (3.9% in men and 2.4% in women) in the population over 15 years of age, and 5.3% (6.8% in men and 3.9% in women) in 45 year-olds and over.", {"entities": []}], ["There was a 7-fold variation in the prevalence across subgroups of the population, with lowest values in Asian women from wealthy rural areas (1.7%), and highest in black men from deprived urban areas (12.5%).", {"entities": []}], ["The model can be used to estimate population prevalence of COPD from large general practices to national level, and as a tool to identify areas of high levels of unmet needs for COPD priority health actions.", {"entities": []}], ["The results from the model highlight the importance of including variables other than age, sex and smoking, i.e.", {"entities": []}], ["levels of deprivation, urbanisation and ethnicity, when estimating population prevalence of COPD.", {"entities": []}], ["The model should be validated at local level and incorporated into case-finding strategies.", {"entities": []}], ["Obstructive sleep apnoea is a common and serious breathing problem that is caused by effects of sleep on pharyngeal muscle tone in individuals with narrow upper airways.", {"entities": []}], ["There has been increasing focus on delineating the brain mechanisms that modulate pharyngeal muscle activity in the awake and asleep states in order to understand the pathogenesis of obstructive apnoeas and to develop novel neurochemical treatments.", {"entities": []}], ["Although initial clinical studies have met with only limited success, it is proposed that more rational and realistic approaches may be devised for neurochemical modulation of pharyngeal muscle tone as the relevant neurotransmitters and receptors that are involved in sleep-dependent modulation are identified following basic experiments.", {"entities": []}], ["TRPA1 is a non-selective cation channel involved in pain sensation and neurogenic inflammation.", {"entities": [[0, 5, "GENE"]]}], ["Although TRPA1 is well established in a number of organs including the nervous system, its presence and function in the mammalian cortex remains unclear.", {"entities": [[9, 14, "GENE"]]}], ["Here, we demonstrate the expression of TRPA1 in rodent somatosensory cortex through immunostaining and investigate its functional activation by whole-cell electrophysiology, Ca n = 17) with the maximal effect observed at \u03bb = 720 nm.", {"entities": [[39, 44, "GENE"]]}], ["Involvement of TRPA1 was further confirmed by repeating the experiment in the presence of HC-030031, which diminished the light modulation.", {"entities": [[15, 20, "GENE"]]}], ["These results demonstrate the presence of TRPA1 in L5 pyramidal neurons and introduce a highly specific approach to further understand its functional significance.", {"entities": [[42, 47, "GENE"]]}], ["Improvement of patient quality of life is the ultimate goal of biomedical research, particularly when dealing with complex, chronic and debilitating conditions such as inflammatory bowel disease (IBD).", {"entities": [[168, 194, "DISEASE"]]}], ["This is largely dependent on receiving an accurate and rapid diagnose, an effective treatment and in the prediction and prevention of side effects and complications.", {"entities": []}], ["The low sensitivity and specificity of current markers burden their general use in the clinical practice.", {"entities": []}], ["New biomarkers with accurate predictive ability are needed to achieve a personalized approach that take the inter-individual differences into consideration.", {"entities": []}], ["We performed a high throughput approach using microarray gene expression profiling of colon pinch biopsies from IBD patients to identify predictive transcriptional signatures associated with intestinal inflammation, differential diagnosis (Crohn\u2019s disease or ulcerative colitis), response to glucocorticoids (resistance and dependence) or prognosis (need for surgery).", {"entities": [[259, 277, "DISEASE"]]}], ["Class prediction was performed with self-validating Prophet software package.", {"entities": []}], ["Transcriptional profiling divided patients in two subgroups that associated with degree of inflammation.", {"entities": []}], ["Class predictors were identified with predictive accuracy ranging from 67 to 100%.", {"entities": []}], ["The expression accuracy was confirmed by real time-PCR quantification.", {"entities": []}], ["Functional analysis of the predictor genes showed that they play a role in immune responses to bacteria (PTN, OLFM4 and LILRA2), autophagy and endocytocis processes (ATG16L1, DNAJC6, VPS26B, RABGEF1, ITSN1 and TMEM127) and glucocorticoid receptor degradation (STS and MMD2).", {"entities": [[105, 108, "GENE"], [110, 115, "GENE"], [120, 126, "GENE"], [166, 173, "GENE"], [175, 181, "GENE"], [183, 189, "GENE"], [200, 205, "GENE"], [210, 217, "GENE"], [260, 263, "GENE"], [268, 272, "GENE"]]}], ["We conclude that using analytical algorithms for class prediction discovery can be useful to uncover gene expression profiles and identify classifier genes with potential stratification utility of IBD patients, a major step towards personalized therapy.", {"entities": []}], ["Estimation of between-study heterogeneity is problematic in small meta-analyses.", {"entities": []}], ["Bayesian meta-analysis is beneficial because it allows incorporation of external evidence on heterogeneity.", {"entities": []}], ["To facilitate this, we provide empirical evidence on the likely heterogeneity between studies in meta-analyses relating to specific research settings.", {"entities": []}], ["Our analyses included 6,492 continuous-outcome meta-analyses within the Cochrane Database of Systematic Reviews.", {"entities": []}], ["We investigated the influence of meta-analysis settings on heterogeneity by modeling study data from all meta-analyses on the standardized mean difference scale.", {"entities": []}], ["Meta-analysis setting was described according to outcome type, intervention comparison type, and medical area.", {"entities": []}], ["Predictive distributions for between-study variance expected in future meta-analyses were obtained, which can be used directly as informative priors.", {"entities": []}], ["Among outcome types, heterogeneity was found to be lowest in meta-analyses of obstetric outcomes.", {"entities": []}], ["Among intervention comparison types, heterogeneity was lowest in meta-analyses comparing two pharmacologic interventions.", {"entities": []}], ["Predictive distributions are reported for different settings.", {"entities": []}], ["In two example meta-analyses, incorporating external evidence led to a more precise heterogeneity estimate.", {"entities": []}], ["Heterogeneity was influenced by meta-analysis characteristics.", {"entities": []}], ["Informative priors for between-study variance were derived for each specific setting.", {"entities": []}], ["Our analyses thus assist the incorporation of realistic prior information into meta-analyses including few studies.", {"entities": []}], ["Despite evidence-based guidelines, aspirin prescribing for the secondary prevention of stroke is sub-optimal.", {"entities": []}], ["Little is known about why general practitioners do not prescribe aspirin to indicated patients.", {"entities": []}], ["We sought to identify and describe factors that lead general practitioners (GPs) not to prescribe aspirin to eligible stroke patients.", {"entities": []}], ["This was the first stage of a study exploring the need for and means of improving levels of appropriate aspirin prescribing.", {"entities": []}], ["Qualitative interviews with 15 GPs in the West Midlands.", {"entities": []}], ["Initially, many GPs did not regard their prescribing as difficult or sub-optimal.", {"entities": []}], ["However on reflection, they gave several reasons that lead to them not prescribing aspirin for eligible patients or being uncertain.", {"entities": []}], ["These include: difficulties in applying generic guidelines to individuals presenting in consultations, patient resistance to taking aspirin, the prioritisation of other issues in a time constrained consultation and problems in reviewing the medication of existing stroke patients.", {"entities": []}], ["In order to improve levels of appropriate aspirin prescribing, the nature and presentation risk information available to GPs and patients must be improved.", {"entities": []}], ["GPs need support in assessing the risks and benefits of prescribing for patients with combinations of complicating risk factors, while means of facilitating improved GP-patient dialogue are required to help address patient uncertainty.", {"entities": []}], ["A decision analysis based support system is one option.", {"entities": []}], ["Decision analysis could synthesise current evidence and identify risk data for a range of patient profiles commonly presenting in primary care.", {"entities": []}], ["These data could then be incorporated into a user-friendly computerised decision support system to help facilitate improved GP-patient communication.", {"entities": []}], ["Measures of optimum prescribing based upon aggregated prescribing data must be interpreted with caution.", {"entities": []}], ["It is not possible to assess whether low levels of prescribing reflect appropriate or inappropriate use of aspirin in specific patients where concordance between the GP and the patient is practised.", {"entities": []}], ["In September 2006, the 7-valent pneumococcal conjugate vaccine (PCV7) was added to the UK immunization programme.", {"entities": []}], ["We aimed to evaluate the impact of PCV7 on the incidence of all-cause community-acquired pneumonia (CAP) in children.", {"entities": [[89, 98, "DISEASE"]]}], ["A prospective survey was undertaken in 2008\u20132009 at 11 hospitals in North East England of children aged 0\u201316 years with radiologically confirmed pneumonia.", {"entities": [[145, 154, "DISEASE"]]}], ["Data were compared to those from a similar survey undertaken in the same hospitals in 2001\u20132002.", {"entities": []}], ["A total of 542 children were enrolled, of which 74% were aged <5 years.", {"entities": []}], ["PCV7 uptake was 90\u00b77%.", {"entities": []}], ["The incidence of pneumonia was 11\u00b78/10 000 [95% confidence interval (CI) 10\u00b79\u201312\u00b79], and the hospitalization rate was 9\u00b79/10 000 (95% CI 9\u00b70\u201310\u00b79).", {"entities": [[17, 26, "DISEASE"]]}], ["Compared to 2001, there was a 19% (95% CI 8\u201329) reduction in the rate of CAP in those aged <5 years, and in those <2 years a 33\u00b71% (95% CI 20\u201345) reduction in the incidence of CAP and 38\u00b71% (95% CI 24\u201350) reduction in hospitalization rates.", {"entities": []}], ["However, for those unvaccinated aged \u2a7e5 years, there was no difference in the incidence of CAP and hospitalization rate between both surveys.", {"entities": []}], ["Since 2001, the overall reduction in incidence was 17\u00b77% (95% CI 8\u201326) and for hospitalization 18\u00b75% (95% CI 8\u201328).", {"entities": []}], ["For the <5 years age group there was a lower incidence of CAP in PCV7-vaccinated children (25\u00b72/10 000, 95% CI 22\u00b76\u201328\u00b72) than in those that were not vaccinated (37\u00b74/10 000, 95% CI 29\u00b72\u201347\u00b71).", {"entities": []}], ["In conclusion, PCV7 has reduced both incidence and rate of hospitalization of pneumonia in children, particularly in the <2 years age group.", {"entities": [[78, 87, "DISEASE"]]}], ["Intercellular adhesion molecule 1 (ICAM-1) is one of three immunoglobulin superfamily members that bind to the integrins lymphocyte function associated 1 (LFA-1) and Mac-1 on leukocytes.", {"entities": []}], ["We have generated mice that are genetically and functionally deficient in ICAM-1.", {"entities": []}], ["These mice have elevated numbers of circulating neutrophils and lymphocytes, as well as diminished allogeneic T cell responses and delayed type hypersensitivity.", {"entities": []}], ["Mutant mice are resistant to lethal effects of high doses of endotoxin (lipopolysaccharide [LPS]), and this correlates with a significant decrease in neutrophil infiltration in the liver.", {"entities": []}], ["Production of inflammatory cytokines such as tumor necrosis factor alpha or interleukin 1 is normal in ICAM-1-deficient mice, and thus protection appears to be related to a diminution in critical leukocyte-endothelial interactions.", {"entities": []}], ["After sensitization with D- galactosamine (D-Gal), ICAM-1-deficient mice are resistant to the lethal effect of low doses of exotoxin (Staphylococcus aureus enterotoxin B [SEB]), which has been shown to mediate its toxic effects via the activation of specific T cells.", {"entities": []}], ["In this model, ICAM-1-mediated protection against SEB lethality correlates with a decrease in the systemic release of inflammatory cytokines, as well as with prevention of extensive hepatocyte necrosis and hemorrhage.", {"entities": []}], ["ICAM-1-deficient mice sensitized with D-Gal, however, are not protected from lethality when challenged with low doses of endotoxin (LPS).", {"entities": []}], ["These studies show that the different contribution of ICAM-1 in the activation of either T cells or macrophages is decisive for the fatal outcome of the shock in these two models.", {"entities": []}], ["This work suggests that anti-ICAM-1 therapy may be beneficial in both gram-positive and -negative septic shock, either by reducing T cell activation or by diminishing neutrophil infiltration.", {"entities": []}], ["Influenza vaccination (IV) coverage remains low in France.", {"entities": [[0, 9, "DISEASE"]]}], ["Objectives were to assess patient knowledge and behaviors and missed opportunities for vaccination (MO) and their impact on vaccine uptake.", {"entities": []}], ["This is a prospective-observational study, including emergency department patients at risk for severe influenza.", {"entities": [[102, 111, "DISEASE"]]}], ["Patients were interviewed about their knowledge and behaviors.", {"entities": []}], ["We evaluated the health-care voucher scheme (HCVS) and MO.", {"entities": []}], ["868 patients were included.", {"entities": []}], ["Vaccine uptake was 33.2%, 42% of patients knew about the possible severity of influenza, 23% thought that they were not at risk for severe influenza, 39% knew that they have an indication for the vaccine, and 4.3% to 11.5% expressed reservations concerning IV side effects and effectiveness.", {"entities": [[78, 87, "DISEASE"], [139, 148, "DISEASE"]]}], ["HCVS was used by 44.3% of patients, but only 14.8% had been vaccinated.", {"entities": []}], ["MO were reported by 484 patients (69.4%) declaring 1104 consultations and 148 IV propositions (86.6%).", {"entities": []}], ["Predictors of vaccine uptake (p<0.0001) were: knowledge of serious and fatal influenza forms [OR 0.36 (CI95% 0.25\u20130.5)]; confidence in influenza vaccine effectiveness [0.38 (0.2\u20130.7)]; opposition to vaccines [0.22 (0.1\u20130.48)]; visit to general practitioner [4.53 (2.9\u20137.1)]; general practitioner proposed IV [2.1 (1.2\u20133.4)].", {"entities": [[77, 86, "DISEASE"], [135, 144, "DISEASE"]]}], ["Our results indicate that high rate of missed opportunities, some patient behaviors and general practitioner visits may explain low influenza vaccine uptake, and that HCVS use is a complex process.", {"entities": [[132, 141, "DISEASE"]]}], ["Of interest, we found that the patient\u2019s knowledge of the potential severity of influenza is not sufficient to promote vaccine, suggesting that the information strategy must be adapted to each patient behavior.", {"entities": [[80, 89, "DISEASE"]]}], ["In the United States, national incentives for offering access to electronic personal health records (ePHRs) through electronic means are geared toward creating a culture of patient engagement.", {"entities": []}], ["One group of patients who stand to benefit from online access to ePHRs is the growing population with multiple chronic conditions (MCC).", {"entities": [[131, 134, "GENE"]]}], ["However, little is known about the current availability and use of ePHRs and patient portals among those managing MCC.", {"entities": [[114, 117, "GENE"]]}], ["The aim was to determine the associations between number of chronic conditions and sociodemographic characteristics and usage of ePHRs, and to assess how the public\u2019s use of ePHRs varies across subpopulations, including those with MCC.", {"entities": [[231, 234, "GENE"]]}], ["This study used data collected from the 2014 Health Information National Trends Survey (HINTS), and assessed differences in use of ePHRs between those with and without MCC (N=3497) using multiple logistic regression techniques.", {"entities": [[168, 171, "GENE"]]}], ["Variables associated with health care systems (insurance status, having a regular provider) and patient-reported self-efficacy were included in the statistical models.", {"entities": []}], ["Those with MCC (n=1555) had significantly higher odds of accessing their records three or more times in the past year compared to those reporting no chronic conditions (n=1050; OR 2.46, 95% CI 1.37-4.45), but the overall percentage of those with MCC using ePHRs remained low (371 of 1529 item respondents, 25.63% weighted).", {"entities": [[11, 14, "GENE"], [246, 249, "GENE"], [11, 14, "GENE"], [246, 249, "GENE"]]}], ["No difference in odds of accessing their records was found between those reporting one chronic condition (n=892) and those reporting none (n=1050; OR 1.02, 95% CI 0.66-1.58).", {"entities": []}], ["Significant differences in odds of accessing ePHRs were seen between income and age groups ( P <.001 and P =.05, respectively), and by whether respondents had a regular provider ( P =.03).", {"entities": []}], ["We conclude that ePHRs provide a unique opportunity to enhance MCC patient self-management, but additional effort is needed to ensure that these patients are able to access their ePHRs.", {"entities": [[63, 66, "GENE"]]}], ["An increase in availability of patient access to their ePHRs may provide an opportunity to increase patient engagement and support self-management for all patients and especially those with MCC.", {"entities": [[190, 193, "GENE"]]}], ["General practice based registration networks (GPRNs) provide information on morbidity rates in the population.", {"entities": []}], ["Morbidity rate estimates from different GPRNs, however, reveal considerable, unexplained differences.", {"entities": []}], ["We studied the range and variation in morbidity estimates, as well as the extent to which the differences in morbidity rates between general practices and networks change if socio-demographic characteristics of the listed patient populations are taken into account.", {"entities": []}], ["The variation in incidence and prevalence rates of thirteen diseases among six Dutch GPRNs and the influence of age, gender, socio economic status (SES), urbanization level, and ethnicity are analyzed using multilevel logistic regression analysis.", {"entities": []}], ["Results are expressed in median odds ratios (MOR).", {"entities": []}], ["We observed large differences in morbidity rate estimates both on the level of general practices as on the level of networks.", {"entities": []}], ["The differences in SES, urbanization level and ethnicity distribution among the networks' practice populations are substantial.", {"entities": []}], ["The variation in morbidity rate estimates among networks did not decrease after adjusting for these socio-demographic characteristics.", {"entities": []}], ["Socio-demographic characteristics of populations do not explain the differences in morbidity estimations among GPRNs.", {"entities": []}], ["Interleukin-28A (IL-28A) modulates CD11c+ dendritic cell (DC) function and promotes type 1T helper (Th1) differentiation, thus suppressing allergic airway diseases.", {"entities": []}], ["However, the function of the IL-28A isoform IL-28B in these diseases remains largely unknown.", {"entities": []}], ["In this study, we revealed a novel role of IL-28B in inducing type 1 immunity and protecting against ovalbumin (OVA)-induced allergic asthma in mice.", {"entities": [[125, 140, "DISEASE"], [134, 140, "DISEASE"]]}], ["IL-28B overexpression in wild-type mice promoted natural killer (NK) cell polarization in the lung, leading to the increased number of interferon (IFN)-\u03b3-producing NK1 cells as well as Th1 differentiation.", {"entities": []}], ["Importantly, IL-28B overexpression had no protective effect on OVA-induced asthma in IFN-\u03b3-knockout (IFN-\u03b3\u2212/\u2212) mice.", {"entities": [[75, 81, "DISEASE"]]}], ["These results demonstrate that IL-28B ameliorates experimental allergic asthma via enhancing NK cell polarization, which might be useful for prevention and treatment of allergic asthma.", {"entities": [[63, 78, "DISEASE"], [169, 184, "DISEASE"], [72, 78, "DISEASE"], [178, 184, "DISEASE"]]}], ["Basic trainees in the US military have historically been vulnerable to respiratory infections.", {"entities": []}], ["Adenovirus and influenza are the most common etiological agents responsible for febrile respiratory illness (FRI) among trainees and present with similar clinical signs and symptoms.", {"entities": [[15, 24, "DISEASE"]]}], ["Identifying demographic and clinical factors associated with the primary viral pathogens causing FRI epidemics among trainees will help improve differential diagnosis and allow for appropriate distribution of antiviral medications.", {"entities": []}], ["The objective of this study was to determine what demographic and clinical factors are associated with influenza and adenovirus among military trainees.", {"entities": [[103, 112, "DISEASE"]]}], ["Specimens were systematically collected from military trainees meeting FRI case definition (fever \u226538.0\u00b0C with either cough or sore throat; or provider-diagnosed pneumonia) at eight basic training centers in the USA.", {"entities": [[162, 171, "DISEASE"]]}], ["PCR and/or cell culture testing for respiratory pathogens were performed on specimens.", {"entities": []}], ["Interviewer-administered questionnaires collected information on patient demographic and clinical factors.", {"entities": []}], ["Polychotomous logistic regression was employed to assess the association between these factors and FRI outcome categories: laboratory-confirmed adenovirus, influenza, or other FRI.", {"entities": [[156, 165, "DISEASE"]]}], ["Sensitivity, specificity, positive and negative predictive value were calculated for individual predictors and clinical combinations of predictors.", {"entities": []}], ["Among 21,570 FRI cases sampled between 2004 and 2009, 63.6% were laboratory-confirmed adenovirus cases and 6.6% were laboratory-confirmed influenza cases.", {"entities": [[138, 147, "DISEASE"]]}], ["Subjects were predominantly young men (86.8% men; mean age 20.8 \u00b1 3.8 years) from Fort Jackson (18.8%), Great Lakes (17.1%), Fort Leonard Wood (16.3%), Marine Corps Recruit Depot (MCRD) San Diego (19.0%), Fort Benning (13.3%), Lackland (7.5%), MCRD Parris Island (8.7%), and Cape May (3.2%).", {"entities": []}], ["The best multivariate predictors of adenovirus were the combination of sore throat (odds ratio [OR], 2.94; 95% confidence interval [CI], 2.66-3.25), cough (OR, 2.33; 95% CI, 2.11-2.57), and fever (OR, 2.07; 95% CI, 1.90-2.26) with a PPV of 77% (p \u2264.05).", {"entities": []}], ["A combination of cough, fever, training week 0-2 and acute onset were most predictive of influenza (PPV =38%; p \u2264 .05).", {"entities": [[89, 98, "DISEASE"]]}], ["Specific demographic and clinical factors were associated with laboratory-confirmed influenza and adenovirus among military trainees.", {"entities": [[84, 93, "DISEASE"]]}], ["Findings from this study can guide clinicians in the diagnosis and treatment of military trainees presenting with FRI.", {"entities": []}], ["The online version of this article (doi:10.1186/s12879-014-0576-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Pediatric anaphylaxis is commonly misdiagnosed in the Emergency Department (ED).", {"entities": []}], ["We aimed to determine the impact of inaccurate diagnosis on the management and follow-up of pediatric anaphylaxis presenting to the ED.", {"entities": []}], ["Retrospective chart review of ED management of children aged 0\u201318\u00a0years with allergic presentations to three EDs in Melbourne, Australia in 2014.", {"entities": []}], ["Cases were included if an ED diagnosis of anaphylaxis was recorded, or the presentation met international consensus criteria for anaphylaxis.", {"entities": []}], ["Of the 60,143 pediatric ED presentations during the study period, 1551 allergy-related presentations were identified and reviewed.", {"entities": []}], ["187 met consensus criteria for anaphylaxis, and another 24 were diagnosed with anaphylaxis without meeting criteria.", {"entities": []}], ["Of the 211 presentations, 105 cases were given an ED diagnosis of anaphylaxis and 106 cases were given an alternative diagnosis in ED.", {"entities": []}], ["Those diagnosed with anaphylaxis were more likely to receive epinephrine [85.7% vs 31.1% (OR\u2009=\u200913.27, 95% CI: 6.09\u201326.3)], to be observed for the recommended four hours [56.2% vs 29.2% (OR\u2009=\u20093.10, 95% CI 1.76\u20135.48, p \u2009<\u20090.001)], to have an epinephrine autoinjector available on discharge [81.9% vs 35.8% (OR\u2009=\u20094.12, 95% CI 2.07\u20138.22, p \u2009<\u20090.001)] and to be referred to an allergist [35.2% vs 16.0% (OR\u2009=\u20092.85, 95% CI 1.48\u20135.49, p \u2009<\u20090.01)].", {"entities": []}], ["Provision of anaphylaxis action plans and allergen avoidance advice was poorly documented for all patients.", {"entities": []}], ["Accurate diagnosis of anaphylaxis in ED has a significant impact on observation times, prescription of epinephrine autoinjectors and referral to an allergist.", {"entities": []}], ["These factors are key to reducing mortality and the significant morbidity that results from childhood anaphylaxis.", {"entities": []}], ["The online version of this article (10.1186/s12887-018-1024-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Irritable Bowel Syndrome (IBS) is a hidden public health disease that affects up to 20% of the general population.", {"entities": [[0, 24, "DISEASE"], [16, 24, "DISEASE"]]}], ["Although co-morbidity can affect diagnose setting and treatment of the disease, there are few studies concerning diagnosed and registered co-morbidity for IBS patients in primary care.", {"entities": []}], ["The aim of this study was to analyse co-morbidity among IBS-patients compared to age- and sex-matched controls from the general population using data from a county-wide computerized medical record system.", {"entities": []}], ["IBS cases were recruited from three Swedish primary health care centres during a five-years period and controls from the same corresponding geographical areas.", {"entities": []}], ["Co-morbidity data for IBS-patients and morbidity data for controls were derived from a population-based Health Care Register (HCR) covering all diagnoses in primary as well as hospital care in the region.", {"entities": [[126, 129, "GENE"]]}], ["Odds Ratios with 95% confidence intervals for morbidity in gastro-intestinal and non-gastrointestinal diagnoses for cases with irritable bowel syndrome compared to controls were calculated separately for each gender and diagnosis.", {"entities": [[127, 151, "DISEASE"], [143, 151, "DISEASE"]]}], ["We identified more co-morbidity among IBS patients of both sexes, compared to matched controls in the general population.", {"entities": []}], ["Patients with IBS were particularly more worried about having a serious disease than their control group.", {"entities": []}], ["The risk among male IBS-cases to get this latter diagnose was three times higher compared to the male controls.", {"entities": []}], ["In this population based case\u2013control study, the analysis of diagnoses from the HCR revealed a broad spectrum of common co-morbidity and significantly more physician-recorded diagnoses among IBS-patients in comparisons to the control group.", {"entities": [[80, 83, "GENE"]]}], ["Chronic inflammation of the airways is a central component in lung diseases and is frequently associated with bacterial infections.", {"entities": []}], ["Monitoring the pro-inflammatory capability of bacterial virulence factors in vivo is challenging and usually requires invasive methods.", {"entities": []}], ["Lung inflammation was induced using the culture supernatants from two Pseudomonas aeruginosa clinical strains, VR1 and VR2, isolated from patients affected by cystic fibrosis and showing different phenotypes in terms of motility, colony characteristics and biofilm production as well as pyoverdine and pyocyanine release.", {"entities": [[159, 174, "DISEASE"]]}], ["More interesting, the strains differ also for the presence in supernatants of metalloproteases, a family of virulence factors with known pro-inflammatory activity.", {"entities": []}], ["We have evaluated the benefit of using a mouse model, transiently expressing the luciferase reporter gene under the control of an heterologous IL-8 bovine promoter, to detect and monitoring lung inflammation.", {"entities": []}], ["In vivo imaging indicated that VR1 strain, releasing in its culture supernatant metalloproteases and other virulence factors, induced lung inflammation while the VR2 strain presented with a severely reduced pro-inflammatory activity.", {"entities": []}], ["The bioluminescence signal was detectable from 4 to 48\u00a0h after supernatant instillation.", {"entities": []}], ["The animal model was also used to test the anti-inflammatory activity of azithromycin (AZM), an antibiotic with demonstrated inhibitory effect on the synthesis of bacterial exoproducts.", {"entities": []}], ["The inflammation signal in mice was in fact significantly reduced when bacteria grew in the presence of a sub-lethal dose of AZM causing inhibition of the synthesis of metalloproteases and other bacterial elements.", {"entities": []}], ["The in vivo data were further supported by quantification of immune cells and cytokine expression in mouse broncho-alveolar lavage samples.", {"entities": []}], ["This experimental animal model is based on the transient transduction of the bovine IL-8 promoter, a gene representing a major player during inflammation, essential for leukocytes recruitment to the inflamed tissue.", {"entities": []}], ["It appears to be an appropriate molecular read-out for monitoring the activation of inflammatory pathways caused by bacterial virulence factors.", {"entities": []}], ["The data presented indicate that the model is suitable to functionally monitor in real time the lung inflammatory response facilitating the identification of bacterial factors with pro-inflammatory activity and the evaluation of the anti-inflammatory activity of old and new molecules for therapeutic use.", {"entities": []}], ["To test adding an interactive voice response (IVR)-supported protocol to standard quitline treatment to prevent relapse among recently quit smokers.", {"entities": []}], ["Parallel randomised controlled trial with three arms: standard quitline, standard plus technology enhanced quitline with 10 risk assessments (TEQ-10), standard plus 20 TEQ assessments (TEQ-20).", {"entities": []}], ["Quit For Life (QFL) programme.", {"entities": []}], ["1785 QFL enrolees through 19 employers or health plans who were 24+ h quit.", {"entities": []}], ["QFL is a 5-call telephone-based cessation programme including medications and web-based support.", {"entities": []}], ["TEQ interventions included 10 or 20 IVR-delivered relapse risk assessments over 8\u2005weeks with automated transfer to counselling for those at risk.", {"entities": []}], ["Self-reported 7-day and 30-day abstinence assessed at 6-month and 12-month post-enrolment (response rates: 61% and 59%, respectively).", {"entities": []}], ["Missing data were imputed.", {"entities": []}], ["1785 were randomised (standard n=592, TEQ-10 n=602, TEQ-20 n=591).", {"entities": []}], ["Multiple imputation-derived, intent-to-treat 30-day quit rates (95% CI) at 6\u2005months were 59.4% (53.7% to 63.8%) for standard, 62.3% (57.7% to 66.9%) for TEQ-10, 59.4% (53.7% to 65.1%) for TEQ-20 and 30-day quit rates at 12\u2005months were 61.2% (55.6% to 66.8%) for standard, 60.6% (56.0% to 65.2%) for TEQ-10, 54.9% (49.0% to 60.9%) for TEQ-20.", {"entities": []}], ["There were no significant differences in quit rates.", {"entities": []}], ["73.3% of TEQ participants were identified as at-risk by IVR assessments; on average, participants completed 0.41 IVR-transferred counselling calls.", {"entities": []}], ["Positive risk assessments identified participants less likely (OR=0.56, 95% CI 0.42 to 0.76) to be abstinent at 6\u2005months.", {"entities": []}], ["Standard treatment was highly effective, with 61% remaining abstinent at 12\u2005months using multiple imputation intent-to-treat (intent-to-treat missing=smoking quit rate: 38%).", {"entities": []}], ["TEQ assessments identified quitters at risk for relapse.", {"entities": []}], ["However, adding IVR-transferred counselling did not yield higher quit rates.", {"entities": []}], ["Research is needed to determine if alternative designs can improve outcomes.", {"entities": []}], ["NCT00888992.", {"entities": []}], ["We have shown previously that Chlamydophila pneumoniae contains a dual-specific Ser/Thr protein kinase that phosphorylates CdsD, a structural component of the type III secretion apparatus.", {"entities": []}], ["To further study the role of PknD in growth and development we sought to identify a PknD inhibitor to determine whether PknD activity is required for replication.", {"entities": []}], ["Using an in vitro kinase assay we screened 80 known eukaryotic protein kinase inhibitors for activity against PknD and identified a 3'-pyridyl oxindole compound that inhibited PknD autophosphorylation and phosphorylation of CdsD.", {"entities": []}], ["The PknD inhibitor significantly retarded the growth rate of C. pneumoniae as evidenced by the presence of very small inclusions with a reduced number of bacteria as seen by electron microscopy.", {"entities": []}], ["These inclusions contained the normal replicative forms including elementary bodies (EB), intermediate bodies (IB) and reticulate bodies (RB), but lacked persistent bodies (PB), indicating that induction of persistence was not the cause of reduced chlamydial growth.", {"entities": []}], ["Blind passage of C. pneumoniae grown in the presence of this PknD inhibitor for 72 or 84 hr failed to produce inclusions, suggesting this compound blocks an essential step in the production of infectious chlamydial EB.", {"entities": [[89, 91, "GENE"]]}], ["The compound was not toxic to HeLa cells, did not block activation of the MEK/ERK pathway required for chlamydial invasion and did not block intracellular replication of either Chlamydia trachomatis serovar D or Salmonella enterica sv.", {"entities": []}], ["Typhimurium suggesting that the inhibitory effect of the compound is specific for C. pneumoniae .", {"entities": []}], ["We have identified a 3'-pyridyl oxindole compound that inhibits the in vitro kinase activity of C. pneumoniae PknD and inhibits the growth and production of infectious C. pneumoniae progeny in HeLa cells.", {"entities": []}], ["Together, these results suggest that PknD may play a key role in the developmental cycle of C. pneumoniae .", {"entities": []}], ["The purpose of this study was to detect the differentially expressed genes between ossified herniated discs and herniated discs without ossification.", {"entities": []}], ["In addition, we sought to identify a few candidate genes and pathways by using bioinformatics analysis.", {"entities": []}], ["We analyzed 6 samples each of ossified herniated discs (experimental group) and herniated discs without ossification (control group).", {"entities": []}], ["Purified mRNA and cDNA extracted from the samples were subjected to sequencing.", {"entities": []}], ["The NOISeq method was used to statistically identify the differentially expressed genes (DEGs) between the 2 groups.", {"entities": []}], ["An in-depth analysis using bioinformatics tools based on the DEGs was performed using Gene Ontology (GO) enrichment, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment, and protein-protein interaction network analysis.", {"entities": []}], ["The top 6 DEGs were verified using reverse transcription-quantitative polymerase chain reaction (RT-qPCR).", {"entities": []}], ["A total of 132 DEGs was detected.", {"entities": []}], ["A total of 129 genes in the ossified group were upregulated and 3 genes were found to be downregulated as compared to the control group.", {"entities": []}], ["The top 3 cellular components in GO ontologies analysis were extracellular matrix components.", {"entities": []}], ["GO functions were mainly related to the glycoprotein in the cell membrane and extracellular matrix.", {"entities": []}], ["The GO process was related to completing response to stimulus, immune reflex and defense.", {"entities": []}], ["The top 5 KEGG enrichment pathways were associated with infection and inflammation.", {"entities": []}], ["Three of the top 20 DEGs [sclerostin (SOST), WNT inhibitory factor 1 (WIF1) and secreted frizzled related protein 4 (SFRP4)] were related to the inhibition of the Wnt pathway.", {"entities": [[38, 42, "GENE"], [70, 74, "GENE"], [117, 122, "GENE"]]}], ["The ossified discs exhibited a higher expression of the top 6 DEGs [SOST, joining chain of multimeric IgA and IgM (IGJ; also known as JCHAIN), defensin alpha 4 (DEFA4), SFRP4, proteinase 3 (PRTN3) and cathepsin G (CTSG)], with the associated P-values of 0.045, 0.000, 0.008, 0.010, 0.015 and 0.002, respectively, as calculated by the independent sample t-test.", {"entities": [[68, 72, "GENE"], [115, 118, "GENE"], [161, 166, "GENE"], [169, 174, "GENE"], [190, 195, "GENE"], [214, 218, "GENE"]]}], ["The gene expression profiling of the 2 groups revealed differential gene expression.", {"entities": []}], ["Thus, our data suggest that Wnt pathway abnormality and local inflammation may be related to disc ossification.", {"entities": []}], ["The internet has had a strong impact on how physicians access information and on the development of continuing medical education activities.", {"entities": []}], ["Evaluation of the effectiveness of these activities has lagged behind their development.", {"entities": []}], ["To determine the effectiveness of a group of 48 internet continuing medical education (CME) activities, case vignette surveys were administered to US physicians immediately following participation, and to a representative control group of non-participant physicians.", {"entities": []}], ["Responses to case vignettes were analyzed based on evidence presented in the content of CME activities.", {"entities": []}], ["An effect size for each activity was calculated using Cohen's d to determine the amount of difference between the two groups in the likelihood of making evidence-based clinical decisions, expressed as the percentage of non-overlap, between the two groups.", {"entities": []}], ["Two formats were compared.", {"entities": []}], ["In a sample of 5621 US physicians, of the more than 100,000 physicians who participated in 48 internet CME activities, the average effect size was 0.75, an increased likelihood of 45% that participants were making choices in response to clinical case vignettes based on clinical evidence.", {"entities": []}], ["This likelihood was higher in interactive case-based activities, 51% (effect size 0.89), than for text-based clinical updates, 40% (effect size 0.63).", {"entities": []}], ["Effectiveness was also higher among primary care physicians than specialists.", {"entities": []}], ["Physicians who participated in selected internet CME activities were more likely to make evidence-based clinical choices than non-participants in response to clinical case vignettes.", {"entities": []}], ["Internet CME activities show promise in offering a searchable, credible, available on-demand, high-impact source of CME for physicians.", {"entities": []}], ["Viral bronchiolitis is the leading cause of hospitalization in young infants.", {"entities": [[6, 19, "DISEASE"]]}], ["It is associated with the development of childhood asthma and contributes to morbidity and mortality in the elderly.", {"entities": [[51, 57, "DISEASE"]]}], ["Currently no therapies effectively attenuate inflammation during the acute viral infection, or prevent the risk of post-viral asthma.", {"entities": [[126, 132, "DISEASE"]]}], ["We hypothesized that early treatment of a paramyxoviral bronchiolitis with azithromycin would attenuate acute and chronic airway inflammation.", {"entities": [[56, 69, "DISEASE"]]}], ["Mice were inoculated with parainfluenza type 1, Sendai Virus (SeV), and treated daily with PBS or azithromycin for 7 days post-inoculation.", {"entities": []}], ["On day 8 and 21 we assessed airway inflammation in lung tissue, and quantified immune cells and inflammatory mediators in bronchoalveolar lavage (BAL).", {"entities": []}], ["Compared to treatment with PBS, azithromycin significantly attenuated post-viral weight loss.", {"entities": []}], ["During the peak of acute inflammation (day 8), azithromycin decreased total leukocyte accumulation in the lung tissue and BAL, with the largest fold-reduction in BAL neutrophils.", {"entities": []}], ["This decreased inflammation was independent of changes in viral load.", {"entities": []}], ["Azithromycin significantly attenuated the concentration of BAL inflammatory mediators and enhanced resolution of chronic airway inflammation evident by decreased BAL inflammatory mediators on day 21.", {"entities": []}], ["In this mouse model of paramyxoviral bronchiolitis, azithromycin attenuated acute and chronic airway inflammation.", {"entities": [[37, 50, "DISEASE"]]}], ["These findings demonstrate anti-inflammatory effects of azithromycin that are not related to anti-viral activity.", {"entities": []}], ["Our findings support the rationale for future prospective randomized clinical trials that will evaluate the effects of macrolides on acute viral bronchiolitis and their long-term consequences.", {"entities": [[145, 158, "DISEASE"]]}], ["\u2018Treatment burden\u2019, defined as both the workload and impact of treatment regimens on function and well-being, has been associated with poor adherence and unfavourable outcomes.", {"entities": []}], ["Previous research focused on treatment workload but our understanding of treatment impact is limited.", {"entities": []}], ["This research aimed to systematically review qualitative research to identify: 1) what are the treatment generated disruptions experienced by patients across all chronic conditions and treatments?", {"entities": []}], ["2) what strategies do patients employ to minimise these treatment generated disruptions?", {"entities": []}], ["The search strategy centred on: treatment burden and qualitative methods.", {"entities": []}], ["Medline, CINAHL, Embase, and PsychINFO were searched electronically from inception to Dec 2013.", {"entities": []}], ["No language limitations were set.", {"entities": []}], ["Teams of two reviewers independently conducted paper screening, data extraction, and data analysis.", {"entities": []}], ["Data were analysed using framework synthesis informed by Cumulative Complexity Model.", {"entities": []}], ["Eleven papers reporting data from 294 patients, across a range of conditions, age groups and nationalities were included.", {"entities": []}], ["Treatment burdens were experienced as a series of disruptions: biographical disruptions involved loss of freedom and independence, restriction of meaningful activities, negative emotions and stigma; relational disruptions included strained family and social relationships and feeling isolated; and, biological disruptions involved physical side-effects.", {"entities": []}], ["Patients employed \u201cadaptive treatment work\u201d and \u201crationalised non-adherence\u201d to minimise treatment disruptions.", {"entities": []}], ["Rationalised non-adherence was sanctioned by health professionals at end of life; at other times it was a \u201csecret-act\u201d which generated feelings of guilt and impacted on family and clinical relationships.", {"entities": []}], ["Treatments generate negative emotions and physical side effects, strain relationships and affect identity.", {"entities": []}], ["Patients minimise these disruptions through additional adaptive work and/or by non-adherence.", {"entities": []}], ["This affects physical outcomes and care relationships.", {"entities": []}], ["There is a need for clinicians to engage with patients in honest conversations about treatment disruptions and the \u2018adhere-ability\u2019 of recommended regimens.", {"entities": []}], ["Patient-centred practice requires management plans which optimise outcomes and minimise disruptions.", {"entities": []}], ["Little evidence is available on the strength of the association between ambient air pollution exposure and health effects in developing countries such as South Africa.", {"entities": []}], ["The association between the 24-h average ambient PM 10 , SO 2 and NO 2 levels and daily respiratory (RD), cardiovascular (CVD) and cerebrovascular (CBD) mortality in Cape Town (2001\u20132006) was investigated with a case-crossover design.", {"entities": [[101, 103, "GENE"]]}], ["For models that included entire year data, an inter-quartile range (IQR) increase in PM 10 (12 mg/m 2 (12 mg/m 2 and SO 2 (8 mg/m 10 was significantly associated with RD and CVD mortality.", {"entities": [[167, 169, "GENE"]]}], ["NO 2 had significant associations with CBD, RD and CVD mortality, whilst SO 2 was associated with CVD mortality.", {"entities": [[44, 46, "GENE"]]}], ["None of the pollutants were associated with any of the three outcomes in the cold period.", {"entities": []}], ["Susceptible groups depended on the cause-specific mortality and air pollutant.", {"entities": []}], ["There is significant RD, CVD and CBD mortality risk associated with ambient air pollution exposure in South Africa, higher than reported in developed countries.", {"entities": [[21, 23, "GENE"]]}], ["Biomass smoke is an important source of particulate matter (PM), and much remains to be discovered with respect to the human health effects associated with this specific PM source.", {"entities": []}], ["Exposure to biomass smoke can occur in one of two main categories: short-term exposures consist of periodic, seasonal exposures typified by communities near forest fires or intentional agricultural burning, and long-term exposures are chronic and typified by the use of biomass materials for cooking or heating.", {"entities": []}], ["Levoglucosan (LG), a sugar anhydride released by combustion of cellulose-containing materials, is an attractive candidate as a biomarker of wood smoke exposure.", {"entities": []}], ["In the present study, Balb/c mice and children were assessed for LG in urine to determine its feasibility as a biomarker.", {"entities": []}], ["We performed urinary detection of LG by gas chromatography/mass spectrometry after intranasal instillations of LG or concentrated PM (mice) or biomass exposure (mice or humans).", {"entities": []}], ["After instillation, we recovered most of the LG within the first 4 hr.", {"entities": [[67, 69, "GENE"]]}], ["Experiments using glucose instillation proved the specificity of our system, and instillation of concentrated PM from wood smoke, ambient air, and diesel exhaust supported a connection between wood smoke and LG.", {"entities": []}], ["In addition, LG was detected in the urine of mice exposed to wood smoke.", {"entities": []}], ["Finally, a pilot human study proved our ability to detect LG in urine of children.", {"entities": []}], ["These results demonstrate that LG in the lungs is detectable in the urine of both mice and humans and that it is a good candidate as a biomarker of exposure to biomass smoke.", {"entities": []}], ["Airway hyper-reactivity is a characteristic feature of many inflammatory lung diseases and is defined as an exaggerated degree of airway narrowing.", {"entities": []}], ["Chemokines and their receptors are involved in several pathological processes that are believed to contribute to airway hyper-responsiveness, including recruitment and activation of inflammatory cells, collagen deposition and airway wall remodeling.", {"entities": []}], ["These proteins are therefore thought to represent important therapeutic targets in the treatment of airway hyper-responsiveness.", {"entities": []}], ["This review highlights the processes thought to be involved in airway hyper-responsiveness in allergic asthma, and the role of chemokines in these processes.", {"entities": [[94, 109, "DISEASE"], [103, 109, "DISEASE"]]}], ["Overall, the application of chemokines to the prevention or treatment of airway hyper-reactivity has tremendous potential.", {"entities": []}], ["The number of people with multiple chronic conditions receiving primary care services is growing.", {"entities": []}], ["To deal with their increasingly complex health care demands, professionals from different disciplines need to collaborate.", {"entities": []}], ["Interprofessional team (IPT) meetings are becoming more popular.", {"entities": []}], ["Several studies describe important factors related to conducting IPT meetings, mostly from a professional perspective.", {"entities": []}], ["However, in the light of patient-centeredness, it is valuable to also explore the patients\u2019 perspective.", {"entities": []}], ["The aim was to explore the patients\u2019 perspectives regarding IPT meetings in primary care.", {"entities": []}], ["A qualitative study with a focus group design was conducted in the Netherlands.", {"entities": []}], ["Two focus group meetings took place, for which the same patients were invited.", {"entities": []}], ["The participants, chronically ill patients with experience on interprofessional collaboration, were recruited through the regional patient association.", {"entities": []}], ["Participants discussed viewpoints, expectations, and concerns regarding IPT meetings in two rounds, using a focus group protocol and selected video-taped vignettes of team meetings.", {"entities": []}], ["The first meeting focused on conceptualization and identification of themes related to IPT meetings that are important to patients.", {"entities": []}], ["The second meeting aimed to gain more in-depth knowledge and understanding of the priorities.", {"entities": []}], ["Discussions were audio-taped and transcribed verbatim, and analyzed by means of content analysis.", {"entities": []}], ["The focus group meetings included seven patients.", {"entities": []}], ["Findings were divided into six key categories, capturing the factors that patients found important regarding IPT meetings: (1) putting the patient at the center, (2) opportunities for patients to participate, (3) appropriate team composition, (4) structured approach, (5) respectful communication, and (6) informing the patient about meeting outcomes.", {"entities": []}], ["Patients identified different elements regarding IPT meetings that are important from their perspective.", {"entities": []}], ["They emphasized the right of patients or their representatives to take part in IPT meetings.", {"entities": []}], ["Results of this study can be used to develop tools and programs to improve interprofessional collaboration.", {"entities": []}], ["The online version of this article (doi:10.1007/s40271-017-0214-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Circadian rhythms are known to regulate immune responses in healthy animals, but it is unclear whether they persist during acute illnesses where clock gene expression is disrupted by systemic inflammation.", {"entities": []}], ["Here, we use a genome-wide approach to investigate circadian gene and metabolite expression in the lungs of endotoxemic mice and find that novel cellular and molecular circadian rhythms are elicited in this setting.", {"entities": []}], ["The endotoxin-specific circadian program exhibits unique features, including a divergent group of rhythmic genes and metabolites compared to the basal state and a distinct periodicity and phase distribution.", {"entities": []}], ["At the cellular level endotoxin treatment also alters circadian rhythms of leukocyte counts within the lung in a bmal1 -dependent manner, such that granulocytes rather than lymphocytes become the dominant oscillating cell type.", {"entities": []}], ["Our results show that inflammation produces a complex reorganization of cellular and molecular circadian rhythms that are relevant to early events in lung injury.", {"entities": []}], ["Consistent evidence is accumulating to link lower socioeconomic position (SEP) and poorer health, and the inflammatory system stands out as a potential pathway through which socioeconomic environment is biologically embedded.", {"entities": []}], ["Using bloodderived genome-wide transcriptional profiles from 268 Italian participants of the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, we evaluated the association between early life, young and later adulthood SEP and the expression of 845 genes involved in human inflammatory responses.", {"entities": []}], ["These were examined individually and jointly using several inflammatory scores.", {"entities": []}], ["Our results consistently show that participants whose father had a manual (as compared to nonmanual) occupation exhibit, later in life, a higher inflammatory score, hence indicating an overall increased level of expression for the selected inflammatory-related genes.", {"entities": []}], ["Adopting a life course approach, these associations remained statistically significant upon adjustment for later-in-life socioeconomic experiences.", {"entities": []}], ["Sensitivity analyses indicated that our findings were not affected by the way the inflammatory score was calculated, and were replicated in an independent study.", {"entities": []}], ["Our study provides additional evidence that childhood SEP is associated with a sustainable upregulation of the inflammatory transcriptome, independently of subsequent socioeconomic experiences.", {"entities": []}], ["Our results support the hypothesis that early social inequalities impacts adult physiology.", {"entities": []}], ["Astrocytes, the major glial cell population of the central nervous system (CNS), play important physiological roles related to CNS homeostasis.", {"entities": []}], ["Growing evidence demonstrates that astrocytes trigger innate immune responses under challenge of a variety of proinflammatory cytokines.", {"entities": []}], ["Macrophage migration inhibitory factor (MIF), a proinflammatory cytokine mainly secreted from monocytes/macrophages, is involved in inflammation-associated pathophysiology.", {"entities": [[40, 43, "GENE"]]}], ["Here, we displayed that expression of MIF significantly increased following spinal cord injury, in colocalization with microglia and astrocytes.", {"entities": [[38, 41, "GENE"]]}], ["MIF elicited inflammatory responses of astrocytes via activation of CD74 receptor and extracellular signal-related kinase (ERK) pathway.", {"entities": [[0, 3, "GENE"], [68, 72, "GENE"]]}], ["Transcriptome analysis revealed that inflammation-related factors cholesterol 25-hydroxylase (Ch25h) and phospholipase A2-IIA (Pla2g2a), downstream of MIF/CD74 axis, were potentially implicated in the mediating inflammatory response of astrocytes.", {"entities": [[94, 99, "GENE"], [127, 134, "GENE"]]}], ["Our results provided a new target for interference of CNS inflammation after insults.", {"entities": []}], ["Cigarette smoking is the major cause of chronic obstructive pulmonary disease (COPD) and lung cancer.", {"entities": [[89, 100, "DISEASE"], [40, 77, "DISEASE"], [94, 100, "DISEASE"]]}], ["Respiratory bacterial infections have been shown to be involved in the development of COPD along with impaired airway innate immunity.", {"entities": []}], ["To address the in vivo impact of cigarette smoke (CS) exclusively on host innate defense mechanisms, we took advantage of Caenorhabditis elegans ( C. elegans ), which has an innate immune system but lacks adaptive immune function.", {"entities": [[50, 52, "GENE"]]}], ["Pseudomonas aeruginosa (PA) clearance from intestines of C. elegans was dampened by CS.", {"entities": [[84, 86, "GENE"]]}], ["Microarray analysis identified 6 candidate genes with a 2-fold or greater reduction after CS exposure, that have a human orthologue, and that may participate in innate immunity.", {"entities": [[90, 92, "GENE"]]}], ["To confirm a role of CS-down-regulated genes in the innate immune response to PA, RNA interference (RNAi) by feeding was carried out in C. elegans to inhibit the gene of interest, followed by PA infection to determine if the gene affected innate immunity.", {"entities": []}], ["Inhibition of lbp-7 , which encodes a lipid binding protein, resulted in increased levels of intestinal PA. Primary human bronchial epithelial cells were shown to express mRNA of human Fatty Acid Binding Protein 5 (FABP-5), the human orthologue of lpb-7 .", {"entities": []}], ["Interestingly, FABP-5 mRNA levels from human smokers with COPD were significantly lower (p\u200a=\u200a0.036) than those from smokers without COPD.", {"entities": []}], ["Furthermore, FABP-5 mRNA levels were up-regulated (7-fold) after bacterial (i.e., Mycoplasma pneumoniae ) infection in primary human bronchial epithelial cell culture (air-liquid interface culture).", {"entities": []}], ["Our results suggest that the C. elegans model offers a novel in vivo approach to specifically study innate immune deficiencies resulting from exposure to cigarette smoke, and that results from the nematode may provide insight into human airway epithelial cell biology and cigarette smoke exposure.", {"entities": []}], ["In the context of population aging, visual impairment has emerged as a growing concern in public health.", {"entities": []}], ["However, there is a need for further research into the relationship between visual impairment and chronic medical conditions in the elderly.", {"entities": []}], ["The aim of our study was to examine the relationship between visual impairment and three main types of co-morbidity: chronic physical conditions (both at an independent and additive level), mental health and cognitive functioning.", {"entities": []}], ["Data were collected from the COURAGE in Europe project, a cross-sectional study.", {"entities": []}], ["A total of 4,583 participants from Spain were included.", {"entities": []}], ["Diagnosis of chronic medical conditions included self-reported medical diagnosis and symptomatic algorithms.", {"entities": []}], ["Depression and anxiety were assessed using CIDI algorithms.", {"entities": []}], ["Visual assessment included objective distance/near visual acuity and subjective visual performance.", {"entities": []}], ["Descriptive analyses included the whole sample (n\u2009=\u20094,583).", {"entities": []}], ["Statistical analyses included participants aged over 50\u00a0years (n\u2009=\u20093,625; mean age\u2009=\u200966.45\u00a0years) since they have a significant prevalence of chronic conditions and visual impairment.", {"entities": []}], ["Crude and adjusted binary logistic regressions were performed to identify independent associations between visual impairment and chronic medical conditions, physical multimorbidity and mental conditions.", {"entities": []}], ["Covariates included age, gender, marital status, education level, employment status and urbanicity.", {"entities": []}], ["The number of chronic physical conditions was found to be associated with poorer results in both distance and near visual acuity [OR 1.75 (CI 1.38-2.23); OR 1.69 (CI 1.27-2.24)].", {"entities": []}], ["At an independent level, arthritis, stroke and diabetes were associated with poorer distance visual acuity results after adjusting for covariates [OR 1.79 (CI 1.46-2.21); OR 1.59 (CI 1.05-2.42); OR 1.27 (1.01-1.60)].", {"entities": [[25, 34, "DISEASE"]]}], ["Only stroke was associated with near visual impairment [OR 3.01 (CI 1.86-4.87)].", {"entities": []}], ["With regard to mental health, poor subjective visual acuity was associated with depression [OR 1.61 (CI 1.14-2.27); OR 1.48 (CI 1.03-2.13)].", {"entities": []}], ["Both objective and subjective poor distance and near visual acuity were associated with worse cognitive functioning.", {"entities": []}], ["Arthritis, stroke and the co-occurrence of various chronic physical diseases are associated with higher prevalence of visual impairment.", {"entities": [[0, 9, "DISEASE"]]}], ["Visual impairment is associated with higher prevalence of depression and poorer cognitive function results.", {"entities": []}], ["There is a need to implement patient-centered care involving special visual assessment in these cases.", {"entities": []}], ["Translocation of ultrafine particles (UFP) into the blood that returns from the lungs to the heart has been forwarded as a mechanism for particle-induced cardiovascular effects.", {"entities": []}], ["The objective of this study was to evaluate the role of the endothelial barrier in the translocation of inhaled UFP from the lung into circulation.", {"entities": []}], ["The isolated perfused rat lung (IPRL) was used under negative pressure ventilation, and radioactive iridium particles (18 nm, CMD, 2 O 2 .", {"entities": []}], ["Particle translocation to the perfusate was assessed by the radioactivity of Particle distribution in the lung was homogenous and similar to in vivo conditions.", {"entities": []}], ["No translocation of Ir particles at negative pressure inhalation was detected in control IPL, but lungs pretreated with histamine (1 \u03bcM) in the perfusate or with luminal H 2 O 2 (0.5 mM) showed small amounts of radioactivity (2\u20133 % dose) in the single pass perfusate starting at 60 min of perfusion.", {"entities": []}], ["Although the kinetics of particle translocation were different from permeability for 2 O 2 , vascular histamine) caused similar changes in the translocation of particles and soluble mediator.", {"entities": []}], ["Increased translocation through epithelium and endothelium with a lag time of one hour occurred in the absence of epithelial and endothelial damage.", {"entities": []}], ["Permeability of the lung barrier to UFP or nanoparticles is controlled both at the epithelial and endothelial level.", {"entities": []}], ["Conditions that affect this barrier function such as inflammation may affect translocation of NP.", {"entities": []}], ["We now know that depression is associated with a chronic, low-grade inflammatory response and activation of cell-mediated immunity, as well as activation of the compensatory anti-inflammatory reflex system.", {"entities": []}], ["It is similarly accompanied by increased oxidative and nitrosative stress (O&NS), which contribute to neuroprogression in the disorder.", {"entities": []}], ["The obvious question this poses is \u2018what is the source of this chronic low-grade inflammation?\u2019 This review explores the role of inflammation and oxidative and nitrosative stress as possible mediators of known environmental risk factors in depression, and discusses potential implications of these findings.", {"entities": []}], ["A range of factors appear to increase the risk for the development of depression, and seem to be associated with systemic inflammation; these include psychosocial stressors, poor diet, physical inactivity, obesity, smoking, altered gut permeability, atopy, dental cares, sleep and vitamin D deficiency.", {"entities": [[206, 213, "DISEASE"]]}], ["The identification of known sources of inflammation provides support for inflammation as a mediating pathway to both risk and neuroprogression in depression.", {"entities": []}], ["Critically, most of these factors are plastic, and potentially amenable to therapeutic and preventative interventions.", {"entities": []}], ["Most, but not all, of the above mentioned sources of inflammation may play a role in other psychiatric disorders, such as bipolar disorder, schizophrenia, autism and post-traumatic stress disorder.", {"entities": [[140, 153, "DISEASE"], [166, 196, "DISEASE"], [122, 138, "DISEASE"]]}], ["Leptospirosis is a worldwide zoonotic and recognized neglected infectious disease.", {"entities": [[0, 13, "DISEASE"]]}], ["It has been observed that only a proportion of individuals exposed to pathogenic species of Leptospira become infected and develop clinically evident disease.", {"entities": []}], ["Moreover, little information is available in subsequent reinfections.", {"entities": []}], ["In the present study, we determine if a first infection with leptospirosis protects against subsequent reinfection, and investigate which of the host genetic factors are involved in the susceptibility and resistance to leptospirosis.", {"entities": [[61, 74, "DISEASE"], [219, 232, "DISEASE"]]}], ["We conducted, in 2011, a retrospective hospital-based case-control study in the S\u00e3o Miguel Island population (Azores archipelago).", {"entities": []}], ["In order to determine the seropositivity against pathogenic Leptospira after the first episode of leptospirosis, we performed a serological evaluation in 97 unrelated participants diagnosed with leptospirosis between 1992 and 2011.", {"entities": [[98, 111, "DISEASE"], [195, 208, "DISEASE"]]}], ["The results revealed that 46.4% of the 97 participants have circulating anti- Leptospira antibodies, and from these participants 35.6% maintained the seroprevalence for the same serogroup.", {"entities": []}], ["Moreover, three of them were reinfected with unrelated Leptospira serovars.", {"entities": []}], ["The genetic study was carried out by adding a control group composed of 470 unrelated healthy blood donors, also from S\u00e3o Miguel Island.", {"entities": []}], ["Twenty five SNPs among twelve innate immune genes \u2013 IL1\u03b1 , IL1\u03b2 , IL6 , IL10 , IL12RB1 , TLR2 , TLR4 , TLR9 , CD14, CISH, LTA and TNF \u2013 were genotyped, as well as HLA class I (\u2013 A and \u2013 B ) genes.", {"entities": [[66, 69, "GENE"], [72, 76, "GENE"], [79, 86, "GENE"], [89, 93, "GENE"], [96, 100, "GENE"], [103, 107, "GENE"], [110, 114, "GENE"], [116, 120, "GENE"], [122, 125, "GENE"], [130, 133, "GENE"], [163, 166, "GENE"]]}], ["Association analysis indicates that genotypes -511GG (OR\u200a=\u200a1.6, 95%CI 1.01-2.56, p\u200a=\u200a0.04) in IL1\u03b2 , +1196CG (OR\u200a=\u200a2.0, 95%CI 1.26-3.27, p\u200a=\u200a0.003) in IL12RB1 , -292TA (OR\u200a=\u200a1.8, 95% CI 1.06\u20132.1, p\u200a=\u200a0.03) and +3415CG (OR\u200a=\u200a1.8, 95% CI 1.08\u20133.08, p\u200a=\u200a0.02), both in CISH confer susceptibility to pathogenic Leptospira .", {"entities": [[151, 158, "GENE"], [266, 270, "GENE"]]}], ["The present study suggests some degree of long-term protection against leptospires with an attenuation of symptoms in case of reinfection.", {"entities": []}], ["Moreover, our data supports the genetic influence of IL1\u03b2 , IL12RB1 and CISH genes and the susceptibility to leptospirosis infection.", {"entities": [[109, 122, "DISEASE"], [60, 67, "GENE"], [72, 76, "GENE"]]}], ["This study aimed to investigate groups of patients with a relatively homogenous health status to evaluate the degree to which use of the Australian hospital system is affected by socio-economic status, locational accessibility to services and patient payment classification.", {"entities": []}], ["Records of all deaths occurring in Western Australia from 1997 to 2000 inclusive were extracted from the WA mortality register and linked to records from the hospital morbidity data system (HMDS) via the WA Data Linkage System.", {"entities": []}], ["Adjusted incidence rate ratios of hospitalisation in the last, second and third years prior to death were modelled separately for five underlying causes of death.", {"entities": []}], ["The independent effects of socioeconomic status on hospital utilisation differed markedly across cause of death.", {"entities": []}], ["Locational accessibility was generally not an independent predictor of utilisation except in those dying from ischaemic heart disease and lung cancer.", {"entities": [[138, 149, "DISEASE"], [120, 133, "DISEASE"], [143, 149, "DISEASE"]]}], ["Private patient status did not globally affect utilisation across all causes of death, but was associated with significantly decreased utilisation three years prior to death for those who died of colorectal, lung or breast cancer, and increased utilisation in the last year of life in those who died of colorectal cancer or cerebrovascular disease.", {"entities": [[324, 347, "DISEASE"], [303, 320, "DISEASE"], [216, 229, "DISEASE"], [223, 229, "DISEASE"], [314, 320, "DISEASE"]]}], ["It appears that the Australian hospital system may not be equitable since equal need did not equate to equal utilisation.", {"entities": []}], ["Further it would appear that horizontal equity, as measured by equal utilisation for equal need, varies by disease.", {"entities": []}], ["This implies that a 'one-size-fits-all' approach to further improvements in equity may be over simplistic.", {"entities": []}], ["Thus initiatives beyond Medicare should be devised and evaluated in relation to specific areas of service provision.", {"entities": []}], ["Please cite this paper as: Neumann G, Kawaoka Y.", {"entities": []}], ["(2011) The first influenza pandemic of the new millennium.", {"entities": [[17, 26, "DISEASE"]]}], ["Influenza and Other Respiratory Viruses DOI: 10.1111/j.1750\u20102659.2011.00202.x.", {"entities": [[0, 9, "DISEASE"]]}], ["In the spring of 2009, a novel influenza A virus of the H1N1 subtype emerged that transmitted efficiently among humans; by June of 2009, the outbreak reached pandemic status.", {"entities": [[31, 40, "DISEASE"]]}], ["The pandemic virus possesses six viral RNA segments from so\u2010called triple reassortant swine viruses that emerged in North American pig populations in the late 1990s and two viral RNA segments from Eurasian avian\u2010like swine influenza viruses.", {"entities": [[217, 232, "DISEASE"], [223, 232, "DISEASE"]]}], ["Most human infections with the virus have been mild; however, severe and fatal infections occurred among certain risk groups, but also among those without any known risk factors.", {"entities": []}], ["Here, we summarize the evolutionary, epidemiological, clinical, and molecular findings on the pandemic virus.", {"entities": []}], ["We also discuss the arsenal of antiviral compounds and vaccines available to prevent and treat infections with the virus.", {"entities": []}], ["The promoter region of human Interleukin \u221210 gene is highly polymorphic and has been associated with numerous autoimmune diseases.", {"entities": []}], ["Recent studies have linked vitiligo with defective autoimmune system.", {"entities": [[27, 35, "DISEASE"]]}], ["This study is aimed to explore a possible association between IL-10 gene polymorphism and vitiligo in Saudi population.", {"entities": [[90, 98, "DISEASE"]]}], ["This case control study consisted of 184 Saudi subjects including 83 vitiligo patients (40 males, 43 females mean age 27.85 \u00b1 12.43 years) and 101 matched controls.", {"entities": [[69, 77, "DISEASE"]]}], ["Genomic DNA was extracted from the blood samples of healthy controls and Vitiligo patients visiting out patient clinic of Department of Dermatology, Riyadh Armed Forces Hospital, using QIA amp The frequencies of GG genotype at \u22121082, and CC genotype at positions \u2212592 and 819 were significantly higher in vitiligo patients compared to healthy subjects suggesting that GG and CC genotypes might be susceptible to vitiligo in Saudis.", {"entities": [[73, 81, "DISEASE"], [305, 313, "DISEASE"], [412, 420, "DISEASE"]]}], ["On the other hand genotypes \u22121082 GA, \u2212819 CT, and \u2212592 CA of IL-10 were more prevalent in healthy controls suggesting protective effects of GA, CT and CA genotypes against vitiligo.", {"entities": [[173, 181, "DISEASE"]]}], ["This study indicates that the IL-10 gene may play a significant role in the etiology of vitiligo among Saudis.", {"entities": [[88, 96, "DISEASE"]]}], ["To verify whether and to what extent the body mass index, airflow obstruction, dyspnea, and exercise capacity (BODE) index correlates with a disease-specific index of health status in patients with COPD.", {"entities": []}], ["Cross-sectional study.", {"entities": []}], ["University-affiliated hospital.", {"entities": []}], ["One hundred patients with stable COPD recruited from the outpatient clinic of a single institution.", {"entities": []}], ["The BODE index was calculated for each patient using variables obtained within 2 weeks of enrollment.", {"entities": []}], ["At enrollment, all patients completed the St George\u2019s Respiratory Questionnaire (SGRQ).", {"entities": []}], ["The Kruskal-Wallis test was used to compare health status scores with clinical and functional categories of COPD.", {"entities": []}], ["The Spearman correlation coefficient (r) was calculated to assess the association between health status scores and clinical or functional variables.", {"entities": []}], ["Categorizing the BODE scores into 4 quartiles, we found that higher BODE quartiles were associated with higher (worse) SGRQ scores.", {"entities": []}], ["The differences among the BODE quartiles in health status indexes were significant for total SGRQ as well as all 3 of the SGRQ sub-scales.", {"entities": []}], ["In all sections of the SGRQ, scores were moderately to strongly associated with the BODE quartiles (r = 0.27\u20130.46).", {"entities": []}], ["In contrast, the association between the SGRQ total, impacts, activity and Global Initiative for Chronic Obstructive Lung Disease (GOLD) stages were weaker (r = 0.27\u20130.28).", {"entities": []}], ["There was no significant association between SGRQ symptoms and GOLD stages.", {"entities": []}], ["The BODE scoring system corresponds to important differences in health status of patients with COPD.", {"entities": []}], ["This grading system is better correlated to the health status indexes of the SGRQ than the GOLD staging criteria.", {"entities": []}], ["Background: Green spaces have been associated with both health benefits and risks in children; however, available evidence simultaneously investigating these conflicting influences, especially in association with different types of greenness, is scarce.", {"entities": []}], ["Objectives: We aimed to simultaneously evaluate health benefits and risks associated with different types of greenness in children, in terms of sedentary behavior (represented by excessive screen time), obesity, current asthma, and allergic rhinoconjunctivitis.", {"entities": [[203, 210, "DISEASE"], [220, 226, "DISEASE"]]}], ["Methods: We conducted a cross-sectional study of a population-based sample of 3,178 schoolchildren (9\u201312 years old) in Sabadell, Spain, in 2006.", {"entities": []}], ["Information on outcomes and covariates was obtained by questionnaire.", {"entities": []}], ["We measured residential surrounding greenness as the average of satellite-derived Normalized Difference Vegetation Index (NDVI) in buffers of 100 m, 250 m, 500 m, and 1,000 m around each home address.", {"entities": []}], ["Residential proximity to green spaces was defined as living within 300 m of a forest or a park, as separate variables.", {"entities": []}], ["We used logistic regression models to estimate associations separately for each exposure\u2013outcome pair, adjusted for relevant covariates.", {"entities": []}], ["Results: An interquartile range increase in residential surrounding greenness was associated with 11\u201319% lower relative prevalence of overweight/obesity and excessive screen time, but was not associated with current asthma and allergic rhinoconjunctivitis.", {"entities": [[145, 152, "DISEASE"], [216, 222, "DISEASE"]]}], ["Similarly, residential proximity to forests was associated with 39% and 25% lower relative prevalence of excessive screen time and overweight/obesity, respectively, but was not associated with current asthma.", {"entities": [[142, 149, "DISEASE"], [201, 207, "DISEASE"]]}], ["In contrast, living close to parks was associated with a 60% higher relative prevalence of current asthma, but had only weak negative associations with obesity/overweight or excessive screen time.", {"entities": [[152, 159, "DISEASE"], [99, 105, "DISEASE"]]}], ["Conclusion: We observed two separable patterns of estimated health benefits and risks associated with different types of greenness.", {"entities": []}], ["Citation: Dadvand P, Villanueva CM, Font-Ribera L, Martinez D, Basaga\u00f1a X, Belmonte J, Vrijheid M, Gra\u017eulevi\u010dien\u0117 R, Kogevinas M, Nieuwenhuijsen MJ.", {"entities": []}], ["Risks and benefits of green spaces for children: a cross-sectional study of associations with sedentary behavior, obesity, asthma, and allergy.", {"entities": [[114, 121, "DISEASE"], [123, 129, "DISEASE"]]}], ["Environ Health Perspect 122:1329\u20131335;\u2002 http://dx.doi.org/10.1289/ehp.1308038", {"entities": []}], ["Objective To determine whether supported self management in chronic obstructive pulmonary disease (COPD) can reduce hospital readmissions in the United Kingdom.", {"entities": [[60, 97, "DISEASE"]]}], ["Design Randomised controlled trial.", {"entities": []}], ["Setting Community based intervention in the west of Scotland.", {"entities": []}], ["Participants Patients admitted to hospital with acute exacerbation of COPD.", {"entities": []}], ["Intervention Participants in the intervention group were trained to detect and treat exacerbations promptly, with ongoing support for 12 months.", {"entities": []}], ["Main outcome measures The primary outcome was hospital readmissions and deaths due to COPD assessed by record linkage of Scottish Morbidity Records; health related quality of life measures were secondary outcomes.", {"entities": []}], ["Results 464 patients were randomised, stratified by age, sex, per cent predicted forced expiratory volume in 1 second, recent pulmonary rehabilitation attendance, smoking status, deprivation category of area of residence, and previous COPD admissions.", {"entities": []}], ["No difference was found in COPD admissions or death (111/232 (48%) v 108/232 (47%); hazard ratio 1.05, 95% confidence interval 0.80 to 1.38).", {"entities": []}], ["Return of health related quality of life questionnaires was poor (n=265; 57%), so that no useful conclusions could be made from these data.", {"entities": []}], ["Pre-planned subgroup analysis showed no differential benefit in the primary outcome relating to disease severity or demographic variables.", {"entities": []}], ["In an exploratory analysis, 42% (75/150) of patients in the intervention group were classified as successful self managers at study exit, from review of appropriateness of use of self management therapy.", {"entities": []}], ["Predictors of successful self management on stepwise regression were younger age (P=0.012) and living with others (P=0.010).", {"entities": []}], ["COPD readmissions/deaths were reduced in successful self managers compared with unsuccessful self managers (20/75 (27%) v 51/105 (49%); hazard ratio 0.44, 0.25 to 0.76; P=0.003).", {"entities": []}], ["Conclusion Supported self management had no effect on time to first readmission or death with COPD.", {"entities": []}], ["Exploratory subgroup analysis identified a minority of participants who learnt to self manage; this group had a significantly reduced risk of COPD readmission, were younger, and were more likely to be living with others.", {"entities": []}], ["Trial registration Clinical trials NCT 00706303.", {"entities": []}], ["Tinospora crispa (TC) has been used in folkloric medicine for the treatment of various diseases and has been reported for several pharmacological activities.", {"entities": []}], ["However, the effects of TC extract on the immune system are largely unknown.", {"entities": []}], ["Therefore, the present study was aimed to investigate the immunomodulatory effects of a standardized 80% ethanol extract of the stem of TC on innate immune responses.", {"entities": []}], ["Male Wistar Kyoto rats were treated daily at 100 mg/kg, 200 mg/kg, and 400 mg/kg doses of the extract for 21 days by oral gavage.", {"entities": []}], ["The immunomodulatory potential of TC was evaluated by determining its effect on chemotaxis and phagocytic activity of neutrophils isolated from the blood of rats.", {"entities": []}], ["To further elucidate the mechanism of action, its effects on the proliferation of T- and B-lymphocytes and T-lymphocytes subsets (CD4+ and CD8+) and on the secretion of Th1 and Th2 cytokines were also monitored.", {"entities": []}], ["The main components of the extracts, syringin and magnoflorine, were identified and quantitatively analyzed in the extracts by using a validated reversed-phase high-performance liquid chromatography method.", {"entities": []}], ["It was observed that the chemotactic activity of neutrophils obtained from extract-treated rats increased as compared to controls.", {"entities": []}], ["A dose-dependent increase in the number of migrated cells and phagocytosis activity of neutrophils was observed.", {"entities": []}], ["Dose-dependent increase was also observed in the T- and B-lymphocytes proliferation stimulated with concanavalin A (5 \u03bcg/mL) and lipopolysaccharide (10 \u03bcg/mL), and was statistically significant at 400 mg/kg ( P >0.01).", {"entities": []}], ["Apart from cell-mediated immune response, the concentrations of Th1 (TNF-\u03b1, IL-2, and IFN-\u03b3) and Th2 (IL-4) cytokines were significantly increased in sera of rats treated with different doses as compared with the control group.", {"entities": []}], ["From these findings, it can be concluded that TC possesses immunostimulatory activity and has therapeutic potential for the prevention of immune diseases.", {"entities": []}], ["Both gravitational loading and the forces generated by muscle contraction have direct effects on serum markers of bone metabolism.", {"entities": []}], ["The object of this study was to examine the direct effects of a single session of resistance exercise or walking on biochemical markers of bone metabolism in participants with low bone mass.", {"entities": []}], ["A total of 150 otherwise healthy female subjects (mean age\u2009=\u200959.1\u2009\u00b1\u20097.1\u00a0years) diagnosed with osteoporosis or osteopenia were randomly allocated to either a resistance exercise group (RG; n \u2009=\u200950), walking group (WG; n \u2009=\u200950), or control group (CG; n \u2009=\u200950).", {"entities": [[94, 106, "DISEASE"]]}], ["Changes in bone-specific alkaline phosphatase (BALP), carboxy-terminal cross-linked telopeptide of type I collagen (CTX), and serum sclerostin concentrations were measured before and immediately after a single exercise intervention.", {"entities": []}], ["There was no significant change in BALP values in any of the groups.", {"entities": []}], ["Sclerostin levels increased in the RG and WG, and there was significant difference between the WG and CG after the exercise intervention ( P \u2009<\u20090.01).", {"entities": []}], ["In contrast, the changes in CTX concentrations from baseline were significant in the RG ( P \u2009<\u20090.01) but not in the WG ( P \u2009=\u20090.11), and there was a significant difference between resistance exercise and walking ( P \u2009<\u20090.01).", {"entities": []}], ["In participants with low bone mass, resistance exercise influenced the serum concentrations of CTX, a marker of bone resorption, but walking did not.", {"entities": []}], ["Current Controlled Trials ISRCTN16329455 ; retrospectively registered on 05/05/2016.", {"entities": []}], ["Studies in animals have shown that a wide range of airborne particulates including cigarette smoke, acid aerosols, metals, organic compounds, and combustion products can interfere with the normal defense processes of the lung to enhance susceptibility to respiratory infection or exacerbate allergic diseases.", {"entities": []}], ["Such detrimental effects are less easy to quantify in humans because of the difficulties in obtaining comprehensive exposure history and health status in large populations and because of the inherent dangers of inducing disease in clinical studies.", {"entities": []}], ["In this article we describe examples of how air pollutants affect lung disease in experimental animal systems.", {"entities": [[66, 78, "DISEASE"]]}], ["This information can be used to predict the health risk of simple and complex exposures and to lend insight into the mechanisms of air pollution toxicity.", {"entities": []}], ["Pulmonary metastasis presenting as lymphangitic carcinomatosis arising from squamous cell carcinoma (SCC) of the cervix is a rare event.", {"entities": [[90, 99, "DISEASE"], [76, 99, "DISEASE"]]}], ["Poorly represented in the literature, this event is associated with a) difficulty in accurate diagnosis, b) grave prognosis, and the c) lack of recognized predisposing risk factors.", {"entities": []}], ["A 50 year-old female presented at our practice with a three-month history of a productive cough associated with dyspnoea and shortness of breath.", {"entities": []}], ["A chest x-ray and computed tomography (CT) scan revealed multiple bilateral patchy areas with subsegmental atelectasis in both lungs which was investigated with a bronchoscopy, left thoracoscopy, and a left lung biopsy.", {"entities": []}], ["Pathological examination of the wedge biopsy of the left upper lobe revealed neoplastic sheets of cell disturbed along the septal vessels, perivascular/peribronchial lymphatics, and the subpleural lymphatics.", {"entities": []}], ["This lymphangitic carcinomatosis was confirmed to be metastatic from SCC of the cervix that had been diagnosed and treated two years ago.", {"entities": []}], ["She was treated with systemic Carbo/Taxol chemotherapy and corticosteroids as a palliative measure.", {"entities": []}], ["Despite temporary improvement, she died 13 months later.", {"entities": []}], ["Pulmonary lymphangitic carcinomatosis is a rare manifestation of metastatic SCC of the cervix.", {"entities": []}], ["As clinical presentations including radiographic imaging mimics other pulmonary entities, accurate diagnosis remains a challenge.", {"entities": []}], ["Increased clinical awareness of such patterns of metastases in cervical cancer supported by accurate pathological diagnosis is imperative to guide appropriate therapy in these patients.", {"entities": [[72, 78, "DISEASE"], [63, 78, "DISEASE"]]}], ["The effect of total exemption from medical service co-payments on drug prescribing practices has not been extensively evaluated.", {"entities": []}], ["We conducted a retrospective cross-sectional study to evaluate the effect of total exemption from medical service co-payments on potentially inappropriate medication (PIM) and benzodiazepine use in elderly ambulatory patients.", {"entities": []}], ["We defined PIM based on the Beers Criteria.", {"entities": []}], ["Six hundred seventy-one consecutive patients aged 65\u00a0years or older who routinely visited internal medicine physicians were included.", {"entities": []}], ["Their mean age was 75.7\u00a0years, and 342 (51.0%) patients were men.", {"entities": []}], ["The proportions of patients taking any PIMs or benzodiazepines were 37.7% and 16.2%, respectively.", {"entities": []}], ["Of all patients, 62 (9.2%) were totally exempt from medical service co-payments.", {"entities": []}], ["The patients who were totally exempt from medical service co-payments showed a significantly increased risk of PIM (OR 2.16, 95% CI 1.28\u20133.66) or benzodiazepine use (OR 2.12, 95% CI 1.16\u20133.87) compared with patients who were not.", {"entities": []}], ["These associations did not change after adjusting for age, gender, comorbidities and polypharmacy.", {"entities": []}], ["These findings should be confirmed in other settings or hospitals in Japan.", {"entities": []}], ["The online version of this article (10.1186/s13104-018-3320-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The increasing number of multidrug-resistant Plasmodium strains warrants exploration of new anti-malarials.", {"entities": []}], ["Medicinal plant research has become more important, particularly after the development of Chinese anti-malarial drug artemisnin from Artemisia annua .", {"entities": []}], ["The present study shows evaluation of anti-malarial effects of two plants commonly used against malaria in the Garhwal region of north-west Himalaya, in order to discover the herbal-based medicine.", {"entities": [[96, 103, "DISEASE"]]}], ["In vitro anti-plasmodial sensitivity of plant extracts was assessed using schizont maturation and parasite lactate dehydrogenase (pLDH) assay.", {"entities": []}], ["Cytotoxic activities of the examined extracts were determined on L-6 cells of rat skeletal muscle myoblast.", {"entities": []}], ["The 4-day test for anti-malarial activity against a chloroquine sensitive Plasmodium berghei NK65 strain in Swiss albino mice was used for monitoring in vivo activity of plant extracts.", {"entities": []}], ["Chloroform extract of H. antidysenterica (HA-2) and petroleum ether extract of V. canescens (VC-1) plants significantly reduced parasitaemia in P. berghei infected mice.", {"entities": []}], ["The extract HA-2 showed in vitro anti-plasmodial activity with its IC 50 value 5.5 \u03bcg/ml using pLDH assay and ED 50 value 18.29 mg/kg in P. berghei infected Swiss albino mice.", {"entities": []}], ["Similarly petroleum ether extract of V. canescens (VC-1) showed in vitro anti-plasmodial activity with its IC 50 value 2.76 \u03bcg/ml using pLDH assay and ED 50 15.8 mg/kg in P. berghei infected mice.", {"entities": []}], ["The extracts coded as HA-2 at 30 mg/kg and VC-1 at 20 mg/kg exhibited parasite inhibition in mice: 73.2% and 63.0% respectively.", {"entities": []}], ["Of these two plant extracts, petroleum ether extract of V. canescens was found slightly cytotoxic.", {"entities": []}], ["The present investigation reflects the use of these traditional medicinal plants against malaria and these plants may work as potential source in the development of variety of herbal formulations for the treatment of malaria.", {"entities": [[89, 96, "DISEASE"], [217, 224, "DISEASE"]]}], ["Thunderclap headache attributed to reversible cerebral vasoconstriction (THARCV) is a syndrome observed in a number of reported cases.", {"entities": [[86, 94, "DISEASE"]]}], ["In this article we reviewed this new headache entity (idiopathic form) using the clinical-radiological findings of 25 reported patients.", {"entities": []}], ["In this series of patients 72% were women, the mean age at the onset of first headache episode was 39.4\u00a0\u00b1\u00a02.3\u00a0years.", {"entities": []}], ["In addition to the sine qua non condition of being abrupt and severe (thunderclap) at the onset, the headache was usually described as being explosive, excruciating, or crushing.", {"entities": []}], ["The feature of pulsatility, accompanied or not by nausea was described by 80% of the patients.", {"entities": []}], ["Forty percent of the cases manifested vomiting and 24% photophobia.", {"entities": []}], ["Usually the headache was generalized, and in three cases it was unilateral at least at the onset.", {"entities": []}], ["In 21 of 25 patients (84%) there was at least one recurrence or a sudden increase in the intensity of the headache.", {"entities": []}], ["A past history of migraine was present in 52% of the patients.", {"entities": [[18, 26, "DISEASE"]]}], ["Precipitating factors were identified in 56% of the patients.", {"entities": []}], ["Sexual intercourse was described by six patients.", {"entities": []}], ["Of the 25 patients with THARCV syndrome studied, 12 (48%) developed focal neurological signs, transitory ischemic attack ( n \u00a0=\u00a01), or ischemic stroke ( n \u00a0=\u00a011, 44%), and two (8%) of them manifested seizures.", {"entities": [[31, 39, "DISEASE"]]}], ["The THARCV syndrome is a neurological disturbance perhaps more frequent than expected, preferentially affecting middle aged female migraineurs, and having an unpredictable prognosis, either showing a benign course or leading to stroke.", {"entities": [[11, 19, "DISEASE"]]}], ["Personal health records (PHRs) are an important tool for empowering patients and stimulating health action.", {"entities": []}], ["To date, the volitional adoption of publicly available PHRs by consumers has been low.", {"entities": []}], ["This may be partly due to patient concerns about issues such as data security, accuracy of the clinical information stored in the PHR, and challenges with keeping the information updated.", {"entities": []}], ["One potential solution to mitigate concerns about security, accuracy, and updating of information that may accelerate technology adoption is the provision of PHRs by employers where the PHR is pre-populated with patients\u2019 health data.", {"entities": []}], ["Increasingly, employers and payers are offering this technology to employees as a mechanism for greater patient engagement in health and well-being.", {"entities": []}], ["Little is known about the antecedents of PHR acceptance in the context of an employer sponsored PHR system.", {"entities": []}], ["Using social cognitive theory as a lens, we theorized and empirically tested how individual factors (patient activation and provider satisfaction) and two environment factors (technology and organization) influence patient intentions to use a PHR among early adopters of the technology.", {"entities": []}], ["In technology factors, we studied tool empowerment potential and value of tool functionality.", {"entities": []}], ["In organization factors, we focused on communication tactics deployed by the organization during PHR rollout.", {"entities": []}], ["We conducted cross-sectional analysis of field data collected during the first 3 months post go-live of the deployment of a PHR with secure messaging implemented by the Air Force Medical Service at Elmendorf Air Force Base in Alaska in December 2010.", {"entities": []}], ["A questionnaire with validated measures was designed and completed by 283 participants.", {"entities": []}], ["The research model was estimated using moderated multiple regression.", {"entities": []}], ["Provider satisfaction, interactions between environmental factors (communication tactics and value of the tool functionality), and interactions between patient activation and tool empowerment potential were significantly ( P <.05) associated with behavioral intentions to use the PHR tool.", {"entities": []}], ["The independent variables collectively explained 42% of the variance in behavioral intentions.", {"entities": []}], ["The study demonstrated that individual and environmental factors influence intentions to use the PHR.", {"entities": []}], ["Patients who were more satisfied with their provider had higher use intentions.", {"entities": []}], ["For patients who perceived the health care process management support features of the tool to be of significant value, communication tactics served to increase their use intentions.", {"entities": []}], ["Finally, patients who believed the tool to be empowering demonstrated higher intentions to use, which were further enhanced for highly activated patients.", {"entities": []}], ["The findings highlight the importance of communication tactics and technology characteristics and have implications for the management of PHR implementations.", {"entities": []}], ["Dendritic cells (DC) are able to present extracellular antigens associated with the molecules of the major histocompatibility complex class I.", {"entities": []}], ["In a previous work, we demonstrated that the histamine (HIS), acting through H1/H4 receptors, increases the cross-presentation of soluble ovalbumin by murine DC and can enhance the recruitment of specific CD8 q subunit, which involves PKC signaling, a pathway related to the apoptotic process.", {"entities": []}], ["Interestingly, we demonstrated for the first time that HIS prevents DC apoptosis induced by heat shock through the inhibition of caspase-3, a mechanism dependent on PKC activation, since it is reversed by its inhibition.", {"entities": []}], ["By contrast, cytolytic activity of T lymphocytes induced by HIS-stimulated DC was independent of PKC pathway.", {"entities": []}], ["Lymphoblastoid cell lines (LCLs), originally collected as renewable sources of DNA, are now being used as a model system to study genotype\u2013phenotype relationships in human cells, including searches for QTLs influencing levels of individual mRNAs and responses to drugs and radiation.", {"entities": []}], ["In the course of attempting to map genes for drug response using 269 LCLs from the International HapMap Project, we evaluated the extent to which biological noise and non-genetic confounders contribute to trait variability in LCLs.", {"entities": []}], ["While drug responses could be technically well measured on a given day, we observed significant day-to-day variability and substantial correlation to non-genetic confounders, such as baseline growth rates and metabolic state in culture.", {"entities": []}], ["After correcting for these confounders, we were unable to detect any QTLs with genome-wide significance for drug response.", {"entities": []}], ["A much higher proportion of variance in mRNA levels may be attributed to non-genetic factors (intra-individual variance\u2014i.e., biological noise, levels of the EBV virus used to transform the cells, ATP levels) than to detectable eQTLs.", {"entities": []}], ["Finally, in an attempt to improve power, we focused analysis on those genes that had both detectable eQTLs and correlation to drug response; we were unable to detect evidence that eQTL SNPs are convincingly associated with drug response in the model.", {"entities": []}], ["While LCLs are a promising model for pharmacogenetic experiments, biological noise and in vitro artifacts may reduce power and have the potential to create spurious association due to confounding.", {"entities": []}], ["The use of lymphoblastoid cell lines (LCLs) has evolved from a renewable source of DNA to an in vitro model system to study the genetics of gene expression, drug response, and other traits in a controlled laboratory setting.", {"entities": []}], ["While convincing relationships between SNPs and mRNA levels (eQTLs) have been described, the degree to which non-genetic variables also influence phenotypes in LCLs is less well characterized.", {"entities": []}], ["In the course of attempting to map genes for drug responses in vitro, we evaluated the reproducibility of in vitro traits across replicates, the impact of the EBV virus used to transform B cells into cell lines, and the effect of in vitro culture conditions.", {"entities": []}], ["We found that responses to at least some drugs and levels of many mRNAs can be technically well measured, but vary both across experiments and with non-genetic confounders such as growth rates, EBV levels, and ATP levels.", {"entities": []}], ["The influence of such non-genetic factors can both decrease power to detect true relationships between DNA variation and traits and create the potential for non-genetic confounding and spurious associations between DNA variants and traits.", {"entities": []}], ["Lunasin is a naturally occurring peptide isolated from soybeans and has been explored in cancer treatment.", {"entities": [[89, 95, "DISEASE"]]}], ["Lunasin inhibits NF-\u03baB activation and thus pro-inflammatory cytokine and mediator production in macrophages.", {"entities": []}], ["In this study we demonstrate that lunasin can effectively suppress allergic airway inflammation in two murine models of asthma.", {"entities": [[120, 126, "DISEASE"]]}], ["In an OVA+Alum sensitization model, intranasal lunasin treatment at the time of OVA challenges significantly reduced total cells counts in bronchoalveolar lavage (BAL) fluid and eosinophilia, peribronchiolar inflammatory infiltration, goblet cell metaplasia and airway IL-4 production.", {"entities": [[178, 190, "DISEASE"]]}], ["In an OVA+LPS intranasal sensitization model, lunasin treatment either at the time of sensitization or challenge has similar effects in suppress allergic airway inflammation including significantly reduced total cell and eosinophil counts in BAL fluid, inflammatory gene Fizz1 expression in the lung, and IL-4 production by OVA re-stimulated cells from mediastinal lymph nodes.", {"entities": []}], ["We further show that intranasal instillation of OVA+lunasin significantly increases OVA-specific regulatory T cell (Treg) accumulation in the lung comparing to OVA only treatment.", {"entities": []}], ["Taken together, our results suggest lunasin as an anti-inflammatory agent can be potentially used in asthma therapy or as an adjuvant to enhance the induction of antigen-specific Tregs and thus boost the efficacy of allergy immunotherapy.", {"entities": [[101, 107, "DISEASE"]]}], ["We performed a systematic review and meta-analysis of all the available evidence comparing efficacy and safety of oral prolonged released beclomethasone dipropionate (BDP) to active oral controls in patients with mild-to-moderate ulcerative colitis (UC).", {"entities": [[230, 248, "DISEASE"]]}], ["A subgroup-analysis compared the effectiveness of BDP and 5-ASA.", {"entities": []}], ["Literature research was performed in different databases, as well as manual search to identify abstracts from international meetings with data not included in extensive publications.", {"entities": []}], ["Experts in the field and companies involved in BDP development and manufacture were contacted to identify unpublished studies used for registration purposes.", {"entities": []}], ["Dichotomous data were pooled to obtain odds ratio meta-analysis.", {"entities": []}], ["Five randomized controlled trials that compared oral BDP 5mg/day vs. all oral active controls in treating UC were identified as eligible.", {"entities": []}], ["Efficacy and safety have been addressed after 4-week treatment period.", {"entities": []}], ["One study evaluated efficacy and safety of BDP vs. prednisone and 4 of BDP vs. 5-ASA.", {"entities": []}], ["Treatment with oral BDP 5 mg/day induces a significant better clinical response compared to oral 5-ASA (OR 1.86, 95% CI = 1.23\u20132.82, P = 0.003).", {"entities": []}], ["The effect is detectable even when the comparison to prednisone is added (OR 1.41, 95% CI = 1.03\u20131.93, P = 0.03).", {"entities": []}], ["Data on remission indicate that the potential clinical efficacy of BDP may be better than 5-ASA (OR 1.55, 95% CI = 1.00\u20132.40, P = 0.05).", {"entities": []}], ["This difference is lost when the comparison with prednisone is added (OR 1.30, 95% CI = 0.76\u20132.23, P = 0.34).", {"entities": []}], ["The safety analysis showed no differences between BDP and 5-ASA (OR 0.55, 95% CI = 0.24\u20131.27, P = 0.16).", {"entities": []}], ["The lack of difference is maintained even when the study with prednisone is added (OR 0.67, 95% CI = 0.44\u20131.01, P = 0.06).", {"entities": []}], ["However, the trend of difference is clear and indicates a more favourable safety profile of BDP compared to 5-ASA and PD.", {"entities": []}], ["Oral prolonged release BDP showed a superior efficacy vs. oral 5-ASA in inducing clinical improvement of mild-to-moderate UC with a similar safety profile.", {"entities": []}], ["Leptin and adiponectin communicate with organ systems in order to regulate energetic and metabolic homeostasis.", {"entities": []}], ["Their different points of action have been well characterized; however, no study has investigated their interrelationship with the metabolism at the molecular level in vivo .", {"entities": []}], ["To examine the associations of leptin and adiponectin with the metabolic profile reflecting the intercellular and interorgan communication as well as activated metabolic pathways.", {"entities": []}], ["We measured plasma concentrations of leptin, adiponectin, and insulin along with concentrations of 196 metabolites in 400 healthy, fasting 8-years old German children who participated in the German Ulm Birth Cohort Study (UBCS).", {"entities": []}], ["Using multiple linear mixed models, we evaluated the associations between hormones and metabolites.", {"entities": []}], ["Leptin levels increased exponentially with increasing BMI.", {"entities": []}], ["Leptin was furthermore strongly associated with alanine and aspartate (Bonferroni corrected P [ P BF ] = 5.7\u00d710 P BF = 0.009 and 0.0001, respectively).", {"entities": []}], ["Insulin showed a similar association pattern, although the associations were less strong than for leptin.", {"entities": []}], ["Adiponectin was neither related to BMI nor to any metabolite.", {"entities": []}], ["Although children were presumably metabolically similar, we found strong associations of insulin and leptin with the metabolite profile.", {"entities": []}], ["High alanine concentrations and the lower concentrations of NEFA in children with high fasting leptin concentrations might arise from an increased gluconeogenesis and from the disinhibiting effect of leptin on the carnitine-palmitoyltransferase-1, respectively.", {"entities": []}], ["As insulin had the same trend towards these associations, both hormones seem to be related to processes that provide the body with energy in fasting state.", {"entities": []}], ["A 35-year-old female was referred to our hospital with bilateral loss of vision of two days duration.", {"entities": []}], ["She gave history of consumption of about 150 ml of neem oil five days back.", {"entities": []}], ["Examination revealed no perception of light in both eyes.", {"entities": []}], ["Both pupils were dilated and sluggishly reacting to light.", {"entities": []}], ["Her fundus examination showed bilateral hyperemic, edematous discs and also edema extending along the superior and inferior temporal vascular arcade.", {"entities": []}], ["Magnetic resonance imaging (MRI) scan showed bilateral putaminal regions with altered signal, hypointensities in T1-weighted images, hyperintensities on T2-weighted, images and hyperintense on Fluid Attenuation Inversion Recovery (FLAIR) images suggestive of cytotoxic edema due to tissue hypoxia.", {"entities": []}], ["Her vision improved to 20/200 in both eyes with treatment after two months.", {"entities": []}], ["This is the first case report of such nature in the literature to the best of our knowledge.", {"entities": []}], ["Adverse events from intrapartum antibiotic prophylaxis (IAP) are poorly documented yet essential to inform clinical practice for neonatal group B Streptococcus (GBS) disease prevention.", {"entities": []}], ["In this systematic review, we appraised and synthesised the evidence on the adverse events of IAP in the mother and/or her child.", {"entities": []}], ["We searched MEDLINE, MEDLINE In-Process & Other Non-Indexed Citations, EMBASE, Cochrane, and Science Citation Index from date of inception until October 16th 2016.", {"entities": []}], ["Reference lists of included studies and relevant systematic reviews were hand-searched.", {"entities": []}], ["We included primary studies in English that reported any adverse events from intrapartum antibiotics for any prophylactic purpose compared to controls.", {"entities": []}], ["The search was not restricted to prophylaxis for GBS but excluded women with symptoms of infection or undergoing caesarean section.", {"entities": []}], ["Two reviewers assessed the methodological quality of studies, using the Cochrane Risk of Bias tool, and the Risk of Bias Assessment Tool for Nonrandomised Studies.", {"entities": []}], ["Results were synthesised narratively and displayed in text and tables.", {"entities": []}], ["From 2364 unique records, 30 studies were included.", {"entities": []}], ["Despite a wide range of adverse events reported in 17 observational studies and 13 randomised controlled trials (RCTs), the evidence was inconsistent and at high risk of bias.", {"entities": []}], ["Only one RCT investigated the long-term effects of IAP reporting potentially serious outcomes such as cerebral palsy; however, it had limited applicability and unclear biological plausibility.", {"entities": [[102, 116, "DISEASE"]]}], ["Seven observational studies showed that IAP for maternal GBS colonisation alters the infant microbiome.", {"entities": []}], ["However, study populations were not followed through to clinical outcomes, therefore clinical significance is unknown.", {"entities": []}], ["There was also observational evidence for increased antimicrobial resistance, however studies were at high or unclear risk of bias.", {"entities": []}], ["The evidence base to determine the frequency of adverse events from intrapartum antibiotic prophylaxis for neonatal GBS disease prevention is limited.", {"entities": []}], ["As RCTs may not be possible, large, better quality, and longitudinal observational studies across countries with widespread IAP could fill this gap.", {"entities": []}], ["CRD42016037195 .", {"entities": []}], ["The online version of this article (doi:10.1186/s12884-017-1432-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The objectives were to identify 1) the clinician and child characteristics associated with; 2) clinical management decisions following from, and; 3) the prognostic value of; a clinician\u2019s \u2018gut feeling something is wrong\u2019 for children presenting to primary care with acute cough and respiratory tract infection (RTI).", {"entities": []}], ["Multicentre prospective cohort study where 518 primary care clinicians across 244 general practices in England assessed 8394 children aged \u22653\u00a0months and <\u200916\u00a0years for acute cough and RTI.", {"entities": []}], ["The main outcome measures were: Self-reported clinician \u2018gut feeling\u2019; clinician management decisions (antibiotic prescribing, referral for acute admission); and child\u2019s prognosis (reconsultation with evidence of illness deterioration, hospital admission in the 30\u00a0days following recruitment).", {"entities": []}], ["Clinician years since qualification, parent reported symptoms (illness severity score\u2009\u2265\u20097/10, severe fever <\u200924\u00a0h, low energy, shortness of breath) and clinical examination findings (crackles/ crepitations on chest auscultation, recession, pallor, bronchial breathing, wheeze, temperature\u2009\u2265\u200937.8\u00a0\u00b0C, tachypnoea and inflamed pharynx) independently contributed towards a clinician \u2018gut feeling that something was wrong\u2019.", {"entities": []}], ["\u2018Gut feeling\u2019 was independently associated with increased antibiotic prescribing and referral for secondary care assessment.", {"entities": []}], ["After adjustment for other associated factors, gut feeling was not associated with reconsultations or hospital admissions.", {"entities": []}], ["Clinicians were more likely to report a gut feeling something is wrong, when they were more experienced or when children were more unwell.", {"entities": []}], ["Gut feeling is independently and strongly associated with antibiotic prescribing and referral to secondary care, but not with two indicators of poor child health.", {"entities": []}], ["The online version of this article (10.1186/s12875-018-0716-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The aim of our study is to determine whether chronic obstructive pulmonary disease (COPD) is an independent risk factor for ischemic heart disease and whether this association is related with a greater prevalence of classical cardiovascular risk factors.", {"entities": [[124, 146, "DISEASE"], [133, 146, "DISEASE"], [45, 82, "DISEASE"]]}], ["Ours is a case-control cross-sectional study design.", {"entities": []}], ["Cases were hospital patients with ischemic heart disease in stable phase, compared with control hospital patients.", {"entities": [[34, 56, "DISEASE"], [43, 56, "DISEASE"]]}], ["All patients underwent post-bronchodilator (PBD) spirometry, a standardized questionnaire, and blood analysis.", {"entities": []}], ["COPD was defined as per GOLD PBD forced expiratory volume in the first second (FEV 1 )/forced vital capacity (FVC) < 0.70.", {"entities": [[79, 82, "GENE"]]}], ["In our series of patient cases (n = 204) and controls (n = 100), there were 169 men in the case group (83%) and 84 in the control group (84%).", {"entities": []}], ["Ages were 67 and 64 years, respectively ( P < 0.05).", {"entities": []}], ["There were no significant differences by weight, body mass index (BMI), packyears, leukocytes, or homocysteine.", {"entities": []}], ["The abdominal perimeter was significantly greater in cases (mean 101 cm \u00b1 standard deviation [SD] 10 versus 96 cm \u00b1 11; P < 0.000).", {"entities": []}], ["Both groups also had significant differences by C-reactive protein (CRP), fibrinogen, and hemoglobin values.", {"entities": [[68, 71, "GENE"]]}], ["In univariate analysis, increased risks for cases to show with individual classical cardiovascular risk factors were seen, with odds ratio (OR) 1.86 and 95% confidence interval (CI) (1.04\u20133.33) for diabetes mellitus, dyslipidemia (OR 2.10, 95% CI: 1.29\u20133.42), arterial hypertension (OR 2.47, 95% CI: 1.51\u20134.05), and increased abdominal perimeter (OR 1.71, 95% CI: 1.06\u20132.78).", {"entities": [[269, 281, "DISEASE"], [198, 215, "DISEASE"]]}], ["Percent predicted PBD FEV 1 was 97.6% \u00b1 23% in the patient group and 104% \u00b1 19% in the control group ( P = 0.01), but the prevalence of COPD was 24.1% in cases and 21% in controls.", {"entities": [[22, 25, "GENE"]]}], ["Therefore, COPD was not associated with ischemic heart disease: at the crude level (OR 1.19, 95% CI: 0.67\u20132.13) or after adjustment (OR 1.14, 95% CI:0.57\u20132.29).", {"entities": [[40, 62, "DISEASE"], [49, 62, "DISEASE"]]}], ["In conclusion, COPD was not associated with ischemic heart disease.", {"entities": [[44, 66, "DISEASE"], [53, 66, "DISEASE"]]}], ["The greater prevalence of classical cardiovascular risk factors in COPD patients could explain the higher occurrence of ischemic heart disease in these patients.", {"entities": [[120, 142, "DISEASE"], [129, 142, "DISEASE"]]}], ["Pharmacokinetic properties, dosing regimen, and potency at the site of action are among the factors that influence activity of a corticosteroid.", {"entities": []}], ["The potency of a corticosteroid at the site of action is determined significantly by its affinity to the glucocorticoid receptor.", {"entities": []}], ["Recent literature on topical corticosteroids reveals an increasing emphasis on comparative relative receptor affinity values as a key method of differentiating among various corticosteroid compounds, particularly with regard to clinical efficacy.", {"entities": []}], ["A response was formulated to: Valotis A, H\u00f6gger P: Human receptor kinetics and lung tissue retention of the enhanced-affinity glucocorticoid fluticasone furoate.", {"entities": []}], ["Respir Res 2007, 8:54.", {"entities": []}], ["Relative receptor binding affinities, while often showing significant variability across different laboratories, are a valid parameter when a comparison of the pharmacological activity of various glucocorticoids at the site of action is desired.", {"entities": []}], ["Unfortunately within this context, scientific literature including the article from Valotis and H\u00f6gger, confuse differences in potency (concentration or dose necessary to achieve a certain effect) with differences in efficacy (a quantitative difference in the overall maximum effect, even if all the receptors are occupied).", {"entities": []}], ["All glucocorticoids will show the same efficacy as long as the selected dose will occupy the same number of receptors.", {"entities": []}], ["While relative receptor affinities are useful for comparing in vitro potencies of corticosteroids, these data are not representative of physiologic conditions and should not be used as a basis for comparing the presumed effectiveness of compounds in a clinical situation.", {"entities": []}], ["Epigenetic adjustments of the chromatin architecture through histone modifications are reactive to the environment and can establish chromatin states which are permissive or repressive to gene expression.", {"entities": []}], ["Epigenetic regulation of gene expression is cell specific and therefore, it is important to understand its contribution to individual cellular responses in tissues like the airway epithelium which forms the mucosal barrier to the inhaled environment within the lung.", {"entities": []}], ["The airway epithelium of asthmatics is abnormal with dysregulation of genes such as epidermal growth factor receptor (EGFR), the \u0394N isoform of the transcription factor p63 (\u0394Np63), and signal transducer and activator of transcription 6 (STAT6), integral to differentiation, proliferation, and inflammation.", {"entities": [[118, 122, "GENE"], [237, 242, "GENE"]]}], ["It is important to establish in diseases like asthma how histone modifications affect tissue responses such as proliferation and differentiation.", {"entities": [[46, 52, "DISEASE"]]}], ["To characterize the global histone acetylation and methylation status in the epithelium of asthmatic compared to healthy subjects and to identify the impact of these variations on genes involved in epithelial functions.", {"entities": []}], ["Whole lungs were obtained from healthy and asthmatic subjects (n\u2009=\u20096) from which airway epithelial cells (AECs) were isolated and airway sections were taken for analysis of histone lysine acetylation and methylation by immunohistochemistry.", {"entities": []}], ["AECs were subjected to chromatin immunoprecipitation (ChIP) using anti-H3K18ac and anti-H3K4me2 antibodies followed by RT-PCR targeting \u0394Np63, EGFR, and STAT6.", {"entities": [[143, 147, "GENE"], [153, 158, "GENE"]]}], ["AECs were also treated with TSA and changes in \u0394Np63, EGFR, and STAT6 expression were determined.", {"entities": [[54, 58, "GENE"], [64, 69, "GENE"]]}], ["We identified an increase in the acetylation of lysine 18 on histone 3 (H3K18ac) and trimethylation of lysine 9 on histone 3 (H3K9me3) in the airway epithelium of asthmatic compared to healthy subjects.", {"entities": []}], ["We found increased association of H3K18ac around the transcription start site of \u0394Np63, EGFR, and STAT6 in AECs of asthmatics.", {"entities": [[88, 92, "GENE"], [98, 103, "GENE"]]}], ["However, we were unable to modify the expression of these genes with the use of the HDAC inhibitor TSA in healthy subjects.", {"entities": []}], ["The airway epithelium from asthmatic subjects displays increased acetylation of H3K18 and association of this mark around the transcription start site of \u0394Np63, EGFR, and STAT6.", {"entities": [[161, 165, "GENE"], [171, 176, "GENE"]]}], ["These findings suggest a complex interaction between histone modifications and gene regulation in asthma.", {"entities": [[98, 104, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12931-015-0254-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The rate of total knee arthroplasty surgery (TKA) is rising in Australia despite varying impacts of TKA on physical function (PF) in population-based studies.", {"entities": []}], ["There are potentially modifiable risk factors that could enhance PF after TKA, so we evaluated (1) the levels of PF in persons with TKA and the rest of the population, (2) potentially modifiable characteristics of those reporting poor PF after TKA.", {"entities": []}], ["Nested case\u2013control study.", {"entities": []}], ["Population-based cohort study in New South Wales, Australia.", {"entities": []}], ["Members of a large (n=267\u2005151) cohort study recruited by a self-completed, mailed questionnaire from 2006 to 2008.", {"entities": []}], ["After exclusions (for hip arthroplasty, partial TKA, missing important variables and mismatching TKA status between self-reported and hospital record data), this study included 205\u2005148 participants.", {"entities": []}], ["Primary outcome, Medical Outcomes Study Physical Function scale (MOS-PF).", {"entities": []}], ["Secondary outcome, dispensings of analgesics or anti-inflammatory drugs.", {"entities": []}], ["We found 2916 TKA participants and 202\u2005232 participants with no TKA (confirmed across datasets).", {"entities": []}], ["Persons with TKA had a lower MOS-PF (59.9, 95% CI 58.5 to 60.6) than those without TKA (83.8, 95% CI 83.7 to 83.9).", {"entities": []}], ["In the matched analysis, the TKA group had a lower MOS-PF (59.9, 95% CI 59.9 to 62.4) than those without TKA (68.4, 95% CI 67.8 to 69.0).", {"entities": []}], ["In persons with TKA, lower levels of MOS-PF were associated with low self-rated health, high psychological distress, comorbidity, greater age, recent treatment for osteoarthritis and use of paracetamol.", {"entities": [[164, 178, "DISEASE"]]}], ["Women had an MOS-PF that was 11.6 points (95% CI 9.5 to 13.8) lower than men.", {"entities": []}], ["Several modifiable risk factors have been identified to influence PF in persons receiving TKA, with notable differences between sexes.", {"entities": []}], ["The importance of these risk factors should be examined in incident TKA to test if early identification and intervention for individuals can improve outcomes.", {"entities": []}], ["Plant pollens are an important source of environmental antigens that stimulate allergic responses.", {"entities": []}], ["In addition to acting as vehicles for foreign protein antigens, they contain lipids that incorporate saturated and unsaturated fatty acids, which are necessary in the reproduction of higher plants.", {"entities": []}], ["The CD1 family of nonpolymorphic major histocompatibility complex\u2013related molecules is highly conserved in mammals, and has been shown to present microbial and self lipids to T cells.", {"entities": []}], ["Here, we provide evidence that pollen lipids may be recognized as antigens by human T cells through a CD1-dependent pathway.", {"entities": []}], ["Among phospholipids extracted from cypress grains, phosphatidyl-choline and phosphatidyl-ethanolamine were able to stimulate the proliferation of T cells from cypress-sensitive subjects.", {"entities": []}], ["Recognition of phospholipids involved multiple cell types, mostly CD4 i Mycobacterium tuberculosis \u2013exposed health care workers, but occasionally seen in nonallergic subjects.", {"entities": [[86, 98, "DISEASE"], [66, 69, "GENE"]]}], ["Finally, allergic, but not normal subjects, displayed circulating specific IgE and cutaneous weal and flare reactions to phospholipids.", {"entities": []}], ["Building upon the findings from the field of automated recognition of respiratory sound patterns, we propose a wearable wireless sensor implementing on-board respiratory sound acquisition and classification, to enable continuous monitoring of symptoms, such as asthmatic wheezing.", {"entities": []}], ["Low-power consumption of such a sensor is required in order to achieve long autonomy.", {"entities": []}], ["Considering that the power consumption of its radio is kept minimal if transmitting only upon (rare) occurrences of wheezing, we focus on optimizing the power consumption of the digital signal processor (DSP).", {"entities": [[204, 207, "GENE"]]}], ["Based on a comprehensive review of asthmatic wheeze detection algorithms, we analyze the computational complexity of common features drawn from short-time Fourier transform (STFT) and decision tree classification.", {"entities": []}], ["Four algorithms were implemented on a low-power TMS320C5505 DSP.", {"entities": [[60, 63, "GENE"]]}], ["Their classification accuracies were evaluated on a dataset of prerecorded respiratory sounds in two operating scenarios of different detection fidelities.", {"entities": []}], ["The execution times of all algorithms were measured.", {"entities": []}], ["The best classification accuracy of over 92%, while occupying only 2.6% of the DSP's processing time, is obtained for the algorithm featuring the time-frequency tracking of shapes of crests originating from wheezing, with spectral features modeled using energy.", {"entities": [[79, 82, "GENE"]]}], ["Asthma is a common complex condition with clear racial and ethnic differences in both prevalence and severity.", {"entities": [[0, 6, "DISEASE"]]}], ["Asthma consultation rates, mortality, and severe symptoms are greatly increased in African descent populations of developed countries.", {"entities": [[0, 6, "DISEASE"]]}], ["African ancestry has been associated with asthma, total serum IgE and lower pulmonary function in African-admixed populations.", {"entities": [[42, 48, "DISEASE"]]}], ["To replicate previous findings, here we aimed to examine whether African ancestry was associated with asthma susceptibility in African Americans.", {"entities": [[102, 108, "DISEASE"]]}], ["In addition, we examined for the first time whether African ancestry was associated with asthma exacerbations.", {"entities": [[89, 95, "DISEASE"]]}], ["After filtering for self-reported ancestry and genotype data quality, samples from 1,117 self-reported African-American individuals from New York and Baltimore (394 cases, 481 controls), and Chicago (321 cases followed for asthma exacerbations) were analyzed.", {"entities": [[223, 229, "DISEASE"]]}], ["Genetic ancestry was estimated based on ancestry informative markers (AIMs) selected for being highly divergent among European and West African populations (95 AIMs for New York and Baltimore, and 66 independent AIMs for Chicago).", {"entities": []}], ["Among case-control samples, the mean African ancestry was significantly higher in asthmatics than in non-asthmatics (82.0\u00b114.0% vs. 77.8\u00b118.1%, mean difference 4.2% [95% confidence interval (CI):2.0\u20136.4], p <0.0001).", {"entities": []}], ["This association remained significant after adjusting for potential confounders (odds ratio: 4.55, 95% CI: 1.69\u201312.29, p \u200a=\u200a0.003).", {"entities": []}], ["African ancestry failed to show an association with asthma exacerbations ( p \u200a=\u200a0.965) using a model based on longitudinal data of the number of exacerbations followed over 1.5 years.", {"entities": [[52, 58, "DISEASE"]]}], ["These data replicate previous findings indicating that African ancestry constitutes a risk factor for asthma and suggest that elevated asthma rates in African Americans can be partially attributed to African genetic ancestry.", {"entities": [[102, 108, "DISEASE"], [135, 141, "DISEASE"]]}], ["Tumor necrosis factor alpha (TNF\u03b1) is the most widely studied pleiotropic cytokine of the TNF superfamily.", {"entities": [[90, 93, "GENE"]]}], ["In pathophysiological conditions, generation of TNF\u03b1 at high levels leads to the development of inflammatory responses that are hallmarks of many diseases.", {"entities": []}], ["Of the various pulmonary diseases, TNF\u03b1 is implicated in asthma, chronic bronchitis (CB), chronic obstructive pulmonary disease (COPD), acute lung injury (ALI) and acute respiratory distress syndrome (ARDS).", {"entities": [[90, 127, "DISEASE"], [191, 199, "DISEASE"], [57, 63, "DISEASE"], [73, 83, "DISEASE"]]}], ["In addition to its underlying role in the inflammatory events, there is increasing evidence for involvement of TNF\u03b1 in the cytotoxicity.", {"entities": []}], ["Thus, pharmacological agents that can either suppress the production of TNF\u03b1 or block its biological actions may have potential therapeutic value against a wide variety of diseases.", {"entities": []}], ["Despite some immunological side effects, anti-TNF\u03b1 therapeutic strategies represent an important breakthrough in the treatment of inflammatory diseases and may have a role in pulmonary diseases characterized by inflammation and cell death.", {"entities": []}], ["Psoriasis is an inflammatory skin disease affecting \u223c2% of the world's population, but the aetiology remains incompletely understood.", {"entities": [[0, 9, "DISEASE"], [29, 41, "DISEASE"]]}], ["Recently, microbiota have been shown to differentially regulate the development of autoimmune diseases, but their influence on psoriasis is incompletely understood.", {"entities": [[127, 136, "DISEASE"]]}], ["We show here that adult mice treated with antibiotics that target Gram-negative and Gram-positive bacteria develop ameliorated psoriasiform dermatitis induced by imiquimod, with decreased pro-inflammatory IL-17- and IL-22-producing T cells.", {"entities": [[140, 150, "DISEASE"]]}], ["Surprisingly, mice treated neonatally with these antibiotics develop exacerbated psoriasis induced by imiquimod or recombinant IL-23 injection when challenged as adults, with increased IL-22-producing \u03b3\u03b4 Commensal microbes are necessary for proper development of the immune system.", {"entities": [[81, 90, "DISEASE"]]}], ["Here Zanvit et al .", {"entities": []}], ["show that neonatal antibiotics treatment causes long-term changes in the gut and skin microbiomes, and exacerbates immune-mediated skin pathology at adult age in mouse experimental models of psoriasis.", {"entities": [[191, 200, "DISEASE"]]}], ["A major part of membrane function is conducted by proteins, both integral and peripheral.", {"entities": []}], ["Peripheral membrane proteins temporarily adhere to biological membranes, either to the lipid bilayer or to integral membrane proteins with noncovalent interactions.", {"entities": []}], ["The aim of this study was to construct and analyze the interactions of the human plasma membrane peripheral proteins (peripherome hereinafter).", {"entities": []}], ["For this purpose, we collected a dataset of peripheral proteins of the human plasma membrane.", {"entities": []}], ["We also collected a dataset of experimentally verified interactions for these proteins.", {"entities": []}], ["The interaction network created from this dataset has been visualized using Cytoscape.", {"entities": []}], ["We grouped the proteins based on their subcellular location and clustered them using the MCL algorithm in order to detect functional modules.", {"entities": []}], ["Moreover, functional and graph theory based analyses have been performed to assess biological features of the network.", {"entities": []}], ["Interaction data with drug molecules show that ~10% of peripheral membrane proteins are targets for approved drugs, suggesting their potential implications in disease.", {"entities": []}], ["In conclusion, we reveal novel features and properties regarding the protein-protein interaction network created by peripheral proteins of the human plasma membrane.", {"entities": []}], ["to validate the health-related quality of life measuring instrument DISABKIDS methodological study in which a sample of 113 participants (54 girls and 59 boys; mean age 11.91 years and SD=2.79) was considered, from four Brazilian states, S\u00e3o Paulo, Paran\u00e1, Minas Gerais and the Federal District, 51 of whom participated in the pilot study and 62 in the field study.", {"entities": []}], ["The answers to the questionnaire were analyzed, considering the frequency distributions with regard to the floor and ceiling effects, Cronbach's Alpha statistics, Pearson's Linear Correlation Coefficient, Mulitrait-Multimethod analysis and Confirmatory Factor Analysis according to Structural Equations Modeling.", {"entities": []}], ["the instrument showed a high internal consistency coefficient (verified using Cronbach's Alpha) and construct validity, according to the Multitrait-Multimethod analysis.", {"entities": []}], ["The DISABKIDS the instrument validation has been finished and indicates that the self version is validated for use in Brazil and can be included into the monitoring routine of this population.", {"entities": []}], ["Pulmonary rehabilitation (PR) improves exercise capacity in most but not all COPD patients.", {"entities": []}], ["The factors associated with treatment success and the role of chest wall mechanics remain unclear.", {"entities": []}], ["We investigated the impact of PR on exercise performance in COPD with severe hyperinflation.", {"entities": []}], ["We evaluated 22 COPD patients (age, 66 \u00b1 7 years; FEV 1 = 37.1 \u00b1 11.8% of predicted) who underwent eight weeks of aerobic exercise and strength training.", {"entities": [[50, 53, "GENE"]]}], ["Before and after PR, each patient also performed a six-minute walk test and an incremental cycle ergometer test.", {"entities": []}], ["During the latter, we measured chest wall volumes (total and compartmental, by optoelectronic plethysmography) and determined maximal workloads.", {"entities": []}], ["We observed significant differences between the pre- and post-PR means for six-minute walk distance (305 \u00b1 78 vs. 330 \u00b1 96 m, p < 0.001) and maximal workload (33 \u00b1 21 vs. 39 \u00b1 20 W; p = 0.02).", {"entities": []}], ["At equivalent workload settings, PR led to lower oxygen consumption, carbon dioxide production (VCO 2 ), and minute ventilation.", {"entities": []}], ["The inspiratory (operating) rib cage volume decreased significantly after PR.", {"entities": []}], ["There were 6 patients in whom PR did not increase the maximal workload.", {"entities": []}], ["After PR, those patients showed no significant decrease in VCO 2 during exercise, had higher end-expiratory chest wall volumes with a more rapid shallow breathing pattern, and continued to experience symptomatic leg fatigue.", {"entities": []}], ["In severe COPD, PR appears to improve oxygen consumption and reduce VCO 2 , with a commensurate decrease in respiratory drive, changes reflected in the operating chest wall volumes.", {"entities": []}], ["Patients with severe post-exercise hyperinflation and leg fatigue might be unable to improve their maximal performance despite completing a PR program.", {"entities": []}], ["Although the burden of malaria in many parts of Tanzania has declined, the proportion of children with fever has not changed.", {"entities": [[23, 30, "DISEASE"]]}], ["This situation underscores the need to explore the possible causes of febrile episodes in patients presenting with symptoms at the Korogwe District Hospital (KDH).", {"entities": []}], ["A hospital based cross-sectional study was conducted at KDH, north-eastern Tanzania.", {"entities": []}], ["Patients aged 2 to 59 months presenting at the outpatient department with an acute medical condition and fever (measured axillary temperature \u226537.5\u00b0C) were enrolled.", {"entities": []}], ["Blood samples were examined for malaria parasites, human immunodeficiency virus (HIV) and bacterial infections.", {"entities": [[32, 39, "DISEASE"]]}], ["A urine culture was performed in selected cases to test for bacterial infection and a chest radiograph was requested if pneumonia was suspected.", {"entities": [[120, 129, "DISEASE"]]}], ["Diagnosis was based on both clinical and laboratory investigations.", {"entities": []}], ["A total of 867 patients with a median age of 15.1 months (Interquartile range 8.6\u201329.9) were enrolled from January 2013 to October 2013.", {"entities": []}], ["Respiratory tract infections were the leading clinical diagnosis with 406/867 (46.8%) of patients diagnosed with upper respiratory tract infection and 130/867 (15.0%) with pneumonia.", {"entities": [[172, 181, "DISEASE"]]}], ["Gastroenteritis was diagnosed in 184/867 (21.2%) of patients.", {"entities": [[0, 15, "DISEASE"]]}], ["Malaria infection was confirmed in 72/867 (8.3%) of patients.", {"entities": [[0, 7, "DISEASE"]]}], ["Bacterial infection in blood and urine accounted for 26/808 (3.2%) infections in the former, and 66/373 (17.7%) infections in the latter.", {"entities": []}], ["HIV infection was confirmed in 10/824 (1.2%) of patients.", {"entities": []}], ["Respiratory tract infections and gastroenteritis were frequent in patients under 36 months of age (87.3% and 91.3% respectively).", {"entities": [[33, 48, "DISEASE"]]}], ["Co-infections were seen in 221/867 (25.5%) of patients.", {"entities": []}], ["The cause of fever was not identified in 65/867 (7.5%) of these patients.", {"entities": []}], ["The different proportions of infections found among febrile children reflect the causes of fever in the study area.", {"entities": []}], ["These findings indicate the need to optimise patient management by developing malaria and non-malaria febrile illnesses management protocols.", {"entities": [[78, 85, "DISEASE"], [94, 101, "DISEASE"]]}], ["We studied oral glucocorticoids and osteonecrosis, a rare but serious bone disease, in individuals with various chronic inflammatory diseases.", {"entities": [[36, 49, "DISEASE"], [70, 82, "DISEASE"]]}], ["We hypothesised that we would find stronger associations in adults versus children and in people with autoimmune diseases.", {"entities": []}], ["Retrospective cohort study.", {"entities": []}], ["Population-representative data (1994\u20132013) from general practices in the UK.", {"entities": []}], ["Children and adults diagnosed with asthma; inflammatory bowel disease; juvenile, psoriatic or rheumatoid arthritis; psoriasis; or systemic lupus.", {"entities": [[43, 69, "DISEASE"], [94, 114, "DISEASE"], [116, 125, "DISEASE"], [105, 114, "DISEASE"], [35, 41, "DISEASE"]]}], ["Oral glucocorticoid patterns.", {"entities": []}], ["Diagnosed osteonecrosis (primary) and osteonecrosis plus clinical features (eg, symptoms, pain medication, surgical repair) (secondary).", {"entities": [[10, 23, "DISEASE"], [38, 51, "DISEASE"]]}], ["Discrete time failure models estimated the adjusted hazard ratio (aHR) of incident osteonecrosis following oral glucocorticoid exposure.", {"entities": [[83, 96, "DISEASE"], [66, 69, "GENE"]]}], ["Hypothesis testing was one sided (with corresponding 90% CI) since glucocorticoids were unlikely protective.", {"entities": []}], ["After adjusting for demographic, disease-related and health utilisation factors, glucocorticoid exposure was associated with osteonecrosis in adults (ages 18\u201349, aHR 2.1 (90% CI 1.5 to 2.9); ages \u226550, aHR 1.3 (90% CI 1.01 to 1.7)).", {"entities": [[125, 138, "DISEASE"], [162, 165, "GENE"], [201, 204, "GENE"], [162, 165, "GENE"], [201, 204, "GENE"]]}], ["However, low-dose glucocorticoids, corresponding to average doses <7.5\u2009mg prednisolone daily and maximum doses <30\u2009mg daily, were not associated with osteonecrosis in adults.", {"entities": [[150, 163, "DISEASE"]]}], ["Furthermore, even at high glucocorticoid doses, there was no evidence of increased osteonecrosis among glucocorticoid-exposed children (p=0.04 for interaction by age) (any glucocorticoid exposure, ages 2\u20139: aHR 1.1 (90% CI 0.7 to 1.7); ages 10\u201317: aHR 0.6 (90% CI 0.3 to 1.6)).", {"entities": [[83, 96, "DISEASE"], [207, 210, "GENE"], [248, 251, "GENE"], [207, 210, "GENE"], [248, 251, "GENE"]]}], ["Arthritis, inflammatory bowel disease and lupus were independently associated with osteonecrosis, but there was a similar dose relationship between glucocorticoids and osteonecrosis among adults with low-risk and high-risk diseases.", {"entities": [[11, 37, "DISEASE"], [83, 96, "DISEASE"], [168, 181, "DISEASE"], [0, 9, "DISEASE"]]}], ["Glucocorticoid use was clearly associated with osteonecrosis in a dose-related fashion in adults, especially young adults, but this risk was not detectable in children.", {"entities": [[47, 60, "DISEASE"]]}], ["The absolute risk of glucocorticoid-associated osteonecrosis in the general paediatric population and in adults taking low glucocorticoid doses is at most extremely small.", {"entities": [[47, 60, "DISEASE"]]}], ["The 5-lipoxygenase (5-LO) is the key enzyme in the formation of leukotrienes.", {"entities": []}], ["We have previously shown that the histone deacetylase (HDAC) inhibitor trichostatin A (TSA) activates 5-LO transcription via recruitment of Sp1, Sp3 and RNA polymerase II to the proximal promoter.", {"entities": [[140, 143, "GENE"], [145, 148, "GENE"]]}], ["To identify the HDACs involved in the regulation of 5-LO promoter activity isoform-specific HDAC inhibitors were applied.", {"entities": []}], ["5-LO promoter activity and mRNA expression were up-regulated by the class I HDAC inhibitors apicidin and MS-275 but not by class II inhibitors.", {"entities": []}], ["Knockdown of HDAC 1, 2 and 3 revealed that HDAC2 and HDAC3 but not HDAC1 is involved in the up-regulation of 5-LO mRNA expression.", {"entities": [[43, 48, "GENE"], [53, 58, "GENE"], [67, 72, "GENE"]]}], ["To analyse the chromatin modifications at the 5-LO promoter associated with HDAC inhibition, the time course of 5-LO mRNA induction by trichostatin A was investigated and the concomitant changes in histone modifications at the 5-LO promoter in HL-60, U937 and Mono Mac6 cells were determined.", {"entities": []}], ["Chromatin immunoprecipitation analysis revealed that trichostatin A increases acetylation of histones H3 and H4 at the 5-LO core promoter in HL-60 and U937 cells whereas no significant changes were observed in Mono Mac6 cells.", {"entities": []}], ["The appearance of H3 and H4 acetylation preceded the 5-LO mRNA induction whereas in all three cell lines, induction of 5-LO mRNA expression correlated with histone H3 lysine 4 trimethylation (H3K4me3), a marker for transcriptional activity of gene promoters.", {"entities": []}], ["FOXO1 is involved in glucocorticoid- and sepsis-induced muscle wasting, in part reflecting regulation of atrogin-1 and MuRF1.", {"entities": [[0, 5, "GENE"]]}], ["Mechanisms influencing FOXO1 expression in muscle wasting are poorly understood.", {"entities": [[23, 28, "GENE"]]}], ["We hypothesized that the transcription factor peroxisome proliferator-activated receptor \u03b2/\u03b4 (PPAR\u03b2/\u03b4) upregulates muscle FOXO1 expression and activity with a downstream upregulation of atrogin-1 and MuRF1 expression during sepsis and glucocorticoid treatment and that inhibition of PPAR\u03b2/\u03b4 activity can prevent muscle wasting.", {"entities": [[122, 127, "GENE"]]}], ["We found that activation of PPAR\u03b2/\u03b4 in cultured myotubes increased FOXO1 activity, atrogin-1 and MuRF1 expression, protein degradation and myotube atrophy.", {"entities": [[67, 72, "GENE"]]}], ["Treatment of myotubes with dexamethasone increased PPAR\u03b2/\u03b4 expression and activity.", {"entities": []}], ["Dexamethasone-induced FOXO1 activation and atrogin-1 and MuRF1 expression, protein degradation, and myotube atrophy were inhibited by PPAR\u03b2/\u03b4 blocker or siRNA.", {"entities": [[22, 27, "GENE"]]}], ["Importantly, muscle wasting induced in rats by dexamethasone or sepsis was prevented by treatment with a PPAR\u03b2/\u03b4 inhibitor.", {"entities": []}], ["The present results suggest that PPAR\u03b2/\u03b4 regulates FOXO1 activation in glucocorticoid- and sepsis-induced muscle wasting and that treatment with a PPAR\u03b2/\u03b4 inhibitor may ameliorate loss of muscle mass in these conditions.", {"entities": [[51, 56, "GENE"]]}], ["\u2022 Small molecule analogues of the helminth immunomodulator ES-62 have been produced.", {"entities": []}], ["\u2022 Two analogues inhibit mast cell functions and prevent airway hypersensitivity.", {"entities": []}], ["\u2022 The analogues are drug-like and could be considered for treatment of human allergy.", {"entities": []}], ["Small molecule analogues of the helminth immunomodulator ES-62 have been produced.", {"entities": []}], ["Two analogues inhibit mast cell functions and prevent airway hypersensitivity.", {"entities": []}], ["The analogues are drug-like and could be considered for treatment of human allergy.", {"entities": []}], ["ES-62, a glycoprotein secreted by the filarial nematode Acanthocheilonema viteae , exhibits anti-inflammatory properties by virtue of covalently attached phosphorylcholine moieties.", {"entities": []}], ["Screening of a library of ES-62 phosphorylcholine-based small molecule analogues (SMAs) revealed that two compounds, termed 11a and 12b, mirrored the helminth product both in inhibiting mast cell degranulation and cytokine responses in vitro and in preventing ovalbumin-induced Th2-associated airway inflammation and eosinophil infiltration of the lungs in mice.", {"entities": []}], ["Furthermore, the two SMAs inhibited neutrophil infiltration of the lungs when administered therapeutically.", {"entities": []}], ["ES-62-SMAs 11a and 12b thus represent starting points for novel drug development for allergies such as asthma.", {"entities": [[103, 109, "DISEASE"]]}], ["During the postpartum period, ethnic minority women have higher rates of inactivity/under-activity than white women.", {"entities": []}], ["The N\u0101 Mikimiki (\u201cthe active ones\u201d) Project is designed to increase moderate-to-vigorous physical activity over 18 months among multiethnic women with infants 2\u201312 months old.", {"entities": []}], ["The study was designed to test, via a randomized controlled trial, the effectiveness of a tailored telephone counseling of moderate-to-vigorous physical activity intervention compared to a print/website materials-only condition.", {"entities": []}], ["Healthy, underactive women (mean age = 32 \u00b1 5.6 years) with a baby (mean age = 5.7 \u00b1 2.8 months) were enrolled from 2008\u20132009 (N = 278).", {"entities": []}], ["Of the total sample, 84% were ethnic minority women, predominantly Asian\u2013American and Native Hawaiian.", {"entities": []}], ["Mean self-reported baseline level of moderate-to-vigorous physical activity was 40 minutes/week with no significant differences by study condition, ethnicity, infant's age, maternal body mass index, or maternal employment.", {"entities": []}], ["Women had high scores on perceived benefits, self-efficacy, and environmental support for exercise but low scores on social support for exercise.", {"entities": []}], ["This multiethnic sample's demographic and psychosocial characteristics and their perceived barriers to exercise were comparable to previous physical activity studies conducted largely with white postpartum women.", {"entities": []}], ["The N\u0101 Mikimiki Project's innovative tailored technology-based intervention and unique population are significant contributions to the literature on moderate-to-vigorous physical activity in postpartum women.", {"entities": []}], ["Mycoplasma pneumoniae is a common pathogen that causes upper and lower respiratory tract infections in people of all ages, responsible for up to 40\u00a0% of community-acquired pneumonias.", {"entities": []}], ["It also causes a wide array of extrapulmonary infections and autoimmune phenomena.", {"entities": []}], ["Phylogenetic studies of the organism have been generally restricted to specific genes or regions of the genome, because whole genome sequencing has been completed for only 4 strains.", {"entities": []}], ["To better understand the physiology and pathogenicity of this important human pathogen, we performed comparative genomic analysis of 15 strains of M. pneumoniae that were isolated between the 1940s to 2009 from respiratory specimens and cerebrospinal fluid originating from the USA, China and England.", {"entities": []}], ["Illumina MiSeq whole genome sequencing was performed on the 15 strains and all genome sequences were completed.", {"entities": []}], ["Results from the comparative genomic analysis indicate that although about 1500 SNP and indel variants exist between type1 and type 2 strains, there is an overall high degree of sequence similarity among the strains (>99\u00a0% identical to each other).", {"entities": []}], ["Within the two subtypes, conservation of most genes, including the CARDS toxin gene and arginine deiminase genes, was observed.", {"entities": []}], ["The major variation occurs in the P1 and ORF6 genes associated with the adhesin complex.", {"entities": []}], ["Multiple hsdS genes (encodes S subunit of type I restriction enzyme) with variable tandem repeat copy numbers were found in all 15 genomes.", {"entities": []}], ["These data indicate that despite conclusions drawn from 16S rRNA sequences suggesting rapid evolution, the M. pneumoniae genome is extraordinarily stable over time and geographic distance across the globe with a striking lack of evidence of horizontal gene transfer.", {"entities": []}], ["The online version of this article (doi:10.1186/s12864-015-1801-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Full-Malaria/Parasites is a database for transcriptome studies of apicomplexa and other parasites, which is based on our original full-length cDNA sequences and physical cDNA clone resources.", {"entities": [[5, 12, "DISEASE"]]}], ["In this update, the database has been expanded to contain the shogun sequencing for the entire sequences of 14 818 non-redundant full-length cDNA clones from six apicomplexa parasites and 6.8 million of transcription start sites (TSS), both of which had been produced by novel protocols using the oligo-capping method and the Illumina GA sequencer.", {"entities": []}], ["The former should be the ultimate data for exact annotation of the expressed genes, while the latter should be useful for ultra-deep expression analysis.", {"entities": []}], ["Furthermore, we have launched Full-Arthropods, a full-length cDNA database for arthropods of medical importance.", {"entities": []}], ["Full-Arthropods contains 50 343 one-pass sequences, 10 399 shotgun complete sequences and 22.4 million TSS tags in anopheles mosquitoes that transmit malaria, tsetse flies that transmit trypanosomiasis and dust mites that cause allergic dermatitis and bronchial asthma.", {"entities": [[150, 157, "DISEASE"], [186, 201, "DISEASE"], [262, 268, "DISEASE"], [237, 247, "DISEASE"]]}], ["By providing the largest integrated full-length cDNA data resources in the apicomplexa parasites as well as their vectors, Full-Malaria/Parasites and Full-Arthropods should help combat parasitic diseases.", {"entities": [[128, 135, "DISEASE"]]}], ["Full-Malaria/Parasites and Full-Arthropods are accessible from http://fullmal.hgc.jp/ .", {"entities": [[5, 12, "DISEASE"]]}], ["Eosinophilic granulomatosis with polyangiitis (EGPA) is part of antineutrophil cytoplasmic antibodies (ANCAs)-associated vasculitides.", {"entities": []}], ["In EGPA small-vessel vasculitis is associated with eosinophilia and asthma.", {"entities": [[21, 31, "DISEASE"], [51, 63, "DISEASE"], [68, 74, "DISEASE"]]}], ["About 40% of EGPA patients are ANCA-positive, suggesting a role for B cells in the pathogenesis of EGPA.", {"entities": []}], ["B cell-depleting therapy with rituximab (RTX) can be effective in ANCA-positive EGPA, but very few patients have been published to date.", {"entities": []}], ["The role of RTX in the treatment of ANCA-negative EGPA is unclear.", {"entities": []}], ["We report a single-center cohort of patients with eosinophilic granulomatosis with polyangiitis.", {"entities": []}], ["Of these patients, nine (six ANCA-positive, three ANCA-negative) had been treated with RTX for relapsing or refractory disease on standard immunosuppressive treatment.", {"entities": []}], ["In a retrospective analysis, data on treatment response, frequency of relapses, adverse events, and peripheral B-cell reconstitution were evaluated.", {"entities": []}], ["Furthermore, serum immunoglobulin concentrations, ANCA status, and peripheral B cell subpopulations were assessed after RTX treatment.", {"entities": []}], ["All patients had high disease activity before RTX treatment.", {"entities": []}], ["At presentation 3 months after RTX therapy, all ANCA-positive and ANCA-negative patients had responded to RTX, with one patient being in complete remission, and eight patients being in partial remission.", {"entities": []}], ["After a mean follow-up of 9 months, C-reactive protein concentrations had normalized, eosinophils had significantly decreased, and prednisone had been tapered in all patients.", {"entities": []}], ["In all patients, RTX therapy was combined with a standard immunosuppressive therapy.", {"entities": []}], ["Within the 9-month observation period, no relapse was recorded.", {"entities": []}], ["Three patients were preemptively retreated with RTX, and during the median follow-up time of 3 years, no relapse occurred in these patients.", {"entities": []}], ["During the follow-up of 13 patient-years, five minor but no major infections were recorded.", {"entities": []}], ["In our analysis on nine patients with EGPA resistant to standard therapy, rituximab proved to be an efficient and safe treatment for ANCA-positive and ANCA-negative patients.", {"entities": []}], ["Preemptive retreatment with RTX, combined with standard maintenance immunosuppressants, resulted in a sustained treatment response.", {"entities": []}], ["Prospective, randomized trials evaluating the use of RTX in EGPA are warranted.", {"entities": []}], ["Staphylococcus aureus ( S. aureus ) plays an important role in the pathogenesis of severe chronic airway disease, such as nasal polyps.", {"entities": []}], ["However the mechanisms underlying the initiation of damage and/or invasion of the nasal mucosa by S. aureus are not clearly understood.", {"entities": []}], ["The aim of this study was to investigate the interaction between S. aureus and herpes simplex virus type 1 (HSV1) in the invasion of the nasal mucosa and nasal polyp tissue.", {"entities": [[79, 93, "DISEASE"]]}], ["Inferior turbinate and nasal polyp samples were cultured and infected with either HSV1 alone, S. aureus alone or a combination of both.", {"entities": []}], ["Both in turbinate mucosa and nasal polyp tissue, HSV1, with or without S. aureus incubation, led to focal infection of outer epithelial cells within 48 h, and loss or damage of the epithelium and invasion of HSV1 into the lamina propria within 72 h. After pre-infection with HSV1 for 24 h or 48 h, S. aureus was able to pass the basement membrane and invade the mucosa.", {"entities": []}], ["Epithelial damage scores were significantly higher for HSV1 and S. aureus co-infected explants compared with control explants or S. aureus only-infected explants, and significantly correlated with HSV1-invasion scores.", {"entities": []}], ["The epithelial damage scores of nasal polyp tissues were significantly higher than those of inferior turbinate tissues upon HSV1 infection.", {"entities": []}], ["Consequently, invasion scores of HSV1 of nasal polyp tissues were significantly higher than those of inferior turbinate mucosa in the HSV1 and co-infection groups, and invasion scores of S. aureus of nasal polyp tissues were significantly higher than those of inferior turbinate tissues in the co-infection group.", {"entities": []}], ["HSV1 may lead to a significant damage of the nasal epithelium and consequently may facilitate invasion of S. aureus into the nasal mucosa.", {"entities": []}], ["Nasal polyp tissue is more susceptible to the invasion of HSV1 and epithelial damage by HSV1 compared with inferior turbinate mucosa.", {"entities": []}], ["The bronchial epithelium plays a key role in providing a protective barrier against many environmental substances of anthropogenic or natural origin which enter the lungs during breathing.", {"entities": []}], ["Appropriate responses to these agents are critical for regulation of tissue homeostasis, while inappropriate responses may contribute to disease pathogenesis.", {"entities": []}], ["Here, we compared epithelial barrier responses to different pollen species, characterized the active pollen components and the signaling pathways leading to epithelial activation.", {"entities": []}], ["Polarized bronchial cells were exposed to extracts of timothy grass ( Phleum pratense ), ragweed ( Ambrosia artemisifolia ), mugwort ( Artemisia vulgaris ), birch ( Betula alba ) and pine ( Pinus sylvestris ) pollens.", {"entities": []}], ["All pollen species caused a decrease in ionic permeability as monitored trans-epithelial electrical resistance (TER) and induced polarized release of mediators analyzed by ELISA, with grass pollen showing the highest activity.", {"entities": []}], ["Ultrafiltration showed that the responses were due to components <3kDa.", {"entities": []}], ["However, lipid mediators, including phytoprostane E1, had no effect on TER, and caused only modest induction of mediator release.", {"entities": []}], ["Reverse-phase chromatography separated 2 active fractions: the most hydrophilic maximally affected cytokine release whereas the other only affected TER.", {"entities": []}], ["Inhibitor studies revealed that JNK played a more dominant role in regulation of barrier permeability in response to grass pollen exposure, whereas ERK and p38 controlled cytokine release.", {"entities": []}], ["Adenosine and the flavonoid isorhamnetin present in grass pollen contributed to the overall effect on airway epithelial barrier responses.", {"entities": []}], ["In conclusion, bronchial epithelial barrier functions are differentially affected by several low molecular weight components released by pollen.", {"entities": []}], ["Furthermore, ionic permeability and innate cytokine production are differentially regulated.", {"entities": []}], ["Inadequate utilization of healthcare services by migrant populations is an important public health concern.", {"entities": []}], ["Inadequate drug consumption and poor compliance to the therapeutic regimen are common manifestations of low health-care seeking behavior present in migrants even in the countries with well-established healthcare systems.", {"entities": []}], ["There are few studies on the use of medicines among the different groups of migrants in Germany.", {"entities": []}], ["The objective of this study is to investigate drug consumption patterns of ethnic German migrants (Aussiedler) and their current health status.", {"entities": []}], ["A cross-sectional study nested into a cohort of 18,621 individuals aged 20-70 years who migrated to Germany from the former Soviet Union between 1990 and 2005 was conducted.", {"entities": []}], ["Data on consumption of drugs, drug handling, major health risk factors, and one-year disease prevalence were obtained for 114 individuals through a self-administered questionnaire and phone interviews.", {"entities": []}], ["Results were compared to the data on the German population derived from the Disease Analyzer database and Robert Koch Institute (RKI) annual reports.", {"entities": []}], ["Direct age standardization, test of differences, Chi-square test, and descriptive statistics were applied as appropriate.", {"entities": []}], ["For drug classification the Anatomical Therapeutic Chemical (ATC) system was used.", {"entities": []}], ["Of the respondents, 97% reported to have at least one disease within a 12-month period.", {"entities": []}], ["The one-year prevalence of asthma (6.9%), hypertension (26.7%), chronic bronchitis (8.6%), and diabetes (4.9%) in migrants was similar to the general German population.", {"entities": [[42, 54, "DISEASE"], [27, 33, "DISEASE"], [72, 82, "DISEASE"]]}], ["51% regularly took either over-the-counter (OTC) medication or prescription medicines.", {"entities": [[44, 47, "GENE"]]}], ["Six ATC groups were analyzed.", {"entities": []}], ["The highest drug consumption was reported for the ATC cardiovascular (22%), nervous (9%), and muskulo-skeletal system (8%).", {"entities": []}], ["30% used OTC medicines obtained in the country of origin.", {"entities": [[9, 12, "GENE"]]}], ["Difficulties with drug handling were rare.", {"entities": []}], ["Alcohol consumption did not differ from the German population (p = 0.19 males and 0.27 females), however smoking prevalence was lower (p < 0.01) in both sexes.", {"entities": []}], ["Ethnic German migrants seem to differ only slightly from Germans in health status, drug utilization, and disease risk factors, and if so, not in an extreme way.", {"entities": []}], ["Country of origin remains a source of medicines for a substantial part of migrants.", {"entities": []}], ["The study is limited by a small sample size and low response rate.", {"entities": []}], ["Staphylococcus lugdunensis is a virulent coagulase-negative staphylococcus.", {"entities": []}], ["It behaves like and can be mistaken in culture for Staphylococcus aureus .", {"entities": []}], ["While originally thought to be a skin commensal rarely responsible for opportunistic infection, it was rapidly established as a significant human pathogen.", {"entities": []}], ["It has been mainly associated with native and prosthetic valve endocarditis, osteomyelitis, and skin and soft tissue cellulitis, but has also been reported as a cause of fasciitis as well as peritonitis.", {"entities": [[117, 127, "DISEASE"], [170, 179, "DISEASE"], [77, 90, "DISEASE"], [63, 75, "DISEASE"], [191, 202, "DISEASE"]]}], ["Staphylococcus lugdunensis has been reported as a cause of endometritis but has not been previously isolated from amniotic fluid.", {"entities": [[59, 71, "DISEASE"]]}], ["Here, amniotic fluid samples were collected in the course of a larger study on amniotic fluid bacteriology, with prior ethical approval and informed patient consent.", {"entities": []}], ["Amniotic fluid was obtained at Caesarean Section by direct needle aspiration from the intact amnion.", {"entities": []}], ["Analysis with Staphylococcal API test kits led to identification of Staphylococcus lugdunensis in two cases.", {"entities": []}], ["The clinical significance of the finding in these reported cases is undetermined.", {"entities": []}], ["Staphylococcus lugdunensis has been shown to be a cause of serious and potentially fatal morbidities, but this is the first report of its culture from amniotic fluid.", {"entities": []}], ["As caesarean delivery is accepted as the single most important factor associated with post-partum infectious complications in both mother and neonate, the identification of this pathogen is a new concern.", {"entities": []}], ["Pregnancy and childbirth represent a critical time period when a woman can be reached through a variety of mechanisms with interventions aimed at reducing her risk of a preterm birth and improving her health and the health of her unborn baby.", {"entities": []}], ["These mechanisms include the range of services delivered during antenatal care for all pregnant women and women at high risk of preterm birth, services provided to manage preterm labour, and workplace, professional and other supportive policies that promote safe motherhood and universal access to care before, during and after pregnancy.", {"entities": []}], ["The aim of this paper is to present the latest information about available interventions that can be delivered during pregnancy to reduce preterm birth rates and improve the health outcomes of the premature baby, and to identify data gaps.", {"entities": []}], ["The paper also focuses on promising avenues of research on the pregnancy period that will contribute to a better understanding of the causes of preterm birth and ability to design interventions at the policy, health care system and community levels.", {"entities": []}], ["At minimum, countries need to ensure equitable access to comprehensive antenatal care, quality childbirth services and emergency obstetric care.", {"entities": []}], ["Antenatal care services should include screening for and management of women at high risk of preterm birth, screening for and treatment of infections, and nutritional support and counselling.", {"entities": []}], ["Health workers need to be trained and equipped to provide effective and timely clinical management of women in preterm labour to improve the survival chances of the preterm baby.", {"entities": []}], ["Implementation strategies must be developed to increase the uptake by providers of proven interventions such as antenatal corticosteroids and to reduce harmful practices such as non-medically indicated inductions of labour and caesarean births before 39 weeks of gestation.", {"entities": []}], ["Behavioural and community-based interventions that can lead to reductions in smoking and violence against women need to be implemented in conjunction with antenatal care models that promote women's empowerment as a strategy for reducing preterm delivery.", {"entities": []}], ["The global community needs to support more discovery research on normal and abnormal pregnancies to facilitate the development of preventive interventions for universal application.", {"entities": []}], ["As new evidence is generated, resources need to be allocated to its translation into new and better screening and diagnostic tools, and other interventions aimed at saving maternal and newborn lives that can be brought to scale in all countries.", {"entities": []}], ["This article is part of a supplement jointly funded by Save the Children's Saving Newborn Lives programme through a grant from The Bill & Melinda Gates Foundation and March of Dimes Foundation and published in collaboration with the Partnership for Maternal, Newborn and Child Health and the World Health Organization (WHO).", {"entities": []}], ["The original article was published in PDF format in the WHO Report \"Born Too Soon: the global action report on preterm birth\" (ISBN 978 92 4 150343 30), which involved collaboration from more than 50 organizations.", {"entities": []}], ["The article has been reformatted for journal publication and has undergone peer review according to Reproductive Health 's standard process for supplements and may feature some variations in content when compared to the original report.", {"entities": []}], ["This co-publication makes the article available to the community in a full-text format.", {"entities": []}], ["IL-22 is elevated in patients with inflammatory arthritis and correlates with disease activity.", {"entities": [[48, 57, "DISEASE"]]}], ["IL-22 deficient mice have reduced incidence of arthritis.", {"entities": [[47, 56, "DISEASE"]]}], ["Recombinant IL-22 restrains progression of arthritis via increase in IL-10 responses when administered prior to onset of arthritis.", {"entities": [[43, 52, "DISEASE"], [121, 130, "DISEASE"]]}], ["These findings imply a possible dual role of IL-22 in inflammatory arthritis depending on the phase of arthritis.", {"entities": [[67, 76, "DISEASE"], [103, 112, "DISEASE"]]}], ["Experiments outlined here were designed to elucidate the contribution of endogenous IL-22 before and after the onset of arthritis.", {"entities": [[120, 129, "DISEASE"]]}], ["Collagen induced arthritis (CIA) was induced in DBA1 or IFN-\u03b3 deficient mice following immunization with collagen and complete Freund's adjuvant.", {"entities": [[17, 26, "DISEASE"]]}], ["Anti-IL-22 antibody or isotype control were administered prior to or after onset of arthritis and disease progression assessed by clinical scoring and histopathology.", {"entities": [[84, 93, "DISEASE"]]}], ["IL-22, IL-17 and IFN-\u03b3 responses were measured by ELISA and flowcytometry.", {"entities": []}], ["Anti-collagen antibody responses were analyzed by ELISA.", {"entities": []}], ["Expression of IL-22R1 in CD4+ cells was elucidated by flowcytometry and real time PCR.", {"entities": []}], ["Collagen specific IL-22 responses were expanded during arthritis and IL-22 producing cells were discrete from IL-17 or IFN-\u03b3 producing cells.", {"entities": [[55, 64, "DISEASE"]]}], ["Neutralization of IL-22 after onset of arthritis resulted in significant increase in Th1 responses and significantly reduced severity of arthritis.", {"entities": [[39, 48, "DISEASE"], [137, 146, "DISEASE"]]}], ["CD4+ cells from arthritic mice showed increased surface expression of IL-22R1.", {"entities": []}], ["In vitro, CD4+T cells cultured with antigen presenting cells in the presence or absence of IL-22 suppressed or induced IFN-\u03b3, respectively.", {"entities": []}], ["The protective effect of anti-IL-22 was reversed in IFN-\u03b3 deficient mice.", {"entities": []}], ["Moreover, administration of anti-IL-22 prior to onset of arthritis augmented arthritis severity.", {"entities": [[57, 66, "DISEASE"], [77, 86, "DISEASE"]]}], ["We show for the first time that IL-22 plays a dual role: protective prior to the onset of arthritis and pathogenic after onset of arthritis.", {"entities": [[90, 99, "DISEASE"], [130, 139, "DISEASE"]]}], ["The pathogenic effect of IL-22 is dependent on suppression of IFN-\u03b3 responses.", {"entities": []}], ["IL-17 responses remained unchanged with the administration of anti-IL22 antibody.", {"entities": []}], ["IL-22R1 is upregulated on CD4+T cells during arthritis and regulates IFN-\u03b3 in T cells.", {"entities": [[45, 54, "DISEASE"]]}], ["Asian countries have a variety of ethnic groups and culture that provide their own traditional treatment in health care.", {"entities": []}], ["Facial candling appears to be one of the popular traditional treatments in Southeast Asian.", {"entities": []}], ["The complementary medicine practitioners promote that the facial candling treatment would help in reducing the symptoms of allergic rhinitis and other problems related to sinus.", {"entities": [[123, 140, "DISEASE"], [132, 140, "DISEASE"]]}], ["Due to the lack of evidence available, the effectiveness of this treatment method and its mechanism, however, remains unknown.", {"entities": []}], ["The objective of this research is therefore to study impact of facial candling on inflammatory mediators, substance P (SP), symptoms severity, and quality of life (QoL) in allergic rhinitis patients.", {"entities": [[172, 189, "DISEASE"], [181, 189, "DISEASE"]]}], ["A randomized, nonblinded, controlled trial will be carried out by recruiting a total of 66 eligible allergic rhinitis patients who fulfill the inclusion criteria from a university health center.", {"entities": [[100, 117, "DISEASE"], [109, 117, "DISEASE"]]}], ["The subjects will be randomly assigned into 2 groups: intervention group receiving facial candling treatment and control group (no treatment given).", {"entities": []}], ["Samples of blood and nasal mucus will be collected right before and after intervention.", {"entities": []}], ["Samples collected will be analyzed.", {"entities": []}], ["The primary outcomes are the changes in the level of SP in both blood and mucus samples between both groups.", {"entities": []}], ["The secondary outcomes include the levels of inflammatory mediators (ie, tumor necrosis factor alpha, interleukin (IL)-3, IL-5, IL-6, IL-10, and IL-13) and the severity of allergic rhinitis symptoms as measured by a visual analogous scale and QoL using the Rhinitis Quality of Life Questionnaire (RQLQ).", {"entities": [[172, 189, "DISEASE"], [181, 189, "DISEASE"], [257, 265, "DISEASE"]]}], ["The study protocols are approved from the Ethical and Research Committee of the Universiti Teknologi MARA (REC/113/15).", {"entities": []}], ["The trial is registered under the Australia New Zealand Clinical Trial Registry (ACTRN12616000299404).", {"entities": []}], ["The trial was registered on 03/07/2016 and the first patient was enrolled on 10/12/2016.", {"entities": []}], ["Facial candling is one of the unique treatments using candles to reduce the severity of symptoms and inflammation.", {"entities": []}], ["This is the first ever study conducted on facial candling that will give rise to new knowledge underlying the effects of facial candling on severity of symptoms and inflammation relief mechanism mediated by substance P and inflammatory mediators.", {"entities": []}], ["Preconception care, including family planning, is a vital component of healthcare for women of reproductive age.", {"entities": []}], ["An average female spends the majority of her reproductive life trying to prevent a pregnancy.", {"entities": []}], ["In order to prevent unintended pregnancy, women often rely on the use of hormonal contraceptives.", {"entities": []}], ["In the United States, the majority of hormonal contraceptive users are prescribed oral contraceptive pills (OCPs).", {"entities": []}], ["Reduced adherence to OCPs decreases their ability to prevent pregnancy.", {"entities": []}], ["The study aimed to measure OCP adherence among female college students, and explore the relationship between OCP adherence, knowledge, and self-efficacy.", {"entities": []}], ["This cross-sectional study recruited a random sample of female college students to participate in an online survey.", {"entities": []}], ["OCP adherence was based on the 8-item Morisky Medication Adherence Scale (MMAS-8).", {"entities": []}], ["Secondary reporting of medication adherence included participant reports of the number of missed OCP doses in the previous month and typical month of use.", {"entities": []}], ["Of the 5000 invited, 1559 (31.3%) completed the survey.", {"entities": []}], ["Of those responding, 670 (41.3%) reported use of OCPs.", {"entities": []}], ["A total of 293 (44.3%) OCP users met criteria for low adherence, 241 (36.4%) met criteria for medium adherence, and 128 (19.3%) met criteria for high adherence.", {"entities": []}], ["Those with high adherence had higher self-efficacy ( P \u2009<\u20090.001) and perceived knowledge ( p \u2009<\u20090.001).", {"entities": []}], ["After controlling for other factors, self-efficacy (b\u2009=\u2009.37) and perceived knowledge (b\u2009=\u2009.09) remained associated with OCP adherence.", {"entities": []}], ["Less than 20% of respondents met the criteria for high adherence to OCPs.", {"entities": []}], ["Self-efficacy and knowledge were associated with higher OCP adherence.", {"entities": []}], ["Targeted interventions from healthcare providers, health educators, and other adherence related media to increase the knowledge and self-efficacy of patients using OCPs may improve adherence rates.", {"entities": []}], ["Additional research is needed to evaluate the impact of innovative interventions focused on social and behavioral patient factors, like knowledge and self-efficacy, on adherence to OCPs.", {"entities": []}], ["Kindlin-2 promotes carcinogenesis through regulation of cell-cell and cell-extracellular matrix adhesion.", {"entities": []}], ["However, the role of Kindlin-2 in glioma has not been elucidated.", {"entities": []}], ["We investigated Kindlin-2 expression in 188 human glioma tissue samples.", {"entities": []}], ["High Kindlin-2 expression was correlated with high pathological grade and a worse prognosis.", {"entities": []}], ["Kindlin-2 promoted glioma cell motility and proliferation both in vitro and in vivo .", {"entities": []}], ["Importantly, Kindlin-2 activated the EGFR pathway and increased EGFR mRNA levels.", {"entities": [[37, 41, "GENE"], [64, 68, "GENE"], [37, 41, "GENE"], [64, 68, "GENE"]]}], ["In addition to up-regulating Y-box binding protein-1 (YB-1) and \u03b2-catenin expression, Kindlin-2 formed a transcriptional complex with YB-1 and \u03b2-catenin that bound to the EGFR promoter and enhanced transcription.", {"entities": [[171, 175, "GENE"]]}], ["The \u03b2-catenin/YB-1/EGFR pathway was required for Kindlin-2-mediated functions.", {"entities": []}], ["Our data provide a better understanding of the mechanisms underlying glioma progression, and suggest that Kindlin-2 may be a biomarker and therapeutic target in glioma.", {"entities": []}], ["If the proportional assist ventilation (PAV) level is known, muscular effort can be estimated from the difference between peak airway pressure and positive end-expiratory pressure (PEEP) (\u0394P) during PAV.", {"entities": []}], ["We conjectured that deducing muscle pressure from \u0394P may be an interesting method to set PAV, and tested this hypothesis using the oesophageal pressure time product calculation.", {"entities": []}], ["Eleven mechanically ventilated patients with oesophageal pressure monitoring under PAV were enrolled.", {"entities": []}], ["Patients were randomly assigned to seven assist levels (20\u201380%, PAV20 means 20% PAV gain) for 15\u00a0min.", {"entities": []}], ["Maximal muscular pressure calculated from oesophageal pressure (P mus, oes ) and from \u0394P (P mus, aw ) and inspiratory pressure time product derived from oesophageal pressure (PTP oes ) and from \u0394P (PTP aw ) were determined from the last minute of each level.", {"entities": []}], ["P mus, oes and PTP oes with consideration of PEEPi were expressed as P mus, oes, PEEPi and PTP oes, PEEPi , respectively.", {"entities": []}], ["Pressure time product was expressed as per minute (PTP oes , PTP oes, PEEPi , PTP aw ) and per breath (PTP oes, br , PTP oes, PEEPi, br , PTP aw, br ).", {"entities": []}], ["PAV significantly reduced the breathing effort of patients with increasing PAV gain (PTP oes 214.3\u2009\u00b1\u200980.0 at PAV20 vs. 83.7\u2009\u00b1\u200949.3 cmH 2 O\u2022s/min at PAV80, PTP oes, PEEPi 277.3\u2009\u00b1\u200996.4 at PAV20 vs. 121.4\u2009\u00b1\u200971.6 cmH 2 O\u2022s/min at PAV80, p \u2009<\u20090.0001).", {"entities": []}], ["P mus, aw overestimates P mus, oes for low-gain PAV and underestimates P mus, oes for moderate-gain to high-gain PAV.", {"entities": []}], ["An optimal P mus, aw could be achieved in 91% of cases with PAV60.", {"entities": []}], ["When the PAV gain was adjusted to P mus, aw of 5\u201310 cmH 2 O, there was a 93% probability of PTP oes <224 cmH 2 O\u2022s/min and 88% probability of PTP oes, PEEPi \u2009<\u2009255 cmH 2 O\u2022s/min.", {"entities": []}], ["Deducing maximal muscular pressure from \u0394P during PAV has limited accuracy.", {"entities": []}], ["The extrapolated pressure time product from \u0394P is usually less than the pressure time product calculated from oesophageal pressure tracing.", {"entities": []}], ["However, when the PAV gain was adjusted to P mus, aw of 5\u201310 cmH 2 O, there was a 90% probability of PTP oes and PTP oes, PEEPi within acceptable ranges.", {"entities": []}], ["This information should be considered when applying \u0394P to set PAV under various gains.", {"entities": []}], ["SOLAR II is the 2 Wherever possible, the same questionnaire instruments were used throughout the studies.", {"entities": []}], ["They included questions on respiratory and allergic diseases, domestic and occupational exposure and work related stress.", {"entities": []}], ["Furthermore, clinical examinations including skin prick tests, spirometry and bronchial challenge with methacholine, exhaled nitric oxide (FeNO) and blood samples were employed at baseline and 2 Of the 3053 SOLAR I study participants who had agreed to be contacted again, about 50% had moved in the meantime and had to be traced using phone directories and the German population registries.", {"entities": []}], ["Overall, 2904 of these participants could be contacted on average five years after the first follow-up.", {"entities": []}], ["From this group, 2051 subjects (71%) completed the questionnaire they received via mail.", {"entities": []}], ["Of these, 57% participated at least in some parts of the clinical examinations.", {"entities": []}], ["Challenges faced included the high mobility of this age group.", {"entities": []}], ["Time constraints and limited interest in the study were substantial.", {"entities": []}], ["Analysing the results, selection bias had to be considered as questionnaire responders (54%) and those participating in the clinical part of the study (63%) were more likely to have a high parental level of education compared to non-participants (42%).", {"entities": []}], ["Similarly, a higher prevalence of parental atopy (e.g.", {"entities": []}], ["allergic rhinitis) at baseline was found for participants in the questionnaire part (22%) and those participating in the clinical part of the study (27%) compared to non-participants (11%).", {"entities": [[0, 17, "DISEASE"], [9, 17, "DISEASE"]]}], ["In conclusion, a 12-year follow-up from childhood to adulthood is feasible resulting in a response of 32% of the baseline population.", {"entities": []}], ["However, our experience shows that researchers need to allocate more time to the field work when studying young adults compared to other populations.", {"entities": []}], ["Quinine remains an important anti-malarial drug almost 400 years after its effectiveness was first documented.", {"entities": []}], ["However, its continued use is challenged by its poor tolerability, poor compliance with complex dosing regimens, and the availability of more efficacious anti-malarial drugs.", {"entities": []}], ["This article reviews the historical role of quinine, considers its current usage and provides insight into its appropriate future use in the treatment of malaria.", {"entities": [[154, 161, "DISEASE"]]}], ["In light of recent research findings intravenous artesunate should be the first-line drug for severe malaria, with quinine as an alternative.", {"entities": [[101, 108, "DISEASE"]]}], ["The role of rectal quinine as pre-referral treatment for severe malaria has not been fully explored, but it remains a promising intervention.", {"entities": [[64, 71, "DISEASE"]]}], ["In pregnancy, quinine continues to play a critical role in the management of malaria, especially in the first trimester, and it will remain a mainstay of treatment until safer alternatives become available.", {"entities": [[77, 84, "DISEASE"]]}], ["For uncomplicated malaria, artemisinin-based combination therapy (ACT) offers a better option than quinine though the difficulty of maintaining a steady supply of ACT in resource-limited settings renders the rapid withdrawal of quinine for uncomplicated malaria cases risky.", {"entities": [[18, 25, "DISEASE"], [254, 261, "DISEASE"]]}], ["The best approach would be to identify solutions to ACT stock-outs, maintain quinine in case of ACT stock-outs, and evaluate strategies for improving quinine treatment outcomes by combining it with antibiotics.", {"entities": []}], ["In HIV and TB infected populations, concerns about potential interactions between quinine and antiretroviral and anti-tuberculosis drugs exist, and these will need further research and pharmacovigilance.", {"entities": [[118, 130, "DISEASE"]]}], ["Asthma is one of the most common conditions which complicate pregnancy.", {"entities": [[0, 6, "DISEASE"]]}], ["Pro- and anti-apoptotic mechanisms can be modulated by asthma accompanying pregnancy.", {"entities": [[55, 61, "DISEASE"]]}], ["Survivin, an anti-apoptotic protein has been implicated in the pathomechanism of asthma and also in the development of pathological pregnancies; however survivin has not been studied in pregnant asthmatics.", {"entities": [[81, 87, "DISEASE"]]}], ["Twenty-eight asthmatic pregnant (AP), 25 asthmatic non-pregnant (ANP), 21 healthy pregnant (HP) and 29 healthy non-pregnant (HNP) women were enrolled in this cross-sectional study.", {"entities": [[92, 94, "GENE"]]}], ["Plasma survivin concentration was determined by ELISA.", {"entities": []}], ["Plasma survivin was significantly lower in HP (1.64 /0-74.9/ pg/ml) than in HNP (24.6 /0-333.3/ pg/ml, p\u2009=\u20090.01).", {"entities": [[43, 45, "GENE"]]}], ["However, this difference was not observed between the asthmatic groups (p\u2009=\u20090.64).", {"entities": []}], ["Similarly, there was no difference either between HNP and ANP (10.5 /0-215.4/ pg/ml, p\u2009=\u20090.23) or between HP and AP (13.9 /0-364.1/ pg/ml, p\u2009=\u20090.30) groups.", {"entities": [[106, 108, "GENE"]]}], ["Decreased plasma survivin levels in physiological but not in asthmatic pregnancy may suggest that the normal apoptotic mechanisms are compromised in asthmatic gestation.", {"entities": []}], ["Exposure to ozone activates innate immune function and causes neutrophilic (PMN) airway inflammation that in some individuals is robustly elevated.", {"entities": []}], ["The interplay between immuno-inflammatory function and genomic signaling in those with heightened inflammatory responsiveness to ozone is not well understood.", {"entities": []}], ["Determine baseline predictors and post exposure discriminators for the immuno-inflammatory response to ozone in inflammatory responsive adult volunteers.", {"entities": []}], ["Sputum induction was performed on 27 individuals before and after a two hour chamber exposure to 0.4\u2009ppm ozone.", {"entities": []}], ["Subjects were classified as inflammatory responders or non-responders to ozone based on their PMN response.", {"entities": []}], ["Innate immune function, inflammatory cell and cytokine modulation and transcriptional signaling pathways were measured in sputum.", {"entities": []}], ["Post exposure, responders showed activated innate immune function (CD16: 31,004 MFI vs 8988 MFI; CD11b: 44,986 MFI vs 24,770 MFI; CD80: 2236 MFI vs 1506 MFI; IL-8: 37,603\u2009pg/ml vs 2828\u2009pg/ml; and IL-1\u03b2: 1380 pg/ml vs 318 pg/ml) with muted signaling of immune cell trafficking pathways.", {"entities": [[130, 134, "GENE"], [233, 238, "GENE"]]}], ["In contrast, non-responders displayed decreased innate immune activity (CD16, CD80; phagocytosis: 2 particles/PMN vs 4 particles/PMN) post exposure that was accompanied by a heightened signaling of immune cell trafficking pathways.", {"entities": [[78, 82, "GENE"]]}], ["Inflammatory responsive and non responsive individuals to ozone show an inverse relationship between immune cell trafficking and immuno-inflammatory functional responses to ozone.", {"entities": []}], ["These distinct genomic signatures may further our understanding about ozone-induced morbidity in individuals with different levels of inflammatory responsiveness.", {"entities": []}], ["Danger signals activate Toll-like receptors (TLRs), thereby initiating inflammatory responses.", {"entities": []}], ["Canonical TLR signalling, via Toll/Interleukin-1 receptor domain (TIR)-containing adaptors and proinflammatory transcription factors such as NF-\u03baB, occurs in many cell types; however, additional mechanisms are required for specificity of inflammatory responses in innate immune cells.", {"entities": []}], ["Here we show that SCIMP, an immune-restricted, transmembrane adaptor protein (TRAP), promotes selective proinflammatory cytokine responses by direct modulation of TLR4.", {"entities": [[163, 167, "GENE"]]}], ["SCIMP is a non-TIR-containing adaptor, binding directly to the TLR4-TIR domain in response to lipopolysaccharide.", {"entities": []}], ["In macrophages, SCIMP is constitutively associated with the Lyn tyrosine kinase, is required for tyrosine phosphorylation of TLR4, and facilitates TLR-inducible production of the proinflammatory cytokines IL-6 and IL-12p40.", {"entities": [[60, 63, "GENE"], [125, 129, "GENE"]]}], ["Point mutations in SCIMP abrogating TLR4 binding also prevent SCIMP-mediated cytokine production.", {"entities": [[36, 40, "GENE"]]}], ["SCIMP is, therefore, an immune-specific TLR adaptor that shapes host defence and inflammation.", {"entities": []}], ["Toll-like receptors engage TIR domain-containing adaptors to control proinflammatory gene expression in response to pathogens and tissue damage.", {"entities": []}], ["Here the authors show that the non-TIR domain-containing transmembrane protein SCIMP is a previously unrecognized TLR adaptor expressed by macrophages.", {"entities": []}], ["There is increasing evidence that a specific immune response contributes to the pathogenesis of COPD.", {"entities": []}], ["B-cell follicles are present in lung tissue and increased anti-elastin titers have been found in plasma of COPD patients.", {"entities": []}], ["Additionally, regulatory T cells (Tregs) have been implicated in its pathogenesis as they control immunological reactions.", {"entities": []}], ["We hypothesize that the specific immune response in COPD is smoke induced, either by a direct effect of smoking or as a result of smoke-induced lung tissue destruction (i.e.", {"entities": []}], ["formation of neo-epitopes or auto antigens).", {"entities": []}], ["Furthermore, we propose that Tregs are involved in the suppression of this smoke-induced specific immune response.", {"entities": []}], ["The presence of B cells, memory B cells and Tregs was assessed by flow cytometry in peripheral blood of 20 COPD patients and 29 healthy individuals and related to their current smoking status.", {"entities": []}], ["COPD patients had lower (memory) B-cell percentages and higher Treg percentages in peripheral blood than healthy individuals, with a significant negative correlation between these cells.", {"entities": []}], ["Interestingly, current smokers had higher percentages of (class-switched) memory B cells than ex-smokers and never smokers, irrespective of COPD.", {"entities": []}], ["This increase in (class-switched) memory B cells in current smokers is intriguing and suggests that smoke-induced neo-antigens may be constantly induced in the lung.", {"entities": []}], ["The negative correlation between B cells and Tregs in blood is in line with previously published observations that Tregs can suppress B cells.", {"entities": []}], ["Future studies focusing on the presence of these (class switched) memory B cells in the lung, their antigen specificity and their interaction with Tregs are necessary to further elucidate the specific B-cell response in COPD.", {"entities": []}], ["Food allergy is an increasing burden worldwide and is a common problem within paediatric populations, affecting 5%\u20138% of children.", {"entities": []}], ["Anaphylaxis caused by food proteins is a potentially life-threatening condition and all healthcare practitioners should be aware of its recognition and management.", {"entities": []}], ["Russia is the largest country in Europe but it is still unknown whether physicians are prepared to diagnose and manage food-induced anaphylaxis effectively.", {"entities": []}], ["We aimed to examine physicians\u2019 knowledge of diagnosis and management of food-induced anaphylaxis.", {"entities": []}], ["A survey was designed and published online at VrachiRF.ru website (for registered Russian-speaking practicing physicians).", {"entities": []}], ["We obtained information on respondents\u2019 clinical settings, experience and specialty.", {"entities": []}], ["Survey questions were based on a characteristic clinical scenario of anaphylaxis due to food ingestion.", {"entities": []}], ["Outcome measures consisted of correct answers to the anaphylaxis diagnosis and management questions.", {"entities": []}], ["From a total of 707 of physicians accessed in the survey, 315 (45%) responded to the clinical scenario.", {"entities": []}], ["16 respondents reported training in allergy-immunology and have been excluded from the analysis, leaving the final sample size of 299.", {"entities": []}], ["Respondents were paediatricians (68%) and other specialties adult physicians (32%).", {"entities": []}], ["Overall, 100 (33%) of respondents diagnosed anaphylaxis, but only 29% of those making the correct diagnosis administered adrenalin (1:1000) intramuscular.", {"entities": []}], ["Respondents working in secondary/tertiary clinics diagnosed anaphylaxis significantly more often (p=0.04) when compared with primary care/private practice physicians.", {"entities": []}], ["This difference was also apparent as the most important influence on responses in the multivariate analysis.", {"entities": []}], ["In this national sample of Russian physicians, we found poor knowledge in both anaphylaxis diagnosis and management.", {"entities": []}], ["Our data show that the chance of being properly diagnosed with anaphylaxis is 33% and being appropriately treated with adrenalin is 10%.", {"entities": []}], ["These findings highlight lack of anaphylaxis knowledge among Russian physicians, both paediatricians and other specialists and illustrates the urgent need for allergy/anaphylaxis training.", {"entities": []}], ["Patients with bronchitis type of chronic obstructive pulmonary disease (COPD) have raised vascular endothelial growth factor (VEGF) levels in induced sputum.", {"entities": [[33, 70, "DISEASE"], [14, 24, "DISEASE"]]}], ["This has been associated with the pathogenesis of COPD through apoptotic and oxidative stress mechanisms.", {"entities": []}], ["Since, chronic airway inflammation is an important pathological feature of COPD mainly initiated by cigarette smoking, aim of this study was to assess smoking as a potential cause of raised airway VEGF levels in bronchitis type COPD and to test the association between VEGF levels in induced sputum and airway inflammation in these patients.", {"entities": [[212, 222, "DISEASE"]]}], ["14 current smokers with bronchitis type COPD, 17 asymptomatic current smokers with normal spirometry and 16 non-smokers were included in the study.", {"entities": [[24, 34, "DISEASE"]]}], ["VEGF, IL-8, and TNF-\u03b1 levels in induced sputum were measured and the correlations between these markers, as well as between VEGF levels and pulmonary function were assessed.", {"entities": []}], ["The median concentrations of VEGF, IL-8, and TNF-\u03b1 were significantly higher in induced sputum of COPD patients (1,070 pg/ml, 5.6 ng/ml and 50 pg/ml, respectively) compared to nonsmokers (260 pg/ml, 0.73 ng/ml, and 15.4 pg/ml, respectively, p < 0.05) and asymptomatic smokers (421 pg/ml, 1.27 ng/ml, p < 0.05, and 18.6 pg/ml, p > 0.05, respectively).", {"entities": []}], ["Significant correlations were found between VEGF levels and pack years (r = 0.56, p = 0.046), IL-8 (r = 0.64, p = 0.026) and TNF-\u03b1 (r = 0.62, p = 0.031) levels both in asymptomatic and COPD smokers (r = 0.66, p = 0.027, r = 0.67, p = 0.023, and r = 0.82, p = 0.002, respectively).", {"entities": []}], ["No correlation was found between VEGF levels in sputum and pulmonary function parameters.", {"entities": []}], ["VEGF levels are raised in the airways of both asymptomatic and COPD smokers.", {"entities": []}], ["The close correlation observed between VEGF levels in the airways and markers of airway inflammation in healthy smokers and in smokers with bronchitis type of COPD is suggestive of VEGF as a marker reflecting the inflammatory process that occurs in smoking subjects without alveolar destruction.", {"entities": [[140, 150, "DISEASE"]]}], ["This analysis characterizes the degree of early organ involvement in a cohort of oligo-symptomatic untreated young patients with Fabry disease enrolled in an ongoing randomized, open-label, parallel-group, phase 3B clinical trial.", {"entities": []}], ["Males aged 5\u201318 years with complete \u03b1-galactosidase A deficiency, without symptoms of major organ damage, were enrolled in a phase 3B trial evaluating two doses of agalsidase beta.", {"entities": []}], ["Baseline disease characteristics of 31 eligible patients (median age 12 years) were studied, including cellular globotriaosylceramide (GL-3) accumulation in skin (n = 31) and kidney biopsy (n = 6; median age 15 years; range 13\u201317 years), renal function, and glycolipid levels (plasma, urine).", {"entities": []}], ["Plasma and urinary GL-3 levels were abnormal in 25 of 30 and 31 of 31 patients, respectively.", {"entities": []}], ["Plasma lyso-GL-3 was elevated in all patients.", {"entities": []}], ["GL-3 accumulation was documented in superficial skin capillary endothelial cells (23/31 patients) and deep vessel endothelial cells (23/29 patients).", {"entities": []}], ["The mean glomerular filtration rate (GFR), measured by plasma disappearance of iohexol, was 118.1 mL/min/1.73 m These data reveal that in this small cohort of children with Fabry disease, histological evidence of GL-3 accumulation, and cellular and vascular injury are present in renal tissues at very early stages of the disease, and are noted before onset of microalbuminuria and development of clinically significant renal events (e.g.", {"entities": []}], ["reduced GFR).", {"entities": []}], ["These data give additional support to the consideration of early initiation of enzyme replacement therapy, potentially improving long-term outcome.", {"entities": []}], ["ClinicalTrials.gov NCT00701415", {"entities": []}], ["G-protein coupled receptors (GPCRs) mediate cellular responses to various hormones and neurotransmitters and are important targets for treating a wide spectrum of diseases.", {"entities": []}], ["G-protein coupled receptors (GPCRs) mediate cellular responses to various hormones and neurotransmitters and are important targets for treating a wide spectrum of diseases.", {"entities": []}], ["They are known to adopt multiple conformational states ( e.g.", {"entities": []}], [", inactive, intermediate and active) during their modulation of various cell signaling pathways.", {"entities": []}], ["Here, the free energy landscape of GPCRs is explored using accelerated molecular dynamics (aMD) simulations as demonstrated on the M2 muscarinic receptor, a key GPCR that regulates human heart rate and contractile forces of cardiomyocytes.", {"entities": []}], ["Free energy profiles of important structural motifs that undergo conformational transitions upon GPCR activation and allosteric signaling are analyzed in detail, including the Arg", {"entities": []}], ["Prenatal stress can affect lifelong physical growth, including increased obesity risk.", {"entities": [[73, 80, "DISEASE"]]}], ["However, human studies remain limited.", {"entities": []}], ["Natural disasters provide models of independent stressors unrelated to confounding maternal characteristics.", {"entities": []}], ["We assessed degree of objective hardship and subjective distress in women pregnant during severe flooding.", {"entities": []}], ["At ages 2.5 and 4 years we assessed body mass index (BMI), subscapular plus triceps skinfolds (SS + TR, an index of total adiposity), and SS\u2009:\u2009TR ratio (an index of central adiposity) in their children ( n = 106).", {"entities": []}], ["Hierarchical regressions controlled first for several potential confounds.", {"entities": []}], ["Controlling for these, flood exposure during early gestation predicted greater BMI increase from age 2.5 to 4, as well as total adiposity at 2.5.", {"entities": []}], ["Greater maternal hardship and distress due to the floods, as well as other nonflood life events during pregnancy, independently predicted greater increase in total adiposity between 2.5 and 4 years.", {"entities": []}], ["These results support the hypothesis that prenatal stress increases adiposity beginning in childhood and suggest that early gestation is a sensitive period.", {"entities": []}], ["Results further highlight the additive effects of maternal objective and subjective stress, life events, and depression, emphasizing the importance of continued studies on multiple, detailed measures of maternal mental health and experience in pregnancy and child growth.", {"entities": []}], ["Respiratory allergic disease represents a global health problem, 30% of the population suffers from allergic rhinoconjunctivitis and 20% suffer from asthma.", {"entities": [[149, 155, "DISEASE"]]}], ["Allergy immunotherapy induce immunological tolerance and thereby modify the response to allergens and sublingual immunotherapy (SLIT) offers the possibility of home administration of allergen therapy, but adherence is more uncertain.", {"entities": []}], ["The aim of the study was to investigate the adherence with GRAZAX in adults and children\u2009\u2265\u20095 years during three consecutive years of treatment.", {"entities": []}], ["This was a non-interventional, prospective, observational, multi-center, open-label study to investigate adherence, quality of life, safety and tolerability of GRAZAX in adult and pediatric patients in a real-life setting.", {"entities": []}], ["During the 3-years study period estimation of adherence was done regularly.", {"entities": []}], ["Quality of life as well as symptom score was also assessed.", {"entities": []}], ["In total, 399 patients (236 adults and 163 children) were included in the study.", {"entities": []}], ["At baseline, 100% suffered from moderate-severe eyes and nose symptoms, and 31% had asthma in the grass pollen season.", {"entities": [[84, 90, "DISEASE"]]}], ["Overall, 55% completed a 3-years treatment period, whereas 37% stopped before end of study and 8% were lost to follow up.", {"entities": []}], ["After 3 years, the adherence rate decreased from 98.2% (first month), 93.7% (first year), 93.2% (second year) and 88.9% (third year) and adverse events were the main reason for pre-term termination.", {"entities": []}], ["The study suggests a good adherence to treatment in a real life setting among the patients finalizing 3-years SLIT therapy.", {"entities": []}], ["The treatment was effective both on symptoms and HRQL.", {"entities": []}], ["A three-year trial of the allergy immunotherapy GRAZAX shows good adherence and tolerance among adults and children.", {"entities": []}], ["Respiratory allergic disease is a significant global health burden, with 30 per cent of Europe\u2019s population suffering from hayfever and 20 per cent from allergic asthma.", {"entities": [[153, 168, "DISEASE"], [162, 168, "DISEASE"]]}], ["While antihistamines and steroids can treat symptoms successfully, they do not tackle the underlying allergy.", {"entities": []}], ["Recent progress in immunotherapies such as GRAZAX\u2014a therapy specifically targeting grass pollen allergy\u2014have shown promise.", {"entities": []}], ["Hampus Kiotseridis at Lund University, Sweden, and co-workers tracked patient adherence and health in 399 adults and children taking GRAZAX over three years.", {"entities": []}], ["55 per cent of patients completed the study treatment, with 85 per cent taking GRAZAX six to seven times a week.", {"entities": []}], ["GRAZAX proved to be well-tolerated overall, effectively tackling symptoms and improving patients\u2019 quality of life.", {"entities": []}], ["Although the intestinal tract plays a major role in early human immunodeficiency virus (HIV) infection, the role of immune activation and viral replication in intestinal tissues is not completely understood.", {"entities": []}], ["Further, increasing evidence suggests the early leukocyte activation antigen CD69 may be involved in the development or regulation of important T cell subsets, as well as a major regulatory molecule of immune responses.", {"entities": [[77, 81, "GENE"]]}], ["Using the simian immunodeficiency virus (SIV) rhesus macaque model, we compared expression of CD69 on T cells from the intestine, spleen, lymph nodes, and blood of normal and SIV-infected macaques throughout infection.", {"entities": [[94, 98, "GENE"]]}], ["In uninfected macaques, the majority of intestinal lamina propria CD4+ T cells had a memory (CD95+) phenotype and co-expressed CD69, and essentially all intestinal CCR5+ cells co-expressed CD69.", {"entities": [[127, 131, "GENE"], [189, 193, "GENE"], [127, 131, "GENE"], [189, 193, "GENE"]]}], ["In contrast, systemic lymphoid tissues had far fewer CD69+ T cells, and many had a na\u00efve phenotype.", {"entities": []}], ["Further, marked, selective depletion of intestinal CD4+CD69+ T cells occurred in early SIV infection, and this depletion persisted throughout infection.", {"entities": []}], ["Markedly increased levels of CD8+CD69+ T cells were detected after SIV infection in virtually all tissues, including the intestine.", {"entities": []}], ["Further, confocal microscopy demonstrated selective, productive infection of CD3+CD69+ T cells in the intestine in early infection.", {"entities": []}], ["Combined, these results indicate CD69+CD4+ T cells are a major early target for viral infection, and their rapid loss by direct infection may have profound effects on intestinal immune regulation in HIV infected patients.", {"entities": []}], ["Glucagon-like peptide 1 (GLP1) is rapidly inactivated by dipeptidyl peptidase 4 (DPP4), but may interact with vagal neurons at its site of secretion.", {"entities": [[81, 85, "GENE"]]}], ["We investigated the role of vagal innervation for handling of oral and i.v.", {"entities": []}], ["Truncally vagotomised subjects ( n =16) and matched controls ( n =10) underwent 50\u200ag-oral glucose tolerance test (OGTT)\u00b1vildagliptin, a DPP4 inhibitor (DPP4i) and isoglycaemic i.v.", {"entities": [[136, 140, "GENE"]]}], ["glucose infusion (IIGI), copying the OGTT without DPP4i.", {"entities": []}], ["Isoglycaemia was obtained with 25\u00b12\u200ag glucose in vagotomised subjects and 18\u00b12\u200ag in controls ( P <0.03); thus, gastrointestinal-mediated glucose disposal (GIGD) \u2013 a measure of glucose handling (100%\u00d7(glucose OGTT \u2212glucose IIGI /glucose OGTT )) \u2013 was reduced in the vagotomised compared with the control group.", {"entities": []}], ["Peak intact GLP1 concentrations were higher in the vagotomised group.", {"entities": []}], ["Gastric emptying was faster in vagotomised subjects after OGTT and was unaffected by DPP4i.", {"entities": []}], ["The early glucose-dependent insulinotropic polypeptide response was higher in vagotomised subjects.", {"entities": []}], ["Despite this, the incretin effect was equal in both groups.", {"entities": []}], ["DPP4i enhanced insulin secretion in controls, but had no effect in the vagotomised subjects.", {"entities": []}], ["Controls suppressed glucagon concentrations similarly, irrespective of the route of glucose administration, whereas vagotomised subjects showed suppression only during IIGI and exhibited hyperglucagonaemia following OGTT.", {"entities": []}], ["DPP4i further suppressed glucagon secretion in controls and tended to normalise glucagon responses in vagotomised subjects.", {"entities": []}], ["GIGD is diminished, but the incretin effect is unaffected in vagotomised subjects despite higher GLP1 levels.", {"entities": []}], ["This, together with the small effect of DPP4i, is compatible with the notion that part of the physiological effects of GLP1 involves vagal transmission.", {"entities": []}], ["The importance of the underlying local and systemic oxidative stress and inflammation in chronic obstructive pulmonary disease (COPD) has long been established.", {"entities": [[89, 126, "DISEASE"]]}], ["In view of the lack of therapy that might inhibit the progress of the disease, there is an urgent need for a successful therapeutic approach that, through affecting the pathological processes, will influence the subsequent issues in COPD management such as lung function, airway clearance, dyspnoea, exacerbation, and quality of life.", {"entities": []}], ["N-acetylcysteine (NAC) is a mucolytic and antioxidant drug that may also influence several inflammatory pathways.", {"entities": []}], ["It provides the sulfhydryl groups and acts both as a precursor of reduced glutathione and as a direct reactive oxygen species (ROS) scavenger, hence regulating the redox status in the cells.", {"entities": []}], ["The changed redox status may, in turn, influence the inflammation-controlling pathways.", {"entities": []}], ["Moreover, as a mucolytic drug, it may, by means of decreasing viscosity of the sputum, clean the bronchi leading to a decrease in dyspnoea and improved lung function.", {"entities": []}], ["Nevertheless, as successful as it is in the in vitro studies and in vivo studies with high dosage, its actions at the dosages used in COPD management are debatable.", {"entities": []}], ["It seems to influence exacerbation rate and limit the number of hospitalization days, however, with little or no influence on the lung function parameters.", {"entities": []}], ["Despite these considerations and in view of the present lack of effective therapies to inhibit disease progression in COPD, NAC and its derivatives with their multiple molecular modes of action remain promising medication once doses and route of administration are optimized.", {"entities": []}], ["The MID1 ubiquitin ligase activates mTOR signaling and regulates mRNA translation.", {"entities": [[4, 8, "GENE"], [36, 40, "GENE"]]}], ["Misregulation of MID1 expression is associated with various diseases including midline malformation syndromes, cancer and neurodegenerative diseases.", {"entities": [[111, 117, "DISEASE"], [17, 21, "GENE"]]}], ["While this indicates that MID1 expression must be tightly regulated to prevent disease states specific mechanisms involved have not been identified.", {"entities": [[26, 30, "GENE"]]}], ["We examined miRNAs to determine mechanisms that regulate MID1 expression.", {"entities": [[57, 61, "GENE"]]}], ["MicroRNAs (miRNA) are small non-coding RNAs that recognize specific sequences in their target mRNAs.", {"entities": []}], ["Upon binding, miRNAs typically downregulate expression of these targets.", {"entities": []}], ["Here, we identified four miRNAs, miR-19, miR-340, miR-374 and miR-542 that bind to the 3\u2019-UTR of the MID1 mRNA.", {"entities": [[41, 48, "GENE"], [101, 105, "GENE"]]}], ["These miRNAs not only regulate MID1 expression but also mTOR signaling and translation of disease associated mRNAs and could therefore serve as potential drugs for future therapy development.", {"entities": [[31, 35, "GENE"], [56, 60, "GENE"]]}], ["Pharmacogenomic developments hold promise for personalized medicine in psychiatry with adjusted therapeutic doses, predictable responses, reduced adverse drug reactions, early diagnosis, and personal health planning.", {"entities": []}], ["The prospects are exciting, but at the same time, these new techniques stand faced with important scientific, ethical, legal, and social challenges that need to be met in order for the scientific advances to be responsibly applied.", {"entities": []}], ["This review discusses the ethical balance between challenge and opportunity of personalized medicine in psychiatry under the aspects of adequacy, costbenefit ratio, and therapeutic equity.", {"entities": []}], ["It is argued that the promising nature of these therapeutic possibilities makes it all the more important to avoid exaggerating the expectations, and that a sophisticated social infrastructure needs to be developed in order to ensure the realistic and responsible application of personalized medicine in psychiatry.", {"entities": []}], ["With the continuous improvement in genotyping and molecular phenotyping technology and the decreasing typing cost, it is expected that in a few years, more and more clinical studies of complex diseases will recruit thousands of individuals for pan-omic genetic association analyses.", {"entities": []}], ["Hence, there is a great need for algorithms and software tools that could scale up to the whole omic level, integrate different omic data, leverage rich structure information, and be easily accessible to non-technical users.", {"entities": []}], ["We present GenAMap, an interactive analytics software platform that 1) automates the execution of principled machine learning methods that detect genome- and phenome-wide associations among genotypes, gene expression data, and clinical or other macroscopic traits, and 2) provides new visualization tools specifically designed to aid in the exploration of association mapping results.", {"entities": []}], ["Algorithmically, GenAMap is based on a new paradigm for GWAS and PheWAS analysis, termed structured association mapping , which leverages various structures in the omic data.", {"entities": []}], ["We demonstrate the function of GenAMap via a case study of the Brem and Kruglyak yeast dataset, and then apply it on a comprehensive eQTL analysis of the NIH heterogeneous stock mice dataset and report some interesting findings.", {"entities": []}], ["GenAMap is available from http://sailing.cs.cmu.edu/genamap .", {"entities": []}], ["The human pharyngeal microbiome, which resides at the juncture of digestive and respiratory tracts, may have an active role in the prevention of respiratory tract infections, similar to the actions of the intestinal microbiome against enteric infections.", {"entities": []}], ["Recent studies have demonstrated that the pharyngeal microbiome comprises an abundance of bacterial species that interacts with the local epithelial and immune cells, and together, they form a unique micro-ecological system.", {"entities": []}], ["Most of the microbial species in microbiomes are obligate symbionts constantly adapting to their unique surroundings.", {"entities": []}], ["Indigenous commensal species are capable of both maintaining dominance and evoking host immune responses to eliminate invading species.", {"entities": []}], ["Temporary damage to the pharyngeal microbiome due to the impaired local epithelia is also considered an important predisposing risk factor for infections.", {"entities": []}], ["Therefore, reinforcement of microbiome homeostasis to prevent invasion of infection-prone species would provide a novel treatment strategy in addition to antibiotic treatment and vaccination.", {"entities": []}], ["Hence continued research efforts on evaluating probiotic treatment and developing appropriate procedures are necessary to both prevent and treat respiratory infections.", {"entities": []}], ["Over the last five years, there have been numerous reports of association of juvenile idiopathic arthritis with single nucleotide polymorphisms (SNPs) at various loci outside the major histocompatibility complex (MHC) region.", {"entities": [[97, 106, "DISEASE"]]}], ["However, the majority of these association findings have been generated using a limited number of international cohorts, and thus there is benefit in further independent replication.", {"entities": []}], ["To address this, we examined a total of 56 SNPs in 42 non-MHC gene regions previously reported to be associated with JIA, in the ChiLdhood Arthritis Risk factor Identification sTudY (CLARITY), a new Australian collection of cases and healthy child controls.", {"entities": [[139, 148, "DISEASE"]]}], ["Genotyping was performed on a total of 324 JIA cases (mean age 9.7\u00a0years, 67.3% female) and 568 controls (mean age 7.8\u00a0years, 40.7% female).", {"entities": []}], ["We demonstrated clear evidence for replication of association of JIA with SNPs in or around c12orf30 , c3orf1 , PTPN22 , STAT4 , and TRAF1-C5, confirming the involvement of these loci in disease risk.", {"entities": [[103, 109, "GENE"], [112, 118, "GENE"], [121, 126, "GENE"]]}], ["Further, we generated evidence supportive of replication of association of JIA with loci containing AFF3 , CD226 , MBL2 , PSTPIP1 , and RANTES (CCL5).", {"entities": [[100, 104, "GENE"], [107, 112, "GENE"], [115, 119, "GENE"], [122, 129, "GENE"], [144, 148, "GENE"]]}], ["These results were robust to sensitivity analyses for ethnicity.", {"entities": []}], ["We have provided valuable independent data as to the underlying genetic architecture of this understudied pediatric autoimmune disease, further confirming five loci outside the MHC, and supporting a role for a further five loci in determining disease risk.", {"entities": []}], ["Autoantibodies against the second extracellular loop of the \u03b2 1 -adrenergic receptor (\u03b2 1 -AA) not only contribute to increased susceptibility to heart failure, but also play a causative role in myocardial remodeling through their sympathomimetic-like effects that are induced upon binding to the \u03b2 1 -adrenergic receptor.", {"entities": []}], ["However, their role in the function of T lymphocytes has never been previously investigated.", {"entities": []}], ["Our present study was designed to determine whether \u03b2 1 -AA isolated from the sera of dilated cardiomyopathy (DCM) patients caused the proliferation of T cells and the secretion of cytokines.", {"entities": [[94, 108, "DISEASE"], [86, 108, "DISEASE"]]}], ["Blood samples were collected from 95 DCM patients as well as 95 healthy subjects, and \u03b2 1 -AA was detected using ELISA.", {"entities": []}], ["The CD3 1 -AA on T lymphocyte proliferation was examined by CCK-8 kits and CFSE assay.", {"entities": []}], ["Western blotting was used to analyze the expressions of phospho-VASP and phospho-p38 MAPK.", {"entities": []}], ["\u03b2 1 -AA enhanced the proliferation of T lymphocytes.", {"entities": []}], ["This effect could be blocked by the selective \u03b2 1 -adrenergic receptor antagonist metoprolol, PKA inhibitor H89, and p38 MAPK inhibitor SB203580.", {"entities": []}], ["Furthermore, the expression of the phosphorylated forms of phospho-VASP and phospho-p38 MAPK were markedly increased in the presence of \u03b2 1 -AA.", {"entities": []}], ["\u03b2 1 -AA also inhibited the secretion of interferon-\u03b3 (IFN-\u03b3) while promoting an increase in interleukin-4 (IL-4) levels.", {"entities": []}], ["These results demonstrate that \u03b2 1 -AA isolated from DCM patients binds to \u03b2 1 -AR on the surface of T cells, causing changes in T-cell proliferation and secretion through the \u03b2 1 -AR/cAMP/PKA and p38 MAPK pathways.", {"entities": []}], ["The local mechanical properties of cells are frequently probed by force indentation experiments carried out with an atomic force microscope.", {"entities": []}], ["Application of common contact models provides a single parameter, the Young\u2019s modulus, to describe the elastic properties of cells.", {"entities": []}], ["The viscoelastic response of cells, however, is generally measured in separate microrheological experiments that provide complex shear moduli as a function of time or frequency.", {"entities": []}], ["Here, we present a straightforward way to obtain rheological properties of cells from regular force distance curves collected in typical force indentation measurements.", {"entities": []}], ["The method allows us to record the stress-strain relationship as well as changes in the weak power law of the viscoelastic moduli.", {"entities": []}], ["We derive an analytical function based on the elastic-viscoelastic correspondence principle applied to Hertzian contact mechanics to model both indentation and retraction curves.", {"entities": []}], ["Rheological properties are described by standard viscoelastic models and the paradigmatic weak power law found to interpret the viscoelastic properties of living cells best.", {"entities": []}], ["We compare our method with atomic force microscopy-based active oscillatory microrheology and show that the method to determine the power law coefficient is robust against drift and largely independent of the indentation depth and indenter geometry.", {"entities": []}], ["Cells were subject to Cytochalasin D treatment to provoke a drastic change in the power law coefficient and to demonstrate the feasibility of the approach to capture rheological changes extremely fast and precisely.", {"entities": []}], ["The method is easily adaptable to different indenter geometries and acquires viscoelastic data with high spatiotemporal resolution.", {"entities": []}], ["To analyze the perception of parents about secondhand smoking in their children's health.", {"entities": []}], ["Ethnographic qualitative and quantitative study.", {"entities": []}], ["We sought the point of view and understanding of the parents who were active smokers in relation to environmental tobacco smoke (ETS) and secondhand smoking.", {"entities": []}], ["Mothers and fathers who are active smokers and that live with their children from seven different public schools in the city of An\u00e1polis, Midwest Brazil, were interviewed in the first semester of in a reserved room in the schools.", {"entities": []}], ["A descriptive and qualitative analysis was carried out through the ethnography.", {"entities": []}], ["58 parents with an average time of smoking of 15.3 years and an average quantity of cigarettes smoked per day of 2 were interviewed.", {"entities": []}], ["Among them, 59% did not know what ETS was, and 60% stated knowing what a secondhand smoker was.", {"entities": []}], ["However, when questioned about their children as secondhand smokers, 52% did not consider them to be.", {"entities": []}], ["Some parents knew some of the effects of secondhand smoking in the health of their children.", {"entities": []}], ["However, the majority (52%) of them did not believe that their children would suffer any respiratory impairment or did not know about these impairments.", {"entities": []}], ["Children were exposed to environmental tobacco pollution in their residence if one considers parental duration of smoking and average of cigarettes smoked per day.", {"entities": []}], ["There was a lack of knowledge of the parents about ETS, secondhand smoking and the evils that cigarettes could cause in the health of their children.", {"entities": []}], ["Analisar a percep\u00e7\u00e3o dos pais a respeito do tabagismo passivo na sa\u00fade de seus filhos.", {"entities": []}], ["Estudo qualiquantitativo de car\u00e1ter etnogr\u00e1fico.", {"entities": []}], ["Buscou-se o ponto de vista e o conhecimento dos pais fumantes ativos quanto \u00e0 polui\u00e7\u00e3o tabag\u00edstica ambiental e ao tabagismo passivo.", {"entities": []}], ["Foram inclu\u00eddos m\u00e3es e pais fumantes ativos que conviviam diariamente com seus filhos em sete escolas p\u00fablicas da cidade de An\u00e1polis (GO) no primeiro semestre de 2014.", {"entities": []}], ["Os pais foram entrevistados em uma sala reservada nas escolas.", {"entities": []}], ["Procedeu-se \u00e0 an\u00e1lise descritiva e qualitativa por meio da etnografia.", {"entities": [[47, 50, "GENE"]]}], ["A amostra foi de 58 pais, o tempo m\u00e9dio de tabagismo de 15,3 anos e a quantidade m\u00e9dia de cigarros fumados por dia de 20,1.", {"entities": [[107, 110, "GENE"]]}], ["Grande parte (59%) dos pais n\u00e3o sabia o que era polui\u00e7\u00e3o tabag\u00edstica ambiental e 60% disseram saber o que era um fumante passivo.", {"entities": []}], ["Contudo, quando perguntados a respeito de considerarem seus filhos fumantes passivos, 52% n\u00e3o os consideravam.", {"entities": []}], ["Observou-se que alguns pais t\u00eam conhecimento sobre a influ\u00eancia do tabagismo passivo na sa\u00fade de seus filhos.", {"entities": []}], ["Contudo, a maioria (52%) deles acredita que seus filhos podem n\u00e3o sofrer preju\u00edzo respirat\u00f3rio ou n\u00e3o sabem quais preju\u00edzo s\u00e3o esses.", {"entities": []}], ["As crian\u00e7as analisadas ficavam expostas \u00e0 polui\u00e7\u00e3o tabag\u00edstica ambiental no domicilio, o que ficou evidente por meio dos dados, do tempo de tabagismo e da m\u00e9dia de cigarros fumados por dia.", {"entities": [[108, 111, "GENE"], [181, 184, "GENE"], [108, 111, "GENE"], [181, 184, "GENE"]]}], ["Entretanto, percebeu-se car\u00eancia no conhecimento dos pais a respeito da polui\u00e7\u00e3o tabag\u00edstica ambiental, do tabagismo passivo e dos males que o cigarro pode causar na sa\u00fade dos filhos.", {"entities": []}], ["The aim of this study is to investigate healing of fractures in patients with concomitant head injuries and to measure blood hormone levels to elucidate the mechanism of a possible accelerated osteogenesis.", {"entities": []}], ["One hundred and sixty-two patients were included in this study and divided into 3 cohorts: group A with head injuries only (n = 52); group B with head injuries as well as long-bone fractures (n = 50); group C with long-bone fractures only (n = 60).", {"entities": []}], ["Fracture-healing parameters including time of appearance and thickness of the bridging callus, and blood hormonal assays were measured and compared using Student's t test.", {"entities": []}], ["The mean time to healing was significantly lower in cohort B (6.9 \u00b1 2.9 weeks) than C (22.4 \u00b1 8.7 weeks; p = 0.001).", {"entities": []}], ["The mean thickness of the healing callus was significantly higher in cohort B (26.3 \u00b1 9.7 mm) than C (8.1 \u00b1 5.9 mm; p = 0.002).", {"entities": []}], ["The mean healing rate was also higher in cohort B (4.5 \u00b1 2.3 mm/week) than C (0.38 \u00b1 0.21 mm/week; p = 0.001).", {"entities": []}], ["Blood hormonal assays in group B showed higher values of parathyroid hormone and growth hormone than in group C. However, adrenaline and noradrenaline values were lower in group B than in group C at all measured time intervals, and correspondingly leptin was lower in all groups (p = 0.001).", {"entities": []}], ["Corticosteroid values were normal in group B compared to slightly higher values in group C, also at all measured time intervals.", {"entities": []}], ["In this study, healing of fractures in patients with concomitant head injuries was accelerated, thereby indicating an involvement of a combined neurohormonal mechanism.", {"entities": []}], ["Objective Measuring the fractional flow reserve (FFR) requires the induction of coronary hyperemia, usually with adenosine, adenosine triphosphate (ATP), or papaverine.", {"entities": []}], ["However, adenosine can induce rhythmic complications, and intracoronary boluses of papaverine that prolong the QT interval can cause ventricular tachycardia.", {"entities": []}], ["Injection of contrast media, which is routinely performed to validate the FFR guidewire placement, also induces hyperemia and may be an alternative method of measuring the FFR.", {"entities": []}], ["We evaluated the diagnostic accuracy of the FFR after contrast hyperemia (FFRcont) compared to FFR evaluated after intracoronary papaverine (FFRpp).", {"entities": []}], ["Methods This study included 109 lesions in 93 patients (mean age 70.4\u00b18.7 years) with stable coronary disease.", {"entities": []}], ["The FFR was measured as follows: 1) baseline pressure value; 2) FFRcont after intracoronary contrast injection (iopamidol, 8 mL for left coronary artery [LCA] or 6 mL for right coronary artery [RCA]); 3) FFRpp after intracoronary injection of papaverine (12 mg for LCA or 8 mg for RCA).", {"entities": []}], ["Results FFRcont values were strongly correlated with FFRpp (R=0.940, p<0.0001; FFRpp = FFRcont \u00d71.007-0.032).", {"entities": []}], ["The best cut-off point in the receiver operator curve analysis for predicting a FFRpp <0.80 was 0.82 (area under the curve =0.980; sensitivity 95.1%, specificity 91.2%, positive predictive value 86.7%, negative predictive value 96.9%).", {"entities": []}], ["Conclusion FFRcont is highly accurate for predicting FFRpp.", {"entities": []}], ["An FFRcont threshold value of 0.82 provides excellent sensitivity and a negative predictive value.", {"entities": []}], ["FFRcont is an alternative method of inducing hyperemia.", {"entities": []}], ["Nanoparticles (NPs) have promising applications in medicine.", {"entities": [[15, 18, "GENE"]]}], ["Immune system is an important protective system to defend organisms from non-self matters.", {"entities": []}], ["NPs interact with the immune system and modulate its function, leading to immunosuppression or immunostimulation.", {"entities": [[0, 3, "GENE"]]}], ["These modulating effects may bring benefits or danger.", {"entities": []}], ["Compositions, sizes, and surface chemistry, and so forth, affect these immunomodulations.", {"entities": []}], ["Here we give an overview of the relationship between the physicochemical properties of NPs, which are candidates to be applied in medicine, and their immunomodulation properties.", {"entities": [[87, 90, "GENE"]]}], ["Physicians\u2019 gender can have an impact on many aspects of patient experience of care.", {"entities": []}], ["Organization processes through which the influence of gender is exerted have not been fully explored.", {"entities": []}], ["The aim of this article is to compare primary health care (PHC) organizations in which female or male doctors are predominant regarding organization and patient characteristics, and to assess their influence on experience of care, preventive care delivery, use of services, and unmet needs.", {"entities": []}], ["In 2010, we conducted surveys of a population stratified sample (N = 9180) and of all PHC organizations (N = 606) in 2 regions of the province of Qu\u00e9bec, Canada.", {"entities": []}], ["Patient and organization variables were entered sequentially into multilevel regression analyses to measure the impact of gender predominance.", {"entities": []}], ["Female-predominant organizations had younger doctors and nurses with more expanded role; they collaborated more with other PHC practices, used more tools for prevention, and allotted more time to patient visits.", {"entities": []}], ["However, doctors spent fewer hours a week at the practice in female-predominant organizations.", {"entities": []}], ["Patients of these organizations reported lower accessibility.", {"entities": []}], ["Conversely, they reported better comprehensiveness, responsiveness, counseling, and screening, but these effects were mainly attributable to doctors\u2019 younger age.", {"entities": []}], ["Their reporting unmet needs and emergency department attendance tended to decrease when controlling for patient and organization variables other than doctors\u2019 age.", {"entities": []}], ["Except for accessibility, female-predominant PHC organizations are comparable with their male counterparts.", {"entities": []}], ["Mean age of doctors was an important confounding variable that mitigated differences, whereas other organization variables enhanced them.", {"entities": []}], ["These findings deserve consideration to better understand and assess the impacts of the growing number of female-predominant PHC organizations on the health care system.", {"entities": []}], ["In paediatric dentistry, epinephrine may contribute to systemic and local side-effects.", {"entities": []}], ["On the other hand it is necessary to provide good and safe local analgesia.", {"entities": []}], ["Therefore, an articaine solution with reduced epinephrine concentration was tested in a clinical setting.", {"entities": []}], ["In a non-interventional clinical study, dental treatment was performed in children and adolescents (4\u201317\u00a0years).", {"entities": []}], ["For local analgesia, articaine 4\u00a0% plus epinephrine 1:400,000 was used in the technique chosen by the dentist.", {"entities": []}], ["Efficacy and tolerance as well as duration of soft tissue analgesia and side-effects were evaluated.", {"entities": []}], ["999 patients (50.5\u00a0% male, 49.5\u00a0% female) with a mean age of 7.9 (SD 2.34) years were treated.", {"entities": []}], ["Two hundred seventy six patients (27.6\u00a0%) received sedation prior to treatment.", {"entities": []}], ["The mean treatment time was 15\u00a0min (SD 10).", {"entities": []}], ["In 93.5\u00a0% of cases, initial local analgesia was sufficient to perform the planned treatment.", {"entities": []}], ["In 99\u00a0% of cases ( n \u00a0=\u00a0989) the planned treatment could be completed.", {"entities": []}], ["A second injection was necessary in 6.5\u00a0% of cases.", {"entities": []}], ["A mean duration of soft tissue analgesia of 2.19\u00a0h (SD 1.01) was seen.", {"entities": []}], ["Slight side-effects occurred in 3.1\u00a0% of subjects.", {"entities": []}], ["Due to high efficacy, tolerance and safety, the articaine 4\u00a0% solution with the reduced epinephrine concentration (1:400,000) was a safe and suitable drug for paediatric routine treatment.", {"entities": []}], ["The course of Strongyloides stercoralis infection is usually asymptomatic with a low discharge of rhabditoid larva in feces.", {"entities": []}], ["However, the deleterious effects of alcohol consumption seem to enhance the susceptibility to infection, as shown by a fivefold higher strongyloidiasis frequency in alcoholics than in nonalcoholics.", {"entities": [[135, 151, "DISEASE"]]}], ["Moreover, the association between S. stercoralis infection and alcoholism presents a risk for hyperinfection and severe strongyloidiasis.", {"entities": [[120, 136, "DISEASE"]]}], ["There are several possible mechanisms for the disruption of the host-parasite equilibrium in ethanol-addicted patients with chronic strongyloidiasis.", {"entities": [[132, 148, "DISEASE"]]}], ["One explanation is that chronic ethanol intake stimulates the hypothalamic-pituitary-adrenal (HPA) axis to produce excessive levels of endogenous cortisol, which in turn can lead to a deficiency in type 2 T helper cells (Th2) protective response, and also to mimic the parasite hormone ecdysone, which promotes the transformation of rhabditiform larvae to filariform larvae, leading to autoinfection.", {"entities": []}], ["Therefore, when untreated, alcoholic patients are continuously infected by this autoinfection mechanism.", {"entities": []}], ["Thus, the early diagnosis of strongyloidiasis and treatment can prevent serious forms of hyperinfection in ethanol abusers.", {"entities": [[29, 45, "DISEASE"]]}], ["For the past two decades, several studies have reported associations between elevated levels of ambient air pollution and adverse pregnancy outcomes, although with varying conclusions.", {"entities": []}], ["To examine possible associations between the traffic pollution situation at the home address, for women who did not change address during pregnancy, and three types of pregnancy outcomes: spontaneous preterm delivery, children born small for gestational age (SGA) and pregnancy-induced hypertensive disorders.", {"entities": []}], ["We used data for the Greater Stockholm Area from the Swedish Medical Birth Register to construct a cohort based on all pregnancies conceived between July 1997 and March 2006, n=100\u2005190.", {"entities": []}], ["The pregnancy average nitrogen oxide, NOx, levels and annual mean daily vehicles at the home address were used as exposure variables.", {"entities": []}], ["Mixed-model logistic regression was performed to assess any associations between exposure and outcome.", {"entities": []}], ["There was an association between elevated traffic pollution exposure during pregnancy and pregnancy-induced hypertensive disorders.", {"entities": []}], ["A 10\u2005\u00b5g/m In this large cohort, there was a fairly strong association between vehicle exhaust levels at the home address and pregnancy-induced hypertensive disorders, after adjustment for important risk factors.", {"entities": []}], ["Millions of people live on the U.S.-Mexico border, drawn by employment opportunities from industry and agriculture, and booming growth is expected to continue in the coming decades.", {"entities": []}], ["But the influx of people has long outstripped the capacity of border towns and cities to provide for their citizens, and a large percentage of the population lives in sprawling, underserviced shantytowns.", {"entities": []}], ["Although investment in environmental infrastructure on both sides has led to improvements, shortages among necessities such as drinking water, wastewater treatment, and solid waste disposal are at crisis levels.", {"entities": []}], ["In addition, a host of diseases including gastrointestinal infections, asthma, tuberculosis, multiple myeloma, systemic lupus erythematosus, hepatitis A, neural tube defects, and lead poisoning have been linked to environmental conditions on the border.", {"entities": [[102, 109, "DISEASE"], [93, 109, "DISEASE"], [79, 91, "DISEASE"], [120, 139, "DISEASE"], [141, 150, "DISEASE"], [71, 77, "DISEASE"], [111, 139, "DISEASE"]]}], ["Ongoing binational studies are attempting to define the breadth of the public and environmental health crisis and find ways to help make the border a healthier place.", {"entities": []}], ["Seronegative rheumatoid arthritis is associated with a milder course of progression compared to seropositive disease.", {"entities": [[13, 33, "DISEASE"], [24, 33, "DISEASE"]]}], ["However, long-term follow-up data of the clinical course of seronegative rheumatoid arthritis are sparse.", {"entities": [[73, 93, "DISEASE"], [84, 93, "DISEASE"]]}], ["Here we describe four cases with a rare disease entity of aggressive destructive seronegative (rheumatoid) arthritis with 20-35 years of follow-up.", {"entities": [[107, 116, "DISEASE"]]}], ["The four cases are women with an initial presentation of seronegative rheumatoid arthritis in 1980-1996 and have received disease-modifying anti-rheumatic drugs since the diagnosis.", {"entities": [[70, 90, "DISEASE"], [81, 90, "DISEASE"]]}], ["In all cases, the condition has been refractory to treatments and evolved into a severe disease with destructions of the wrists, sub-talar and ankle joints, as well as large joints but not small joints of fingers and toes.", {"entities": []}], ["All cases are negative with regard to rheumatoid factor, anti-cyclic citrullinated peptide antibodies and antibodies against carbamylated proteins.", {"entities": []}], ["This report adds to the existing literature, making the reader aware of this sub-type of inflammatory arthritis which despite being seronegative, can have devastating disease consequences.", {"entities": [[102, 111, "DISEASE"]]}], ["The report highlights the need for further research into this field in order to better understand this disease sub-type, the pathogenesis, disease course and outcomes.", {"entities": []}], ["Throughout childhood and adolescence, periods of heightened neuroplasticity are critical for the development of healthy brain function and behavior.", {"entities": []}], ["Given the high prevalence of neurodevelopmental disorders, such as autism, identifying disruptors of developmental plasticity represents an essential step for developing strategies for prevention and intervention.", {"entities": []}], ["Applying a novel computational approach that systematically assessed connections between 436 transcriptional signatures of disease and multiple signatures of neuroplasticity, we identified inflammation as a common pathological process central to a diverse set of diseases predicted to dysregulate plasticity signatures.", {"entities": []}], ["We tested the hypothesis that inflammation disrupts developmental cortical plasticity in vivo using the mouse ocular dominance model of experience-dependent plasticity in primary visual cortex.", {"entities": []}], ["We found that the administration of systemic lipopolysaccharide suppressed plasticity during juvenile critical period with accompanying transcriptional changes in a particular set of molecular regulators within primary visual cortex.", {"entities": []}], ["These findings suggest that inflammation may have unrecognized adverse consequences on the postnatal developmental trajectory and indicate that treating inflammation may reduce the burden of neurodevelopmental disorders.", {"entities": []}], ["In mammals, carcinoembryonic antigen cell adhesion molecules (CEACAMs) and pregnancy-specific glycoproteins (PSGs) play important roles in the regulation of pathogen transmission, tumorigenesis, insulin signaling turnover, and fetal\u2013maternal interactions.", {"entities": []}], ["However, how these genes evolved and to what extent they diverged in humans remain to be investigated specifically.", {"entities": []}], ["Based on syntenic mapping of chordate genomes, we reveal that diverging homologs with a prototypic CEACAM architecture\u2013including an extracellular domain with immunoglobulin variable and constant domain-like regions, and an intracellular domain containing ITAM motif\u2013are present from cartilaginous fish to humans, but are absent in sea lamprey, cephalochordate or urochordate.", {"entities": []}], ["Interestingly, the CEACAM/PSG gene inventory underwent radical divergence in various vertebrate lineages: from zero in avian species to dozens in therian mammals.", {"entities": []}], ["In addition, analyses of genetic variations in human populations showed the presence of various types of copy number variations (CNVs) at the CEACAM/PSG locus.", {"entities": []}], ["These copy number polymorphisms have 3\u201380% frequency in select populations, and encompass single to more than six PSG genes.", {"entities": []}], ["Furthermore, we found that CEACAM/PSG genes contain a significantly higher density of nonsynonymous single nucleotide polymorphism (SNP) compared to the chromosome average, and many CEACAM/PSG SNPs exhibit high population differentiation.", {"entities": []}], ["Taken together, our study suggested that CEACAM/PSG genes have had a more dynamic evolutionary history in vertebrates than previously thought.", {"entities": []}], ["Given that CEACAM/PSGs play important roles in maternal\u2013fetal interaction and pathogen recognition, these data have laid the groundwork for future analysis of adaptive CEACAM/PSG genotype-phenotypic relationships in normal and complicated pregnancies as well as other etiologies.", {"entities": []}], ["Afferent nerves in the airways serve to regulate breathing pattern, cough, and airway autonomic neural tone.", {"entities": []}], ["Pharmacologic agents that influence afferent nerve activity can be subclassified into compounds that modulate activity by indirect means (e.g.", {"entities": []}], ["bronchial smooth muscle spasmogens) and those that act directly on the nerves.", {"entities": []}], ["Directly acting agents affect afferent nerve activity by interacting with various ion channels and receptors within the membrane of the afferent terminals.", {"entities": []}], ["Whether by direct or indirect means, most compounds that enter the airspace will modify afferent nerve activity, and through this action alter airway physiology.", {"entities": []}], ["In response to cytokine signalling and other factors, CD4-positive T lymphocytes differentiate into distinct populations that are characterized by the production of certain cytokines and are controlled by different master transcription factors.", {"entities": []}], ["The spectrum of such populations, which was initially limited to Th1 and Th2 subsets, is currently broadened to include Th17 and Treg subsets, as well as a number of less studied subtypes, such as Tfh, Th9, and Th22.", {"entities": []}], ["Although these subsets appear to be relatively stable, certain plasticity exists that allows for transition between the subsets and formation of hybrid transition forms.", {"entities": []}], ["This provides the immune system flexibility needed for adequate response to pathogens but, at the same time, can play a role in the pathogenic processes in cases of deregulation.", {"entities": []}], ["In this review, we will discuss the properties of T lymphocyte subsets and their plasticity, as well as its implications for cancer and autoimmune diseases.", {"entities": [[125, 131, "DISEASE"]]}], ["There is substantial epidemiological evidence supporting the concept that respiratory syncytial virus (RSV) lower respiratory tract infection in infancy may be linked to the development of reactive airway disease (RAD) in childhood.", {"entities": []}], ["However, much less is known concerning the mechanisms by which this self-limiting infection leads to airway dysfunction that persists long after the virus is cleared from the lungs.", {"entities": []}], ["A better understanding of the RSV\u2013RAD link may have important clinical implications, particularly because prevention of RSV lower respiratory tract infection may reduce the occurrence of RAD later in life.", {"entities": []}], ["Among the mechanisms proposed to explain the chronic sequelae of RSV infection is the interaction between the subepithelial neural network of the airway mucosa and the cellular effectors of inflammatory and immune responses to the virus.", {"entities": []}], ["The body of clinical literature linking RSV and RAD is reviewed herein, as are the cellular and molecular mechanisms of neuroimmune interactions and neural remodeling that may underlie this link, and the possibility that preventing the infection may result in a decreased incidence of its chronic sequelae.", {"entities": []}], ["Aquilaria crassna has been used in traditional Asian medicine to treat vomiting, rheumatism, asthma, and cough.", {"entities": [[93, 99, "DISEASE"]]}], ["Furthermore, earlier studies from our laboratory have revealed that the essential oil extract from agarwood inhibited colorectal carcinoma cells.", {"entities": [[129, 138, "DISEASE"]]}], ["Despite of the wide range of ethno-pharmacological uses of agarwood, its toxicity has not been previously evaluated through systematic toxicological studies.", {"entities": []}], ["Therefore, the potential safety of essential oil extract and its in vivo anti-tumor activity had been investigated.", {"entities": []}], ["In the acute toxicity study, Swiss female mice were given a single dose of the essential oil extract at 2000\u00a0mg/kg/day orally and screened for two weeks after administration.", {"entities": []}], ["Meanwhile, in the sub-chronic study, two different doses of the extract were administered for 28\u00a0days.", {"entities": []}], ["Mortality, clinical signs, body weight changes, hematological and biochemical parameters, gross findings, organ weights, and histological parameters were monitored during the study.", {"entities": []}], ["Other than that, in vivo anti-tumor study was assessed by using subcutaneous tumors model established in nude mice.", {"entities": []}], ["The acute toxicity study showed that the LD 50 of the extract was greater than 2000\u00a0mg/kg.", {"entities": []}], ["In the repeated dose for 28-day oral toxicity study, the administration of 100\u00a0mg/kg and 500\u00a0mg/kg of essential oil per body weight revealed insignificant difference in food and water intakes, bodyweight change, hematological and biochemical parameters, relative organ weights, gross findings or histopathology compared to the control group.", {"entities": []}], ["Nevertheless, the essential oil extract, when supplemented to nude mice, caused significant growth inhibition of the subcutaneous tumor of HCT 116 colorectal carcinoma cells.", {"entities": [[158, 167, "DISEASE"]]}], ["Collectively, the data obtained indicated that essential oil extract from agarwood might be a safe material, and this essential oil is suggested as a potential anti-colon cancer candidate.", {"entities": [[165, 177, "DISEASE"], [171, 177, "DISEASE"]]}], ["Understanding immunity, incidence and risk factors of the 2009 influenza A(H1N1) pandemic (2009 H1N1) through a national seroprevalence study is necessary for informing public health interventions and disease modelling.", {"entities": [[63, 72, "DISEASE"]]}], ["We collected 1687 serum samples and individual risk factor data between November-2009 to March-2010, three months after the end of the 2009 H1N1 wave in New Zealand.", {"entities": []}], ["Participants were randomly sampled from selected general practices countrywide and hospitals in the Auckland region.", {"entities": []}], ["Baseline immunity was measured from 521 sera collected during 2004 to April-2009.", {"entities": []}], ["Haemagglutination inhibition (HI) antibody titres of \u22651\u223640 against 2009 H1N1 were considered seroprotective as well as seropositive.", {"entities": []}], ["The overall community seroprevalence was 26.7% (CI:22.6\u201329.4).", {"entities": []}], ["The seroprevalence varied across age and ethnicity.", {"entities": []}], ["Children aged 5\u201319 years had the highest seroprevalence (46.7%;CI:38.3\u201355.0), a significant increase from the baseline (14%;CI:7.2\u201320.8).", {"entities": []}], ["Older adults aged \u226560 had no significant difference in seroprevalence between the serosurvey (24.8%;CI:18.7\u201330.9) and baseline (22.6%;CI:15.3\u201330.0).", {"entities": []}], ["Pacific peoples had the highest seroprevalence (49.5%;CI:35.1\u201364.0).", {"entities": []}], ["There was no significant difference in seroprevalence between both primary (29.6%;CI:22.6\u201336.5) and secondary healthcare workers (25.3%;CI:20.8\u201329.8) and community participants.", {"entities": []}], ["No significant regional variation was observed.", {"entities": []}], ["Multivariate analysis indicated age as the most important risk factor followed by ethnicity.", {"entities": []}], ["Previous seasonal influenza vaccination was associated with higher HI titres.", {"entities": [[18, 27, "DISEASE"]]}], ["Approximately 45.2% of seropositive individuals reported no symptoms.", {"entities": []}], ["Based on age and ethnicity standardisation to the New Zealand Population, about 29.5% of New Zealanders had antibody titers at a level consistent with immunity to 2009 H1N1.", {"entities": []}], ["Around 18.3% of New Zealanders were infected with the virus during the first wave including about one child in every three.", {"entities": []}], ["Older people were protected due to pre-existing immunity.", {"entities": []}], ["Age was the most important factor associated with infection followed by ethnicity.", {"entities": []}], ["Healthcare workers did not appear to have an increased risk of infection compared with the general population.", {"entities": []}], ["The impact of body mass index (BMI; kg/m With special attention to the lower BMI categories, associations between BMI and both total and cause-specific mortality were explored in 7604 men and 9107 women aged \u226565\u2005years who participated in the Troms\u00f8 Study (1994\u20131995) or the North-Tr\u00f8ndelag Health Study (1995\u20131997).", {"entities": []}], ["A Cox proportional hazards model adjusted for age, marital status, education and smoking was used to estimate HRs for mortality in different BMI categories using the BMI range of 25\u201327.5 as a reference.", {"entities": []}], ["The impact of each 2.5\u2005kg/m We identified 7474 deaths during a mean follow-up of 9.3\u2005years.", {"entities": []}], ["The lowest mortality was found in the BMI range 25\u201329.9 and 25\u201332.4 in men and women, respectively.", {"entities": []}], ["Mortality was increased in all BMI categories below 25 and was moderately increased in obese individuals.", {"entities": []}], ["U-shaped relationships were also found between WC and total mortality.", {"entities": []}], ["About 40% of the excess mortality in the lower BMI range in men was explained by mortality from respiratory diseases.", {"entities": []}], ["BMI below 25 in elderly men and women was associated with increased mortality.", {"entities": []}], ["A modest increase in mortality was found with increasing BMI among obese men and women.", {"entities": []}], ["Overweight individuals (BMI 25\u201329.9) had the lowest mortality.", {"entities": []}], ["A well established \"midlevel\" of patient care, such as nurse practitioners and/or physician assistants, exits in many countries like the US, Canada, and Australia.", {"entities": []}], ["In Germany, however there is only one kind of profession assisting the physician in practices, the practice nurse.", {"entities": []}], ["Little is known about the present involvement of practice nurses in patients' care in Germany and about the attitudes of GPs, assistants and patients concerning an increased involvement.", {"entities": []}], ["The aim of our study was to get qualitative information on the extent to which practice nurses are currently involved in the treatment of patients and about possibilities of increased involvement as well as on barriers of increased involvement.", {"entities": []}], ["We performed qualitative, semi-structured interviews with 20 GPs, 20 practice nurses and 20 patients in the Heidelberg area.", {"entities": []}], ["The interviews were digitally recorded, transcribed and content-analysed with ATLAS.ti.", {"entities": []}], ["Practice nurses are only marginally involved in the treatment of patients.", {"entities": []}], ["GPs as well as patients were very sceptical about increased involvement in care.", {"entities": []}], ["Patients were sceptical about nurses' professional background and feared a worsening of the patient doctor relationship.", {"entities": []}], ["GPs also complained about the nurses' deficient education concerning medical knowledge.", {"entities": []}], ["They feared a lack of time as well as a missing reimbursement for the efforts of an increased involvement.", {"entities": []}], ["Practice nurses were mostly willing to be more involved, regarding it as an appreciation of their role.", {"entities": []}], ["Important barriers were lack of time, overload with administrative work, and a lack of professional knowledge.", {"entities": []}], ["Practice nurses were only little involved in patient care.", {"entities": []}], ["GPs were more sceptical than patients regarding an increased involvement.", {"entities": []}], ["One possible area, accepted by all interviewed groups, was patient education as for instance dietary counselling.", {"entities": []}], ["New treatment approaches as the chronic care model will require a team approach which currently only marginally exists in the German health care system.", {"entities": []}], ["Better medical education of practice nurses is indispensable, but GPs also have to accept that they cannot fulfil the requirement of future care alone.", {"entities": []}], ["The prevalence of SARS-CoV in bodily excretions was determined.", {"entities": []}], ["Severe acute respiratory syndrome (SARS) is caused by a novel coronavirus (SARS-CoV).", {"entities": [[25, 33, "DISEASE"], [35, 39, "GENE"], [75, 79, "GENE"]]}], ["In a longitudinal cross-sectional study, we determined the prevalence of virus in bodily excretions and time of seroconversion in discharged patients with SARS.", {"entities": [[155, 159, "GENE"]]}], ["Conjunctival, throat, stool, and urine specimens were collected weekly from 64 patients and tested for SARS-CoV RNA by real-time polymerase chain reaction; serum samples were collected weekly and tested for SARS-CoV antibody with indirect enzyme immunoassay and immunofluorescence assay.", {"entities": []}], ["In total, 126 conjunctival, 124 throat swab, 116 stool, and 124 urine specimens were analyzed.", {"entities": []}], ["Five patients had positive stool samples, collected in weeks 5\u20139.", {"entities": []}], ["Two patients seroconverted in weeks 7 and 8; the others were seropositive at the first serum sample collection.", {"entities": []}], ["In this study, 5 (7.8%) of 64 patients continued to shed viral RNA in stool samples only, for up to week 8 of illness.", {"entities": []}], ["Most seroconversions occurred by week 6 of illness.", {"entities": []}], ["Work stress is a risk factor for cardio-metabolic diseases, but few large-scale studies have examined the clinical profile of individuals with work stress.", {"entities": []}], ["To address this limitation, we conducted a cross-sectional study including 43,593 working adults from a French population-based sample aged 18\u201372 years (the CONSTANCES cohort).", {"entities": []}], ["According to the Effort-Reward Imbalance model, work stress was defined as an imbalance between perceived high efforts and low rewards at work.", {"entities": []}], ["A standardized health examination included measures of anthropometry, lung function, blood pressure and standard blood-based biomarkers.", {"entities": []}], ["Linear regression analyses before and after multivariable adjustment for age, socioeconomic status, depressive symptoms, health-related behaviours, and chronic conditions showed that work stress was associated with higher BMI, waist circumference, waist-hip ratio, alanine transaminase, white blood cell count and lower high-density lipoprotein cholesterol in men, and with higher BMI and white blood cell count in women (differences 0.03\u20130.06 standard deviations, P\u2009<\u20090.05 between individuals with and without work stress).", {"entities": []}], ["No robust associations were observed with lung function, haemoglobin, creatinine, glucose levels or resting blood pressure measures.", {"entities": []}], ["This indicates that work stress is associated altered metabolic profile, increased systemic inflammation, and, in men, poorer liver function, which is a marker of high alcohol consumption.", {"entities": []}], ["Respiratory syncytial virus (RSV) infection is the most common cause of hospitalization in infants and small children.", {"entities": []}], ["The aim was to present a 13-months old boy diagnosed with acute airway infection, acute otitis media (AOM) and hepatitis during the RSV-infection.", {"entities": [[88, 100, "DISEASE"], [111, 120, "DISEASE"]]}], ["Serum catalytic activities of alkaline phosphatase (ALP), aspartate aminotranspherase (AST), alanine aminotranspherase (ALT), gamma glutamyl transpherase (GGT), lactate dehydrogenase (LD), and concentrations of bilirubin were monitored during hospitalization and at control examination.", {"entities": []}], ["The child had clinical signs and symptoms of respiratory failure, AOM, and laboratory findings of virus infection and liver disease.", {"entities": [[45, 64, "DISEASE"], [118, 131, "DISEASE"]]}], ["On admission, catalytic activities of enzymes were markedly increased, especially the activity of ALP (10333 U/L, i.e.", {"entities": []}], ["24-fold increase in comparison with the upper reference limit).", {"entities": []}], ["The highest increased in AST (339 U/L, 4.5-fold), ALT (475 U/L, 10.3-fold) and LD (545 U/L, 1.5-fold) were registered on the 3 Laboratory results in patient with RSV infection needs to be interpreted in the light of both, respiratory and extrapulmonary manifestations of the infection, respectively.", {"entities": []}], ["Retinal ischemic injuries play an important role in the pathogenesis of several eye disorders.", {"entities": []}], ["Inflammation and oxidative stress are key players in ischemic injuries.", {"entities": []}], ["Following retinal ischemia, vascular endothelial cells and leukocytes express several inflammatory adhesion receptors, such as selectins and cell adhesion molecules.", {"entities": [[10, 26, "DISEASE"], [18, 26, "DISEASE"]]}], ["P-selectin stimulates leukocyte recruitment to platelet aggregates and has an important role in vascular homeostasis and inflammatory leukocyte extravasation.", {"entities": []}], ["Soluble P-selectin can be neuroprotective through competitive binding to the receptors of endogenous P-selectin molecules.", {"entities": []}], ["Here, we demonstrate the neuroprotective effect of a recombinant P-selectin immunoglobin G (P-sel-IgG) chimeric fusion protein in a rat anterior ischemic optic neuropathy (rAION) model.", {"entities": [[160, 170, "DISEASE"], [145, 170, "DISEASE"]]}], ["rAION was induced by photodynamic therapy.", {"entities": []}], ["P-sel-IgG treatment reduced optic nerve edema and stabilized the blood\u2013optic nerve barrier (BONB) in the acute phase of rAION.", {"entities": []}], ["Further, P-sel-IgG increased the retinal ganglion cell (RGC) survival rate, reduced RGC apoptosis, preserved visual function, maintained retinal nerve fiber layer thickness, and reduced macrophage infiltration in optic nerve tissue in the chronic phase (day 28).", {"entities": []}], ["Increased NAD(P)H quinone dehydrogenase 1 (NQO1) and heme oxygenase 1(HO-1) expression levels, along with increased transcription factor Nrf2, suggesting an antioxidant role of P-sel-IgG via the Nrf2 signaling pathway.", {"entities": [[43, 47, "GENE"]]}], ["In conclusion, this study is the first to demonstrate that P-sel-IgG treatment promotes RGC survival by stabilizing the BONB and activating the Nrf2 signaling pathway in a rAION model.", {"entities": []}], ["Pulmonary exposure to Aspergillus fumigatus has been associated with morbidity and mortality, particularly in immunocompromised individuals.", {"entities": []}], ["A. fumigatus conidia produce \u03b2-glucan, proteases, and other immunostimulatory factors upon germination.", {"entities": []}], ["Murine models have shown that the ability of A. fumigatus to germinate at physiological temperature may be an important factor that facilitates invasive disease.", {"entities": []}], ["We observed a significant increase in IFN-\u03b3-producing CD8 A. fumigatus conidia in contrast to mice challenged with A. versicolor , a species that is not typically associated with invasive, disseminated disease.", {"entities": []}], ["Analysis of tissue sections indicated the presence of germinating spores in the lungs of mice challenged with A. fumigatus , but not A. versicolor .", {"entities": []}], ["Airway IFN-\u03b3 A. fumigatus conidia that were formaldehyde-fixed or heat-inactivated.", {"entities": []}], ["Furthermore, A. fumigatus particles exhibited greater persistence in the lungs of recipient mice when compared to non-viable A. fumigatus or A. versicolor , and this correlated with increased maintenance of airway memory-phenotype CD8 Aspergillus conidia may be mediated in part by the ability of conidia to germinate in the host lung tissue.", {"entities": []}], ["These results provide further evidence of induction of immune responses to fungi based on their ability to invade host tissue.", {"entities": []}], ["A host of studies support that younger, better performing adults express greater moment-to-moment blood oxygen level-dependent (BOLD) signal variability (SD BOLD ) in various cortical regions, supporting an emerging view that the aging brain may undergo a generalized reduction in dynamic range.", {"entities": []}], ["However, the exact physiological nature of age differences in SD BOLD remains understudied.", {"entities": []}], ["In a sample of 29 younger and 45 older adults, we examined the contribution of vascular factors to age group differences in fixation-based SD BOLD using (1) a dual-echo BOLD/pseudo-continuous arterial spin labeling (pCASL) sequence, and (2) hypercapnia via a computer-controlled gas delivery system.", {"entities": []}], ["We tested the hypothesis that, although SD BOLD may relate to individual differences in absolute cerebral blood flow (CBF), BOLD cerebrovascular reactivity (CVR), or maximum BOLD signal change (M), robust age differences in SD BOLD would remain after multiple statistical controls for these vascular factors.", {"entities": []}], ["As expected, our results demonstrated that brain regions in which younger adults expressed higher SD BOLD persisted after comprehensive control of vascular effects.", {"entities": []}], ["Our findings thus further establish BOLD signal variability as an important marker of the aging brain.", {"entities": []}], ["The aim of the present study is to investigate association between septic shock (SS) and angiotensin I-converting enzyme ( ACE ) single nucleotide polymorphisms (SNPs).", {"entities": []}], ["From October 2009 to December 2016, 238 SS patients and 242 healthy individuals were selected for our study.", {"entities": []}], ["ACE activity was detected, ACE rs4291 and rs4646994 polymorphisms were detected using PCR-restriction fragment length polymorphism (PCR-RFLP).", {"entities": []}], ["The Kaplan\u2013Meier survival curve was employed to evaluate the association between ACE SNPs and patients\u2019 survival and univariate and multivariate analyses to estimate risk factors for SS.", {"entities": []}], ["ACE activity in the case group was increased in comparison with the control group.", {"entities": []}], ["Allele and genotype frequencies of rs4291 and rs4646994 were different between the case and control groups.", {"entities": []}], ["The TT genotype frequency of the rs4291 polymorphisms and the DD genotype of the rs4646994 polymorphisms of the case group were higher than those in the control group.", {"entities": []}], ["The AT and TT genotypes indicated a significant elevation of ACE activity than the AA genotype, while a significant decline was found in the DI and II genotypes in comparison with the DI genotype.", {"entities": []}], ["Patients with TT or DD genotypes had increased fatality rate within 7 and 30 days when compared with those with non-TT or non-DD genotypes.", {"entities": []}], ["Lower sepsis-related organ failure assessment (SOFA) scores, rs4291, serum ACE and rs4646994 were all considered as risky factors for SS patients.", {"entities": []}], ["The study demonstrates that TT genotype of rs4291 or DD genotype of rs4646994 may be indicative of a higher risk of SS and a poorer prognosis in SS patients.", {"entities": []}], ["Numerous randomized controlled trials (RCTs) have arrived at conflicting conclusions on expressive writing (EW) as an intervention for breast cancer (BC) patients, but there has been no meta-analysis of these studies to assess the effectiveness of EW in BC population.", {"entities": [[135, 148, "DISEASE"], [142, 148, "DISEASE"]]}], ["PubMed, Web of Science, The Cochrane Library, EMBASE, and CINAHL and the www.clinicaltrial.gov database on ongoing clinical trials were searched to identify all the RCTs investigating efficacy of EW on the physical and psychological health in BC patients.", {"entities": []}], ["The risk of bias of the original studies was assessed using the Cochrane Collaboration\u2019s tool.", {"entities": []}], ["Our primary outcomes for physical and psychological health were respectively negative somatic symptoms and negative mood which were stratified by emotional, benefit-finding and multiple prompts in sub-group analyses.", {"entities": []}], ["The data were analyzed using Review Manager 5.2 and Stata version 12.0 statistical software.", {"entities": []}], ["Of the 5,232 titles screened, we identified 11 RCTs with a total of 1,178 participants.", {"entities": []}], ["The pooled results showed a significant effect of EW using either an emotional prompt or a benefit-finding prompt on reducing negative somatic symptoms in BC patients in the \u22643-month follow-up group [Mean Difference (MD), -13.03, 95% CI, -19.23 to -6.83, P<0.0001; MD, -9.18, 95% CI, -15.57 to -2.79, P = 0.005].", {"entities": []}], ["There was no significant effect of EW on physical health in the >3-month follow-up group.", {"entities": []}], ["There were no significant differences regarding psychological health indexes between EW intervention and control groups at any of the follow-up time-points (P>0.05).", {"entities": []}], ["This systematic review and meta-analysis reveals that EW intervention may have a significantly positive impact on the physical health but not the psychological health in BC patients, but this benefit may not last long.", {"entities": []}], ["However, further high-quality studies with more homogeneity are needed to confirm the current findings.", {"entities": []}], ["Treatment of severe asthma may include high dose systemic-steroid therapy which is associated with substantial additional morbidity.", {"entities": [[20, 26, "DISEASE"]]}], ["This study estimates the additional healthcare costs associated with steroid-induced morbidity by comparing three patients groups: those with severe asthma, moderate asthma and no asthma.", {"entities": [[149, 155, "DISEASE"], [166, 172, "DISEASE"], [180, 186, "DISEASE"]]}], ["Patients with severe asthma ( n \u2009=\u2009808, GINA step 5 treatment) were matched by age and gender with patients with mild/moderate asthma ( n \u2009=\u20093,975, GINA step 2 and 3 treatment) and a non-asthma control cohort (with a diagnosis of rhinitis; n \u2009=\u20092,412) from the Optimum Patient Care Research Database (OPCRD), a nationally representative primary care database.", {"entities": [[230, 238, "DISEASE"], [21, 27, "DISEASE"], [127, 133, "DISEASE"], [187, 193, "DISEASE"]]}], ["Prescribed drugs and publicly funded healthcare activity were monetised and annual costs per patient estimated.", {"entities": []}], ["Regression analyses were used to estimate the additional healthcare cost associated with steroid-induced morbidity.", {"entities": []}], ["Average healthcare costs per person per year range from \u00a32603 - \u00a34533 for the severe asthma cohort, to \u00a3978 - \u00a32072 for the mild/moderate asthma cohort, to \u00a3560 - \u00a31324 for the non-asthma control cohort, depending on the costing scenario.", {"entities": [[85, 91, "DISEASE"], [138, 144, "DISEASE"], [181, 187, "DISEASE"]]}], ["Differences in induced morbidity costs were evident between patients with asthma differentiated by steroid exposure.", {"entities": [[74, 80, "DISEASE"]]}], ["In relation to prescription drugs used to treat steroid-induced co-morbidities, females with severe asthma and high steroid exposure cost approximately \u00a3789 more per year than a corresponding female with no asthma, while males cost approximately \u00a3744 more than their counterparts with no asthma.", {"entities": [[100, 106, "DISEASE"], [207, 213, "DISEASE"], [288, 294, "DISEASE"]]}], ["Estimates were extrapolated to all healthcare costs.", {"entities": []}], ["This study provides the first robust estimates of the additional cost of healthcare related to steroid-induced morbidity relative to patients with no steroid exposure.", {"entities": []}], ["The study will help inform use of steroid-sparing strategies in this patient group.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-017-0614-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Cow's milk is the most common food allergen in infants and the diagnosis of cow's milk allergy is difficult, even with the use of several diagnostic tests.", {"entities": []}], ["Therefore, elimination diets and challenge tests are essential for the diagnosis and treatment of this disorder.", {"entities": []}], ["The aim of this study is to report the clinical presentation and nutritional status of children evaluated by pediatric gastroenterologists for the assessment of symptoms suggestive of cow's milk allergy.", {"entities": []}], ["An observational cross-sectional study was performed among 9,478 patients evaluated by 30 pediatric gastroenterologists for 40 days in 5 different geographical regions in Brazil.", {"entities": []}], ["Clinical data were collected from patients with symptoms suggestive of cow's milk allergy.", {"entities": []}], ["The nutritional status of infants (age \u2264 24 months) seen for the first time was evaluated according to z-scores for weight-for-age, weight-for-height, and height-for-age.", {"entities": []}], ["Epi-Info (CDC-NCHS, 2000) software was used to calculate z-scores.", {"entities": []}], ["The prevalence of suspected cow's milk allergy in the study population was 5.4% (513/9,478), and the incidence was 2.2% (211/9,478).", {"entities": []}], ["Among 159 infants seen at first evaluation, 15.1% presented with a low weight-for-age z score (< -2.0 standard deviation - SD), 8.7% with a low weight-for-height z score (< -2.0 SD), and 23.9% with a low height-for-age z score (< -2.0 SD).", {"entities": []}], ["The high prevalence of nutritional deficits among infants with symptoms suggestive of cow's milk allergy indicates that effective elimination diets should be prescribed to control allergy symptoms and to prevent or treat malnutrition.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is characterized by poorly reversible airflow limitation.", {"entities": []}], ["The pathological hallmarks of COPD are inflammation of the peripheral airways and destruction of lung parenchyma or emphysema.", {"entities": []}], ["The functional consequences of these abnormalities are expiratory airflow limitation and dynamic hyperinflation, which then increase the elastic load of the respiratory system and decrease the performance of the respiratory muscles.", {"entities": []}], ["These pathophysiologic features contribute significantly to the development of dyspnea, exercise intolerance and ventilatory failure.", {"entities": []}], ["Several treatments may palliate flow limitation, including interventions that modify the respiratory pattern (deeper, slower) such as pursed lip breathing, exercise training, oxygen, and some drugs.", {"entities": []}], ["Other therapies are aimed at its amelioration, such as bronchodilators, lung volume reduction surgery or breathing mixtures of helium and oxygen.", {"entities": []}], ["Finally some interventions, such as inspiratory pressure support, alleviate the threshold load associated to flow limitation.", {"entities": []}], ["The degree of flow limitation can be assessed by certain spirometry indexes, such as vital capacity and inspiratory capacity, or by other more complexes indexes such as residual volume/total lung capacity or functional residual capacity/total lung capacity.", {"entities": []}], ["Two of the best methods to measure flow limitation are to superimpose a flow\u2013volume loop of a tidal breath within a maximum flow\u2013volume curve, or to use negative expiratory pressure technique.", {"entities": []}], ["Likely this method is more accurate and can be used during spontaneous breathing.", {"entities": []}], ["A definitive definition of dynamic hyperinflation is lacking in the literature, but serial measurements of inspiratory capacity during exercise will document the trend of end-expiratory lung volume and allow establishing relationships with other measurements such as dyspnea, respiratory pattern, exercise tolerance, and gas exchange.", {"entities": []}], ["Proton-pump inhibitors (PPIs) are among the most frequently prescribed medications.", {"entities": []}], ["Community-acquired pneumonia (CAP) is a common cause of morbidity, mortality and healthcare spending.", {"entities": [[19, 28, "DISEASE"]]}], ["Some studies suggest an increased risk of CAP among PPI users.", {"entities": []}], ["We conducted a systematic review and meta-analysis to determine the association between outpatient PPI therapy and risk of CAP in adults.", {"entities": []}], ["We conducted systematic searches of MEDLINE, EMBASE, CINAHL, Cochrane Central Register of Controlled Trials, Scopus and Web of Science on February 3, 2014.", {"entities": []}], ["Case-control studies, case-crossover, cohort studies and randomized controlled trials reporting outpatient PPI exposure and CAP diagnosis for patients \u226518 years old were eligible.", {"entities": []}], ["Our primary outcome was the association between CAP and PPI therapy.", {"entities": []}], ["A secondary outcome examined the risk of hospitalization for CAP and subgroup analyses evaluated the association between PPI use and CAP among patients of different age groups, by different PPI doses, and by different durations of PPI therapy.", {"entities": []}], ["Systematic review of 33 studies was performed, of which 26 studies were included in the meta-analysis.", {"entities": []}], ["These 26 studies included 226,769 cases of CAP among 6,351,656 participants.", {"entities": []}], ["We observed a pooled risk of CAP with ambulatory PPI therapy of 1.49 (95% CI 1.16, 1.92; I2 99.2%).", {"entities": []}], ["This risk was increased during the first month of therapy (OR 2.10; 95% CI 1.39, 3.16), regardless of PPI dose or patient age.", {"entities": []}], ["PPI therapy also increased risk for hospitalization for CAP (OR 1.61; 95% CI: 1.12, 2.31).", {"entities": []}], ["Outpatient PPI use is associated with a 1.5-fold increased risk of CAP, with the highest risk within the first 30 days after initiation of therapy.", {"entities": []}], ["Providers should be aware of this risk when considering PPI use, especially in cases where alternative regimens may be available or the benefits of PPI use are uncertain.", {"entities": []}], ["Protein denitrosylation by thioredoxin reductase (TrxR) is key for maintaining S -nitrosothiol (SNO) homeostasis, although its role in tumor progression is unknown.", {"entities": []}], ["Therefore, the present study aimed to assess the role of altered SNO homeostasis in breast cancer cells.", {"entities": [[84, 97, "DISEASE"], [91, 97, "DISEASE"]]}], ["The impairment of SNO homeostasis in breast cancer cells was achieved with the highly specific TrxR inhibitor auranofin and/or exposure to S -nitroso- L -cysteine.", {"entities": [[37, 50, "DISEASE"], [44, 50, "DISEASE"]]}], ["S -nitrosylated proteins were detected using the biotin switch assay.", {"entities": []}], ["Estrogen receptor (ER) alpha knockdown was achieved using RNA silencing technologies and subcellular localization of ER\u03b1 was analyzed by confocal microscopy.", {"entities": []}], ["The Oncomine database was explored for TrxR1 (TXNRD1) expression in breast tumors and TrxR1, ER and p53 expression was analyzed by immunohistochemistry in a panel of breast tumors.", {"entities": [[46, 52, "GENE"]]}], ["The impairment of SNO homeostasis enhanced cell proliferation and survival of ER+ MCF-7 cells, but not of MDA-MB-231 (ER-, mut p53) or BT-474 (ER+, mut p53) cells.", {"entities": [[123, 126, "GENE"], [148, 151, "GENE"], [123, 126, "GENE"], [148, 151, "GENE"]]}], ["This enhanced cell growth and survival was associated with Akt, Erk1/2 phosphorylation, and augmented cyclin D 1 expression and was abolished by the ER antagonist fulvestrant or the p53 specific inhibitor pifithrin-\u03b1.", {"entities": []}], ["The specific silencing of ER\u03b1 expression in MCF-7 cells also abrogated the growth effect of TrxR inhibition.", {"entities": []}], ["Estrogenic deprivation in MCF-7 cells potentiated the pro-proliferative effect of impaired SNO homeostasis.", {"entities": []}], ["Moreover, the subcellular distribution of ER\u03b1 was altered, with a predominant nuclear localization associated with phosphorylation at Thr311 in those cells with impaired SNO homeostasis.", {"entities": []}], ["The impairment of SNO homeostasis also expanded a cancer stem cell-like subpopulation in MCF-7 cells, as indicated by the increase of percentage of CD44 in vitro .", {"entities": [[50, 56, "DISEASE"], [148, 152, "GENE"]]}], ["Notably, ER+ status in breast tumors was significantly associated with lower TXNDR1 mRNA expression and immunohistochemical studies confirmed this association, particularly when p53 abnormalities were absent.", {"entities": []}], ["The ER status in breast cancer may dictate tumor response to different nitrosative environments.", {"entities": [[17, 30, "DISEASE"], [24, 30, "DISEASE"]]}], ["Impairment of SNO homeostasis confers survival advantages to ER+ breast tumors, and these molecular mechanisms may also participate in the development of resistance against hormonal therapies that arise in this type of mammary tumors.", {"entities": []}], ["Allergic asthma is a chronic airway disorder characterized by airway inflammation, mucus hypersecretion, and airway hyperresponsiveness (AHR).", {"entities": [[9, 15, "DISEASE"], [137, 140, "GENE"]]}], ["A murine model of asthma was used to examine the antiasthmatic effect of inhaled inactived Mycobacterium phlei ( M. phlei ).", {"entities": [[18, 24, "DISEASE"]]}], ["AHR, neutrophil levels, eosinophil levels and levels of interleukin (IL)-17 and IL-23 receptor (IL-23R) were monitored.", {"entities": [[0, 3, "GENE"]]}], ["The results demonstrated that inactivated M. phlei alleviates the IL-17+\u03b3\u03b4T cell-mediated immune response and attenuates airway inflammation and airway hyperresponsiveness in the asthmatic murine lung, partially through inhibiting the expression of IL-23R.", {"entities": []}], ["In conclusion, inactivated M. phlei may be an effective antiasthmatic treatment, regulating IL-17-producing \u03b3\u03b4T (IL-17+\u03b3\u03b4T) cell-mediated airway inflammation and airway hyperresponsiveness to relieve the symptoms of mice with asthma.", {"entities": [[226, 232, "DISEASE"]]}], ["Unlike traditional detection of a disease state in which there are clear phenomena, it is usually a challenge to identify the pre-disease state during the progression of a complex disease just before the serious deterioration, not only because of the high complexity of the biological system, but there may be few clues and apparent changes appearing until the catastrophic critical transition occurs.", {"entities": []}], ["In this work, by exploiting the different dynamical features between the normal and pre-disease states, we present a hidden-Markov-model (HMM) based computational method to identify the pre-disease state and elucidate the essential mechanisms during the critical transition at the network level.", {"entities": []}], ["Specifically, by considering the network variation and regarding that the pre-disease state is the end or shift-point of a stationary Markov process, a consistence score is proposed to measure the probability that a system is in consistency with the normal state.", {"entities": []}], ["As validation, this approach is applied to detect the upcoming critical transition of complex systems based on both the dataset generated from a simulated network and the rich information provided by high-throughput microarray data.", {"entities": []}], ["The effectiveness of our method has been demonstrated by the identification of the pre-disease states for two real datasets including HCV-induced hepatocellular carcinoma and virus-induced influenza infection.", {"entities": [[189, 198, "DISEASE"], [146, 170, "DISEASE"], [161, 170, "DISEASE"]]}], ["From dynamical view point, the critical-transition phenomena in many biological processes are of some generic properties, which can be detected by the established method.", {"entities": []}], ["Previously we showed that reduced availability of the essential amino acid tryptophan per se attenuates post-transcriptional control of interleukin (IL)-6 and IL-8 leading to hyperresponsive production of these inflammatory mediators by airway epithelial cells.", {"entities": []}], ["Availability of the non-essential amino acid arginine in the inflamed airway mucosa of patients with asthma is reduced markedly, but it is not known whether this can also lead to an exaggerated production of IL-6 and IL-8.", {"entities": [[101, 107, "DISEASE"]]}], ["IL-6 and IL-8 were determined by ELISA in culture supernatants of NCI-H292 airway epithelial-like cells and normal bronchial epithelial (NHBE) cells that were exposed to TNF-\u03b1, LPS or no stimulus, in medium with or without arginine.", {"entities": []}], ["Arginine deficiency may also result from exposure to poly-L-arginine or major basic protein (MBP), which can block arginine uptake.", {"entities": [[93, 96, "GENE"]]}], ["Epithelial cells were exposed to these polycationic proteins and L- For both NCI-H292 and NHBE cells, low arginine concentrations enhanced basal epithelial IL-6 and IL-8 production and synergized with TNF-\u03b1-induced IL-6 and IL-8 production.", {"entities": []}], ["Poly-L-arginine enhanced the stimulus-induced IL-6 and IL-8 production, however, blocking arginine uptake and the enhanced IL-6 and IL-8 production appeared unrelated.", {"entities": []}], ["The exaggerated IL-6 and IL-8 production due to arginine deficiency and to poly-L-arginine depend on a post-transcriptional and a transcriptional process, respectively.", {"entities": []}], ["We conclude that both reduced arginine availability per se and the presence of polycationic proteins may promote airway inflammation by enhanced pro-inflammatory mediator production in airway epithelial cells, but due to distinct mechanisms.", {"entities": []}], ["To characterize patients of primary health care services according to demographic and socioeconomic aspects, habits and lifestyle, health condition, and demand for health services and medicines.", {"entities": []}], ["This study is part of the Pesquisa Nacional sobre Acesso, Utiliza\u00e7\u00e3o e Promo\u00e7\u00e3o do Uso Racional de Medicamentos \u2013 Servi\u00e7os (PNAUM \u2013 National Survey on Access, Use and Promotion of Rational Use of Medicines \u2013 Services), a cross-sectional study carried out between 2014 and 2015.", {"entities": []}], ["Interviews were conducted with patients over the age of 17 years, with a standardized questionnaire, in primary health care services of a representative sample of cities, stratified by regions of Brazil.", {"entities": []}], ["The analysis was performed for complex samples and weighted according to the population size of each region.", {"entities": []}], ["A total of 8,676 patients were interviewed, being 75.8% women, most of them aged from 18 to 39 years; 24.2% men, most of them aged from 40 to 59 years; 53.7% with elementary school; 50.5% reported to be of mixed race ethnicity, 39.7%, white, and 7.8%, black.", {"entities": []}], ["Half of patients were classified as class C and 24.8% received the Bolsa Familia benefit.", {"entities": []}], ["Only 9.8% had health insurance, with higher proportion in the South and lower in the North and Midwest.", {"entities": []}], ["The proportion of men who consumed alcohol was higher than among women, as well as smokers.", {"entities": []}], ["The self-assessment of health showed that 57% believed it to be very good or good, with lower proportion in the Northeast.", {"entities": []}], ["The prevalence of chronic diseases/conditions, such as hypertension (38.6%), dyslipidemia (22.7%), arthritis/rheumatism (19.4%), depression (18.5%), diabetes (13.6%), and others are higher in these patients them among the general population.", {"entities": [[55, 67, "DISEASE"], [99, 108, "DISEASE"]]}], ["Medicines were predominantly sought in the health care service or in pharmacies of the Brazilian Unified Health System.", {"entities": []}], ["It was possible to characterize the profile of patients of Primary Health Care, but the originality of the research and its national scope hinders the comparison of results with official data or other articles.", {"entities": []}], ["With improved survival rates, short- and long-term respiratory complications of premature birth are increasing, adding significantly to financial and health burdens in the United States.", {"entities": []}], ["In response, in May 2010, the National Institutes of Health (NIH) and the National Heart, Lung, and Blood Institute (NHLBI) funded a 5-year $18.5 million research initiative to ultimately improve strategies for managing the respiratory complications of preterm and low birth weight infants.", {"entities": []}], ["Using a collaborative, multi-disciplinary structure, the resulting Prematurity and Respiratory Outcomes Program (PROP) seeks to understand factors that correlate with future risk for respiratory morbidity.", {"entities": []}], ["The PROP is an observational prospective cohort study performed by a consortium of six clinical centers (incorporating tertiary neonatal intensive care units [NICU] at 13 sites) and a data-coordinating center working in collaboration with the NHLBI.", {"entities": []}], ["Each clinical center contributes subjects to the study, enrolling infants with gestational ages 23 0/7 to 28 6/7\u00a0weeks with an anticipated target of 750 survivors at 36\u00a0weeks post-menstrual age.", {"entities": []}], ["In addition, each center brings specific areas of scientific focus to the Program.", {"entities": []}], ["The primary study hypothesis is that in survivors of extreme prematurity specific biologic, physiologic and clinical data predicts respiratory morbidity between discharge and 1\u00a0year corrected age.", {"entities": []}], ["Analytic statistical methodology includes model-based and non-model-based analyses, descriptive analyses and generalized linear mixed models.", {"entities": []}], ["PROP incorporates aspects of NICU care to develop objective biomarkers and outcome measures of respiratory morbidity in the <29\u00a0week gestation population beyond just the NICU hospitalization, thereby leading to novel understanding of the nature and natural history of neonatal lung disease and of potential mechanistic and therapeutic targets in at-risk subjects.", {"entities": [[277, 289, "DISEASE"]]}], ["Clinical Trials.gov NCT01435187 .", {"entities": []}], ["The online version of this article (doi:10.1186/s12887-015-0346-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Sound and timely microbial gut colonization completes newborn\u2019s healthy metabolic programming and manifests in infant appropriate growth and weight development.", {"entities": []}], ["Feces, collected at 3, 30, and 90 days after birth from 60 breastfed Slovenian newborns, was submitted to microbial DNA extraction and qPCR quantification of selected gut associated taxa.", {"entities": []}], ["Multivariate regression analysis was applied to evaluate microbial dynamics with respect to infant demographic, environmental, clinical characteristics and first year growth data.", {"entities": []}], ["Early microbial variability was marked by the proportion of Bacilli , but diminished and converged in later samples, as bifidobacteria started to prevail.", {"entities": []}], ["The first month proportions of enterococci were associated with maternity hospital locality and supplementation of breastfeeding with formulae, while Enterococcus faecalis proportion reflected the mode of delivery.", {"entities": []}], ["Group Bacteroides-Prevotella proportion was associated with infant weight and ponderal index at first month.", {"entities": []}], ["Infant mixed feeding pattern and health issues within the first month revealed the most profound and extended microbial perturbations.", {"entities": []}], ["Our findings raise concerns over the ability of the early feeding supplementation to emulate and support the gut microbiota in a way similar to the exclusively breastfed infants.", {"entities": []}], ["Additionally, practicing supplementation beyond the first month also manifested in higher first year weight and weight gain Z-score.", {"entities": []}], ["Resource and geographic barriers are the commonly cited constraints preventing the uptake of psychological treatment for chronic pain management.", {"entities": []}], ["For adults, there is some evidence to support the use of information and communication technology (ICT) as a mode of treatment delivery.", {"entities": []}], ["However, mixed findings have been reported for the effectiveness and acceptability of psychological interventions delivered using information and communication technology for children and adolescents.", {"entities": []}], ["This is a protocol for a review that aims to (i) evaluate the effectiveness of psychological interventions delivered using information and communication technology for children and adolescents with chronic pain and (ii) identify the intervention components and usability factors in technology-based treatments associated with behaviour change.", {"entities": []}], ["We will conduct a systematic review to evaluate the effectiveness of psychological interventions for paediatric chronic pain delivered using ICT.", {"entities": []}], ["We plan to directly compare ICT-based, psychological interventions with active control, treatment as usual or waiting list control conditions.", {"entities": []}], ["This systematic review will be reported in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidance.", {"entities": []}], ["Published and unpublished randomised controlled trials will be included and the literature search will comprise Ovid MEDLINE, Ovid Embase, PsycINFO and the Cochrane Library on Wiley, including CENTRAL and Cochrane Database of Systematic Reviews.", {"entities": []}], ["Grey literature including theses, dissertations, technical and research reports will also be examined.", {"entities": []}], ["Two review authors will independently conduct study selection, relevant data extraction and assessment of methodological quality.", {"entities": []}], ["Risk of bias in included studies will be assessed using the Cochrane Collaboration risk of bias tool criteria.", {"entities": []}], ["Two qualified coders will independently code behaviour change techniques according to the behaviour change taxonomy (v1) of 93 hierarchically clustered techniques and a novel coding scheme for mode of delivery and usability factors.", {"entities": []}], ["A quantitative synthesis will be conducted if appropriate.", {"entities": []}], ["The findings of this review may offer insight for healthcare professionals working in chronic pain services and to researchers involved in designing and evaluating information and communication technology-based interventions.", {"entities": []}], ["PROSPERO CRD42016017657 The online version of this article (doi:10.1186/s13643-016-0350-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Recent studies strongly suggest that some respiratory viruses are associated with the induction of acute wheezing and/or exacerbation of bronchial asthma.", {"entities": [[147, 153, "DISEASE"]]}], ["However, molecular epidemiology of these viruses is not exactly known.", {"entities": []}], ["Using PCR technology, we attempted to detect various respiratory viruses from 115 Japanese children.", {"entities": []}], ["Furthermore, the detected viruses were subjected to homology, pairwise distance, and phylogenetic analysis.", {"entities": []}], ["Viruses were detected from 99 (86.1%) patients.", {"entities": []}], ["Respiratory syncytial virus (RSV) alone and human rhinovirus (HRV) alone were detected in 47 (40.9%) and 36 (31.3%) patients, respectively.", {"entities": []}], ["Both RSV and HRV were detected in 14 (12.2%) patients.", {"entities": []}], ["Human metapneumovirus (HMPV) alone and human parainfluenza virus (HPIV) alone were detected in 1 (0.9%) patient each, respectively.", {"entities": []}], ["Homology and phylogenetic analyses showed that the RSV and HRV strains were classified into genetically diverse species or subgroups.", {"entities": []}], ["In addition, RSV was the dominant virus detected in patients with no history of wheezing, whereas HRV was dominant in patients with a history of wheezing.", {"entities": []}], ["The results suggested that these genetically diverse respiratory viruses, especially RSV and HRV, might be associated with wheezing in Japanese children.", {"entities": []}], ["The development of gastritis during Helicobacter pylori infection is dependent on an activated adaptive immune response orchestrated by T helper (Th) cells.", {"entities": [[19, 28, "DISEASE"]]}], ["However, the relative contributions of the Th1 and Th17 subsets to gastritis and control of infection are still under investigation.", {"entities": [[67, 76, "DISEASE"]]}], ["To investigate the role of interleukin-21 (IL-21) in the gastric mucosa during H.\u00a0pylori infection, we combined mathematical modeling of CD4 in vivo mechanistic studies.", {"entities": [[137, 140, "GENE"]]}], ["We infected IL-21-deficient and wild-type mice with H.\u00a0pylori strain SS1 and assessed colonization, gastric inflammation, cellular infiltration, and cytokine profiles.", {"entities": []}], ["Chronically H.\u00a0pylori -infected IL-21-deficient mice had higher H.\u00a0pylori colonization, significantly less gastritis, and reduced expression of proinflammatory cytokines and chemokines compared to these parameters in infected wild-type littermates.", {"entities": [[107, 116, "DISEASE"]]}], ["These in vivo data were used to calibrate an H.\u00a0pylori infection-dependent, CD4 H.\u00a0pylori infection.", {"entities": [[76, 79, "GENE"]]}], ["The model predicted activated expression of T-bet and ROR\u03b3t and the phosphorylation of STAT3 and STAT1 and suggested a potential role of IL-21 in the modulation of IL-10.", {"entities": [[87, 92, "GENE"], [97, 102, "GENE"]]}], ["Driven by our modeling-derived predictions, we found reduced levels of CD4 tbx21 and rorc expression, reduced phosphorylation of STAT1 and STAT3, and an increase in CD4 H.\u00a0pylori -infected IL-21-deficient mice.", {"entities": [[71, 74, "GENE"], [165, 168, "GENE"], [75, 80, "GENE"], [85, 89, "GENE"], [129, 134, "GENE"], [139, 144, "GENE"], [71, 74, "GENE"], [165, 168, "GENE"]]}], ["Our results indicate that IL-21 regulates Th1 and Th17 effector responses during chronic H.\u00a0pylori infection in a STAT1- and STAT3-dependent manner, therefore playing a major role controlling H.\u00a0pylori infection and gastritis .", {"entities": [[216, 225, "DISEASE"]]}], ["Helicobacter pylori is the dominant member of the gastric microbiota in more than 50% of the world\u2019s population.", {"entities": []}], ["H.\u00a0pylori colonization has been implicated in gastritis and gastric cancer, as infection with H.\u00a0pylori is the single most common risk factor for gastric cancer.", {"entities": [[46, 55, "DISEASE"], [68, 74, "DISEASE"], [154, 160, "DISEASE"]]}], ["Current data suggest that, in addition to bacterial virulence factors, the magnitude and types of immune responses influence the outcome of colonization and chronic infection.", {"entities": []}], ["This study uses a combined computational and experimental approach to investigate how IL-21, a proinflammatory T cell-derived cytokine, maintains the chronic proinflammatory T cell immune response driving chronic gastritis during H.\u00a0pylori infection.", {"entities": [[213, 222, "DISEASE"]]}], ["This research will also provide insight into a myriad of other infectious and immune disorders in which IL-21 is increasingly recognized to play a central role.", {"entities": []}], ["The use of IL-21-related therapies may provide treatment options for individuals chronically colonized with H.\u00a0pylori as an alternative to aggressive antibiotics.", {"entities": []}], ["Etanercept plus methotrexate combination therapy has not been adequately investigated in psoriasis.", {"entities": [[89, 98, "DISEASE"]]}], ["To evaluate etanercept plus methotrexate vs. etanercept monotherapy in patients with moderate to severe plaque psoriasis who had not failed prior methotrexate or tumour necrosis factor-inhibitor therapy.", {"entities": [[111, 120, "DISEASE"]]}], ["Patients received etanercept 50 mg twice weekly for 12 weeks followed by 50 mg once weekly for 12 weeks and were randomized 1 : 1 to receive methotrexate (7\u00b75\u201315 mg weekly) or placebo.", {"entities": []}], ["The primary endpoint was the proportion of patients achieving \u226575% improvement in Psoriasis Area and Severity Index (PASI 75) at week 24.", {"entities": [[82, 91, "DISEASE"]]}], ["In total, 239 patients were enrolled in each arm.", {"entities": []}], ["PASI 75 was significantly higher at week 24 for the combination therapy group compared with the monotherapy group (77\u00b73% vs. 60\u00b73%; P < 0\u00b70001).", {"entities": []}], ["Other PASI improvement scores at week 12 [PASI 75, 70\u00b72% vs. 54\u00b73% ( P = 0\u00b701); PASI 50, 92\u00b74% vs. 83\u00b78% ( P = 0\u00b701); and PASI 90, 34\u00b70% vs. 23\u00b71% ( P = 0\u00b703)] showed similar results as did week 24 PASI 50 (91\u00b76% vs. 84\u00b76%; P = 0\u00b701) and PASI 90 (53\u00b78% vs. 34\u00b72%; P = 0\u00b701).", {"entities": []}], ["Significantly more patients receiving combination therapy than monotherapy had static Physician\u2019s Global Assessment of clear/almost clear at week 12 (65\u00b75% vs. 47\u00b70%; P = 0\u00b701) and week 24 (71\u00b78% vs. 54\u00b73%; P = 0\u00b701).", {"entities": []}], ["Adverse events (AEs) were reported in 74\u00b79% and 59\u00b78% of combination therapy and monotherapy groups, respectively; three serious AEs were reported in each arm.", {"entities": []}], ["Combination therapy with etanercept plus methotrexate had acceptable tolerability and increased efficacy compared with etanercept monotherapy in patients with moderate to severe psoriasis.", {"entities": [[178, 187, "DISEASE"]]}], ["There are increasing numbers of emergency medical paediatric admissions.", {"entities": []}], ["Our hypothesis was that characteristics of children and details of their emergency admissions are also changing over time.", {"entities": []}], ["Details of emergency admissions in Scotland 2000\u20132013 were analysed.", {"entities": []}], ["There were 574,403 emergency admissions, median age 2.3\u00a0years.", {"entities": []}], ["The age distribution, proportion of boys and socioeconomic status of children admitted were essentially unchanged.", {"entities": []}], ["Emergency admissions rose by 49% from 36/1000 children per annum to 54/1000 between 2000 and 2013.", {"entities": []}], ["Emergency admissions that were discharged on the same day rose by 186% from 8.6/1000 to 24.6/1000.", {"entities": []}], ["The mean duration of emergency admission fell from 1.7 to 1.0\u00a0days.", {"entities": []}], ["The odds for an emergency admission with upper respiratory infection, \u201cviral infection\u201d, tonsillitis, bronchiolitis and lower respiratory tract infection all rose.", {"entities": [[89, 100, "DISEASE"], [102, 115, "DISEASE"]]}], ["In contrast the odds for an emergency admission with asthma and gastroenteritis fell.", {"entities": [[64, 79, "DISEASE"], [53, 59, "DISEASE"]]}], ["Conclusions : The demographics of children with emergency admissions have not changed substantially but characteristics of admissions have changed considerably, in particular admissions which are short stay and due to respiratory infection are much more common.", {"entities": []}], ["The fall in the absolute number of children with some acute medical diagnoses suggests that the rise in admissions is not necessarily inexorable.", {"entities": []}], ["The online version of this article (10.1007/s00431-017-3064-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["A novel avian influenza A (H7N9) virus has caused great morbidity as well as mortality since its emergence in Eastern China in February 2013.", {"entities": [[14, 23, "DISEASE"], [8, 23, "DISEASE"]]}], ["However, the possible risk factors for death are not yet fully known.", {"entities": []}], ["Patients with H7N9 virus infection between March 1 and August 14, 2013 in Jiangsu province were enrolled.", {"entities": []}], ["Data were collected with a standard form.", {"entities": []}], ["Mean or percentage was used to describe the features, and Fisher's exact test or t -test test was used to compare the differences between fatal and nonfatal cases with H7N9 virus infection.", {"entities": []}], ["A total of 28 patients with H7N9 virus infection were identified among whom, nine (32.1%) died.", {"entities": []}], ["The median age of fatal cases was significant higher than nonfatal cases ( P <0.05).", {"entities": []}], ["Patients with older age were more strongly associated with increased odds of death (OR\u200a=\u200a30.0; 95% CI, 2.85\u2013315.62).", {"entities": []}], ["Co-morbidity with chronic lung disease and hypertension were risk factors for mortality (OR\u200a=\u200a14.40; 95% CI, 1.30\u2013159.52, OR\u200a=\u200a6.67; 95% CI, 1.09\u201340.43, respectively).", {"entities": [[43, 55, "DISEASE"], [26, 38, "DISEASE"]]}], ["Moreover, the presence of either bilateral lung inflammation or pulmonary consolidation on chest imaging on admission was related with fatal outcome (OR\u200a=\u200a7.00; 95%CI, 1.10\u201344.61).", {"entities": []}], ["Finally, dynamic monitoring showed that lymphopenia was more significant in fatal group than in nonfatal group from day 11 to week five ( P <0.05).", {"entities": [[40, 51, "DISEASE"]]}], ["The decrease in oxygenation indexes were observed in most cases and more significantly in fatal cases after week three ( P <0.05), and the value of nearly all fatal cases were below 200 mmHg during our evaluation period.", {"entities": []}], ["Among cases with H7N9 virus infection, increased age accompanied by co-morbidities was the risk of death.", {"entities": []}], ["The severity of lung infection at admission, the persistence of lymphocytopenia, and the extended duration of lower oxygenation index all contributed to worsened outcomes of patients with H7N9 virus infection.", {"entities": []}], ["Hydrogen sulfide (H 2 S) is a promising cardioprotective agent and a potential modulator of cardiac ion currents.", {"entities": []}], ["Yet its cardiac effects on humans are poorly understood due to lack of functional cardiomyocytes.", {"entities": []}], ["This study investigates electrophysiological responses of human pluripotent stem cells (hPSCs) derived cardiomyocytes towards H 2 S. Cardiomyocytes of ventricular, atrial and nodal subtypes differentiated from H9 embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) were electrophysiologically characterized.", {"entities": []}], ["The effect of NaHS, a donor of H 2 S, on action potential (AP), outward rectifier potassium currents ( I Ks and I Kr ), L-type Ca I CaL ) and hyperpolarization-activated inward current ( I f ) were determined by patch-clamp electrophysiology and confocal calcium imaging.", {"entities": []}], ["In a concentration-dependent manner, NaHS (100 to 300 \u00b5M) consistently altered the action potential properties including prolonging action potential duration (APD) and slowing down contracting rates of ventricular-and atrial-like cardiomyocytes derived from both hESCs and hiPSCs.", {"entities": []}], ["Moreover, inhibitions of slow and rapid I K ( I Ks and I Kr ), I CaL and I f were found in NaHS treated cardiomyocytes and it could collectively contribute to the remodeling of AP properties.", {"entities": []}], ["This is the first demonstration of effects of H 2 S on cardiac electrophysiology of human ventricular-like, atrial-like and nodal-like cardiomyocytes.", {"entities": []}], ["It reaffirmed the inhibitory effect of H 2 S on I CaL and revealed additional novel inhibitory effects on I f , I Ks and I Kr currents in human cardiomyocytes.", {"entities": []}], ["Depression and anxiety have been reported to be associated with chronic physical conditions.", {"entities": []}], ["We examined the excess risk of chronic physical conditions associated with depression and/or anxiety within a multivariate framework controlling for demographic and modifiable lifestyle risk factors.", {"entities": []}], ["We used a retrospective cross-sectional study design.", {"entities": []}], ["Study participants were adults aged 22\u201364\u00a0years from 2007 and 2009 Medical Expenditure Panel Survey.", {"entities": []}], ["We defined presence of depression-anxiety based on self-reported depression and anxiety and classified adults into 4 groups: 1) depression only; 2) anxiety only; 3) comorbid depression and anxiety 4) no depression and no anxiety.", {"entities": []}], ["We included presence/absence of arthritis, asthma, chronic obstructive pulmonary disorder, diabetes, heart disease, hypertension, and osteoporosis as dependent variables.", {"entities": [[116, 128, "DISEASE"], [101, 114, "DISEASE"], [134, 146, "DISEASE"], [32, 41, "DISEASE"], [43, 49, "DISEASE"]]}], ["Complementary log-log regressions were used to examine the excess risk associated with depression and/or anxiety for chronic physical conditions using a multivariate framework that controlled for demographic (gender, age, race/ethnicity) and modifiable lifestyle (obesity, lack of physical activity, smoking) risk factors.", {"entities": [[264, 271, "DISEASE"]]}], ["Bonferroni correction for multiple comparisons was applied and p \u22640.007 was considered statistically significant.", {"entities": []}], ["Overall, 7% had only depression, 5.2% had only anxiety and 2.5% had comorbid depression and anxiety.", {"entities": []}], ["Results from multivariable regressions indicated that compared to individuals with no depression and no anxiety, individuals with comorbid depression and anxiety, with depression only and with anxiety only, all had higher risk of all the chronic physical conditions.", {"entities": []}], ["ARRs for comorbid depression and anxiety ranged from 2.47 (95% CI: 1.47, 4.15; P\u2009=\u20090.0007) for osteoporosis to 1.64 (95% CI: 1.33, 2.04; P\u2009<\u20090.0001) for diabetes.", {"entities": [[95, 107, "DISEASE"]]}], ["Presence of depression only was also found to be significantly associated with all chronic conditions except for osteoporosis.", {"entities": [[113, 125, "DISEASE"]]}], ["Individuals with anxiety only were found to have a higher risk for arthritis, COPD, heart disease and hypertension.", {"entities": [[102, 114, "DISEASE"], [84, 97, "DISEASE"], [67, 76, "DISEASE"]]}], ["Presence of depression and/or anxiety conferred an independent risk for having chronic physical conditions after adjusting for demographic and modifiable lifestyle risk factors.", {"entities": []}], ["The environmental contribution to autism spectrum disorders (ASD) is largely unknown, but household pesticides are receiving increased attention.", {"entities": []}], ["We examined associations between ASD and maternally-reported use of imidacloprid, a common flea and tick treatment for pets.", {"entities": []}], ["Bayesian logistic models were used to estimate the association between ASD and imidacloprid and to correct for potential differential exposure misclassification due to recall in a case control study of ASD.", {"entities": []}], ["Our analytic dataset included complete information for 262 typically developing controls and 407 children with ASD.", {"entities": []}], ["Compared with exposure among controls, the odds of prenatal imidacloprid exposure among children with ASD were slightly higher, with an odds ratio (OR) of 1.3 (95% Credible Interval [CrI] 0.78, 2.2).", {"entities": []}], ["A susceptibility window analysis yielded higher ORs for exposures during pregnancy than for early life exposures, whereas limiting to frequent users of imidacloprid, the OR increased to 2.0 (95% CI 1.0, 3.9).", {"entities": []}], ["Within plausible estimates of sensitivity and specificity, the association could result from exposure misclassification alone.", {"entities": []}], ["The association between imidacloprid exposure and ASD warrants further investigation, and this work highlights the need for validation studies regarding prenatal exposures in ASD.", {"entities": []}], ["Most research on adults with chronic conditions focuses on a single disease or condition, such as hypertension or diabetes, rather than on multiple chronic conditions (MCC).", {"entities": [[98, 110, "DISEASE"], [168, 171, "GENE"]]}], ["Our study\u2019s objective was to compare physician office visits by adults with MCC with visits by adults without MCC, by selected patient demographic characteristics.", {"entities": [[76, 79, "GENE"], [110, 113, "GENE"], [76, 79, "GENE"], [110, 113, "GENE"]]}], ["We also identified the most prevalent dyads and triads of chronic conditions among these patients.", {"entities": []}], ["We used the National Ambulatory Medical Care Survey, a nationally representative survey of office visits to nonfederal physicians and used 13 of the 20 conditions defined by the National Strategic Framework on Multiple Chronic Conditions.", {"entities": []}], ["Descriptive estimates were generated and significant differences were tested.", {"entities": []}], ["In 2009, an estimated 326 million physician office visits, were made by adults aged 18 years or older with MCC representing 37.6% of all medical office visits by adults.", {"entities": [[107, 110, "GENE"]]}], ["Hypertension was the most prevalent chronic condition that appeared in the top 5 MCC dyads and triads, by sex and age groups.", {"entities": [[0, 12, "DISEASE"], [81, 84, "GENE"]]}], ["The number of visits by patients with MCC increased with age and was greater for men than for women and for adults with public rather than private insurance.", {"entities": [[38, 41, "GENE"]]}], ["Physicians were more likely to prescribe medications at office visits made by patients with MCC.", {"entities": [[92, 95, "GENE"]]}], ["Physician office visits by adults with MCC were not evenly distributed by demographic characteristics.", {"entities": [[39, 42, "GENE"]]}], ["We explored the association between gestational age and cord blood DNA methylation at birth and whether DNA methylation could be effective in predicting gestational age due to limitations with the presently used methods.", {"entities": []}], ["We used data from the Norwegian Mother and Child Birth Cohort study (MoBa) with Illumina HumanMethylation450 data measured for 1753 newborns in two batches: MoBa 1, n\u2009=\u20091068; and MoBa 2, n\u2009=\u2009685.", {"entities": []}], ["Gestational age was computed using both ultrasound and the last menstrual period.", {"entities": []}], ["We evaluated associations between DNA methylation and gestational age and developed a statistical model for predicting gestational age using MoBa 1 for training and MoBa 2 for predictions.", {"entities": []}], ["The prediction model was additionally used to compare ultrasound and last menstrual period-based gestational age predictions.", {"entities": []}], ["Furthermore, both CpGs and associated genes detected in the training models were compared to those detected in a published prediction model for chronological age.", {"entities": []}], ["There were 5474 CpGs associated with ultrasound gestational age after adjustment for a set of covariates, including estimated cell type proportions, and Bonferroni-correction for multiple testing.", {"entities": []}], ["Our model predicted ultrasound gestational age more accurately than it predicted last menstrual period gestational age.", {"entities": []}], ["DNA methylation at birth appears to be a good predictor of gestational age.", {"entities": []}], ["Ultrasound gestational age is more strongly associated with methylation than last menstrual period gestational age.", {"entities": []}], ["The CpGs linked with our gestational age prediction model, and their associated genes, differed substantially from the corresponding CpGs and genes associated with a chronological age prediction model.", {"entities": []}], ["The online version of this article (doi:10.1186/s13059-016-1063-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The major allergen domain (MA) is widely distributed in insects.", {"entities": []}], ["The crystal structure of a single Bla g 1 MA revealed a novel protein fold in which the fundamental structure was a duplex of two subsequences (monomers), which had diverged over time.", {"entities": []}], ["This suggested that the evolutionary origin of the MA structure may have been a homodimer of this smaller subsequence.", {"entities": []}], ["Using publicly available genomic data, the distribution of the basic unit of this class of proteins was determined to better understand its evolutionary history.", {"entities": []}], ["The duplication and divergence is examined at three distinct levels of resolution: 1) within the orders Diptera and Hymenoptera, 2) within one genus Drosophila , and 3) within one species Aedes aegypti .", {"entities": []}], ["Within the family Culicidae, we have found two separate occurrences of monomers as independent genes.", {"entities": []}], ["The organization of the gene family in A. aegypti shows a common evolutionary origin for its monomer and several closely related MAs.", {"entities": []}], ["Molecular modeling of the A. aegypti monomer with the unique Bla g 1 fold confirms the distant evolutionary relationship and supports the feasibility of homodimer formation from a single monomer.", {"entities": []}], ["RNAseq data for A. aegypti confirms that the monomer is expressed in the mosquito similar to other A. aegypti MAs after a blood meal.", {"entities": []}], ["Together, these data support the contention that the detected monomer shares similar functional characteristics to related MAs in other insects.", {"entities": []}], ["An extensive search for this domain outside of Insecta confirms that the MAs are restricted to insects.", {"entities": []}], ["Little is known about the trajectory of health and well\u2010being from before to after a cancer diagnosis.", {"entities": [[85, 91, "DISEASE"]]}], ["This study aimed to examine changes in health and well\u2010being across three time points (0\u20132\u00a0years before a cancer diagnosis, 0\u20132\u00a0years post\u2010diagnosis and 2\u20134\u00a0years post\u2010diagnosis) in individuals receiving a new cancer diagnosis, and at matched time points in a cancer\u2010free comparison group.", {"entities": [[106, 112, "DISEASE"], [210, 216, "DISEASE"], [260, 266, "DISEASE"]]}], ["Data were from waves 1\u20136 of the English Longitudinal Study of Ageing.", {"entities": []}], ["Repeated\u2010measures ANOVAs were used to examine differences in self\u2010rated health, mobility impairments, activities of daily living impairments, quality of life, depressive symptoms and life satisfaction by group and time, and group\u2010by\u2010time interactions.", {"entities": []}], ["Of the 4565 participants with data from three time points, 444 (9.7%) reported a new cancer diagnosis.", {"entities": [[85, 91, "DISEASE"]]}], ["Those in the cancer group reported poorer self\u2010rated health ( p \u2009<\u2009.001), quality of life ( p \u2009<\u2009.001) and life satisfaction ( p \u2009<\u2009.01) than participants in the comparison group, and a higher proportion reported depressive symptoms ( p \u2009<\u2009.001) and impairments in mobility ( p \u2009<\u2009.001) and activities of daily living ( p \u2009<\u2009.001).", {"entities": [[13, 19, "DISEASE"]]}], ["All markers of health and well\u2010being worsened significantly over time.", {"entities": []}], ["The group\u2010by\u2010time interaction was significant for self\u2010rated health ( p \u2009<\u2009.001), with a greater decline in health over time in the cancer group.", {"entities": [[132, 138, "DISEASE"]]}], ["Cancer survivors in this sample had poorer health and well\u2010being than those with no diagnosis, and self\u2010rated health deteriorated more rapidly following a cancer diagnosis.", {"entities": [[0, 6, "DISEASE"], [155, 161, "DISEASE"]]}], ["Screening for these factors around the time of a cancer diagnosis could allow for interventions to be targeted effectively and improve the health and well\u2010being of cancer survivors.", {"entities": [[49, 55, "DISEASE"], [164, 170, "DISEASE"]]}], ["\u00a9 2015 The Authors.", {"entities": []}], ["Psycho\u2010Oncology published by John Wiley & Sons Ltd.", {"entities": []}], ["Ethnic diversity has been long considered as one of the factors explaining why the severe forms of dengue are more prevalent in Southeast Asia than anywhere else.", {"entities": []}], ["Here we take advantage of the admixed profile of Southeast Asians to perform coupled association-admixture analyses in Thai cohorts.", {"entities": []}], ["For dengue shock syndrome (DSS), the significant haplotypes are located in genes coding for phospholipase C members ( PLCB4 added to previously reported PLCE1 ), related to inflammation of blood vessels.", {"entities": [[17, 25, "DISEASE"], [4, 25, "DISEASE"], [118, 123, "GENE"], [153, 158, "GENE"]]}], ["For dengue fever (DF), we found evidence of significant association with CHST10 , AHRR , PPP2R5E and GRIP1 genes, which participate in the xenobiotic metabolism signaling pathway.", {"entities": [[73, 79, "GENE"], [82, 86, "GENE"], [89, 96, "GENE"], [101, 106, "GENE"]]}], ["We conducted functional analyses for PPP2R5E , revealing by immunofluorescence imaging that the coded protein co-localizes with both DENV1 and DENV2 NS5 proteins.", {"entities": [[37, 44, "GENE"]]}], ["Interestingly, only DENV2-NS5 migrated to the nucleus, and a deletion of the predicted top-linking motif in NS5 abolished the nuclear transfer.", {"entities": []}], ["These observations support the existence of differences between serotypes in their cellular dynamics, which may contribute to differential infection outcome risk.", {"entities": []}], ["The contribution of the identified genes to the genetic risk render Southeast and Northeast Asian populations more susceptible to both phenotypes, while African populations are best protected against DSS and intermediately protected against DF, and Europeans the best protected against DF but the most susceptible against DSS.", {"entities": []}], ["Dengue fever is endemic in tropical and subtropical areas of East Asia and America, but globalization and climate changes are introducing vector and virus to the na\u00efve regions of Europe and North America.", {"entities": []}], ["In this work we conducted a statistically robust, coupled association-admixture test in two dengue cohorts from Thailand (classical dengue fever, DF, and dengue shock syndrome, DSS) and a published Vietnamese (DSS only) cohort.", {"entities": [[167, 175, "DISEASE"], [154, 175, "DISEASE"]]}], ["We identified new candidate genes associated with DF risk and confirmed known gene family association with DSS risk.", {"entities": []}], ["In DF, phosphatase control is crucial, including through binding to viral proteins, as we showed for PPP2R5E protein co-localization with DENV1 and DENV2-NS5 proteins within liver cells and differential cellular localizations along time.", {"entities": [[101, 108, "GENE"]]}], ["In DSS, cytokine dynamics, inflammation and activation of vascular endothelium cells are dominant features.", {"entities": []}], ["The particular genetic risk conferred by these genes indicates that Southeast and Northeast Asians are highly susceptible to both phenotypes, while Africans are best protected against DSS, and Europeans best protected against DF but the most susceptible against DSS.", {"entities": []}], ["Patients with comorbidities do not receive optimal treatment for their cancer, leading to lower cancer survival.", {"entities": [[71, 77, "DISEASE"], [96, 102, "DISEASE"]]}], ["Information on individual comorbidities is not straightforward to derive from population-based administrative health datasets.", {"entities": []}], ["We described the development of a reproducible algorithm to extract the individual Charlson index comorbidities from such data.", {"entities": []}], ["We illustrated the algorithm with 1,789 laryngeal cancer patients diagnosed in England in 2013.", {"entities": [[50, 56, "DISEASE"]]}], ["We aimed to clearly set out and advocate the time-related assumptions specified in the algorithm by providing empirical evidence for them.", {"entities": []}], ["Comorbidities were assessed from hospital records in the ten years preceding cancer diagnosis and internal reliability of the hospital records was checked.", {"entities": [[77, 83, "DISEASE"]]}], ["Data were right-truncated 6 or 12 months prior to cancer diagnosis to avoid inclusion of potentially cancer-related comorbidities.", {"entities": [[50, 56, "DISEASE"], [101, 107, "DISEASE"]]}], ["We tested for collider bias using Cox regression.", {"entities": []}], ["Our administrative data showed weak to moderate internal reliability to identify comorbidities (ICC ranging between 0.1 and 0.6) but a notably high external validity (86.3%).", {"entities": []}], ["We showed a reverse protective effect of non-cancer related Chronic Obstructive Pulmonary Disease (COPD) when the effect is split into cancer and non-cancer related COPD (Age-adjusted HR: 0.95, 95% CI:0.7\u20131.28 for non-cancer related comorbidities).", {"entities": [[45, 51, "DISEASE"], [135, 141, "DISEASE"], [150, 156, "DISEASE"], [218, 224, "DISEASE"], [184, 186, "GENE"]]}], ["Furthermore, we showed that a window of 6 years before diagnosis is an optimal period for the assessment of comorbidities.", {"entities": []}], ["To formulate a robust approach for assessing common comorbidities, it is important that assumptions made are explicitly stated and empirically proven.", {"entities": []}], ["We provide a transparent and consistent approach useful to researchers looking to assess comorbidities for cancer patients using administrative health data.", {"entities": [[107, 113, "DISEASE"]]}], ["Evidence shows ethnic-inequality is a very effective variable in the Community and individual health associated outcomes.", {"entities": []}], ["This study focused on gaining a deeper understanding of people\u2019s perception on inequality of health in Iranian-Kurds and its determinants.", {"entities": []}], ["The study was conducted in the three cities of Marivan, Sanandaj (capital of Kurdistan province in Iran) and Tehran (capital of the country).", {"entities": []}], ["The study was conducted through 34 in-depth interviews and ten focus group discussions with health services users, academic graduates and health delivery service personnel.", {"entities": []}], ["Consensus on social, mental and physical health inequality did not exist within the study participants.", {"entities": []}], ["However, there were concerns about differences in healthcare access and utilization.", {"entities": []}], ["Several participants believed that access to health services and socio-cultural differences of Kurds affected the healthcare utilization.", {"entities": []}], ["Since, people perceived ethnic-inequality in healthcare access and utilization, ethnicity must be considered as a mandatory stratifier in monitoring health status and a concern during planning health interventions.", {"entities": []}], ["People\u2019s awareness, resources management and allocation are factors requiring more consideration when choosing policy options.", {"entities": []}], ["A 10-year-old female spayed American Pitt Bull Terrier was presented with a slow growing mass on the temporal limbus area of the right eye.", {"entities": []}], ["Canine nodular granulomatous episclerokeratitis was suspected, and the affected eye was treated with 1% prednisolone acetate ophthalmic suspension and 0.03% Tacrolimus ophthalmic solution.", {"entities": []}], ["As the lesion did not respond to the medical treatments and continued to grow, the mass was excised by lamellar sclerokeratectomy.", {"entities": []}], ["Microscopically, the mass was composed of granulomatous inflammation with intrahistiocytic lipids and lakes of acicular cholesterol clefts, histopathology findings consistent with xanthogranuloma.", {"entities": []}], ["To the authors\u2019 knowledge, this is the first canine report of limbal xanthogranuloma.", {"entities": []}], ["Chitinase 3-like 1 (CHI3L1), one of mammalian members of the chitinase family, is expressed in several types of human cancer, and elevated serum level of CHI3L1 is suggested to be a biomarker of poor prognosis in advanced cancer patients.", {"entities": [[118, 124, "DISEASE"], [222, 228, "DISEASE"], [20, 26, "GENE"], [154, 160, "GENE"], [20, 26, "GENE"], [154, 160, "GENE"]]}], ["However, the overall biological function of CHI3L1 in human cancers still remains unknown.", {"entities": [[44, 50, "GENE"]]}], ["Studies were performed to characterize the role of CHI3L1 in cancer pathophysiology utilizing human colorectal cancer samples and human cell lines.", {"entities": [[100, 117, "DISEASE"], [61, 67, "DISEASE"], [111, 117, "DISEASE"], [51, 57, "GENE"]]}], ["Plasma protein and tissue mRNA expression levels of CHI3L1 in colorectal cancer were strongly upregulated.", {"entities": [[62, 79, "DISEASE"], [73, 79, "DISEASE"], [52, 58, "GENE"]]}], ["Immunohistochemical analysis showed that CHI3L1 was expressed in cancer cells and CHI3L1 expression had a significant association with the number of infiltrated macrophages and microvessel density.", {"entities": [[65, 71, "DISEASE"], [41, 47, "GENE"], [82, 88, "GENE"], [41, 47, "GENE"], [82, 88, "GENE"]]}], ["By utilizing trans-well migration and tube formation assays, overexpression of CHI3L1 in SW480 cells (human colon cancer cells) enhanced the migration of THP-1 cells (human macrophage cells) and HUVECs (human endothelial cells), and the tube formation of HUVECs.", {"entities": [[108, 120, "DISEASE"], [114, 120, "DISEASE"], [79, 85, "GENE"]]}], ["The knockdown of CHI3L1 by RNA interference or the neutralization of CHI3L1 by anti-CHI3L1 antibody displayed strong suppression of CHI3L1-induced migration and tube formation.", {"entities": [[17, 23, "GENE"], [69, 75, "GENE"], [84, 90, "GENE"], [132, 138, "GENE"], [17, 23, "GENE"], [69, 75, "GENE"], [84, 90, "GENE"], [132, 138, "GENE"]]}], ["Cell proliferation assay showed that CHI3L1 overexpression significantly enhanced the proliferation of SW480 cells.", {"entities": [[37, 43, "GENE"]]}], ["ELISA analysis showed that CHI3L1 increased the secretion of inflammatory chemokines, IL-8 and MCP-1, from SW480 cells through mitogen-activated protein kinase (MAPK) signaling pathway.", {"entities": [[27, 33, "GENE"]]}], ["Both neutralization of IL-8 or MCP-1 and inhibition or knockdown of MAPK in SW480 cells significantly inhibited CHI3L1-induced migration and tube formation.", {"entities": []}], ["In a xenograft mouse model, overexpression of CHI3L1 in HCT116 cells (human colon cancer cells) enhanced the tumor growth as well as macrophage infiltration and microvessel density.", {"entities": [[76, 88, "DISEASE"], [82, 88, "DISEASE"], [46, 52, "GENE"]]}], ["In conclusion, CHI3L1 expressed in colon cancer cells promotes cancer cell proliferation, macrophage recruitment and angiogenesis.", {"entities": [[35, 47, "DISEASE"], [41, 47, "DISEASE"], [63, 69, "DISEASE"], [15, 21, "GENE"]]}], ["Thus, the inhibition of CHI3L1 activity may be a novel therapeutic strategy for human colorectal cancer.", {"entities": [[86, 103, "DISEASE"], [97, 103, "DISEASE"], [24, 30, "GENE"]]}], ["This article provides an overview of the scientific literature in which chemically sensitive patients have been directly evaluated.", {"entities": []}], ["For that purpose, consideration of various case definitions is offered along with summaries of subjects' demographic profiles, exposure characteristics, and symptom profiles across studies.", {"entities": []}], ["Controlled investigations of chemically sensitive subjects without other organic illnesses are reviewed.", {"entities": []}], ["To date, psychiatric, personality, cognitive/neurologic, immunologic, and olfactory studies have been conducted comparing subjects with primary chemical sensitivity to various control groups.", {"entities": []}], ["Thus far, the most consistent finding is that chemically sensitive patients have a higher rate of psychiatric disorders across studies and relative to diverse comparison groups.", {"entities": []}], ["However, since these studies are cross-sectional, causality cannot be implied.", {"entities": []}], ["Demonstrating the role of low-level chemical exposure in a controlled environment has yet to be undertaken with this patient group and is crucial to the understanding of this phenomenon.", {"entities": []}], ["Cell counts of leukocytes subpopulations are demonstrating to have an important value in predicting outcome in severe infections.", {"entities": []}], ["We evaluated here the render of leukogram counts to predict outcome in patients with ventilator-associated pneumonia (VAP) caused by Staphylococcus aureus .", {"entities": [[107, 116, "DISEASE"]]}], ["Data from patients admitted to the ICU of Hospital Cl\u00ednico Universitario de Valladolid from 2006 to 2011 with diagnosis of VAP caused by S. aureus were retrospectively collected for the study ( n = 44).", {"entities": []}], ["Leukocyte counts were collected at ICU admission and also at VAP diagnosis.", {"entities": []}], ["Our results showed that nonsurvivors had significant lower eosinophil counts at VAP diagnosis.", {"entities": []}], ["Multivariate Cox regression analysis performed by the Wald test for forward selection showed that eosinophil increments from ICU admission to VAP diagnosis and total eosinophil counts at VAP diagnosis were protective factors against mortality in the first 28 days following diagnosis: (HR [CI 95%], P ): (0.996 [0.993\u20130.999], 0.010); (0.370 [0.180\u20130.750], 0.006).", {"entities": [[286, 288, "GENE"]]}], ["Patients with eosinophil counts <30\u2009cells/mm P ): (0.701 [0.519\u20130.882], 0.042).", {"entities": []}], ["Eosinophil behaves as a protective cell in patients with VAP caused by S. aureus .", {"entities": []}], ["Exposure to chemicals in the environment is believed to play a critical role in the etiology of many human diseases.", {"entities": []}], ["To enhance understanding about environmental effects on human health, the Comparative Toxicogenomics Database (CTD; http://ctdbase.org ) provides unique curated data that enable development of novel hypotheses about the relationships between chemicals and diseases.", {"entities": []}], ["CTD biocurators read the literature and curate direct relationships between chemicals-genes, genes-diseases, and chemicals-diseases.", {"entities": []}], ["These direct relationships are then computationally integrated to create additional inferred relationships; for example, a direct chemical-gene statement can be combined with a direct gene-disease statement to generate a chemical-disease inference (inferred via the shared gene).", {"entities": []}], ["In CTD, the number of inferences has increased exponentially as the number of direct chemical, gene and disease interactions has grown.", {"entities": []}], ["To help users navigate and prioritize these inferences for hypothesis development, we implemented a statistic to score and rank them based on the topology of the local network consisting of the chemical, disease and each of the genes used to make an inference.", {"entities": []}], ["In this network, chemicals, diseases and genes are nodes connected by edges representing the curated interactions.", {"entities": []}], ["Like other biological networks, node connectivity is an important consideration when evaluating the CTD network, as the connectivity of nodes follows the power-law distribution.", {"entities": []}], ["Topological methods reduce the influence of highly connected nodes that are present in biological networks.", {"entities": []}], ["We evaluated published methods that used local network topology to determine the reliability of protein\u2013protein interactions derived from high-throughput assays.", {"entities": []}], ["We developed a new metric that combines and weights two of these methods and uniquely takes into account the number of common neighbors and the connectivity of each entity involved.", {"entities": []}], ["We present several CTD inferences as case studies to demonstrate the value of this metric and the biological relevance of the inferences.", {"entities": []}], ["Located in the heart of the community and widely distributed geographically, community pharmacies provide a platform for a more proactive involvement in public health services.", {"entities": []}], ["So far, little information has been gathered in Ethiopia on community pharmacists\u2019 level of involvement in public health services.", {"entities": []}], ["The aim of the present study was, therefore, to document the level of involvement of community pharmacy professionals in the provision of public health services and the barriers to such involvement.", {"entities": []}], ["This study employed a self-administered questionnaire based survey, which asked participants to indicate their frequency and level of involvement in providing public health services and their perceived barriers in providing such services.", {"entities": []}], ["Surveys were undertaken from May to July, 2016 with 472 community pharmacy professionals working in community pharmacies in six cities of Amhara regional state of Ethiopia: Debre Markos, Gondar, Dessie, Bahir Dar, Woldya and Debre Birhan.", {"entities": []}], ["Among 472 community pharmacy professionals approached, 412 (233 pharmacists and 179 pharmacy technicians) completed the survey with a response rate of 87.3%.", {"entities": []}], ["Most respondents reported as being either \u201cnot at all involved\u201d or \u201clittle involved\u201d in counselling on smoking cessation (79.3%), and screening for hypertension (86.9%), diabetes (89.5%), and dyslipidemia (88.9%).", {"entities": [[148, 160, "DISEASE"]]}], ["On the other hand, they reported a higher level of involvement in the management and screening of infectious diseases (72.8%) and counseling with partners when initiating treatment for sexually transmitted diseases (68.9%).", {"entities": []}], ["Lack of knowledge or clinical skills and lack of personnel or resources were the most commonly reported barrier for expanding such services.", {"entities": []}], ["This survey revealed a low level of involvement of community pharmacists in public health services.", {"entities": []}], ["In order to better integrate community pharmacies into future public health programs and optimize the contribution of community pharmacy professionals, interventions should focus on overcoming the identified barriers.", {"entities": []}], ["Our previous results showed that intrasynovial Rifamycin SV caused the lysis of synoviocites and freed the autoantigens which in turn stimulated the immunoregulatory rather than autoreactive T cell response in rheumatoid patients.", {"entities": []}], ["Here, we hypothesize that disruption in vitro of peripheral blood mononuclear cells, by freeze/thawing or by lytic action of Rifamycin SV, would induce the release of endosomal pathogenic autoantigens from APCs present in the circulation, which could then be isolated from degrading enzymes by ultrafiltration.", {"entities": [[206, 210, "GENE"]]}], ["The preparation of the ultrafiltrates are based on the rupture of PBMCs (5\u00a0\u00d7\u00a010 At clinical monitoring of the 30th\u00a0day, 22/58 (38\u00a0%) patients subcutaneously treated with the autologous ultrafiltrate prepared by the freeze/thawing of PBMCs reached an ACR20.", {"entities": []}], ["Comparable results were obtained with the other two ultrafiltrates.", {"entities": []}], ["Cell cultures The addition of ultrafiltrates to rheumatoid PBMCs cultures led to the upregulation of a marker for T-regulatory cells, and downregulation of a cell proliferation marker; changes that together have the meaning of a global immunomodulatory response and that only a specific antigen (ultrafiltrate UF-f/t) might induce in the rheumatoid patient, probably by activating pre-existing protective network.", {"entities": []}], ["Experimental arthritis All the ultrafiltrates except that prepared by Rifamycin SV were able to modulate the adjuvant arthritis in rats.", {"entities": [[13, 22, "DISEASE"], [118, 127, "DISEASE"]]}], ["In particular, longlasting synovial fluid induced a significant reduction of the severity of subsequent arthritis (p\u00a0<\u00a00.01) while SF from recent RA effusion (5\u201310\u00a0days after a previous complete extraction) and knee osteoarthrosis were ineffective.", {"entities": [[104, 113, "DISEASE"]]}], ["It is reasonable to assume there are at least two unknown endosomal immunoactive epitopes; one developing its immunotherapeutic property in RA, and the other, related to the molecule of HSP60, reduces the severity of oncoming arthritis.", {"entities": [[226, 235, "DISEASE"]]}], ["Both epitopes are present in humans, have a molecular weight of \u226410\u00a0kDa and do not appear to be bystander antigens.", {"entities": []}], ["Please see Additional file The online version of this article (doi:10.1186/s12967-016-0908-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The forecast consequences of climate change on human health are profound, especially in low- and middle-income countries and among the most disadvantaged populations.", {"entities": []}], ["Innovative policy tools are needed to address the adverse health effects of climate change.", {"entities": []}], ["Cash transfers are established policy tools for protecting population health before, during and after climate-related disasters.", {"entities": []}], ["For example, the Ethiopian Productive Safety Net Programme provides cash transfers to reduce food insecurity resulting from droughts.", {"entities": []}], ["We propose extending cash transfer interventions to more proactive measures to improve health in the context of climate change.", {"entities": []}], ["We identify promising cash transfer schemes that could be used to prevent the adverse health consequences of climatic hazards.", {"entities": []}], ["Cash transfers for using emission-free, active modes of transport \u2013 e.g.", {"entities": []}], ["cash for cycling to work \u2013 could prevent future adverse health consequences by contributing to climate change mitigation and, at the same time, improving current population health.", {"entities": []}], ["Another example is cash transfers provided to communities that decide to move to areas in which their lives and health are not threatened by climatic disasters.", {"entities": []}], ["More research on such interventions is needed to ensure that they are effective, ethical, equitable and cost\u2013effective.", {"entities": []}], ["SerpinF2, SerpinG1, CystatinC and CD14 are involved in inflammatory processes and plasma extracellular vesicle (EV) -levels of these proteins have been reported to be associated with systemic vascular events.", {"entities": [[0, 8, "GENE"], [10, 18, "GENE"], [34, 38, "GENE"]]}], ["Evidence is accumulating that inflammatory processes may play a pivotal role both in systemic vascular events and in heart failure.", {"entities": []}], ["Therefore, we studied the association between plasma extracellular vesicle SerpinF2-, SerpinG1-, CystatinC and CD14-levels and the occurrence of acute heart failure in patients.", {"entities": []}], ["Extracellular vesicle protein levels of SerpinG1, SerpinF2, CystatinC and CD14 were measured in an observational study of 404 subjects presenting with dysponea at the emergency department (4B-cohort).", {"entities": [[40, 48, "GENE"], [50, 58, "GENE"], [74, 78, "GENE"]]}], ["Plasma extracellular vesicles were precipitated in a total extracellular vesicles (TEX)-fraction and in separate LDL- and HDL-subfractions.", {"entities": []}], ["Extracellular vesicle protein levels were measured with a quantitative immune assay in all 3 precipitates.", {"entities": []}], ["Out of 404 subjects, 141 (35%) were diagnosed with acutely decompensated heart failure.", {"entities": []}], ["After correction for confounders (including comorbidities and medications), levels of CD14 in the HDL-fraction (OR 1.53, p = 0.01), SerpinF2 in the TEX-and LDL-fraction (ORs respectively 0.71 and 0.65, p<0.05) and SerpinG1 in the TEX-fraction (OR 1.55, p = 0.004) were statistically significantly related to heart failure.", {"entities": [[86, 90, "GENE"], [132, 140, "GENE"], [214, 222, "GENE"]]}], ["Furthermore, extracellular vesicle CD14- and SerpinF2-levels were significantly higher in heart failure patients with preserved ejection fraction than in those with reduced ejection fraction.", {"entities": []}], ["Extracellular vesicle levels of CD14, SerpinG1 and SerpinF2 are associated with the occurrence of heart failure in subjects suspected for acute heart failure, suggesting common underlying pathophysiological mechanisms for heart failure and vascular events.", {"entities": [[32, 36, "GENE"], [38, 46, "GENE"], [51, 59, "GENE"]]}], ["The spread of influenza and highly pathogenic avian influenza (H5N1) presents a significant threat to human health.", {"entities": [[14, 23, "DISEASE"], [52, 61, "DISEASE"], [46, 61, "DISEASE"]]}], ["Avian influenza outbreaks in downwind areas of Asian dust storms (ADS) suggest that viruses might be transported by dust storms.", {"entities": [[6, 15, "DISEASE"], [0, 15, "DISEASE"]]}], ["We developed a technique to measure ambient influenza and avian influenza viruses.", {"entities": [[44, 53, "DISEASE"], [64, 73, "DISEASE"], [58, 73, "DISEASE"]]}], ["We then used this technique to measure concentrations of these viruses on ADS days and background days, and to assess the relationships between ambient influenza and avian influenza viruses, and air pollutants.", {"entities": [[152, 161, "DISEASE"], [172, 181, "DISEASE"], [166, 181, "DISEASE"]]}], ["A high-volume air sampler was used in parallel with a filter cassette to evaluate spiked samples and unspiked samples.", {"entities": []}], ["Then, air samples were monitored during ADS seasons using a filter cassette coupled with a real-time quantitative polymerase chain reaction (qPCR) assay.", {"entities": []}], ["Air samples were monitored during ADS season (1 January to 31 May 2006).", {"entities": []}], ["We successfully quantified ambient influenza virus using the filtration/real-time qPCR method during ADS days and background days.", {"entities": [[35, 44, "DISEASE"]]}], ["To our knowledge, this is the first report describing the concentration of influenza virus in ambient air.", {"entities": [[75, 84, "DISEASE"]]}], ["In both the spiked and unspiked samples, the concentration of influenza virus sampled using the filter cassette was higher than that using the high-volume sampler.", {"entities": [[62, 71, "DISEASE"]]}], ["The concentration of ambient influenza A virus was significantly higher during the ADS days than during the background days.", {"entities": [[29, 38, "DISEASE"]]}], ["Our data imply the possibility of long-range transport of influenza virus.", {"entities": [[58, 67, "DISEASE"]]}], ["Lack of bone formation-related health problems are a major problem for the aging population in the modern world.", {"entities": []}], ["As a part of the ongoing trend of developing natural substances that attenuate osteoporotic bone loss conditions, dioxinodehydroeckol (DHE) from edible brown alga Ecklonia cava was tested for its effects on osteoblastogenic differentiation in MC3T3-E1 pre-osteoblasts.", {"entities": []}], ["DHE was observed to successfully enhance osteoblast differentiation, as indicated by elevated cell proliferation, alkaline phosphatase activity, intracellular cell mineralization, along with raised levels of osteoblastogenesis indicators at the concentration of 20 \u03bcM.", {"entities": []}], ["Results suggested a possible intervening of DHE on the bone morphogenetic protein (BMP) signaling pathway, according to elevated protein levels of BMP-2, collagen-I, and Smads.", {"entities": []}], ["In addition, the presence of DHE was also able to raise the phosphorylated extracellular signal\u2013regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) levels which are also activated by the BMP signaling pathway.", {"entities": []}], ["In conclusion, DHE is suggested to be a potential bioactive compound against bone loss that could enhance osteoblastogenesis with a suggested BMP pathway interaction.", {"entities": []}], ["An internet-based survey of influenza-like illness (ILI) \u2013 the Great Influenza Survey or GIS \u2013 was launched in the Netherlands in the 2003\u20132004 influenza season.", {"entities": [[28, 37, "DISEASE"], [69, 78, "DISEASE"], [144, 153, "DISEASE"]]}], ["The aim of the present study was to validate the representativeness of the GIS population and to compare the GIS data with the official ILI data obtained by Dutch GPs participating in the Dutch Sentinel Practice Network.", {"entities": []}], ["Direct mailings to schools and universities, and repeated interviews on television and radio, and in newspapers were used to kindle the enthusiasm of a broad section of the public for GIS.", {"entities": []}], ["Strict symptomatic criteria for ILI were formulated with the assistance of expert institutes and only participants who responded at least five times to weekly e-mails asking them about possible ILI symptoms were included in the survey.", {"entities": []}], ["Validation of GIS was done at different levels: 1) some key demographic (age distribution) and public health statistics (prevalence of asthma and diabetes, and influenza vaccination rates) for the Dutch population were compared with corresponding figures calculated from GIS; 2) the ILI rates in GIS were compared with the ILI consultation rates reported by GPs participating in the Dutch Sentinel Practice Network.", {"entities": [[160, 169, "DISEASE"], [135, 141, "DISEASE"]]}], ["13,300 persons (53% of total responders), replied at least five times to weekly e-mails and were included in the survey.", {"entities": []}], ["As expected, there was a marked under-representation of the age groups 0\u201310 years and 81->90 years in the GIS population, although the similarities were remarkable for most other age groups, albeit that the age groups between 21 and 70 years were slightly overrepresented.", {"entities": []}], ["There were striking similarities between GIS and the Dutch population with regard to the prevalence of asthma (6.4% vs. 6.9%) and the influenza vaccination rates, and to a lesser degree for diabetes (2.4% vs. 3.5%).", {"entities": [[134, 143, "DISEASE"], [103, 109, "DISEASE"]]}], ["The vaccination rates in patients with asthma or diabetes, and persons older than 65 years were 68%, 85%, and 85% respectively in GIS, while the corresponding percentages in the Dutch population were 73%, 85% and 87%.", {"entities": [[39, 45, "DISEASE"]]}], ["There was also a marked similarity between the seasonal course of ILI measured by GIS and the GPs.", {"entities": []}], ["Although the ILI rate in GIS was about 10 times higher, the curves followed an almost similar pattern, with peak incidences occurring in the same week.", {"entities": []}], ["The current study demonstrates that recruitment of a high number of persons willing to participate in on-line health surveillance is feasible.", {"entities": []}], ["The information gathered proved to be reliable, as it paralleled the information obtained via an undisputed route.", {"entities": []}], ["We believe that the interactive nature of GIS and the appealing subject were keys to its success.", {"entities": []}], ["Processes that repeat in time, such as the cell cycle, the circadian rhythm, and seasonal variations, are prevalent in biology.", {"entities": []}], ["Mathematical models can represent our knowledge of the underlying mechanisms, and numerical methods can then facilitate analysis, which forms the foundation for a more integrated understanding as well as for design and intervention.", {"entities": []}], ["Here, the intracellular molecular network responsible for the mammalian circadian clock system was studied.", {"entities": []}], ["A new formulation of detailed sensitivity analysis is introduced and applied to elucidate the influence of individual rate processes, represented through their parameters, on network functional characteristics.", {"entities": []}], ["One of four negative feedback loops in the model, the Per2 loop, was uniquely identified as most responsible for setting the period of oscillation; none of the other feedback loops were found to play as substantial a role.", {"entities": [[54, 58, "GENE"]]}], ["The analysis further suggested that the activity of the kinases CK1\u03b4 and CK1\u025b were well placed within the network such that they could be instrumental in implementing short-term adjustments to the period in the circadian clock system.", {"entities": []}], ["The numerical results reported here are supported by previously published experimental data.", {"entities": []}], ["Network models of biological systems are appearing at an increasing rate.", {"entities": []}], ["By encapsulating mechanistic detail of chemical and physical processes, mathematical models can successfully simulate and predict emergent network properties.", {"entities": []}], ["However, methods are needed for analyzing the role played by individual biochemical steps in producing context-dependent system behavior, thereby linking individual molecular knowledge with network properties.", {"entities": []}], ["Here, we apply sensitivity analysis to analyze mammalian circadian rhythms and find that a contiguous series of reactions in one of the four negative feedback loops carries primary responsibility for determining the intrinsic length of day.", {"entities": []}], ["The key reactions, all involving the gene per2 and its products, include Per2 mRNA export and degradation, and PER2 phosphorylation, transcription, and translation.", {"entities": [[42, 46, "GENE"], [73, 77, "GENE"], [111, 115, "GENE"], [42, 46, "GENE"], [73, 77, "GENE"], [111, 115, "GENE"], [42, 46, "GENE"], [73, 77, "GENE"], [111, 115, "GENE"]]}], ["Interestingly, mutations affecting PER2 phosphorylation have previously been linked to circadian disorders.", {"entities": [[35, 39, "GENE"]]}], ["The method may be generally applicable to probe structure\u2013function relationships in biological networks.", {"entities": []}], ["Self-management is considered as an essential component of chronic care by primary care professionals.", {"entities": []}], ["eHealth is expected to play an important role in supporting patients in their self-management.", {"entities": []}], ["For effective implementation of eHealth it is important to investigate patients\u2019 expectations and needs regarding self-management and eHealth.", {"entities": []}], ["The objectives of this study are to investigate expectations and needs of people with a chronic condition regarding self-management and eHealth for self-management purposes, their willingness to use eHealth, and possible differences between patient groups regarding these topics.", {"entities": []}], ["Five focus groups with people with diabetes ( n \u2009=\u200914), COPD ( n \u2009=\u20099), and a cardiovascular condition ( n \u2009=\u20097) were conducted in this qualitative research.", {"entities": []}], ["Separate focus groups were organized based on patients\u2019 chronic condition.", {"entities": []}], ["The following themes were discussed: 1) the impact of the chronic disease on patients\u2019 daily life; 2) their opinions and needs regarding self-management; and 3) their expectations and needs regarding, and willingness to use, eHealth for self-management purposes.", {"entities": []}], ["A conventional content analysis approach was used for coding.", {"entities": []}], ["Patient groups seem to differ in expectations and needs regarding self-management and eHealth for self-management purposes.", {"entities": []}], ["People with diabetes reported most needs and benefits regarding self-management and were most willing to use eHealth, followed by the COPD group.", {"entities": []}], ["People with a cardiovascular condition mentioned having fewer needs for self-management support, because their disease had little impact on their life.", {"entities": []}], ["In all patient groups it was reported that the patient, not the care professional, should choose whether or not to use eHealth.", {"entities": []}], ["Moreover, participants reported that eHealth should not replace, but complement personal care.", {"entities": []}], ["Many participants reported expecting feelings of anxiety by doing measurement themselves and uncertainty about follow-up of deviant data of measurements.", {"entities": []}], ["In addition, many participants worried about the implementation of eHealth being a consequence of budget cuts in care.", {"entities": []}], ["This study suggests that aspects of eHealth, and the way in which it should be implemented, should be tailored to the patient.", {"entities": []}], ["Patients\u2019 expected benefits of using eHealth to support self-management and their perceived controllability over their disease seem to play an important role in patients\u2019 willingness to use eHealth for self-management purposes.", {"entities": []}], ["The online version of this article (doi:10.1186/s12913-016-1484-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Acrylamide, a probable human carcinogen, is present in many everyday foods.", {"entities": []}], ["Since the finding of its presence in foods in 2002, epidemiological studies have found some suggestive associations between dietary acrylamide exposure and the risk of various cancers.", {"entities": []}], ["The aim of this prospective study is to investigate for the first time the association between dietary acrylamide intake and the risk of several histological subtypes of lymphatic malignancies.", {"entities": []}], ["The Netherlands Cohort Study on diet and cancer includes 120,852 men and women followed-up since September 1986.", {"entities": [[41, 47, "DISEASE"]]}], ["The number of person years at risk was estimated by using a random sample of participants from the total cohort that was chosen at baseline (n \u200a=\u200a5,000).", {"entities": []}], ["Acrylamide intake was estimated from a food frequency questionnaire combined with acrylamide data for Dutch foods.", {"entities": []}], ["Hazard ratios (HRs) were calculated for acrylamide intake as a continuous variable as well as in categories (quintiles and tertiles), for men and women separately and for never-smokers, using multivariable-adjusted Cox proportional hazards models.", {"entities": []}], ["After 16.3 years of follow-up, 1,233 microscopically confirmed cases of lymphatic malignancies were available for multivariable-adjusted analysis.", {"entities": []}], ["For multiple myeloma and follicular lymphoma, HRs for men were 1.14 (95% CI: 1.01, 1.27) and 1.28 (95% CI: 1.03, 1.61) per 10 \u00b5g acrylamide/day increment, respectively.", {"entities": [[13, 20, "DISEASE"], [4, 20, "DISEASE"], [36, 44, "DISEASE"]]}], ["For never-smoking men, the HR for multiple myeloma was 1.98 (95% CI: 1.38, 2.85).", {"entities": [[43, 50, "DISEASE"], [34, 50, "DISEASE"], [27, 29, "GENE"]]}], ["No associations were observed for women.", {"entities": []}], ["We found indications that acrylamide may increase the risk of multiple myeloma and follicular lymphoma in men.", {"entities": [[71, 78, "DISEASE"], [62, 78, "DISEASE"], [94, 102, "DISEASE"]]}], ["This is the first epidemiological study to investigate the association between dietary acrylamide intake and the risk of lymphatic malignancies, and more research into these observed associations is warranted.", {"entities": []}], ["Recent development in the field of COPD has focused on strategies aimed at reducing the underlying inflammation through selective inhibition of the phosphodiesterase type IV (PDE4) isoform.", {"entities": []}], ["Although the anti-inflammatory and bronchodilator activity of selective PDE4 inhibitors has been well documented, their low therapeutic ratio and dose-dependent systemic side effects have limited their clinical utility.", {"entities": []}], ["This study examined the effect of 2'-deoxy-2'-Fluoro-\u03b2-D-Arabinonucleic Acid (FANA)-containing antisense oligonucleotides (AON) targeting the mRNA for the PDE4B/4D and 7A subtypes on lung inflammatory markers, both in vitro and in vivo .", {"entities": []}], ["Normal human bronchial epithelial (NHBE) cells were transfected with FANA AON against PDE4B/4D and 7A alone or in combination.", {"entities": []}], ["mRNA levels for target PDE subtypes, as well as secretion of pro-inflammatory chemokines were then measured following cell stimulation.", {"entities": []}], ["Mice were treated with combined PDE4B/4D and 7A AON via endo-tracheal delivery, or with roflumilast via oral delivery, and exposed to cigarette smoke for one week.", {"entities": []}], ["Target mRNA inhibition, as well as influx of inflammatory cells and mediators were measured in lung lavages.", {"entities": []}], ["A two-week smoke exposure protocol was also used to test the longer term potency of PDE4B/4D and 7A AONs.", {"entities": []}], ["In NHBE cells, PDE4B/4D and 7A AONs dose-dependently and specifically inhibited expression of their respective target mRNA.", {"entities": []}], ["When used in combination, PDE4B/4D and 7A AONs significantly abrogated the cytokine-induced secretion of IL-8 and MCP-1 to near baseline levels.", {"entities": []}], ["In mice treated with combined PDE4B/4D and 7A AONs and exposed to cigarette smoke, significant protection against the smoke-induced recruitment of neutrophils and production of KC and pro-MMP-9 was obtained, which was correlated with inhibition of target mRNA in cells from lung lavages.", {"entities": []}], ["In this model, PDE AONs exerted more potent and broader anti-inflammatory effects against smoke-induced lung inflammation than roflumilast.", {"entities": []}], ["Moreover, the protective effect of PDE4B/4D and 7A AON was maintained when a once-weekly treatment schedule was used.", {"entities": []}], ["These results indicate that inhaled AON against PDE4B/4D and 7A have unique effects on biomarkers that are believed to be important in the pathophysiology of COPD, which supports further development as a potential therapy in this disease.", {"entities": []}], ["Respiratory syncytial virus (RSV) is the most common viral pathogen that causes lower respiratory tract infections in infants.", {"entities": []}], ["Studies have implicated severe RSV infections early in life as a risk factor for subsequent development of reactive airway disease.", {"entities": []}], ["We are conducting a study to validate RSV-associated diagnoses in the Danish National Patient Registry, to assess whether the incidence of severe RSV infection is increasing in Denmark, to identify predisposing and protective factors for RSV-associated hospitalization in Denmark, and to examine the association of severe RSV infection with reactive airway disease.", {"entities": []}], ["The influence of various biological, social and environmental factors on hospitalization for RSV infection will be studied through several population-based registers, including the Danish National Birth Cohort: 'Better health for mothers and children'.", {"entities": []}], ["The RSV hospitalization cases will be compared with control individuals selected within the same population groups on a case\u2013control or a cohort basis in order to produce estimates of age-adjusted and sex-adjusted relative risks (odds ratio and relative risk) for hospitalization associated with various risk factors.", {"entities": []}], ["Using register linkage and unique registration of exposures collected through interviews and blood samples from the Danish National Birth Cohort, we will be able to resolve the issues referred to above in a very large sample of Danish children.", {"entities": []}], ["Pelvic organ prolapse (POP) and other disorders, such as varicose veins and joint hypermobility, have been associated with changes in collagen strength and metabolism.", {"entities": [[57, 71, "DISEASE"]]}], ["We hypothesized that these various disorders were more prevalent in both POP patients and their family members.", {"entities": []}], ["In this study, the prevalence of various collagen-associated disorders, including POP, was compared between POP patients ( n \u2009=\u2009110) and control patients ( n \u2009=\u2009100) and their first and second degree family members.", {"entities": []}], ["POP patients reported a higher prevalence of varicose veins, joint hypermobility and rectal prolapse and were more likely to have family members with POP as compared to the control group ( p \u2009<\u20090.01).", {"entities": [[85, 100, "DISEASE"], [45, 59, "DISEASE"]]}], ["In contrast, the family members of the POP group did not report a higher prevalence of collagen-associated disorders compared to the family members of the control group ( p \u2009=\u20090.82).", {"entities": []}], ["POP and other collagen-associated disorders may have a common aetiology, originating at the molecular level of the collagens.", {"entities": []}], ["To assess the safety of an AS03-adjuvanted split virion H1N1 (2009) vaccine (Pandemrix) in persons vaccinated during the national pandemic influenza vaccination campaign in the UK.", {"entities": [[139, 148, "DISEASE"]]}], ["Prospective, cohort, observational, postauthorisation safety study.", {"entities": []}], ["87 general practices forming part of the Medical Research Council General Practice Research Framework and widely distributed throughout England.", {"entities": []}], ["A cohort of 9143 individuals aged 7\u2005months to 97\u2005years who received at least one dose of the AS03-adjuvanted H1N1 pandemic vaccine during the national pandemic influenza vaccination campaign in the UK was enrolled.", {"entities": [[160, 169, "DISEASE"]]}], ["94% completed the 6-month follow-up.", {"entities": []}], ["Exclusion criteria were previous vaccination with other H1N1 pandemic vaccine and any child in care.", {"entities": []}], ["Medically attended adverse events (MAEs) occurring within 31\u2005days after any dose, serious adverse events (SAEs) and adverse events of special interest (AESIs) following vaccination were collected for all participants.", {"entities": []}], ["Solicited adverse events (AEs) were assessed in a subset of participants.", {"entities": []}], ["MAEs were reported in 1219 participants and SAEs in 113 participants during the 31-day postvaccination period.", {"entities": []}], ["The most frequently reported MAEs and SAEs were consistent with events expected to be reported during the winter season in this population: lower respiratory tract infections, asthma and pneumonia.", {"entities": [[187, 196, "DISEASE"], [176, 182, "DISEASE"]]}], ["The most commonly reported solicited AEs were irritability in young children aged <5\u2005years (61.8%), muscle aches in children aged 5\u201317\u2005years (61.9%) and adults (46.9%).", {"entities": []}], ["18 AESIs, experienced by 14 patients, met the criteria to be considered for the observed-to-expected analyses.", {"entities": []}], ["AESIs above the expected number were neuritis (1 case within 31\u2005days) and convulsions (8 cases within 181\u2005days).", {"entities": [[37, 45, "DISEASE"]]}], ["There were 41 deaths during the 181-day period after vaccination, fewer than expected.", {"entities": []}], ["Results indicate that the AS03-adjuvanted H1N1 pandemic vaccine showed a clinically acceptable reactogenicity and safety profile in all age and risk groups studied.", {"entities": []}], ["ClinicalTrials.gov, NCT00996853.", {"entities": []}], ["To compare the efficacy and safety of budesonide/formoterol (Symbicort 2 -agonist therapy.", {"entities": []}], ["In a 3 hour, randomized, double-blind study, a total of 115 patients with acute asthma (mean FEV 1 40% of predicted normal) and a refractory response to salbutamol (mean reversibility 2% of predicted normal after inhalation of 400 \u03bcg), were randomized to receive either budesonide/formoterol (320/9 \u03bcg, 2 inhalations at t = -5 minutes and 2 inhalations at 0 minutes [total dose 1280/36 \u03bcg]) or formoterol (9 \u03bcg, 2 inhalations at t = -5 minutes and 2 inhalations at 0 minutes [total dose 36 \u03bcg]).", {"entities": [[80, 86, "DISEASE"], [93, 96, "GENE"]]}], ["The primary efficacy variable was the average FEV 1 from the first intake of study medication to the measurement at 90 minutes.", {"entities": [[46, 49, "GENE"]]}], ["Secondary endpoints included changes in FEV 1 at other timepoints and change in respiratory rate at 180 minutes.", {"entities": [[40, 43, "GENE"]]}], ["Treatment success, treatment failure and patient assessment of the effectiveness of the study medication were also measured.", {"entities": []}], ["FEV 1 increased after administration of the study medication in both treatment groups.", {"entities": [[0, 3, "GENE"]]}], ["No statistically significant difference between the treatment groups was apparent for the primary outcome variable, or for any of the other efficacy endpoints.", {"entities": []}], ["There were no statistically significant between-group differences for treatment success, treatment failure or patient assessment of medication effectiveness.", {"entities": []}], ["Both treatments were well tolerated.", {"entities": []}], ["Budesonide/formoterol and formoterol provided similarly rapid relief of acute bronchoconstriction in patients with asthma who showed evidence of refractoriness to a short-acting \u03b2 2 -agonist.", {"entities": [[115, 121, "DISEASE"]]}], ["Preserved Ratio Impaired Spirometry (PRISm), defined as a reduced FEV 1 in the setting of a preserved FEV 1 /FVC ratio, is highly prevalent and is associated with increased respiratory symptoms, systemic inflammation, and mortality.", {"entities": [[66, 69, "GENE"], [102, 105, "GENE"], [66, 69, "GENE"], [102, 105, "GENE"]]}], ["Studies investigating quantitative chest tomographic features, genetic associations, and subtypes in PRISm subjects have not been reported.", {"entities": []}], ["Data from current and former smokers enrolled in COPDGene (n\u2009=\u200910,192), an observational, cross-sectional study which recruited subjects aged 45\u201380 with \u226510 pack years of smoking, were analyzed.", {"entities": []}], ["To identify epidemiological and radiographic predictors of PRISm, we performed univariate and multivariate analyses comparing PRISm subjects both to control subjects with normal spirometry and to subjects with COPD.", {"entities": []}], ["To investigate common genetic predictors of PRISm, we performed a genome-wide association study (GWAS).", {"entities": []}], ["To explore potential subgroups within PRISm, we performed unsupervised k-means clustering.", {"entities": []}], ["The prevalence of PRISm in COPDGene is 12.3%.", {"entities": []}], ["Increased dyspnea, reduced 6-minute walk distance, increased percent emphysema and decreased total lung capacity, as well as increased segmental bronchial wall area percentage were significant predictors (p-value <0.05) of PRISm status when compared to control subjects in multivariate models.", {"entities": []}], ["Although no common genetic variants were identified on GWAS testing, a significant association with Klinefelter\u2019s syndrome (47XXY) was observed (p-value\u2009<\u20090.001).", {"entities": [[114, 122, "DISEASE"]]}], ["Subgroups identified through k-means clustering include a putative \u201cCOPD-subtype\u201d, \u201cRestrictive-subtype\u201d, and a highly symptomatic \u201cMetabolic-subtype\u201d.", {"entities": []}], ["PRISm subjects are clinically and genetically heterogeneous.", {"entities": []}], ["Future investigations into the pathophysiological mechanisms behind and potential treatment options for subgroups within PRISm are warranted.", {"entities": []}], ["Clinicaltrials.gov Identifier: NCT000608764 .", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-014-0089-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The cause of idiopathic pulmonary fibrosis (IPF) remains unknown, yet gastro-esophageal reflux disease (GERD) is highly prevalent in this population.", {"entities": [[24, 42, "DISEASE"], [13, 42, "DISEASE"]]}], ["GERD prevalence was studied, and esophageal function tests (EFT) were assessed in Chinese IPF patients.", {"entities": []}], ["We prospectively studied 69 IPF patients who undertook both stationary High Resolution esophageal Manometry/Impedance (HRiM) and 24-hour esophageal Multi-Channel Intraluminal Impedance with pH Recordings (MII/pH).", {"entities": []}], ["Patients were divided into GERD+ and GERD- groups according to pH results.", {"entities": []}], ["Controls were HRiM treated healthy volunteers, and patients without IPF received HRiM and MII/pH diagnosed with GERD.", {"entities": []}], ["69 IPF patients, 62 healthy volunteers, and 88 IPF negative GERD patients were selected.", {"entities": []}], ["GERD prevalence in IPF was 43/69 (62.3%), and 58.1% of patients presented with at least one typical symptom.", {"entities": []}], ["Symptoms had a sensitivity of 58.1%, a specificity of 61.6%, a positive predictive value of 71.4% and a negative predictive of 47.1%.", {"entities": []}], ["Compared with healthy volunteers, IPF patients had significantly decreased lower esophageal sphincter pressure (LESP), upper esophageal sphincter pressure (UESP) and complete bolus transit rate (CBTR).", {"entities": []}], ["By contrast, IPF patients had increased total bolus transit time and prevalence of weak peristalsis.", {"entities": []}], ["MII/pH showed that one third of IPF patients had abnormal distal and proximal reflux, especially non-acid reflux.", {"entities": []}], ["Compared with GERD patients without IPF, GERD patients with IPF had significantly decreased CBTR and UESP with increased bolus exposure time.", {"entities": []}], ["GERD prevalence in IPF was high, but symptoms alone were an unreliable predictor of reflux.", {"entities": []}], ["IPF patients had lower LESP and UESP, impaired esophageal peristalsis and bolus clearance function with more proximal reflux events.", {"entities": []}], ["Medicines are a major treatment modality for many mental illnesses, and with the growing burden of mental disorders worldwide pharmacists are ideally positioned to play a greater role in supporting people with a mental illness.", {"entities": []}], ["This narrative review aims to describe the evidence for pharmacist-delivered services in mental health care and address the barriers and facilitators to increasing the uptake of pharmacist services as part of the broader mental health care team.", {"entities": []}], ["This narrative review is divided into three main sections: (1) the role of the pharmacist in mental health care in multidisciplinary teams and in supporting early detection of mental illness; (2) the pharmacists\u2019 role in supporting quality use of medicines in medication review, strategies to improve medication adherence and antipsychotic polypharmacy, and shared decision making; and (3) barriers and facilitators to the implementation of mental health pharmacy services with a focus on organizational culture and mental health stigma.", {"entities": []}], ["In the first section, the review presents new roles for pharmacists within multidisciplinary teams, such as in case conferencing or collaborative drug therapy management; and new roles that would benefit from increased pharmacist involvement, such as the early detection of mental health conditions, development of care plans and follow up of people with mental health problems.", {"entities": []}], ["The second section describes the impact of medication review services and other pharmacist-led interventions designed to reduce inappropriate use of psychotropic medicines and improve medication adherence.", {"entities": []}], ["Other new potential roles discussed include the management of antipsychotic polypharmacy and involvement in patient-centered care.", {"entities": []}], ["Finally, barriers related to pharmacists\u2019 attitudes, stigma and skills in the care of patients with mental health problems and barriers affecting pharmacist-physician collaboration are described, along with strategies to reduce mental health stigma.", {"entities": []}], ["The complexity of the systemic inflammatory response and the lack of a treatment breakthrough in the treatment of pathogenic infection demand that advanced tools be brought to bear in the treatment of severe sepsis and trauma.", {"entities": []}], ["Systems medicine , the translational science counterpart to basic science's systems biology , is the interface at which these tools may be constructed.", {"entities": []}], ["Rapid initial strides in improving sepsis treatment are possible through the use of phenomenological modelling and optimization tools for process understanding and device design.", {"entities": []}], ["Higher impact, and more generalizable, treatment designs are based on mechanistic understanding developed through the use of physiologically based models, characterization of population variability, and the use of control-theoretic systems engineering concepts.", {"entities": []}], ["In this review we introduce acute inflammation and sepsis as an example of just one area that is currently underserved by the systems medicine community, and, therefore, an area in which contributions of all types can be made.", {"entities": []}], ["School children may transmit pathogens with cluster cases occurring on campuses and in families.", {"entities": []}], ["In response to the 2009 influenza A (H1N1) pandemic, Taipei City Government officials developed a School-based Infectious Disease Syndromic Surveillance System (SID-SSS).", {"entities": [[24, 33, "DISEASE"]]}], ["Teachers and nurses from preschools to universities in all 12 districts within Taipei are required to daily report cases of symptomatic children or sick leave requests through the SID-SSS.", {"entities": []}], ["The pre-diagnosis at schools is submitted firstly as common pediatric disease syndrome-groups and re-submitted after confirmation by physicians.", {"entities": [[78, 86, "DISEASE"]]}], ["We retrieved these data from January 2010 to August 2011 for spatio-temporal analysis and evaluated the temporal trends with cases obtained from both the Emergency Department-based Syndromic Surveillance System (ED-SSS) and the Longitudinal Health Insurance Database 2005 (LHID2005).", {"entities": []}], ["Through the SID-SSS, enterovirus-like illness (EVI) and influenza-like illness (ILI) were the two most reported syndrome groups (77.6% and 15.8% among a total of 19,334 cases, respectively).", {"entities": [[56, 65, "DISEASE"], [112, 120, "DISEASE"]]}], ["The pre-diagnosis judgments made by school teachers and nurses showed high consistency with physicians\u2019 clinical diagnoses for EVI (97.8%) and ILI (98.9%).", {"entities": []}], ["Most importantly, the SID-SSS had better timeliness with earlier peaks of EVI and ILI than those in the ED-SSS.", {"entities": []}], ["Furthermore, both of the syndrome groups in these two surveillance systems had the best correlation reaching 0.98 and 0.95, respectively (p<0.01).", {"entities": [[25, 33, "DISEASE"]]}], ["Spatio-temporal analysis observed the patterns of EVI and ILI both diffuse from the northern suburban districts to central Taipei, with ILI spreading faster.", {"entities": []}], ["This novel system can identify early suspected cases of two important pediatric infections occurring at schools, and clusters from schools/families.", {"entities": []}], ["It was also cost-effective (95.5% of the operation cost reduced and 59.7% processing time saved).", {"entities": []}], ["The timely surveillance of mild EVI and ILI cases integrated with spatial analysis may help public health decision-makers with where to target for enhancing surveillance and prevention measures to minimize severe cases.", {"entities": []}], ["Little is known about asthma trend in Morocco, particularly in early childhood.", {"entities": [[22, 28, "DISEASE"]]}], ["Furthermore, when dealing with asthma related environmental risk factors in Morocco, decision-making focus is in one region R9, while 16 regions make up the country.", {"entities": [[31, 37, "DISEASE"]]}], ["This work aims at studying 9-year trends in consultations for asthma in under-5 children in the 16 individual regions with respect to area and age group.", {"entities": [[62, 68, "DISEASE"]]}], ["Direct method use, based on the only available national data from the open access files of the ministry of health, standardizing data for three age groups (0\u201311 ; 12\u201323 and 24\u201359 months).", {"entities": []}], ["We compared age-adjusted rates, stratified by area (urban and rural areas) within each region (Wilcoxon's signed ranks test), and between all regions emphasizing on R9.", {"entities": []}], ["Secular trends are examined (Kendall's rank correlation test).", {"entities": []}], ["We also compared directly standardized rates as a rate ratio for two study populations (that of R9 and any region with highest rates).", {"entities": []}], ["We finally compared rates by age group in selected regions.", {"entities": []}], ["Secular increase in prevalence rates was shown in both urban and rural Morocco, particularly in urban areas of R10, R14, R16 and R5, and in rural areas of R14 and R16.", {"entities": []}], ["In urban area of R10 (the highest age-adjusted prevalence rates area) the rates showed secular increase from 6.82 at 95 % CI\u2009=\u2009[6.44 to 7.19] per 1000 childhood population in 2004 to 20.91 at 95 % CI\u2009=\u2009[20.26 to 21.56] per 1000 childhood population in 2012 (P\u2009=\u20090.001).", {"entities": []}], ["Rates were higher in urban than rural Morocco, particularly in R8, R9, R10, R14, R15 ; R6 was an exception.", {"entities": []}], ["Rates in R10 were 1.63 higher than that in R9 in 2004 and rose to be 2.55 higher in 2012 ; rates in urban area of R14, about 3 times lower than that in R9 in 2004, increased to be similar in 2012.", {"entities": []}], ["The highest-prevalence age group varied according to region and area.", {"entities": []}], ["The regions that worth decision making attention are the urban areas of R10 (the highest prevalence rates Moroccan area, showing continuous increase), of R9, of R14 and the rural area of R6.", {"entities": []}], ["The rates in the urban area of R9 (a current continuous decision making focus) remained high but stable within the study period and less important than those in R10.", {"entities": []}], ["Environmental factors (biological particules, non-biological particules or gazes) are suspected.The potential unavailability of treatment at regular basis at the primary health care centers may reduce frequency of consultations for asthma in early childhood\u00a0: outpatients may consult only if asthma causes problems\u00a0in an attempt to get free medicines\u00a0; chances of outpatients' follow-up by the primary health care center's physicians are therefore reduced and optimal asthma control is not achieved.", {"entities": [[232, 238, "DISEASE"], [292, 298, "DISEASE"], [468, 474, "DISEASE"]]}], ["Social, health care policy and environmental factors, to which decision-making has to be responsive, are suspected to be affecting both frequency of and time secular trend in consultations for asthma in early childhood in Morocco.", {"entities": [[193, 199, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12889-015-2262-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Gingipain cysteine proteases are considered key virulence factors of Porphyromonas gingivalis .", {"entities": []}], ["They significantly influence antibacterial and homeostatic functions of macrophages, neutrophils, the complement system, and cytokine networks.", {"entities": []}], ["Recent data indicate the role of P. gingivalis in T cell differentiation; however, the involvement of gingipains in this process remains elusive.", {"entities": []}], ["Therefore, the aim of this study was to investigate the contribution of danger signals triggered by the gingipains on the generation of Th17 cells, which play a key role in protection against bacterial diseases but may cause chronic inflammation and bone resorption.", {"entities": []}], ["To this end we compared the effects of the wild-type strain of P. gingivalis (W83) with its isogenic mutant devoid of gingipain activity (\u0394K\u0394RAB), and bacterial cells pretreated with a highly-specific inhibitor of gingipains activity (KYTs).", {"entities": []}], ["Antigen presenting cells (APCs), both professional (dendritic cells), and non-professional (gingival keratinocytes), exposed to viable bacteria expressed high amounts of cytokines (IL-6, IL-21, IL-23).", {"entities": [[26, 30, "GENE"]]}], ["These cytokines are reported to either stimulate or balance the Th17-dependent immune response.", {"entities": []}], ["Surprisingly, cells infected with P. gingivalis devoid of gingipain activity showed increased levels of all tested cytokines compared to bacteria with fully active enzymes.", {"entities": []}], ["The effect was dependent on both the reduction of cytokine proteolysis and the lack of cross-talk with other bacterial virulence factors, including LPS and fimbriae that induce de novo synthesis of cytokines.", {"entities": []}], ["The profile of lymphocyte T differentiation from naive T cells showed enhanced generation of Th17 in response to bacteria with inactive gingipains.", {"entities": []}], ["Moreover, we found that gingipain-dependent induction of Th17 cells was highly specific, since other T cell-subsets remained unchanged.", {"entities": []}], ["Finally, inhibition of IL-6 signaling in dendritic cells led to a significant depletion of the Th17 population.", {"entities": []}], ["Cumulatively, this study revealed a previously undisclosed role of gingipain activity in the process of Th17 differentiation reliant on blocking signaling through IL-6.", {"entities": []}], ["Since inactivation of gingipains accelerates the skewing of T cells toward Th17 cells, which are detrimental in periodontitis, IL-6 signaling may serve as an attractive target for treatment of the disease.", {"entities": [[112, 125, "DISEASE"]]}], ["Efficacy and safety of tiotropium+olodaterol fixed-dose combination (FDC) compared with the mono-components was evaluated in patients with moderate to very severe chronic obstructive pulmonary disease (COPD) in two replicate, randomised, double-blind, parallel-group, multicentre, phase III trials.", {"entities": [[163, 200, "DISEASE"]]}], ["Patients received tiotropium+olodaterol FDC 2.5/5\u2005\u03bcg or 5/5\u2005\u03bcg, tiotropium 2.5\u2005\u03bcg or 5\u2005\u03bcg, or olodaterol 5\u2005\u03bcg delivered once-daily via Respimat inhaler over 52\u2005weeks.", {"entities": []}], ["Primary end points were forced expiratory volume in 1\u2005s (FEV1) area under the curve from 0 to 3\u2005h (AUC0\u20133) response, trough FEV1 response and St George's Respiratory Questionnaire (SGRQ) total score at 24\u2005weeks.", {"entities": []}], ["In total, 5162 patients (2624 in Study 1237.5 and 2538 in Study 1237.6) received treatment.", {"entities": []}], ["Both FDCs significantly improved FEV1 AUC0\u20133 and trough FEV1 response versus the mono-components in both studies.", {"entities": []}], ["Statistically significant improvements in SGRQ total score versus the mono-components were only seen for tiotropium+olodaterol FDC 5/5\u2005\u03bcg.", {"entities": []}], ["Incidence of adverse events was comparable between the FDCs and the mono-components.", {"entities": []}], ["These studies demonstrated significant improvements in lung function and health-related quality of life with once-daily tiotropium+olodaterol FDC versus mono-components over 1\u2005year in patients with moderate to very severe COPD.", {"entities": []}], ["Lung function and symptomatic benefits of daily tiotropium+olodaterol fixed-dose combination in moderate to very severe COPD http://ow.ly/DIKiY", {"entities": []}], ["Intercellular communication can occur via the release of membrane vesicles.", {"entities": []}], ["Exosomes are nanovesicles released from the endosomal compartment of cells.", {"entities": []}], ["Depending on their cell of origin and their cargo they can exert different immunoregulatory functions.", {"entities": []}], ["Recently, fungi were found to produce extracellular vesicles that can influence host-microbe interactions.", {"entities": []}], ["The yeast Malassezia sympodialis which belongs to our normal cutaneous microbial flora elicits specific IgE- and T-cell reactivity in approximately 50% of adult patients with atopic eczema (AE).", {"entities": []}], ["Whether exosomes or other vesicles contribute to the inflammation has not yet been investigated.", {"entities": []}], ["To investigate if M. sympodialis can release nanovesicles and whether they or endogenous exosomes can activate PBMC from AE patients sensitized to M. sympodialis .", {"entities": []}], ["Extracellular nanovesicles isolated from M. sympodialis , co-cultures of M. sympodialis and dendritic cells, and from plasma of patients with AE and healthy controls (HC) were characterised using flow cytometry, sucrose gradient centrifugation, Western blot and electron microscopy.", {"entities": []}], ["Their ability to stimulate IL-4 and TNF-alpha responses in autologous CD14, CD34 depleted PBMC was determined using ELISPOT and ELISA, respectively.", {"entities": [[70, 74, "GENE"], [76, 80, "GENE"]]}], ["We show for the first time that M. sympodialis releases extracellular vesicles carrying allergen.", {"entities": []}], ["These vesicles can induce IL-4 and TNF-\u03b1 responses with a significantly higher IL-4 production in patients compared to HC.", {"entities": []}], ["Exosomes from dendritic cell and M. sympodialis co-cultures induced IL-4 and TNF-\u03b1 responses in autologous CD14, CD34 depleted PBMC of AE patients and HC while plasma exosomes induced TNF-\u03b1 but not IL-4 in undepleted PBMC.", {"entities": [[107, 111, "GENE"], [113, 117, "GENE"]]}], ["Extracellular vesicles from M. sympodialis , dendritic cells and plasma can contribute to cytokine responses in CD14, CD34 depleted and undepleted PBMC of AE patients and HC.", {"entities": [[112, 116, "GENE"], [118, 122, "GENE"]]}], ["These novel observations have implications for understanding host-microbe interactions in the pathogenesis of AE.", {"entities": []}], ["At the onset of adolescence, asthma becomes less prevalent in males than in females, suggesting a protective role of male sex hormones.", {"entities": [[29, 35, "DISEASE"]]}], ["Here, Laffont et al.", {"entities": []}], ["show that androgens negatively control ILC2 development and ILC2-driven lung inflammation in male mice.", {"entities": []}], ["Prevalence of asthma is higher in women than in men, but the mechanisms underlying this sex bias are unknown.", {"entities": [[14, 20, "DISEASE"]]}], ["Group 2 innate lymphoid cells (ILC2s) are key regulators of type 2 inflammatory responses.", {"entities": []}], ["Here, we show that ILC2 development is greatly influenced by male sex hormones.", {"entities": []}], ["Male mice have reduced numbers of ILC2 progenitors (ILC2Ps) and mature ILC2s in peripheral tissues compared with females.", {"entities": []}], ["In consequence, males exhibit reduced susceptibility to allergic airway inflammation in response to environmental allergens and less severe IL-33\u2013driven lung inflammation, correlating with an impaired expansion of lung ILC2s.", {"entities": []}], ["Importantly, orchiectomy, but not ovariectomy, abolishes the sex differences in ILC2 development and restores IL-33\u2013mediated lung inflammation.", {"entities": []}], ["ILC2Ps express the androgen receptor (AR), and AR signaling inhibits their differentiation into mature ILC2s.", {"entities": []}], ["Finally, we show that hematopoietic AR expression limits IL-33\u2013driven lung inflammation through a cell-intrinsic inhibition of ILC2 expansion.", {"entities": []}], ["Thus, androgens play a crucial protective role in type 2 airway inflammation by negatively regulating ILC2 homeostasis, thereby limiting their capacity to expand locally in response to IL-33.", {"entities": []}], ["PARP-14, a member of the poly ADP-ribose polymerase super family, promotes T helper cell 2 (Th2) differentiation by regulating interleukin-4 (IL-4) and STAT6-dependent transcription.", {"entities": []}], ["Yet, whether PARP-14 globally impacts gene regulation has not been determined.", {"entities": []}], ["In this report, using an RNA pol II ChIP-seq approach, we identify genes in Th2 cells that are regulated by PARP-14, and either dependent or independent of ADP-ribosyltransferase catalytic activity.", {"entities": []}], ["Our data demonstrate that PARP-14 enhances the expression of Th2 genes as it represses the expression of Th1-associated genes.", {"entities": []}], ["Among the relevant targets are Signal Transducer and Activator of Transcription genes required for polarizing Th1 and Th2 cells.", {"entities": []}], ["To define a mechanism for PARP-14 function, we use an informatics approach to identify putative PARP-14 DNA binding sites.", {"entities": []}], ["Two putative PARP-14 binding motifs are identified in multiple Th2 cytokine genes, and we demonstrate that PARP-14 interacts with each motif using in vitro binding assays.", {"entities": []}], ["Taken together our results indicate that PARP-14 is an important factor for T helper cell differentiation and it binds to specific DNA sequences to mediate its function.", {"entities": []}], ["The neurotrophin receptor p75", {"entities": []}], ["Central disinhibition is a mechanism involved in the physiopathology of fibromyalgia.", {"entities": [[72, 84, "DISEASE"]]}], ["Melatonin can improve sleep quality, pain and pain threshold.", {"entities": []}], ["We hypothesized that treatment with melatonin alone or in combination with amitriptyline would be superior to amitriptyline alone in modifying the endogenous pain-modulating system (PMS) as quantified by conditional pain modulation (CPM), and this change in CPM could be associated with serum brain-derived neurotrophic factor (BDNF).", {"entities": [[233, 236, "GENE"], [258, 261, "GENE"], [233, 236, "GENE"], [258, 261, "GENE"], [328, 332, "GENE"]]}], ["We also tested whether melatonin improves the clinical symptoms of pain, pain threshold and sleep quality.", {"entities": []}], ["Sixty-three females, aged 18 to 65, were randomized to receive bedtime amitriptyline (25\u00a0mg) (n\u2009=\u200921), melatonin (10\u00a0mg) (n\u2009=\u200921) or melatonin (10\u00a0mg)\u2009+\u2009amitriptyline (25\u00a0mg) (n\u2009=\u200921) for a period of six weeks.", {"entities": []}], ["The descending PMS was assessed with the CPM-TASK.", {"entities": []}], ["It was assessed the pain score on the Visual Analog Scale (VAS 0-100\u00a0mm), the score on Fibromyalgia Impact Questionnaire (FIQ), heat pain threshold (HPT), sleep quality and BDNF serum.", {"entities": [[87, 99, "DISEASE"], [173, 177, "GENE"]]}], ["Delta values (post- minus pre-treatment) were used to compare the treatment effect.", {"entities": []}], ["The outcomes variables were collected before, one and six weeks after initiating treatment.", {"entities": []}], ["Melatonin alone or in combination with amitriptyline reduced significantly pain on the VAS compared with amitriptyline alone ( P \u2009<\u20090.01).", {"entities": []}], ["The delta values on the VAS scores were-12.85 (19.93),-17.37 (18.69) and-20.93 (12.23) in the amitriptyline, melatonin and melatonin+amitriptyline groups, respectively.", {"entities": []}], ["Melatonin alone and in combination increased the inhibitory PMS as assessed by the Numerical Pain Scale [NPS (0-10) ] reduction during the CPM-TASK:-2.4 (2.04) melatonin + amitriptyline,-2.65 (1.68) melatonin, and-1.04 (2.06) amitriptyline, (P\u2009<\u20090.05).", {"entities": [[105, 108, "GENE"]]}], ["Melatonin\u2009+\u2009amitriptyline treated displayed better results than melatonin and amitriptyline alone in terms of FIQ and PPT improvement (P\u2009<\u20090.05, fort both).", {"entities": []}], ["Melatonin increased the inhibitory endogenous pain-modulating system as assessed by the reduction on NPS (0-10) during the CPM-TASK.", {"entities": [[101, 104, "GENE"]]}], ["Melatonin alone or associated with amitriptyline was better than amitriptyline alone in improving pain on the VAS, whereas its association with amitriptyline produced only marginal additional clinical effects on FIQ and PPT.", {"entities": []}], ["Current controlled trail is registered at clinical trials.gov upon under number NCT02041455 .", {"entities": []}], ["Registered January 16, 2014.", {"entities": []}], ["Toxocara canis is a zoonotic parasite of major socioeconomic importance worldwide.", {"entities": []}], ["In humans, this nematode causes disease (toxocariasis) mainly in the under-privileged communities in developed and developing countries.", {"entities": [[41, 53, "DISEASE"]]}], ["Although relatively well studied from clinical and epidemiological perspectives, to date, there has been no global investigation of the molecular biology of this parasite.", {"entities": []}], ["Here we use next-generation sequencing to produce a draft genome and transcriptome of T. canis to support future biological and biotechnological investigations.", {"entities": []}], ["This genome is 317\u2009Mb in size, has a repeat content of 13.5% and encodes at least 18,596 protein-coding genes.", {"entities": [[19, 21, "GENE"]]}], ["We study transcription in a larval, as well as adult female and male stages, characterize the parasite\u2019s gene-silencing machinery, explore molecules involved in development or host\u2013parasite interactions and predict intervention targets.", {"entities": []}], ["The draft genome of T. canis should provide a useful resource for future molecular studies of this and other, related parasites.", {"entities": []}], ["Toxocara canis is a zoonotic parasite of major worldwide socioeconomic importance.", {"entities": []}], ["Here, the authors sequence the genome and transcriptome of T. canis , and highlight potential mechanisms involved in development and host\u2013parasite interactions that could support the pursuit of new drug interventions.", {"entities": []}], ["Systematic genome-wide scans to date have shown that genes of major effect are not common causes of schizophrenia, but independent linkage studies looking for schizophrenia susceptibility genes are converging on a number of key chromosomal locations.", {"entities": [[100, 113, "DISEASE"], [159, 172, "DISEASE"]]}], ["Microarray expression analysis may identify new candidate genes and pathways, and a number of intriguing preliminary findings have already been reported.", {"entities": []}], ["Lumbar disc herniation is a common and costly problem.", {"entities": []}], ["Moxibustion is employed to relieve symptoms and might therefore act as a therapeutic alternative.", {"entities": []}], ["Many studies have already reported encouraging results in heat-sensitive moxibustion for lumbar disc herniation.", {"entities": []}], ["Hence, we designed a randomized controlled clinical trial to investigate the effectiveness of heat-sensitive moxibustion compared with conventional moxibustion.", {"entities": []}], ["This trial is a multicenter, prospective, randomized controlled clinical trial.", {"entities": []}], ["The 316 eligible patients are randomly allocated to two different groups.", {"entities": []}], ["The experimental group is treated with heat-sensitive moxibustion (n = 158); while the control group (n = 158) is treated with conventional moxibustion.", {"entities": []}], ["The moxibustion locations are different for the groups.", {"entities": []}], ["The experimental group selects heat-sensitization acupoints from the region which consists of bilateral Da Changshu (BL25) and Yao Shu (Du2).", {"entities": []}], ["Meanwhile, fixed acupoints are used in control group; patients in both groups receive 18 sessions in 2 weeks.", {"entities": []}], ["The study design guarantees a high internal validity for the results.", {"entities": []}], ["It is one large-scale randomized controlled trial to evaluate the efficacy of heat-sensitive moxibustion compared to conventional moxibustion and may provide evidence for this therapy as a treatment for moderate and severe lumbar disc herniation.", {"entities": []}], ["Moreover, the result may uncover the inherent laws to improve the therapeutic effect with suspended moxibustion.", {"entities": []}], ["The trial is registered at Chinese Clinical Trials Registry: ChiCTR-TRC-09000604.", {"entities": []}], ["The application date was 27 November 2009.", {"entities": []}], ["The first patient was randomized on the 16 June 2011.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is a debilitating condition characterized by airflow limitation that is not fully reversible.", {"entities": []}], ["It is a major cause of morbidity and mortality and represents substantial economic and social burden throughout the world.", {"entities": []}], ["A range of interventions has been developed that decrease symptoms and address complications associated with COPD.", {"entities": []}], ["However, to date few interventions have been unequivocally demonstrated to modify disease progression.", {"entities": []}], ["Assessment of the potential for interventions to modify disease progression is complicated by the lack of a clear definition of disease modification and disagreement over appropriate markers by which modification should be evaluated.", {"entities": []}], ["To clarify these issues, a working group of physicians and scientists from the USA, Canada and Europe was convened.", {"entities": []}], ["The proposed working definition of disease modification resulting from the group discussions was \u201can improvement in, or stabilization of, structural or functional parameters as a result of reduction in the rate of progression of these parameters which occurs whilst an intervention is applied and may persist even if the intervention is withdrawn\u201d.", {"entities": []}], ["According to this definition, pharmacologic interventions may be considered disease-modifying if they provide consistent and sustained improvements in structural and functional parameters.", {"entities": []}], ["Smoking cessation and lung volume reduction surgery would both qualify as disease-modifying interventions.", {"entities": []}], ["Clinical audits have reported considerable variability in COPD medical care and frequent inconsistencies with recommendations.", {"entities": []}], ["The objectives of this study were to identify factors associated with a better adherence to clinical practice guidelines and to explore determinants of this variability at the the hospital level.", {"entities": []}], ["EPOCONSUL is a Spanish nationwide clinical audit that evaluates the outpatient management of COPD.", {"entities": []}], ["Multilevel logistic regression with two levels was performed to assess the relationships between individual and disease-related factors, as well as hospital characteristics.", {"entities": []}], ["A total of 4508 clinical records of COPD patients from 59 Spanish hospitals were evaluated.", {"entities": []}], ["High variability was observed among hospitals in terms of medical care.", {"entities": []}], ["Some of the patient\u2019s characteristics (airflow obstruction, degree of dyspnea, exacerbation risk, presence of comorbidities), the hospital factors (size and respiratory nurses available) and treatment at a specialized COPD outpatient clinic were identified as factors associated with a better adherence to recommendations, although this only explains a small proportion of the total variance.", {"entities": []}], ["To be treated at a specialized COPD outpatient clinic and some intrinsic patient characteristics were factors associated with a better adherence to guideline recommendations, although these variables were only explaining part of the high variability observed among hospitals in terms of COPD medical care.", {"entities": []}], ["To determine the role of the recently discovered primary open angle glaucoma (POAG) single nucleotide polymorphism (SNP) rs4236601 near the caveolin-1 ( CAV1 ) and CAV2 among patients and controls from Saudi Arabia.", {"entities": [[49, 76, "DISEASE"], [68, 76, "DISEASE"], [153, 157, "GENE"], [164, 168, "GENE"]]}], ["A cohort of 220 POAG patients and 405 control subjects from Saudi Arabia were genotyped for a SNP (rs4236601;g.2891 G>A) in the chromosome 7q31 locus near CAV1 and CAV2 using a standard polymerase chain reaction (PCR) and sequencing method.", {"entities": [[155, 159, "GENE"], [164, 168, "GENE"]]}], ["The minor allele frequency (MAF) of rs4236601 was 0.3 in controls and 0.31 in POAG patients.", {"entities": [[28, 31, "GENE"]]}], ["We detected no statistical difference when we compared the allele frequencies between POAG patients and control subjects (p=0.699).", {"entities": []}], ["Similarly, we detected no statistical difference in the frequency of the three possible rs4236601 genotypes between patients and controls.", {"entities": []}], ["The p-values were 0.928 and 0.683 for heterozygous genotype (G/A) and homozygous mutant genotype (A/A), respectively.", {"entities": []}], ["We found no statistically significant difference among patients with any of the three possible genotypes and various clinical indices important for glaucoma.", {"entities": [[148, 156, "DISEASE"]]}], ["Among patients with homozygous (A/A), the mean IOP was higher (21.4) compared to patients with G/G wildtype (20.4) and to patients with G/A genotype (18.5).", {"entities": []}], ["However, this apparent difference did not reach the statistical significance threshold (p=0.062).", {"entities": []}], ["We were unable to detect this association in our POAG-patients from Saudi Arabia, suggesting that this risk factor may not have a strong effect in all populations.", {"entities": []}], ["A founder effect may play a role in certain populations where the link was established.", {"entities": []}], ["Sera from chagasic patients possess antibodies recognizing the carboxy- terminal part of the ribosomal P0 protein of Trypanosoma cruzi and the second extracellular loop of the human beta 1-adrenergic receptor.", {"entities": []}], ["Comparison of both peptides showed that they contain a pentapeptide with very high homology (AESEE in P0 and AESDE in the human beta 1- adrenergic receptor).", {"entities": []}], ["Using a competitive immunoenzyme assay, recognition of the peptide corresponding to the second extracellular loop (H26R) was inhibited by both P0-14i (AAAESEEEDDDDDF) and P0-beta (AESEE).", {"entities": []}], ["Concomitantly, recognition of P0-beta was inhibited with the H26R peptide.", {"entities": []}], ["Recognition of P0 in Western blots was inhibited by P0- 14i, P0-beta, and H26R, but not by a peptide corresponding to the second extracellular loop of the human beta 2-adrenergic receptor or by an unrelated peptide.", {"entities": []}], ["Autoantibodies affinity purified with the immobilized H26R peptide were shown to exert a positive chronotropic effect in vitro on cardiomyocytes from neonatal rats.", {"entities": []}], ["This effect was blocked by both the specific beta 1 blocker bisoprolol and the peptide P0-beta.", {"entities": []}], ["These results unambiguously prove that T. cruzi is able to induce a functional autoimmune response against the cardiovascular human beta 1-adrenergic receptor through a molecular mimicry mechanism.", {"entities": []}], ["An increased prevalence of autoimmune diseases in family members of children with autism spectrum disorders (ASD) has been previously reported.", {"entities": []}], ["ASD is also a common problem co-occurring in children with fragile X syndrome (FXS).", {"entities": [[69, 77, "DISEASE"]]}], ["Why ASD occurs in some individuals with FXS, but not all, is largely unknown.", {"entities": []}], ["Furthermore, in premutation carrier mothers, there is an increased risk for autoimmune diseases.", {"entities": []}], ["This study compared the rate of ASD and other neurodevelopmental/behavioral problems in 61 children with FXS born to 41 carrier mothers who had autoimmune disease and in 97 children with FXS of 78 carrier mothers who did not have autoimmune disease.", {"entities": []}], ["There were no significant differences in the mean age (9.61\u00a0\u00b1\u00a05.59 vs. 9.41\u00a0\u00b1\u00a06.31, P \u00a0=\u00a00.836), cognitive and adaptive functioning in children of mothers with and without autoimmune disease.", {"entities": []}], ["Among children whose mothers had autoimmune disease, the odds ratio (OR) for ASD was 1.27 (95% CI 0.62\u20132.61, P \u00a0=\u00a00.5115).", {"entities": []}], ["Interestingly, the OR for seizures and tics was 3.81 (95% CI 1.13\u201312.86, P \u00a0=\u00a00.031) and 2.94 (95% CI 1.19\u20137.24, P \u00a0=\u00a00.019), respectively, in children of mothers with autoimmune disease compared to children of mothers without autoimmune disease.", {"entities": []}], ["In conclusion, autoimmune disease in carrier mothers was not associated with the presence of ASD in their children.", {"entities": []}], ["However, seizures and tics were significantly increased in children of mothers with autoimmune disease.", {"entities": []}], ["This suggests a potential new mechanism of seizure and tic exacerbation in FXS related to an intergenerational influence from autoimmunity in the carrier mother.", {"entities": []}], ["The design of a service-oriented architecture for multisensor surveillance in smart homes is presented as an integrated solution enabling automatic deployment, dynamic selection, and composition of sensors.", {"entities": []}], ["Sensors are implemented as Web-connected devices, with a uniform Web API.", {"entities": []}], ["RESTdesc is used to describe the sensors and a novel solution is presented to automatically compose Web APIs that can be applied with existing Semantic Web reasoners.", {"entities": []}], ["We evaluated the solution by building a smart Kinect sensor that is able to dynamically switch between IR and RGB and optimizing person detection by incorporating feedback from pressure sensors, as such demonstrating the collaboration among sensors to enhance detection of complex events.", {"entities": []}], ["The performance results show that the platform scales for many Web APIs as composition time remains limited to a few hundred milliseconds in almost all cases.", {"entities": []}], ["Oviposition is induced upon mating in most insects.", {"entities": []}], ["Ovulation is a primary step in oviposition, representing an important target to control insect pests and vectors, but limited information is available on the underlying mechanism.", {"entities": []}], ["Here we report that the beta adrenergic-like octopamine receptor Oct\u03b22R serves as a key signaling molecule for ovulation and recruits protein kinase A and Ca oct\u03b22r homozygous mutant females are sterile.", {"entities": []}], ["They displayed normal courtship, copulation, sperm storage and post-mating rejection behavior but were unable to lay eggs.", {"entities": []}], ["We have previously shown that octopamine neurons in the abdominal ganglion innervate the oviduct epithelium.", {"entities": []}], ["Consistently, restored expression of Oct\u03b22R in oviduct epithelial cells was sufficient to reinstate ovulation and full fecundity in the oct\u03b22r mutant females, demonstrating that the oviduct epithelium is a major site of Oct\u03b22R\u2019s function in oviposition.", {"entities": []}], ["We also found that overexpression of the protein kinase A catalytic subunit or Ca oct\u03b22r \u2019s sterility.", {"entities": []}], ["This suggests that Oct\u03b22R activates cAMP as well as additional effectors including Ca in vitro .", {"entities": []}], ["Oct\u03b21R, when ectopically expressed in the oct\u03b22r \u2019s oviduct epithelium, fully reinstated ovulation and fecundity.", {"entities": []}], ["Ectopically expressed Oct\u03b23R, on the other hand, partly restored ovulation and fecundity while OAMB-K3 and OAMB-AS that increase Ca in vivo and activate multiple signaling pathways to induce egg laying.", {"entities": []}], ["The findings reported here narrow the knowledge gap and offer insight into novel strategies for insect control.", {"entities": []}], ["The aim of the study was to determine the rate of Potentially Inappropriate Medicines (PIM) and Potential Prescription Omissions (PPO) according to Screening Tool of Older Person's potentially inappropriate Prescriptions/Screening Tool to Alert doctors to the Right Treatment (STOPP/START) criteria.", {"entities": []}], ["A cross-sectional survey in community pharmacy.", {"entities": []}], ["A prospective cross-sectional study was performed, during March-May 2012, in five community pharmacies.", {"entities": []}], ["Patients aged \u226565 years, who collected one or more prescribed medications, were asked to participate in the study, and an interview was scheduled.", {"entities": []}], ["Patients were asked to provide their complete medical and biochemical record from their general practitioner.", {"entities": []}], ["509 patients, mean age 74.8\u00b16.5 years, 57.4% female, participated in the study.", {"entities": []}], ["164 PIM were identified in 139 patients (27.3%).", {"entities": []}], ["The most common were: long-term use of long-acting benzodiazepines (20.7%), use of non-steroidal antiinflammatory drugs (NSAID) in patients with moderate-severe hypertension (20.1%), use of theophylline as monotherapy for chronic obstructive pulmonary disease (COPD, 15.9%) and use of aspirin without appropriate indication (15.2%).", {"entities": [[161, 173, "DISEASE"], [222, 259, "DISEASE"]]}], ["Patients with more than four prescpritions had a higher risk for PIM (OR 2.85, 95% CI 1.97\u20134.14, p<0.001).", {"entities": []}], ["There were 439 PPO, identified in 257, (50.5%) patients.", {"entities": []}], ["Predictors for PPO were older age, presence of diabetes, myocardial infarction, osteoporosis, stroke, COPD and/or angina pectoris.", {"entities": [[57, 78, "DISEASE"], [80, 92, "DISEASE"]]}], ["STOPP/START criteria may be useful in identifying inappropriate prescribing and improving the current prescribing practices.", {"entities": []}], ["Pharmacists should focus more on patients with more than four medications and/or patients with gout or pain accompanied with arterial hypertension because those patient may be at higher risk of PIM.", {"entities": [[134, 146, "DISEASE"], [95, 99, "DISEASE"]]}], ["Additionlly, patients older than 74 years with diabetes, osteoporosis, myocardial infarction, stroke, angina pectoris and/or COPD may have an increased risk of PPO.", {"entities": [[71, 92, "DISEASE"], [57, 69, "DISEASE"]]}], ["Airway mucus is a complex airway secretion whose primary function as part of the mucociliary transport mechanism is to to serve as renewable and transportable barrier against inhaled particulates and toxic agents.", {"entities": []}], ["The rheologic properties necessary for this function are imparted by glycoproteins, or mucins.", {"entities": []}], ["Some respiratory disease states, e.g., asthma, cystic fibrosis, and bronchitis, are characterized by quantitative and qualitative changes in mucus biosynthesis that contribute to pulmonary pathology.", {"entities": [[47, 62, "DISEASE"], [39, 45, "DISEASE"], [68, 78, "DISEASE"]]}], ["Similar alterations in various aspects of mucin biochemistry and biophysics, leading to mucus hypersecretion and altered mucus rheology, result from inhalation of certain air pollutants, such as ozone, sulfur dioxide, nitrogen dioxide, and cigarette smoke.", {"entities": []}], ["The consequences of these pollutant-induced alterations in mucus biology are discussed in the context of pulmonary pathophysiology and toxicology.", {"entities": []}], ["Acute psychological stress (PS) mobilizes metabolic responses that are of immediate benefit to the host, but the current medical paradigm holds that PS exacerbates systemic and cutaneous inflammatory disorders.", {"entities": []}], ["Although the adverse consequences of PS are usually attributed to neuroimmune mechanisms, PS also stimulates an increase in endogenous glucocorticoids (GCs) that compromises permeability barrier homeostasis, stratum corneum cohesion, wound healing, and epidermal innate immunity in normal skin.", {"entities": []}], ["Yet, if such PS-induced increases in GC were uniformly harmful, natural selection should have eliminated this component of the stress response.", {"entities": [[37, 39, "GENE"]]}], ["Hence, we hypothesized here instead that stress-induced elevations in endogenous GC could benefit, rather than aggravate, cutaneous function and reduce inflammation in three immunologically diverse mouse models of inflammatory diseases.", {"entities": [[81, 83, "GENE"]]}], ["Indeed, superimposed exogenous (motion-restricted) stress reduced, rather than aggravated inflammation and improved epidermal function in all three models, even normalizing serum IgE levels in the atopic dermatitis model.", {"entities": [[197, 214, "DISEASE"], [204, 214, "DISEASE"]]}], ["Elevations in endogenous GC accounted for these apparent benefits, because coadministration of mifepristone prevented stress-induced disease amelioration.", {"entities": [[25, 27, "GENE"]]}], ["Thus, exogenous stress can benefit rather than aggravate cutaneous inflammatory dermatoses through the anti-inflammatory activity of increased endogenous GC.", {"entities": [[154, 156, "GENE"]]}], ["Socio-economic, cultural and environmental factors are becoming increasingly important determinants of chronic obstructive pulmonary disease (COPD).", {"entities": [[103, 140, "DISEASE"]]}], ["We conducted a study to investigate socio-demographic, lifestyle and clinical factors, and to assess their role as predictors of acute events (mortality or hospitalization for respiratory causes) in a group of COPD patients.", {"entities": []}], ["Subjects were recruited among outpatients who were undertaking respiratory function tests at the Pneumology Unit of the Sant\u2019Orsola-Malpighi Hospital, Bologna.", {"entities": []}], ["Patients were classified according to the GOLD Guidelines.", {"entities": []}], ["229 patients with COPD were included in the study, 44 with Mild, 68 Moderate, 52 Severe and 65 Very Severe COPD (GOLD stage).", {"entities": []}], ["Significant differences among COPD stage, in terms of smoking status and fragility index, were detected.", {"entities": []}], ["COPD stage significantly affected the values of all clinical tests (spirometry and ABG analysis).", {"entities": []}], ["Kaplan-Meier estimates showed a significant difference between survival curves by COPD stage with lower event-free probability in very severe COPD stage.", {"entities": []}], ["Significant risk factors for acute events were: underweight (HR = 4.08; 95% CI 1.01\u201316.54), having two or more comorbidities (HR = 4.71; 95% CI 2.52\u20138.83), belonging to moderate (HR = 3.50; 95% CI 1.01\u201312.18) or very severe COPD stage (HR = 8.23; 95% CI 2.35\u201328.85).", {"entities": [[61, 63, "GENE"], [126, 128, "GENE"], [179, 181, "GENE"], [236, 238, "GENE"], [61, 63, "GENE"], [126, 128, "GENE"], [179, 181, "GENE"], [236, 238, "GENE"], [61, 63, "GENE"], [126, 128, "GENE"], [179, 181, "GENE"], [236, 238, "GENE"], [61, 63, "GENE"], [126, 128, "GENE"], [179, 181, "GENE"], [236, 238, "GENE"]]}], ["Our findings indicate that fragility is associated with COPD stage and that comorbidities and the low body mass index are predictors of mortality or hospitalization.", {"entities": []}], ["Besides spirometric analyses, FeNO measure and comorbidities, body mass index could also be considered in the management and monitoring of COPD patients.", {"entities": []}], ["Non\u2010cystic fibrosis bronchiectasis ( NCFB ) is a chronic, progressive respiratory disorder characterised by irreversibly and abnormally dilated airways, persistent cough, excessive sputum production and recurrent pulmonary infections.", {"entities": [[20, 34, "DISEASE"], [4, 19, "DISEASE"]]}], ["In the last several decades, its prevalence has increased, making it likely to be encountered in the primary care setting.", {"entities": []}], ["The aim was to review the clinical presentation and diagnosis of NCFB , with an emphasis on the role of computed tomography ( CT ).", {"entities": []}], ["For this review, trials and reports were identified from PubMed/Medline and ClinicalTrials.gov from the US NIH and the Cochrane Register of Controlled Trials.", {"entities": []}], ["The search used keywords: bronchiectasis, non\u2010cystic fibrosis bronchiectasis, chronic pulmonary infection and computed tomography.", {"entities": [[26, 40, "DISEASE"], [62, 76, "DISEASE"], [46, 61, "DISEASE"]]}], ["No date/language restrictions were used.", {"entities": []}], ["Non\u2010cystic fibrosis bronchiectasis often coexists with other respiratory conditions, such as chronic obstructive pulmonary disease.", {"entities": [[93, 130, "DISEASE"], [20, 34, "DISEASE"], [4, 19, "DISEASE"]]}], ["The prevalence of NCFB is increasing, particularly in women and older individuals, possibly as a result of increased physician awareness and widespread use of CT , which is the gold standard for the diagnosis of NCFB .", {"entities": []}], ["CT can assist in identifying an underlying cause of NCFB and determining the extent and severity of the disease.", {"entities": []}], ["Non\u2010cystic fibrosis bronchiectasis should be suspected in the primary care setting in patients with chronic cough, purulent sputum and frequent respiratory infections that tend to resolve slowly or partially.", {"entities": [[20, 34, "DISEASE"], [4, 19, "DISEASE"]]}], ["Early diagnosis and determination of the extent and severity of the disease by CT and other tests are critical to establish therapy to improve quality of life and potentially slow progressive decline of lung function in patients with NCFB .", {"entities": []}], ["Respiratory syncytial virus (RSV) infection is the major cause of bronchiolitis in infants and is a risk factor for the development of asthma.", {"entities": [[135, 141, "DISEASE"], [66, 79, "DISEASE"]]}], ["Allergic asthmatics are more susceptible to RSV infection and viral exacerbation.", {"entities": []}], ["Since the effectiveness of corticosteroids in treating RSV infection has been controversial, we tested fluticasone propionate (FP) and salmeterol (Sal) alone versus FP plus Sal (FPS) on RSV-induced airway inflammation.", {"entities": []}], ["Mice were sensitized and challenged with ovalbumin (OVA) and infected with RSV.", {"entities": []}], ["Following infection they were treated with FP, Sal, or FPS intranasally and airway hyperreactivity (AHR), inflammation and RSV titers were examined.", {"entities": [[100, 103, "GENE"]]}], ["The group treated with FPS showed significantly lower AHR compared to the group treated with FP or Sal alone.", {"entities": [[54, 57, "GENE"]]}], ["The group treated with FP alone showed slightly decreased (non-significant) AHR compared to controls.", {"entities": [[76, 79, "GENE"]]}], ["Treatment with FPS resulted in significant decreases in the percentage of eosinophils and neutrophils in bronchoalveolar lavage fluid and in lung pathology compared to FP or Sal.", {"entities": []}], ["FP alone decreased eosinophils but not neutrophils or lymphocytes, while Sal alone decreased eosinophils and neutrophils but not lymphocytes.", {"entities": []}], ["FPS treatment of mice infected with RSV in the absence of allergen sensitization resulted in a 50% decrease of RSV titer in the lung and a reduction in neutrophils compared to FP or Sal.", {"entities": []}], ["Together, these results indicate that fluticasone in combination with salmeterol is a more effective treatment for decreasing airway hyperreactivity and inflammation than either of them alone in allergen-sensitized, RSV-infected mice.", {"entities": []}], ["This paper crystallises the experience developed by the pan-European PALANTE Consortium in dealing with the generation of relevant evidence from heterogeneous eHealth services for patient empowerment in nine European Regions.", {"entities": []}], ["The European Commission (EC) recently funded a number of pan-European eHealth projects aimed at empowering European patients/citizens thus transforming the traditional patient/citizen role in the management of their health ( e.g.", {"entities": []}], [", PALANTE, SUSTAIN, CARRE, HeartCycle, Empower).", {"entities": []}], ["However, the heterogeneity of the healthcare systems, of the implemented services and of the target patients, the use of ad-hoc definitions of the salient concepts and the development of small-size experiences have prevented the dissemination of \u201cglobal\u201d results and the development of cumulative knowledge.", {"entities": []}], ["The main challenge has been the generation of large-scale evidence from heterogeneous small-size experiences.", {"entities": []}], ["Three lessons have been collectively learnt during the development of the PALANTE project, which involves 9 sites that have implemented different eHealth services for empowering different typologies of patients.", {"entities": []}], ["These lessons have been refined progressively through project meetings, reviews with the EC Project Officer and Reviewers.", {"entities": []}], ["The paper illustrates the ten steps followed to develop the three lessons.", {"entities": []}], ["The first lesson learnt is about how EC-funded projects should develop cumulative knowledge by avoiding self-crafted measures of outcome and by adopting literature-grounded definitions and scales.", {"entities": []}], ["The second lesson learnt is about how EC-funded projects should identify ambitious, cross-pilot policy and research questions that allow pooling of data from across heterogeneous experiences even if a multi-centre study design was not agreed before.", {"entities": []}], ["The third lesson learnt is about how EC-funded projects should open their collections of data and make them freely-accessible to the scientific community shortly after the conclusion of the project in order to guarantee the replicability of results and conclusions.", {"entities": []}], ["The three lessons might provide original elements for fuelling the ongoing debate about the capability of the EC to develop evidence-based policies by pooling evidence from heterogeneous, local experiences.", {"entities": []}], ["Background: Phthalates are used as plasticizers in soft polyvinyl chloride (PVC) and in a large number of consumer products.", {"entities": []}], ["Because of reported health risks, diisononyl phthalate (DiNP) has been introduced as a replacement for di(2-ethylhexyl) phthalate (DEHP) in soft PVC.", {"entities": []}], ["This raises concerns because animal data suggest that DiNP may have antiandrogenic properties similar to those of DEHP.", {"entities": []}], ["The anogenital distance (AGD)\u2014the distance from the anus to the genitals\u2014has been used to assess reproductive toxicity.", {"entities": []}], ["Objective: The objective of this study was to examine the associations between prenatal phthalate exposure and AGD in Swedish infants.", {"entities": []}], ["Methods: AGD was measured in 196 boys at 21 months of age, and first-trimester urine was analyzed for 10 phthalate metabolites of DEP (diethyl phthalate), DBP (dibutyl phthalate), DEHP, BBzP (benzylbutyl phthalate), as well as DiNP and creatinine.", {"entities": [[155, 158, "GENE"]]}], ["Data on covariates were collected by questionnaires.", {"entities": []}], ["Results: The most significant associations were found between the shorter of two AGD measures (anoscrotal distance; AGDas) and DiNP metabolites and strongest for oh-MMeOP [mono-(4-methyl-7-hydroxyloctyl) phthalate] and oxo-MMeOP [mono-(2-ethyl-5-oxohexyl) phthalate].", {"entities": []}], ["However, the AGDas reduction was small (4%) in relation to more than an interquartile range increase in DiNP exposure.", {"entities": []}], ["Conclusions: These findings call into question the safety of substituting DiNP for DEHP in soft PVC, particularly because a shorter male AGD has been shown to relate to male genital birth defects in children and impaired reproductive function in adult males and the fact that human levels of DiNP are increasing globally.", {"entities": []}], ["Citation: Bornehag CG, Carlstedt F, J\u00f6nsson BA, Lindh CH, Jensen TK, Bodin A, Jonsson C, Janson S, Swan SH.", {"entities": []}], ["Prenatal phthalate exposures and anogenital distance in Swedish boys.", {"entities": []}], ["Environ Health Perspect 123:101\u2013107;\u2002 http://dx.doi.org/10.1289/ehp.1408163", {"entities": []}], ["Gut-dwelling helminthes induce potent IL-4 and IL-13 dominated type 2 T helper cell (T H 2) immune responses, with IL-13 production being essential for Nippostrongylus brasiliensis expulsion.", {"entities": []}], ["This T H 2 response results in intestinal inflammation associated with local infiltration by T cells and macrophages.", {"entities": []}], ["The resulting increased IL-4/IL-13 intestinal milieu drives goblet cell hyperplasia, alternative macrophage activation and smooth muscle cell hypercontraction.", {"entities": []}], ["In this study we investigated how IL-4-promoted T cells contributed to the parasite induced effects in the intestine.", {"entities": []}], ["This was achieved using pan T cell-specific IL-4 receptor alpha-deficient mice (iLck N. brasiliensis .", {"entities": []}], ["Infected T cell-specific IL-4R\u03b1-deficient mice showed comparable worm expulsion, goblet cell hyperplasia and IgE responses to control mice.", {"entities": []}], ["However, impaired IL-4-promoted T H 2 cells in T cell-specific IL-4R\u03b1 deficient mice led to strikingly reduced IL-4 production by mesenteric lymph node CD4 N. brasiliensis infection.", {"entities": [[152, 155, "GENE"]]}], ["However, they do contribute significantly to an important physiological manifestation of helminth infection; namely intestinal smooth muscle cell-driven hypercontractility.", {"entities": []}], ["The few studies carried out on the effects of Ramadan fasting (RF) on spirometric values present contradictory conclusions.", {"entities": []}], ["This study aimed at assessing whether RF affects healthy adults\u2019 spirometric values.", {"entities": []}], ["Twenty-nine nonsmoking healthy males ( M \u00b1 standard error of mean [ SEM ] of age: 27 \u00b1 1 years) who fasted during Ramadan (June 29-July 28, 2014) volunteered to the study.", {"entities": []}], ["Three periods (before-Ramadan [June 23-25], mid-Ramadan [July 14-16] and after-Ramadan [August 11-14]) were selected for spirometry measurements that were consistently performed 5.5 to 3.5 hours (between 15:00 and 17:00 hours) before fasting break.", {"entities": []}], ["Assessment sessions comprised following: weight (kg), forced vital capacity (FVC), first second expiratory volume (FEV 1 ), FEV 1 /FVC, peak expiratory flow (PEF), maximal mid expiratory flow (MMEF), and forced expiratory flow rate at the x % of FVC to be exhaled (FEF x % ).", {"entities": [[115, 118, "GENE"], [124, 127, "GENE"], [115, 118, "GENE"], [124, 127, "GENE"]]}], ["Spirometric data were expressed in percentages of reference values.", {"entities": []}], ["Results were analyzed by applying repeated measures analysis of variance.", {"entities": []}], ["The M \u00b1 SEM of weight (before-R: 81.6 \u00b1 2.8 kg, mid-R: 80.8 \u00b1 2.9 kg, after-R: 81.2 \u00b1 2.9 kg), FEV 1 (before-R: 99 \u00b1 2%, mid-R: 98 \u00b1 2%, after-R: 98 \u00b1 2%), FVC (before-R: 103 \u00b1 2%, mid-R: 101 \u00b1 2%, after-R: 101 \u00b1 2%), PEF (before-R: 112 \u00b1 3%, mid-R: 113 \u00b1 2%, after-R: 114 \u00b1 3%), MMEF (before-R: 83 \u00b1 3%, mid-R: 83 \u00b1 3%, after-R: 82 \u00b1 3%), FEF 25% (before-R: 90 \u00b1 5%, mid-R: 89 \u00b1 6%, after-R: 87 \u00b1 6%), FEF 50% (before-R: 94 \u00b1 4%, mid-R: 91 \u00b1 4%, after-R: 93 \u00b1 3%), and FEF 75% (before-R: 108 \u00b1 3%, mid-R: 111 \u00b1 2%, after-R:111 \u00b1 3%) were not significantly influenced by RF.", {"entities": [[95, 98, "GENE"]]}], ["To conclude, RF did not bring about any significant changes in the spirometric values of nonsmoking healthy adult males.", {"entities": []}], ["The National Program for Quality Indicators in Community Healthcare in Israel (QICH) was developed to provide policy makers and consumers with information on the quality of community healthcare in Israel.", {"entities": []}], ["In what follows we present the most recent results of the QICH indicator set for 2009 and an examination of changes that have occurred since 2007.", {"entities": []}], ["Data for 28 quality indicators were collected from all four health plans in Israel for the years 2007-2009.", {"entities": []}], ["The QICH indicator set examined six areas of healthcare: asthma, cancer screening, cardiovascular health, child health, diabetes and immunizations for older adults.", {"entities": [[57, 63, "DISEASE"], [65, 71, "DISEASE"]]}], ["Dramatic increases in the documentation of anthropometric measures were observed over the measurement period.", {"entities": []}], ["Documentation of BMI for adolescents and adults increased by 30 percentage points, reaching rates of 61% and 70%, respectively, in 2009.", {"entities": []}], ["Modest increases (3%-7%) over time were observed for other primary prevention quality measures including immunizations for older adults, cancer screening, anemia screening for young children, and documentation of cardiovascular risks.", {"entities": [[155, 161, "DISEASE"], [137, 143, "DISEASE"]]}], ["Overall, rates of recommended care for chronic diseases (asthma, cardiovascular disease and diabetes) increased over time.", {"entities": [[57, 63, "DISEASE"]]}], ["Changes in rates of quality care for diabetes were varied over the measurement period.", {"entities": []}], ["The overall quality of community healthcare in Israel has improved over the past three years.", {"entities": []}], ["Future research should focus on the adherence to quality indicators in population subgroups and compare the QICH data with those in other countries.", {"entities": []}], ["In addition, one of the next steps in assessing and further improving healthcare quality in Israel is to relate these process and performance indicators to health outcomes.", {"entities": []}], ["To identify the role of chemokine receptor 6 (D6) expression by dendritic cells (DCs) and its role in corneal transplant immunity.", {"entities": []}], ["Flow cytometry analysis was used to assess the expression level of the D6 chemokine receptor in different leukocyte populations and DC maturation following lipopolysaccharides (LPS) stimulation of bone marrow\u2013derived DCs isolated from wild-type (WT) or D6 Expression of the D6 chemokine receptor was significantly higher in DCs compared to other leukocyte subpopulations, including neutrophils, lymphocytes, and monocytes/macrophages.", {"entities": []}], ["LPS challenge of D6 We demonstrated D6 chemokine receptor expression by DCs and identified its critical function in multiple aspects of DC biology, including maturation and consequent elicitation of alloreactive T-cell responses that are responsible for corneal allograft rejection.", {"entities": []}], ["Genomewide association studies have resulted in a great many genomic regions that are likely to harbor disease genes.", {"entities": []}], ["Thorough interrogation of these specific regions is the logical next step, including regional haplotype studies to identify risk haplotypes upon which the underlying critical variants lie.", {"entities": []}], ["Pedigrees ascertained for disease can be powerful for genetic analysis due to the cases being enriched for genetic disease.", {"entities": [[107, 122, "DISEASE"]]}], ["Here we present a Monte Carlo based method to perform haplotype association analysis.", {"entities": []}], ["Our method, hapMC, allows for the analysis of full-length and sub-haplotypes, including imputation of missing data, in resources of nuclear families, general pedigrees, case-control data or mixtures thereof.", {"entities": []}], ["Both traditional association statistics and transmission/disequilibrium statistics can be performed.", {"entities": []}], ["The method includes a phasing algorithm that can be used in large pedigrees and optional use of pseudocontrols.", {"entities": []}], ["Our new phasing algorithm substantially outperformed the standard expectation-maximization algorithm that is ignorant of pedigree structure, and hence is preferable for resources that include pedigree structure.", {"entities": []}], ["Through simulation we show that our Monte Carlo procedure maintains the correct type 1 error rates for all resource types.", {"entities": []}], ["Power comparisons suggest that transmission-disequilibrium statistics are superior for performing association in resources of only nuclear families.", {"entities": []}], ["For mixed structure resources, however, the newly implemented pseudocontrol approach appears to be the best choice.", {"entities": []}], ["Results also indicated the value of large high-risk pedigrees for association analysis, which, in the simulations considered, were comparable in power to case-control resources of the same sample size.", {"entities": []}], ["We propose hapMC as a valuable new tool to perform haplotype association analyses, particularly for resources of mixed structure.", {"entities": []}], ["The availability of meta-association and haplotype-mining modules in our suite of Monte Carlo haplotype procedures adds further value to the approach.", {"entities": []}], ["Previous studies suggested that dietary fatty acids could affect blood lipids by interacting with genetic variations in fatty acid desaturase 1 (FADS1) .", {"entities": [[145, 150, "GENE"]]}], ["However, little is known about their direct effects on coronary artery disease (CAD).", {"entities": []}], ["The aim of this study was to evaluate whether dietary n-3 long-chain polyunsaturated fatty acids (LCPUFAs) -eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) could modulate the effect of FADS1 rs174547 polymorphism on CAD.", {"entities": [[196, 201, "GENE"]]}], ["FADS1 single-nucleotide polymorphisms rs174547 genotypes were measured in 440 CAD patients and 838 healthy controls.", {"entities": [[0, 5, "GENE"]]}], ["Dietary EPA and DHA intakes were assessed with a validated quantitative frequency food questionnaire.", {"entities": []}], ["The association between FADS1 rs174547 and CAD was estimated using logistic regression under both dominant and additive genetic models.", {"entities": [[24, 29, "GENE"]]}], ["The interactions between rs174547 polymorphism and LCPUFAs were analyzed by using multiple logistic regression and the \u201cgenotype \u00d7 n-3 LCPUFAs\u201d interaction term was included into the model.", {"entities": []}], ["We found that the minor T allele of FADS1 rs174547 increased CAD risk (OR = 1.36, 95%CIs 1.03-1.80), and observed significant interaction between rs174547 and dietary EPA intakes on CAD ( P -interaction = 0.028).", {"entities": [[36, 41, "GENE"]]}], ["The T -allele was only associated with higher CAD risk among individuals with lower dietary EPA intakes, but not in those with higher EPA intakes.", {"entities": []}], ["Similarly, significant interaction was also observed between rs174547 and dietary DHA intakes on CAD ( P -interaction = 0.020).", {"entities": []}], ["Dietary n-3 LCPUFA intakes could modulate the association between FADS1 rs174547 polymorphism and CAD.", {"entities": [[66, 71, "GENE"]]}], ["High dietary n-3 LCPUFA intakes could negate the unfavorable effect of genetic variation in FADS1 on CAD in middle-aged and elderly Chinese population.", {"entities": [[92, 97, "GENE"]]}], ["Both dietary and serum levels of inorganic phosphate (Pi) have been linked to development of cancer in experimental studies.", {"entities": [[93, 99, "DISEASE"]]}], ["This is the first population-based study investigating the relation between serum Pi and risk of cancer in humans.", {"entities": [[97, 103, "DISEASE"]]}], ["From the Swedish Apolipoprotein Mortality Risk (AMORIS) study, we selected all participants (> 20 years old) with baseline measurements of serum Pi, calcium, alkaline phosphatase, glucose, and creatinine (n = 397,292).", {"entities": []}], ["Multivariable Cox proportional hazards regression analyses were used to assess serum Pi in relation to overall cancer risk.", {"entities": [[111, 117, "DISEASE"]]}], ["Similar analyses were performed for specific cancer sites.", {"entities": [[45, 51, "DISEASE"]]}], ["We found a higher overall cancer risk with increasing Pi levels in men ( HR: 1.02 (95% CI: 1.00-1.04) for every SD increase in Pi), and a negative association in women (HR: 0.97 (95% CI: 0.96-0.99) for every SD increase in Pi).", {"entities": [[26, 32, "DISEASE"], [73, 75, "GENE"], [169, 171, "GENE"], [73, 75, "GENE"], [169, 171, "GENE"]]}], ["Further analyses for specific cancer sites showed a positive link between Pi quartiles and the risk of cancer of the pancreas, lung, thyroid gland and bone in men, and cancer of the oesophagus, lung, and nonmelanoma skin cancer in women.", {"entities": [[216, 227, "DISEASE"], [30, 36, "DISEASE"], [103, 109, "DISEASE"], [168, 174, "DISEASE"], [221, 227, "DISEASE"]]}], ["Conversely, the risks for developing breast and endometrial cancer as well as other endocrine cancer in both men and women were lower in those with higher Pi levels.", {"entities": [[48, 66, "DISEASE"], [60, 66, "DISEASE"], [94, 100, "DISEASE"]]}], ["Abnormal Pi levels are related to development of cancer.", {"entities": [[49, 55, "DISEASE"]]}], ["Furthermore, the in verse association between Pi levels and risk of breast, endometrial and other endocrine cancers may indicate the role of hormonal factors in the relation between Pi metabolism and cancer.", {"entities": [[200, 206, "DISEASE"]]}], ["Activation and differentiation of T-helper (Th) cells into Th1 and Th2 types is a complex process orchestrated by distinct gene activation programs engaging a number of genes.", {"entities": []}], ["This process is crucial for a robust immune response and an imbalance might lead to disease states such as autoimmune diseases or allergy.", {"entities": []}], ["Therefore, identification of genes involved in this process is paramount to further understand the pathogenesis of, and design interventions for, immune-mediated diseases.", {"entities": []}], ["We aimed at identifying protein-coding genes and long non-coding RNAs (lncRNAs) involved in early differentiation of T-helper cells by transcriptome analysis of cord blood-derived na\u00efve precursor, primary and polarized cells.", {"entities": []}], ["Here, we identified lineage-specific genes involved in early differentiation of Th1 and Th2 subsets by integrating transcriptional profiling data from multiple platforms.", {"entities": []}], ["We have obtained a high confidence list of genes as well as a list of novel genes by employing more than one profiling platform.", {"entities": []}], ["We show that the density of lineage-specific epigenetic marks is higher around lineage-specific genes than anywhere else in the genome.", {"entities": []}], ["Based on next-generation sequencing data we identified lineage-specific lncRNAs involved in early Th1 and Th2 differentiation and predicted their expected functions through Gene Ontology analysis.", {"entities": []}], ["We show that there is a positive trend in the expression of the closest lineage-specific lncRNA and gene pairs.", {"entities": []}], ["We also found out that there is an enrichment of disease SNPs around a number of lncRNAs identified, suggesting that these lncRNAs might play a role in the etiology of autoimmune diseases.", {"entities": []}], ["The results presented here show the involvement of several new actors in the early differentiation of T-helper cells and will be a valuable resource for better understanding of autoimmune processes.", {"entities": []}], ["The online version of this article (doi:10.1186/s13073-015-0237-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Cytochrome P450 1A2 (CYP1A2) is one of the CYP450 mixed-function oxidase system that is of clinical importance due to the large number of drug interactions associated with its induction and inhibition.", {"entities": [[21, 27, "GENE"]]}], ["In addition, significant inter-individual differences in the elimination of drugs metabolized by CYP1A2 enzyme have been observed which are largely due to the highly polymorphic nature of CYP1A2 gene.", {"entities": [[97, 103, "GENE"], [188, 194, "GENE"], [97, 103, "GENE"], [188, 194, "GENE"]]}], ["However, there are limited studies on CYP1A2 phenotypes and CYP1A2 genotypes among Emiratis and thus this study was carried out to fill this gap.", {"entities": [[38, 44, "GENE"], [60, 66, "GENE"], [38, 44, "GENE"], [60, 66, "GENE"]]}], ["Five hundred and seventy six non-smoker Emirati subjects were asked to consume a soft drink containing caffeine (a non-toxic and reliable probe for predicting CYP1A2 phenotype) and then provide a buccal swab along with a spot urine sample.", {"entities": [[159, 165, "GENE"]]}], ["Taq-Man Real Time PCR was used to determine the CYP1A2 genotype of each individual.", {"entities": [[48, 54, "GENE"]]}], ["Phenotyping was carried out by analyzing the caffeine metabolites using High Performance Liquid Chromatography (HPLC) analysis.", {"entities": []}], ["We found that 1.4%, 16.3% and 82.3% of the Emirati subjects were slow, intermediate and rapid CYP1A2 metabolizers, respectively.", {"entities": [[94, 100, "GENE"]]}], ["In addition, we found that 1.4% of the subjects were homozygote for derived alleles while 16.1% were heterozygote and 82.5% were homozygote for the ancestral allele.", {"entities": []}], ["The genotype frequency of the ancestral allele, CYP1A2*1A/*1A , is the highest in this population, followed by CYP1A2 *1A/*1C and CYP1A2 *1A/*1K genotypes, with frequencies of 0.825, 0.102 and 0.058, respectively.", {"entities": [[48, 54, "GENE"], [111, 117, "GENE"], [130, 136, "GENE"], [48, 54, "GENE"], [111, 117, "GENE"], [130, 136, "GENE"]]}], ["The degree of phenotype/genotype concordance was equal to 81.6%.", {"entities": []}], ["The CYP1A2*1C/*1C and CYP1A2*3/*3 genotypes showed significantly the lowest enzyme phenotypic activity.", {"entities": []}], ["The frequency of slow activity CYP1A2 enzyme alleles is very low among Emiratis which correlates with the presence of low frequencies of derived alleles in CYP1A2 gene.", {"entities": [[31, 37, "GENE"], [156, 162, "GENE"], [31, 37, "GENE"], [156, 162, "GENE"]]}], ["Screening with dynamic mass redistribution (DMR) assays in a native cell line HT-29 led to identification of two novel series of chemical compounds, 2-(4-methylfuran-2(5 H )-ylidene)malononitrile and thieno[3,2- b ]thiophene-2-carboxylic acid derivatives, as GPR35 agonists.", {"entities": [[259, 264, "GENE"]]}], ["Of these, 2-(3-cyano-5-(3,4-dichlorophenyl)-4,5-dimethylfuran-2(5 H )-ylidene)malononitrile (YE120) and 6-bromo-3-methylthieno[3,2- b ]thiophene-2-carboxylic acid (YE210) were found to be the two most potent GPR35 agonists with an EC 50 of 32.5 \u00b1 1.7 nM and 63.7 \u00b1 4.1 nM, respectively.", {"entities": [[208, 213, "GENE"]]}], ["Both agonists exhibited better potency than that of zaprinast, a known GPR35 agonist.", {"entities": [[71, 76, "GENE"]]}], ["DMR antagonist assays, knockdown of GPR35 with interference RNA, receptor internalization assays, and Tango \u03b2-arrestin translocation assays confirmed that the agonist activity of these ligands is specific to GPR35.", {"entities": [[36, 41, "GENE"], [208, 213, "GENE"], [36, 41, "GENE"], [208, 213, "GENE"]]}], ["The present study provides novel chemical series as a starting point for further investigations of GPR35 biology and pharmacology.", {"entities": [[99, 104, "GENE"]]}], ["The complex composition of secondhand smoke (SHS) provides a range of constituents that can be measured in environmental samples (air, dust and on surfaces) and therefore used to assess non-smokers' exposure to tobacco smoke.", {"entities": []}], ["Monitoring SHS exposure (SHSe) in indoor environments provides useful information on the extent and consequences of SHSe, implementing and evaluating tobacco control programmes and behavioural interventions, and estimating overall burden of disease caused by SHSe.", {"entities": []}], ["The most widely used markers have been vapour-phase nicotine and respirable particulate matter (PM).", {"entities": []}], ["Numerous other environmental analytes of SHS have been measured in the air including carbon monoxide, 3-ethenylpyridine, polycyclic aromatic hydrocarbons, tobacco-specific nitrosamines, nitrogen oxides, aldehydes and volatile organic compounds, as well as nicotine in dust and on surfaces.", {"entities": []}], ["The measurement of nicotine in the air has the advantage of reflecting the presence of tobacco smoke.", {"entities": []}], ["While PM measurements are not as specific, they can be taken continuously, allowing for assessment of exposure and its variation over time.", {"entities": []}], ["In general, when nicotine and PM are measured in the same setting using a common sampling period, an increase in nicotine concentration of 1\u2005\u03bcg/m", {"entities": []}], ["Several instruments for evaluating patient complexity have been developed from a biopsychosocial perspective.", {"entities": []}], ["Although relationships between the results obtained by these instruments and the length of stay in hospital have been examined, many instruments are complicated and not easy to use.", {"entities": []}], ["The Patient Centred Assessment Method (PCAM) is a candidate for practical use.", {"entities": []}], ["This study aimed to test the validity and reliability of the PCAM and examine the correlations between length of hospital stay and PCAM scores in a regional secondary care hospital in Japan.", {"entities": []}], ["Prospective cohort study.", {"entities": []}], ["Two hundred and one patients admitted to Ouji Coop Hospital between July 2014 and September 2014.", {"entities": []}], ["PCAM total score in initial phase of hospital admission.", {"entities": []}], ["Length of stay in hospital.", {"entities": []}], ["Among 201 patients (Female/Male=98/103) with mean (SD) age of 77.4\u00b111.9 years, the mean PCAM score was 25\u00b17.3\u2009and mean (SD) length of stay in hospital (LOS) 34.1\u00b140.9 days.", {"entities": []}], ["Using exploratory factor analysis to examine construct validity, PCAM evidently has a two-factor structure, comprising medicine-oriented and patient-oriented complexity.", {"entities": []}], ["The Spearman rank correlation coefficient for evaluating criterion-based validity between PCAM and INTERMED was 0.90.", {"entities": []}], ["For reliability, Cronbach\u2019s alpha was 0.85.", {"entities": []}], ["According to negative binomial regression analyses, PCAM scores are a statistically significant predictor (p<0.001) of LOS after adjusting for age, gender, Mini Nutritional Assessment Short-Form, Charlson Comorbidity Index, serum sodium concentration, total number of medications and whether public assistance was required.", {"entities": []}], ["In another model, each factor in PCAM was independently correlated with length of stay in hospital after adjustment (medicine-oriented complexity: p=0.001, patient-oriented complexity: p=0.014).", {"entities": []}], ["PCAM is a reliable and valid measurement of patient complexity and PCAM scores have a significant correlation with hospital length of stay.", {"entities": []}], ["In addition to their proliferative and differentiating effects, several growth factors are capable of inducing a sustained airway smooth muscle (ASM) contraction.", {"entities": []}], ["These contractile effects were previously found to be dependent on Rho-kinase and have also been associated with the production of eicosanoids.", {"entities": []}], ["However, the precise mechanisms underlying growth factor-induced contraction are still unknown.", {"entities": []}], ["In this study we investigated the role of contractile prostaglandins and Rho-kinase in growth factor-induced ASM contraction.", {"entities": []}], ["Growth factor-induced contractions of guinea pig open-ring tracheal preparations were studied by isometric tension measurements.", {"entities": []}], ["The contribution of Rho-kinase, mitogen-activated protein kinase (MAPK) and cyclooxygenase (COX) to these reponses was established, using the inhibitors Y-27632 (1 \u03bcM), U-0126 (3 \u03bcM) and indomethacin (3 \u03bcM), respectively.", {"entities": []}], ["The Rho-kinase dependency of contractions induced by exogenously applied prostaglandin F 2\u03b1 (PGF 2\u03b1 ) and prostaglandin E 2 (PGE 2 ) was also studied.", {"entities": [[93, 96, "GENE"]]}], ["In addition, the effects of the selective FP-receptor antagonist AL-8810 (10 \u03bcM) and the selective EP 1 -antagonist AH-6809 (10 \u03bcM) on growth factor-induced contractions were investigated, both in intact and epithelium-denuded preparations.", {"entities": []}], ["Growth factor-induced PGF 2\u03b1 -and PGE 2 -release in the absence and presence of Y-27632, U-0126 and indomethacin, was assessed by an ELISA-assay.", {"entities": [[22, 25, "GENE"]]}], ["Epidermal growth factor (EGF)-and platelet-derived growth factor (PDGF)-induced contractions of guinea pig tracheal smooth muscle preparations were dependent on Rho-kinase, MAPK and COX.", {"entities": [[25, 28, "GENE"]]}], ["Interestingly, growth factor-induced PGF 2\u03b1 -and PGE 2 -release from tracheal rings was significantly reduced by U-0126 and indomethacin, but not by Y-27632.", {"entities": [[37, 40, "GENE"]]}], ["Also, PGF 2\u03b1 -and PGE 2 -induced ASM contractions were largely dependent on Rho-kinase, in contrast to other contractile agonists like histamine.", {"entities": [[6, 9, "GENE"]]}], ["The FP-receptor antagonist AL-8810 (10 \u03bcM) significantly reduced (approximately 50 %) and the EP 1 -antagonist AH-6809 (10 \u03bcM) abrogated growth factor-induced contractions, similarly in intact and epithelium-denuded preparations.", {"entities": []}], ["The results indicate that growth factors induce ASM contraction through contractile prostaglandins \u2013 not derived from the epithelium \u2013 which in turn rely on Rho-kinase for their contractile effects.", {"entities": []}], ["Common variable immunodeficiency (CVID) is a form of severe antibody deficiency with an estimated prevalence of 1 in 25,000 to 1 in 100,000.", {"entities": []}], ["The disorder apparently results from currently undefined immune deregulations resulting in failed B-cell differentiation with impaired secretion of immunoglobulins.", {"entities": []}], ["It has a broad range of clinical symptoms including recurrent infections of the respiratory tract, chronic lung disease, autoimmune diseases, liver and gastrointestinal disorders, granulomatous infiltrations, lymphoma and solid tumors.", {"entities": [[209, 217, "DISEASE"], [107, 119, "DISEASE"]]}], ["A 42-year-old Caucasian female presented with a one-day history of high-grade fever and productive cough associated with retrosternal chest pain.", {"entities": []}], ["The patient had been discharged one week prior after a prolonged stay in an intensive care unit with multiorgan failure requiring temporary hemodialysis for two weeks secondary to sepsis.", {"entities": []}], ["Past medical history was significant for chronic obstructive pulmonary disease, recurrent pneumonias and recurrent sinus infections since adolescence.", {"entities": [[41, 78, "DISEASE"]]}], ["She had a temperature of 99.8\u00b0F, was tachycardic (137/min), tachypneic (26/min) with a blood pressure of 109/59 mmHg and oxygen saturation of 88% on 2 l/min nasal oxygen.", {"entities": []}], ["Physical examination was significant for bibasilar rhonchi.", {"entities": []}], ["Laboratory data were significant for leukocytosis of 15,700/mm This case emphasizes the need for a high index of clinical suspicion for CVID in patients presenting with recurrent sinopulmonary infections.", {"entities": []}], ["Although intravenous immunoglobulin provides improvement in these patients, early diagnosis is the key to preventing significant morbidity and mortality and improving prognosis.", {"entities": []}], ["To describe the obstacles that parents face when caring for a child with food protein-induced enterocolitis syndrome (FPIES) and discuss initiatives of key importance to the FPIES community.", {"entities": [[108, 116, "DISEASE"]]}], ["Findings from a previous survey indicate that 80% of pediatricians have little or no knowledge of FPIES, suggesting that awareness is severely lacking among frontline providers.", {"entities": []}], ["A preliminary study also indicates that the condition can have a profound effect on quality of life for patients and families.", {"entities": []}], ["FPIES is a rare but growing condition that poses significant personal and familial challenges for parents before and after diagnosis.", {"entities": []}], ["Increased efforts from the medical community are needed to raise awareness among medical providers, establish improved criteria and guidelines for diagnosis and management, increase understanding through research, and offer parent information and support at every stage.", {"entities": []}], ["To evaluate alcohol/tobacco and/or illicit drug misuse in Chronic Diseases (CDs).", {"entities": []}], ["A cross-sectional study with 220 CDs adolescents and 110 healthy controls including: demographic/anthropometric data; puberty markers; modified questionnaire evaluating sexual function, alcohol/smoking/illicit drug misuse and bullying; and the physician-conducted CRAFFT (car/relax/alone/forget/friends/trouble) screen tool for substance abuse/dependence high risk.", {"entities": [[328, 343, "DISEASE"]]}], ["The frequencies of alcohol/tobacco and/or illicit drug use were similar in both groups (30% vs. 34%, p =0.529), likewise the frequencies of bullying (42% vs. 41%, p =0.905).", {"entities": []}], ["Further analysis solely in CDs patients that used alcohol/tobacco/illicit drug versus those that did not use showed that the median current age [15 (11\u201318) vs. 14 (10\u201318) years, p <0.0001] and education years [9 (5\u201314) vs. 8 (3\u201312) years, p <0.0001] were significant higher in substance use group.", {"entities": []}], ["The frequencies of Tanner 5 ( p <0.0001), menarche ( p <0.0001) and spermarche ( p =0.001) were also significantly higher in patients with CDs that used alcohol/tobacco/illicit, likewise sexual activity (23% vs. 3%, p <0.0001).", {"entities": []}], ["A trend of a low frequency of drug therapy was observed in patients that used substances (70% vs. 82%, p =0.051).", {"entities": []}], ["A positive correlation was observed between CRAFFT score and current age in CD patients ( p =0.005, r=+0.189) and controls ( p =0.018, r=+0.226).", {"entities": []}], ["A later age was evidenced in CDs patients that reported licit/ilicit drug misuse.", {"entities": []}], ["In CDs adolescent, substance use was more likely to have sexual intercourse.", {"entities": []}], ["Our study reinforces that these patients should be systematically screened by pediatricians for drug related health behavioral patterns.", {"entities": []}], ["Penetrating keratoplasty is the most common type of tissue transplant in humans.", {"entities": []}], ["Irreversible immune rejection leads to loss of vision and graft failure.", {"entities": []}], ["This complex immune response further predisposes future corneal transplants to rejection and failure.", {"entities": []}], ["A diverse armamentarium of surgical and pharmacologic tools is available to improve graft survival.", {"entities": []}], ["In this review, we will discuss the various gene therapeutic strategies aimed at potentiating the anterior chamber-associated immune deviation to extend graft survival.", {"entities": []}], ["Asthma and allergy represent complex phenotypes, which disproportionately burden ethnic minorities in the United States.", {"entities": [[0, 6, "DISEASE"]]}], ["Strong evidence for genomic factors predisposing subjects to asthma/allergy is available.", {"entities": [[61, 67, "DISEASE"]]}], ["However, methods to utilize this information to identify high risk groups are variable and replication of genetic associations in African Americans is warranted.", {"entities": []}], ["We evaluated 41 single nucleotide polymorphisms (SNP) and a deletion corresponding to 11 genes demonstrating association with asthma in the literature, for association with asthma, atopy, testing positive for food allergens, eosinophilia, and total serum IgE among 141 African American children living in Detroit, Michigan.", {"entities": [[225, 237, "DISEASE"], [126, 132, "DISEASE"], [173, 179, "DISEASE"]]}], ["Independent SNP and haplotype associations were investigated for association with each trait, and subsequently assessed in concert using a genetic risk score (GRS).", {"entities": []}], ["Statistically significant associations with asthma were observed for SNPs in GSTM1, MS4A2 , and GSTP1 genes, after correction for multiple testing.", {"entities": [[44, 50, "DISEASE"], [77, 82, "GENE"], [84, 89, "GENE"], [96, 101, "GENE"]]}], ["Chromosome 11 haplotype CTACGAGGCC (corresponding to MS4A2 rs574700, rs1441586, rs556917, rs502581, rs502419 and GSTP1 rs6591256, rs17593068, rs1695, rs1871042, rs947895) was associated with a nearly five-fold increase in the odds of asthma (Odds Ratio (OR) = 4.8, p = 0.007).", {"entities": [[234, 240, "DISEASE"], [53, 58, "GENE"], [113, 118, "GENE"]]}], ["The GRS was significantly associated with a higher odds of asthma (OR = 1.61, 95% Confidence Interval = 1.21, 2.13; p = 0.001).", {"entities": [[59, 65, "DISEASE"]]}], ["Variation in genes associated with asthma in predominantly non-African ethnic groups contributed to increased odds of asthma in this African American study population.", {"entities": [[35, 41, "DISEASE"], [118, 124, "DISEASE"]]}], ["Evaluating all significant variants in concert helped to identify the highest risk subset of this group.", {"entities": []}], ["Interferences between pathogenic bacteria and specific commensals are known.", {"entities": []}], ["We determined the interactions between nasopharyngeal microbial pathogens and commensals during viral upper respiratory tract infection (URI) and acute otitis media (AOM) in infants.", {"entities": [[152, 164, "DISEASE"]]}], ["We analyzed 971 specimens collected monthly and during URI and AOM episodes from 139 infants.", {"entities": []}], ["The 16S rRNA V4 gene regions were sequenced on the Illumina MiSeq platform.", {"entities": []}], ["Among the high abundant genus-level nasopharyngeal microbiota were Moraxella , Haemophilus , and Streptococcus (3 otopathogen genera), Corynebacterium , Dolosigranulum , Staphylococcus , Acinetobacter , Pseudomonas , and Bifidobacterium .", {"entities": []}], ["Bacterial diversity was lower in culture-positive samples for Streptococcus pneumoniae , and Haemophilus influenzae , compared to cultured-negative samples.", {"entities": []}], ["URI frequencies were positively associated with increasing trend in otopathogen colonization.", {"entities": []}], ["AOM frequencies were associated with decreasing trend in Micrococcus colonization.", {"entities": []}], ["During URI and AOM, there were increases in abundance of otopathogen genera and decreases in Pseudomonas , Myroides , Yersinia , and Sphingomonas .", {"entities": []}], ["Otopathogen abundance was increased during symptomatic viral infection, but not during asymptomatic infection.", {"entities": []}], ["The risk for AOM complicating URI was reduced by increased abundance of Staphylococcus and Sphingobium .", {"entities": []}], ["Otopathogen genera played the key roles in URI and AOM occurrences.", {"entities": []}], ["Staphylococcus counteracts otopathogens thus Staphylococcal colonization may be beneficial, rather than harmful.", {"entities": []}], ["While Sphingobium may play a role in preventing AOM complicating URI, the commonly used probiotic Bifidobacterium did not play a significant role during URI or AOM.", {"entities": []}], ["The role of less common commensals in counteracting the deleterious effects of otopathogens requires further studies.", {"entities": []}], ["The human respiratory syncytial virus (hRSV) is the causative agent for high rates of hospitalizations due to viral bronchiolitis and pneumonia worldwide.", {"entities": [[134, 143, "DISEASE"], [116, 129, "DISEASE"]]}], ["Such a disease is characterized by an infection of epithelial cells of the distal airways that leads to inflammation and subsequently to respiratory failure.", {"entities": [[137, 156, "DISEASE"]]}], ["Upon infection, different pattern recognition receptors recognize the virus and trigger the innate immune response against the hRSV.", {"entities": []}], ["Further, T cell immunity plays an important role for virus clearance.", {"entities": []}], ["Based on animal studies, it is thought that the host immune response to hRSV is based on a biased T helper (Th)-2 and Th17 T cell responses with the recruitment of T cells, neutrophils and eosinophils to the lung, causing inflammation and tissue damage.", {"entities": []}], ["In contrast, human immunity against RSV has been shown to be more complex with no definitive T cell polarization profile.", {"entities": []}], ["Nowadays, only a humanized monoclonal antibody, known as palivizumab, is available to protect against hRSV infection in high-risk infants.", {"entities": []}], ["However, such treatment involves several injections at a significantly high cost.", {"entities": []}], ["For these reasons, intense research has been focused on finding novel vaccines or therapies to prevent hRSV infection in the population.", {"entities": []}], ["Here, we comprehensively review the recent literature relative to the immunological features during hRSV infection, as well as the new insights into preventing the disease caused by this virus.", {"entities": []}], ["Behcet's disease (BD) is a rare systemic vasculitis disorder that can involve vessels of any size.", {"entities": [[41, 51, "DISEASE"]]}], ["A 60-year-old female had recurrent painful mouth ulcers about 30 years ago and recently presented with abdominal distension, conjunctival congestion, and chest pain in sequence.", {"entities": []}], ["The patient was diagnosed with BD according to the International Criteria for Behcet's Disease (ICBD).", {"entities": []}], ["A therapy of glucocorticoids and cyclophosphamide was administered.", {"entities": []}], ["After a 3-month treatment, follow-up examination showed a depression of the inflammation and a slight decrease of the arterial aneurysms.", {"entities": []}], ["BD patients may get a delayed diagnosis because of the long duration between the first and subsequent manifestations.", {"entities": []}], ["Suspect patients should be followed-up and the diagnosis of BD should be considered when multiple tissues or organs are involved.", {"entities": []}], ["CD4 Tph1 ), independently of well-established transcription factors.", {"entities": [[0, 3, "GENE"], [4, 8, "GENE"]]}], ["In the presence of NAD T-bet The mechanism by which NAD", {"entities": []}], ["Inhalation of ambient levels of ozone causes airway inflammation and epithelial injury.", {"entities": []}], ["To examine the responses of airway cells to ozone-induced oxidative injury, 19 subjects (7 with asthma) were exposed to clean air (0ppb), medium (100ppb), and high (200ppb) ambient levels of ozone for 4h on three separate occasions in a climate-controlled chamber followed by bronchoscopy with bronchoalveolar lavage (BAL) 24h later.", {"entities": [[96, 102, "DISEASE"]]}], ["BAL cell mRNA expression was examined using Affymetrix GeneChip Microarray.", {"entities": []}], ["The role of a differentially expressed gene (DEG) in epithelial injury was evaluated in an in vitro model of injury [16HBE14o- cell line scratch assay].", {"entities": []}], ["Ozone exposure caused a dose-dependent up-regulation of several biologic pathways involved in inflammation and repair including chemokine and cytokine secretion, activity, and receptor binding; metalloproteinase and endopeptidase activity; adhesion, locomotion, and migration; and cell growth and tumorigenesis regulation.", {"entities": []}], ["Asthmatic subjects had 1.7- to 3.8-fold higher expression of many DEGs suggestive of increased proinflammatory and matrix degradation and remodeling signals.", {"entities": []}], ["The most highly up-regulated gene was osteopontin, the protein level of which in BAL fluid increased in a dose-dependent manner after ozone exposure.", {"entities": []}], ["Asthmatic subjects had a disproportionate increase in non-polymerized osteopontin with increasing exposure to ozone.", {"entities": []}], ["Treatment with polymeric, but not monomeric, osteopontin enhanced the migration of epithelial cells and wound closure in an \u03b19\u03b21 integrin-dependent manner.", {"entities": []}], ["Expression profiling of BAL cells after ozone exposure reveals potential regulatory genes and pathways activated by oxidative stress.", {"entities": []}], ["One DEG, osteopontin, promotes epithelial wound healing in an in vitro model of injury.", {"entities": []}], ["As the most stable and experimentally accessible epigenetic mark, DNA methylation is of great interest to the research community.", {"entities": []}], ["The landscape of DNA methylation across tissues, through development and in disease pathogenesis is not yet well characterized.", {"entities": []}], ["Thus there is a need for rapid and cost effective methods for assessing genome-wide levels of DNA methylation.", {"entities": []}], ["The Illumina Infinium HumanMethylation450 (450K) BeadChip is a very useful addition to the available methods for DNA methylation analysis but its complex design, incorporating two different assay methods, requires careful consideration.", {"entities": []}], ["Accordingly, several normalization schemes have been published.", {"entities": []}], ["We have taken advantage of known DNA methylation patterns associated with genomic imprinting and X-chromosome inactivation (XCI), in addition to the performance of SNP genotyping assays present on the array, to derive three independent metrics which we use to test alternative schemes of correction and normalization.", {"entities": []}], ["These metrics also have potential utility as quality scores for datasets.", {"entities": []}], ["The standard index of DNA methylation at any specific CpG site is \u03b2 = M /( M + U + 100) where M and U are methylated and unmethylated signal intensities, respectively.", {"entities": []}], ["Betas ( \u03b2 s) calculated from raw signal intensities (the default GenomeStudio behavior) perform well, but using 11 methylomic datasets we demonstrate that quantile normalization methods produce marked improvement, even in highly consistent data, by all three metrics.", {"entities": []}], ["The commonly used procedure of normalizing betas is inferior to the separate normalization of M and U, and it is also advantageous to normalize Type I and Type II assays separately.", {"entities": []}], ["More elaborate manipulation of quantiles proves to be counterproductive.", {"entities": []}], ["Careful selection of preprocessing steps can minimize variance and thus improve statistical power, especially for the detection of the small absolute DNA methylation changes likely associated with complex disease phenotypes.", {"entities": []}], ["For the convenience of the research community we have created a user-friendly R software package called wateRmelon, downloadable from bioConductor, compatible with the existing methylumi, minfi and IMA packages, that allows others to utilize the same normalization methods and data quality tests on 450K data.", {"entities": []}], ["Drug hypersensitivity is responsible for substantial mortality and morbidity, and increased health costs.", {"entities": []}], ["However, epidemiological data on drug hypersensitivity in general or specific populations are scarce.", {"entities": []}], ["We performed a cross-sectional survey of 1015 university students, using a self-reported questionnaire.", {"entities": []}], ["The prevalence of self-reported drug hypersensitivity was 12,11% (123/1015).", {"entities": []}], ["The most frequently implicated drugs were non-steroidal anti-inflammatory drugs (45,9%) and beta-lactam and sulfonamide antibiotics (25,40%).", {"entities": []}], ["The majority of the patients reported dermatological manifestations (99), followed by respiratory (40), digestive (23) and other (19).", {"entities": []}], ["Forty-five patients had an immediate type reaction, and 76,72% (89) had the drug by oral route.", {"entities": []}], ["The results showed that drug hypersensitivity is highly prevalent in university students, and that non-steroidal anti-inflammatory drug and antibiotics (beta-lactams and sulfonamide) are the most frequently concerned drugs.", {"entities": []}], ["The aim of this study is to evaluate the analgesic and anti-inflammatory activities of atorvastatin and simvastatin in different experimental models in mice and rats.", {"entities": []}], ["Analgesic activity of simvastatin and atorvastatin was assessed in tail flick model in rats ( n = 6), where it was compared with aspirin and tramadol and in acetic acid induced writhing in mice ( n = 6), where it was compared with aspirin.", {"entities": []}], ["Anti-inflammatory activity of statins was evaluated using carrageenin induced paw edema and formalin induced arthritis in rats.", {"entities": [[109, 118, "DISEASE"]]}], ["In the tail flick method, analgesic effect of tramadol was significantly more than the other drugs except at two observation times, when it was comparable to simvastatin and atorvastatin.", {"entities": []}], ["Effect of simvastatin was found to be comparable to aspirin.", {"entities": []}], ["In acetic acid induced writhing method, analgesic activity of simvastatin was comparable to that of aspirin while that of atorvastatin was significantly less.", {"entities": []}], ["In carrageenin induced paw edema in rats, both simvastatin and atorvastatin showed anti-inflammatory activity which was comparable to aspirin.", {"entities": []}], ["Both the statins exhibited significant anti-inflammatory activity ( P < 0.01) in formalin induced arthritis model though less than aspirin ( P < 0.05).", {"entities": [[98, 107, "DISEASE"]]}], ["The results of this study if substantiated by further experimental and clinical research suggest that simvastatin and atorvastatin may play an adjuvant role, which may be particularly beneficial in the treatment of inflammatory disorders, especially when there is coexisting dyslipidemia.", {"entities": []}], ["The ongoing Farmers\u2019 Cohort for Agricultural Work-related Musculoskeletal Disorders (FARM) study was developed to evaluate health status and related factors in farmers.", {"entities": []}], ["Farmers in Kangwon Province, South Korea, were recruited.", {"entities": []}], ["Baseline characteristics were determined using questionnaires about sociodemographic and health characteristics and agricultural work-related factors.", {"entities": []}], ["In addition, laboratory examinations (lumbar spinal radiography and serologic testing) were conducted.", {"entities": []}], ["The FARM study covers eight rural areas and recruited 1013 subjects (534 women; mean [standard deviation {SD}] age, 57.2 [7.5] years).", {"entities": []}], ["Musculoskeletal pain in multiple areas was reported by 925 subjects (91.3%), and low back pain (63.8%) was the most frequent site of pain.", {"entities": []}], ["Farmer\u2019s Stress Inventory (mean [SD], 77.7 [10.2]; range, 28\u2013112] and subjective stress index (mean [SD], 5.3 [2.4]; range, 0\u201310) were above median scale values, reflecting a stressful condition, while the EuroQol-5D-3L index and the EuroQol-Visual Analog Scale scores were high (mean [SD], 0.9 [0.1]; range \u22120.171\u20131 and mean [SD], 67.7 [18.7]; range 0\u2013100, respectively), reflecting good life quality.", {"entities": []}], ["In total, 53% of participants had worked in farming for more than 30 years, and workers involved in dry-field farming comprised the largest subgroup (41.5%).", {"entities": []}], ["Most participants (94.3%) had no more than a high school education, and families with annual income below 20 million won constituted the largest subgroup (36.3%).", {"entities": []}], ["The FARM study may provide data on the current health status and related sociodemographic and agricultural work-related risk factors in Korean farmers, with the goal of providing a scientific basis for developing coping interventions and preventive strategies.", {"entities": []}], ["Clarifying these effects could show potential benefits of RSV vaccination of pregnant women.", {"entities": []}], ["Given the illness and deaths caused by respiratory syncytial virus (RSV) infection during the first year of life, preventing infant RSV infections through maternal vaccination is intriguing.", {"entities": []}], ["However, little is known about the extent and maternal effects of RSV infection during pregnancy.", {"entities": []}], ["We describe 3 cases of maternal RSV infection diagnosed at a US center during winter 2014.", {"entities": []}], ["Case-patient 1 (26 years old, week 33 of gestation) received a diagnosis of RSV infection and required mechanical ventilation.", {"entities": []}], ["Case-patient 2 (27 years old, week 34 of gestation) received a diagnosis of infection with influenza A(H1N1) virus and RSV and required mechanical ventilation.", {"entities": [[91, 100, "DISEASE"]]}], ["Case-patient 3 (21 years old, week 32 of gestation) received a diagnosis of group A streptococcus pharyngitis and RSV infection and was monitored as an outpatient.", {"entities": [[98, 109, "DISEASE"]]}], ["Clarifying the effects of maternal RSV infection could yield valuable insights into potential maternal and fetal benefits of an effective RSV vaccination program.", {"entities": []}], ["Bik reduces hyperplastic epithelial cells by releasing calcium from endoplasmic reticulum stores and causing apoptosis, but the detailed mechanisms are not known.", {"entities": [[0, 3, "GENE"]]}], ["Here we report that Bik dissociates the Bak/Bcl-2 complex to enrich for ER-associated Bak and interacts with the kinase domain of DAPk1 to form Bik\u2013DAPk1\u2013ERK1/2\u2013Bak complex.", {"entities": [[20, 23, "GENE"], [144, 147, "GENE"], [130, 135, "GENE"], [148, 153, "GENE"]]}], ["Bik also disrupts the Bcl2\u2013IP 3 R interaction to cause ER Ca Bcl-2 interacting killer (Bik) decreases airway epithelial hyperplasia via apoptosis mediated by calcium release from the endoplasmic reticulum (ER), but the mechanism is unclear.", {"entities": [[0, 3, "GENE"], [87, 90, "GENE"], [0, 3, "GENE"], [87, 90, "GENE"]]}], ["Here the authors show that Bik promotes Bak enrichment at the ER to tether mitochondria for efficient calcium transfer.", {"entities": [[27, 30, "GENE"]]}], ["Little evidence on the validity of simple and widely applicable tools to predict mortality in patients with chronic obstructive pulmonary disease (COPD) exists.", {"entities": [[108, 145, "DISEASE"]]}], ["To conduct a large international study to validate the ADO index that uses age, dyspnoea and FEV 1 to predict 3-year mortality and to update it in order to make prediction of mortality in COPD patients as generalisable as possible.", {"entities": [[93, 96, "GENE"]]}], ["Individual subject data analysis of 10 European and American cohorts (n=13\u2005914).", {"entities": []}], ["Population-based, primary, secondary and tertiary care.", {"entities": []}], ["COPD GOLD stages I\u2013IV.", {"entities": []}], ["We validated the original ADO index.", {"entities": []}], ["We then obtained an updated ADO index in half of our cohorts to improve its predictive accuracy, which in turn was validated comprehensively in the remaining cohorts using discrimination, calibration and decision curve analysis and a number of sensitivity analyses.", {"entities": []}], ["1350 (9.7%) of all subjects with COPD (60% male, mean age 61\u2005years, mean FEV 1 66% predicted) had died at 3\u2005years.", {"entities": [[73, 76, "GENE"]]}], ["The original ADO index showed high discrimination but poor calibration (p<0.001 for difference between predicted and observed risk).", {"entities": []}], ["The updated ADO index (scores from 0 to 14) preserved excellent discrimination (area under curve 0.81, 95% CI 0.80 to 0.82) but showed much improved calibration with predicted 3-year risks from 0.7% (95% CI 0.6% to 0.9%, score of 0) to 64.5% (61.2% to 67.7%, score of 14).", {"entities": []}], ["The ADO index showed higher net benefit in subjects at low-to-moderate risk of 3-year mortality than FEV 1 alone.", {"entities": [[101, 104, "GENE"]]}], ["The updated 15-point ADO index accurately predicts 3-year mortality across the COPD severity spectrum and can be used to inform patients about their prognosis, clinical trial study design or benefit harm assessment of medical interventions.", {"entities": []}], ["\u201cEngagement\u201d with digital behaviour change interventions (DBCIs) is considered important for their effectiveness.", {"entities": []}], ["Evaluating engagement is therefore a priority; however, a shared understanding of how to usefully conceptualise engagement is lacking.", {"entities": []}], ["This review aimed to synthesise literature on engagement to identify key conceptualisations and to develop an integrative conceptual framework involving potential direct and indirect influences on engagement and relationships between engagement and intervention effectiveness.", {"entities": []}], ["Four electronic databases (Ovid MEDLINE, PsycINFO, ISI Web of Knowledge, ScienceDirect) were searched in November 2015.", {"entities": []}], ["We identified 117 articles that met the inclusion criteria: studies employing experimental or non-experimental designs with adult participants explicitly or implicitly referring to engagement with DBCIs, digital games or technology.", {"entities": []}], ["Data were synthesised using principles from critical interpretive synthesis.", {"entities": []}], ["Engagement with DBCIs is conceptualised in terms of both experiential and behavioural aspects.", {"entities": []}], ["A conceptual framework is proposed in which engagement with a DBCI is influenced by the DBCI itself (content and delivery), the context (the setting in which the DBCI is used and the population using it) and the behaviour that the DBCI is targeting.", {"entities": []}], ["The context and \u201cmechanisms of action\u201d may moderate the influence of the DBCI on engagement.", {"entities": []}], ["Engagement, in turn, moderates the influence of the DBCI on those mechanisms of action.", {"entities": []}], ["In the research literature, engagement with DBCIs has been conceptualised in terms of both experience and behaviour and sits within a complex system involving the DBCI, the context of use, the mechanisms of action of the DBCI and the target behaviour.", {"entities": []}], ["The online version of this article (doi:10.1007/s13142-016-0453-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The mechanism of imidazole-induced contraction on the bovine tracheal smooth muscle was investigated.", {"entities": []}], ["Imidazole induced muscle contraction in a concentration-dependent manner on bovine, porcine and guinea-pig tracheas, but not in rat or mouse.", {"entities": []}], ["In bovine tracheas, imidazole was cumulatively applied and induced muscle tension and increasesd intracellular Ca \u00b5 M, the concentration at which maximum contractile response occurs, did not significantly increase in cAMP content relative to control.", {"entities": []}], ["Atropine inhibited imidazole-induced contraction at a concentration- dependent manner and pretreatment of hemicholinium-3 almost abolished imidazole-induced contraction.", {"entities": []}], ["Conversely, pretreatment of tripelennamine, indomethacin or tetrodotoxin did not affect imidazole-induced contraction.", {"entities": []}], ["Acetylcholine or eserine induced contraction in bovine, porcine, guinea pig, rat and mice trachea in a concentration-dependent manner.", {"entities": []}], ["However, there was little difference in the rank order of maximum contraction of these agents.", {"entities": []}], ["Imidazole-induced contraction was greater in bovine trachea compared to the other species tested.", {"entities": []}], ["Further, cAMP did not appear to play a role in imidazole-induced contraction, suggesting other mechanisms, such as the release of endogenous acetylcholine.", {"entities": []}], ["Exposure to environmental tobacco smoke (ETS) leads to molecular damage in the form of DNA adducts.", {"entities": []}], ["While lung cancer risk is higher among African Americans compared to White Americans, a few studies have tested for racial differences in DNA adducts among children exposed to ETS.", {"entities": [[6, 17, "DISEASE"], [11, 17, "DISEASE"]]}], ["The purpose of this study was to test whether African American children have higher DNA adducts levels compared to White children adjusted for ETS exposure.", {"entities": []}], ["Data and biologic specimens were drawn from an existing cohort of 212 asthmatic children.", {"entities": []}], ["These subjects participated in a 12-month ETS-reduction trial that employed HEPA air cleaners with active filter cartridges and sham filter cartridges.", {"entities": []}], ["White blood cell (WBC) DNA was analyzed for DNA adducts using The mean age of the subjects was 8.4\u00a0years; 55% were African American.", {"entities": []}], ["There was no difference in DNA adduct levels between African American and White children (11.8 vs. 11.2 adducts per 10 p \u00a0=\u00a00.86), despite slightly higher levels of air nicotine exposure (3.4 vs. 2.2\u00a0\u03bcg/m p \u00a0=\u00a00.14).", {"entities": []}], ["African American children used their air cleaners less often than White children.", {"entities": []}], ["We found that the best predictor of DNA adduct levels was the duration of air cleaner use ( r \u00a0=\u00a0\u22120.133, p \u00a0=\u00a00.056).", {"entities": []}], ["This association was independent of cartridge type.", {"entities": []}], ["We did not see differences in adduct levels by race even after accounting for the level of ETS exposure.", {"entities": []}], ["However, there was a marginal inverse association between air cleaner use and adducts.", {"entities": []}], ["Additional research is required to understand this phenomenon.", {"entities": []}], ["Inhibiting osteoclasts and osteoclast precursors to reduce bone resorption is an important strategy to treat osteoclast-related diseases, such as osteoporosis, inflammatory bone loss, and malignant bone metastasis.", {"entities": [[146, 158, "DISEASE"]]}], ["However, the mechanism by which apoptosis is induced in the osteoclasts and their precursors are not completely understood.", {"entities": []}], ["Here, we used nitrogen-containing bisphosphonate zoledronic acid (ZA) to induce cell apoptosis in human and murine osteoclast precursors and mature osteoclast-like cells.", {"entities": []}], ["Caspase-3-mediated cell apoptosis occurred following the ZA (100\u2009\u03bcM) treatment.", {"entities": []}], ["Reactive oxygen species (ROS) were also generated in a time-dependent manner.", {"entities": []}], ["Following knock-down of the p47", {"entities": []}], ["Ketamine is a derivative of phencyclidine and is a dissociative anaesthetic.", {"entities": []}], ["Its use as a recreational drug is on the increase among young adults attending clubs and parties.", {"entities": []}], ["We describe the case of a 20-year-old man who presented with a 7-month history of urinary frequency, nocturia, urgency, suprapubic discomfort during micturition and episodes of severe haematuria shortly after commencing weekly recreational ketamine use.", {"entities": []}], ["Complementary examinations were negative except for a thickened bladder wall on ultrasound examination and mild inflammatory changes on cystoscopy.", {"entities": []}], ["So far only nine cases of ketamine-associated ulcerative cystitis have been described.", {"entities": [[57, 65, "DISEASE"]]}], ["We expect that in the future an increasing number of cases of cystitis caused by ketamine use will be seen in young adults.", {"entities": [[62, 70, "DISEASE"]]}], ["Early-onset cataracts are associated with insufficient antioxidative activity, and, therefore, a potential risk of cancer.", {"entities": [[115, 121, "DISEASE"]]}], ["This study investigated the risk of cancer after being diagnosed with early-onset cataracts.", {"entities": [[36, 42, "DISEASE"]]}], ["Retrospective claims data from the Taiwan National Health Insurance Research Database were analyzed.", {"entities": []}], ["Study subjects were comprised of patients with early-onset cataracts, aged 20\u201355 years (International Classification of Diseases, 9th Revision, Clinical Modification [ICD-9-CM] code 366.00, 366.01, 366.02, 366.03, 366.04, 366.09, 366.17 and 366.18) and newly diagnosed between 1997 and 2010 ( n = 1281), and a comparison cohort without the disease ( n = 5124).", {"entities": []}], ["Both cohorts were followed up until 2010 to estimate the incidences of cancer.", {"entities": [[71, 77, "DISEASE"]]}], ["We used the Poisson regression model to compare incidence rate ratios and the 95% confidence interval (CI).", {"entities": []}], ["Cox proportional hazards regression was used to assess the hazard ratio (HR) of cancer associated with early-onset cataracts.", {"entities": [[80, 86, "DISEASE"], [73, 75, "GENE"]]}], ["The overall incidence rate of all cancers was 2.19-fold higher in the early-onset cataract cohort than in the comparison cohort (8.06 vs 3.68 per 1000 person-years) with an adjusted HR of 2.13 (95% CI = 1.48, 3.07).", {"entities": [[82, 90, "DISEASE"], [182, 184, "GENE"]]}], ["The site-specific analysis also showed a strong relationship, with adjusted HR of 3.24 ((95% CI = 1.30, 8.10) for head and neck cancer, 3.29 (95% CI 1.16, 9.31) for hepatoma and 3.19 (95% CI 1.34, 7.58) for breast cancer.", {"entities": [[207, 220, "DISEASE"], [128, 134, "DISEASE"], [214, 220, "DISEASE"], [76, 78, "GENE"]]}], ["The present study suggests that patients with early-onset cataracts are at an increased risk of being diagnosed with cancer in subsequent years.", {"entities": [[117, 123, "DISEASE"]]}], ["Anemia is commonly seen in preterm infants.", {"entities": [[0, 6, "DISEASE"]]}], ["It may reduce the capacity of hemoglobin to transport oxygen throughout the body and may result in tissue and organ dysfunction.", {"entities": []}], ["This study aimed to investigate the effect of anemia on the development of bronchopulmonary dysplasia (BPD) in preterm infants.", {"entities": [[46, 52, "DISEASE"]]}], ["243 infants who were admitted to BaYi Children\u2019s Hospital Affiliated to Clinical Medical College in Beijing Military General Hospital with gestational age (GA) less than 32 weeks from February, 2014 to February, 2015 were included in the study.", {"entities": []}], ["Maternal and infant data were recorded.", {"entities": []}], ["Multivarariate logistic regression analysis was performed to determine the association between anemia and BPD.", {"entities": [[95, 101, "DISEASE"]]}], ["Of 243 preterm infants, the incidence of anemia was higher in BPD patients than non-BPD patients ( p \u2009<\u20090.001).", {"entities": [[41, 47, "DISEASE"]]}], ["Mean Hct in BPD patients was lower than non-BPD patients at different time points in 1d, 7d, 14d, and 21d.", {"entities": []}], ["Controlling for other confounding factors, early anemia was associated with an increased risk of BPD.", {"entities": [[49, 55, "DISEASE"]]}], ["Number of transfusions is also a significant risk factor for BPD ( p \u2009=\u20090.001).", {"entities": []}], ["Therefore, prevention and treatment of early anemia is necessary and reducing number of transfusions may reduce the incidence of BPD in preterm infants.", {"entities": [[45, 51, "DISEASE"]]}], ["This study explored the development and comorbidity of allergic diseases by analysing the relationship between allergic manifestations in infancy and at the age of 8.", {"entities": []}], ["We included 5654 children born in Sweden in 2003 in a longitudinal study.", {"entities": []}], ["Parents answered postal questionnaires when the children were six months and one, four\u2010and\u2010a\u2010half and eight\u00a0years of age.", {"entities": []}], ["The response rate at eight years was 4051 (71.6%), and we analysed 3382 children with complete data.", {"entities": []}], ["The number of manifestations in infancy increased the risk of allergic disease at eight years of age: 72% of children with one early manifestation were symptom free at 8, compared to 45% with two or more manifestations.", {"entities": []}], ["Similar manifestations occurred in infancy and at the age of 8, for example recurrent wheeze increased the risk of doctor\u2010diagnosed asthma by an adjusted odds ratio of 6.5.", {"entities": [[132, 138, "DISEASE"]]}], ["Eczema and food allergy independently increased the risk of all four allergic manifestations at eight years.", {"entities": [[11, 23, "DISEASE"]]}], ["Allergic disease at the age of 8 was related to the number of allergic manifestations in infancy.", {"entities": []}], ["Manifestations were similar at both ages, suggesting an allergic march with the coexistence of disease patterns rather than the progressive development of one disease.", {"entities": []}], ["Systemic inflammation may be one of the mechanisms mediating the association between ambient air pollution and cardiovascular morbidity and mortality.", {"entities": []}], ["Interleukin-6 (IL-6) and fibrinogen are biomarkers of systemic inflammation that are independent risk factors for cardiovascular disease.", {"entities": []}], ["We investigated the association between ambient air pollution and systemic inflammation using baseline measurements of IL-6 and fibrinogen from controlled human exposure studies.", {"entities": []}], ["In this retrospective analysis we used repeated-measures data in 45 nonsmoking subjects.", {"entities": []}], ["Hourly and daily moving averages were calculated for ozone, nitrogen dioxide, sulfur dioxide, and particulate matter \u2264 2.5 \u03bcm in aerodynamic diameter (PM 2.5 ).", {"entities": []}], ["Linear mixed-model regression determined the effects of the pollutants on systemic IL-6 and fibrinogen.", {"entities": []}], ["Effect modification by season was considered.", {"entities": []}], ["We observed a positive association between IL-6 and O 3 [0.31 SD per O 3 interquartile range (IQR); 95% confidence interval (CI), 0.08\u20130.54] and between IL-6 and SO 2 (0.25 SD per SO 2 IQR; 95% CI, 0.06\u20130.43).", {"entities": []}], ["We observed the strongest effects using 4-day moving averages.", {"entities": []}], ["Responses to pollutants varied by season and tended to be higher in the summer, particularly for O 3 and PM 2.5 .", {"entities": []}], ["Fibrinogen was not associated with pollution.", {"entities": []}], ["This study demonstrates a significant association between ambient pollutant levels and baseline levels of systemic IL-6.", {"entities": []}], ["These findings have potential implications for controlled human exposure studies.", {"entities": []}], ["Future research should consider whether ambient pollution exposure before chamber exposure modifies IL-6 response.", {"entities": []}], ["Non-Alcoholic Fatty Liver Disease (NAFLD) is a distinct coronary artery disease (CAD) risk factor.", {"entities": []}], ["The atherosclerotic process predisposing to CAD includes altered lipid profile and inflammatory processes.", {"entities": []}], ["The available evidence suggests that increased circulating levels of eotaxin, an eosinophil chemoattractant cytokine implicated in allergic responses, are detected in the serum of patients with CAD.", {"entities": []}], ["Relationships were sought between serum eotaxin on the one hand, and intima-media thickness\u2014an early predictor of the atherosclerotic process, hepatic steatosis, arterial blood pressure values, as well as inflammation/immune markers and angiogenetic factors\u2014on the other.", {"entities": []}], ["Eighty obese patients with NAFLD, diagnosed at ultrasonography, without evident cytolysis, formed our study population.", {"entities": []}], ["Anthropometric measures, metabolic profile, serum concentrations of interleukin-1\u03b2, C-reactive protein, interleukin-6, fibrinogen, ferritin, TNF-\u03b1, spleen size, vascular endothelial growth factor, platelet-derived growth factor-BB and heat shock protein-70 were evaluated.", {"entities": []}], ["Serum eotaxin concentrations were distinctly associated with TNF \u03b1, IL-6, IL-1\u03b2, VEGF and PDGF-BB levels but not with CRP, fibrinogen, heat shock protein-70 or spleen size.", {"entities": [[61, 64, "GENE"], [118, 121, "GENE"]]}], ["Among the metabolic and anthropometric parameters, a significant predictive power emerged when comparing eotaxin to insulin resistance, expressed as HOMA.", {"entities": []}], ["NAFLD was distinctly associated with HOMA (P\u200a=\u200a0.0005).", {"entities": []}], ["Intima-media thickness was well predicted by both eotaxin levels and severity of NAFLD at ultrasonography, although no relation was detected between these last two variables.", {"entities": []}], ["A role for insulin resistance in mediating the interplay between eotaxin and other inflammation/immune parameters could be evidenced in the induction/maintenance of atherosclerosis of obese patients with NAFLD.", {"entities": [[165, 180, "DISEASE"]]}], ["Surgery is supposed to modulate the production of carbon monoxide by the reduction of heme oxygenase activity or transcriptional regulation of inducible heme oxygenase.", {"entities": []}], ["On the other hand, the inhalation of tobacco smoke can substantially raise the level of carboxyhemoglobin in the blood.", {"entities": []}], ["Furthermore, methemoglobin is maintained at a constant level.", {"entities": []}], ["However, excessive production of methemoglobin relative to total methemoglobin reductase activity results in methemoglobin increase.", {"entities": []}], ["The aim of our study was to investigate the perioperative variations of carboxyhemoglobin and methemoglobin during urologic surgeries, and at the same time to evaluate the changes in methemoglobin as a possible indicator of nitric oxide generation.", {"entities": []}], ["Our second aim was to evaluate the effect of preoxygenation on the level of carboxyhemoglobin and methemoglobin and the influence of blood transfusion on their changes.", {"entities": []}], ["The study included 30 patients scheduled for urologic surgery under general endotracheal anesthesia, aged 18\u201360 years without any history of respiratory disease, divided into two groups.", {"entities": []}], ["The study group comprised patients who were smoking cigarettes or tobacco pipe, while the control group included non-smokers.", {"entities": []}], ["In both groups carboxyhemoglobin (COHb) and methemoglobin (MetHb) levels were determined preoperatively, after preoxygenation, and postoperatively.", {"entities": []}], ["COHb levels were decreased postoperatively in both groups.", {"entities": []}], ["The average values of COHb between the two groups were statistically significantly different (p=0.00).", {"entities": []}], ["MetHb levels increased postoperatively in the group of smokers and decreased in the group of non-smokers.", {"entities": []}], ["There were no statistically significant differences in the average postoperative MetHb levels between the two groups.", {"entities": []}], ["Changes in carboxyhemoglobin and methemoglobin concentrations in arterial blood occur during urologic surgery, although these amplitudes are small when compared with carbon monoxide intoxication and methemoglobinemia.", {"entities": [[199, 216, "DISEASE"]]}], ["It is likely that organ perfusion and functions are affected by these monoxide gas mediators during urologic surgery.", {"entities": []}], ["In our previous study, we identified an association of high expression of c3orf1 , also known as TIMMDC1 (translocase of inner mitochondrial membrane domain-containing protein 1), with metastatic characteristics in lung carcinoma cells.", {"entities": [[220, 229, "DISEASE"], [215, 229, "DISEASE"], [74, 80, "GENE"]]}], ["To investigate the preliminary function and mechanism of this mitochondrial protein, we depleted C3orf1 expression by introducing siRNA into 95D lung carcinoma cells.", {"entities": [[150, 159, "DISEASE"], [145, 159, "DISEASE"], [97, 103, "GENE"]]}], ["We demonstrated that C3orf1 depletion significantly suppressed 95D cell growth and migration.", {"entities": [[21, 27, "GENE"]]}], ["We confirmed C3orf1 localization in the inner mitochondrial membrane and showed that mitochondrial viability, membrane potential, and ATPase activity were remarkably reduced upon depletion of C3orf1.", {"entities": [[13, 19, "GENE"], [192, 198, "GENE"], [13, 19, "GENE"], [192, 198, "GENE"]]}], ["Microarray data indicated that genes involved in regulation of cell death, migration, and cell-cycle arrest were significantly altered after C3orf1 depletion for 48 h. The expression of genes involved in focal adhesion, ECM-receptor interaction, and p53-signaling pathways were notably altered.", {"entities": [[141, 147, "GENE"]]}], ["Furthermore, cell-cycle arrest genes such as CCNG2 and PTEN as well as genes involved in cell migration inhibition, such as TIMP3 and COL3A1, were upregulated after C3orf1 depletion in 95D cells.", {"entities": [[45, 50, "GENE"], [55, 59, "GENE"], [124, 129, "GENE"], [134, 140, "GENE"], [165, 171, "GENE"]]}], ["Concurrently, expression of the migration-promoting gene NUPR1 was markedly reduced, as confirmed by real-time PCR.", {"entities": [[57, 62, "GENE"]]}], ["We conclude that C3orf1 is critical for mitochondrial function, migration, and proliferation in 95D lung carcinoma cells.", {"entities": [[105, 114, "DISEASE"], [100, 114, "DISEASE"], [17, 23, "GENE"]]}], ["Depletion of C3orf1 inhibited cell migration and cell proliferation in association with upregulation of genes involved in cell-cycle arrest and cell migration inhibition.", {"entities": [[13, 19, "GENE"]]}], ["These results suggest that C3orf1 (TIMMDC1) may be a viable treatment target for lung carcinoma, and that further study of the role of this protein in lung carcinoma pathogenesis is justified.", {"entities": [[86, 95, "DISEASE"], [156, 165, "DISEASE"], [81, 95, "DISEASE"], [151, 165, "DISEASE"], [27, 33, "GENE"]]}], ["Brazil never had segregation laws defining membership of an ethnoracial group.", {"entities": []}], ["Thus, the composition of the Brazilian population is mixed, and its ethnoracial classification is complex.", {"entities": []}], ["Previous studies showed conflicting results on the correlation between genome ancestry and ethnoracial classification in Brazilians.", {"entities": []}], ["We used 370,539 Single Nucleotide Polymorphisms to quantify this correlation in 5,851 community-dwelling individuals in the South (Pelotas), Southeast (Bambui) and Northeast (Salvador) Brazil.", {"entities": []}], ["European ancestry was predominant in Pelotas and Bambui (median = 85.3% and 83.8%, respectively).", {"entities": []}], ["African ancestry was highest in Salvador (median = 50.5%).", {"entities": []}], ["The strength of the association between the phenotype and median proportion of African ancestry varied largely across populations, with pseudo R", {"entities": []}], ["Type 2 diabetes in midlife or late life increases the risk of Alzheimer disease (AD), and type 1 diabetes has been associated with a higher risk of detrimental cognitive outcomes, although studies from older adults are lacking.", {"entities": []}], ["We investigated whether individuals with AD were more likely to have a history of diabetes than matched controls from the general aged population.", {"entities": []}], ["Information on reimbursed diabetes medication (including both type 1 and 2 diabetes) of all Finnish individuals with reimbursed AD medication in 2005 ( n = 28,093) and their AD-free control subjects during 1972\u20132005 was obtained from a special reimbursement register maintained by the Social Insurance Institute of Finland.", {"entities": []}], ["The prevalence of diabetes was 11.4% in the whole study population, 10.7% ( n = 3,012) among control subjects, and 12.0% ( n = 3,372) among AD case subjects.", {"entities": []}], ["People with AD were more likely to have diabetes than matched control subjects (unadjusted OR 1.14 [95% CI 1.08\u20131.20]), even after adjusting for cardiovascular diseases (OR 1.31 [1.22\u20131.41]).", {"entities": []}], ["The associations were stronger with diabetes diagnosed at midlife (adjusted OR 1.60 [1.34\u20131.84] and 1.25 [1.16\u20131.36] for midlife and late-life diabetes, respectively).", {"entities": []}], ["Individuals with clinically verified AD are more likely to have a history of clinically verified and medically treated diabetes than the general aged population, although the difference is small.", {"entities": []}], ["Using the French claims database (Syst\u00e8me National d'Information Inter-R\u00e9gimes de l'Assurance Maladie) linked to the hospital discharge database (Programme de M\u00e9dicalisation des Syst\u00e8mes d'Information), this observational study compared the effectiveness of rosuvastatin and simvastatin prescribed at doses with close LDL-cholesterol-lowering potency on all-cause mortality and cardiovascular and cerebrovascular diseases (CCDs) in primary prevention.", {"entities": [[174, 177, "GENE"]]}], ["This historical cohort included patients with no prior CCD, aged 40\u201379\u2009years, who initiated statin therapy with rosuvastatin 5\u2009mg or simvastatin 20\u2009mg in 2008\u20132009 in general practice.", {"entities": []}], ["Follow-up started after a 1-year period used to select patients who regularly received the initial treatment.", {"entities": []}], ["In an intention-to-treat analysis, patients were followed up to December 2011.", {"entities": []}], ["In a per-protocol analysis, they were censored prematurely when they discontinued their initial treatment.", {"entities": []}], ["Adjustment for baseline covariates (age, deprivation index, comedications, comorbidities, prior hospital admissions) was carried out by a Cox proportional hazards model.", {"entities": []}], ["In the per-protocol analysis, estimation was done by \u201cinverse probability of censoring weighting\u201d using additional time-dependent covariates.", {"entities": []}], ["Analyses were gender-specific.", {"entities": []}], ["A total of 106\u2009941 patients initiated statin therapy with rosuvastatin 5\u2009mg and 56\u2009860 with simvastatin 20\u2009mg.", {"entities": []}], ["Mean follow-up was 35.8\u2009months.", {"entities": []}], ["For both genders and both types of analyses, the difference in incidence rates of mortality and/or CCD between rosuvastatin 5\u2009mg and simvastatin 20\u2009mg users was not statistically significant after adjustment (e.g., for CCD and/or mortality in men, in intention-to-treat analysis HR\u2009=\u20090.94 [95% CI\u2009=\u20090.85\u20131.04], in per-protocol analysis HR\u2009=\u20090.98 [0.87\u20131.10]).", {"entities": [[279, 281, "GENE"], [336, 338, "GENE"], [279, 281, "GENE"], [336, 338, "GENE"]]}], ["The results of this real-life study based on medico-administrative databases do not support preferential prescription of rosuvastatin compared to simvastatin for primary prevention of CCD.", {"entities": []}], ["To characterize the extent and impact of ancestry-related biases in precision genomic medicine, we use 642 whole-genome sequences from the Consortium on Asthma among African-ancestry Populations in the Americas (CAAPA) project to evaluate typical filters and databases.", {"entities": []}], ["We find significant correlations between estimated African ancestry proportions and the number of variants per individual in all variant classification sets but one.", {"entities": []}], ["The source of these correlations is highlighted in more detail by looking at the interaction between filtering criteria and the ClinVar and Human Gene Mutation databases.", {"entities": []}], ["ClinVar's correlation, representing African ancestry-related bias, has changed over time amidst monthly updates, with the most extreme switch happening between March and April of 2014 ( r =0.733 to r =\u22120.683).", {"entities": []}], ["We identify 68 SNPs as the major drivers of this change in correlation.", {"entities": []}], ["As long as ancestry-related bias when using these clinical databases is minimally recognized, the genetics community will face challenges with implementation, interpretation and cost-effectiveness when treating minority populations.", {"entities": []}], ["Personalized medicine requires accurate and ethnicity-optimized reference genome panels.", {"entities": []}], ["Here, the Consortium on Asthma among African-ancestry Populations in the Americas (CAAPA) evaluates typical variant filters and existing genome databases against newly sequenced African-ancestry populations.", {"entities": []}], ["Several studies conducted during the past two decades suggested increasing trend of childhood allergic diseases in China.", {"entities": []}], ["However, few studies have provided detailed description of geographic variation and explored risk factors of these diseases.", {"entities": []}], ["This study investigated the pattern and risk factors of asthma, allergic rhinitis and eczema in eight metropolitan cities in China.", {"entities": [[64, 81, "DISEASE"], [73, 81, "DISEASE"], [56, 62, "DISEASE"]]}], ["We conducted a cross-sectional survey during November-December 2005 in eight metropolitan cities in China.", {"entities": []}], ["A total of 23791 children aged 6-13 years participated in this survey.", {"entities": []}], ["Questions from the standard questionnaire of the International Study of Asthma and Allergies in Children (ISAAC) were used to examine the pattern of current asthma, allergic rhinitis and eczema.", {"entities": [[165, 182, "DISEASE"], [174, 182, "DISEASE"], [72, 78, "DISEASE"], [157, 163, "DISEASE"]]}], ["Logistic regression analyses were performed to assess the risk factors for childhood allergies.", {"entities": []}], ["The average prevalence of childhood asthma, allergic rhinitis and eczema across the eight cities was 3\u22193% (95% Confidence interval (CI): 3\u22191%, 3\u22196%), 9\u22198% (95% CI: 9\u22194%, 10\u22192%) and 5\u22195% (95% CI: 5\u22192%, 5\u22198%), respectively.", {"entities": [[44, 61, "DISEASE"], [53, 61, "DISEASE"], [36, 42, "DISEASE"]]}], ["Factors related to lifestyle, mental health and socio-economic status were found to be associated with the prevalence of childhood allergies.", {"entities": []}], ["These risk factors were unevenly distributed across cities and disproportionately affected the local prevalence.", {"entities": []}], ["There was apparent geographic variation of childhood allergies in China.", {"entities": []}], ["Socio-environmental factors had strong impacts on the prevalence of childhood allergies; but these impacts differed across regions.", {"entities": []}], ["Thus public health policies should specifically target at the local risk factors for each individual area.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) has been associated with periodontal disease (PD), and periodontal treatment (PT) has been connected to reduction of lung disease exacerbations.", {"entities": [[70, 89, "DISEASE"], [162, 174, "DISEASE"]]}], ["Bronchiectasis has many clinical similarities with COPD but, although it is also a chronic lung disease, to date it has not been studied with relation to PD.", {"entities": [[0, 14, "DISEASE"], [91, 103, "DISEASE"]]}], ["The aim of this study is to evaluate whether PT associated with photodynamic therapy (PDT) reduces the number of exacerbations, improves pulmonary function, periodontal clinical parameters and quality of life after 1\u00a0year of periodontal treatment follow-up.", {"entities": []}], ["Bronchiectasis patients will undergo medical anamnesis and periodontal examination.", {"entities": [[0, 14, "DISEASE"]]}], ["Participants with periodontitis will be divided into two groups and PT will be performed as G1 control group ( n \u2009=\u200932) \u2013 OHO (oral hygiene orientation)\u2009+\u2009supragingival treatment\u2009+\u2009simulation of using photodynamic therapy (PDT); G2 experimental ( n \u2009=\u200932) \u2013 scaling and root planing\u2009+\u2009PDT\u2009+\u2009OHO.", {"entities": [[18, 31, "DISEASE"]]}], ["Lung function will be assessed both at baseline and after 1\u00a0year by spirometry, exacerbation history will be analyzed through clinical records monitoring.", {"entities": []}], ["Three instruments for quality of life assessment will also be applied \u2013 Saint George\u2019s Respiratory Questionnaire and Impact Profile Analysis Oral health (OHIP-14).", {"entities": []}], ["It is expected that periodontal treatment can improve the analyzed parameters after 1\u00a0year.", {"entities": []}], ["Although only one study evaluates exacerbation in COPD after 1\u00a0year of PT, bronchiectasis has not been studied in the dentistry field to date.", {"entities": [[75, 89, "DISEASE"]]}], ["Trial registration: NCT02514226.", {"entities": []}], ["Version #1.", {"entities": []}], ["This study protocol receives grant from FAPESP (S\u00e3o Paulo Research Foundation) #2015/20535-1.", {"entities": []}], ["First received: July 22, 2015, 1", {"entities": []}], ["Direct chest-wall percussion can reduce breathlessness in Chronic Obstructive Pulmonary Disease and respiratory function may be improved, in health and disease, by respiratory muscle training (RMT).", {"entities": []}], ["We tested whether high-frequency airway oscillation (HFAO), a novel form of airflow oscillation generation can modulate induced dyspnoea and respiratory strength and/or patterns following 5 weeks of HFAO training (n\u200a=\u200a20) compared to a SHAM-RMT (conventional flow-resistive RMT) device (n\u200a=\u200a15) in healthy volunteers (13 males; aged 20\u201336 yrs).", {"entities": []}], ["HFAO causes oscillations with peak-to-peak amplitude of 1 cm H 2 O, whereas the SHAM-RMT device was identical but created no pressure oscillation.", {"entities": []}], ["Respiratory function, dyspnoea and ventilation during 3 minutes of spontaneous resting ventilation, 1 minute of maximal voluntary hyperventilation and 1 minute breathing against a moderate inspiratory resistance, were compared PRE and POST 5-weeks of training (2\u00d730 breaths at 70% peak flow, 5 days a week).", {"entities": []}], ["Training significantly reduced NRS dyspnoea scores during resistive loaded ventilation, both in the HFAO (p\u200a=\u200a0.003) and SHAM-RMT (p\u200a=\u200a0.005) groups.", {"entities": []}], ["Maximum inspiratory static pressure (cm H 2 O) was significantly increased by HFAO training (vs. PRE; p<0.001).", {"entities": []}], ["Maximum inspiratory dynamic pressure was increased by training in both the HFAO (vs. PRE; p<0.001) and SHAM-RMT (vs. PRE; p\u200a=\u200a0.021) groups.", {"entities": []}], ["Peak inspiratory flow rate (L.s", {"entities": []}], ["Background: Immunoglobulin E (IgE) has two cellular receptors, Fc\u03f5RI and CD23, that mediate distinct functional effects.", {"entities": []}], ["Results: We have identified the CD23 binding site on IgE and show that Fc\u03f5RI and CD23 allosterically compete for binding.", {"entities": []}], ["Conclusion: A mechanism of communication exists within the IgE molecule to prevent simultaneous engagement with the two receptors.", {"entities": []}], ["Significance: Competition between IgE receptors explains ligand cross-regulation.", {"entities": []}], ["IgE, the antibody that mediates allergic responses, acts as part of a self-regulating protein network.", {"entities": []}], ["Its unique effector functions are controlled through interactions of its Fc region with two cellular receptors, Fc\u03f5RI on mast cells and basophils and CD23 on B cells.", {"entities": []}], ["IgE cross-linked by allergen triggers mast cell activation via Fc\u03f5RI, whereas IgE-CD23 interactions control IgE expression levels.", {"entities": []}], ["We have determined the CD23 binding site on IgE, using a combination of NMR chemical shift mapping and site-directed mutagenesis.", {"entities": []}], ["We show that the CD23 and Fc\u03f5RI interaction sites are at opposite ends of the C\u03f53 domain of IgE, but that receptor binding is mutually inhibitory, mediated by an allosteric mechanism.", {"entities": []}], ["This prevents CD23-mediated cross-linking of IgE bound to Fc\u03f5RI on mast cells and resulting antigen-independent anaphylaxis.", {"entities": []}], ["The mutually inhibitory nature of receptor binding provides a degree of autonomy for the individual activities mediated by IgE-Fc\u03f5RI and IgE-CD23 interactions.", {"entities": []}], ["Organelle remodeling processes are evolutionarily conserved and involved in cell functions during development, aging, and cell death.", {"entities": []}], ["Some endogenous and exogenous molecules can modulate these processes.", {"entities": []}], ["Docosahexaenoic acid (DHA), an omega-3 polyunsaturated fatty acid, has mainly been considered as a modulator of plasma membrane fluidity in brain development and aging, while DHA\u2019s role in organelle remodeling in specific neural cell types at the ultrastructural level remains largely unexplored.", {"entities": []}], ["DHA is notably incorporated into dynamic organelles named lipid bodies (LBs).", {"entities": []}], ["We hypothesized that DHA could attenuate the inflammatory response in lipopolysaccharide (LPS)-activated microglia by remodeling LBs and altering their functional interplay with mitochondria and other associated organelles.", {"entities": []}], ["We used electron microscopy to analyze at high spatial resolution organelle changes in N9 microglial cells exposed to the proinflammogen LPS, with or without DHA supplementation.", {"entities": []}], ["Our results revealed that DHA reverses several effects of LPS in organelles.", {"entities": []}], ["In particular, a large number of very small and grouped LBs was exclusively found in microglial cells exposed to DHA.", {"entities": []}], ["In contrast, LBs in LPS-stimulated cells in the absence of DHA were sparse and large.", {"entities": []}], ["LBs formed in the presence of DHA were generally electron-dense, suggesting DHA incorporation into these organelles.", {"entities": []}], ["The accumulation of LBs in microglial cells from mouse and human was confirmed in situ.", {"entities": []}], ["In addition, DHA induced numerous contacts between LBs and mitochondria and reversed the frequent disruption of mitochondrial integrity observed upon LPS stimulation.", {"entities": []}], ["Dilation of the endoplasmic reticulum lumen was also infrequent following DHA treatment, suggesting that DHA reduces oxidative stress and protein misfolding.", {"entities": []}], ["Lipidomic analysis in N9 microglial cells treated with DHA revealed an increase in phosphatidylserine, indicating the role of this phospholipid in normalization and maintenance of physiological membrane functions.", {"entities": []}], ["This finding was supported by a marked reduction of microglial filopodia and endosome number and significant reduction of LPS-induced phagocytosis.", {"entities": []}], ["DHA attenuates the inflammatory response in LPS-stimulated microglial cells by remodeling LBs and altering their interplay with mitochondria and other associated organelles.", {"entities": []}], ["Our findings point towards a mechanism by which omega-3 DHA participates in organelle reorganization and contributes to the maintenance of neural cell homeostasis.", {"entities": []}], ["The online version of this article (doi:10.1186/s12974-016-0580-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The present study investigated the associations of active, passive, and electronic cigarette (E-cigarette) smoking with asthma in Korean adolescents.", {"entities": [[120, 126, "DISEASE"]]}], ["We used the cross-sectional study of Korea Youth Risk Behavior Web-based Survey conducted in 2011, 2012 and 2013.", {"entities": []}], ["Active smoking was classified into 4 groups (0 days, 1\u20135 days, 6\u201319 days, and \u226520 days a month).", {"entities": []}], ["Passive smoking was also categorized into 4 groups (0 days, 1\u20132 days, 3\u20134 days, and \u22655 days a week).", {"entities": []}], ["E-cigarette was defined as yes or no in the last 30 days.", {"entities": []}], ["Age, sex, obesity, region of residence, economic level, and parental educational level were adjusted for as confounders.", {"entities": [[10, 17, "DISEASE"]]}], ["Smoking variables were adjusted for one another.", {"entities": []}], ["Adjusted odd ratios (AORs) and 95% confidence intervals (CIs) were calculated using multiple logistic regression analysis with complex sampling.", {"entities": []}], ["In total, 2.3% (4,890/216,056) of participants reported asthma in the past 12 months.", {"entities": [[56, 62, "DISEASE"]]}], ["Active smoking was significantly associated with asthma (AOR [95% CI] of smoking \u226520 days/month\u2009=\u20091.57 [1.38\u20131.77], P\u2009<\u20090.001).", {"entities": [[49, 55, "DISEASE"]]}], ["Passive smoking was also related with asthma (AOR [95% CI] of smoking \u22655 days/week\u2009=\u20091.40 [1.28\u20131.53], P\u2009<\u20090.001).", {"entities": [[38, 44, "DISEASE"]]}], ["E-cigarette showed positive relation with asthma, although the effects of past smoking history could not be excluded (AOR [95% CI]\u2009=\u20091.12 [1.01\u20131.26], P\u2009=\u20090.027).", {"entities": [[42, 48, "DISEASE"]]}], ["Exposure to ambient particulate matter (PM) has been associated with reduced lung function.", {"entities": []}], ["Elemental components of PM have been suggested to have critical roles in PM toxicity, but their contribution to respiratory effects remains under-investigated.", {"entities": []}], ["We evaluated the effects of traffic-related PM 2.5 and its elemental components on lung function in two highly exposed groups of healthy adults in Beijing, China.", {"entities": []}], ["The Beijing Truck Driver Air Pollution Study (BTDAS) included 60 truck drivers and 60 office workers evaluated in 2008.", {"entities": []}], ["On two days separated by 1-2 weeks, we measured lung function at the end of the work day, personal PM 2.5 , and nine elemental components of PM 2.5 during eight hours of work, i.e., elemental carbon (EC), potassium (K), sulfur (S), iron (Fe), silicon (Si), aluminum (Al), zinc (Zn), calcium (Ca), and titanium (Ti).", {"entities": []}], ["We used covariate-adjusted mixed-effects models including PM 2.5 as a covariate to estimate the percentage change in lung function associated with an inter-quartile range (IQR) exposure increase.", {"entities": []}], ["The two groups had high and overlapping exposure distributions with mean personal PM 2.5 of 94.6\u00a0\u03bcg/m 2.5 .", {"entities": []}], ["However, FEV1 showed negative associations with concentrations of four elements: Si (-3.07%, 95% CI: -5.00; -1.11, IQR: 1.54), Al (-2.88%, 95% CI: -4.91; -0.81, IQR: 0.86), Ca (-1.86%, 95% CI: -2.95; -0.76, IQR: 1.33), and Ti (-2.58%, 95% CI: -4.44; -0.68, IQR: 0.03), and FVC showed negative associations with concentrations of three elements: Si (-3.23%, 95% CI: -5.61; -0.79), Al (-3.26%, 95% CI: -5.73; -0.72), and Ca (-1.86%, 95% CI: -3.23; -0.47).", {"entities": []}], ["In stratified analysis, Si, Al, Ca, and Ti showed associations with lung function only among truck drivers, and no significant association among office workers.", {"entities": []}], ["Selected elemental components of PM 2.5 showed effects on lung function that were not found in analyses of particle levels alone.", {"entities": []}], ["The online version of this article (doi:10.1186/s12989-014-0051-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Obesity and physical inactivity are major societal challenges and significant contributors to the global burden of disease and healthcare costs.", {"entities": []}], ["Information and communication technologies are increasingly being used in interventions to promote behaviour change in diet and physical activity.", {"entities": []}], ["In particular, social networking platforms seem promising for the delivery of weight control interventions.", {"entities": []}], ["We intend to pilot test an intervention involving the use of a social networking mobile application and tracking devices ( Fitbit Flex 2 and Fitbit Aria scale) to promote the social comparison of weight and physical activity, in order to evaluate whether mechanisms of social influence lead to changes in those outcomes over the course of the study.", {"entities": []}], ["Mixed-methods study involving semi-structured interviews and a pre\u2013post quasi-experimental pilot with one arm, where healthy participants in different body mass index (BMI) categories, aged between 19 and 35 years old, will be subjected to a social networking intervention over a 6-month period.", {"entities": []}], ["The primary outcome is the average difference in weight before and after the intervention.", {"entities": []}], ["Secondary outcomes include BMI, number of steps per day, engagement with the intervention, social support and system usability.", {"entities": []}], ["Semi-structured interviews will assess participants\u2019 expectations and perceptions regarding the intervention.", {"entities": []}], ["Ethics approval was granted by Macquarie University\u2019s Human Research Ethics Committee for Medical Sciences on 3 November 2016 (ethics reference number 5201600716).", {"entities": []}], ["The social network will be moderated by a researcher with clinical expertise, who will monitor and respond to concerns raised by participants.", {"entities": []}], ["Monitoring will involve daily observation of measures collected by the fitness tracker and the wireless scale, as well as continuous supervision of forum interactions and posts.", {"entities": []}], ["Additionally, a protocol is in place to monitor for participant misbehaviour and direct participants-in-need to appropriate sources of help.", {"entities": []}], ["Children with abuse who are admitted to the intensive care unit (ICU) may have high mortality and morbidity and commonly require critical care immediately.", {"entities": []}], ["It is important to understand the epidemiology and clinical characteristics of these critical cases of child maltreatment.", {"entities": []}], ["We retrospectively evaluated the data for 355 children with maltreatments admitted to the ICU between 2001 and 2015.", {"entities": []}], ["Clinical factors were analyzed and compared between the abuse and the neglect groups, including age, gender, season of admission, identifying settings, injury severity score (ISS), etiologies, length of stay (LOS) in the ICU, clinical outcomes, and mortality.", {"entities": []}], ["In addition, neurologic assessments were conducted with the Pediatric Cerebral Performance Category (PCPC) scale.", {"entities": []}], ["The most common type of child maltreatments was neglect (n\u200a=\u200a259), followed by physical abuse (n\u200a=\u200a96).", {"entities": []}], ["The mean age of the abuse group was less than that of the neglect group ( P \u200a<\u200a.05).", {"entities": []}], ["Infants accounted for the majority of the abuse group, and the most common etiology of abuse was injury of the central nervous system (CNS).", {"entities": []}], ["In the neglect group, most were of the preschool age and the most common etiologies of abuse were injury of the CNS and musculoskeletal system ( P \u200a<\u200a.001).", {"entities": []}], ["The mortality rate in the ICU was 9.86%.", {"entities": []}], ["The ISS was significantly associated with mortality in both the 2 groups (both P \u200a<\u200a.05), whereas the LOS in the ICU and injuries of the CNS, musculoskeletal system, and respiratory system were all associated with mortality in the neglect group (all P \u200a<\u200a.05).", {"entities": []}], ["The PCPC scale showed poor prognosis in the abuse group as compared to the neglect group ( P \u200a<\u200a.01).", {"entities": []}], ["In the ICU, children in the abuse group had younger age, higher ISS, and worse neurologic outcome than those in the neglect group.", {"entities": []}], ["The ISS was a predictor for mortality in the abuse and neglect groups but the LOS in the ICUs, injuries of the CNS, musculoskeletal system, and respiratory system were indicators for mortality in the neglect group.", {"entities": []}], ["Most importantly, identifying the epidemiological information may provide further strategies to reduce the harm, lower the medical costs, and improve clinical care quality and outcomes in children with abuse.", {"entities": []}], ["It was nearly 100 years since heparin was discovered, but the role of this widely used anticoagulant is still remarkably thought provoking now.", {"entities": []}], ["During pathological processes such as atherosclerosis, inflammation, cancer and infection, phenomena of cell adhesion are ubiquitous and complicated.", {"entities": [[38, 53, "DISEASE"], [69, 75, "DISEASE"]]}], ["Heparin exerts anti-adhesion activity appearing as a common mechanism of its potential polypharmacology in those diseases.", {"entities": []}], ["Furthermore, heparin can bind a variety of signalling molecules such as growth factors, cell surface proteins of pathogens and most notably, cell adhesion molecules.", {"entities": []}], ["These signalling molecules are involved in cell communication, acting as ligands, receptors and second messengers.", {"entities": []}], ["Considering that heparan sulphate glycosaminoglycan is increasingly recognized as a key mediator in many cellular processes, the structural similarity with heparan sulphate suggests that heparin is a multifunctional intervenor in cell communication.", {"entities": []}], ["Due to global mercury pollution and the adverse health effects of prenatal exposure to methylmercury (MeHg), an assessment of the economic benefits of prevented developmental neurotoxicity is necessary for any cost-benefit analysis.", {"entities": []}], ["Distributions of hair-Hg concentrations among women of reproductive age were obtained from the DEMOCOPHES project (1,875 subjects in 17 countries) and literature data (6,820 subjects from 8 countries).", {"entities": []}], ["The exposures were assumed to comply with log-normal distributions.", {"entities": []}], ["Neurotoxicity effects were estimated from a linear dose-response function with a slope of 0.465 Intelligence Quotient (IQ) point reduction per \u03bcg/g increase in the maternal hair-Hg concentration during pregnancy, assuming no deficits below a hair-Hg limit of 0.58\u00a0\u03bcg/g thought to be safe.", {"entities": []}], ["A logarithmic IQ response was used in sensitivity analyses.", {"entities": []}], ["The estimated IQ benefit cost was based on lifetime income, adjusted for purchasing power parity.", {"entities": []}], ["The hair-mercury concentrations were the highest in Southern Europe and lowest in Eastern Europe.", {"entities": []}], ["The results suggest that, within the EU, more than 1.8 million children are born every year with MeHg exposures above the limit of 0.58\u00a0\u03bcg/g, and about 200,000 births exceed a higher limit of 2.5\u00a0\u03bcg/g proposed by the World Health Organization (WHO).", {"entities": []}], ["The total annual benefits of exposure prevention within the EU were estimated at more than 600,000 IQ points per year, corresponding to a total economic benefit between \u20ac8,000 million and \u20ac9,000 million per year.", {"entities": []}], ["About four-fold higher values were obtained when using the logarithmic response function, while adjustment for productivity resulted in slightly lower total benefits.", {"entities": []}], ["These calculations do not include the less tangible advantages of protecting brain development against neurotoxicity or any other adverse effects.", {"entities": []}], ["These estimates document that efforts to combat mercury pollution and to reduce MeHg exposures will have very substantial economic benefits in Europe, mainly in southern countries.", {"entities": []}], ["Some data may not be entirely representative, some countries were not covered, and anticipated changes in mercury pollution all suggest a need for extended biomonitoring of human MeHg exposure.", {"entities": []}], ["Some studies have reported a ceiling effect in EQ-5D-3L, especially in healthy and/or young individuals.", {"entities": []}], ["Recently, two further levels have been included in its measurement model (EQ-5D-5L).", {"entities": []}], ["The purposes of this study were (1) to assess the properties of the EQ-5D-5L in comparison with the standard EQ-5D-3L in a sample of young adults, (2) to foreground the importance of collecting qualitative data to confirm, validate or refine the EQ-5D questionnaire items and (3) to raise questions pertaining to the wording in these questionnaire items.", {"entities": []}], ["The data used came from a sample of respondents aged 30 or under ( n \u2009=\u2009624).", {"entities": []}], ["They completed both versions of the EQ-5D, which were compared in terms of feasibility, level of inconsistency and ceiling effect.", {"entities": []}], ["Agreement between the instruments was assessed using correlation coefficients and Bland-Altman plots.", {"entities": []}], ["Known-groups validity of the EQ-5D-5L was also assessed using non-parametric tests.", {"entities": []}], ["The discriminative properties were compared using receiver operating characteristic curves.", {"entities": []}], ["Finally, four interviews were conducted for retrospective reports to elicit respondents\u2019 understanding and perceptions of the format, instructions, items, and responses.", {"entities": []}], ["Quantitative results show a ceiling effect reduction of 25.3\u00a0% and a high level agreement between both indices.", {"entities": []}], ["Known-groups validity was confirmed for the EQ-5D-5L.", {"entities": []}], ["Explorative interviews indicated ambiguity and low degree of certainty in regards to conceptualizing differences between levels moderate-slight across three dimensions.", {"entities": []}], ["The EQ-5D-5L performed better than the EQ-5D-3L.", {"entities": []}], ["However, the explorative interviews demonstrated several limitations in the EQ-5D questionnaire wording and high context-dependent answers point to lack of illnesses\u2019 experience amongst young adults.", {"entities": []}], ["Incarceration of a household member has been linked to poor mental and behavioral health outcomes in children, but less is known about the health behaviors of these children once they reach adulthood.", {"entities": []}], ["We analyzed data from 81,910 respondents to the 2009\u20132010 Behavioral Risk Factor Surveillance System to identify associations between the childhood experience of having a household member incarcerated and adult smoking status, weight status, physical activity, and drinking patterns.", {"entities": []}], ["We used multivariable logistic regression to control for sex, age, education, and additional adverse childhood events in the whole population and in separate models for Hispanic, non-Hispanic white, and non-Hispanic black adults.", {"entities": []}], ["We also assessed for having multiple risk behaviors.", {"entities": []}], ["People who lived with an incarcerated household member during childhood were more likely as adults than those who did not to engage in smoking (adjusted odds ratio [AOR] 1.50; 95% confidence interval [CI], 1.27\u20131.77) and heavy drinking (AOR 1.39; 95% CI, 1.03\u20131.87), after controlling for demographics and additional adverse childhood events.", {"entities": []}], ["Exposure to incarceration in the household as a child among Hispanic adults was associated with being a smoker, being a heavy drinker, and having multiple risk behaviors and among white adults was associated with being a smoker and having multiple risk behaviors; among black adults there were no significant associations.", {"entities": []}], ["Incarceration of a household member during childhood is associated with adult risk behaviors, and race/ethnicity may be a factor in this association.", {"entities": []}], ["Associations between epigenetic alterations and disease status have been identified for many diseases.", {"entities": []}], ["However, there is no strong evidence that epigenetic alterations are directly causal for disease pathogenesis.", {"entities": []}], ["In this study, we combined SNP and DNA methylation data with measurements of protein biomarkers for cancer, inflammation or cardiovascular disease, to investigate the relative contribution of genetic and epigenetic variation on biomarker levels.", {"entities": [[100, 106, "DISEASE"]]}], ["A total of 121 protein biomarkers were measured and analyzed in relation to DNA methylation at 470,000 genomic positions and to over 10 million SNPs.", {"entities": []}], ["We performed epigenome-wide association study (EWAS) and genome-wide association study (GWAS) analyses, and integrated biomarker, DNA methylation and SNP data using between 698 and 1033 samples depending on data availability for the different analyses.", {"entities": []}], ["We identified 124 and 45 loci (Bonferroni adjusted P < 0.05) with effect sizes up to 0.22 standard units\u2019 change per 1% change in DNA methylation levels and up to four standard units\u2019 change per copy of the effective allele in the EWAS and GWAS respectively.", {"entities": []}], ["Most GWAS loci were cis -regulatory whereas most EWAS loci were located in trans .", {"entities": []}], ["Eleven EWAS loci were associated with multiple biomarkers, including one in NLRC5 associated with CXCL11, CXCL9, IL-12, and IL-18 levels.", {"entities": [[76, 81, "GENE"], [98, 104, "GENE"], [106, 111, "GENE"]]}], ["All EWAS signals that overlapped with a GWAS locus were driven by underlying genetic variants and three EWAS signals were confounded by smoking.", {"entities": []}], ["While some cis -regulatory SNPs for biomarkers appeared to have an effect also on DNA methylation levels, cis -regulatory SNPs for DNA methylation were not observed to affect biomarker levels.", {"entities": []}], ["We present associations between protein biomarker and DNA methylation levels at numerous loci in the genome.", {"entities": []}], ["The associations are likely to reflect the underlying pattern of genetic variants, specific environmental exposures, or represent secondary effects to the pathogenesis of disease.", {"entities": []}], ["Every human being is unique, each with an individual risk of developing disease.", {"entities": []}], ["Variation between humans can be attributed to genetic variation or the environment to which we are exposed.", {"entities": []}], ["However, phenotypic differences can also be due to the epigenetic pattern of our genes, which refers to chemical modification that affects the activity of our genes.", {"entities": []}], ["Epigenetic factors have recently gained a lot of interest, and aberrant epigenetic patterns, have been linked to many diseases.", {"entities": []}], ["In the present study, we have identified genetic and epigenetic factors that influence the activity of our genes, by way of comparing to the level of different proteins that our genes encode, proteins that have previously been associated with human diseases such as cardiovascular diseases or cancer.", {"entities": [[293, 299, "DISEASE"]]}], ["We could clearly see that the epigenetic pattern was associated with the expression of specific genes but that such associations were mainly caused by genetic variants, or environmental factors influencing both epigenetic and expression patterns.", {"entities": []}], ["However, it appeared that some disease-associated proteins could have altering effects on the epigenetic pattern, then suggesting that some epigenetic alterations represent secondary effects to the pathogenesis of disease.", {"entities": []}], ["A major problem in cost-effectiveness studies is where to draw the line between interventions which are cost-effective and those who are not.", {"entities": []}], ["Lacking a notion about the value of a QALY, all ultimate values to the cost-effectiveness ratio are essentially arbitrary.", {"entities": []}], ["This paper presents a simple empirical model to estimate the compensating income variation of diseases and health problems.", {"entities": []}], ["The model is estimated using data for the Netherlands.", {"entities": []}], ["The compensating income variation is between \u20ac20,000 and \u20ac90,000.", {"entities": []}], ["This is higher than most of the ultimate values used by policy-makers to decide whether an intervention is cost-effective.", {"entities": []}], ["Our figures are roughly similar to those found in studies about the value of a statistical life year.", {"entities": []}], ["Estimates on the compensating income variation of diseases and health problems may provide useful information on the maximum acceptable cost-effectiveness ratio of medical interventions than those currently used by policy makers.", {"entities": []}], ["MicroRNAs (miRNAs) are post-transcriptional gene suppressors and potential mediators of environmental effects.", {"entities": []}], ["In addition to human miRNAs, viral miRNAs expressed from latent viral sequences are detectable in human cells.", {"entities": []}], ["In a highly exposed population in Beijing, China, we evaluated the associations of particulate air pollution exposure on blood miRNA profiles.", {"entities": []}], ["The Beijing Truck Driver Air Pollution Study (BTDAS) included 60 truck drivers and 60 office workers.", {"entities": []}], ["We investigated associations of short-term air pollution exposure, using measures of personal PM 2.5 (particulate matter \u2264 2.5 \u03bcm) and elemental carbon (EC), and ambient PM 10 (\u2264 10 \u03bcm), with blood NanoString nCounter miRNA profiles at two exams separated by 1\u20132 weeks.", {"entities": []}], ["No miRNA was significantly associated with personal PM 2.5 at a false discovery rate (FDR) of 20%.", {"entities": []}], ["Short-term ambient PM 10 was associated with the expression of 12 miRNAs in office workers only (FDR < 20%).", {"entities": []}], ["Short-term EC was associated with differential expression of 46 human and 7 viral miRNAs, the latter including 3 and 4 viral miRNAs in office workers and truck drivers, respectively.", {"entities": []}], ["EC-associated miRNAs differed between office workers and truck drivers with significant effect modification by occupational group.", {"entities": []}], ["Functional interaction network analysis suggested enriched cellular proliferation/differentiation pathways in truck drivers and proinflammation pathways in office workers.", {"entities": []}], ["Short-term EC exposure was associated with the expression of human and viral miRNAs that may influence immune responses and other biological pathways.", {"entities": []}], ["Associations between EC exposure and viral miRNA expression suggest that latent viral miRNAs are potential mediators of air pollution\u2013associated health effects.", {"entities": []}], ["PM 2.5 /PM 10 exposures showed no consistent relationships with miRNA expression.", {"entities": []}], ["Hou L, Barupal J, Zhang W, Zheng Y, Liu L, Zhang X, Dou C, McCracken JP, D\u00edaz A, Motta V, Sanchez-Guerra M, Wolf KR, Bertazzi PA, Schwartz JD, Wang S, Baccarelli AA.", {"entities": []}], ["Particulate air pollution exposure and expression of viral and human microRNAs in blood: the Beijing Truck Driver Air Pollution Study.", {"entities": []}], ["Environ Health Perspect 124:344\u2013350;\u2002 http://dx.doi.org/10.1289/ehp.1408519", {"entities": []}], ["Increasing biomedical applications of iron oxide nanoparticles (IONPs) in academic and commercial settings have alarmed the scientific community about the safety and assessment of toxicity profiles of IONPs.", {"entities": []}], ["The great amount of diversity found in the cytotoxic measurements of IONPs points toward the necessity of careful characterization and quantification of IONPs.", {"entities": []}], ["The present document discusses the major developments related to in vitro and in vivo toxicity assessment of IONPs and its relationship with the physicochemical parameters of IONPs.", {"entities": []}], ["Major discussion is included on the current spectrophotometric and imaging based techniques used for quantifying, and studying the clearance and biodistribution of IONPs.", {"entities": []}], ["Several invasive and non-invasive quantification techniques along with the pitfalls are discussed in detail.", {"entities": []}], ["Finally, critical guidelines are provided to optimize the design of IONPs to minimize the toxicity.", {"entities": []}], ["Fluticasone furoate (FF; GW685698) is a novel inhaled corticosteroid that is active at 24\u00a0h and under development for once-daily administration in combination with the long-acting \u03b2 2 -adrenoceptor agonist vilanterol (GW642444) for chronic obstructive pulmonary disease and asthma.", {"entities": [[232, 269, "DISEASE"], [274, 280, "DISEASE"]]}], ["In vitro studies examining the respiratory tissue-binding properties of corticosteroids showed FF to have the largest cellular accumulation and slowest rate of efflux compared with other clinically used inhaled corticosteroids, consistent with greater tissue retention.", {"entities": []}], ["The enhanced affinity of the glucocorticoid receptor binding of FF, coupled with its extended tissue association, may be expected to lead to greater and more prolonged anti-inflammatory effects and should provide relevant once-daily efficacy.", {"entities": []}], ["The aim of this study was to assess the rate and extent of systemic absorption of FF from the lung following inhaled administration of FF from three exploratory dry powder formulations (via DISKHALER This open-label, part-randomized, six-way crossover study evaluated three early development dry powder inhaled formulations of FF administered as single doses via DISKHALER n \u00a0=\u00a024) each received FF (2,000\u00a0\u03bcg; three formulations), inhaled FP (1,000\u00a0\u03bcg; via DISKHALER The terminal elimination half-life (t \u00bd\u03b2 ) for inhaled FF was considerably longer (range 17\u201324\u00a0h) than the t \u00bd\u03b2 estimated for intravenous FF (14\u00a0h), whereas t \u00bd\u03b2 for FP was similar whether inhaled or given intravenously (11 and 14\u00a0h, respectively).", {"entities": []}], ["This would suggest that FF is exhibiting absorption rate-limited pharmacokinetics following inhaled FF dosing and that the apparent t \u00bd\u03b2 is an estimate of absorption rate.", {"entities": []}], ["The lung mean absorption time for FF was approximately 7\u00a0h irrespective of formulation, which was considerably longer than FP (2.1\u00a0h).", {"entities": []}], ["The time for 90\u00a0% absorption from the lung was significantly longer for FF (20\u201330\u00a0h) than for FP (8\u00a0h), indicating a significantly longer lung retention time for FF.", {"entities": []}], ["In comparison with inhaled FP, inhaled FF (independent of formulation) demonstrated prolonged absorption from the lung into the systemic circulation, indicating a longer lung retention time and suggesting the potential for maintained efficacy with once-daily administration.", {"entities": []}], ["Quartz crystal microbalance (QCM) sensor array was developed for multi-purpose human respiration assessment.", {"entities": []}], ["The sensor system was designed to provide feedback for human respiration.", {"entities": []}], ["Thorough optimization of measurement conditions: air flow, temperature in the QCM chamber, frequency measurement rate, and electrode position regarding to the gas flow\u2014was performed.", {"entities": []}], ["As shown, acquisition of respiratory parameters (rate and respiratory pattern) could be achieved even with a single electrode used in the system.", {"entities": []}], ["The prototype system contains eight available QCM channels that can be potentially used for selective responses to certain breath chemicals.", {"entities": []}], ["At present, the prototype machine is ready for the assessment of respiratory functions in larger populations in order to gain statistical validation.", {"entities": []}], ["To the best of our knowledge, the developed prototype is the only respiratory assessment system based on surface modified QCM sensors.", {"entities": []}], ["The increased risks of death and adverse events with erythropoiesis-stimulating agent (ESA) therapy targeting a higher hemoglobin level are established.", {"entities": []}], ["It is uncertain whether the adverse effects of ESA therapy are related to dose and are mitigated when a fixed low ESA dose is used.", {"entities": []}], ["We conducted a multicenter, prospective randomized open-label, blinded-endpoint (PROBE) trial to evaluate fixed low versus high dose ESA therapy on patient outcomes.", {"entities": []}], ["We intended to recruit 2104 hemodialysis patients >18 years with anemia or receiving ESA treated at dialysis clinics in Italy.", {"entities": [[65, 71, "DISEASE"]]}], ["The intervention was fixed low (4000 IU epoetin alfa equivalent weekly) or high (18,000 IU epoetin alfa equivalent weekly) dose ESA for 12 months.", {"entities": []}], ["Primary outcomes were serum transferrin, ferritin, albumin, C-reactive protein and ESA dose.", {"entities": []}], ["Secondary outcomes were the composite of death or cardiovascular event, all-cause mortality, cardiovascular mortality, myocardial infarction, stroke, cardiovascular hospitalization, and quality of life.", {"entities": [[119, 140, "DISEASE"]]}], ["Study recruitment was terminated after inclusion of 656 participants with convergence of ESA dose between groups during follow up.", {"entities": []}], ["Fixed low dose ESA had uncertain effects on serum ferritin (delta of delta (DD) 3.9 ng/ml, 95% CI -85.0 to 92.8), transferrin (9.2 mg/dl, -6.3 to 24.8), transferrin saturation (3.7%, -5.0 to 12.3), serum albumin (-0.03 g/dl, -0.2 to 0.1), or C-reactive protein (-0.6 mg/l, -3.3 to 2.1).", {"entities": []}], ["In addition, fixed dose therapy had inconclusive effects on the composite endpoint of mortality and cardiovascular events (hazard ratio [HR] 0.95, 95% CI 0.66 to 1.37), death (0.98, 0.64 to 1.52), nonfatal myocardial infarction (0.52, 0.18 to 1.52), nonfatal stroke (no events), hospital admission for cardiovascular causes (0.93, 0.50 to 1.72) or health-related quality of life.", {"entities": [[206, 227, "DISEASE"], [137, 139, "GENE"]]}], ["A fixed low ESA dose in hemodialysis patients has uncertain effects on serum parameters, mortality, cardiovascular events, and quality of life.", {"entities": []}], ["Hemoglobin targets may be so entrenched in nephrology practice that a trial of ESA dose is no longer possible.", {"entities": []}], ["Background: Air pollution and obesity are hypothesized to contribute to accelerated decline in lung function with age through their inflammatory properties.", {"entities": [[30, 37, "DISEASE"]]}], ["Objective: We investigated whether the previously reported association between improved air quality and lung health in the population-based SAPALDIA cohort is modified by obesity.", {"entities": [[171, 178, "DISEASE"]]}], ["Methods: We used adjusted mixed-model analyses to estimate the association of average body mass index (BMI) and changes in particulate matter with aerodynamic diameter \u2264 10 \u00b5m (PM 10 ; \u0394PM 10 ) with lung function decline over a 10-year follow-up period.", {"entities": []}], ["Results: Lung function data and complete information were available for 4,664 participants.", {"entities": []}], ["Age-related declines in lung function among participants with high average BMI were more rapid for FVC (forced vital capacity), but slower for FEV 1 /FVC (forced expiratory volume in 1 sec/FVC) and FEF 25\u201375 (forced expiratory flow at 25\u201375%) than declines among those with low or normal average BMI.", {"entities": [[143, 146, "GENE"]]}], ["Improved air quality was associated with attenuated reductions in FEV 1 /FVC, FEF 25\u201375 , and FEF 25\u201375 /FVC over time among low- and normal-BMI participants, but not overweight or obese participants.", {"entities": [[66, 69, "GENE"]]}], ["The attenuation was most pronounced for \u0394FEF 25\u201375 /FVC (30% and 22% attenuation in association with a 10-\u03bcg/m 10 among low- and normal-weight participants, respectively.)", {"entities": []}], ["Conclusion: Our results point to the importance of considering health effects of air pollution exposure and obesity in parallel.", {"entities": [[108, 115, "DISEASE"]]}], ["Further research must address the mechanisms underlying the observed interaction.", {"entities": []}], ["Citation: Schikowski T, Schaffner E, Meier F, Phuleria HC, Vierk\u00f6tter A, Schindler C, Kriemler S, Zemp E, Kr\u00e4mer U, Bridevaux P-O, Rochat T, Schwartz J, K\u00fcnzli N, Probst-Hensch N. 2013.", {"entities": []}], ["Improved air quality and attenuated lung function decline: modification by obesity in the SAPALDIA cohort.", {"entities": [[75, 82, "DISEASE"]]}], ["Environ Health Perspect 121:1034\u20131039; http://dx.doi.org/10.1289/ehp.1206145", {"entities": []}], ["Identification of disease genes is a hot topic in biomedicine and genomics.", {"entities": []}], ["However, it is a challenging problem because of the complexity of diseases.", {"entities": []}], ["Inflammatory bowel disease (IBD) is an idiopathic disease caused by a dysregulated immune response to host intestinal microflora.", {"entities": []}], ["It has been proven to be associated with the development of intestinal malignancies.", {"entities": []}], ["Although the specific pathological characteristics and genetic background of IBD have been partially revealed, it is still an overdetermined disease and the blueprint of all genetic variants still needs to be improved.", {"entities": []}], ["In this study, a novel computational method was built to identify genes related to IBD.", {"entities": []}], ["Samples from two subtypes of IBD (ulcerative colitis and Crohn's disease) and normal samples were employed.", {"entities": [[34, 52, "DISEASE"]]}], ["By analyzing the gene expression profiles of these samples using minimum redundancy maximum relevance and incremental feature selection, 21 genes were obtained that could effectively distinguish samples from the two subtypes of IBD and the normal samples.", {"entities": []}], ["Then, the shortest-path approach was used to search for an additional 20 genes in a large network constructed using protein-protein interactions based on the above-mentioned 21 genes.", {"entities": []}], ["Analyses of the 41 genes obtained indicate that they are closely associated with this disease.", {"entities": []}], ["Neurodegeneration is a complex process involving different cell types and neurotransmitters.", {"entities": []}], ["A common characteristic of neurodegenerative disorders is the occurrence of a neuroinflammatory reaction in which cellular processes involving glial cells, mainly microglia and astrocytes, are activated in response to neuronal death.", {"entities": []}], ["Microglia do not constitute a unique cell population but rather present a range of phenotypes closely related to the evolution of neurodegeneration.", {"entities": []}], ["In a dynamic equilibrium with the lesion microenvironment, microglia phenotypes cover from a proinflammatory activation state to a neurotrophic one directly involved in cell repair and extracellular matrix remodeling.", {"entities": []}], ["At each moment, the microglial phenotype is likely to depend on the diversity of signals from the environment and of its response capacity.", {"entities": []}], ["As a consequence, microglia present a high energy demand, for which the mitochondria activity determines the microglia participation in the neurodegenerative process.", {"entities": []}], ["As such, modulation of microglia activity by controlling microglia mitochondrial activity constitutes an innovative approach to interfere in the neurodegenerative process.", {"entities": []}], ["In this review, we discuss the mitochondrial K ATP channel as a new target to control microglia activity, avoid its toxic phenotype, and facilitate a positive disease outcome.", {"entities": []}], ["The expression of metallothionein (MT) is involved in acquiring resistance to immune-mediated apoptosis; it is also a negative regulator of the immune response.", {"entities": []}], ["Nasal polyps are typified by a resistance to immune-mediated apoptosis as well as by excessive immune cell infiltration.", {"entities": []}], ["RCAS1 (receptor-binding cancer antigen expressed on SiSo cells) is a membrane protein capable of inducing the apoptosis of CTLs and NK cells.", {"entities": [[24, 30, "DISEASE"]]}], ["The aim of the present study has been to explore the expression of metallothionein with respect to immune cell presence and immune cell activity.", {"entities": []}], ["In our study, we identified immune cells using CD4 and CD68 antigen expression and evaluated their activity using CD25 antigen expression.", {"entities": [[47, 50, "GENE"], [55, 59, "GENE"]]}], ["We then analyzed metallothionein, RCAS1, CD25, CD4, and CD68 in a sampling of 50 nasal polyps using the immunohistochemistry method.", {"entities": [[47, 50, "GENE"], [56, 60, "GENE"]]}], ["We were able to divide the nasal polyps into three main groups according to their predominant immune cell infiltration: eosinophilic nasal polyps (21 cases), lymphocytic nasal polyps (17 cases), and neutrophilic nasal polyps (12 cases).", {"entities": []}], ["In the present study, statistically significant differences between the MT expression in the epithelium and that in the stroma of the nasal polyps along with the accompanying alterations in activation markers on immune cells were found and the number of macrophages in both the eosinophilic and the lymphocytic nasal polyps was assessed.", {"entities": []}], ["RCAS1-expressing macrophages were found only in the eosinophilic nasal polyps.", {"entities": []}], ["MT expression seems to favor the survival of nasal polyp epithelial cells in the adjacent area of increasingly cytotoxic immune activity.", {"entities": []}], ["RCAS1-expressing macrophages seem to participate in creating the immune suppressive microenvironment and so help to sustain local inflammation.", {"entities": []}], ["Reliable population-based data on HIV infection and AIDS mortality in sub-Saharan Africa are scanty, even though that is the region where most of the world\u2019s AIDS deaths occur.", {"entities": []}], ["There is therefore a great need for reliable and valid public health tools for assessing AIDS mortality.", {"entities": []}], ["The aim of this article is to validate the InterVA-4 verbal autopsy (VA) interpretative model within African populations where HIV sero-status is recorded on a prospective basis, and examine the distribution of cause-specific mortality among HIV-positive and HIV-negative people.", {"entities": []}], ["Data from six sites of the Alpha Network, including HIV sero-status and VA interviews, were pooled.", {"entities": []}], ["VA data according to the 2012 WHO format were extracted, and processed using the InterVA-4 model into likely causes of death.", {"entities": []}], ["The model was blinded to the sero-status data.", {"entities": []}], ["Cases with known pre-mortem HIV infection status were used to determine the specificity with which InterVA-4 could attribute HIV/AIDS as a cause of death.", {"entities": []}], ["Cause-specific mortality fractions by HIV infection status were calculated, and a person-time model was built to analyse adjusted cause-specific mortality rate ratios.", {"entities": []}], ["The InterVA-4 model identified HIV/AIDS-related deaths with a specificity of 90.1% (95% CI 88.7\u201391.4%).", {"entities": []}], ["Overall sensitivity could not be calculated, because HIV-positive people die from a range of causes.", {"entities": []}], ["In a person-time model including 1,739 deaths in 1,161,688 HIV-negative person-years observed and 2,890 deaths in 75,110 HIV-positive person-years observed, the mortality ratio HIV-positive:negative was 29.0 (95% CI 27.1\u201331.0), after adjustment for age, sex, and study site.", {"entities": []}], ["Cause-specific HIV-positive:negative mortality ratios for acute respiratory infections, HIV/AIDS-related deaths, meningitis, tuberculosis, and malnutrition were higher than the all-cause ratio; all causes had HIV-positive:negative mortality ratios significantly higher than unity.", {"entities": [[125, 137, "DISEASE"], [113, 123, "DISEASE"]]}], ["These results were generally consistent with relatively small post-mortem and hospital-based diagnosis studies in the literature.", {"entities": []}], ["The high specificity in cause of death attribution achieved in relation to HIV status, and large differences between specific causes by HIV status, show that InterVA-4 is an effective and valid tool for assessing HIV-related mortality.", {"entities": []}], ["There is little data on the effect of exercise on markers of airway inflammation in human asthmatics.", {"entities": []}], ["The main objective of this review is to determine the effects of physical training on markers of airway inflammation in animal models of asthma.", {"entities": [[137, 143, "DISEASE"]]}], ["A peer reviewed search was applied to Medline, Embase, Web of Science, Cochrane, and DARE databases.", {"entities": []}], ["Data extraction was performed in a blinded fashion.", {"entities": []}], ["From the initial 2336 studies, a total of 10 studies were selected for the final analysis.", {"entities": []}], ["All were randomized controlled trials with low to moderate intensity training on ovalbumin-sensitized mice.", {"entities": []}], ["In the exercised group of mice, there was a reduction in BAL eosinophils and Th-2 cytokines, no change in Th-1 cytokines, an increase in IL-10, and a reversal of airway remodeling.", {"entities": []}], ["The data was not pooled owing to significant heterogeneity between studies, and a funnel plot test for publication bias was not performed because there were few studies reporting on any one outcome measure.", {"entities": []}], ["The asthma models differed between studies in age and gender of mice, as well as in timing of physical training after sensitization.", {"entities": [[4, 10, "DISEASE"]]}], ["The risk of bias was unclear for some studies though this may not influence outcome measures.", {"entities": []}], ["The accuracy of data extracted from graphics is unknown.", {"entities": []}], ["Physical training improves airway inflammation in animal asthma models.", {"entities": [[57, 63, "DISEASE"]]}], ["Exacerbations of COPD are clinically relevant events with therapeutic and prognostic implications.", {"entities": []}], ["Yet, significant heterogeneity of clinical presentation and disease progression exists within acute exacerbations of COPD (AECOPD).", {"entities": []}], ["Currently, different phenotypes have been widely used to describe the characteristics among patients with AECOPD.", {"entities": []}], ["This has proved to be significant in the treatment and prediction of the outcomes of the disease.", {"entities": []}], ["In this review of published literature, the phenotypes of AECOPD were classified according to etiology, inflammatory biomarkers, clinical manifestation, comorbidity, the frequency of exacerbations, and so on.", {"entities": []}], ["This review concentrates on advancements in the use of phenotypes of AECOPD.", {"entities": []}], ["There is evidence that outdoor workers exposed to high levels of air pollution exhibit airway inflammation and increased airway symptoms.", {"entities": []}], ["We hypothesized that these workers would experience increased airway symptoms and decreased nasal mucociliary clearance associated with their exposure to air pollution.", {"entities": []}], ["In total, 25 non-smoking commercial motorcyclists, aged 18-44 years, were included in this study.", {"entities": []}], ["These drivers work 8-12 hours per day, 5 days per week, driving on urban streets.", {"entities": []}], ["Nasal mucociliary clearance was measured by the saccharine transit test; airway acidification was measured by assessing the pH of exhaled breath condensate; and airway symptoms were measured by the Sino-nasal Outcome Test-20 questionnaire.", {"entities": []}], ["To assess personal air pollution exposure, the subjects used a passive-diffusion nitrogen dioxide (NO 2 ) concentration-monitoring system during the 14 days before each assessment.", {"entities": []}], ["The associations between NO 2 and the airway outcomes were analyzed using the Mann-Whitney test and the Chi-Square test.", {"entities": []}], ["Clinicaltrials.gov: NCT01976039.", {"entities": []}], ["Compared with clearance in healthy adult males, mucociliary clearance was decreased in 32% of the motorcyclists.", {"entities": []}], ["Additionally, 64% of the motorcyclists had airway acidification and 92% experienced airway symptoms.", {"entities": []}], ["The median personal NO 2 exposure level was 75 mg/m 2 and impaired mucociliary clearance ( p \u200a=\u200a0.036).", {"entities": []}], ["Non-smoking commercial motorcyclists exhibit increased airway symptoms and airway acidification as well as decreased nasal mucociliary clearance, all of which are significantly associated with the amount of exposure to air pollution.", {"entities": []}], ["Fetal/neonatal alloimmune thrombocytopenia (FNAIT) is a relatively rare condition (1/1000\u20131/2000) that was granted orphan status by the European Medicines Agency in 2011.", {"entities": [[26, 42, "DISEASE"]]}], ["Clinical consequences of FNAIT, however, may be severe.", {"entities": []}], ["A thrombocytopenic fetus or new-born is at risk of intracranial hemorrhage that may result in lifelong disability or death.", {"entities": []}], ["Preventing such bleeding is thus vital and requires a solution.", {"entities": []}], ["Anti-HPA1a antibodies are the most frequent cause of FNAIT in Caucasians.", {"entities": []}], ["Its pathogenesis is similar to hemolytic disease of the newborn (HDN) due to anti-RhD antibodies, but is characterized by platelet destruction and is more often observed in the first pregnancy.", {"entities": []}], ["In 75\u00a0% of these women, alloimmunization by HPA-1a antigens, however, occurs at delivery, which enables development of antibody-mediated immune suppression to prevent maternal immunization.", {"entities": []}], ["As for HDN, the recurrence rate of FNAIT is high.", {"entities": []}], ["For advancing diagnostic efforts and treatment, it is thereby crucial to understand the pathogenesis of FNAIT, including cellular immunity involvement.", {"entities": []}], ["This review presents the current knowledge on FNAIT.", {"entities": []}], ["Also described is a program for HPA-1a screening in identifying HPA-1a negative pregnant women at risk of immunization.", {"entities": []}], ["This program is now performed at the Institute of Hematology and Transfusion Medicine in cooperation with the Department of Obstetrics and Gynecology of the Medical Centre of Postgraduate Education in Warsaw as well as the UiT The Arctic University of Norway.", {"entities": []}], ["African Americans have disproportionately higher incidence and death rates of colorectal cancer among all ethnic groups in the United States.", {"entities": [[78, 95, "DISEASE"], [89, 95, "DISEASE"]]}], ["Several lifestyle factors (e.g.", {"entities": []}], ["diet, physical activity and alcohol intake) have been suggested as risk factors for colorectal cancer.", {"entities": [[84, 101, "DISEASE"], [95, 101, "DISEASE"]]}], ["Stressful life events have also been identified as risk factors for colorectal cancer.", {"entities": [[68, 85, "DISEASE"], [79, 85, "DISEASE"]]}], ["The association between stressful life events and colon polyps, which are precursors of colorectal cancer, has yet to be determined.", {"entities": [[88, 105, "DISEASE"], [99, 105, "DISEASE"]]}], ["We aimed to evaluate the relationship between stressful life events and the presence of colon polyps and adenomas in African American men and women.", {"entities": []}], ["In this cross-sectional study, 110 participants were recruited from a colon cancer screening program at Howard University Hospital.", {"entities": [[70, 82, "DISEASE"], [76, 82, "DISEASE"]]}], ["Participants completed an 82-item Life Events Questionnaire (Norbeck 1984), assessing major events that have occurred in the participants\u2019 life within the past 12\u00a0months.", {"entities": []}], ["Participants also reported whether the event had a positive or negative impact.", {"entities": []}], ["Three scores were derived (total, positive, and negative).", {"entities": []}], ["Total life events scores were higher (Median [M]\u2009=\u200929 and Interquartile range [IQR]\u2009=\u200918-43) in patients with one or more polyps compared to patients without polyps (M, IQR\u2009=\u200921,13-38; P\u2009=\u20090.029).", {"entities": []}], ["Total, positive or negative Life Events scores did not differ significantly between normal and adenoma patients.", {"entities": [[95, 102, "DISEASE"]]}], ["Total, negative and positive Life Events scores did not differ between patients who underwent diagnostic colonoscopy (symptomatic) and patients who underwent colonoscopy for colon cancer screening (asymptomatic) and patients for surveillance colonoscopies due to a personal history of colon polyps.", {"entities": [[174, 186, "DISEASE"], [180, 186, "DISEASE"]]}], ["Linear regression analysis indicated that male gender is associated with 9.0 unit lower total Life Events score (P\u2009=\u20090.025).", {"entities": []}], ["This study suggests that patients who experienced total life events may be at higher risk of having colon polyps and adenomas which indicates an association between stress and the development of colorectal polyps.", {"entities": []}], ["Amphotericin B (AmB) induces oxidative and nitrosative stresses, characterized by production of reactive oxygen and nitrogen species, in fungi.", {"entities": []}], ["Yet, how these toxic species contribute to AmB-induced fungal cell death is unclear.", {"entities": []}], ["We investigated the role of superoxide and nitric oxide radicals in AmB's fungicidal activity in Saccharomyces cerevisiae, using a digital microfluidic platform, which enabled monitoring individual cells at a spatiotemporal resolution, and plating assays.", {"entities": []}], ["The nitric oxide synthase inhibitor L-NAME was used to interfere with nitric oxide radical production.", {"entities": []}], ["L-NAME increased and accelerated AmB-induced accumulation of superoxide radicals, membrane permeabilization, and loss of proliferative capacity in S. cerevisiae .", {"entities": []}], ["In contrast, the nitric oxide donor S-nitrosoglutathione inhibited AmB's action.", {"entities": []}], ["Hence, superoxide radicals were important for AmB's fungicidal action, whereas nitric oxide radicals mediated tolerance towards AmB.", {"entities": []}], ["Finally, also the human pathogens Candida albicans and Candida glabrata were more susceptible to AmB in the presence of L-NAME, pointing to the potential of AmB-L-NAME combination therapy to treat fungal infections.", {"entities": []}], ["Aim of the present study was to investigate the prevalence of allergy in patients affected by both organic and/or functional vocal fold disorders.", {"entities": []}], ["The secondary aim was to assess the correlation between sex and allergy in dysphonic patients.", {"entities": []}], ["A retrospective chart review was performed on dysphonic patients.", {"entities": []}], ["A total of 76 patients underwent fiberoptic endoscopy to assess the objective picture.", {"entities": []}], ["Logistic regression analyses have been conducted to assess the association between sex and the outcome variables.", {"entities": []}], ["The laryngoscopic examination revealed the presence of poor glottic closure in 32.9%, hyperkinesias in 11.8%, redness in 11.84%, polyps in 5.3%, oedema in 3.95%, vocal fold hypertrophy in 5.3%, nodules in 42.1%, cordectomy in 2.6%.", {"entities": []}], ["Allergic rhinitis was present in 56.6%, milk intolerance in 13.2%, asthma in 9.2%, atopic dermatitis in 3.9%, drugs intolerance in 11.8%.", {"entities": [[83, 100, "DISEASE"], [9, 17, "DISEASE"], [67, 73, "DISEASE"], [90, 100, "DISEASE"]]}], ["A total of 76.32% patients presenting with dysphonia were allergic.", {"entities": []}], ["A statistically significant association was found between female sex and presence of allergy.", {"entities": []}], ["In conclusion, allergy testing should be performed routinely on female professional voice users.", {"entities": []}], ["Mild respiratory disorders must be taken into serious consideration in female professional voice users, who may primarily complain of vocal dysfunction rather than upper and lower respiratory diseases.", {"entities": []}], ["To assess the oxygenation behavior and ventilatory mechanics after hemodialysis in patients under ventilatory support.", {"entities": []}], ["The present study was performed in the general intensive care unit of a tertiary public hospital.", {"entities": []}], ["Patients over 18 years of age under mechanical ventilation and in need of dialysis support were included.", {"entities": []}], ["Each patient was submitted to 2 evaluations (pre- and post-dialysis) regarding the cardiovascular and ventilatory parameters, the ventilatory mechanics and a laboratory evaluation.", {"entities": []}], ["Eighty patients with acute or chronic renal failure were included.", {"entities": []}], ["The analysis of the ventilatory mechanics revealed a reduction in the plateau pressure and an increased static compliance after dialysis that was independent of a reduction in blood volume.", {"entities": []}], ["The patients with acute renal failure also exhibited a reduction in peak pressure (p=0.024) and an increase in the dynamic compliance (p=0.026), whereas the patients with chronic renal failure exhibited an increase in the resistive pressure (p=0.046) and in the resistance of the respiratory system (p=0.044).", {"entities": []}], ["The group of patients with no loss of blood volume after dialysis exhibited an increase in the resistive pressure (p=0.010) and in the resistance of the respiratory system (p=0.020), whereas the group with a loss of blood volume >2,000mL exhibited a reduction in the peak pressure (p=0.027).", {"entities": []}], ["No changes in the partial pressure of oxygen in arterial blood (PaO 2 ) or in the PaO 2 /the fraction of inspired oxygen (PaO 2 /FiO 2 ) ratio were observed.", {"entities": []}], ["Hemodialysis was able to alter the mechanics of the respiratory system and specifically reduced the plateau pressure and increased the static compliance independent of a reduction in blood volume.", {"entities": []}], ["Adult-onset asthma and chronic obstructive pulmonary disease (COPD) are major public health burdens.", {"entities": [[23, 60, "DISEASE"], [12, 18, "DISEASE"]]}], ["This review presents a comprehensive synopsis of their epidemiology, pathophysiology, and clinical presentations; describes how they can be distinguished; and considers both established and proposed new approaches to their management.", {"entities": []}], ["Both adult-onset asthma and COPD are complex diseases arising from gene\u2013environment interactions.", {"entities": [[17, 23, "DISEASE"]]}], ["Early life exposures such as childhood infections, smoke, obesity, and allergy influence adult-onset asthma.", {"entities": [[58, 65, "DISEASE"], [101, 107, "DISEASE"]]}], ["While the established environmental risk factors for COPD are adult tobacco and biomass smoke, there is emerging evidence that some childhood exposures such as maternal smoking and infections may cause COPD.", {"entities": []}], ["Asthma has been characterized predominantly by Type 2 helper T cell (Th2) cytokine-mediated eosinophilic airway inflammation associated with airway hyperresponsiveness.", {"entities": [[0, 6, "DISEASE"]]}], ["In established COPD, the inflammatory cell infiltrate in small airways comprises predominantly neutrophils and cytotoxic T cells (CD8 positive lymphocytes).", {"entities": []}], ["Parenchymal destruction (emphysema) in COPD is associated with loss of lung tissue elasticity, and small airways collapse during exhalation.", {"entities": []}], ["The precise definition of chronic airflow limitation is affected by age; a fixed cut-off of forced expiratory volume in 1 second/forced vital capacity leads to overdiagnosis of COPD in the elderly.", {"entities": []}], ["Traditional approaches to distinguishing between asthma and COPD have highlighted age of onset, variability of symptoms, reversibility of airflow limitation, and atopy.", {"entities": [[49, 55, "DISEASE"]]}], ["Each of these is associated with error due to overlap and convergence of clinical characteristics.", {"entities": []}], ["The management of chronic stable asthma and COPD is similarly convergent.", {"entities": [[33, 39, "DISEASE"]]}], ["New approaches to the management of obstructive airway diseases in adults have been proposed based on inflammometry and also multidimensional assessment, which focuses on the four domains of the airways, comorbidity, self-management, and risk factors.", {"entities": []}], ["Short-acting beta-agonists provide effective symptom relief in airway diseases.", {"entities": []}], ["Inhalers combining a long-acting beta-agonist and corticosteroid are now widely used for both asthma and COPD.", {"entities": [[94, 100, "DISEASE"]]}], ["Written action plans are a cornerstone of asthma management although evidence for self-management in COPD is less compelling.", {"entities": [[42, 48, "DISEASE"]]}], ["The current management of chronic asthma in adults is based on achieving and maintaining control through step-up and step-down approaches, but further trials of back-titration in COPD are required before a similar approach can be endorsed.", {"entities": [[34, 40, "DISEASE"]]}], ["Long-acting inhaled anticholinergic medications are particularly useful in COPD.", {"entities": []}], ["Other distinctive features of management include pulmonary rehabilitation, home oxygen, and end of life care.", {"entities": []}], ["Awareness that disease susceptibility is not only dependent on genetic make up, but can be affected by lifestyle decisions, has brought more attention to the role of diet.", {"entities": []}], ["However, food is often treated as a black box, or the focus is limited to few, well-studied compounds, such as polyphenols, lipids and nutrients.", {"entities": []}], ["In this work, we applied text mining and Na\u00efve Bayes classification to assemble the knowledge space of food-phytochemical and food-disease associations, where we distinguish between disease prevention/amelioration and disease progression.", {"entities": []}], ["We subsequently searched for frequently occurring phytochemical-disease pairs and we identified 20,654 phytochemicals from 16,102 plants associated to 1,592 human disease phenotypes.", {"entities": []}], ["We selected colon cancer as a case study and analyzed our results in three directions; i) one stop legacy knowledge-shop for the effect of food on disease, ii) discovery of novel bioactive compounds with drug-like properties, and iii) discovery of novel health benefits from foods.", {"entities": [[12, 24, "DISEASE"], [18, 24, "DISEASE"]]}], ["This works represents a systematized approach to the association of food with health effect, and provides the phytochemical layer of information for nutritional systems biology research.", {"entities": []}], ["Until recently diet was considered a supplier of energy and building blocks for growth and development.", {"entities": []}], ["However, current research in the field suggests that the complex mixture of natural compounds present in our food has a variety of biological activities and plays an important role for health maintenance and disease prevention.", {"entities": []}], ["The mixture of bioactive components of our diet interacts with the human body through complex processes that modify network function and stability.", {"entities": []}], ["In order to increase our limited understanding on how components of food affect human health, we borrow methods that are well established in medical and pharmacological research.", {"entities": []}], ["By using text mining in PubMed abstracts we collected more than 20,000 diverse chemical structures present in our diet, while by applying chemoinformatics methods we could systematically explore their numerous targets.", {"entities": []}], ["Integrating the above datasets with food-disease associations allowed us to use a statistical framework for identifying specific phytochemicals as perturbators of drug targets and disease related pathways.", {"entities": []}], ["Levels of precursor proteins of collagen I and III are increased in fibrotic pulmonary diseases.", {"entities": []}], ["This study determined whether the expression of precursors of type I and III collagen proteins would be increased in small and large airways of COPD patients in various stages of the disease reflecting fibrogenesis.", {"entities": []}], ["The levels of precursor proteins of collagen I and III were studied by immunohistochemistry and quantified by image analysis in lung tissue of 16 non-smokers, 20 smokers with normal lung function, 20 smokers with stage I-II COPD and 8 ex-smokers with stage IV COPD.", {"entities": []}], ["In large airways, the subepithelial layer which was positive for precursor proteins of collagen I and III was thicker in smokers and in stage I-II COPD compared to non-smokers.", {"entities": []}], ["Large airways in stage IV COPD showed reduced expression of precursor protein of collagen I whereas precursor of collagen III was increased.", {"entities": []}], ["The amount of precursor protein of collagen III was increased in small airways of smokers and stage I-II COPD but reduced in stage IV COPD.", {"entities": []}], ["Precursor proteins of collagen I and III revealed different expression profiles in large and small airways in various stages of COPD.", {"entities": []}], ["Smoking enhanced expression of both precursors in large airways with a positive correlation with pack-years.", {"entities": []}], ["To evaluate the associations of emergent genome-wide-association study-derived coronary heart disease (CHD)-associated single nucleotide polymorphisms (SNPs) with established and emerging risk factors, and the association of genome-wide-association study-derived lipid-associated SNPs with other risk factors and CHD events.", {"entities": [[88, 101, "DISEASE"], [79, 101, "DISEASE"]]}], ["Using two case\u2013control studies, three cross-sectional, and seven prospective studies with up to 25 000 individuals and 5794 CHD events we evaluated associations of 34 genome-wide-association study-identified SNPs with CHD risk and 16 CHD-associated risk factors or biomarkers.", {"entities": []}], ["The Ch9p21 SNPs rs1333049 (OR 1.17; 95% confidence limits 1.11\u20131.24) and rs10757274 (OR 1.17; 1.09\u20131.26), MIA3 rs17465637 (OR 1.10; 1.04\u20131.15), Ch2q36 rs2943634 (OR 1.08; 1.03\u20131.14), APC rs383830 (OR 1.10; 1.02, 1.18), MTHFD1L rs6922269 (OR 1.10; 1.03, 1.16), CXCL12 rs501120 (OR 1.12; 1.04, 1.20), and SMAD3 rs17228212 (OR 1.11; 1.05, 1.17) were all associated with CHD risk, but not with the CHD biomarkers and risk factors measured.", {"entities": [[106, 110, "GENE"], [183, 186, "GENE"], [219, 226, "GENE"], [260, 266, "GENE"], [303, 308, "GENE"]]}], ["Among the 20 blood lipid-related SNPs, LPL rs17411031 was associated with a lower risk of CHD (OR 0.91; 0.84\u20130.97), an increase in Apolipoprotein AI and HDL-cholesterol, and reduced triglycerides.", {"entities": [[39, 42, "GENE"]]}], ["SORT1 rs599839 was associated with CHD risk (OR 1.20; 1.15\u20131.26) as well as total- and LDL-cholesterol, and apolipoprotein B. ANGPTL3 rs12042319 was associated with CHD risk (OR 1.11; 1.03, 1.19), total- and LDL-cholesterol, triglycerides, and interleukin-6.", {"entities": [[0, 5, "GENE"], [126, 133, "GENE"]]}], ["Several SNPs predicting CHD events appear to involve pathways not currently indexed by the established or emerging risk factors; others involved changes in blood lipids including triglycerides or HDL-cholesterol as well as LDL-cholesterol.", {"entities": []}], ["The overlapping association of SNPs with multiple risk factors and biomarkers supports the existence of shared points of regulation for these phenotypes.", {"entities": []}], ["The action of dexamethasone is initiated by, and strictly dependent upon, the interaction of the drug with its receptor followed by its translocation into the nucleus where modulates gene expression.", {"entities": []}], ["Where the drug localizes at the intranuclear level is not yet known.", {"entities": []}], ["We aimed to study the localization of the drug in nuclear lipid microdomains rich in sphingomyelin content that anchor active chromatin and act as platform for transcription modulation.", {"entities": []}], ["The study was performed in non-Hodgkin\u2019s T cell human lymphoblastic lymphoma (SUP-T1 cell line).", {"entities": [[68, 76, "DISEASE"]]}], ["We found that when dexamethasone enters into the nucleus it localizes in nuclear lipid microdomains where influences sphingomyelin metabolism.", {"entities": []}], ["This is followed after 24 h by a cell cycle block accompanied by the up-regulation of cyclin-dependent kinase inhibitor 1A ( CDKN1A ), cyclin-dependent kinase inhibitor 1B ( CDKN1B ), growth arrest and DNA-damage 45A ( GADD45A ), and glyceraldehyde 3-phosphate dehydrogenase ( GAPDH ) genes and by the reduction of signal transducer and activator of transcription 3 (STAT3) and phospho signal transducer and activator of transcription 3 (phoshoSTAT3) proteins.", {"entities": [[125, 131, "GENE"], [174, 180, "GENE"], [219, 226, "GENE"], [277, 282, "GENE"], [367, 372, "GENE"]]}], ["After 48 h some cells show morphological changes characteristic of apoptosis while the number of the cells that undergo cell division and express B-cell lymphoma-2 (Bcl-2) is very low.", {"entities": [[153, 161, "DISEASE"]]}], ["We suggest that the integrity of nuclear lipid microdomains is important for the response to glucocorticoids of cancer cells.", {"entities": [[112, 118, "DISEASE"]]}], ["Libby, Montana is a Superfund site and epicenter of one of the worst environmental disasters in the USA history in terms of asbestos-related mortality and morbidity.", {"entities": []}], ["Perceptions of access and financial aspects of care were explored among a national cohort of persons postasbestos exposure and prior to a 2009 Public Health Emergency Declaration.", {"entities": []}], ["Our findings indicated the Libby cohort was significantly less satisfied with access and financial aspects of care as measured by two PSQ-III scales when compared to an adult, chronically ill patient sample.", {"entities": []}], ["Participants with higher levels of respiratory morbidity and depression had significantly lower satisfaction scores.", {"entities": []}], ["Systemic oxidative stress in horses with recurrent airway obstruction ( RAO ) is poorly characterized.", {"entities": []}], ["The goal of this study was to investigate whether equine RAO is associated with systemic disturbances in the oxidant\u2010antioxidant equilibrium.", {"entities": []}], ["Seven healthy horses and 7 horses with symptomatic RAO .", {"entities": []}], ["A prospective study.", {"entities": []}], ["Healthy and RAO \u2010affected horses were exposed to a 48\u2010hour challenge with moldy hay and straw to induce clinical exacerbation of RAO .", {"entities": []}], ["Venous blood was collected and the activities of the superoxide dismutase ( SOD ), catalase ( CAT ), glutathione peroxidase ( GP x), and glutathione reductase ( GR ) in equine erythrocyte lysates were measured.", {"entities": []}], ["The concentration of thiobarbituric acid\u2010reactive substances ( TBARS s) was assessed both in erythrocyte lysates and in plasma.", {"entities": []}], ["A significant increase in the activities of GP x and SOD was detected in RAO \u2010affected horses compared with the control animals.", {"entities": []}], ["There was no significant difference between groups in terms of the erythrocyte lysate activities of CAT , GR , or TBAR s or the plasma concentration of TBAR s. Our results support the hypothesis that RAO in horses is associated with systemic oxidative stress.", {"entities": []}], ["Future studies are needed to assess whether horses suffering from RAO can benefit from antioxidant supplementation.", {"entities": []}], ["Giant cell arteritis (GCA) is an autoimmune disease commonest in Northern Europe and Scandinavia.", {"entities": [[22, 25, "GENE"]]}], ["Previous studies report various associations with HLA-DRB1* 04 and HLA-DRB1 *01; HLA-DRB1 alleles show a gradient in population prevalence within Europe.", {"entities": [[50, 58, "GENE"], [67, 75, "GENE"], [81, 89, "GENE"], [50, 58, "GENE"], [67, 75, "GENE"], [81, 89, "GENE"]]}], ["Our aims were (1) to determine which amino acid residues within HLA-DRB1 best explained HLA-DRB1 allele susceptibility and protective effects in GCA, seen in UK data combined in meta-analysis with previously published data, and (2) to determine whether the incidence of GCA in different countries is associated with the population prevalence of the HLA-DRB1 alleles that we identified in our meta-analysis.", {"entities": [[64, 72, "GENE"], [88, 96, "GENE"], [349, 357, "GENE"], [64, 72, "GENE"], [88, 96, "GENE"], [349, 357, "GENE"], [145, 148, "GENE"], [270, 273, "GENE"], [145, 148, "GENE"], [270, 273, "GENE"], [64, 72, "GENE"], [88, 96, "GENE"], [349, 357, "GENE"]]}], ["GCA patients from the UK GCA Consortium were genotyped by using single-strand oligonucleotide polymerization, allele-specific polymerase chain reaction, and direct sequencing.", {"entities": [[0, 3, "GENE"], [25, 28, "GENE"], [0, 3, "GENE"], [25, 28, "GENE"]]}], ["Meta-analysis was used to compare and combine our results with published data, and public databases were used to identify amino acid residues that may explain observed susceptibility/protective effects.", {"entities": []}], ["Finally, we determined the relationship of HLA-DRB1 *04 population carrier frequency and latitude to GCA incidence reported in different countries.", {"entities": [[43, 51, "GENE"], [101, 104, "GENE"]]}], ["In our UK data (225 cases and 1378 controls), HLA-DRB1* 04 carriage was associated with GCA susceptibility (odds ratio (OR) = 2.69, P = 1.5\u00d710 HLA-DRB1* 01 was protective (adjusted OR = 0.55, P = 0.0046).", {"entities": [[88, 91, "GENE"]]}], ["In meta-analysis combined with 14 published studies (an additional 691 cases and 4038 controls), protective effects were seen from HLA-DR2, which comprises HLA-DRB1 *15 and HLA-DRB1 *16 (OR = 0.65, P = 8.2\u00d710 HLA-DRB1 *01 (OR = 0.73, P = 0.037).", {"entities": [[156, 164, "GENE"], [173, 181, "GENE"], [209, 217, "GENE"], [156, 164, "GENE"], [173, 181, "GENE"], [209, 217, "GENE"], [156, 164, "GENE"], [173, 181, "GENE"], [209, 217, "GENE"]]}], ["GCA incidence ( n = 17 countries) was associated with population HLA-DRB1 *04 allele frequency ( P = 0.008; adjusted R We confirm that HLA-DRB1 *04 is a GCA susceptibility allele.", {"entities": [[0, 3, "GENE"], [153, 156, "GENE"], [65, 73, "GENE"], [135, 143, "GENE"], [65, 73, "GENE"], [135, 143, "GENE"], [0, 3, "GENE"], [153, 156, "GENE"]]}], ["The susceptibility data are best explained by amino acid risk residues V, H, and H at positions 11, 13, and 33, contrary to previous suggestions of amino acids in the second hypervariable region.", {"entities": []}], ["Worldwide, GCA incidence was independently associated both with population frequency of HLA-DRB1 *04 and with latitude itself.", {"entities": [[11, 14, "GENE"], [88, 96, "GENE"]]}], ["We conclude that variation in population HLA-DRB1 *04 frequency may partly explain variations in GCA incidence and that HLA-DRB1 *04 may warrant investigation as a potential prognostic or predictive biomarker.", {"entities": [[41, 49, "GENE"], [120, 128, "GENE"], [97, 100, "GENE"], [41, 49, "GENE"], [120, 128, "GENE"]]}], ["The online version of this article (doi:10.1186/s13075-015-0692-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Extrapulmonary involvement by sarcoidosis is observed in about 30\u201340% of patients with sarcoidosis.", {"entities": [[30, 41, "DISEASE"], [87, 98, "DISEASE"]]}], ["Little is known about the frequency and clinical characteristics of sinonasal sarcoidosis.", {"entities": [[78, 89, "DISEASE"]]}], ["We retrospectively analyzed 12 cases of biopsy-proven sinonasal sarcoidosis.", {"entities": [[64, 75, "DISEASE"]]}], ["Patients were identified from a patient population of 1360 patients with sarcoidosis at the Outpatient Clinic for Sarcoidosis and Rare Lung Diseases at LungClinic Grosshansdorf, a tertiary care hospital for respiratory medicine.", {"entities": [[73, 84, "DISEASE"], [114, 125, "DISEASE"]]}], ["The most frequent signs and symptoms were nasal polyps (4 cases), epistaxis (3 cases), nasal crusts (8 cases) and anosmia (5 cases).", {"entities": []}], ["Pulmonary sarcoidosis of the patients was staged as stage I (n = 1) and stage II (n = 11) on chest radiographs.", {"entities": [[10, 21, "DISEASE"]]}], ["Spirometry was normal in 11 patients.", {"entities": []}], ["7 patients had a diffusion capacity of the lung for carbon monoxide of less than 90% of predicted.", {"entities": []}], ["Other organs were affected in 8 patients.", {"entities": []}], ["All patients received systemic corticosteroid treatment and most patients received topical steroids.", {"entities": []}], ["5 patients received steroid sparing agents.", {"entities": []}], ["Repeated sinus surgery had to be performed in 4 patients.", {"entities": []}], ["Sinonasal involvement is a rare disease manifestation of sarcoidosis with a frequency slightly lower than 1% in our patient population.", {"entities": [[57, 68, "DISEASE"]]}], ["The clinical course of sinonasal sarcoidosis can be complicated by relapse despite systemic immunosuppressive treatment and repeated sinus surgery.", {"entities": [[33, 44, "DISEASE"]]}], ["Although dendritic cells (DCs) play an important role in sensitization to inhaled allergens, their function in ongoing T helper (Th)2 cell\u2013mediated eosinophilic airway inflammation underlying bronchial asthma is currently unknown.", {"entities": [[202, 208, "DISEASE"]]}], ["Here, we show in an ovalbumin (OVA)-driven murine asthma model that airway DCs acquire a mature phenotype and interact with CD4", {"entities": [[50, 56, "DISEASE"], [124, 127, "GENE"]]}], ["Chronic conditions are the most common themes in doctor-patient communication, especially for older patients with multimorbidity and their GPs.", {"entities": []}], ["Former quantitative studies identified a variety of socio-demographic and health-related factors which were associated with the (dis-)agreement between medical records and patient self-reported diseases.", {"entities": []}], ["The aim of this qualitative study was to identify reasons for disagreement regarding illnesses between patients and their GPs.", {"entities": []}], ["We conducted three focus groups with GPs (n\u2009=\u200915) and three focus groups with multimorbid patients aged 65 to 85 (n\u2009=\u200921).", {"entities": []}], ["The participants were recruited from the MultiCare Cohort Study.", {"entities": []}], ["Focus groups were audiotaped and transcribed verbatim.", {"entities": []}], ["The transcripts of the focus groups were analysed using the qualitative content analysis according to Mayring.", {"entities": []}], ["Categories were determined deductively and inductively.", {"entities": []}], ["The analysis revealed seven themes concerning reasons for disagreement regarding illnesses between patients and their GPs: problems with communication and cooperation between health care professionals, disease management by the GP and the patient, the documentation behaviour of the GP, communication challenges between GP and patient, differences in the understanding of a disease between GP and patient, the prioritization and rating of diseases by GP and patient and obliviousness, repression and avoidance by the patient.", {"entities": []}], ["For older patients with multimorbidity, our study demonstrated that there is a need to enhance the cooperation between GPs, specialists and outpatient care, a demand to improve doctor-patient communication and a need for interventions to increase patients\u2019 knowledge of diseases.", {"entities": []}], ["The online version of this article (doi:10.1186/s12875-015-0286-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Hospital inpatients often experience medical and psychiatric problems simultaneously.", {"entities": []}], ["Although this implies a certain relationship between healthcare utilization and costs, this relationship has never been systematically reviewed.", {"entities": []}], ["The objective is to examine the extent to which medical-psychiatric comorbidities relate to health-economic outcomes in general and in different subgroups.", {"entities": []}], ["If the relationship is significant, this would give additional reasons to facilitate the search for targeted and effective treatments for this complex population.", {"entities": []}], ["A systematic review in Embase, Medline, Psycinfo, Cochrane, Web of Science and Google Scholar was performed up to August 2016 and included cross-references from included studies.", {"entities": []}], ["Only peer-reviewed empirical studies examining the impact of inpatient medical-psychiatric comorbidities on three health-economic outcomes (length of stay (LOS), medical costs and rehospitalizations) were included.", {"entities": []}], ["Study design was not an exclusion criterion, there were no restrictions on publication dates and patients included had to be over 18 years.", {"entities": []}], ["The examined populations consisted of inpatients with medical-psychiatric comorbidities and controls.", {"entities": []}], ["The controls were inpatients without a comorbid medical or psychiatric disorder.", {"entities": []}], ["Non-English studies were excluded.", {"entities": []}], ["From electronic literature databases, 3165 extracted articles were scrutinized on the basis of title and abstract.", {"entities": []}], ["This resulted in a full-text review of 86 articles: 52 unique studies were included.", {"entities": []}], ["The review showed that the presence of medical-psychiatric comorbidity was related to increased LOS, higher medical costs and more rehospitalizations.", {"entities": []}], ["The meta-analysis revealed that patients with comorbid depression had an increased mean LOS of 4.38 days compared to patients without comorbidity (95% CI: 3.07 to 5.68, I2 = 31%).", {"entities": []}], ["Medical-psychiatric comorbidity is related to increased LOS, medical costs and rehospitalization; this is also shown for specific subgroups.", {"entities": []}], ["This study had some limitations; namely, that the studies were very heterogenetic and, in some cases, of poor quality in terms of risk of bias.", {"entities": []}], ["Nevertheless, the findings remain valid and justify the search for targeted and effective interventions for this complex population.", {"entities": []}], ["Apoptotic epithelial cells signal to neighboring cells to induce dying cell extrusion by releasing sphingosine-1-phosphate.", {"entities": []}], ["To maintain an intact barrier, epithelia eliminate dying cells by extrusion.", {"entities": []}], ["During extrusion, a cell destined for apoptosis signals its neighboring cells to form and contract a ring of actin and myosin, which squeezes the dying cell out of the epithelium.", {"entities": []}], ["Here, we demonstrate that the signal produced by dying cells to initiate this process is sphingosine-1-phosphate (S1P).", {"entities": []}], ["Decreasing S1P synthesis by inhibiting sphingosine kinase activity or by blocking extracellular S1P access to its receptor prevented apoptotic cell extrusion.", {"entities": []}], ["Extracellular S1P activates extrusion by binding the S1P 2 receptor in the cells neighboring a dying cell, as S1P 2 knockdown in these cells or its loss in a zebrafish mutant disrupted cell extrusion.", {"entities": []}], ["Because live cells can also be extruded, we predict that this S1P pathway may also be important for driving delamination of stem cells during differentiation or invasion of cancer cells.", {"entities": [[173, 179, "DISEASE"]]}], ["Objectives .", {"entities": []}], ["To describe (i) the clinical characteristics of workers, exposed to hymenoptera stings, with an ascertained diagnosis of Hymenoptera Venom Allergy (HVA), (ii) the specific role of occupational exposure, (iii) the effect of Venom Immunotherapy (VIT) in reducing the severity of allergic episodes in workers exposed to repeated stings of hymenoptera, and (iv) the management of the occupational consequences caused by allergic reactions due to hymenoptera stings.", {"entities": [[244, 247, "GENE"]]}], ["Between 2000 and 2013 an observational study, including patients referred to the regional reference hospital of Liguria, Italy, with an ascertained diagnosis of HVA and treated with VIT, was performed.", {"entities": [[182, 185, "GENE"]]}], ["A structured questionnaire was administered to all patients to investigate the occupational features of allergic reactions.", {"entities": []}], ["These were graded according to standard systems in patients at the first episode, and after re-stings, during VIT.", {"entities": [[110, 113, "GENE"]]}], ["One-hundred and 8four out of the 202 patients referred had a complete data set.", {"entities": []}], ["In 32 (17.4%) patients, the allergic reaction occurred during work activities performed outdoor.", {"entities": []}], ["Of these, 31.2% previously stung by hymenoptera at work, and receiving VIT, were re-stung during occupational activity.", {"entities": [[71, 74, "GENE"]]}], ["The grades of reaction developed under VIT treatment resulted clinically less severe than of those occurred at the first sting (p-value = 0.031).", {"entities": [[39, 42, "GENE"]]}], ["Conclusion .", {"entities": []}], ["Our findings confirmed the clinical relevance of HVA, and described its occupational features in outdoor workers with sensitization, stressing the importance of an early identification and proper management of the professional categories recognized at high risk of hymenoptera stings.", {"entities": []}], ["The Occupational Physician should be supported by other specialists to recommend appropriate diagnostic procedures and the prescription of VIT, which resulted an effective treatment for the prevention of episodes of severe reactions in workers with a proven HVA.", {"entities": [[139, 142, "GENE"]]}], ["It was our aim to systematically analyze pulmonary artery blood flow within different age-groups in the general population using 4D flow cardiovascular magnetic resonance (CMR) in order to provide a context for interpreting results of future studies (e.g., in pulmonary hypertension) using this technique.", {"entities": [[270, 282, "DISEASE"], [260, 282, "DISEASE"]]}], ["An age-stratified sample ( n \u2009=\u2009126) of the population of the city of Freiburg, Germany, underwent ECG-triggered and navigator-gated 4D flow CMR at 3\u00a0T of the pulmonary arteries and the thoracic aorta.", {"entities": []}], ["Analysis planes were placed in the main, left, and right pulmonary artery using dedicated software.", {"entities": []}], ["Study participants were divided into three groups (1:20\u201339; 2:40\u201359; and 3:60\u201380 years of age).", {"entities": []}], ["Subsequently, pulmonary blood flow was visualized, quantified and compared between groups.", {"entities": []}], ["Time-to-peak of systolic antegrade flow was shorter, peak and average velocities and flow volumes were lower in older subjects.", {"entities": []}], ["At the end of systole, retrograde flow in the main pulmonary artery was observed in all but one subject.", {"entities": []}], ["Subsequently, a second antegrade flow peak occurred in diastole which was lower in older subjects.", {"entities": []}], ["Age was an independent predictor of hemodynamic change after adjustment for cardiovascular risk factors and body-mass-index.", {"entities": []}], ["During systole, abnormal vortices occurred in the main pulmonary artery in four male subjects.", {"entities": []}], ["Comprehensive analysis of pulmonary blood flow was feasible in all subjects.", {"entities": []}], ["We were able to detect an independent effect of ageing on pulmonary hemodynamics reflecting increased vessel stiffness and reduced pulmonary circulation.", {"entities": []}], ["Findings of this study may be helpful for discriminating physiological from pathological flow in patients with pulmonary diseases in the future.", {"entities": []}], ["The online version of this article (doi:10.1186/s12968-016-0252-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The diagnosis of chronic rhinosinusitis (CRS) based on clinical presentation alone remains challenging.", {"entities": []}], ["To improve the accuracy of clinical diagnosis, the Canadian Rhinosinusitis Guidelines recommend the use of specific symptom and endoscopic criteria.", {"entities": []}], ["Our study objective was to determine whether symptom and endoscopic criteria, as defined by the Canadian Rhinosinusitis Guidelines, accurately predict CT-confirmed CRS diagnosis.", {"entities": []}], ["A retrospective cohort study of 126 patients who underwent CT sinuses based on clinical suspicion of possible CRS.", {"entities": []}], ["The presence of symptom and endoscopic criteria, as defined by the Canadian Rhinosinusitis Guidelines, were compared between patients with and without a CT-confirmed CRS diagnosis using two-tailed Fisher\u2019s exact tests.", {"entities": []}], ["Positive predictive values and likelihood ratios were determined for each symptom and endoscopic finding.", {"entities": []}], ["Overall, 56.3% of patients had a CT-confirmed diagnosis of CRS.", {"entities": []}], ["With the exception of nasal polyps, none of the symptom or endoscopic criteria had a statistically significant correlation with positive CT sinuses.", {"entities": []}], ["For symptom criteria, positive predictive values ranged from 52.4% to 63.4%; likelihood ratios ranged from 0.85 to 1.34.", {"entities": []}], ["For endoscopic criteria, positive predictive values and likelihood ratios were 71.4% and 1.94 (edema); 63.0% and 1.32 (discharge); and 92.9% and 10.1 (nasal polyps).", {"entities": []}], ["35.2% of patients with CT-confirmed CRS had normal endoscopic exams.", {"entities": []}], ["The Canadian Rhinosinusitis Guidelines\u2019 symptom and endoscopic criteria for CRS, with the exception of nasal polyps on endoscopy, do not accurately predict CT-confirmed disease.", {"entities": []}], ["In addition, a normal endoscopic exam does not rule out CRS.", {"entities": []}], ["Narrative resources in electronic health records make clinical phenotyping study difficult to achieve.", {"entities": []}], ["If a narrative patient history can be represented in a timeline, this would greatly enhance the efficiency of information-based studies.", {"entities": []}], ["However, current timeline representations have limitations in visualizing narrative events.", {"entities": []}], ["In this paper, we propose a temporal model named the \u2018V-Model\u2019 which visualizes clinical narratives into a timeline.", {"entities": []}], ["We developed the V-Model which models temporal clinical events in v-like graphical structure.", {"entities": []}], ["It visualizes patient history on a timeline in an intuitive way.", {"entities": []}], ["For the design, the representation, reasoning, and visualization (readability) aspects were considered.", {"entities": []}], ["Furthermore, the unique graphical notation helps to find hidden patterns of a specific patient group.", {"entities": []}], ["For evaluation, we verified our distinctive solutions, and surveyed usability.", {"entities": []}], ["The experiments were carried out between the V-Model and a conventional timeline model group.", {"entities": []}], ["Eighty medical students and physicians participated in this evaluation.", {"entities": []}], ["The V-Model was proven to be superior in representing narrative medical events, provide sufficient information for temporal reasoning, and outperform in readability compared to a conventional timeline model.", {"entities": []}], ["The usability of the V-Model was assessed as positive.", {"entities": []}], ["The V-Model successfully resolves visualization issues of clinical documents, and provides better usability compared to a conventional timeline model.", {"entities": []}], ["The online version of this article (doi:10.1186/1472-6947-14-90) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Background : Cigarette smoking is a tough addiction to break.", {"entities": []}], ["This dependence is the most common dual diagnosis for individuals with schizophrenia.", {"entities": [[71, 84, "DISEASE"]]}], ["Currently three effective drugs are approved for smoking cessation: nicotine replacement therapy (NRT), varenicline and bupropion.", {"entities": []}], ["However, some serious side effects of varenicline have been reported, including depression, suicidal thoughts, and suicide.", {"entities": []}], ["The use of bupropion also has side effects.", {"entities": []}], ["It should not be used by people who have epilepsy or any condition that lowers the seizure threshold, nor by people who take a specific class of drugs called monoamine oxidase inhibitors.", {"entities": []}], ["Hence, there are pharmacodynamic reason to believe they could precipitate or exacerbate psychosis.", {"entities": []}], ["For its capacity to deliver nicotine and provide a coping mechanism for conditioned smoking cues by replacing some of the rituals associated with smoking gestures, electronic-cigarettes may reduce nicotine withdrawal symptoms without serious side effects.", {"entities": []}], ["Our recent work with ECs in healthy smokers not intending to quit consistently show surprisingly high success rates.", {"entities": []}], ["We hypothesised that these positive findings could be replicated in difficult patients with schizophrenia This tool may help smokers with schizophrenia remain abstinent during their quitting attempts or to reduce cigarette consumption.", {"entities": [[92, 105, "DISEASE"], [138, 151, "DISEASE"]]}], ["Efficacy and safety of these devices in long-term smoking cessation and/or smoking reduction studies have never been investigated for this special population.", {"entities": []}], ["Methods : In this study we monitored possible modifications in smoking habits of 14 smokers (not intending to quit) with schizophrenia experimenting with the \u201cCategoria\u201d e-Cigarette with a focus on smoking reduction and smoking abstinence.", {"entities": [[121, 134, "DISEASE"]]}], ["Study participants were invited to attend six study visits: at baseline, week-4, week-8, week-12 week-24 and week 52.", {"entities": []}], ["Product use, number of cigarettes smoked, carbon monoxide in exhaled breath (eCO) and positive and negative symptoms of schizophrenia levels were measured at each visit.", {"entities": [[120, 133, "DISEASE"]]}], ["Smoking reduction and abstinence rates were calculated.", {"entities": []}], ["Adverse events were also reviewed.", {"entities": []}], ["Results : Sustained 50% reduction in the number of cig/day at week-52 was shown in 7/14 (50%) participants; their median of 30 cig/day decreasing significantly to 15 cig/day ( p = 0.018).", {"entities": []}], ["Sustained smoking abstinence at week-52 was observed in 2/14 (14.3%) participants.", {"entities": []}], ["Combined sustained 50% reduction and smoking abstinence was shown in 9/14 (64.3%) participants.", {"entities": []}], ["Nausea was observed in 2/14 (14.4%) of participants, throat irritation in 2/14 (14.4%) of participants, headache in 2/14 (14.4%) of participants , and dry cough in 4/14 (28.6%) of participants.", {"entities": []}], ["However, these adverse events diminished substantially by week-24.", {"entities": []}], ["Overall, one to two cartridges/day were used throughout the study.", {"entities": []}], ["Positive and negative symptoms of schizophrenia are not increased after smoking reduction/cessation in patients using e-cigarettes.", {"entities": [[34, 47, "DISEASE"]]}], ["Conclusions : We have shown for the first time that the use of e-cigarette substantially decreased cigarette consumption without causing significant side effects in chronic schizophrenic patients who smoke not intending to quit.", {"entities": []}], ["This was achieved without negative impacts on the symptoms of schizophrenia as assessed by SAPS and SANS symptoms scales.", {"entities": [[62, 75, "DISEASE"]]}], ["To investigate the incidence of asthma and chronic obstructive pulmonary disease (COPD) exacerbations in primary care during one year and to identify risk factors for such events.", {"entities": [[43, 80, "DISEASE"], [32, 38, "DISEASE"]]}], ["The study was carried out at seven general practice offices in Norway.", {"entities": []}], ["Patients aged 40 years or more registered with a diagnosis of asthma and/or COPD the previous 5 years were included.", {"entities": [[62, 68, "DISEASE"]]}], ["After a baseline examination, the participants consulted their GP during exacerbations for the following 12 months.", {"entities": []}], ["A questionnaire on exacerbations during the follow-up year was distributed to all.", {"entities": []}], ["Univariable and multivariable logistic regression was performed to determine predictors of future exacerbations.", {"entities": []}], ["Three hundred and eighty patients attended the baseline examination and complete follow-up data were retrieved from 340 patients.", {"entities": []}], ["COPD as defined by forced expiratory volume in the first second of expiration/forced vital capacity (FEV 1 /FVC) < 0.7, was found in 132 (38.8%) patients.", {"entities": [[101, 104, "GENE"]]}], ["One hundred and fifty-nine patients (46.8%) experienced one exacerbation or more and 101 (29.7%) two exacerbations or more.", {"entities": []}], ["Patients who had an exacerbation treated with antibiotics or systemic corticosteroids or leading to hospitalization the year before baseline ( N = 88) had the highest risk of getting an exacerbation during the subsequent year (odds ratio 9.2), whether the FEV 1 /FVC was below 0.7 or not.", {"entities": [[256, 259, "GENE"]]}], ["Increased risk of future exacerbations was also related to age \u2265 65 years and limitations in social activities, but not to the FEV 1 .", {"entities": [[127, 130, "GENE"]]}], ["The study confirms that previous exacerbations strongly predict future exacerbations in patients with COPD or asthma.", {"entities": [[110, 116, "DISEASE"]]}], ["Identification and a closer follow-up of patients at risk of such events could promote earlier treatment when necessary and prevent a rapid deterioration of their condition.", {"entities": []}], ["Vitamin C, as an antioxidant, has recently been suggested to provide protection against COPD; however, only few national cohort studies have investigated these effects.", {"entities": []}], ["We aimed to confirm the protective effects of vitamin C against COPD in Korean patients.", {"entities": []}], ["We analyzed the data of 3,283 adults aged \u226540 years (representing 23,541,704 subjects) who underwent pulmonary function tests and responded to questionnaires on smoking history and vitamin C intake, with stratification variables and sampling weight designated by the Korea 2012 National Health and Nutrition Examination Survey.", {"entities": []}], ["Among all the subjects, 512 (representing 3,459,679 subjects; 15.6%) were diagnosed as having COPD based on pulmonary function test results.", {"entities": []}], ["Male gender, old age, residence in suburban/rural regions, low household income, low educational level, an occupation in agriculture or fisheries, and heavy smoking were significantly associated with COPD.", {"entities": []}], ["Low intake of nutrients, including potassium, vitamin A, carotene, retinol, and vitamin C, was significantly associated with COPD.", {"entities": []}], ["The prevalence of COPD in heavy smokers with the lowest quartile (Q1, <48.50 mg; 63.0%) and low-middle quartile (Q2, 48.50\u221284.38 mg; 56.4%) of vitamin C intake was significantly higher than that in subjects with the high-middle quartile (Q3, 84.38\u2212141.63 mg; 29.5%) and highest quartile (Q4, >141.63 mg; 32.6%) of vitamin C intake ( P =0.015).", {"entities": []}], ["In multivariate analysis, male gender, old age, heavy smoking, and a low intake of vitamin C were significant independent risk factors for COPD.", {"entities": []}], ["A significant reduction of 76.7% in COPD risk was observed with a Q3 vitamin C intake compared to Q1 vitamin C intake (odds ratio, 0.233; 95% confidence interval, 0.094\u22120.576) in heavy smokers.", {"entities": []}], ["This large-scale national study suggests that dietary vitamin C provides protection against COPD, independent of smoking history, in the general Korean population.", {"entities": []}], ["Although the association between lead and cardiovascular disease is well established, potential mechanisms are still poorly understood.", {"entities": []}], ["Calcium metabolism plays a role in lead toxicity and thus, vitamin D receptor ( VDR ) polymorphisms have been suggested to modulate the association between lead and health outcomes.", {"entities": [[80, 83, "GENE"]]}], ["We investigated effect modification by VDR genetic polymorphisms in the association between cumulative lead exposure and pulse pressure, a marker of arterial stiffness.", {"entities": [[39, 42, "GENE"]]}], ["We examined 727 participants (3,100 observations from follow-ups from 1991 to 2011) from the Normative Aging Study (NAS), a longitudinal study of aging.", {"entities": []}], ["Tibia and patella bone lead levels were measured using K-x-ray fluorescence.", {"entities": []}], ["Four single nucleotide polymorphisms (SNPs) in the VDR gene, Bsm1 , Taq1 , Apa1 , and Fok1 , were genotyped.", {"entities": [[51, 54, "GENE"]]}], ["Linear mixed effects models with random intercepts were implemented to take into account repeated measurements.", {"entities": []}], ["Adjusting for potential confounders, pulse pressure was 2.5\u00a0mmHg (95% CI: 0.4-4.7) and 1.9\u00a0mmHg (95% CI: 0.1-3.8) greater per interquartile range (IQR) increase in tibia lead (15\u00a0\u03bcg/g) and patella lead (20\u00a0\u03bcg/g), respectively, in those with at least one minor frequency allele in Bsm1 compared with those with major frequency allele homozygotes.", {"entities": []}], ["The observed interaction effect between bone lead and the Bsm1 genotype persists over time during the follow-up.", {"entities": []}], ["Similar results were observed in effect modification by Taq1 .", {"entities": []}], ["This study suggests that subjects with the minor frequency alleles of VDR Bsm1 or Taq1 may be more susceptible to cumulative lead exposure-related elevated pulse pressure.", {"entities": [[70, 73, "GENE"]]}], ["The online version of this article (doi:10.1186/1476-069X-14-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Mast cells contain large amounts of fully active proteases that are stored in complex with serglycin proteoglycan in their secretory granules.", {"entities": []}], ["Upon degranulation, such serglycin:protease complexes are released to the extracellular space and can potentially have an impact on the local inflammatory reaction, either through direct effects of serglycin proteoglycan or through effects mediated by its bound proteases.", {"entities": []}], ["The objective of this study was to address this scenario by investigating the possibility that serglycin\u2010associated proteases can regulate levels of pro\u2010inflammatory cytokines.", {"entities": []}], ["Indeed, we show here that activated cultured peritoneal mast cells from wild type mice efficiently reduced the levels of exogenously administered IL\u20106 and IL\u201017A, whereas serglycin\u2010deficient mast cells lacked this ability.", {"entities": []}], ["Furthermore, our data suggest that the reduction of IL\u20106 and IL\u201017A concentrations is due to proteolytic degradation mediated by serglycin\u2010dependent serine proteases.", {"entities": []}], ["Moreover, we show that activated mast cells have the capacity to release IL\u20106 and that the levels of this cytokine in supernatants were markedly higher in cultures of serglycin\u2010deficient versus serglycin\u2010sufficient mast cells, suggesting that serglycin\u2010dependent serine proteases also participate in the regulation of endogenously produced IL\u20106.", {"entities": []}], ["In summary, although the general consensus is that mast cells have a pathogenic impact on inflammatory settings, this study identifies a role for a mast cell\u2010derived serglycin:serine protease axis in down\u2010regulating levels of major inflammatory cytokines.", {"entities": []}], ["These findings support the notion that mast cells could have a dual role in inflammatory settings, by both being able to secrete pathogenic compounds and being able to regulate their levels after release.", {"entities": []}], ["HbA1c is associated with cardiovascular risk in persons without diabetes and cardiovascular risk accumulates over the life course.", {"entities": []}], ["Therefore, insight in factors determining HbA1c from childhood onwards is important.", {"entities": []}], ["We investigated (lifestyle) determinants of HbA1c at age 12 years and the effects of growth on change in HbA1c and the tracking of HbA1c between the age of 8 and 12 years.", {"entities": []}], ["Anthropometric measurements were taken and HbA1c levels were assessed in 955 children without diabetes aged around 12 years participating in the PIAMA birth cohort study.", {"entities": []}], ["In 363 of these children HbA1c was also measured at age 8 years.", {"entities": []}], ["Data on parents and children were collected prospectively by questionnaires.", {"entities": []}], ["We found no significant association between known risk factors for diabetes and HbA1c at age 12 years.", {"entities": []}], ["Mean(SD) change in HbA1c between ages 8 and 12 years was 0.6(0.7) mmol/mol per year (or 0.1(0.1) %/yr).", {"entities": []}], ["Anthropometric measures at age 8 and their change between age 8 and 12 years were not associated with the change in HbA1c.", {"entities": []}], ["68.9% of the children remained in the same quintile or had an HbA1c one quintile higher or lower at age 8 years compared to age 12 years.", {"entities": []}], ["The lack of association between known risk factors for diabetes and HbA1c suggest that HbA1c in children without diabetes is relatively unaffected by factors associated with glycaemia.", {"entities": []}], ["HbA1c at age 8 years is by far the most important predictor of HbA1c at age 12.", {"entities": []}], ["Therefore, the ranking of HbA1c levels appear to be fairly stable over time.", {"entities": []}], ["(1) Background: A growing body of literature suggest that polymorphisms (SNPs) from inflammation-related genes could possibly play a role in cytokine production and then interact with dietary n -3 fatty acids (FAs) to modulate inflammation.", {"entities": [[210, 213, "GENE"]]}], ["The aim of the present study was to test whether gene expression of selected inflammatory genes was altered following an n -3 PUFA supplementation and to test for gene\u2013diet interactions modulating plasma inflammatory biomarker levels.", {"entities": []}], ["(2) Methods: 191 subjects completed a 6-week n -3 FA supplementation with 5 g/day of fish oil.", {"entities": []}], ["Gene expression of TNF -\u03b1 and IL6 was assessed in peripheral blood mononuclear cells (PBMCs) using the TaqMan technology.", {"entities": [[19, 22, "GENE"], [30, 33, "GENE"]]}], ["Genotyping of 20 SNPs from the TNF - LTA gene cluster, IL1 \u03b2, IL6 and CRP genes was performed.", {"entities": [[31, 34, "GENE"], [37, 40, "GENE"], [62, 65, "GENE"], [70, 73, "GENE"]]}], ["(3) Results: There was no significant reduction of plasma IL-6, TNF-\u03b1 and C-reactive protein (CRP) levels after the 6-week fish oil supplementation.", {"entities": [[94, 97, "GENE"]]}], ["TNF -\u03b1 and IL6 were slightly overexpressed in PBMCs after the supplementation (fold changes of 1.05 \u00b1 0.38 and 1.18 \u00b1 0.49, respectively ( n = 191)), but relative quantification (RQ) within the \u22120.5 to 2.0 fold are considered as nonbiologically significant.", {"entities": [[0, 3, "GENE"], [11, 14, "GENE"]]}], ["In a MIXED model for repeated measures adjusted for the effects of age, sex and BMI, gene by supplementation interaction effects were observed for rs1143627, rs16944, rs1800797, and rs2069840 on IL6 levels, for rs2229094 on TNF-\u03b1 levels and for rs1800629 on CRP levels ( p < 0.05 for all).", {"entities": [[195, 198, "GENE"], [258, 261, "GENE"]]}], ["(4) Conclusions: This study shows that a 6-week n -3 FA supplementation with 5 g/day of fish oil did not alter gene expression levels of TNF -\u03b1 and IL6 in PBMCs and did not have an impact on inflammatory biomarker levels.", {"entities": [[137, 140, "GENE"], [148, 151, "GENE"]]}], ["However, gene\u2013diet interactions were observed between SNPs within inflammation-related genes modulating plasma inflammatory biomarker levels.", {"entities": []}], ["In a recent observational study, we found that the risk of serious infection following anti\u2013tumor necrosis factor \u03b1 (anti-TNF\u03b1) therapy in patients with rheumatoid arthritis (RA) was not importantly increased compared with the background risk in routinely treated RA patients with similar disease severity.", {"entities": [[153, 173, "DISEASE"], [164, 173, "DISEASE"]]}], ["Observational data sets are, however, subject to a number of important biases related to selection factors for the timing of starting and stopping therapy.", {"entities": []}], ["Infection risk is also likely to vary with duration of therapy.", {"entities": []}], ["This study was undertaken to examine the influences of these biases and of the method of analysis on the risk of infection.", {"entities": []}], ["We compared the risk of serious infection in 8,659 patients treated with anti-TNF\u03b1 with that in 2,170 patients treated with traditional disease-modifying antirheumatic drugs (DMARDs) recruited to the British Society for Rheumatology Biologics Register.", {"entities": []}], ["We applied a number of statistical models in which we varied the length of the followup period by using different definitions of the date of discontinuation of treatment and different lag periods of risk following drug cessation.", {"entities": []}], ["When the at-risk period was defined as \u201creceiving treatment\u201d, the adjusted incidence rate ratio comparing patients receiving anti-TNF\u03b1 therapy with patients receiving DMARD therapy was 1.22 (95% confidence interval [95% CI] 0.88\u20131.69).", {"entities": []}], ["Limiting followup to the first 90 days, however, revealed an adjusted incidence rate ratio of 4.6 (95% CI 1.8\u201311.9).", {"entities": []}], ["Rates of infection were increased in the 90 days immediately following drug discontinuation and beyond, explained by selection factors for drug discontinuation.", {"entities": []}], ["These findings show that overall, the way in which UK rheumatologists select patients for starting and discontinuing anti-TNF\u03b1 therapy explains our previous finding of no increase in risk.", {"entities": []}], ["However, there may be important increases in true risk, notably early in the course of treatment, that would become more evident depending on the definition of at-risk period.", {"entities": []}], ["The primary objective of the present study was to evaluate the efficacy and safety of using acupressure as an adjunctive therapy to sodium valproate (SV) combined with acupressure (ASV) on the prevention of chronic migraine with aura (CMA).", {"entities": [[215, 233, "DISEASE"], [215, 223, "DISEASE"]]}], ["A total of 98 patients with CMA were randomly divided into an intervention group and a control group, with 49 patients in each group.", {"entities": []}], ["The patients in the intervention group received ASV, while the participants in the control group received SV alone.", {"entities": []}], ["The primary outcome was measured by the numeric rating scale (NRS).", {"entities": []}], ["The secondary outcomes including frequency of migraine attacks, the times of using analgesics, and quality of life, measured by the short-form 36 Health Survey Scale (SF-36) score.", {"entities": [[46, 54, "DISEASE"]]}], ["In addition, adverse events (AEs) were also recorded throughout the trial.", {"entities": []}], ["The outcomes were measured at the end of the 8-week treatment, and 4-week follow-up.", {"entities": []}], ["After the 8-week treatment and 4-week follow-up, ASV efficacy was not greater than that of SV alone regarding pain relief, as measured using the NRS, and frequency of migraine attacks, consumption of analgesics, and quality of life, as measured using the SF-36.", {"entities": [[167, 175, "DISEASE"]]}], ["However, ASV can significantly reduce the nausea when compared with SV ( P \u200a=\u200a.04).", {"entities": []}], ["The present results indicate that ASV can decrease migraine-related nausea during treatment, but cannot relieve pain or enhance quality of life in patients with CMA.", {"entities": [[51, 59, "DISEASE"]]}], ["Human placental stem villi (PSV) present contractile properties.", {"entities": []}], ["In vitro mechanics were investigated in 40 human PSV.", {"entities": []}], ["Contraction of PSV was induced by both KCl exposure (n\u200a=\u200a20) and electrical tetanic stimulation (n\u200a=\u200a20).", {"entities": []}], ["Isotonic contractions were registered at several load levels ranging from zero-load up to isometric load.", {"entities": []}], ["The tension-velocity relationship was found to be hyperbolic.", {"entities": []}], ["This made it possible to apply the A. Huxley formalism for determining the rate constants for myosin cross-bridge (CB) attachment and detachment, CB single force, catalytic constant, myosin content, and maximum myosin ATPase activity.", {"entities": []}], ["These molecular characteristics of myosin CBs did not differ under either KCl exposure or tetanus.", {"entities": [[90, 97, "DISEASE"], [42, 45, "GENE"]]}], ["A comparative approach was established from studies previously published in the literature and driven by mean of a similar method.", {"entities": []}], ["As compared to that described in mammalian striated muscles, we showed that in human PSV, myosin CB rate constants for attachment and detachment were about 10", {"entities": []}], ["The Global Burden of Disease 2010 and the WHO Global Health Estimates of years lived with disability (YLDs) uses disability-weights obtained from lay health-state descriptions, which cannot fully reflect different disease manifestations, according to severity, treatment, and environment.", {"entities": []}], ["The aim of this study was to provide population-representative YLDs of noncommunicable diseases and injuries using a prevalence-based approach, with the disability weight measured in subjects with specific diseases or injuries.", {"entities": []}], ["We included a total of 44969 adults, who completed the EQ-5D questionnaire as participation in the Korea National Health and Nutrition Examination Survey 2007\u20132014.", {"entities": []}], ["We estimated the prevalence of each of 40 conditions identified from the noncommunicable diseases and injuries in the WHO list.", {"entities": []}], ["Modified condition-specific disability-weight was determined from the adjusted mean difference of the EQ-5D index between the condition and reference groups.", {"entities": []}], ["Condition-specific YLDs were calculated as the condition\u2019s prevalence multiplied by the condition\u2019s disability-weight.", {"entities": []}], ["All-cause YLDs, estimated as \u201cnumber of population \u00d7 (1 \u2212 mean score of EQ-5D)\u201d were 2165 thousands in 39044 thousand adults aged \u226520.", {"entities": []}], ["The combined YLDs for all 40 conditions accounted for 67.6% of all-cause YLDs, and were 1604, 2126, 8749, and 12847 per 100000 young (age 20\u221259) males, young females, old (age \u226560) males, and old females, respectively.", {"entities": []}], ["Back pain/osteoarthritis YLDs were exceptionally large (442/40, 864/146, 2037/836, and 4644/3039 per 100000 young males, young females, old males, and old females, respectively).", {"entities": [[10, 24, "DISEASE"]]}], ["Back pain, osteoarthritis, depression, diabetes, periodontitis, and stroke accounted for 22.3%, 9.1%, 4.6%, 3.3%, 3.2%, and 2.9% of all-cause YLDs, respectively.", {"entities": [[49, 62, "DISEASE"], [11, 25, "DISEASE"]]}], ["In conclusion, this estimation of YLDs using prevalence rates and disability-weights measured in a population-representative survey may form the basis for population-level strategies to prevent age-related worsening of disability.", {"entities": []}], ["The mycobiome, referring primarily to the fungal biota in an environment, is an important component of the human microbiome.", {"entities": []}], ["Despite its importance, it has remained understudied.", {"entities": []}], ["New culture-independent approaches to determine microbial diversity, such as next-generation sequencing methods, are greatly broadening our view of fungal importance.", {"entities": []}], ["An integrative analysis of current studies shows that different body sites harbor specific fungal populations, and that diverse mycobiome patterns are associated with various diseases.", {"entities": []}], ["By interfacing with other biomes, as well as with the host, the mycobiome probably contributes to the progression of fungus-associated diseases and plays an important role in health and disease.", {"entities": []}], ["Anti-fibrotic therapeutic methods with safety and efficiency after glaucoma filtration surgery (GFS) are desirable.", {"entities": [[67, 75, "DISEASE"]]}], ["In our previous study, by using Human Tenon's Fibroblasts (HTFs) as a model, we proved the expression of peroxisome proliferator activates receptor-\u03b3 (PPAR-\u03b3) in HTFs; in addition, rosiglitazone (RSG), an agonist of PPAR-\u03b3, can inhibit transforming growth factors\u03b21 (TGF-\u03b21)-induced reactivation of HTFs, thus to inhibit specifically scarring after GFS through intervening TGF-\u03b2/Smads signal pathway.", {"entities": []}], ["However, a better drug delivery way of RSG, to prolong the duration of its function, and to reduce the toxicity of RSG to ocular tissue still remains challenges.", {"entities": []}], ["Low density lipoprotein receptor (LDLr) is strongly expressed in hyper-proliferation HTFs after GFS.", {"entities": [[34, 38, "GENE"]]}], ["Therefore, we structured targeting LDL-RSG complexes and channel them into HTFs through LDL-LDLr pathway in order to promote anti-proliferation of HTFs and reduce the toxicity to ocular tissue.", {"entities": []}], ["Meanwhile, in order to improve the release properties of LDL-RSG complexes, we structured slow release system of LDL-RSG/chitosan-calcium alginate - nanoparticles (CSNP), which effectively inhibited TGF-\u03b21-induced HTFs proliferation, synthesis of extracellular matrix and activation of TGF-\u03b21/SMAD pathway.", {"entities": []}], ["These data suggested that LDL-RSG/CSNP can be a new anti-fibrotic therapeutic method on scarring after GFS and also a novelty administration of RSG.", {"entities": []}], ["Asthma is a chronic airway disease characterized by inflammation, mucus hypersecretion and abnormal airway smooth muscle (ASM) contraction.", {"entities": [[0, 6, "DISEASE"]]}], ["Bacterial permeability family member A1, BPIFA1, is a secreted innate defence protein.", {"entities": []}], ["Here we show that BPIFA1 levels are reduced in sputum samples from asthmatic patients and that BPIFA1 is secreted basolaterally from healthy, but not asthmatic human bronchial epithelial cultures (HBECs), where it suppresses ASM contractility by binding to and inhibiting the Ca Bpifa1 Asthma is characterized by abnormal airway hyperresponsiveness.", {"entities": [[286, 292, "DISEASE"]]}], ["Here the authors identify BPIFA1 as a factor secreted by airway epithelial cells, and show that it regulates contractility of airway smooth muscle cells by binding to and regulating the Orai1 Ca", {"entities": [[186, 191, "GENE"]]}], ["To analyze the strength of association between self-rated health and six anthropometric and body composition measures to explore the best indicator.", {"entities": []}], ["Analyses were based on the cross-sectional data from the China Kadoorie Biobank Study and approximately 300,000 adults were analyzed.", {"entities": []}], ["Logistics regression was used to analyze the association between self-rated health (good or poor) and anthropometric and body composition measures (height, weight, body mass index (BMI), waist circumference (WC), hip circumference (HC) and body fat percentage, waist-to-hip ratio and waist-to-height ratio).", {"entities": []}], ["Stratified analyses were undertaken to understand the effect modification of socioeconomic status on the association.", {"entities": []}], ["Odds ratio of self-rated better health had an inverted U-shape association with weight, BMI, WC and body fat, with weight levels increasing until around 73.8 and 65.7\u00a0kg for male and female, BMI around 26.8\u00a0kg/m Being underweight and overweight are both risk factors for poor self-rated health in males and females, and weight is the best indicator of self-rated health compared with other measures.", {"entities": []}], ["Throughout evolution, both helminths and bacteria have inhabited our intestines.", {"entities": []}], ["As intestinal helminths and bacteria inhabit the same environmental niche, it is likely that these organisms interact with, and impact on, each other.", {"entities": []}], ["In addition, intestinal helminths are well known to alter intestinal physiology, permeability, mucous secretion and the production of antimicrobial peptides \u2013 all of which may impact on bacterial survival and spatial organization.", {"entities": []}], ["Yet despite rapid advances in our understanding of host\u2013intestinal bacteria interactions, the impact of helminths on this relationship has remained largely unexplored.", {"entities": []}], ["Moreover, although intestinal helminths are generally accepted to possess potent immuno\u2010modulatory activity, it is unknown whether this capacity requires interactions with intestinal bacteria.", {"entities": []}], ["We propose that this \u2018m\u00e9nage \u00e0 trois\u2019 situation is likely to have exerted a strong selective pressure on the development of our metabolic and immune systems.", {"entities": []}], ["Whilst such pressures remain in developing countries, the eradication of helminths in industrialized countries has shifted this evolutionary balance, possibly underlying the increased development of chronic inflammatory diseases.", {"entities": []}], ["Thus, helminth\u2013bacteria interactions may represent a key determinant of healthy homoeostasis.", {"entities": []}], ["In July 2009, French public health authorities embarked in a mass vaccination campaign against A/H1N1 2009 pandemic-influenza.", {"entities": [[116, 125, "DISEASE"]]}], ["We explored the attitudes and behaviors of the general population toward pandemic vaccination.", {"entities": []}], ["We conducted a cross-sectional online survey among 2,253 French representative adults aged 18 to 64 from November 17 to 25, 2009 (completion rate: 93.8%).", {"entities": []}], ["The main outcome was the acceptability of A/H1N1 vaccination as defined by previous receipt or intention to get vaccinated (\u201cYes, certainly\u201d, \u201cYes, probably\u201d).", {"entities": []}], ["Overall 17.0% (CI 95%, 15.5% to 18.7%) of respondents accepted A/H1N1 vaccination.", {"entities": []}], ["Independent factors associated with acceptability included: male sex (p\u200a=\u200a.0001); older age (p\u200a=\u200a.002); highest or lowest level of education (p\u200a=\u200a.016); non-clerical occupation (p\u200a=\u200a.011); having only one child (p\u200a=\u200a.008); and having received seasonal flu vaccination in prior 3 years (p<.0001).", {"entities": []}], ["Acceptability was also significantly higher among pregnant women (37.9%) and other at risk groups with chronic diseases (34.8%) (p\u200a=\u200a.002).", {"entities": []}], ["Only 35.5% of respondents perceived A/H1N1 influenza illness as a severe disease and 12.7% had experienced A/H1N1 cases in their close relationships with higher acceptability (p<.0001 and p\u200a=\u200a.006, respectively).", {"entities": [[43, 52, "DISEASE"]]}], ["In comparison to 26.0% respondents who did not consult their primary care physician, acceptability was significantly higher among 8.0% respondents who were formally advised to get vaccinated, and lower among 63.7% respondents who were not advised to get vaccinated (respectively: 15.8%, 59.5% and 11.7%- p<.0001).", {"entities": []}], ["Among respondents who refused vaccination, 71.2% expressed concerns about vaccine safety.", {"entities": []}], ["Our survey occurred one week before the peak of the pandemic in France.", {"entities": []}], ["We found that alarming public health messages aiming at increasing the perception of risk severity were counteracted by daily personal experience which did not confirm the threat, while vaccine safety was a major issue.", {"entities": []}], ["This dissonance may have been amplified by having not involved primary care physicians in the mass vaccination campaign.", {"entities": []}], ["Chronic pain is a common reason for consultation in general practice.", {"entities": []}], ["Current research distinguishes between chronic localized pain (CLP) and chronic widespread pain (CWP).", {"entities": []}], ["The aim of this study was to identify differences between CWP and chronic low back pain (CLBP), a common type of CLP, in primary care settings.", {"entities": []}], ["Fifty-eight German general practitioners (GPs) consecutively recruited all eligible patients who consulted for chronic low back pain during a 5-month period.", {"entities": []}], ["All patients received a questionnaire on sociodemographic data, pain characteristics, comorbidities, psychosomatic symptoms, and previous therapies.", {"entities": []}], ["GPs recruited 647 eligible patients where of a quarter (n\u2009=\u2009163, 25.2%) met the CWP criteria according to the American College of Rheumatology.", {"entities": []}], ["CWP patients had significantly more comorbidities and psychosomatic symptoms, showed longer pain duration, and suffered predominantly from permanent pain instead of distinguishable pain attacks.", {"entities": []}], ["CWP patients were more often females, are less working and reported a current pension application or a state-approved grade of disability more frequently.", {"entities": []}], ["We found no other differences in demographic parameters such as age, nationality, marital status, number of persons in household, education, health insurance status, or in health care utilization data.", {"entities": []}], ["This project is the largest study performed to date which analyzes differences between CLBP and CWP in primary care settings.", {"entities": []}], ["Our results showed that CWP is a frequent and particularly severe pain syndrome.", {"entities": [[71, 79, "DISEASE"]]}], ["German Clinical Trial Register, DRKS00003123 .", {"entities": []}], ["Western lifestyle is associated with high prevalence of allergy, asthma and other chronic inflammatory disorders.", {"entities": [[65, 71, "DISEASE"]]}], ["To explain this association, we tested the \u2018biodiversity hypothesis\u2019, which posits that reduced contact of children with environmental biodiversity, including environmental microbiota in natural habitats, has adverse consequences on the assembly of human commensal microbiota and its contribution to immune tolerance.", {"entities": []}], ["We analysed four study cohorts from Finland and Estonia ( n\u00a0 = \u00a0 1044) comprising children and adolescents aged 0.5\u201320\u00a0years.", {"entities": []}], ["The prevalence of atopic sensitization was assessed by measuring serum IgE specific to inhalant allergens.", {"entities": []}], ["We calculated the proportion of five land-use types \u2013 forest, agricultural land, built areas, wetlands and water bodies \u2013 in the landscape around the homes using the CORINE2006 classification.", {"entities": []}], ["The cover of forest and agricultural land within 2\u20135\u00a0km from the home was inversely and significantly associated with atopic sensitization.", {"entities": []}], ["This relationship was observed for children 6\u00a0years of age and older.", {"entities": []}], ["Land-use pattern explained 20% of the variation in the relative abundance of Proteobacteria on the skin of healthy individuals, supporting the hypothesis of a strong environmental effect on the commensal microbiota.", {"entities": []}], ["The amount of green environment (forest and agricultural land) around homes was inversely associated with the risk of atopic sensitization in children.", {"entities": []}], ["The results indicate that early-life exposure to green environments is especially important.", {"entities": []}], ["The environmental effect may be mediated via the effect of environmental microbiota on the commensal microbiota influencing immunotolerance.", {"entities": []}], ["The objective of this study was to evaluate associations between short-term (hourly) exposures to particulate matter with aerodynamic diameters < 2.5 \u03bcm (PM 2.5 ) and the fractional concentration of nitric oxide in exhaled breath (F e NO ) in children with asthma participating in an intensive panel study in Seattle, Washington.", {"entities": [[257, 263, "DISEASE"]]}], ["The exposure data were collected with tapered element oscillation microbalance (TEOM) PM 2.5 monitors operated by the local air agency at three sites in the Seattle area.", {"entities": []}], ["F e NO is a marker of airway inflammation and is elevated in individuals with asthma.", {"entities": [[78, 84, "DISEASE"]]}], ["Previously, we reported that offline measurements of F e NO are associated with 24-hr average PM 2.5 in a panel of 19 children with asthma in Seattle.", {"entities": [[132, 138, "DISEASE"]]}], ["In the present study using the same children, we used a polynomial distributed lag model to assess the association between hourly lags in PM 2.5 exposure and F e NO levels.", {"entities": []}], ["Our model controlled for age, ambient NO levels, temperature, relative humidity, and modification by use of inhaled corticosteroids.", {"entities": []}], ["We found that F e NO was associated with hourly averages of PM 2.5 up to 10\u201312 hr after exposure.", {"entities": [[79, 81, "GENE"]]}], ["The sum of the coefficients for the lag times associated with PM 2.5 in the distributed lag model was 7.0 ppm F e NO .", {"entities": []}], ["The single-lag-model F e NO effect was 6.9 [95% confidence interval (CI), 3.4 to 10.6 ppb] for a 1-hr lag, 6.3 (95% CI, 2.6 to 9.9 ppb ) for a 4-hr lag, and 0.5 (95% CI, \u22121.1 to 2.1 ppb) for an 8-hr lag.", {"entities": []}], ["These data provide new information concerning the lag structure between PM 2.5 exposure and a respiratory health outcome in children with asthma.", {"entities": [[138, 144, "DISEASE"]]}], ["This study was conducted to determine COPD severity at the time of diagnosis as confirmed by spirometry in patients treated in a US managed care setting.", {"entities": []}], ["All patients with one or more inpatient stays, one or more emergency department visits, or two or more outpatient visits with diagnosis codes for COPD during 1994\u20132006 were identified from the Lovelace Patient Database.", {"entities": []}], ["From this group, a subset of continuously enrolled patients with evidence in claims of a first available pulmonary function test or pulmonary clinic visit and a confirmatory claim for a COPD diagnosis was selected.", {"entities": []}], ["Medical chart abstraction was undertaken for this subset to gather information for diagnosis and severity staging of each patient based on the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for COPD.", {"entities": []}], ["Of the 12,491 patients with a primary or secondary COPD diagnosis between 1994 and 2006, there were 1520 continuously enrolled patients who comprised the study cohort.", {"entities": []}], ["Among the 648 eligible records from patients with evidence of a pulmonary function test, 366 were identified by spirometry as having COPD of GOLD stage I or higher (average percentage of predicted forced expiratory volume in 1 second: 60%): 19% were diagnosed at the stage of mild disease (GOLD stage I); 50% at moderate disease (GOLD stage II); and 31% at severe or very severe disease (GOLD stage III or IV, respectively).", {"entities": []}], ["The majority of patients in these groups were not receiving maintenance treatment.", {"entities": []}], ["The results demonstrate a very low incidence of early-stage diagnosis, confirmed by a pulmonary function test, of COPD in a large US sample and support calls for increased screening for COPD and treatment upon diagnosis.", {"entities": []}], ["Complications of pneumonia development in patients with chronic obstructive pulmonary disease (COPD) receiving inhaled corticosteroid (ICS) therapy have been documented.", {"entities": [[17, 26, "DISEASE"], [56, 93, "DISEASE"]]}], ["The aim of this study was to focus on clinical efficacy and the incidence of pneumonia between COPD patients receiving medium and high doses of ICS.", {"entities": [[77, 86, "DISEASE"]]}], ["This prospective, randomized study included COPD patients identified from three tertiary medical centers from 2010 to 2012.", {"entities": []}], ["The patients were randomized into two groups: high dose (HD; fluticasone 1,000 \u03bcg + salmeterol 100 \u03bcg/day) and medium dose (MD; fluticasone 500 \u03bcg + salmeterol 100 \u03bcg/day).", {"entities": []}], ["Lung function with forced expiratory volume in 1 second (FEV 1 ), forced vital capacity, and COPD-assessment test (CAT) were checked every 2 months.", {"entities": [[57, 60, "GENE"]]}], ["The frequency of acute exacerbations and number of pneumonia events were measured.", {"entities": [[51, 60, "DISEASE"]]}], ["The duration of the study period was 1 year.", {"entities": []}], ["In total, 237 COPD patients were randomized into the two treatment arms (115 in the HD group, 122 in the MD group).", {"entities": []}], ["The FEV 1 level was significantly improved in the patients in the HD group compared with those in the MD group (HD 103.9\u00b126.6 mL versus MD 51.4\u00b119.7 mL, P <0.01) at the end of the study.", {"entities": [[4, 7, "GENE"]]}], ["CAT scores were markedly improved in patients using an HD compared to those using an MD (HD 13\u00b15 versus MD 16\u00b17, P =0.05).", {"entities": []}], ["There was a significant difference in the percentage of annual rates in acute exacerbations (HD 0.16 versus MD 0.34, P <0.01) between the two groups.", {"entities": []}], ["The incidence of pneumonia was similar in the two groups (HD 0.08 versus MD 0.10, P =0.38).", {"entities": [[17, 26, "DISEASE"]]}], ["COPD patients treated with high doses of ICS had more treatment benefits and no significant increases in the incidence in pneumonia.", {"entities": [[122, 131, "DISEASE"]]}], ["Higher-dose ICS treatment may be suitable for COPD therapy.", {"entities": []}], ["Asthma is a common comorbid factor in sickle cell disease (SCD).", {"entities": [[0, 6, "DISEASE"], [59, 62, "GENE"]]}], ["However, the incidence of asthma in SCD is much higher than expected compared to rates in the general population.", {"entities": [[26, 32, "DISEASE"], [36, 39, "GENE"]]}], ["Whether \u201casthma\u201d in SCD is purely related to genetic and environmental factors or rather is the consequence of the underlying hemolytic and inflammatory state is a topic of recent debate.", {"entities": [[9, 15, "DISEASE"], [20, 23, "GENE"]]}], ["Regardless of the etiology, hypoxemia induced by bronchoconstriction and inflammation associated with asthma exacerbations will contribute to a cycle of sickling and subsequent complications of SCD.", {"entities": [[102, 108, "DISEASE"], [194, 197, "GENE"]]}], ["Recent studies confirm that asthma predisposes to complications of SCD such as pain crises, acute chest syndrome, and stroke and is associated with increased mortality.", {"entities": [[92, 112, "DISEASE"], [104, 112, "DISEASE"], [28, 34, "DISEASE"], [67, 70, "GENE"]]}], ["Early recognition and aggressive standard of care management of asthma may prevent serious pulmonary complications and reduce mortality.", {"entities": [[64, 70, "DISEASE"]]}], ["However, data regarding the management of asthma in SCD is very limited.", {"entities": [[42, 48, "DISEASE"], [52, 55, "GENE"]]}], ["Clinical trials are needed to evaluate the effectiveness of current asthma therapy in patients with SCD and coincident asthma, while mechanistic studies are needed to delineate the underlying pathophysiology.", {"entities": [[68, 74, "DISEASE"], [119, 125, "DISEASE"], [100, 103, "GENE"]]}], ["Behavioral coding of videotaped eating and feeding interactions can provide researchers with rich observational data and unique insights into eating behaviors, food intake, food selection as well as interpersonal and mealtime dynamics of children and their families.", {"entities": []}], ["Unlike self-report measures of eating and feeding practices, the coding of videotaped eating and feeding behaviors can allow for the quantitative and qualitative examinations of behaviors and practices that participants may not self-report.", {"entities": []}], ["While this methodology is increasingly more common, behavioral coding protocols and methodology are not widely shared in the literature.", {"entities": []}], ["This has important implications for validity and reliability of coding schemes across settings.", {"entities": []}], ["Additional guidance on how to design, implement, code and analyze videotaped eating and feeding behaviors could contribute to advancing the science of behavioral nutrition.", {"entities": []}], ["The objectives of this narrative review are to\u00a0review methodology for the design, operationalization, and coding of videotaped behavioral eating and feeding data in children and their families, and to highlight best practices.", {"entities": []}], ["When capturing eating and feeding behaviors through analysis of videotapes, it is important for the study and coding to be hypothesis driven.", {"entities": []}], ["Study design considerations include how to best capture the target behaviors through selection of a controlled experimental laboratory environment versus home mealtime, duration of video recording, number of observations to achieve reliability across eating episodes, as well as technical issues in video recording and sound quality.", {"entities": []}], ["Study design must also take into account plans for coding the target behaviors, which may include behavior frequency, duration, categorization or qualitative descriptors.", {"entities": []}], ["Coding scheme creation and refinement occur through an iterative process.", {"entities": []}], ["Reliability between coders can be challenging to achieve but is paramount to the scientific rigor of the methodology.", {"entities": []}], ["Analysis approach is dependent on the how data were coded and collapsed.", {"entities": []}], ["Behavioral coding of videotaped eating and feeding behaviors can capture rich data \u201cin-vivo\u201d that is otherwise unobtainable from self-report measures.", {"entities": []}], ["While data collection and coding are time-intensive the data yielded can be extremely valuable.", {"entities": []}], ["Additional sharing of methodology and coding schemes around eating and feeding behaviors could advance the science and field.", {"entities": []}], ["The knowledge of where particles deposit in the respiratory tract is crucial for understanding the health effects associated with inhaled drug particles.", {"entities": []}], ["An ex vivo study was conducted to assess regional deposition patterns (thoracic vs. extrathoracic) of radioactive polydisperse aerosols with different size ranges [0.15\u00a0\u03bcm\u20130.5\u00a0\u03bcm], [0.25\u00a0\u03bcm\u20131\u00a0\u03bcm] and [1\u00a0\u03bcm\u20139\u00a0\u03bcm].", {"entities": []}], ["SPECT/CT analyses were performed complementary in order to assess more precisely the regional deposition of aerosols within the pulmonary tract.", {"entities": []}], ["Experiments were set using an original respiratory tract model composed of a human plastinated head connected to an ex vivo porcine pulmonary tract.", {"entities": []}], ["The model was ventilated by passive expansion, simulating pleural depressions.", {"entities": []}], ["Aerosol was administered during nasal breathing.", {"entities": []}], ["Planar scintigraphies allowed to calculate the deposited aerosol fractions for particles in the three size ranges from sub-micron to micron The deposited fractions obtained, for thoracic vs. extra-thoracic regions respectively, were 89\u2009\u00b1\u20094\u00a0% vs. 11\u2009\u00b1\u20094\u00a0% for [0.15\u00a0\u03bcm\u20130.5\u00a0\u03bcm], 78\u2009\u00b1\u20095\u00a0% vs. 22\u2009\u00b1\u20095\u00a0% for [0.25\u00a0\u03bcm\u20131\u00a0\u03bcm] and 35\u2009\u00b1\u200911\u00a0% vs. 65\u2009\u00b1\u200911\u00a0% for [1\u00a0\u03bcm\u20139\u00a0\u03bcm].", {"entities": []}], ["Results obtained with this new ex vivo respiratory tract model are in good agreement with the in vivo data obtained in studies with baboons and humans.", {"entities": []}], ["Prior to the availability of generic third-generation cephalosporins, penicillins were widely used for treatment of pneumococcal meningitis in developing countries despite concerns about rising levels of penicillin resistance among pneumococcal isolates.", {"entities": [[129, 139, "DISEASE"]]}], ["We examined the impact of penicillin resistance on outcomes of pneumococcal meningitis over a ten year period in an infectious diseases hospital in Brazil.", {"entities": [[76, 86, "DISEASE"]]}], ["Clinical presentation, antimicrobial therapy and outcomes were reviewed for 548 patients with culture-confirmed pneumococcal meningitis from December, 1995, to November, 2005.", {"entities": [[125, 135, "DISEASE"]]}], ["Pneumococcal isolates from meningitis patients were defined as penicillin-resistant if Minimum Inhibitory Concentrations for penicillin were greater than 0.06 \u03bcg/ml.", {"entities": [[27, 37, "DISEASE"]]}], ["Proportional hazards regression was used to identify risk factors for fatal outcomes.", {"entities": []}], ["During the ten-year period, ceftriaxone replaced ampicillin as first-line therapy for suspected bacterial meningitis.", {"entities": [[106, 116, "DISEASE"], [96, 116, "DISEASE"]]}], ["In hospital case-fatality for pneumococcal meningitis was 37%.", {"entities": [[43, 53, "DISEASE"]]}], ["Of 548 pneumococcal isolates from meningitis cases, 92 (17%) were resistant to penicillin.", {"entities": [[34, 44, "DISEASE"]]}], ["After controlling for age and severity of disease at admission, penicillin resistance was associated with higher case-fatality (Hazard Ratio [HR], 1.62; 95% Confidence Interval [CI], 1.08-2.43).", {"entities": [[142, 144, "GENE"]]}], ["Penicillin-resistance remained associated with higher case-fatality when initial therapy included ceftriaxone (HR, 1.68; 95% CI 1.02-2.76).", {"entities": [[111, 113, "GENE"]]}], ["Findings support the use of third generation cephalosporin antibiotics for treatment of suspected pneumococcal meningitis even at low prevalence of pneumococcal resistance to penicillins.", {"entities": [[111, 121, "DISEASE"]]}], ["To determine the cut-off points for FEV 1 , FEV 0.75 , FEV 0.5 , and FEF 25-75% bronchodilator responses in healthy preschool children and to generate reference values for FEV 0.75 .", {"entities": [[36, 39, "GENE"], [44, 47, "GENE"], [55, 58, "GENE"], [172, 175, "GENE"], [36, 39, "GENE"], [44, 47, "GENE"], [55, 58, "GENE"], [172, 175, "GENE"], [36, 39, "GENE"], [44, 47, "GENE"], [55, 58, "GENE"], [172, 175, "GENE"], [36, 39, "GENE"], [44, 47, "GENE"], [55, 58, "GENE"], [172, 175, "GENE"]]}], ["This was a cross-sectional community-based study involving children 3-5 years of age.", {"entities": []}], ["Healthy preschool children were selected by a standardized questionnaire.", {"entities": []}], ["Spirometry was performed before and after bronchodilator use.", {"entities": []}], ["The cut-off point of the response was defined as the 95th percentile of the change in each parameter.", {"entities": []}], ["We recruited 266 children, 160 (60%) of whom were able to perform acceptable, reproducible expiratory maneuvers before and after bronchodilator use.", {"entities": []}], ["The mean age and height were 57.78 \u00b1 7.86 months and 106.56 \u00b1 6.43 cm, respectively.", {"entities": []}], ["The success rate for FEV 0.5 was 35%, 68%, and 70% in the 3-, 4-, and 5-year-olds, respectively.", {"entities": [[21, 24, "GENE"]]}], ["The 95th percentile of the change in the percentage of the predicted value in response to bronchodilator use was 11.6%, 16.0%, 8.5%, and 35.5% for FEV 1 , FEV 0.75 , FEV 0.5 , and FEF 25-75% , respectively.", {"entities": [[147, 150, "GENE"], [155, 158, "GENE"], [166, 169, "GENE"], [147, 150, "GENE"], [155, 158, "GENE"], [166, 169, "GENE"], [147, 150, "GENE"], [155, 158, "GENE"], [166, 169, "GENE"]]}], ["Our results provide cut-off points for bronchodilator responsiveness for FEV 1 , FEV 0.75 , FEV 0.5 , and FEF 25-75% in healthy preschool children.", {"entities": [[73, 76, "GENE"], [81, 84, "GENE"], [92, 95, "GENE"], [73, 76, "GENE"], [81, 84, "GENE"], [92, 95, "GENE"], [73, 76, "GENE"], [81, 84, "GENE"], [92, 95, "GENE"]]}], ["In addition, we proposed gender-specific reference equations for FEV 0.75 .", {"entities": [[65, 68, "GENE"]]}], ["Our findings could improve the physiological assessment of respiratory function in preschool children.", {"entities": []}], ["Families of children affected with atopic dermatitis (AD) often report fear and anxiety regarding treatment with topical corticosteroids (TCS), which may lead to reduced compliance.", {"entities": [[35, 52, "DISEASE"], [42, 52, "DISEASE"]]}], ["The objective of our study was to measure, through a standardized questionnaire, fear of TCS in families of pediatric patients with AD and to identify items associated with fear.", {"entities": []}], ["Families of pediatric patients with AD were enrolled in 9 Italian centers of pediatric dermatology.", {"entities": []}], ["Enrolled parents were invited to fill in a questionnaire including questions on sociodemographic and clinical characteristics and 3 sets of questions on corticosteroid phobia (general fear, specific fears, behaviours regarding TCS).", {"entities": []}], ["Determinants of the level of general fear were investigated through multivariable analysis.", {"entities": []}], ["A total of 300 outpatients with AD were enrolled.", {"entities": []}], ["Most parents (80%) had a high instruction level.", {"entities": []}], ["Eighty-one percent reported to have a certain amount of fear of TCS.", {"entities": []}], ["At the multivariable analysis, fear of TCS was associated with the following items: believing that TCS treatment advantages do not overweight disadvantages ( P \u2009=\u20090.011); believing that TCS may be dangerous independently from the specific side effect ( P \u2009<\u20090.001).", {"entities": []}], ["Moreover, TCS fear was associated with fear of applying too much cream ( P \u2009=\u20090.001).", {"entities": []}], ["TCS phobia is widespread among Italian families of children with AD.", {"entities": []}], ["Fear of TCS is associated with fear of applying too much cream, thus increasing the risk of poor compliance and treatment failure.", {"entities": []}], ["Therapeutic education of families on the use of TCS should be implemented.", {"entities": []}], ["The online version of this article (doi:10.1186/s13052-017-0330-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Immunoglobulin A deficiency (IgAD) is the most common primary immune deficiency disorder in both humans and dogs, characterized by recurrent mucosal tract infections and a predisposition for allergic and other immune mediated diseases.", {"entities": []}], ["In several dog breeds, low IgA levels have been observed at a high frequency and with a clinical resemblance to human IgAD.", {"entities": []}], ["In this study, we used genome-wide association studies (GWAS) to identify genomic regions associated with low IgA levels in dogs as a comparative model for human IgAD.", {"entities": []}], ["We used a novel percentile groups-approach to establish breed-specific cut-offs and to perform analyses in a close to continuous manner.", {"entities": []}], ["GWAS performed in four breeds prone to low IgA levels (German shepherd, Golden retriever, Labrador retriever and Shar-Pei) identified 35 genomic loci suggestively associated (p <0.0005) to IgA levels.", {"entities": []}], ["In German shepherd, three genomic regions (candidate genes include KIRREL3 and SERPINA9 ) were genome-wide significantly associated (p <0.0002) with IgA levels.", {"entities": [[67, 74, "GENE"], [79, 87, "GENE"]]}], ["A ~20kb long haplotype on CFA28, significantly associated (p = 0.0005) to IgA levels in Shar-Pei, was positioned within the first intron of the gene SLIT1 .", {"entities": [[149, 154, "GENE"]]}], ["Both KIRREL3 and SLIT1 are highly expressed in the central nervous system and in bone marrow and are potentially important during B-cell development.", {"entities": [[5, 12, "GENE"], [17, 22, "GENE"]]}], ["SERPINA9 expression is restricted to B-cells and peaks at the time-point when B-cells proliferate into antibody-producing plasma cells.", {"entities": [[0, 8, "GENE"]]}], ["The suggestively associated regions were enriched for genes in Gene Ontology gene sets involving inflammation and early immune cell development.", {"entities": []}], ["Soil-transmitted helminths (STH) infect more than 2 billion humans worldwide, causing significant morbidity in children.", {"entities": []}], ["There are few data on the epidemiology and risk factors for infection in pre-school children.", {"entities": []}], ["To investigate risk factors for infection in early childhood, we analysed data prospectively collected in the ECUAVIDA birth cohort in Ecuador.", {"entities": []}], ["Children were recruited at birth and followed up to 3 years of age with periodic collection of stool samples that were examined microscopically for STH parasites.", {"entities": []}], ["Data on social, demographic, and environmental risk factors were collected from the mother at time of enrolment.", {"entities": []}], ["Associations between exposures and detection of STH infections were analysed by multivariable logistic regression.", {"entities": []}], ["Data were analysed from 1,697 children for whom a stool sample was obtained at 3 years.", {"entities": []}], ["42.3% had at least one STH infection in the first 3 years of life and the most common infections were caused by A. lumbricoides (33.2% of children) and T. trichiura (21.2%).", {"entities": []}], ["Hookworm infection was detected in 0.9% of children.", {"entities": []}], ["Risk of STH infection was associated with factors indicative of poverty in our study population such as Afro-Ecuadorian ethnicity and low maternal educational level.", {"entities": []}], ["Maternal STH infections during pregnancy were strong risk factors for any childhood STH infection, infections with either A. lumbricoides or T. trichiura , and early age of first STH infection.", {"entities": []}], ["Children of mothers with moderate to high infections intensities with A. lumbricoides were most at risk.", {"entities": []}], ["Our data show high rates of infection with STH parasites during the first 3 years of life in an Ecuadorian birth cohort, an observation that was strongly associated with maternal STH infections during pregnancy.", {"entities": []}], ["The targeted treatment of women of childbearing age, in particular before pregnancy, with anthelmintic drugs could offer a novel approach to the prevention of STH infections in pre-school children.", {"entities": []}], ["Soil-transmitted helminths (STH) are intestinal worms that cause significant morbidity in school age and pre-school children in developing countries.", {"entities": []}], ["Infections are associated with poverty, particularly through lack of access to sanitation and clean drinking water.", {"entities": []}], ["Current control strategies rely on periodic anthelmintic treatment of schoolchildren but new strategies are required for STH control in young children.", {"entities": []}], ["There are few data on modifiable risk factors in pre-school children.", {"entities": []}], ["We investigated environmental and socioeconomic risk factors for STH infection in the first 3 years of life in a birth cohort from an STH-endemic region of Latin America.", {"entities": []}], ["Our data provide evidence that maternal STH infections documented during pregnancy are an important risk factor for infection in young children, raising the possibility of a novel intervention for the prevention of STH-associated morbidity in early childhood through the deworming of women of childbearing age, in particular before pregnancy.", {"entities": []}], ["The study aim was to compare lifestyle behaviors, body mass index (BMI) and perceived health in subjects with and without chronic bronchitis or emphysema, and to explore if these comparisons differed between demographic subgroups.", {"entities": [[130, 140, "DISEASE"]]}], ["A stratified two-stage sample of the population of Serbia was used; 14.522 adults aged \u226520 years were interviewed.", {"entities": []}], ["Compared with controls, respondents with chronic bronchitis or emphysema reported a 23% increased likelihood of eating fresh vegetables every day (CI 1.02-1.48), 58% increased likelihood of currently smoking (CI 1.32-1.88) and more likely to perceive their health as very bad or bad (OR 4.67, CI 3.64-5.98).", {"entities": [[49, 59, "DISEASE"]]}], ["After stratification for sex, education, and type of settlement, smoking was significantly associated with chronic bronchitis or emphysema in all subgroups except males.", {"entities": [[115, 125, "DISEASE"]]}], ["The increased likelihood of very bad or bad perceived health in respondents with chronic bronchitis or emphysema was significant in all subgroups, and was highest for respondents \u226465 years of age (adjusted OR 6.51; CI 4.87-8.72) and lowest for respondents >65 years of age (adjusted OR 3.25; CI 2.12-4.97).", {"entities": [[89, 99, "DISEASE"]]}], ["Efforts to enhance perceived health and healthy lifestyle behaviors in subjects with chronic bronchitis or emphysema are necessary.", {"entities": [[93, 103, "DISEASE"]]}], ["Special attention should be paid to smoking cessation in almost all demographic subgroups.", {"entities": []}], ["The replication of picornaviruses has been described to cause fragmentation of the Golgi apparatus that blocks the secretory pathway.", {"entities": []}], ["The inhibition of major histocompatibility complex class I upregulation and cytokine, chemokine and interferon secretion may have important implications for host defense.", {"entities": []}], ["Previous studies have shown that disruption of the secretory pathway can be replicated by expression of individual nonstructural proteins; however the situation with different serotypes of human rhinovirus (HRV) is unclear.", {"entities": []}], ["The expression of 3A protein from HRV14 or HRV2 did not cause Golgi apparatus disruption or a block in secretion, whereas other studies showed that infection of cells with HRV1A did cause Golgi apparatus disruption which was replicated by the expression of 3A.", {"entities": []}], ["HRV16 is the serotype most widely used in clinical HRV challenge studies; consequently, to address the issue of Golgi apparatus disruption for HRV16, we have systematically and quantitatively examined the effect of HRV16 on both Golgi apparatus fragmentation and protein secretion in HeLa cells.", {"entities": []}], ["First, we expressed each individual nonstructural protein and examined their cellular localization and their disruption of endoplasmic reticulum and Golgi apparatus architecture.", {"entities": []}], ["We quantified their effects on the secretory pathway by measuring secretion of the reporter protein Gaussia luciferase.", {"entities": []}], ["Finally, we examined the same outcomes following infection of cells with live virus.", {"entities": []}], ["We demonstrate that expression of HRV16 3A and 3AB and, to a lesser extent, 2B caused dispersal of the Golgi structure, and these three nonstructural proteins also inhibited protein secretion.", {"entities": []}], ["The infection of cells with HRV16 also caused significant Golgi apparatus dispersal; however, this did not result in the inhibition of protein secretion.", {"entities": []}], ["IMPORTANCE The ability of replicating picornaviruses to influence the function of the secretory pathway has important implications for host defense.", {"entities": []}], ["However, there appear to be differences between different members of the family and inconsistent results when comparing infection with live virus to expression of individual nonstructural proteins.", {"entities": []}], ["We demonstrate that individual nonstructural HRV16 proteins, when expressed in HeLa cells, can both fragment the Golgi apparatus and block secretion, whereas viral infection fragments the Golgi apparatus without blocking secretion.", {"entities": []}], ["This has major implications for how we interpret mechanistic evidence derived from the expression of single viral proteins.", {"entities": []}], ["Cyclic voltammetry (CV) and chronoamperometry (CA) have been used to sense and determine simultaneously L-ascorbic acid (AA) and acetaminophen (AC) at a boron-doped diamond electrode (BDDE) in a Britton-Robinson buffer solution.", {"entities": []}], ["The calibration plots of anodic current peak versus concentration obtained from CV and CA data for both investigated compounds in single and di-component solutions over the concentration range 0.01 mM \u2013 0.1 mM proved to be linear, with very good correlation parameters.", {"entities": []}], ["Sensitivity values and RSD of 2-3% were obtained for various situations, involving both individual and simultaneous presence of AA and AC.", {"entities": []}], ["The chronoamperometric technique associated with standard addition in sequential one step and/or two successive and continuous chronoamperograms at two characteristic potential levels represented a feasible option for the simultaneous determination of AA and AC in real sample systems such as pharmaceutical formulations.", {"entities": []}], ["The average values indicated by the supplier were confirmed to a very close approximation from chronoamperomgrams by using several additions with the application of suitable current correction factors.", {"entities": []}], ["Pen c 13, identified as a 33-kDa alkaline serine protease, is a major allergen secreted by Penicillium citrinum .", {"entities": []}], ["Detailed knowledge about the epitopes responsible for IgE binding would help inform the diagnosis/prognosis of fungal allergy and facilitate the rational design of hypoallergenic candidate vaccines.", {"entities": []}], ["The goal of the present study was to characterize the IgE epitopes of Pen c 13.", {"entities": []}], ["Serum samples were collected from 10 patients with mold allergy and positive Pen c 13 skin test results.", {"entities": []}], ["IgE-binding epitopes on rPen c 13 were mapped using an enzymatic digestion and chemical cleavage method, followed by dot-blotting and mass spectrometry.", {"entities": []}], ["A B-cell epitope-predicting server and molecular modeling were used to predict the residues most likely involved in IgE binding.", {"entities": []}], ["Theoretically predicted IgE-binding regions were further confirmed by site-directed mutagenesis assays.", {"entities": []}], ["At least twelve different IgE-binding epitopes located throughout Pen c 13 were identified.", {"entities": []}], ["Of these, peptides S16 (A Experimental analyses confirmed in silico- predicted residues involved in an important antigenic region of Pen c 13.", {"entities": []}], ["The G270A mutant of Pen c 13 has the potential to serve as an additional tool for the diagnosis/prognosis of mold allergy, and the K274A mutant, as a hypoallergenic form of the epitope, may provide a framework for the design and development of a safe and efficient therapeutic strategy for treating human allergic diseases.", {"entities": []}], ["The Patient Assessment of Chronic Illness Care (PACIC) survey is a patient-centered instrument for evaluating the quality and patient-centeredness of chronic illness care received according to the Chronic Care Model paradigm.", {"entities": []}], ["This study validates the Spanish translation of the PACIC in an urban, Spanish-speaking population.", {"entities": []}], ["One hundred Spanish-speaking patients with diabetes completed the translated PACIC and sociodemographic and cultural questionnaires.", {"entities": []}], ["Test-retest reliability was assessed in a subset of 20 patients who completed the questionnaire 2 to 4 months later.", {"entities": []}], ["Internal consistency was evaluated with Cronbach \u03b1. PACIC score and subscale associations with sociodemographic characteristics were examined.", {"entities": []}], ["Test-retest reliability for the overall translated PACIC scale was 0.77.", {"entities": []}], ["Scores were not associated with patient sociodemographic characteristics, including age, country of birth, years living in the United States, or education level ( P >.05).", {"entities": []}], ["The Spanish translation of the PACIC survey demonstrated high reliability, internal consistency, and test-retest reliability.", {"entities": []}], ["Scores showed no association with sociodemographic or cultural characteristics.", {"entities": []}], ["The Spanish version can reliably be used to assess care delivered according to the Chronic Care Model in a heterogeneous Spanish-speaking population.", {"entities": []}], ["The present study was designed to explore the interrelationship between single nucleotide polymorphisms (SNP) of the tumor necrosis factor superfamily (TNFSF) and its respective receptor superfamily (TNFRSF) genes and Behcet's disease (BD) and Vogt-Koyanagi-Harada syndrome (VKH) in Han Chinese.", {"entities": [[265, 273, "DISEASE"]]}], ["The study sample included 796 patients with BD, 792 patients with VKH syndrome, and 1604 healthy controls.", {"entities": [[70, 78, "DISEASE"]]}], ["The genotyping of 35 SNPs was performed by MassARRAY platform (Sequenom), iPLEX Gold Assay, PCR-restriction fragment length polymorphism assay and TaqMan SNP assay.", {"entities": []}], ["The mRNA expression levels of TNFSF4, TNFSF8 and TNFSF15 were analyzed by real-time PCR.", {"entities": [[30, 36, "GENE"], [38, 44, "GENE"], [49, 56, "GENE"]]}], ["The IL-6 and TNF-\u03b1 expression levels were measured by ELISA.", {"entities": []}], ["The A allele and AA genotype frequencies of TNFSF4 /rs1234313 were significantly increased, and the GG genotype frequency of rs1234313 was decreased in subjects with BD.", {"entities": [[44, 50, "GENE"]]}], ["Significantly lower frequencies of the C allele and the CC genotype and higher frequencies of the TT and CT genotypes of TNFSF15 /rs4246905 were observed in BD patients.", {"entities": [[121, 128, "GENE"]]}], ["A decreased frequency of the A allele of TNFSF8 /rs7028891 was observed in BD patients.", {"entities": [[41, 47, "GENE"]]}], ["The expression of TNFSF15 in CT carriers was significantly higher than that in CC/TT individuals.", {"entities": [[18, 25, "GENE"]]}], ["Increased IL-6 expression and TNF-\u03b1 production were found in the TNFSF15 CT carriers compared with the CC/TT genotype carriers.", {"entities": [[65, 72, "GENE"]]}], ["No significant differences were observed between the VKH patients and controls.", {"entities": []}], ["This study indicates that TNFSF4, TNFSF15 and TNFSF8 may participate in the susceptibility to BD among Han Chinese.", {"entities": [[26, 32, "GENE"], [34, 41, "GENE"], [46, 52, "GENE"]]}], ["We investigated the inhibitory effects of hydroquinone on cytokine release, phagocytosis, NO production, ROS generation, cell-cell/cell fibronectin adhesion, and lymphocyte proliferation.", {"entities": []}], ["We found that hydroquinone suppressed the production of proinflammatory cytokines [tumor necrosis factor (TNF)- \u03b1 , interleukin (IL)-1 \u03b2 , and IL-6], secretion of toxic molecules [nitric oxide (NO) and reactive oxygen species (ROS)], phagocytic uptake of FITC-labeled dextran, upregulation of costimulatory molecules, U937 cell-cell adhesion induced by CD18 and CD29, and the proliferation of lymphocytes from the bone marrow and spleen.", {"entities": [[106, 109, "GENE"]]}], ["Considering that (1) environmental chemical stressors reduce the immune response of chronic cigarette smokers and children against bacterial and viral infections and that (2) workers in petroleum factories are at higher risk for cancer, our data suggest that hydroquinone might pathologically inhibit inflammatory responses mediated by monocytes, macrophages, and lymphocytes.", {"entities": [[229, 235, "DISEASE"]]}], ["Nanosized dry powder inhalers provide higher stability for poorly water-soluble drugs as compared with liquid formulations.", {"entities": []}], ["However, the respirable particles must have a diameter of 1\u20135 \u03bcm in order to deposit in the lungs.", {"entities": []}], ["Controlled agglomeration of the nanoparticles increases their geometric particle size so they can deposit easily in the lungs.", {"entities": []}], ["In the lungs, they fall apart to reform nanoparticles, thus enhancing the dissolution rate of the drugs.", {"entities": []}], ["Theophylline is a bronchodilator with poor solubility in water.", {"entities": []}], ["Nanosized theophylline colloids were formed using an amphiphilic surfactant and destabilized using dilute sodium chloride solutions to form the agglomerates.", {"entities": []}], ["The theophylline nanoparticles thus obtained had an average particle size of 290 nm and a zeta potential of \u221239.5 mV, whereas the agglomerates were 2.47 \u03bcm in size with a zeta potential of \u221228.9 mV.", {"entities": []}], ["The release profile was found to follow first-order kinetics (r The results obtained lend support to the hypothesis that controlled agglomeration strategies provide an efficient approach for the delivery of poorly water-soluble drugs into the lungs.", {"entities": []}], ["The use of chromium supplements is widespread for the prevention and treatment of diabetes mellitus but there are conflicting reports on efficacy, possibly reflecting discrepant effects across different populations.", {"entities": [[82, 99, "DISEASE"]]}], ["In the present studies, we test the hypothesis that chromium supplementation raises serum chromium levels and correspondingly improves insulin sensitivity.", {"entities": []}], ["A double blind placebo-controlled randomized trial was conducted on 31 non-obese, normoglycemic subjects.", {"entities": []}], ["After baseline studies, the subjects were randomized to placebo or chromium picolinate 500 \u03bcg twice a day.", {"entities": []}], ["The primary endpoint was change in insulin sensitivity as measured by euglycemic hyperinsulinemic clamp.", {"entities": []}], ["Pre-specified secondary endpoints included fasting lipids, blood pressure, weight, body composition measured by DXA scan.", {"entities": []}], ["After 16 weeks of chromium picolinate therapy there was no significant change in insulin sensitivity between groups (p=0.83).", {"entities": []}], ["There was, however, a strong association between serum chromium and change in insulin resistance (\u03b2 = -0.83, p=0.01), where subjects with the highest serum chromium had a worsening of insulin sensitivity.", {"entities": []}], ["This effect could not be explained by changes in physiological parameters such as body weight, truncal fat and serum lipids with chromium therapy.", {"entities": []}], ["Chromium therapy did not improve insulin sensitivity in non-obese normoglycemic individuals.", {"entities": []}], ["Further, subjects who have high serum chromium levels paradoxically had a decline in insulin sensitivity.", {"entities": []}], ["Caution therefore should be exercised in recommending the use of this supplement.", {"entities": []}], ["The study was registered on the NIH registry (clinicaltrials.gov) and the identifier is NCT00846248", {"entities": []}], ["The aim of this study was to investigate the anti-inflammatory effects of Ursodeoxycholic acid (UDCA) in lipopolysaccharide (LPS)-stimulated RAW 264.7 macrophages.", {"entities": []}], ["We induced an inflammatory process in RAW 264.7 macrophages using LPS.", {"entities": []}], ["The anti-inflammatory effects of UDCA on LPS-stimulated RAW 264.7 macrophages were analyzed using nitric oxide (NO).", {"entities": []}], ["Pro-inflammatory and anti-inflammatory cytokines were analyzed by quantitative real time polymerase chain reaction (qRT-PCR) and enzyme-linked immunosorbent assay (ELISA).", {"entities": []}], ["The phosphorylations of extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 in mitogen-activated protein kinase (MAPK) signaling pathways and nuclear factor kappa-light polypeptide gene enhancer in B-cells inhibitor, alpha (I\u03baB\u03b1) signaling pathways were evaluated by western blot assays.", {"entities": []}], ["UDCA decreased the LPS-stimulated release of the inflammatory mediator NO.", {"entities": []}], ["UDCA also decreased the pro-inflammatory cytokines tumor necrosis factor-\u03b1 (TNF-\u03b1), interleukin 1-\u03b1 (IL-1\u03b1), interleukin 1-\u03b2 (IL-1\u03b2), and interleukin 6 (IL-6) in mRNA and protein levels.", {"entities": []}], ["In addition, UDCA increased an anti-inflammatory cytokine interleukin 10 (IL-10) in the LPS-stimulated RAW 264.7 macrophages.", {"entities": []}], ["UDCA inhibited the expression of inflammatory transcription factor nuclear factor kappa B (NF-\u03baB) in LPS-stimulated RAW 264.7 macrophages.", {"entities": []}], ["Furthermore, UDCA suppressed the phosphorylation of ERK, JNK, and p38 signals related to inflammatory pathways.", {"entities": []}], ["In addition, the phosphorylation of I\u03baB\u03b1, the inhibitor of NF-\u03baB, also inhibited by UDCA.", {"entities": []}], ["UDCA inhibits the pro-inflammatory responses by LPS in RAW 264.7 macrophages.", {"entities": []}], ["UDCA also suppresses the phosphorylation by LPS on ERK, JNK, and p38 in MAPKs and NF-\u03baB pathway.", {"entities": []}], ["These results suggest that UDCA can serve as a useful anti-inflammatory drug.", {"entities": []}], ["Background : Sleep-related breathing disorders (SRBD) have been identified as a major public health problem closely related to adolescent obesity.", {"entities": [[138, 145, "DISEASE"]]}], ["We aimed to estimate the prevalences of SRBD and snoring in adolescents in Changchun City, Northeastern China, and to evaluate the associated factors in this population.", {"entities": []}], ["Methods: In total, 1955 adolescents aged 11\u201318 years were recruited in Changchun City using stratified cluster sampling.", {"entities": []}], ["Parents and caretakers of children completed the questionnaires, which included demographic characteristics, anthropometric parameters and a pediatric sleep questionnaire (SRBD scale).", {"entities": []}], ["Logistic regression was used to analyze the relationship between SRBD, snoring and other factors.", {"entities": []}], ["Results: The prevalences of SRBD and snoring in our population were 3.7% and 3.3%, respectively, and the prevalences of overweight and obesity were 12.6% and 4.9%.", {"entities": [[135, 142, "DISEASE"]]}], ["Multivariate logistic regression showed that urban residence (OR = 2.356, 95%CI: 1.251\u20134.435) and post-term birth (OR = 3.275, 95%CI: 1.396\u20137.683) were significantly associated with SRBD.", {"entities": []}], ["Preterm birth (OR = 2.255, 95%CI: 1.021\u20134.980) and parental education level of university and above (OR = 0.265, 95%CI: 0.083\u20130.850) were significantly associated with snoring.", {"entities": []}], ["Overweight (OR = 2.063, 95%CI: 1.062\u20134.006) was also related to snoring.", {"entities": []}], ["Conclusions : The prevalences of SRBD and snoring were similar to those reported in previous studies.", {"entities": []}], ["Urban residence and post-term birth were important influencing factors for SRBD; overweight, highest parental education level (university and above) and preterm birth were key factors affecting snoring in adolescents.", {"entities": []}], ["Roflumilast is a phosphodiesterase-4 inhibitor, which can decrease exacerbation in patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[97, 134, "DISEASE"]]}], ["However, adverse effects are a major barrier to medication use, and little is known regarding the risk factors for discontinuation of roflumilast in COPD patients.", {"entities": []}], ["A search of the clinical databases identified all patients who were prescribed roflumilast between December 2012 and April 2015 in the four hospitals of The Catholic University of Korea, Korea.", {"entities": []}], ["The study subjects were limited to patients who had taken 500 \u03bcg of roflumilast.", {"entities": []}], ["We studied the factors associated with drug discontinuation and drug adverse events by univariate and multivariate analyses.", {"entities": []}], ["Among 154 eligible patients, 54 (35.1%) discontinued their roflumilast prescription.", {"entities": []}], ["Most patients were elderly, male, current or former smokers, and had moderate-to-severe airflow limitation.", {"entities": []}], ["Low\u2013body mass index (BMI) patients were more likely to undergo drug discontinuation (1-unit decrease in BMI: odds ratio [OR] =1.165, p =0.006; BMI <23 kg/m p =0.004).", {"entities": []}], ["Fifty-five patients (35.7%) had adverse events.", {"entities": []}], ["Loss of appetite, diarrhea, nausea, headache, and weight loss were the most frequent adverse events.", {"entities": [[18, 26, "DISEASE"]]}], ["Low-BMI patients were more likely to experience adverse events (1-unit decrease in BMI: OR =1.151, p =0.010; BMI <23 kg/m p =0.009).", {"entities": []}], ["The patient discontinuation and adverse events rates in this study were higher than in previous randomized controlled studies.", {"entities": []}], ["Discontinuation of roflumilast in ethnic Koreans is more likely to occur in low-BMI patients.", {"entities": []}], ["In a clinical setting, low-BMI patients can more easily discontinue roflumilast; clinicians should, therefore, provide greater care for these patients.", {"entities": []}], ["Both the T cell immunoglobulin domain- and mucin domain-containing molecule-3 (Tim-3) and the death receptor Fas contribute to the pathogenesis of various autoimmune diseases, including systemic lupus erythematosus (SLE).", {"entities": [[195, 214, "DISEASE"], [186, 214, "DISEASE"], [109, 112, "GENE"]]}], ["The aim of the present study was to determine whether Tim-3 and Fas are co-expressed on certain peripheral T lymphocyte subsets, and whether this expression is associated with greater disease activity in SLE.", {"entities": [[64, 67, "GENE"]]}], ["Peripheral blood mononuclear cells were isolated from 46 patients newly diagnosed with SLE and 28 age- and sex-matched healthy controls (HCs).", {"entities": []}], ["Expression of Tim-3 and Fas on T subsets was analyzed by flow cytometry, while mRNA levels of the Tim-3 ligand galectin-9 and Fas ligand FasL were assayed using real-time RT-PCR.", {"entities": [[24, 27, "GENE"], [126, 129, "GENE"], [24, 27, "GENE"], [126, 129, "GENE"]]}], ["The proportions of CD3 Expression of Tim-3 and co-expression of Tim-3 and Fas on certain peripheral T subsets are associated with disease activity in SLE patients.", {"entities": [[74, 77, "GENE"]]}], ["Future research should examine whether the same is true of other T subsets implicated in SLE, and should explore the potential role(s) of Tim-3 in the disease pathway.", {"entities": []}], ["http://www.diagnosticpathology.diagnomx.eu/vs/1855527845145188", {"entities": []}], ["In multidrug regimens, including an intravenous aminoglycoside (e.g.", {"entities": []}], ["amikacin [AMK]) is recommended for difficult-to-treat non-tuberculous mycobacterial (NTM) lung diseases.", {"entities": [[85, 88, "GENE"]]}], ["We aimed to evaluate the efficacy, safety, and feasibility of inhaled AMK therapy in patients with difficult-to-treat NTM lung diseases in a retrospective chart review.", {"entities": [[118, 121, "GENE"]]}], ["The study population consisted of patients with NTM lung diseases who received combination therapy, including inhaled AMK therapy, at Keio University Hospital (Tokyo, Japan), from January 2014 through May 2016.", {"entities": [[48, 51, "GENE"]]}], ["A total of 26 cases, consisting of 23 Mycobacterium avium complex (MAC) and three Mycobacterium abscessus complex (MABC) infections cases, were included in this study.", {"entities": []}], ["The efficacy, safety, and feasibility of inhaled AMK therapy were retrospectively investigated.", {"entities": []}], ["The Research Ethics Committee of Keio University Hospital approved this study, and informed consent was obtained from all patients.", {"entities": []}], ["All 26 patients were culture-positive at enrolment.", {"entities": []}], ["Twenty-three of the 26 patients (88.5%), including 21/23 MAC patients (91.3%) and 2/3 MABC patients (66.7%), were administered inhaled AMK therapy for >3\u00a0months.", {"entities": []}], ["The proportion of patients who had clinical symptoms, including, cough and sputum, declined after inhalation AMK therapy.", {"entities": []}], ["Ten of the 23 patients (43.5%) who received AMK inhalation, including 8/21 MAC (38.1%) and 2/2 MABC patients (100%), showed sputum conversion, defined as at least three consecutive negative sputum cultures.", {"entities": []}], ["Seven of the 23 patients, including, 5/21 MAC and 2/2 MABC patients, showed improvements in high-resolution computed tomography imaging of the chest.", {"entities": []}], ["In addition, the serum AMK trough levels before the second inhalation were <1.2\u00a0\u03bcg/mL in all 26 patients, with no occurrence of severe adverse events, such as renal toxicity.", {"entities": []}], ["One patient (3.8%) experienced auditory toxicity, in the form of tinnitus.", {"entities": []}], ["However, this symptom was reversible, after temporary interruption of AMK, the patient was able to safely resume the therapy.", {"entities": []}], ["Inhaled AMK therapy is an effective and feasible therapy for difficult-to-treat NTM lung disease.", {"entities": [[84, 96, "DISEASE"], [80, 83, "GENE"]]}], ["The online version of this article (doi:10.1186/s12879-017-2665-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Recruiting family physicians to participate as subjects of clinical studies is challenging.", {"entities": []}], ["Monetary incentives are often used to increase enrolment, but few studies have measured the impact of doing so.", {"entities": []}], ["As part of a trial seeking to compare two formats of interactive activities within an online continuing medical education (CME) program, we compared family physicians\u2019 recruitment rates with and without a monetary incentive.", {"entities": []}], ["Recruitment took place by email.", {"entities": []}], ["Family physicians listed in the directory of the College of Physicians of the Province of Quebec (Canada) were emailed a one-page letter inviting them to participate in a randomized trial designed to evaluate a three-hour online CME program on rheumatology.", {"entities": []}], ["Half of physicians were randomly allocated to receive a version of the letter that offered them $300 to participate (incentive group); the other half was not offered compensation (no-incentive group).", {"entities": []}], ["A total of 1314 (91%) physicians had a valid email address as listed in the directory.", {"entities": []}], ["The response rate was 7.5% (54/724) in the incentive group and 2.6% (19/724) in the no-incentive group (absolute difference [AD] 4.8%, 95% confidence interval [95% CI]\u2009=\u20092.6 \u2013 7.2%; risk ratio [RR] 2.8, 95% CI\u2009=\u20091.7 - 4.7).", {"entities": []}], ["Recruitment rates were 3.5% (25/724) in the incentive group and 0.6% (4/724) in the no-incentive group (AD 2.9%, 95% CI\u2009=\u20091.5 - 4.5%; RR 6.3, 95% CI\u2009=\u20092.2 - 17.9).", {"entities": []}], ["Monetary incentives significantly increased recruitment, which nonetheless remained low.", {"entities": []}], ["To reach recruitment targets, researchers are advised to plan for an extensive list of email contacts and to minimize restrictive eligibility criteria.", {"entities": []}], ["The paper presents the process of translation and cultural adaptation of the Religious Coping Questionnaire (the RCOPE) by Pargament et al.", {"entities": []}], ["The eruptions of Eyjafjallaj\u00f6kull (2010) and Gr\u00edmsv\u00f6tn (2011), Iceland, triggered immediate, international consideration of the respiratory health hazard of inhaling volcanic ash, and prompted the need to estimate the potential hazard posed by future eruptions of Iceland\u2019s volcanoes to Icelandic and Northern European populations.", {"entities": []}], ["A physicochemical characterization and toxicological assessment was conducted on a suite of archived ash samples spanning the spectrum of past eruptions (basaltic to rhyolitic magmatic composition) of Icelandic volcanoes following a protocol specifically designed by the International Volcanic Health Hazard Network.", {"entities": []}], ["Icelandic ash can be of a respirable size (up to 11.3 vol.%\u00a0<\u00a04\u00a0\u03bcm), but the samples did not display physicochemical characteristics of pathogenic particulate in terms of composition or morphology.", {"entities": []}], ["Ash particles were generally angular, being composed of fragmented glass and crystals.", {"entities": []}], ["Few fiber-like particles were observed, but those present comprised glass or sodium oxides, and are not related to pathogenic natural fibers, like asbestos or fibrous zeolites, thereby limiting concern of associated respiratory diseases.", {"entities": []}], ["None of the samples contained cristobalite or tridymite, and only one sample contained quartz, minerals of interest due to the potential to cause silicosis.", {"entities": [[146, 155, "DISEASE"]]}], ["Sample surface areas are low, ranging from 0.4 to 1.6\u00a0m The primary particle-specific concern is the potential for future eruptions of Iceland\u2019s volcanoes to generate fine, respirable material and, thus, to increase ambient PM concentrations.", {"entities": []}], ["This particularly applies to highly explosive silicic eruptions, but can also hold true for explosive basaltic eruptions or discrete events associated with basaltic fissure eruptions.", {"entities": []}], ["Serous carcinoma arising in adenomyosis and adenomyotic cyst is very rare.", {"entities": [[7, 16, "DISEASE"]]}], ["Only 3 serous carcinomas and 5 serous endometrial intraepithelial carcinomas (EIC) have been reported to date.", {"entities": []}], ["We reviewed the clinicopathological features of 2 serous carcinoma in uterine adenomyosis and 1 serous EIC in adenomyotic cyst of the cervical stump.", {"entities": [[57, 66, "DISEASE"]]}], ["Case 1 had an endometrial serous carcinoma in the uterine myometrium and the left ovary.", {"entities": [[33, 42, "DISEASE"]]}], ["A minor component of benign endometrial glands with minimal endometrial stroma was found in the uterine mass and the surrounding myometrium.", {"entities": []}], ["Case 2 showed 3 small foci of serous carcinoma, serous EIC and endometrial glandular dysplasia (EmGD) in the adenomyosis.", {"entities": [[37, 46, "DISEASE"]]}], ["Scanty serous carcinoma was present in the endometrium without evidence of myometrial invasion.", {"entities": [[14, 23, "DISEASE"]]}], ["The eutopic endometrium in both case 1 and 2 had no evidence of neoplastic changes after complete examination.", {"entities": []}], ["Case 3 had 3 microscopic serous EICs in the adenomyotic cysts of the cervical stump.", {"entities": []}], ["One EIC lesion coexisted with EmGD.", {"entities": []}], ["No cancer was found in the endocervical tube although the preoperative endocervical biopsy showed a poorly differentiated endometrioid carcinoma.", {"entities": [[135, 144, "DISEASE"], [3, 9, "DISEASE"]]}], ["Immunohistochemistry demonstrated that serous carcinoma in case 1 and EIC in all 3 cases showed a characteristic pattern of p53 and p16 over expression, high Ki67 index, and lack of WT1, ER and PR staining.", {"entities": [[46, 55, "DISEASE"], [182, 185, "GENE"]]}], ["EmGD in case 1 and 3 had a similar staining pattern except a lower Ki67 index and the presence of ER expression.", {"entities": []}], ["We believe that this case series may expand our recognition on serous carcinoma arising in uterine adenomyosis/adenomyotic cyst including extra-uterine spread and the potential synchronous growth of carcinomas in eutopic endometrium.", {"entities": [[70, 79, "DISEASE"]]}], ["Although allergic rhinitis (AR) is recognized as a growing global health disease with considerable importance for patients\u2019 lives, especially among children and adolescents, there is a lack of population studies concerning symptomatology patterns of the disease.", {"entities": [[9, 26, "DISEASE"], [18, 26, "DISEASE"]]}], ["The present study aimed to explore symptoms prevalence among school-aged children, to detect any correlation between allergen sensitivities with symptomatology patterns, and, finally, to evaluate the association of the sensitivity grade score with symptoms severity or seasonality.", {"entities": []}], ["This was a cross-sectional, observational study in a childhood population.", {"entities": []}], ["The first stage included recruitment of children and parental-completed questionnaires.", {"entities": []}], ["The second stage included skin-prick tests for the most common allergens.", {"entities": []}], ["Severity of symptoms was self-evaluated using a scale that ranged from \u201c0\u201d (no symptoms), \u201c1\u201d (mild), and \u201c2\u201d (moderate-to-severe).", {"entities": []}], ["AR was classified as seasonal (SAR) or perennial (PAR).", {"entities": []}], ["The most frequent symptoms were reported for nasal obstruction, sneezing, and rhinorrhea.", {"entities": []}], ["All nasal symptoms were significantly more profound among children with HDM sensitivity.", {"entities": []}], ["However, more symptoms, not only nasal, but also ocular and general ones, were detected among patients with grass pollen sensitivity.", {"entities": []}], ["Patients with PAR reported more severe symptoms.", {"entities": []}], ["SAR was associated with mild disease.", {"entities": []}], ["Finally, the sensitivity grade score was significantly correlated with symptom severity.", {"entities": []}], ["Our results suggest that allergen sensitivity may be correlated with symptomatology patterns among children who have allergic rhinitis.", {"entities": [[117, 134, "DISEASE"], [126, 134, "DISEASE"]]}], ["Mechanical pain serves as a base clinical symptom for many of the world\u2019s most debilitating syndromes.", {"entities": []}], ["Ion channels expressed by peripheral sensory neurons largely contribute to mechanical hypersensitivity.", {"entities": []}], ["Transient Receptor Potential A 1 (TRPA1) is a ligand-gated ion channel that contributes to inflammatory mechanical hypersensitivity, yet little is known as to the post-translational mechanism behind its somatosensitization.", {"entities": [[34, 39, "GENE"]]}], ["Here, we utilize biochemical, electrophysiological, and behavioral measures to demonstrate that metabotropic glutamate receptor-induced sensitization of TRPA1 nociceptors stimulates targeted modification of the receptor.", {"entities": [[153, 158, "GENE"]]}], ["Type 1 mGluR5 activation increases TRPA1 receptor agonist sensitivity in an AKA-dependent manner.", {"entities": [[35, 40, "GENE"]]}], ["As a scaffolding protein for Protein Kinases A and C (PKA and PKC, respectively), AKAP facilitates phosphorylation and sensitization of TRPA1 in ex vivo sensory neuronal preparations.", {"entities": [[136, 141, "GENE"]]}], ["Furthermore, hyperalgesic priming of mechanical hypersensitivity requires both TRPA1 and AKAP.", {"entities": [[79, 84, "GENE"]]}], ["Collectively, these results identify a novel AKAP-mediated biochemical mechanism that increases TRPA1 sensitivity in peripheral sensory neurons, and likely contributes to persistent mechanical hypersensitivity.", {"entities": [[96, 101, "GENE"]]}], ["Population-based data on hospital admissions for children aged 0-17 years concerning all respiratory diseases are scarce.", {"entities": []}], ["This study examined hospital admissions in relation to the preceding consultations in general practice in this age group.", {"entities": []}], ["Data on children aged 0-17 years with respiratory diseases included in the Second Dutch National Survey of General Practice (DNSGP-2) were linked to all hospital admissions in the Dutch National Medical Registration.", {"entities": []}], ["Admission rates for respiratory diseases were calculated.", {"entities": []}], ["Data were analysed using multivariate logistic regression.", {"entities": []}], ["Of all 79,272 children within the DNSGP-2, 1.8% were admitted to hospital for any respiratory diagnosis.", {"entities": []}], ["The highest admission rates per 1000 children were for chronic disease of tonsils and adenoids (12.9); pneumonia and influenza (0.97); and asthma (0.92).", {"entities": [[117, 126, "DISEASE"], [103, 112, "DISEASE"], [139, 145, "DISEASE"]]}], ["Children aged 0-4 years and boys were admitted more frequently.", {"entities": []}], ["Of children with asthma, 2.3% were admitted for respiratory diseases.", {"entities": [[17, 23, "DISEASE"]]}], ["For asthma, admission rates varied by urbanisation level: 0.47/1000 children/year in cities with \u2264 30,000 inhabitants, 1.12 for cities with \u2265 50,000 inhabitants, and 1.73 for the three largest cities (p = 0.002).", {"entities": [[4, 10, "DISEASE"]]}], ["Multivariate logistic regression showed that within two weeks after a GP consultation, younger age (OR 0.81, 95% CI 0.76-0.88) and more severe respiratory diseases (5.55, 95% CI 2.99-8.11) predicted hospital admission.", {"entities": []}], ["Children in the general population with respiratory diseases (especially asthma) had very low hospital admission rates.", {"entities": [[73, 79, "DISEASE"]]}], ["In urban regions children were more frequently admitted due to respiratory morbidity.", {"entities": []}], ["For effectiveness studies in a primary care setting, hospital admission rates should not be used as quality end-point.", {"entities": []}], ["Emerging evidence suggests that vitamin D might be implicated in asthma pathophysiology.", {"entities": [[65, 71, "DISEASE"]]}], ["This study aims to compare Vitamin D mean serum levels and status between asthmatic and non-asthmatic adolescents and investigate the association of vitamin D with asthma severity.", {"entities": [[164, 170, "DISEASE"]]}], ["In a cohort of adolescents aged 16\u201317 years, those reporting wheezing in the past 12\u00a0months and Ever asthma on the ISAAC questionnaire were invited to participate and formed the Active Asthmatics group.", {"entities": [[101, 107, "DISEASE"]]}], ["Controls were selected amongst Never Wheezers/Never Asthmatics (NWNA).", {"entities": []}], ["Differences in mean 25(OH)D serum levels and vitamin D status between AA and NWNA were examined in multivariate linear and logistic regression models respectively, adjusting for potential confounders.", {"entities": []}], ["Within AA, differences in vitamin D levels were assessed across asthma severity indicators.", {"entities": [[64, 70, "DISEASE"]]}], ["A total of 69 AA and 671 NWNA participated in the study.", {"entities": []}], ["Unadjusted mean 25(OH)D serum levels were 22.90 (SD 6.41), and 21.15 (SD 5.59) ng/mL in NWNA and AA respectively (p\u2009=\u20090.03).", {"entities": []}], ["In adjusted models, mean 25(OH)D levels remained significantly lower amongst AA compared to NWNA (adjusted beta coefficient \u22121.68, 95% CI \u22123.24, \u22120.13).", {"entities": []}], ["Severe (<12\u00a0ng/mL), moderate (<25\u00a0ng/mL) or insufficient (<30\u00a0ng/mL) vitamin D status was more prevalent among AA who were 1.6 times (95% CI 1.01, 2.53) more likely to belong to a lower vitamin D category compared to NWNA.", {"entities": []}], ["Within AA, there was a negative trend between vitamin D levels and the number of reported asthma severity indicators.", {"entities": [[90, 96, "DISEASE"]]}], ["Levels of vitamin D tend to be lower among asthmatic compared to non-asthmatic children and in those with severe asthma independent of important confounders.", {"entities": [[113, 119, "DISEASE"]]}], ["The high costs and environmental concerns associated with using marine resources as sources of oils rich in polyunsaturated fatty acids have prompted searches for alternative sources of such oils.", {"entities": []}], ["Some microorganisms, among them members of the genus Aurantiochytrium , can synthesize large amounts of these biocompounds.", {"entities": []}], ["However, various parameters that affect the polyunsaturated fatty acids production of these organisms, such as the carbon and nitrogen sources supplied during their cultivation, require further elucidation.", {"entities": []}], ["The objective of this investigation was to study the effect of different concentrations of carbon and total nitrogen on the production of polyunsaturated fatty acids, particularly docosahexaenoic acid, by Aurantiochytrium sp.", {"entities": []}], ["ATCC PRA-276.", {"entities": []}], ["We performed batch system experiments using an initial glucose concentration of 30\u00a0g/L and three different concentrations of total nitrogen, including 3.0, 0.44, and 0.22\u00a0g/L, and fed-batch system experiments in which 0.14\u00a0g/L of glucose and 0.0014\u00a0g/L of total nitrogen were supplied hourly.", {"entities": []}], ["To assess the effects of these different treatments, we determined the biomass, glucose, total nitrogen and polyunsaturated fatty acids concentration.", {"entities": []}], ["The maximum cell concentration (23.9\u00a0g/L) was obtained after 96\u00a0h of cultivation in the batch system using initial concentrations of 0.22\u00a0g/L total nitrogen and 30\u00a0g/L glucose.", {"entities": []}], ["Under these conditions, we observed the highest level of polyunsaturated fatty acids production (3.6\u00a0g/L), with docosahexaenoic acid and docosapentaenoic acid \u03c96 concentrations reaching 2.54 and 0.80\u00a0g/L, respectively.", {"entities": []}], ["Many people with diabetes have suboptimal glycaemic control due to not being adherent to their treatment regimen.", {"entities": []}], ["Behavioural economic theory suggests that the lack of adherence results from the disconnect between the timing of when costs and benefits accrue.", {"entities": []}], ["One strategy to address this discontinuity is to offer patients a near-term benefit, such as a financial reward.", {"entities": []}], ["Whereas there is evidence that rewards can improve treatment adherence and sometimes health outcomes, further research is needed to determine whether rewards are more effective when targeting processes or intermediary health outcomes.", {"entities": []}], ["In the Trial to Incentivise Adherence for Diabetes (TRIAD) we test whether adding financial incentives to usual care can improve HbA1c levels among people with diabetes and whether the financial incentives work better when targeting processes (adherence to blood glucose testing, medication, and daily physical activity) or the primary intermediary health outcome of self-monitored blood glucose within an acceptable range.", {"entities": []}], ["TRIAD is a randomised, controlled, open-label, single-centre superiority trial with three parallel arms.", {"entities": []}], ["A total of 240 patients with suboptimally controlled diabetes (HbA1c\u2009\u2265\u20098%) from a polyclinic in Singapore are block-randomised (blocking factor: current vs. new glucometer users) into three arms, namely (1) usual care (UC) only, (2) UC with process incentive and (3) UC with outcome incentive, in a 2:3:3 ratio.", {"entities": []}], ["Masking the arm allocation will be precluded by the behavioural nature of the intervention but blocking size will not be disclosed to protect concealment.", {"entities": []}], ["The primary outcome (change in HbA1c level at month 6) will be measured by a laboratory that is independent from the study team.", {"entities": []}], ["Secondary outcomes (at month 6) include the number of blood glucose testing days, glucose readings within the normal range (between 4 to 7\u00a0mmol/L), medication-adherent days, physically active days, and average incentives earned and time spent administrating the incentives.", {"entities": []}], ["This study will provide evidence on whether financial incentives can cost-effectively improve glycaemic control.", {"entities": []}], ["It will also provide evidence on the benefit incidence of interventions involving financial incentives.", {"entities": []}], ["By comparing process to outcome incentives, this study will inform the design of future incentive strategies in chronic disease management and beyond.", {"entities": []}], ["ClinicalTrials.gov registry, ID: NCT02224417 .", {"entities": []}], ["Registered on 22 August 2014.", {"entities": []}], ["The online version of this article (doi:10.1186/s13063-017-2288-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Upon allergen challenge, DC subsets are recruited to target sites under the influence of chemotactic agents; however, details pertinent to their trafficking remain largely unknown.", {"entities": []}], ["We investigated the kinetic profiles of blood and skin-infiltrating DC subsets in twelve atopic subjects receiving six weekly intradermal allergen and diluent injections.", {"entities": []}], ["The role of activin-A, a cytokine induced in allergic and tissue repair processes, on the chemotactic profiles of DC subsets was also examined.", {"entities": []}], ["Plasmacytoid (pDCs) and conventional DCs (cDCs) were evaluated at various time-points in the blood and skin.", {"entities": []}], ["In situ activin-A expression was assessed in the skin and its effects on chemokine receptor expression of isolated cDCs were investigated.", {"entities": []}], ["Blood pDCs were reduced 1\u2009h after challenge, while cDCs decreased gradually within 24\u2009h. Skin cDCs increased significantly 24\u2009h after the first challenge, inversely correlating with blood cDCs.", {"entities": []}], ["Activin-A in the skin increased 24\u2009h after the first allergen challenge and correlated with infiltrating cDCs.", {"entities": []}], ["Activin-A increased the CCR10/CCR4 expression ratio in cultured human cDCs.", {"entities": []}], ["DC subsets demonstrate distinct kinetic profiles in the blood and skin especially during acute allergic inflammation, pointing to disparate roles depending on each phase of the inflammatory response.", {"entities": []}], ["The effects of activin-A on modulating the chemotactic profile of cDCs suggest it may be a plausible therapeutic target for allergic diseases.", {"entities": []}], ["The aim of this study was to evaluate the pattern of fixed dose combinations (FDCs) in Ahmedabad, a city in western part of India.", {"entities": []}], ["Over a period of 24 months, prescriptions were collected from 24 pharmacy stores across 6 zones of Ahmedabad city.", {"entities": []}], ["The information was recorded in pre-formed Data Record Form after written consent from the patients (or relative (s) of the patients).", {"entities": []}], ["The pattern of use of FDC, rationality and seasonal variation in their use were analyzed.", {"entities": []}], ["At the end of study, results were analyzed using Chi-square test.", {"entities": []}], ["Out of the total 1170 prescriptions, 941 (80.3%) contained 1647 FDC formulations.", {"entities": []}], ["The average number of FDCs prescribed was 1.41 \u00b1 1.04 (mean \u00b1 SD).", {"entities": []}], ["The FDCs were more frequently prescribed in the age group of 31 to 40 years (23.7%) and in males (54.4%).", {"entities": []}], ["FDCs were most commonly prescribed by oral route (92.7%).", {"entities": []}], ["As per drug category analysis, a higher number of FDCs containing nutritional supplements (20.2%), and those for CNS (18.1%) complaints were prescribed.", {"entities": []}], ["A seasonal analysis showed that FDCs were commonly prescribed for respiratory complaints (23.4%), central nervous system (CNS) complaints (20.3%) and as nutritional supplements (22.4%) in winter, monsoon and summer months, respectively.", {"entities": []}], ["Only 5.8%, 9.8% and 10.9% FDCs prescribed were included in WHO (2010), National (2011) and Gujarat State (2011) Essential Medicines Lists (EML), respectively ( P < 0.0001).", {"entities": []}], ["Irrational FDCs that are banned or FDCs containing irrational active ingredients were 1343 (81.5%) and 203 (12.3%), respectively.", {"entities": []}], ["FDCs are widely prescribed with seasonal influence in their use.", {"entities": []}], ["FDCs containing banned or controversial ingredients are prescribed widely.", {"entities": []}], ["We have identified candidate protein and microRNA (miRNA) biomarkers for dyspnea by studying serum, lavage fluid, and urine from military personnel who reported serious respiratory symptoms after they were deployed to Iraq or Afghanistan.", {"entities": []}], ["Forty-seven soldiers with the complaint of dyspnea who enrolled in the STudy of A ctive Duty Military Personnel for Environmental Dust Exposure (STAMPEDE) underwent comprehensive pulmonary evaluations at the San Antonio Military Medical Center.", {"entities": []}], ["The evaluation included fiber-optic bronchoscopy with bronchoalveolar lavage.", {"entities": []}], ["The clinical findings from the STAMPEDE subjects pointed to seven general underlying diagnoses or findings including airway hyperreactivity, asthma, low diffusivity of carbon monoxide, and abnormal cell counts.", {"entities": [[141, 147, "DISEASE"]]}], ["The largest category was undiagnosed.", {"entities": []}], ["As an exploratory study, not a classification study, we profiled proteins or miRNAs in lavage fluid, serum, or urine in this group to look for any underlying molecular patterns that might lead to biomarkers.", {"entities": []}], ["Proteins in lavage fluid and urine were identified by accurate mass tag (database-driven) proteomics methods while miRNAs were profiled by a hybridization assay applied to serum, urine, and lavage fluid.", {"entities": []}], ["Over seventy differentially expressed proteins were reliably identified both from lavage and from urine in forty-eight dyspnea subjects compared to fifteen controls with no known lung disorder.", {"entities": []}], ["Six of these proteins were detected both in urine and lavage.", {"entities": []}], ["One group of subjects was distinguished from controls by expressing a characteristic group of proteins.", {"entities": []}], ["A related group of dyspnea subjects expressed a unique group of miRNAs that included one miRNA that was differentially overexpressed in all three fluids studied.", {"entities": []}], ["The levels of several miRNAs also showed modest but direct associations with several standard clinical measures of lung health such as forced vital capacity or gas exchange efficiency.", {"entities": []}], ["Candidate proteins and miRNAs associated with the general diagnosis of dyspnea have been identified in subjects with differing medical diagnoses.", {"entities": []}], ["Since these markers can be measured in readily obtained clinical samples, further studies are possible that test the value of these findings in more formal classification or case\u2013control studies in much larger cohorts of subjects with specific lung diseases such as asthma, emphysema, or some other well-defined lung disease.", {"entities": [[266, 272, "DISEASE"], [312, 324, "DISEASE"]]}], ["Respiratory syncytial virus (RSV) infection upregulates genes of the suppressor of cytokine signaling (SOCS) family, which utilize a feedback loop to inhibit type I interferon dependent antiviral signaling pathway.", {"entities": []}], ["Here, we reconstituted RSV nonstructural (NS) protein expression plasmids (pNS1, pNS2, and pNS1/2) and tested whether NS1 or NS2 would trigger SOCS1 and SOCS3 protein expression.", {"entities": [[143, 148, "GENE"], [153, 158, "GENE"]]}], ["These NS proteins inhibited interferon- (IFN-) \u03b1 signaling through a mechanism involving the induction of SOCS1 and SOCS3, which appeared to be different from autocrine IFN dependent.", {"entities": [[106, 111, "GENE"], [116, 121, "GENE"]]}], ["NS1 induced both SOCS1 and SOCS3 upregulation, while NS2 only induced SOCS1 expression.", {"entities": [[17, 22, "GENE"], [70, 75, "GENE"], [27, 32, "GENE"], [17, 22, "GENE"], [70, 75, "GENE"]]}], ["The induced expression of SOCS1 and SOCS3 preceded endogenous IFN-signaling activation and inhibited the IFN-inducible antiviral response as well as chemokine induction.", {"entities": [[26, 31, "GENE"], [36, 41, "GENE"]]}], ["Treatments with INF- \u03b1 and NS proteins both induced SOCS1 expression; however, they had opposing effects on IFN- \u03b1 -dependent antiviral gene expression.", {"entities": [[52, 57, "GENE"]]}], ["Our results indicate that NS1 and NS2, which induce the expression of SOCS1 or SOCS3, might represent an independent pathway of stimulating endogenous IFN signaling.", {"entities": [[70, 75, "GENE"], [79, 84, "GENE"]]}], ["Early recognition improves the prognosis of isocyanate asthma.", {"entities": [[55, 61, "DISEASE"]]}], ["A major unanswered question is whether IgE-dependent mechanisms are of diagnostic value?", {"entities": []}], ["Our objective was to appraise serological methods using various methylenediphenyl diisocyanate (MDI)-albumin conjugates and weigh up the data versus the outcome of standardized comprehensive clinical diagnostics to evaluate the viability of immunological analysis in supportive MDI-asthma diagnosis (OA I ).", {"entities": [[282, 288, "DISEASE"]]}], ["Specific IgE (sIgE) and IgG (sIgG) binding was measured with fluorescence enzyme immunoassay in 43 study subjects (using conjugates prepared in-vapor, in-solution and commercial preparations).", {"entities": []}], ["The differential clinical diagnosis included standardized measurement of pulmonary function, non-specific bronchial hyper-responsiveness, specific MDI-prick test (MDI-SPT) and specific inhalation challenge (MDI-SIC).", {"entities": []}], ["Detailed diagnostic scheme allows the differential OA I and MDI-induced hypersensitivity pneumonitis (P I ).", {"entities": []}], ["The presumed OA I diagnoses were confirmed in 84\u00a0% (45\u00a0% cases having demonstrable sIgE antibodies) with RR 5.7, P \u00a0>\u00a00.001, when OA I diagnosis is correlated with MDI-SIC/MDI-SPT (RR 1.28 for MDI-SIC alone); sIgG antibodies were clinically relevant for P I and not for the OA diagnosis.", {"entities": []}], ["MDI-specific IgE data generated with commercial ImmunoCAP preparations show high correlation with our in-vapor generated MDI conjugates.", {"entities": []}], ["Isocyanate-specific IgE antibodies are not always detectable but their presence is strongly predictive of OA I and supportive for the diagnosis.", {"entities": []}], ["MDI-SPT can be a valuable parameter differentiating OA I and P I .", {"entities": []}], ["We have confirmed and extended published data showing that isocyanate-albumin conjugates perform better in specific antibody assays when prepared with volatile phase formulations and would like to stress additionally the necessity for further refinements and standardization in clinical diagnostics procedures.", {"entities": []}], ["The online version of this article (doi:10.1007/s00420-012-0772-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Systems navigation provided by individuals or teams is emerging as a strategy to reduce barriers to care.", {"entities": []}], ["Complex clients with health and social support needs in primary care experience fragmentation and gaps in service delivery.", {"entities": []}], ["There is great diversity in the design of navigation and a lack of consensus on navigation roles and models in primary care.", {"entities": []}], ["We conducted a scoping literature review following established methods to explore the existing evidence on system navigation in primary care.", {"entities": []}], ["To be included, studies had to be published in English between 1990 and 2013, and include a navigator or navigation process in a primary care setting that involves the community- based social services beyond the health care system.", {"entities": []}], ["We included 34 papers in our review, most of which were descriptive papers, and the majority originated in the US.", {"entities": []}], ["Most of the studies involved studies of individual navigators (lay person or nurse) and were developed to meet the needs of specific patient populations.", {"entities": []}], ["We make an important contribution to the literature by highlighting navigation models that address both health and social service navigation.", {"entities": []}], ["The emergence and development of system navigation signals an important shift in the recognition that health care and social care are inextricably linked especially to address the social determinants of health.", {"entities": []}], ["There is a high degree of variance in the literature, but descriptive studies can inform further innovation and development of navigation interventions in primary care.", {"entities": []}], ["Multiciliated cells of the airways, brain ventricles, and female reproductive tract provide the motive force for mucociliary clearance, cerebrospinal fluid circulation, and ovum transport.", {"entities": []}], ["Despite their clear importance to human biology and health, the molecular mechanisms underlying multiciliated cell differentiation are poorly understood.", {"entities": []}], ["Prior studies implicate the distal appendage/transition fiber protein CEP164 as a central regulator of primary ciliogenesis; however, its role in multiciliogenesis remains unknown.", {"entities": [[70, 76, "GENE"]]}], ["In this study, we have generated a novel conditional mouse model that lacks CEP164 in multiciliated tissues and the testis.", {"entities": [[76, 82, "GENE"]]}], ["These mice show a profound loss of airway, ependymal, and oviduct multicilia and develop hydrocephalus and male infertility.", {"entities": [[107, 123, "DISEASE"], [89, 102, "DISEASE"], [112, 123, "DISEASE"]]}], ["Using primary cultures of tracheal multiciliated cells as a model system, we found that CEP164 is critical for multiciliogenesis, at least in part, via its regulation of small vesicle recruitment, ciliary vesicle formation, and basal body docking.", {"entities": [[88, 94, "GENE"]]}], ["In addition, CEP164 is necessary for the proper recruitment of another distal appendage/transition fiber protein Chibby1 (Cby1) and its binding partners FAM92A and FAM92B to the ciliary base in multiciliated cells.", {"entities": [[13, 19, "GENE"], [122, 126, "GENE"], [164, 170, "GENE"]]}], ["In contrast to primary ciliogenesis, CEP164 is dispensable for the recruitment of intraflagellar transport (IFT) components to multicilia.", {"entities": [[37, 43, "GENE"]]}], ["Finally, we provide evidence that CEP164 differentially controls the ciliary targeting of membrane-associated proteins, including the small GTPases Rab8, Rab11, and Arl13b, in multiciliated cells.", {"entities": [[34, 40, "GENE"], [165, 171, "GENE"]]}], ["Altogether, our studies unravel unique requirements for CEP164 in primary versus multiciliogenesis and suggest that CEP164 modulates the selective transport of membrane vesicles and their cargoes into the ciliary compartment in multiciliated cells.", {"entities": [[56, 62, "GENE"], [116, 122, "GENE"], [56, 62, "GENE"], [116, 122, "GENE"]]}], ["Furthermore, our mouse model provides a useful tool to gain physiological insight into diseases associated with defective multicilia.", {"entities": []}], ["Lining the airways, brain ventricles, and oviducts, multicilia are small hair-like structures that beat in a whip-like motion to propel fluids, such as mucus, over cell surfaces.", {"entities": []}], ["Dysfunction of multicilia arising from genetic perturbations is most prominently associated with a devastating disorder called primary ciliary dyskinesia (PCD).", {"entities": [[127, 153, "DISEASE"]]}], ["PCD is a rare genetic disease characterized by hydrocephalus, chronic airway infection, and infertility.", {"entities": [[47, 60, "DISEASE"], [92, 103, "DISEASE"], [14, 29, "DISEASE"]]}], ["Furthermore, defective airway multicilia have been implicated in several respiratory diseases, including cystic fibrosis, asthma, and chronic obstructive pulmonary disorder (COPD).", {"entities": [[105, 120, "DISEASE"], [122, 128, "DISEASE"]]}], ["While important to human health, the detailed molecular mechanisms of how multiciliated cells develop remain largely unknown.", {"entities": []}], ["Here, we establish a new mouse model that lacks the key ciliary protein CEP164 in multiciliated cells.", {"entities": [[72, 78, "GENE"]]}], ["These mice recapitulate many symptoms of PCD patients such as hydrocephalus and infertility.", {"entities": [[62, 75, "DISEASE"], [80, 91, "DISEASE"]]}], ["We show that, in the absence of CEP164, differentiation of airway multiciliated cells is severely perturbed at multiple steps.", {"entities": [[32, 38, "GENE"]]}], ["Importantly, our data also suggest that CEP164 differentially regulates the proper recruitment of membrane-associated ciliary proteins.", {"entities": [[40, 46, "GENE"]]}], ["In summary, we have developed a powerful mouse model to study diseases affecting multicilia and shed light on novel roles of CEP164 in multiciliogenesis.", {"entities": [[125, 131, "GENE"]]}], ["Policy makers, clinicians and researchers are demonstrating increasing interest in using data linked from multiple sources to support measurement of clinical performance and patient health outcomes.", {"entities": []}], ["However, the utility of data linkage may be compromised by sub-optimal or incomplete linkage, leading to systematic bias.", {"entities": []}], ["In this study, we synthesize the evidence identifying participant or population characteristics that can influence the validity and completeness of data linkage and may be associated with systematic bias in reported outcomes.", {"entities": []}], ["A narrative review, using structured search methods was undertaken.", {"entities": []}], ["Key words \"data linkage\" and Mesh term \"medical record linkage\" were applied to Medline, EMBASE and CINAHL databases between 1991 and 2007.", {"entities": []}], ["Abstract inclusion criteria were; the article attempted an empirical evaluation of methodological issues relating to data linkage and reported on patient characteristics, the study design included analysis of matched versus unmatched records, and the report was in English.", {"entities": []}], ["Included articles were grouped thematically according to patient characteristics that were compared between matched and unmatched records.", {"entities": []}], ["The search identified 1810 articles of which 33 (1.8%) met inclusion criteria.", {"entities": []}], ["There was marked heterogeneity in study methods and factors investigated.", {"entities": []}], ["Characteristics that were unevenly distributed among matched and unmatched records were; age (72% of studies), sex (50% of studies), race (64% of studies), geographical/hospital site (93% of studies), socio-economic status (82% of studies) and health status (72% of studies).", {"entities": []}], ["A number of relevant patient or population factors may be associated with incomplete data linkage resulting in systematic bias in reported clinical outcomes.", {"entities": []}], ["Readers should consider these factors in interpreting the reported results of data linkage studies.", {"entities": []}], ["Data on the burden of pneumococcal disease and the most frequent serotypes demonstrated that invasive disease and pneumonia were important manifestations affecting children under 5 years of age.", {"entities": [[114, 123, "DISEASE"]]}], ["Therefore, pneumococcal diseases prevention became a public health priority.", {"entities": []}], ["Uruguay was the first Latin American country to incorporate PCV7 into its National Immunization Program.", {"entities": []}], ["The aim of this study is to compare the incidence rates for hospitalized pneumonia in children from the pre PCV introduction period and the following five years of PCVs application in Uruguay.", {"entities": [[73, 82, "DISEASE"]]}], ["Population-based surveillance of pneumonia hospitalization rates, in children, less than 14 years of age, had been performed prior pneumococcal vaccination, and continued following PCV7 introduction and PCV13 replacement, using the same methodology.", {"entities": [[33, 42, "DISEASE"]]}], ["Hospitalized children with pneumonia were enrolled from January 1, 2009 through December 31 An overall significant reduction in pneumonia hospitalizations was observed following the introduction of PCV7 and furthermore following the change to PCV13.", {"entities": [[27, 36, "DISEASE"], [128, 137, "DISEASE"]]}], ["Myeloperoxidase (MPO) is a metabolic/oxidative lysosomal enzyme secreted by reactive neutrophils at the sites of inflamed organs and tissues during phagocytosis.", {"entities": [[17, 20, "GENE"]]}], ["MPO has been either directly or indirectly linked to neoplasia, which is a well-established risk factor for many types of cancer.", {"entities": [[122, 128, "DISEASE"], [0, 3, "GENE"]]}], ["A large number of studies have reported the role of MPO G-463A polymorphism regarding breast-cancer risk.", {"entities": [[93, 99, "DISEASE"], [52, 55, "GENE"]]}], ["However, the published findings are inconsistent.", {"entities": []}], ["Therefore, we conducted a meta-analysis to determine more precise estimations for the relationship.", {"entities": []}], ["Eligible studies were identified by searching several electronic databases for relevant reports published before June 2012.", {"entities": []}], ["According to the inclusion criteria and exclusion criteria, a total of five eligible studies were included in the pooled analyses.", {"entities": []}], ["When the five eligible studies concerning MPO G-463A polymorphism were pooled into this meta-analysis, there was no evidence found for a significant association between MPO G-463A polymorphism and breast-cancer risk in any genetic model.", {"entities": [[204, 210, "DISEASE"], [42, 45, "GENE"], [169, 172, "GENE"], [42, 45, "GENE"], [169, 172, "GENE"]]}], ["We also categorized by ethnicity (Caucasian or Asian) for subgroup analysis; according to this subgroup analysis, we found no significant association between MPO G-463A polymorphism and breast-cancer risk in any genetic model.", {"entities": [[193, 199, "DISEASE"], [158, 161, "GENE"]]}], ["However, in the stratified analysis for the premenopausal group, women carrying the AA genotype were found to have a significantly reduced risk (OR\u200a=\u200a0.56, 95% CI 0.34\u20130.94, p\u200a=\u200a0.027).", {"entities": []}], ["Under the recessive model, there was a significant association between MPO G-463A polymorphism and breast-cancer risk (OR\u200a=\u200a0.57, 95% CI 0.34\u20130.93, p\u200a=\u200a0.025).", {"entities": [[106, 112, "DISEASE"], [71, 74, "GENE"]]}], ["We conclude that MPO-G463A polymorphism might not be a good predictor of breast-cancer risk, though menopausal status modified women\u2019s risk of developing breast cancer.", {"entities": [[154, 167, "DISEASE"], [80, 86, "DISEASE"], [161, 167, "DISEASE"]]}], ["In this study, we investigated the expression of lipocortin I and II (annexin I and I in the human bronchial epithelium, both in vivo and in vitro .", {"entities": []}], ["A clear expression of lipocortin I and II protein was found in the epithelium in sections of bronchial tissue.", {"entities": []}], ["In cultured human bronchial epithelial cells we demonstrated the expression of lipocortin I and II mRNA and protein using Northern blotting, FACScan analysis and ELISA.", {"entities": []}], ["No induction of lipocortin I or II mRNA or protein was observed after incubation with dexamethasone.", {"entities": []}], ["Stimulation of bronchial epithelial cells with IL-1\u03b2, TNF-\u03b1 or LPS for 24 h did not affect the lipocortin I or II mRNA or protein expression, although PGE 2 and 6-keto-PGF 1\u03b1 production was significantly increased.", {"entities": []}], ["This IL-1\u03b2- and LPS-mediated increase in eicosanoids could be reduced by dexamethasone, but was not accompanied by an increase in lipocortin I or II expression.", {"entities": []}], ["In human bronchial epithelial cells this particular glucocorticoid action is not mediated through lipocortin I or II induction.", {"entities": []}], ["Asthma is strongly associated with allergic sensitization, but the mechanisms that determine why only a subset of atopics develop asthma are not well understood.", {"entities": [[0, 6, "DISEASE"], [130, 136, "DISEASE"]]}], ["The aim of this study was to test the hypothesis that variations in allergen-driven CD4 T cell responses are associated with susceptibility to expression of asthma symptoms.", {"entities": [[157, 163, "DISEASE"], [84, 87, "GENE"]]}], ["The study population consisted of house dust mite (HDM) sensitized atopics with current asthma ( n \u2009=\u200922), HDM-sensitized atopics without current asthma ( n \u2009=\u200926), and HDM-nonsensitized controls ( n \u2009=\u200924).", {"entities": [[88, 94, "DISEASE"], [146, 152, "DISEASE"]]}], ["Peripheral blood mononuclear cells from these groups were cultured in the presence or absence of HDM extract for 24\u00a0h. CD4 T cells were then isolated by immunomagnetic separation, and gene expression patterns were profiled on microarrays.", {"entities": [[119, 122, "GENE"]]}], ["Differential network analysis of HDM-induced CD4 T cell responses in sensitized atopics with or without asthma unveiled a cohort of asthma-associated genes that escaped detection by more conventional data analysis techniques.", {"entities": [[104, 110, "DISEASE"], [132, 138, "DISEASE"], [45, 48, "GENE"]]}], ["These asthma-associated genes were enriched for targets of STAT6 signaling, and they were nested within a larger coexpression module comprising 406 genes.", {"entities": [[6, 12, "DISEASE"], [59, 64, "GENE"]]}], ["Upstream regulator analysis suggested that this module was driven primarily by IL-2, IL-4, and TNF signaling; reconstruction of the wiring diagram of the module revealed a series of hub genes involved in inflammation (IL-1B, NFkB, STAT1, STAT3), apoptosis (BCL2, MYC), and regulatory T cells (IL-2Ra, FoxP3).", {"entities": [[95, 98, "GENE"], [231, 236, "GENE"], [238, 243, "GENE"], [257, 261, "GENE"], [263, 266, "GENE"], [301, 306, "GENE"]]}], ["Finally, we identified several negative regulators of asthmatic CD4 T cell responses to allergens (e.g.", {"entities": [[64, 67, "GENE"]]}], ["IL-10, type I interferons, microRNAs, drugs, metabolites), and these represent logical candidates for therapeutic intervention.", {"entities": []}], ["Differential network analysis of allergen-induced CD4 T cell responses can unmask covert disease-associated genes and pin point novel therapeutic targets.", {"entities": [[50, 53, "GENE"]]}], ["The online version of this article (doi:10.1186/s12920-016-0171-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Abnormalities of the intracellular metabolism of the hydrophobic surfactant proteins SP-B and SP-C and their precursors may be causally linked to chronic childhood diffuse lung diseases.", {"entities": []}], ["The profile of these proteins in the alveolar space is unknown in such subjects.", {"entities": []}], ["We analyzed bronchoalveolar lavage fluid by Western blotting for SP-B, SP-C and their proforms in children with pulmonary alveolar proteinosis (PAP, n = 15), children with no SP-B (n = 6), children with chronic respiratory distress of unknown cause (cRD, n = 7), in comparison to children without lung disease (n = 15) or chronic obstructive bronchitis (n = 19).", {"entities": [[112, 142, "DISEASE"], [297, 309, "DISEASE"], [342, 352, "DISEASE"]]}], ["Pro-SP-B of 25\u201326 kD was commonly abundant in all groups of subjects, suggesting that their presence is not of diagnostic value for processing defects.", {"entities": []}], ["In contrast, pro-SP-B peptides cleaved off during intracellular processing of SP-B and smaller than 19\u201321 kD, were exclusively found in PAP and cRD.", {"entities": []}], ["In 4 of 6 children with no SP-B, mutations of SFTPB or SPTPC genes were found.", {"entities": [[46, 51, "GENE"]]}], ["Pro-SP-C forms were identified at very low frequency.", {"entities": []}], ["Their presence was clearly, but not exclusively associated with mutations of the SFTPB and SPTPC genes, impeding their usage as candidates for diagnostic screening.", {"entities": [[81, 86, "GENE"]]}], ["Immuno-analysis of the hydrophobic surfactant proteins and their precursor forms in bronchoalveolar lavage is minimally invasive and can give valuable clues for the involvement of processing abnormalities in pediatric pulmonary disorders.", {"entities": []}], ["Peroxisome proliferator-activated receptor gamma (PPAR-\u03b3) is a nuclear receptor that modulates inflammation in models of asthma.", {"entities": [[121, 127, "DISEASE"]]}], ["To determine whether pioglitazone improves measures of asthma control and airway inflammation, we performed a single-center randomized, double-blind, placebo-controlled, parallel-group trial.", {"entities": [[55, 61, "DISEASE"]]}], ["Sixty-eight participants with mild asthma were randomized to 12 weeks pioglitazone (30 mg for 4 weeks, then 45 mg for 8 weeks) or placebo.", {"entities": [[35, 41, "DISEASE"]]}], ["The primary outcome was the adjusted mean forced expiratory volume in one second (FEV 1 ) at 12 weeks.", {"entities": [[82, 85, "GENE"]]}], ["The secondary outcomes were mean peak expiratory flow (PEF), scores on the Juniper Asthma Control Questionnaire (ACQ) and Asthma Quality of Life Questionnaire (AQLQ), fractional exhaled nitric oxide (FeNO), bronchial hyperresponsiveness (PD 20 ), induced sputum counts, and sputum supernatant interferon gamma-inducible protein-10 (IP-10), vascular endothelial growth factor (VEGF), monocyte chemotactic protein-1 (MCP-1), and eosinophil cationic protein (ECP) levels.", {"entities": [[83, 89, "DISEASE"], [122, 128, "DISEASE"]]}], ["Study recruitment was closed early after considering the European Medicines Agency\u2019s reports of a potential increased risk of bladder cancer with pioglitazone treatment.", {"entities": [[134, 140, "DISEASE"]]}], ["Fifty-five cases were included in the full analysis (FA) and 52 in the per-protocol (PP) analysis.", {"entities": []}], ["There was no difference in the adjusted FEV 1 at 12 weeks (-0.014 L, 95% confidence interval [CI] -0.15 to 0.12, p = 0.84) or in any of the secondary outcomes in the FA.", {"entities": [[40, 43, "GENE"]]}], ["The PP analysis replicated the FA, with the exception of a lower evening PEF in the pioglitazone group (-21 L/min, 95% CI -39 to -4, p = 0.02).", {"entities": []}], ["We found no evidence that treatment with 12 weeks of pioglitazone improved asthma control or airway inflammation in mild asthma.", {"entities": [[75, 81, "DISEASE"], [121, 127, "DISEASE"]]}], ["ClinicalTrials.gov NCT01134835", {"entities": []}], ["It has been shown that amyloid \u00df (A\u03b2), a product of proteolytic cleavage of the amyloid \u03b2 precursor protein (APP), accumulates in neuronal cytoplasm in non-affected individuals in a cell type\u2013specific amount.", {"entities": [[109, 112, "GENE"]]}], ["In the present study, we found that the percentage of amyloid-positive neurons increases in subjects diagnosed with idiopathic autism and subjects diagnosed with duplication 15q11.2-q13 (dup15) and autism spectrum disorder (ASD).", {"entities": [[198, 222, "DISEASE"]]}], ["In spite of interindividual differences within each examined group, levels of intraneuronal A\u03b2 load were significantly greater in the dup(15) autism group than in either the control or the idiopathic autism group in 11 of 12 examined regions (p<0.0001 for all comparisons; Kruskall-Wallis test).", {"entities": []}], ["In eight regions, intraneuronal A\u03b2 load differed significantly between idiopathic autism and control groups (p<0.0001).", {"entities": []}], ["The intraneuronal A\u03b2 was mainly N-terminally truncated.", {"entities": []}], ["Increased intraneuronal accumulation of A\u03b2 17\u201340/42 in children and adults suggests a life-long enhancement of APP processing with \u03b1-secretase in autistic subjects.", {"entities": [[111, 114, "GENE"]]}], ["A\u03b2 accumulation in neuronal endosomes, autophagic vacuoles, Lamp1-positive lysosomes and lipofuscin, as revealed by confocal microscopy, indicates that products of enhanced \u03b1-secretase processing accumulate in organelles involved in proteolysis and storage of metabolic remnants.", {"entities": []}], ["Diffuse plaques containing A\u03b2 1\u201340/42 detected in three subjects with ASD, 39 to 52 years of age, suggest that there is an age-associated risk of alterations of APP processing with an intraneuronal accumulation of a short form of A\u03b2 and an extracellular deposition of full-length A\u03b2 in nonfibrillar plaques.", {"entities": [[161, 164, "GENE"]]}], ["The higher prevalence of excessive A\u03b2 accumulation in neurons in individuals with early onset of intractable seizures, and with a high risk of sudden unexpected death in epilepsy in autistic subjects with dup(15) compared to subjects with idiopathic ASD, supports the concept of mechanistic and functional links between autism, epilepsy and alterations of APP processing leading to neuronal and astrocytic A\u03b2 accumulation and diffuse plaque formation.", {"entities": [[356, 359, "GENE"]]}], ["Health information systems (HISs) hold the promise to transform health care; however, their adoption is challenged.", {"entities": []}], ["We have developed the Clinical Adoption Meta-Model (CAMM) to help describe processes and possible challenges with clinical adoption.", {"entities": []}], ["The CAMM, developed through an action research study to evaluate a provincial HIS, is a temporal model with four dimensions: availability, use, behaviour changes, and outcome changes.", {"entities": []}], ["Seven CAMM archetypes are described, illustrating classic trajectories of adoption of HISs over time.", {"entities": []}], ["Each archetype includes an example from the literature.", {"entities": []}], ["The CAMM and its archetypes can support HIS implementers, evaluators, learners, and researchers.", {"entities": []}], ["Obesity is recognized as a global health crisis.", {"entities": [[0, 7, "DISEASE"]]}], ["Bariatric surgery offers a treatment that can reduce weight, induce remission of obesity-related diseases, and improve the quality of life.", {"entities": [[81, 88, "DISEASE"]]}], ["In this article, we outline the different options in bariatric surgery and summarize the recommendations for selecting and assessing potential candidates before proceeding to surgery.", {"entities": []}], ["We present current data on post-surgical outcomes and evaluate the psychosocial and economic effects of bariatric surgery.", {"entities": []}], ["Finally, we evaluate the complication rates and present recommendations for post-operative care.", {"entities": []}], ["Bullous pemphigoid (BP) is the most common autoimmune skin disease of blistering character.", {"entities": [[54, 66, "DISEASE"]]}], ["The underlying pathophysiological mechanism involves an immune attack, usually by IgG class autoantibodies, on the autoantigen BP 180/BPAg2, which is a type XVII collagen (COL17) protein acting as the adhesion molecule between the epidermis and the basement membrane of the dermis.", {"entities": []}], ["About 40\u00a0years ago, following consistent findings of elevated total serum IgE levels in BP patients, it was hypothesized that IgE may be involved in the pathophysiology of BP.", {"entities": []}], ["Our objective was to determine whether there is strong evidence for an association between IgE class autoantibodies and the clinical severity or phenotype of BP.", {"entities": []}], ["Three databases were searched for relevant studies and appropriate exclusion and inclusion criteria were applied.", {"entities": []}], ["Data was extracted and assessed in relation to the study questions concerning the clinical significance of IgE autoantibodies in BP.", {"entities": []}], ["Nine studies found that anti-BP180 autoantibodies of IgE class are associated with increased severity of BP, whereas two studies did not find such an association.", {"entities": []}], ["The number of studies which found an association between higher IgE autoantibody levels and the erythematous urticarial phenotype of BP (5) was equal in number to the studies which found no such association (5).", {"entities": []}], ["In conclusion, higher serum IgE autoantibody levels are associated with more severe clinical manifestations of BP.", {"entities": []}], ["There is insufficient evidence to support higher IgE autoantibody levels being associated with specific clinical phenotypes of BP.", {"entities": []}], ["We describe a method for mapping quantitative trait loci that allows for locus heterogeneity.", {"entities": []}], ["A genome-wide linkage analysis of blood pressure was performed using sib-pair data from the Framingham Heart Study.", {"entities": []}], ["Evidence of linkage was found on four markers (GATA89G08, GATA23D06, GATA14E09, and 049xd2) at a significance level of 0.01.", {"entities": []}], ["Two of them (GATA14E09 and 049xd2) seem to overlap with linkage signals reported previously, while the other two are not linked to any known signals.", {"entities": []}], ["The European DISABKIDS project aims to enhance the Health Related Quality of Life (HRQoL) of children and adolescents with chronic medical conditions and their families.", {"entities": []}], ["We describe the development of the seven cross-nationally tested condition-specific modules of the European DISABKIDS HRQoL instrument in a population of children and adolescents.", {"entities": []}], ["The condition-specific modules are intended for use in conjunction with the DISABKIDS chronic generic module.", {"entities": []}], ["Focus groups were used to construct the pilot version of the DISABKIDS condition-specific HRQoL modules for asthma, juvenile idiopathic arthritis, atopic dermatitis, cerebral palsy, cystic fibrosis, diabetes and epilepsy.", {"entities": [[147, 164, "DISEASE"], [166, 180, "DISEASE"], [182, 197, "DISEASE"], [136, 145, "DISEASE"], [108, 114, "DISEASE"], [154, 164, "DISEASE"]]}], ["Analyses were conducted on pilot test data in order to construct field test versions of the modules.", {"entities": []}], ["A series of factor analyses were run, first, to determine potential structures for each condition-specific module, and, secondly, to select a reduced number of items from the pilot test to be included in the field test.", {"entities": []}], ["Post-field test analyses were conducted to retest the domain structure for the final DISABKIDS condition-specific modules.", {"entities": []}], ["The DISABKIDS condition-specific modules were tested in a pilot study of 360 respondents, and subsequently in a field test of 1152 respondents in 7 European countries.", {"entities": []}], ["The final condition-specific modules consist of an 'Impact' domain and an additional domain (e.g.", {"entities": []}], ["worry, stigma, treatment) with between 10 to 12 items in total.", {"entities": []}], ["The Cronbach's alpha of the final domains was found to vary from 0.71 to 0.90.", {"entities": []}], ["The condition-specific modules of the DISABKIDS instrument were developed through a step-by-step process including cognitive interview, clinical expertise, factor analysis, correlations and internal consistency.", {"entities": []}], ["A cross-national pilot and field test were necessary to collect these data.", {"entities": []}], ["In general, the internal consistency of the domains was satisfactory to high.", {"entities": []}], ["In future, the DISABKIDS instrument may serve as a useful tool with which to assess HRQoL in children and adolescents with a chronic condition.", {"entities": []}], ["The condition-specific modules can be used in conjunction with the DISABKIDS chronic generic module.", {"entities": []}], ["Although corticosteroid is a powerful anti-inflammatory drug that is used widely to control asthma, still severe asthmatics can develop steroid resistance.", {"entities": [[92, 98, "DISEASE"]]}], ["Airway fibroblasts are quite resistant to steroids during Idiopathic pulmonary fibrosis (IPF) and fibrosis in asthmatic lungs is not always controlled.", {"entities": [[69, 87, "DISEASE"]]}], ["Th-17 regulatory cytokine which are elevated in lung tissues of asthmatics were shown to enhance the survival of various types of cells.", {"entities": []}], ["STAT factors are central to this anti-apoptotic function.", {"entities": []}], ["However, it is not yet clear whether these cytokines contribute to steroid hypo-responsiveness in asthma.", {"entities": [[98, 104, "DISEASE"]]}], ["Therefore, in this study, we investigated the ability of Th-17 regulatory cytokines, specifically IL-21, IL22 and IL23, to protect structural airway cells against dexamethasone-induced apoptosis.", {"entities": [[105, 109, "GENE"]]}], ["Primary human fibroblasts, ASM cells, and lung endothelial cells line were treated with IL-21, IL-22, and IL-23 cytokines before incubation with dexamethasone and the level of apoptosis was determined by measuring cellular Annexin-V using Flow cytometry.", {"entities": []}], ["Our data indicated that treatment with Th-17 regulatory cytokines was effective in inhibiting induced apoptosis for both fibroblasts and endothelial cells but not ASM cells.", {"entities": []}], ["STAT3 phosphorylation levels were also upregulated in fibroblasts and endothelial upon treatment with these cytokines.", {"entities": [[0, 5, "GENE"]]}], ["Interestingly, inhibiting STAT3 phosphorylation abrogated IL-21, IL-22, and IL-23 anti-apoptotic effect on fibroblasts and endothelial cells.", {"entities": [[26, 31, "GENE"]]}], ["This data suggest that Th-17 regulatory cytokines may play a critical role in regulating the survival of fibroblasts during asthma, IPF as well as other chronic lung inflammatory diseases leading to enhanced fibrosis.", {"entities": [[124, 130, "DISEASE"]]}], ["Accordingly, findings of this paper may pave the way for more extensive research on the role of these regulatory cytokines in fibrosis development in various chronic inflammatory diseases.", {"entities": []}], ["Immunoglobulin E (IgE) is a central player in the allergic response, and raised total IgE levels are considered as an indicator of atopy or potential development of atopy.", {"entities": []}], ["A recent genome-wide scan in a German population-based cohort of adults identified the gene encoding the alpha chain of the high affinity receptor for IgE (FCER1A) as a susceptibility locus influencing total serum IgE levels.", {"entities": [[156, 162, "GENE"]]}], ["The aim of this study was to investigate whether the polymorphisms in the FCER1A gene are associated with allergic rhinitis (AR) in a Han Chinese population.", {"entities": [[106, 123, "DISEASE"], [115, 123, "DISEASE"], [74, 80, "GENE"]]}], ["A population of 378 patients with AR and 288 healthy controls was studied.", {"entities": []}], ["Precise phenotyping of patients was accomplished by means of a questionnaire and clinical examination.", {"entities": []}], ["Blood was drawn for DNA extraction and total serum immunoglobulin E (IgE) measurement.", {"entities": []}], ["A total of 16 single nucleotide polymorphisms (SNPs) in FCER1A were selected and individually genotyped.", {"entities": [[56, 62, "GENE"]]}], ["None of the SNPs in the FCER1A showed an association with AR.", {"entities": [[24, 30, "GENE"]]}], ["Similarly, the lack of association was also evident in subgroup analysis for the presence of different allergen sensitivities.", {"entities": []}], ["None of the selected SNPs in FCER1A was associated with total IgE level.", {"entities": [[29, 35, "GENE"]]}], ["Although FCER1A presents itself as a good candidate for contributing to total serum IgE, this study failed to find an association between SNPs in the FCER1A gene region and IgE level or AR susceptibility.", {"entities": [[9, 15, "GENE"], [150, 156, "GENE"], [9, 15, "GENE"], [150, 156, "GENE"]]}], ["COPD is the most frequent chronic respiratory disease and a leading cause of morbidity and mortality.", {"entities": []}], ["The major risk factor for COPD development is cigarette smoke, and the most efficient treatment for COPD is smoking cessation.", {"entities": []}], ["However, even after smoking cessation, inflammation, apoptosis, and oxidative stress may persist and continue contributing to disease progression.", {"entities": []}], ["Although current therapies for COPD (primarily based on anti-inflammatory agents) contribute to the reduction of airway obstruction and minimize COPD exacerbations, none can avoid disease progression or reduce mortality.", {"entities": []}], ["Within this context, recent advances in mesenchymal stromal cell (MSC) therapy have made this approach a strong candidate for clinical use in the treatment of several pulmonary diseases.", {"entities": [[66, 69, "GENE"]]}], ["MSCs can be readily harvested from diverse tissues and expanded with high efficiency, and have strong immunosuppressive properties.", {"entities": []}], ["Preclinical studies have demonstrated encouraging outcomes of MSCs therapy for lung disorders, including emphysema.", {"entities": []}], ["These findings instigated research groups to assess the impact of MSCs in human COPD/emphysema, but clinical results have fallen short of expectations.", {"entities": []}], ["However, MSCs have demonstrated a good adjuvant role in the clinical scenario.", {"entities": []}], ["Trials that used MSCs combined with another, primary treatment (eg, endobronchial valves) found that patients derived greater benefit in pulmonary function tests and/or quality of life reports, as well as reductions in systemic markers of inflammation.", {"entities": []}], ["The present review summarizes and describes the more recent preclinical studies that have been published about MSC therapy for COPD/emphysema and discusses what has already been applied about MSCs treatment in COPD patients in the clinical setting.", {"entities": [[111, 114, "GENE"]]}], ["After activation CD4", {"entities": [[17, 20, "GENE"]]}], ["The aim of the present study was to develop and validate a prediction score for postoperative complications by severity and guide perioperative management and patient selection in hepatitis B-related hepatocellular carcinoma patients undergoing liver resection.", {"entities": [[200, 224, "DISEASE"], [215, 224, "DISEASE"], [180, 189, "DISEASE"]]}], ["A total of 1543 consecutive liver resections cases were included in the study.", {"entities": []}], ["Randomly selected sample set of 70% of the study cohort was used to develop a score to predict complications III\u2013V and the remaining 30% was used to validate the score.", {"entities": []}], ["Based on the preoperative and predictable intraoperative parameters, logistic regression analysis was used to identify risk factors and create an integer score for the predicting of complication.", {"entities": []}], ["American Society of Anesthesiologists category, portal hypertension, major liver resection (more than 3 segments) and extrahepatic procedures were identified as independent predictors for complications III\u2013V by logistic regression analysis.", {"entities": [[55, 67, "DISEASE"], [48, 67, "DISEASE"]]}], ["A score system integrating these 4 factors was stratified into three groups and significantly predicted the risk of complications III\u2013V, with a rate of 1.6%, 11.9% and 65.6% for low, moderate and high risk, respectively.", {"entities": []}], ["Using the score, the complications risk could be predicted accurately in the validation set, without significant differences between predicted (10.4%) and observed (8.4%) risks for complications III\u2013V (P\u200a=\u200a0.466).", {"entities": []}], ["Based on four preoperative risk factors, we have developed and validated an integer-based risk score to predict postoperative severe complications after liver resection for hepatitis B-related hepatocellular carcinoma patients in high-volume surgical center.", {"entities": [[193, 217, "DISEASE"], [208, 217, "DISEASE"], [173, 182, "DISEASE"]]}], ["This score may contribute to preoperative risk stratification and clinical decision-making.", {"entities": []}], ["HDM allergy is associated with asthma, allergic rhinitis and atopic dermatitis.", {"entities": [[39, 56, "DISEASE"], [61, 78, "DISEASE"], [48, 56, "DISEASE"], [31, 37, "DISEASE"], [68, 78, "DISEASE"]]}], ["In many countries childhood asthma is predominantly found in HDM-allergic children with their probability of developing disease being proportional to their IgE antibody titers and the early development of Th2 responses.", {"entities": [[28, 34, "DISEASE"]]}], ["While the pathogenesis is complex and increasingly linked to infection the immunologically-based allergen immunotherapy and anti-IgE antibody therapy are highly beneficial.", {"entities": []}], ["Immunotherapy could be a short-term treatment providing lifelong relief but the current regimens depend on repeated administration of allergen over years.", {"entities": []}], ["Immunological investigations point to a contribution of responses outside the Th2 pathway and multiple potential but unproven control mechanisms.", {"entities": []}], ["Over half of the IgE antibodies are directed to the group 1 and 2 allergens with most of remainder to the group 4, 5, 7 and 21 allergens.", {"entities": []}], ["This hierarchy found in high and low responders provides a platform for introducing defined allergens into immunotherapy and defined reagents for investigation.", {"entities": []}], ["Ocular allergy represents one of the most common conditions encountered by allergists and ophthalmologists.", {"entities": []}], ["Allergic conjunctivitis is often underdiagnosed and consequently undertreated.", {"entities": [[0, 23, "DISEASE"], [9, 23, "DISEASE"]]}], ["Basic and clinical research has provided a better understanding of the cells, mediators, and immunologic events, which occur in ocular allergy.", {"entities": []}], ["New pharmacological agents have improved the efficacy and safety of ocular allergy treatment.", {"entities": []}], ["An understanding of the immunologic mechanisms, clinical features, differential diagnosis, and treatment of ocular allergy may be useful to all specialists who deal with these patients.", {"entities": []}], ["The purpose of this review is to systematically review literature underlining all the forms classified as ocular allergy: seasonal allergic conjunctivitis, perennial allergic conjunctivitis, vernal keratoconjunctivitis, atopic keratocongiuntivitis, contact allergy, and giant papillary conjunctivitis.", {"entities": [[131, 154, "DISEASE"], [166, 189, "DISEASE"], [276, 300, "DISEASE"], [270, 300, "DISEASE"], [198, 218, "DISEASE"], [140, 154, "DISEASE"], [175, 189, "DISEASE"], [286, 300, "DISEASE"]]}], ["In the absence of current cumulative dietary exposure assessments, this analysis was conducted to estimate exposure to multiple dietary contaminants for children, who are more vulnerable to toxic exposure than adults.", {"entities": []}], ["We estimated exposure to multiple food contaminants based on dietary data from preschool-age children (2\u20134 years, n=207), school-age children (5\u20137 years, n=157), parents of young children (n=446), and older adults (n=149).", {"entities": []}], ["We compared exposure estimates for eleven toxic compounds (acrylamide, arsenic, lead, mercury, chlorpyrifos, permethrin, endosulfan, dieldrin, chlordane, DDE, and dioxin) based on self-reported food frequency data by age group.", {"entities": []}], ["To determine if cancer and non-cancer benchmark levels were exceeded, chemical levels in food were derived from publicly available databases including the Total Diet Study.", {"entities": [[16, 22, "DISEASE"], [31, 37, "DISEASE"]]}], ["Cancer benchmark levels were exceeded by all children (100%) for arsenic, dieldrin, DDE, and dioxins.", {"entities": [[0, 6, "DISEASE"]]}], ["Non-cancer benchmarks were exceeded by >95% of preschool-age children for acrylamide and by 10% of preschool-age children for mercury.", {"entities": [[4, 10, "DISEASE"]]}], ["Preschool-age children had significantly higher estimated intakes of 6 of 11 compounds compared to school-age children (p<0.0001 to p=0.02).", {"entities": []}], ["Based on self-reported dietary data, the greatest exposure to pesticides from foods included in this analysis were tomatoes, peaches, apples, peppers, grapes, lettuce, broccoli, strawberries, spinach, dairy, pears, green beans, and celery.", {"entities": []}], ["Dietary strategies to reduce exposure to toxic compounds for which cancer and non-cancer benchmarks are exceeded by children vary by compound.", {"entities": [[67, 73, "DISEASE"], [82, 88, "DISEASE"]]}], ["These strategies include consuming organically produced dairy and selected fruits and vegetables to reduce pesticide intake, consuming less animal foods (meat, dairy, and fish) to reduce intake of persistent organic pollutants and metals, and consuming lower quantities of chips, cereal, crackers, and other processed carbohydrate foods to reduce acrylamide intake.", {"entities": []}], ["Parasitic nematodes have evolved powerful immunomodulatory molecules to enable their survival in immunocompetent hosts by subverting immune responses and minimizing pathological processes.", {"entities": []}], ["One filarial molecule known to counteract host immune responses by inducing IL-10 and regulatory macrophages in mice is filarial cystatin.", {"entities": []}], ["During a patent filarial infection monocytes encounter microfilariae in the blood, an event that occurs in asymptomatically infected filariasis patients that are immunologically hyporeactive.", {"entities": [[133, 143, "DISEASE"]]}], ["The microfilarial larval stage was formerly shown to induce human regulatory monocytes and macrophages.", {"entities": []}], ["Thus, here we aim was to determine how filarial cystatin of the human pathogenic filaria Brugia malayi (BmCPI-2) contributes to immune hyporesponsiveness in human monocytes and macrophages elicited by microfilaria.", {"entities": []}], ["For this purpose, filarial cystatin was depleted from microfilarial lysate (Mf).", {"entities": []}], ["Detecting the immunomodulatory potential of cystatin-depleted Mf revealed that IL-10, but not IL-8 and IL-6 induction in monocytes and macrophages is dependent on the presence of cystatin.", {"entities": []}], ["In addition, the Mf-induced expression of the regulatory surface markers PD-L1 and PD-L2 in human monocytes, but not in macrophages, is dependent on cystatin.", {"entities": []}], ["While Mf-treated monocytes result in decreased CD4", {"entities": [[47, 50, "GENE"]]}], ["The diagnosis of bacterium-negative pulmonary tuberculosis (TB) and extra-pulmonary TB is challenging clinically.", {"entities": [[46, 58, "DISEASE"], [36, 58, "DISEASE"]]}], ["The detection of the anti-TB antibody has an important, auxiliary, clinical diagnostic value.", {"entities": []}], ["Therefore, TB antibody detection kits should be screened and evaluated, and the reagents with the highest sensitivity and specificity should be chosen and used clinically.", {"entities": []}], ["The diagnostic performance of 7 commercially available TB antibody detection kits (kits A, B, C, D, E, F and G) based on the gold immunoassay detection of immunoglobulin (Ig) G or IgM antibodies were simultaneously evaluated and compared in 62\u00a0TB cases and 56 non-TB cases in a laboratory.", {"entities": []}], ["A retrospective analysis including 2549 cases was carried out to assess the clinical diagnosis values of bacteriological examinations and TB antibody tests (kits B and H used in the clinic).", {"entities": []}], ["The sensitivities of TB antibody kits A, B, C, D, E, F and G in the sera from 62\u00a0TB patients were 50.0%, 83.9%, 38.7%, 9.7%, 48.4%, 69.4% and 79.0%, respectively; the sensitivities in the sera from 24 smear-negative TB patients were 29.2%, 79.2%, 29.2%, 12.5%, 29.2%, 54.2% and 79.2%, respectively; the specificities in the sera from 56 non-TB patients were 73.2%, 25.0%, 85.7%, 96.4%, 78.6%, 78.6% and 50.0%, respectively.", {"entities": []}], ["Of the 2549 clinically diagnosed cases, there were 1752 pulmonary TB cases, 505 extra-pulmonary TB cases, 87 old pulmonary TB cases and 205 non-TB cases.", {"entities": []}], ["The positive results for smear, culture, TB antibody kit B and kit H in pulmonary TB cases were 39.8% (543/1365), 48.6% (372/765), 45.8% (802/1752) and 25.2% (442/1752), respectively; the results in extra-pulmonary TB cases were 3.4% (6/178), 5.8% (4/69), 35.4% (179/505), and 11.3% (57/505), respectively; the results in old pulmonary TB cases were 0% (0/64), 0% (0/30), 32.2% (28/87), and 9.2% (8/87), respectively; and the results in non-TB cases were 0% (0/121), 0% (0/56), 21.5% (44/205), and 2.4% (5/205), respectively.", {"entities": []}], ["Of 624 smear-positive and/or culture-positive pulmonary TB cases, the sensitivities of antibody test kits B and H were 53.0% and 36.4%, respectively.", {"entities": []}], ["Of 901 smear-negative and/or culture-negative pulmonary TB cases, the sensitivities of antibody test kits B and H were 42.5% and 19.0%, respectively.", {"entities": []}], ["The positive rate of antibody detection in the bacterium-positive pulmonary TB cases was significantly higher than that in the bacterium-negative pulmonary TB cases ( P \u2009<\u20090.05).", {"entities": []}], ["The colloidal gold-labeled TB antibody IgG detection assay is a simple, rapid and economical method that provides a better clinical auxiliary diagnosis value on TB, especially in smear-negative pulmonary TB and extra-pulmonary TB.", {"entities": []}], ["The production, quality control, screening and evaluation of antibody detection kits are very important for its clinical application.", {"entities": []}], ["With ageing populations, it becomes increasingly important to understand the determinants of cognitive ability among the elderly.", {"entities": []}], ["We apply survey data of 17,070 respondents from ten countries to examine several domains of cognitive functioning at ages 60+, and we link them to the macro-economic deviations in the year of birth.", {"entities": []}], ["We find that economic conditions at birth significantly influence cognitive functioning late in life in various domains.", {"entities": []}], ["Recessions negatively influence numeracy, verbal fluency, recall abilities, as well as the score on the omnibus cognitive indicator.", {"entities": []}], ["The results are robust; controlling for current characteristics does not change effect sizes and significance.", {"entities": []}], ["We discuss possible causal social and biological pathways.", {"entities": []}], ["The impact of environmental tobacco smoke (ETS) exposure on adult pulmonary function has not been clearly determined.", {"entities": []}], ["Because adults with asthma have chronic airway inflammation, they may be a particularly susceptible group.", {"entities": [[20, 26, "DISEASE"]]}], ["Using data from the Third National Health and Nutrition Examination Survey (NHANES III), I examined the cross-sectional relationship between serum cotinine, a biomarker of ETS exposure, and pulmonary function among 10,581 adult nonsmokers and 440 nonsmoking adults with asthma whose cotinine and spirometry data were available.", {"entities": [[270, 276, "DISEASE"]]}], ["I generated residuals, which are observed minus predicted values (based on Crapo equations), for forced expiratory volume in 1 sec (FEV1), forced vital capacity (FVC), and FEV1/FVC ratio to adjust for age, sex, and height.", {"entities": []}], ["In addition, I used multivariate linear regression to control for sociodemographic characteristics and previous smoking history.", {"entities": []}], ["Most adults with and without asthma had detectable serum cotinine levels, indicating recent ETS exposure (85.7% and 83.4%, respectively).", {"entities": [[29, 35, "DISEASE"]]}], ["Among nonsmoking male participants, I found no evidence that ETS exposure was related to decreased pulmonary function.", {"entities": []}], ["In the nonsmoking female stratum, the highest cotinine tertile was associated with a lower FEV1 [-100 mL; 95% confidence interval (CI), -143 to -56 mL], FVC (-119 mL; 95% CI, -168 to -69 mL), and FEV1/FVC ratio (-1.77%; 95% CI, -2.18% to -1.36%).", {"entities": []}], ["Among women with asthma, the highest cotinine tertile was also associated with decreased FEV1 (-261 mL; 95% CI, -492 to -30 mL), FVC (-291 mL; 95% CI, -601 to 20 mL), and FEV1/FVC ratio (-1.6%; 95% CI, -3.3% to 0.19%).", {"entities": [[17, 23, "DISEASE"]]}], ["In conclusion, ETS exposure is associated with decreased pulmonary function in adult females, especially those with asthma.", {"entities": [[116, 122, "DISEASE"]]}], ["This analysis should provide further impetus for public policies that promote smoke-free environments.", {"entities": []}], ["Mobile health (mHealth) is gaining widespread attention for its potential to engage patients in their health and health care in their daily lives.", {"entities": []}], ["Emerging evidence suggests that mHealth interventions can be used effectively to support behavior change, but numerous challenges remain when implementing these programs at the community level.", {"entities": []}], ["This paper provides an overview of considerations when implementing community-based mHealth initiatives, based on the experiences of three Beacon Communities across the United States that have launched text messaging (short message service, SMS) pilot programs aimed at diabetes risk reduction and disease management.", {"entities": [[241, 244, "GENE"]]}], ["The paper addresses lessons learned and suggests strategies to overcome challenges related to developing text message content, conducting marketing and outreach, enrolling participants, engaging providers, evaluating program effectiveness, and sustaining and scaling the programs.", {"entities": []}], ["To estimate the proportion of live-attenuated influenza vaccine (LAIV) doses administered beyond expiry date in children and adolescents during influenza seasons 2013\u20132014 and 2014\u20132015 in the UK.", {"entities": [[46, 55, "DISEASE"], [144, 153, "DISEASE"]]}], ["This was a retrospective cohort study.", {"entities": []}], ["Two cohorts of children and adolescents who received LAIV from 1 September 2013 to 31 March 2014 and from 1 September 2014 to 31 March 2015 and aged 2\u201317 years at time of LAIV administration were identified from the Clinical Practice Research Datalink (CPRD).", {"entities": []}], ["More than 500 primary care practices in the UK.", {"entities": []}], ["Proportions of vaccine doses administered beyond expiry date were assessed among 47\u2009396 and 67\u2009099 LAIV recipients with a documented vaccine lot identifier in influenza seasons 2013\u20132014 and 2014\u20132015, respectively.", {"entities": [[159, 168, "DISEASE"]]}], ["Administrations of expired LAIV were ascertained by comparison of vaccination dates in CPRD records with expiration dates in AstraZeneca/MedImmune lot distribution data.", {"entities": []}], ["Overall, 245 LAIV recipients, 80 in 2013\u20132014 and 165 in 2014\u20132015, received a dose after its expiration date, yielding proportion estimates of 1.7 per 1000 doses (95% CI 1.3 to 2.1) in season 2013\u20132014 and 2.5 per 1000 doses (95% CI 2.1 to 2.8) in season 2014\u20132015.", {"entities": []}], ["This proportion increased above 1.0% after December during each season.", {"entities": []}], ["Most (84% in influenza season 2013\u20132014 and 59% in influenza season 2014\u20132015) received an expired dose <30 days after its expiration date.", {"entities": [[13, 22, "DISEASE"], [51, 60, "DISEASE"]]}], ["The proportion was higher in London (relative risk 1.93 (95% CI 1.25 to 2.99)) and when the number of LAIV recipients registered in the practice was lower than the median number per practice (relative risk 2.69 (95% CI 1.99 to 3.62)).", {"entities": []}], ["Administration of expired LAIV doses occurs infrequently.", {"entities": []}], ["Abdominal aortic aneurysms (AAAs) are characterized by chronic inflammation, which contributes to the pathological remodeling of the extracellular matrix.", {"entities": [[28, 32, "GENE"]]}], ["Although mechanical stress has been suggested to promote inflammation in AAA, the molecular mechanism remains uncertain.", {"entities": []}], ["Periostin is a matricellular protein known to respond to mechanical strain.", {"entities": []}], ["The aim of this study was to elucidate the role of periostin in mechanotransduction in the pathogenesis of AAA.", {"entities": []}], ["We found significant increases in periostin protein levels in the walls of human AAA specimens.", {"entities": []}], ["Tissue localization of periostin was associated with inflammatory cell infiltration and destruction of elastic fibers.", {"entities": []}], ["We examined whether mechanical strain could stimulate periostin expression in cultured rat vascular smooth muscle cells.", {"entities": []}], ["Cells subjected to 20% uniaxial cyclic strains showed significant increases in periostin protein expression, focal adhesion kinase (FAK) activation, and secretions of monocyte chemoattractant protein-1 (MCP-1) and the active form of matrix metalloproteinase (MMP)-2.", {"entities": []}], ["These changes were largely abolished by a periostin-neutralizing antibody and by the FAK inhibitor, PF573228.", {"entities": []}], ["Interestingly, inhibition of either periostin or FAK caused suppression of the other, indicating a positive feedback loop.", {"entities": []}], ["In human AAA tissues in ex vivo culture, MCP-1 secretion was dramatically suppressed by PF573228.", {"entities": []}], ["Moreover, in vivo , periaortic application of recombinant periostin in mice led to FAK activation and MCP-1 upregulation in the aortic walls, which resulted in marked cellular infiltration.", {"entities": []}], ["Our findings indicated that periostin plays an important role in mechanotransduction that maintains inflammation via FAK activation in AAA.", {"entities": []}], ["COPD is one of the most debilitating diseases.", {"entities": []}], ["Frailty syndrome and advanced age may decrease the acceptance of illness, quality of life, and worsen health conditions in these patients, as well as lead to an increase in health care expenses.", {"entities": [[8, 16, "DISEASE"]]}], ["The aim of the study was to assess how the level of frailty affects the acceptance of illness in elderly patients with COPD.", {"entities": []}], ["We also aimed to evaluate the associations between sociodemographic and clinical factors and the level of acceptance of illness, anxiety, and frailty in this group of patients.", {"entities": []}], ["The study included 102 COPD patients with a mean age of 63.2 (standard deviation =6.5) years and grades I (3%), II (37%), III (52%), and IV (8%) by Global Initiative for Chronic Obstructive Lung Disease.", {"entities": []}], ["The Polish versions of the Acceptance of Illness Scale and Tilburg frailty indicator were used.", {"entities": []}], ["Frailty syndrome was found in 77 (75.5%) patients, with an average score of 7.42 (standard deviation =2.24).", {"entities": [[8, 16, "DISEASE"]]}], ["Coexisting diseases such as hypertension (46.07%), coronary artery disease (32.35%), heart failure (28.43%), diabetes (18.63%), and heart arrhythmia (9.8%) were found among the subjects.", {"entities": [[28, 40, "DISEASE"]]}], ["The overall level of acceptance of illness was 20.6 (standard deviation =7.62).", {"entities": []}], ["A lower level of acceptance of illness was associated with a higher level of frailty, especially in the physical and social domain.", {"entities": []}], ["Elderly patients with severe COPD are more prone to frailty and decreased acceptance of their disease in comparison to patients with other chronic diseases.", {"entities": []}], ["Assessment and management of frailty in the care of older COPD patients are likely to improve risk stratification significantly and help personalize management, leading to better patient outcomes.", {"entities": []}], ["Evaluation of impaired left ventricular (LV) filling has focused on intrinsic causes of LV dysfunction; however, pulmonary vascular changes may contribute to reduced LV filling and dyspnea.", {"entities": []}], ["We hypothesized that lower total pulmonary vascular volume (TPVV) on computed tomography (CT) would be associated with dyspnea and decrements in LV end-diastolic volume, particularly among ever-smokers.", {"entities": []}], ["The Multi-Ethnic Study of Atherosclerosis recruited adults without clinical cardiovascular disease in 2000\u201302.", {"entities": []}], ["In 2010\u201312, TPVV was ascertained as the volume of arteries and veins in the lungs detectable on non-contrast chest CT (vessels \u22651 mm diameter).", {"entities": []}], ["Cardiac measures were assessed by magnetic resonance imaging (MRI).", {"entities": []}], ["Dyspnea was self-reported.", {"entities": []}], ["Of 2303 participants, 53% had ever smoked cigarettes.", {"entities": []}], ["Among ever-smokers, a lower TPVV was associated with a lower LV end-diastolic volume (6.9 mL per SD TPVV), stroke volume, and cardiac output and with dyspnea (all P-values <0.001).", {"entities": []}], ["Findings were similar among those without lung disease and those with 0\u201310 pack-years but were mostly non-significant among never-smokers.", {"entities": [[42, 54, "DISEASE"]]}], ["TPVV was associated smaller left atrial volume but not with LV ejection fraction or MRI measures of impaired LV relaxation.", {"entities": []}], ["In a second sample of ever-smokers, a lower pulmonary microvascular blood volume on contrast-enhanced MRI was also associated with a lower LV end-diastolic volume (P-value = 0.008).", {"entities": []}], ["Reductions in pulmonary vascular volume were associated with lower LV filling and dyspnea among ever-smokers, including those without lung disease, suggesting that smoking-related pulmonary vascular changes may contribute to symptoms and impair cardiac filling and function without evidence of impaired LV relaxation.", {"entities": [[134, 146, "DISEASE"]]}], ["Cough is the most common symptom presenting to doctors.", {"entities": []}], ["The quality of cough (productive or wet vs dry) is used clinically as well as in epidemiology and clinical research.", {"entities": []}], ["There is however no data on the validity of cough quality descriptors.", {"entities": []}], ["The study aims were to compare (1) cough quality (wet/dry and brassy/non-brassy) to bronchoscopic findings of secretions and tracheomalacia respectively and, (2) parent's vs clinician's evaluation of the cough quality (wet/dry).", {"entities": []}], ["Cough quality of children (without a known underlying respiratory disease) undergoing elective bronchoscopy was independently evaluated by clinicians and parents.", {"entities": []}], ["A 'blinded' clinician scored the secretions seen at bronchoscopy on pre-determined criteria and graded (1 to 6).", {"entities": []}], ["Kappa (K) statistics was used for agreement, and inter-rater and intra-rater agreement examined on digitally recorded cough.", {"entities": []}], ["A receiver operating characteristic (ROC) curve was used to determine if cough quality related to amount of airway secretions present at bronchoscopy.", {"entities": []}], ["Median age of the 106 children (62 boys, 44 girls) enrolled was 2.6 years (IQR 5.7).", {"entities": []}], ["Parent's assessment of cough quality (wet/dry) agreed with clinicians' (K = 0.75, 95%CI 0.58\u20130.93).", {"entities": []}], ["When compared to bronchoscopy (bronchoscopic secretion grade 4), clinicians' cough assessment had the highest sensitivity (0.75) and specificity (0.79) and were marginally better than parent(s).", {"entities": []}], ["The area under the ROC curve was 0.85 (95%CI 0.77\u20130.92).", {"entities": []}], ["Intra-observer (K = 1.0) and inter-clinician agreement for wet/dry cough (K = 0.88, 95%CI 0.82\u20130.94) was very good.", {"entities": []}], ["Weighted K for inter-rater agreement for bronchoscopic secretion grades was 0.95 (95%CI 0.87\u20131).", {"entities": []}], ["Sensitivity and specificity for brassy cough (for tracheomalacia) were 0.57 and 0.81 respectively.", {"entities": []}], ["K for both intra and inter-observer clinician agreement for brassy cough was 0.79 (95%CI 0.73\u20130.86).", {"entities": []}], ["Dry and wet cough in children, as determined by clinicians and parents has good clinical validity.", {"entities": []}], ["Clinicians should however be cognisant that children with dry cough may have minimal to mild airway secretions.", {"entities": []}], ["Brassy cough determined by respiratory physicians is highly specific for tracheomalacia.", {"entities": []}], ["MRL/Mp- lpr / lpr (MRL/ lpr ) mice spontaneously develop systemic lupus erythematosus (SLE)-like disease.", {"entities": [[66, 85, "DISEASE"], [57, 85, "DISEASE"]]}], ["The natural history of the pulmonary involvement and the underlying mechanism of leukocyte infiltration into the lungs of MRL/ lpr mice and SLE patients remains elusive.", {"entities": []}], ["We aimed to investigate the expression profiles of chemokines and chemokine receptors in the lung of the SLE-prone mouse.", {"entities": []}], ["We examined the correlation between lung inflammation and expression of IP-10 (interferon-\u03b3-inducible protein 10), a CXC chemokine, and TARC (thymus- and activation-regulated chemokine), a CC chemokine, in MRL/ lpr mice, MRL/Mp-+/+ (MRL/+) mice, and C57BL/6 (B6) control mice.", {"entities": []}], ["The extent of cell infiltration in the lung was assessed histopathologically.", {"entities": []}], ["Reverse transcriptase PCR showed up-regulation of IP-10 mRNA expression in the lungs ( P < 0.05) of MRL/ lpr mice, in comparison with MRL/+ or B6 mice.", {"entities": []}], ["The increase paralleled increased expression of a specific IP-10 receptor, CXCR3, and correlated with the degree of infiltration of mononuclear lymphocytes.", {"entities": [[75, 80, "GENE"]]}], ["In contrast, lung expression of TARC and its specific receptor, CCR4, were suppressed in MRL/ lpr mice.", {"entities": [[64, 68, "GENE"]]}], ["Immunohistology showed that macrophage-like cells were the likely source of IP-10.", {"entities": []}], ["Flow cytometric analyses revealed that the CXCR3-expressing cells were mainly infiltrating CD4 T cells and macrophages, which correlated with the degree of mononuclear lymphocyte infiltration.", {"entities": [[91, 94, "GENE"]]}], ["Recent data suggest that Th1 cells and Th1-derived cytokines play an important role in the development of SLE-like disease in MRL/ lpr mice.", {"entities": []}], ["Our results suggest that IP-10 expression in the lung is involved, through CXCR3, in the pathogenesis of pulmonary inflammation associated with migration of Th1 cells.", {"entities": [[75, 80, "GENE"]]}], ["Electronic monitoring is recommended for accurate measurement of medication adherence but a possible limitation is that it may influence adherence.", {"entities": []}], ["To test the reactive effect of electronic monitoring in a randomized controlled trial.", {"entities": []}], ["A total of 226 adults with type 2 diabetes and HbA1c \u226558\u00a0mmol/mol were randomized to receiving their main oral glucose lowering medication in electronic containers or standard packaging.", {"entities": []}], ["The primary outcomes were self-reported adherence measured with the MARS (Medication Adherence Report Scale; range 5\u201325) and HbA 1c at 8\u00a0weeks.", {"entities": [[68, 72, "GENE"]]}], ["Non-significantly higher adherence and lower HbA 1c were observed in the electronic container group (differences in means, adjusting for baseline value: MARS, 0.4 [95\u00a0% CI \u22120.1 to 0.8, p \u2009=\u20090.11]; HbA 1c (mmol/mol), \u22121.02 [\u22122.73 to 0.71, p \u2009=\u20090.25]).", {"entities": [[153, 157, "GENE"]]}], ["Electronic containers may lead to a small increase in adherence but this potential limitation is outweighed by their advantages.", {"entities": []}], ["Our findings support electronic monitoring as the method of choice in research on medication adherence.", {"entities": []}], ["(Trial registration Current Controlled Trials ISRCT N30522359)", {"entities": []}], ["Matrix metalloproteases (MMPs) comprise a family of enzymes that cleave protein substrates based on a conserved mechanism involving activation of an active site-bound water molecule by a Zn", {"entities": []}], ["Anti-inflammatory drug development efforts for lung disease have been hampered in part by the lack of noninvasive inflammation biomarkers and the limited ability of animal models to predict efficacy in humans.", {"entities": [[47, 59, "DISEASE"]]}], ["We used For this single center, single-blind, placebo-controlled cohort study, we enrolled healthy volunteers sequentially into the following treatment cohorts (N = 6 per cohort): pioglitazone plus placebo, zileuton plus placebo, or dual placebo prior to bronchoscopic endotoxin instillation.", {"entities": []}], ["K i (primary outcome measure).", {"entities": []}], ["Secondary outcome measures included the mean standard uptake value (SUV mean ), post-endotoxin bronchoalveolar lavage (BAL) cell counts and differentials and blood adiponectin and urinary leukotriene E 4 (LTE 4 ) levels, determined by enzyme-linked immunosorbent assay, to verify treatment compliance.", {"entities": []}], ["One- or two-way analysis of variance assessed for differences among cohorts in the outcome measures (expressed as mean \u00b1 standard deviation).", {"entities": []}], ["Ten females and eight males (29\u00b16 years of age) completed all study procedures except for one volunteer who did not complete the post-endotoxin BAL.", {"entities": []}], ["K i and SUV mean increased in all cohorts after endotoxin instillation ( K i increased by 0.0021\u00b10.0019, 0.0023\u00b10.0017, and 0.0024\u00b10.0020 and SUV mean by 0.47\u00b10.14, 0.55\u00b10.15, and 0.54\u00b10.38 in placebo, pioglitazone, and zileuton cohorts, respectively, p<0.001) with no differences among treatment cohorts (p = 0.933).", {"entities": []}], ["Adiponectin levels increased as expected with pioglitazone treatment but not urinary LTE 4 levels as expected with zileuton treatment.", {"entities": []}], ["BAL cell counts (p = 0.442) and neutrophil percentage (p = 0.773) were similar among the treatment cohorts.", {"entities": []}], ["Endotoxin-induced lung inflammation in humans is not responsive to pioglitazone or zileuton, highlighting the challenge in translating anti-inflammatory drug efficacy results from murine models to humans.", {"entities": []}], ["ClinicalTrials.gov NCT01174056 .", {"entities": []}], ["The implementation of evidence-based treatments to deliver high-quality care is essential to meet the healthcare demands of aging populations.", {"entities": []}], ["However, the sustainable application of recommended practice is difficult to achieve and variable outcomes well recognised.", {"entities": []}], ["The NHS Institute for Innovation and Improvement Sustainability Model (SM) was designed to help healthcare teams recognise determinants of sustainability and take action to embed new practice in routine care.", {"entities": [[4, 7, "GENE"]]}], ["This article describes a formative evaluation of the application of the SM by the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care for Northwest London (CLAHRC NWL).", {"entities": []}], ["Data from project teams\u2019 responses to the SM and formal reviews was used to assess acceptability of the SM and the extent to which it prompted teams to take action.", {"entities": []}], ["Projects were classified as \u2018engaged,\u2019 \u2018partially engaged\u2019 and \u2018non-engaged.\u2019 Quarterly survey feedback data was used to explore reasons for variation in engagement.", {"entities": []}], ["Score patterns were compared against formal review data and a \u2018diversity of opinion\u2019 measure was derived to assess response variance over time.", {"entities": []}], ["Of the 19 teams, six were categorized as \u2018engaged,\u2019 six \u2018partially engaged,\u2019 and seven as \u2018non-engaged.\u2019 Twelve teams found the model acceptable to some extent.", {"entities": []}], ["Diversity of opinion reduced over time.", {"entities": []}], ["A minority of teams used the SM consistently to take action to promote sustainability but for the majority SM use was sporadic.", {"entities": []}], ["Feedback from some team members indicates difficulty in understanding and applying the model and negative views regarding its usefulness.", {"entities": []}], ["The SM is an important attempt to enable teams to systematically consider determinants of sustainability, provide timely data to assess progress, and prompt action to create conditions for sustained practice.", {"entities": []}], ["Tools such as these need to be tested in healthcare settings to assess strengths and weaknesses and findings disseminated to aid development.", {"entities": []}], ["This study indicates the SM provides a potentially useful approach to measuring teams\u2019 views on the likelihood of sustainability and prompting action.", {"entities": []}], ["Securing engagement of teams with the SM was challenging and redesign of elements may need to be considered.", {"entities": []}], ["Capacity building and facilitation appears necessary for teams to effectively deploy the SM.", {"entities": []}], ["We have explored whether assessing the degree of concavity in the descending limb of the maximum expiratory flow\u2013volume curve enhanced spirometric detection of early small airway disease.", {"entities": []}], ["We used spirometry records from 890 individuals aged \u226540 years (mean 59 years), recruited for the Burden of Obstructive Lung Disease Australia study.", {"entities": []}], ["Central and peripheral concavity indices were developed from forced expired flows at 50% and 75% of the forced vital capacity, respectively, using an ideal line joining peak flow to zero flow.", {"entities": []}], ["From the 268 subjects classified as normal never smokers, mean values for post-bronchodilator central concavity were 18.6% in males and 9.1% in females and those for peripheral concavity were 50.5% in males and 52.4% in females.", {"entities": []}], ["There were moderately strong correlations between concavity and forced expired ratio (forced expiratory volume in 1 second/forced vital capacity) and mid-flow rate (forced expiratory flow between 25% and 75% of the FVC [FEF 25%\u201375% ]; r=\u22120.70 to \u22120.79).", {"entities": []}], ["The additional number of individuals detected as abnormal using the concavity indices was substantial, especially compared with FEF 25%\u201375% , where it was approximately doubled.", {"entities": []}], ["Concavity was more specific for symptoms.", {"entities": []}], ["The inclusion of these concavity measures in the routine reports of spirometry would add information on small airway obstruction at no extra cost, time, or effort.", {"entities": []}], ["Acute exacerbations are a leading cause of worsening COPD in terms of lung function decline, quality of life, and survival.", {"entities": []}], ["They also have a relevant economic burden on the health care system.", {"entities": []}], ["Determining the risk factors for acute exacerbation and early relapse could be a crucial element for a better management of COPD patients.", {"entities": []}], ["This review analyzes the current knowledge and underlines the main risk factors for recurrent acute exacerbations.", {"entities": []}], ["Comprehensive evaluation of COPD patients during stable phase and exacerbation could contribute to prevent treatment failure and relapses.", {"entities": []}], ["Antibodies (Abs) containing two different antigen-binding sites in one molecule are called bispecific.", {"entities": []}], ["Bispecific Abs (BsAbs) were first described in the 1960s, the first monoclonal BsAbs were generated in the 1980s by hybridoma technology, and the first article describing the therapeutic use of BsAbs was published in 1992, but the number of papers devoted to BsAbs has increased significantly in the last 10 years.", {"entities": []}], ["Particular interest in BsAbs is due to their therapeutic use.", {"entities": []}], ["In the last decade, two BsAbs \u2013 catumaxomab in 2009 and blinatumomab in 2014, were approved for therapeutic use.", {"entities": []}], ["Papers published in recent years have been devoted to various methods of BsAb generation by genetic engineering and chemical conjugation, and describe preclinical and clinical trials of these drugs in a variety of diseases.", {"entities": []}], ["This review considers diverse BsAb-production methods, describes features of therapeutic BsAbs approved for medical use, and summarizes the prospects of practical application of promising new BsAbs.", {"entities": []}], ["The growing availability of electronic health records (EHRs) in the US could provide researchers with a more detailed and clinically relevant alternative to using claims-based data.", {"entities": []}], ["In this study we compared a very large EHR database (Health Facts\u00a9) to a well-established population estimate (Nationwide Inpatient Sample).", {"entities": []}], ["Weighted comparisons were made using t-value and relative difference over diagnoses and procedures for the year 2010.", {"entities": []}], ["The two databases have a similar distribution pattern across all data elements, with 24 of 50 data elements being statistically similar between the two data sources.", {"entities": []}], ["In general, differences that were found are consistent across diagnosis and procedures categories and were specific to the psychiatric\u2013behavioral and obstetrics\u2013gynecology services areas.", {"entities": []}], ["Large EHR databases have the potential to be a useful addition to health services researchers, although they require different analytic techniques compared to administrative databases; more research is needed to understand the differences.", {"entities": []}], ["Symptomatic hypogammaglobulinemia in infancy and childhood (SHIC), may be an early manifestation of a primary immunodeficiency or a maturational delay in the normal production of immunoglobulins (Ig).", {"entities": []}], ["We aimed to evaluate the natural course of SHIC and correlate in vitro lymphoproliferative and secretory responses with recovery of immunoglobulin values and clinical resolution.", {"entities": []}], ["Children, older than 1 year of age, referred to our specialist clinic because of recurrent infections and serum immunoglobulin (Ig) levels 2 SD below the mean for age, were followed for a period of 8 years.", {"entities": []}], ["Patient with any known familial, clinical or laboratory evidence of cellular immunodeficiency or other immunodeficiency syndromes were excluded from this cohort.", {"entities": []}], ["Evaluation at 6- to 12-months intervals continued up to 1 year after resolution of symptoms.", {"entities": []}], ["In a subgroup of patients, in vitro lymphocyte proliferation and Ig secretion in response to mitogens was performed.", {"entities": []}], ["32 children, 24 (75%) males, 8 (25%) females, mean age 3.4 years fulfilled the inclusion criteria.", {"entities": []}], ["Clinical presentation: ENT infections 69%, respiratory 81%, diarrhea 12.5%.", {"entities": [[60, 68, "DISEASE"]]}], ["During follow-up, 17 (53%) normalized serum Ig levels and were diagnosed as transient hypogammaglobulinemia of infancy (THGI).", {"entities": [[76, 118, "DISEASE"], [76, 107, "DISEASE"]]}], ["THGI patients did not differ clinically or demographically from non-transient patients, both having a benign clinical outcome.", {"entities": []}], ["In vitro Ig secretory responses, were lower in hypogammaglobulinemic, compared to normal children and did not normalize concomitantly with serum Ig's in THGI patients.", {"entities": []}], ["The majority of children with SHIC in the first decade of life have THGI.", {"entities": []}], ["Resolution of symptoms as well as normalization of Ig values may be delayed, but overall the clinical outcome is good and the clinical course benign.", {"entities": []}], ["The peptidyl-prolyl isomerase Pin1 is over-expressed in several cancer tissues is a potential prognostic marker in prostate cancer, and Pin1 ablation can suppress tumorigenesis in breast and prostate cancers.", {"entities": [[64, 70, "DISEASE"], [124, 130, "DISEASE"], [115, 130, "DISEASE"], [30, 34, "GENE"], [136, 140, "GENE"], [30, 34, "GENE"], [136, 140, "GENE"]]}], ["Pin1 can co-operate with activated ErbB2 or Ras to enhance tumorigenesis.", {"entities": [[0, 4, "GENE"], [35, 40, "GENE"]]}], ["It does so by regulating the activity of proteins that are essential for gene expression and cell proliferation.", {"entities": []}], ["Several targets of Pin1 such as c-Myc, the Androgen Receptor, Estrogen Receptor-alpha, Cyclin D1, Cyclin E, p53, RAF kinase and NCOA3 are deregulated in cancer.", {"entities": [[153, 159, "DISEASE"], [19, 23, "GENE"], [128, 133, "GENE"]]}], ["At the posttranscriptional level, emerging evidence indicates that Pin1 also regulates mRNA decay of histone mRNAs, GM-CSF , Pth , and TGF\u03b2 mRNAs by interacting with the histone mRNA specific protein SLBP, and the ARE-binding proteins AUF1 and KSRP, respectively.", {"entities": [[67, 71, "GENE"], [125, 128, "GENE"], [200, 204, "GENE"]]}], ["To understand how Pin1 may affect mRNA abundance on a genome-wide scale in mammalian cells, we used RNAi along with DNA microarrays to identify genes whose abundance is significantly altered in response to a Pin1 knockdown.", {"entities": [[18, 22, "GENE"], [208, 212, "GENE"], [18, 22, "GENE"], [208, 212, "GENE"]]}], ["Functional scoring of differentially expressed genes showed that Pin1 gene targets control cell adhesion, leukocyte migration, the phosphatidylinositol signaling system and DNA replication.", {"entities": [[65, 69, "GENE"]]}], ["Several mRNAs whose abundance was significantly altered by Pin1 knockdown contained AU-rich element (ARE) sequences in their 3\u2032 untranslated regions.", {"entities": [[59, 63, "GENE"]]}], ["We identified HuR and AUF1 as Pin1 interacting ARE-binding proteins in vivo .", {"entities": [[30, 34, "GENE"]]}], ["Pin1 was also found to stabilize all core histone mRNAs in this study, thereby validating our results from a previously published study.", {"entities": [[0, 4, "GENE"]]}], ["Statistical analysis suggests that Pin1 may target the decay of essential mRNAs that are inherently unstable and have short to medium half-lives.", {"entities": [[35, 39, "GENE"]]}], ["Thus, this study shows that an important biological role of Pin1 is to regulate mRNA abundance and stability by interacting with specific RNA-binding proteins that may play a role in cancer progression.", {"entities": [[183, 189, "DISEASE"], [60, 64, "GENE"]]}], ["This study aimed to assess the association between 14 single nucleotide polymorphisms (SNPs) in six genes ( IRF8 , TMEM39A , IKZF3 , ORMDL3 , GSDMB , and ZPBP2 ) and systemic lupus erythematosus (SLE) in a Chinese Han population sample.", {"entities": [[175, 194, "DISEASE"], [166, 194, "DISEASE"], [108, 112, "GENE"], [115, 122, "GENE"], [125, 130, "GENE"], [133, 139, "GENE"], [142, 147, "GENE"], [154, 159, "GENE"]]}], ["We carried out a case-control study of 415 patients with SLE and 470 healthy controls without autoimmune disease or cancer.", {"entities": [[116, 122, "DISEASE"]]}], ["DNA for genetic analysis was isolated from the blood of all subjects using standard phenol-chloroform method.", {"entities": []}], ["TagSNPs were identified using genotype data from the panel (Han Chinese in Beijing) of the HapMap Project and were selected using the Haploview program.", {"entities": []}], ["Genotyping assay was conducted using the Sequenom MassARRAY iPLEX Gold platform.", {"entities": []}], ["The frequencies of the alleles and genotypes were calculated and analyzed.", {"entities": []}], ["Association studies and haplotype analysis were also performed.", {"entities": []}], ["The genotypic frequencies of rs12493175 and rs13062955 were significantly different between the SLE patients and the healthy controls.", {"entities": []}], ["Compared with the common homozygous genotype, the CT and CT\u2009+\u2009TT genotypes in rs12493175 and the AC and AC\u2009+\u2009AA genotypes in rs13062955 was observed to significantly reduce the risk of SLE.", {"entities": []}], ["The haplotype analysis of TMEM39A polymorphisms showed that the CGTA haplotype frequency was significantly low in the SLE patients.", {"entities": [[26, 33, "GENE"]]}], ["Our findings identified three novel associations in SNPs located in the TMEM39A gene associated with SLE susceptibility in a Chinese Han population.", {"entities": [[72, 79, "GENE"]]}], ["Mucociliary clearance is a biomechanical mechanism of airway protection.", {"entities": []}], ["It consists of the active transport along the bronchial tree of the mucus, a fluid propelled by the coordinated beating of a myriad of cilia on the epithelial surface of the respiratory tract.", {"entities": []}], ["The physics of mucus transport is poorly understood because it involves complex phenomena such as long-range hydrodynamic interactions, active collective ciliary motion, and the complex rheology of mucus.", {"entities": []}], ["We propose a quantitative physical analysis of the ciliary activity and mucus transport on a large panel of human bronchial cultures from control subjects, patients with asthma and chronic obstructive pulmonary disease obtained from endobronchial biopsies.", {"entities": [[181, 218, "DISEASE"], [170, 176, "DISEASE"]]}], ["Here we report on the existence of multiple ciliary domains with sizes ranging from the tens of a micron to the centimeter, where ciliary beats present a circular orientational order.", {"entities": []}], ["These domains are associated with circular mucus flow patterns, whose size scales with the average cilia density.", {"entities": []}], ["In these domains, we find that the radial increase of the ciliated cell density coupled with the increase in the orientational order of ciliary beats result in a net local force proportional to the mucus velocity.", {"entities": []}], ["We propose a phenomenological physical model that supports our results.", {"entities": []}], ["Research investigating cognition and behaviour in Sotos syndrome has been sporadic and to date, there is no published overview of study findings.", {"entities": [[56, 64, "DISEASE"]]}], ["A systematic review of all published literature (1964\u20132015) presenting empirical data on cognition and behaviour in Sotos syndrome.", {"entities": [[122, 130, "DISEASE"]]}], ["Thirty four journal articles met inclusion criteria.", {"entities": []}], ["Within this literature, data relating to cognition and/or behaviour in 247 individuals with a diagnosis of Sotos syndrome were reported.", {"entities": [[113, 121, "DISEASE"]]}], ["Ten papers reported group data on cognition and/or behaviour.", {"entities": []}], ["The remaining papers employed a case study design.", {"entities": []}], ["Intelligence quotient (IQ) scores were reported in twenty five studies.", {"entities": []}], ["Intellectual disability (IQ < 70) or borderline intellectual functioning (IQ 70\u201384) was present in the vast majority of individuals with Sotos syndrome.", {"entities": [[143, 151, "DISEASE"]]}], ["Seven studies reported performance on subscales of intelligence tests.", {"entities": []}], ["Data from these studies indicate that verbal IQ scores are consistently higher than performance IQ scores.", {"entities": []}], ["Fourteen papers provided data on behavioural features of individuals with Sotos syndrome.", {"entities": [[80, 88, "DISEASE"]]}], ["Key themes that emerged in the behavioural literature were overlap with ASD, ADHD, anxiety and high prevalence of aggression/tantrums.", {"entities": []}], ["Although a range of studies have provided insight into cognition and behaviour in Sotos syndrome, specific profiles have not yet been fully specified.", {"entities": [[88, 96, "DISEASE"]]}], ["Recommendations for future research are provided.", {"entities": []}], ["Epithelial ovarian cancer (EOC) patients frequently suffer from thrombocytosis, which leads to a poor prognosis.", {"entities": [[64, 78, "DISEASE"], [11, 25, "DISEASE"], [19, 25, "DISEASE"]]}], ["However, the mechanism underlying platelet regulation of biological behavior in EOC remains unclear.", {"entities": []}], ["The associations between clinicopathological characteristics and thrombocytosis in 171 EOC patients were studied, preoperative thrombocytosis was significantly associated with the stage, metastasis scope, level of preoperative CA125 and overall survival.", {"entities": [[65, 79, "DISEASE"], [127, 141, "DISEASE"]]}], ["When SKOV3 cells were cocultured with platelet microparticles (PMPs), the expression of molecules associated with epithelial-mesenchymal transition (EMT) was increased.", {"entities": []}], ["The proliferation and migration of SKOV3 cells were also enhanced.", {"entities": []}], ["Based on the miRNA microarray of the PMPs derived between thrombin-stimulating and apoptotic platelets, we demonstrated that over-expression or complete knockdown of miR-939 in the SKOV3 cells strengthened or weakened EMT.", {"entities": [[166, 173, "GENE"]]}], ["Secretory phospholipase A2 type IIA (sPLA 2 -IIa) has been shown to mediate PMPs intake by SKOV3 cells.", {"entities": []}], ["The knockdown of sPLA 2 -IIa in SKOV3 cells verified that PMPs were involved in crosstalk during the regulation of cancer cells by transferring miRNA.", {"entities": [[115, 121, "DISEASE"]]}], ["This study revealed an important role for PMPs in the crosstalk of platelets and cancer cells through miR-939 shedding mediated by sPLA 2 -IIa, which enables EOC to undergo EMT and enhances cancer progression.", {"entities": [[81, 87, "DISEASE"], [190, 196, "DISEASE"], [102, 109, "GENE"]]}], ["Our findings pave the way for developing a novel therapeutic strategy for EOC targets such as PMPs, miR-939 or sPLA 2 -IIa.", {"entities": [[100, 107, "GENE"]]}], ["Combining two long-acting bronchodilators with complementary mechanisms of action may provide treatment benefits to patients with chronic obstructive pulmonary disease (COPD) that are greater than those derived from either treatment alone.", {"entities": [[130, 167, "DISEASE"]]}], ["The efficacy and safety of a fixed-dose combination (FDC) of aclidinium bromide, a long-acting muscarinic antagonist, and formoterol fumarate, a long-acting \u03b2 2 -agonist, in patients with moderate to severe COPD are presented.", {"entities": []}], ["In this 24-week double-blind study, 1692 patients with stable COPD were equally randomized to twice-daily treatment with FDC aclidinium 400\u00a0\u03bcg/formoterol 12\u00a0\u03bcg (ACL400/FOR12 FDC), FDC aclidinium 400\u00a0\u03bcg/formoterol 6\u00a0\u03bcg (ACL400/FOR6 FDC), aclidinium 400\u00a0\u03bcg, formoterol 12\u00a0\u03bcg, or placebo administered by a multidose dry powder inhaler (Genuair 1 (FDCs versus aclidinium) and change from baseline to week 24 in morning predose (trough) FEV 1 (FDCs versus formoterol).", {"entities": [[432, 435, "GENE"]]}], ["Secondary endpoints were change from baseline in St. George\u2019s Respiratory Questionnaire (SGRQ) total score and improvement in Transition Dyspnea Index (TDI) focal score at week 24.", {"entities": []}], ["Safety and tolerability were also assessed.", {"entities": []}], ["At study end, improvements from baseline in 1-hour postdose FEV 1 were significantly greater in patients treated with ACL400/FOR12 FDC or ACL400/FOR6 FDC compared with aclidinium (108\u00a0mL and 87\u00a0mL, respectively; p < 0.0001).", {"entities": [[60, 63, "GENE"]]}], ["Improvements in trough FEV 1 were significantly greater in patients treated with ACL400/FOR12 FDC versus formoterol (45\u00a0mL; p = 0.0102), a numerical improvement of 26\u00a0mL in trough FEV 1 over formoterol was observed with ACL400/FOR6 FDC.", {"entities": [[23, 26, "GENE"], [180, 183, "GENE"], [23, 26, "GENE"], [180, 183, "GENE"]]}], ["Significant improvements in both SGRQ total and TDI focal scores were observed in the ACL400/FOR12 FDC group at study end (p < 0.0001), with differences over placebo exceeding the minimal clinically important difference of \u22654 points and \u22651 unit, respectively.", {"entities": []}], ["All treatments were well tolerated, with safety profiles of the FDCs similar to those of the monotherapies.", {"entities": []}], ["Treatment with twice-daily aclidinium 400\u00a0\u03bcg/formoterol 12\u00a0\u03bcg FDC provided rapid and sustained bronchodilation that was greater than either monotherapy; clinically significant improvements in dyspnea and health status were evident compared with placebo.", {"entities": []}], ["Aclidinium/formoterol FDC may be an effective and well tolerated new treatment option for patients with COPD.", {"entities": []}], ["Clinicaltrials.gov NCT01437397 .", {"entities": []}], ["*Registered trademarks of Almirall S.A., Barcelona, Spain; for use within the US as Pressair The online version of this article (doi:10.1186/s12931-014-0123-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The Asthma Symptom Utility Index (ASUI) is a preference-based outcome measure used in US clinical trials and cost-effectiveness studies for asthma.", {"entities": [[4, 10, "DISEASE"], [140, 146, "DISEASE"]]}], ["This study evaluated ASUI preference weights in Europe to determine whether the multi-attribute utility function, based on preferences from a US population, is generalizable across countries.", {"entities": []}], ["Data were collected from ninety asthma patients from Italy, France, and the United Kingdom using the Asthma Control Questionnaire, the Asthma Quality of Life Questionnaire, and the ASUI.", {"entities": [[32, 38, "DISEASE"], [101, 107, "DISEASE"], [135, 141, "DISEASE"]]}], ["Subjects rated their preferences for 10 asthma health states using a visual analogue scale (VAS) and a standard gamble (SG) interview.", {"entities": [[40, 46, "DISEASE"]]}], ["All multi-symptom states showed statistically significant differences (p < 0.001) between countries in mean VAS scores.", {"entities": []}], ["Mean SG utility scores between the US and France and the US and Italy demonstrated statistically significant differences (p < 0.001) for three states: severe wheeze; moderate cough and wheeze; and moderate cough and dyspnea.", {"entities": []}], ["Because of these differences, the multi-attribute utility functions derived within countries were somewhat different.", {"entities": []}], ["Despite these differences, country-specific algorithms captured a similar rank ordering of patients by disease severity, were strongly correlated (r = 0.971 to 0.995), and demonstrated similar relationships with symptom and AQLQ scores.", {"entities": []}], ["Results of this study suggest that the ASUI may be a complementary patient-reported outcome for clinical studies and may be useful for applications in cost-effectiveness studies comparing different asthma treatments.", {"entities": [[198, 204, "DISEASE"]]}], ["Objectives: To conduct a systematic review of studies that examined associations between physical illness/functional disability and suicidal behaviour (including ideation, nonfatal and fatal suicidal behaviour) among individuals aged 65 and older.", {"entities": []}], ["Method: Articles published through November 2014 were identified through electronic searches using the ERIC, Google Scholar, PsycINFO, PubMed, and Scopus databases.", {"entities": []}], ["Search terms used were suicid* or death wishes or deliberate self-harm.", {"entities": []}], ["Studies about suicidal behaviour in individuals aged 65 and older with physical illness/functional disabilities were included in the review.", {"entities": []}], ["Results: Sixty-five articles (across 61 independent samples) met inclusion criteria.", {"entities": []}], ["Results from 59 quantitative studies conducted in four continents suggest that suicidal behaviour is associated with functional disability and numerous specific conditions including malignant diseases, neurological disorders, pain, COPD, liver disease, male genital disorders, and arthritis/arthrosis.", {"entities": [[238, 251, "DISEASE"], [281, 290, "DISEASE"]]}], ["Six qualitative studies from three continents contextualized these findings, providing insights into the subjective experiences of suicidal individuals.", {"entities": []}], ["Implications for interventions and future research are discussed.", {"entities": []}], ["Conclusion: Functional disability, as well as a number of specific physical illnesses, was shown to be associated with suicidal behaviour in older adults.", {"entities": []}], ["We need to learn more about what at-risk, physically ill patients want, and need, to inform prevention efforts for older adults.", {"entities": []}], ["Prospective syndromic surveillance of emergency department visits has been used for near-real time tracking of communicable diseases to detect outbreaks or other unexpected disease clusters.", {"entities": []}], ["The utility of syndromic surveillance for tracking cardiovascular events, which may be influenced by environmental factors and influenza, has not been evaluated.", {"entities": [[127, 136, "DISEASE"]]}], ["We developed and evaluated a method for tracking cardiovascular events using emergency department free-text chief complaints.", {"entities": []}], ["There were three phases to our analysis.", {"entities": []}], ["First we applied text processing algorithms based on sensitivity, specificity, and positive predictive value to chief complaint data reported by 11 New York City emergency departments for which ICD-9 discharge diagnosis codes were available.", {"entities": []}], ["Second, the same algorithms were applied to data reported by a larger sample of 50 New York City emergency departments for which discharge diagnosis was unavailable.", {"entities": []}], ["From this more complete data, we evaluated the consistency of temporal variation of cardiovascular syndromic events and hospitalizations from 76 New York City hospitals.", {"entities": []}], ["Finally, we examined associations between particulate matter \u22642.5 \u00b5m (PM 2.5 ), syndromic events, and hospitalizations.", {"entities": []}], ["Sensitivity and positive predictive value were low for syndromic events, while specificity was high.", {"entities": []}], ["Utilizing the larger sample of emergency departments, a strong day of week pattern and weak seasonal trend were observed for syndromic events and hospitalizations.", {"entities": []}], ["These time-series were highly correlated after removing the day-of-week, holiday, and seasonal trends.", {"entities": []}], ["The estimated percent excess risks in the cold season (October to March) were 1.9% (95% confidence interval (CI): 0.6, 3.2), 2.1% (95% CI: 0.9, 3.3), and 1.8% (95%CI: 0.5, 3.0) per same-day 10 \u00b5g/m 2.5 for cardiac-only syndromic data, cardiovascular syndromic data, and hospitalizations, respectively.", {"entities": []}], ["Near real-time emergency department chief complaint data may be useful for timely surveillance of cardiovascular morbidity related to ambient air pollution and other environmental events.", {"entities": []}], ["Aeroallergens such as house dust mite (HDM), cockroach, and grass or tree pollen are innocuous substances that can induce allergic sensitization upon inhalation.", {"entities": []}], ["The serine proteases present in these allergens are thought to activate the protease-activated receptor (PAR)-2, on the airway epithelium, thereby potentially inducing allergic sensitization at the expense of inhalation tolerance.", {"entities": []}], ["We hypothesized that the proteolytic activity of allergens may play an important factor in the allergenicity to house dust mite and is essential to overcome airway tolerance.", {"entities": []}], ["Here, we aimed to investigate the role of PAR-2 activation in allergic sensitization and HDM-induced allergic airway inflammation.", {"entities": []}], ["In our study, Par-2 deficient mice were treated with two different HDM extracts containing high and low serine protease activities twice a week for a period of 5 weeks.", {"entities": []}], ["We determined airway inflammation through quantification of percentages of mononuclear cells, eosinophils and neutrophils in the bronchial alveolar lavage fluid and measured total IgE and HDM-specific IgE and IgG1 levels in serum.", {"entities": []}], ["Furthermore, Th2 and pro-inflammatory cytokines including IL-5, IL-13, Eotaxin-1, IL-17, KC, Chemokine (C-C motif) ligand 17 (CCL17) and thymic stromal lymphopoietin (TSLP), were measured in lung tissue homogenates.", {"entities": [[126, 131, "GENE"], [167, 171, "GENE"]]}], ["We observed that independent of the serine protease content, HDM was able to induce elevated levels of eosinophils and neutrophils in the airways of both wild-type (WT) and Par-2 deficient mice.", {"entities": []}], ["Furthermore, we show that induction of pro-inflammatory cytokines by HDM exposure is independent of Par-2 activation.", {"entities": []}], ["In contrast, serine protease activity of HDM does contribute to enhanced levels of total IgE, but not HDM-specific IgE.", {"entities": []}], ["We conclude that, while Par-2 activation contributes to the development of IgE responses, it is largely dispensable for the HDM-induced induction of pro-inflammatory cytokines and airway inflammation in an experimental mouse model of HDM-driven allergic airway disease.", {"entities": []}], ["Observational studies suggest that insomnia might be associated with an increased risk of depression with inconsistent results.", {"entities": []}], ["This study aimed at conducting a meta-analysis of prospective cohort studies to evaluate the association between insomnia and the risk of depression.", {"entities": []}], ["Relevant cohort studies were comprehensively searched from the PubMed, Embase, Web of Science, and China National Knowledge Infrastructure databases (up to October 2014) and from the reference lists of retrieved articles.", {"entities": []}], ["A random-effects model was used to calculate the pooled risk estimates and 95\u00a0% confidence intervals (CIs).", {"entities": []}], ["The I Thirty-four cohort studies involving 172,077 participants were included in this meta-analysis with an average follow-up period of 60.4\u00a0months (ranging from 3.5 to 408).", {"entities": []}], ["Statistical analysis suggested a positive relationship between insomnia and depression, the pooled RR was 2.27 (95\u00a0% CI: 1.89\u20132.71), and a high heterogeneity was observed ( I P \u2009<\u20090.001).", {"entities": []}], ["Visual inspection of the funnel plot revealed some asymmetry.", {"entities": []}], ["The Egger\u2019s test identified evidence of substantial publication bias ( P <0.05), but correction for this bias using trim-and-fill method did not alter the combined risk estimates.", {"entities": []}], ["This meta-analysis indicates that insomnia is significantly associated with an increased risk of depression, which has implications for the prevention of depression in non-depressed individuals with insomnia symptoms.", {"entities": []}], ["A new spectrophotometric assay was developed to measure, continuously and specifically, phospholipase A 1 (PLA 1 ) or phospholipase A 2 (PLA 2 ) activities using synthetic glycerophosphatidylcholines (PCs) containing \u03b1-eleostearic acid, either at the sn -1 position [1-\u03b1-eleostearoyl-2-octadecyl- rac -glycero-3-phosphocholine (EOPC)] or at the sn -2 position [1-octadecyl-2-\u03b1-eleostearoyl- rac -glycero-3-phosphocholine (OEPC)].", {"entities": []}], ["The substrates were coated onto the wells of microtiter plates.", {"entities": []}], ["A nonhydrolyzable ether bond, with a non-UV-absorbing alkyl chain, was introduced at the other sn position to prevent acyl chain migration during lipolysis.", {"entities": []}], ["Upon enzyme action, \u03b1-eleostearic acid is liberated and then solubilized into the micellar phase.", {"entities": []}], ["The PLA 1 or PLA 2 activity was measured by the increase in absorbance at 272 nm due to the transition of \u03b1-eleostearic acid from the adsorbed to the soluble state.", {"entities": []}], ["EOPC and OEPC differentiate, with excellent accuracy, between PLA 1 and PLA 2 activity.", {"entities": []}], ["Lecitase 1 enzyme), bee venom PLA 2 , and porcine pancreatic PLA 2 were all used to validate the assay.", {"entities": []}], ["Compared with current assays used for continuously measuring PLA 1 or PLA 2 activities and/or their inhibitors, the development of this sensitive enzymatic method, using coated PC substrate analogs to natural lipids and based on the UV spectroscopic properties of \u03b1-eleostearic acid, is a significant improvement.", {"entities": [[177, 179, "GENE"]]}], ["Few studies have evaluated the association between Sjogren's syndrome (SS) and respiratory failure (RF).", {"entities": [[79, 98, "DISEASE"], [61, 69, "DISEASE"]]}], ["Thus, we conducted a retrospective national cohort study to investigate whether Sjogren's syndrome (SS) increases the risk of respiratory failure (RF).", {"entities": [[126, 145, "DISEASE"], [90, 98, "DISEASE"]]}], ["The cohort consisted of 4954 newly diagnosed patients with SS but without a previous diagnosis of RF, and 19816 patients as the comparison cohort from the catastrophic illnesses registry, obtained from the 2000\u20132005 period.", {"entities": []}], ["All of the study participants were followed from the index date to December 31, 2011.", {"entities": []}], ["We analyzed the association between the risk of RF and SS by using a Cox proportional hazards regression model, controlling for sex, age, and comorbidities.", {"entities": []}], ["The overall incidence rate of RF showed a 3.21-fold increase in the SS cohort compared with the comparison cohort.", {"entities": []}], ["The adjusted HR of RF was 3.04 for the SS cohort compared with the comparison cohort, after we adjusted for sex, age, and comorbidities.", {"entities": [[13, 15, "GENE"]]}], ["The HRs of RF for patients with primary SS and secondary SS compared with the comparison cohort were 2.99 and 3.93, respectively ( P for trend <.001).", {"entities": []}], ["The HRs of RF increased as the severity of SS increased, from 2.34 for those with no inpatient care experience to 5.15 for those with inpatient care experience ( P for trend <.001).", {"entities": []}], ["This study indicates that clinical physicians should not only consider secondary SS but also primary SS as a critical factor that increases the risk of RF.", {"entities": []}], ["Health status, disease spectrum and use of healthcare have been reported to vary across groups of migrants and according to the different phases of migration.", {"entities": []}], ["However, most studies are conducted among adults.", {"entities": []}], ["This study assesses usage of primary healthcare (PHC) by children with immigrant background compared with non-immigrant children in Norway and describes their relative morbidity burden.", {"entities": []}], ["Population-based retrospective cohort study.", {"entities": []}], ["This study used 3 linked population-based registers in Norway for children under 18\u2005years of age in 2008.", {"entities": []}], ["Immigrants were defined as children with both parents born abroad, and further classified into first and second generation, and according to the World Bank income categories of their parents' country of origin.", {"entities": []}], ["Usage and morbidity were assessed with negative binomial regression and logistic regression analyses, respectively.", {"entities": []}], ["Further, population-attributable fraction analyses on PHC visits were conducted to estimate the impact on the primary health system.", {"entities": []}], ["1\u2005168\u2005365 children including 119\u2005251 with immigrant background.", {"entities": []}], ["The mean number of visits to PHC for non-immigrant children was 1.40 compared with 1.19 for immigrants from high-income countries (HIC) and 1.76 for immigrants from low-income countries (LIC).", {"entities": []}], ["Compared with non-immigrants, first generation immigrants used PHC significantly less after adjusting for age and sex (incidence risk ratio (IRR) 0.70 (HIC) to 0.93 (LIC)) while second generation immigrant children generally used PHC more (IRR 1.03 (HIC) to 1.43 (LIC)); however, the median number of visits were similar between all groups.", {"entities": []}], ["The morbidity spectrum also varied between the groups.", {"entities": []}], ["Compared with non-immigrants, the excess number of consultations attributable to immigrant groups corresponds to around 1.3% of PHC visits among children.", {"entities": []}], ["Human kallikrein-related peptidases (KLKs) are a subgroup of serine proteases that participate in proteolytic pathways and control protein levels in normal physiology as well as in several pathological conditions.", {"entities": []}], ["Their complex network of stimulatory and inhibitory interactions may induce inflammatory and immune responses and contribute to the neoplastic phenotype through the regulation of several cellular processes, such as proliferation, survival, migration, and invasion.", {"entities": []}], ["This family of proteases, which includes one of the most useful cancer biomarkers, kallikrein-related peptidase 3 or PSA, also has a protective effect against cancer promoting apoptosis or counteracting angiogenesis and cell proliferation.", {"entities": [[64, 70, "DISEASE"], [159, 165, "DISEASE"]]}], ["Therefore, they represent attractive therapeutic targets and may have important applications in clinical oncology.", {"entities": []}], ["Despite being intensively studied, many gaps in our knowledge on several molecular aspects of KLK functions still exist.", {"entities": []}], ["This review aims to summarize recent data on their involvement in different processes related to health and disease, in particular those directly or indirectly linked to the neoplastic process.", {"entities": []}], ["It is curious that East Asian women have a low incidence and mortality of ovarian cancer in various epidemiological studies.", {"entities": [[74, 88, "DISEASE"], [82, 88, "DISEASE"]]}], ["Although different explanations were given, they appear unsubstantial.", {"entities": []}], ["We notice that East Asian population usually are inactive aldehyde dehydrogenase 2 mutation (ALDH2", {"entities": [[93, 98, "GENE"]]}], ["Tissue infiltration by neutrophils during acute inflammatory states causes substantial tissue injury.", {"entities": []}], ["While the magnitude of tissue neutrophil accumulation in innate immune responses is profoundly greater in males than females, fundamental aspects of the molecular mechanisms underlying these sex differences remain largely unknown.", {"entities": []}], ["We investigated sex differences in neutrophil stimulation and recruitment in ischemia/reperfusion (I/R; mesenteric or renal) or carrageenan pleurisy in rats or mice, as well as skin injury in human volunteers.", {"entities": [[140, 148, "DISEASE"], [77, 85, "DISEASE"]]}], ["The induction of potent chemoattractive mediators (chemokines) and neutrophil adhesion molecules were measured by real-time PCR, flow cytometry, and protein assays.", {"entities": []}], ["Mesenteric I/R in age-matched Wistar rats resulted in substantially more neutrophil accumulation and tissue injury at 2\u00a0h reperfusion in males than females.", {"entities": []}], ["Using intravital microscopy, we show that the immediate (<30\u00a0min) neutrophil response to I/R is similar in males and females but that prolonged neutrophil recruitment occurs in males at sites local and distal to inflammatory insult partly due to an increase in circulating neutrophil populations with elevated surface expression of adhesion molecules.", {"entities": []}], ["Sex differences in neutrophil kinetics were correlated with sustained induction of chemokine Cxcl5 in the tissue, circulation, and bone marrow of males but not females.", {"entities": [[93, 98, "GENE"]]}], ["Furthermore, blockade of Cxcl5 in males prior to ischemia resulted in neutrophil responses that were similar in magnitude to those in females.", {"entities": [[49, 57, "DISEASE"], [25, 30, "GENE"]]}], ["Conversely, administration of Cxcl5 to males in the absence of I/R was sufficient to increase levels of systemic neutrophils.", {"entities": [[30, 35, "GENE"]]}], ["Cxcl5 treatment of bone marrow neutrophils in vitro caused substantial induction of neutrophil-mobilizing cytokine granulocyte colony-stimulating factor (GCSF) and expression of \u03b22 integrin that accounts for sexual dimorphism in circulating neutrophil populations in I/R.", {"entities": [[0, 5, "GENE"]]}], ["Moreover, male Cxcl5-stimulated bone marrow neutrophils had an increased capacity to adhere to \u03b22 integrin ligand ICAM-1, implicating a greater sensitivity of male leukocytes to Cxcl5-mediated activation.", {"entities": []}], ["Differential induction of Cxcl5 (human CXCL6) between the sexes was also evident in murine renal I/R, rat pleurisy, and human skin blisters and correlated with the magnitude of neutrophil accumulation in tissues.", {"entities": [[106, 114, "DISEASE"], [26, 31, "GENE"], [39, 44, "GENE"]]}], ["Our study reveals that sex-specific induction of chemokine Cxcl5/CXCL6 contributes to sexual dimorphism in neutrophil recruitment in diverse acute inflammatory responses partly due to increased stimulation and trafficking of bone marrow neutrophils in males.", {"entities": []}], ["The online version of this article (doi:10.1186/s13293-015-0047-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Objectives: Patients with chronic graft-versus-host disease (cGVHD) often suffer from dry mouth and oral mucosal lesions.", {"entities": []}], ["The primary objective of this study was to investigate the safety of an intra-oral electrostimulator (GenNarino) in symptomatic cGVHD patients.", {"entities": []}], ["The secondary objective was to study the impact on the salivary gland involvement of cGVHD patients.", {"entities": []}], ["Study Design: This paper presents a case series.", {"entities": []}], ["The study included patients treated for 4 weeks, randomly assigned to the active device and then crossed-over to a sham-device or vice versa.", {"entities": []}], ["The patients and clinicians were blind to the treatment delivered.", {"entities": []}], ["Data regarding oral mucosal and salivary gland involvement were collected.", {"entities": []}], ["Results: Six patients were included in this series.", {"entities": []}], ["Most of the intraoral areas with manifestations of cGVHD were not in contact with the GenNarino device.", {"entities": []}], ["Two patients developed mild mucosal lesions in areas in contact with the GenNarino during the study.", {"entities": []}], ["However, only one of them had a change in the National Institutes of Health (NIH) score for oral cGVHD.", {"entities": []}], ["The unstimulated and stimulated salivary flow rate increased in 4 out of the 5 patients included in this analysis.", {"entities": []}], ["Symptoms of dry mouth and general oral comfort improved.", {"entities": []}], ["Conclusion: This study suggests that GenNarino is safe in cGVHD patients with respect to oral tissues.", {"entities": []}], ["Furthermore the use of GenNarino resulted in subjective and objective improvements in dry mouth symptoms.", {"entities": []}], ["A large scale study is needed to confirm the impact and safety of GenNarino on systemic cGVHD.", {"entities": []}], ["Key words: Dry mouth, graft versus host disease, electrostimulation, oral mucosa, hematopoietic stem cell transplantation.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) imposes a substantial burden on individuals with the disease, which can include a range of symptoms (breathlessness, cough, sputum production, wheeze, chest tightness) of varying severities.", {"entities": []}], ["We present an overview of the biomedical literature describing reported relationships between COPD symptoms and disease burden in terms of quality of life, health status, daily activities, physical activity, sleep, comorbid anxiety, and depression, as well as risk of exacerbations and disease prognosis.", {"entities": []}], ["In addition, the substantial variability of COPD symptoms encountered (morning, daytime, and nighttime) is addressed and their implications for disease burden considered.", {"entities": []}], ["The findings from this narrative review, which mainly focuses on real-world and observational studies, demonstrate the impact of COPD symptoms on the burden of disease and that improved recognition and understanding of their impact is central to alleviating this burden.", {"entities": []}], ["To identify the physiological role of Hck, a functionally redundant member of the Src family of tyrosine kinases expressed in myelomonocytic cells, we generated Hck 499 -residue in the Hck protein.", {"entities": [[38, 41, "GENE"], [161, 164, "GENE"], [185, 188, "GENE"], [82, 85, "GENE"], [38, 41, "GENE"], [161, 164, "GENE"], [185, 188, "GENE"], [38, 41, "GENE"], [161, 164, "GENE"], [185, 188, "GENE"]]}], ["Unlike their Hck", {"entities": [[13, 16, "GENE"]]}], ["As the literature now stands, a bewildering number and variety of biological, psychological and social factors are, apparently, implicated in back problems.", {"entities": []}], ["However, if and how these have a direct influence on back problems is not clear.", {"entities": []}], ["Obesity, for example, has in many studies been shown to be associated with back problems but there is no evidence for a causal link.", {"entities": [[0, 7, "DISEASE"]]}], ["This could be explained by a dearth of suitably designed studies but also because obesity may be but a proxy for some other, truly explanatory variable.", {"entities": [[82, 89, "DISEASE"]]}], ["Coping has been linked with, particularly, persistent back problems as well as with health in general.", {"entities": []}], ["The question is, whether coping could be the explanatory link between, for example, these two variables.", {"entities": []}], ["A cross-sectional study was undertaken using data from the Swedish Army, consisting of the entire cohort of males (N = 48,502) summoned in 1998 to serve in the military.", {"entities": []}], ["The purpose of the study was to investigate the relation between five independent variables and two dependent variables (\"outcome variables\").", {"entities": []}], ["The independent variables were two anthropomorphic variables (height and body mass index), two psychological variables (intellectual capacity and coping in relation to stress), and one social variable (type of education).", {"entities": []}], ["The two outcome variables were back problems and ill health.", {"entities": []}], ["In particular, we wanted to determine whether controlling for coping would affect the associations between the other four independent variables and the two outcome variables.", {"entities": []}], ["Data for the analysis come from a battery of standardized examinations, including medical examinations, a test of intellectual capacity, and a test of coping in relation to stress.", {"entities": []}], ["Each of these examinations was conducted independently of the others.", {"entities": []}], ["Unadjusted and adjusted odds ratios were calculated for the outcome variables of back problems and ill health.", {"entities": []}], ["The associations between height, body mass index, intellectual capacity, type of education and the two outcome variables (back problems and ill health) were weak to moderate.", {"entities": []}], ["Additionally, there were strong associations between coping and the two outcome variables and when controlling for coping the previously noted associations diminished or disappeared, whereas none of the other variables had a large effect on the association between coping and the two outcome variables.", {"entities": []}], ["Coping emerged as strongly associated with both back problem and ill health and coping had a leveling effect on the associations between the other independent variables and the two outcome variables.", {"entities": []}], ["This study is noteworthy particularly because the association with coping is so robust.", {"entities": []}], ["It is a retrospective, cross-sectional study, however, and, as such it raises questions of causality; which \u2013 if any \u2013 came first, inability to cope or back pain?", {"entities": []}], ["The results of this study call attention to the need for a prospective study, in which coping is clearly defined.", {"entities": []}], ["Such a study has been undertaken and will be presented separately.", {"entities": []}], ["Index terms: back pain, coping, education, height, BMI, intellectual capacity, bio-psycho-social model, epidemiology, cohort, cross-sectional study", {"entities": []}], ["The chicken immune system is immature at the time of hatching.", {"entities": []}], ["The development of the respiratory immune system after hatching is vital to young chicks.", {"entities": []}], ["The aim of this study was to investigate the effect of dietary vitamin A supplement levels on respiratory mucin and IgA production in chicks.", {"entities": []}], ["In this study, 120 one-day-old broiler chicks were randomly divided into 4 groups consisting of three replicates of 10 broilers and subjected to dietary vitamin A supplement levels of 0, 1,500, 6,000, or 12,000 IU/kg for seven days.", {"entities": []}], ["Compared with control birds, vitamin A supplementation significantly increased the mucin and IgA levels in the bronchoalveolar lavage fluid (BALF) as well as the IgA level in serum.", {"entities": []}], ["In the lungs, vitamin A supplementation downregulated TNF-\u03b1 and EGFR mRNA expression.", {"entities": [[64, 68, "GENE"]]}], ["The TGF-\u03b2 and MUC5AC mRNA expression levels were upregulated by vitamin A supplementation at a dose of 6,000 IU/kg, and the IL-13 mRNA expression level was increased at the 12,000 IU/kg supplement level.", {"entities": []}], ["Vitamin A deficiency (control) significantly decreased the mRNA expression levels of MUC2, IgA, EGFR, IL-13 and TGF-\u03b2 in trachea tissue.", {"entities": [[85, 89, "GENE"], [96, 100, "GENE"]]}], ["Histological section analysis revealed that the number of goblet cells in the tracheal epithelium was less in the 0 and 12,000 IU/kg vitamin A supplement groups than in the other groups.", {"entities": []}], ["In conclusion, vitamin A deficiency suppressed the immunity of the airway by decreasing the IgA and mucin concentrations in neonatal chicks.", {"entities": []}], ["This study suggested that a suitable level of vitamin A is essential for the secretion of IgA and mucin in the respiratory tract by regulating the gene expression of cytokines and epithelial growth factors.", {"entities": []}], ["Calcium-activated chloride channel regulator 1 (CLCA1) activates calcium-dependent chloride currents; neither the target, nor mechanism, is known.", {"entities": [[48, 53, "GENE"]]}], ["We demonstrate that secreted CLCA1 activates calcium-dependent chloride currents in HEK293T cells in a paracrine fashion, and endogenous TMEM16A/Anoctamin1 conducts the currents.", {"entities": [[29, 34, "GENE"]]}], ["Exposure to exogenous CLCA1 increases cell surface levels of TMEM16A and cellular binding experiments indicate CLCA1 engages TMEM16A on the surface of these cells.", {"entities": [[22, 27, "GENE"], [111, 116, "GENE"], [22, 27, "GENE"], [111, 116, "GENE"]]}], ["Altogether, our data suggest that CLCA1 stabilizes TMEM16A on the cell surface, thus increasing surface expression, which results in increased calcium-dependent chloride currents.", {"entities": [[34, 39, "GENE"]]}], ["Our results identify the first Cl DOI: http://dx.doi.org/10.7554/eLife.05875.001 Many biological processes that are important for our health involve the movement of ions into, and out of, our cells.", {"entities": []}], ["For example, the flow of chloride ions out of cells controls the production of the sticky mucus that lines our windpipe and other airways.", {"entities": []}], ["This mucus helps trap pollution and other foreign particles before they reach our lungs, and thus protects the lungs from harm.", {"entities": []}], ["However in some diseases\u2014such as cystic fibrosis and asthma\u2014excessive amounts of thick mucus are produced; this can lead to breathing difficulties and an increased risk of infection.", {"entities": [[33, 48, "DISEASE"], [53, 59, "DISEASE"]]}], ["Proteins belonging to the CLCA protein family were first thought to act as channels that allow chloride ions to flow through cell membranes.", {"entities": []}], ["Later studies then revealed that these proteins are not channels; instead they trigger the movement of chloride ions across cell membranes by activating other channel proteins.", {"entities": []}], ["However, the identity of these channel proteins was unknown, and it was unclear how CLCA proteins might activate these channels.", {"entities": []}], ["Sala-Rabanal, Yurtsever et al.", {"entities": []}], ["have now shown that a member of the CLCA protein family, called CLCA1, is released from human cells and causes nearby cells to release chloride ions when the channel detects calcium ions.", {"entities": [[64, 69, "GENE"]]}], ["The movement of chloride ions triggered by CLCA1 looked very similar to the way chloride ions flow through a channel protein called TMEM16A, and so Sala-Rabanal, Yurtsever et al.", {"entities": [[43, 48, "GENE"]]}], ["asked whether these two proteins interact.", {"entities": []}], ["TMEM16A was discovered several years ago, but remains the only calcium-dependent chloride channel known in mammals.", {"entities": []}], ["Sala-Rabanal, Yurtsever et al.", {"entities": []}], ["showed that adding CLCA1 to cells caused more TMEM16A channels to appear in the cell surface membrane and thereby increased the flow of chloride ions.", {"entities": [[19, 24, "GENE"]]}], ["The CLCA protein also physically interacted with the chloride channel in the membrane to stabilize it; no other protein has been shown to regulate ion channels in this way before.", {"entities": []}], ["The findings of Sala-Rabanal, Yurtsever et al.", {"entities": []}], ["provide a much clearer understanding of how the CLCA protein and the chloride channel work.", {"entities": []}], ["Both of these proteins are known to contribute to excess mucus production in airway diseases; and both have been linked to cardiovascular diseases and certain cancers.", {"entities": []}], ["These new findings may therefore also help researchers to target these proteins and develop treatments for these diseases.", {"entities": []}], ["DOI: http://dx.doi.org/10.7554/eLife.05875.002", {"entities": []}], ["Compatible solutes are natural substances that are known to stabilize cellular functions.", {"entities": []}], ["Preliminary ex vivo and in vivo studies demonstrated that the compatible solute ectoine restores natural apoptosis rates of lung neutrophils and contributes to the resolution of lung inflammation.", {"entities": []}], ["Due to the low toxicity and known compatibility of the substance, an inhalative application as an intervention strategy for humans suffering from diseases caused by neutrophilic inflammation, like COPD, had been suggested.", {"entities": []}], ["As a first approach to test the feasibility and efficacy of such a treatment, we performed a population-based randomized trial.", {"entities": []}], ["The objective of the study was to test whether the daily inhalation of the registered ectoine-containing medical device (Ectoin A double-blinded placebo-controlled trial was performed to study the efficacy and safety of an ectoine-containing therapeutic.", {"entities": []}], ["Prior to and after both inhalation periods, lung function, inflammatory parameters in sputum, serum markers, and quality-of-life parameters were determined.", {"entities": []}], ["While the other outcomes revealed no significant effects, sputum parameters were changed by the intervention.", {"entities": []}], ["Nitrogen oxides (nitrate and nitrite) were significantly reduced after ectoine inhalation with a mean quotient of 0.65 (95% confidence interval 0.45\u20130.93).", {"entities": []}], ["Extended analyses considering period effects revealed that the percentage of neutrophils in sputum was significantly lower after ectoine inhalation than in the placebo group ( P =0.035) even after the washout phase.", {"entities": []}], ["The current study is the first human trial in which the effects of inhaled ectoine on neutrophilic lung inflammation were investigated.", {"entities": []}], ["Besides demonstrating beneficial effects on inflammatory sputum parameters, the study proves the feasibility of the therapeutic approach in an aged study group.", {"entities": []}], ["A transdermal patch preparation of the \u03b2 2 agonist tulobuterol has been designed to yield sustained \u03b2 2 agonistic effects and has been used as a long-acting \u03b2 2 agonist (LABA) in Japan.", {"entities": []}], ["LABAs reduce the frequency of exacerbations of chronic obstructive pulmonary disease and bronchial asthma.", {"entities": [[47, 84, "DISEASE"], [99, 105, "DISEASE"]]}], ["However, inhibitory effects of LABAs on the replication of rhinovirus (RV), the major cause of exacerbations, have not been demonstrated.", {"entities": []}], ["To examine the effects of tulobuterol on RV replication and on the production of the replication-induced pro-inflammatory cytokines, human tracheal epithelial cells were infected with a major group RV, type 14 rhinovirus (RV14).", {"entities": []}], ["Tulobuterol reduced the RV14 titers and RNA levels; the concentrations of cytokines, including interleukin (IL)-1\u03b2, IL-6, and IL-8, in the supernatants; and susceptibility to RV14 infection.", {"entities": []}], ["Tulobuterol reduced the expression of intercellular adhesion molecule-1 (ICAM-1), the receptor for RV14, and the number of acidic endosomes in the cells in which RV14 RNA enters the cytoplasm.", {"entities": []}], ["Tulobuterol inhibited the activation of nuclear factor kappa B (NF-\u03baB) proteins in nuclear extracts.", {"entities": []}], ["A selective \u03b2 2 -adrenergic receptor antagonist, ICI 118551 [erythro-dl-1-(7-methylindan-4-yloxy)-3-isopropylaminobutan-2-ol], reversed the inhibitory effects of tulobuterol on the RV14 titers and RNA levels, the susceptibility to RV14 infection, cytokine production, and ICAM-1 expression.", {"entities": []}], ["Tulobuterol may inhibit RV replication by reducing ICAM-1 expression and acidic endosomes and modulate airway inflammation during RV replication.", {"entities": []}], ["Accurate and rapid diagnosis of acute myocardial infarction (MI) is of major clinical significance.", {"entities": [[38, 59, "DISEASE"], [32, 59, "DISEASE"]]}], ["The troponin is the biomarker of choice for detection of cardiac injury.", {"entities": []}], ["The objective of this study was to identify salivary levels of cardiac troponin I (cTnI) in patients with acute MI.", {"entities": []}], ["Thirty patients with acute MI and 28 normal healthy individuals were included in the study.", {"entities": []}], ["cTnI levels were assayed in serum and saliva 12 and 24 h of acute MI by ELISA method.", {"entities": []}], ["In patients with acute MI, the serum and resting (unstimulated) saliva concentrations of cTnI, but not stimulated saliva cTnI, at both 12 and 24 h of onset of MI, were significantly higher than in controls.", {"entities": []}], ["Resting saliva cTnI concentrations correlated significantly with serum cTnI levels (spearman rho = 0.34 and 0.45 in the total individuals and in the MI patients respectively).", {"entities": []}], ["The present results suggest that saliva can be an analytical matrix for measurement of cTnI in patients with acute MI.", {"entities": []}], ["Further studies may reveal capability of salivary cTnI for being used for developing point-of-care testing for early detection of MI in pre-clinical settings.", {"entities": []}], ["Previous studies have demonstrated that hyperoxia-induced stress and oxidative damage to the lungs of mice lead to an increase in IL-6, TNF-\u03b1, and TGF-\u03b2 expression.", {"entities": []}], ["Together, IL-6 and TGF-\u03b2 have been known to direct T cell differentiation toward the TH 17 phenotype.", {"entities": []}], ["In the current study, we tested the hypothesis that hyperoxia promotes the polarization of T cells to the TH 17 cell phenotype in response to ovalbumin-induced acute airway inflammation.", {"entities": []}], ["Airway inflammation was induced in female BALB/c mice by intraperitoneal sensitization and intranasal introduction of ovalbumin, followed by challenge methacholine.", {"entities": []}], ["After the methacholine challenge, animals were exposed to hyperoxic conditions in an inhalation chamber for 24\u2009h. The controls were subjected to normoxia or aluminum hydroxide dissolved in phosphate buffered saline.", {"entities": []}], ["After 24\u2009h of hyperoxia, the number of macrophages and lymphocytes decreased in animals with ovalbumin-induced airway inflammation, whereas the number of neutrophils increased after ovalbumin-induced airway inflammation.", {"entities": []}], ["The results showed that expression of Nrf2, iNOS, T-bet and IL-17 increased after 24 of hyperoxia in both alveolar macrophages and in lung epithelial cells, compared with both animals that remained in room air, and animals with ovalbumin-induced airway inflammation.", {"entities": []}], ["Hyperoxia alone without the induction of airway inflammation lead to increased levels of TNF-\u03b1 and CCL5, whereas hyperoxia after inflammation lead to decreased CCL2 levels.", {"entities": [[99, 103, "GENE"], [160, 164, "GENE"]]}], ["Histological evidence of extravasation of inflammatory cells into the perivascular and peribronchial regions of the lungs was observed after pulmonary inflammation and hyperoxia.", {"entities": []}], ["Hyperoxia promotes polarization of the immune response toward the TH 17 phenotype, resulting in tissue damage associated with oxidative stress, and the migration of neutrophils to the lung and airways.", {"entities": []}], ["Elucidating the effect of hyperoxia on ovalbumin-induced acute airway inflammation is relevant to preventing or treating asthmatic patients that require oxygen supplementation to reverse the hypoxemia.", {"entities": []}], ["Current cigarette smoking is associated with reduced acute responses to corticosteroids and worse clinical outcomes in stable chronic asthma.", {"entities": [[134, 140, "DISEASE"]]}], ["The mechanism by which current smoking promotes this altered behavior is currently unclear.", {"entities": []}], ["Whilst cytokines can induce corticosteroid insensitivity in-vitro, how current and former smoking affects airway cytokine concentrations and their responses to oral corticosteroids in stable chronic asthma is unclear.", {"entities": [[199, 205, "DISEASE"]]}], ["To examine blood and sputum cytokine concentrations in never, ex and current smokers with asthma before and after oral corticosteroids.", {"entities": [[90, 96, "DISEASE"]]}], ["Exploratory study utilizing two weeks of oral dexamethasone (equivalent to 40 mg/day prednisolone) in 22 current, 21 never and 10 ex-smokers with asthma.", {"entities": [[146, 152, "DISEASE"]]}], ["Induced sputum supernatant and plasma was obtained before and after oral dexamethasone.", {"entities": []}], ["25 cytokines were measured by multiplex microbead system (Invitrogen, UK) on a Luminex platform.", {"entities": []}], ["Smokers with asthma had elevated sputum cytokine interleukin (IL) -6, -7, and -12 concentrations compared to never smokers with asthma.", {"entities": [[13, 19, "DISEASE"], [128, 134, "DISEASE"]]}], ["Few sputum cytokine concentrations changed in response to dexamethasone IL-17 and IFN\u03b1 increased in smokers, CCL4 increased in never smokers and CCL5 and CXCL10 reduced in ex-smokers with asthma.", {"entities": [[188, 194, "DISEASE"], [109, 113, "GENE"], [145, 149, "GENE"], [154, 160, "GENE"]]}], ["Ex-smokers with asthma appeared to have evidence of an ongoing corticosteroid resistant elevation of cytokines despite smoking cessation.", {"entities": [[16, 22, "DISEASE"]]}], ["Several plasma cytokines were lower in smokers with asthma compared to never smokers with asthma.", {"entities": [[52, 58, "DISEASE"], [90, 96, "DISEASE"]]}], ["Cigarette smoking in asthma is associated with a corticosteroid insensitive increase in multiple airway cytokines.", {"entities": [[21, 27, "DISEASE"]]}], ["Distinct airway cytokine profiles are present in current smokers and never smokers with asthma and could provide an explanatory mechanism for the altered clinical behavior observed in smokers with asthma.", {"entities": [[88, 94, "DISEASE"], [197, 203, "DISEASE"]]}], ["Hepatocellular carcinoma (HCC), the most commonly occurring type of primary liver cancer, has been increasing in incidence worldwide.", {"entities": [[15, 24, "DISEASE"], [76, 88, "DISEASE"], [82, 88, "DISEASE"]]}], ["Vitamin D, acquired from sunlight exposure, diet, and dietary supplements, has been hypothesized to impact hepatocarcinogenesis.", {"entities": []}], ["However, previous epidemiologic studies examining the associations between dietary and serum vitamin D reported mixed results.", {"entities": []}], ["The purpose of this study was to examine the association between ambient ultraviolet (UV) radiation exposure and HCC risk in the U.S.", {"entities": []}], ["The Surveillance, Epidemiology, and End Results (SEER) database provided information on HCC cases diagnosed between 2000 and 2014 from 16 population-based cancer registries across the U.S. Ambient UV exposure was estimated by linking the SEER county with a spatiotemporal UV exposure model using a geographic information system.", {"entities": [[155, 161, "DISEASE"]]}], ["Poisson regression with robust variance estimation was used to calculate incidence rate ratios (IRRs) and 95% confidence intervals (CIs) for the association between ambient UV exposure per interquartile range (IQR) increase (32.4\u00a0mW/m Higher levels of ambient UV exposure were associated with statistically significant lower HCC risk ( n \u00a0=\u00a056,245 cases; adjusted IRR per IQR increase: 0.83, 95% CI 0.77, 0.90; p \u00a0<\u00a00.01).", {"entities": []}], ["A statistically significant inverse association between ambient UV and HCC risk was observed among males (p for interaction\u00a0=\u00a00.01) and whites (p for interaction\u00a0=\u00a00.01).", {"entities": []}], ["Higher ambient UV exposure was associated with a decreased risk of HCC in the U.S. UV exposure may be a potential modifiable risk factor for HCC that should be explored in future research.", {"entities": []}], ["The online version of this article (doi:10.1186/s12940-017-0299-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The CEASE (Clinical Effort Against Secondhand Smoke Exposure) intervention was developed to help pediatricians routinely and effectively address the harms of family smoking behaviors.", {"entities": []}], ["Based on paper versions of CEASE, we partnered with the American Academy of Pediatrics\u2019 online education department and developed a completely distance-based training, including an online CME training, handouts and education materials for families, and phone and email support.", {"entities": []}], ["The pediatric offices of two low income health clinics with primarily Medicaid populations were selected for the study.", {"entities": []}], ["Pre and post intervention data by survey of the parents was collected in both practices (Practice 1 n\u2009=\u2009470; Practice 2 n\u2009=\u2009177).", {"entities": []}], ["The primary outcome for this study was a comparison of rates of clinician\u2019s asking and advising parents about smoking and smoke-free home and cars.", {"entities": [[142, 146, "GENE"]]}], ["Exit surveys of parents revealed statistically significant increases in rates of clinicians asking about parental smoking (22% vs. 41%), smoke-free rules (25% vs. 44%), and asking about other smoking household members (26% vs. 48%).", {"entities": []}], ["Through a completely distance based intervention, we were able to train pediatricians who see low income children to ask parents about smoking, smoke-free home and car rules, and whether other household members smoke.", {"entities": []}], ["Implementing a system to routinely ask about family tobacco use and smoke-free home and car rules is a first step to effectively addressing tobacco in a pediatric office setting.", {"entities": []}], ["By knowing which family members use tobacco, pediatricians can take the next steps to help families become completely tobacco-free.", {"entities": []}], ["Clinical trials number: NCT01087177", {"entities": []}], ["There is growing awareness that dyspnoea, like pain, is a multidimensional experience, but measurement instruments have not kept pace.", {"entities": []}], ["The Multidimensional Dyspnea Profile (MDP) assesses overall breathing discomfort, sensory qualities, and emotional responses in laboratory and clinical settings.", {"entities": []}], ["Here we provide the MDP, review published evidence regarding its measurement properties and discuss its use and interpretation.", {"entities": []}], ["The MDP assesses dyspnoea during a specific time or a particular activity (focus period) and is designed to examine individual items that are theoretically aligned with separate mechanisms.", {"entities": []}], ["In contrast, other multidimensional dyspnoea scales assess recalled recent dyspnoea over a period of days using aggregate scores.", {"entities": []}], ["Previous psychophysical and psychometric studies using the MDP show that: 1) subjects exposed to different laboratory stimuli could discriminate between air hunger and work/effort sensation, and found air hunger more unpleasant; 2) the MDP immediate unpleasantness scale (A 1 ) was convergent with common dyspnoea scales; 3) in emergency department patients, two domains were distinguished (immediate perception, emotional response); 4) test\u2013retest reliability over hours was high; 5) the instrument responded to opioid treatment of experimental dyspnoea and to clinical improvement; 6) convergent validity with common instruments was good; and 7) items responded differently from one another as predicted for multiple dimensions.", {"entities": []}], ["The Multidimensional Dyspnea Profile provides a unified, reliable instrument for both clinical and laboratory research http://ow.ly/Ix8ic", {"entities": []}], ["Respiratory syncytial virus (RSV) is a common cause of severe lower respiratory tract diseases (bronchiolitis and pneumonia) during infancy and early childhood.", {"entities": [[114, 123, "DISEASE"], [96, 109, "DISEASE"]]}], ["There is increasing evidence which indicates that severe pulmonary disease caused by RSV infection in infancy is associated with recurrent wheezing and development of asthma later in childhood.", {"entities": [[167, 173, "DISEASE"]]}], ["However, the underlying mechanisms linking RSV infection to persistent airway hyperresponsiveness and dysfunction are not fully defined.", {"entities": []}], ["To study these processes in ways which are not available in humans, animal models have been established and have provided valuable insight into the pathophysiology of RSV-induced disease.", {"entities": []}], ["In this paper, we discuss experimental models of RSV infection in mice and highlight a new investigative approach in which mice are initially infected as neonates and then reinfected later in life.", {"entities": []}], ["The findings shed light on the mechanisms underlying the association between early severe RSV infection and development of asthma later in childhood.", {"entities": [[123, 129, "DISEASE"]]}], ["The vascular endothelium is a layer of cells lining the inner surface of vessels, serving as a barrier that mediates microenvironment homeostasis.", {"entities": []}], ["Deterioration of either the structure or function of endothelial cells (ECs) results in a variety of cardiovascular diseases.", {"entities": []}], ["Previous studies have shown that reactive oxygen species (ROS) is a key factor that contributes to the impairment of ECs and the subsequent endothelial dysfunction.", {"entities": []}], ["The longevity regulator Sirt1 is a NAD \u03ba B, Sirt1/NOX, Sirt1/SOD, and Sirt1/eNOs pathways.", {"entities": [[24, 29, "GENE"], [44, 49, "GENE"], [55, 60, "GENE"], [70, 75, "GENE"]]}], ["In this review, we summarize the most recent reports in this field to recapitulate the potent mechanisms involving the protective role of Sirt1 in oxidative stress and to highlight the beneficial effects of Sirt1 on cardiovascular functions.", {"entities": [[138, 143, "GENE"], [207, 212, "GENE"], [138, 143, "GENE"], [207, 212, "GENE"]]}], ["Although generally mild, the 2009\u20132010 influenza A/H1N1 pandemic caused two major surges in hospital admissions in the UK.", {"entities": [[39, 48, "DISEASE"]]}], ["The characteristics of patients admitted during successive waves are described.", {"entities": []}], ["Data were systematically obtained on 1520 patients admitted to 75 UK hospitals between May 2009 and January 2010.", {"entities": []}], ["Multivariable analyses identified factors predictive of severe outcome.", {"entities": []}], ["Patients aged 5\u201354\u2005years were over-represented compared with winter seasonal admissions for acute respiratory infection, as were non-white ethnic groups (first wave only).", {"entities": []}], ["In the second wave patients were less likely to be school age than in the first wave, but their condition was more likely to be severe on presentation to hospital and they were more likely to have delayed admission.", {"entities": []}], ["Overall, 45% had comorbid conditions, 16.5% required high dependency (level 2) or critical (level 3) care and 5.3% died.", {"entities": []}], ["As in 1918\u20131919, the likelihood of severe outcome by age followed a W-shaped distribution.", {"entities": []}], ["Pre-admission antiviral drug use decreased from 13.3% to 10% between the first and second waves (p=0.048), while antibiotic prescribing increased from 13.6% to 21.6% (p<0.001).", {"entities": []}], ["Independent predictors of severe outcome were age 55\u201364\u2005years, chronic lung disease (non-asthma, non-chronic obstructive pulmonary disease), neurological disease, recorded obesity, delayed admission (\u22655\u2005days after illness onset), pneumonia, C-reactive protein \u2265100\u2005mg/litre, and the need for supplemental oxygen or intravenous fluid replacement on admission.", {"entities": [[230, 239, "DISEASE"], [101, 138, "DISEASE"], [172, 179, "DISEASE"], [89, 95, "DISEASE"], [71, 83, "DISEASE"]]}], ["There were demographic, ethnic and clinical differences between patients admitted with pandemic H1N1 infection and those hospitalised during seasonal influenza activity.", {"entities": [[150, 159, "DISEASE"]]}], ["Despite national policies favouring use of antiviral drugs, few patients received these before admission and many were given antibiotics.", {"entities": []}], ["Several phytochemicals were shown to interfere with redox biology in the human system.", {"entities": []}], ["Moreover, redox biochemistry is crucially involved in the orchestration of immunological cascades.", {"entities": []}], ["When screening for immunomodulatory compounds, the two interferon gamma- (IFN- \u03b3 -) dependent immunometabolic pathways of tryptophan breakdown via indoleamine 2,3-dioxygenase-1 (IDO-1) and neopterin formation by GTP-cyclohydrolase 1 (GTP-CH-I) represent prominent targets, as IFN- \u03b3 -related signaling is strongly sensitive to oxidative triggers.", {"entities": []}], ["Herein, the analysis of these pathway activities in human peripheral mononuclear cells was successfully applied in a bioactivity-guided fractionation strategy to screen for anti-inflammatory substances contained in the root of Horminum (H.) pyrenaicum L. (syn.", {"entities": []}], ["Dragon's mouth), the only representative of the monophyletic genus Horminum .", {"entities": []}], ["Four abietane diterpene quinone derivatives (horminone, 7- O -acetylhorminone, inuroyleanol and its 15,16-dehydro-derivative, a novel natural product), two nor-abietane diterpene quinones (agastaquinone and 3-deoxyagastaquinone) and two abeo 18 (4\u2009\u2192\u20093) abietane diterpene quinones (agastol and its 15,16-dehydro-derivative) could be identified.", {"entities": []}], ["These compounds were able to dose-dependently suppress the above mentioned pathways with different potency.", {"entities": []}], ["Beside the description of new active compounds, this study demonstrates the feasibility of integrating IDO-1 and GTP-CH-I activity in the search for novel anti-inflammatory compounds, which can then be directed towards a more detailed mode of action analysis.", {"entities": []}], ["Individual exposure to trihalomethanes (THMs) in tap water can occur through ingestion, inhalation, or dermal exposure.", {"entities": []}], ["Studies indicate that activities associated with inhaled or dermal exposure routes result in a greater increase in blood THM concentration than does ingestion.", {"entities": []}], ["We measured blood and exhaled air concentrations of THM as biomarkers of exposure to participants conducting 14 common household water use activities, including ingestion of hot and cold tap water beverages, showering, clothes washing, hand washing, bathing, dish washing, and indirect shower exposure.", {"entities": []}], ["We conducted our study at a single residence in each of two water utility service areas, one with relatively high and the other low total THM in the residence tap water.", {"entities": []}], ["To maintain a consistent exposure environment for seven participants, we controlled water use activities, exposure time, air exchange, water flow and temperature, and nonstudy THM sources to the indoor air.", {"entities": []}], ["We collected reference samples for water supply and air (pre\u2013water use activity), as well as tap water and ambient air samples.", {"entities": []}], ["We collected blood samples before and after each activity and exhaled breath samples at baseline and postactivity.", {"entities": []}], ["All hot water use activities yielded a 2-fold increase in blood or breath THM concentrations for at least one individual.", {"entities": []}], ["The greatest observed increase in blood and exhaled breath THM concentration in any participant was due to showering (direct and indirect), bathing, and hand dishwashing.", {"entities": []}], ["Average increase in blood THM concentration ranged from 57 to 358 pg/mL due to these activities.", {"entities": []}], ["More research is needed to determine whether acute and frequent exposures to THM at these concentrations have public health implications.", {"entities": []}], ["Further research is also needed in designing epidemiologic studies that minimize data collection burden yet maximize accuracy in classification of dermal and inhalation THM exposure during hot water use activities.", {"entities": []}], ["The complications of atherosclerosis such as coronary and cerebrovascular disease, are the most prevalent causes of mortality and morbidity worldwide.", {"entities": [[21, 36, "DISEASE"], [58, 81, "DISEASE"]]}], ["A single nucleotide polymorphism (SNP) rs1883832 (-1C/T) in CD40 gene has been recently suggested to contribute to the susceptibility to atherosclerosis in Chinese population; however, previous genetic association studies yielded inconsistent results.", {"entities": [[137, 152, "DISEASE"], [60, 64, "GENE"]]}], ["A meta-analysis of eligible studies reporting the association between rs1883832 and atherosclerosis in Chinese population was carried out.", {"entities": [[84, 99, "DISEASE"]]}], ["Pooling 7 eligible case-control studies involving 2129 patients and 1895 controls demonstrated a significant association between rs1883832 and atherosclerosis under dominant model [odds ratio (OR)\u200a=\u200a1.631, 95% confidence interval [CI] [1.176, 2.260] in Chinese population with evident heterogeneity.", {"entities": [[143, 158, "DISEASE"]]}], ["Meta-regression analysis indicated that the heterogeneity could be completely explained by disease category.", {"entities": []}], ["In subgroup analysis, rs1883832 conferred ORs of 2.866 (C/C versus T/T, 95%CI [2.203, 3.729]) and 1.680 (C/T versus T/T, 95%CI [1.352, 2.086]) for coronary artery disease (CAD) under co-dominant model without heterogeneity.", {"entities": []}], ["Similar results were obtained for acute coronary syndrome (ACS) (C/C versus T/T, 3.674, 95%CI [2.638, 5.116]; C/T versus T/T, 1.981, 95%CI [1.483, 2.646]).", {"entities": [[49, 57, "DISEASE"]]}], ["The other genetic models including dominant, recessive and additive models, yielded consistent results without heterogeneity for CAD and ACS, respectively.", {"entities": []}], ["However, a protective role was found for C allele in ischemic stroke (IS) under recessive model (0.582, 95%CI [0.393, 0.864]) and additive model (0.785, 95%CI [0.679, 0.909]) with reduced heterogeneity.", {"entities": []}], ["This meta-analysis provided evidence of association of rs1883832 C allele with an overall increased risk of atherosclerosis but distinct effect of C allele on CAD (including ACS) and IS in Chinese population, respectively.", {"entities": [[108, 123, "DISEASE"]]}], ["Endometriosis is a gynecological disease characterized by implantation of endometrial tissue outside of the uterus.", {"entities": [[0, 13, "DISEASE"]]}], ["Early familial aggregation and twin studies noted a higher risk of endometriosis among relatives.", {"entities": [[67, 80, "DISEASE"]]}], ["Studies on the roles of the environment, genetics and aberrant regulation in the endometrium and endometriotic lesions of women with endometriosis suggest that endometriosis arises from the interplay between genetic variants and environmental factors.", {"entities": [[133, 146, "DISEASE"], [160, 173, "DISEASE"]]}], ["Elucidating the hereditary component has proven difficult because multiple genes seem to produce a susceptibility to developing endometriosis.", {"entities": [[128, 141, "DISEASE"]]}], ["Molecular techniques, including linkage and genome-wide analysis, have identified candidate genes located near known loci related to development and regulation of the female reproductive tract.", {"entities": []}], ["As new candidate genes are discovered and hereditary pathways identified using technologies such as genome-wide analysis, the possibility of prevention and treatment becomes more tangible for millions of women affected by endometriosis.", {"entities": [[222, 235, "DISEASE"]]}], ["Here, we discuss the advances of genetic research in endometriosis and describe technologies that have contributed to the current understanding of the genetic variability in endometriosis, variability that includes regulatory polymorphisms in key genes.", {"entities": [[53, 66, "DISEASE"], [174, 187, "DISEASE"]]}], ["The plasticizer di-(2-ethylhexyl) phthalate (DEHP) has been shown to stimulate a non-allergy related immune response with increased levels of IgG1 and IgG2a, but not IgE, after co-administration with the model allergen ovalbumin (OVA) in mice.", {"entities": []}], ["In mice, decreased IgG1 and increased IgG2a have been associated with the development of mucosal tolerance towards inhaled allergens.", {"entities": []}], ["As DEHP selectively promote formations of IgG1 and IgG2a without stimulating the IgE response, it was hypothesized that DEHP may suppress an established IgE mediated allergic response.", {"entities": []}], ["Mice pre-sensitised to OVA were repeatedly co-exposed to DEHP and OVA and the effects were evaluated on the levels of OVA-specific antibodies, ex vivo cytokine levels and the degree of lung inflammation after challenge with an OVA aerosol.", {"entities": []}], ["Compared to the OVA-sensitised control mice, multiple co-exposures to DEHP+OVA reduced the IgG1 level and reduced the IgE/IgG2a ratio.", {"entities": []}], ["This suggests that DEHP may attenuate allergic sensitisation, as the IgE/IgG2a ratio has been shown to correlate with the degree of anaphylaxis.", {"entities": []}], ["Nevertheless, no effect of DEHP exposures was seen on inflammatory cells in bronchoalveolar lavage fluid and on cytokine levels in spleen cell culture.", {"entities": []}], ["Data from humane and murine studies suggest that DEHP may attenuate the allergic response.", {"entities": []}], ["More studies are necessary in order to assess the size of this effect and to rule out the underlying mechanism.", {"entities": []}], ["Natural killer (NK) cells may play an important role in the pathogenesis of SLE.", {"entities": []}], ["Interleukin(IL)-15, an NK-enhancing cytokine, is over-expressed in SLE patients.", {"entities": []}], ["In the present study, we examined the effect of IL-15 on NK cytotoxicity of SLE patients, and the expression of various activating and inhibitory NK receptors on NK cells from SLE patients in relation to disease activity.", {"entities": []}], ["We also sought to determine how IL-15 would affect the NK receptor expression on NK cells from SLE patients.", {"entities": []}], ["PBMCs were collected from 88 SLE patients with inactive disease activity (SLEDAI score<6) and active disease activity (SLEDAI score\u22656), 26 age-matched healthy adults were used as controls.", {"entities": []}], ["PBMC were incubated in the presence or absence of IL-15 (10ng/ml) for eighteen hours.", {"entities": []}], ["Patients with chronic obstructive pulmonary disease (COPD) exhibit poor sleep quality and consider morning as the worst time of day for their symptoms.", {"entities": [[14, 51, "DISEASE"]]}], ["While work has been done to characterize nighttime (NT) and early morning (EM) symptoms in various populations, the impact and factors associated with NT/EM symptoms among patients with COPD in the United States is not well understood.", {"entities": []}], ["Commercially insured patients aged \u226540 years with one or more medical claim for COPD and one or more pharmacy claim for COPD maintenance medication were identified from the HealthCore Integrated Research Database between September 1, 2010 and August 31, 2011.", {"entities": []}], ["Consenting respondents were asked whether they had COPD symptoms on at least three nights or at least three mornings during the past week.", {"entities": []}], ["Respondents were then either assigned to one of three symptom groups to complete the survey or excluded if their predefined group quota limit had been met.", {"entities": []}], ["Survey completers completed the survey with questions about COPD symptoms and other commonly used patient-reported outcome measures.", {"entities": []}], ["Respondents with NT/EM symptoms were asked about the frequency, severity, and impact of the symptoms on sleep, morning activities, and anxiety levels.", {"entities": []}], ["Among respondents with symptoms, 73.1% of respondents with NT symptoms (N=376) and 83% of respondents with EM symptoms (N=506) experienced at least three distinct types of symptoms over the past week, with cough being the most frequently reported symptom.", {"entities": []}], ["Approximately half of respondents with NT or EM symptoms perceived their symptoms as moderate to very severe, with a majority reporting their symptoms affected their NT sleep and morning activities, and more than half felt anxious due to their symptoms.", {"entities": []}], ["Multinomial logistic regression showed COPD patients with both or either NT/EM symptoms were associated with poorer health status compared to those without.", {"entities": []}], ["Improved disease management may reduce NT/EM symptoms and improve health status in patients with COPD.", {"entities": []}], ["Genome-wide association studies (GWAS) have demonstrated the ability to identify the strongest causal common variants in complex human diseases.", {"entities": []}], ["However, to date, the massive data generated from GWAS have not been maximally explored to identify true associations that fail to meet the stringent level of association required to achieve genome-wide significance.", {"entities": []}], ["Genetics of gene expression (GGE) studies have shown promise towards identifying DNA variations associated with disease and providing a path to functionally characterize findings from GWAS.", {"entities": []}], ["Here, we present the first empiric study to systematically characterize the set of single nucleotide polymorphisms associated with expression (eSNPs) in liver, subcutaneous fat, and omental fat tissues, demonstrating these eSNPs are significantly more enriched for SNPs that associate with type 2 diabetes (T2D) in three large-scale GWAS than a matched set of randomly selected SNPs.", {"entities": []}], ["This enrichment for T2D association increases as we restrict to eSNPs that correspond to genes comprising gene networks constructed from adipose gene expression data isolated from a mouse population segregating a T2D phenotype.", {"entities": []}], ["Finally, by restricting to eSNPs corresponding to genes comprising an adipose subnetwork strongly predicted as causal for T2D, we dramatically increased the enrichment for SNPs associated with T2D and were able to identify a functionally related set of diabetes susceptibility genes.", {"entities": []}], ["We identified and validated malic enzyme 1 ( Me1 ) as a key regulator of this T2D subnetwork in mouse and provided support for the association of this gene to T2D in humans.", {"entities": [[45, 48, "GENE"]]}], ["This integration of eSNPs and networks provides a novel approach to identify disease susceptibility networks rather than the single SNPs or genes traditionally identified through GWAS, thereby extracting additional value from the wealth of data currently being generated by GWAS.", {"entities": []}], ["Genome-wide association studies (GWAS) seek to identify loci in which changes in DNA are correlated with disease.", {"entities": []}], ["However, GWAS do not necessarily lead directly to genes associated with disease, and they do not typically inform the broader context in which disease genes operate, thereby providing limited insights into the mechanisms driving disease.", {"entities": []}], ["One critical task to providing further insights into GWAS is developing an understanding of the genetics of gene expression (GGE).", {"entities": []}], ["We present the first empiric study demonstrating that SNPs in human cohorts that associate with gene expression in liver and adipose tissues are enriched for associating with Type 2 Diabetes (T2D) in humans.", {"entities": []}], ["By filtering \u201ceSNPs\u201d based on causal gene networks defined in an experimental cross population segregating T2D traits, we demonstrate a dramatically increased enrichment of T2D SNPs that enhance our ability to assess T2D risk.", {"entities": []}], ["We demonstrate the utility of this approach by identifying malic enzyme 1 (ME1) as a novel T2D susceptibility gene in humans and then functionally validating the causal connection between ME1 and T2D in a mouse knockout model for Me1.", {"entities": [[75, 78, "GENE"], [188, 191, "GENE"], [230, 233, "GENE"], [75, 78, "GENE"], [188, 191, "GENE"], [230, 233, "GENE"], [75, 78, "GENE"], [188, 191, "GENE"], [230, 233, "GENE"]]}], ["This approach provides a path to identifying disease susceptibility networks rather than single SNPs or genes traditionally identified through GWAS.", {"entities": []}], ["Human T-lymphotropic virus types I and II (HTLV-I and -II) cause myelopathy; HTLV-I, but not HTLV-II, causes adult T-cell leukemia.", {"entities": [[122, 130, "DISEASE"]]}], ["Whether HTLV-II is associated with other diseases is unknown.", {"entities": []}], ["Using survival analysis, we studied medical history data from a prospective cohort of HTLV-I\u2013 and HTLV-II\u2013infected and \u2013uninfected blood donors, all HIV seronegative.", {"entities": []}], ["A total of 152 HTLV-I, 387 HTLV-II, and 799 uninfected donors were enrolled and followed for a median of 4.4, 4.3, and 4.4 years, respectively.", {"entities": []}], ["HTLV-II participants had significantly increased incidences of acute bronchitis (incidence ratio [IR] = 1.68), bladder or kidney infection (IR = 1.55), arthritis (IR = 2.66), and asthma (IR = 3.28), and a borderline increase in pneumonia (IR = 1.82, 95% confidence interval [CI] 0.98 to 3.38).", {"entities": [[228, 237, "DISEASE"], [152, 161, "DISEASE"], [179, 185, "DISEASE"], [69, 79, "DISEASE"]]}], ["HTLV-I participants had significantly increased incidences of bladder or kidney infection (IR = 1.82), and arthritis (IR = 2.84).", {"entities": [[107, 116, "DISEASE"]]}], ["We conclude that HTLV-II infection may inhibit immunologic responses to respiratory infections and that both HTLV-I and -II may induce inflammatory or autoimmune reactions.", {"entities": []}], ["PAF, a small antifungal protein from Penicillium chrysogenum , inhibits the growth of several pathogenic filamentous fungi, including members of the Aspergillus genus.", {"entities": []}], ["PAF has been proven to have no toxic effects in vivo in mice by intranasal application.", {"entities": []}], ["To test its efficacy against invasive pulmonary aspergillosis (IPA), experiments were carried out in mice suffering from IPA.", {"entities": [[48, 61, "DISEASE"]]}], ["Adult mice were immunosuppressed and then infected with Aspergillus fumigatus.", {"entities": []}], ["After stable infection, the animals were inoculated with PAF intranasally at a concentration of 2.7\u2009mg/kg twice per day.", {"entities": []}], ["At this concentration\u2014which is highly toxic in vitro to A. fumigatus \u2014the mortality of the animals was slightly delayed but finally all animals died.", {"entities": []}], ["Histological examinations revealed massive fungal infections in the lungs of both PAF-treated and untreated animal groups.", {"entities": []}], ["Because intranasally administered PAF was unable to overcome IPA, modified and combined therapies were introduced.", {"entities": []}], ["The intraperitoneal application of PAF in animals with IPA prolonged the survival of the animals only 1 day.", {"entities": []}], ["Similar results were obtained with amphotericin B (AMB), with PAF and AMB being equally effective.", {"entities": []}], ["Combined therapy with AMB and PAF\u2014which are synergistic in vitro \u2014was found to be more effective than either AMB or PAF treatment alone.", {"entities": []}], ["As no toxic effects of PAF in mammals have been described thus far, and, moreover, there are so far no A. fumigatus strains with reported inherent or acquired PAF resistance, it is worth carrying out further studies to introduce PAF as a potential antifungal drug in human therapy.", {"entities": []}], ["Nematode infections, in particular gastrointestinal nematodes, are widespread and co-infections with other parasites and pathogens are frequently encountered in humans and animals.", {"entities": []}], ["To decipher the immunological effects of a widespread protozoan infection on the anti-helminth immune response we studied a co-infection with the enteric nematode Heligmosomoides polygyrus in mice previously infected with Toxoplasma gondii .", {"entities": []}], ["Protective immune responses against nematodes are dependent on parasite-specific Th2 responses associated with IL-4, IL-5, IL-13, IgE, and IgG1 antibodies.", {"entities": []}], ["In contrast, Toxoplasma gondii infection elicits a strong and protective Th1 immune response characterized by IFN-\u03b3, IL-12, and IgG2a antibodies.", {"entities": []}], ["Co-infected animals displayed significantly higher worm fecundity although worm burden remained unchanged.", {"entities": []}], ["In line with this, the Th2 response to H. polygyrus in co-infected animals showed a profound reduction of IL-4, IL-5, IL-13, and GATA-3 expressing T cells.", {"entities": []}], ["Co-infection also resulted in the lack of eosinophilia and reduced expression of the Th2 effector molecule RELM-\u03b2 in intestinal tissue.", {"entities": [[42, 54, "DISEASE"]]}], ["In contrast, the Th1 response to the protozoan parasite was not diminished and parasitemia of T. gondii was unaffected by concurrent helminth infection.", {"entities": []}], ["Importantly, H. polygyrus specific restimulation of splenocytes revealed H. polygyrus -reactive CD4 H. polygyrus -specific IgG2a antibodies in co-infected mice mirrored this finding.", {"entities": [[96, 99, "GENE"]]}], ["This study suggests that polarization rather than priming of naive CD4 T. gondii .", {"entities": [[67, 70, "GENE"]]}], ["In conclusion, a previous T. gondii infection limits a helminth-specific Th2 immune response while promoting a shift toward a Th1-type immune response.", {"entities": []}], ["The aim of the study was to characterize pharmacokinetics of tiotropium solution 5\u2009\u00b5g compared to powder 18\u2009\u00b5g and assess dose-dependency of tiotropium solution pharmacodynamics in comparison to placebo.", {"entities": []}], ["In total 154 patients with chronic obstructive pulmonary disease (COPD) were included in this multicenter, randomized, double-blind within-solution (1.25, 2.5, 5\u2009\u00b5g, and placebo), and open-label powder 18\u2009\u00b5g, crossover study, including 4-week treatment periods.", {"entities": [[27, 64, "DISEASE"]]}], ["Primary end points were peak plasma concentration (C max,ss ), and area under the plasma concentration\u2013time profile (AUC 0\u20136h,ss ), both at steady state.", {"entities": [[53, 56, "GENE"]]}], ["The pharmacodynamic response was assessed by serial spirometry (forced expiratory volume in 1\u2009second/forced vital capacity).", {"entities": []}], ["Safety was evaluated as adverse events and by electrocardiogram/Holter.", {"entities": []}], ["Tiotropium was rapidly absorbed with a median t max,ss of 5\u20137\u2009minutes postdosing for both devices.", {"entities": [[48, 51, "GENE"]]}], ["The gMean ratio of solution 5\u2009\u00b5g over powder 18\u2009\u00b5g was 81% (90% confidence interval, 73\u201389%) for C max,ss and 76% (70\u201382%) for AUC 0\u20136h,ss , indicating that bioequivalence was not established.", {"entities": [[99, 102, "GENE"]]}], ["Dose ordering for bronchodilation was observed.", {"entities": []}], ["Powder 18\u2009\u00b5g and solution 5\u2009\u00b5g were most effective, providing comparable bronchodilation.", {"entities": []}], ["All treatments were well tolerated with no apparent relation to dose or device.", {"entities": []}], ["Comparable bronchodilator efficacy to powder18\u2009\u00b5g at lower systemic exposure supports tiotropium solution 5\u2009\u00b5g for maintenance treatment of COPD.", {"entities": []}], ["Celiac Disease (CD) is a chronic autoimmune disease triggered by dietary gluten.", {"entities": []}], ["Gluten avoidance, which is the only available treatment for CD, could impact on quality of life of children with CD.", {"entities": []}], ["We present the results of a qualitative study on the emotional impact of gluten free diet (GFD) on the everyday life of children affected with CD.", {"entities": []}], ["We investigated 76 celiac patients aged 2\u201318 years (average age: 9.5 years).", {"entities": []}], ["By using the Critical Incident Technique (CIT), we defined emotions related to difficulties and awkward situations experienced by the patients.", {"entities": []}], ["Written answers to open-ended questions from either children (older than 8 years) and parents (children younger than 8 years) were analyzed qualitatively.", {"entities": []}], ["We found 80 dilemmas experienced in three different arenas (food situations at school, meals at home, meals outside) and characterized lived experiences of children with CD in everyday life (specific emotions, difficulties in relationships and in management of daily life).", {"entities": []}], ["Children with CD experience strong emotions related to the GFD, permeating several aspects of everyday life.", {"entities": []}], ["These dilemmas may be missed by a conventional, questionnaire-based approach to the psycho-social consequences of CD treatment.", {"entities": []}], ["Acute poisoning is a major public health issue in many parts of the world.", {"entities": []}], ["The epidemiology and the mortality rate is higher in low and middle income countries, including Sri Lanka.", {"entities": []}], ["The aim of this study was to provide details about the epidemiology of acute poisoning in a rural Sri Lankan district and to identify the changing patterns and epidemiology of poisoning.", {"entities": []}], ["A prospective study was conducted from September 2008 to January 2010 in all hospitals with inpatient facilities in Anuradhapura district of North Central Province of Sri Lanka.", {"entities": []}], ["Acute poisoning data was extracted from patient charts.", {"entities": []}], ["Selected data were compared to the data collected from a 2005 study in 28 hospitals.", {"entities": []}], ["There were 3813 poisoned patients admitted to the hospitals in the Anuradhapura district over 17 months.", {"entities": []}], ["The annual population incidence was 447 poisoning cases per 100,000 population.", {"entities": []}], ["The total number of male and female patients was approximately similar, but the age distribution differed by gender.", {"entities": []}], ["There was a very high incidence of poisoning in females aged 15\u201319, with an estimated cumulative incidence of 6% over these five years.", {"entities": []}], ["Although, pesticides are still the most common type of poison, medicinal drug poisonings are now 21% of the total and have increased 1.6 fold since 2005.", {"entities": []}], ["Acute poisoning remains a major public health problem in rural Sri Lanka and pesticide poisoning remains the most important poison.", {"entities": []}], ["However, cases of medicinal drug poisoning have recently dramatically increased.", {"entities": []}], ["Youth in these rural communities remain very vulnerable to acute poisoning and the problem is so common that school-based primary prevention programs may be worthwhile.", {"entities": []}], ["Lalith Senarathna, Shaluka F Jayamanna, Patrick J Kelly, Nick A Buckley,michael J Dibley, Andrew H Dawson.", {"entities": []}], ["These authors contributed equally to this work.", {"entities": []}], ["The aims of this study were to investigate the effects of manganese (Mn) dust exposure on lung functions and evaluate the potential synergistic effect between smoking and Mn dust exposure among refinery workers.", {"entities": []}], ["A retrospective study including 1658 workers in a ferromanganese refinery was conducted, with subjects who were from the Guangxi manganese-exposed workers healthy cohort (GXMEWHC).", {"entities": []}], ["Based on the Mn manganese cumulative exposure index (Mn-CEI), all subjects were divided into the low exposure group (n = 682) and the high exposure group (n = 976).", {"entities": []}], ["A pulmonary function test was performed using an electronic spirometer, including the values and percentages of FVC, FEV 1 , FEV 1 /FVC, MMEF, PEFR, MVV, respectively.", {"entities": [[117, 120, "GENE"], [125, 128, "GENE"], [117, 120, "GENE"], [125, 128, "GENE"]]}], ["No significant effect of Mn dust exposure on the pulmonary function was found in the female workers (all p >0.05).", {"entities": []}], ["However, there was an obvious decrease in the male workers in the high exposure group compared with those in the low exposure group (FVC -60 ml, FEV 1 -120 ml, MMEF -260 ml/s, MVV -5.06 L, all p <0.05).", {"entities": [[145, 148, "GENE"]]}], ["In the high exposure group, the reduction in FVC% predicted, MMEF and MMEF% predicted was 1.0%, 210 mL/s, and 4.9%, respectively.", {"entities": []}], ["In particular, among the exposed subjects smokers had a statistically significant decrease in lung function compared with non-smokers and the reduction in FVC% predicted, MMEF and MMEF% predicted was 1.0%, 210 mL/s, and 4.9%, respectively ( p <0.05).", {"entities": []}], ["Partial correlation analysis showed that there was also negative correlation between Mn-CEI and decreased changes in MMEF (r = -0.159, p = 0.018) and also MMEF% predicted (r = -0.163, p = 0.015).", {"entities": []}], ["Mn dust can impair the pulmonary ventilation function of male workers but not females, and individual smoking habits and manganese exposure had a synergistic effect on the lung function decrease.", {"entities": []}], ["This paper examines the impact of climate change on children\u2019s health, in the Limpopo Province of South Africa.", {"entities": []}], ["Twenty one years climatic data were collected to analyse climatic conditions in the province.", {"entities": []}], ["The study also employs 12 years hospital records of clinically diagnosed climate-related ailments among children under 13 years to examine the incidence, spatio-temporal, age and sex variations of the diseases.", {"entities": []}], ["Regression analysis was employed to examine the relationships between climatic parameters and incidence of diseases and also to predict distribution of disease by 2050.", {"entities": []}], ["The results show that the most prevalent diseases were diarrhea (42.4%), followed by respiratory infection (31.3%), asthma (6.6%) and malaria (6.5%).", {"entities": [[134, 141, "DISEASE"], [55, 63, "DISEASE"], [116, 122, "DISEASE"]]}], ["The incidence varied within city, with the high density areas recording the highest proportion (76.7%), followed by the medium (9.4%) and low (2.5%) density residential areas.", {"entities": []}], ["The most tropical location, Mussina, had the highest incidence of the most prevalent disease, diarrhea, with 59.4%.", {"entities": [[94, 102, "DISEASE"]]}], ["Mortality rate was higher for males (54.2%).", {"entities": []}], ["Analysis of 21 years of climatic data show that maximum temperature is positively correlated with years in four cities with r coefficients of 0.50; 0.56, 0.48 and 0.02, thereby indicating local warming.", {"entities": []}], ["Similarly rainfall decreased over time in all the cities, with r ranging from \u22120.02 for Bela Bela to r = 0.18 for Makhado.", {"entities": []}], ["Results of the regression analysis show that 37.9% of disease incidence is accounted for by the combined influence of temperature and rainfall.", {"entities": []}], ["In contrast to cigarette smoking, the association between water pipe smoking and airway hyperresponsiveness remains widely unexplored.", {"entities": []}], ["A bronchoprovocation challenge with mannitol was performed in young adults recruited at the University of Basel, Switzerland.", {"entities": []}], ["Subjects were categorized as acute water pipe smokers (single episode of water pipe smoking, no or <0.5 pack-years cigarette smoking); chronic water pipe smokers (weekly for \u22654 weeks, no or <0.5 pack-years cigarette smoking); cigarette smokers (no water pipe smokers); and never-smokers (no cigarette or water pipe smokers).", {"entities": []}], ["Primary outcomes were airway reactivity as measured by the response-to-dose ratio (RDR) and airway responsiveness measured by the provocation dose to cause a 15% fall in forced expiratory volume in 1s (FEV 1 ; PD 15 ).", {"entities": [[202, 205, "GENE"]]}], ["Seventy-four subjects with a mean age of 22.5\u00b12.5 years and FEV 1 % predicted 90.1%\u00b18.6% were included.", {"entities": [[60, 63, "GENE"]]}], ["Subgroups were matched in terms of age, gender, and spirometry results.", {"entities": []}], ["RDR in chronic water pipe smokers and cigarette smokers was similar (0.013%/mg [0.010\u20130.015] vs 0.023%/mg [0.011\u20130.051], respectively; p =0.12) but significantly higher than in never-smokers (0.007%/mg [0.005\u20130.010], p <0.01).", {"entities": []}], ["Neither a history of asthma ( p =0.88) nor a positive skin prick test ( p =0.69) was associated with increased airway reactivity to the mannitol challenge test.", {"entities": [[21, 27, "DISEASE"]]}], ["PD 15 differed significantly between cigarette smokers and never-smokers (155 mg [115\u2013395] vs 315 mg [155\u2013475], respectively; p =0.04).", {"entities": []}], ["Weekly water pipe smoking may increase airway reactivity to a similar extent as cigarette smoking.", {"entities": []}], ["This study aims to describe current trends in Australia regarding chronic obstructive pulmonary disease (COPD) mortality and morbidity rates, and in its treatment and prevention from 2000 to 2010.", {"entities": [[66, 103, "DISEASE"]]}], ["The study\u2019s purpose is to better define future directions in curbing COPD.", {"entities": []}], ["People with COPD and their caregivers who attend patient support groups (n = 21), pulmonary rehabilitation group coordinators (n = 27) within Victoria, and the Australian Lung Foundation provided informed feedback.", {"entities": []}], ["COPD was a leading underlying cause of death in both sexes during these years.", {"entities": []}], ["Nevertheless, mortality rates declined from 1980 to 2007, with rates for males almost halving.", {"entities": []}], ["Its prevalence has also substantially declined.", {"entities": []}], ["Smoking rates have declined in age groups over 40 years old in both sexes.", {"entities": []}], ["The COPD-X Plan provides evidence-based guidelines for the management of COPD.", {"entities": []}], ["Many government, professional, and community initiatives have been recently implemented to promote the Plan.", {"entities": []}], ["Two studies\u2014one conducted before and one conducted after the publication of the COPD-X Plan\u2014report some progress, but there are still very considerable departures from evidence-based practice.", {"entities": []}], ["The Australian Lung Foundation estimates that only 1% of patients who could benefit from pulmonary rehabilitation programs have suitable access to such programs.", {"entities": []}], ["A common priority for all informants was that there needed to be greater awareness of\u2014and a more positive orientation to\u2014COPD in both the Australian and health professional communities.", {"entities": []}], ["The study concluded that substantial reductions in COPD and smoking cessation rates contrast with more limited progress toward adopting other aspects of evidence-based practice.", {"entities": []}], ["The \u201cgood news\u201d story concerning reductions in COPD disease with improving smoking cessation rates could form the basis for suitable media campaigns.", {"entities": []}], ["Depression is a psychiatric condition that affects approximately one in five U.S. adults in their lifetime.", {"entities": []}], ["No study that we know of has examined depressive symptoms and health service deficits in rural compared with non-rural populations.", {"entities": []}], ["Four factors constitute the variable health service deficits: did not have health insurance, did not have a healthcare provider, deferred medical care because of cost and did not have a routine medical exam, all within the last 12\u2009months.", {"entities": []}], ["The aim of this study was to ascertain the prevalence of health service deficits in rural versus non-rural adults with depressive symptoms.", {"entities": []}], ["Examining depressive symptoms by health service deficits is important because it allows us to approximate those with the condition who might not be receiving care for it.", {"entities": []}], ["By analyzing national, population-based data, this study sought to fill in some important epidemiological gaps regarding depressive symptoms and health service deficits.", {"entities": []}], ["For this analysis the population of interest was U.S. adults identified as currently having depressive symptoms using the PHQ-8 criteria.", {"entities": []}], ["Behavior Risk Factor Surveillance Survey 2006 data were used in this analysis.", {"entities": []}], ["Health service deficits was the primary dependent variable.", {"entities": []}], ["Multivariate logistic regression analysis was performed to examine health service deficits experienced by adults with depression controlling for socioeconomic status, race and ethnicity and geographic locale (rural or non-rural).", {"entities": []}], ["Logistic regression analysis yielded that U.S. adults currently having depressive symptoms who were of low socioeconomic status, Hispanic ethnicity, or living in a rural locale were more likely to have at least one health service deficit.", {"entities": []}], ["Analyzing data collected by a large surveillance system such as BRFSS, allows for an analysis incorporating an array of covariates not available from clinically-based data such as electronic health records.", {"entities": []}], ["By identifying clinically depressed U.S. adults who also have at least one health service deficit, we were able to ascertain those most likely not receiving care for this debilitating condition.", {"entities": []}], ["We believe community pharmacists are well suited to assist in connecting depressed, vulnerable populations with appropriate and needed care.", {"entities": []}], ["This care would be best provided by an inter-professional team led by a primary care provider.", {"entities": []}], ["Farming has been associated with rheumatoid arthritis (RA), but the role of pesticides is not known.", {"entities": [[33, 53, "DISEASE"], [44, 53, "DISEASE"]]}], ["We examined associations between RA and pesticides or other agricultural exposures among female spouses of licensed pesticide applicators in the Agricultural Health Study.", {"entities": []}], ["Women were enrolled between 1993 and 1997 and followed through 2010.", {"entities": []}], ["Cases (n = 275 total, 132 incident), confirmed by a physician or by self-reported use of disease modifying antirheumatic drugs, were compared with noncases (n = 24,018).", {"entities": []}], ["Odds ratios (OR) and 95% confidence intervals (CI) were estimated using logistic regression models adjusted for age, state, and smoking pack-years.", {"entities": []}], ["Overall, women with RA were somewhat more likely to have reported lifetime use of any specific pesticide versus no pesticides (OR = 1.4; 95% CI: 1.0, 1.6).", {"entities": []}], ["Of the 15 pesticides examined, maneb/mancozeb (OR = 3.3; 95% CI: 1.5, 7.1) and glyphosate (OR = 1.4; 95% CI: 1.0, 2.1) were associated with incident RA compared with no pesticide use.", {"entities": []}], ["An elevated, but non-statistically significant association with incident RA was seen for DDT (OR = 1.9; 95% CI: 0.97, 3.6).", {"entities": []}], ["Incident RA was also associated with the application of chemical fertilizers (OR = 1.7; 95% CI: 1.1, 2.7) and cleaning with solvents (OR = 1.6; 95% CI: 1.1, 2.4), but inversely associated with lifetime livestock exposure as a child and adult (OR = 0.48; 95% CI: 0.24, 0.97) compared with no livestock exposure.", {"entities": []}], ["Our results suggest that specific agricultural pesticides, solvents, and chemical fertilizers may increase the risk of RA in women, while exposures involving animal contact may be protective.", {"entities": []}], ["Parks CG, Hoppin JA, De Roos AJ, Costenbader KH, Alavanja MC, Sandler DP.", {"entities": []}], ["Rheumatoid arthritis in Agricultural Health Study spouses: associations with pesticides and other farm exposures.", {"entities": [[0, 20, "DISEASE"], [11, 20, "DISEASE"]]}], ["Environ Health Perspect 124:1728\u20131734;\u2002http://dx.doi.org/10.1289/EHP129", {"entities": []}], ["There is growing interest in Singing for Lung Health (SLH), an approach where patients with respiratory disease take part in singing groups, intended to improve their condition.", {"entities": []}], ["A consensus group was convened in early 2016 to address issues including: the specific features that make SLH distinct from other forms of participation in singing; the existing evidence base via a systematic review; gaps in the evidence base including the need to define value-based outcome measures for sustainable commissioning of SLH; defining the measures needed to evaluate both individuals' responses to SLH and the quality of singing programmes.", {"entities": []}], ["and core training, expertise and competencies required by singing group leaders to deliver high-quality programmes.", {"entities": []}], ["A systematic review to establish the extent of the evidence base for SLH was undertaken.", {"entities": []}], ["Electronic databases, including Pubmed, OVID Medline and Embase, Web of Science, Cochrane central register of controlled trials and PEDro, were used.", {"entities": []}], ["Six studies were included in the final review.", {"entities": []}], ["Quantitative data suggest that singing has the potential to improve health-related quality of life, particularly related to physical health, and levels of anxiety without causing significant side effects.", {"entities": []}], ["There is a significant risk of bias in many of the existing studies with small numbers of subjects overall.", {"entities": []}], ["Little comparison can be made between studies owing to their heterogeneity in design.", {"entities": []}], ["Qualitative data indicate that singing is an enjoyable experience for patients, who consistently report that it helps them to cope with their condition better.", {"entities": []}], ["Larger and longer-term trials are needed.", {"entities": []}], ["COPD is characterized by persistent airflow limitation, neutrophilia and oxidative stress from endogenous and exogenous insults.", {"entities": []}], ["Current COPD therapy involving anticholinergics, \u03b2 2 -adrenoceptor agonists and/or corticosteroids, do not specifically target oxidative stress, nor do they reduce chronic pulmonary inflammation and disease progression in all patients.", {"entities": []}], ["Here, we explore the effects of Sul-121, a novel compound with anti-oxidative capacity, on hyperresponsiveness (AHR) and inflammation in experimental models of COPD.", {"entities": [[112, 115, "GENE"]]}], ["Using a guinea pig model of lipopolysaccharide (LPS)-induced neutrophilia, we demonstrated that Sul-121 inhalation dose-dependently prevented LPS-induced airway neutrophilia (up to ~60%) and AHR (up to ~90%).", {"entities": [[191, 194, "GENE"]]}], ["Non-cartilaginous airways neutrophilia was inversely correlated with blood H 2 S, and LPS-induced attenuation of blood H 2 S (~60%) was prevented by Sul-121.", {"entities": []}], ["Concomitantly, Sul-121 prevented LPS-induced production of the oxidative stress marker, malondialdehyde by ~80%.", {"entities": []}], ["In immortalized human airway smooth muscle (ASM) cells, Sul-121 dose-dependently prevented cigarette smoke extract-induced IL-8 release parallel with inhibition of nuclear translocation of the NF-\u03baB subunit, p65 (each ~90%).", {"entities": []}], ["Sul-121 also diminished cellular reactive oxygen species production in ASM cells, and inhibited nuclear translocation of the anti-oxidative response regulator, Nrf2.", {"entities": []}], ["Our data show that Sul-121 effectively inhibits airway inflammation and AHR in experimental COPD models, prospectively through inhibition of oxidative stress.", {"entities": [[72, 75, "GENE"]]}], ["The aims of this study were (1) to characterise the type of patient prescribed MP-AzeFlu (Dymista, a novel formulation of azelastine hydrochloride, fluticasone propionate and excipients in a single spray) in real life in the UK and physicians' reasons for prescribing it and (2) to quantify the personal and societal burden of allergic rhinitis (AR) in the UK prior to MP-AzeFlu prescription.", {"entities": [[327, 344, "DISEASE"], [336, 344, "DISEASE"]]}], ["This multicentre, non-interventional study enrolled patients (n=193) with moderate-to-severe AR and acute symptoms who were eligible to receive treatment with MP-AzeFlu according to its licensed indications.", {"entities": []}], ["Information was gathered on patient demographics, AR history and symptom severity, symptomatology and AR treatments in the previous calendar year (prior to MP-AzeFlu prescription).", {"entities": []}], ["Physicians also recorded the number of previous AR visits, specific reasons for these visits and their reason for prescribing MP-AzeFlu.", {"entities": []}], ["Most patients had seasonal AR either alone (10.4%) or in combination with perennial AR (35.2%), but many had AR of unknown origin (35.8%).", {"entities": []}], ["Prior to MP-AzeFlu prescription, patients reported troublesome symptoms (78.2%) and sleep disturbance (64.8%), with congestion considered the most bothersome (54.4%) and ocular symptoms reported by 68.4% of patients.", {"entities": []}], ["The most frequent reason for MP-AzeFlu prescription was that other therapies were not sufficient in the past (78.8%) or not sufficient to treat acute symptoms (16.1%).", {"entities": []}], ["79.3% of patients reported using \u22652 AR therapies in the past year.", {"entities": []}], ["An average of 1.6 (SD 1.9) doctor visits due to AR were reported prior to MP-AzeFlu prescription.", {"entities": []}], ["In the UK, MP-AzeFlu was prescribed for individuals (\u226512\u2005years) with moderate/severe AR irrespective of (1) previous AR treatment (mono or multiple), (2) previous or likely treatment failure, (3) phenotype, (4) number of previous physician visits for AR and (5) for the relief of both acute symptoms and in anticipation of allergen exposure.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is characterised by chronic pulmonary inflammation punctuated by periods of viral exacerbations.", {"entities": []}], ["Recent evidence suggests that the combination of roflumilast with corticosteroids may improve the compromised anti-inflammatory properties of corticosteroids in COPD.", {"entities": []}], ["We analyzed differential and combination anti-inflammatory effects of dexamethasone and roflumilast N-oxide in human bronchial epithelial cells (HBECs) stimulated with viral toll like receptor (TLR) agonists.", {"entities": []}], ["Lung tissue and HBECs were isolated from healthy (n\u2009=\u200915), smokers (n\u2009=\u200912) and smokers with COPD (15).", {"entities": []}], ["TLR3 expression was measured in lung tissue and in HBECs.", {"entities": [[0, 4, "GENE"]]}], ["IL-8 secretion was measured in cell cultures after TLR3 stimulation with poly I:C 10\u00a0\u03bcg/mL.", {"entities": [[51, 55, "GENE"]]}], ["We found that TLR3 expression was increased by 1.95 fold (protein) and 2.5 fold (mRNA) in lung tissues from smokers with COPD and inversely correlated with lung function.", {"entities": [[14, 18, "GENE"]]}], ["The TLR3 agonist poly I:C 10\u00a0\u03bcg/mL increased the IL-8 release in HBECs that was poorly inhibited by dexamethasone in smokers (24.5%) and smokers with COPD (21.6%).", {"entities": [[4, 8, "GENE"]]}], ["In contrast, roflumilast showed similar inhibitory effects on IL-8 release in healthy (58.8%), smokers (56.6%) and smokers with COPD (50.5%).", {"entities": []}], ["The combination of roflumilast N-oxide and dexamethasone showed additive inhibitory effects.", {"entities": []}], ["Mechanistically, roflumilast N-oxide when combined with dexamethasone increased the expression of MKP1, and enhanced the inhibitory effects on phospho-p38, AP1 and NF\u03baB activities which may explain the additive anti-inflammatory effects.", {"entities": []}], ["Altogether, our data provide in vitro evidence for a possible clinical utility to add roflumilast on top of inhaled corticosteroid in COPD.", {"entities": []}], ["Supplemental Digital Content is available in the text The current population-based study investigated the onset of neonatal urinary tract infection (UTI) and the associated risks of allergic rhinitis.", {"entities": [[182, 199, "DISEASE"], [191, 199, "DISEASE"]]}], ["From 2000 to 2005, 3285 children with neonatal UTI and 13,128 randomly selected controls were enrolled from the National Health Insurance Research Database in Taiwan and frequency matched by gender, urbanization of residential area, parental occupation, and baseline year.", {"entities": []}], ["We compared the risk of allergic rhinitis between the non-UTI and UTI cohorts by performing multivariable Cox regression analysis.", {"entities": [[24, 41, "DISEASE"], [33, 41, "DISEASE"]]}], ["We observed a significant relationship between UTI and allergic rhinitis.", {"entities": [[55, 72, "DISEASE"], [64, 72, "DISEASE"]]}], ["This study examined 16,413 patients, among whom 3285 had UTI and 13,128 did not have UTI.", {"entities": []}], ["The overall incidence rate ratio of allergic rhinitis was 1.41-fold higher in the UTI cohort than in the non-UTI cohort (100.2 vs 70.93 per 1000 person-y).", {"entities": [[36, 53, "DISEASE"], [45, 53, "DISEASE"]]}], ["After potential risk factors were adjusted for, the adjusted hazard ratio of allergic rhinitis was 1.32 (95% confidence interval\u200a=\u200a1.23\u20131.41).", {"entities": [[77, 94, "DISEASE"], [86, 94, "DISEASE"]]}], ["Regardless of gender, the UTI cohort had a higher risk of allergic rhinitis than that of the non-UTI cohort.", {"entities": [[58, 75, "DISEASE"], [67, 75, "DISEASE"]]}], ["The patients with UTI in different follow-up durations were equally susceptible to developing allergic rhinitis compared with those without UTI, especially in follow-up durations shorter than 5 years.", {"entities": [[94, 111, "DISEASE"], [103, 111, "DISEASE"]]}], ["Patients with UTI and particular comorbidities such as infections and neonatal jaundice had a significantly increased risk of allergic rhinitis.", {"entities": [[126, 143, "DISEASE"], [70, 87, "DISEASE"], [135, 143, "DISEASE"]]}], ["UTI in newborns is significantly associated with the development of allergic rhinitis in childhood and might be a risk factor for subsequent childhood allergic rhinitis.", {"entities": [[68, 85, "DISEASE"], [151, 168, "DISEASE"], [77, 85, "DISEASE"], [160, 168, "DISEASE"]]}], ["Neurotrophins (nerve growth factor [NGF], brain-derived neurotrophic factor [BDNF], neurotrophin [NT]-3, and NT-4) have been observed in elevated concentrations in allergic diseases.", {"entities": [[36, 39, "GENE"], [77, 81, "GENE"]]}], ["Neurotrophin levels are up-regulated endobronchially after allergen challenge.", {"entities": []}], ["This coincides with an influx of activated eosinophils into the bronchial lumen.", {"entities": []}], ["These eosinophils have an increased viability and CD69 expression 18 h after segmental allergen provocation (SAP) which is not present in peripheral blood.", {"entities": [[50, 54, "GENE"]]}], ["To investigate whether these observations are related we studied the influence of neurotrophins on eosinophil function in allergic asthma.", {"entities": [[122, 137, "DISEASE"], [131, 137, "DISEASE"]]}], ["Incubation with NGF, BDNF, NT-3, or NT-4 caused a significant increase in the viability and CD69 expression of isolated eosinophils from bronchoalveolar lavage fluid (BALF) but not from peripheral blood, suggesting a unique sensitivity of endobronchial eosinophils to neurotrophins.", {"entities": [[16, 19, "GENE"], [21, 25, "GENE"], [92, 96, "GENE"]]}], ["To elucidate the underlying mechanisms expression of the neurotrophin receptors p75NTR, trkA, trkB, and trkC on eosinophils was analyzed by RT-PCR and immunocytology.", {"entities": []}], ["After SAP expression of all neurotrophin receptors was markedly elevated on eosinophils from BALF.", {"entities": []}], ["Our findings suggest that neurotrophin-mediated activation of bronchial eosinophils might play a role in the regulation of eosinophilic inflammation in allergic asthma.", {"entities": [[152, 167, "DISEASE"], [161, 167, "DISEASE"]]}], ["Sepsis induced cardiac dysfunction (SIC) is a severe complication to sepsis which significantly worsens patient outcomes.", {"entities": []}], ["It is known that bacteria have the capacity to release outer membrane vesicles (OMVs), which are nano-sized bilayered vesicles composed of lipids and proteins, that can induce a fatal inflammatory response.", {"entities": []}], ["The aim of this study was to determine whether OMVs from a uropathogenic Escherichia coli strain can induce cardiac dysfunction, and to elucidate any mechanisms involved.", {"entities": []}], ["OMVs induced irregular Ca E. coli OMVs induce cardiac injury in vitro and in vivo , in the absence of bacteria, and may be a causative microbial signal in SIC.", {"entities": []}], ["The role of OMVs in clinical disease warrant further studies, as bacterial OMVs in addition to live bacteria may be good therapeutic targets to control sepsis.", {"entities": []}], ["The introduction of proton pump inhibitors (PPIs) into clinical practice has revolutionized the management of acid-related diseases.", {"entities": []}], ["Studies in primary care and emergency settings suggest that PPIs are frequently prescribed for inappropriate indications or for indications where their use offers little benefit.", {"entities": []}], ["Inappropriate PPI use is a matter of great concern, especially in the elderly, who are often affected by multiple comorbidities and are taking multiple medications, and are thus at an increased risk of long-term PPI-related adverse outcomes as well as drug-to-drug interactions.", {"entities": []}], ["Herein, we aim to review the current literature on PPI use and develop a position paper addressing the benefits and potential harms of acid suppression with the purpose of providing evidence-based guidelines on the appropriate use of these medications.", {"entities": []}], ["The topics, identified by a Scientific Committee, were assigned to experts selected by three Italian Scientific Societies, who independently performed a systematic search of the relevant literature using Medline/PubMed, Embase, and the Cochrane databases.", {"entities": []}], ["Search outputs were distilled, paying more attention to systematic reviews and meta-analyses (where available) representing the best evidence.", {"entities": []}], ["The draft prepared on each topic was circulated amongst all the members of the Scientific Committee.", {"entities": []}], ["Each expert then provided her/his input to the writing, suggesting changes and the inclusion of new material and/or additional relevant references.", {"entities": []}], ["The global recommendations were then thoroughly discussed in a specific meeting, refined with regard to both content and wording, and approved to obtain a summary of current evidence.", {"entities": []}], ["Twenty-five years after their introduction into clinical practice, PPIs remain the mainstay of the treatment of acid-related diseases, where their use in gastroesophageal reflux disease, eosinophilic esophagitis, Helicobacter pylori infection, peptic ulcer disease and bleeding as well as, and Zollinger\u2013Ellison syndrome is appropriate.", {"entities": [[244, 256, "DISEASE"], [200, 211, "DISEASE"], [312, 320, "DISEASE"], [154, 185, "DISEASE"], [187, 211, "DISEASE"]]}], ["Prevention of gastroduodenal mucosal lesions (and symptoms) in patients taking non-steroidal anti-inflammatory drugs (NSAIDs) or antiplatelet therapies and carrying gastrointestinal risk factors also represents an appropriate indication.", {"entities": []}], ["On the contrary, steroid use does not need any gastroprotection, unless combined with NSAID therapy.", {"entities": []}], ["In dyspeptic patients with persisting symptoms, despite successful H. pylori eradication, short-term PPI treatment could be attempted.", {"entities": []}], ["Finally, addition of PPIs to pancreatic enzyme replacement therapy in patients with refractory steatorrhea may be worthwhile.", {"entities": [[95, 106, "DISEASE"]]}], ["Overall, PPIs are irreplaceable drugs in the management of acid-related diseases.", {"entities": []}], ["However, PPI treatment, as any kind of drug therapy, is not without risk of adverse effects.", {"entities": []}], ["The overall benefits of therapy and improvement in quality of life significantly outweigh potential harms in most patients, but those without clear clinical indication are only exposed to the risks of PPI prescription.", {"entities": []}], ["Adhering with evidence-based guidelines represents the only rational approach to effective and safe PPI therapy.", {"entities": []}], ["Please see related Commentary: doi:10.1186/s12916-016-0724-1.", {"entities": []}], ["Wireless body sensor networks (WBSNs) for healthcare and medical applications are real-time and life-critical infrastructures, which require a strict guarantee of quality of service (QoS), in terms of latency, error rate and reliability.", {"entities": []}], ["Considering the criticality of healthcare and medical applications, WBSNs need to fulfill users/applications and the corresponding network's QoS requirements.", {"entities": []}], ["For instance, for a real-time application to support on-time data delivery, a WBSN needs to guarantee a constrained delay at the network level.", {"entities": []}], ["A network coding-based error recovery mechanism is an emerging mechanism that can be used in these systems to support QoS at very low energy, memory and hardware cost.", {"entities": []}], ["However, in dynamic network environments and user requirements, the original non-adaptive version of network coding fails to support some of the network and user QoS requirements.", {"entities": []}], ["This work explores the QoS requirements of WBSNs in both perspectives of QoS.", {"entities": []}], ["Based on these requirements, this paper proposes an adaptive network coding-based, QoS-aware error recovery mechanism for WBSNs.", {"entities": []}], ["It utilizes network-level and user-/application-level information to make it adaptive in both contexts.", {"entities": []}], ["Thus, it provides improved QoS support adaptively in terms of reliability, energy efficiency and delay.", {"entities": []}], ["Simulation results show the potential of the proposed mechanism in terms of adaptability, reliability, real-time data delivery and network lifetime compared to its counterparts.", {"entities": []}], ["Exhaled nitric oxide has been proposed as a noninvasive marker of eosinophilic airway inflammation in lower airways.", {"entities": []}], ["The aim of the study was to investigate the impact of atopy, pollen exposure, and pharmacological treatment on NO production in lower airways of patients with allergic rhinitis.", {"entities": [[159, 176, "DISEASE"], [168, 176, "DISEASE"]]}], ["Measurements of exhaled NO were performed in 79 non-asthmatic subjects with seasonal allergic rhinitis outside and in pollen season, before and after pharmacological treatment, and in 54 healthy controls.", {"entities": [[85, 102, "DISEASE"], [94, 102, "DISEASE"]]}], ["Patients with allergic rhinitis had significantly higher levels of exhaled NO (18.3 \u00b1 11.0 ppb) than healthy controls (13.0 \u00b1 7.2 ppb) measured outside the pollen season (P = 0.0024).", {"entities": [[14, 31, "DISEASE"], [23, 31, "DISEASE"]]}], ["Increased exhaled NO levels were also found in patients with allergic rhinitis in the pollen season (27.0 \u00b1 20.0 ppb) compared with the levels outside pollen season (P = 0.0001), before pharmacological treatment.", {"entities": [[61, 78, "DISEASE"], [70, 78, "DISEASE"]]}], ["In rhinitic patients treated by nasal corticosteroids and antihistamines in the pollen season, the levels of exhaled NO were significantly lower (17.0 \u00b1 16.4 ppb; P = 0.045) than those before treatment.", {"entities": []}], ["No difference was found in NO levels in rhinitic patients outside and in pollen season after pharmacological treatment.", {"entities": []}], ["This study has shown the presence of eosinophilic airway inflammation in the lower airways in allergic rhinitis patients.", {"entities": [[94, 111, "DISEASE"], [103, 111, "DISEASE"]]}], ["A significant increase of exhaled NO after pollen exposure in rhinitic patients underlies the impact of inflammation on the upper respiratory tract.", {"entities": []}], ["A bidirectional link between upper and lower airways is confirmed by a decrease in exhaled NO in the pollen season, almost to the starting levels, after application of topic corticosteroids and antihistamines.", {"entities": []}], ["In Lao People\u2019s Democratic Republic (Lao PDR), the cause of death is not registered in death reports.", {"entities": []}], ["As a result, the government cannot produce official reports that show mortality according to cause of death.", {"entities": []}], ["This study aimed to report the underlying cause of death in a tertiary general hospital (Mittaphab Hospital) in Vientiane capital.", {"entities": []}], ["Mittaphab hospital is a governmental teaching hospital with 300 beds for inpatient services specialized in orthopedics, neurology, and hemodialysis.", {"entities": []}], ["Since a children hospital exists beside Mittaphab Hospital, severe pediatric cases are referred to the child hospital.", {"entities": []}], ["HIV-positive cases and sputum positive tuberculosis are also transferred to the other specialized hospitals.", {"entities": [[39, 51, "DISEASE"]]}], ["All of the subjects in this study were patients who died in 2013\u20132015 at Mittaphab Hospital.", {"entities": []}], ["Paper-based medical charts were examined by a medical doctor and staff from the medical records division.", {"entities": []}], ["This chart review revealed that 1,509 patients (1,006 males and 503 females) died in this hospital during the study period.", {"entities": []}], ["Of those, the number of patients aged <20 years and >80 years was small (6.2% and 7.7%, respectively).", {"entities": []}], ["The most common underlying causes were injury (29.7%), cerebrovascular diseases (26.8%), renal disease (13.3%), infectious diseases (12.4%), and malignant neoplasm including brain tumor (4.8%).", {"entities": []}], ["Among those aged 20\u201359 years, these percentages were 37.9%, 23.7%, 12.3%, 10.2%, and 5.0%, respectively.", {"entities": []}], ["Although the patients visiting the hospital did not represent the whole population, the distribution of cause of death in the hospital was the only available information reported in Lao PDR.", {"entities": []}], ["Background .", {"entities": []}], ["When data on preferences are not available, analysts rely on condition-specific or generic measures of health status like the SF-12 for predicting or mapping preferences.", {"entities": []}], ["Such prediction is challenging because of the characteristics of preference data, which are bounded, have multiple modes, and have a large proportion of observations clustered at values of 1.", {"entities": []}], ["We developed a finite mixture model for cross-sectional data that maps the SF-12 to the EQ-5D-3L preference index.", {"entities": []}], ["Our model characterizes the observed EQ-5D-3L index as a mixture of 3 distributions: a degenerate distribution with mass at values indicating perfect health and 2 censored (Tobit) normal distributions.", {"entities": []}], ["Using estimation and validation samples derived from the Medical Expenditure Panel Survey 2000 dataset, we compared the prediction performance of these mixture models to that of 2 previously proposed methods: ordinary least squares regression (OLS) and two-part models.", {"entities": []}], ["Finite mixture models in which predictions are based on classification outperform two-part models and OLS regression based on mean absolute error, with substantial improvement for samples with fewer respondents in good health.", {"entities": []}], ["The potential for misclassification is reflected on larger root mean square errors.", {"entities": []}], ["Moreover, mixture models underperform around the center of the observed distribution.", {"entities": []}], ["Conclusions .", {"entities": []}], ["Finite mixtures offer a flexible modeling approach that can take into account idiosyncratic characteristics of the distribution of preferences.", {"entities": []}], ["The use of mixture models allows researchers to obtain estimates of health utilities when only summary scores from the SF-12 and a limited number of demographic characteristics are available.", {"entities": []}], ["Mixture models are particularly useful when the target sample does not have a large proportion of individuals in good health.", {"entities": []}], ["Surgery is the mainstay therapy for HPV-induced laryngeal papillomatosis (LP) and adjuvant therapies are palliative at best.", {"entities": []}], ["Research revealed that conjugated-linoleic acid (CLA) may improve the outcome of virally-induced diseases.", {"entities": []}], ["The effects of Clarinol\u2122 G-80 (CLA) and high oleic safflower oil (HOSF) on children with LP (concomitant with surgery) were evaluated.", {"entities": []}], ["A randomized, double-blinded, crossover and reference-oil controlled trial was conducted at a South African medical university.", {"entities": []}], ["Study components included clinical, HPV type/load and lymphocyte/cytokine analyses, according to routine laboratory methods.", {"entities": []}], ["Overall: ten children enrolled; eight completed the trial; five remained randomized; seven received CLA first; all treatments remained double-blinded.", {"entities": []}], ["Children (4 to 12 years) received 2.5 ml p/d CLA (8 weeks) and 2.5 ml p/d HOSF (8 weeks) with a washout period (6 weeks) in-between.", {"entities": []}], ["The one-year trial included a post-treatment period (30 weeks) and afterwards was a one-year follow-up period.", {"entities": []}], ["Changes in numbers of surgical procedures for improved disease outcome, total/anatomical scores (staging system) for papillomatosis prevention/viral inhibition, and lymphocyte/cytokine counts for immune responses between baselines and each treatment/end of trial were measured.", {"entities": []}], ["After each treatment all the children were in remission (no surgical procedures); after the trial two had recurrence (surgical procedures in post-treatment period); after the follow-up period three had recurrence (several surgical procedures) and five recovered (four had no surgical procedures).", {"entities": []}], ["Effects of CLA (and HOSF to a lesser extent) were restricted to mildly/moderately aggressive papillomatosis.", {"entities": []}], ["Children with low total scores (seven/less) and reduced infections (three/less laryngeal sub-sites) recovered after the trial.", {"entities": []}], ["No harmful effects were observed.", {"entities": []}], ["The number of surgical procedures during the trial (n6/available records) was significantly lower [(p 0.03) (95% CI 1.1; 0)].", {"entities": []}], ["Changes in scores between baselines and CLA treatments (n8) were significantly lower: total scores [(p 0.02) (95% CI \u221230.00; 0.00)]; anatomical scores [(p 0.008) (95% CI \u221233.00: -2.00)].", {"entities": []}], ["Immune enhancement could not be demonstrated.", {"entities": []}], ["These preliminary case and group findings pave the way for further research on the therapeutic potential of adjuvant CLA in the treatment of HPV-induced LP.", {"entities": []}], ["In the first in a series of three articles on evaluating eHealth, Aziz Sheikh and Lorraine Catwell outline the background to the series and discuss the importance of evaluating the widespread investments in and adoption of information communication technology in health care.", {"entities": []}], ["Impulsivity is a heritable, multifaceted construct with clinically relevant links to multiple psychopathologies.", {"entities": []}], ["We assessed impulsivity in young adult ( N ~2100) participants in a longitudinal study, using self-report questionnaires and computer-based behavioral tasks.", {"entities": []}], ["Analysis was restricted to the subset ( N =426) who underwent genotyping.", {"entities": []}], ["Multivariate association between impulsivity measures and single-nucleotide polymorphism data was implemented using parallel independent component analysis (Para-ICA).", {"entities": []}], ["Pathways associated with multiple genes in components that correlated significantly with impulsivity phenotypes were then identified using a pathway enrichment analysis.", {"entities": []}], ["Para-ICA revealed two significantly correlated genotype\u2013phenotype component pairs.", {"entities": []}], ["One impulsivity component included the reward responsiveness subscale and behavioral inhibition scale of the Behavioral-Inhibition System/Behavioral-Activation System scale, and the second impulsivity component included the non-planning subscale of the Barratt Impulsiveness Scale and the Experiential Discounting Task.", {"entities": []}], ["Pathway analysis identified processes related to neurogenesis, nervous system signal generation/amplification, neurotransmission and immune response.", {"entities": []}], ["We identified various genes and gene regulatory pathways associated with empirically derived impulsivity components.", {"entities": []}], ["Our study suggests that gene networks implicated previously in brain development, neurotransmission and immune response are related to impulsive tendencies and behaviors.", {"entities": []}], ["Smoking cessation is the only effective intervention to slow down the accelerated decline in lung function in smokers with chronic obstructive pulmonary disease.", {"entities": [[123, 160, "DISEASE"]]}], ["Nevertheless, physicians often do not routinely provide evidence-based smoking cessation treatment to their patients.", {"entities": []}], ["To understand underlying reasons, we explored how physicians engage in smoking cessation treatment in their chronic obstructive pulmonary disease patients.", {"entities": [[108, 145, "DISEASE"]]}], ["In total, 21 focus group discussions were held with general practitioners and pulmonologists in seven different countries in Europe and Asia.", {"entities": []}], ["We generated three themes, whereby some of the issues concerned smokers in general: first, \u2018physicians\u2019 frustration with chronic obstructive pulmonary disease patients who smoke\u2019.", {"entities": [[121, 158, "DISEASE"]]}], ["These frustrations interfered with the provision of evidence-based treatment and could result in this group of patients being treated unequally.", {"entities": []}], ["Second: \u2018physicians\u2019 limited knowledge of, and negative beliefs about, smoking cessation treatment\u2019.", {"entities": []}], ["This hindered treating smokers effectively.", {"entities": []}], ["Third: \u2018healthcare organisational factors that influence the use of smoking cessation treatments\u2019.", {"entities": []}], ["Money and time issues, as well as the failure to regard smoking as a disease, influenced how physicians engaged in smoking cessation treatment.", {"entities": []}], ["Our results indicate that there is a number of barriers to the provision of effective smoking cessation treatment in patients with chronic obstructive pulmonary disease and smokers in general.", {"entities": [[131, 168, "DISEASE"]]}], ["Introducing an informative smoking cessation programme, including communication skills and ethical issues, in the vocational and postgraduate medical training may help to address these barriers.", {"entities": []}], ["This is important in order to increase engagement with smoking cessation treatment and to improve quality of chronic obstructive pulmonary disease care.", {"entities": [[109, 146, "DISEASE"]]}], ["Doctors should be given careful, ethically-informed guidance during medical training to help them to support patients to quit smoking.", {"entities": []}], ["The most important part of treatment for patients with chronic obstructive pulmonary disease (COPD) is help to stop smoking.", {"entities": [[55, 92, "DISEASE"]]}], ["However, there is evidence to suggest that doctors don\u2019t always motivate COPD patients to quit.", {"entities": []}], ["Eva Anne Marije van Eerd at Maastrict University, The Netherlands, together with an international team of scientists, conducted focus group interviews with doctors in seven different countries to assess barriers to smoking cessation.", {"entities": []}], ["They found that doctors\u2019 frustration with and negative attitudes towards patients who continued to smoke contributed to poor cessation management and treatment inequalities in some cases.", {"entities": []}], ["Many doctors also cited a lack of experience with smoking cessation techniques alongside time and money issues as barriers to effective treatment.", {"entities": []}], ["The instantaneous spread of information, low costs, and broad availability of information and communication technologies (ICTs) make them an attractive platform for managing care, patient communication, and medical interventions in cancer treatment.", {"entities": [[232, 238, "DISEASE"]]}], ["There is little information available in Latin America about the level of usage of ICTs for and by cancer patients.", {"entities": [[99, 105, "DISEASE"]]}], ["Our study attempts to fill this gap.", {"entities": []}], ["The aim of this study was to assess the level of ICT use and patterns of preferences among cancer patients.", {"entities": [[91, 97, "DISEASE"]]}], ["We conducted an anonymous cross-sectional survey study in 500 Ecuadorian cancer patients.", {"entities": [[73, 79, "DISEASE"]]}], ["This questionnaire consisted of 22 items about demographic and clinical data, together with the preferences of people who use ICTs.", {"entities": []}], ["Chi-square, crude, and adjusted logistic regressions were performed.", {"entities": []}], ["Of the total, 43.2% (216/500) of participants reported that they had access to the Internet, and 25.4% (127/500) reported that they neither owned a cell phone nor did they have access to the Internet.", {"entities": []}], ["The Internet constituted the highest usage rate as a source of information about malignant diseases (74.3%, 162/218) regardless of age ( P <.001).", {"entities": []}], ["With regard to the preferences on how patients would like to use ICTs to receive information about diseases, WhatsApp (66.5%, 145/218) and short message service (SMS) text messaging (61.0%, 133/218) were widely reported as interesting communication channels.", {"entities": [[162, 165, "GENE"]]}], ["Similarly, WhatsApp (72.0%, 157/218) followed by SMS (63.8%, 139/218) were reported as the preferred ICTs through which patients would like to ask physicians about diseases.", {"entities": [[49, 52, "GENE"]]}], ["Adjusted regression analysis showed that patients aged between 40 and 64 years were more likely to be interested in receiving information through SMS (odds ratio, OR 5.09, 95% CI 1.92-13.32), as well as for asking questions to physicians through this same media (OR 9.78, CI 3.45-27.67) than the oldest group.", {"entities": [[146, 149, "GENE"]]}], ["WhatsApp, SMS, and email are effective and widely used ICTs that can promote communication between cancer patients and physicians.", {"entities": [[99, 105, "DISEASE"], [10, 13, "GENE"]]}], ["According to age range, new ICTs such as Facebook are still emerging.", {"entities": []}], ["Future studies should investigate how to develop and promote ICT-based resources more effectively to engage the outcomes of cancer patients.", {"entities": [[124, 130, "DISEASE"]]}], ["The widespread use of ICTs narrows the gap between cancer patients with restricted socioeconomic conditions and those with wealth and easily available technological means, thereby opening up new possibilities in low-income countries.", {"entities": [[51, 57, "DISEASE"]]}], ["Osteoporosis is common in patients with COPD but the likely multi-factorial causes contributing to this condition ( e.g .", {"entities": [[0, 12, "DISEASE"]]}], ["sex, age, smoking, therapy) mask the potential contribution from elements related to COPD.", {"entities": []}], ["In order to study osteoporosis and bone mineral density (BMD) related to COPD, we studied a well-defined group of patients and controls.", {"entities": [[18, 30, "DISEASE"]]}], ["BMD, forced expiratory volume in one second (FEV 1 ), circulating bone biomarkers and biochemistry were determined in 30 clinically stable male ex-smokers with confirmed COPD and 15 age matched \"ex-smoker\" male controls.", {"entities": [[45, 48, "GENE"]]}], ["None of the patients were on inhaled corticosteroids or received more than one short course of steroids.", {"entities": []}], ["Mean (SD) FEV 1 % predicted of patients was 64(6)%, the majority having Global Initiative for Chronic Obstructive Lung Disease (GOLD) II airflow obstruction.", {"entities": [[10, 13, "GENE"]]}], ["There were 5/30 patients and 1/15 controls who were osteoporotic, while a further 17 patients and 5 controls were osteopenic.", {"entities": []}], ["The BMD at the hip was lower in patients than controls, but not at the lumbar spine.", {"entities": []}], ["Mean values of procollagen type 1 amino-terminal propeptide and osteocalcin, both markers of bone formation, and Type 1 collagen \u03b2 C-telopeptide, a marker of bone resorption, were similar between patients and controls.", {"entities": []}], ["However, all bone biomarkers were inversely related to hip BMD in patients (r = -0.51, r = -0.67, r = -0.57, p < 0.05) but did not relate to lumbar spine BMD.", {"entities": []}], ["25-OH Vitamin D was lower in patients.", {"entities": []}], ["Men with COPD had a greater prevalence of osteoporosis and osteopenia than age matched male controls, with a marked difference in BMD at the hip.", {"entities": [[42, 54, "DISEASE"]]}], ["Bone biomarkers suggest increased bone turnover.", {"entities": []}], ["A growing number of severe Mycoplasma pneumoniae pneumonia (MPP) cases have been reported recently.", {"entities": [[49, 58, "DISEASE"]]}], ["However, the pathogenesis of severe MPP is not clear.", {"entities": []}], ["In the current study, transcriptome sequencing was used to identify gene expression and alternative splicing profiles to provide insights into the pathogenesis of severe MPP.", {"entities": []}], ["RNAs of bronchoalveolar lavage fluid (BALF) samples from three severe MPP children and three mild MPP children were analyzed respectively by deep sequencing followed by computational annotation and quantification.", {"entities": []}], ["The gene expression analysis revealed 14 up-regulated and 34 down-regulated genes in severe MPP children comparing to mild MPP children.", {"entities": []}], ["The top 10 most up-regulated genes were IGHV1-69 , CH17-472G23.1 , ATP1B2 , FCER2 , MUC21 , IL13 , FCRLB , CLEC5A , FAM124A , and INHBA .", {"entities": [[40, 48, "GENE"], [67, 73, "GENE"], [76, 81, "GENE"], [84, 89, "GENE"], [92, 96, "GENE"], [99, 104, "GENE"], [107, 113, "GENE"], [130, 135, "GENE"]]}], ["The top 10 most down-regulated genes were OSTN-AS1 , IL22RA2 , COL3A1 , C1orf141 , IGKV2-29 , RP11-731F5.2 , IGHV4-4 , KIRREL , DNASE1L3 , and COL6A2 .", {"entities": [[53, 60, "GENE"], [63, 69, "GENE"], [72, 80, "GENE"], [119, 125, "GENE"], [128, 136, "GENE"], [143, 149, "GENE"]]}], ["Clustering analysis revealed similar expression pattern of CLEC5A , IL13 , FCER2 , and FLT1 .", {"entities": [[59, 65, "GENE"], [68, 72, "GENE"], [75, 80, "GENE"], [87, 91, "GENE"]]}], ["Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses revealed changes related to primary immunodeficiency in severe MPP children comparing to mild MPP children; the pathway involves CD19 , TNFRSF13C , CD79A , and AICDA genes.", {"entities": [[204, 208, "GENE"], [211, 220, "GENE"], [223, 228, "GENE"], [235, 240, "GENE"]]}], ["Among the differentially expressed genes, significant alternative splicing events were found in FCER2 and FCRLA .", {"entities": [[96, 101, "GENE"], [106, 111, "GENE"]]}], ["The current study on RNA sequencing provides novel insights into the pathogenesis of severe MPP in terms of gene expression and alternative splicing.", {"entities": []}], ["The up-regulation of IL13 , FCER2 , FLT1 , and CLEC5A and the down-regulation of CD79A , AICDA , CD19 , and TNFRSF13C may contribute to the pathogenesis of severe MPP.", {"entities": [[21, 25, "GENE"], [28, 33, "GENE"], [36, 40, "GENE"], [47, 53, "GENE"], [81, 86, "GENE"], [89, 94, "GENE"], [97, 101, "GENE"], [108, 117, "GENE"]]}], ["The differential expressions of FCER2 and FCRLA could be due to their alternative splicing.", {"entities": [[32, 37, "GENE"], [42, 47, "GENE"]]}], ["The online version of this article (doi:10.1186/s40246-017-0101-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["We conducted in-depth interviews with 11 Korean Disaster Relief Team (KDRT) members about stress related to disaster relief work and analyzed the interview data using the Consensual Qualitative Research (CQR) method in order to evaluate difficulties in disaster relief work and to develop solutions to these problems in cooperation with related organizations.", {"entities": []}], ["Results showed that members typically experienced stress related to untrained team members, ineffective cooperation, and the shock and aftermath of aftershock experiences.", {"entities": []}], ["Stress tended to stem from several factors: difficulties related to cooperation with new team members, the frightening disaster experience, and the aftermath of the disaster.", {"entities": []}], ["Other stressors included conflict with the control tower, diverse problems at the disaster relief work site, and environmental factors.", {"entities": []}], ["The most common reason that members participated in KDRT work despite all the stressors and difficulties was pride about the kind of work it involved.", {"entities": []}], ["Many subjects in this study suffered from various stresses after the relief work, but they had no other choice than to attempt to forget about their experiences over time.", {"entities": []}], ["It is recommended that the mental health of disaster relief workers will improve through the further development of effective treatment and surveillance programs in the future.", {"entities": []}], ["A zero-inflated continuous outcome is characterized by occurrence of \"excess\" zeros that more than a single distribution can explain, with the positive observations forming a skewed distribution.", {"entities": []}], ["Mixture models are employed for regression analysis of zero-inflated data.", {"entities": []}], ["Moreover, for repeated measures zero-inflated data the clustering structure should also be modeled for an adequate analysis.", {"entities": []}], ["Diary of Asthma and Viral Infections Study (DAVIS) was a one year (2004) cohort study conducted at McMaster University to monitor viral infection and respiratory symptoms in children aged 5-11 years with and without asthma.", {"entities": [[9, 15, "DISEASE"], [216, 222, "DISEASE"]]}], ["Respiratory symptoms were recorded daily using either an Internet or paper-based diary.", {"entities": []}], ["Changes in symptoms were assessed by study staff and led to collection of nasal fluid specimens for virological testing.", {"entities": []}], ["The study objectives included investigating the response of respiratory symptoms to respiratory viral infection in children with and without asthma over a one year period.", {"entities": [[141, 147, "DISEASE"]]}], ["Due to sparse data daily respiratory symptom scores were aggregated into weekly average scores.", {"entities": []}], ["More than 70% of the weekly average scores were zero, with the positive scores forming a skewed distribution.", {"entities": []}], ["We propose a random effects probit/log-skew-normal mixture model to analyze the DAVIS data.", {"entities": []}], ["The model parameters were estimated using a maximum marginal likelihood approach.", {"entities": []}], ["A simulation study was conducted to assess the performance of the proposed mixture model if the underlying distribution of the positive response is different from log-skew normal.", {"entities": []}], ["Viral infection status was highly significant in both probit and log-skew normal model components respectively.", {"entities": []}], ["The probability of being symptom free was much lower for the week a child was viral positive relative to the week she/he was viral negative.", {"entities": []}], ["The severity of the symptoms was also greater for the week a child was viral positive.", {"entities": []}], ["The probability of being symptom free was smaller for asthmatics relative to non-asthmatics throughout the year, whereas there was no difference in the severity of the symptoms between the two groups.", {"entities": []}], ["A positive association was observed between viral infection status and both the probability of experiencing any respiratory symptoms, and their severity during the year.", {"entities": []}], ["For DAVIS data the random effects probit -log skew normal model fits significantly better than the random effects probit -log normal model, endorsing our parametric choice for the model.", {"entities": []}], ["The simulation study indicates that our proposed model seems to be robust to misspecification of the distribution of the positive skewed response.", {"entities": []}], ["For optimal compatibility with biopharmaceutical manufacturing and gene therapy, heterologous transgene control systems must be responsive to side-effect-free physiologic inducer molecules.", {"entities": []}], ["The arginine-inducible interaction of the ArgR repressor and the ArgR-specific ARG box, which synchronize arginine import and synthesis in the intracellular human pathogen Chlamydia pneumoniae , was engineered for arginine-regulated transgene (ART) expression in mammalian cells.", {"entities": []}], ["A synthetic arginine-responsive transactivator (ARG), consisting of ArgR fused to the Herpes simplex VP16 transactivation domain, reversibly adjusted transgene transcription of chimeric ARG box-containing mammalian minimal promoters (P ART ) in an arginine-inducible manner.", {"entities": []}], ["Arginine-controlled transgene expression showed rapid induction kinetics in a variety of mammalian cell lines and was adjustable and reversible at concentrations which were compatible with host cell physiology.", {"entities": []}], ["ART variants containing different transactivation domains, variable spacing between ARG box and minimal promoter and several tandem ARG boxes showed modified regulation performance tailored for specific expression scenarios and cell types.", {"entities": []}], ["Mice implanted with microencapsulated cells engineered for ART-inducible expression of the human placental secreted alkaline phosphatase (SEAP) exhibited adjustable serum phosphatase levels after treatment with different arginine doses.", {"entities": []}], ["Using a physiologic inducer, such as the amino acid l -arginine, to control heterologous transgenes in a seamless manner which is devoid of noticeable metabolic interference will foster novel opportunities for precise expression dosing in future gene therapy scenarios as well as the manufacturing of difficult-to-produce protein pharmaceuticals.", {"entities": []}], ["Systematic reviews are a commonly used research design in the medical field to synthesize study findings.", {"entities": []}], ["At present\u2014although several systematic reviews of patient preference studies are published\u2014there is no clear guidance available for researchers to conduct this type of systematic review.", {"entities": []}], ["The aim of our study was to learn the most current practice of conducting these systematic reviews by conducting a survey of the literature regarding reviews of quantitative patient preference studies.", {"entities": []}], ["Our survey included systematic reviews of studies that used a stated quantitative preference design to elicit patient preferences.", {"entities": []}], ["We identified eligible reviews through a search of the PubMed database.", {"entities": []}], ["Two investigators with knowledge of the design of patient preference studies independently screened the titles and abstracts, and where needed, screened the full-text of the reviews to determine eligibility.", {"entities": []}], ["We developed and pilot-tested a form to extract data on the methods used in each systematic review.", {"entities": []}], ["Our search and screening identified 29 eligible reviews.", {"entities": []}], ["A large proportion of the reviews (19/29, 66%) were published in 2014 or after; among them, nine reviews were published in 2016.", {"entities": []}], ["The median number of databases searched for preference studies was four (interquartile range\u2009=\u20092 to 7).", {"entities": []}], ["We found that less than half of the reviews (13/29, 45%) clearly reported assessing risk of bias or the methodological quality of the included preference studies; not a single review was able to perform quantitative synthesis (meta-analysis) of the data on patient preferences.", {"entities": []}], ["These results suggest that several methodological issues of performing systematic reviews of patient preferences are not yet fully addressed by research and that the methodology may require future development.", {"entities": []}], ["Modern flexible multiple daily injection (MDI) therapy requires people with diabetes to manage complex mathematical calculations to determine insulin doses on a day to day basis.", {"entities": []}], ["Automated bolus calculators assist with these calculations, add additional functionality to protect against hypoglycaemia and enhance the record keeping process, however uptake and use depends on the devices meeting the needs of the user.", {"entities": []}], ["We aimed to obtain user feedback on the usability of a mobile phone bolus calculator application in adults with T1DM to inform future development of mobile phone diabetes support applications.", {"entities": []}], ["Adults with T1DM who had previously received education in flexible MDI therapy were invited to participate.", {"entities": []}], ["Eligible respondents attended app education and one month later participated in a focus group to provide feedback on the features of the app in relation to usability for patient-based flexible MDI and future app development.", {"entities": [[30, 33, "GENE"], [137, 140, "GENE"], [208, 211, "GENE"], [30, 33, "GENE"], [137, 140, "GENE"], [208, 211, "GENE"], [30, 33, "GENE"], [137, 140, "GENE"], [208, 211, "GENE"]]}], ["Seven adults participated in the app training and follow up interview.", {"entities": [[33, 36, "GENE"]]}], ["App features that support dose adjustment to reduce hypoglycaemia risk and features that enable greater efficiency in dose calculation, record keeping and report generation were highly valued.", {"entities": [[0, 3, "GENE"]]}], ["Adults who are self managing flexible MDI found the Rapidcalc mobile phone app to be a useful self-management tool and additional features to further improve usability, such as connectivity with BG meter and food databases, shortcut options to economise data entry and web based storage of data, were identified.", {"entities": [[75, 78, "GENE"]]}], ["Further work is needed to ascertain specific features and benefit for those with lower health literacy.", {"entities": []}], ["Several hydrolyzed cow's milk ( CM ) formulas are available for avoidance of allergic reactions in CM \u2010allergic children and for prevention of allergy development in high\u2010risk infants.", {"entities": []}], ["Our aim was to compare CM formulas regarding the presence of immunoreactive CM components, IgE reactivity, allergenic activity, ability to induce T\u2010cell proliferation, and cytokine secretion.", {"entities": []}], ["A blinded analysis of eight CM formulas, one nonhydrolyzed, two partially hydrolyzed (PH), four extensively hydrolyzed (EH), and one amino acid formula, using biochemical techniques and specific antibody probes was conducted.", {"entities": []}], ["IgE reactivity and allergenic activity of the formulas were tested with sera from CM \u2010allergic patients ( n = 26) in RAST \u2010based assays and with rat basophils transfected with the human Fc\u03b5 RI , respectively.", {"entities": []}], ["The induction of T\u2010cell proliferation and the secretion of cytokines in Peripheral blood mononuclear cell (PBMC) culture from CM allergic patients and nonallergic individuals were assessed.", {"entities": []}], ["Immune\u2010reactive \u03b1\u2010lactalbumin and \u03b2\u2010lactoglobulin were found in the two PH formulas and casein components in one of the EH formulas.", {"entities": []}], ["One PH formula and the EH formula containing casein components showed remaining IgE reactivity, whereas the other hydrolyzed formulas lacked IgE reactivity.", {"entities": []}], ["Only two EH formulas and the amino acid formula did not induce T\u2010cell proliferation and proinflammatory cytokine release.", {"entities": []}], ["The remaining formulas varied regarding the induction of Th2, Th1, and proinflammatory cytokines.", {"entities": []}], ["Our results show that certain CM formulas without allergenic and low proinflammatory properties can be identified and they may also explain different outcomes obtained in clinical studies using CM formulas.", {"entities": []}], ["Soybean oil content is one of main quality traits.", {"entities": []}], ["In this study, we used the multifactor dimensionality reduction (MDR) method and a soybean high-density genetic map including 5,308 markers to identify stable single nucleotide polymorphism (SNP)\u2014SNP interactions controlling oil content in soybean across 23 environments.", {"entities": []}], ["In total, 36,442,756 SNP-SNP interaction pairs were detected, 1865 of all interaction pairs associated with soybean oil content were identified under multiple environments by the Bonferroni correction with p <3.55\u00d710", {"entities": []}], ["Fungi are a large, complex group, increasingly recognized as emerging threats.", {"entities": []}], ["Their roles as modifiers of health mandate accurate portrayals of fungal communities in humans.", {"entities": []}], ["As an entry point into the airways and gastrointestinal tract, fungi in the mouth are relevant to several biocompartments.", {"entities": []}], ["We have revised current practices in sequence-based taxonomy assignments and employed the improvements to address the question of the fungal genera present in the healthy human mouth.", {"entities": []}], ["The human oral mycobiome was surveyed using massively parallel, high throughput sequencing of internal transcribed spacer 1 (ITS1) amplicons from saliva following robust extraction methods.", {"entities": []}], ["Taxonomy was assigned by comparison to a curated reference dataset, followed by filtering with an empirically determined BLAST E-value match statistic (10 Malassezia .", {"entities": []}], ["Previously identified as an important pathogen of the skin, and recently reported as the predominant fungal genus at the nostril and backs of the head and ear, this is the first account of Malassezia in the human mouth.", {"entities": []}], ["Findings from this study were in good agreement with others on the existence of many consensus members of the core mycobiome, and on unique patterns for individual subjects.", {"entities": []}], ["This research offered a cautionary note about unconditional acceptance of lengthy lists of community members produced by automated assignments, provided a roadmap for enhancing the likely biological relevance of sequence-based fungal surveys, and built the foundation for understanding the role of fungi in health and disease of the oral cavity.", {"entities": []}], ["Background and Objectives .", {"entities": []}], ["Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by loss of motor neurons in the brainstem, motor cortex, and spinal cord.", {"entities": [[53, 78, "DISEASE"], [12, 29, "DISEASE"]]}], ["Oxidative stress and neuroinflammation have been implicated in the pathophysiology of ALS.", {"entities": []}], ["Members of the family of damage-associated molecular patterns, including reactive oxygen species, high-mobility group box 1, and eosinophil-derived neurotoxin (EDN), may participate in pathological conditions.", {"entities": []}], ["In this study, we aim to discover new biomarker for detecting ALS.", {"entities": []}], ["Materials and Methods .", {"entities": []}], ["We examined 44 patients with ALS, 41 patients with Alzheimer's disease, 41 patients with Parkinson's disease, and 44 healthy controls.", {"entities": []}], ["The concentration of serum EDN was measured using an enzyme-linked immunosorbent assay.", {"entities": []}], ["EDN levels were significantly increased 2.17-fold in the serum of patients with ALS as compared with healthy controls ( P < 0.05).", {"entities": []}], ["No correlation between the levels of serum EDN and various clinical parameters of ALS was found.", {"entities": []}], ["Moreover, the levels of serum EDN in patients with Parkinson's disease and Alzheimer's disease and healthy controls were similar.", {"entities": []}], ["Conclusion .", {"entities": []}], ["A higher level of serum EDN was found specifically in patients with ALS, indicating that EDN may participate in the pathophysiology of ALS.", {"entities": []}], ["CD40L is essential for the development of adaptive immune responses.", {"entities": []}], ["It is generally thought that CD40L expression in CD4", {"entities": [[49, 52, "GENE"]]}], ["The 6-minute walk test (6MWT) in a regular hallway is commonly used to assess functional exercise capacity in patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[124, 161, "DISEASE"]]}], ["However, treadmill walking might provide additional advantages over overground walking, especially if virtual reality and self-paced treadmill walking are combined.", {"entities": []}], ["Therefore, this study aimed to assess the reproducibility and validity of the 6MWT using the Gait Real-time Analysis Interactive Lab (GRAIL) in patients with COPD and healthy elderly.", {"entities": []}], ["Sixty-one patients with COPD and 48 healthy elderly performed two 6MWTs on the GRAIL.", {"entities": []}], ["Patients performed two overground 6MWTs and healthy elderly performed one overground test.", {"entities": []}], ["Differences between consecutive 6MWTs and the test conditions (GRAIL vs. overground) were analysed.", {"entities": []}], ["Patients walked further in the second overground test (24.8 m, 95% CI 15.2\u201334.4 m, p<0.001) and in the second GRAIL test (26.8 m, 95% CI 13.9\u201339.6 m).", {"entities": []}], ["Healthy elderly improved their second GRAIL test (49.6 m, 95% CI 37.0\u201362.3 m).", {"entities": []}], ["The GRAIL 6MWT was reproducible (intra-class coefficients = 0.65\u20130.80).", {"entities": []}], ["The best GRAIL 6-minute walk distance (6MWD) in patients was shorter than the best overground 6MWD (-27.3 \u00b1 49.1 m, p<0.001).", {"entities": []}], ["Healthy elderly walked further on the GRAIL than in the overground condition (23.6 \u00b1 41.4 m, p<0.001).", {"entities": []}], ["Validity of the GRAIL 6MWT was assessed and intra-class coefficient values ranging from 0.74\u20130.77 were found.", {"entities": []}], ["The GRAIL is a promising system to assess the 6MWD in patients with COPD and healthy elderly.", {"entities": []}], ["The GRAIL 6MWD seems to be more comparable to the 6MWDs assessed overground than previous studies on treadmills have reported.", {"entities": []}], ["Furthermore, good construct validity and reproducibility were established in assessing the 6MWD using the GRAIL in patients with COPD and healthy elderly.", {"entities": []}], ["The oral mucosa is a barrier site constantly exposed to rich and diverse commensal microbial communities, yet little is known of the immune cell network maintaining immune homeostasis at this interface.", {"entities": []}], ["We have performed a detailed characterization of the immune cell subsets of the oral cavity in a large cohort of healthy subjects.", {"entities": []}], ["We focused our characterization on the gingival interface, a particularly vulnerable mucosal site, with thin epithelial lining and constant exposure to the tooth adherent biofilm.", {"entities": []}], ["In health, we find a predominance of T cells, minimal B cells, a large presence of granulocytes/neutrophils, a sophisticated network of professional antigen presenting cells (APC) and a small population of innate lymphoid cells (ILC) policing the gingival barrier.", {"entities": [[175, 178, "GENE"]]}], ["We further characterize cellular subtypes in health and interrogate shifts in immune cell populations in the common oral inflammatory disease periodontitis.", {"entities": [[142, 155, "DISEASE"]]}], ["In disease we document an increase in neutrophils and an up regulation of IL-17 responses.", {"entities": []}], ["We identify the main source of IL-17 in health and periodontitis within the CD4", {"entities": [[51, 64, "DISEASE"], [76, 79, "GENE"]]}], ["In this study we investigated the immunohistochemical expression of inducible nitric oxide synthase (iNOS) in a set of normal pleural mesothelial tissues, malignant mesotheliomas, mesothelioma cell lines and metastatic pleural adenocarcinomas.", {"entities": []}], ["Furthermore, the expression of mRNA was assessed in four malignant mesothelioma cell lines in culture.", {"entities": [[57, 79, "DISEASE"]]}], ["Apoptosis and vascular density in malignant mesotheliomas was assessed by the TUNEL method and by immunohistochemistry with an antibody against FVIII-related antigen.", {"entities": []}], ["Immunohistochemically mesothelial cells in non-neoplastic healthy pleural tissues were mostly negative for iNOS.", {"entities": []}], ["Positivity for iNOS was observed in 28/38 (74%) and 24/25 (96%) of malignant mesotheliomas and metastatic pleural adenocarcinomas, respectively.", {"entities": []}], ["Epithelial and mixed mesotheliomas expressed more often strong iNOS immunoreactivity compared to the sarcomatoid subtype ( P = 0.023).", {"entities": []}], ["Moreover, metastatic adenocarcinomas expressed more often iNOS positivity than mesotheliomas ( P = 0.021).", {"entities": []}], ["Experiments with the cell lines confirmed that malignant mesothelioma cells are capable of synthesizing iNOS.", {"entities": [[47, 69, "DISEASE"]]}], ["No significant association was found between iNOS expression and apoptosis or vascular density in malignant mesotheliomas.", {"entities": []}], ["The higher expression of iNOS in the epithelial subtype of mesothelioma and pleural metastatic adenocarcinoma might be due to an increased sensitivity of these cell types to cytokine-mediated iNOS upregulation.", {"entities": [[95, 109, "DISEASE"]]}], ["The strong expression of iNOS suggests a putative role for NO in the growth and progression of these tumours.", {"entities": []}], ["\u00a9 2000 Cancer Research Campaign", {"entities": []}], ["Cysteine cathepsins are a group of enzymes normally found in the endolysosomes where they are primarily involved in intracellular protein turnover but also have a critical role in MHC II-mediated antigen processing and presentation.", {"entities": []}], ["However, in a number of pathologies cysteine cathepsins were found to be heavily upregulated and secreted into extracellular milieu, where they were found to degrade a number of extracellular proteins.", {"entities": []}], ["A major role in modulating cathepsin activities play glycosaminoglycans, which were found not only to facilitate their autocatalytic activation including at neutral pH, but also to critically modulate their activities such as in the case of the collagenolytic activity of cathepsin K. The interaction between cathepsins and glycosaminoglycans will be discussed in more detail.", {"entities": []}], ["Type I interferon (IFN) inhibits virus replication by activating multiple antiviral mechanisms and pathways.", {"entities": []}], ["It has long been recognized that type I IFNs can potently block HIV-1 replication in vitro ; as such, HIV-1 has been used as a system to identify and characterize IFN-induced antiviral proteins responsible for this block.", {"entities": []}], ["IFN-induced HERC5 contains an amino-terminal Regulator of Chromosome Condensation 1 (RCC1)-like domain and a carboxyl-terminal Homologous to the E6-AP Carboxyl Terminus (HECT) domain.", {"entities": [[12, 17, "GENE"], [85, 89, "GENE"]]}], ["HERC5 is the main cellular E3 ligase that conjugates the IFN-induced protein ISG15 to proteins.", {"entities": [[0, 5, "GENE"], [77, 82, "GENE"]]}], ["This E3 ligase activity was previously shown to inhibit the replication of evolutionarily diverse viruses, including HIV-1.", {"entities": []}], ["The contribution of the RCC1-like domain to the antiviral activity of HERC5 was previously unknown.", {"entities": [[70, 75, "GENE"]]}], ["In this study, we showed that HERC5 inhibits HIV-1 particle production by a second distinct mechanism that targets the nuclear export of Rev/RRE-dependent RNA.", {"entities": [[30, 35, "GENE"]]}], ["Unexpectedly, the E3 ligase activity of HERC5 was not required for this inhibition.", {"entities": [[40, 45, "GENE"]]}], ["Instead, this activity required the amino-terminal RCC1-like domain of HERC5.", {"entities": [[71, 76, "GENE"]]}], ["Inhibition correlated with a reduction in intracellular RanGTP protein levels and/or the ability of RanGTP to interact with RanBP1.", {"entities": [[124, 130, "GENE"]]}], ["Inhibition also correlated with altered subcellular localization of HIV-1 Rev.", {"entities": []}], ["In addition, we demonstrated that positive evolutionary selection is operating on HERC5.", {"entities": [[82, 87, "GENE"]]}], ["We identified a region in the RCC1-like domain that exhibits an exceptionally high probability of having evolved under positive selection and showed that this region is required for HERC5-mediated inhibition of nuclear export.", {"entities": []}], ["We have identified a second distinct mechanism by which HERC5 inhibits HIV-1 replication and demonstrate that HERC5 is evolving under strong positive selection.", {"entities": [[56, 61, "GENE"], [110, 115, "GENE"], [56, 61, "GENE"], [110, 115, "GENE"]]}], ["Together, our findings contribute to a growing body of evidence suggesting that HERC5 is a novel host restriction factor.", {"entities": [[80, 85, "GENE"]]}], ["Although human torque teno viruses (TTVs) were first discovered in 1997, still many associated aspects are not clarified yet.", {"entities": []}], ["The viruses reveal a remarkable heterogeneity and it is possible that some genotypes are more pathogenic than others.", {"entities": []}], ["The identification of all genotypes is essential to confirm previous pathogenicity data, and an unbiased search for novel viruses is needed to identify TTVs that might be related to disease.", {"entities": []}], ["The virus discovery technique VIDISCA-454 was used to screen serum of 55 HIV-1 positive injecting drug users, from the Amsterdam Cohort Studies, in search for novel blood-blood transmittable viruses which are undetectable via normal diagnostics or panvirus-primer PCRs.", {"entities": []}], ["A novel torque teno mini virus (TTMV) was identified in two patients and the sequence of the full genomes were determined.", {"entities": []}], ["The virus is significantly different from the known TTMVs (< 40% amino acid identity in ORF1), yet it contains conserved characteristics that are also present in other TTMVs.", {"entities": []}], ["The virus is chronically present in both patients, and these patients both suffered from a pneumococcal pneumonia during follow up and had extremely low B-cells counts.", {"entities": [[104, 113, "DISEASE"]]}], ["We describe a novel TTMV which we tentatively named TTMV-13.", {"entities": []}], ["Further research is needed to address the epidemiology and pathogenicity of this novel virus.", {"entities": []}], ["This study aimed to identify the phytochemical content and evaluate the antioxidant, anti-inflammatory, and antiproliferative capacities of various solvent extracts of Ephedra campylopoda stems.", {"entities": []}], ["Fresh stems were suspended in 3 different solvent systems, including distilled water, ethanol, and methanol .", {"entities": []}], ["The chemical composition was determined using high-performance liquid chromatography (HPLC), and the content of essential oil of this plant species was determined by gas chromatography (GC) coupled with mass spectrometry (MS).", {"entities": [[186, 188, "GENE"]]}], ["Antioxidant activity was determined using DPPH radical scavenging and Fe 2 using ELISA technique, and quantifying the mRNA level of the pro-inflammatory cytokines (IL-\u03b1, IL-\u03b2 and IL-6), chemokines (CCL3 and CCL4), and inflammation-inducible COX-2 and iNOS enzymes using quantitative real-time PCR (qRT-PCR).", {"entities": [[198, 202, "GENE"], [207, 211, "GENE"]]}], ["The antiproliferative potential was determined using the XTT viability assay.", {"entities": []}], ["Our results showed that the alcoholic extracts were better than the aqueous one in terms of their chemical composition.", {"entities": []}], ["In parallel, the alcoholic extracts showed more potent antioxidant, anti-inflammatory, and antiproliferative capacities than aqueous extract.", {"entities": []}], ["Our observations suggest that Ephedra campylopoda plant could be a promising resource of natural products with antioxidant, anti-inflammatory and antiproliferative capacities.", {"entities": []}], ["Gardeners with chronic obstructive pulmonary disease or a history of smoking should take extra precautions to prevent infection.", {"entities": [[15, 52, "DISEASE"]]}], ["Legionella longbeachae , found in soil and compost-derived products, is a globally underdiagnosed cause of Legionnaires\u2019 disease.", {"entities": []}], ["We conducted a case\u2013control study of L. longbeachae Legionnaires\u2019 disease in Canterbury, New Zealand.", {"entities": []}], ["Case-patients were persons hospitalized with L. longbeachae pneumonia, and controls were persons randomly sampled from the electoral roll for the area served by the participating hospital.", {"entities": [[60, 69, "DISEASE"]]}], ["Among 31 cases and 172 controls, risk factors for Legionnaires\u2019 disease were chronic obstructive pulmonary disease, history of smoking > 10 years, and exposure to compost or potting mix.", {"entities": [[77, 114, "DISEASE"]]}], ["Gardening behaviors associated with L. longbeachae disease included having unwashed hands near the face after exposure to or tipping and troweling compost or potting mix.", {"entities": []}], ["Mask or glove use was not protective among persons exposed to compost-derived products.", {"entities": []}], ["Precautions against inhaling compost and attention to hand hygiene might effectively prevent L. longbeachae disease.", {"entities": []}], ["Long-term smokers and those with chronic obstructive pulmonary disease should be particularly careful.", {"entities": [[33, 70, "DISEASE"]]}], ["Nonsteroidal anti-inflammatory drugs (NSAIDs) may disrupt control of blood pressure in hypertensive patients and increase their risk of morbidity, mortality, and the costs of care.", {"entities": []}], ["The objective of this study was to examine the association between incident use of NSAIDs and blood pressure in patients with hypertension.", {"entities": [[126, 138, "DISEASE"]]}], ["We conducted a retrospective cohort study of adult hypertensive patients to determine the effects of their first prescription for NSAID on systolic blood pressure and antihypertensive drug intensification.", {"entities": []}], ["Data were collected from an electronic medical record serving an academic general medicine practice in Indianapolis, Indiana, USA.", {"entities": []}], ["Using propensity scores to minimize bias, we matched a cohort of 1,340 users of NSAIDs with 1,340 users of acetaminophen.", {"entities": []}], ["Propensity score models included covariates likely to affect blood pressure or the use of NSAIDs.", {"entities": []}], ["The study outcomes were the mean systolic blood pressure measurement after starting NSAIDs and changes in antihypertensive therapy.", {"entities": []}], ["Compared to patients using acetaminophen, NSAID users had a 2 mmHg increase in systolic blood pressure (95% CI, 0.7 to 3.3).", {"entities": []}], ["Ibuprofen was associated with a 3 mmHg increase in systolic blood pressure compared to naproxen (95% CI, 0.5 to 4.6), and a 5 mmHg increase compared to celecoxib (95% CI, 0.4 to 10).", {"entities": []}], ["The systolic blood pressure increase was 3 mmHg in a subgroup of patients concomitantly prescribed angiotensin converting enzyme inhibitors or calcium channel blockers and 6 mmHg among those prescribed a beta-adrenergic blocker.", {"entities": []}], ["Blood pressure changes in patients prescribed diuretics or multiple antihypertensives were not statistically significant.", {"entities": []}], ["Compared to acetaminophen, incident use of NSAIDs, particularly ibuprofen, is associated with a small increase in systolic blood pressure in hypertensive patients.", {"entities": []}], ["Effects in patients prescribed diuretics or multiple antihypertensives are negligible.", {"entities": []}], ["Exercise limitation, dynamic hyperinflation, and exertional dyspnea are key features of symptomatic chronic obstructive pulmonary disease (COPD).", {"entities": [[100, 137, "DISEASE"]]}], ["We assessed the effects of glycopyrronium bromide (NVA237), a once-daily, long-acting muscarinic antagonist, on exercise tolerance in patients with moderate to severe COPD.", {"entities": []}], ["Patients were randomized to a cross-over design of once-daily NVA237 50 \u03bcg or placebo for 3 weeks, with a 14-day washout.", {"entities": []}], ["Exercise endurance, inspiratory capacity (IC) during exercise, IC and expiratory volumes from spirometry, plethysmographic lung volumes, leg discomfort and dyspnea under exercise (Borg scales), and transition dyspnea index were measured on Days 1 and 21 of treatment.", {"entities": []}], ["The primary endpoint was endurance time during a submaximal constant-load cycle ergometry test on Day 21.", {"entities": []}], ["A total of 108 patients were randomized to different treatment groups (mean age, 60.5 years; mean post-bronchodilator, forced expiratory volume in 1 second [FEV 1 ] 57.1% predicted).", {"entities": [[157, 160, "GENE"]]}], ["Ninety-five patients completed the study.", {"entities": []}], ["On Day 21, a 21% difference in endurance time was observed between patients treated with NVA237 and those treated with placebo ( P < 0.001); the effect was also significant from Day 1, with an increase of 10%.", {"entities": []}], ["Dynamic IC at exercise isotime and trough FEV 1 showed significant and clinically relevant improvements from Day 1 of treatment that were maintained throughout the study.", {"entities": [[42, 45, "GENE"]]}], ["This was accompanied by inverse decreases in residual volume and functional residual capacity.", {"entities": []}], ["NVA237 was superior to placebo ( P < 0.05) in decreasing leg discomfort (Borg CR10 scale) on Day 21 and exertional dyspnea on Days 1 and 21 (transition dyspnea index and Borg CR10 scale at isotime).", {"entities": []}], ["The safety profile of NVA237 was similar to that of the placebo.", {"entities": []}], ["NVA237 50 \u03bcg once daily produced immediate and significant improvement in exercise tolerance from Day 1.", {"entities": []}], ["This was accompanied by sustained reductions in lung hyperinflation (indicated by sustained and significant improvements in IC at isotime), and meaningful improvements in trough FEV 1 and dyspnea.", {"entities": [[178, 181, "GENE"]]}], ["Improvements in exercise endurance increased over time, suggesting that mechanisms beyond improved lung function may be involved in enhanced exercise tolerance.", {"entities": []}], ["(ClinicalTrials.gov Identifier: NCT01154127).", {"entities": []}], ["The human respiratory tract is constantly exposed to a wide variety of viruses, microbes and inorganic particulates from environmental air, water and food.", {"entities": []}], ["Physical characteristics of inhaled particles and airway mucosal immunity determine which viruses and microbes will persist in the airways.", {"entities": []}], ["Here we present the first metagenomic study of DNA viral communities in the airways of diseased and non-diseased individuals.", {"entities": []}], ["We obtained sequences from sputum DNA viral communities in 5 individuals with cystic fibrosis (CF) and 5 individuals without the disease.", {"entities": [[78, 93, "DISEASE"]]}], ["Overall, diversity of viruses in the airways was low, with an average richness of 175 distinct viral genotypes.", {"entities": []}], ["The majority of viral diversity was uncharacterized.", {"entities": []}], ["CF phage communities were highly similar to each other, whereas Non-CF individuals had more distinct phage communities, which may reflect organisms in inhaled air.", {"entities": []}], ["CF eukaryotic viral communities were dominated by a few viruses, including human herpesviruses and retroviruses.", {"entities": []}], ["Functional metagenomics showed that all Non-CF viromes were similar, and that CF viromes were enriched in aromatic amino acid metabolism.", {"entities": []}], ["The CF metagenomes occupied two different metabolic states, probably reflecting different disease states.", {"entities": []}], ["There was one outlying CF virome which was characterized by an over-representation of Guanosine-5\u2032-triphosphate,3\u2032-diphosphate pyrophosphatase, an enzyme involved in the bacterial stringent response.", {"entities": []}], ["Unique environments like the CF airway can drive functional adaptations, leading to shifts in metabolic profiles.", {"entities": []}], ["These results have important clinical implications for CF, indicating that therapeutic measures may be more effective if used to change the respiratory environment, as opposed to shifting the taxonomic composition of resident microbiota.", {"entities": []}], ["Idiopathic pulmonary fibrosis (IPF) involves alveolar epithelial injury and abnormal collagen production caused by activated fibroblasts; transforming growth factor (TGF)-\u03b21 is implicated in this activation.", {"entities": [[11, 29, "DISEASE"]]}], ["In this study, we screened for chemicals capable of inhibiting TGF-\u03b21-induced collagen production in cultured fibroblasts from medicines already in clinical use.", {"entities": []}], ["We selected felodipine based on its extent of collagen production inhibition, clinical safety profile, and other pharmacological activity.", {"entities": []}], ["Felodipine is a dihydropyridine Ca in vitro and partially prevented bleomycin-induced pulmonary fibrosis, alteration of lung mechanics and respiratory dysfunction in vivo .", {"entities": [[86, 104, "DISEASE"]]}], ["We propose that these Ca", {"entities": []}], ["Hypoxia preconditioning is an effective strategy of intrinsic cell protection.", {"entities": []}], ["An acute repetitive hypoxic mice model was developed.", {"entities": []}], ["High-throughput microarray analysis was performed to explore the integrative alterations of gene expression in repetitive hypoxic mice.", {"entities": []}], ["Data obtained was analyzed via multiple bioinformatics approaches to identify the hub genes, pathways and biological processes related to hypoxia preconditioning.", {"entities": []}], ["The current study, for the first time, provides insights into the gene expression profiles in repetitive hypoxic mice.", {"entities": []}], ["It was found that a total of 1175 genes expressed differentially between the hypoxic mice and normal mice.", {"entities": []}], ["Overall, 113 significantly up-regulated and 138 significantly down-regulated functions were identified from the differentially expressed genes in repetitive hypoxic brains.", {"entities": []}], ["Among them, at least fourteen of these genes were very associated with hypoxia preconditioning.", {"entities": []}], ["The change trends of these genes were validated by reverse-transcription polymerase chain reaction and were found to be consistent with the microarray data.", {"entities": []}], ["Combined the results of pathway and gene co-expression networks, we defined Plcb1 , Cacna2d1 , Atp2b4 , Grin2a , Grin2b and Glra1 as the main hub genes tightly related with hypoxia preconditioning.", {"entities": [[76, 81, "GENE"], [84, 92, "GENE"], [95, 101, "GENE"], [104, 110, "GENE"], [113, 119, "GENE"], [124, 129, "GENE"]]}], ["The differential functions mainly included the mitogen-activated protein kinase pathway and ion or neurotransmitter transport.", {"entities": []}], ["The multiple reactions in cell could be initiated by activating MAPK pathway to prevent hypoxia damage.", {"entities": []}], ["Plcb1 was an important and hub gene and node in the hypoxia preconditioning signal networks.", {"entities": [[0, 5, "GENE"]]}], ["The findings in the hub genes and integrated gene networks provide very useful information for further exploring the molecular mechanisms of hypoxia preconditioning.", {"entities": []}], ["Fuels from renewable resources have gained worldwide interest due to limited fossil oil sources and the possible reduction of atmospheric greenhouse gas.", {"entities": []}], ["One of these fuels is so called biodiesel produced from vegetable oil by transesterification into fatty acid methyl esters (FAME).", {"entities": []}], ["To get a first insight into changes of health hazards from diesel engine emissions (DEE) by use of biodiesel scientific studies were reviewed which compared the combustion of FAME with common diesel fuel (DF) for legally regulated and non-regulated emissions as well as for toxic effects.", {"entities": []}], ["A total number of 62 publications on chemical analyses of DEE and 18 toxicological in vitro studies were identified meeting the criteria.", {"entities": []}], ["In addition, a very small number of human studies and animal experiments were available.", {"entities": []}], ["In most studies, combustion of biodiesel reduces legally regulated emissions of carbon monoxide, hydrocarbons, and particulate matter.", {"entities": []}], ["Nitrogen oxides are regularly increased.", {"entities": []}], ["Among the non-regulated emissions aldehydes are increased, while polycyclic aromatic hydrocarbons are lowered.", {"entities": []}], ["Most biological in vitro assays show a stronger cytotoxicity of biodiesel exhaust and the animal experiments reveal stronger irritant effects.", {"entities": []}], ["Both findings are possibly caused by the higher content of nitrogen oxides and aldehydes in biodiesel exhaust.", {"entities": []}], ["The lower content of PAH is reflected by a weaker mutagenicity compared to DF exhaust.", {"entities": []}], ["However, recent studies show a very low mutagenicity of DF exhaust as well, probably caused by elimination of sulfur in present DF qualities and the use of new technology diesel engines.", {"entities": []}], ["Combustion of vegetable oil (VO) in common diesel engines causes a strongly enhanced mutagenicity of the exhaust despite nearly unchanged regulated emissions.", {"entities": []}], ["The newly developed fuel \u201chydrotreated vegetable oil\u201d (HVO) seems to be promising.", {"entities": []}], ["HVO has physical and chemical advantages compared to FAME.", {"entities": []}], ["Preliminary results show lower regulated and non-regulated emissions and a decreased mutagenicity.", {"entities": []}], ["Many antibiotics require dose adjustments in patients with renal impairment and/or in those undergoing hemodialysis.", {"entities": []}], ["Omadacycline, the first aminomethylcycline antibiotic in late-stage clinical development, displays activity against a broad spectrum of bacterial pathogens, including drug-resistant strains.", {"entities": []}], ["Data from completed phase 3 studies of omadacycline for the treatment of acute bacterial skin and skin structure infections (ABSSSI) and community-acquired bacterial pneumonia (CABP) showed intravenous (i.v.)", {"entities": [[166, 175, "DISEASE"], [156, 175, "DISEASE"]]}], ["to once-daily oral omadacycline to be clinically effective and well tolerated.", {"entities": []}], ["To determine if the dosing of omadacycline should be adjusted in patients with impaired renal function, a phase 1 study examining the pharmacokinetics (PK) and safety of i.v.", {"entities": []}], ["omadacycline (100 mg) was conducted in subjects with end-stage renal disease (ESRD) on stable hemodialysis ( n = 8) and in matched healthy subjects ( n = 8).", {"entities": []}], ["administration of omadacycline produced similar plasma concentration-time profiles in subjects with ESRD and healthy subjects.", {"entities": []}], ["Further, in subjects with ESRD, similar values of the PK parameters were observed when omadacycline was administered i.v.", {"entities": []}], ["after or before dialysis.", {"entities": []}], ["The mean area under the concentration-time curve from time zero extrapolated to infinity in plasma was 10.30 \u03bcg \u00b7 h/ml when omadacycline was administered to ESRD subjects after dialysis, 10.20 \u03bcg \u00b7 h/ml when omadacycline was administered to ESRD subjects before dialysis, and 9.76 \u03bcg \u00b7 h/ml when omadacycline was administered to healthy subjects.", {"entities": []}], ["The mean maximum observed concentration of omadacycline in plasma in ESRD subjects was 1.88 \u03bcg/ml when it was administered after dialysis and 2.33 \u03bcg/ml when it was administered before dialysis, and in healthy subjects it was 1.92 \u03bcg/ml.", {"entities": []}], ["The 100-mg i.v.", {"entities": []}], ["dose of omadacycline was generally safe and well tolerated in both ESRD and healthy subjects.", {"entities": []}], ["This study demonstrates that no dose adjustment is necessary for omadacycline in patients with impaired renal function or on days when patients are receiving hemodialysis.", {"entities": []}], ["Prevalence of asthma increases with increasing dichlorodiphenyldichloroethylene (DDE) levels.", {"entities": [[14, 20, "DISEASE"]]}], ["However, the effect of early-life exposure, the fundamental window of exposure, is unknown.", {"entities": []}], ["We assessed the association between prenatal DDE and other organochlorine compounds, and atopy and asthma during infancy.", {"entities": [[99, 105, "DISEASE"]]}], ["All women presenting for antenatal care in Menorca (Spain) over 12 months starting in mid-1997 were invited to take part in a longitudinal study; 482 children were subsequently enrolled, and 468 (97.1%) provided complete outcome data up to the fourth year of study.", {"entities": []}], ["Prenatal exposure of organochlorine compounds was measured in cord serum in 405 (83%) children.", {"entities": []}], ["Asthma was defined on the basis of wheezing at 4 years of age, persistent wheezing, or doctor-diagnosed asthma.", {"entities": [[0, 6, "DISEASE"], [104, 110, "DISEASE"]]}], ["We measured specific immunoglobulin-E (IgE) against house dust mite, cat, and grass in sera extracted at 4 years of age.", {"entities": []}], ["DDE (median = 1.03 ng/mL) was detected in all children, as well as hexachlorobenzene (0.68 ng/mL) and polychlorobiphenyls (0.69 ng/mL).", {"entities": []}], ["Wheezing at 4 years of age increased with DDE concentration, particularly at the highest quartile [9% in the lowest quartile (< 0.57 ng/mL) vs. 19% in the highest quartile (1.90 ng/mL); relative risk = 2.63 (95% confidence interval 1.19\u20134.69), adjusting for maternal asthma, breast-feeding, education, social class, or other organochlorines].", {"entities": [[267, 273, "DISEASE"]]}], ["The association was not modified by IgE sensitization and occurred with the same strength among nonatopic subjects and among those with persistent wheezing or diagnosed asthma.", {"entities": [[169, 175, "DISEASE"]]}], ["DDE was not associated with atopy alone.", {"entities": []}], ["Prenatal exposure to DDE residues may contribute to development of asthma.", {"entities": [[67, 73, "DISEASE"]]}], ["This study examines the relationship between toner-handling work and its health effects on self-reported respiratory symptoms.", {"entities": []}], ["The subjects were 1,504 male workers in a Japanese toner and photocopier manufacturing company.", {"entities": []}], ["Personal exposure measurement, pulmonary function tests, chest X-ray examination, measurement of biomarkers, and a questionnaire about self-reported respiratory symptoms were performed annually.", {"entities": []}], ["This study discusses the questionnaire results.", {"entities": []}], ["We found that the toner-handling group showed significantly higher prevalence of breathlessness than the never-toner-handling group.", {"entities": []}], ["The significant reduction of pulmonary function and fibrosis change in the chest X-ray examination associated with breathlessness were not observed.", {"entities": []}], ["However the morbidity of asthma was higher compared to the Japanese population in both of the toner-handling group and the never-toner handling group, the effect of toner exposure was not clarified.", {"entities": [[25, 31, "DISEASE"]]}], ["Nevertheless, while the toner exposure levels in the current well-controlled working environment may be sufficiently low to prevent adverse health effects, further studies are needed to assess the more long-term latent health effects of toner exposure.", {"entities": []}], ["A variety of definitions of evidence-based practice (EBP) exist.", {"entities": [[53, 56, "GENE"]]}], ["However, definitions are in themselves insufficient to explain the underlying processes of EBP and to differentiate between an evidence-based process and evidence-based outcome .", {"entities": [[91, 94, "GENE"]]}], ["There is a need for a clear statement of what Evidence-Based Practice (EBP) means, a description of the skills required to practise in an evidence-based manner and a curriculum that outlines the minimum requirements for training health professionals in EBP.", {"entities": [[71, 74, "GENE"], [253, 256, "GENE"], [71, 74, "GENE"], [253, 256, "GENE"]]}], ["This consensus statement is based on current literature and incorporating the experience of delegates attending the 2003 Conference of Evidence-Based Health Care Teachers and Developers (\"Signposting the future of EBHC\").", {"entities": []}], ["Evidence-Based Practice has evolved in both scope and definition.", {"entities": []}], ["Evidence-Based Practice (EBP) requires that decisions about health care are based on the best available, current, valid and relevant evidence.", {"entities": [[25, 28, "GENE"]]}], ["These decisions should be made by those receiving care, informed by the tacit and explicit knowledge of those providing care, within the context of available resources.", {"entities": []}], ["Health care professionals must be able to gain, assess, apply and integrate new knowledge and have the ability to adapt to changing circumstances throughout their professional life.", {"entities": []}], ["Curricula to deliver these aptitudes need to be grounded in the five-step model of EBP, and informed by ongoing research.", {"entities": [[83, 86, "GENE"]]}], ["Core assessment tools for each of the steps should continue to be developed, validated, and made freely available.", {"entities": []}], ["All health care professionals need to understand the principles of EBP, recognise EBP in action, implement evidence-based policies, and have a critical attitude to their own practice and to evidence.", {"entities": [[67, 70, "GENE"], [82, 85, "GENE"], [67, 70, "GENE"], [82, 85, "GENE"]]}], ["Without these skills, professionals and organisations will find it difficult to provide 'best practice'.", {"entities": []}], ["Uncertainty remains about the potential harmful effects of antihypertensive therapy on the developing fetus, especially for beta-blockers (\u03b2b).", {"entities": []}], ["We prospectively enrolled all singleton women with a blood pressure \u2265 140/90 mm Hg during pregnancy.", {"entities": []}], ["The main analysis included 1948 women with all forms of hypertension and compared the use of \u03b2b drugs, non-\u03b2b drugs or a combination of both, to no treatment.", {"entities": [[56, 68, "DISEASE"]]}], ["The primary study outcome was a composite of the diseases of prematurity, need for assisted ventilation for greater than 1 day, or perinatal death.", {"entities": []}], ["A sub-group analysis evaluated the four treatment options among 583 singleton women with chronic hypertension before 20 weeks gestation.", {"entities": [[97, 109, "DISEASE"]]}], ["In the main analysis, no association was observed between \u03b2b use and the primary composite outcome [adjusted odds ratio (OR) 1.4, 95% CI 0.9\u20132.2], while an association was seen with non-\u03b2b therapy (OR 5.0, 95% CI 2.6\u20139.6) and combination therapy (OR 2.9, 95% CI 1.8\u20134.7).", {"entities": []}], ["In the sub-group of 583 women with hypertension before 20 weeks, use of a non-\u03b2b drug (OR 4.9, 95% CI 1.7\u201314.2) or combination therapy (OR 2.9.", {"entities": [[35, 47, "DISEASE"]]}], ["95% CI 1.1\u20137.7) was significantly associated with the primary composite outcome, while \u03b2b monotherapy was not (OR 1.4, 95% CI 0.6\u20133.4).", {"entities": []}], ["Maternal use of antihypertensive medications other than \u03b2bs was associated with both major perinatal morbidity and mortality, while \u03b2b monotherapy was not.", {"entities": []}], ["The combined use of \u03b2b and non-\u03b2b medications demonstrated the strongest association.", {"entities": []}], ["Before definitive conclusions can be drawn, a large multicentre randomized controlled trial is needed to address the issues of both maternal efficacy and fetal safety with the use of one or more antihypertensive agents in pregnancy.", {"entities": []}], ["The authors use machine learning of compound-protein interactions to explore drug polypharmacology and to efficiently identify bioactive ligands, including novel scaffold-hopping compounds for two pharmaceutically important protein families: G-protein coupled receptors and protein kinases.", {"entities": []}], ["We have demonstrated that machine learning of multiple compound\u2013protein interactions is useful for efficient ligand screening and for assessing drug polypharmacology.", {"entities": []}], ["This approach successfully identified novel scaffold-hopping compounds for two pharmaceutically important protein families: G-protein-coupled receptors and protein kinases.", {"entities": []}], ["These bioactive compounds were not detected by existing computational ligand-screening methods in comparative studies.", {"entities": []}], ["The results of this study indicate that data derived from chemical genomics can be highly useful for exploring chemical space, and this systems biology perspective could accelerate drug discovery processes.", {"entities": []}], ["We have demonstrated that machine learning of multiple compound\u2013protein interactions is useful for efficient ligand screening and for assessing drug polypharmacology.", {"entities": []}], ["This approach successfully identified novel scaffold-hopping compounds for two pharmaceutically important protein families: G-protein-coupled receptors and protein kinases.", {"entities": []}], ["These bioactive compounds were not detected by existing computational ligand-screening methods in comparative studies.", {"entities": []}], ["The results of this study indicate that data derived from chemical genomics can be highly useful for exploring chemical space, and this systems biology perspective could accelerate drug discovery processes.", {"entities": []}], ["The discovery of novel bioactive molecules advances our systems-level understanding of biological processes and is crucial for innovation in drug development.", {"entities": []}], ["Perturbations of biological systems by chemical probes provide broader applications not only for analysis of complex systems but also for intentional manipulations of these systems.", {"entities": []}], ["Nevertheless, the lack of well-characterized chemical modulators has limited their use.", {"entities": []}], ["Recently, chemical genomics has emerged as a promising area of research applicable to the exploration of novel bioactive molecules, and researchers are currently striving toward the identification of all possible ligands for all target protein families ( High-throughput screening (HTS) and computational screening have greatly aided in the identification of early lead compounds for drug discovery.", {"entities": []}], ["However, the large number of assays required for HTS to identify drugs that target multiple proteins render this process very costly and time-consuming.", {"entities": []}], ["Therefore, interest in using in silico strategies for screening has increased.", {"entities": []}], ["The most common computational approaches, ligand-based virtual screening (LBVS) and structure-based virtual screening (SBVS; The CGBVS strategy used in this study was made up of five steps: CPI data collection, descriptor calculation, representation of interaction vectors, predictive model construction using training data sets, and predictions from test data ( To evaluate the predictive value of CGBVS, we first compared its performance with that of LBVS by fivefold cross-validation.", {"entities": []}], ["CGBVS performed with considerably higher accuracy (91.9%) than did LBVS (84.4%; We then evaluated the ability of the CGBVS method to predict the polypharmacology of ADRB2 by attempting to identify novel ADRB2 ligands from a group of G-protein-coupled receptor (GPCR) ligands.", {"entities": [[165, 170, "GENE"], [203, 208, "GENE"], [165, 170, "GENE"], [203, 208, "GENE"]]}], ["We ranked the prediction scores for the interactions of 826 reported GPCR ligands with ADRB2 and then analyzed the 50 highest-ranked compounds in greater detail.", {"entities": [[87, 92, "GENE"]]}], ["Of 21 commercially available compounds, 11 showed ADRB2-binding activity and were not previously reported to be ADRB2 ligands.", {"entities": [[50, 55, "GENE"], [112, 117, "GENE"]]}], ["These compounds included ligands not only for aminergic receptors but also for neuropeptide Y-type 1 receptors (NPY1R), which have low protein homology to ADRB2.", {"entities": [[112, 117, "GENE"], [155, 160, "GENE"]]}], ["Most ligands we identified were not detected by LBVS and SBVS, which suggests that only CGBVS could identify this unexpected cross-reaction for a ligand developed as a target to a peptidergic receptor.", {"entities": []}], ["The true value of CGBVS in drug discovery must be tested by assessing whether this method can identify scaffold-hopping lead compounds from a set of compounds that is structurally more diverse.", {"entities": []}], ["To assess this ability, we analyzed 11 500 commercially available compounds to predict compounds likely to bind to two GPCRs and two protein kinases.", {"entities": []}], ["Functional assays revealed that nine ADRB2 ligands, three NPY1R ligands, five epidermal growth factor receptor (EGFR) inhibitors, and two cyclin-dependent kinase 2 (CDK2) inhibitors were concentrated in the top-ranked compounds (hit rate=30, 15, 25, and 10%, respectively).", {"entities": [[37, 42, "GENE"], [58, 63, "GENE"], [112, 116, "GENE"], [165, 169, "GENE"]]}], ["We also evaluated the extent of scaffold hopping achieved in the identification of these novel ligands.", {"entities": []}], ["One ADRB2 ligand, two NPY1R ligands, and one CDK2 inhibitor exhibited scaffold hopping ( In summary, we have demonstrated that data mining of multiple CPIs is of great practical value for exploration of chemical space.", {"entities": [[4, 9, "GENE"], [22, 27, "GENE"], [45, 49, "GENE"]]}], ["As a predictive model, CGBVS could provide an important step in the discovery of such multi-target drugs by identifying the group of proteins targeted by a particular ligand, leading to innovation in pharmaceutical research.", {"entities": []}], ["The discovery of novel bioactive molecules advances our systems-level understanding of biological processes and is crucial for innovation in drug development.", {"entities": []}], ["For this purpose, the emerging field of chemical genomics is currently focused on accumulating large assay data sets describing compound\u2013protein interactions (CPIs).", {"entities": []}], ["Although new target proteins for known drugs have recently been identified through mining of CPI databases, using these resources to identify novel ligands remains unexplored.", {"entities": []}], ["Herein, we demonstrate that machine learning of multiple CPIs can not only assess drug polypharmacology but can also efficiently identify novel bioactive scaffold-hopping compounds.", {"entities": []}], ["Through a machine-learning technique that uses multiple CPIs, we have successfully identified novel lead compounds for two pharmaceutically important protein families, G-protein-coupled receptors and protein kinases.", {"entities": []}], ["These novel compounds were not identified by existing computational ligand-screening methods in comparative studies.", {"entities": []}], ["The results of this study indicate that data derived from chemical genomics can be highly useful for exploring chemical space, and this systems biology perspective could accelerate drug discovery processes.", {"entities": []}], ["Neutralizing antibodies against nerve growth factor ( NGF ) are analgesic in rodent models, naturally occurring degenerative joint disease ( DJD ) pain in dogs, and chronic pain in humans.", {"entities": [[54, 57, "GENE"]]}], ["To evaluate the efficacy of a fully felinized anti\u2010 NGF antibody ( NV \u201002) for the treatment of DJD pain and mobility impairment in cats.", {"entities": [[52, 55, "GENE"]]}], ["Thirty\u2010four client\u2010owned cats with DJD \u2010associated pain and mobility impairment.", {"entities": []}], ["In a placebo\u2010controlled, pilot, masked clinical study, cats were randomized to a single treatment with NV \u201002 (0.4 mg/kg SC [n = 11] or 0.8 mg/kg SC [n = 12]) or placebo (saline, SC [n = 11]).", {"entities": []}], ["Activity was measured objectively.", {"entities": []}], ["Additionally, owners completed clinical metrology instruments (client\u2010specific outcome measures [ CSOM ] and feline musculoskeletal pain index [ FMPI ]) on days 0 (screening), 14 (baseline), 35, 56, and 77.", {"entities": []}], ["A repeated\u2010measures model was used to evaluate the objective activity data.", {"entities": []}], ["NV \u201002 significantly increased objectively measured activity overall ( P = .017) and at 2 ( P = .035), 3 ( P = .007), 4 ( P = .006), 5 ( P = .007), and 6 ( P = .017) weeks after treatment.", {"entities": []}], ["CSOM scores ( P = .035) and pain ( P = .024) showed a significant effect of treatment 3 weeks after administration.", {"entities": []}], ["In the treatment group, 83% of the owners correctly identified the treatment administered compared with 45% of owners in the placebo group ( P = .013).", {"entities": []}], ["No treatment\u2010related adverse effects were identified.", {"entities": []}], ["These pilot data demonstrate a 6\u2010week duration positive analgesic effect of this fully felinized anti\u2010 NGF antibody in cats suffering from DJD \u2010associated pain.", {"entities": [[103, 106, "GENE"]]}], ["Gene regulatory networks (GRNs) provide insight into the mechanisms of differential gene expression at a system level.", {"entities": []}], ["However, the methods for inference, functional analysis and visualization of gene regulatory modules and GRNs require the user to collect heterogeneous data from many sources using numerous bioinformatics tools.", {"entities": []}], ["This makes the analysis expensive and time-consuming.", {"entities": []}], ["In this work, the BiologicalNetworks application\u2013the data integration and network based research environment\u2013was extended with tools for inference and analysis of gene regulatory modules and networks.", {"entities": []}], ["The backend database of the application integrates public data on gene expression, pathways, transcription factor binding sites, gene and protein sequences, and functional annotations.", {"entities": []}], ["Thus, all data essential for the gene regulation analysis can be mined publicly.", {"entities": []}], ["In addition, the user\u2019s data can either be integrated in the database and become public, or kept private within the application.", {"entities": []}], ["The capabilities to analyze multiple gene expression experiments are also provided.", {"entities": []}], ["The generated modular networks, regulatory modules and binding sites can be visualized and further analyzed within this same application.", {"entities": []}], ["The developed tools were applied to the mouse model of asthma and the OCT4 regulatory network in embryonic stem cells.", {"entities": [[55, 61, "DISEASE"]]}], ["Developed methods and data are available through the Java application from BiologicalNetworks program at http://www.biologicalnetworks.org .", {"entities": []}], ["Please cite this paper as: Castilla et\u00a0al.", {"entities": []}], ["(2013) Risk factors and effectiveness of preventive measures against influenza in the community.", {"entities": [[69, 78, "DISEASE"]]}], ["Influenza and Other Respiratory Viruses 7(2) 177\u2013183.", {"entities": [[0, 9, "DISEASE"]]}], ["Background\u00a0 The role of different risk exposures and preventive measures against influenza has not been well established.", {"entities": [[81, 90, "DISEASE"]]}], ["Objective\u00a0 The aim of this study was to evaluate risk factors and measures to prevent influenza infection in the community.", {"entities": [[86, 95, "DISEASE"]]}], ["Methods\u00a0 We conducted a multicenter case\u2013control study.", {"entities": []}], ["Cases were 481 outpatients aged 18\u2003years or older with laboratory\u2010confirmed influenza A(H1N1)09 in the 2009\u20132010 season in Spain.", {"entities": [[76, 85, "DISEASE"]]}], ["A control was selected for each case from outpatients from the same area matched by age and date of consultation.", {"entities": []}], ["Information on risk situations, preventive measures and other variables was obtained by interview and review of the medical record.", {"entities": []}], ["Results\u00a0 In the multivariate conditional logistic regression analysis, the risk of a diagnosis of influenza increased with the number of cohabitants (compared with <3 cohabitants, three cohabitants had an OR\u2003=\u20031\u00b780, 95% CI 1\u00b712\u20132\u00b789, and \u22655 cohabitants had an OR\u2003=\u20032\u00b766, 95% CI 1\u00b731\u20135\u00b741) and for health care workers (OR\u2003=\u20032\u00b794, 95% CI 1\u00b753\u20135\u00b766).", {"entities": [[98, 107, "DISEASE"]]}], ["The use of metropolitan public transport was associated with a lower frequency of a diagnosis of influenza (OR\u2003=\u20030\u00b745, 95% CI 0\u00b730\u20130\u00b768) but not the use of taxis or long\u2010distance transport.", {"entities": [[97, 106, "DISEASE"]]}], ["The influenza A(H1N1)09 vaccine had a protective effect (OR\u2003=\u20030\u00b713, 95% CI 0\u00b704\u20130\u00b748), unlike hand washing after touching contaminated surfaces or the use of alcohol\u2010based hand sanitizers.", {"entities": [[4, 13, "DISEASE"]]}], ["Conclusion\u00a0 The home environment appears to play an important role in the spread of influenza in adults, but not the use of public transport.", {"entities": [[84, 93, "DISEASE"]]}], ["Health care workers have a higher risk of contracting influenza.", {"entities": [[54, 63, "DISEASE"]]}], ["Vaccination was the most effective preventive measure.", {"entities": []}], ["Sternocostoclavicular hyperostosis (SCCH) is a rare, debilitating, chronic inflammatory disorder of the anterior chest wall due to a chronic sterile osteomyelitis of unknown origin.", {"entities": [[149, 162, "DISEASE"], [22, 34, "DISEASE"]]}], ["SCCH is largely underdiagnosed and often misdiagnosed.", {"entities": []}], ["In individual cases it can remain unrecognized for years.", {"entities": []}], ["The purpose of this study is twofold.", {"entities": []}], ["Firstly, to evaluate the psychological condition of SCCH patients, both in the sometimes quite extended pre-diagnostic period between first manifestations and confirmed diagnosis of the disease, and in the current situation.", {"entities": []}], ["Secondly, to investigate the relationships between the pre-diagnostic and the current psychological conditions of confirmed SCCH patients.", {"entities": []}], ["Structured interviews were held with 52 confirmed SCCH patients.", {"entities": []}], ["Questionnaires were included to assess posttraumatic stress symptoms, social support, aspects of pain, illness perceptions, self-reported health status, and quality of life.", {"entities": []}], ["SCCH patients reported stronger posttraumatic stress symptoms, more unfavorable illness perceptions, lower health status, and poorer quality of life than healthy individuals and patients with other diseases or traumatic experiences.", {"entities": []}], ["Psychological distress in the pre-diagnostic period was associated with unfavorable conditions in the current situation.", {"entities": []}], ["SCCH is an illness with serious psychological consequences.", {"entities": []}], ["Psychological monitoring of patients with unexplained complaints is recommended as long as a diagnosis has not been reached.", {"entities": []}], ["Outreach facilitation has been proven successful in improving the adoption of clinical preventive care guidelines in primary care practice.", {"entities": []}], ["The net costs and savings of delivering such an intensive intervention need to be understood.", {"entities": []}], ["We wanted to estimate the proportion of a facilitation intervention cost that is offset and the potential for savings by reducing inappropriate screening tests and increasing appropriate screening tests in 22 intervention primary care practices affecting a population of 90,283 patients.", {"entities": []}], ["A cost-consequences analysis of one successful outreach facilitation intervention was done, taking into account the estimated cost savings to the health system of reducing five inappropriate tests and increasing seven appropriate tests.", {"entities": []}], ["Multiple data sources were used to calculate costs and cost savings to the government.", {"entities": []}], ["The cost of the intervention and costs of performing appropriate testing were calculated.", {"entities": []}], ["Costs averted were calculated by multiplying the number of tests not performed as a result of the intervention.", {"entities": []}], ["Further downstream cost savings were determined by calculating the direct costs associated with the number of false positive test follow-ups avoided.", {"entities": []}], ["Treatment costs averted as a result of increasing appropriate testing were similarly calculated.", {"entities": []}], ["The total cost of the intervention over 12 months was $238,388 and the cost of increasing the delivery of appropriate care was $192,912 for a total cost of $431,300.", {"entities": []}], ["The savings from reduction in inappropriate testing were $148,568 and from avoiding treatment costs as a result of appropriate testing were $455,464 for a total savings of $604,032.", {"entities": []}], ["On a yearly basis the net cost saving to the government is $191,733 per year (2003 $Can) equating to $3,687 per physician or $63,911 per facilitator, an estimated return on intervention investment and delivery of appropriate preventive care of 40%.", {"entities": []}], ["Outreach facilitation is more expensive but more effective than other attempts to modify primary care practice and all of its costs can be offset through the reduction of inappropriate testing and increasing appropriate testing.", {"entities": []}], ["Our calculations are based on conservative assumptions.", {"entities": []}], ["The potential for savings is likely considerably higher.", {"entities": []}], ["The aim of this study was to identify plant species among the diverse flora of the caatinga ecosystem that are used therapeutically.", {"entities": []}], ["Research was undertaken in the municipalities of Piranhas and Delmiro Gouveia, in the Xing\u00f3 region (state of Alagoas, NE Brazil).", {"entities": []}], ["In order to identify the medicinal plants used in this region, semi-structured questionnaires were applied.", {"entities": []}], ["The species cited were collected and sent to the Xing\u00f3 Herbarium for taxonomic analysis.", {"entities": []}], ["The relative importance (RI) of each species cited was calculated to verify their cultural importance.", {"entities": []}], ["The therapeutic indications attributed to the species were classified under 16 body systems.", {"entities": []}], ["A total of 187 medicinal species were cited, from 64 families and 128 genera.", {"entities": []}], ["The main indications for medicinal plant use were against common colds, bronchitis, cardiovascular problems, kidney problems, inflammations in general, and as tranquilizers.", {"entities": [[72, 82, "DISEASE"]]}], ["Approximately 16% (30 plant species) were versatile in relation to their use, with an Relative Importance value over 1, having been indicated for up to nine body systems.", {"entities": []}], ["The body systems that stood out the most were: the respiratory system, the gastrointestinal system, and infectious diseases.", {"entities": []}], ["Most cited plant parts used for medicinal purposes were flowers, leaves, and inner stem bark.", {"entities": []}], ["In addition to the deleterious effect on health, there is considerable economic and psychosocial morbidity associated with primary immunodeficiency diseases (PID).", {"entities": []}], ["Also, the cost of a late diagnosis frequently results in a heavy disease burden on the patient.", {"entities": []}], ["The objective of this study was to collect and analyze data on patients with PID in the state of Guanajuato in Mexico, to indirectly estimate the burden of the disease.", {"entities": []}], ["An observational, longitudinal, and comparative study was conducted.", {"entities": []}], ["A total of 44 patients were included and grouped according to the updated classification of PID.", {"entities": []}], ["The median time elapsed from the onset of symptoms to the reference and diagnosis by a tertiary hospital was of 2.17 (IQR = 6.44) years.", {"entities": []}], ["Before diagnosis, the number of hospitalizations/year per patient was 0.86 (IQR = 2.28), the number of visit to emergency room/year per patient was 0.92 (IQR = 1.77), the number of doctor\u2019s visits/year per patient was 15 (IQR = 11.25), whereas the school/work absence days per patient were reported in 52.72 (IQR = 56.35) days per year.", {"entities": []}], ["After diagnosis, 20 patients (45.45%) received IVIG replacement therapy, and all of them presented a significant improvement (p <0.05) in all the mentioned variables.", {"entities": []}], ["Characteristically, even when patients with PID received IVIG, there was still an important disease burden when comparing them against healthy controls.", {"entities": []}], ["Complications secondary to PID were detected in 19 patients (43.18%).", {"entities": []}], ["The reported overall mortality rate was 6.82% (n = 3).", {"entities": []}], ["We were able to indirectly estimate an important disease burden in patients with PID; which is considered to be preventable, at least in part, with effective interventions like health planning, research, collaboration with primary care providers, and generation of policies and practices, in order to improve the quality of life and care of families with PID.", {"entities": []}], ["Chemotaxis and cell migration are fundamental, universal eukaryotic processes essential for biological functions such as embryogenesis, immunity, cell renewal, and wound healing, as well as for pathogenesis of many diseases including cancer metastasis and chronic inflammation.", {"entities": [[234, 240, "DISEASE"]]}], ["To identify novel chemotaxis inhibitors as probes for mechanistic studies and leads for development of new therapeutics, we developed a unique, unbiased phenotypic chemotaxis-dependent Dictyostelium aggregation assay for high-throughput screening using rapid, laser-scanning cytometry.", {"entities": []}], ["Under defined conditions, individual Dictyostelium secrete chemoattractants, migrate, and aggregate.", {"entities": []}], ["Chemotaxis is quantified by laser-scanning cytometry with a GFP marker expressed only in cells after chemotaxis/multi-cell aggregation.", {"entities": []}], ["We applied the assay to screen 1,280 known compounds in a 1536-well plate format and identified two chemotaxis inhibitors.", {"entities": []}], ["The chemotaxis inhibitory activities of both compounds were confirmed in both Dictyostelium and in human neutrophils in a directed EZ-TAXIscan chemotaxis assay.", {"entities": []}], ["The compounds were also shown to inhibit migration of two human cancer cell lines in monolayer scratch assays.", {"entities": [[64, 70, "DISEASE"]]}], ["This test screen demonstrated that the miniaturized assay is extremely suited for high-throughput screening of very large libraries of small molecules to identify novel classes of chemotaxis/migratory inhibitors for drug development and research tools for targeting chemotactic pathways universal to humans and other systems.", {"entities": []}], ["Seasonal influenza viruses are typically restricted to the human upper respiratory tract whereas influenza viruses with greater pathogenic potential often also target extra-pulmonary organs.", {"entities": [[9, 18, "DISEASE"], [97, 106, "DISEASE"]]}], ["Infants, pregnant women, and breastfeeding mothers are highly susceptible to severe respiratory disease following influenza virus infection but the mechanisms of disease severity in the mother-infant dyad are poorly understood.", {"entities": [[114, 123, "DISEASE"]]}], ["Here we investigated 2009 H1N1 influenza virus infection and transmission in breastfeeding mothers and infants utilizing our developed infant-mother ferret influenza model.", {"entities": [[31, 40, "DISEASE"], [156, 165, "DISEASE"]]}], ["Infants acquired severe disease and mortality following infection.", {"entities": []}], ["Transmission of the virus from infants to mother ferrets led to infection in the lungs and mother mortality.", {"entities": []}], ["Live virus was also found in mammary gland tissue and expressed milk of the mothers which eventually led to milk cessation.", {"entities": []}], ["Histopathology showed destruction of acini glandular architecture with the absence of milk.", {"entities": []}], ["The virus was localized in mammary epithelial cells of positive glands.", {"entities": []}], ["To understand the molecular mechanisms of mammary gland infection, we performed global transcript analysis which showed downregulation of milk production genes such as Prolactin and increased breast involution pathways indicated by a STAT5 to STAT3 signaling shift.", {"entities": [[243, 248, "GENE"]]}], ["Genes associated with cancer development were also significantly increased including JUN, FOS and M2 macrophage markers.", {"entities": [[22, 28, "DISEASE"], [85, 88, "GENE"], [90, 93, "GENE"]]}], ["Immune responses within the mammary gland were characterized by decreased lymphocyte-associated genes CD3e, IL2Ra, CD4 with IL1\u03b2 upregulation.", {"entities": [[102, 106, "GENE"], [108, 113, "GENE"], [115, 118, "GENE"]]}], ["Direct inoculation of H1N1 into the mammary gland led to infant respiratory infection and infant mortality suggesting the influenza virus was able to replicate in mammary tissue and transmission is possible through breastfeeding.", {"entities": [[122, 131, "DISEASE"]]}], ["In vitro infection studies with human breast cells showed susceptibility to H1N1 virus infection.", {"entities": []}], ["Together, we have shown that the host-pathogen interactions of influenza virus infection in the mother-infant dyad initiate immunological and oncogenic signaling cascades within the mammary gland.", {"entities": [[63, 72, "DISEASE"]]}], ["These findings suggest the mammary gland may have a greater role in infection and immunity than previously thought.", {"entities": []}], ["Influenza is known as a respiratory infectious disease.", {"entities": [[0, 9, "DISEASE"]]}], ["Breastfeeding allows for frequent microbial exchange between infant and mother.", {"entities": []}], ["Although infants, pregnant women and breastfeeding mothers are more susceptible to severe respiratory disease following influenza virus infection, the mechanisms of disease severity in infants and mothers is poorly understood.", {"entities": [[120, 129, "DISEASE"]]}], ["We were interested in understanding the immune responses, pathogenicity, and transmission dynamics in the infant-mother system.", {"entities": []}], ["With this aim we developed an infant-mother ferret influenza model.", {"entities": [[51, 60, "DISEASE"]]}], ["Influenza infection in infants led to virus transmission to mothers causing severe disease and mortality.", {"entities": [[0, 9, "DISEASE"]]}], ["Unexpectedly, influenza-infected infant ferrets transmitted the virus to mother mammary glands leading to live influenza virus in expressed breast milk.", {"entities": [[14, 23, "DISEASE"], [111, 120, "DISEASE"]]}], ["Gene regulation analysis in the mammary gland showed reduction of milk production genes such as Prolactin and increased genes involved with breast shutdown.", {"entities": []}], ["Genes associated with cancer development were significantly increased including JUN , FOS and BRCA2 .", {"entities": [[22, 28, "DISEASE"], [80, 83, "GENE"], [86, 89, "GENE"], [94, 99, "GENE"]]}], ["We found human breast cells were able to be infected with the influenza virus suggesting the importance of our results to human health.", {"entities": [[62, 71, "DISEASE"]]}], ["Our data suggests influenza transmission can occur through the mammary glands initiating immunological and pathological events contributing to influenza disease severity impacting infant and maternal health.", {"entities": [[18, 27, "DISEASE"], [143, 152, "DISEASE"]]}], ["It has recently been hypothesised that acute dehydration in early childhood may \u201cprogramme\u201d increased blood pressure via salt retention.", {"entities": []}], ["We examined whether there was an association between episodes of diarrhoea (a proxy for acute dehydration) and later measured blood pressure.", {"entities": []}], ["In the 1982 Pelotas birth cohort study (Brazil), parents/carers reported hospital admissions for diarrhoea in the first 12 and 20 months of study members\u2019 lives.", {"entities": []}], ["Blood pressure was subsequently measured directly in adolescence (aged 15, 18, 19 years) and early adulthood (aged 23 years).", {"entities": []}], ["We found no evidence of an association between diarrhoea in the first 12 months of life and blood pressure measured at any point in adolescence or early adulthood.", {"entities": []}], ["These findings were unchanged after adjustment for a range of covariates.", {"entities": []}], ["Equally null results were apparent when diarrhoea admissions in the first 20 months of life, access to home sanitation and use of piped water were the exposures of interest.", {"entities": []}], ["Early life proxies for dehydration and diarrhoea were unrelated to later blood pressure in this examination, the most comprehensive to date, of the potential association.", {"entities": []}], ["Researchers investigating lung diseases, such as asthma, have questioned whether certain compounds previously reported in exhaled breath condensate (EBC) originate from saliva contamination.", {"entities": [[49, 55, "DISEASE"]]}], ["Moreover, despite its increasing use in \u2018omics profiling studies, the constituents of EBC remain largely uncharacterized.", {"entities": []}], ["The present study aims to define the usefulness of EBC in investigating lung disease by comparing EBC, saliva, and saliva-contaminated EBC using targeted and untargeted mass spectrometry and the potential of metabolite loss from adsorption to EBC sample collection tubes.", {"entities": [[72, 84, "DISEASE"]]}], ["Liquid chromatography mass spectrometry (LC-MS) was used to analyze samples from 133 individuals from three different cohorts.", {"entities": []}], ["Levels of amino acids and eicosanoids, two classes of molecules previously reported in EBC and saliva, were measured using targeted LC-MS. Cohort 1 was used to examine contamination of EBC by saliva.", {"entities": []}], ["Samples from Cohort 1 consisted of clean EBC, saliva-contaminated EBC, and clean saliva from 13 healthy volunteers; samples were analyzed using untargeted LC-MS. Cohort 2 was used to compare eicosanoid levels from matched EBC and saliva collected from 107 asthmatic subjects.", {"entities": []}], ["Samples were analyzed using both targeted and untargeted LC-MS. Cohort 3 samples consisted of clean-EBC collected from 13 subjects, including smokers and non-smokers, and were used to independently confirm findings; samples were analyzed using targeted LC-MS, untargeted LC-MS, and proteomics.", {"entities": []}], ["In addition to human samples, an in-house developed nebulizing system was used to determine the potential for EBC samples to be contaminated by saliva.", {"entities": []}], ["Out of the 400 metabolites detected in both EBC and saliva, 77 were specific to EBC; however, EBC samples were concentrated 20-fold to achieve this level of sensitivity.", {"entities": []}], ["Amino acid concentrations ranged from 196\u00a0pg/mL \u2013 4\u00a0\u03bcg/mL (clean EBC), 1.98\u00a0ng/mL \u2013 6\u00a0\u03bcg/mL (saliva-contaminated EBC), and 13.84\u00a0ng/mL \u2013 1256\u00a0mg/mL (saliva).", {"entities": []}], ["Eicosanoid concentration ranges were an order of magnitude lower; 10\u00a0pg/mL \u2013 76.5\u00a0ng/mL (clean EBC), 10\u00a0pg/mL \u2013 898\u00a0ng/mL (saliva-contaminated EBC), and 2.54\u00a0ng/mL \u2013 272.9\u00a0mg/mL (saliva).", {"entities": []}], ["Although the sample size of the replication cohort (Cohort 3) did not allow for statistical comparisons, two proteins and 19 eicosanoids were detected in smoker vs. non-smoker clean-EBC.", {"entities": []}], ["We conclude that metabolites are present and detectable in EBC using LC-MS; however, a large starting volume of sample is required.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-017-0538-5) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Tracheobronchial mucoepidermoid carcinoma (MEC) is a rare airway tumor in adults for which surgery is considered a first-line treatment.", {"entities": [[32, 41, "DISEASE"], [17, 41, "DISEASE"]]}], ["However, some patients already lost the best opportunity of a surgical intervention when diagnoses are confirmed, and surgery causes considerable trauma resulting in partial loss of pulmonary function.", {"entities": []}], ["Moreover, the tumor is resistant to radiotherapy and chemotherapy.", {"entities": []}], ["These factors make the treatment of tracheobronchial MEC challenging.", {"entities": []}], ["This study aimed to evaluate the safety and efficacy of interventional bronchoscopic therapy in adult patients with tracheobronchial MEC.", {"entities": []}], ["We retrospectively analyzed the clinical manifestations, bronchoscopic interventions, complications, and outcomes of 11 adult patients with tracheobronchial MEC.", {"entities": []}], ["Paired t -test was used to analyze the parameters of the American Thoracic Society Dyspnea Index and the Karnofsky Score before and after the first interventional bronchoscopic therapy.", {"entities": []}], ["All tumors occurred in the main bronchus and were easily visualized by bronchoscopy.", {"entities": []}], ["After interventional bronchoscopic therapy, the symptoms of all patients showed significant improvement.", {"entities": []}], ["The American Thoracic Society Dyspnea Index decreased from 1.91 \u00b1 1.22 to 0.27 \u00b1 0.47 ( t = 6.708, P < 0.001) and the Karnofsky Score increased from 78.18 \u00b1 16.62 to 95.46 \u00b1 8.20 ( t = \u22125.190, P < 0.001).", {"entities": []}], ["Bronchoscopic intervention did not result in serious complications or mortality.", {"entities": []}], ["During the follow-up period between 3 and 96 months after the first therapy, the following results were noted: (1) among the eight patients with low-grade tracheobronchial MEC, only one patient had a relapse and agreed to surgical treatment; (2) among the three patients with high-grade tracheobronchial MEC, one patient required repeated bronchoscopic interventions, one patient died of pulmonary infection, and one patient died of systemic failure owing to tumor metastasis.", {"entities": []}], ["Interventional bronchoscopic therapy, as an alternative treatment, shows promise in some adult patients with low-grade tracheobronchial MEC confined to the bronchus.", {"entities": []}], ["However, for adult patients with high-grade tracheobronchial MEC, early diagnosis and surgical treatment are still strongly recommended.", {"entities": []}], ["Obesity, in particular abdominal obesity, alters the composition of plasma and tissue fatty acids (FAs), which contributes to inflammation and insulin resistance.", {"entities": [[0, 7, "DISEASE"], [33, 40, "DISEASE"], [99, 102, "GENE"]]}], ["FA metabolism is modulated by desaturases and may affect adipokine and insulin secretion.", {"entities": []}], ["Therefore, we examined relationships between adipokines, a marker of insulin production, and plasma FA desaturase enzyme activity estimates (EAEs) in obesity.", {"entities": [[150, 157, "DISEASE"]]}], ["Plasma phospholipid (PPL) FAs were isolated from 126 males (ages 48 to 65 years), derivatized, and analyzed using gas chromatography.", {"entities": [[21, 24, "GENE"], [26, 29, "GENE"]]}], ["Delta-6 desaturase (D6D) and delta-5 desaturase (D5D) EAEs were calculated as the ratio of PPL 20:3/18:2 and 20:4/20:3, respectively.", {"entities": [[91, 94, "GENE"]]}], ["In body mass index (BMI) and waist circumference (WC) adjusted polytomous logistic regression analyses, PPL FAs and FA desaturase EAEs were associated with C-peptide and adiponectin.", {"entities": [[104, 107, "GENE"], [108, 111, "GENE"]]}], ["Individuals with elevated D6D EAEs were less likely (OR 0.33) to have serum adiponectin concentrations > 5.37 \u03bcg/mL, compared with adiponectin concentrations \u2264 3.62 \u03bcg/mL.", {"entities": []}], ["Individuals with increased D5D EAEs were less likely (OR 0.8) to have C-peptide concentrations \u2265 3.32 ng/mL, and > 1.80 and \u2264 3.29 ng/mL, compared with those with C-peptide \u2264 1.76 ng/mL.", {"entities": []}], ["The proinflammatory cytokine tumor necrosis factor-\u03b1 (TNF- \u03b1) was positively associated with C-peptide, but TNF- \u03b1 was not associated with the D5D EAE.", {"entities": []}], ["C-peptide and adiponectin concentrations are associated with specific PPL FAs and FA desaturase EAEs.", {"entities": [[70, 73, "GENE"], [74, 77, "GENE"]]}], ["The relationship between C-peptide concentrations and D5D EAEs remained significant after adjusting for BMI, WC, and TNF-\u03b1.", {"entities": []}], ["Thus, future research should investigate whether D5D inhibition may occur through a C-peptide mediated pathway.", {"entities": []}], ["Toll-Like Receptors (TLR) are critical elements of the innate arm of the vertebrate immune system.", {"entities": []}], ["They constitute a multigenic family of receptors which collectively bind a diverse array of \u2013 exogeneous as well as endogeneous \u2013 ligands.", {"entities": []}], ["An exponential burst of knowledge has defined their biological role in fight against infections and generation/modulation of auto-immune disorders.", {"entities": []}], ["Hence, they could at least be conceptually recognized \u2013 despite being structurally unrelated \u2013 as innate counterparts to Major Histocompatibility Complex (MHC) molecules \u2013 equally recognizing antigenic ligands (albeit structurally more homogeneous i.e., peptides), again derived from self and/or non-self sources \u2013 preeminent this time in adaptive immunity.", {"entities": []}], ["Our great disparities in face of infections and/or susceptibility to auto-immune diseases have provoked an intense search for genetic explanations, in part satisfied by the extraordinary MHC allelic repertoire.", {"entities": []}], ["An equally in-depth and systematic analysis of TLR diversity is lacking despite numerous independent reports of a growing number of SNPs within these loci.", {"entities": []}], ["The work described here aims at providing a preliminary picture of the allelic repertoire \u2013 and not purely SNPs \u2013 of all 10 human TLR coding sequences (with exception of TLR3) within a single cohort of up to 100 individuals.", {"entities": [[170, 174, "GENE"]]}], ["It appears from our work that TLR are unequally polymorphic: TLR2 (DNA alleles: 7/protein alleles: 3), 4 (4/3), 7 (6/3), 8 (9/2) and 9 (8/3) being comparatively least diverse whereas TLR1 (11/10), 5 (14/12), 6 (10/8) and 10 (15/10) show a substantial number of alleles.", {"entities": [[61, 65, "GENE"], [183, 187, "GENE"]]}], ["In addition to allelic assignment of a large number of SNPs, 10 new polymorphic positions were hereby identified.", {"entities": []}], ["Hence this work depicts a first overview of the diversity of almost all human TLR genes, a prelude for large-scale population genetics as well as genetic association studies.", {"entities": []}], ["A comparative analysis of SNPs and their exonic and intronic environments identifies the features predictive of splice affecting variants.", {"entities": []}], ["Single point mutations at both synonymous and non-synonymous positions within exons can have severe effects on gene function through disruption of splicing.", {"entities": []}], ["Predicting these mutations in silico purely from the genomic sequence is difficult due to an incomplete understanding of the multiple factors that may be responsible.", {"entities": []}], ["In addition, little is known about which computational prediction approaches, such as those involving exonic splicing enhancers and exonic splicing silencers, are most informative.", {"entities": []}], ["We assessed the features of single-nucleotide genomic variants verified to cause exon skipping and compared them to a large set of coding SNPs common in the human population, which are likely to have no effect on splicing.", {"entities": []}], ["Our findings implicate a number of features important for their ability to discriminate splice-affecting variants, including the naturally occurring density of exonic splicing enhancers and exonic splicing silencers of the exon and intronic environment, extensive changes in the number of predicted exonic splicing enhancers and exonic splicing silencers, proximity to the splice junctions and evolutionary constraint of the region surrounding the variant.", {"entities": []}], ["By extending this approach to additional datasets, we also identified relevant features of variants that cause increased exon inclusion and ectopic splice site activation.", {"entities": []}], ["We identified a number of features that have statistically significant representation among exonic variants that modulate splicing.", {"entities": []}], ["These analyses highlight putative mechanisms responsible for splicing outcome and emphasize the role of features important for exon definition.", {"entities": []}], ["We developed a web-tool, Skippy, to score coding variants for these relevant splice-modulating features.", {"entities": []}], ["A number of studies have been conducted to estimate willingness to pay (WTP) per quality-adjusted life years (QALY) in patients or general population for various diseases.", {"entities": []}], ["However, there has not been any systematic review summarizing the relationship between WTP per QALY and cost-effectiveness (CE) threshold based on World Health Organization (WHO) recommendation.", {"entities": []}], ["To systematically review willingness-to-pay per quality-adjusted-life-year (WTP per QALY) literature, to compare WTP per QALY with Cost-effectiveness (CE) threshold recommended by WHO, and to determine potential influencing factors.", {"entities": []}], ["We searched MEDLINE, EMBASE, Psyinfo, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Center of Research Dissemination (CRD), and EconLit from inception through 15 July 2014.", {"entities": []}], ["To be included, studies have to estimate WTP per QALY in health-related issues using stated preference method.", {"entities": []}], ["Two investigators independently reviewed each abstract, completed full-text reviews, and extracted information for included studies.", {"entities": []}], ["We compared WTP per QALY to GDP per capita, analyzed, and summarized potential influencing factors.", {"entities": []}], ["Out of 3,914 articles founded, 14 studies were included.", {"entities": []}], ["Most studies (92.85%) used contingent valuation method, while only one study used discrete choice experiments.", {"entities": []}], ["Sample size varied from 104 to 21,896 persons.", {"entities": []}], ["The ratio between WTP per QALY and GDP per capita varied widely from 0.05 to 5.40, depending on scenario outcomes (e.g., whether it extended/saved life or improved quality of life), severity of hypothetical scenarios, duration of scenario, and source of funding.", {"entities": []}], ["The average ratio of WTP per QALY and GDP per capita for extending life or saving life (2.03) was significantly higher than the average for improving quality of life (0.59) with the mean difference of 1.43 (95% CI, 1.81 to 1.06).", {"entities": []}], ["This systematic review provides an overview summary of all studies estimating WTP per QALY studies.", {"entities": []}], ["The variation of ratio of WTP per QALY and GDP per capita depended on several factors may prompt discussions on the CE threshold policy.", {"entities": []}], ["Our research work provides a foundation for defining future direction of decision criteria for an evidence-informed decision making system.", {"entities": []}], ["The bioflavonoid apigenin has been shown to possess cancer-preventive and anti-cancer activities.", {"entities": [[52, 58, "DISEASE"], [79, 85, "DISEASE"]]}], ["In a drug screening, we found that apigenin can inhibit Wnt/\u03b2-catenin signaling, a pathway that participates in pivotal biological functions, which dis-regulation results in various human diseases including cancers.", {"entities": []}], ["However, the underlying mechanism of apigenin in this pathway and its link to anti-cancer activities remain largely unknown.", {"entities": [[83, 89, "DISEASE"]]}], ["Here we showed that apigenin reduced the amount of total, cytoplasmic, and nuclear \u03b2-catenin, leading to the suppression in the \u03b2-catenin/TCF-mediated transcriptional activity, the expression of Wnt target genes, and cell proliferation of Wnt-stimulated P19 cells and Wnt-driven colorectal cancer cells.", {"entities": [[279, 296, "DISEASE"], [290, 296, "DISEASE"]]}], ["Western blotting and immunofluorescent staining analyses further revealed that apigenin could induce autophagy-mediated down-regulation of \u03b2-catenin in treated cells.", {"entities": []}], ["Treatment with autophagy inhibitors wortmannin and chloroquine compromised this effect, substantiating the involvement of autophagy-lysosomal system on the degradation of \u03b2-catenin during Wnt signaling through inhibition of the AKT/mTOR signaling pathway.", {"entities": []}], ["Our data not only pointed out a route for the inhibition of canonical Wnt signaling through the induction of autophagy-lysosomal degradation of key player \u03b2-catenin, but also suggested that apigenin or other treatments which can initiate this degradation event are potentially used for the therapy of Wnt-related diseases including cancers.", {"entities": []}], ["The rates of influenza illness and associated complications are high among children in Bangladesh.", {"entities": [[13, 22, "DISEASE"]]}], ["We assessed the clinical efficacy and safety of a Russian-backbone live attenuated influenza vaccine (LAIV) at two field sites in Bangladesh.", {"entities": [[83, 92, "DISEASE"]]}], ["Between Feb 27 and April 9, 2013, children aged 2\u20134 years in urban Kamalapur and rural Matlab, Bangladesh, were randomly assigned in a 2:1 ratio, according to a computer-generated schedule, to receive one intranasal dose of LAIV or placebo.", {"entities": []}], ["After vaccination, we monitored children in weekly home visits until Dec 31, 2013, with study clinic surveillance for influenza illness.", {"entities": [[118, 127, "DISEASE"]]}], ["The primary outcome was symptomatic, laboratory-confirmed influenza illness due to vaccine-matched strains.", {"entities": [[58, 67, "DISEASE"]]}], ["Analysis was per protocol.", {"entities": []}], ["The trial is registered with ClinicalTrials.gov , number NCT01797029 .", {"entities": []}], ["Of 1761 children enrolled, 1174 received LAIV and 587 received placebo.", {"entities": []}], ["Laboratory-confirmed influenza illness due to vaccine-matched strains was seen in 93 (15\u00b78%) children in the placebo group and 79 (6\u00b77%) in the LAIV group.", {"entities": [[21, 30, "DISEASE"]]}], ["Vaccine efficacy of LAIV for vaccine-matched strains was 57\u00b75% (95% CI 43\u00b76\u201368\u00b70).", {"entities": []}], ["The vaccine was well tolerated, and adverse events were balanced between the groups.", {"entities": []}], ["The most frequent adverse events were tachypnoea (n=86 in the LAIV group and n=54 in the placebo group), cough (n=73 and n=43), and runny nose (n=68 and n=39), most of which were mild.", {"entities": []}], ["This single-dose Russian-backbone LAIV was safe and efficacious at preventing symptomatic laboratory-confirmed influenza illness due to vaccine-matched strains.", {"entities": [[111, 120, "DISEASE"]]}], ["LAIV programmes might reduce the burden of influenza illness in Bangladesh.", {"entities": [[43, 52, "DISEASE"]]}], ["The Bill & Melinda Gates Foundation.", {"entities": []}], ["To measure levels of indoor pollution in relation to smoking in four English prisons.", {"entities": []}], ["TSI SidePak AM510 Personal Aerosol Monitors were used to measure concentrations of particulate matter less than 2.5 \u03bcm in diameter (PM 2.5 ) for periods of up to 9\u00a0h in selected smoking and non-smoking areas, and personal exposure monitoring of prison staff during a work shift, in four prisons.", {"entities": []}], ["PM 2.5 data were collected for average periods of 6.5\u00a0h from 48 locations on 25 wing landings where smoking was permitted in cells, on 5 non-smoking wings, 13 prisoner cells, and personal monitoring of 22 staff members.", {"entities": []}], ["Arithmetic mean PM 2.5 concentrations were significantly higher on smoking than non-smoking wing landings (43.9\u00a0\u03bcg/m p \u2009<\u20090.001) and in smoking than non-smoking cells (226.2\u00a0\u03bcg/m p \u2009<\u20090.001).", {"entities": []}], ["Staff members wore monitors for an average of 4.18\u00a0h, during which they were exposed to arithmetic mean PM 2.5 concentration of 23.5\u00a0\u03bcg/m The concentration of PM 2.5 pollution in smoking areas of prisons are extremely high.", {"entities": []}], ["Smoking in prisons therefore represents a significant health hazard to prisoners and staff\u00a0members.", {"entities": []}], ["Exposure to oxidant air pollution is associated with increased respiratory morbidities and susceptibility to infections.", {"entities": []}], ["Ozone is a commonly encountered oxidant air pollutant, yet its effects on influenza infections in humans are not known.", {"entities": [[74, 83, "DISEASE"]]}], ["The greater Mexico City area was the primary site for the spring 2009 influenza A H1N1 pandemic, which also coincided with high levels of environmental ozone.", {"entities": [[70, 79, "DISEASE"]]}], ["Proteolytic cleavage of the viral membrane protein hemagglutinin (HA) is essential for influenza virus infectivity.", {"entities": [[87, 96, "DISEASE"]]}], ["Recent studies suggest that HA cleavage might be cell-associated and facilitated by the type II transmembrane serine proteases (TTSPs) human airway trypsin-like protease (HAT) and transmembrane protease, serine 2 (TMPRSS2), whose activities are regulated by antiproteases, such as secretory leukocyte protease inhibitor (SLPI).", {"entities": [[214, 221, "GENE"], [321, 325, "GENE"]]}], ["Based on these observations, we sought to determine how acute exposure to ozone may modulate cellular protease/antiprotease expression and function, and to define their roles in a viral infection.", {"entities": []}], ["We utilized our in vitro model of differentiated human nasal epithelial cells (NECs) to determine the effects of ozone on influenza cleavage, entry, and replication.", {"entities": [[122, 131, "DISEASE"]]}], ["We show that ozone exposure disrupts the protease/antiprotease balance within the airway liquid.", {"entities": []}], ["We also determined that functional forms of HAT, TMPRSS2, and SLPI are secreted from human airway epithelium, and acute exposure to ozone inversely alters their expression levels.", {"entities": [[49, 56, "GENE"], [62, 66, "GENE"]]}], ["We also show that addition of antioxidants significantly reduces virus replication through the induction of SLPI.", {"entities": [[108, 112, "GENE"]]}], ["In addition, we determined that ozone-induced cleavage of the viral HA protein is not cell-associated and that secreted endogenous proteases are sufficient to activate HA leading to a significant increase in viral replication.", {"entities": []}], ["Our data indicate that pre-exposure to ozone disrupts the protease/antiprotease balance found in the human airway, leading to increased influenza susceptibility.", {"entities": [[136, 145, "DISEASE"]]}], ["Atrial fibrillation or flutter (AFF) are not infrequent presenting problems in Emergency Departments (ED); however, little is known of the pattern of these presentations.", {"entities": []}], ["This study provides a description of AFF presentations and outcomes after ED discharge in Alberta.", {"entities": []}], ["Provincial administrative databases were used to obtain all primary ED encounters for AFF during 1999 to 2011 for patients aged >35\u00a0years.", {"entities": []}], ["Data extracted included demographics, ED visit timing, and subsequent visits to non-ED settings.", {"entities": []}], ["Analysis included summaries and standardized rates.", {"entities": []}], ["During the study period, there were 63,398 ED AFF visits from 32,104 distinct adults.", {"entities": []}], ["Median ages for females and males were 75 and 67\u00a0years, respectively; more men (52%) and patients\u2009>\u200965 presented.", {"entities": []}], ["Overall, the standardized rates remained similar (2.8 per 1,000 over the study period).", {"entities": []}], ["Specific populations of human services recipients and First Nations had higher ED visit rates for AFF than other groups.", {"entities": []}], ["Predictable daily, weekly, and monthly trends were observed.", {"entities": []}], ["The ED visits were followed by numerous subsequent visits in non-ED settings; however, First Nations and women had lower rates of specialist follow-up.", {"entities": []}], ["Annually, over 5,000 ED presentations of patients experiencing AFF occur in Alberta and admissions proportions are declining.", {"entities": []}], ["While presentation rates across the province are stable, follow-up with physicians, consultation with cardiologists and health outcomes vary based on socio-economic, age, sex, and First Nations status.", {"entities": []}], ["Further research is required to understand the causes and consequences of these inequalities and to standardize care.", {"entities": []}], ["The online version of this article (doi:10.1186/s12873-016-0113-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["S-nitrosothiols have been implicated in the etiology of various pulmonary diseases.", {"entities": []}], ["Many of these diseases display gender preferences in presentation or altered severity that occurs with puberty, the mechanism by which is unknown.", {"entities": []}], ["Estrogen has been shown to influence the expression and activity of endothelial nitric oxide synthase (eNOS) which is associated with increased S-nitrosothiol production.", {"entities": []}], ["The effects of gender hormones on the expression and activity of the de-nitrosylating enzyme S-nitrosoglutathione reductase (GSNO-R) are undefined.", {"entities": []}], ["This report evaluates the effects of gender hormones on the activity and expression of GSNO-R and its relationship to N-acetyl cysteine (NAC)-induced pulmonary hypertension (PH).", {"entities": [[160, 172, "DISEASE"], [150, 172, "DISEASE"]]}], ["GSNO-R activity was elevated in lung homogenates from female compared to male mice.", {"entities": []}], ["Increased activity was not due to changes in GSNO-R expression, but correlated with GSNO-R S-nitrosylation: females were greater than males.", {"entities": []}], ["The ability of GSNO-R to be activated by S-nitrosylation was confirmed by: 1) the ability of S-nitrosoglutathione (GSNO) to increase the activity of GSNO-R in murine pulmonary endothelial cells and 2) reduced activity of GSNO-R in lung homogenates from eNOS", {"entities": []}], ["The acute inhalation of endotoxin mimicks several aspects of the inflammation related to chronic obstructive pulmonary disease (COPD).", {"entities": [[89, 126, "DISEASE"]]}], ["The aim of the current study was to identify and to validate biomarkers of endotoxin-induced airways\u2019 inflammation.", {"entities": []}], ["The cellular count in the induced-sputum, was measured before and after an inhalation of 20 mcg endotoxin, in 8 healthy volunteers.", {"entities": []}], ["A proteomic analysis was applied to identify the more relevant proteins expression, before measurement by ELISA.", {"entities": []}], ["The amplitude and the repeatability of the markers were evaluated among another population of 12 healthy subjects.", {"entities": []}], ["There was a significant rise of viable cells (p <0.01), macrophages (p <0.05), and neutrophils (p <0.02) 24\u00a0hours after endotoxin inhalation, and of neutrophils (p <0.02) and lymphocytes (p <0.05) at 6\u00a0hours.", {"entities": []}], ["Among the highest amplitude responses, the two dimensional electrophoretic separation shown proteolytic activity and overexpression of protein spots.", {"entities": []}], ["By MALDI-TOF mass spectrometry, the last were identified as calgranulin A and B.", {"entities": []}], ["The expression of the bioactive A/B heterodimeric complex was confirmed by ELISA both in the sputum (p <0.01) and at the blood level (p <0.01).", {"entities": []}], ["The intra-subject repeatability of the sputum calgranulin A/B was highly significant (p <0.0001).", {"entities": []}], ["In healthy subjects, the inhalation of endotoxin induced expression of sputum calgranulin A/B that could be a biomarker of the endotoxin response/exposure.", {"entities": []}], ["Connexin (Cx)-based gap junction channels play important roles in the inflammatory response.", {"entities": []}], ["Cx43 is involved in the pathogenesis of some lung diseases such as acute lung injury.", {"entities": []}], ["However, the Cx43 expression in asthma is unclear.", {"entities": [[32, 38, "DISEASE"]]}], ["In the present study, we used a murine model of ovalbumin (OVA)-induced allergic airway disease to examine the levels of Cx43 and analyze the relationship between Cx43 and airway inflammation in allergic airway disease.", {"entities": []}], ["Asthma was induced in mice via sensitization and challenge with OVA.", {"entities": [[0, 6, "DISEASE"]]}], ["Cx43 mRNA and protein expression levels were investigated via QT-PCR, western blot, and immunohistochemistry 0 h, 8 h, 1 d, 2 d and 4 d after the first challenge.", {"entities": []}], ["The relationship between Cx43 protein levels and inflammatory cell infiltration, cytokine levels was analyzed.", {"entities": []}], ["The OVA-induced mice exhibited typical pathological features of asthma, including airway hyper-responsiveness; strong inflammatory cell infiltration surrounding the bronchia and vessels; many inflammatory cells in the bronchoalveolar lavage fluid (BALF); higher IL-4, IL-5 and IL-13 levels; and high OVA specific IgE levels.", {"entities": [[64, 70, "DISEASE"]]}], ["Low Cx43 expression was detected in the lungs of control (PBS) mice.", {"entities": []}], ["A dramatic increase in the Cx43 mRNA and protein levels was found in the asthmatic mice.", {"entities": []}], ["Cx43 mRNA and protein expression levels increased in a time-dependent manner in asthma mice, and Cx43 was mostly localized in the alveolar and bronchial epithelial layers.", {"entities": [[80, 86, "DISEASE"]]}], ["Moreover, lung Cx43 protein levels showed a significant positive correlation with inflammatory cell infiltration in the airway and IL-4 and IL-5 levels in the BALF at different time points after challenge.", {"entities": []}], ["Interestingly, the increase in Cx43 mRNA and protein levels occurred prior to the appearance of the inflammatory cell infiltration.", {"entities": []}], ["Our data suggest that there is a strong upregulation of Cx43 mRNA and protein levels in the lungs in asthma.", {"entities": [[101, 107, "DISEASE"]]}], ["Cx43 levels also exhibited a positive correlation with allergic airway inflammation.", {"entities": []}], ["Cx43 may represent a target to treat allergic airway diseases in the future.", {"entities": []}], ["This study was performed to determine the effects of environmental tobacco smoke (ETS) on nitric oxide (NO) and immunoglobulin (Ig) production in a murine model of allergic bronchopulmonary aspergillosis (ABPA).", {"entities": [[190, 203, "DISEASE"], [164, 203, "DISEASE"]]}], ["Adult BALB/c mice were exposed to aged and diluted sidestream cigarette smoke from day 0 through day 43 to simulate \u201csecond-hand smoke\u201d.", {"entities": []}], ["During exposure, mice were sensitized to soluble Aspergillus fumigatus (Af) antigen intranasally between day 14 and 24.", {"entities": []}], ["All Af sensitized mice in ambient air (Af + AIR) made elevated levels of IgE, IgG1, IgM, IgG2a and IgA.", {"entities": []}], ["Af sensitized mice housed in ETS (Af + ETS) made similar levels of immunoglobulins except for IgE that was significantly reduced in the serum and bronchoalveolar lavage (BAL).", {"entities": []}], ["However, immunohistochemical evaluation of the lung revealed a marked accumulation of IgE positive cells in the lung parenchyma of these Af + ETS mice.", {"entities": []}], ["LPS stimulation of BAL cells revealed elevated levels of NO in the Af + AIR group, which was further enhanced in the Af+ETS group.", {"entities": []}], ["In vitro restimulation of the BAL cells on day 45 showed a TH0 response with elevated levels of IL3, 4, 5, 10 and IFN-\u03b3.", {"entities": [[96, 99, "GENE"]]}], ["However, by day 28 the response shifted such that TH2 cytokines increased while IFN-\u03b3 decreased.", {"entities": []}], ["The Af + ETS group showed markedly reduced levels in all cytokines tested, including the inflammatory cytokine IL6, when compared to the Af+AIR group.", {"entities": [[111, 114, "GENE"]]}], ["These results demonstrate that ETS affects ABPA by further enhancing the NO production and reduces the TH2 and the inflammatory cytokines while altering the pattern of IgE responses.", {"entities": []}], ["There are numerous indicators that Hispanics face a disproportionate risk of exposure to environmental hazards.", {"entities": []}], ["Ambient air pollution, worker exposure to chemicals, indoor air pollution, and drinking water quality are among the top four threats to human health and are all areas in which indicators point to elevated risk for Hispanic populations.", {"entities": []}], ["These data, juxtaposed with data on the health status of Hispanics, tell us that the environmental health status of Hispanics and their children is poor.", {"entities": []}], ["At the same time, significant inadequacies in the collection of data on Hispanics make it difficult to make improving Hispanic environmental health status a priority.", {"entities": []}], ["These inadequacies include the failure to use Hispanic identifiers in data collection and failure to collect sample sizes large enough to allow for breakouts of data by Hispanic subgroup.", {"entities": []}], ["In addressing environmental justice issues, the U. S. Environmental Protection Agency (U.S. EPA) and the Department of Health and Human Services (DHHS) should prioritize improving the quantifiability of environmental exposures and risk based on race or ethnicity.", {"entities": []}], ["However, improving data should not be the prerequisite to significant, affirmative steps by DHHS and U.S. EPA to address environmental and environmental health problems facing Hispanic communities.", {"entities": []}], ["In particular, a health-based approach to environmental justice should be the priority.", {"entities": []}], ["Decrease in intrinsic motivation is a common complaint among elementary and junior high school students, and is related to poor academic performance.", {"entities": []}], ["Since grade-dependent development of cognitive functions also influences academic performance by these students, we examined whether cognitive functions are related to the prevalence of decrease in intrinsic academic motivation.", {"entities": []}], ["The study group consisted of 134 elementary school students from 4th to 6th grades and 133 junior high school students from 7th to 9th grades.", {"entities": []}], ["Participants completed a questionnaire on intrinsic academic motivation.", {"entities": []}], ["They also performed paper-and-pencil and computerized cognitive tests to measure abilities in motor processing, spatial construction, semantic fluency, immediate memory, short-term memory, delayed memory, spatial working memory, and selective, alternative, and divided attention.", {"entities": []}], ["In multivariate logistic regression analyses adjusted for grade and gender, scores of none of the cognitive tests were correlated with the prevalence of decrease in intrinsic academic motivation in elementary school students.", {"entities": []}], ["However, low digit span forward test score and score for comprehension of the story in the kana pick-out test were positively correlated with the prevalence of decrease in intrinsic academic motivation in junior high school students.", {"entities": []}], ["The present findings suggest that decrease in capacity for verbal memory is associated with the prevalence of decrease in intrinsic academic motivation among junior high school students.", {"entities": []}], ["Asthma is a multifactorial airway disease that arises from a relatively common genetic background interphased with exposures to allergens and airborne irritants.", {"entities": [[0, 6, "DISEASE"]]}], ["The rapid rise in asthma over the past three decades in Western societies has been attributed to numerous diverse factors, including increased awareness of the disease, altered lifestyle and activity patterns, and ill-defined changes in environmental exposures.", {"entities": [[18, 24, "DISEASE"]]}], ["It is well accepted that persons with asthma are more sensitive than persons without asthma to air pollutants such as cigarette smoke, traffic emissions, and photochemical smog components.", {"entities": [[38, 44, "DISEASE"], [85, 91, "DISEASE"]]}], ["It has also been demonstrated that exposure to a mix of allergens and irritants can at times promote the development phase (induction) of the disease.", {"entities": []}], ["Experimental evidence suggests that complex organic molecules from diesel exhaust may act as allergic adjuvants through the production of oxidative stress in airway cells.", {"entities": []}], ["It also seems that climate change is increasing the abundance of aeroallergens such as pollen, which may result in greater incidence or severity of allergic diseases.", {"entities": []}], ["In this review we illustrate how environmental tobacco smoke, outdoor air pollution, and climate change may act as environmental risk factors for the development of asthma and provide mechanistic explanations for how some of these effects can occur.", {"entities": [[165, 171, "DISEASE"]]}], ["Depression is an important comorbidity of asthma.", {"entities": [[42, 48, "DISEASE"]]}], ["However, little information is available about depression and its potential impact on asthma control in Korean adult asthma patients.", {"entities": [[86, 92, "DISEASE"], [117, 123, "DISEASE"]]}], ["We aimed to estimate the prevalence and risk factors for depression in Korean adults with persistent asthma.", {"entities": [[101, 107, "DISEASE"]]}], ["The 127 non-elderly (20-64 yr) and 75 elderly (\u226565 yr) patients with asthma were recruited.", {"entities": [[69, 75, "DISEASE"]]}], ["Demographic and clinical data were extracted, and the patients completed the Asthma Specific Quality of Life (AQOL) questionnaire and asthma control test (ACT).", {"entities": [[77, 83, "DISEASE"], [134, 140, "DISEASE"]]}], ["Depression status was defined using the Korean version of the Patient Health Questionnaire-9 (PHQ-9).", {"entities": []}], ["Depression was more prevalent in non-elderly (18.9%) than in elderly patients with asthma (13.3%).", {"entities": [[83, 89, "DISEASE"]]}], ["Patients with depression were significantly younger, had lower economic status, shorter disease duration, poorer asthma control, and worse AQOL scores ( P <0.05).", {"entities": [[113, 119, "DISEASE"]]}], ["Within the non-elderly group, younger age and shorter disease duration were significantly associated with depression ( P <0.05).", {"entities": []}], ["Within the elderly group, a higher body mass index and current smoking status were significantly associated with depression ( P <0.05).", {"entities": []}], ["The PHQ-9 score was significantly correlated with worse ACT and AQOL scores in both groups.", {"entities": []}], ["In conclusion, depression is strongly associated with poor asthma control and quality of life in Korean adult asthma patients.", {"entities": [[59, 65, "DISEASE"], [110, 116, "DISEASE"]]}], ["Our results provide important clues that used to target modifiable factors which contribute to development of depression in asthma patients.", {"entities": [[124, 130, "DISEASE"]]}], ["Increased mortality from asthma, chronic bronchitis and emphysema has previously been reported among workers in the silicon carbide (SiC) industry.", {"entities": [[25, 31, "DISEASE"], [41, 51, "DISEASE"]]}], ["The objective of the present study was to evaluate the influence of specific exposure factors on mortality from obstructive lung diseases (OLD), using a newly revised job-exposure matrix.", {"entities": []}], ["1687 long-term workers employed in 1913\u20132003 in the Norwegian SiC industry were characterised with respect to cumulative exposure to quartz, cristobalite, SiC particles and SiC fibres.", {"entities": []}], ["Standardised mortality ratios (SMRs) for underlying causes of death, 1951\u20132007, were calculated stratified by category of cumulative exposure, and Poisson regression analyses of OLD were performed using cumulative exposure variables.", {"entities": []}], ["An increased total mortality (SMR 1.1, 95% CI 1.0 to 1.2) and increased mortality from cancer, non-malignant respiratory diseases and external factors, were observed.", {"entities": [[87, 93, "DISEASE"]]}], ["The SMR of OLD was increased at the highest level of cumulative exposure to all investigated exposure factors.", {"entities": []}], ["In the internal analyses, a twofold increased risk of OLD was observed with increasing levels of cumulative exposure to SiC particles.", {"entities": []}], ["In a multivariate model, SiC particles showed the most stable increased risk estimate when controlled for other exposure factors, among workers with less than 15\u2005years of employment.", {"entities": []}], ["Among workers with more than 15\u2005years of employment, crystalline silica, primarily cristobalite, seemed to be the most important exposure factor.", {"entities": []}], ["Exposure to SiC and crystalline silica may contribute to OLD development among SiC industry workers in different time windows, and possibly through different mechanisms.", {"entities": []}], ["Kabuki syndrome (KS) is a rare, multiple congenital anomalies/intellectual disability syndrome caused by mutations of MLL2 gene, which codifies for a histone methyltrasferase that regulates the embryogenesis and the tissue development.", {"entities": [[62, 85, "DISEASE"], [7, 15, "DISEASE"], [86, 94, "DISEASE"], [118, 122, "GENE"]]}], ["Left-bronchial isomerism is a rare congenital abnormality that can be defined as the absence of the normal lateralizing features which distinguish right and left-sides in the lungs.", {"entities": []}], ["To date, this is the first report of left-bronchial isomerism in association with KS.", {"entities": []}], ["A one-month-old Caucasian male patient underwent our attention for microcephaly, dysmorphic features (long palpebral fissures, eyebrows with sparse lateral third, everted lower eyelids, blue sclerae, large dysplastic ears, lower lip pits), persistent fetal fingertip pads, short stature, heart defects (interventricular defect and aortic coarctation), unilateral cryptorchidism, hypotonia and delay in gross motor skills.", {"entities": [[363, 377, "DISEASE"], [67, 79, "DISEASE"]]}], ["These features suggested a diagnosis of KS and a molecular analysis confirmed a novel frame-shift mutation in the exon 11 of MLL2 gene.", {"entities": [[125, 129, "GENE"]]}], ["Subsequently, given recurrent respiratory infections with a normal immunological status, he underwent a chest CT scan that showed a left bronchial isomerism.", {"entities": []}], ["We report a patient affected by KS, with a novel MLL2 mutation and an atypical phenotype characterized by left-side bronchial isomerism.", {"entities": [[49, 53, "GENE"]]}], ["Interestingly, genes involved in the heterotaxia/isomerism such as ROCK2 and SHROOM3 are known to interact with MLL2 gene.", {"entities": [[67, 72, "GENE"], [77, 84, "GENE"], [112, 116, "GENE"]]}], ["In order to achieve a correct diagnosis and an appropriate therapy, the presence of pulmonary anatomical variations should be investigated in KS patients with respiratory signs not associated to immunological deficiency.", {"entities": []}], ["Finally, our findings support the hypothesis that the mutations leading to a complete loss of function of MLL2 gene is often associated with complex visceral malformations.", {"entities": [[106, 110, "GENE"]]}], ["C-reactive Protein (CRP) measurements above 10 mg/L have been conventionally treated as acute inflammation and excluded from epidemiologic studies of chronic inflammation.", {"entities": [[20, 23, "GENE"]]}], ["However, recent evidence suggest that such CRP elevations can be seen even with chronic inflammation.", {"entities": [[43, 46, "GENE"]]}], ["The authors assessed 3,300 participants in The Coronary Artery Risk Development in Young Adults study, who had two or more CRP measurements between 1992/3 and 2005/6 to a) investigate characteristics associated with repeated CRP elevation above 10 mg/L; b) identify subgroups at high risk of repeated elevation; and c) investigate the effect of different CRP thresholds on the probability of an elevation being one-time rather than repeated.", {"entities": [[123, 126, "GENE"], [225, 228, "GENE"], [355, 358, "GENE"], [123, 126, "GENE"], [225, 228, "GENE"], [355, 358, "GENE"], [123, 126, "GENE"], [225, 228, "GENE"], [355, 358, "GENE"]]}], ["225 participants (6.8%) had one-time and 103 (3.1%) had repeated CRP elevation above 10 mg/L.", {"entities": [[65, 68, "GENE"]]}], ["Repeated elevation was associated with obesity, female gender, low income, and sex hormone use.", {"entities": [[39, 46, "DISEASE"]]}], ["The probability of an elevation above 10 mg/L being one-time rather than repeated was lowest (51%) in women with body mass index above 31 kg/m", {"entities": []}], ["Pneumonia is the leading cause of death in children.", {"entities": [[0, 9, "DISEASE"]]}], ["The objectives were to evaluate the microbiological agents linked with hypoxemia in hospitalized children with pneumonia from developing countries, to identify predictors of hypoxemia, and to characterize factors associated with in-hospital mortality.", {"entities": [[111, 120, "DISEASE"]]}], ["A multicenter, observational study was conducted in five hospitals, from India (Lucknow, Vadu), Madagascar (Antananarivo), Mali (Bamako), and Paraguay (San Lorenzo).", {"entities": []}], ["Children aged 2\u201360 months with radiologically confirmed pneumonia were enrolled prospectively.", {"entities": [[56, 65, "DISEASE"]]}], ["Respiratory and whole blood specimens were collected, identifying viruses and bacteria by real-time multiplex polymerase chain reaction (PCR).", {"entities": []}], ["Microbiological agents linked with hypoxemia at admission (oxygen saturation < 90%) were analyzed by multivariate logistic regression, and factors associated with 14-day in-hospital mortality were assessed by bivariate Cox regression.", {"entities": []}], ["Overall, 405 pneumonia cases (3,338 hospitalization days) were analyzed; 13 patients died within 14 days of hospitalization.", {"entities": [[13, 22, "DISEASE"]]}], ["Hypoxemia prevalence was 17.3%.", {"entities": []}], ["Detection of human metapneumovirus (hMPV) and respiratory syncytial virus (RSV) in respiratory samples was independently associated with increased risk of hypoxemia (adjusted odds ratio [aOR] = 2.4, 95% confidence interval [95% CI] = 1.0\u20135.8 and aOR = 2.5, 95% CI = 1.1\u20135.3, respectively).", {"entities": []}], ["Lower chest indrawing and cyanosis were predictive of hypoxemia (positive likelihood ratios = 2.3 and 2.4, respectively).", {"entities": []}], ["Predictors of death were Streptococcus pneumoniae detection by blood PCR (crude hazard ratio [cHR] = 4.6, 95% CI = 1.5\u201314.0), procalcitonin \u2265 50 ng/mL (cHR = 22.4, 95% CI = 7.3\u201368.5) and hypoxemia (cHR = 4.8, 95% CI = 1.6\u201314.4).", {"entities": []}], ["These findings were consistent on bivariate analysis.", {"entities": []}], ["hMPV and RSV in respiratory samples were linked with hypoxemia, and S. pneumoniae in blood was associated with increased risk of death among hospitalized children with pneumonia in developing countries.", {"entities": [[168, 177, "DISEASE"]]}], ["An association between obesity and asthma has been reported.", {"entities": [[23, 30, "DISEASE"], [35, 41, "DISEASE"]]}], ["The prevalence of airway hyperresponsiveness (AHR), results of skin prick tests, body mass index (BMI), and asthma symptoms were examined in schoolchildren.", {"entities": [[108, 114, "DISEASE"], [46, 49, "GENE"]]}], ["The results of BMI (kg/m 1 (PC 20 ) was used as the threshold of AHR.", {"entities": [[28, 30, "GENE"], [65, 68, "GENE"]]}], ["If the PC 20 was less than 16 mg/mL, the subject was considered to have methachloine mediated AHR.", {"entities": [[7, 9, "GENE"], [94, 97, "GENE"]]}], ["The mean BMI was 17.1\u00b10.09 kg/m 20 in children with BMIs \u226517.1 kg/m 20 by sex were not different.", {"entities": []}], ["The children were grouped by sex into percentile of BMI.", {"entities": []}], ["PC 20 in boys was lower in the obese group than in the non-weight and overweight groups ( p <0.05).", {"entities": [[0, 2, "GENE"]]}], ["PC 20 in boys and girls with atopy was significantly lower than in those without atopy.", {"entities": [[0, 2, "GENE"]]}], ["In a multiple logistic regression model that included all of the children and adjusted for confounding variables, independent associations with AHR were seen with BMI, asthma symptoms, and atopy.", {"entities": [[168, 174, "DISEASE"], [144, 147, "GENE"]]}], ["BMI had an association with AHR in school-age boys.", {"entities": [[28, 31, "GENE"]]}], ["Prostaglandin D 2 (PGD 2 ) is a major prostanoid, produced mainly by mast cells, in allergic diseases, including bronchial asthma.", {"entities": [[123, 129, "DISEASE"], [19, 22, "GENE"]]}], ["PGD 2 -induced vasodilatation and increased permeability are well-known classical effects that may be involved in allergic inflammation.", {"entities": [[0, 3, "GENE"]]}], ["Recently, novel functions of PGD 2 have been identified.", {"entities": [[29, 32, "GENE"]]}], ["To date, D prostanoid receptor (DP) and chemoattractant receptor homologous molecule expressed on T H 2 cells (CRTH2) have been shown to be major PGD 2 -related receptors.", {"entities": [[146, 149, "GENE"]]}], ["These two receptors have pivotal roles mediating allergic diseases by regulating the functions of various cell types, such as T H 2 cells, eosinophils, basophils, mast cells, dendritic cells, and epithelial cells.", {"entities": []}], ["This review will focus on the current understanding of the roles of PGD 2 and its metabolites in T H 2 inflammation and the pathogenesis of bronchial asthma.", {"entities": [[150, 156, "DISEASE"], [68, 71, "GENE"]]}], ["Recent research into the role of the human microbiome in maintaining health has identified the potentially harmful impact of antimicrobials.", {"entities": []}], ["The association with bacterial and viral meningitis following antimicrobial prescription during the previous year was investigated to determine whether antimicrobials have a deleterious effect on the nasopharyngeal microbiome.", {"entities": [[35, 51, "DISEASE"], [41, 51, "DISEASE"]]}], ["A case-control study (1:4 cases to controls) was conducted examining the rate of previous antimicrobial exposure in cases of meningitis and in a matched control group.", {"entities": [[125, 135, "DISEASE"]]}], ["Data from a UK primary care clinical database were analysed using conditional logistic regression.", {"entities": []}], ["A total of 7346 cases of meningitis were identified, 3307 (45%) viral, 1812 (25%) bacterial, and 2227 (30%) unspecified.", {"entities": [[25, 35, "DISEASE"]]}], ["The risks of viral (adjusted odds ratio [AOR] 2.45; 95% confidence interval [CI] = 2.24 to 2.68) or bacterial (AOR 1.98; 95% CI = 1.71 to 2.30) meningitis were both increased following antimicrobial prescription in the preceding year.", {"entities": [[144, 154, "DISEASE"]]}], ["Patients who received \u22654 antimicrobial prescriptions in the preceding year were at significantly increased risk of all types of meningitis (AOR 2.85; 95% CI = 2.44 to 3.34), bacterial meningitis (AOR 3.06; 95% CI = 2.26 to 4.15) and viral meningitis (AOR 3.23; 95% CI = 2.55 to 4.08) compared to their matched controls.", {"entities": [[233, 249, "DISEASE"], [128, 138, "DISEASE"], [184, 194, "DISEASE"], [239, 249, "DISEASE"], [174, 194, "DISEASE"]]}], ["There was an increased risk of meningitis following antimicrobial prescription in the previous year.", {"entities": [[31, 41, "DISEASE"]]}], ["It is possible that this increase was due to an effect of antimicrobials on the microbiome or reflected an increased general susceptibility to infections in these patients.", {"entities": []}], ["Bilastine is a new, well-tolerated, nonsedating H1 receptor antihistamine.", {"entities": []}], ["In the fasting state bilastine is quickly absorbed, but the absorption is slowed when it is taken with food or fruit juice.", {"entities": []}], ["Therefore, it is recommended that bilastine is taken at least one hour before and no sooner than two hours after a meal.", {"entities": []}], ["Clinical studies sponsored by the manufacturer have shown that bilastine 20\u2009mg once daily is as efficacious as other nonsedating antihistamines in allergic rhinoconjunctivitis and chronic urticaria in individuals from 12 and 18 years of age, respectively.", {"entities": [[188, 197, "DISEASE"]]}], ["Bilastine is efficacious in all nasal symptoms including obstruction and in eye symptoms.", {"entities": []}], ["The observations indicate that non-sedating antihistamines, as opposed to what has been thought previously, may be helpful in patients with allergic rhinitis in whom nasal obstruction is a major concern.", {"entities": [[140, 157, "DISEASE"], [149, 157, "DISEASE"]]}], ["Current international guidelines need to be revised in the light of the recent evidence.", {"entities": []}], ["Research into aspects of pharmacokinetics and efficacy and adverse effect profiles of bilastine in children under 12 years of age is needed as are dose-response assessments and studies planned rigorously with the aim of assessing quality of life effects.", {"entities": []}], ["There are few studies about school-environment in relation to pupils' respiratory health, and Korean school-environment has not been characterized.", {"entities": []}], ["All pupils in 4th grade in 12 selected schools in three urban cities in Korea received a questionnaire (n = 2,453), 96% participated.", {"entities": []}], ["Gaseous pollutants and ultrafine particles (UFPs) were measured indoors (n = 34) and outdoors (n = 12) during winter, 2004.", {"entities": []}], ["Indoor dampness at home was investigated by the questionnaire.", {"entities": []}], ["To evaluate associations between respiratory health and environment, multiple logistic- and multi-level regression models were applied adjusting for potential confounders.", {"entities": []}], ["The mean age of pupils was 10 yr and 49% were boys.", {"entities": []}], ["No school had mechanical ventilation and CO 2 -levels exceeded 1,000 ppm in all except one of the classrooms.", {"entities": []}], ["The indoor mean concentrations of SO 2 , NO 2 , O 3 and formaldehyde were 0.6 \u00b5g/m 2 , and between current asthma and outdoor UFPs.", {"entities": [[107, 113, "DISEASE"]]}], ["With dampness at home, pupils had more wheeze.", {"entities": []}], ["In conclusion, outdoor UFPs and even low levels of NO 2 may adversely contribute to respiratory health in children.", {"entities": []}], ["High CO 2 -levels in classrooms and indoor dampness/mold at home should be reduced.", {"entities": []}], ["The intent of adopting managed care plans is to improve access to health care services while containing costs.", {"entities": []}], ["To date, there have been a number of studies that examine the relationship between managed care and access to health care.", {"entities": []}], ["However, the results from previous studies have been inconsistent.", {"entities": []}], ["Specifically, previous studies did not demonstrate a clear benefit of Medicaid managed care.", {"entities": []}], ["In this study we have examine whether Medicaid managed care is associated with the probabilities of preventable hospitalizations.", {"entities": []}], ["This study also analyzes the spillover effect of Medicaid managed care into Medicaid patients in traditional FFS plans and the interaction effects of other patient- and county-level variables on preventable hospitalizations.", {"entities": []}], ["The study included 254,321 Medicaid patients who were admitted to short-term general hospital in the 67 counties in Florida.", {"entities": []}], ["Using 2008 hospital inpatient discharge data for working-age adult Medicaid enrollees (18-64 years) in Florida, we conduct multivariate logistic regression analyses to identify possible factors associated with preventable hospitalizations.", {"entities": []}], ["The first model includes patient- and county-level variables.", {"entities": []}], ["Then, we add interaction terms between Medicaid HMO and other variables such as race, rurality, market-level factors, and resource for primary care.", {"entities": []}], ["The results show that Medicaid HMO patients are more likely to be hospitalized for ambulatory care sensitive conditions (ACSCs) (OR\u2009=\u20091.30; CI\u2009=\u20091.21, 1.40).", {"entities": []}], ["We also find that market structure (i.e., competition) is significantly associated with preventable hospitalizations.", {"entities": []}], ["However, our study does not support that there are spillover effects of Medicaid managed care on preventable hospitalizations for other Medicaid recipients.", {"entities": []}], ["We find that interactions between Medicaid managed care and race, rurality and market structure are significant.", {"entities": []}], ["The results of our study show that the Medicaid managed care program in Florida was associated with an increase in potentially preventable hospitalizations for Medicaid enrollees.", {"entities": []}], ["The results suggest that lower capitation rate has been associated with a greater likelihood of preventable hospitalizations for Medicaid managed care patients.", {"entities": []}], ["Our findings also indicate that increased competition in the Medicaid managed care market has no clear benefit in Medicaid managed care patients.", {"entities": []}], ["Patients with myocardial infarction (MI) and concomitant chronic obstructive pulmonary disease (COPD) constitute a high\u2010risk group with increased mortality.", {"entities": [[57, 94, "DISEASE"], [14, 35, "DISEASE"]]}], ["\u03b2\u2010Blocker therapy has been shown to reduce mortality, prevent arrhythmias, and delay heart failure development after an MI in broad populations.", {"entities": []}], ["However, the effect of \u03b2\u2010blockers in COPD patients is less well established and they may also be less treated due to fear of adverse reactions.", {"entities": []}], ["We investigated \u03b2\u2010blocker prescription at discharge in patients with COPD after MI.", {"entities": []}], ["Patients hospitalized for MI between 2005 and 2010 were identified from the nationwide Swedish SWEDEHEART registry.", {"entities": []}], ["Patients with COPD who were alive and discharged after an MI were selected as the study population.", {"entities": []}], ["In this cohort, patients who were discharged with \u03b2\u2010blockers were compared to patients not discharged with \u03b2\u2010blockers.", {"entities": []}], ["The primary end point was all\u2010cause mortality.", {"entities": []}], ["A total of 4858 patients were included, of which 4086 (84.1%) were discharged with a \u03b2\u2010blocker while 772 (15.9%) were not.", {"entities": []}], ["After adjusting for potential confounders including baseline characteristics, comorbidities, and in\u2010hospital characteristics, patients discharged with a \u03b2\u2010blocker had lower all\u2010cause mortality (hazard ratio 0.87, 95% CI 0.78 to 0.98) during the total follow\u2010up time (maximum 7.2 years).", {"entities": []}], ["In the subgroup of patients with a history of heart failure, the corresponding hazard ratio was 0.77 (95% CI 0.63 to 0.95).", {"entities": []}], ["Patients with COPD discharged with \u03b2\u2010blockers after an MI had a lower all\u2010cause mortality compared to patients not prescribed \u03b2\u2010blockers.", {"entities": []}], ["The results indicate that MI patients with COPD may benefit from \u03b2\u2010blockers.", {"entities": []}], ["Tobacco-related illnesses are leading causes of death and healthcare use.", {"entities": []}], ["Our objective was to determine whether implementation of a hospital-initiated smoking cessation intervention would reduce mortality and downstream healthcare usage.", {"entities": []}], ["A 2-group effectiveness study was completed comparing patients who received the \u2018Ottawa Model\u2019 for Smoking Cessation intervention (n=726) to usual care controls (n=641).", {"entities": []}], ["Participants were current smokers, >17\u2005years old, and recruited during admission to 1 of 14 participating hospitals in Ontario, Canada.", {"entities": []}], ["Baseline data were linked to healthcare administrative data.", {"entities": []}], ["Competing-risks regression analysis was used to compare outcomes between groups.", {"entities": []}], ["The intervention group experienced significantly lower rates of all-cause readmissions, smoking-related readmissions, and all-cause emergency department (ED) visits at all time points.", {"entities": []}], ["The largest absolute risk reductions (ARR) were observed for all-cause readmissions at 30\u2005days (13.3% vs 7.1%; ARR, 6.1% (2.9% to 9.3%); p<0.001), 1\u2005year (38.4% vs 26.7%; ARR, 11.7% (6.7% to 16.6%); p<0.001), and 2\u2005years (45.2% vs 33.6%; ARR, 11.6% (6.5% to 16.8%); p<0.001).", {"entities": []}], ["The greatest reduction in risk of all-cause ED visits was at 30\u2005days (20.9% vs 16.4%; ARR, 4.5% (0.4% to 8.7%); p=0.03).", {"entities": []}], ["Reduction in mortality was not evident at 30\u2005days, but significant reductions were observed by year 1 (11.4% vs 5.4%; ARR 6.0% (3.1% to 9.0%); p<0.001) and year 2 (15.1% vs 7.9%; ARR, 7.3% (3.9% to 10.7%); p<0.001).", {"entities": []}], ["Considering the relatively low cost, greater adoption of hospital-initiated tobacco cessation interventions should be considered to improve patient outcomes and decrease subsequent healthcare usage.", {"entities": []}], ["While the antigenic specificity and pathogenic relevance of immunologic reactivity to gluten in celiac disease have been extensively researched, the immune response to nongluten proteins of wheat has not been characterized.", {"entities": [[96, 110, "DISEASE"]]}], ["We aimed to investigate the level and molecular specificity of antibody response to wheat nongluten proteins in celiac disease.", {"entities": [[112, 126, "DISEASE"]]}], ["Serum samples from patients and controls were screened for IgG and IgA antibody reactivity to a nongluten protein extract from the wheat cultivar Triticum aestivum Butte 86.", {"entities": []}], ["Antibodies were further analyzed for reactivity to specific nongluten proteins by two-dimensional gel electrophoresis and immunoblotting.", {"entities": []}], ["Immunoreactive molecules were identified by tandem mass spectrometry.", {"entities": []}], ["Compared with healthy controls, patients exhibited significantly higher levels of antibody reactivity to nongluten proteins.", {"entities": []}], ["The main immunoreactive nongluten antibody target proteins were identified as serpins, purinins, \u03b1-amylase/protease inhibitors, globulins, and farinins.", {"entities": []}], ["Assessment of reactivity toward purified recombinant proteins further confirmed the presence of antibody response to specific antigens.", {"entities": []}], ["The results demonstrate that, in addition to the well-recognized immune reaction to gluten, celiac disease is associated with a robust humoral response directed at a specific subset of the nongluten proteins of wheat.", {"entities": [[92, 106, "DISEASE"]]}], ["The transforming growth factor-beta 1 (TGF\u03b21) promotes fibrosis, differentiating epithelial cells and quiescent fibroblasts into myofibroblasts and increasing expression of extracellular matrix.", {"entities": []}], ["Recent investigations have shown that PPAR (peroxisome proliferator-activated receptor*) is a negative regulator of fibrotic events induced by TGF\u03b21.", {"entities": []}], ["Dehydroepiandrosterone (DHEA) is an immunomodulatory hormone essential for PPAR functions, and is reduced in some processes characterized by fibrosis.", {"entities": []}], ["Although scarring alopecia characteristically develops in the female biological period in which occurs decreased production of DHEA, there are no data in the literature relating its reduction to fibrogenic process of this condition.", {"entities": [[18, 26, "DISEASE"]]}], ["This article aims to review the fibrogenic activity of TGF\u03b21, its control by PPAR and its relation with DHEA in the frontal fibrosing alopecia.", {"entities": [[134, 142, "DISEASE"]]}], ["We evaluated the prevalence of human bocavirus and KI and WU polyomaviruses in pediatric intensive care patients with and without lower respiratory tract infection (LRTI).", {"entities": []}], ["The prevalence of these viruses was 5.1%, 0%, and 2.6%, respectively, in children with LRTI and 4.8%, 4.8%, and 2.4%, respectively, in those without LRTI.", {"entities": []}], ["The implementation of new medical knowledge into general practice is a complex process.", {"entities": []}], ["Blended learning may offer an effective and efficient educational intervention to reduce the knowledge-to-practice gap.", {"entities": []}], ["The aim of this study was to compare knowledge acquisition about dementia management between a blended learning approach using online modules in addition to quality circles (QCs) and QCs alone.", {"entities": [[65, 73, "DISEASE"]]}], ["In this cluster-randomised trial with QCs as clusters and general practitioners (GPs) as participants, 389 GPs from 26 QCs in the western part of Germany were invited to participate.", {"entities": []}], ["Data on the GPs' knowledge were obtained at three points in time by means of a questionnaire survey.", {"entities": []}], ["Primary outcome was the knowledge gain before and after the interventions.", {"entities": []}], ["A subgroup analysis of the users of the online modules was performed.", {"entities": []}], ["166 GPs were available for analysis and filled out a knowledge test at least two times.", {"entities": []}], ["A significant increase of knowledge was found in both groups that indicated positive learning effects of both approaches.", {"entities": []}], ["However, there was no significant difference between the groups.", {"entities": []}], ["A subgroup analysis of the GPs who self-reported that they had actually used the online modules showed that they had a significant increase in their knowledge scores.", {"entities": []}], ["A blended learning approach was not superior to a QCs approach for improving knowledge about dementia management.", {"entities": [[93, 101, "DISEASE"]]}], ["However, a subgroup of GPs who were motivated to actually use the online modules had a gain in knowledge.", {"entities": []}], ["Current Controlled Trials ISRCTN36550981.", {"entities": []}], ["The control of infectious diseases is a major current challenge in intensive aquaculture.", {"entities": []}], ["Most commercial vaccines are based on live attenuated or inactivated pathogens that are usually combined with adjuvants, oil emulsions being as the most widely used for vaccination in aquaculture.", {"entities": []}], ["Although effective, the use of these oil emulsions is plagued with important side effects.", {"entities": []}], ["Thus, the development of alternative safer and cost-effective immunostimulants and adjuvants is highly desirable.", {"entities": []}], ["Here we have explored the capacity of inclusion bodies produced in bacteria to immunostimulate and protect fish against bacterial infections.", {"entities": []}], ["Bacterial inclusion bodies are highly stable, non-toxic protein-based biomaterials produced through fully scalable and low-cost bio-production processes.", {"entities": []}], ["The present study shows that the composition and structured organization of inclusion body components (protein, lipopolysaccharide, peptidoglycan, DNA and RNA) make these protein biomaterials excellent immunomodulators able to generically protect fish against otherwise lethal bacterial challenges.", {"entities": []}], ["The results obtained in this work provide evidence that their inherent nature makes bacterial inclusion bodies exceptionally attractive as immunostimulants and this opens the door to the future exploration of this biomaterial as an alternative adjuvant for vaccination purposes in veterinary.", {"entities": []}], ["In this study, we determined the extent to which U.S. schools are implementing indoor air quality (IAQ) programs.", {"entities": []}], ["We administered a questionnaire on IAQ programs and practices to a representative sample of schools.", {"entities": []}], ["Participants were asked to provide information on the use, administration, implementation, challenges, and benefits of the IAQ program in their school.", {"entities": []}], ["We developed an IAQ Practice Index to determine the level of activity directed toward IAQ in schools.", {"entities": []}], ["The index was computed based on responses to specific survey questions and was normalized to a range of 0 to 100.", {"entities": []}], ["Each question was weighted qualitatively according to its contribution to strong IAQ management practices.", {"entities": []}], ["Forty-two percent of schools in the United States have an IAQ management program, and there has been sustained growth from 1998 through 2002 in the number of schools that have such programs.", {"entities": []}], ["Nearly half of those schools use the U.S. Environmental Protection Agency\u2019s IAQ Tools for Schools program.", {"entities": []}], ["The IAQ Practice Index scores varied widely for schools with an IAQ management program, suggesting that having a program is not equivalent to implementing effective IAQ policies and procedures.", {"entities": []}], ["Respondents indicated that their IAQ programs led to improved workplace satisfaction, fewer asthma attacks, fewer visits to the school nurse, and lower absenteeism.", {"entities": [[92, 98, "DISEASE"]]}], ["When actively supported by the school administration, an IAQ program appears to be a valuable factor in improving the learning environment for U.S. schoolchildren.", {"entities": []}], ["The aim of our study was to evaluate the serum concentration of klotho in a cohort of systemic sclerosis (SSc) patients compared to that of healthy controls and to correlate its levels with the degree and the kind of organ involvement.", {"entities": []}], ["Blood samples obtained from both patients and controls were collected and analysed by an ELISA test for the determination of human soluble klotho.", {"entities": []}], ["Scleroderma patients were evaluated for disease activity through clinical, laboratory, and instrumental assessment.", {"entities": []}], ["Our cohort consisted of 81 SSc patients (74 females, mean age 63.9\u2009\u00b1\u200913.1 years) and 136 healthy controls (78 females, mean age 50.5\u2009\u00b1\u200910.7 years).", {"entities": []}], ["When matched for age, serum klotho concentration significantly differed between controls and patients ( p < 0.001).", {"entities": []}], ["However, in SSc patients, we did not find any significant association between serum klotho and clinical, laboratory, and instrumental findings.", {"entities": []}], ["Lower serum levels of klotho were detected in 4 patients who were anticitrullinated peptide antibody (ACPA) positive ( p = 0.005).", {"entities": []}], ["Our data show a lower concentration of klotho in the serum of SSc patients compared to that of healthy controls, without any significant association with clinical manifestations and laboratory and instrumental findings.", {"entities": []}], ["The association between serum klotho and ACPA positivity requires further investigation.", {"entities": []}], ["Rheumatoid Arthritis (RA) is a systemic, autoimmune and inflammatory disease with an unknown etiology that is associated with progressive joint degeneration, limitation of physical activity and disability.", {"entities": []}], ["The aim of the study was to evaluate self-management behaviors and their associated factors in RA patients.", {"entities": []}], ["This cross-sectional study was performed in 2013 on 185 patients in Iran.", {"entities": []}], ["Data were selected through convenient sampling.", {"entities": []}], ["The collected data included demographic variables, disease related variables, Arthritis Impact Measurement Scale 2 (AIMS-2SF), and Self-Management Behaviors (SMB).", {"entities": []}], ["Data were analyzed by SPSS17 using Spearman correlation and logistic regression test.", {"entities": []}], ["In this study drug management, regular follow-up, and food supplement were used as the most frequently applied SMB and aquatic exercise, diet, massage therapy, and relaxation were the least common SMBs.", {"entities": []}], ["Age, education, health status, occupation, marital status, sex, DAS28 (Disease Activity Score 28 joints), and PGA (Physician Global Assessment) were significantly related with SMB.", {"entities": []}], ["The result of the study highlight the influence of demographic variables, health status, and disease related data on SMB.", {"entities": []}], ["Thus, more studies are required to find factors influencing SMB in order to improve SMB.", {"entities": []}], ["Swanson's literature-based discovery focus on resurrecting previously published but neglected knowledge.", {"entities": []}], ["In this study, we propose a two-step model of the discovery process and generate a hypothesis between anandamide and gastric cancer.", {"entities": [[125, 131, "DISEASE"]]}], ["Further, the potential relationship was confirmed by follow-up experimentation.", {"entities": []}], ["The anandamide treatment resulted in cell cycle redistribution of gastric cancer cells.", {"entities": [[74, 80, "DISEASE"]]}], ["Most importantly, the variation of cell cycle was mediated by some genes from the B-terms of the closed discovery, indicating the potential role of the B-terms.", {"entities": []}], ["Swanson's literature-based discovery not only collates data for possible interactions, but also provides the potential to observe the larger background behind these direct links and is an invaluable discovery tool for investigators.", {"entities": []}], ["Please cite this paper as: Toback et al.", {"entities": []}], ["(2012) Maternal outcomes among pregnant women receiving live attenuated influenza accine.", {"entities": [[72, 81, "DISEASE"]]}], ["Influenza and Other Respiratory Viruses 6(1), 44\u201351.", {"entities": [[0, 9, "DISEASE"]]}], ["Background\u2002 Although the live attenuated influenza vaccine (LAIV) prescribing information contains warnings/precautions against use during pregnancy, administration of LAIV to pregnant women does occur.", {"entities": [[41, 50, "DISEASE"]]}], ["Data regarding maternal outcomes after LAIV administration during pregnancy are limited.", {"entities": []}], ["Objectives\u2002 Maternal outcomes after LAIV vaccination during pregnancy were examined.", {"entities": []}], ["Methods\u2002 Data from a health insurance claims database that covers approximately 50\u2003million individuals were analyzed for the six influenza seasons from 2003\u20132004 through 2008\u20132009.", {"entities": [[129, 138, "DISEASE"]]}], ["Emergency department (ED) visits and hospitalizations occurring within 42\u2003days of vaccination were analyzed by primary diagnosis; outcomes were categorized as cardiopulmonary, obstetric, and other.", {"entities": []}], ["Cohort characteristics were analyzed using descriptive statistics.", {"entities": []}], ["Results\u2002 Of 834\u2003999 pregnancies identified, 138 (0\u00b7017%) were among women who received LAIV vaccinations.", {"entities": []}], ["Of the 138 pregnant women, 13% were \u226419\u2003years, 67% were 20\u201334\u2003years, and 20% were \u226535\u2003years of age.", {"entities": []}], ["Eight events occurred within 42\u2003days of vaccination: one ED visit for bronchitis, two hospitalizations for hyperemesis gravidarum and premature labor, and five ED visits/hospitalizations for common medical conditions.", {"entities": [[70, 80, "DISEASE"]]}], ["All outcomes identified after LAIV exposure occurred at rates similar to rates in unvaccinated pregnant women reported in the medical literature.", {"entities": []}], ["Conclusions\u2002 Administration of LAIV to pregnant women is rare; the rate has remained constant since 2004\u20132005.", {"entities": []}], ["In this cohort, there was no evidence of significant maternal adverse outcomes after receipt of LAIV.", {"entities": []}], ["These data may offer some reassurance to providers and pregnant women in the event of inadvertent LAIV administration, but do not support the routine use of LAIV in pregnant women.", {"entities": []}], ["We analyze the scientific basis and methodology used by the German MAK Commission in their recommendations for exposure limits and carcinogen classification of \u201cgranular biopersistent particles without known specific toxicity\u201d (GBS).", {"entities": [[67, 70, "GENE"]]}], ["These recommendations are under review at the European Union level.", {"entities": []}], ["We examine the scientific assumptions in an attempt to reproduce the results.", {"entities": []}], ["MAK\u2019s human equivalent concentrations (HECs) are based on a particle mass and on a volumetric model in which results from rat inhalation studies are translated to derive occupational exposure limits (OELs) and a carcinogen classification.", {"entities": [[0, 3, "GENE"]]}], ["We followed the methods as proposed by the MAK Commission and Pauluhn 2011.", {"entities": [[43, 46, "GENE"]]}], ["We also examined key assumptions in the metrics, such as surface area of the human lung, deposition fractions of inhaled dusts, human clearance rates; and risk of lung cancer among workers, presumed to have some potential for lung overload, the physiological condition in rats associated with an increase in lung cancer risk.", {"entities": [[163, 174, "DISEASE"], [308, 319, "DISEASE"], [168, 174, "DISEASE"], [313, 319, "DISEASE"]]}], ["The MAK recommendations on exposure limits for GBS have numerous incorrect assumptions that adversely affect the final results.", {"entities": [[4, 7, "GENE"]]}], ["The procedures to derive the respirable occupational exposure limit (OEL) could not be reproduced, a finding raising considerable scientific uncertainty about the reliability of the recommendations.", {"entities": []}], ["Moreover, the scientific basis of using the rat model is confounded by the fact that rats and humans show different cellular responses to inhaled particles as demonstrated by bronchoalveolar lavage (BAL) studies in both species.", {"entities": []}], ["Classifying all GBS as carcinogenic to humans based on rat inhalation studies in which lung overload leads to chronic inflammation and cancer is inappropriate.", {"entities": [[135, 141, "DISEASE"]]}], ["Studies of workers, who have been exposed to relevant levels of dust, have not indicated an increase in lung cancer risk.", {"entities": [[104, 115, "DISEASE"], [109, 115, "DISEASE"]]}], ["Using the methods proposed by the MAK, we were unable to reproduce the OEL for GBS recommended by the Commission, but identified substantial errors in the models.", {"entities": [[34, 37, "GENE"]]}], ["Considerable shortcomings in the use of lung surface area, clearance rates, deposition fractions; as well as using the mass and volumetric metrics as opposed to the particle surface area metric limit the scientific reliability of the proposed GBS OEL and carcinogen classification.", {"entities": []}], ["Some individuals in the population may be sensitive or susceptible be to the effects of air pollutants.", {"entities": []}], ["Such sensitivity may be to specific pollutants or classes of pollutants.", {"entities": []}], ["However, sensitivity or susceptibility in some individuals can be to all irritants, but the sensitivity is likely to be response specific or organ specific.", {"entities": []}], ["The U.S. Clean Air Act specifically recognizes that some individuals in the population are sensitive to air pollutants and indicates that such individuals need to be protected by air quality standards.", {"entities": []}], ["It is usually difficult to determine the cause of sensitivity, though various biological mechanisms have been studied.", {"entities": []}], ["Biological age may be a factor, with the young being most sensitive and susceptible to being affected.", {"entities": []}], ["An example is the heightened bronchial lability and responsiveness in the very young that appears to disappear with growth.", {"entities": []}], ["Susceptibility may be innate (e.g., genetic) and/or induced by events/exposures.", {"entities": []}], ["Frequently, those with preexisting illnesses are part of the sensitive population because they may often respond, sometimes hyperrespond, to a pollutant exposure that may not affect most people.", {"entities": []}], ["Asthmatics are excellent examples of individuals who were susceptible to the disease and, once inflicted, are susceptible to the effects of many environmental and nonenvironmental agents.", {"entities": []}], ["Usually only a fraction of the general population will respond with heightened reactions at lower doses.", {"entities": []}], ["Such individuals require special evaluation and attention in all exposure-response studies and risk assessments.", {"entities": []}], ["Thus, the conditions defining populations at risk and the methodologies to discover and study them can be reviewed.", {"entities": []}], ["We report a case of recurrent cutaneous necrotizing eosinophilic vasculitis (RCNEV) in a 57-year-old male.", {"entities": [[65, 75, "DISEASE"]]}], ["The patient presented with papules and pruritus of the lower limbs of more than 1\u00a0month duration, and with angioedema and intensively pruritic, necrotizing lesions of the bilateral anterior tibias and feet for 2\u00a0weeks.", {"entities": [[107, 117, "DISEASE"]]}], ["Treatment with systemic corticosteroids was administered for 1\u00a0month, and resulted in a significant improvement.", {"entities": []}], ["We also present a review of the pertinent literature and discuss the clinical features, histopathological features, and differentiation of RCNEV.", {"entities": []}], ["The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/2065600765102207", {"entities": []}], ["Practical approaches to protect individuals from ambient particulate matter (PM) are urgently needed in developing countries.", {"entities": []}], ["Evidence on the health benefits of wearing particulate-filtering respirators is limited.", {"entities": []}], ["We evaluated the short-term cardiovascular health effects of wearing respirators in China.", {"entities": []}], ["A randomized crossover trial was performed in 24 healthy young adults in Shanghai, China in 2014.", {"entities": []}], ["The subjects were randomized into two groups and wore particulate-filtering respirators for 48 hr alternating with a 3-week washout interval.", {"entities": [[95, 97, "GENE"]]}], ["Heart rate variability (HRV) and ambulatory blood pressure (BP) were continuously monitored during the 2nd 24 hr in each intervention.", {"entities": [[110, 112, "GENE"]]}], ["Circulating biomarkers were measured at the end of each intervention.", {"entities": []}], ["Linear mixed-effect models were applied to evaluate the effects of wearing respirators on health outcomes.", {"entities": []}], ["During the intervention periods, the mean daily average concentration of PM with an aerodynamic diameter < 2.5 \u03bcm (PM2.5) was 74.2 \u03bcg/m3.", {"entities": []}], ["Compared with the absence of respirators, wearing respirators was associated with a decrease of 2.7 mmHg [95% confidence interval (CI): 0.1, 5.2 mmHg] in systolic BP and increases of HRV parameters, including 12.5% (95% CI: 3.8%, 21.2%) in high frequency (HF) power, 10.9% (95% CI: 1.8%, 20.0%) in the root mean square of the successive differences, and 22.1% (95% CI: 3.6%, 40.7%) in the percentage of normal RR intervals with duration > 50 msec different from the previous normal RR interval (pNN50).", {"entities": []}], ["The presence of respirators was also associated with a decrease of 7.8% (95% CI: 3.5%, 12.1%) in the ratio of low frequency (LF)/HF power.", {"entities": []}], ["Short-term wearing of particulate-filtering respirators may produce cardiovascular benefits by improving autonomic nervous function and reducing BP.", {"entities": []}], ["Shi J, Lin Z, Chen R, Wang C, Yang C, Cai J, Lin J, Xu X, Ross JA, Zhao Z, Kan H. 2017.", {"entities": []}], ["Cardiovascular benefits of wearing particulate-filtering respirators: a randomized crossover trial.", {"entities": []}], ["Environ Health Perspect 125:175\u2013180;\u2002http://dx.doi.org/10.1289/EHP73", {"entities": []}], ["A case of patient with intractable cough due to renal cell carcinoma is reported.", {"entities": [[59, 68, "DISEASE"], [48, 68, "DISEASE"]]}], ["The discussion reviews the literature regarding this unusual paraneoplastic manifestation of renal malignancy.", {"entities": []}], ["The integrated chronic disease management (ICDM) model was introduced as a response to the dual burden of HIV/AIDS and non-communicable diseases (NCDs) in South Africa, one of the first of such efforts by an African Ministry of Health.", {"entities": []}], ["The aim of the ICDM model is to leverage HIV programme innovations to improve the quality of chronic disease care.", {"entities": []}], ["There is a dearth of literature on the perspectives of healthcare providers and users on the quality of care in the novel ICDM model.", {"entities": []}], ["This paper describes the viewpoints of operational managers and patients regarding quality of care in the ICDM model.", {"entities": []}], ["In 2013, we conducted a case study of the seven PHC facilities in the rural Agincourt sub-district in northeast South Africa.", {"entities": []}], ["Focus group discussions ( n \u2009=\u20098) were used to obtain data from 56 purposively selected patients\u2009\u226518 years.", {"entities": []}], ["In-depth interviews were conducted with operational managers of each facility and the sub-district health manager.", {"entities": []}], ["Donabedian\u2019s structure , process and outcome theory for service quality evaluation underpinned the conceptual framework in this study.", {"entities": []}], ["Qualitative data were analysed, with MAXQDA 2 software, to identify 17 a priori dimensions of care and unanticipated themes that emerged during the analysis.", {"entities": []}], ["The manager and patient narratives showed the inadequacies in structure (malfunctioning blood pressure machines and staff shortage); process (irregular prepacking of drugs); and outcome (long waiting times).", {"entities": []}], ["There was discordance between managers and patients regarding reasons for long patient waiting time which managers attributed to staff shortage and missed appointments, while patients ascribed it to late arrival of managers to the clinics.", {"entities": []}], ["Patients reported anti-hypertension drug stock-outs ( structure ); sub-optimal defaulter-tracing ( process ); rigid clinic appointment system ( process ).", {"entities": [[23, 35, "DISEASE"]]}], ["Emerging themes showed that patients reported HIV stigmatisation in the community due to defaulter-tracing activities of home-based carers, while managers reported treatment of chronic diseases by traditional healers and reduced facility-related HIV stigma because HIV and NCD patients attended the same clinic.", {"entities": []}], ["Leveraging elements of HIV programmes for NCDs, specifically hypertension management, is yet to be achieved in the study setting in part because of malfunctioning blood pressure machines and anti-hypertension drug stock-outs.", {"entities": [[61, 73, "DISEASE"], [196, 208, "DISEASE"]]}], ["This has implications for the nationwide scale up of the ICDM model in South Africa and planning of an integrated chronic disease care in other low- and middle-income countries.", {"entities": []}], ["There is increasing evidence for a close link between the upper and the lower respiratory tracts and the fact that rhinitis has an important impact on asthma.", {"entities": [[115, 123, "DISEASE"], [151, 157, "DISEASE"]]}], ["Several clinical and experimental observations suggest a similar immunopathology between the upper and lower airways in allergic subjects.", {"entities": []}], ["The common inflammatory process that develops in the respiratory tract explains some of the complex interactions among different clinical diseases such as rhinitis, sinusitis, asthma, bronchial hyperresponsiveness and viral infections.", {"entities": [[155, 163, "DISEASE"], [165, 174, "DISEASE"], [176, 182, "DISEASE"]]}], ["There are also non-inflammatory mechanisms that may contribute to the link between rhinitis and asthma.", {"entities": [[83, 91, "DISEASE"], [96, 102, "DISEASE"]]}], ["Moreover, the outcomes of various pharmacological treatments of rhinitis have recently provided further support for the hypothesis of the united airways.", {"entities": [[64, 72, "DISEASE"]]}], ["We discuss some of the recent observations on the nose-lung interaction and some of the novel therapeutic approaches used to treat rhinitis and asthma that arise from this.", {"entities": [[131, 139, "DISEASE"], [144, 150, "DISEASE"]]}], ["Sensing ion or ligand concentrations, physico-chemical conditions, and molecular dimerization or conformation change is possible by assays involving fluorescent lifetime imaging.", {"entities": []}], ["The inherent low throughput of imaging impedes rigorous statistical data analysis on large cell numbers.", {"entities": []}], ["We address this limitation by developing a fluorescence lifetime-measuring flow cytometer for fast fluorescence lifetime quantification in living or fixed cell populations.", {"entities": []}], ["The instrument combines a time-correlated single photon counting epifluorescent microscope with microfluidics cell-handling system.", {"entities": []}], ["The associated computer software performs burst integrated fluorescence lifetime analysis to assign fluorescence lifetime, intensity, and burst duration to each passing cell.", {"entities": []}], ["The maximum safe throughput of the instrument reaches 3,000 particles per minute.", {"entities": []}], ["Living cells expressing spectroscopic rulers of varying peptide lengths were distinguishable by F\u00f6rster resonant energy transfer measured by donor fluorescence lifetime.", {"entities": []}], ["An epidermal growth factor (EGF)-stimulation assay demonstrated the technique's capacity to selectively quantify EGF receptor phosphorylation in cells, which was impossible by measuring sensitized emission on a standard flow cytometer.", {"entities": [[28, 31, "GENE"], [113, 116, "GENE"], [28, 31, "GENE"], [113, 116, "GENE"]]}], ["Dual-color fluorescence lifetime detection and cell-specific chemical environment sensing were exemplified using di-4-ANEPPDHQ, a lipophilic environmentally sensitive dye that exhibits changes in its fluorescence lifetime as a function of membrane lipid order.", {"entities": []}], ["To our knowledge, this instrument opens new applications in flow cytometry which were unavailable due to technological limitations of previously reported fluorescent lifetime flow cytometers.", {"entities": []}], ["The presented technique is sensitive to lifetimes of most popular fluorophores in the 0.5\u20135 ns range including fluorescent proteins and is capable of detecting multi-exponential fluorescence lifetime decays.", {"entities": []}], ["This instrument vastly enhances the throughput of experiments involving fluorescence lifetime measurements, thereby providing statistically significant quantitative data for analysis of large cell populations.", {"entities": []}], ["\u00a9 2014 International Society for Advancement of Cytometry", {"entities": []}], ["To evaluate the immediate improvement rate of irritative cough in patients treated with the combination of Ananas comosus extract and honey (Bromelin Pragmatic, double-blind, randomized, parallel-group study with children aged between 2 and 15 years, with irritative cough for at least 24hours.", {"entities": []}], ["The double-blind assessment of cough was through the number of observed coughing episodes and intensity score for a period of 10minutes of observation.", {"entities": []}], ["The decrease of one point in the mean total score was considered as a therapeutic effect.", {"entities": []}], ["There was a reduction in coughing episodes in both groups, as well as in the cough score after 30minutes of drug or honey administration.", {"entities": []}], ["The change in clinical score above two points, which could indicate marked improvement, occurred in five patients in the bromelin group and only in one in the placebo group, but without significant difference.", {"entities": []}], ["There were no adverse events.", {"entities": []}], ["The immediate improvement rate of irritative cough was similar in patients treated with combination of Ananas comosus extract and honey (Bromelin", {"entities": []}], ["Asthma is a common problem in children and, if inadequately controlled, may seriously diminish their quality of life.", {"entities": []}], ["Inhaled short-acting beta2 agonists such as salbutamol are usually prescribed as \u2018reliever\u2019 medication to help control day-to-day symptoms such as wheeze.", {"entities": []}], ["As with many medications currently prescribed for younger children (defined as those aged 2\u00a0years 6\u00a0months to 6\u00a0years 11\u00a0months), there has been no pre-licensing age-specific pharmacological testing; consequently, the doses currently prescribed (200\u20131000\u00a0\u03bcg) may be ineffective or likely to induce unnecessary side effects.", {"entities": []}], ["We plan to use the interrupter technique to measure airway resistance in this age group, allowing us for the first time to correlate inhaled salbutamol dose with changes in clinical response.", {"entities": []}], ["We will measure urinary salbutamol levels 30\u00a0min after dosing as an estimate of salbutamol doses in the lungs, and also look for genetic polymorphisms linked to poor responses to inhaled salbutamol.", {"entities": []}], ["This is a phase IV, randomised, controlled, observer-blinded, single-centre trial with four parallel groups (based on a sparse sampling approach) and a primary endpoint of the immediate bronchodilator response to salbutamol so that we can determine the most appropriate dose for an individual younger child.", {"entities": []}], ["Simple randomisation will be used with a 1:1:1:1 allocation.", {"entities": []}], ["The proposed research will exploit simple, non-invasive and inexpensive tests that can mostly be performed in an outpatient setting in order to help develop the evidence for the correct dose of salbutamol in younger children with recurrent wheeze who have been prescribed salbutamol by their doctor.", {"entities": []}], ["EudraCT2014-001978-33, ISRCTN15513131.", {"entities": []}], ["Registered on 8 April 2015.", {"entities": []}], ["End stage renal disease (ESRD) patients on maintenance hemodialysis, are high utilizers of inpatient services.", {"entities": []}], ["Because of data showing improved outcomes in medical patients admitted to hospitalist-run, non-teaching services, we hypothesized that discharge from a hospitalist-run, non-teaching service is associated with lower risk of 30-day re-hospitalization in a cohort of patients on hemodialysis.", {"entities": []}], ["One thousand and 84 consecutive patients with ESRD on maintenance hemodialysis who were admitted to Montefiore, a tertiary care center, in 2014 were analyzed using the electronic medical records.", {"entities": []}], ["We evaluated factors associated with 30-day readmission in multivariable regression models.", {"entities": []}], ["We then tested the association of care by a hospitalist-run, non-teaching service with 30-day readmission in a propensity score matched analysis.", {"entities": []}], ["Patients cared for on the hospitalist-run, non-teaching service had lower socio-economic scores (SES) and had longer lengths of stay (LOS), as compared to a standard teaching service, but otherwise the populations were similar.", {"entities": []}], ["In multivariable testing, severity of illness, (OR 2.40, (95%CI: 1.43\u20134.03) for highest quartile) number of previous hospitalizations (OR 1.22 (95%CI:1.16\u20131.28) for each admission), and discharge to a skilled nursing facility (SNF)(OR 1.56 (95%CI:1.01\u20132.43) were significantly associated with 30-day re-admissions.", {"entities": []}], ["Care by the non-teaching service was associated with a lower risk of 30-day readmission, even after adjusting for clinical factors and matching based on propensity score (OR 0.65(95%CI:0.46\u20130.91) and 0.71(95%CI:0.66\u20130.77) respectively).", {"entities": []}], ["Patients with ESRD on hemodialysis discharged from a hospitalist-run, non-teaching medicine service had lower odds of readmission as compared to those patients discharged from a standard teaching service.", {"entities": []}], ["Copeptin is a novel biomarker that predicts mortality in lower respiratory tract infections and heart failure (HF), but the diagnostic value of copeptin in acute dyspnea and the prognostic significance of copeptin in acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is not clear.", {"entities": [[239, 276, "DISEASE"]]}], ["We determined copeptin and NT-proBNP concentrations at hospital admission in 314 patients with acute dyspnea who were categorized by diagnosis.", {"entities": []}], ["Survival was registered after a median follow-up of 816\u00a0days, and the prognostic and diagnostic properties of copeptin and NT-proBNP were analyzed in acute HF ( n \u00a0=\u00a0143) and AECOPD ( n \u00a0=\u00a084) separately.", {"entities": []}], ["The median concentration of copeptin at admission was lower in AECOPD compared to acute HF (8.8 [5.2\u201319.7] vs. 22.2 [10.2\u201347.9]) pmol/L, p \u00a0<\u00a00.001), but NT-proBNP discriminated acute HF from non-HF related dyspnea more accurately than copeptin (ROC-AUC 0.85 [0.81\u20130.89] vs. 0.71 [0.66\u20130.77], p \u00a0<\u00a00.0001).", {"entities": []}], ["Adjusted for basic risk factors, increased copeptin concentrations predicted mortality in AECOPD (HR per log (ln) unit 1.72 [95% CI 1.21\u20132.45], p \u00a0=\u00a00.003) and acute HF (1.61 [1.25\u20132.09], p \u00a0<\u00a00.001), whereas NT-proBNP concentrations predicted mortality only in acute HF (1.62 [1.27\u20132.06], p \u00a0<\u00a00.001).", {"entities": [[98, 100, "GENE"]]}], ["On top of a basic model copeptin reclassified a significant proportion of patients into a more accurate risk strata in AECOPD (NRI 0.60 [0.19\u20131.02], p \u00a0=\u00a00.004) and acute HF (0.39 [0.06\u20130.71], p \u00a0=\u00a00.020).", {"entities": []}], ["Copeptin is a strong prognostic marker in both AECOPD and acute HF, while NT-proBNP concentrations predict mortality only in patients with acute HF.", {"entities": []}], ["NT-proBNP levels are superior to copeptin levels to diagnose acute HF in patients with acute dyspnea.", {"entities": []}], ["The online version of this article (10.1186/s12931-017-0665-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Mammalian immune system development depends on instruction from resident commensal microorganisms.", {"entities": []}], ["Diseases associated with abnormal immune responses towards environmental and self antigens have been rapidly increasing over the last 50 years.", {"entities": []}], ["These diseases include inflammatory bowel disease (IBD), multiple sclerosis (MS), type I diabetes (T1D), allergies and asthma.", {"entities": [[23, 49, "DISEASE"], [57, 75, "DISEASE"], [119, 125, "DISEASE"]]}], ["The observation that people with immune mediated diseases house a different microbial community when compared to healthy individuals suggests that pathogenesis arises from improper training of the immune system by the microbiota.", {"entities": []}], ["However, with hundreds of different microorganisms on our bodies it is hard to know which of these contribute to health and more importantly how?", {"entities": []}], ["Microbiologists studying pathogenic organisms have long adhered to Koch's postulates to directly relate a certain disease to a specific microbe, raising the question of whether this might be true of commensal\u2013host relationships as well.", {"entities": []}], ["Emerging evidence supports that rather than one or two dominant organisms inducing host health, the composition of the entire community of microbial residents influences a balanced immune response.", {"entities": []}], ["Thus, perturbations to the structure of complex commensal communities (referred to as dysbiosis ) can lead to deficient education of the host immune system and subsequent development of immune mediated diseases.", {"entities": []}], ["Here we will overview the literature that describes the causes of dysbiosis and the mechanisms evolved by the host to prevent these changes to community structure.", {"entities": []}], ["Building off these studies, we will categorize the different types of dysbiosis and define how collections of microorganisms can influence the host response.", {"entities": []}], ["This research has broad implications for future therapies that go beyond the introduction of a single organism to induce health.", {"entities": []}], ["We propose that identifying mechanisms to re-establish a healthy complex microbiota after dysbiosis has occurred, a process we will refer to as rebiosis, will be fundamental to treating complex immune diseases.", {"entities": []}], ["B lymphocyte-induced maturation protein-1 (Blimp-1) serves as a master regulator of the development and function of antibody-producing B cells.", {"entities": []}], ["Given that its function in T lymphocytes has been identified within the past decade, we review recent findings with emphasis on its role in coordinated control of gene expression during the development, differentiation, and function of T cells.", {"entities": []}], ["Expression of Blimp-1 is mainly confined to activated T cells and is essential for the production of interleukin (IL)-10 by a subset of forkhead box (Fox)p3", {"entities": []}], ["Several studies in wealthy countries suggest that utilization of GP and hospital services, after adjusting for health care need, is equitable or pro-poor, whereas specialist care tends to favour the better off.", {"entities": []}], ["Horizontal equity in these studies has not been evaluated appropriately, since the use of healthcare services is analysed without distinguishing between public and private services.", {"entities": []}], ["The purpose of this study is to estimate the relation between socioeconomic position and health services use to determine whether the findings are compatible with the attainment of horizontal equity: equal use of public healthcare services for equal need.", {"entities": []}], ["Data from a sample of 18,837 Spanish subjects were analysed to calculate the percentage of use of public and private general practitioner (GP), specialist and hospital care according to three indicators of socioeconomic position: educational level, social class and income.", {"entities": []}], ["The percentage ratio was used to estimate the magnitude of the relation between each measure of socioeconomic position and the use of each health service.", {"entities": []}], ["After adjusting for age, sex and number of chronic diseases, a gradient was observed in the magnitude of the percentage ratio for public GP visits and hospitalisation: persons in the lowest socioeconomic position were 61\u201388% more likely to visit public GPs and 39\u201357% more likely to use public hospitalisation than those in the highest socioeconomic position.", {"entities": []}], ["In general, the percentage ratio did not show significant socioeconomic differences in the use of public sector specialists.", {"entities": []}], ["The magnitude of the percentage ratio in the use of the three private services also showed a socioeconomic gradient, but in exactly the opposite direction of the gradient observed in the public services.", {"entities": []}], ["These findings show inequity in GP visits and hospitalisations, favouring the lower socioeconomic groups, and equity in the use of the specialist physician.", {"entities": []}], ["These inequities could represent an overuse of public healthcare services or could be due to the fact that persons in high socioeconomic positions choose to use private health services.", {"entities": []}], ["General practitioners (GPs) are the most important providers of primary health care, as proven by related research published several decades ago.", {"entities": []}], ["However, the knowledge structure and theme trends of such research remain unclear.", {"entities": []}], ["Accordingly, this study aimed to provide an overview of the development of research on GPs over the period of 1999 to 2014.", {"entities": []}], ["Studies on GPs conducted from 1999 to 2014 were retrieved from PubMed.", {"entities": []}], ["In this work, co-word, social network analysis, and theme trends analyses were conducted to reveal the knowledge structures and thematic evolution of research on GPs.", {"entities": []}], ["The number of conducted studies on GPs increased.", {"entities": []}], ["However, growth speed slowed down during the past 16\u00a0years.", {"entities": []}], ["A total of 27 high-frequency keywords were identified in 1999 to 2003, and more new and specific high-frequency keywords emerged in the subsequent periods.", {"entities": []}], ["The dynamic of this field was first divergent and then considered convergent.", {"entities": []}], ["Specifically, network centralization is 19.77\u2009%, 19.09\u2009%, and 13.04\u2009% in 1999 to 2003, 2004 to 2008 and 2009 to 2014, respectively.", {"entities": []}], ["The major topics of research on GPs completed from 1999 to 2014 were \u201cphysician/family,\u201d\u201cattitude of health personnel,\u201d and \u201cprimary health care,\u201d and \u201cgeneral practitioner\u201d communities, and so on.", {"entities": []}], ["The research themes on GPs are relatively stable at the beginning of the 21", {"entities": []}], ["Silicosis is a chronic and incurable occupational disease that can progress even after the cessation of exposure.", {"entities": [[0, 9, "DISEASE"]]}], ["Recent studies suggest that the forced oscillation technique may help to clarify the changes in lung mechanics resulting from silicosis as well as the detection of these changes.", {"entities": [[126, 135, "DISEASE"]]}], ["We investigated the effects of airway obstruction in silicosis on respiratory impedance and evaluated the diagnostic efficacy of the forced oscillation technique in these patients.", {"entities": [[53, 62, "DISEASE"]]}], ["Spirometry was used to classify the airway obstruction, which resulted in four subject categories: controls (n\u200a=\u200a21), patients with a normal exam (n\u200a=\u200a12), patients with mild obstruction (n\u200a=\u200a22), and patients with moderate-to-severe obstruction (n\u200a=\u200a12).", {"entities": []}], ["Resistive data were interpreted using the zero-intercept resistance (R0), the resistance at 4 Hz (Rrs4), and the mean resistance.", {"entities": []}], ["We also analyzed the mean reactance (Xm) and the dynamic compliance.", {"entities": []}], ["The total mechanical load was evaluated using the absolute value of the respiratory impedance (Z4Hz).", {"entities": []}], ["The diagnostic potential was evaluated by investigating the area under the receiver operating characteristic curve.", {"entities": []}], ["ClinicalTrials.gov: NCT01725971.", {"entities": []}], ["We observed significant ( p <0.0002) increases in R0, Rrs4, Rm, and Z4Hz and significant reductions in Crs,dyn ( p <0.0002) and Xm ( p <0.0001).", {"entities": []}], ["R0, Rrs4, Rm, and Z4Hz performed adequately in the diagnosis of mild obstruction (area under the curve>0.80) and highly accurately in the detection of moderate-to-severe obstruction (area under the curve>0.90).", {"entities": []}], ["The forced oscillation technique may contribute to the study of the pathophysiology of silicosis and may improve the treatment offered to these patients, thus representing an alternative and/or complementary tool for evaluating respiratory mechanics.", {"entities": [[87, 96, "DISEASE"]]}], ["On sedation motivated by the clinical needs for safety and reliability, recent studies have attempted to identify brain-specific signatures for tracking patient transition into and out of consciousness, but the differences in neurophysiological effects between 1) the sedative types and 2) the presence/absence of surgical stimulations still remain unclear.", {"entities": []}], ["Here we used multimodal electroencephalography\u2013functional near-infrared spectroscopy (EEG\u2013fNIRS) measurements to observe electrical and hemodynamic responses during sedation simultaneously.", {"entities": []}], ["Forty healthy volunteers were instructed to push the button to administer sedatives in response to auditory stimuli every 9\u201311 s. To generally illustrate brain activity at repetitive transition points at the loss of consciousness (LOC) and the recovery of consciousness (ROC), patient-controlled sedation was performed using two different sedatives (midazolam (MDZ) and propofol (PPF)) under two surgical conditions.", {"entities": []}], ["Once consciousness was lost via sedatives, we observed gradually increasing EEG power at lower frequencies (<15 Hz) and decreasing power at higher frequencies (>15 Hz), as well as spatially increased EEG powers in the delta and lower alpha bands, and particularly also in the upper alpha rhythm, at the frontal and parieto-occipital areas over time.", {"entities": []}], ["During ROC from unconsciousness, these spatio-temporal changes were reversed.", {"entities": []}], ["Interestingly, the level of consciousness was switched on/off at significantly higher effect-site concentrations of sedatives in the brain according to the use of surgical stimuli, but the spatio-temporal EEG patterns were similar, regardless of the sedative used.", {"entities": []}], ["We also observed sudden phase shifts in fronto-parietal connectivity at the LOC and the ROC as critical points.", {"entities": []}], ["fNIRS measurement also revealed mild hemodynamic fluctuations.", {"entities": []}], ["Compared with general anesthesia, our results provide insights into critical hallmarks of sedative-induced (un)consciousness, which have similar spatio-temporal EEG-fNIRS patterns regardless of the stage and the sedative used.", {"entities": []}], ["Objective To assess the associations between different antidepressant treatments and the rates of suicide and attempted suicide or self harm in people with depression.", {"entities": []}], ["Design Cohort study.", {"entities": []}], ["Setting Patients registered with UK general practices contributing data to the QResearch database.", {"entities": []}], ["Participants 238\u2009963 patients aged 20 to 64 years with a first diagnosis of depression between 1 January 2000 and 31 July 2011, followed up until 1 August 2012.", {"entities": []}], ["Exposures Antidepressant class (tricyclic and related antidepressants, selective serotonin reuptake inhibitors, other antidepressants), dose, and duration of use, and commonly prescribed individual antidepressant drugs.", {"entities": []}], ["Cox proportional hazards models were used to calculate hazard ratios adjusting for potential confounding variables.", {"entities": []}], ["Main outcome measures Suicide and attempted suicide or self harm during follow-up.", {"entities": []}], ["Results During follow-up, 87.7% (n=209\u2009476) of the cohort received one or more prescriptions for antidepressants.", {"entities": []}], ["The median duration of treatment was 221 days (interquartile range 79-590 days).", {"entities": []}], ["During the first five years of follow-up 198 cases of suicide and 5243 cases of attempted suicide or self harm occurred.", {"entities": []}], ["The difference in suicide rates during periods of treatment with tricyclic and related antidepressants compared with selective serotonin reuptake inhibitors was not significant (adjusted hazard ratio 0.84, 95% confidence interval 0.47 to 1.50), but the suicide rate was significantly increased during periods of treatment with other antidepressants (2.64, 1.74 to 3.99).", {"entities": []}], ["The hazard ratio for suicide was significantly increased for mirtazapine compared with citalopram (3.70, 2.00 to 6.84).", {"entities": []}], ["Absolute risks of suicide over one year ranged from 0.02% for amitriptyline to 0.19% for mirtazapine.", {"entities": []}], ["There was no significant difference in the rate of attempted suicide or self harm with tricyclic antidepressants (0.96, 0.87 to 1.08) compared with selective serotonin reuptake inhibitors, but the rate of attempted suicide or self harm was significantly higher for other antidepressants (1.80, 1.61 to 2.00).", {"entities": []}], ["The adjusted hazard ratios for attempted suicide or self harm were significantly increased for three of the most commonly prescribed drugs compared with citalopram: venlafaxine (1.85, 1.61 to 2.13), trazodone (1.73, 1.26 to 2.37), and mirtazapine (1.70, 1.44 to 2.02), and significantly reduced for amitriptyline (0.71, 0.59 to 0.85).", {"entities": []}], ["The absolute risks of attempted suicide or self harm over one year ranged from 1.02% for amitriptyline to 2.96% for venlafaxine.", {"entities": []}], ["Rates were highest in the first 28 days after starting treatment and remained increased in the first 28 days after stopping treatment.", {"entities": []}], ["Conclusion Rates of suicide and attempted suicide or self harm were similar during periods of treatment with selective serotonin reuptake inhibitors and tricyclic and related antidepressants.", {"entities": []}], ["Mirtazapine, venlafaxine, and trazodone were associated with the highest rates of suicide and attempted suicide or self harm, but the number of suicide events was small leading to imprecise estimates.", {"entities": []}], ["As this is an observational study the findings may reflect indication biases and residual confounding from severity of depression and differing characteristics of patients prescribed these drugs.", {"entities": []}], ["The increased rates in the first 28 days of starting and stopping antidepressants emphasise the need for careful monitoring of patients during these periods.", {"entities": []}], ["Our previous study indicated that the presence of wheat-specific IgG1 and IgG4 antibodies was associated with work-related symptoms in workers exposed to wheat flour.", {"entities": []}], ["We performed this study to investigate the genetic polymorphisms of \u03b2 2 -adrenergic receptors and wheat-specific antibodies in association with the clinical parameters of baker's asthma.", {"entities": [[179, 185, "DISEASE"]]}], ["In total, 379 subjects working in a single industrial bakery were enrolled in this study.", {"entities": []}], ["The skin prick test was performed with common inhalant allergens and wheat flour extract.", {"entities": []}], ["The presence of serum- specific IgE, IgG1, and IgG4 antibodies to wheat flour were determined by ELISA.", {"entities": []}], ["Whole blood samples were obtained for genotype analysis.", {"entities": []}], ["Subjects were genotyped with regard to five candidate single nucleotide polymorphisms (SNPs) of the \u03b2 2 -adrenergic receptor gene (ADRB2; -47 T>C, 46 A>G, 79 C>G, 252 G>A, and 523 C>A) using a single-base extension method.", {"entities": [[131, 136, "GENE"]]}], ["No significant associations were observed between the genotype/allele frequencies of any of the SNPs tested and any clinical parameters.", {"entities": []}], ["The haplotype of ADRB2 (GAA composed of 46 A>G, 252 G>A, and 523 C>A) was significantly associated with work-related symptoms ( p <0.05).", {"entities": [[17, 22, "GENE"], [24, 27, "GENE"]]}], ["Moreover, in subjects with the AG or GG genotype at 46 A>G and haplotype [GAA] of ADRB2, the prevalence rates of wheat-specific IgG1 antibodies and lower respiratory symptoms increased significantly with exposure intensity (both p <0.05).", {"entities": [[74, 77, "GENE"], [82, 87, "GENE"]]}], ["The findings of the present study suggest that ADRB2 genetic polymorphism may contribute to the development of work-related symptoms in workers exposed to wheat flour, which can lead to baker's asthma.", {"entities": [[194, 200, "DISEASE"], [47, 52, "GENE"]]}], ["TOR ( T arget O f R apamycin) is a highly conserved protein kinase that is important in both fundamental and clinical biology.", {"entities": []}], ["In fundamental biology, TOR is a nutrient-sensitive, central controller of cell growth and aging.", {"entities": []}], ["In clinical biology, TOR is implicated in many diseases and is the target of the drug rapamycin used in three different therapeutic areas.", {"entities": []}], ["The yeast Saccharomyces cerevisiae has played a prominent role in both the discovery of TOR and the elucidation of its function.", {"entities": []}], ["Here we review the TOR signaling network in S. cerevisiae .", {"entities": []}], ["Asthma exacerbations are frequently triggered by rhinovirus infections.", {"entities": [[0, 6, "DISEASE"]]}], ["Both asthma and respiratory tract infection can activate haemostasis.", {"entities": [[5, 11, "DISEASE"]]}], ["Therefore we hypothesized that experimental rhinovirus-16 infection and asthmatic airway inflammation act in synergy on the haemostatic balance.", {"entities": []}], ["28 patients (14 patients with mild allergic asthma and 14 healthy non-allergic controls) were infected with low-dose rhinovirus type 16.", {"entities": [[35, 50, "DISEASE"], [44, 50, "DISEASE"]]}], ["Venous plasma and bronchoalveolar lavage fluid (BAL fluid) were obtained before and 6\u00a0days after infection to evaluate markers of coagulation activation, thrombin-antithrombin complexes, von Willebrand factor, plasmin-antiplasmin complexes, plasminogen activator inhibitor type-1, endogenous thrombin potential and tissue factor-exposing microparticles by fibrin generation test, in plasma and/or BAL fluid.", {"entities": []}], ["Data were analysed by nonparametric tests (Wilcoxon, Mann Whitney and Spearman correlation).", {"entities": []}], ["13 patients with mild asthma (6 females, 19-29 y) and 11 healthy controls (10 females, 19-31 y) had a documented Rhinovirus-16 infection.", {"entities": [[22, 28, "DISEASE"]]}], ["Rhinovirus-16 challenge resulted in a shortening of the fibrin generation test in BAL fluid of asthma patients (t\u2009=\u2009-1: 706\u00a0s vs. t\u2009=\u20096: 498\u00a0s; p\u2009=\u20090.02), but not of controls (t\u2009=\u2009-1: 693\u00a0s vs. t\u2009=\u20096: 636\u00a0s; p\u2009=\u20090.65).", {"entities": [[95, 101, "DISEASE"]]}], ["The fold change in tissue factor-exposing microparticles in BAL fluid inversely correlated with the fold changes in eosinophil cationic protein and myeloperoxidase in BAL fluid after virus infection (r\u2009=\u2009-0.517 and -0.528 resp., both p\u2009=\u20090.01).", {"entities": []}], ["Rhinovirus-16 challenge led to increased plasminogen activator inhibitor type-1 levels in plasma in patients with asthma (26.0\u00a0ng/mL vs. 11.5\u00a0ng/mL in healthy controls, p\u2009=\u20090.04).", {"entities": [[114, 120, "DISEASE"]]}], ["Rhinovirus-16 load in BAL showed a linear correlation with the fold change in endogenous thrombin potential, plasmin-antiplasmin complexes and plasminogen activator inhibitor type-1.", {"entities": []}], ["Experimental rhinovirus infection induces procoagulant changes in the airways of patients with asthma through increased activity of tissue factor-exposing microparticles.", {"entities": [[95, 101, "DISEASE"]]}], ["These microparticle-associated procoagulant changes are associated with both neutrophilic and eosinophilic inflammation.", {"entities": []}], ["Systemic activation of haemostasis increases with Rhinoviral load.", {"entities": []}], ["This trial was registered at the Dutch trial registry ( http://www.trialregister.nl ): NTR1677 .", {"entities": []}], ["Interleukin (IL)-13 is a key mediator of tissue fibrosis caused by T helper cell type 2 inflammation.", {"entities": []}], ["We hypothesized that the fibrogenic effects of IL-13 are mediated by transforming growth factor (TGF)-\u03b2.", {"entities": []}], ["To test this hypothesis we compared the regulation of TGF-\u03b2 in lungs from wild-type mice and CC10-IL-13 mice in which IL-13 overexpression causes pulmonary fibrosis.", {"entities": [[146, 164, "DISEASE"]]}], ["IL-13 selectively stimulated TGF-\u03b2 1 production in transgenic animals and macrophages were the major site of TGF-\u03b2 1 production and deposition in these tissues.", {"entities": []}], ["IL-13 also activated TGF-\u03b2 1 in vivo.", {"entities": []}], ["This activation was associated with decreased levels of mRNA encoding latent TGF-\u03b2\u2013binding protein-1 and increased mRNA encoding urinary plasminogen activator, matrix metalloproteinase (MMP)-9, and CD44.", {"entities": [[198, 202, "GENE"]]}], ["TGF-\u03b2 1 activation was abrogated by the plasmin/serine protease antagonist aprotinin.", {"entities": []}], ["It was also decreased in progeny of crosses of CC10-IL-13 mice and MMP-9 null mice but was not altered in crosses with CD44 null animals.", {"entities": [[119, 123, "GENE"]]}], ["IL-13\u2013induced fibrosis was also significantly ameliorated by treatment with the TGF-\u03b2 antagonist soluble TGF\u03b2R-Fc (sTGF\u03b2R-Fc).", {"entities": []}], ["These studies demonstrate that IL-13 is a potent stimulator and activator of TGF-\u03b2 1 in vivo.", {"entities": []}], ["They also demonstrate that this activation is mediated by a plasmin/serine protease- and MMP-9\u2013dependent and CD44-independent mechanism(s) and that the fibrogenic effects of IL-13 are mediated, in great extent, by this TGF-\u03b2 pathway.", {"entities": []}], ["In a large population-based study among adults in northern Europe the relation between occupational exposure and new-onset asthma was studied.", {"entities": [[123, 129, "DISEASE"]]}], ["The study comprised 13 284 subjects born between 1945 and 1973, who answered a questionnaire 1989\u20131992 and again 1999\u20132001.", {"entities": []}], ["Asthma was defined as \u2018Asthma diagnosed by a physician\u2019 with reported year of diagnose.", {"entities": [[0, 6, "DISEASE"], [23, 29, "DISEASE"]]}], ["Hazard ratios (HR), for new-onset adult asthma during 1980\u20132000, were calculated using a modified job-exposure matrix as well as high-risk occupations in Cox regression models.", {"entities": [[40, 46, "DISEASE"], [15, 17, "GENE"]]}], ["The analyses were made separately for men and women and were also stratified for atopy.", {"entities": []}], ["During the observation period there were 429 subjects with new-onset asthma with an asthma incidence of 1.3 cases per 1000 person-years for men and 2.4 for women.", {"entities": [[69, 75, "DISEASE"], [84, 90, "DISEASE"]]}], ["A significant increase in new-onset asthma was seen for men exposed to plant-associated antigens (HR = 3.6; 95% CI [confidence interval] = 1.4\u20139.0), epoxy (HR = 2.4; 95% CI = 1.3\u20134.5), diisocyanates (HR = 2.1; 95% CI = 1.2\u20133.7) and accidental peak exposures to irritants (HR = 2.4; 95% CI = 1.3\u20134.7).", {"entities": [[36, 42, "DISEASE"], [98, 100, "GENE"], [156, 158, "GENE"], [200, 202, "GENE"], [272, 274, "GENE"], [98, 100, "GENE"], [156, 158, "GENE"], [200, 202, "GENE"], [272, 274, "GENE"], [98, 100, "GENE"], [156, 158, "GENE"], [200, 202, "GENE"], [272, 274, "GENE"], [98, 100, "GENE"], [156, 158, "GENE"], [200, 202, "GENE"], [272, 274, "GENE"]]}], ["Both men and women exposed to cleaning agents had an increased asthma risk.", {"entities": [[63, 69, "DISEASE"]]}], ["When stratifying for atopy an increased asthma risk were seen in non-atopic men exposed to acrylates (HR = 3.3; 95% CI = 1.4\u20137.5), epoxy compounds (HR = 3.6; 95% CI = 1.6\u20137.9), diisocyanates and accidental peak exposures to irritants (HR = 3.0; 95% CI = 1.2\u20137.2).", {"entities": [[40, 46, "DISEASE"], [102, 104, "GENE"], [148, 150, "GENE"], [235, 237, "GENE"], [102, 104, "GENE"], [148, 150, "GENE"], [235, 237, "GENE"], [102, 104, "GENE"], [148, 150, "GENE"], [235, 237, "GENE"]]}], ["Population attributable risk for occupational asthma was 14% for men and 7% for women.", {"entities": [[46, 52, "DISEASE"]]}], ["This population-based study showed that men exposed to epoxy, diisocyanates and acrylates had an increased risk of new-onset asthma.", {"entities": [[125, 131, "DISEASE"]]}], ["Non-atopics seemed to be at higher risk than atopics, except for exposure to high molecular weight agents.", {"entities": []}], ["Increased asthma risks among cleaners, spray painters, plumbers, and hairdressers were confirmed.", {"entities": [[10, 16, "DISEASE"]]}], ["So far, it has not yet been studied whether socioeconomic status is associated with distinct frailty components and for which frailty component this association is the strongest.", {"entities": []}], ["We aimed to examine the association between socioeconomic status and frailty and frailty components.", {"entities": []}], ["In addition we assessed the mediating effect of the number of morbidities on the association between socioeconomic status and other frailty components.", {"entities": []}], ["This is a cross-sectional study of pooled data of The Older Persons and Informal Caregivers Survey Minimum DataSet in the Netherlands among community-dwelling persons aged 55 years and older (n = 26,014).", {"entities": []}], ["Frailty was measured with a validated Frailty Index that consisted of 45 items.", {"entities": []}], ["The Frailty Index contained six components: morbidities, limitations in activities of daily living (ADL), limitations in instrumental ADL (IADL), health-related quality of life, psychosocial health and self-rated health.", {"entities": []}], ["Socioeconomic indicators used were education level and neighbourhood socioeconomic status.", {"entities": []}], ["Persons with primary or secondary education had higher overall frailty and frailty component scores compared to persons with tertiary education (P < .001).", {"entities": []}], ["Lower education levels were most consistently associated with higher overall frailty, more morbidities and worse self-rated health (P < .05 in all age groups).", {"entities": []}], ["The strongest association was found between primary education and low psychosocial health for persons aged 55\u201369 years and more IADL limitations for persons aged 80+ years.", {"entities": []}], ["Associations between neighborhood socioeconomic status and frailty (components) also showed inequalities, although less strong.", {"entities": []}], ["The number of morbidities moderately to strongly mediated the association between socioeconomic indicators and other frailty components.", {"entities": []}], ["There are socioeconomic inequalities in frailty and frailty components.", {"entities": []}], ["Inequalities in frailty, number of morbidities and self-rated health are most consistent across age groups.", {"entities": []}], ["The number of morbidities a person has play an important role in explaining socioeconomic inequalities in frailty and should be taken into account in the management of frailty.", {"entities": []}], ["Tracheal epithelial cells are anchored to a dynamic basement membrane that contains a variety of extracellular matrix proteins including collagens and laminins.", {"entities": []}], ["During development, wound repair and disease of the airway epithelium, significant changes in extracellular matrix proteins may directly affect cell migration, differentiation and events mediated by intercellular communication.", {"entities": []}], ["We hypothesized that alterations in cell matrix, specifically type I collagen and laminin \u03b13\u03b23\u03b32 (LM-332) proteins within the matrix, directly affect intercellular communication in ciliated rabbit tracheal epithelial cells (RTEC).", {"entities": []}], ["Functional coupling of RTEC was monitored by microinjection of the negatively charged fluorescent dyes, Lucifer Yellow and Alexa 350, into ciliated RTEC grown on either a LM-332/collagen or collagen matrix.", {"entities": []}], ["Coupling of physiologically significant molecules was evaluated by the mechanism and extent of propagated intercellular Ca When compared to RTEC grown on collagen alone, RTEC grown on LM-332/collagen displayed a significant increase in dye transfer.", {"entities": []}], ["Although mechanical stimulation of RTEC grown on either LM-332/collagen or collagen alone resulted in intercellular Ca Alterations in airway basement membrane proteins such as LM-332 can induce connexin reorganizations and result in altered cellular communication mechanisms that could contribute to airway tissue function.", {"entities": []}], ["Management of acute respiratory tract infection varies substantially despite this being a condition frequently encountered in pediatric emergency departments.", {"entities": []}], ["Previous studies have suggested that the use of antibiotics was higher when chest radiography was performed.", {"entities": []}], ["However none of these analyses had considered the inherent indication bias of observational studies.", {"entities": []}], ["The aim of this work was to assess the relationship between performing chest radiography and prescribing antibiotics using a propensity score analysis to address the indication bias due to non-random radiography assignment.", {"entities": []}], ["We conducted a prospective study of 697 children younger than 2 years of age who presented during the winter months of 2006\u20132007 for suspicion of respiratory tract infection at the Pediatric Emergency Department of an urban general hospital in France (Paris suburb).", {"entities": []}], ["We first determined the individual propensity score (probability of having a chest radiography according to baseline characteristics).", {"entities": []}], ["Then we assessed the relation between radiography and antibiotic prescription using two methods: adjustment and matching on the propensity score.", {"entities": []}], ["We found that performing a chest radiography lead to more frequent antibiotic prescription that may be expressed as OR\u200a=\u200a2.3, CI [1.3\u20134.1], or as an increased use of antibiotics of 18.6% [0.08\u20130.29] in the group undergoing chest radiography.", {"entities": []}], ["Chest radiography has a significant impact on the management of infants admitted for suspicion of respiratory tract infection in a pediatric emergency department and may lead to unnecessary administration of antibiotics.", {"entities": []}], ["Objectives To determine the accuracy of a clinical decision rule (the traffic light system developed by the National Institute for Health and Clinical Excellence (NICE)) for detecting three common serious bacterial infections (urinary tract infection, pneumonia, and bacteraemia) in young febrile children.", {"entities": [[252, 261, "DISEASE"]]}], ["Design Retrospective analysis of data from a two year prospective cohort study Setting A paediatric emergency department.", {"entities": []}], ["Participants 15\u00a0781 cases of children under 5 years of age presenting with a febrile illness.", {"entities": []}], ["Main outcome measures Clinical features were used to categorise each febrile episodes as low, intermediate, or high probability of serious bacterial infection (green, amber, and red zones of the traffic light system); these results were checked (using standard radiological and microbiological tests) for each of the infections of interest and for any serious bacterial infection.", {"entities": []}], ["Results After combination of the intermediate and high risk categories, the NICE traffic light system had a test sensitivity of 85.8% (95% confidence interval 83.6% to 87.7%) and specificity of 28.5% (27.8% to 29.3%) for the detection of any serious bacterial infection.", {"entities": []}], ["Of the 1140 cases of serious bacterial infection, 157 (13.8%) were test negative (in the green zone), and, of these, 108 (68.8%) were urinary tract infections.", {"entities": []}], ["Adding urine analysis (leucocyte esterase or nitrite positive), reported in 3653 (23.1%) episodes, to the traffic light system improved the test performance: sensitivity 92.1% (89.3% to 94.1%), specificity 22.3% (20.9% to 23.8%), and relative positive likelihood ratio 1.10 (1.06 to 1.14).", {"entities": []}], ["Conclusion The NICE traffic light system failed to identify a substantial proportion of serious bacterial infections, particularly urinary tract infections.", {"entities": []}], ["The addition of urine analysis significantly improved test sensitivity, making the traffic light system a more useful triage tool for the detection of serious bacterial infections in young febrile children.", {"entities": []}], ["It is unknown whether using different published thresholds (PTs) for classifying physical activity (PA) impacts upon activity-health relationships.", {"entities": [[60, 63, "GENE"]]}], ["This study explored whether relationships between PA (sedentary [SED], light PA [LPA], moderate PA [MPA], moderate-to-vigorous PA, vigorous PA [VPA]) and health markers differed in children when classified using three different PTs.", {"entities": [[81, 84, "GENE"], [228, 231, "GENE"]]}], ["104 children (63 girls) aged 10\u201314 years wore an RT3 triaxial accelerometer for seven days and measures of adiposity and cardiometabolic risk markers were taken.", {"entities": []}], ["Significant associations ( p < .05) in boys were found between LPA and body mass index z -score and waist circumference z -score for the Rowlands et al PT only (\u03b2\u200a=\u200a .459 and.401, respectively) and body fat% (BF%) for the Chu et al PT only (\u03b2\u200a=\u200a.322) and in girls with BF% for the Rowlands et al PT only (\u03b2\u200a=\u200a .303) and systolic BP and blood glucose for the Vanhelst et al PT only (\u03b2\u200a=\u200a\u2212.298 and \u2212.283, respectively).", {"entities": [[63, 66, "GENE"]]}], ["MPA was significantly ( p <.05) associated with BF%, diastolic BP, and cardiorespiratory fitness (CRF) for the Chu et al PT only in girls (\u03b2\u200a=\u200a\u2212.436, \u2212.529, and .446, respectively).", {"entities": []}], ["SED was significantly ( p <.05) associated with triglycerides (\u03b2\u200a=\u200a.492) for the Rowlands et al PT only in boys and VPA with CRF ( p <.05) for the Rowlands et al and Vanhelst et al PTs only in girls (\u03b2\u200a=\u200a.416 and .352, respectively).", {"entities": [[181, 184, "GENE"]]}], ["The choice of PT impacted upon activity-health relationships.", {"entities": []}], ["A consensus on appropriate accelerometer thresholds for quantifying PA intensity and sedentary behaviour is needed in order to make accurate evidence-based recommendations for health promotion.", {"entities": []}], ["The global burden of diabetes and other non-communicable diseases is rising dramatically worldwide and is causing a double poor health burden in low- and middle-income countries.", {"entities": []}], ["Early life influences play an important part in this scenario because maternal lifestyle and conditions such as gestational diabetes and obesity affect the risk of diabetes in the next generation.", {"entities": [[112, 132, "DISEASE"], [137, 144, "DISEASE"]]}], ["This indicates important periods during the lifecourse when interventions could have powerful affects in reducing incidence of non-communicable diseases.", {"entities": []}], ["However, interventions to promote diet and lifestyle in prospective parents before conception have not received sufficient attention, especially in low- and middle-income countries undergoing socio-economic transition.", {"entities": []}], ["Interventions to produce weight loss in adults or to reduce weight gain in pregnancy have had limited success and might be too late to produce the largest effects on the health of the child and his/her later risk of non-communicable diseases.", {"entities": []}], ["A very important factor in the prevention of the developmental component of diabetes risk is the physiological state in which the parents enter pregnancy.", {"entities": []}], ["We argue that the most promising strategy to improve prospective parents\u2019 body composition and lifestyle is the promotion of health literacy in adolescents.", {"entities": []}], ["Multiple but integrated forms of community-based interventions that focus on nutrition, physical activity, family planning, breastfeeding and infant feeding practices are needed.", {"entities": []}], ["They need to address the wider social economic context in which adolescents live and to be linked with existing public health programmes in sexual and reproductive health and maternal and child health initiatives.", {"entities": []}], ["Interventions aimed at ensuring a healthy body composition, diet and lifestyle before pregnancy offer a most effective solution in many settings, especially in low- and middle-income countries undergoing socio-economic transition.", {"entities": []}], ["Preparing a mother, her partner and her future child for \u201cthe 1000 days\u201d, whether from planned or unplanned conception would break the cycle of risk and demonstrate benefit in the shortest possible time.", {"entities": []}], ["Such interventions will be particularly important in adolescents and young women in disadvantaged groups and can improve the physiological status of the fetus as well as reduce the prevalence of pregnancy conditions such as gestational diabetes mellitus which both predispose to non-communicables diseases in both the mother and her child.", {"entities": [[224, 244, "DISEASE"], [236, 253, "DISEASE"]]}], ["Pre-conception interventions require equipping prospective parents with the necessary knowledge and skills to make healthy lifestyle choices for themselves and their children.", {"entities": []}], ["Addressing the promotion of such health literacy in parents-to-be in low- and middle-income countries requires a wider social perspective.", {"entities": []}], ["It requires a range of multisectoral agencies to work together and could be linked to the issues of women\u2019s empowerment, to reproductive health, to communicable disease prevention and to the Millennium Development Goals 4 and 5.", {"entities": []}], ["Mast cells are known to play a pivotal role in allergic diseases such as allergic rhinitis, asthma, and atopic dermatitis by releasing granules containing histamine, LTC4, and other preformed chemical mediators.", {"entities": [[73, 90, "DISEASE"], [104, 121, "DISEASE"], [82, 90, "DISEASE"], [92, 98, "DISEASE"], [111, 121, "DISEASE"]]}], ["Previous reports have demonstrated that IKK2 (also called IKK\u03b2), a central intracellular component of NF-\u03baB activation pathways, plays a critical role in IgE-mediated degranulation of mast cells and anaphylaxis in mice.", {"entities": []}], ["In this study, we show that protein levels of tumor suppressor p53 are up-regulated upon IgE-mediated activation in mast cells and lack of p53 results in enhanced responses in both early and late phase anaphylaxis.", {"entities": []}], ["p53 inhibits not only the catalytic activity of IKK2 presumably through the modulation of glycosylation but also p65 (RelA)-mediated transactivation.", {"entities": [[118, 122, "GENE"]]}], ["Our findings are the first to demonstrate that p53 functions as a negative regulator in mast cells.", {"entities": []}], ["Toxocariasis is increasingly recognized as an important neglected infection of poverty (NIP) in developed countries, and may constitute the most important NIP in the United States (US) given its association with chronic sequelae such as asthma and poor cognitive development.", {"entities": [[0, 12, "DISEASE"], [237, 243, "DISEASE"]]}], ["Its potential public health burden notwithstanding, toxocariasis surveillance is minimal throughout the US and so the true burden of disease remains uncertain in many areas.", {"entities": [[52, 64, "DISEASE"]]}], ["The Third National Health and Nutrition Examination Survey conducted a representative serologic survey of toxocariasis to estimate the prevalence of infection in diverse US subpopulations across different regions of the country.", {"entities": [[106, 118, "DISEASE"]]}], ["Using the NHANES III surveillance data, the current study applied the predicted probabilities of toxocariasis to the sociodemographic composition of New York census tracts to estimate the local probability of infection across the city.", {"entities": [[97, 109, "DISEASE"]]}], ["The predicted probability of toxocariasis ranged from 6% among US-born Latino women with a university education to 57% among immigrant men with less than a high school education.", {"entities": [[29, 41, "DISEASE"]]}], ["The predicted probability of toxocariasis exhibited marked spatial variation across the city, with particularly high infection probabilities in large sections of Queens, and smaller, more concentrated areas of Brooklyn and northern Manhattan.", {"entities": [[29, 41, "DISEASE"]]}], ["This investigation is the first attempt at small-area estimation of the probability surface of toxocariasis in a major US city.", {"entities": [[95, 107, "DISEASE"]]}], ["While this study does not define toxocariasis risk directly, it does provide a much needed tool to aid the development of toxocariasis surveillance in New York City.", {"entities": [[33, 45, "DISEASE"], [122, 134, "DISEASE"]]}], ["Over the last 100 years, several persistent misconceptions or \u2018false beliefs\u2019 have built up around allergen immunotherapy and its use in allergic rhinitis.", {"entities": [[137, 154, "DISEASE"], [146, 154, "DISEASE"]]}], ["This is perhaps because enthusiastic physicians administered complex allergen extracts to a diverse population of patients suffering from heterogeneous atopic conditions.", {"entities": []}], ["Here, we review evidence that counters seven of these \u2018false beliefs.\u2019 1.", {"entities": []}], ["The symptoms of allergic rhinitis can be more heterogeneous, more severe and more troublesome in everyday life than many physicians believe.", {"entities": [[16, 33, "DISEASE"], [25, 33, "DISEASE"]]}], ["Large-scale epidemiological surveys show that the majority of allergic rhinitis patients have at least one symptom severe enough to interfere with sleep quality, productivity and/or well-being.", {"entities": [[62, 79, "DISEASE"], [71, 79, "DISEASE"]]}], ["Allergen immunotherapy is not necessarily suitable for all allergic rhinitis patients (notably those with mild symptoms).", {"entities": [[59, 76, "DISEASE"], [68, 76, "DISEASE"]]}], ["Recent evidence from double-blind, placebo-controlled, randomized clinical trials suggests that the more severe the disease, the greater the treatment effect.", {"entities": []}], ["Allergen immunotherapy is often accused of lack of efficacy (relative to pharmacotherapy, for example).", {"entities": []}], ["However, there are now many meta-analyses, systematic reviews and high-quality clinical trials that find overwhelmingly in favor of the efficacy of allergen immunotherapy (including sublingual formulations) in allergic rhinitis induced by pollen and, increasingly, other allergens.", {"entities": [[210, 227, "DISEASE"], [219, 227, "DISEASE"]]}], ["Natural-exposure and challenge-chamber trials have shown that symptom relief may become apparent within months or even weeks of the initiation of allergen immunotherapy.", {"entities": []}], ["In pollen-induced allergic rhinitis, several years of subcutaneous or sublingual allergen immunotherapy are associated with sustained clinical efficacy after subsequent treatment cessation \u2013 confirming the disease-modifying nature of this therapy.", {"entities": [[18, 35, "DISEASE"], [27, 35, "DISEASE"]]}], ["Most patients seeking treatment for allergic rhinitis are polysensitized, and allergen immunotherapy has proven efficacy in large, robust clinical trials in these groups.", {"entities": [[36, 53, "DISEASE"], [45, 53, "DISEASE"]]}], ["Polysensitization is not a contraindication to allergen immunotherapy.", {"entities": []}], ["Sublingual allergen immunotherapy is safe for home administration.", {"entities": []}], ["A recent review calculated that 1 billion doses were administered worldwide between 2000 and 2010 and found that the 11 case reports of anaphylaxis (all non-fatal) corresponded to non-standard practice.", {"entities": []}], ["Modern, evidence-based medicine has generated more than enough robust evidence to remove misconceptions about allergen immunotherapy and allergic rhinitis.", {"entities": [[137, 154, "DISEASE"], [146, 154, "DISEASE"]]}], ["The biased agonism of the G protein-coupled receptors (GPCRs), where in addition to a traditional G protein-signaling pathway a GPCR promotes intracellular signals though \u03b2-arrestin, is a novel paradigm in pharmacology.", {"entities": []}], ["Biochemical and biophysical studies have suggested that a GPCR forms a distinct ensemble of conformations signaling through the G protein and \u03b2-arrestin.", {"entities": []}], ["Here we report on the dynamics of the \u03b2 2 adrenergic receptor bound to the \u03b2-arrestin and G protein-biased agonists and the empty receptor to further characterize the receptor conformational changes caused by biased agonists.", {"entities": []}], ["We use conventional and accelerated molecular dynamics (aMD) simulations to explore the conformational transitions of the GPCR from the active state to the inactive state.", {"entities": []}], ["We found that aMD simulations enable monitoring of the transition within the nanosecond time scale while capturing the known microscopic characteristics of the inactive states, such as the ionic lock, the inward position of F6.44, and water clusters.", {"entities": []}], ["Distinct conformational states are shown to be stabilized by each biased agonist.", {"entities": []}], ["In particular, in simulations of the receptor with the \u03b2-arrestin-biased agonist N -cyclopentylbutanepherine, we observe a different pattern of motions in helix 7 when compared to simulations with the G protein-biased agonist salbutamol that involves perturbations of the network of interactions within the NPxxY motif.", {"entities": []}], ["Understanding the network of interactions induced by biased ligands and the subsequent receptor conformational shifts will lead to development of more efficient drugs.", {"entities": []}], ["Exposure to harmful environmental factors is particularly detrimental to younger children.", {"entities": []}], ["We investigated the relationship between environmental tobacco smoke (ETS) exposure in pre-schoolers at home and the level of high-sensitivity C-reactive protein (hs-CRP), a predictive factor for cardiovascular disease.", {"entities": []}], ["This study was conducted in 2014 and was based on the data of preschool children from the Korean Environmental Health Survey in Children and Adolescents (2012 to 2014), a nationally representative sample.", {"entities": []}], ["Of 577 children, aged three to five years, 482 were eventually selected for the analysis after excluding those with missing variables, or whose hs-CRP level exceeded the reference value.", {"entities": []}], ["The proportion of pre-school children exposed to ETS at home was 14.8%.", {"entities": []}], ["The odd ratios (OR)s of hs-CRP > 1mg/L were 4.90 (95% Confidence Interval (CI) = 1.04\u201323.17) and 11.66 (95% CI = 1.90\u201371.65) in the groups exposed to ETS 3\u20134 times and \u22655 times daily, respectively, compared to the non-exposed group.", {"entities": []}], ["The risk of elevated levels of hs-CRP showed an increasing trend proportionally to the increase in ETS exposure frequency ( p for trend = 0.03).", {"entities": []}], ["Anti-smoking educational programs for parents and guardians may be helpful to reduce ETS exposure at home.", {"entities": []}], ["Trichuris muris , the mouse whipworm, is used as a laboratory model of the human parasite T. trichiura .", {"entities": []}], ["Three laboratory isolates of T. muris exist \u2014 the E, J and S isolates.", {"entities": []}], ["Previous data have shown that the S isolate survives to chronicity in C57BL/6 mice unlike the E and J isolates, which are expelled.", {"entities": []}], ["The ability of the S isolate to persist is thought to be due to it secreting unique excretory/secretory antigens, which interact with APCs such that protective T cell responses do not develop.", {"entities": [[134, 138, "GENE"]]}], ["To determine whether APCs respond differently to E/S antigens from the three isolates we cultured isolate-specific E/S with bone marrow-derived macrophages (BMM\u03a6) and dendritic cells (BMDCs) in vitro .", {"entities": [[21, 25, "GENE"]]}], ["Markers of co-stimulation and levels of MHC-II were analysed by FACS and cytokine levels in supernatants quantified.", {"entities": []}], ["E/S antigens from the S isolate consistently stimulated significantly higher levels of IL-10 and IL-6 from both macrophages (F4/80 in vitro differences in APC-derived cytokines, particularly IL-10, are biologically significant in vivo , they may contribute to the S isolate survival, by creating a regulatory cytokine environment in which protective immune responses are less effective.", {"entities": []}], ["It has been proposed that the histamine 1-receptor (H1-receptor) not only promotes allergic reactions, but also modulates innate immunity and autoimmune reactions.", {"entities": []}], ["In line with this, we have recently reported that the H1-receptor antagonist cetirizine partially counteracts cytokine-induced beta-cell signaling and destruction.", {"entities": []}], ["Therefore, the aim of this study was to determine whether cetirizine affects diabetes in NOD mice, a model for human type 1 diabetes, and glucose intolerance in high-fat diet C57BL/6 mice, a model for human glucose intolerance.", {"entities": [[138, 157, "DISEASE"], [207, 226, "DISEASE"]]}], ["Female NOD mice were treated with cetirizine in the drinking water (25 mg/kg body weight) from 9 until 30 weeks of age during which precipitation of diabetes was followed.", {"entities": []}], ["Male C57BL/6 mice were given a high-fat diet from 5 weeks of age.", {"entities": []}], ["When the mice were 12 weeks of age cetirizine was given for 2 weeks in the drinking water.", {"entities": []}], ["The effects of cetirizine were analyzed by blood glucose determinations, glucose tolerance tests, and insulin sensitivity tests.", {"entities": []}], ["Cetirizine did not affect diabetes development in NOD mice.", {"entities": []}], ["On the other hand, cetirizine treatment for 1 week protected against high-fat diet-induced hyperglycemia.", {"entities": [[91, 104, "DISEASE"]]}], ["The glucose tolerance after 2 weeks of cetirizine treatment was improved in high-fat diet mice.", {"entities": []}], ["We observed no effect of cetirizine on the insulin sensitivity of high-fat diet mice.", {"entities": []}], ["Our results suggest a protective effect of cetirizine against high-fat diet-induced beta-cell dysfunction, but not against autoimmune beta-cell destruction.", {"entities": []}], ["To analyze the epidemiological clinical profile of women with maternal near miss according to the new World Health Organization criteria.", {"entities": []}], ["A descriptive crosssectional study was conducted, in which the records of patients admitted to the obstetric intensive care unit of a tertiary hospital in Recife (Brazil) over a period of four years were analyzed.", {"entities": []}], ["Women who presented at least one near miss criterion were included.", {"entities": []}], ["The variables studied were age, race/color, civil status, education, place of origin, number of pregnancies and prenatal consultations, complications and procedures performed, mode of delivery, gestational age at delivery, and maternal near miss criteria.", {"entities": []}], ["The descriptive analysis was performed using the program Epi-Info 3.5.1.", {"entities": []}], ["Two hundred fifty-five cases of maternal near miss were identified, with an overall ratio of maternal near miss of 12.8/1,000 live births.", {"entities": []}], ["Among these cases, 43.2% of the women had incomplete primary education, 44.7% were primiparous, and 20.5% had undergone a previous cesarean section.", {"entities": []}], ["Regarding specific diagnoses, there was a predominance of hypertensive disorders (62.7%), many of which were complicated by HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome (41.2%).", {"entities": [[185, 193, "DISEASE"]]}], ["The laboratory near miss criteria were the most often observed (59.6%), due mainly to the high frequency of acute thrombocytopenia (32.5%).", {"entities": [[114, 130, "DISEASE"]]}], ["A high frequency of women who had a low level of education and who were primiparous was observed.", {"entities": []}], ["According to the new criteria proposed by the World Health Organization, hypertensive pregnancy disorders are still the most common among maternal near miss cases.", {"entities": []}], ["The high frequency of HELLP syndrome was also striking, which contributed to acute thrombocytopenia being the most frequent near miss criterion.", {"entities": [[83, 99, "DISEASE"], [28, 36, "DISEASE"]]}], ["Air pollution is thought to exert health effects through oxidative stress, which causes damage to DNA and lipids.", {"entities": []}], ["We determined whether levels of oxidatively damaged DNA and lipid peroxidation products in cells or bodily fluids from humans are useful biomarkers of biologically effective dose in studies of the health effects of exposure to particulate matter (PM) from combustion processes.", {"entities": []}], ["We identified publications that reported estimated associations between environmental exposure to PM and oxidative damage to DNA and lipids in PubMed and EMBASE.", {"entities": []}], ["We also identified publications from reference lists and articles cited in the Web of Science.", {"entities": []}], ["For each study, we obtained information on the estimated effect size to calculate the standardized mean difference (unitless) and determined the potential for errors in exposure assessment and analysis of each of the biomarkers, for total and stratified formal meta-analyses.", {"entities": []}], ["In the meta-analysis, the standardized mean differences (95% confidence interval) between exposed and unexposed subjects for oxidized DNA and lipids were 0.53 (0.29\u20130.76) and 0.73 (0.18\u20131.28) in blood and 0.52 (0.22\u20130.82) and 0.49 (0.01\u20130.97) in urine, respectively.", {"entities": []}], ["The standardized mean difference for oxidized lipids was 0.64 (0.07\u20131.21) in the airways.", {"entities": []}], ["Restricting analyses to studies unlikely to have substantial biomarker or exposure measurement error, studies likely to have biomarker and/or exposure error, or studies likely to have both sources of error resulted in standardized mean differences of 0.55 (0.19\u20130.90), 0.66 (0.37\u20130.95), and 0.65 (0.34\u20130.96), respectively.", {"entities": []}], ["Exposure to combustion particles is consistenly associated with oxidatively damaged DNA and lipids in humans, suggesting that it is possible to use these measurements as biomarkers of biologically effective dose.", {"entities": []}], ["Delirium is common in adult intensive care, with validated tools for measurement, known risk factors and adverse neurocognitive outcomes.", {"entities": []}], ["We aimed to determine what is known about pediatric delirium in the pediatric intensive care unit (PICU).", {"entities": []}], ["We conducted a systematic search for and review of studies of the accuracy of delirium diagnosis in children in the PICU.", {"entities": []}], ["Secondary aims were to determine the prevalence, risk factors and outcomes associated with pediatric delirium.", {"entities": []}], ["We created screening and data collection tools based on published recommendations.", {"entities": []}], ["After screening 145 titles and abstracts, followed by 35 full-text publications and reference lists of included publications, 9 reports of 5 studies were included.", {"entities": []}], ["Each of the five included studies was on a single index test: (1) the Pediatric Anesthesia Emergence Delirium Scale (PAED; for ages 1 to 17\u00a0years), (2) the Pediatric Confusion Assessment Method for the Intensive Care Unit (p-CAM-ICU; for ages \u22655\u00a0years), (3) the Cornell Assessment of Pediatric Delirium (CAP-D; a modification of the PAED designed to detect hypoactive delirium), (4) the revised Cornell Assessment of Pediatric Delirium (CAP-D(R)) and (5) clinical suspicion.", {"entities": []}], ["We found that all five studies had a high risk of bias on at least one domain in the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2).", {"entities": []}], ["Sample size, sensitivity, specificity, and effectiveness (correct classification divided by total tests done) were: PAED 144, 91%, 98%, <91% (>16% of scores required imputation for missing data); p-CAM 68, 78%, 98%, 96%; CAP-D 50, 91%, 100%, 89%; CAP-D (R) 111, and of assessments 94%, 79%, <82% (it is not clear if any assessments were not included); and clinical suspicion 877, N/A (only positive predictive value calculable, 66%).", {"entities": []}], ["Prevalence of delirium was 17%, 13%, 28%, 21%, and 5% respectively.", {"entities": []}], ["Only the clinical suspicion study researchers statistically determined any risk factors for delirium (pediatric risk of mortality, pediatric index of mortality, ventilation, age) or outcomes of delirium (length of stay and mortality).", {"entities": []}], ["High-quality research to determine the accuracy of delirium screening tools in the PICU are required before prevalence, risk factors and outcomes can be determined and before a routine screening tool can be recommended.", {"entities": []}], ["Direct comparisons of the p-CAM-ICU and CAP-D(R) should be performed.", {"entities": []}], ["The online version of this article (doi:10.1186/s13054-014-0489-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Chemo/radiotherapy-induced free oxygen radicals and reactive oxygen derivatives contribute to the development of early and late transplantation-related pulmonary and extra-pulmonary complications in hematopoietic stem cell transplantation (HSCT) recipients.", {"entities": []}], ["It has been proposed that an increase in fractional exhaled nitric oxide (FeNO) level indicates oxidative stress and inflammation in the airways.", {"entities": []}], ["The aim of this prospective study is to evaluate the pre-transplantation FeNO levels in HSCT patients and to search for its role in predicting post-transplantation pulmonary complications and mortality.", {"entities": []}], ["HSCT patients were included in the study prospectively between October 2009 and July 2011.", {"entities": []}], ["Pre-transplantation FeNO levels were measured with a NIOX MINO\u00ae device prior to conditioning regimens.", {"entities": []}], ["All patients were monitored prospectively for post-transplantation pulmonary complications with medical history, physical examination, chest X-ray, and pulmonary function tests.", {"entities": []}], ["A total of 56 patients (33 autologous, 23 allogeneic) with mean age of 45\u00b113 years were included in the study, among whom 40 (71%) were male.", {"entities": []}], ["Pre-transplantation FeNO level of the whole study group was found to be 24\u00b113 (mean \u00b1 standard deviation) parts per billion (ppb).", {"entities": []}], ["The FeNO level in allogeneic HSCT recipients was 19\u00b16 ppb while it was 27\u00b115 ppb in autologous HSCT recipients (p=0.042).", {"entities": []}], ["No significant correlation was found between the pre-transplantation chemotherapy and radiotherapy protocols and baseline FeNO levels (p>0.05).", {"entities": []}], ["Post-transplantation pulmonary toxicity was identified in 12 (21%) patients and no significant relationship was found between baseline FeNO levels and pulmonary toxicity.", {"entities": []}], ["The survival rate of the whole study group for 1 year after transplantation was 70%.", {"entities": []}], ["No significant relationship was identified between baseline FeNO values and survival (FeNO 19\u00b17 ppb in patients who died and 26\u00b115 ppb in the survivors; p=0.114).", {"entities": []}], ["Pre-transplantation FeNO measurement does not seem to have a role in predicting post-transplantation pulmonary complications and mortality.", {"entities": []}], ["To assess benefits of telephone-delivered health mentoring in community-based chronic obstructive pulmonary disease (COPD).", {"entities": [[78, 115, "DISEASE"]]}], ["Cluster randomised controlled trial.", {"entities": []}], ["Tasmanian general practices: capital city (11), large rural (3), medium rural (1) and small rural (16).", {"entities": []}], ["Patients were invited (1207) from general practitioner (GP) databases with COPD diagnosis and/or tiotropium prescription, response rate 49% (586), refused (176) and excluded (criteria: smoking history or previous study, 68).", {"entities": []}], ["Spirometry testing (342) confirmed moderate or severe COPD in 182 (53%) patients.", {"entities": []}], ["By random numbers code, block stratified on location, allocation by sequentially numbered, opaque and sealed envelopes.", {"entities": []}], ["Health mentor (HM) group received regular calls to manage illness issues and health behaviours from trained community health nurses using negotiated goal setting: problem solving, decision-making and action planning.", {"entities": []}], ["Control: usual care (UC) group received GP care plus non-interventional brief phone calls.", {"entities": []}], ["Measured at 0, 6 and 12\u2005months, the Short Form 36 (SF-36) and St George\u2019s Respiratory Questionnaire (SGRQ, primary); Partners In Health (PIH) Scale for self-management capacity, Hospital Anxiety and Depression Scale (HADS), Center for Epidemiologic Studies-Depression (CES-D) questionnaire, Post-Traumatic Stress Disorder Checklist, Satisfaction with life and hospital admissions (secondary).", {"entities": []}], ["182 participants with COPD (age 68\u00b18\u2005years, 62% moderate COPD and 53% men) were randomised (HM=90 and UC=92).", {"entities": []}], ["Mixed model regression analysis accounting for clustering, adjusting for age, gender, smoking status and airflow limitation assessed efficacy (regression coefficient, \u03b2, reported per 6-month visit).", {"entities": []}], ["There was no difference in quality of life between groups, but self-management capacity increased in the HM group (PIH overall 0.15, 95% CI 0.03\u00a0to 0.29; knowledge domain 0.25, 95% CI 0.00 to\u00a00.50).", {"entities": []}], ["Anxiety decreased in both groups (HADS A 0.35; 95% CI \u22120.65\u00a0to \u22120.04) and coping capacity improved (PIH coping 0.15; 95% CI 0.04 to 0.26).", {"entities": []}], ["Health mentoring improved self-management capacity but not quality of life compared to regular phone contact, which itself had positive effects where decline is generally expected.", {"entities": []}], ["Strongyloidiasis is commonly a clinically unapparent, chronic infection, but immuno suppressed subjects can develop fatal disease.", {"entities": [[0, 16, "DISEASE"]]}], ["We carried out a review of literature on hyperinfection syndrome (HS) and disseminated strongyloidiasis (DS), in order to describe the most challenging aspects of severe strongyloidiasis.", {"entities": [[56, 64, "DISEASE"], [87, 103, "DISEASE"], [170, 186, "DISEASE"]]}], ["We conducted a structured search using PubMed to collect case reports and short case series on HS/DS published from 1991 to 2011.", {"entities": []}], ["We restricted search to papers in English, Spanish, Italian and French.", {"entities": []}], ["Case reports were classified as HS/DS according to given definitions.", {"entities": []}], ["Records screened were 821, and 311 were excluded through titles and abstract evaluation.", {"entities": []}], ["Of 510 full-text articles assessed for eligibility, 213 were included in qualitative analysis.", {"entities": []}], ["As some of them were short case series, eventually the number of cases analyzed was 244.", {"entities": []}], ["Steroids represented the main trigger predisposing to HS and DS (67% cases): they were mostly administered to treat underlying conditions (e.g.", {"entities": []}], ["lymphomas, rheumatic diseases).", {"entities": []}], ["However, sometimes steroids were empirically prescribed to treat signs and symptoms caused by unsuspected/unrecognized strongyloidiasis.", {"entities": [[119, 135, "DISEASE"]]}], ["Diagnosis was obtained by microscopy examination in 100% cases, while serology was done in a few cases (6.5%).", {"entities": []}], ["Only in 3/29 cases of solid organ/bone marrow transplantation there is mention of pre-transplant serological screening.", {"entities": []}], ["Therapeutic regimens were different in terms of drugs selection and combination, administration route and duration.", {"entities": []}], ["Similar fatality rate was observed between patients with DS (68.5%) and HS (60%).", {"entities": []}], ["Proper screening (which must include serology) is mandatory in high - risk patients, for instance candidates to immunosuppressive medications, currently or previously living in endemic countries.", {"entities": []}], ["In some cases, presumptive treatment might be justified.", {"entities": []}], ["Ivermectin is the gold standard for treatment, although the optimal dosage is not clearly defined in case of HS/DS.", {"entities": []}], ["In Quebec, various actors fund activities aimed at increasing physical activity, improving eating habits and reducing smoking.", {"entities": []}], ["The objective was to evaluate how effective does the healthy lifestyle habits promotion (HLHP) strategy need to be to make to offset its costs.", {"entities": []}], ["First, we built the logic model of the HLHP strategy.", {"entities": []}], ["We then assessed the strategy\u2019s total cost as well as the direct health care expenditures associated with lifestyle-related risk factors (smoking, physical inactivity, insufficient intake of fruits and vegetables, obesity and overweight).", {"entities": [[214, 221, "DISEASE"]]}], ["Finally, we estimated the break-even point beyond which the economic benefits of the HLHP strategy would outweigh its costs.", {"entities": []}], ["The HLHP strategy cost for 2010\u20132011 was estimated at $110\u00a0million.", {"entities": []}], ["Direct healthcare expenditures associated with lifestyle-related risk factors were estimated at $4.161\u00a0billion.", {"entities": []}], ["We estimated that 47\u00a0% of these expenditures were attributable to these risk factors.", {"entities": []}], ["We concluded that the HLHP strategy cost corresponded to 5.6\u00a0% of the annual healthcare expenditures attributable to these risk factors.", {"entities": []}], ["This study compared the economic value of HLHP activities against healthcare expenditures associated with targeted risk factors.", {"entities": []}], ["The online version of this article (doi:10.1007/s00038-016-0884-y) contains supplementary material, which is available to authorized users.", {"entities": []}], ["During the 2009 H1N1v influenza epidemic, the total number of symptomatic cases was estimated by combining influenza-like illness (ILI) consultations, virological surveillance and assumptions about healthcare-seeking behaviour.", {"entities": [[22, 31, "DISEASE"], [107, 116, "DISEASE"]]}], ["Changes in healthcare-seeking behaviour due to changing scientific information, media coverage and public anxiety, were not included in case estimates.", {"entities": []}], ["The purpose of the study was to improve estimates of the number of symptomatic H1N1v cases and the case fatality rate (CFR) in England by quantifying healthcare-seeking behaviour using an internet-based survey carried out during the course of the 2009 H1N1v influenza epidemic.", {"entities": [[258, 267, "DISEASE"]]}], ["We used an online survey that ran continuously from July 2009 to March 2010 to estimate the proportion of ILI cases that sought healthcare during the 2009 H1N1v influenza epidemic.", {"entities": [[161, 170, "DISEASE"]]}], ["We used dynamic age- and gender-dependent measures of healthcare-seeking behaviour to re-interpret consultation numbers and estimate the true number of cases of symptomatic ILI in 2009 and the case fatality rate (CFR).", {"entities": []}], ["There were significant differences between age groups in healthcare usage.", {"entities": []}], ["From the start to the end of the epidemic, the percentage of individuals with influenza-like symptoms who sought medical attention decreased from 43% to 32% (p < 0.0001).", {"entities": [[78, 87, "DISEASE"]]}], ["Adjusting official numbers accordingly, we estimate that there were 1.1 million symptomatic cases in England, over 320,000 (40%) more cases than previously estimated and that the autumn epidemic wave was 45% bigger than previously thought.", {"entities": []}], ["Combining symptomatic case numbers with reported deaths leads to a reduced overall CFR estimate of 17 deaths per 100,000 cases, with the largest reduction in adults.", {"entities": []}], ["Active surveillance of healthcare-seeking behaviour, which can be achieved using novel data collection methods, is vital for providing accurate real-time estimates of epidemic size and disease severity.", {"entities": []}], ["The differences in healthcare-seeking between different population groups and changes over time have significant implications for estimates of total case numbers and the case fatality rate.", {"entities": []}], ["Aromatic hydrocarbons emitted from gasoline-powered vehicles contribute to the formation of secondary organic aerosol (SOA), which increases the atmospheric mass concentration of fine particles (PM 2.5 ).", {"entities": []}], ["Here we estimate the public health burden associated with exposures to the subset of PM 2.5 that originates from vehicle emissions of aromatics under business as usual conditions.", {"entities": []}], ["The PM 2.5 contribution from gasoline aromatics is estimated using the Community Multiscale Air Quality (CMAQ) modeling system and the results are compared to ambient measurements from the literature.", {"entities": []}], ["Marginal PM 2.5 annualized concentration changes are used to calculate premature mortalities using concentration-response functions, with a value of mortality reduction approach used to monetize the social cost of mortality impacts.", {"entities": []}], ["Morbidity impacts are qualitatively discussed.", {"entities": []}], ["Modeled aromatic SOA concentrations from CMAQ fall short of ambient measurements by approximately a factor of two nationwide, with strong regional differences.", {"entities": []}], ["After accounting for this model bias, the estimated public health impacts from exposure to PM 2.5 originating from aromatic hydrocarbons in gasoline lead to a central estimate of approximately 3800 predicted premature mortalities nationwide, with estimates ranging from 1800 to over 4700 depending on the specific concentration-response function used.", {"entities": []}], ["These impacts are associated with total social costs of $28.2B, and range from $13.6B to $34.9B in 2006$.", {"entities": []}], ["These preliminary quantitative estimates indicate particulates from vehicular emissions of aromatic hydrocarbons demonstrate a nontrivial public health burden.", {"entities": []}], ["The results provide a baseline from which to evaluate potential public health impacts of changes in gasoline composition.", {"entities": []}], ["Background: Animal data demonstrate associations of dioxin, furan, and polychlorinated biphenyl (PCB) exposures with altered male gonadal maturation.", {"entities": []}], ["It is unclear whether these associations apply to human populations.", {"entities": []}], ["Objectives: We investigated the association of dioxins, furans, PCBs, and corresponding toxic equivalent (TEQ) concentrations with pubertal onset among boys in a dioxin-contaminated region.", {"entities": []}], ["Methods: Between 2003 and 2005, 499 boys 8\u20139 years of age were enrolled in a longitudinal study in Chapaevsk, Russia.", {"entities": []}], ["Pubertal onset [stage 2 or higher for genitalia (G2+) or testicular volume (TV) > 3 mL] was assessed annually between ages 8 and 12 years.", {"entities": []}], ["Serum levels at enrollment were analyzed by the Centers for Disease Control and Prevention, Atlanta, Georgia, USA.", {"entities": []}], ["We used Cox proportional hazards models to assess age at pubertal onset as a function of exposure adjusted for potential confounders.", {"entities": []}], ["We conducted sensitivity analyses excluding boys with pubertal onset at enrollment.", {"entities": []}], ["Results: The median (range) total serum TEQ concentration was 21 (4\u2013175) pg/g lipid, approximately three times higher than values in European children.", {"entities": []}], ["At enrollment, boys were generally healthy and normal weight (mean body mass index, 15.9 kg/m p -dioxin and dioxin concentrations for TV but not G2+.", {"entities": []}], ["Results were robust to sensitivity analyses.", {"entities": []}], ["Conclusions: Findings support an association of higher peripubertal serum dioxin TEQs and concentrations with later male pubertal onset reflected in delayed testicular maturation.", {"entities": []}], ["Two human parvoviruses were recently discovered by metagenomics in Africa, bufavirus (BuV) in 2012 and tusavirus (TuV) in 2014.", {"entities": []}], ["These viruses have been studied exclusively by PCR in stool and detected only in patients with diarrhoea, although at low prevalence.", {"entities": []}], ["Three genotypes of BuV have been identified.", {"entities": []}], ["We detected, by in-house EIA, BuV1-3 IgG antibodies in 7/228 children (3.1%) and 10/180 adults (5.6%), whereas TuV IgG was found in one child (0.4%).", {"entities": []}], ["All children and 91% of the adults were Finnish, yet interestingly 3/6 adults of Indian origin were BuV-IgG positive.", {"entities": []}], ["By competition EIA, no cross-reactivity between the BuVs was detected, indicating that the BuV genotypes represent distinct serotypes.", {"entities": []}], ["Furthermore, we analysed by BuV qPCR stool and nasal swab samples from 955 children with gastroenteritis, respiratory illness, or both, and found BuV DNA in three stools (0.3%) and for the first time in a nasal swab (0.1%).", {"entities": [[89, 104, "DISEASE"]]}], ["This is the first study documenting the presence of BuV and TuV antibodies in humans.", {"entities": []}], ["Although the seroprevalences of both viruses were low in Finland, our results indicate that BuV infections might be widespread in Asia.", {"entities": []}], ["The BuV-specific humoral immune responses appeared to be strong and long-lasting, pointing to systemic infection in humans.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is associated with increased cardiovascular morbidity and mortality.", {"entities": []}], ["Elevated arterial stiffness, measured by aortic pulse wave velocity (aPWV), is a cardiovascular risk surrogate and is potentially modifiable by inhaled corticosteroid/long-acting beta 2 -agonist combinations in patients with COPD.", {"entities": []}], ["The effects of once-daily inhaled fluticasone furoate/vilanterol (FF/VI) 100/25 \u00b5g, VI 25 \u00b5g, versus placebo on arterial stiffness in patients with COPD and baseline aPWV \u226511.0 m/s were investigated in a 24-week, multicenter, double-blind, randomized, stratified (by COPD exacerbation history), parallel-group, placebo-controlled trial.", {"entities": []}], ["Eligible patients were \u226540 years old, with \u226510 pack-year smoking history, forced expiratory volume in 1 s (FEV 1 )/forced vital capacity \u22640.70, and post-bronchodilator FEV 1 \u226470% of predicted.", {"entities": [[107, 110, "GENE"], [168, 171, "GENE"], [107, 110, "GENE"], [168, 171, "GENE"]]}], ["Patients with a major cardiovascular event in the previous 6 months/current severe heart failure/uncontrolled hypertension were excluded.", {"entities": [[110, 122, "DISEASE"]]}], ["Primary endpoint is change from baseline in aPWV after 24 weeks of treatment.", {"entities": []}], ["Safety analyses included adverse events (AEs).", {"entities": []}], ["The intent-to-treat population included 430 patients: FF/VI (n=135), VI (n=154), and placebo (n=141).", {"entities": []}], ["Patients were predominantly male (79%) and Asian or White (each 48%), with a mean age of 68.5 years (standard deviation [SD] =7.9), percentage predicted post-bronchodilator FEV 1 50.1% (SD =13.3), and aPWV 13.26 m/s (SD =2.22) at screening.", {"entities": [[173, 176, "GENE"]]}], ["At 24 weeks, mean (standard error [SE]) changes from baseline in aPWV were \u22121.75 m/s (SE =0.26, FF/VI), \u22121.95 m/s (SE =0.24, VI), and \u22121.97 m/s (SE =0.28, placebo).", {"entities": []}], ["AEs occurred in 57% (FF/VI), 51% (VI), and 41% (placebo) of patients.", {"entities": []}], ["No differences were observed in aPWV-adjusted mean change from baseline for FF/VI 100/25 \u00b5g, compared with placebo.", {"entities": []}], ["Endometriosis is a debilitating condition that is categorized by the abnormal growth of endometrial tissue outside the uterus.", {"entities": [[0, 13, "DISEASE"]]}], ["Although the pathogenesis of this disease remains unknown, it is well established that endometriosis patients exhibit immune dysfunction.", {"entities": [[87, 100, "DISEASE"]]}], ["Interleukin (IL)-33 is a danger signal that is a critical regulator of chronic inflammation.", {"entities": []}], ["Although plasma and peritoneal fluid levels of IL-33 have been associated with deep infiltrating endometriosis, its contribution to the disease pathophysiology is unknown.", {"entities": [[97, 110, "DISEASE"]]}], ["We investigated the role of IL-33 in the pathology of endometriosis using patient samples, cell lines and a syngeneic mouse model.", {"entities": [[54, 67, "DISEASE"]]}], ["We found that endometriotic lesions produce significantly higher levels of IL-33 compared to the endometrium of healthy, fertile controls.", {"entities": []}], ["In vitro stimulation of endometrial epithelial, endothelial and endometriotic epithelial cells with IL-33 led to the production of pro-inflammatory and angiogenic cytokines.", {"entities": []}], ["In a syngeneic mouse model of endometriosis, IL-33 injections caused systemic inflammation, which manifested as an increase in plasma pro-inflammatory cytokines compared to control mice.", {"entities": [[30, 43, "DISEASE"]]}], ["Furthermore, endometriotic lesions from IL-33 treated mice were highly vascularized and exhibited increased proliferation.", {"entities": []}], ["Collectively, we provide convincing evidence that IL-33 perpetuates inflammation, angiogenesis and lesion proliferation, which are critical events in the lesion survival and progression of endometriosis.", {"entities": [[189, 202, "DISEASE"]]}], ["This was a systematic review and meta\u2010analysis to evaluate the incidence of adverse events in adults undergoing procedural sedation in the emergency department ( ED ).", {"entities": []}], ["Eight electronic databases were searched, including MEDLINE , EMBASE , EBSCO , CINAHL , CENTRAL , Cochrane Database of Systematic Reviews, Web of Science, and Scopus, from January 2005 through 2015.", {"entities": []}], ["Randomized controlled trials and observational studies of adults undergoing procedural sedation in the ED that reported a priori selected outcomes and adverse events were included.", {"entities": []}], ["Meta\u2010analysis was performed using a random\u2010effects model and reported as incidence rates with 95% confidence intervals ( CI s).", {"entities": []}], ["The search yielded 2,046 titles for review.", {"entities": []}], ["Fifty\u2010five articles were eligible, including 9,652 procedural sedations.", {"entities": []}], ["The most common adverse event was hypoxia, with an incidence of 40.2 per 1,000 sedations (95% CI \u00a0=\u00a032.5 to 47.9), followed by vomiting with 16.4 per 1,000 sedations (95% CI \u00a0=\u00a09.7 to 23.0) and hypotension with 15.2 per 1,000 sedations (95% CI \u00a0=\u00a010.7 to 19.7).", {"entities": []}], ["Severe adverse events requiring emergent medical intervention were rare, with one case of aspiration in 2,370 sedations (1.2 per 1,000), one case of laryngospasm in 883 sedations (4.2 per 1,000), and two intubations in 3,636 sedations (1.6 per 1,000).", {"entities": []}], ["The incidence of agitation and vomiting were higher with ketamine (164.1 per 1,000 and 170.0 per 1,000, respectively).", {"entities": []}], ["Apnea was more frequent with midazolam (51.4 per 1,000), and hypoxia was less frequent in patients who received ketamine/propofol compared to other combinations.", {"entities": []}], ["The case of laryngospasm was in a patient who received ketamine, and the aspiration and intubations were in patients who received propofol.", {"entities": []}], ["When propofol and ketamine are combined, the incidences of agitation, apnea, hypoxia, bradycardia, hypotension, and vomiting were lower compared to each medication separately.", {"entities": []}], ["Serious adverse events during procedural sedation like laryngospasm, aspiration, and intubation are exceedingly rare.", {"entities": []}], ["Quantitative risk estimates are provided to facilitate shared decision\u2010making, risk communication, and informed consent.", {"entities": []}], ["Recent literature has highlighted the possible role of vitamin D in atopic dermatitis (AD), and that vitamin D supplementation might help to treat AD.", {"entities": [[68, 85, "DISEASE"], [75, 85, "DISEASE"]]}], ["This study determined the relationship between vitamin D level and AD, and assessed the efficacy of vitamin D supplementation.", {"entities": []}], ["We searched the MEDLINE, EMBASE, and Cochrane databases up to May 2015.", {"entities": []}], ["Observational studies and randomized controlled trials were included based on the available data on the serum 25-hydroxyvitamin D (25(OH)D) level and quantified data available for severity assessed using the Scoring Atopic Dermatitis (SCORAD) index or Eczema Area and Severity Index (EASI) score.", {"entities": [[216, 233, "DISEASE"], [223, 233, "DISEASE"]]}], ["Compared with healthy controls, the serum 25(OH)D level was lower in the AD patients of all ages (standardized mean difference = \u22122.03 ng/mL; 95% confidence interval (CI) = \u22122.52 to \u22120.78), and predominantly in the pediatric AD patients (standardized mean difference = \u22123.03 ng/mL; 95% CI = \u22124.76 to \u22121.29).", {"entities": []}], ["In addition, the SCORAD index and EASI score decreased after vitamin D supplementation (standardized mean difference = \u22125.85; 95% CI = \u22127.66 to \u22124.05).", {"entities": []}], ["This meta-analysis showed that serum vitamin D level was lower in the AD patients and vitamin D supplementation could be a new therapeutic option for AD.", {"entities": []}], ["A birth cohort dedicated to studying infections in early childhood may be assisted by parental recording of symptoms on a daily basis and a collection of biomaterials.", {"entities": []}], ["We aimed at testing the feasibility of this approach for use in a long-term study focusing on infections in children in Germany.", {"entities": []}], ["Parents of 1- to 3-year-old children ( n \u2009=\u200975) were recruited in nursery schools.", {"entities": []}], ["They were asked to complete a symptom diary on a daily basis and to take monthly and symptom-triggered nasal swabs and stool samples from their child over the study period of three months.", {"entities": []}], ["Feasibility was measured by means of the return proportions of symptom diaries and bio samples; acceptance was assessed by a questionnaire delivered to participants at the end of the study.", {"entities": []}], ["The majority of the participants filled in the symptom diary during the three months study for 75 or more days (77.3\u00a0%), and provided the monthly nasal swabs (62.7\u00a0%) and stool samples (65.3\u00a0%).", {"entities": []}], ["The time needed for the tasks was acceptable for most participants (symptom diary: 92.3\u00a0%, nasal swabs: 98.5\u00a0%, stool samples: 100.0\u00a0%).", {"entities": []}], ["In 64.3\u00a0% of the symptom-triggered nasal swabs, respiratory viruses were found compared to 55.5\u00a0% in throat swabs taken by health-care professionals within the \u201cARE surveillance Lower Saxony\u201d, a special project by the Governmental Institute of Public Health of Lower Saxony to investigate causal pathogens for acute respiratory infections in children.", {"entities": []}], ["The parental assessment of symptoms and collection of biomaterials in a birth cohort dedicated to studying infections appears feasible in a middle class German population.", {"entities": []}], ["The success of the study will depend on the ability to maintain these activities over a long time period.", {"entities": []}], ["The online version of this article (doi:10.1186/s12879-015-1189-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Supplemental digital content is available in the text.", {"entities": []}], ["Advances in knowledge regarding mechanical ventilation (MV), in particular lung-protective ventilation strategies, have been shown to reduce mortality.", {"entities": []}], ["However, the translation of these advances in knowledge into better therapeutic performance in real-life clinical settings continues to lag.", {"entities": []}], ["High-fidelity simulation with a mannequin allows students to interact in lifelike situations; this may be a valuable addition to traditional didactic teaching.", {"entities": []}], ["The purpose of this study is to compare computer-based and mannequin-based approaches for training residents on MV.", {"entities": []}], ["This prospective randomized single-blind trial involved 50 residents.", {"entities": []}], ["All participants attended the same didactic lecture on respiratory pathophysiology and were subsequently randomized into two groups: the mannequin group (n = 25) and the computer screen\u2013based simulator group (n = 25).", {"entities": []}], ["One week later, each underwent a training assessment using five different scenarios of acute respiratory failure of different etiologies.", {"entities": [[93, 112, "DISEASE"]]}], ["Later, both groups underwent further testing of patient management, using in situ high-fidelity simulation of a patient with acute respiratory distress syndrome.", {"entities": [[152, 160, "DISEASE"]]}], ["Baseline knowledge was not significantly different between the two groups ( P = 0.72).", {"entities": []}], ["Regarding the training assessment, no significant differences were detected between the groups.", {"entities": []}], ["In the final assessment, the scores of only the mannequin group significantly improved between the training and final session in terms of either global rating score [3.0 (2.5\u20134.0) vs. 2.0 (2.0\u20133.0), P = 0.005] or percentage of key score (82% vs. 71%, P = 0.001).", {"entities": []}], ["Mannequin-based simulation has the potential to improve skills in managing MV.", {"entities": []}], ["Human CRTh2", {"entities": []}], ["Endogenous pain-inhibitory substances have rarely been found.", {"entities": []}], ["A group of powerful pain suppressor molecules that are endogenously generated are now emerging: resolvins and related compounds including neuroprotectins and maresins.", {"entities": []}], ["These molecules began to be unveiled in a series of inflammation studies more than a decade ago, rapidly shifting the paradigm that explains the mechanism for the inflammatory phase switch.", {"entities": []}], ["The resolution phase was considered a passive process as proinflammatory mediators disappeared; it is now understood to be actively drawn by the actions of resolvins.", {"entities": []}], ["Surprisingly, these substances potently affect the pain state.", {"entities": []}], ["Although this research area is not fully matured, consistently beneficial outcomes have been observed in a various in vivo and in vitro pain models.", {"entities": []}], ["Furthermore, multiple hypotheses on the neuronal and molecular mechanisms for alleviating pain are being tested, deriving inspiration from existing inflammation and pain studies.", {"entities": []}], ["This paper serves as a brief summary of the proresolving roles of resolvins and related lipid mediators in inflammation and also as a review for accumulated information of their painkilling actions.", {"entities": []}], ["This also includes potential receptor-mediated mechanisms and discusses future scientific perspectives.", {"entities": []}], ["Further diverse approaches will help to construct a hidden axis of natural protection principles and establish proofs of concept for pain relief.", {"entities": []}], ["Cyclooxygenase (COX) is the main pharmacodynamic target of nonsteroidal anti-inflammatory drugs (NSAIDs).", {"entities": []}], ["We investigated the inhibitory effects on COX-2 after NSAIDs administration using a lipopolysaccharide (LPS)-derived COX-2 induction model in whole blood, according to the genotypes of COX-2 single-nucleotide polymorphisms (SNPs).", {"entities": []}], ["Seven genotypes of COX-2 SNPs were selected from public databases and analyzed in 324 healthy subjects.", {"entities": []}], ["Two genotypes showing a high percentage of variability were selected.", {"entities": []}], ["A clinical trial examining pharmacodynamics according to the genotype of two SNPs (rs5275 and rs689466) was conducted.", {"entities": []}], ["Twenty subjects were administered a single oral dose of 200 mg of celecoxib, and pharmacokinetic and pharmacodynamic analyses were performed.", {"entities": []}], ["In the analysis of the pharmacokinetic parameters, significant differences in drug exposure were not investigated for each SNP genotype.", {"entities": []}], ["The pharmacodynamic analysis revealed that the maximum effect of COX-2 inhibition was achieved at 2.0 hours for all genotypes of COX-2 SNPs after a single oral administration of 200 mg celecoxib.", {"entities": []}], ["The inhibitory effects according to the genotype of COX-2 SNPs were investigated, and the area under the effect curve of the rs689466 GG genotype was significantly lower than that for the AA or AG genotype.", {"entities": []}], ["Our results demonstrated that inhibitory effects of celecoxib on COX-2 induction were different according to the genotype of COX-2 SNPs.", {"entities": []}], ["In the present study, rs689466 is responsible for the variability of the response to celecoxib, suggesting that a subject with the GG genotype of rs689466 would be more responsive to celecoxib in terms of COX-2 inhibition.", {"entities": []}], ["Recent observational studies suggest that \u03b2-blockers may improve long-term prognosis in patients with chronic obstructive pulmonary disease (COPD).", {"entities": [[102, 139, "DISEASE"]]}], ["We assessed whether \u03b2-blocker use improves all-cause mortality in patients with episodes of acute bronchitis.", {"entities": [[98, 108, "DISEASE"]]}], ["An observational cohort study using data from the electronic medical records of 23 general practices in the Netherlands.", {"entities": []}], ["The data included standardized information about daily patient contacts, diagnoses, and drug prescriptions.", {"entities": []}], ["Cox regression was applied with time-varying treatment and covariates.", {"entities": []}], ["The study included 4,493 patients aged 45 years and older, with at least one episode of acute bronchitis between 1996 and 2006.", {"entities": [[94, 104, "DISEASE"]]}], ["The mean (SD) age of the patients was 66.9 (11.7) years, and 41.9% were male.", {"entities": []}], ["During a mean (SD) follow up period of 7.7 (2.5) years, 20.4% developed COPD.", {"entities": []}], ["In total, 22.7% had cardiovascular comorbidities, resulting in significant higher mortality rates than those without (51.7% vs. 12.0%, p<0.001).", {"entities": []}], ["The adjusted hazard ratio of cardioselective \u03b2-blocker use for mortality was 0.62 (95% confidence interval [CI], 0.50\u20130.77), and 1.01 (95% CI 0.75\u20131.36) for non-selective ones.", {"entities": []}], ["Some other cardiovascular drugs also reduced the risk of mortality, with adjusted HRs of 0.60 (95% CI 0.46\u20130.79) for calcium channel blockers, 0.88 (95% CI 0.73\u20131.06) for ACE inhibitors/angiotensin receptor blockers, and 0.42 (95% CI 0.31\u20130.57) for statins, respectively.", {"entities": []}], ["Cardiovascular comorbidities are common and increase the risk of mortality in adults with episodes of acute bronchitis.", {"entities": [[108, 118, "DISEASE"]]}], ["Cardioselective \u03b2-blockers, but also calcium channel blockers and statins may reduce mortality, possibly as a result of cardiovascular protective properties.", {"entities": []}], ["The wolf ( Canis lupus ) is one of the most widely distributed terrestrial mammals, because it is well adapted to various ecological niches and their corresponding pathogen environments.", {"entities": []}], ["Immunological competence is a crucial factor involved in adapting to a changing environment and fighting pathogen infection in animals.", {"entities": []}], ["In this study, the peripheral blood transcriptome of wolves was generated via RNA-seq to advance understanding of the wolf immunome, with a special focus on the major histocompatibility complex class I (MHC I) and toll-like receptor (TLR) gene families, which are involved in pathogen recognition and defense.", {"entities": []}], ["The blood transcriptomic libraries of eight wolves originating from Tibet and Inner Mongolia were sequenced, and approximately 383 million reads were generated.", {"entities": []}], ["Using a genome-guided assembly strategy, we obtained 123,851 unigenes, with a mean length of 845\u00a0bp and an N50 length of 1121\u00a0bp.", {"entities": []}], ["On the basis of BLAST searches against the NCBI non-redundant protein database (Nr), a total of 36,192 (29.22%) unigenes were annotated.", {"entities": []}], ["For functional classification, 24,663 unigenes were assigned to 13,016 Gene Ontology (GO) terms belonging to 51 sub-categories of the three main GO categories.", {"entities": []}], ["Additionally, 7682 unigenes were classified into 6 Kyoto Encyclopedia of Genes and Genomes (KEGG) categories, in which the most represented functional sub-categories were signal transduction and the immune system, and 16,238 unigenes were functionally classified into 25 Eukaryotic Orthologous Groups (KOG) categories.", {"entities": []}], ["We observed an overall higher \u03c9 ( d N / d S ) value at antigen-binding sites (ABSs) than at non-ABS regions as well as clear evidence of intergenic/intragenic recombination events at wolf MHC I loci.", {"entities": []}], ["Additionally, our analysis revealed that carnivorous TLRs were dominated by purifying selection, with mean \u03c9 values at each TLR locus ranging from 0.173 to 0.527.", {"entities": []}], ["However, we also found significant instances of positive selection that acted on several codons in pathogen recognition domains and were linked to species-specific differences in pathogen recognition.", {"entities": []}], ["This study represents the first attempt to characterize the blood transcriptome of the wolf and to highlight the value of investigating the immune system.", {"entities": []}], ["Balancing selection and recombination have contributed to the historical evolution of wolf MHC I genes.", {"entities": []}], ["Moreover, TLRs in carnivores have undergone adaptive evolution against the background of purifying selection, and a high level of adaptive evolution was detected in the wolf TLR system.", {"entities": []}], ["The online version of this article (doi:10.1186/s12864-017-3983-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Normal guinea pigs treated by four to six instillations of horse serum into the nose on alternate days become either hypersensitive or refractory to an intravenous injection of 0.38 cc.", {"entities": []}], ["of serum given 16 days after the last instillation.", {"entities": []}], ["If the amount of serum in each instillation is as much as 0.2 cc., anaphylactic death is caused by the toxic injection.", {"entities": []}], ["If the amount of serum in each instillation is reduced to 0.04 cc.", {"entities": []}], ["the first intravenous injection is without marked effect, and a second injection and subsequent injections of the same amount of antigen are well tolerated in about half the cases.", {"entities": []}], ["The effect produced by a given dose of serum, whether protective or anaphylactic, depends probably upon the extent of contact with the mucous membrane of the nose.", {"entities": []}], ["Guinea pigs which, after nasal treatment, have become tolerant to a definite maximum intravenous injection of the antigen appear to increase the degree of their tolerance, at least up to a resting period of more than 4 months.", {"entities": []}], ["The same does not hold in animals immunized by the peritoneal route.", {"entities": []}], ["The first two or three instillations of a series probably determine the biologic character, whether of hypersensitiveness or hyposensitiveness, of reaction towards the serum.", {"entities": []}], ["It is probable that, contrary to the case in parenteral sensitization, hypersensitiveness and protection, respectively, set up by nasal instillations and not followed by parenteral injections, gradually disappear in about 50 to 100 days.", {"entities": []}], ["We have failed in attempts to eliminate hypersensitiveness, due to subcutaneous injection of serum, by nasal instillations which would protect the normal animal from the development of anaphylaxis.", {"entities": []}], ["It is suggested that the principles of prophylaxis evolved under these relatively simple conditions should be applied in the study of infectious disease.", {"entities": []}], ["Respiratory syncytial virus (RSV) is a major health care burden with a particularly high worldwide morbidity and mortality rate among infants.", {"entities": []}], ["Data suggest that severe RSV-associated illness is in part caused by immunopathology associated with a robust type 2 response.", {"entities": []}], ["We sought to determine the capacity of RSV infection to stimulate group 2 innate lymphoid cells (ILC2s) and the associated mechanism in a murine model.", {"entities": []}], ["Wild-type (WT) BALB/c, thymic stromal lymphopoietin receptor (TSLPR) knockout (KO), or WT mice receiving an anti-TSLP neutralizing antibody were infected with the RSV strain 01/2-20.", {"entities": []}], ["During the first 4 to 6\u00a0days of infection, lungs were collected for evaluation of viral load, protein concentration, airway mucus, airway reactivity, or ILC2 numbers.", {"entities": []}], ["Results were confirmed with 2 additional RSV clinical isolates, 12/11-19 and 12/12-6, with known human pathogenic potential.", {"entities": []}], ["RSV induced a 3-fold increase in the number of IL-13\u2013producing ILC2s at day 4 after infection, with a concurrent increase in total lung IL-13 levels.", {"entities": []}], ["Both thymic stromal lymphopoietin (TSLP) and IL-33 levels were increased 12\u00a0hours after infection.", {"entities": [[35, 39, "GENE"]]}], ["TSLPR KO mice did not mount an IL-13\u2013producing ILC2 response to RSV infection.", {"entities": []}], ["Additionally, neutralization of TSLP significantly attenuated the RSV-induced IL-13\u2013producing ILC2 response.", {"entities": [[32, 36, "GENE"]]}], ["TSLPR KO mice displayed reduced lung IL-13 protein levels, decreased airway mucus and reactivity, attenuated weight loss, and similar viral loads as WT mice.", {"entities": []}], ["Both 12/11-19 and 12/12-6 similarly induced IL-13\u2013producing ILC2s through a TSLP-dependent mechanism.", {"entities": []}], ["These data demonstrate that multiple pathogenic strains of RSV induce IL-13\u2013producing ILC2 proliferation and activation through a TSLP-dependent mechanism in a murine model and suggest the potential therapeutic targeting of TSLP during severe RSV infection.", {"entities": [[130, 134, "GENE"], [224, 228, "GENE"]]}], ["A key event in the pathogenesis of allergies is the production of antibodies of the immunoglobulin (Ig)E class.", {"entities": []}], ["In normal individuals the levels of IgE are tightly regulated, as illustrated by the low serum IgE concentration.", {"entities": []}], ["In addition, multiple immunizations are usually required to generate detectable IgE responses in normal experimental animals.", {"entities": []}], ["To define the parameters that regulate IgE production in vivo, we generated mice bearing monoclonal populations of B and T lymphocytes specific for influenza virus hemagglutinin (HA) and chicken ovalbumin (OVA), respectively.", {"entities": [[148, 157, "DISEASE"]]}], ["A single immunization of the monoclonal mice with the cross-linked OVA-HA antigen led to serum IgE levels that reached 30\u2013200 \u03bcg/ml.", {"entities": []}], ["This unusually high IgE response was prevented by the infusion of regulatory \u03b1/\u03b2 CD4", {"entities": [[81, 84, "GENE"]]}], ["The literature is filled with reports that link medications with the onset or progression of depression.", {"entities": []}], ["Because depression is so common in patients with medical illness, assessing whether a medication has in fact caused depression, or whether the relationship is coincidental, can be challenging.", {"entities": []}], ["In this article, we review the literature on the association between medications and depression.", {"entities": []}], ["For most agents, there are case reports or small studies linking the medication with the onset of depression, but more rigorous prospective studies are either lacking or found no association between the agent and depression.", {"entities": []}], ["However, several medications, (eg, barbiturates, vigabatrin, topiramate, flunarizine, corticosteroids, mefloquine, efavirenz, and interferon-\u03b1) do appear to cause depression in some patients and should be used with caution in patients at risk for depression.", {"entities": []}], ["Systemic onset juvenile idiopathic arthritis (SoJIA) represents up to 20% of juvenile idiopathic arthritis.", {"entities": [[35, 44, "DISEASE"], [97, 106, "DISEASE"]]}], ["We recently reported that interleukin (IL) 1 is an important mediator of this disease and that IL-1 blockade induces clinical remission.", {"entities": []}], ["However, lack of specificity of the initial systemic manifestations leads to delays in diagnosis and initiation of therapy.", {"entities": []}], ["To develop a specific diagnostic test, we analyzed leukocyte gene expression profiles of 44 pediatric SoJIA patients, 94 pediatric patients with acute viral and bacterial infections, 38 pediatric patients with systemic lupus erythematosus (SLE), 6 patients with PAPA syndrome, and 39 healthy children.", {"entities": [[219, 238, "DISEASE"], [267, 275, "DISEASE"], [210, 238, "DISEASE"]]}], ["Statistical group comparison and class prediction identified genes differentially expressed in SoJIA patients compared with healthy children.", {"entities": []}], ["These genes, however, were also changed in patients with acute infections and SLE.", {"entities": []}], ["An analysis of significance across all diagnostic groups identified 88 SoJIA-specific genes, 12 of which accurately classified an independent set of SoJIA patients with systemic disease.", {"entities": []}], ["Transcripts that changed significantly in patients undergoing IL-1 blockade were also identified.", {"entities": []}], ["Thus, leukocyte transcriptional signatures can be used to distinguish SoJIA from other febrile illnesses and to assess response to therapy.", {"entities": []}], ["Availability of early diagnostic markers may allow prompt initiation of therapy and prevention of disabilities.", {"entities": []}], ["Vasicine (VAS), a potential natural cholinesterase inhibitor, exhibited promising anticholinesterase activity in preclinical models and has been in development for treatment of Alzheimer\u2019s disease.", {"entities": []}], ["This study systematically investigated the in vitro and in vivo metabolism of VAS in rat using ultra performance liquid chromatography combined with electrospray ionization quadrupole time-of-flight mass spectrometry.", {"entities": []}], ["A total of 72 metabolites were found based on a detailed analysis of their", {"entities": []}], ["To evaluate the potential effects of betel quid chewing on mortality.", {"entities": []}], ["(A quid consists of betel nut, wrapped in betel leaves; tobacco is added to the quid by some users).", {"entities": []}], ["Prospective data were available on 20\u2009033 individuals aged 18\u201375 years, living in Araihazar, Bangladesh.", {"entities": []}], ["Demographic and exposure data were collected at baseline using a standardized questionnaire.", {"entities": []}], ["Cause of death was defined by verbal autopsy questionnaires administered to next of kin.", {"entities": []}], ["We estimated hazard ratios (HR) and their 95% confidence intervals (CI) for associations between betel use and mortality from all causes and from specific causes, using Cox proportional hazards models.", {"entities": [[28, 30, "GENE"]]}], ["We adjusted for age, sex, body mass index, educational attainment and tobacco smoking history.", {"entities": []}], ["There were 1072 deaths during an average of 10 years of follow-up.", {"entities": []}], ["Participants who had ever used betel were significantly more likely to die from all causes (HR: 1.26; 95% CI: 1.09\u20131.44) and cancer (HR: 1.55; 95% CI: 1.09\u20132.22); but not cardiovascular disease (HR: 1.16; 95% CI: 0.93\u20131.43).", {"entities": [[125, 131, "DISEASE"], [92, 94, "GENE"], [133, 135, "GENE"], [195, 197, "GENE"], [92, 94, "GENE"], [133, 135, "GENE"], [195, 197, "GENE"], [92, 94, "GENE"], [133, 135, "GENE"], [195, 197, "GENE"]]}], ["These findings were robust to adjustment for potential confounders.", {"entities": []}], ["There was a dose\u2013response relationship between mortality from all causes and both the duration and the intensity of betel use.", {"entities": []}], ["The population attributable fraction for betel use was 14.1% for deaths from all causes and 24.2% for cancer.", {"entities": [[102, 108, "DISEASE"]]}], ["Betel quid use was associated with mortality from all causes and from cancer in this cohort.", {"entities": [[70, 76, "DISEASE"]]}], ["Silver nanoparticles (AgNPs) have been associated with the exacerbation of asthma; however, the immunological basis for the adjuvant effects of AgNPs is not well understood.", {"entities": [[75, 81, "DISEASE"]]}], ["The aim of the study reported here was to investigate the allergic effects of AgNP inhalation using proteomic approaches.", {"entities": []}], ["Allergen provoked mice were exposed to 33 nm AgNPs at 3.3 mg/m In total, 106 and 79 AgNP-unique proteins were identified in the BALF of control and allergic mice, respectively.", {"entities": []}], ["Additionally, 40 and 26 AgNP-unique proteins were found in the plasma of control and allergic mice, respectively.", {"entities": []}], ["The BALF and plasma protein profiles suggested that metabolic, cellular, and immune system processes were associated with pulmonary exposure to AgNPs.", {"entities": []}], ["In addition, we observed 18 proteins associated with systemic lupus erythematosus that were commonly expressed in both control and allergic mice after AgNP exposure.", {"entities": [[62, 81, "DISEASE"], [53, 81, "DISEASE"]]}], ["Significant allergy responses were observed after AgNP exposure in control and allergic mice, as determined by ovalbumin-specific immunoglobulin E. Inhaled AgNPs may regulate immune responses in the lungs of both control and allergic mice.", {"entities": []}], ["Our results suggest that immunology is a vital response to AgNPs.", {"entities": []}], ["The study was designed to investigate the hepatoprotective activity of methanol extract of Cissus quadrangularis (CQ) against isoniazid-induced hepatotoxicity in rats.", {"entities": []}], ["The successive petroleum ether (60\u201380\u00b0C) and methanol extracts of C. quadrangularis were used.", {"entities": []}], ["Hepatic damage was induced in Wistar rats by administering isoniazid (54 mg/kg, p.o.)", {"entities": []}], ["once daily for 30 days.", {"entities": []}], ["Simultaneously, CQ (500 mg/kg p.o) was administered 1 h prior to the administration of isoniazid (54 mg/kg, p.o.)", {"entities": []}], ["once daily for 30 days.", {"entities": []}], ["Silymarin (50 mg/kg p.o) was used as a reference drug.", {"entities": []}], ["Elevated levels of aspartate transaminase, alanine transaminase, alkaline posphatase, and bilirubin following isoniazid administration were significantly lowered due to pretreatment with CQ.", {"entities": []}], ["Isoniazid administration significantly increased lipid peroxidation (LPO) and decreased antioxidant activities such as reduced glutathione, superoxide dismutase, and catalase.", {"entities": [[69, 72, "GENE"]]}], ["Pretreatment of rats with CQ significantly decreased LPO and increased the antioxidant activities.", {"entities": [[53, 56, "GENE"]]}], ["The results of this study indicated that the hepatoprotective effect of CQ might be attributed to its antioxidant property.", {"entities": []}], ["The use of a simple screening questionnaire to detect persistent airflow obstruction (AO) in COPD may facilitate the early, accurate diagnosis of COPD in general practice settings.", {"entities": []}], ["This study developed an original persistent AO questionnaire for screening individuals with COPD in a general Japanese population.", {"entities": []}], ["A working group was established to generate initial draft questionnaire items about COPD.", {"entities": []}], ["Eligible subjects aged 40 and older living in Japan were solicited to participate in a health checkup from 2014 to 2015.", {"entities": []}], ["In study I, 2,338 subjects who fully completed the initial draft questionnaire and who had valid spirometry measurements were statistically analyzed to determine the final questionnaire items as a COPD screening questionnaire (COPD-Q).", {"entities": []}], ["Persistent AO was defined as a post-bronchodilator FEV 1 /FVC <0.70.", {"entities": [[51, 54, "GENE"]]}], ["In study II, the working group analyzed the weighted scores for individual items and established a cutoff point for the COPD-Q based on the data of 2,066 subjects in the Hisayama study.", {"entities": []}], ["Receiver operating characteristic (ROC) curves were used to examine the ability of the COPD-Q to discriminate between subjects with and without AO.", {"entities": []}], ["The five-item COPD-Q was established based on 19 initial draft items in study I and the weighted scores of individual items.", {"entities": []}], ["The overall area under the ROC curve for the COPD-Q was 0.796 (95% confidence interval, 0.707\u20130.788).", {"entities": []}], ["A cutoff of 4 points resulted in a sensitivity of 71.0% and a specificity of 70.1%.", {"entities": []}], ["The positive predictive value was 10.8%, and the negative predictive value was 97.9%.", {"entities": []}], ["The crude odds ratio of the COPD-Q for AO was 5.8.", {"entities": []}], ["The five-item COPD-Q is a useful questionnaire for diagnosing persistent AO in a general Japanese population and is expected to be an effective first-stage screening tool for detecting COPD.", {"entities": []}], ["Audit and feedback aims to guide health professionals in improving aspects of their practice that need it most.", {"entities": []}], ["Evidence suggests that feedback fails to increase accuracy of professional perceptions about clinical performance, which likely reduces audit and feedback effectiveness.", {"entities": []}], ["This study investigates health professionals\u2019 perceptions about their clinical performance and the influence of feedback on their intentions to change practice.", {"entities": []}], ["We conducted an online laboratory experiment guided by Control Theory with 72 intensive care professionals from 21\u00a0units.", {"entities": []}], ["For each of four new pain management indicators, we collected professionals\u2019 perceptions about their clinical performance; peer performance; targets; and improvement intentions before and after receiving first-time feedback.", {"entities": []}], ["An electronic audit and feedback dashboard provided ICU\u2019s own performance, median and top 10% peer performance, and improvement recommendations.", {"entities": []}], ["The experiment took place approximately 1\u00a0month before units enrolled into a cluster-randomised trial assessing the impact of adding a toolbox with suggested actions and materials to improve intensive care pain management.", {"entities": []}], ["During the experiment, the toolbox was inaccessible; all participants accessed the same version of the dashboard.", {"entities": []}], ["We analysed 288 observations.", {"entities": []}], ["In 53.8%, intensive care professionals overestimated their clinical performance; but in only 13.5%, they underestimated it.", {"entities": []}], ["On average, performance was overestimated by 22.9% (on a 0\u2013100% scale).", {"entities": []}], ["Professionals similarly overestimated peer performance, and set targets 20.3% higher than the top performance benchmarks.", {"entities": []}], ["In 68.4% of cases, intentions to improve practice were consistent with actual gaps in performance, even before professionals had received feedback; which increased to 79.9% after receiving feedback (odds ratio, 2.41; 95% CI, 1.53 to 3.78).", {"entities": []}], ["However, in 56.3% of cases, professionals still wanted to improve care aspects at which they were already top performers.", {"entities": []}], ["Alternatively, in 8.3% of cases, they lacked improvement intentions because they did not consider indicators important; did not trust the data; or deemed benchmarks unrealistic.", {"entities": []}], ["Audit and feedback helps health professionals to work on aspects for which improvement is recommended.", {"entities": []}], ["Given the abundance of professionals\u2019 prior good improvement intentions, the limited effects typically found by audit and feedback studies are likely predominantly caused by barriers to translation of intentions into actual change in clinical practice.", {"entities": []}], ["ClinicalTrials.gov NCT02922101 .", {"entities": []}], ["Registered 26 September 2016.", {"entities": []}], ["The online version of this article (10.1186/s13012-018-0727-8) contains supplementary material, which is available to authorized users.", {"entities": []}], ["To estimate and compare the prevalence and type of potentially inappropriate prescribing (PIP) and potential prescribing omissions (PPOs) among community-dwelling older adults (\u226565 years) enrolled to a clinical trial in three European countries.", {"entities": []}], ["A secondary analysis of the Thyroid Hormone Replacement for Subclinical Hypothyroidism Trial dataset.", {"entities": []}], ["A subset of 48/80 PIP and 22/34 PPOs indicators from the Screening Tool of Older Persons Prescriptions/Screening Tool to Alert doctors to Right Treatment (STOPP/START) V2 criteria were applied to prescribed medication data for 532/737 trial participants in Ireland, Switzerland and the Netherlands.", {"entities": []}], ["The overall prevalence of PIP was lower in the Irish participants (8.7%) compared with the Swiss (16.7%) and Dutch (12.5%) participants (P=0.15) and was not statistically significant.", {"entities": []}], ["The overall prevalence of PPOs was approximately one-quarter in the Swiss (25.3%) and Dutch (24%) participants and lower in the Irish (14%) participants (P=0.04) and the difference was statistically significant.", {"entities": []}], ["The hypnotic Z-drugs were the most frequent PIP in Irish participants, (3.5%, n=4), while it was non-steroidal anti-inflammatory drug and oral anticoagulant combination, sulfonylureas with a long duration of action, and benzodiazepines (all 4.3%, n=7) in Swiss, and benzodiazepines (7.1%, n=18) in Dutch participants.", {"entities": []}], ["The most frequent PPOs in Irish participants were vitamin D and calcium in osteoporosis (3.5%, n=4).", {"entities": [[75, 87, "DISEASE"]]}], ["In the Swiss and Dutch participants, they were bone antiresorptive/anabolic therapy in osteoporosis (9.9%, n=16, 8.6%, n=22) respectively.", {"entities": [[87, 99, "DISEASE"]]}], ["The odds of any PIP after adjusting for age, sex, multimorbidity and polypharmacy were (adjusted OR (aOR)) 3.04 (95% CI 1.33 to 6.95, P<0.01) for Swiss participants and aOR 1.74 (95% CI 0.79 to 3.85, P=0.17) for Dutch participants compared with Irish participants.", {"entities": []}], ["The odds of any PPOs were aOR 2.48 (95% CI 1.27 to 4.85, P<0.01) for Swiss participants and aOR 2.10 (95% CI 1.11 to 3.96, P=0.02) for Dutch participants compared with Irish participants.", {"entities": []}], ["This study has estimated and compared the prevalence and type of PIP and PPOs among this cohort of community-dwelling older people.", {"entities": []}], ["It demonstrated a significant difference in the prevalence of PPOs between the three populations.", {"entities": []}], ["Further research is urgently needed into the impact of system level factors as this has important implications for patient safety, healthcare provision and economic costs.", {"entities": []}], ["Neutrophil trafficking in tissues critically regulates the body\u2019s immune response.", {"entities": []}], ["Neutrophil migration can either play a protective role in host defense or cause health problems.", {"entities": []}], ["Fibroblast growth factor 23 (FGF23) is a known biomarker for chronic kidney disease (CKD) and was recently shown to impair neutrophil arrest on endothelium and transendothelial migration.", {"entities": [[69, 83, "DISEASE"], [29, 34, "GENE"]]}], ["In the present study, we further examined the effect of FGF23 on human blood neutrophil chemotaxis using two new microfluidic devices.", {"entities": [[56, 61, "GENE"]]}], ["Our results showed that chemotaxis of FGF23 pre-treated neutrophils to a f MLP gradient, in the presence or absence of a uniform FGF23 background, is quantitatively lower compared to the control cells.", {"entities": [[38, 43, "GENE"], [129, 134, "GENE"], [38, 43, "GENE"], [129, 134, "GENE"]]}], ["This effect is accompanied with a stronger drifting of FGF23 pre-treated cells along the flow.", {"entities": [[55, 60, "GENE"]]}], ["However, without the FGF23 pre-treatment, the FGF23 background only reduces chemotaxis of transmigrated cells through the thin barrier channel to the f MLP gradient.", {"entities": [[21, 26, "GENE"], [46, 51, "GENE"], [21, 26, "GENE"], [46, 51, "GENE"]]}], ["The effect of FGF23 on neutrophil migration and the correlation between multiple cell migration parameters are further revealed by chemotactic entropy and principle component analysis.", {"entities": [[14, 19, "GENE"]]}], ["Collectively, these results revealed the effect of FGF23 on weakening neutrophil chemotaxis, which shed light on FGF23 mediated neutrophil migration with direct disease relevance such as CKD.", {"entities": [[51, 56, "GENE"], [113, 118, "GENE"], [51, 56, "GENE"], [113, 118, "GENE"]]}], ["The pre- and postnatal environment may represent a window of opportunity for allergy and asthma prevention, and the hygiene hypothesis implies that microbial agents may play an important role in this regard.", {"entities": [[89, 95, "DISEASE"]]}], ["Using the cowshed-derived bacterium Acinetobacter lwoffii F78 together with a mouse model of experimental allergic airway inflammation, this study investigated the hygiene hypothesis, maternal (prenatal) microbial exposure, and the involvement of Toll-like receptor (TLR) signaling in prenatal protection from asthma.", {"entities": [[310, 316, "DISEASE"]]}], ["Maternal intranasal exposure to A. lwoffii F78 protected against the development of experimental asthma in the progeny.", {"entities": [[97, 103, "DISEASE"]]}], ["Maternally, A. lwoffii F78 exposure resulted in a transient increase in lung and serum proinflammatory cytokine production and up-regulation of lung TLR messenger RNA.", {"entities": []}], ["Conversely, suppression of TLRs was observed in placental tissue.", {"entities": []}], ["To investigate further, the functional relevance of maternal TLR signaling was tested in TLR2/3/4/7/9 knockout mice.", {"entities": []}], ["The asthma-preventive effect was completely abolished in heterozygous offspring from A. lwoffii F78\u2013treated TLR2/3/4/7/9 homozygous mother mice.", {"entities": [[4, 10, "DISEASE"]]}], ["Furthermore, the mild local and systemic inflammatory response was also absent in these A. lwoffii F78\u2013exposed mothers.", {"entities": []}], ["These data establish a direct relationship between maternal bacterial exposures, functional maternal TLR signaling, and asthma protection in the progeny.", {"entities": [[120, 126, "DISEASE"]]}], ["Human respiratory epithelia function in airway mucociliary clearance and barrier function and have recently been implicated in sensory functions.", {"entities": []}], ["We investigated a link between chronic obstructive pulmonary disease (COPD) pathogenesis and molecular mechanisms underlying Ca Using primary cultures of human respiratory epithelial (HRE) cells, we determined that these cells possess proteolytic signaling machinery, whereby proteinase-activated receptor-2 (PAR-2) activates Ca P19S variant enhances Ca MMP 1 activation, providing mechanistic linkage between man-made air pollution and human airway disease.", {"entities": [[31, 68, "DISEASE"]]}], ["DEP evoked protracted Ca P19S .", {"entities": []}], ["This mechanism reprograms maladaptive inflammatory and extracellular-matrix\u2013remodeling responses in human airways.", {"entities": []}], ["The novel concept of air pollution\u2013responsive ciliary signal transduction from PAR-2 to TRPV4 in human respiratory epithelia will accelerate rationally targeted therapies, possibly via the inhalatory route.", {"entities": [[88, 93, "GENE"]]}], ["Inflammation is a response to infections or tissue injuries.", {"entities": []}], ["Inflammation was once defined by clinical signs, later by the presence of leukocytes, and nowadays by expression of \u201cproinflammatory\u201d cytokines and chemokines.", {"entities": []}], ["But leukocytes and cytokines often have rather anti-inflammatory, proregenerative, and homeostatic effects.", {"entities": []}], ["Is there a need to redefine \u201cinflammation\u201d?", {"entities": []}], ["In this review, we discuss the functions of \u201cinflammatory\u201d mediators/regulators of the innate immune system that determine tissue environments to fulfill the need of the tissue while regaining homeostasis after injury.", {"entities": []}], ["The human respiratory syncytial virus (hRSV) is the leading cause of severe bronchiolitis in infants worldwide.", {"entities": [[76, 89, "DISEASE"]]}], ["The most severe RSV diseases occur between 2 and 6 months-of-age, so pediatric vaccination will have to be started within the first weeks after birth, when the immune system is prone to Th2 responses that may turn deleterious upon exposure to the virus.", {"entities": []}], ["So far, the high risk to prime for immunopathological responses in infants has hampered the development of vaccine.", {"entities": []}], ["In the present study we investigated the safety and efficacy of ring-nanostructures formed by the recombinant nucleoprotein N of hRSV (N A single intranasal administration of N E.coli enterotoxin LT(R192G) to 5\u20137 day old neonates provided a significant reduction of the viral load after an RSV challenge at five weeks of age.", {"entities": [[196, 198, "GENE"]]}], ["However, neonatal vaccination also generated an enhanced lung infiltration by neutrophils and eosinophils following the RSV challenge.", {"entities": []}], ["Analysis of antibody subclasses and cytokines produced after an RSV challenge or a boost administration of the vaccine suggested that neonatal vaccination induced a Th2 biased local immune memory.", {"entities": []}], ["This Th2 bias and the eosinophilic reaction could be prevented by adding CpG to the vaccine formulation, which, however did not prevent pulmonary inflammation and neutrophil infiltration upon viral challenge.", {"entities": []}], ["In conclusion, protective vaccination against RSV can be achieved in neonates but requires an appropriate combination of adjuvants to prevent harmful Th2 imprinting.", {"entities": []}], ["Vernal keratoconjunctivitis is an ocular allergy that is common in the pediatric age group.", {"entities": [[7, 27, "DISEASE"]]}], ["It is often chronic, severe, and nonresponsive to the available treatment options.", {"entities": []}], ["Management of these children is difficult and often a dilemma for the practitioner.", {"entities": []}], ["There is a need to simplify and standardize its management.", {"entities": []}], ["To achieve this goal, we require a grading system to judge the severity of inflammation and an algorithm to select the appropriate medications.", {"entities": []}], ["This article provides a simple and practically useful grading system and a stepladder algorithm for systematic treatment of these patients.", {"entities": []}], ["Use of appropriate treatment modalities can reduce treatment and disease-related complications.", {"entities": []}], ["The inflammatory potential of diet has been inconsistently linked to colorectal cancer (CRC) risk.", {"entities": [[69, 86, "DISEASE"], [80, 86, "DISEASE"]]}], ["This meta-analysis aimed to evaluate the association of the inflammatory potential of diet, as estimated by the dietary inflammatory index (DII) score, with CRC risk.", {"entities": []}], ["The PubMed and Embase databases were searched for relevant studies from inception to February 2017.", {"entities": []}], ["All cohort and case\u2013control studies investigating the association of the DII score with CRC risk were selected.", {"entities": []}], ["Four prospective cohorts and four case\u2013control studies, which enrolled a total of 880,380 participants, were included.", {"entities": []}], ["The pooled adjusted risk ratio (RR) of CRC for the highest DII score versus the lowest category was 1.43 (95% confidence interval [CI]: 1.26\u20131.62).", {"entities": []}], ["When stratified by study design, the RRs for the case\u2013control and cohort studies were 1.27 (95% CI: 1.16\u20131.38) and 1.81 (95% CI: 1.48\u20132.22), respectively.", {"entities": []}], ["Subgroup analysis showed that individuals with the highest category of DII score were independently associated with CRC risk in men (RR=1.51; 95% CI: 1.29\u20131.76), women (RR=1.25; 95% CI: 1.10\u20131.41), colon cancer (RR=1.39; 95% CI: 1.19\u20131.62), and rectal cancer (RR=1.32; 95% CI: 1.01\u20131.74).", {"entities": [[198, 210, "DISEASE"], [204, 210, "DISEASE"], [252, 258, "DISEASE"]]}], ["However, the pooled RR was 1.07 (95% CI: 0.87\u20131.31) for rectal cancer among the prospective cohort studies.", {"entities": [[63, 69, "DISEASE"]]}], ["As estimated by a high DII score, pro-inflammatory diet is independently associated with increased CRC risk.", {"entities": []}], ["This finding confirms that low inflammatory potential diet may reduce CRC risk.", {"entities": []}], ["However, the gender- and cancer site-specific associations of the DII score with CRC risk need to be further investigated.", {"entities": [[25, 31, "DISEASE"]]}], ["Evidence suggests that early life infections, presence of older siblings and furred pets in the household affect the risk of developing allergic diseases through altered microbial exposure.", {"entities": []}], ["Recently, low gut microbial diversity during infancy has also been linked with later development of allergies.", {"entities": []}], ["We investigated whether presence of older siblings, furred pets and early life infections affected gut microbial communities at 9 and 18\u00a0months of age and whether these differences were associated with the cumulative prevalence of atopic symptoms of eczema and asthmatic bronchitis at 3 years of age.", {"entities": [[271, 281, "DISEASE"]]}], ["Bacterial compositions and diversity indices were determined in fecal samples collected from 114 infants in the SKOT I cohort at age 9 and 18\u00a0months by 16S rRNA gene sequencing.", {"entities": []}], ["These were compared to the presence of older siblings, furred pets and early life infections and the cumulative prevalence of diagnosed asthmatic bronchitis and self-reported eczema at 3 years of age.", {"entities": [[146, 156, "DISEASE"]]}], ["The number of older siblings correlated positively with bacterial diversity ( p \u2009=\u20090.030), diversity of the phyla Firmicutes ( p \u2009=\u20090.013) and Bacteroidetes ( p \u2009=\u20090.004) and bacterial richness ( p \u2009=\u20090.006) at 18\u00a0months.", {"entities": []}], ["Further, having older siblings was associated with increased relative abundance of several bacterial taxa at both 9 and 18\u00a0months of age.", {"entities": []}], ["Compared to the effect of having siblings, presence of household furred pets and early life infections had less pronounced effects on the gut microbiota.", {"entities": []}], ["Gut microbiota characteristics were not significantly associated with cumulative occurrence of eczema and asthmatic bronchitis during the first 3 years of life.", {"entities": [[116, 126, "DISEASE"]]}], ["Presence of older siblings is associated with increased gut microbial diversity and richness during early childhood, which could contribute to the substantiation of the hygiene hypothesis.", {"entities": []}], ["However, no associations were found between gut microbiota and atopic symptoms of eczema and asthmatic bronchitis during early childhood and thus further studies are required to elucidate whether sibling-associated gut microbial changes influence development of allergies later in childhood.", {"entities": [[103, 113, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12866-015-0477-6) contains supplementary material, which is available to authorized users.", {"entities": []}], ["We conducted a campus forest-walking program targeting university and graduate students during their lunchtime and examined the physical and psychological effects of the program.", {"entities": []}], ["We utilized a quasi-experimental design with a control group and a pretest\u2013posttest design.", {"entities": []}], ["Forty-seven men (M = 25.5 \u00b1 3.8 years) and 52 women (M = 23.3 \u00b1 4.3 years) volunteered to participate (experimental group n = 51, control group n = 48).", {"entities": []}], ["The intervention group participated in campus forest-walking program once a week for six weeks; they were also asked to walk once a week additionally on an individual basis.", {"entities": []}], ["Additionally, participants received one lecture on stress management.", {"entities": []}], ["Post-tests were conducted both just after the program ended and three months after.", {"entities": []}], ["A chi-square test, t -test, and repeated measures analysis of variance were used to evaluate the effects of the program.", {"entities": []}], ["Health promoting behaviors ( F = 7.27, p = 0.001, ES = 0.27) and parasympathetic nerve activity ( F = 3.69, p = 0.027, ES = 0.20) significantly increased and depression ( F = 3.15, p = 0.045, ES = 0.18) significantly decreased in the experimental group after the intervention compared to the control group.", {"entities": []}], ["In conclusion, using the campus walking program to target students during their lunchtime is an efficient strategy to promote their physical and psychological health.", {"entities": []}], ["Health state valuations, used to evaluate the effectiveness of healthcare interventions, can be obtained either by the patients or by the general population.", {"entities": []}], ["The general population seems to value somatic conditions more negatively than patients, but little is known about valuations of psychological conditions.", {"entities": []}], ["This study examined whether individuals with and without depression differ in their valuations of depression and whether perceptions regarding depression (empathy, perceived susceptibility, stigma, illness perceptions) and individual characteristics (mastery, self-compassion, dysfunctional attitudes) bias valuations of either individuals with or without depression.", {"entities": []}], ["In an online study, a general population sample used a time-trade-off task to value 30 vignettes describing depression states (four per participant) and completed questionnaires on perceptions regarding depression and individual characteristics.", {"entities": []}], ["Participants were assigned to depression groups (with or without depression), based on the PHQ-9.", {"entities": []}], ["A generalized linear mixed model was used to assess discrepancies in valuations and identify their determinants.", {"entities": []}], ["The sample ( N \u00a0=\u00a01268) was representative of the Dutch population on age, gender, education and residence.", {"entities": []}], ["We found that for mild depression states, individuals with depression ( N \u00a0=\u00a0200) valued depression more negatively than individuals without depression ( N \u00a0=\u00a01068) ( p \u00a0=\u00a0.007).", {"entities": []}], ["Variables related to perceptions of depression and individual characteristics were not found to affect valuations of either individuals with or individuals without depression.", {"entities": []}], ["Since the general population values depression less negatively, using their perspective might result in less effectiveness for interventions for mild depression.", {"entities": []}], ["Perceptions of depression or to individual characteristics did not seem to differentially affect valuations made by either individuals with or without depression.", {"entities": []}], ["The cyclic tetrapeptide 1-alaninechlamydocin was purified from a Great Lakes-derived fungal isolate identified as a Tolypocladium sp.", {"entities": []}], ["Although the planar structure was previously described, a detailed analysis of its spectroscopic data and biological activity are reported here for the first time.", {"entities": []}], ["Its absolute configuration was determined using a combination of spectroscopic ( 50 5.3 nM, TGI 8.8 nM, LC 50 22 nM).", {"entities": []}], ["Further analysis revealed that 1-alaninechlamydocin induced G2/M cell cycle arrest and apoptosis.", {"entities": []}], ["Similar to other cyclic epoxytetrapeptides, the inhibitory effects of 1-alaninechlamydocin are proposed to be produced primarily via inhibition of histone deacetylase (HDAC) activity.", {"entities": []}], ["Muscarinic acetylcholine receptors (mAChRs) have been identified in airway epithelium, and epithelium-derived chemokines can initiate the migration of airway smooth muscle (ASM) cells.", {"entities": []}], ["However, the mAChRs that are expressed in airway epithelium and the mechanism underlying the regulation of ASM cell migration are not clear.", {"entities": []}], ["The aim of this study was to test whether the effects of the epithelium-derived chemokines on ASM cell migration could be modulated by mAChRs.", {"entities": []}], ["Human epithelial cells (A549 cells) were stimulated with cigarette smoke extract (CSE) or the mAChRs agonist carbachol.", {"entities": []}], ["IL-8 and TGF-\u03b21 production were measured by ELISA, and human ASM cell migration was measured using the transwell migration assay and scratch assay.", {"entities": []}], ["The mRNA levels of the mAChRs subtypes and the acetylcholine concentrations were measured using RT-PCR and LC\u2013MS/MS, respectively.", {"entities": []}], ["ASM cell migration toward CSE-stimulated A549 cells was markedly reduced by Ac-RRWWCR-NH2 (IL-8 inhibitor) and SB431542 (TGF-\u03b21 inhibitor).", {"entities": []}], ["CSE-induced ASM cell migration was also suppressed by the mAChRs antagonist tiotropium.", {"entities": []}], ["Interestingly, carbachol-stimulated A549 cells also induced ASM cell migration; this migration event was suppressed by tiotropium, Ac-RRWWCR-NH2 and SB431542.", {"entities": []}], ["In addition, the effects of CSE on ASM cell migration were significantly and cooperatively enhanced by carbachol compared to CSE alone.", {"entities": []}], ["Carbachol-induced ASM cell migration was reduced by selective inhibitors of PI3K/Akt (LY294002) and p38 (SB203580), suggesting that it occurred through p38 and Akt phosphorylation, which was inhibited by the M3 mAChR antagonist 4-DAMP.", {"entities": []}], ["These findings indicate that M3 mAChR may be important therapeutic target for obstructive airway diseases, as it regulates the effects of the epithelial-derived chemokines on ASM cell migration, which results in lung remodeling.", {"entities": []}], ["The increased morbidity, mortality, and ineffective treatment associated with the pathogenesis of chronic inflammatory diseases such as asthma and chronic obstructive pulmonary disease (COPD) have generated much research interest.", {"entities": [[147, 184, "DISEASE"], [136, 142, "DISEASE"]]}], ["The key role is played by phospholipases from the A 2 superfamily: enzymes which are involved in inflammation through participation in pro- and anti-inflammatory mediators production and have an impact on many immunocompetent cells.", {"entities": []}], ["The 30 members of the A 2 superfamily are divided into 7 groups.", {"entities": []}], ["Their role in asthma and COPD has been studied in vitro and in vivo (animal models, cell cultures, and patients).", {"entities": [[14, 20, "DISEASE"]]}], ["This paper contains complete and updated information about the involvement of particular enzymes in the etiology and course of asthma and COPD.", {"entities": [[127, 133, "DISEASE"]]}], ["The impact of particulate matter (PM) on stroke may vary by particle size, stroke subtype, and patient characteristics and temperature.", {"entities": []}], ["We examined the association of stroke admissions with PM in different subgroups in Beijing, China, during 2013\u20132014.", {"entities": []}], ["A time\u2010stratified case\u2010crossover design was used to assess the relation between PM of different particle sizes and hospital admissions for ischemic and hemorrhagic stroke.", {"entities": []}], ["Stratified analyses were performed by age, sex, and temperature.", {"entities": []}], ["In total, there were 147\u00a0624 stroke admissions during the study period.", {"entities": []}], ["In the whole\u2010period analysis, both PM 2.5 and PM 10 were positively associated with ischemic stroke admissions on the day of hospital admission and negatively associated with ischemic stroke at lag2 and lag3 day.", {"entities": [[203, 207, "GENE"]]}], ["In warm days (>13.5\u00b0C), the odds ratios of ischemic stroke admissions were 2.071 (95% CI 1.959\u20132.190), 1.470 (95% CI 1.391\u20131.554), and 1.590 (95% CI 1.493\u20131.694) per IQR increase in the same\u2010day PM 2.5 (82.0\u00a0\u03bcg/m 2.5\u201310 (36.6\u00a0\u03bcg/m 10 (93.5\u00a0\u03bcg/m This study suggests that the associations of PM 2.5 , PM 2.5\u201310 , and PM 10 with stroke admissions differed across levels of temperature.", {"entities": []}], ["Short\u2010term exposure to PM 2.5 , PM 2.5\u201310 , and PM 10 was positively associated with hospital admissions for ischemic and hemorrhagic stroke on warm days (>13.5\u00b0C).", {"entities": []}], ["While the relationship of asthma and coronary heart disease (CHD) (a specific manifestation of cardiovascular disease) has not been described consistently, we tried to defined this relation and explore the influence of gender and asthma status (child- and adult-onset asthma) on this issue.", {"entities": [[46, 59, "DISEASE"], [37, 59, "DISEASE"], [26, 32, "DISEASE"], [230, 236, "DISEASE"], [268, 274, "DISEASE"]]}], ["We searched published reports that described the relationship of asthma and CHD.", {"entities": [[65, 71, "DISEASE"]]}], ["Eleven trials were identified, covering 666,355 subjects.", {"entities": []}], ["Asthma overall was significantly associated with CHD both for prospective trials (HR 1.34 [1.09,1.64], P = 0.005) and for retrospective trials(OR 1.29 [1.13,1.46], P = 0.001), when compared to individuals without asthma.", {"entities": [[0, 6, "DISEASE"], [213, 219, "DISEASE"], [82, 84, "GENE"]]}], ["Subgroup analysis split by gender indicated that females with asthma were significantly associated with CHD (HR 1.40 [1.20,1.62], P<0.001), but males with asthma were not significantly related with CHD (HR 1.19 [0.98,1.44], P = 0.07).", {"entities": [[62, 68, "DISEASE"], [155, 161, "DISEASE"], [109, 111, "GENE"], [203, 205, "GENE"], [109, 111, "GENE"], [203, 205, "GENE"]]}], ["For the four subgroups (Females with adult-onset asthma,males with adult-onset asthma,females with child-onset asthma,and males with child-onset asthma), pooled analysis of two trials indicated that only females with adult-onset asthma were significantly associated with CHD (HR 2.06 [1.32,3.19], P<0.001).", {"entities": [[49, 55, "DISEASE"], [79, 85, "DISEASE"], [111, 117, "DISEASE"], [145, 151, "DISEASE"], [229, 235, "DISEASE"], [276, 278, "GENE"]]}], ["Our data indicated that asthma was associated with CHD, and the relationship between them seemed to derived mostly from females with adult-onset asthma.", {"entities": [[24, 30, "DISEASE"], [145, 151, "DISEASE"]]}], ["Considering the limits of our study, these findings should be taken with caution.", {"entities": []}], ["Mammals have developed evolutionarily conserved programs of transcriptional response to hypoxia and inflammation.", {"entities": []}], ["These stimuli commonly occur together in vivo and there is significant crosstalk between the transcription factors that are classically understood to respond to either hypoxia or inflammation.", {"entities": []}], ["This crosstalk can be used to modulate the overall response to environmental stress.", {"entities": []}], ["Several common disease processes are characterised by aberrant transcriptional programs in response to environmental stress.", {"entities": []}], ["In this review, we discuss the current understanding of the role of the hypoxia-responsive (hypoxia-inducible factor) and inflammatory (nuclear factor-\u03baB) transcription factor families and their crosstalk in rheumatoid arthritis, inflammatory bowel disease and colorectal cancer, with relevance for future therapies for the management of these conditions.", {"entities": [[230, 256, "DISEASE"], [208, 228, "DISEASE"], [261, 278, "DISEASE"], [219, 228, "DISEASE"], [272, 278, "DISEASE"]]}], ["Drugs have tremendous potential to cure and relieve disease, but the risk of unintended effects is always present.", {"entities": []}], ["Healthcare providers increasingly record data in electronic patient records (EPRs), in which we aim to identify possible adverse events (AEs) and, specifically, possible adverse drug events (ADEs).", {"entities": [[77, 81, "GENE"]]}], ["Based on the undesirable effects section from the summary of product characteristics (SPC) of 7446 drugs, we have built a Danish ADE dictionary.", {"entities": []}], ["Starting from this dictionary we have developed a pipeline for identifying possible ADEs in unstructured clinical narrative text.", {"entities": []}], ["We use a named entity recognition (NER) tagger to identify dictionary matches in the text and post-coordination rules to construct ADE compound terms.", {"entities": []}], ["Finally, we apply post-processing rules and filters to handle, for example, negations and sentences about subjects other than the patient.", {"entities": []}], ["Moreover, this method allows synonyms to be identified and anatomical location descriptions can be merged to allow appropriate grouping of effects in the same location.", {"entities": []}], ["The method identified 1\u2005970\u2005731 (35\u2005477 unique) possible ADEs in a large corpus of 6011 psychiatric hospital patient records.", {"entities": []}], ["Validation was performed through manual inspection of possible ADEs, resulting in precision of 89% and recall of 75%.", {"entities": []}], ["The presented dictionary-building method could be used to construct other ADE dictionaries.", {"entities": []}], ["The complication of compound words in Germanic languages was addressed.", {"entities": []}], ["Additionally, the synonym and anatomical location collapse improve the method.", {"entities": []}], ["The developed dictionary and method can be used to identify possible ADEs in Danish clinical narratives.", {"entities": []}], ["There are no prospective studies that have examined for chronic cough in children without lung disease but with gastroesophageal reflux (GER).", {"entities": [[90, 102, "DISEASE"]]}], ["In otherwise healthy children undergoing flexible upper gastrointestinal endoscopy (esophago-gastroscopy), the aims of the study were to (1) define the frequency of cough in relation to symptoms of GER, (2) examine if children with cough and reflux esophagitis (RE) have different airway cellularity and microbiology in bronchoalveolar lavage (BAL) when compared to those without.", {"entities": [[249, 260, "DISEASE"]]}], ["Data specific for chronic cough (>4-weeks), symptoms of GER and cough severity were collected.", {"entities": []}], ["Children aged <16-years (n = 150) were defined as 'coughers' (C+) if a history of cough in association with their GER symptoms was elicited before BAL were obtained during elective esophago-gastroscopy.", {"entities": []}], ["Presence of esophagitis on esophageal biopsies was considered reflux esophagitis positive (E+).", {"entities": [[12, 23, "DISEASE"], [69, 80, "DISEASE"]]}], ["C+ (n = 69) were just as likely as C- (n = 81) to have esophagitis, odds ratio 0.87 (95%CI 0.46, 1.7).", {"entities": [[55, 66, "DISEASE"]]}], ["Median neutrophil percentage in BAL was significantly different between groups; highest in C+E- (7, IQR 28) and lowest in C-E+ (5, IQR 6).", {"entities": []}], ["BAL positive bacterial culture occurred in 20.7% and were more likely present in current coughers (OR 3.37, 95%CI 1.39, 8.08).", {"entities": []}], ["Airway neutrophilia (median 20%, IQR 34) was significantly higher in those with BAL positive bacterial cultures than those without (5%, 4; p = 0.0001).", {"entities": []}], ["In children without lung disease, the common co-existence of cough with symptoms of GER is independent of the occurrence of esophagitis.", {"entities": [[124, 135, "DISEASE"], [20, 32, "DISEASE"]]}], ["Airway neutrophilia when present in these children is more likely to be related to airway bacterial infection and not to esophagitis.", {"entities": [[121, 132, "DISEASE"]]}], ["Serelaxin is effective in relieving dyspnoea and improving multiple outcomes in acute heart failure (AHF).", {"entities": []}], ["Many AHF patients have preserved ejection fraction (HFpEF).", {"entities": []}], ["Given the lack of evidence-based therapies in this population, we evaluated the effects of serelaxin according to EF in RELAX-AHF trial.", {"entities": []}], ["RELAX-AHF randomized 1161 AHF patients to 48-h serelaxin (30 \u03bcg/kg/day) or placebo within 16 h from presentation.", {"entities": []}], ["We compared the effects of serelaxin on efficacy endpoints, safety endpoints, and biomarkers of organ damage between preserved (\u226550%) and reduced (<50%, HFrEF) EF.", {"entities": []}], ["HFpEF was present in 26% of patients.", {"entities": []}], ["Serelaxin induced a similar dyspnoea relief in HFpEF vs. HFrEF patients by visual analogue scale-area under the curve (VAS-AUC) through Day 5 [mean change, 461 (\u2212195, 1117) vs. 397 (10, 783) mm h, P = 0.87], but had possibly different effects on the proportion of patients with moderately or markedly dyspnoea improvement by Likert scale at 6, 12, and 24 h [odds ratio for favourable response, 1.70 (0.98, 2.95) vs. 0.85 (0.62, 1.15), interaction P = 0.030].", {"entities": []}], ["No differences were encountered in the effect of serelaxin on short- or long-term outcome between HFpEF and HFrEF patients including cardiovascular death or hospitalization for heart/renal failure through Day 60, cardiovascular death through Day 180, and all-cause death through Day 180.", {"entities": []}], ["Similar safety and changes in biomarkers (high-sensitivity troponin T, cystatin-C, and alanine/aspartate aminotransferases) were found in both groups.", {"entities": []}], ["In AHF patients with HFpEF compared with those with HFrEF, serelaxin was well tolerated and effective in relieving dyspnoea and had a similar effect on short- and long-term outcome, including survival improvement.", {"entities": []}], ["Emerging eHealth tools could facilitate the delivery of comprehensive care in time-constrained clinical settings.", {"entities": []}], ["One such tool is interactive computer-assisted health-risk assessments (HRA), which may improve provider-patient communication at the point of care, particularly for psychosocial health concerns, which remain under-detected in clinical encounters.", {"entities": []}], ["The research team explored the perspectives of healthcare providers representing a variety of disciplines (physicians, nurses, social workers, allied staff) regarding the factors required for implementation of an interactive HRA on psychosocial health.", {"entities": []}], ["The research team employed a semi-qualitative participatory method known as Concept Mapping, which involved three distinct phases.", {"entities": []}], ["First, in face-to-face and online brainstorming sessions, participants responded to an open-ended central question: \u201cWhat factors should be in place within your clinical setting to support an effective computer-assisted screening tool for psychosocial risks?\u201d The brainstormed items were consolidated by the research team.", {"entities": []}], ["Then, in face-to-face and online sorting sessions, participants grouped the items thematically as \u2018it made sense to them\u2019.", {"entities": []}], ["Participants also rated each item on a 5-point scale for its \u2018importance\u2019 and \u2018action feasibility\u2019 over the ensuing six month period.", {"entities": []}], ["The sorted and rated data was analyzed using multidimensional scaling and hierarchical cluster analyses which produced visual maps.", {"entities": []}], ["In the third and final phase, the face-to-face Interpretation sessions, the concept maps were discussed and illuminated by participants collectively.", {"entities": []}], ["Overall, 54 providers participated (emergency care 48%; primary care 52%).", {"entities": []}], ["Participants brainstormed 196 items thought to be necessary for the implementation of an interactive HRA emphasizing psychosocial health.", {"entities": []}], ["These were consolidated by the research team into 85 items.", {"entities": []}], ["After sorting and rating, cluster analysis revealed a concept map with a seven-cluster solution: 1) the HRA\u2019s equitable availability; 2) the HRA\u2019s ease of use and appropriateness; 3) the content of the HRA survey; 4) patient confidentiality and choice; 5) patient comfort through humanistic touch; 6) professional development, care and workload; and 7) clinical management protocol.", {"entities": []}], ["Drawing insight from the theoretical lens of Sociotechnical theory, the seven clusters of factors required for HRA implementation could be read as belonging to three overarching aspects : Technical (cluster 1, 2 and 3), Social-Patient (cluster 4 and 5), and Social-Provider (cluster 6 and 7).", {"entities": []}], ["Participants rated every one of the clusters as important, with mean scores from 4.0 to 4.5.", {"entities": []}], ["Their scores for feasibility were somewhat lower, ranging from 3.4 to.", {"entities": []}], ["Comparing the scores for importance and feasibility, a significant difference was found for one cluster from each region (cluster 2, 5, 6).", {"entities": []}], ["The cluster on professional development, care and workload was perceived as especially challenging in emergency department settings, and possible reasons were discussed in the interpretation sessions.", {"entities": []}], ["A number of intertwined multilevel factors emerged as important for the implementation of a computer-assisted, interactive HRA with a focus on psychosocial health.", {"entities": []}], ["Future developments in this area could benefit from systems thinking and insights from theoretical perspectives, such as sociotechnical system theory for joint optimization and responsible autonomy, with emphasis on both the technical and social aspects of HRA implementation.", {"entities": []}], ["Commensal bacteria control the micro-ecology of metazoan epithelial surfaces with pivotal effect on tissue homeostasis and host defense.", {"entities": []}], ["In contrast to the upper respiratory tract, the lower respiratory tract of healthy individuals has largely been considered free of microorganisms.", {"entities": []}], ["To understand airway micro-ecology we studied microbiota of sterilely excised lungs from mice of different origin including outbred wild mice caught in the natural environment or kept under non-specific-pathogen-free (SPF) conditions as well as inbred mice maintained in non-SPF, SPF or germ-free (GF) facilities.", {"entities": []}], ["High-throughput pyrosequencing of reverse transcribed 16S rRNA revealed metabolically active murine lung microbiota in all but GF mice.", {"entities": []}], ["The overall composition across samples was similar at the phylum and family level.", {"entities": []}], ["However, species richness was significantly different between lung microbiota from SPF and non-SPF mice.", {"entities": []}], ["Non-cultivatable Betaproteobacteria such as Ralstonia spp.", {"entities": []}], ["made up the major constituents and were also confirmed by 16S rRNA gene cloning analysis.", {"entities": []}], ["Additionally, Pasteurellaceae, Enterobacteria and Firmicutes were isolated from lungs of non-SPF mice.", {"entities": []}], ["Bacterial communities were detectable by fluorescent in situ hybridization (FISH) at alveolar epithelia in the absence of inflammation.", {"entities": []}], ["Notably, higher bacterial abundance in non-SPF mice correlated with more and smaller size alveolae, which was corroborated by transplanting Lactobacillus spp.", {"entities": []}], ["lung isolates into GF mice.", {"entities": []}], ["Our data indicate a common microbial composition of murine lungs, which is diversified through different environmental conditions and affects lung architecture.", {"entities": []}], ["Identification of the microbiota of murine lungs will pave the path to study their influence on pulmonary immunity to infection and allergens using mouse models.", {"entities": []}], ["School-located influenza vaccination (SLIV) programs can substantially enhance the sub-optimal coverage achieved under existing delivery strategies.", {"entities": [[15, 24, "DISEASE"]]}], ["Randomized SLIV trials have shown these programs reduce laboratory-confirmed influenza among both vaccinated and unvaccinated children.", {"entities": [[77, 86, "DISEASE"]]}], ["This work explores the effectiveness of a SLIV program in reducing the community risk of influenza and influenza-like illness (ILI) associated emergency care visits.", {"entities": [[89, 98, "DISEASE"], [103, 112, "DISEASE"]]}], ["For the 2011/12 and 2012/13 influenza seasons, we estimated age-group specific attack rates (AR) for ILI from routine surveillance and census data.", {"entities": [[28, 37, "DISEASE"]]}], ["Age-group specific SLIV program effectiveness was estimated as one minus the AR ratio for Alachua County versus two comparison regions: the 12 county region surrounding Alachua County, and all non-Alachua counties in Florida.", {"entities": []}], ["Vaccination of \u223c50% of 5\u201317 year-olds in Alachua reduced their risk of ILI-associated visits, compared to the rest of Florida, by 79% (95% confidence interval: 70, 85) in 2011/12 and 71% (63, 77) in 2012/13.", {"entities": []}], ["The greatest indirect effectiveness was observed among 0\u20134 year-olds, reducing AR by 89% (84, 93) in 2011/12 and 84% (79, 88) in 2012/13.", {"entities": []}], ["Among all non-school age residents, the estimated indirect effectiveness was 60% (54, 65) and 36% (31, 41) for 2011/12 and 2012/13.", {"entities": []}], ["The overall effectiveness among all age-groups was 65% (61, 70) and 46% (42, 50) for 2011/12 and 2012/13.", {"entities": []}], ["Wider implementation of SLIV programs can significantly reduce the influenza-associated public health burden in communities.", {"entities": [[67, 76, "DISEASE"]]}], ["Objective To determine whether patients who are not admitted to hospital after attending an emergency department during shifts with long waiting times are at risk for adverse events.", {"entities": []}], ["Design Population based retrospective cohort study using health administrative databases.", {"entities": []}], ["Setting High volume emergency departments in Ontario, Canada, fiscal years 2003-7.", {"entities": []}], ["Participants All emergency department patients who were not admitted (seen and discharged; left without being seen).", {"entities": []}], ["Outcome measures Risk of adverse events (admission to hospital or death within seven days) adjusted for important characteristics of patients, shift, and hospital.", {"entities": []}], ["Results 13\u2009934\u2009542 patients were seen and discharged and 617\u2009011 left without being seen.", {"entities": []}], ["The risk of adverse events increased with the mean length of stay of similar patients in the same shift in the emergency department.", {"entities": []}], ["For mean length of stay \u22656 v <1 hour the adjusted odds ratio (95% confidence interval) was 1.79 (1.24 to 2.59) for death and 1.95 (1.79 to 2.13) for admission in high acuity patients and 1.71 (1.25 to 2.35) for death and 1.66 (1.56 to 1.76) for admission in low acuity patients).", {"entities": []}], ["Leaving without being seen was not associated with an increase in adverse events at the level of the patient or by annual rates of the hospital.", {"entities": []}], ["Conclusions Presenting to an emergency department during shifts with longer waiting times, reflected in longer mean length of stay, is associated with a greater risk in the short term of death and admission to hospital in patients who are well enough to leave the department.", {"entities": []}], ["Patients who leave without being seen are not at higher risk of short term adverse events.", {"entities": []}], ["T cells secreting interleukin (IL)-4 and IL-5 (T helper cell type 2 [Th2] cells) play a detrimental role in a variety of diseases, but specific methods of regulating their activity remain elusive.", {"entities": []}], ["T1/ST2 is a surface ligand of the IL-1 receptor family, expressed on Th2- but not on interferon (IFN)-\u03b3\u2013producing Th1 cells.", {"entities": []}], ["Prior exposure of BALB/c mice to the attachment (G) or fusion (F) protein of respiratory syncytial virus (RSV) increases illness severity during intranasal RSV challenge, due to Th2-driven lung eosinophilia and exuberant Th1-driven pulmonary infiltration, respectively.", {"entities": [[194, 206, "DISEASE"]]}], ["We used these polar models of viral illness to study the recruitment of T1/ST2 cells to the lung and to test the effects of anti-T1/ST2 treatment in vivo.", {"entities": []}], ["T1/ST2 was present on a subset of CD4", {"entities": [[34, 37, "GENE"]]}], ["Salmon trypsin is shown to increase secretion of the pro-inflammatory cytokine interleukin (IL)-8 from human airway epithelial cells through activation of PAR-2.", {"entities": []}], ["Secretion of IL-8 induced by king crab trypsin is observed in a different concentration range compared to salmon trypsin, and seems to be only partially related to PAR-2 activation.", {"entities": []}], ["This report aim to identify differences in the molecular structure of king crab trypsin ( Paralithodes camtschaticus ) compared to salmon ( Salmo salar ) and bovine trypsin ( Bos taurus ) that might influence the ability to activate protease-activated receptor-2 (PAR-2).", {"entities": []}], ["During purification king crab trypsin displayed stronger binding capacity to the anionic column used in fast protein liquid chromatography compared to fish trypsins, and was identified as a slightly bigger molecule.", {"entities": []}], ["Measurements of enzymatic activity yielded no obvious differences between the trypsins tested.", {"entities": []}], ["Molecular modelling showed that king crab trypsin has a large area with strong negative electrostatic potential compared to the smaller negative areas in bovine and salmon trypsins.", {"entities": []}], ["Bovine and salmon trypsins also displayed areas with strong positive electrostatic potential, a feature lacking in the king crab trypsin.", {"entities": []}], ["Furthermore we have identified 3 divergent positions (Asp These preliminary results indicate that electrostatic interactions could be of importance in binding, cleavage and subsequent activation of PAR-2.", {"entities": []}], ["In Sri Lanka, an endemic of chronic kidney disease of unknown origin (CKDu) is affecting rural communities.", {"entities": [[36, 50, "DISEASE"]]}], ["The endemic has similarities with Mesoamerican Nephropathy (MeN) in Central America, however it has not yet been clarified if the endemics are related diagnostic entities.", {"entities": []}], ["We designed this study of kidney biopsies from patients with CKDu in Sri Lanka to compare with MeN morphology.", {"entities": []}], ["Eleven patients with CKDu were recruited at the General Hospital, Polonnaruwa, using similar inclusion and exclusion criteria as our previous MeN studies.", {"entities": []}], ["Inclusion criteria were 20\u201365 years of age and plasma creatinine 100\u2013220 \u03bcmol/L.", {"entities": []}], ["Exclusion criteria were diabetes mellitus, uncontrolled hypertension and albuminuria >1g/24h.", {"entities": [[56, 68, "DISEASE"], [24, 41, "DISEASE"]]}], ["Kidney biopsies, blood and urine samples were collected, and participants answered a questionnaire.", {"entities": []}], ["Included participants were between 27\u201361 years of age and had a mean eGFR of 38\u00b114 ml/min/1.73m", {"entities": [[69, 73, "GENE"]]}], ["M\u00e9tis are descendants of early 17 Using de-identified administrative databases plus the M\u00e9tis Population Database housed at the Manitoba Centre for Health Policy, age/sex-adjusted rates of mortality and disease were calculated for M\u00e9tis (n = 73,016) and all other Manitobans (n = 1,104,672).", {"entities": []}], ["Diseases included: hypertension, arthritis, diabetes, ischemic heart disease (age 19+); osteoporosis (age 50+); acute myocardial infarction (AMI) and stroke (age 40+); total respiratory morbidity (TRM, all ages).", {"entities": [[19, 31, "DISEASE"], [54, 76, "DISEASE"], [63, 76, "DISEASE"], [118, 139, "DISEASE"], [88, 100, "DISEASE"], [33, 42, "DISEASE"], [112, 139, "DISEASE"]]}], ["Using logistic regression, predictors of diabetes (2004/05-2006/07) and diabetes-related lower-limb amputations (2002/03-2006/07) were analyzed.", {"entities": []}], ["Disease rates were higher for M\u00e9tis compared to all others: premature mortality before age 75 (4.0 vs. 3.3 per 1000, p < .001); total mortality (9.7 vs. 8.4 per 1000, p < .001); injury mortality (0.58 vs. 0.51 per 1000, p < .03); Potential Years of Life Lost (64.6 vs. 54.6 per 1000, p < .001); all-cause 5-year mortality for people with diabetes (20.8% vs. 18.6%, p < .02); hypertension (27.9% vs. 24.8%, p < .001); arthritis (24.2% vs. 19.9%, p < .001), TRM (13.6% vs. 10.6%, p < .001); diabetes (11.8% vs. 8.8%, p < .001); diabetes-related lower limb amputation (24.1 vs. 16.2 per 1000, p < .001); ischemic heart disease (12.2% vs. 8.7%, p < .001); osteoporosis (12.2% vs. 12.3%, NS), dialysis initiation (0.46% vs. 0.34%, p < .001); AMI (5.4 vs. 4.3 per 1000, p < .001); stroke (3.6 vs. 2.9 per 1000, p < .001).", {"entities": [[375, 387, "DISEASE"], [601, 623, "DISEASE"], [610, 623, "DISEASE"], [652, 664, "DISEASE"], [417, 426, "DISEASE"]]}], ["Controlling for geography, age, sex, income, continuity of care and comorbidities, M\u00e9tis were more likely to have diabetes (aOR = 1.29, 95% CI 1.25-1.34), but not diabetes-related lower limb amputation (aOR = 1.13, 95% CI 0.90-1.40, NS).", {"entities": []}], ["Continuity of care was associated with decreased risk of amputation both provincially (aOR = 0.71, 95% CI 0.62-0.81) and for M\u00e9tis alone (aOR = 0.62, 95% CI 0.40-0.96).", {"entities": []}], ["Despite universal healthcare, M\u00e9tis' illness and mortality rates are mostly higher.", {"entities": []}], ["Although elevated diabetes risk persists for the M\u00e9tis even after adjusting for sociodemographic, healthcare and comorbidity variables, the risk of amputation for M\u00e9tis appears more related to healthcare access rather than ethnicity.", {"entities": []}], ["Angiogenesis is important for many physiological processes, diseases, and also regenerative medicine.", {"entities": []}], ["Therapies that inhibit the vascular endothelial growth factor (VEGF) pathway have been used in the clinic for cancer and macular degeneration.", {"entities": [[121, 141, "DISEASE"], [110, 116, "DISEASE"]]}], ["In cancer applications, these treatments suffer from a \u201ctumor escape phenomenon\u201d where alternative pathways are upregulated and angiogenesis continues.", {"entities": [[3, 9, "DISEASE"]]}], ["The redundancy of angiogenesis regulation indicates the need for additional studies and new drug targets.", {"entities": []}], ["We aimed to (i) identify novel and missing angiogenesis annotations and (ii) verify their significance to angiogenesis.", {"entities": []}], ["To achieve these goals, we integrated the human interactome with known angiogenesis-annotated proteins to identify a set of 202 angiogenesis-associated proteins.", {"entities": []}], ["Across endothelial cell lines, we found that a significant fraction of these proteins had highly perturbed gene expression during angiogenesis.", {"entities": []}], ["After treatment with VEGF-A, we found increasing expression of HIF-1\u03b1, APP, HIV-1 tat interactive protein 2, and MEF2C, while endoglin, liprin \u03b21 and HIF-2\u03b1 had decreasing expression across three endothelial cell lines.", {"entities": [[71, 74, "GENE"], [113, 118, "GENE"]]}], ["The analysis showed differential regulation of HIF-1\u03b1 and HIF-2\u03b1.", {"entities": []}], ["The data also provided additional evidence for the role of endothelial cells in Alzheimer's disease.", {"entities": []}], ["The Minimum Data Set (MDS) for nursing home resident assessment has been required in all U.S. nursing homes since 1990 and has been universally computerized since 1998.", {"entities": []}], ["Initially intended to structure clinical care planning, uses of the MDS expanded to include policy applications such as case-mix reimbursement, quality monitoring and research.", {"entities": []}], ["The purpose of this paper is to summarize a series of analyses examining the internal consistency and predictive validity of the MDS data as used in the \"real world\" in all U.S. nursing homes between 1999 and 2007.", {"entities": []}], ["We used person level linked MDS and Medicare denominator and all institutional claim files including inpatient (hospital and skilled nursing facilities) for all Medicare fee-for-service beneficiaries entering U.S. nursing homes during the period 1999 to 2007.", {"entities": []}], ["We calculated the sensitivity and positive predictive value (PPV) of diagnoses taken from Medicare hospital claims and from the MDS among all new admissions from hospitals to nursing homes and the internal consistency (alpha reliability) of pairs of items within the MDS that logically should be related.", {"entities": []}], ["We also tested the internal consistency of commonly used MDS based multi-item scales and examined the predictive validity of an MDS based severity measure viz.", {"entities": []}], ["one year survival.", {"entities": []}], ["Finally, we examined the correspondence of the MDS discharge record to hospitalizations and deaths seen in Medicare claims, and the completeness of MDS assessments upon skilled nursing facility (SNF) admission.", {"entities": []}], ["Each year there were some 800,000 new admissions directly from hospital to US nursing homes and some 900,000 uninterrupted SNF stays.", {"entities": []}], ["Comparing Medicare enrollment records and claims with MDS records revealed reasonably good correspondence that improved over time (by 2006 only 3% of deaths had no MDS discharge record, only 5% of SNF stays had no MDS, but over 20% of MDS discharges indicating hospitalization had no associated Medicare claim).", {"entities": []}], ["The PPV and sensitivity levels of Medicare hospital diagnoses and MDS based diagnoses were between .6 and .7 for major diagnoses like CHF, hypertension, diabetes.", {"entities": [[139, 151, "DISEASE"]]}], ["Internal consistency, as measured by PPV, of the MDS ADL items with other MDS items measuring impairments and symptoms exceeded .9.", {"entities": []}], ["The Activities of Daily Living (ADL) long form summary scale achieved an alpha inter-consistency level exceeding .85 and multi-item scale alpha levels of .65 were achieved for well being and mood, and .55 for behavior, levels that were sustained even after stratification by ADL and cognition.", {"entities": []}], ["The Changes in Health, End-stage disease and Symptoms and Signs (CHESS) index, a summary measure of frailty was highly predictive of one year survival.", {"entities": []}], ["The MDS demonstrates a reasonable level of consistency both in terms of how well MDS diagnoses correspond to hospital discharge diagnoses and in terms of the internal consistency of functioning and behavioral items.", {"entities": []}], ["The level of alpha reliability and validity demonstrated by the scales suggest that the data can be useful for research and policy analysis.", {"entities": []}], ["However, while improving, the MDS discharge tracking record should still not be used to indicate Medicare hospitalizations or mortality.", {"entities": []}], ["It will be important to monitor the performance of the MDS 3.0 with respect to consistency, reliability and validity now that it has replaced version 2.0, using these results as a baseline that should be exceeded.", {"entities": []}], ["Recent studies report systematic differences in how individuals categorize the severity of identical health and work limitation vignettes.", {"entities": []}], ["We investigate how health professionals and disability recipients characterize the severity of work limitations and whether their reporting patterns are robust to demographic, education, and health characteristics.", {"entities": []}], ["We use the results to illustrate the potential impact of reporting heterogeneity on the distribution of work disability estimated from self-reported categorical health and disability data.", {"entities": []}], ["Nationally representative data on anchoring disability vignettes from the 2004 Health and Retirement Study (HRS) are used to investigate how respondents with an occupation background in health and Social Security disability beneficiaries categorize work limitation vignettes.", {"entities": []}], ["Using pain, cardiovascular health, and depression vignettes, we estimate generalized ordered probit models ( N = 2,660 individuals or 39,681 person-vignette observations) that allow the severity thresholds to vary by respondent characteristics.", {"entities": []}], ["We find that health professionals (excluding nurses) and disability recipients tend to classify identical work limitations as more severe compared to non-health professional non-disabled respondents.", {"entities": []}], ["For disability recipients, the differences are most pronounced and particularly visible in the tails of the work limitations distribution.", {"entities": []}], ["For health professionals, we observe smaller differences, affecting primarily the classification of mildly and moderately severe work limitations.", {"entities": []}], ["The patterns for health professionals (excluding nurses) are robust to demographics, education, and health conditions.", {"entities": []}], ["The greater likelihood of viewing the vignette person as more severely work limited observed among disability recipients is mostly explained by the fact that these respondents also tend to be in poorer health which itself predicts a more inclusive scale.", {"entities": []}], ["Knowledge of reporting scales from health professionals and disabled individuals can benefit researchers in a broad range of applications in health and disability research.", {"entities": []}], ["They may be useful as reference scales to evaluate disability survey data.", {"entities": []}], ["Such knowledge may be beneficial when studying disability programs.", {"entities": []}], ["Given the increasing availability of anchoring vignette data in surveys, this is a promising area for future evaluation research.", {"entities": []}], ["The immune modulating properties of statins may benefit smokers with asthma.", {"entities": [[69, 75, "DISEASE"]]}], ["We tested the hypothesis that short-term treatment with atorvastatin improves lung function or indices of asthma control in smokers with asthma.", {"entities": [[106, 112, "DISEASE"], [137, 143, "DISEASE"]]}], ["Seventy one smokers with mild to moderate asthma were recruited to a randomized double-blind parallel group trial comparing treatment with atorvastatin (40 mg per day) versus placebo for 4 weeks.", {"entities": [[42, 48, "DISEASE"]]}], ["After 4 weeks treatment inhaled beclometasone (400 \u03bcg per day) was added to both treatment arms for a further 4 weeks.", {"entities": []}], ["The primary outcome was morning peak expiratory flow after 4 weeks treatment.", {"entities": []}], ["Secondary outcome measures included indices of asthma control and airway inflammation.", {"entities": [[47, 53, "DISEASE"]]}], ["At 4 weeks, there was no improvement in the atorvastatin group compared to the placebo group in morning peak expiratory flow [-10.67 L/min, 95% CI -38.70 to 17.37, p = 0.449], but there was an improvement with atorvastatin in asthma quality of life score [0.52, 95% CI 0.17 to 0.87 p = 0.005].", {"entities": [[226, 232, "DISEASE"]]}], ["There was no significant improvement with atorvastatin and inhaled beclometasone compared to inhaled beclometasone alone in outcome measures at 8 weeks.", {"entities": []}], ["Short-term treatment with atorvastatin does not alter lung function but may improve asthma quality of life in smokers with mild to moderate asthma.", {"entities": [[84, 90, "DISEASE"], [140, 146, "DISEASE"]]}], ["Clinicaltrials.gov identifier: NCT00463827", {"entities": []}], ["One of the key immunological characteristics of active visceral leishmaniasis (VL) is a profound immunosuppression and impaired production of Interferon-\u03b3 (IFN-\u03b3).", {"entities": [[55, 77, "DISEASE"], [64, 77, "DISEASE"]]}], ["However, recent studies from Bihar in India showed using a whole blood assay, that whole blood cells have maintained the capacity to produce IFN-\u03b3.", {"entities": []}], ["Here we tested the hypothesis that a population of low-density granulocytes (LDG) might contribute to T cell responses hyporesponsiveness via the release of arginase.", {"entities": []}], ["Our results show that this population is affected by the anticoagulant used to collect blood: the frequency of LDGs is significantly lower when the blood is collected with heparin as compared to EDTA; however, the anticoagulant does not impact on the levels of arginase released.", {"entities": []}], ["Next, we assessed the capacity of whole blood cells from patients with active VL to produce IFN-\u03b3 and IL-10 in response to antigen-specific and polyclonal activation.", {"entities": []}], ["Our results show that whole blood cells produce low or levels below detection limit of IFN-\u03b3 and IL-10, however, after successful treatment of VL patients, these cells gradually regain their capacity to produce IFN-\u03b3, but not IL-10, in response to activation.", {"entities": []}], ["These results suggest that in contrast to VL patients from Bihar, India, whole blood cells from VL patients from Gondar, Ethiopia, have lost their ability to produce IFN-\u03b3 during active VL and that active disease is not associated with sustained levels of IL-10 production following stimulation.", {"entities": []}], ["The leishmaniases, a group of diseases caused by Leishmania parasites, belong to the most neglected tropical diseases: they are mainly found in low-income countries and affect the poorest populations.", {"entities": []}], ["These parasites infect cells of the immune system called macrophages, which can kill the intracellular parasites in response to soluble mediators they receive from other cells of the immune system, the lymphocytes.", {"entities": []}], ["Visceral leishmaniasis is the most severe form of the leishmaniases and is characterized by enlarged liver and spleen, fever, weight-loss and anaemia and represents a major public health problem in Ethiopia.", {"entities": [[0, 22, "DISEASE"], [9, 22, "DISEASE"]]}], ["Currently there is no vaccine available, the existing treatment has many severe side effects and drug-resistance is increasing.", {"entities": []}], ["In the present study, we worked with patients suffering from visceral leishmaniasis.", {"entities": [[61, 83, "DISEASE"], [70, 83, "DISEASE"]]}], ["This form of the disease is fatal if the patients are not treated.", {"entities": []}], ["We studied the ability of lymphocytes isolated from their blood to produce soluble mediators before and at different times after the end of treatment.", {"entities": []}], ["Our results show that the lymphocytes have an impaired capacity to produce the soluble mediator required to instruct infected cells to kill the intracellular parasites, but that this lack of response is gradually restored with time after successful treatment.", {"entities": []}], ["The aim of the study was to determine age- and race-related, and overall incidence rates of insulin-requiring diabetes in adults in the US military.", {"entities": []}], ["Electronic records for admissions to US military and Tricare hospitals during 1990\u20132005 and visits to military clinics during 2000\u20132005 were identified using the Career History Archival Medical and Personnel System at the Naval Health Research Center, San Diego, CA, USA.", {"entities": []}], ["Population data were obtained from the Defense Manpower Data Center and Defense Medical Epidemiology Database.", {"entities": []}], ["In men there were 2,918 new cases of insulin-requiring diabetes in 20,427,038 person-years at ages 18\u201344\u00a0years (median age 28\u00a0years) for a total age-adjusted incidence rate of 17.5 per 100,000 person-years (95% CI 16.4\u201318.6).", {"entities": []}], ["Incidence rates were twice as high in black men as in white men (31.5 vs 14.5 per 100,000, p \u2009<\u20090.001).", {"entities": []}], ["In women there were 414 new cases in 3,285,000 person-years at ages 18\u201344\u00a0years (median age 27\u00a0years), for a total age-adjusted incidence rate of 13.6 per 100,000 (95% CI 12.4\u201314.9).", {"entities": []}], ["Incidence rates were twice as high in black women as in white women (21.8 vs 9.7 per 100,000, p \u2009<\u20090.001).", {"entities": []}], ["In a regression model, incidence of insulin-requiring diabetes peaked annually in the winter\u2013spring season (OR 1.46, p \u2009<\u20090.01).", {"entities": []}], ["Race and seasonal differences persisted in the multivariate analysis.", {"entities": []}], ["Differences in incidence rates by race and season suggest a need for further research into possible reasons, including the possibility of a contribution from vitamin D deficiency.", {"entities": []}], ["Cohort studies using prediagnostic serum 25-hydroxyvitamin D should be conducted to further evaluate this relationship.", {"entities": []}], ["The online version of this article (doi:10.1007/s00125-009-1449-x) contains supplementary material which is available to authorised users.", {"entities": []}], ["In Sweden, information on drug use during pregnancy is obtained through an interview and recorded in a standardized medical record at every visit to the antenatal care clinic throughout the pregnancy.", {"entities": []}], ["Antenatal, delivery, and neonatal records constitute the basis for the Swedish Medical Birth Register (MBR).", {"entities": []}], ["The purpose of this exploratory study was to investigate the reliability of reported drug use by simultaneous screening for drug substances in the blood stream of the pregnant woman and thereby validate self-reported data in the MBR.", {"entities": []}], ["Plasma samples from 200 women were obtained at gestational weeks 10\u201312 and 25 and screened for drugs by using ultra-high performance liquid chromatography with time of flight mass spectrometry (UHPLC-TOF-MS).", {"entities": []}], ["The results from the analysis were then compared to medical records.", {"entities": []}], ["At the first sampling occasion, the drugs found by screening had been reported by 86% of the women and on the second sampling, 85.5%.", {"entities": []}], ["Missed reported information was clearly associated with drugs for occasional use.", {"entities": []}], ["The most common drugs in plasma taken in early and mid-pregnancy were meclizine and paracetamol.", {"entities": []}], ["Two types of continuously used drugs, selective serotonin reuptake inhibitors and propranolol, were used.", {"entities": []}], ["All women using them reported it and the drug screening revealed a 100% coherence.", {"entities": []}], ["This study shows good coherence between reported drug intake and the drugs found in plasma samples, which in turn positively validates the MBR.", {"entities": []}], ["The role of microRNAs (miRNAs) in regulating gene expression is currently an area of intense interest.", {"entities": []}], ["Relatively little is known, however, about the role of miRNAs in inflammatory and immunologically-driven disorders.", {"entities": []}], ["In a mouse model, we have previously shown that miRNAs are potentially important therapeutic targets in allergic asthma, because inhibition of miR-126, one of a small subset of miRNAs upregulated in the airway wall, effectively suppressed Th2-driven airway inflammation and other features of asthma.", {"entities": [[104, 119, "DISEASE"], [113, 119, "DISEASE"], [292, 298, "DISEASE"], [143, 150, "GENE"]]}], ["In the present study, we extended investigation of the therapeutic potential of miRNA inhibition to our well-established model of chronic asthma.", {"entities": [[138, 144, "DISEASE"]]}], ["Female BALB/c mice were systemically sensitised with ovalbumin (OVA) and chronically challenged with low mass concentrations of aerosolised OVA for up to 6 weeks.", {"entities": []}], ["Airway tissue was obtained by blunt dissection and RNA was isolated for miRNA profiling.", {"entities": []}], ["On the basis of the results obtained, animals were subsequently treated with either an antagomir to miR-126 (ant-miR-126) or a scrambled control antagomir once weekly during the 6 weeks of chronic challenge, and the effects on airway inflammation and remodelling were assessed using established morphometric techniques.", {"entities": [[100, 107, "GENE"], [113, 120, "GENE"]]}], ["Compared to na\u00efve mice, there was selective upregulation of a modest number of miRNAs, notably miR-126, in the airway wall tissue of chronically challenged animals.", {"entities": [[95, 102, "GENE"]]}], ["The relative increase was maximal after 2 weeks of inhalational challenge and subsequently declined to baseline levels.", {"entities": []}], ["Compared to treatment with the scrambled control, ant-miR-126 significantly reduced recruitment of intraepithelial eosinophils, but had no effect on the chronic inflammatory response, or on changes of airway remodelling.", {"entities": []}], ["In this model of chronic asthma, there was an initial increase in expression of a small number of miRNAs in the airway wall, notably miR-126.", {"entities": [[25, 31, "DISEASE"], [133, 140, "GENE"]]}], ["However, this later declined to baseline levels, suggesting that sustained changes in miRNA may not be essential for perpetuation of chronic asthma.", {"entities": [[141, 147, "DISEASE"]]}], ["Moreover, inhibition of miR-126 by administration of an antagomir suppressed eosinophil recruitment into the airways but had no effect on chronic inflammation in the airway wall, or on changes of remodelling, suggesting that multiple miRNAs are likely to regulate the development of these lesions.", {"entities": [[24, 31, "GENE"]]}], ["Asthma is a complex trait for which different strategies have been used to identify its environmental and genetic predisposing factors.", {"entities": [[0, 6, "DISEASE"]]}], ["Here, we describe a novel methodological approach to select candidate genes for asthma genetic association studies.", {"entities": [[80, 86, "DISEASE"]]}], ["In this regard, the Genes to Diseases (G2D) computational tool has been used in combination with a genome-wide scan performed in a sub-sample of the Saguenay\u2212Lac-St-Jean (SLSJ) asthmatic familial collection (n\u200a=\u200a609) to identify candidate genes located in two suggestive loci shown to be linked with asthma (6q26) and atopy (10q26.3), and presenting differential parent-of-origin effects.", {"entities": [[300, 306, "DISEASE"]]}], ["This approach combined gene selection based on the G2D data mining analysis of the bibliographic and protein public databases, or according to the genes already known to be associated with the same or a similar phenotype.", {"entities": []}], ["Ten genes ( LPA , NOX3 , SNX9 , VIL2 , VIP , ADAM8 , DOCK1 , FANK1 , GPR123 and PTPRE ) were selected for a subsequent association study performed in a large SLSJ sample (n\u200a=\u200a1167) of individuals tested for asthma and atopy related phenotypes.", {"entities": [[207, 213, "DISEASE"], [12, 15, "GENE"], [18, 22, "GENE"], [25, 29, "GENE"], [39, 42, "GENE"], [45, 50, "GENE"], [53, 58, "GENE"], [61, 66, "GENE"], [69, 75, "GENE"], [80, 85, "GENE"]]}], ["Single nucleotide polymorphisms (n\u200a=\u200a91) within the candidate genes were genotyped and analysed using a family-based association test.", {"entities": []}], ["The results suggest a protective association to allergic asthma for PTPRE rs7081735 in the SLSJ sample (p\u200a=\u200a0.000463; corrected p\u200a=\u200a0.0478).", {"entities": [[48, 63, "DISEASE"], [57, 63, "DISEASE"], [68, 73, "GENE"]]}], ["This association has not been replicated in the Childhood Asthma Management Program (CAMP) cohort.", {"entities": [[58, 64, "DISEASE"]]}], ["Sequencing of the regions around rs7081735 revealed additional polymorphisms, but additional genotyping did not yield new associations.", {"entities": []}], ["These results demonstrate that the G2D tool can be useful in the selection of candidate genes located in chromosomal regions linked to a complex trait.", {"entities": []}], ["The assessment of risk from exposure to environmental air pollutants is complex, and involves the disciplines of epidemiology, animal toxicology, and human inhalation studies.", {"entities": []}], ["Controlled, quantitative studies of exposed humans help determine health-related effects that result from breathing the atmosphere.", {"entities": []}], ["The major unique feature of the clinical study is the ability to select, control, and quantify pollutant exposures of subjects of known clinical status, and determine their effects under ideal experimental conditions.", {"entities": []}], ["The choice of outcomes to be assessed in human clinical studies can be guided by both scientific and practical considerations, but the diversity of human responses and responsiveness must be considered.", {"entities": []}], ["Subjects considered to be among the most susceptible include those with asthma, chronic obstructive lung disease, and cardiovascular disease.", {"entities": [[88, 112, "DISEASE"], [72, 78, "DISEASE"], [100, 112, "DISEASE"]]}], ["New experimental approaches include exposures to concentrated ambient air particles, diesel engine exhaust, combustion products from smoking machines, and experimental model particles.", {"entities": []}], ["Future investigations of the health effects of air pollution will benefit from collaborative efforts among the disciplines of epidemiology, animal toxicology, and human clinical studies.", {"entities": []}], ["Increased reactive oxygen species (ROS) generation and the ensuing oxidative stress contribute to Alzheimer's disease pathology.", {"entities": []}], ["We reported previously that amyloid- \u03b2 peptide oligomers (A \u03b2 Os) produce aberrant Ca \u03b2 Os-induced excessive mitochondrial ROS generation, NFATc4 activation, and RyR2 mRNA downregulation.", {"entities": [[139, 145, "GENE"], [162, 166, "GENE"]]}], ["To determine mitochondrial H 2 O 2 production or NFATc4 nuclear translocation, neurons were transfected with plasmids coding for HyperMito or NFATc4-eGFP, respectively.", {"entities": [[49, 55, "GENE"], [142, 148, "GENE"]]}], ["Primary hippocampal cultures were incubated with 0.1\u2009 \u03bc M ATX for 1.5\u2009h prior to A \u03b2 Os addition (500\u2009nM).", {"entities": []}], ["We found that incubation with ATX (\u226410\u2009 \u03bc M) for \u226424\u2009h was nontoxic to neurons, evaluated by the live/dead assay.", {"entities": []}], ["Preincubation with 0.1\u2009 \u03bc M ATX also prevented the neuronal mitochondrial H 2 O 2 generation induced within minutes of A \u03b2 Os addition.", {"entities": []}], ["Longer exposures to A \u03b2 Os (6\u2009h) promoted NFATc4-eGFP nuclear translocation and decreased RyR2 mRNA levels, evaluated by detection of the eGFP-tagged fluorescent plasmid and qPCR, respectively.", {"entities": [[90, 94, "GENE"]]}], ["Preincubation with 0.1\u2009 \u03bc M ATX prevented both effects.", {"entities": []}], ["These results indicate that ATX protects neurons from the noxious effects of A \u03b2 Os on mitochondrial ROS production, NFATc4 activation, and RyR2 gene expression downregulation.", {"entities": [[117, 123, "GENE"], [140, 144, "GENE"]]}], ["X-ray Computed Tomography (CT) is one of the most commonly utilized anatomical imaging modalities for both research and clinical purposes.", {"entities": []}], ["CT combines high-resolution, three-dimensional data with relatively fast acquisition to provide a solid platform for non-invasive human or specimen imaging.", {"entities": []}], ["The primary limitation of CT is its inability to distinguish many soft tissues based on native contrast.", {"entities": []}], ["While bone has high contrast within a CT image due to its material density from calcium phosphate, soft tissue is less dense and many are homogenous in density.", {"entities": []}], ["This presents a challenge in distinguishing one type of soft tissue from another.", {"entities": []}], ["A couple exceptions include the lungs as well as fat, both of which have unique densities owing to the presence of air or bulk hydrocarbons, respectively.", {"entities": []}], ["In order to facilitate X-ray CT imaging of other structures, a range of contrast agents have been developed to selectively identify and visualize the anatomical properties of individual tissues.", {"entities": []}], ["Most agents incorporate atoms like iodine, gold, or barium because of their ability to absorb X-rays, and thus impart contrast to a given organ system.", {"entities": []}], ["Here we review the strategies available to visualize lung, fat, brain, kidney, liver, spleen, vasculature, gastrointestinal tract, and liver tissues of living mice using either innate contrast, or commercial injectable or ingestible agents with selective perfusion.", {"entities": []}], ["Further, we demonstrate how each of these approaches will facilitate the non-invasive, longitudinal, in vivo imaging of pre-clinical disease models at each anatomical site.", {"entities": []}], ["This research develops methods for determining the effect of geocoding quality on relationships between environmental exposures and health.", {"entities": []}], ["The likelihood of detecting an existing relationship \u2013 statistical power \u2013 between measures of environmental exposures and health depends not only on the strength of the relationship but also on the level of positional accuracy and completeness of the geocodes from which the measures of environmental exposure are made.", {"entities": []}], ["This paper summarizes the results of simulation studies conducted to examine the impact of inaccuracies of geocoded addresses generated by three types of geocoding processes: a) addresses located on orthophoto maps, b) addresses matched to TIGER files (U.S Census or their derivative street files); and, c) addresses from E-911 geocodes (developed by local authorities for emergency dispatch purposes).", {"entities": []}], ["The simulated odds of disease using exposures modelled from the highest quality geocodes could be sufficiently recovered using other, more commonly used, geocoding processes such as TIGER and E-911; however, the strength of the odds relationship between disease exposures modelled at geocodes generally declined with decreasing geocoding accuracy.", {"entities": []}], ["Although these specific results cannot be generalized to new situations, the methods used to determine the sensitivity of results can be used in new situations.", {"entities": []}], ["Estimated measures of positional accuracy must be used in the interpretation of results of analyses that investigate relationships between health outcomes and exposures measured at residential locations.", {"entities": []}], ["Analyses similar to those employed in this paper can be used to validate interpretation of results from empirical analyses that use geocoded locations with estimated measures of positional accuracy.", {"entities": []}], ["Background: Ozone (O 3 ) is a well-documented respiratory oxidant, but increasing epidemiological evidence points to extrapulmonary effects, including positive associations between ambient O 3 concentrations and cardiovascular morbidity and mortality.", {"entities": []}], ["Objective: With preliminary reports linking O 3 exposure with changes in heart rate (HR), we investigated the hypothesis that a single inhalation exposure to O 3 will cause concentration-dependent autonomic modulation of cardiac function in rats.", {"entities": [[85, 87, "GENE"]]}], ["Methods: Rats implanted with telemeters to monitor HR and cardiac electrophysiology [electrocardiography (ECG)] were exposed once by whole-body inhalation for 4 hr to 0.2 or 0.8 ppm O 3 or filtered air.", {"entities": [[51, 53, "GENE"], [161, 163, "GENE"], [51, 53, "GENE"], [161, 163, "GENE"]]}], ["A separate cohort was tested for vulnerability to aconitine-induced arrhythmia 24 hr after exposure.", {"entities": [[82, 84, "GENE"]]}], ["Results: Exposure to 0.8 ppm O 3 caused bradycardia, PR prolongation, ST depression, and substantial increases in atrial premature beats, sinoatrial block, and atrioventricular block, accompanied by concurrent increases in several HR variability parameters that were suggestive of increased parasympathetic tone.", {"entities": [[231, 233, "GENE"]]}], ["Low-O 3 exposure failed to elicit any overt changes in autonomic tone, heart rhythm, or ECG.", {"entities": []}], ["However, both 0.2 and 0.8 ppm O 3 increased sensitivity to aconitine-induced arrhythmia formation, suggesting a latent O 3 -induced alteration in myocardial excitability.", {"entities": []}], ["Conclusions: O 3 exposure causes several alterations in cardiac electrophysiology that are likely mediated by modulation of autonomic input to the heart.", {"entities": []}], ["Moreover, exposure to low O 3 concentrations may cause subclinical effects that manifest only when triggered by a stressor, suggesting that the adverse health effects of ambient levels of air pollutants may be insidious and potentially underestimated.", {"entities": []}], ["Environmental pollution is a known risk factor for multiple diseases and furthermore increases rate of hospitalisations.", {"entities": []}], ["We investigated the correlation between emergency room admissions (ERAs) of the general population for respiratory diseases and the environmental pollutant levels in Milan, a metropolis in northern Italy.", {"entities": [[67, 71, "GENE"]]}], ["We collected data from 45770 ERAs for respiratory diseases.", {"entities": [[29, 33, "GENE"]]}], ["A time-stratified case-crossover design was used to investigate the association between air pollution levels and ERAs for acute respiratory conditions.", {"entities": [[113, 117, "GENE"]]}], ["The effects of air pollutants were investigated at lag 0 to lag 5, lag 0\u20132 and lag 3\u20135 in both single and multi-pollutant models, adjusted for daily weather variables.", {"entities": []}], ["An increase in ozone (O 3 ) levels at lag 3\u20135 was associated with a 78% increase in the number of ERAs for asthma, especially during the warm season.", {"entities": [[107, 113, "DISEASE"], [98, 102, "GENE"]]}], ["Exposure to carbon monoxide (CO) proved to be a risk factor for pneumonia at lag 0\u20132 and in the warm season increased the risk of ERA by 66%.", {"entities": [[64, 73, "DISEASE"]]}], ["A significant association was found between ERAs for COPD exacerbation and levels of sulphur dioxide (SO 2 ), CO, nitrate dioxide (NO 2 ), and particulate matter (PM 10 and PM 2.5 ).", {"entities": [[44, 48, "GENE"]]}], ["The multipollutant model that includes all pollutants showed a significant association between CO (26%) and ERA for upper respiratory tract diseases at lag 0\u20132.", {"entities": []}], ["For chronic obstructive pulmonary disease (COPD) exacerbations, only CO (OR 1.19) showed a significant association.", {"entities": [[4, 41, "DISEASE"]]}], ["Exposure to environmental pollution, even at typical low levels, can increase the risk of ERA for acute respiratory diseases and exacerbation of obstructive lung diseases in the general population.", {"entities": []}], ["Unstable angina (UA) patients have lower mortality and reinfarction risks than ST-elevation (STEMI) or non-ST elevation myocardial infarction (NSTEMI) patients and, accordingly, receive less aggressive treatment.", {"entities": [[120, 141, "DISEASE"]]}], ["Little is known, however, about the health status outcomes (angina, physical function, and quality of life) of UA versus MI patients among survivors of an ACS hospitalization.", {"entities": []}], ["In a cohort of 1,192 consecutively enrolled ACS survivors from two Kansas City hospitals, we evaluated the associations between ACS presentation (UA, NSTEMI, and STEMI) and one-year health status (angina, physical functioning and quality of life), one-year cardiac rehospitalization rates, and two-year mortality outcomes, using multivariable regression modeling.", {"entities": []}], ["After multivariable adjustment for demographic, hospital, co-morbidity, baseline health status, and treatment characteristics, UA patients had a greater prevalence of angina at 1 year than STEMI patients (adjusted relative risk [RR] = 1.42; 95% CI [1.06, 1.90]) and similar rates as NSTEMI patients (adjusted RR = 1.1; 95% CI [0.85, 1.42]).", {"entities": []}], ["In addition, UA patients fared no better than MI patients in Short Form-12 physical component scores (UA vs. STEMI score difference -0.05 points; 95% CI [-2.41, 2.3]; UA vs. NSTEMI score difference -1.91 points; 95% CI [-4.01, 0.18]) or Seattle Angina Questionnaire quality of life scores (UA vs. STEMI score difference -1.39 points; 95% CI [-5.63, 2.85]; UA vs. NSTEMI score difference -0.24 points 95% CI [-4.01, 3.54]).", {"entities": []}], ["Finally, UA patients had similar rehospitalization rates as MI patients (UA vs. STEMI adjusted hazard ratio [HR] = 1.31; 95% CI [0.86, 1.99]; UA vs. NSTEMI adjusted HR = 1.03; 95% CI [0.73, 1.47]), despite better 2-year survival (UA vs. STEMI adjusted HR = 0.51; 95% confidence interval (CI) [0.28, 0.95]; UA vs. NSTEMI adjusted HR = 0.40; 95% CI [0.24, 0.65]).", {"entities": [[109, 111, "GENE"], [165, 167, "GENE"], [252, 254, "GENE"], [329, 331, "GENE"], [109, 111, "GENE"], [165, 167, "GENE"], [252, 254, "GENE"], [329, 331, "GENE"], [109, 111, "GENE"], [165, 167, "GENE"], [252, 254, "GENE"], [329, 331, "GENE"], [109, 111, "GENE"], [165, 167, "GENE"], [252, 254, "GENE"], [329, 331, "GENE"]]}], ["Although UA patients have better survival rates, they have similar or worse one-year health status outcomes and cardiac rehospitalization rates as compared with MI patients.", {"entities": []}], ["Clinicians should be aware of the adverse health status outcome risks for UA patients and consider close monitoring for the opportunity to improve their health status and minimize the need for subsequent rehospitalization.", {"entities": []}], ["Diabetes mellitus (DM) is a cluster of metabolic diseases with chronic hyperglycemia as a defining feature, associated with long-term organ damage and dysfunction.", {"entities": [[71, 84, "DISEASE"]]}], ["In this study we examined the effect of Tulbaghia violacea rhizome methanolic extract on blood glucose and lipids in normal and streptozotocin-induced diabetic rats.", {"entities": []}], ["Male Wistar rats (250-300g) were injected intraperitoneally (i.p.)", {"entities": []}], ["with streptozotocin (60mg/kg body weight) to induce diabetes; or provided with distilled water for the control (CON) (3 ml/kg/b.w.)", {"entities": []}], ["animals and treatment with TVL (60mg/kg.b.w).", {"entities": []}], ["The rats were divided into 5 groups of 6 animals per group as follows: Non-diabetic control (NDC)-received distilled water (3ml/kg.b.w), Non-diabetic TVL (ND+TVL)-received TVL (60mh/kg b.w), Diabetic control (DC)-received distilled water (3ml/kg.b.w), Diabetic experimental (D+TVL)-received TVL (60mg/kg.b.w), Diabetic experimental (D+M)-received Metformin (250 mg/kg.b.w).", {"entities": []}], ["All doses were administered daily via oral gavage.", {"entities": []}], ["TVL-treated animals showed reduced blood glucose, increased plasma insulin, reduced plasma TG, TC, VLDL and increased HDL.", {"entities": [[91, 93, "GENE"]]}], ["Furthermore we found decreased thiobarbituric acid reactive substances (TBARS) and increased superoxide dismutase (SOD) activity and nitric oxide significantly.", {"entities": []}], ["Regarding renal parameters we found increased blood urea nitrogen (BUN), and improved renal morphology in TVL-treated animals.", {"entities": []}], ["Tulbaghia violacea has a hypoglycaemic effect which could due to its effects on multiple pathways of the hyperglycemic process.", {"entities": []}], ["Further work is needed to identify the mechanism of its antidiabetic effect.", {"entities": []}], ["Tang et al.", {"entities": []}], ["show that cytotoxic effector cells produce and respond to cysteinyl leukotrienes to allow target cell killing dependent on NKG2D and IL-15.", {"entities": []}], ["They further demonstrate a role for cysteinyl leukotrienes in celiac disease pathogenesis.", {"entities": [[62, 76, "DISEASE"]]}], ["Eicosanoids are inflammatory mediators that play a key but incompletely understood role in linking the innate and adaptive immune systems.", {"entities": []}], ["Here, we show that cytotoxic effector T cells (CTLs) are capable of both producing and responding to cysteinyl leukotrienes (CystLTs), allowing for the killing of target cells in a T cell receptor\u2013independent manner.", {"entities": []}], ["This process is dependent on the natural killer receptor NKG2D and exposure to IL-15, a cytokine induced in distressed tissues.", {"entities": []}], ["IL-15 and NKG2D signaling drives the up-regulation of key enzymes implicated in the synthesis of CystLTs, as well as the expression of CystLT receptors, suggesting a positive feedback loop.", {"entities": []}], ["Finally, although the CystLT pathway has been previously linked to various allergic disorders, we provide unexpected evidence for its involvement in the pathogenesis of celiac disease (CD), a T helper 1 cell\u2013mediated enteropathy induced by gluten.", {"entities": [[169, 183, "DISEASE"]]}], ["These findings provide new insights into the cytolytic signaling pathway of NKG2D and the pathogenesis of organ-specific immune disorders.", {"entities": []}], ["Furthermore, they suggest that the blockade of CystLT receptors may represent a potent therapeutic target for CD or potentially other autoimmune disorders in which NKG2D has been implicated.", {"entities": []}], ["KL-6 is a high-molecular-weight glycoprotein classified as a human MUC1 mucin.", {"entities": [[67, 71, "GENE"]]}], ["It was hypothesized that KL-6 could be detectable in the circulating blood and especially in airway secretions in lung diseases associated with mucus production such as chronic obstructive pulmonary disease (COPD).", {"entities": [[169, 206, "DISEASE"]]}], ["Additional aims of this study were to investigate whether the levels of KL-6 in plasma and sputum are related to ageing and smoking history.", {"entities": []}], ["The concentrations of KL-6 in plasma and induced sputum supernatants from young and/or middle aged/elderly non-smokers, smokers and patients with COPD were assayed by ELISA (n = 201).", {"entities": []}], ["The subjects were classified into five groups according to age, smoking status and presence of COPD.", {"entities": []}], ["In addition, KL-6 expression in control and diseased lung i.e.", {"entities": []}], ["samples from patients with COPD (n = 28), were analyzed by immunohistochemistry and digital image analysis.", {"entities": []}], ["The plasma levels of KL-6 increased with age both in non-smokers and smokers.", {"entities": []}], ["Among middle aged/elderly subjects, plasma KL-6 levels in all smokers regardless of COPD were significantly higher than in non-smokers, whereas sputum levels of KL-6 were significantly higher in COPD compared not only to non-smokers but also to smokers.", {"entities": []}], ["KL-6 was more prominently expressed in the bronchiolar/alveolar epithelium in COPD than in the control lungs.", {"entities": []}], ["Plasma and sputum KL-6 levels correlated inversely with obstruction and positively with smoking history and ageing.", {"entities": []}], ["The linear multiple regression analysis confirmed that age and cigarette smoking had independent effects on plasma KL-6.", {"entities": []}], ["KL-6 increases with ageing and chronic smoking history, but prospective studies will be needed to elucidate the significance of KL-6 in chronic airway diseases.", {"entities": []}], ["Mast cell-derived prostaglandin D 2 (PGD 2 ), may contribute to eosinophilic inflammation and mucus production in allergic asthma.", {"entities": [[114, 129, "DISEASE"], [123, 129, "DISEASE"], [37, 40, "GENE"]]}], ["Chemoattractant receptor homologous molecule expressed on TH 2 cells (CRTH2), a high affinity receptor for prostaglandin D 2 , mediates trafficking of TH 2 -cells, mast cells, and eosinophils to inflammatory sites, and has recently attracted interest as target for treatment of allergic airway diseases.", {"entities": []}], ["The present study involving mice explores the specificity of CRTH2 antagonism of TM30089, which is structurally closely related to the dual TP/CRTH2 antagonist ramatroban, and compares the ability of ramatroban and TM30089 to inhibit asthma-like pathology.", {"entities": [[234, 240, "DISEASE"]]}], ["Affinity for and antagonistic potency of TM30089 on many mouse receptors including thromboxane A 2 receptor mTP, CRTH2 receptor, and selected anaphylatoxin and chemokines receptors were determined in recombinant expression systems in vitro .", {"entities": []}], ["In vivo effects of TM30089 and ramatroban on tissue eosinophilia and mucus cell histopathology were examined in a mouse asthma model.", {"entities": [[52, 64, "DISEASE"], [120, 126, "DISEASE"]]}], ["TM30089, displayed high selectivity for and antagonistic potency on mouse CRTH2 but lacked affinity to TP and many other receptors including the related anaphylatoxin C3a and C5a receptors, selected chemokine receptors and the cyclooxygenase isoforms 1 and 2 which are all recognized players in allergic diseases.", {"entities": []}], ["Furthermore, TM30089 and ramatroban, the latter used as a reference herein, similarly inhibited asthma pathology in vivo by reducing peribronchial eosinophilia and mucus cell hyperplasia.", {"entities": [[147, 159, "DISEASE"], [96, 102, "DISEASE"]]}], ["This is the first report to demonstrate anti-allergic efficacy in vivo of a highly selective small molecule CRTH2 antagonist.", {"entities": []}], ["Our data suggest that CRTH2 antagonism alone is effective in mouse allergic airway inflammation even to the extent that this mechanism can explain the efficacy of ramatroban.", {"entities": []}], ["Background: Concerns regarding the health impact of urban air pollution on asthmatic children are pronounced along the U.S.\u2013Mexico border because of rapid population growth near busy border highways and roads.", {"entities": []}], ["Objectives: We conducted the first binational study of the impacts of air pollution on asthmatic children in Ciudad Juarez, Mexico, and El Paso, Texas, USA, and compared different exposure metrics to assess acute respiratory response.", {"entities": []}], ["Methods: We recruited 58 asthmatic children from two schools in Ciudad Juarez and two schools in El Paso.", {"entities": []}], ["A marker of airway inflammation [exhaled nitric oxide (eNO)], respiratory symptom surveys, and pollutant measurements (indoor and outdoor 48-hr size-fractionated particulate matter, 48-hr black carbon, and 96-hr nitrogen dioxide) were collected at each school for 16 weeks.", {"entities": []}], ["We examined associations between the pollutants and respiratory response using generalized linear mixed models.", {"entities": []}], ["Results: We observed small but consistent associations between eNO and numerous pollutant metrics, with estimated increases in eNO ranging from 1% to 3% per interquartile range increase in pollutant concentrations.", {"entities": []}], ["Effect estimates from models using school-based concentrations were generally stronger than corresponding estimates based on concentrations from ambient air monitors.", {"entities": []}], ["Both traffic-related and non\u2013traffic-related particles were typically more robust predictors of eNO than was nitrogen dioxide, for which associations were highly sensitive to model specification.", {"entities": []}], ["Associations differed significantly across the four school-based cohorts, consistent with heterogeneity in pollutant concentrations and cohort characteristics.", {"entities": []}], ["Models examining respiratory symptoms were consistent with the null.", {"entities": []}], ["Conclusions: The results indicate adverse effects of air pollution on the subclinical respiratory health of asthmatic children in this region and provide preliminary support for the use of air pollution monitors close to schools to track exposure and potential health risk in this population.", {"entities": []}], ["Studies have found HIV-infected patients to be at increased risk of myocardial infarction, which may be caused by coronary microvascular dysfunction.", {"entities": [[68, 89, "DISEASE"]]}], ["For the first time among HIV-infected patients, we assessed the myocardial flow reserve (MFR) by Rubidium-82 ( In a prospective cross-sectional study, HIV-infected patients all receiving antiretroviral therapy (ART) with full viral suppression and HIV-uninfected controls were scanned using Fifty-six HIV-infected patients and 25 controls were included.", {"entities": []}], ["The HIV-infected patients had a mean age of 53 years (range 37\u201368 years) with 23% active smokers.", {"entities": []}], ["The controls had a mean age of 52 years (range 36\u201368 years) and 26% active smokers.", {"entities": []}], ["In the HIV-infected group 73% had a normal MFR, 17% borderline, and 10% low values of MFR.", {"entities": []}], ["Among controls these values were 71%, 19%, and 10%, respectively ( P \u200a=\u200a0.99).", {"entities": []}], ["However, the HIV-infected group had lower values of stress myocardial blood flow (MBF) (2.63\u200a\u00b1\u200a0.09\u200amL/g/min vs 2.99\u200a\u00b1\u200a0.14\u200amL/g/min; P \u200a=\u200a0.03).", {"entities": []}], ["We found no evidence of decreased MFR as assessed by", {"entities": []}], ["When the A(H1N1)pdm09 pandemic influenza virus moved into the post-pandemic period, there was a worldwide predominance of the seasonal influenza A(H3N2) and B viruses.", {"entities": [[31, 40, "DISEASE"], [135, 144, "DISEASE"]]}], ["However, A(H1N1)pdm09 became the prevailing subtype in the 2011\u20132012 influenza season in Mexico and most of Central America.", {"entities": [[69, 78, "DISEASE"]]}], ["During this season, we collected nasopharyngeal swabs of individuals presenting with influenza-like illness at our institution in Mexico City.", {"entities": [[85, 94, "DISEASE"]]}], ["Samples were tested for seasonal A(H3N2) and B influenza viruses, as well as A(H1N1)pdm09 by real-time reverse transcription\u2013polymerase chain reaction.", {"entities": [[47, 56, "DISEASE"]]}], ["Of 205 samples tested, 46% were positive to influenza, all of them A(H1N1)pdm09.", {"entities": [[44, 53, "DISEASE"]]}], ["The clinical characteristics of patients showed a similar pattern to the 2009 pandemic cases.", {"entities": []}], ["Using next generation sequencing, we obtained whole genome sequences of viruses from 4 different patients, and in 8 additional viruses we performed partial Sanger sequencing of the HA segment.", {"entities": []}], ["Non-synonymous changes found in the Mexican isolates with respect to the prototype isolate H1N1 (A/California/04/2009) included HA S69T, K163R and N260D unique to 2012 Mexican and North American isolates and located within or adjacent to HA antigenic sites; HA S143G, S185T, A197T and S203T previously reported in viruses from the 2010\u20132011 season, located within or adjacent to HA antigenic sites; and HA E374K located in a relevant site for membrane fusion.", {"entities": []}], ["All Mexican isolates had an oseltamivir-sensitive genotype.", {"entities": []}], ["Phylogenetic analysis with all 8 influenza gene segments showed that 2012 Mexican sequences formed a robust, distinct cluster.", {"entities": [[33, 42, "DISEASE"]]}], ["In all cases, 2012 Mexican sequences tended to group with 2010\u20132011 Asian and European sequences, but not with 2009 Mexican sequences, suggesting a possible recent common ancestor between these latter regions and the 2012 Mexican viruses.", {"entities": []}], ["It remains to be defined if these viral changes represent an important antigenic drift that would enable viral immune evasion and/or affect influenza vaccine effectiveness.", {"entities": [[140, 149, "DISEASE"]]}], ["Considerable interest has been shown in the ability of caloric restriction (CR) to improve multiple parameters of health and to extend lifespan.", {"entities": []}], ["CR is the reduction of caloric intake - typically by 20 - 40% of ad libitum consumption - while maintaining adequate nutrient intake.", {"entities": []}], ["Several alternatives to CR exist.", {"entities": []}], ["CR combined with exercise (CE) consists of both decreased caloric intake and increased caloric expenditure.", {"entities": []}], ["Alternate-day fasting (ADF) consists of two interchanging days; one day, subjects may consume food ad libitum (sometimes equaling twice the normal intake); on the other day, food is reduced or withheld altogether.", {"entities": []}], ["Dietary restriction (DR) - restriction of one or more components of intake (typically macronutrients) with minimal to no reduction in total caloric intake - is another alternative to CR.", {"entities": []}], ["Many religions incorporate one or more forms of food restriction.", {"entities": []}], ["The following religious fasting periods are featured in this review: 1) Islamic Ramadan; 2) the three principal fasting periods of Greek Orthodox Christianity (Nativity, Lent, and the Assumption); and 3) the Biblical-based Daniel Fast.", {"entities": []}], ["This review provides a summary of the current state of knowledge related to CR and DR. A specific section is provided that illustrates related work pertaining to religious forms of food restriction.", {"entities": []}], ["Where available, studies involving both humans and animals are presented.", {"entities": []}], ["The review includes suggestions for future research pertaining to the topics of discussion.", {"entities": []}], ["Asthma affects more than 5 million patients in the United Kingdom.", {"entities": [[0, 6, "DISEASE"]]}], ["Nearly 500,000 of these patients have severe asthma with severe symptoms and frequent exacerbations that are inadequately controlled with available treatments.", {"entities": [[45, 51, "DISEASE"]]}], ["The burden of severe asthma on the NHS is enormous, accounting for 80\u00a0% of the total asthma cost (\u00a31 billion), with frequent exacerbations and expensive medications generating much of this cost.", {"entities": [[21, 27, "DISEASE"], [85, 91, "DISEASE"], [35, 38, "GENE"]]}], ["Of those patients with severe asthma, 70\u00a0% are sensitised to indoor aeroallergens, and the level of exposure to allergens determines the symptoms; patients exposed to high levels are therefore most at risk of exacerbations and hospital admissions.", {"entities": [[30, 36, "DISEASE"]]}], ["The LASER trial aims to assess whether a new treatment, temperature controlled laminar airflow (TLA) delivered by the Airsonett\u2122 device, can reduce the frequency of exacerbations in patients with severe allergic asthma by reducing exposure to aeroallergens overnight.", {"entities": [[203, 218, "DISEASE"], [212, 218, "DISEASE"]]}], ["This multicentre study is a placebo-controlled, blinded, randomised controlled, parallel group trial.", {"entities": []}], ["A total of 222 patients with a new or current diagnosis of severe allergic asthma will be assigned with a random element in a 1:1 ratio to receive either an active device for one year or a placebo device.", {"entities": [[66, 81, "DISEASE"], [75, 81, "DISEASE"]]}], ["The primary outcome is the frequency of severe asthma exacerbations occurring over a 12-month period, defined in accordance with the American Thoracic Society/European Respiratory Society (ATS/ERS) guidelines.", {"entities": [[47, 53, "DISEASE"]]}], ["Secondary outcomes include changes in asthma control, lung function, asthma-specific and global quality of life for participants and their carers, adherence to intervention, healthcare resource use and costs, and cost-effectiveness.", {"entities": [[38, 44, "DISEASE"], [69, 75, "DISEASE"]]}], ["Qualitative interviews will be conducted to elicit participant\u2019s and their partner\u2019s perceptions of the treatment.", {"entities": []}], ["Effective measures of allergen avoidance have, to date, proved elusive.", {"entities": []}], ["The LASER trial aims to address this.", {"entities": []}], ["The study will ascertain whether home-based nocturnal TLA usage over a 12-month period can reduce the frequency of exacerbations and improve asthma control and quality of life as compared to placebo, whilst being cost-effective and acceptable to adults with poorly controlled, severe allergic asthma.", {"entities": [[284, 299, "DISEASE"], [141, 147, "DISEASE"], [293, 299, "DISEASE"]]}], ["The results of this study will be widely applicable to the many patients with allergic asthma both in the UK and internationally.", {"entities": [[78, 93, "DISEASE"], [87, 93, "DISEASE"]]}], ["Current controlled trials ISRCTN46346208 (Date assigned 22 January 2014).", {"entities": []}], ["During specialty training for general practice, trainees acquire the required competencies through work-based learning.", {"entities": []}], ["Previous small-scale and older studies suggest that the patient mix of general practitioner (GP) trainees differs from that of their trainers: trainees are exposed to more minor illnesses, and fewer chronic diseases and severe conditions, which may influence the development of their competency.", {"entities": []}], ["What are the differences in the patient mix between trainees and trainers?", {"entities": []}], ["49 first- and 24 third-year trainees and their trainers (n=114) were included in the study.", {"entities": []}], ["International Classification of Primary Care (ICPC) contact and diagnosis codes were extracted from electronic patient records over 6\u2005months.", {"entities": []}], ["Trainers had double the number of face-to-face consultations, and treble the number of telephone consultations compared with trainees.", {"entities": []}], ["The trainees' patient mix consisted of significantly more patients with eye diseases, ear diseases, respiratory diseases, skin diseases and minor illnesses compared with their trainers.", {"entities": []}], ["Trainers encountered significantly more patients with circulatory diseases, psychiatric diseases, metabolic diseases, male genital conditions, social problems, and chronic and oncological diseases.", {"entities": []}], ["Female trainers and trainees encountered almost twice the number of female conditions compared with their male counterparts, while for male conditions, the opposite was found.", {"entities": []}], ["Considerable differences between the patient mix of trainers and trainees were found.", {"entities": []}], ["Specialty trainers and teachers must be aware of areas of low exposure.", {"entities": []}], ["Trainers should ensure trainees handle more chronic, complex, psychosocial and circulatory conditions.", {"entities": []}], ["Differences in patient mix between trainees and trainers were examined.", {"entities": []}], ["There are considerable differences between the patient mixes of trainers and trainees.", {"entities": []}], ["Trainers and teachers must be aware of these disparities and of areas of low exposure.", {"entities": []}], ["Trainers should ensure that trainees handle more chronic, complex, psychosocial and circulatory conditions.", {"entities": []}], ["The patient mix during specialty training for general practice was studied on a large scale and over a long period.", {"entities": []}], ["Information on patient mix extracted from electronic patient records system is excellent for monitoring patient mix.", {"entities": []}], ["The validity of the study is potentially diminished by dependence on the diagnostic competence of the doctors and the accurate attribution of diagnosis codes.", {"entities": []}], ["Diverse socioeconomic and clinical factors influence susceptibility to tuberculosis (TB) disease in Mexico.", {"entities": [[71, 83, "DISEASE"]]}], ["The role of genetic factors, particularly those that differ between the parental groups that admixed in Mexico, is unclear.", {"entities": []}], ["The objectives of this study are to identify the socioeconomic and clinical predictors of the transition from latent TB infection (LTBI) to pulmonary TB disease in an urban population in northeastern Mexico, and to examine whether genetic ancestry plays an independent role in this transition.", {"entities": []}], ["We recruited 97 pulmonary TB disease patients and 97 LTBI individuals from a public hospital in Monterrey, Nuevo Le\u00f3n.", {"entities": []}], ["Socioeconomic and clinical variables were collected from interviews and medical records, and genetic ancestry was estimated for a subset of 142 study participants from 291,917 single nucleotide polymorphisms (SNPs).", {"entities": []}], ["We examined crude associations between the variables and TB disease status.", {"entities": []}], ["Significant predictors from crude association tests were analyzed using multivariable logistic regression.", {"entities": []}], ["We also compared genetic ancestry between LTBI individuals and TB disease patients at 1,314 SNPs in 273 genes from the TB biosystem in the NCBI BioSystems database.", {"entities": []}], ["In crude association tests, 12 socioeconomic and clinical variables were associated with TB disease.", {"entities": []}], ["Multivariable logistic regression analyses indicated that marital status, diabetes, and smoking were independently associated with TB status.", {"entities": []}], ["Genetic ancestry was not associated with TB disease in either crude or multivariable analyses.", {"entities": []}], ["Separate analyses showed that LTBI individuals recruited from hospital staff had significantly higher European genetic ancestry than LTBI individuals recruited from the clinics and waiting rooms.", {"entities": []}], ["Genetic ancestry differed between individuals with LTBI and TB disease at SNPs located in two genes in the TB biosystem.", {"entities": []}], ["These results indicate that Monterrey may be structured with respect to genetic ancestry, and that genetic differences in TB susceptibility in parental populations may contribute to variation in disease susceptibility in the region.", {"entities": []}], ["The objective of the paper is to compare population health in the United States (US) and Canada.", {"entities": []}], ["Although the two countries are very similar in many ways, there are potentially important differences in the levels of social and economic inequality and the organization and financing of and access to health care in the two countries.", {"entities": []}], ["Data are from the Joint Canada/United States Survey of Health 2002/03.", {"entities": []}], ["The Health Utilities Index Mark 3 (HUI3) was used to measure overall health-related quality of life (HRQL).", {"entities": []}], ["Mean HUI3 scores were compared, adjusting for major determinants of health, including body mass index, smoking, education, gender, race, and income.", {"entities": []}], ["In addition, estimates of life expectancy were compared.", {"entities": []}], ["Finally, mean HUI3 scores by age and gender and Canadian and US life tables were used to estimate health-adjusted life expectancy (HALE).", {"entities": []}], ["Life expectancy in Canada is higher than in the US.", {"entities": []}], ["For those < 40 years, there were no differences in HRQL between the US and Canada.", {"entities": []}], ["For the 40+ group, HRQL appears to be higher in Canada.", {"entities": []}], ["The results comparing the white-only population in both countries were very similar.", {"entities": []}], ["For a 19-year-old, HALE was 52.0 years in Canada and 49.3 in the US.", {"entities": []}], ["The population of Canada appears to be substantially healthier than the US population with respect to life expectancy, HRQL, and HALE.", {"entities": []}], ["Factors that account for the difference may include access to health care over the full life span (universal health insurance) and lower levels of social and economic inequality, especially among the elderly.", {"entities": []}], ["Nitric oxide (NO) is produced within the respiratory tract and can be detected in exhaled bronchial and nasal air.", {"entities": []}], ["The concentration varies in specific diseases, being elevated in patients with asthma and bronchiectasis, but decreased in primary ciliary dyskinesia.", {"entities": [[123, 149, "DISEASE"], [90, 104, "DISEASE"], [79, 85, "DISEASE"]]}], ["In cystic fibrosis (CF), conflicting data exist on NO levels, which are reported unexplained as either decreased or normal.", {"entities": [[3, 18, "DISEASE"]]}], ["Functionally, NO production in the paranasal sinuses is considered as a location-specific first-line defence mechanism.", {"entities": []}], ["The aim of this study was to investigate the correlation between upper and lower airway NO levels and blood inflammatory parameters, CF-pathogen colonisation, and clinical data.", {"entities": []}], ["Nasal and bronchial NO concentrations from 57 CF patients were determined using an electrochemical analyser and correlated to pathogen colonisation of the upper and lower airways which were microbiologically assessed from nasal lavage and sputum samples.", {"entities": []}], ["Statistical analyses were performed with respect to clinical parameters (lung function, BMI), laboratory findings (CRP, leucocytes, total-IgG, fibrinogen), and anti-inflammatory and antibiotic therapy.", {"entities": [[115, 118, "GENE"]]}], ["There were significant correlations between nasal and bronchial NO levels (rho\u200a=\u200a0.48, p<0.001), but no correlation between NO levels and specific pathogen colonisation.", {"entities": []}], ["In patients receiving azithromycin, significantly reduced bronchial NO and a tendency to reduced nasal NO could be found.", {"entities": []}], ["Interestingly, a significant inverse correlation of nasal NO to CRP (rho\u200a=\u200a\u22120.28, p\u200a=\u200a0.04) and to leucocytes (rho\u200a=\u200a\u22120.41, p\u200a=\u200a0.003) was observed.", {"entities": [[64, 67, "GENE"]]}], ["In contrast, bronchial NO levels showed no correlation to clinical or inflammatory parameters.", {"entities": []}], ["Given that NO in the paranasal sinuses is part of the first-line defence mechanism against pathogens, our finding of reduced nasal NO in CF patients with elevated systemic inflammatory markers indicates impaired upper airway defence.", {"entities": []}], ["This may facilitate further pathogen acquisition in the sinonasal area, with consequences for lung colonisation and the overall outcome in CF.", {"entities": []}], ["House dust mite allergen exposure is a postulated risk factor for allergic sensitization, asthma development, and asthma morbidity; however, practical and effective methods to mitigate these allergens from low-income, urban home environments remain elusive.", {"entities": [[90, 96, "DISEASE"], [114, 120, "DISEASE"]]}], ["The purpose of this study was to assess the feasibility and effectiveness of physical interventions to mitigate house dust mite allergens in this setting.", {"entities": []}], ["Homes with high levels of house dust mite allergen (Der f 1 + Der p 1 > or = 10 microg/g dust by enzyme-linked immunosorbent assay) in the bed, bedroom carpet, and/or upholstered furniture were enrolled in the study.", {"entities": []}], ["Carpets and upholstered furniture were subjected to a single treatment of either dry steam cleaning plus vacuuming (carpet only) or intensive vacuuming alone.", {"entities": []}], ["Bed interventions consisted of complete encasement of the mattress, box spring, and pillows plus either weekly professional or in-home laundering of nonencased bedding.", {"entities": []}], ["Dust samples were collected at baseline and again at 3 days (carpet and upholstery only) and 2, 4, and 8 weeks posttreatment.", {"entities": []}], ["We compared pretreatment mean allergen concentrations and loads to posttreatment values and performed between-group analyses after adjusting for differences in the pretreatment means.", {"entities": []}], ["Both dry steam cleaning plus vacuuming and vacuuming alone resulted in a significant reduction in carpet house dust mite allergen concentration and load (p < 0.05).", {"entities": []}], ["Levels approached pretreatment values by 4 weeks posttreatment in the intensive vacuuming group, whereas steam cleaning plus vacuuming effected a decrease that persisted for up to 8 weeks.", {"entities": []}], ["Significant decreases in bed house dust mite allergen concentration and load were obtained in response to encasement and either professional or in-home laundering (p < 0.001).", {"entities": []}], ["Between-group analysis revealed significantly less postintervention house dust mite allergen load in professionally laundered compared to home-laundered beds (p < 0.05).", {"entities": []}], ["Intensive vacuuming and dry steam cleaning both caused a significant reduction in allergen concentration and load in upholstered furniture samples (p < 0.005).", {"entities": []}], ["Based on these data, we conclude that physical interventions offer practical, effective means of reducing house dust mite allergen levels in low-income, urban home environments.", {"entities": []}], ["Vitamin D levels are alarmingly low (<75 nmol/L) in 65-70% of North American children older than 1 year.", {"entities": []}], ["An increased risk of viral upper respiratory tract infections (URTI), asthma-related hospitalizations and use of anti-inflammatory medication have all been linked with low vitamin D. No study has determined whether wintertime vitamin D supplementation can reduce the risk of URTI and asthma exacerbations, two of the most common and costly illnesses of early childhood.", {"entities": [[70, 76, "DISEASE"], [284, 290, "DISEASE"]]}], ["The objectives of this study are: 1) to compare the effect of \u2018high dose\u2019 (2000 IU/day) vs. \u2018standard dose\u2019 (400 IU/day) vitamin D supplementation in achieving reductions in laboratory confirmed URTI and asthma exacerbations during the winter in preschool-aged Canadian children; and 2) to assess the effect of \u2018high dose\u2019 vitamin D supplementation on vitamin D serum levels and specific viruses that cause URTI.", {"entities": [[204, 210, "DISEASE"]]}], ["This study is a pragmatic randomized controlled trial.", {"entities": []}], ["Over 4 successive winters we will recruit 750 healthy children 1\u20135 years of age.", {"entities": []}], ["Participating physicians are part of a primary healthcare research network called TARGet Kids!", {"entities": []}], ["Children will be randomized to the \u2018standard dose\u2019 or \u2018high dose\u2019 oral supplemental vitamin D for a minimum of 4 months (200 children per group).", {"entities": []}], ["Parents will obtain a nasal swab from their child with each URTI, report the number of asthma exacerbations and complete symptom checklists.", {"entities": [[87, 93, "DISEASE"]]}], ["Unscheduled physician visits for URTIs and asthma exacerbations will be recorded.", {"entities": [[43, 49, "DISEASE"]]}], ["By May, a blood sample will be drawn to determine vitamin D serum levels.", {"entities": []}], ["The primary analysis will be a comparison of URTI rate between study groups using a Poisson regression model.", {"entities": []}], ["Secondary analyses will compare vitamin D serum levels, asthma exacerbations and the frequency of specific viral agents between groups.", {"entities": [[56, 62, "DISEASE"]]}], ["Identifying whether vitamin D supplementation of preschoolers can reduce wintertime viral URTIs and asthma exacerbations and what dose is optimal may reduce population wide morbidity and associated health care and societal costs.", {"entities": [[100, 106, "DISEASE"]]}], ["This information will assist in determining practice and health policy recommendations related to vitamin D supplementation in healthy Canadian preschoolers.", {"entities": []}], ["Like in several other Western countries, in the Dutch health care system regulated competition has been introduced.", {"entities": []}], ["In order to make this work, comparable information is required about the performance of health care providers in terms of effectiveness, safety and patient experiences.", {"entities": []}], ["Without further coordination, external actors will all try to force health care providers to be transparent.", {"entities": []}], ["For health care providers this might result in a situation in which they have to deliver data for several sets of indicators, defined by different actors.", {"entities": []}], ["Therefore, in the Netherlands an effort is made to define national sets of performance indicators and related measuring instruments.", {"entities": []}], ["In this article, the following questions are addressed, using patient experiences as an example: - When and how are stakeholders involved in the development of indicators and instruments that measure the patients' experiences with health care providers?", {"entities": []}], ["- Does this involvement lead to indicators and instruments that match stakeholders' information needs?", {"entities": []}], ["The Dutch experiences show that it is possible to implement national indicator sets and to reach consensus about what needs to be measured.", {"entities": []}], ["Preliminary evaluations show that for health care providers and health insurers the benefits of standardization outweigh the possible loss of tailor-made information.", {"entities": []}], ["However, it has also become clear that particular attention should be given to the participation of patient/consumer organisations.", {"entities": []}], ["Stakeholder involvement is complex and time-consuming.", {"entities": []}], ["However, it is the only way to balance the information needs of all the parties that ask for and benefit from transparency, without frustrating the health care system.", {"entities": []}], ["Eosinophil degranulation of peroxidase promotes DC activation and mobilization from the intestine to LNs to induce Th2 immunity and food allergy.", {"entities": [[132, 144, "DISEASE"]]}], ["Eosinophils natively inhabit the small intestine, but a functional role for them there has remained elusive.", {"entities": []}], ["Here, we show that eosinophil-deficient mice were protected from induction of Th2-mediated peanut food allergy and anaphylaxis, and Th2 priming was restored by reconstitution with il4 il4", {"entities": [[98, 110, "DISEASE"], [180, 183, "GENE"], [184, 187, "GENE"], [180, 183, "GENE"], [184, 187, "GENE"]]}], ["Allergic rhinitis and urticaria are chronic persistent allergic conditions that need proper management as they significantly reduce quality of life measures.", {"entities": [[0, 17, "DISEASE"], [22, 31, "DISEASE"], [9, 17, "DISEASE"]]}], ["Of the many pharmacological options of allergic rhinitis and urticaria, second-generation antihistamines are the mainstay of therapy.", {"entities": [[39, 56, "DISEASE"], [61, 70, "DISEASE"], [48, 56, "DISEASE"]]}], ["This review focuses on the knowledge of medical residents toward prescribing antihistamines, according to the new ARIA and GA2LEN guidelines for allergic rhinitis and urticaria, attempting to find the cause of less prescription of newer second-generation antihistamines by finding out the knowledge and attitude of the doctors prescribing them to the patients.", {"entities": [[145, 162, "DISEASE"], [167, 176, "DISEASE"], [154, 162, "DISEASE"]]}], ["The study was carried out among resident doctors at a tertiary care teaching hospital.", {"entities": []}], ["Primary data from 100 resident doctors, who gave their informed consent, was collected.", {"entities": []}], ["A prevalidated questionnaire regarding knowledge, attitude and prescribing practice of antihistamines was filled up.", {"entities": []}], ["The data was then analyzed with suitable statistical tests.", {"entities": []}], ["Every question was first validated using the Chi-square test, and significance was below 10% hence proving validity of the questions.", {"entities": []}], ["Out of the doctors surveyed, 82% of doctors said they prescribed second-generation antihistamines, while 18% still prescribed first-generation antihistamines.", {"entities": []}], ["Out of the 82% that prescribed second-generation antihistamines, 8.9% also prescribed first-generation antihistamines as well.", {"entities": []}], ["23% of doctors surveyed had heard about the ARIA and GAL2EN guidelines and their recommendations for prescribing second-generation antihistamines over the older first-generation antihistamines, while 77% of them had not heard of these position papers.", {"entities": []}], ["First-generation or classic antihistamines are still overused due to the lack of knowledge of various guidelines that have been published.", {"entities": []}], ["The main reason for not prescribing the second-generation antihistamines was due to the increased cost per tablet compared to the more economical first-generation antihistamines.", {"entities": []}], ["A number of previous studies examined a possible association of toxic metals and autism, and over half of those studies suggest that toxic metal levels are different in individuals with Autism Spectrum Disorders (ASD).", {"entities": []}], ["Additionally, several studies found that those levels correlate with the severity of ASD.", {"entities": []}], ["In order to further investigate these points, this paper performs the most detailed statistical analysis to date of a data set in this field.", {"entities": []}], ["First morning urine samples were collected from 67 children and adults with ASD and 50 neurotypical controls of similar age and gender.", {"entities": []}], ["The samples were analyzed to determine the levels of 10 urinary toxic metals (UTM).", {"entities": []}], ["Autism-related symptoms were assessed with eleven behavioral measures.", {"entities": []}], ["Statistical analysis was used to distinguish participants on the ASD spectrum and neurotypical participants based upon the UTM data alone.", {"entities": []}], ["The analysis also included examining the association of autism severity with toxic metal excretion data using linear and nonlinear analysis.", {"entities": []}], ["\u201cLeave-one-out\u201d cross-validation was used to ensure statistical independence of results.", {"entities": []}], ["Average excretion levels of several toxic metals (lead, tin, thallium, antimony) were significantly higher in the ASD group.", {"entities": []}], ["However, ASD classification using univariate statistics proved difficult due to large variability, but nonlinear multivariate statistical analysis significantly improved ASD classification with Type I/II errors of 15% and 18%, respectively.", {"entities": []}], ["These results clearly indicate that the urinary toxic metal excretion profiles of participants in the ASD group were significantly different from those of the neurotypical participants.", {"entities": []}], ["Similarly, nonlinear methods determined a significantly stronger association between the behavioral measures and toxic metal excretion.", {"entities": []}], ["The association was strongest for the Aberrant Behavior Checklist (including subscales on Irritability, Stereotypy, Hyperactivity, and Inappropriate Speech), but significant associations were found for UTM with all eleven autism-related assessments with cross-validation R", {"entities": []}], ["Forskolin is a unique structurally complex labdane-type diterpenoid used in the treatment of glaucoma and heart failure based on its activity as a cyclic AMP booster.", {"entities": [[93, 101, "DISEASE"]]}], ["Commercial production of forskolin relies exclusively on extraction from its only known natural source, the plant Coleus forskohlii , in which forskolin accumulates in the root cork.", {"entities": []}], ["Here, we report the discovery of five cytochrome P450s and two acetyltransferases which catalyze a cascade of reactions converting the forskolin precursor 13 R -manoyl oxide into forskolin and a diverse array of additional labdane-type diterpenoids.", {"entities": []}], ["A minimal set of three P450s in combination with a single acetyl transferase was identified that catalyzes the conversion of 13 R -manoyl oxide into forskolin as demonstrated by transient expression in Nicotiana benthamiana .", {"entities": []}], ["The entire pathway for forskolin production from glucose encompassing expression of nine genes was stably integrated into Saccharomyces cerevisiae and afforded forskolin titers of 40 mg/L.", {"entities": []}], ["DOI: http://dx.doi.org/10.7554/eLife.23001.001 Unlike animals, plants cannot move away from a herbivore or other threats.", {"entities": []}], ["Instead, they have evolved to produce a vast array of chemical compounds to protect themselves.", {"entities": []}], ["Some of these compounds are also important to humans, for example, as medicines or fragrances.", {"entities": []}], ["Plants usually only produce small amounts of these compounds in mixtures with many other compounds, which makes it difficult to purify them.", {"entities": []}], ["As a result, the methods of purifying the compounds may require huge amounts of plant material, or be expensive and not environmentally friendly.", {"entities": []}], ["One solution to this would be to genetically engineer microbes like bacteria or yeast to produce the compounds instead.", {"entities": []}], ["In order to do that, we need to understand exactly which enzymes the plant uses to make each compound and introduce them into suitable microbes.", {"entities": []}], ["A compound called forskolin has been used since ancient times in traditional Indian medicine to treat conditions like high blood pressure, asthma and heart complications.", {"entities": [[139, 145, "DISEASE"]]}], ["Forskolin is found exclusively in the root of a plant called Coleus forskohlii , which is native to India and south-east Asia.", {"entities": []}], ["It is stored inside cells within the bark of the root in structures called oil bodies, which are similar to oil drops.", {"entities": []}], ["However, it is not known where forskolin is made, or which enzymes are involved.", {"entities": []}], ["Pateraki, Andersen-Ranberg et al.", {"entities": []}], ["set out to uncover how C. forskohlii produces this compound.", {"entities": []}], ["The experiments show that forskolin is produced within the cells that contain the oil bodies.", {"entities": []}], ["A technique called RNA sequencing was used to identify several genes that are highly active in these cells and encode enzymes that could potentially be involved in producing forskolin.", {"entities": []}], ["Further experiments demonstrated that these enzymes drive a cascade of chemical reactions that convert a molecule called 13R-manoyl oxide into forskolin.", {"entities": []}], ["Next, Pateraki, Andersen-Ranberg et al.", {"entities": []}], ["inserted the genes into yeast cells that could already produce 13R-manoyl oxide, which allowed the yeast to produce relatively high amounts of forskolin.", {"entities": []}], ["These findings show that it is possible to identify the genes involved in the production of medicinal compounds in a relatively short amount of time.", {"entities": []}], ["This knowledge will aid the development of a method that can be used to produce forskolin and other similar compounds on a large scale without needing to harvest C. forskohlii plants.", {"entities": []}], ["DOI: http://dx.doi.org/10.7554/eLife.23001.002", {"entities": []}], ["Although proven to be associated with bronchial obstruction, chest signs are not listed among cues that should prompt spirometry in the early diagnosis of chronic obstructive pulmonary disease (COPD) in established guidelines.", {"entities": [[155, 192, "DISEASE"]]}], ["We aimed to explore how chest findings add to respiratory symptoms and a history of smoking in the diagnosis of COPD.", {"entities": []}], ["In a cross-sectional study, patients aged 40 years or older, previously diagnosed with either asthma or COPD in primary care, answered questionnaires and underwent physical chest examination and spirometry.", {"entities": [[94, 100, "DISEASE"]]}], ["Among the 375 patients included, 39.7% had forced expiratory volume in 1 second/forced vital capacity <0.7.", {"entities": []}], ["Hyperresonance to percussion was the strongest predictor of COPD, with a sensitivity of 20.8, a specificity of 97.8, and likelihood ratio of 9.5.", {"entities": []}], ["In multivariate logistic regression, where pack-years, shortness of breath, and chest findings were among the explanatory variables, three physical chest findings were independent predictors of COPD.", {"entities": []}], ["Hyperresonance to percussion yielded the highest odds ratio (OR = 6.7), followed by diminished breath sounds (OR = 5.0), and thirdly wheezes (OR = 2.3).", {"entities": []}], ["These three chest signs also gave significant diagnostic information when added to shortness of breath and pack-years in receiver operating-characteristic curve analysis.", {"entities": []}], ["We found that chest signs may add to respiratory symptoms and a history of smoking in the diagnosis of COPD, and we conclude that chest signs should be reinstated as cues to early diagnosis of COPD in patients 40 years or older.", {"entities": []}], ["This article examines how social and health inequalities shape the health impacts of climate change in the UK, and what the implications are for climate change adaptation and health care provision.", {"entities": []}], ["The evidence generated by the other articles of the special issue were interpreted using social justice reasoning in light of additional literature, to draw out the key implications of health and social inequalities for health outcomes of climate change.", {"entities": []}], ["Exposure to heat and cold, air pollution, pollen, food safety risks, disruptions to access to and functioning of health services and facilities, emerging infections and flooding are examined as the key impacts of climate change influencing health outcomes.", {"entities": []}], ["Age, pre-existing medical conditions and social deprivation are found to be the key (but not only) factors that make people vulnerable and to experience more adverse health outcomes related to climate change impacts.", {"entities": []}], ["In the future, climate change, aging population and decreasing public spending on health and social care may aggravate inequality of health outcomes related to climate change.", {"entities": []}], ["Health education and public preparedness measures that take into account differential exposure, sensitivity and adaptive capacity of different groups help address health and social inequalities to do with climate change.", {"entities": []}], ["Adaptation strategies based on individual preparedness, action and behaviour change may aggravate health and social inequalities due to their selective uptake, unless they are coupled with broad public information campaigns and financial support for undertaking adaptive measures.", {"entities": []}], ["The online version of this article (10.1186/s12940-017-0328-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["This article evaluates whether the use of high school students as simulated patients who provide formative feedback enhances the capacity of medical students in their fifth year of training to initiate screening conversations and communicate effectively with adolescents about sensitive health issues.", {"entities": []}], ["Focus group interviews with medical students (n\u2009=\u200952) and school students aged 15\u201316 (n\u2009=\u2009107) were conducted prior to and following involvement in Learning Partnerships workshops.", {"entities": []}], ["Prior to workshops focus groups with school students asked about attitudes to help-seeking in relation to sensitive health issues, and following workshops asked whether the workshop had made a difference to their concerns.", {"entities": []}], ["Prior to workshops focus groups with medical students asked about their needs in relation to initiating conversations with adolescents about sensitive health issues, and following workshops asked whether the workshop had made a difference to their concerns.", {"entities": []}], ["Surveys were also completed by 164 medical students and 66 school students following the workshops.", {"entities": []}], ["This survey featured 19 items asking participants to rank the usefulness of the workshops out of 10 (1\u2009=\u2009not at all useful, 10\u2009=\u2009extremely useful) across areas such as skills and understanding, value of learning activities and overall value of the workshop.", {"entities": []}], ["SPSS software was used to obtain mean plus standard deviation scores for each item on the survey.", {"entities": []}], ["The Learning Partnerships workshops assisted medical students to improve their skills and confidence in communicating with adolescents about sensitive health issues such as mental health, sexual health and drug and alcohol use.", {"entities": []}], ["They also assisted young people to perceive doctors as more likely potential sources for help.", {"entities": []}], ["These findings suggest that the innovative methods included in Learning Partnerships may assist in broader education programs training doctors to be more effective helping agents and aid the promotion of adolescent friendly health care.", {"entities": []}], ["This research provides evidence that a new way of teaching may contribute to enhancing doctors\u2019 capacity and willingness to initiate screening conversations and enhance adolescents\u2019 preparedness to seek help.", {"entities": []}], ["This has implications for educational design, content and communication style within adolescent health.", {"entities": []}], ["The online version of this article (doi:10.1186/s12909-015-0315-4) contains supplementary material, which is available to authorized users.", {"entities": []}], ["We aimed to investigate associations of the dietary inflammatory index (DII) with glucose-insulin homeostasis markers, and the risk of glucose intolerance.", {"entities": [[135, 154, "DISEASE"]]}], ["This cross-sectional study included 2975 adults from the Tehran Lipid and Glucose Study.", {"entities": []}], ["Fasting plasma glucose (FPG), 2-h post-load glucose (2h-PG), and fasting serum insulin were measured.", {"entities": []}], ["Homeostatic model assessment of insulin resistance index (HOMA-IR) and \u03b2-cell function (HOMA-B), and the quantitative insulin sensitivity check index (QUICKI) were calculated.", {"entities": []}], ["Glucose tolerance abnormalities included impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and type 2 diabetes (T2DM).", {"entities": []}], ["DII scores were positively associated with 2h-PG (\u03b2 = 0.04; p = 0.05).", {"entities": []}], ["There was no significant linear trend across quartiles of DII for adjusted means of glucose-insulin homeostasis markers.", {"entities": []}], ["Participants in the highest quartile of DII score tended to have higher FPG compared to those in the second quartile of DII score (5.46 vs. 5.38 mmol/L, p = 0.07) and higher fasting insulin and HOMA-IR compared to those in the lowest quartile (8.52 vs. 8.12 \u00b5U/mL for fasting insulin, p = 0.07; 2.06 vs. 1.96 for HOMA-IR, p = 0.08).", {"entities": []}], ["No significant associations were observed between DII and risk of IFG, IGT, T2DM, and insulin resistance.", {"entities": []}], ["Among glucose-insulin homeostasis markers, DII had a positive weak association only with 2h-PG.", {"entities": []}], ["Antithrombotic therapy carries high risks for patient safety.", {"entities": []}], ["Antithrombotics belong to the top 5 medications involved in potentially preventable hospital admissions related to medication.", {"entities": []}], ["To provide a standard for antithrombotic therapy and stress the importance of providing optimal care to patients on antithrombotic therapy, the Landelijke Standaard Ketenzorg Antistolling (LSKA; Dutch guideline on integrated antithrombotic care) was drafted.", {"entities": []}], ["However, the mere publication of this guideline does not guarantee its implementation.", {"entities": []}], ["This may require a multidisciplinary team effort.", {"entities": []}], ["Therefore, we designed a study aiming to determine the influence of hospital-based antithrombotic stewardship on the effect and safety of antithrombotic therapy outcomes during and after hospitalisation.", {"entities": []}], ["In this study, the effect of the implementation of a multidisciplinary antithrombotic team is compared with usual care using a pre-post study design.", {"entities": []}], ["The study is performed at the Erasmus University Medical Center Rotterdam and the Reinier de Graaf Hospital Delft.", {"entities": []}], ["Patients who are or will be treated with antithrombotics are included in the study.", {"entities": []}], ["We aim to include 1900 patients, 950 in each hospital.", {"entities": []}], ["Primary outcome is the proportion of patients with a composite end point consisting of \u22651 bleeding or \u22651 thrombotic event from the beginning of antithrombotic therapy (or hospitalisation) until 3\u2005months after hospitalisation.", {"entities": []}], ["Bleeding is defined according to the International Society of Thrombosis and Haemostasis (ISTH) classification.", {"entities": []}], ["A thrombotic event is defined as any objectively confirmed arterial or venous thrombosis, including acute myocardial infarction or stroke for arterial thrombosis and deep venous thrombosis or pulmonary embolism or venous thrombosis.", {"entities": [[106, 127, "DISEASE"], [192, 210, "DISEASE"], [100, 127, "DISEASE"]]}], ["An economic evaluation is performed to determine whether the implementation of the multidisciplinary antithrombotic team will be cost-effective.", {"entities": []}], ["This protocol was approved by the Medical Ethical Committee of the Erasmus University Medical Center.", {"entities": []}], ["The findings of the study will be disseminated through peer-reviewed journals and presented at relevant conferences.", {"entities": []}], ["NTR4887 ; pre-results.", {"entities": []}], ["Studies have shown that epinephrine release is impaired in patients with asthma.", {"entities": [[73, 79, "DISEASE"]]}], ["The pregnancy of female rats (dams) with asthma promotes in their pups the differentiation of adrenal medulla chromaffin cells (AMCCs) into sympathetic neurons, mediated by nerve growth factor, which leads to a reduction in epinephrine secretion.", {"entities": [[41, 47, "DISEASE"]]}], ["However, the relatedness between the alteration of AMCCs and increased asthma susceptibility in such offspring has not been established.", {"entities": [[71, 77, "DISEASE"]]}], ["In this study, we observed the effects of allergization via ovalbumin on rat pups born of asthmatic dams.", {"entities": []}], ["Compared to the offspring of untreated controls, bronchial hyperreactivity and airway inflammation were more severe in the pups from sensitized (asthmatic) dams.", {"entities": []}], ["In pups exposed to nerve growth factor (NGF) in utero these effects were aggravated further, but the effects were blocked in pups whose dams had been treated with anti-NGF.", {"entities": [[40, 43, "GENE"], [168, 171, "GENE"]]}], ["Furthermore, alterations in AMCC phenotype corresponded to the degree of bronchial hyperreactivity and lung lesions of the different treatment groups.", {"entities": []}], ["Such AMCC alterations included degranulation of chromaffin granules, reduction of epinephrine and phenylethanolamine-n-methyl transferase, and elevation of NGF and peripherin levels.", {"entities": [[156, 159, "GENE"]]}], ["Our results present evidence that asthma during the pregnancy of rat dams promotes asthma susceptibility in their offspring, and that the transformation of AMCCs to neurons induced by NGF plays an important role in this process.", {"entities": [[34, 40, "DISEASE"], [83, 89, "DISEASE"], [184, 187, "GENE"]]}], ["Female patients with cystic fibrosis (CF) have consistently poorer survival rates than males across all ages.", {"entities": [[21, 36, "DISEASE"]]}], ["To determine if gender differences exist in health-related quality of life (HRQOL) of adolescent patients with CF, we performed a cross-section analysis of CF patients recruited from 2 medical centers in 2 cities during 1997\u20132001.", {"entities": []}], ["We used the 87-item child self-report form of the Child Health Questionnaire to measure 12 health domains.", {"entities": []}], ["Data was also collected on age and forced expiratory volume in 1 second (FEV 1 ).", {"entities": [[73, 76, "GENE"]]}], ["We analyzed data from 98 subjects and performed univariate analyses and linear regression or ordinal logistic regression for multivariable analyses.", {"entities": []}], ["The mean (SD) age was 14.6 (2.5) years; 50 (51.0%) were female; and mean FEV 1 was 71.6% (25.6%) of predicted.", {"entities": [[73, 76, "GENE"]]}], ["There were no statistically significant gender differences in age or FEV 1 .", {"entities": [[69, 72, "GENE"]]}], ["In univariate analyses, females reported significantly poorer HRQOL in 5 of the 12 domains.", {"entities": []}], ["In multivariable analyses controlling for FEV 1 and age, we found that female gender was associated with significantly lower global health (p < 0.05), mental health (p < 0.01), and general health perceptions (p < 0.05) scores.", {"entities": [[42, 45, "GENE"]]}], ["Further research will need to focus on the causes of these differences in HRQOL and on potential interventions to improve HRQOL of adolescent patients with CF.", {"entities": []}], ["The prevalence of obesity is rising.", {"entities": [[18, 25, "DISEASE"]]}], ["Obesity can lead to cardiovascular and ventilatory complications through multiple mechanisms.", {"entities": [[0, 7, "DISEASE"]]}], ["Cardiac and pulmonary function in asymptomatic subjects and the effect of structured dietary programs on cardiac and pulmonary function is unclear.", {"entities": []}], ["To determine lung and cardiac function in asymptomatic obese adults and to evaluate whether weight loss positively affects functional parameters.", {"entities": []}], ["We prospectively evaluated bodyplethysmographic and echocardiographic data in asymptomatic subjects undergoing a structured one-year weight reduction program.", {"entities": []}], ["74 subjects (32 male, 42 female; mean age 42\u00b112 years) with an average BMI 42.5\u00b17.9, body weight 123.7\u00b124.9 kg were enrolled.", {"entities": []}], ["Body weight correlated negatively with vital capacity (R\u200a=\u200a\u22120.42, p<0.001 ), FEV1 (R\u200a=\u200a\u22120.497, p<0.001 ) and positively with P 0.1 (R\u200a=\u200a0.32, p\u200a=\u200a0.02) and myocardial mass (R\u200a=\u200a0.419, p \u200a=\u200a0.002).", {"entities": []}], ["After 4 months the study subjects had significantly reduced their body weight (\u221226.0\u00b111.8 kg) and BMI (\u22128.9\u00b13.8) associated with a significant improvement of lung function (absolute changes: vital capacity +5.5\u00b17.5% pred., p<0.001 ; FEV1+9.8\u00b18.3% pred., p<0.001 , ITGV+16.4\u00b116.0% pred., p<0.001 , SR tot \u221217.4\u00b141.5% pred., p<0.01 ).", {"entities": []}], ["Moreover, P0.1/Pimax decreased to 47.7% (p<0.01) indicating a decreased respiratory load.", {"entities": []}], ["The change of FEV1 correlated significantly with the change of body weight (R\u200a=\u200a\u22120.31, p \u200a=\u200a0.03).", {"entities": []}], ["Echocardiography demonstrated reduced myocardial wall thickness (\u22120.08\u00b10.2 cm, p\u200a=\u200a0.02) and improved left ventricular myocardial performance index (\u22120.16\u00b10.35, p\u200a=\u200a0.02).", {"entities": []}], ["Mitral annular plane systolic excursion (+0.14, p\u200a=\u200a0.03) and pulmonary outflow acceleration time (AT +26.65\u00b141.3 ms, p\u200a=\u200a0.001) increased.", {"entities": []}], ["Even in asymptomatic individuals obesity is associated with abnormalities in pulmonary and cardiac function and increased myocardial mass.", {"entities": [[33, 40, "DISEASE"]]}], ["All the abnormalities can be reversed by a weight reduction program.", {"entities": []}], ["To describe patterns of disclosure of symptoms experienced among people in the general population to persons in their personal and/or professional network.", {"entities": []}], ["A population-based cross-sectional study.", {"entities": []}], ["Data were collected from a web-based survey.", {"entities": []}], ["The general population in Denmark.", {"entities": []}], ["100\u2009000 individuals randomly selected, representative of the adult Danish population aged \u226520 years were invited.", {"entities": []}], ["Approximately 5% were not eligible for inclusion.", {"entities": []}], ["49\u2009706 (men=23\u2009240; women=26\u2009466) of 95\u2009253 eligible individuals completed the questionnaire; yielding a response rate of 52.2%.", {"entities": []}], ["Individuals completing all questions regarding social network relations form the study base (n=44\u2009313).", {"entities": []}], ["Activation of personal and/or professional relations when experiencing a symptom.", {"entities": []}], ["The 44\u2009313 individuals reported in total 260\u2009079 symptom experiences within the last 4\u2009weeks.", {"entities": []}], ["No professional network relation was used in two-thirds of all reported symptoms.", {"entities": []}], ["The general practitioner (GP) was the most frequently reported professional relation activated (22.5%).", {"entities": []}], ["People reporting to have available personal relations were slightly less inclined to contact the GP (21.9%) when experiencing a symptom compared with people with no reported personal relations (26.8%).", {"entities": []}], ["The most commonly activated personal relations were spouse/partner (56.4%) and friend (19.6%).", {"entities": []}], ["More than a quarter of all reported symptom experiences was not shared with anyone, personal nor professional.", {"entities": []}], ["The symptom experiences with the lowest frequency of network activation were symptoms such as black stool, constipation, change in stool texture and frequent urination.", {"entities": [[107, 119, "DISEASE"]]}], ["This study emphasises variation in the activation of network relations when experiencing a symptom.", {"entities": []}], ["Symptoms were shared with both personal and professional relations, but different patterns of disclosures were discovered.", {"entities": []}], ["For symptoms derived from the urogenital or colorectal region, the use of both personal and professional relations was relatively small, which might indicate reticence to involve other people when experiencing symptoms of that nature.", {"entities": []}], ["Fungi can cause a variety of infectious diseases, including invasive mycosis and non-invasive mycosis, as well as allergic diseases.", {"entities": []}], ["The different forms of mycosis usually have been described as mutually exclusive, independent entities, with few descriptions of overlapping cases.", {"entities": []}], ["Here, we describe the first reported case of a patient with the complication of pulmonary eosinophilia in the course of invasive mucormycosis.", {"entities": [[90, 102, "DISEASE"], [80, 102, "DISEASE"]]}], ["A 74-year-old Japanese man with asthma-COPD overlap underwent emergency surgery for a ruptured abdominal aortic aneurysm.", {"entities": [[95, 120, "DISEASE"], [86, 120, "DISEASE"], [105, 120, "DISEASE"], [32, 38, "DISEASE"]]}], ["The surgery was successful, but fever and worsening dyspnea appeared and continued from postoperative day (POD) 10.", {"entities": []}], ["A complete blood count showed leukocytosis with neutrophilia and eosinophilia, and the chest X-ray showed consolidation of the left upper lung at POD 15.", {"entities": [[65, 77, "DISEASE"]]}], ["We suspected nosocomial pneumonia together with an exacerbation of the asthma-COPD overlap, and both antibiotics and bronchodilator therapy were initiated.", {"entities": [[24, 33, "DISEASE"], [71, 77, "DISEASE"]]}], ["However, the symptoms, eosinophilia and imaging findings deteriorated.", {"entities": [[23, 35, "DISEASE"]]}], ["We then performed a bronchoscopy, and bronchoalveolar lavage (BAL) fluid analysis revealed an increased percentage of eosinophils (82% of whole cells) as well as filamentous fungi.", {"entities": []}], ["We first suspected that this was a case of allergic bronchopulmonary mycosis (ABPM) caused by Aspergillus infection and began corticosteroid therapy with an intravenous administration of voriconazole at POD 27.", {"entities": []}], ["However, the fungal culture examination of the BAL fluid revealed mucormycetes, which were later identified as Cunninghamella bertholletiae by PCR and DNA sequencing.", {"entities": []}], ["We then switched the antifungal agent to liposomal amphotericin B for the treatment of the pulmonary mucormycosis at POD 29.", {"entities": []}], ["Despite replacing voriconazole with liposomal amphotericin B, the patient developed septic shock and died at POD 39.", {"entities": []}], ["The autopsy revealed that filamentous fungi had invaded the lung, heart, thyroid glands, kidneys, and spleen, suggesting that disseminated mucormycosis had occurred.", {"entities": []}], ["We describe the first reported case of pulmonary mucormycosis with pulmonary eosinophilia caused by Cunninghamella bertholletiae , which resulted in disseminated mucormycosis.", {"entities": [[77, 89, "DISEASE"], [67, 89, "DISEASE"]]}], ["Although it is a rather rare case, two important conclusions can be drawn: i) mycosis can simultaneously cause both invasive infection and a host allergic reaction, and ii) Cunninghamella bertholletiae rarely infects immunocompetent patients.", {"entities": []}], ["Although lincRNAs are implicated in gene regulation in various tissues, little is known about lincRNA transcriptomes in the T cell lineages.", {"entities": []}], ["Here we identify 1,524 lincRNA clusters in 42 T cell samples from early T cell progenitors to terminally differentiated T helper (T H ) subsets.", {"entities": []}], ["Our analysis revealed highly dynamic and cell-specific expression patterns of lincRNAs during T cell differentiation.", {"entities": []}], ["Importantly, these lincRNAs are located in genomic regions enriched for protein-coding genes with immune-regulatory functions.", {"entities": []}], ["Many of them are bound and regulated by the key T cell transcription factors T-bet, GATA-3, STAT4 and STAT6.", {"entities": [[92, 97, "GENE"], [102, 107, "GENE"]]}], ["We demonstrate that the lincRNA LincR-Ccr2-5\u2032AS, together with GATA-3, is an essential component of a regulatory circuit in T H 2-specific gene expression and important for T H 2 cell migration.", {"entities": []}], ["The gene encoding CD14 has been proposed as an IBD-susceptibility gene with its polymorphism C-260T being widely evaluated, yet with conflicting results.", {"entities": [[18, 22, "GENE"]]}], ["The aim of this study was to investigate the association between this polymorphism and IBD by conducting a meta-analysis.", {"entities": []}], ["Seventeen articles met the inclusion criteria, which included a total of 18 case-control studies, including 1900 ulcerative colitis (UC) cases, 2535 Crohn's disease (CD) cases, and 4004 controls.", {"entities": [[113, 131, "DISEASE"]]}], ["Data were analyzed using STATA software.", {"entities": []}], ["Overall, association between C-260T polymorphism and increased UC risk was significant in allelic comparison (odds ratio [OR] \u200a=\u200a1.21, 95% confidence interval [CI]: 1.02\u20131.43; P\u200a=\u200a0.027), homozygote model (OR \u200a=\u200a1.44, 95% CI: 1.03\u20132.01; P\u200a=\u200a0.033), as well as dominant model (OR \u200a=\u200a1.36, 95% CI: 1.06\u20131.75; P\u200a=\u200a0.016).", {"entities": []}], ["However, there was negative association between this polymorphism and CD risk across all genetic models.", {"entities": []}], ["Subgroup analyses by ethnicity suggested the risk-conferring profiles of -260T allele and -260 TT genotype with UC in Asians, but not in Caucasians.", {"entities": []}], ["There was a low probability of publication bias.", {"entities": []}], ["Expanding previous results of individual studies, our findings demonstrated that CD14 gene C-260T polymorphism might be a promising candidate marker in susceptibility to UC, especially in Asians.", {"entities": [[81, 85, "GENE"]]}], ["Whilst BCG inhibits allergic airway responses in murine models, IL-18 has adversary effects depending on its environment.", {"entities": []}], ["We therefore constructed a BCG strain producing murine IL-18 (BCG-IL-18) and evaluated its efficiency to prevent an asthma-like reaction in mice.", {"entities": [[116, 122, "DISEASE"]]}], ["BALB/cByJ mice were sensitized (day (D) 1 and D10) by intraperitoneal injection of ovalbumin (OVA)-alum and primary (D20\u201322) and secondary (D62, 63) challenged with OVA aerosols.", {"entities": []}], ["BCG or BCG-IL-18 were intraperitonealy administered 1 hour before each immunization (D1 and D10).", {"entities": []}], ["BCG-IL-18 and BCG were shown to similarly inhibit the development of AHR, mucus production, eosinophil influx, and local Th2 cytokine production in BAL, both after the primary and secondary challenge.", {"entities": [[69, 72, "GENE"]]}], ["These data show that IL-18 did not increase allergic airway responses in the context of the mycobacterial infection, and suggest that BCG-IL-18 and BCG are able to prevent the development of local Th2 responses and therefore inhibit allergen-induced airway responses even after restimulation.", {"entities": []}], ["Historically, Bifidobacterium species were reported as abundant in the breastfed infant gut.", {"entities": []}], ["However, recent studies in resource-rich countries show an increased abundance of taxa regarded as signatures of dysbiosis.", {"entities": []}], ["Historically, Bifidobacterium species were reported as abundant in the breastfed infant gut.", {"entities": []}], ["However, recent studies in resource-rich countries show an increased abundance of taxa regarded as signatures of dysbiosis.", {"entities": []}], ["It is unclear whether these differences are the product of genetics, geographic factors, or interventions such as formula feeding, antibiotics, and caesarean section.", {"entities": []}], ["Fecal pH is strongly associated with Bifidobacterium abundance; thus, pH could be an indicator of its historical abundance.", {"entities": []}], ["A review of 14 clinical studies published between 1926 and 2017, representing more than 312 healthy breastfed infants, demonstrated a change in fecal pH from 5.0 to 6.5 (adjusted r Bifidobacterium species abundance in the gut microbiome in resource-rich countries compared to that in historical reports.", {"entities": []}], ["Our analysis showed that increased fecal pH and abundance of members of the families Enterobacteriaceae , Clostridiaceae , Peptostreptococcaceae , and Veillonellaceae are associated, indicating that loss of highly specialized Bifidobacterium species may result in dysbiosis, the implications of which are not yet fully elucidated.", {"entities": []}], ["Critical assessment of interventions that restore this ecosystem, measured by key parameters such as ecosystem productivity, gut function, and long-term health, are necessary to understand the magnitude of this change in human biology over the past century.", {"entities": []}], ["The risk of allergic diseases among Kawasaki disease (KD) patients relative to the general population is not known.", {"entities": []}], ["The aim of this study was to perform a population-based cohort study to investigate the risk of allergic diseases among children after KD in Taiwan- a country with the third highest incidence of KD in the world.", {"entities": []}], ["Data were obtained from the Taiwan National Health Insurance Research Database.", {"entities": []}], ["In total, 253 patients who were 5\u00a0years of age or younger and had a first-time hospitalization with a diagnosis of KD between 1997 and 2005 were included as the study cohort and 1,012 non-KD patients matched for age and sex were included as comparison cohort.", {"entities": []}], ["Multivariate Cox proportional hazard regression model was used to adjust for confounding and to compare the 6-year allergic-free survival rate between these two cohorts.", {"entities": []}], ["The incidence rate of allergic diseases (184.66 per 1000 person-year) was significantly higher in the KD cohort than in the control cohort (124.99 per 1000 person-years).", {"entities": []}], ["After adjusting for potential confounders, the adjusted hazard ratios of asthma and allergic rhinitis were 1.51 (95% confidence interval\u2009=\u20091.17-1.95) and 1.30 (95% confidence interval\u2009=\u20091.04-1.62), respectively.", {"entities": [[84, 101, "DISEASE"], [93, 101, "DISEASE"], [73, 79, "DISEASE"]]}], ["We conclude that KD patients were at an increased risk for allergic diseases compared with the comparison cohort.", {"entities": []}], ["The aim of this paper is to examine the association of physical inactivity with incidence of obesity in the South Australian adult population.", {"entities": [[93, 100, "DISEASE"]]}], ["Two representative data sources were used \u2013 the South Australian Monitoring and Surveillance System (SAMSS), a monthly surveillance system, and the North West Adelaide Health Study (NWAHS), a biomedical cohort study.", {"entities": []}], ["There were 75.3% (n\u200a=\u200a12873) SAMSS participants and 72.8% (n\u200a=\u200a1521) of NWAHS participants that were not obese at baseline.", {"entities": []}], ["The cumulative incidence of obesity for SAMSS participants from the previous year to the current year was 2.7%.", {"entities": [[28, 35, "DISEASE"]]}], ["The cumulative incidence of obesity for NWAHS participants between baseline and stage 3 was 14.4%.", {"entities": [[28, 35, "DISEASE"]]}], ["Physical inactivity was associated with incident obesity (RR 1.48, 95% CI 1.14\u20131.90 [SAMSS] and RR 1.41, 95% CI 1.03\u20131.93 [NWAHS]).", {"entities": [[49, 56, "DISEASE"]]}], ["This association remained, but was attenuated after adjustment for chronic conditions, risk factors and socio-demographic factors.", {"entities": []}], ["However, physical activity should be continued to be encouraged in the population for its known additional health benefits.", {"entities": []}], ["Our previous work implied that interleukin 6 (IL6) may be a biological marker for major depressive disorder (MDD).", {"entities": [[82, 107, "DISEASE"], [46, 49, "GENE"]]}], ["In this study, we performed a comprehensive genetic study to determine the association between the gene encoding IL6 ( IL6 ) and MDD in Han Chinese.", {"entities": [[113, 116, "GENE"], [119, 122, "GENE"], [113, 116, "GENE"], [119, 122, "GENE"]]}], ["There were 50 drug-na\u00efve MDD patients and 50 healthy controls undergoing an mRNA expression study.", {"entities": []}], ["A sample of 772 patients with MDD and 759 healthy controls were used for genetic analysis.", {"entities": []}], ["Next, we performed an eQTL analysis to identify whether risk SNP(s) is associated with IL6 expression in brain.", {"entities": [[87, 90, "GENE"]]}], ["Our results showed that patients with MDD have higher levels of IL6 than healthy controls ( P \u2009=\u20090.008).", {"entities": [[64, 67, "GENE"]]}], ["The SNP rs1800797 has a significant association with MDD ( P \u2009=\u20090.01) in a dominant model.", {"entities": []}], ["The eQTL analysis showed a marginally significant association between the rs1800797 and IL6 expression in the frontal cortex ( P \u2009=\u20090.087).", {"entities": [[88, 91, "GENE"]]}], ["Our preliminary findings are suggestive of an association between rs1800797 and the risk of MDD.", {"entities": []}], ["Further investigations are required to evaluate this association in larger samples to increase statistical power, and to examine the correlation between rs1800797 and IL6 methylation patterns.", {"entities": [[167, 170, "GENE"]]}], ["The vast amounts of clinical data collected in electronic health records (EHR) is analogous to the data explosion from the \u201c-omics\u201d revolution.", {"entities": []}], ["In the EHR clinicians often maintain patient-specific problem summary lists which are used to provide a concise overview of significant medical diagnoses.", {"entities": []}], ["We hypothesized that by tapping into the collective wisdom generated by hundreds of physicians entering problems into the EHR we could detect significant associations among diagnoses that are not described in the literature.", {"entities": []}], ["We employed an analytic approach original developed for detecting associations between sets of gene expression data, called Molecular Concept Map (MCM), to find significant associations among the 1.5 million clinical problem summary list entries in 327,000 patients from our institution's EHR.", {"entities": []}], ["An odds ratio (OR) and p-value was calculated for each association.", {"entities": []}], ["A subset of the 750,000 associations found were explored using the MCM tool.", {"entities": []}], ["Expected associations were confirmed and recently reported but poorly known associations were uncovered.", {"entities": []}], ["Novel associations which may warrant further exploration were also found.", {"entities": []}], ["Examples of expected associations included non-insulin dependent diabetes mellitus and various diagnoses such as retinopathy, hypertension, and coronary artery disease.", {"entities": [[126, 138, "DISEASE"], [65, 82, "DISEASE"]]}], ["A recently reported association included irritable bowel and vulvodynia (OR 2.9, p\u200a=\u200a5.6\u00d710 Computer programs developed for analyses of \u201c-omic\u201d data can be successfully applied to the area of clinical medicine.", {"entities": []}], ["The results of the analysis may be useful for hypothesis generation as well as supporting clinical care by reminding clinicians of likely problems associated with a patient's existing problems.", {"entities": []}], ["Recruitment of general practices and their patients into research studies is frequently reported as a challenge.", {"entities": []}], ["The Preventing and Lessening Exacerbations of Asthma in School-aged children Associated with a New Term (PLEASANT) trial recruited 142 general practices, across England and Wales and delivered the study intervention to time and target.", {"entities": []}], ["To describe the process of recruitment used within the cluster randomised PLEASANT trial and present results on factors that influenced recruitment.", {"entities": []}], ["Data were collected on the number of and types of contact used to gain expression of interest and subsequent randomisation into the PLEASANT trial.", {"entities": []}], ["Practice size and previous research experience were also collected.", {"entities": []}], ["The mean number of contacts required to gain expression of interest were m =3.01 (s.d.", {"entities": []}], ["1.6) and total number of contacts from initial invitation to randomisation m =6.8 (s.d.", {"entities": []}], ["Previous randomised controlled trial involvement (hazard ratio (HR)=1.81 (confidence interval (CI) 95%, 1.55\u20132.11) P <0.001) and number of studies a practice had previously engaged in (odds ratio (OR) 1.91 (CI 95%, (1.52\u20132.42)) P <0.001), significantly influenced whether a practice would participate in PLEASANT.", {"entities": [[64, 66, "GENE"]]}], ["Practice size was not a significant deciding factor (OR=1.04 (95% CI 0.99\u20131.08) P =0.137).", {"entities": []}], ["Recruitment to time and target can be achieved in general practice.", {"entities": []}], ["The amount of resource required for site recruitment should not, however, be underestimated and multiple strategies for contacting practices should be considered.", {"entities": []}], ["General practitioners with more research experience are more likely to participate in studies.", {"entities": []}], ["Approximately 10% (40\u2005000) of US quitline enrollees who smoke cigarettes report current use of electronic nicotine delivery systems (ENDS); however, little is known about callers' ENDS use.", {"entities": []}], ["Our aim was to describe why and how quitline callers use ENDS, their beliefs about ENDS and the impact of ENDS use on callers' quit processes and use of FDA-approved cessation medications.", {"entities": []}], ["Qualitative interviews conducted 1-month postregistration.", {"entities": []}], ["Interviews were recorded, transcribed, double-coded and analysed to identify themes.", {"entities": []}], ["Oklahoma Tobacco Helpline.", {"entities": []}], ["40 callers aged \u226518 who were seeking help to quit smoking were using ENDS at registration and completed \u22651 programme calls.", {"entities": []}], ["At 1-month postregistration interview, 80% of callers had smoked cigarettes in the last 7\u2005days, almost two-thirds were using ENDS, and half were using cessation medications.", {"entities": []}], ["Nearly all believed ENDS helped them quit or cut down on smoking; however, participants were split on whether they would recommend cessation medications, ENDS or both together for quitting.", {"entities": []}], ["Confusion and misinformation about potential harms of ENDS and cessation medications were reported.", {"entities": []}], ["Participants reported using ENDS in potentially adaptive ways (eg, using ENDS to cut down and nicotine replacement therapy to quit, and stepping down nicotine in ENDS to wean off ENDS after quitting) and maladaptive ways (eg, frequent automatic ENDS use, using ENDS in situations they did not previously smoke, cutting down on smoking using ENDS without a schedule or plan to quit), which could impact the likelihood of quitting smoking or continuing ENDS use.", {"entities": []}], ["These qualitative findings suggest quitline callers who use ENDS experience confusion and misinformation about ENDS and FDA-approved cessation medications.", {"entities": []}], ["Callers also use ENDS in ways that may not facilitate quitting smoking.", {"entities": []}], ["Opportunities exist for quitlines to educate ENDS users and help them create a coordinated plan most likely to result in completely quitting combustible tobacco.", {"entities": []}], ["The transcriptome is a powerful proxy for the physiological state of a cell, healthy or diseased.", {"entities": []}], ["As a result, transcriptome analysis has become a key tool in understanding the molecular changes that accompany bacterial infections of eukaryotic cells.", {"entities": []}], ["Until recently, such transcriptomic studies have been technically limited to analyzing mRNA expression changes in either the bacterial pathogen or the infected eukaryotic host cell.", {"entities": []}], ["However, the increasing sensitivity of high-throughput RNA sequencing now enables \u201cdual RNA-seq\u201d studies, simultaneously capturing all classes of coding and noncoding transcripts in both the pathogen and the host.", {"entities": []}], ["In the five years since the concept of dual RNA-seq was introduced, the technique has been applied to a range of infection models.", {"entities": []}], ["This has not only led to a better understanding of the physiological changes in pathogen and host during the course of an infection but has also revealed hidden molecular phenotypes of virulence-associated small noncoding RNAs that were not visible in standard infection assays.", {"entities": []}], ["Here, we use the knowledge gained from these recent studies to suggest experimental and computational guidelines for the design of future dual RNA-seq studies.", {"entities": []}], ["We conclude this review by discussing prospective applications of the technique.", {"entities": []}], ["Uncontrolled asthma is a risk factor for pregnancy-related complications.", {"entities": [[13, 19, "DISEASE"]]}], ["Hyaluronic acid (HA), a potential peripheral blood marker of tissue fibrosis in various diseases, promotes eosinophil survival and plays a role in asthmatic airway inflammation as well as in physiological processes necessary to maintain normal pregnancy; however the level of circulating HA in asthma and asthmatic pregnancy is unknown.", {"entities": [[294, 300, "DISEASE"]]}], ["We investigated HA levels in asthmatic patients (N\u200a=\u200a52; asthmatic pregnant (AP) N\u200a=\u200a16; asthmatic non-pregnant (ANP) N\u200a=\u200a36) and tested their relationship to asthma control.", {"entities": [[159, 165, "DISEASE"]]}], ["Serum HA level was lower in AP than in ANP patients (27 [24.7\u201331.55] vs. 37.4 [30.1\u201366.55] ng/mL, p\u200a=\u200a0.006); the difference attenuated to a trend after its adjustment for patients\u2019 age (p\u200a=\u200a0.056).", {"entities": []}], ["HA levels and airway resistance were positively (r\u200a=\u200a0.467, p\u200a=\u200a0.004), HA levels and Asthma Control Test (ACT) total score inversely (r\u200a=\u200a\u22120.437, p\u200a=\u200a0.01) associated in ANP patients; these relationships remained significant even after their adjustments for age.", {"entities": [[86, 92, "DISEASE"]]}], ["The potential value of HA in the determination of asthma control was analyzed using ROC analysis which revealed that HA values discriminate patients with ACT total score \u226520 (controlled patients) and <20 (uncontrolled patients) with a 0.826 efficacy (AUC, 95% CI: 0.69\u20130.97, p\u200a=\u200a0.001) when 37.4 ng/mL is used as cut-off value in ANP group, and with 0.78 efficacy (AUC, 95% CI: 0.65\u20130.92, p\u200a=\u200a0.0009) in the whole asthmatic cohort.", {"entities": [[50, 56, "DISEASE"]]}], ["In conclusion circulating HA might be a marker of asthma control, as it correlates with airway resistance and has good sensitivity in the detection of impaired asthma control.", {"entities": [[50, 56, "DISEASE"], [160, 166, "DISEASE"]]}], ["Decrease of HA level in pregnancy may be the consequence of pregnancy induced immune tolerance.", {"entities": []}], ["Arginine-specific mono-ADP-ribosyltransferase 1 (ART1) is an important enzyme that catalyzes arginine-specific mono-ADP-ribosylation.", {"entities": [[49, 53, "GENE"]]}], ["There is evidence that arginine-specific mono-ADP-ribosylation may affect the proliferation of smooth muscle cells via the Rho-dependent signaling pathway.", {"entities": []}], ["Previous studies have demonstrated that ART1 may have a role in the proliferation, invasion and apoptosis of colon carcinoma in vitro .", {"entities": [[115, 124, "DISEASE"], [109, 124, "DISEASE"], [40, 44, "GENE"]]}], ["However, the effect of ART1 on the proliferation and invasion of colon carcinoma in vivo has yet to be elucidated.", {"entities": [[71, 80, "DISEASE"], [65, 80, "DISEASE"], [23, 27, "GENE"]]}], ["In the present study, mouse colon carcinoma CT26 cells were infected with a lentivirus to produce ART1 gene silencing or overexpression, and were then subcutaneously transplanted.", {"entities": [[34, 43, "DISEASE"], [28, 43, "DISEASE"], [98, 102, "GENE"]]}], ["To observe the effect of ART1 on tumor growth or liver metastasis in vivo , a spleen transplant tumor model of CT26 cells in BALB/c mice was successfully constructed.", {"entities": [[25, 29, "GENE"]]}], ["Expression levels of focal adhesion kinase (FAK), Ras homolog gene family member A (RhoA) and the downstream factors, c-myc, c-fos and cyclooxygenase-2 (COX-2) proteins, were measured in vivo .", {"entities": [[84, 88, "GENE"]]}], ["The results demonstrated that ART1 gene silencing inhibited the growth of the spleen transplanted tumor and its ability to spread to the liver via metastasis.", {"entities": [[30, 34, "GENE"]]}], ["There was also an accompanying increase in expression of FAK, RhoA, c-myc, c-fos and COX-2, whereas CT26 cells with ART1 overexpression demonstrated the opposite effect.", {"entities": [[62, 66, "GENE"], [116, 120, "GENE"]]}], ["These results suggest a potential role for ART1 in the proliferation and invasion of CT26 cells and a possible mechanism in vivo .", {"entities": [[43, 47, "GENE"]]}], ["Injections into or adjacent to soft tissue structures, including muscle, tendon, bursa, and fascia, for pain relief and an earlier return to play have become common in the field of sports medicine.", {"entities": []}], ["Clinical review.", {"entities": []}], ["Corticosteroids, local anesthetics, and ketorolac tromethamine (Toradol) are the most commonly used injectable agents in athletes.", {"entities": []}], ["The use of these injectable agents have proven efficacy in some disorders, whereas the clinical benefit for others remain questionable.", {"entities": []}], ["All soft tissue injections performed for pain control and/or an anti-inflammatory effect have potentially serious side effects, which must be considered, especially in the pregame setting.", {"entities": []}], ["The primary concern regarding corticosteroid and local anesthetic injections is an increased risk of tendon rupture associated with the direct injection into the tendon.", {"entities": []}], ["Intramuscular Toradol injections provide significant analgesia, as well as an anti-inflammatory effect via its inhibitory effect on the cyclooxygenase pathway.", {"entities": []}], ["The risk of bleeding associated with Toradol use is recognized but not accurately quantified.", {"entities": []}], ["Background: Laboratory and human studies raise concerns about endocrine disruption and asthma resulting from exposure to chemicals in consumer products.", {"entities": [[87, 93, "DISEASE"]]}], ["Limited labeling or testing information is available to evaluate products as exposure sources.", {"entities": []}], ["Objectives: We analytically quantified endocrine disruptors and asthma-related chemicals in a range of cosmetics, personal care products, cleaners, sunscreens, and vinyl products.", {"entities": [[64, 70, "DISEASE"]]}], ["We also evaluated whether product labels provide information that can be used to select products without these chemicals.", {"entities": []}], ["Methods: We selected 213 commercial products representing 50 product types.", {"entities": []}], ["We tested 42 composited samples of high-market-share products, and we tested 43 alternative products identified using criteria expected to minimize target compounds.", {"entities": []}], ["Analytes included parabens, phthalates, bisphenol A (BPA), triclosan, ethanolamines, alkylphenols, fragrances, glycol ethers, cyclosiloxanes, and ultraviolet (UV) filters.", {"entities": []}], ["Results: We detected 55 compounds, indicating a wide range of exposures from common products.", {"entities": []}], ["Vinyl products contained > 10% bis(2-ethylhexyl) phthalate (DEHP) and could be an important source of DEHP in homes.", {"entities": []}], ["In other products, the highest concentrations and numbers of detects were in the fragranced products (e.g., perfume, air fresheners, and dryer sheets) and in sunscreens.", {"entities": []}], ["Some products that did not contain the well-known endocrine-disrupting phthalates contained other less-studied phthalates (dicyclohexyl phthalate, diisononyl phthalate, and di- n -propyl phthalate; also endocrine-disrupting compounds), suggesting a substitution.", {"entities": []}], ["Many detected chemicals were not listed on product labels.", {"entities": []}], ["Conclusions: Common products contain complex mixtures of EDCs and asthma-related compounds.", {"entities": [[66, 72, "DISEASE"]]}], ["Toxicological studies of these mixtures are needed to understand their biological activity.", {"entities": []}], ["Regarding epidemiology, our findings raise concern about potential confounding from co-occurring chemicals and misclassification due to variability in product composition.", {"entities": []}], ["Consumers should be able to avoid some target chemicals\u2014synthetic fragrances, BPA, and regulated active ingredients\u2014using purchasing criteria.", {"entities": []}], ["More complete product labeling would enable consumers to avoid the rest of the target chemicals.", {"entities": []}], ["Here we present two cases of human infection with cowpox virus with distinct clinical courses.", {"entities": [[50, 56, "DISEASE"]]}], ["A series of clinical photographs documents lesion progression over time.", {"entities": []}], ["In the first case\u2014an unvaccinated young veterinary assistant\u2014a pustule was treated locally with cortisone.", {"entities": []}], ["The lesion turned into a large ulcer accompanied by severe lymphadenitis.", {"entities": [[59, 72, "DISEASE"]]}], ["Based on her close contact to a sick stray cat, infection with cowpox virus was assumed and confirmed by virus isolation, PCR, and serology.", {"entities": [[63, 69, "DISEASE"]]}], ["The clinical course took up to eleven months until healing of the wound was complete.", {"entities": []}], ["Transmission of cowpox virus from the cat was likely because a skin swab was PCR-positive and the cat had a high titer of anti-orthopoxvirus antibodies.", {"entities": [[16, 22, "DISEASE"]]}], ["In contrast, a rather mild clinical course of cowpox was confirmed in a 49-year-old male farmer vaccinated against smallpox.", {"entities": [[115, 123, "DISEASE"], [46, 52, "DISEASE"]]}], ["Only a small eschar developed, and wound closure was complete after 6 weeks.", {"entities": []}], ["The human leukocyte antigen (HLA) region, the 3.8-Mb segment of the human genome at 6p21, has been associated with more than 100 different diseases, mostly autoimmune diseases.", {"entities": [[29, 32, "GENE"]]}], ["Due to the complex nature of HLA genes, there are difficulties in elucidating complete HLA gene sequences especially HLA gene haplotype structures by the conventional sequencing method.", {"entities": [[29, 32, "GENE"], [87, 90, "GENE"], [117, 120, "GENE"], [29, 32, "GENE"], [87, 90, "GENE"], [117, 120, "GENE"], [29, 32, "GENE"], [87, 90, "GENE"], [117, 120, "GENE"]]}], ["We propose a novel, accurate, and cost-effective method for generating phase-defined complete sequencing of HLA genes by using indexed multiplex next generation sequencing.", {"entities": [[108, 111, "GENE"]]}], ["A total of 33 HLA homozygous samples, 11 HLA heterozygous samples, and 3 parents-child families were subjected to phase-defined HLA gene sequencing.", {"entities": [[14, 17, "GENE"], [41, 44, "GENE"], [128, 131, "GENE"], [14, 17, "GENE"], [41, 44, "GENE"], [128, 131, "GENE"], [14, 17, "GENE"], [41, 44, "GENE"], [128, 131, "GENE"]]}], ["We applied long-range PCR to amplify six HLA genes ( HLA-A, -C, -B, DRB1, -DQB1 , and \u2013DPB1 ) followed by transposase-based library construction and multiplex sequencing with the MiSeq sequencer.", {"entities": [[41, 44, "GENE"], [53, 56, "GENE"], [53, 58, "GENE"], [68, 72, "GENE"]]}], ["Paired-end reads (2\u2009\u00d7\u2009250 bp) derived from the sequencer were aligned to the six HLA gene segments of UCSC hg19 allowing at most 80 bases mismatch.", {"entities": [[81, 84, "GENE"]]}], ["For HLA homozygous samples, the six amplicons of an individual were pooled and simultaneously sequenced and mapped as an individual-tagging method.", {"entities": [[4, 7, "GENE"]]}], ["The paired-end reads were aligned to corresponding genes of UCSC hg19 and unambiguous, continuous sequences were obtained.", {"entities": []}], ["For HLA heterozygous samples, each amplicon was separately sequenced and mapped as a gene-tagging method.", {"entities": [[4, 7, "GENE"]]}], ["After alignments, we detected informative paired-end reads harboring SNVs on both forward and reverse reads that are used to separate two chromosomes and to generate two phase-defined sequences in an individual.", {"entities": []}], ["Consequently, we were able to determine the phase-defined HLA gene sequences from promoter to 3\u2032-UTR and assign up to 8-digit HLA allele numbers, regardless of whether the alleles are rare or novel.", {"entities": [[58, 61, "GENE"], [126, 129, "GENE"], [58, 61, "GENE"], [126, 129, "GENE"]]}], ["Parent\u2013child trio-based sequencing validated our sequencing and phasing methods.", {"entities": []}], ["Our protocol generated phased-defined sequences of the entire HLA genes, resulting in high resolution HLA typing and new allele detection.", {"entities": [[62, 65, "GENE"], [102, 105, "GENE"], [62, 65, "GENE"], [102, 105, "GENE"]]}], ["Optimization of skin prick test (SPT) panels, especially in view of significant differences in sensitizations patterns within different geographical areas, is an unmet need within China.", {"entities": []}], ["Our aim was to assess the patterns and clinical relevance of aeroallergen sensitizations in allergic rhinitis (AR) and define the minimal battery of SPT allergens, classified according to the K\u00f6ppen-Geiger climate map.", {"entities": [[92, 109, "DISEASE"], [101, 109, "DISEASE"]]}], ["Overall, 7148 subjects with self-reported AR completed a standard questionnaire and were assessed for sensitization to relevant allergens by SPT.", {"entities": []}], ["6340 (88.7%) patients had at least one positive skin prick reaction, and demonstrated unique sensitization patterns by stratification with age, gender, and geographic region.", {"entities": []}], ["Sensitization to house dust mites (HDM) was highest in south China, whereas the three most prevalent aeroallergens were mugwort, ragweed and dandelion pollen in north-west China.", {"entities": []}], ["Higher sensitization rates and multiple sensitizations were associated with AR comorbidities.", {"entities": []}], ["Eight allergens ( Der f , mugwort, Blatella , hazel, goosefoot, Penicillium notatum , animal dander and Der p ) allowed identification >96% of sensitized subjects in central China.", {"entities": []}], ["Differences in optimal panels were observed between regions, with five to six allergens being sufficient for north-east, north-west and south China.", {"entities": []}], ["These SPT panels may provide a cost-effective tool for screening sensitized patients in China.", {"entities": []}], ["Diagnosis and treatment of patients in the clinical setting is often driven by known symptomatic factors that distinguish one particular condition from another.", {"entities": []}], ["Treatment based on noticeable symptoms, however, is limited to the types of clinical biomarkers collected, and is prone to overlooking dysfunctions in physiological factors not easily evident to medical practitioners.", {"entities": []}], ["We used a vector-based representation of patient clinical biomarkers, or clinarrays, to search for latent physiological factors that underlie human diseases directly from clinical laboratory data.", {"entities": []}], ["Knowledge of these factors could be used to improve assessment of disease severity and help to refine strategies for diagnosis and monitoring disease progression.", {"entities": []}], ["Applying Independent Component Analysis on clinarrays built from patient laboratory measurements revealed both known and novel concomitant physiological factors for asthma, types 1 and 2 diabetes, cystic fibrosis, and Duchenne muscular dystrophy.", {"entities": [[227, 245, "DISEASE"], [197, 212, "DISEASE"], [165, 171, "DISEASE"]]}], ["Serum sodium was found to be the most significant factor for both type 1 and type 2 diabetes, and was also significant in asthma.", {"entities": [[122, 128, "DISEASE"]]}], ["TSH3, a measure of thyroid function, and blood urea nitrogen, indicative of kidney function, were factors unique to type 1 diabetes respective to type 2 diabetes.", {"entities": []}], ["Platelet count was significant across all the diseases analyzed.", {"entities": []}], ["The results demonstrate that large-scale analyses of clinical biomarkers using unsupervised methods can offer novel insights into the pathophysiological basis of human disease, and suggest novel clinical utility of established laboratory measurements.", {"entities": []}], ["Radiant skin and hair are universally recognized as indications of good health.", {"entities": []}], ["However, this \u2018glow of health\u2019 display remains poorly understood.", {"entities": []}], ["We found that feeding of probiotic bacteria to aged mice induced integumentary changes mimicking peak health and reproductive fitness characteristic of much younger animals.", {"entities": []}], ["Eating probiotic yogurt triggered epithelial follicular anagen-phase shift with sebocytogenesis resulting in thick lustrous fur due to a bacteria-triggered interleukin-10-dependent mechanism.", {"entities": []}], ["Aged male animals eating probiotics exhibited increased subcuticular folliculogenesis, when compared with matched controls, yielding luxuriant fur only in probiotic-fed subjects.", {"entities": []}], ["Female animals displayed probiotic-induced hyperacidity coinciding with shinier hair, a feature that also aligns with fertility in human females.", {"entities": []}], ["Together these data provide insights into mammalian evolution and novel strategies for integumentary health.", {"entities": []}], ["Several chronic respiratory diseases exhibit hyperactive immune responses in the lung: abundant inflammatory mediators; infiltrating neutrophils, macrophages, lymphocytes and other immune cells; and increased level of proteases.", {"entities": []}], ["Such diseases include cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD) and severe/neutrophilic asthma.", {"entities": [[44, 81, "DISEASE"], [22, 37, "DISEASE"], [113, 119, "DISEASE"]]}], ["Paradoxically, patients with these diseases are also susceptible to detrimental bacterial infection and colonization.", {"entities": []}], ["In this paper, we seek to explain how a positive feedback mechanism via IL-8 could lead to desensitization of epithelial cells to pathogen recognition thus perpetuating bacterial colonization and chronic disease states in the lung.", {"entities": []}], ["Such insight was obtained from mathematical modeling of the IRAK/TRAF6 signaling module, and is consistent with existing clinical evidence.", {"entities": []}], ["The potential implications for targeted treatment regimes for these persistent respiratory diseases are explored.", {"entities": []}], ["The Agricultural Health Study (AHS) is a prospective cohort study of licensed pesticide applicators from Iowa and North Carolina enrolled 1993\u20131997 and followed for incident cancer through 2002.", {"entities": [[174, 180, "DISEASE"]]}], ["A previous investigation in this cohort linked exposure to the organophosphate fonofos with incident prostate cancer in subjects with family history of prostate cancer.", {"entities": [[110, 116, "DISEASE"], [161, 167, "DISEASE"], [101, 116, "DISEASE"], [152, 167, "DISEASE"]]}], ["This finding along with findings of associations between organophosphate pesticides and cancer more broadly led to this study of fonofos and risk of any cancers among 45,372 pesticide applicators enrolled in the AHS.", {"entities": [[88, 94, "DISEASE"]]}], ["Pesticide exposure and other data were collected using self-administered questionnaires.", {"entities": []}], ["Poisson regression was used to calculate rate ratios (RRs) and 95% confidence intervals (CIs) while controlling for potential confounders.", {"entities": []}], ["Relative to the unexposed, leukemia risk was elevated in the highest category of lifetime (RR = 2.24; 95% CI, 0.94\u20135.34, p trend = 0.07) and intensity-weighted exposure-days (RR = 2.67; 95% CI, 1.06\u20136.70, p trend = 0.04), a measure that takes into account factors that modify pesticide exposure.", {"entities": [[27, 35, "DISEASE"]]}], ["Although prostate cancer risk was unrelated to fonofos use overall, among applicators with a family history of prostate cancer, we observed a significant dose\u2013response trend for lifetime exposure-days ( p trend = 0.02, RR highest tertile vs. unexposed = 1.77, 95% CI, 1.03\u20133.05; RR interaction = 1.28, 95% CI, 1.07\u20131.54).", {"entities": [[18, 24, "DISEASE"], [120, 126, "DISEASE"], [9, 24, "DISEASE"], [111, 126, "DISEASE"]]}], ["Intensity-weighted results were similar.", {"entities": []}], ["No associations were observed with other examined cancer sites.", {"entities": [[50, 56, "DISEASE"]]}], ["Further study is warranted to confirm findings with respect to leukemia and determine whether genetic susceptibility modifies prostate cancer risk from pesticide exposure.", {"entities": [[63, 71, "DISEASE"], [135, 141, "DISEASE"], [126, 141, "DISEASE"]]}], ["Breastfeeding effects on cognition are attributed to long-chain polyunsaturated fatty acids (LC-PUFAs), but controversy persists.", {"entities": []}], ["Genetic variation in fatty acid desaturase (FADS) and elongase (ELOVL) enzymes has been overlooked when studying the effects of LC-PUFAs supply on cognition.", {"entities": []}], ["We aimed to: 1) to determine whether maternal genetic variants in the FADS cluster and ELOVL genes contribute to differences in LC-PUFA levels in colostrum; 2) to analyze whether these maternal variants are related to child cognition; and 3) to assess whether children's variants modify breastfeeding effects on cognition.", {"entities": []}], ["Data come from two population-based birth cohorts (n\u200a=\u200a400 mother-child pairs from INMA-Sabadell; and n\u200a=\u200a340 children from INMA-Menorca).", {"entities": []}], ["LC-PUFAs were measured in 270 colostrum samples from INMA-Sabadell.", {"entities": []}], ["Tag SNPs were genotyped both in mothers and children (13 in the FADS cluster, 6 in ELOVL2 , and 7 in ELOVL5 ).", {"entities": [[83, 89, "GENE"], [101, 107, "GENE"]]}], ["Child cognition was assessed at 14 mo and 4 y using the Bayley Scales of Infant Development and the McCarthy Scales of Children's Abilities, respectively.", {"entities": []}], ["Children of mothers carrying genetic variants associated with lower FADS1 activity (regulating AA and EPA synthesis), higher FADS2 activity (regulating DHA synthesis), and with higher EPA/AA and DHA/AA ratios in colostrum showed a significant advantage in cognition at 14 mo (3.5 to 5.3 points).", {"entities": [[68, 73, "GENE"], [125, 130, "GENE"]]}], ["Not being breastfed conferred an 8- to 9-point disadvantage in cognition among children GG homozygote for rs174468 (low FADS1 activity) but not among those with the A allele.", {"entities": [[120, 125, "GENE"]]}], ["Moreover, not being breastfed resulted in a disadvantage in cognition (5 to 8 points) among children CC homozygote for rs2397142 (low ELOVL5 activity), but not among those carrying the G allele.", {"entities": [[134, 140, "GENE"]]}], ["Genetically determined maternal supplies of LC-PUFAs during pregnancy and lactation appear to be crucial for child cognition.", {"entities": []}], ["Breastfeeding effects on cognition are modified by child genetic variation in fatty acid desaturase and elongase enzymes.", {"entities": []}], ["We demonstrate a novel dual strategy against inflammation and pain through body-wide desensitization of nociceptors via TRPA1.", {"entities": [[120, 125, "GENE"]]}], ["Attenuation of experimental colitis by capsazepine (CPZ) has long been attributed to its antagonistic action on TRPV1 and associated inhibition of neurogenic inflammation.", {"entities": [[52, 55, "GENE"], [112, 117, "GENE"]]}], ["In contrast, we found that CPZ exerts its anti-inflammatory effects via profound desensitization of TRPA1.", {"entities": [[27, 30, "GENE"], [100, 105, "GENE"]]}], ["Micromolar CPZ induced calcium influx in isolated dorsal root ganglion (DRG) neurons from wild-type (WT) but not TRPA1-deficient mice.", {"entities": [[11, 14, "GENE"]]}], ["CPZ-induced calcium transients in human TRPA1-expressing HEK293t cells were blocked by the selective TRPA1 antagonists HC 030031 and A967079 and involved three cysteine residues in the N-terminal domain.", {"entities": [[40, 45, "GENE"], [101, 106, "GENE"]]}], ["Intriguingly, both colonic enemas and drinking water with CPZ led to profound systemic hypoalgesia in WT and TRPV1", {"entities": [[58, 61, "GENE"], [109, 114, "GENE"]]}], ["Please cite this paper as: Damak et\u00a0al.", {"entities": []}], ["(2011) Clinical features, complications and mortality in critically ill patients with 2009 influenza A(H1N1) in Sfax,Tunisia.", {"entities": [[91, 100, "DISEASE"]]}], ["Influenza and Other Respiratory Viruses 5(4), 230\u2013240 Purpose\u2002 Africa, as the rest of the world, was touched by the 2009 pandemic influenza A(H1N1).", {"entities": [[0, 9, "DISEASE"], [130, 139, "DISEASE"]]}], ["In the literature, a few publications covering this subject emerged from this continent.", {"entities": []}], ["We prospectively describe baseline characteristics, treatment and outcomes of consecutive critically ill patients with confirmed 2009 influenza A(H1N1) in the intensive care unit (ICU) of Sfax hospital.", {"entities": [[134, 143, "DISEASE"]]}], ["Methods\u2002 From 29 November 2009 through 21 January 2010, 32 patients with confirmed 2009 influenza A(H1N1) were admitted to our ICU.", {"entities": [[88, 97, "DISEASE"]]}], ["We prospectively analysed data and outcomes of these patients and compared survivors and dead patients to identify any predictors of death.", {"entities": []}], ["Results\u2002 Patients were young (mean, 36\u00b71 [SD], 20\u00b77\u2003years) and 21 (65\u00b76%) of whom had co\u2010morbidities.", {"entities": []}], ["During ICU care, 29 (90\u00b76%) patients had respiratory failure; among these, 15 (46\u00b79%) patients required invasive ventilation with a median duration of 9 (IQR 3\u201312) days.", {"entities": [[41, 60, "DISEASE"]]}], ["In our experience, respiratory dysfunction can remain isolated but may also be associated with other dysfunctions or complications, such as, septic shock, seizures, myasthenia gravis exacerbation, Guillan\u2013Barre syndrome, acute renal failure, nosocomial infections and biological disturbances.", {"entities": [[165, 182, "DISEASE"], [211, 219, "DISEASE"]]}], ["The nine patients (28\u00b71%) who died had greater initial severity of illness (SAPS II and sequential organ failure assessment (SOFA) scores) but also a higher SOFA score and increasing severity of organ dysfunction during their ICU evolution.", {"entities": []}], ["Conclusion\u2002 Critical illness from the 2009 influenza A(H1N1) in Sfax occurred in young individuals and was associated with severe acute respiratory and additional organ system failure.", {"entities": [[43, 52, "DISEASE"]]}], ["SAPS II and SOFA scores at ICU admission, and also during evolution, constitute a good predictor of death.", {"entities": []}], ["This work reviews the neuropharmacology of the vestibular system, with an emphasis on the mechanism of action of drugs used in the treatment of vestibular disorders.", {"entities": []}], ["Otolaryngologists are confronted with a rapidly changing field in which advances in the knowledge of ionic channel function and synaptic transmission mechanisms have led to the development of new scientific models for the understanding of vestibular dysfunction and its management.", {"entities": []}], ["In particular, there have been recent advances in our knowledge of the fundamental mechanisms of vestibular system function and drug mechanisms of action.", {"entities": []}], ["In this work, drugs acting on vestibular system have been grouped into two main categories according to their primary mechanisms of action: those with effects on neurotransmitters and neuromodulator receptors and those that act on voltage-gated ion channels.", {"entities": []}], ["Particular attention is given in this review to drugs that may provide additional insight into the pathophysiology of vestibular diseases.", {"entities": []}], ["A critical review of the pharmacology and highlights of the major advances are discussed in each case.", {"entities": []}], ["Cow's milk allergy in children is often of short duration, which makes this disorder an interesting clinical model for studies of tolerance to dietary antigens.", {"entities": []}], ["Here, we studied T cell responses in 21 initially allergic children who, after a milk-free period of >2 mo, had cow's milk reintroduced to their diet.", {"entities": []}], ["Children who outgrew their allergy (tolerant children) had higher frequencies of circulating CD4", {"entities": [[93, 96, "GENE"]]}], ["By modifying dendritic cell cytokine production, Dectin-1 suppresses Th1 differentiation in mice infected with the fungal pathogen Aspergillus fumigatus .", {"entities": []}], ["Pulmonary infection of mice with Aspergillus fumigatus induces concurrent T helper type 1 (Th1) and Th17 responses that depend on Toll-like receptor/MyD88 and Dectin-1, respectively.", {"entities": []}], ["However, the mechanisms balancing Th1 and Th17 CD4 T cell populations during infection remain incompletely defined.", {"entities": [[47, 50, "GENE"]]}], ["In this study, we show that Dectin-1 deficiency disproportionally increases Th1 responses and decreases Th17 differentiation after A. fumigatus infection.", {"entities": []}], ["Dectin-1 signaling in A. fumigatus \u2013infected wild-type mice reduces IFN-\u03b3 and IL-12p40 expression in the lung, thereby decreasing T-bet expression in responding CD4 T cells and enhancing Th17 responses.", {"entities": [[161, 164, "GENE"]]}], ["Absence of IFN-\u03b3 or IL-12p35 in infected mice or T-bet in responding CD4 T cells enhances Th17 differentiation, independent of Dectin-1 expression, in A. fumigatus \u2013infected mice.", {"entities": [[69, 72, "GENE"]]}], ["Transient deletion of monocyte-derived dendritic cells also reduces Th1 and boosts Th17 differentiation of A. fumigatus \u2013specific CD4 T cells.", {"entities": [[130, 133, "GENE"]]}], ["Our findings indicate that Dectin-1\u2013mediated signals alter CD4 T cell responses to fungal infection by decreasing the production of IL-12 and IFN-\u03b3 in innate cells, thereby decreasing T-bet expression in A. fumigatus \u2013specific CD4 T cells and enabling Th17 differentiation.", {"entities": [[59, 62, "GENE"], [227, 230, "GENE"], [59, 62, "GENE"], [227, 230, "GENE"]]}], ["The overall burden of disease (BOD) especially for infectious diseases is higher in Sub-Saharan Africa than other regions of the world.", {"entities": []}], ["Existing data collected through the Health Management Information System (HMIS) may not be optimal to measure BOD.", {"entities": []}], ["The Infectious Diseases Capacity Building Evaluation (IDCAP) cooperated with the Ugandan Ministry of Health to improve the quality of HMIS data.", {"entities": []}], ["We describe diagnoses with associated clinical assessments and laboratory investigations of outpatients attending primary care in Uganda.", {"entities": []}], ["IDCAP supported HMIS data collection at 36 health center IVs in Uganda for five months (November 2009 to March 2010) prior to implementation of the IDCAP interventions.", {"entities": []}], ["Descriptive analyses were performed on a cross-sectional dataset of 209,734 outpatient visits during this period.", {"entities": []}], ["Over 500 illnesses were diagnosed.", {"entities": []}], ["Infectious diseases accounted for 76.3% of these and over 30% of visits resulted in multiple diagnoses.", {"entities": []}], ["Malaria (48.3%), cough/cold (19.4%), and intestinal worms (6.6%) were the most frequently diagnosed illnesses.", {"entities": []}], ["Body weight was recorded for 36.8% of patients and less than 10% had other clinical assessments recorded.", {"entities": []}], ["Malaria smears (64.2%) and HIV tests (12.2%) accounted for the majority of 84,638 laboratory tests ordered.", {"entities": []}], ["Fewer than 30% of patients for whom a laboratory investigation was available to confirm the clinical impression had the specific test performed.", {"entities": []}], ["We observed a broad range of diagnoses, a high percentage of multiple diagnoses including true co-morbidities, and underutilization of laboratory support.", {"entities": []}], ["This emphasizes the complexity of illnesses to be addressed by primary healthcare workers.", {"entities": []}], ["An improved HMIS collecting timely, quality data is needed.", {"entities": []}], ["This would adequately describe the burden of disease and processes of care at primary care level, enable appropriate national guidelines, programs and policies and improve accountability for the quality of care.", {"entities": []}], ["The online version of this article (doi:10.1186/1471-2296-15-165) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Trichomonas vaginalis is a flagellated parasite affecting about 276 million people annually worldwide.", {"entities": []}], ["Tricomoniasis is associated with different complications in pregnant women and infants.", {"entities": []}], ["5\u2019-nitroimidazole derivatives (metronidazole, ornidazole, and tinidazole) are FDA approved drugs recommended for trichomoniasis treatment.", {"entities": [[113, 127, "DISEASE"]]}], ["Treatment with metronidazole 5\u2019-nitroimidazole derivatives is associated with many side effects, and drug resistance to metronidazole has been reported in some cases.", {"entities": []}], ["Recently, many attempts have been made to evaluate the effects of plants on causative agents of vaginal infections.", {"entities": []}], ["In our research, the national and international databases were searched and the effects of various herbal extracts on T. vaginalis in Iran were reviewed from 2006 to 2016.", {"entities": []}], ["In articles investigated, some plants had favorable antitrichomonal effects and needed to be further investigated.", {"entities": []}], ["All the plant extracts have only been evaluated in vitro .", {"entities": []}], ["Surveys of different articles in this review show that the active ingredients present in different parts of plants, including aerial parts, leaves, flowers, stems, and root can be suitable sources for introducing and developing new antitrichomonal compounds", {"entities": []}], ["Please cite this paper as: Peltola et\u00a0al.", {"entities": []}], ["(2011) Pandemic influenza A (H1N1) virus in households with young children.", {"entities": [[16, 25, "DISEASE"]]}], ["Influenza and Other Respiratory Viruses 6(3), e21\u2013e24.", {"entities": [[0, 9, "DISEASE"]]}], ["Background\u2002 Influenza viruses may cause a severe infection in infants and young children.", {"entities": [[12, 21, "DISEASE"]]}], ["The transmission patterns of pandemic 2009 influenza A (H1N1) within households with young children are poorly characterized.", {"entities": [[43, 52, "DISEASE"]]}], ["Methods\u2002 Household members of six children younger than 1\u00b75\u2003years with documented 2009 influenza A (H1N1) infection were studied by daily symptom diaries and serial parent\u2010collected nasal swab samples for detection of influenza A by reverse transcription polymerase chain reaction (RT\u2010PCR) assay.", {"entities": [[87, 96, "DISEASE"], [218, 227, "DISEASE"]]}], ["Results\u2002 Laboratory\u2010confirmed, symptomatic influenza was documented in 11 of 15 household contacts of young children with pandemic influenza (73%; 95% CI, 48\u201399).", {"entities": [[43, 52, "DISEASE"], [131, 140, "DISEASE"]]}], ["In five contact cases symptoms started earlier, in three cases on the same day, and in three cases after the onset of symptoms in the youngest child.", {"entities": []}], ["The first case with influenza A (H1N1) within the household was an elder sibling in two households, father in two households, the youngest child in one household, and the youngest child at the same time with a sibling in one household.", {"entities": [[20, 29, "DISEASE"]]}], ["The median copy number of influenza virus was higher in children than in adults (4\u00b72\u2003\u00d7\u200310 P\u2003 = \u2003 0\u00b702).", {"entities": [[26, 35, "DISEASE"]]}], ["Conclusions\u2002 This study demonstrates the feasibility of nasal swab sampling by parents in investigation of household transmission of influenza.", {"entities": [[133, 142, "DISEASE"]]}], ["The results support influenza vaccination of all household contacts of young children.", {"entities": [[20, 29, "DISEASE"]]}], ["Background: Conflicting interests, power imbalance and relationships characterized by distrust are just a few of the many challenges community\u2013academic research partnerships face.", {"entities": []}], ["In addition, the time it takes to build relationships is often overlooked, which further complicates matters and can leave well-intentioned individuals re-creating oppressive conditions through inauthentic partnerships.", {"entities": []}], ["This paper presents a novel approach of using meeting minutes to explore partnership dynamics.", {"entities": []}], ["The Community Assessment of Freeway Exposure and Health (CAFEH) partnership is used as an illustrative case study to identify how community academic partnerships overcome the challenges associated with community-based participatory research (CBPR).", {"entities": []}], ["CAFEH is a study of ultrafine particle exposure (UFP) near highways in the Boston, MA area.", {"entities": []}], ["Methods: Qualitative analysis was applied to meeting minutes and process evaluation reports from the first three years of the CAFEH study ( n = 73 files).", {"entities": []}], ["In addition, a group meeting was held with project partners in order to contextualize the findings from the document analysis.", {"entities": []}], ["Results: The three most commonly referenced challenges included language barriers, the overall project structure and budgetary constraints.", {"entities": []}], ["Meanwhile, a heavy emphasis on process and an approach steeped in participatory democracy facilitated CAFEH\u2019s ability to overcome these challenges, as well as sustain and augment strong partnership ties.", {"entities": []}], ["Conclusions: This experience suggests that leadership that incorporates an organizing approach and a transformational style facilitates CBPR processes and helps teams surmount challenges.", {"entities": []}], ["Malignant mesothelioma is a largely incurable disease that is refractory to current therapies.", {"entities": [[0, 22, "DISEASE"]]}], ["CD26 is a multifunctional cell surface protein involved in autoimmune disease, diabetes, and cancer.", {"entities": [[93, 99, "DISEASE"]]}], ["It has a role in T cell function, extracellu-lar protein modification, as a prognostic factor for cancer, and as a therapeutic target for malignant mesothelioma.", {"entities": [[98, 104, "DISEASE"], [138, 160, "DISEASE"]]}], ["New treatment strategies are urgently needed for malig-nant pleural mesothelioma (MPM), and CD26-targeted therapy represents a novel ap-proach.", {"entities": []}], ["In this review, the most current and up-to-date literature available was reviewed and the current state of malignant mesothelioma treatment is described.", {"entities": [[107, 129, "DISEASE"]]}], ["Throughout the review the need for new therapeutic approaches is highlighted in the shortcomings of current therapy.", {"entities": []}], ["CD26 is a target that is fit to take on these shortcom-ings.", {"entities": []}], ["In this review we discuss the structure and function of CD26, its role in malignant mesothelioma and the future of anti-CD26 therapy as a versatile immunotherapeutic option.", {"entities": [[74, 96, "DISEASE"]]}], ["This review highlights the areas of most promise in treating MPM, these in-clude immune checkpoint blockade, passive immunization, and based on our recently published data, targeting of CD26 with its specific mAb.", {"entities": []}], ["Finally we describe how the an-ti-CD26 mAb YS110 was recently evaluated in the first-in-human phase I clinical trial, showing prolonged disease stabilization and a favorable side effect profile.", {"entities": []}], ["Through better understanding of CD26, new pathways to treating and potentially curing malig-nant mesothelioma may be discovered.", {"entities": []}], ["The hyper-IgE syndromes (HIES; originally named Job's syndrome) are a collection of primary immunodeficiency syndromes resulting in elevated serum IgE levels and typified by recurrent staphylococcal skin abscesses, eczema and pulmonary infections.", {"entities": [[54, 62, "DISEASE"]]}], ["The disorder has autosomal dominant and recessive forms.", {"entities": []}], ["Autosomal dominant HIES has been shown to be mainly due to STAT3 mutations and additionally results in connective tissue, skeletal, vascular and dental abnormalities.", {"entities": [[59, 64, "GENE"]]}], ["Autosomal recessive HIES has been shown to be mainly due to mutations in DOCK8 ; these patients are more prone to viral skin infections instead.", {"entities": [[73, 78, "GENE"]]}], ["This review article discusses the common clinical features of the syndrome, the genetic mutations responsible and the pathogenesis of the disease, as well as treatments currently used.", {"entities": [[66, 74, "DISEASE"]]}], ["In chronic obstructive pulmonary disease (COPD) the inflammation occurring in the airways and in other lung tissues is complex and is orchestrated by various mediators including the isoenzyme 4 of the phosphodiesterases family (PDE4), which contributes to bronchoconstriction and inflammation.", {"entities": [[3, 40, "DISEASE"]]}], ["Various PDE4 inhibitors have been evaluated as potential therapies in asthma or COPD but among these only roflumilast have been authorized in Europe to be used in patients with severe COPD as an add-on to the bronchodilator therapy.", {"entities": [[70, 76, "DISEASE"]]}], ["This review discusses the existing preclinical and clinical data supporting the use of roflumilast for this therapeutic indication and tackles some of the pending issues related to PDE4 in general and to roflumilast in particular.", {"entities": []}], ["Glucocorticoids (GCs) have been used as therapeutic agents for children with acute lymphoblastic leukaemia (ALL) for over 50 years.", {"entities": []}], ["However, much remains to be understood about the molecular mechanism of GCs actions in ALL subtypes.", {"entities": []}], ["In this study, we delineate differential responses of ALL subtypes, B- and T-ALL, to GCs treatment at systems level by identifying the differences among biological processes, molecular pathways, and interaction networks that emerge from the action of GCs through the use of a selected number of available bioinformatics methods and tools.", {"entities": []}], ["We provide biological insight into GC-regulated genes, their related functions, and their networks specific to the ALL subtypes.", {"entities": []}], ["We show that differentially expressed GC-regulated genes participate in distinct underlying biological processes affected by GCs in B-ALL and T-ALL with little to no overlap.", {"entities": []}], ["These findings provide the opportunity towards identifying new therapeutic targets.", {"entities": []}], ["Modulation of P-glycoprotein (P-gp, encoded by Mdr1) by xenobiotics plays central role in pharmacokinetics of various drugs.", {"entities": []}], ["Quercetin has a potential to modulate P-gp in rodents, however, its effects on P-gp modulation in chicken are still unclear.", {"entities": []}], ["Herein, study reports role of quercetin in modulation of P-gp expression and subsequent effects on the pharmacokinetics of enrofloxacin in broilers.", {"entities": []}], ["Results show that P-gp expression was increased in a dose-dependent manner following exposure to quercetin in Caco-2 cells and tissues of chicken.", {"entities": []}], ["Absorption rate constant and apparent permeability coefficient of rhodamine 123 were decreased, reflecting efflux function of P-gp in chicken intestine increased by quercetin.", {"entities": []}], ["Quercetin altered pharmacokinetic of enrofloxacin by decreasing area under curve, peak concentration, and time to reach peak concentration and by increasing clearance rate.", {"entities": []}], ["Molecular docking shows quercetin can form favorable interactions with binding pocket of chicken xenobiotic receptor (CXR).", {"entities": []}], ["Results provide convincing evidence that quercetin induced P-gp expression in tissues by possible interaction with CXR, and consequently reducing bioavailability of orally administered enrofloxacin through restricting its intestinal absorption and liver/kidney clearance in broilers.", {"entities": []}], ["The results can be further extended to guide reasonable use of quercetin to avoid drug-feed interaction occurred with co-administered enrofloxacin or other similar antimicrobials.", {"entities": []}], ["Aggressive non-melanoma skin cancer (deeply infiltrating, recurrent, and morphea form lesions) are therapeutically challenging because they require considerable tissue loss and may demand radical disfiguring surgery.", {"entities": [[24, 35, "DISEASE"], [15, 23, "DISEASE"], [29, 35, "DISEASE"]]}], ["Interferons (IFN) may provide a non-surgical approach to the management of these tumors.", {"entities": []}], ["The aim of this work was to evaluate the effect of a formulation containing IFNs-\u03b1 and -\u03b3 in synergistic proportions on patients with recurrent, advanced basal cell (BCC) or squamous cell skin carcinomas (SCSC).", {"entities": []}], ["Patients with extensive, recurrent, resistant to other procedures BCC or SCSC received the IFN formulation peri- and intralesionally, three times per week for 3 weeks.", {"entities": []}], ["They had been previously treated with surgery and/or radiotherapy or chemotherapy.", {"entities": []}], ["Thirteen weeks after the end of treatment, the original lesion sites were examined for histological evidence of remaining tumor.", {"entities": []}], ["Sixteen elder (median 70 years-old) patients were included.", {"entities": []}], ["They beared 12 BCC and 4 SCSC ranging from 1.5 to 12.5 cm in the longest dimension.", {"entities": []}], ["At the end of treatment 47% CR (complete tumor elimination), 40% PR (>30% tumor reduction), and 13% stable disease were obtained.", {"entities": []}], ["None of the patients relapsed during the treatment period.", {"entities": []}], ["The median duration of the response was 38 months.", {"entities": []}], ["Only one patient with complete response had relapsed until today.", {"entities": []}], ["Principal adverse reactions were influenza-like symptoms well known to occur with interferon therapy, which were well tolerated.", {"entities": [[33, 42, "DISEASE"]]}], ["The peri- and intralesional combination of IFNs-\u03b1 and -\u03b3 was safe and showed effect for the treatment of advanced, recurrent and resistant to previous treatments of BCC and SCSC in elder patients.", {"entities": []}], ["This is the first report of such treatment in patients with advance non-melanoma skin cancer.", {"entities": [[81, 92, "DISEASE"], [72, 80, "DISEASE"], [86, 92, "DISEASE"]]}], ["The encouraging result justifies further confirmatory trials.", {"entities": []}], ["Current Controlled Trials RPCEC00000052.", {"entities": []}], ["Handheld computers are increasingly favoured over paper and pencil methods to capture data in clinical research.", {"entities": []}], ["This study systematically identified and reviewed randomized controlled trials (RCTs) that compared the two methods for self-recording and reporting data, and where at least one of the following outcomes was assessed: data accuracy; timeliness of data capture; and adherence to protocols for data collection.", {"entities": []}], ["A comprehensive key word search of NLM Gateway's database yielded 9 studies fitting the criteria for inclusion.", {"entities": []}], ["Data extraction was performed and checked by two of the authors.", {"entities": []}], ["None of the studies included all outcomes.", {"entities": []}], ["The results overall, favor handheld computers over paper and pencil for data collection among study participants but the data are not uniform for the different outcomes.", {"entities": []}], ["Handheld computers appear superior in timeliness of receipt and data handling (four of four studies) and are preferred by most subjects (three of four studies).", {"entities": []}], ["On the other hand, only one of the trials adequately compared adherence to instructions for recording and submission of data (handheld computers were superior), and comparisons of accuracy were inconsistent between five studies.", {"entities": []}], ["Handhelds are an effective alternative to paper and pencil modes of data collection; they are faster and were preferred by most users.", {"entities": []}], ["Studies have shown that area-level deprivation measured by factors, such as non-home ownership, non-car ownership and household overcrowding, can increase the risk for mental disorders over and above individual-level circumstances, such as education and social class.", {"entities": []}], ["Whether area-level deprivation is associated with generalised anxiety disorder (GAD) independent of personal circumstances, and whether this association is different between British women and men is unknown.", {"entities": [[62, 78, "DISEASE"]]}], ["Large, population study.", {"entities": []}], ["UK population-based cohort.", {"entities": []}], ["30\u2005445 people from the general population aged 40\u2005years and older and living in England consented to participate at study baseline, and of these, 21\u2005921 participants completed a structured health and lifestyle questionnaire used to capture GAD.", {"entities": []}], ["Area deprivation was measured in 1991 using Census data, and GAD was assessed in 1996\u20132000.", {"entities": []}], ["10\u2005275 women and 8219 men had complete data on all covariates.", {"entities": []}], ["Past-year GAD defined according to the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV).", {"entities": []}], ["In this study, 2.5% (261/10\u2005275) of women and 1.8% (145/8219) of men had GAD.", {"entities": []}], ["Women living in the most deprived areas were over 60% more likely to develop anxiety than those living in areas that were not deprived (OR=1.63, 95% CI 1.21 to 2.21; p=0.001), but this association between deprivation and GAD was not apparent in men (OR=1.13, 95% CI 0.72 to 1.77; p=0.598).", {"entities": []}], ["The absolute numbers of people living in deprived conditions are large worldwide.", {"entities": []}], ["This, combined with a growing mental health burden, means that the findings obtained in this study remain highly relevant.", {"entities": []}], ["The WHO has emphasised the need to reduce social and health inequalities.", {"entities": []}], ["Our findings provide a strong evidence base to this call, showing that the environment needs to be taken into account when developing mental health policy; gender is important when it comes to assessing the influence of the environment on our mental health.", {"entities": []}], ["Changes in DNA methylation have been associated with traffic-related air pollution in observational studies, but the specific mechanisms and temporal dynamics therein have not been explored in a controlled study of asthmatics.", {"entities": []}], ["In this study, we investigate short-term effects of diesel exhaust inhalation on DNA methylation levels at CpG sites across the genome in circulating blood in asthmatics.", {"entities": []}], ["A double-blind crossover study of filtered air and diesel exhaust exposures was performed on sixteen non-smoking asthmatic subjects.", {"entities": []}], ["Blood samples were collected pre-exposure, and then 6 and 30\u00a0hours post-exposure.", {"entities": []}], ["Peripheral blood mononuclear cell DNA methylation was interrogated using the Illumina Infinium HumanMethylation450 Array.", {"entities": []}], ["Exposure-related changes in DNA methylation were identified.", {"entities": []}], ["In addition, CpG sites overlapping with Alu or LINE1 repetitive elements and candidate microRNA loci were also analyzed.", {"entities": []}], ["DNA methylation at 2827 CpG sites were affected by exposure to diesel exhaust but not filtered air; these sites enriched for genes involved in protein kinase and NFkB pathways.", {"entities": []}], ["CpG sites with significant changes in response to diesel exhaust exposure primarily became less methylated, with a site residing within GSTP1 being among the significant hits.", {"entities": [[136, 141, "GENE"]]}], ["Diesel exhaust-associated change was also found for CpG sites overlapping with Alu and LINE1 elements as well as for a site within miR-21 .", {"entities": [[131, 137, "GENE"]]}], ["Short-term exposure to diesel exhaust resulted in DNA methylation changes at CpG sites residing in genes involved in inflammation and oxidative stress response, repetitive elements, and microRNA.", {"entities": []}], ["This provides plausibility for the role of DNA methylation in pathways by which airborne particulate matter impacts gene expression and offers support for including DNA methylation analysis in future efforts to understand the interactions between environmental exposures and biological systems.", {"entities": []}], ["The online version of this article (doi:10.1186/s12989-014-0071-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["MicroRNAs (miRNAs) are small non-coding RNAs that play a mostly post-transcriptional regulatory role in gene expression.", {"entities": []}], ["Using RAW264.7 pre-osteoclast cells and genome-wide expression analysis, we identified a set of miRNAs that are involved in osteoclastogenesis.", {"entities": []}], ["Based on in silico analysis, we specifically focused on miR-222-3p and evaluated its role in osteoclastogenesis.", {"entities": []}], ["The results show that the inhibitor of miR-222-3p upregulated the mRNA levels of nuclear factor of activated T-cells, cytoplasmic 1 (NFATc1) and tartrate-resistant acid phosphatase (TRAP), while its mimicking agent downregulated their mRNA levels.", {"entities": [[133, 139, "GENE"]]}], ["Western blot analysis showed that its inhibitor increased the protein levels of TRAP and cathepsin K, while its mimicking agent decreased their levels.", {"entities": []}], ["Genome-wide mRNA expression analysis in the presence and absence of receptor activator of nuclear factor \u03ba-B ligand (RANKL) predicted c-Src as a potential regulatory target of miR-222-3p.", {"entities": []}], ["Live cell imaging using a fluorescence resonance energy transfer (FRET) technique revealed that miR-222-3p acted as an inhibitor of c-Src activity, and a partial silencing of c-Src suppressed RANKL-induced expression of TRAP and cathepsin K, as well as the number of multi-nucleated osteoclasts and their pit formation.", {"entities": []}], ["Collectively, the study herein demonstrates that miR-222-3p serves as an inhibitor of osteoclastogenesis and c-Src mediates its inhibition of cathepsin K and TRAP.", {"entities": []}], ["Allergic rhinitis and migraine remain on the list of the most common diseases affecting adults.", {"entities": [[0, 17, "DISEASE"], [22, 30, "DISEASE"], [9, 17, "DISEASE"]]}], ["Migraines and headaches due to allergic rhinitis are easily confused because the symptoms of both conditions often overlap.", {"entities": [[31, 48, "DISEASE"], [40, 48, "DISEASE"]]}], ["Both may occur with sinus headache, nasal congestion, and lacrimation and may worsen with weather changes and exposure to allergens.", {"entities": []}], ["No precise clinical definition exists for what constitutes a sinus headache, which has always been a diagnostic dilemma.", {"entities": []}], ["Contrary to popular belief, headache is not a typical symptom of rhinitis.", {"entities": [[65, 73, "DISEASE"]]}], ["Some studies have shown that up to 90\u00a0% of sinus headaches are actually migraines.", {"entities": []}], ["Nevertheless, patients with self-diagnosed sinus headache self-treat or are treated by primary care physicians and/or otolaryngologists with medications for rhinosinusitis, ignoring the neurogenic causes of the symptoms when most of these patients fulfill diagnostic criteria for chronic migraine.", {"entities": [[288, 296, "DISEASE"]]}], ["Chronic migraine affects 2\u00a0% of the general population and has a significant socioeconomic impact on society, incurring health care costs and diminishing quality of life; therefore, the proper diagnosis and treatment of these headache patients should be a priority.", {"entities": [[8, 16, "DISEASE"]]}], ["Nonvaccine serotypes occur more often among children with comorbid conditions.", {"entities": []}], ["We assessed known risk factors, clinical presentation, and outcome of invasive pneumococcal disease (IPD) in children 3\u201359 months of age after introduction of the 7-valent pneumococcal conjugate vaccine (PCV7) in England and Wales.", {"entities": []}], ["During September 2006\u2013March 2010, a total of 1,342 IPD episodes occurred in 1,332 children; 14.9% (198/1,332) had comorbidities.", {"entities": []}], ["Compared with IPD caused by PCV7 serotypes (44/248; 17.7%), comorbidities were less common for the extra 3 serotypes in the 10-valent vaccine (15/299; 5.0%) but similar to the 3 additional PCV13 serotypes (45/336; 13.4%) and increased for the 11 extra serotypes in 23-valent polysaccharide vaccine (PPV23) (39/186; 21.0%) and non-PPV23 serotypes (38/138; 27.5%).", {"entities": []}], ["Fifty-two (3.9%) cases resulted from PCV7 failure; 9 (0.7%) case-patients had recurrent IPD.", {"entities": []}], ["Case-fatality rate was 4.4% (58/1,332) but higher for meningitis (11.0%) and children with comorbidities (9.1%).", {"entities": [[54, 64, "DISEASE"]]}], ["Thus, comorbidities were more prevalent in children with IPD caused by non-PCV13 serotypes and were associated with increased case fatality.", {"entities": []}], ["Hospital quality improvement efforts absorb substantial time and resources, but many innovations fail to integrate into organizational routines, undermining the potential to sustain the new practices.", {"entities": []}], ["Despite a well-developed literature on the initial implementation of new practices, we have limited knowledge about the mechanisms by which integration occurs.", {"entities": []}], ["We conducted a qualitative study using a purposive sample of hospitals that participated in the State Action on Avoidable Rehospitalizations (STAAR) initiative, a collaborative to reduce hospital readmissions that encouraged members to adopt new practices.", {"entities": []}], ["We selected hospitals where risk-standardized readmission rates (RSRR) had improved ( n \u2009=\u20097) or deteriorated ( n \u2009=\u20093) over the course of the first 2\u00a0years of the STAAR initiative (2010\u20132011 to 2011\u20132012) and interviewed a range of staff at each site (90 total).", {"entities": []}], ["We recruited hospitals until reaching theoretical saturation.", {"entities": []}], ["The constant comparative method was used to conduct coding and identification of key themes.", {"entities": []}], ["When innovations were successfully integrated, participants consistently reported that a small number of key staff held the innovation in place for as long as a year while more permanent integrating mechanisms began to work.", {"entities": []}], ["Depending on characteristics of the innovation, one of three categories of integrating mechanisms eventually took over the role of holding new practices in place.", {"entities": []}], ["Innovations that proved intrinsically rewarding to the staff, by making their jobs easier or more gratifying, became integrated through shifts in attitudes and norms over time.", {"entities": []}], ["Innovations for which the staff did not perceive benefits to themselves were integrated through revised performance standards if the innovation involved complex tasks and through automation if the innovation involved simple tasks.", {"entities": []}], ["Hospitals have an opportunity to promote the integration of new practices by planning for the extended effort required to hold a new practice in place while integration mechanisms take hold.", {"entities": []}], ["By understanding how integrating mechanisms correspond to innovation characteristics, hospitals may be able to foster integrating mechanisms most likely to work for particular innovations.", {"entities": []}], ["Erythema Nodosum Leprosum (ENL) is a serious complication of leprosy.", {"entities": [[61, 68, "DISEASE"]]}], ["It is normally treated with high dose steroids, but its recurrent nature leads to prolonged steroid usage and associated side effects.", {"entities": []}], ["There is little evidence on the efficacy of alternative treatments for ENL, especially for patients who have become steroid resistant or have steroid side effects.", {"entities": []}], ["These two pilot studies compare the efficacy and side effect profile of ciclosporin plus prednisolone against prednisolone alone in the treatment of patients with either new ENL or chronic and recurrent ENL.", {"entities": []}], ["Thirteen patients with new ENL and twenty patients with chronic ENL were recruited into two double-blinded randomised controlled trials.", {"entities": []}], ["Patients were randomised to receive ciclosporin and prednisolone or prednisolone treatment only.", {"entities": []}], ["Patients with acute ENL had a delay of 16 weeks in the occurrence of ENL flare-up episode, with less severe flare-ups and decreased requirements for additional prednisolone.", {"entities": []}], ["Patients with chronic ENL on ciclosporin had the first episode of ENL flare-up 4 weeks earlier than those on prednisolone, as well as more severe ENL flare-ups requiring 2.5 times more additional prednisolone.", {"entities": []}], ["Adverse events attributable to prednisolone were more common that those attributable to ciclosporin.", {"entities": []}], ["This is the first clinical trial on ENL management set in the African context, and also the first trial in leprosy to use patients\u2019 assessment of outcomes.", {"entities": [[107, 114, "DISEASE"]]}], ["Patients on ciclosporin showed promising results in the management of acute ENL in this small pilot study.", {"entities": []}], ["But ciclosporin, did not appear to have a significant steroid\u2013sparing effects in patients with chronic ENL, which may have been due to the prolonged use of steroids in these patients in combination with a too rapid decrease of steroids in patients given ciclosporin.", {"entities": []}], ["Further research is needed to determine whether the promising results of ciclosporin in acute ENL can be reproduced on a larger scale.", {"entities": []}], ["Leprosy is caused by a mycobacterium, and is curable with multi-drug therapy, a combination of antibiotics taken for 6 or 12 months.", {"entities": [[0, 7, "DISEASE"]]}], ["However, some leprosy patients develop an inflammatory condition known as erythema nodosum leprosum (ENL), or Type 2 reaction.", {"entities": [[14, 21, "DISEASE"]]}], ["ENL affects multiple organs and causes systemic illness as well as nerve damage that leads to disability and deformity.", {"entities": []}], ["ENL is often chronic and patients have multiple flare-ups requiring prolonged steroid treatment.", {"entities": []}], ["Patients are at risk of developing adverse events related to long term steroids.", {"entities": []}], ["There are no effective, non-teratogenic alternative treatments for patients who no longer respond to steroids or have contra-indications to steroids.", {"entities": []}], ["We conducted two studies to see if ciclosporin, an immunosuppressant used in many inflammatory conditions, could safely be used either as an alternative or in conjunction with prednisolone to treat ENL.", {"entities": []}], ["Patients with acute ENL showed promising results with ciclosporin treatment, with a 16 week median delay in recurrence of ENL.", {"entities": []}], ["It did not however appear to have a significant steroid\u2013sparing effects in patients with chronic ENL.", {"entities": []}], ["This suggests that further ENL studies should look at carefully tailored regimens of medication in order to assess the effect of ciclosporin or other immunosuppressant drugs.", {"entities": []}], ["Asthma is a complex inflammatory disorder controlled by both genetic and environmental influences.", {"entities": [[0, 6, "DISEASE"]]}], ["Multiple genetic analyses have identified the T helper type 2 (Th2) cytokine gene cluster on chromosome 5q as a susceptibility locus for asthma.", {"entities": [[137, 143, "DISEASE"]]}], ["Recently, the Th2 cytokine interleukin-13 has been shown to be a critical mediator of the asthma phenotype in murine models.", {"entities": [[90, 96, "DISEASE"]]}], ["In this commentary we discuss several recent studies that have identified polymorphisms in the gene encoding interleukin-13.", {"entities": []}], ["The consistent genetic associations of interleukin-13 with asthma and related traits across diverse ethnic populations in these studies provides strong support for the candidacy of this cytokine as a susceptibility locus for asthma and atopy on chromosome 5q31.", {"entities": [[59, 65, "DISEASE"], [225, 231, "DISEASE"]]}], ["Gas chromatography-mass spectrometry (GC-MS) analysis revealed the major components in black cumin essential oils which were thymoquinone (37.6%) followed by p-cymene (31.2%), \u03b1 -thujene (5.6%), thymohydroquinone (3.4%), and longifolene (2.0%), whereas the oleoresins extracted in different solvents contain linoleic acid as a major component.", {"entities": []}], ["The antioxidant activity of essential oil and oleoresins was evaluated against linseed oil system at 200\u2009ppm concentration by peroxide value, thiobarbituric acid value, ferric thiocyanate, ferrous ion chelating activity, and 1,1-diphenyl-2-picrylhydrazyl radical scavenging methods.", {"entities": []}], ["The essential oil and ethyl acetate oleoresin were found to be better than synthetic antioxidants.", {"entities": []}], ["The total phenol contents (gallic acid equivalents, mg\u2009GAE\u2009per\u2009g) in black cumin essential oil, ethyl acetate, ethanol, and n-hexane oleoresins were calculated as 11.47 \u00b1 0.05, 10.88 \u00b1 0.9, 9.68 \u00b1 0.06, and 8.33 \u00b1 0.01, respectively, by Folin-Ciocalteau method.", {"entities": []}], ["The essential oil showed up to 90% zone inhibition against Fusarium moniliforme in inverted petri plate method.", {"entities": []}], ["Using agar well diffusion method for evaluating antibacterial activity, the essential oil was found to be highly effective against Gram-positive bacteria.", {"entities": []}], ["Anti-viral treatment has been used to treat severe or progressive illness due to pandemic H1N1 2009.", {"entities": []}], ["A main cause of severe illness in pandemic H1N1 2009 is viral pneumonia; however, it is unclear how effective antiviral treatment is against pneumonia when administered >48 hours after symptom onset.", {"entities": [[62, 71, "DISEASE"], [141, 150, "DISEASE"], [56, 71, "DISEASE"]]}], ["Therefore, we aimed to determine how time from symptom onset to antiviral administration affected the effectiveness of antiviral treatment against pneumonia due to pandemic (H1N1) 2009.", {"entities": [[147, 156, "DISEASE"]]}], ["A retrospective medical chart review of 442 patients was conducted in a hospital in Mexico.", {"entities": []}], ["Subjects had tested positive for pandemic H1N1 2009 virus by real-time reverse-transcriptase-polymerase-chain-reaction and were administered oseltamivir.", {"entities": []}], ["Median time from symptom onset to oseltamivir administration was 5.0 days (range, 0\u201343).", {"entities": []}], ["442 subjects, 71 (16.1%) had severe pneumonia which required mechanical ventilation, 191 (43.2%) had mild to moderate pneumonia, and 180 (40%) did not have pneumonia.", {"entities": [[36, 45, "DISEASE"], [118, 127, "DISEASE"], [156, 165, "DISEASE"]]}], ["Subjects were divided into four groups based on time to oseltamivir administration: \u22642, 3\u20137, 8\u201314, and >14 days.", {"entities": []}], ["Severity of respiratory features was associated with time to treatment, and multivariate analysis indicated that time to oseltamivir administration was associated with severity of respiratory features.", {"entities": []}], ["A proportional odds model indicated that 50% probability for occurrence of pneumonia of any severity and that of severe pneumonia in patients who would develop pneumonia reached at approximately 3.4 and 21 days, respectively, after symptom onset.", {"entities": [[75, 84, "DISEASE"], [120, 129, "DISEASE"], [160, 169, "DISEASE"]]}], ["Patients with a shorter time to oseltamivir administration were discharged earlier from the hospital.", {"entities": []}], ["Earlier initiation of oseltamivir administration after symptom onset significantly reduced occurrence and severity of pneumonia and shortened hospitalization due to pandemic H1N1 2009.", {"entities": [[118, 127, "DISEASE"]]}], ["Even when administered >48 hours after symptom onset, oseltamivir showed considerable potential for reducing pneumonia.", {"entities": [[109, 118, "DISEASE"]]}], ["Application of these results would benefit patients affected by future influenza pandemics.", {"entities": [[71, 80, "DISEASE"]]}], ["Long-acting \u03b22 adrenergic agonists (LABAs) are commonly used combined with inhaled corticosteroids (ICS) to treat asthmatic patients.", {"entities": []}], ["Previous reports suggest that LABAs have an anti-inflammatory effect in bronchial asthma, and this should be further investigated.", {"entities": [[82, 88, "DISEASE"]]}], ["The aim of this study was to investigate whether LABAs inhibit allergic airway inflammation and how this occurs.", {"entities": []}], ["We assessed the effect of the LABA formoterol (FORM) on inflammatory cell responses in airway, lung and regional lymph nodes, using an HDM-induced murine allergic asthma model in vivo .", {"entities": [[154, 169, "DISEASE"], [163, 169, "DISEASE"]]}], ["The effect of FORM on cytokine production from bone marrow derived dendritic cells (BMDCs) stimulated with HDM was evaluated in vitro .", {"entities": []}], ["Adoptive transfer of BMDCs pulsed with HDM in the presence or absence of FORM to na\u00efve mice was performed and the inflammatory response to subsequent HDM challenge was analyzed.", {"entities": []}], ["FORM treatment suppressed HDM-induced changes and caused an increase in the number of eosinophils and neutrophils in bronchoalveolar lavage.", {"entities": []}], ["The concentration of IL-4 and IL-17 in lung tissue homogenate was elevated and led to an accumulation of IL-4, IL-13, IL-5 and IL-17 producing cells in regional lymph nodes.", {"entities": []}], ["FORM inhibited the production of IL-6 and IL-23 from BMDCs stimulated with HDM in vitro , and enhanced IL-10 production.", {"entities": []}], ["The BMDCs adoptive transfer experiment indicated that dendritic cells mediate the effect of FORM, since FORM treatment of BMDCs in vitro attenuated airway inflammation.", {"entities": []}], ["These results suggested that FORM modulates dendritic cell function and attenuates Th2 and Th17 responses induced by HDM.", {"entities": []}], ["Thus, we propose that the clinical significance of LABAs should be re-investigated taking into account these immune-modulating effects.", {"entities": []}], ["Atmospheric pollution is one of the worst threats to modern society.", {"entities": []}], ["The consequences derived from different forms of atmospheric pollution vary from the local to the global scale, with deep impacts on climate, environment and human health.", {"entities": []}], ["Several gaseous pollutants, even when present in trace concentrations, play a fundamental role in important processes that occur in atmosphere.", {"entities": []}], ["Phenomena such as global warming, photochemical smog formation, acid rain and the depletion of the stratospheric ozone layer are strongly related to the increased concentration of certain gaseous species in the atmosphere.", {"entities": []}], ["The transport sector significantly produces atmospheric pollution, mainly when diesel oil is used as fuel.", {"entities": []}], ["Therefore, new methodologies based on selective and sensitive gas detection schemes must be developed in order to detect and monitor pollutant gases from this source.", {"entities": []}], ["In this work, CO 2 Laser Photoacoustic Spectroscopy was used to evaluate ethylene emissions and electrochemical analyzers were used to evaluate the emissions of CO, NO x and SO 2 from the exhaust of diesel powered vehicles (rural diesel with 5% of biodiesel, in this paper called only diesel) at different engine rotation speeds.", {"entities": []}], ["Concentrations in the range 6 to 45 ppmV for ethylene, 109 to 1,231 ppmV for carbon monoxide, 75 to 868 ppmV for nitrogen oxides and 3 to 354 ppmV for sulfur dioxide were obtained.", {"entities": []}], ["The results indicate that the detection techniques used were sufficiently selective and sensitive to detect the gaseous species mentioned above in the ppmV range.", {"entities": []}], ["Maternal influenza infection is known to cause substantial morbidity and mortality among pregnant women and young children.", {"entities": [[9, 18, "DISEASE"]]}], ["Many professional healthcare bodies including the World Health Organization (WHO) have identified pregnant women as a priority risk group for receipt of inactivated seasonal influenza vaccination.", {"entities": [[174, 183, "DISEASE"]]}], ["However influenza prevention in this group is not yet a public health priority in India.", {"entities": [[8, 17, "DISEASE"]]}], ["This literature review was undertaken to examine the Indian studies of influenza among pregnant women.", {"entities": [[71, 80, "DISEASE"]]}], ["Eight Indian studies describing influenza burden and/or outcomes among pregnant women with influenza were identified.", {"entities": [[32, 41, "DISEASE"], [91, 100, "DISEASE"]]}], ["In most studies, influenza A (pH1N1) was associated with increased maternal mortality (25\u201375%), greater disease severity, and adverse fetal outcomes as compared to nonpregnant women.", {"entities": [[17, 26, "DISEASE"]]}], ["Surveillance for seasonal influenza infections along with higher quality prospective studies among pregnant women is needed to quantify disease burden, improve awareness among antenatal care providers, and formulate antenatal influenza vaccine policies.", {"entities": [[26, 35, "DISEASE"], [226, 235, "DISEASE"]]}], ["Studies on the association between access to health care and household income have rarely included an assessment of 'forgone care', but this indicator could add to our understanding of the inverse care law.", {"entities": []}], ["We hypothesize that reporting forgone care is more prevalent in low income groups.", {"entities": []}], ["The study is based on the 'Survey of Health, Ageing and Retirement in Europe (SHARE)', focusing on the non-institutionalized population aged 50 years or older.", {"entities": []}], ["Data are included from France, Germany, Greece, Italy and Sweden.", {"entities": []}], ["The dependent variable is assessed by the following question: During the last twelve months, did you forgo any types of care because of the costs you would have to pay, or because this care was not available or not easily accessible?", {"entities": []}], ["The main independent variable is household income, adjusted for household size and split into quintiles, calculating the quintile limits for each country separately.", {"entities": []}], ["Information on age, sex, self assessed health and chronic disease is included as well.", {"entities": []}], ["Logistic regression models were used for the multivariate analyses.", {"entities": []}], ["The overall level of forgone care differs considerably between the five countries (e.g.", {"entities": []}], ["about 10 percent in Greece and 6 percent in Sweden).", {"entities": []}], ["Low income groups report forgone care more often than high income groups.", {"entities": []}], ["This association can also be found in analyses restricted to the subsample of persons with chronic disease.", {"entities": []}], ["Associations between forgone care and income are particularly strong in Germany and Greece.", {"entities": []}], ["Taking the example of Germany, forgone care in the lowest income quintile is 1.98 times (95% CI: 1.08\u20133.63) as high as in the highest income quintile.", {"entities": []}], ["Forgone care should be reduced even if it is not justified by an 'objective' need for health care, as it could be an independent stressor in its own right, and as patient satisfaction is a strong predictor of compliance.", {"entities": []}], ["These efforts should focus on population groups with particularly high prevalence of forgone care, for example on patients with poor self assessed health, on women, and on low income groups.", {"entities": []}], ["The inter-country differences point to the need to specify different policy recommendations for different countries.", {"entities": []}], ["Epidemiological studies have shown adverse effects of short-term exposure to air pollution on respiratory disease outcomes; however, few studies examined this association on an hourly time scale.", {"entities": []}], ["We evaluated the associations between hourly changes in air pollution and the risk of respiratory disease in the elderly, using the time of the emergency call as the disease onset for each case.", {"entities": []}], ["We used a time-stratified case-crossover design.", {"entities": []}], ["Study participants were 6,925 residents of the city of Okayama, Japan, aged 65 or above who were taken to hospital emergency rooms between January 2006 and December 2010 for onset of respiratory disease.", {"entities": []}], ["We calculated city-representative hourly average concentrations of air pollutants from several monitoring stations.", {"entities": []}], ["By using conditional logistic regression models, we estimated odds ratios per interquartile-range increase in each pollutant by exposure period prior to emergency call, adjusting for hourly ambient temperature, hourly relative humidity, and weekly numbers of reported influenza cases aged \u226560.", {"entities": [[268, 277, "DISEASE"]]}], ["Suspended particulate matter (SPM) exposure 24 to <72\u00a0hours prior to the onset and ozone exposure 48 to <96\u00a0hours prior to the onset were associated with the increased risk of respiratory disease.", {"entities": []}], ["For example, following one interquartile-range increase, odds ratios were 1.05 (95% confidence interval: 1.01, 1.09) for SPM exposure 24 to <48\u00a0hours prior to the onset and 1.13 (95% confidence interval: 1.04, 1.23) for ozone exposure 72 to <96\u00a0hours prior to the onset.", {"entities": []}], ["Sulfur dioxide (SO 2 ) exposure 0 to <24\u00a0hours prior to onset was associated with the increased risk of pneumonia and influenza: odds ratio was 1.07 per one interquartile-range increase (95% confidence interval: 1.00, 1.14).", {"entities": [[118, 127, "DISEASE"], [104, 113, "DISEASE"]]}], ["Elevated risk for pneumonia and influenza of SO 2 was observed at shorter lags (i.e., 8\u201318 hours) than the elevated risks for respiratory disease of SPM or ozone.", {"entities": [[32, 41, "DISEASE"], [18, 27, "DISEASE"]]}], ["Overall, the effect estimates for chronic obstructive pulmonary disease and allied conditions were equivocal.", {"entities": [[34, 71, "DISEASE"]]}], ["This study provides further evidence that hourly changes in air pollution exposure increase the risks of respiratory disease, and that SO 2 may be related with more immediate onset of the disease than other pollutants.", {"entities": []}], ["Gender differences in asthma have been observed with a preponderance of boys affected before puberty and girls during and after puberty.", {"entities": [[22, 28, "DISEASE"]]}], ["The known influences of the menstrual cycle on asthma support a role for female sex hormones on the changing expression of asthma during adolescence.", {"entities": [[47, 53, "DISEASE"], [123, 129, "DISEASE"]]}], ["The purpose of this study was to investigate obesity, the menstrual cycle and lung function in adolescent girls.", {"entities": [[45, 52, "DISEASE"]]}], ["One hundred and three female high school girls (mean age: 15.9\u00b10.8 yr) were enrolled.", {"entities": []}], ["The investigation was performed using a questionnaire that included history of asthma, the menstrual cycle, other combined allergic disease and obesity.", {"entities": [[144, 151, "DISEASE"], [79, 85, "DISEASE"]]}], ["The skin prick and pulmonary function test during menstruation period and non-menstruation period.", {"entities": []}], ["Analyses of these factors were compared.", {"entities": []}], ["The forced expiratory volume in one second (FEV 1 )/forced vital capacity (FVC) was significantly lower in the obese group compared to the non-obese group (99.8\u00b113.8 vs. 107.1\u00b110.2, p =0.03).", {"entities": [[44, 47, "GENE"]]}], ["The FEV 1 was significantly lower in the girls during menstruation period than in the girls who were not on menstruation (77.5\u00b110.2 vs. 80.4\u00b18.6, p =0.03).", {"entities": [[4, 7, "GENE"]]}], ["Our results showed that changes of pulmonary function were related to menstrual cycle and obesity in Korean adolescent girls.", {"entities": [[90, 97, "DISEASE"]]}], ["Tuberculosis (TB) destroys lung tissues and this immunopathology is mediated in part by Matrix Metalloproteinases (MMPs).", {"entities": [[0, 12, "DISEASE"]]}], ["There are no data on the relationship between local tissue MMPs concentrations, anti-tuberculosis therapy and sputum conversion.", {"entities": [[85, 97, "DISEASE"]]}], ["Induced sputum was collected from 68 TB patients and 69 controls in a cross-sectional study.", {"entities": []}], ["MMPs concentrations were measured by Luminex array, TIMP concentrations by ELISA and were correlated with a disease severity score (TBscore).", {"entities": []}], ["46 TB patients were then studied longitudinally at the 2nd, 8th week and end of treatment.", {"entities": []}], ["Sputum MMP-1,-2,-3,-8,-9 and TIMP-1 and -2 concentrations are increased in TB.", {"entities": []}], ["Elevated MMP-1 and -3 concentrations are independently associated with higher TB severity scores (p<0.05).", {"entities": []}], ["MMP-1, -3 and -8 concentrations decreased rapidly during treatment (p<0.05) whilst there was a transient increase in TIMP-1/2 concentrations at week 2.", {"entities": []}], ["MMP-2, -8 and -9 and TIMP-2 concentrations were higher at TB diagnosis in patients who remain sputum culture positive at 2 weeks and MMP-3, -8 and TIMP-1 concentrations were higher in these patients at 2nd week of TB treatment.", {"entities": []}], ["MMPs are elevated in TB patients and associate with disease severity.", {"entities": []}], ["This matrix-degrading phenotype resolves rapidly with treatment.", {"entities": []}], ["The MMP profile at presentation correlates with a delayed treatment response.", {"entities": []}], ["Children and patients with cognitive deficits may find it difficult to understand the implication of research.", {"entities": []}], ["In the European Union (EU), clinical studies outside the EU directives concerning medicinal products or medical devices, i.e., \u201cmiscellaneous clinical studies\u201d, have no legally mandated timelines for institutional review boards\u2019 (IRB) decisions.", {"entities": []}], ["To evaluate the review process of IRBs for two different \u201cmiscellaneous\u201d multicenter clinical research protocols involving vulnerable subjects (children and adult stroke patients).", {"entities": []}], ["Descriptive and comparative statistics.", {"entities": []}], ["Protocol 1 is a prospective, multicenter, cross-sectional screening study of a symptomatic pediatric population at risk for Fabry disease involving genetic testing (NCT02152189).", {"entities": []}], ["Protocol 2 is a prospective, multicenter, randomized, controlled, open-label, blinded endpoint post-market study to evaluate the effectiveness of stent retrievers (NCT02135926).", {"entities": []}], ["After having obtained positive initial IRB votes at the main study site, both protocols were subsequently submitted to the remaining IRBs.", {"entities": []}], ["Protocol 1 was submitted to 19 IRBs.", {"entities": []}], ["No IRB objected to the study.", {"entities": []}], ["Median time-to-final vote was 34 (IQR 10\u201365; range 0 to 130) days.", {"entities": []}], ["Two IRBs accepted the coordinating center\u2019s IRB votes without re-evaluation.", {"entities": []}], ["Changes to the informed consent documents were asked by 7/19 IRBs, amendments to the protocol by 2.", {"entities": []}], ["Protocol 2 was submitted to 16 IRBs.", {"entities": []}], ["Fifteen decisions were made.", {"entities": []}], ["No IRB objected to the study.", {"entities": []}], ["Median time-to final vote was 59 (IQR 10 to 65; range 0 to 128) days, which was not statistically significantly different compared with protocol 1 (Wilcoxon test).", {"entities": []}], ["Two IRBs accepted a previous IRB decision and did not conduct an independent review.", {"entities": []}], ["Eight/16 IRBs required changes to the informed consent documents; two IRBs recommended an amendment of the protocol.", {"entities": []}], ["Both clinical research protocols involving vulnerable populations were well accepted.", {"entities": []}], ["IRB workflows and decision times varied substantially.", {"entities": []}], ["Some IRBs accepted a previous IRB decision without the necessity of another reevaluation process.", {"entities": []}], ["Requested changes were focused on the informed consent documents.", {"entities": []}], ["A more standardized approach across jurisdictions is desirable.", {"entities": []}], ["To determine demographic and clinical variables associated with inhaled corticosteroid administration and to evaluate between-hospital variation in inhaled steroid use for infants with bronchopulmonary dysplasia (BPD).", {"entities": []}], ["Retrospective Cohort Study.", {"entities": []}], ["Neonatal units of 35 US children's hospitals; as recorded in the Pediatric Health Information System (PHIS) database.", {"entities": []}], ["1429 infants with evolving BPD at 28 days who were born at <29 weeks gestation with birth weight <1500 grams, admitted within the first 7 postnatal days, and discharged between January 2007\u2013June 2011.", {"entities": []}], ["Inhaled steroids were prescribed to 25% ( n \u200a=\u200a352) of the cohort with use steadily increasing during the first two months of hospitalization.", {"entities": []}], ["The most frequently prescribed steroid was beclomethasone ( n \u200a=\u200a194, 14%), followed by budesonide ( n \u200a=\u200a125, 9%), and then fluticasone ( n \u200a=\u200a90, 6%).", {"entities": []}], ["Birth gestation <24 weeks, birth weight 500\u2013999 grams, and prolonged ventilation all increased the adjusted odds of ever receiving inhaled corticosteroids (p<0.05).", {"entities": []}], ["Wide variations between hospitals in the frequency of infants ever receiving inhaled steroids (range: 0\u201360%) and the specific drug prescribed were noted.", {"entities": []}], ["This variation persisted, even after controlling for observed confounders.", {"entities": []}], ["Inhaled corticosteroid administration to infants with BPD is common in neonatal units within U.S. Children's hospitals.", {"entities": []}], ["However, its utilization varies markedly between centers from no treatment at some institutions to the majority of infants with BPD being treated at others.", {"entities": []}], ["This supports the need for further research to identify the benefits and potential risks of inhaled steroid usage in infants with BPD.", {"entities": []}], ["Hypothermia is associated with increased morbidity and mortality in trauma patients and poses a challenge in pre-hospital treatment.", {"entities": []}], ["The aim of this study was to identify equipment to prevent, diagnose, and treat hypothermia in Norwegian pre-hospital services.", {"entities": []}], ["In the period of April-August 2011, we conducted a survey of 42 respondents representing a total of 543 pre-hospital units, which included all the national ground ambulance services, the fixed wing and helicopter air ambulance service, and the national search and rescue service.", {"entities": []}], ["The survey explored available insulation materials, active warming devices, and the presence of protocols describing wrapping methods, temperature monitoring, and the use of warm i.v.", {"entities": []}], ["Throughout the services, hospital duvets, cotton blankets and plastic \u201cbubble-wrap\u201d were the most common insulation materials.", {"entities": []}], ["Active warming devices were to a small degree available in vehicle ambulances (14%) and the fixed wing ambulance service (44%) but were more common in the helicopter services (58-70%).", {"entities": []}], ["Suitable thermometers for diagnosing hypothermia were lacking in the vehicle ambulance services (12%).", {"entities": []}], ["Protocols describing how to insulate patients were present for 73% of vehicle ambulances and 70% of Search and Rescue helicopters.", {"entities": []}], ["The minority of Helicopter Emergency Medical Services (42%) and Fixed Wing (22%) units was reported to have such protocols.", {"entities": []}], ["The most common equipment types to treat and prevent hypothermia in Norwegian pre-hospital services are duvets, plastic \u201cbubble wrap\u201d, and cotton blankets.", {"entities": []}], ["Active external heating devices and suitable thermometers are not available in most vehicle ambulance units.", {"entities": []}], ["The use of pooled DNA on SNP microarrays (SNP-MaP) has been shown to be a cost effective and rapid manner to perform whole-genome association evaluations.", {"entities": []}], ["While the accuracy of SNP-MaP was extensively evaluated on the early Affymetrix 10 k and 100 k platforms, there have not been as many similarly comprehensive studies on more recent platforms.", {"entities": []}], ["In the present study, we used the data generated from the full Affymetrix 500 k SNP set together with the polynomial-based probe-specific correction (PPC) to derive allele frequency estimates.", {"entities": []}], ["These estimates were compared to genotyping results of the same individuals on the same platform, as the basis to evaluate the reliability and accuracy of pooled genotyping on these high-throughput platforms.", {"entities": []}], ["We subsequently extended this comparison to the new SNP6.0 platform capable of genotyping 1.8 million genetic variants.", {"entities": []}], ["We showed that pooled genotyping on the 500 k platform performed as well as those previously shown on the relatively lower throughput 10 k and 100 k array sets, with high levels of accuracy (correlation coefficient: 0.988) and low median error (0.036) in allele frequency estimates.", {"entities": []}], ["Similar results were also obtained from the SNP6.0 array set.", {"entities": []}], ["A novel pooling strategy of overlapping sub-pools was attempted and comparison of estimated allele frequencies showed this strategy to be as reliable as replicate pools.", {"entities": []}], ["The importance of an appropriate reference genotyping data set for the application of the PPC algorithm was also evaluated; reference samples with similar ethnic background to the pooled samples were found to improve estimation of allele frequencies.", {"entities": []}], ["We conclude that use of the PPC algorithm to estimate allele frequencies obtained from pooled genotyping on the high throughput 500 k and SNP6.0 platforms is highly accurate and reproducible especially when a suitable reference sample set is used to estimate the beta values for PPC.", {"entities": []}], ["Fatigue is the most frequent symptom reported by patients with chronic illnesses.", {"entities": []}], ["As a subjective experience, fatigue is commonly assessed with patient-reported outcome measures (PROMs).", {"entities": []}], ["Currently, there are more than 40 generic and disease-specific PROMs for assessing fatigue in use today.", {"entities": []}], ["The interpretation of changes in PROM scores may be enhanced by estimates of the so-called minimal important difference (MID).", {"entities": []}], ["MIDs are not fixed attributes of PROMs but rather vary in relation to estimation method, clinical and demographic characteristics of the study group, etc.", {"entities": []}], ["The purpose of this paper is to compile published MIDs for fatigue PROMs, spanning diagnostic/patient groups and estimation methods, and to provide information relevant for appraising their appropriateness for use in specific clinical trials and in monitoring fatigue in defined patient groups in routine clinical practice.", {"entities": []}], ["A systematic search of three databases (Scopus, CINAHL and Cochrane) for studies published between January 2000 to April 2015 using fatigue and variations of the term MID, e.g.", {"entities": []}], ["MCID, MIC, etc.", {"entities": []}], ["Two authors screened search hits and extracted data independently.", {"entities": []}], ["Data regarding MIDs, anchors used and study designs were compiled in tables.", {"entities": []}], ["Included studies ( n\u2009= \u200941) reported 60 studies or substudies estimating MID for 28 fatigue scales, subscales or single item measures in a variety of diagnostic groups and study designs.", {"entities": []}], ["All studies used anchor-based methods, 21/60 measures also included distribution-based methods and 17/60 used triangulation of methods.", {"entities": []}], ["Both similarities and dissimilarities were seen within the MIDs.", {"entities": []}], ["Magnitudes of published MIDs for fatigue PROMs vary considerably.", {"entities": []}], ["Information about the derivation of fatigue MIDs is needed to evaluate their applicability and suitability for use in clinical practice and research.", {"entities": []}], ["Xylitol is a 5-carbon sugar that can lower the airway surface salt concentration, thus enhancing innate immunity.", {"entities": []}], ["We tested the safety and tolerability of aerosolized iso-osmotic xylitol in mice and human volunteers.", {"entities": []}], ["This was a prospective cohort study of C57Bl/6 mice in an animal laboratory and healthy human volunteers at the clinical research center of a university hospital.", {"entities": []}], ["Mice underwent a baseline methacholine challenge, exposure to either aerosolized saline or xylitol (5% solution) for 150 minutes and then a follow-up methacholine challenge.", {"entities": []}], ["The saline and xylitol exposures were repeated after eosinophilic airway inflammation was induced by sensitization and inhalational challenge to ovalbumin.", {"entities": []}], ["Normal human volunteers underwent exposures to aerosolized saline (10 ml) and xylitol, with spirometry performed at baseline and after inhalation of 1, 5, and 10 ml.", {"entities": []}], ["Serum osmolarity and electrolytes were measured at baseline and after the last exposure.", {"entities": []}], ["A respiratory symptom questionnaire was administered at baseline, after the last exposure, and five days after exposure.", {"entities": []}], ["In another group of normal volunteers, bronchoalveolar lavage (BAL) was done 20 minutes and 3 hours after aerosolized xylitol exposure for levels of inflammatory markers.", {"entities": []}], ["In na\u00efve mice, methacholine responsiveness was unchanged after exposures to xylitol compared to inhaled saline (p = 0.49).", {"entities": []}], ["There was no significant increase in Penh in antigen-challenged mice after xylitol exposure (p = 0.38).", {"entities": []}], ["There was no change in airway cellular response after xylitol exposure in na\u00efve and antigen-challenged mice.", {"entities": []}], ["In normal volunteers, there was no change in FEV1 after xylitol exposures compared with baseline as well as normal saline exposure (p = 0.19).", {"entities": []}], ["Safety laboratory values were also unchanged.", {"entities": []}], ["The only adverse effect reported was stuffy nose by half of the subjects during the 10 ml xylitol exposure, which promptly resolved after exposure completion.", {"entities": []}], ["BAL cytokine levels were below the detection limits after xylitol exposure in normal volunteers.", {"entities": []}], ["Inhalation of aerosolized iso-osmotic xylitol was well-tolerated by na\u00efve and atopic mice, and by healthy human volunteers.", {"entities": []}], ["We draw on cognitive discrepancy theory to hypothesize and test a pathway from poor health to loneliness in later life.", {"entities": []}], ["We hypothesize that poor health will have a negative influence on social participation and social resources, and these factors will mediate between health and loneliness.", {"entities": []}], ["We hypothesize that rural environments will amplify any difficulties associated with social participation or accessing social resources and that depression will moderate how intensely people react to levels of social contact and support.", {"entities": []}], ["We conceptualize a mediation model and a moderated-mediation model.", {"entities": []}], ["Nationally representative data on older people living in the Republic of Ireland are used to validate the hypothesized pathways.", {"entities": []}], ["In the mediation model, health has a significant indirect effect on loneliness through the mediating variables social resources and social participation.", {"entities": []}], ["In the moderated-mediation model, rurality moderates the pathway between health and social resources but not social participation.", {"entities": []}], ["Depressive symptoms moderate the effect of social resources on loneliness but not social participation.", {"entities": []}], ["The results provide further credence to cognitive discrepancy theory, suggesting that depressive symptoms influence cognitive processes, interfering with judgments about the adequacy of social interaction.", {"entities": []}], ["The theory is extended by demonstrating the impact of the environment on loneliness.", {"entities": []}], ["This research explored whether asking patients about their pets would enable better environmental/social history taking, and improve patient communication/care.", {"entities": []}], ["Primary health care providers (PHPs) were surveyed about prevalence of patients living with pets, the health impact of pets, and influences on patient communication.", {"entities": []}], ["Following an educational intervention, they committed to asking patients about their pets.", {"entities": []}], ["A follow-up survey was conducted electronically.", {"entities": []}], ["PHPs were recruited at a continuing medical education (CME) conference and at CME workshops.", {"entities": []}], ["All 225 participants were PHPs.", {"entities": []}], ["At the conference, participants were educated one-on-one about the clinical relevance of pets in the family.", {"entities": []}], ["CME sessions were large or small group teaching.", {"entities": []}], ["Baseline and final surveys measured awareness of pets in patients\u2019 families, assessment of determinants of health, impact on rapport with patients, and patient care.", {"entities": []}], ["A sign test assessed difference in scores using repeated-measures analysis.", {"entities": []}], ["Binomial outcomes were assessed using Fisher\u2019s exact test.", {"entities": []}], ["Comments were themed.", {"entities": []}], ["Ninety-four PHPs (42%) completed the study.", {"entities": []}], ["Pet-related discussions opened communication with patients.", {"entities": []}], ["Two-thirds of participants identified positive effects on practice and on relationships with patients.", {"entities": []}], ["PHPs were able to leverage the health benefits of pets (zooeyia) and mitigate zoonotic risk.", {"entities": []}], ["Asking patients about pets in the family reveals clinically relevant information, improves communication, and strengthens the therapeutic alliance.", {"entities": []}], ["Persistently high sulphur dioxide (SO 2 ) emissions from platinum group metal (PGM) smelting pose a major threat to communities located around smelters.", {"entities": []}], ["This paper examined SO 2 emission trends, emission regulations and residents\u2019 perceived health risks from exposures to such emissions at Selous Metallurgical Complex (SMC) PGM smelting facility in Zimbabwe.", {"entities": []}], ["SO 2 data from roof monitoring sites at the smelter furnace were aggregated into annual, quarterly and monthly emission trends from 2008 to 2015.", {"entities": []}], ["The regulatory regime\u2019s ability to protect human health from SO 2 pollution in communities located around the\u00a0smelter was examined.", {"entities": []}], ["Questionnaire responses to perceived health risks from SO 2 exposure from 40 purposively sampled residents were assessed.", {"entities": []}], ["The relationships between SO 2 emission trends and residents\u2019 self-reported health risks from exposure to SO 2 emissions were explored using STATA version 11.", {"entities": []}], ["Descriptive statistics were used to illustrate SO 2 emission trends and residents\u2019 self-reported health risks from exposure to SO 2 .", {"entities": []}], ["Between 2008 and 2015, annual SO 2 emissions increased from 7951 to 2500\u00a0tonnes.", {"entities": []}], ["Emissions exceeded the recommended standard limit of 50\u00a0mg/Nm 2 emission exceedance penalties were identified as major drivers of emission increase.", {"entities": []}], ["Thirty-two (80%) of the forty respondents perceived exposure to SO 2 emissions as adverse and the cause of their illnesses, with coughing, nasal congestion and shortness of breath the most frequently self-reported symptoms.", {"entities": []}], ["A set of legally-binding SO 2 emission standards supported by stringent EIA licensing arrangements for smelting industries are suggested for development and enforcement to reduce the SO 2 emission problem.", {"entities": []}], ["Community participation in SO 2 emissions monitoring is also proposed as a core part of sustainable environmental management in communities located around smelters.", {"entities": []}], ["This study aimed to reveal the appropriate timing for the intravenous administration of flurbiprofen axetil for preventing mesenteric traction syndrome (MTS), caused by prostacyclin release.", {"entities": [[143, 151, "DISEASE"]]}], ["In this prospective, randomized, clinical study, forty-five patients who were undergoing elective surgery for colorectal cancer via laparotomy were enrolled.", {"entities": [[110, 127, "DISEASE"], [121, 127, "DISEASE"]]}], ["Patients were randomly divided into 3 groups: a preoperative group ( n \u00a0=\u00a016) receiving flurbiprofen axetil directly before surgery; a post-MTS group ( n \u00a0=\u00a014) receiving following MTS onset; and a control group ( n \u00a0=\u00a015) who were not administered flurbiprofen axetil.", {"entities": []}], ["6-keto-PGF1\u03b1, a stable metabolite of prostacyclin, levels were measured and mean blood pressures were recorded.", {"entities": []}], ["In the preoperative group, 6-keto-PGF1\u03b1 levels did not increase, blood pressure levels did not decrease, and no facial flushing was observed.", {"entities": []}], ["In both the post-MTS and control groups, 6-keto-PGF1\u03b1 levels increased markedly after mesenteric traction and blood pressure decreased significantly.", {"entities": []}], ["The post-MTS group exhibited a faster decreasing trend in 6-keto-PGF1\u03b1 levels and quick restore of the mean blood pressure, and the use of vasopressors and phenylephrine were lower than that in the control group.", {"entities": []}], ["Even therapeutic administration of flurbiprofen axetil after the onset of MTS has also effects on MTS by suppressing prostacyclin production.", {"entities": []}], ["Clinical trial number: UMIN000009111 .", {"entities": []}], ["(Registered 14 October 2012)", {"entities": []}], ["Airway hyperresponsiveness (AHR) is one of the important traits that characterize bronchial asthma.", {"entities": [[92, 98, "DISEASE"], [28, 31, "GENE"]]}], ["Goishi tea is a post-heating fermented tea that has been reported to have higher free radical scavenging activity.", {"entities": []}], ["In this study, we evaluated the prophylactic effects of Goishi tea on AHR in BALB/c mice.", {"entities": [[70, 73, "GENE"]]}], ["The number of inflammatory cells in BAL fluid was considerably reduced in Goishi tea/ Der f and Gallic acid/ Der f groups as compared with Tap water/ Der f group.", {"entities": []}], ["Regarding inflammatory cells in BAL, a significant reduction of eosinophils and neutrophils was observed in Goishi tea-treated mice (p < 0.01), as well as in the Gallic acid/ Der f group (p < 0.05), as compared with Tap water/ Der f group.", {"entities": []}], ["In asthmatic mice (Tap water/ Der f group), the intensity of airway resistance increased simultaneously with the increase in acetylcholine concentration in a dose-dependant way.", {"entities": []}], ["AHR was significantly inhibited in Goishi tea/ Der f and Gallic acid/ Der f (p < 0.01) groups as compared with the Tap water/ Der f group.", {"entities": [[0, 3, "GENE"]]}], ["Regarding serum specific-IgG 1 , significantly lower levels of this antibody were observed in Goishi tea/ Der f and Gallic acid/ Der f groups as compared with the Tap water/ Der f group (p < 0.05).", {"entities": []}], ["In addition, adiponectin level was significantly higher in the Goishi tea group as compared with the Tap water treated mice (p < 0.01).", {"entities": []}], ["The results suggest that Goishi tea consumption exerted an inhibitory effect on eosinophilic and neutrophilic infiltration in the lung, attenuated the increase in airway resistance and increased the production of adiponectin; thus reducing Der f induced allergic inflammatory process in mice.", {"entities": []}], ["Yersinia pestis causes pneumonic plague, a disease characterized by inflammation, necrosis and rapid bacterial growth which together cause acute lung congestion and lethality.", {"entities": [[33, 39, "DISEASE"], [23, 39, "DISEASE"]]}], ["The bacterial type III secretion system (T3SS) injects 7 effector proteins into host cells and their combined activities are necessary to establish infection.", {"entities": []}], ["Y. pestis infection of the lungs proceeds as a biphasic inflammatory response believed to be regulated through the control of apoptosis and pyroptosis by a single, well-conserved T3SS effector protein YopJ.", {"entities": []}], ["Recently, YopJ-mediated pyroptosis, which proceeds via the NLRP3-inflammasome, was shown to be regulated by a second T3SS effector protein YopK in the related strain Y. pseudotuberculosis .", {"entities": []}], ["In this work, we show that for Y. pestis , YopK appears to regulate YopJ-mediated apoptosis, rather than pyroptosis, of macrophages.", {"entities": []}], ["Inhibition of caspase-8 blocked YopK-dependent apoptosis, suggesting the involvement of the extrinsic pathway, and appeared cell-type specific.", {"entities": []}], ["However, in contrast to yopJ , deletion of yopK caused a large decrease in virulence in a mouse pneumonic plague model.", {"entities": [[106, 112, "DISEASE"], [96, 112, "DISEASE"]]}], ["YopK-dependent modulation of macrophage apoptosis was observed at 6 and 24 hours post-infection (HPI).", {"entities": []}], ["When YopK was absent, decreased populations of macrophages and dendritic cells were seen in the lungs at 24 HPI and correlated with resolution rather than progression of inflammation.", {"entities": []}], ["Together the data suggest that Y. pestis YopK may coordinate the inflammatory response during pneumonic plague through the regulation of apoptosis of immune cells.", {"entities": [[104, 110, "DISEASE"], [94, 110, "DISEASE"]]}], ["In this work, we studied the mechanism whereby bacteria manipulate innate immune responses by controlling host cell death.", {"entities": []}], ["Yersinia pestis , the causative agent of plague, requires effector Yops of the Type III Secretion System (T3SS) to evade the innate immune system during infection.", {"entities": [[41, 47, "DISEASE"]]}], ["We show that Yersinia induces apoptosis of macrophages through two distinct mechanisms, each through the activity of the well-characterized T3SS effector YopJ, yet regulated in an opposing manner through the activity of a second effector protein YopK.", {"entities": []}], ["In a murine pneumonic plague model, we found evidence that YopK regulates apoptosis of macrophages during the early stage of infection, leading to uncontrolled inflammation and disease.", {"entities": [[22, 28, "DISEASE"], [12, 28, "DISEASE"]]}], ["In contrast, the absence of YopK-regulated apoptosis allowed recruitment of lymphocytes and CCR2 Yersinia YopK modulates apoptosis of immune cells to control the inflammatory response during plague.", {"entities": [[191, 197, "DISEASE"], [92, 96, "GENE"]]}], ["Initial glitches and unexpected inconsistencies are unavoidable in the early stage of a large, multi-centre trial.", {"entities": []}], ["Adaptive modifications of the trial\u2019s protocol and operational procedures to ensure its smooth running are therefore imperative.", {"entities": []}], ["We started a large pragmatic, multi-centre, assessor-blinded, 25-week trial to investigate the optimal first- and second-line treatments for untreated episodes of nonpsychotic major depression in 2010 [Strategic Use of New generation antidepressants for Depression, abbreviated SUN(^_^)D] and would like to herein report an examination of the trial\u2019s feasibility and adherence among the first 100 participants.", {"entities": []}], ["We examined the participants\u2019 characteristics, the treatments that were allocated and received during each step of the trial, and the quality of the outcome assessments among the first 100 patients enrolled in the SUN(^_^)D trial.", {"entities": []}], ["Of the 2,743 first-visit patients who visited the two collaborating centres between December 2010 and July 2011, 382 were judged as potentially eligible, and 100 of these patients provided written informed consent.", {"entities": []}], ["These patients represented the whole spectrum of mild to very severe depression.", {"entities": []}], ["Of the 93 patients who had reached Week 3 of the study by the end of July 2011, one withdrew consent for both the treatment and the assessment, and eight withdrew consent for the treatment only.", {"entities": []}], ["Altogether, the primary outcomes were successfully assessed in 90 (96.8%) of the patients at Week 3.", {"entities": []}], ["Of the 72 patients who had reached Week 9, three withdrew consent for the treatment, but 70 were successfully interviewed (97.2%).", {"entities": []}], ["Of the 32 patients who had reached Week 25, 29 (90.5%) were successfully followed up.", {"entities": []}], ["The inter-rater reliability of the assessments of the primary outcomes was nearly perfect and their successful blinding was confirmed.", {"entities": []}], ["Minor modifications and clarifications to the protocol were deemed necessary.", {"entities": []}], ["Given the satisfactory feasibility and adherence to the study protocol and the minor modifications that were necessary, we conclude that the data obtained from the first 100 patients can be safely included in the main study.", {"entities": []}], ["We now intend to accelerate the study by recruiting more collaborating centres and clinics/hospitals.", {"entities": []}], ["ClinicalTrials.gov identifier: NCT01109693", {"entities": []}], ["To study the course and consequences of work-related upper extremity disorders in the registry of the Netherlands Centre for Occupational Diseases (NCvB).", {"entities": []}], ["A follow-up study was performed in a sample of consecutive cases of work-related upper extremity disorders notified to the NCvB.", {"entities": []}], ["Perceived severity was measured with VAS (0-100), quality of life with VAS (0-100) and SF-36, functional impairment with DASH and sickness absence with a questionnaire.", {"entities": []}], ["Measurements took place directly after notification (T0) and after 3, 6 and 12\u00a0months (T1-T3).", {"entities": []}], ["A linear mixed model was used to compare scores over time.", {"entities": []}], ["Average age of the 48 consecutive patients (89% response) was 42\u00a0years; 48% were men.", {"entities": []}], ["Perceived severity, functional impairment and sickness absence decreased statistically significant during the follow-up period, and quality of life scores improved.", {"entities": []}], ["Patients older than 45\u00a0years scored worse on perceived severity of the disease, functional impairment and quality of life than did younger patients.", {"entities": []}], ["The role of registries of occupational diseases for preventive policy can be extended by creating longitudinal data in sample projects.", {"entities": []}], ["In the sample from our registry, work-related upper extremity disorders had a favourable course.", {"entities": []}], ["Microorganisms establish with their animal hosts close interactions.", {"entities": []}], ["They are involved in many aspects of the host life, physiology and evolution, including nutrition, reproduction, immune homeostasis, defence and speciation.", {"entities": []}], ["Thus, the manipulation and the exploitation the microbiota could result in important practical applications for the development of strategies for the management of insect\u2010related problems.", {"entities": []}], ["This approach, defined as \u2018Microbial Resource Management\u2019 (MRM), has been applied successfully in various environments and ecosystems, as wastewater treatments, prebiotics in humans, anaerobic digestion and so on.", {"entities": []}], ["MRM foresees the proper management of the microbial resource present in a given ecosystem in order to solve practical problems through the use of microorganisms.", {"entities": []}], ["In this review we present an interesting field for application for MRM concept, i.e.", {"entities": []}], ["the microbial communities associated with arthropods and nematodes.", {"entities": []}], ["Several examples related to this field of applications are presented.", {"entities": []}], ["Insect microbiota can be manipulated: (i) to control insect pests for agriculture; (ii) to control pathogens transmitted by insects to humans, animals and plants; (iii) to protect beneficial insects from diseases and stresses.", {"entities": []}], ["Besides, we prospect further studies aimed to verify, improve and apply MRM by using the insect\u2013symbiont ecosystem as a model.", {"entities": []}], ["Implementing current vaccine recommendations can save thousands of lives and decrease illness among persons 50 years of age and older.", {"entities": []}], ["For older populations, most of whom are women, preventing illnesses and deaths through the use of vaccines is a leading public health challenge.", {"entities": []}], ["Our understanding about how age and sex affect the immune system is limited, and basic and translational research aimed at improving vaccines and immune responses of older persons is needed.", {"entities": []}], ["In the meantime, fully implementing current vaccine recommendations, particularly those for influenza and pneumococcal vaccines, can save thousands of lives and prevent illnesses in persons >50 years of age.", {"entities": [[92, 101, "DISEASE"]]}], ["Endotoxins stimulate T helper 1 cell maturation and send a negative signal to T helper 2 polarisation.", {"entities": []}], ["This causes a decrease IgE levels and prevents atopy (Hygiene hypothesis).", {"entities": []}], ["It is shown that this response is under genetic control by polymorphisms in CD14 and TLR4 genes in some researchs.", {"entities": [[76, 80, "GENE"], [85, 89, "GENE"]]}], ["We aimed to investigate the effects of genetic variants of CD14 (\u2212) and TLR4 (Asp299Gly, Thr399Ile) genes on asthma phenotypes in adults with asthma.", {"entities": [[109, 115, "DISEASE"], [142, 148, "DISEASE"], [59, 63, "GENE"], [72, 76, "GENE"]]}], ["Asthma patients (n\u2009=\u2009131) and healthy control cases (n\u2009=\u200975) were included in the study.", {"entities": [[0, 6, "DISEASE"]]}], ["Relations between CD14 C-159\u00a0T, TLR4 299 and TLR4 399 genotypes and duration of asthma history of allergic rhinitis-dermatitis, total IgE, eosinophil, skin prick test, forced expiratory volume 1 (FEV1) and severity of disease were evaluated.", {"entities": [[98, 115, "DISEASE"], [107, 115, "DISEASE"], [80, 86, "DISEASE"], [116, 126, "DISEASE"], [18, 22, "GENE"], [32, 36, "GENE"], [45, 49, "GENE"], [32, 36, "GENE"], [45, 49, "GENE"]]}], ["Real time PCR (RT-PCR) was used for genotyping.", {"entities": []}], ["For CD14-159, presence of the C allele (CC\u2009+\u2009CT) was more frequent among those with low median log (logarithm) IgE levels, but no statistically significant difference in all asthma group (p\u2009=\u20090.09).", {"entities": [[174, 180, "DISEASE"]]}], ["C allele was significantly correlated with low total IgE levels and T allele with high total IgE levels in atopics (p\u2009=\u20090.04).", {"entities": []}], ["CC\u2009+\u2009CT genotype was more frequent in moderate and severe asthma group in atopics (p\u2009=\u20090.049).", {"entities": [[58, 64, "DISEASE"]]}], ["TLR4 299 and TLR4 399 genotypes and asthma phenotypes were not found to be significantly correlated (p\u2009>\u20090.05).", {"entities": [[36, 42, "DISEASE"], [0, 4, "GENE"], [13, 17, "GENE"], [0, 4, "GENE"], [13, 17, "GENE"]]}], ["Total IgE levels were found to be low among patients with the CC\u2009+\u2009CT genotype, and high among patients with the TT genotype contrary to the results of many other studies, which is therefore an important finding.", {"entities": []}], ["Another important finding was that the C allele is a risk factor for moderate and severe asthma.", {"entities": [[89, 95, "DISEASE"]]}], ["Surgical trauma triggers an important postoperative stress response characterized by significantly elevated levels of cytokines, an event that can favor the emergence of immune disorders which lead to disturbances in the patient's body defense.", {"entities": []}], ["The magnitude of postoperative stress is related to the degree of surgical trauma.", {"entities": []}], ["To evaluate the expression of pro-inflammatory (TNF-\u03b1, IFN-\u03b3, IL-1\u03b2, and IL-17) and anti-inflammatory (IL-4) cytokines in patients submitted to conventional and single-port laparoscopic cholecystectomy before and 24 h after surgery.", {"entities": []}], ["Forty women with symptomatic cholelithiasis, ranging in age from 18 to 70 years, participated in the study.", {"entities": [[29, 43, "DISEASE"]]}], ["The patients were divided into two groups: 21 submitted to conventional laparoscopic cholecystectomy and 19 to single-port laparoscopic cholecystectomy.", {"entities": []}], ["Evaluation of the immune response showed no significant difference in IFN-\u03b3 and IL-1\u03b2 levels between the groups or time points analyzed.", {"entities": []}], ["With respect to TNF-\u03b1 and IL-4, serum levels below the detection limit (10 pg/ml) were observed in the two groups and at the time points analyzed.", {"entities": []}], ["Significantly higher postoperative expression of IL-17A was detected in patients submitted to single-port laparoscopic cholecystectomy when compared to preoperative levels (p=0.0094).", {"entities": []}], ["Significant postoperative expression of IL-17 was observed in the group submitted to single-port laparoscopic cholecystectomy when compared to preoperative levels, indicating that surgical stress in this group was higher compared to the conventional laparoscopic cholecystectomy.", {"entities": []}], ["Given an elevated prevalence of respiratory disease and density of pollution sources, residents of Roxbury, Massachusetts, have been interested in better understanding their exposures to air pollution.", {"entities": []}], ["To determine whether local transportation sources contribute significantly to exposures, we conducted a community-based pilot investigation to measure concentrations of fine particulate matter (particulate matter < 2.5 microm; PM(2.5)) and particle-bound polycyclic aromatic hydrocarbons (PAHs) in Roxbury in the summer of 1999.", {"entities": []}], ["Community members carried portable monitors on the streets in a 1-mile radius around a large bus terminal to create a geographic information system (GIS) map of concentrations and gathered data on site characteristics that could predict ambient concentrations.", {"entities": []}], ["Both PM(2.5) and PAH concentrations were greater during morning rush hours and on weekdays.", {"entities": []}], ["In linear mixed-effects regressions controlling for temporal autocorrelation, PAH concentrations were significantly higher with closer proximity to the bus terminal (p < 0.05), and both pollutants were elevated, but not statistically significantly so, on bus routes.", {"entities": []}], ["Regressions on a subset of measurements for which detailed site characteristics were gathered showed higher concentrations of both pollutants on roads reported to have heavy bus traffic.", {"entities": []}], ["Although a more comprehensive monitoring protocol would be needed to develop robust predictive functions for air pollution, our study demonstrates that pollution patterns in an urban area can be characterized with limited monitoring equipment and that university-community partnerships can yield relevant exposure information.", {"entities": []}], ["Research is needed on chronic health conditions among lesbian, gay, and bisexual populations.", {"entities": []}], ["The objective of this study was to examine 10 diagnosed chronic conditions, and multiple (\u22652) chronic conditions (MCC), by sexual orientation among US adults.", {"entities": [[114, 117, "GENE"]]}], ["The 2013 National Health Interview Survey was used to generate age-adjusted prevalence rates and adjusted odds ratios of diagnosed chronic conditions and MCC for civilian, noninstitutionalized US adults who identified as gay/lesbian, straight, or bisexual, and separately for men and women.", {"entities": [[154, 157, "GENE"]]}], ["Chronic conditions were selected for this study on the basis of previous research.", {"entities": []}], ["Hypertension and arthritis were the most prevalent conditions for all groups.", {"entities": [[17, 26, "DISEASE"]]}], ["Gay/lesbian adults had a 4.7 percentage-point higher prevalence of cancer than bisexual adults, and a 5.6 percentage-point higher prevalence of arthritis and a 2.9 percentage point higher prevalence of hepatitis than straight adults.", {"entities": [[202, 211, "DISEASE"], [144, 153, "DISEASE"], [67, 73, "DISEASE"]]}], ["The prevalence of chronic obstructive pulmonary disease was 8.1 percentage points higher among bisexual adults than among gay/lesbian adults and 7.0 percentage points higher than among straight adults.", {"entities": [[18, 55, "DISEASE"]]}], ["These differences remained in the multivariate analyses.", {"entities": []}], ["Additional differences were found in the sex-stratified analyses.", {"entities": []}], ["No significant differences were found in MCC by sexual orientation.", {"entities": [[41, 44, "GENE"]]}], ["After age adjustment and controlling for sociodemographic characteristics, only a few significant health disparities for diagnosed chronic conditions were found by sexual orientation, and none for MCC.", {"entities": [[197, 200, "GENE"]]}], ["However, for conditions where differences were found, magnitudes were relatively large.", {"entities": []}], ["Further examination of these differences among gay/lesbian and bisexual adults could yield a better understanding of why these disparities exist.", {"entities": []}], ["A case-control study was conducted on patients with chronic periodontitis (CP) and healthy controls with the aim of evaluating possible association between interleukin 17A (IL17A) G197A (rs2275913) and IL17F T7488C (rs763780) polymorphisms and periodontitis.", {"entities": [[60, 73, "DISEASE"], [244, 257, "DISEASE"], [75, 77, "GENE"], [173, 178, "GENE"], [202, 207, "GENE"]]}], ["Genotypes were determined by PCR-RFLP method.", {"entities": []}], ["Statistical analyses were conducted using the OpenEpi and SNPStas software to calculate Chi-square with Yates correction or Fisher's exact tests, odds ratios (OR), and 95% confidence intervals (CIs).", {"entities": []}], ["SNPStas software was used to calculate Hardy-Weinberg equilibrium.", {"entities": []}], ["IL17A AA genotype was more frequent in patients with chronic periodontitis (CP) in the codominant and recessive models ( P = 0.09; OR = 2.53 and P = 0.03; OR = 2.46, resp.", {"entities": [[61, 74, "DISEASE"], [0, 5, "GENE"], [76, 78, "GENE"]]}], ["), the females with CP ( P = 0.01, OR = 4.34), Caucasoid patients with CP ( P = 0.01, OR = 3.45), and nonsmoking Caucasian patients with CP ( P = 0.04, OR = 3.51).", {"entities": [[20, 22, "GENE"], [71, 73, "GENE"], [137, 139, "GENE"], [20, 22, "GENE"], [71, 73, "GENE"], [137, 139, "GENE"], [20, 22, "GENE"], [71, 73, "GENE"], [137, 139, "GENE"]]}], ["The IL17A A allele was also more frequent in Caucasians with CP ( P = 0.04, OR = 1.59).", {"entities": [[4, 9, "GENE"], [61, 63, "GENE"]]}], ["IL17F T7488C polymorphism was not associated with chronic periodontitis.", {"entities": [[58, 71, "DISEASE"], [0, 5, "GENE"]]}], ["In these patients from Southern Brazil, the IL17A rs2275913 polymorphisms, IL17A AA genotype, and the A allele were associated with a susceptibility to chronic periodontitis.", {"entities": [[160, 173, "DISEASE"], [44, 49, "GENE"], [75, 80, "GENE"], [44, 49, "GENE"], [75, 80, "GENE"]]}], ["In June of 2009, the World Health Organization declared the first influenza pandemic of the 21 We present the signs in the NYPH electronic health records (EHR) that distinguished the 2009 pandemic from previous seasonal influenza outbreaks via various statistical analyses.", {"entities": [[66, 75, "DISEASE"], [220, 229, "DISEASE"]]}], ["These signs include (1) an increase in the number of patients diagnosed with influenza, (2) a preponderance of influenza diagnoses outside of the normal flu season, and (3) marked vaccine failure.", {"entities": [[77, 86, "DISEASE"], [111, 120, "DISEASE"]]}], ["The NYPH EHR also reveals distinct age distributions of patients affected by seasonal influenza and the pandemic strain, and via available longitudinal data, suggests that the two may be associated with distinct sets of comorbid conditions as well.", {"entities": [[86, 95, "DISEASE"]]}], ["In particular, we find significantly more pandemic flu patients with diagnoses associated with asthma and underlying lung disease.", {"entities": [[95, 101, "DISEASE"], [117, 129, "DISEASE"]]}], ["We further observe that the NYPH EHR is capable of tracking diseases at a resolution as high as particular zip codes in New York City.", {"entities": []}], ["The NYPH EHR permits early detection of pandemic influenza and hypothesis generation via identification of those significantly associated illnesses.", {"entities": [[49, 58, "DISEASE"]]}], ["As data standards develop and databases expand, EHRs will contribute more and more to disease detection and the discovery of novel disease associations.", {"entities": []}], ["Mechanical ventilators are increasingly used in critical care units.", {"entities": []}], ["However, they can cause lung injury, including pulmonary edema.", {"entities": [[47, 62, "DISEASE"]]}], ["Our previous studies indicated that \u03b3-aminobutyric acid (GABA) receptors are involved in alveolar-fluid homeostasis.", {"entities": []}], ["The present study investigated the role of GABA receptors in ventilator-induced lung injury.", {"entities": []}], ["Adult female Sprague-Dawley rats were subjected to high-tidal-volume ventilation of 40 ml/kg body weight for 1 hour, and lung injuries were assessed.", {"entities": []}], ["High-tidal-volume ventilation resulted in lung injury, as indicated by an increase in total protein in bronchoalveolar fluid, wet-to-dry ratio (indication of pulmonary edema), and Evans Blue dye extravasation (indication of vascular damage).", {"entities": [[158, 173, "DISEASE"]]}], ["Intratracheal administration of GABA before ventilation significantly reduced the wet-to-dry ratio.", {"entities": []}], ["Further, histopathologic analysis indicated that GABA reduced ventilator-induced lung injury and apoptosis.", {"entities": []}], ["GABA-mediated reduction was effectively blocked by the GABA A -receptor antagonist, bicuculline.", {"entities": []}], ["The GABA-mediated effect was not due to the vascular damage, because no differences in Evans Blue dye extravasation were noted.", {"entities": []}], ["However, the decrease in alveolar fluid clearance by high-tidal-volume ventilation was partly prevented by GABA, which was blocked by bicuculline.", {"entities": []}], ["These results suggest that GABA reduces pulmonary edema induced by high-tidal-volume ventilation via its effects on alveolar fluid clearance and apoptosis.", {"entities": [[40, 55, "DISEASE"]]}], ["The effects of an analgesic treatment (lidocaine patches) on brain activity in chronic low back pain (CBP) and in knee osteoarthritis (OA) were investigated using serial fMRI (contrasting fMRI between before and after two weeks of treatment).", {"entities": [[119, 133, "DISEASE"]]}], ["Prior to treatment brain activity was distinct between the two groups: CBP spontaneous pain was associated mainly with activity in medial prefrontal cortex, while OA painful mechanical knee stimulation was associated with bilateral activity in the thalamus, secondary somatosensory, insular, and cingulate cortices, and unilateral activity in the putamen and amygdala.", {"entities": []}], ["After 5% lidocaine patches were applied to the painful body part for two weeks, CBP patients exhibited a significant decrease in clinical pain measures, while in OA clinical questionnaire based outcomes showed no treatment effect but stimulus evoked pain showed a borderline decrease.", {"entities": []}], ["The lidocaine treatment resulted in significantly decreased brain activity in both patient groups with distinct brain regions responding in each group, and sub-regions within these areas were correlated with pain ratings specifically for each group (medial prefrontal cortex in CBP and thalamus in OA).", {"entities": []}], ["We conclude that the two chronic pain conditions involve distinct brain regions, with OA pain engaging many brain regions commonly observed in acute pain.", {"entities": []}], ["Moreover, lidocaine patch treatment modulates distinct brain circuitry in each condition, yet in OA we observe divergent results with fMRI and with questionnaire based instruments.", {"entities": []}], ["Adipose tissue receptors C5aR and C5L2 and their heterodimerization/functionality and interaction with ligands C5a and acylation stimulating protein (ASP) have been evaluated in cell and rodent studies.", {"entities": []}], ["Their contribution to obesity factors in humans remains unclear.", {"entities": [[22, 29, "DISEASE"]]}], ["We hypothesized that C5a receptors, classically required for host defense, are also associated with adiposity.", {"entities": []}], ["Anthropometry and fasting blood parameters were measured in 136 women divided by body mass index (BMI): normal/overweight (\u226430\u2009kg/m n = 34), obese I (\u226445\u2009kg/m n = 33), obese II (\u226451\u2009kg/m n = 33), and obese III (\u226480\u2009kg/m n = 36).", {"entities": []}], ["Subcutaneous and omental adipose tissue C5aR and C5L2 expression were analysed.", {"entities": []}], ["C5L2 expression was comparable between subcutaneous and omental across all BMI groups.", {"entities": []}], ["Plasma ASP and ASP/omental C5L2 expression increased with BMI ( P < 0.001 and P < 0.01, resp.).", {"entities": []}], ["While plasma C5a was unchanged, C5aR expression decreased with increasing BMI in subcutaneous and omental tissues ( P < 0.01 and P < 0.05, resp.", {"entities": []}], ["), with subcutaneous omental depots.", {"entities": []}], ["Omental C5L2/C5aR ratio increased with BMI ( P < 0.01) with correlations between C5L2/C5aR and waist circumference, HDL-C, and adiponectin.", {"entities": []}], ["Tissue and BMI differences in receptors and ligands, particularly in omental, suggest relationship to metabolic disturbances and highlight adipose-immune interactions.", {"entities": []}], ["The impact of headache disorders is a problem of enormous proportions, both for individual and society.", {"entities": []}], ["The medical literature tried to assess its effects on individuals, by examining prevalence, distribution, attack frequency and duration, and headache-related disability, as well as effects on society, looking at the socio-economic burden of headache disorders [Rasmussen (Cephalalgia 19:20\u201323,", {"entities": []}], ["Light detection and ranging (LIDAR) can estimate daily volumes of sand dust particles from the East Asian desert to Japan.", {"entities": []}], ["The objective of this study was to investigate the relationship between sand dust particles and pulmonary function, and respiratory symptoms in adult patients with asthma.", {"entities": [[164, 170, "DISEASE"]]}], ["One hundred thirty-seven patients were included in the study.", {"entities": []}], ["From March 2013 to May 2013, the patients measured their morning peak expiratory flow (PEF) and kept daily lower respiratory symptom diaries.", {"entities": []}], ["A linear mixed model was used to estimate the correlation of the median daily levels of sand dust particles, symptoms scores, and PEF.", {"entities": []}], ["A heavy sand dust day was defined as an hourly concentration of sand dust particles of >0.1 km", {"entities": []}], ["Gastroesophageal reflux disease (GERD) is the most common digestive disease, affecting one third of the world\u2019s population.", {"entities": []}], ["The minimally invasive endoscopic Stretta procedure is being increasingly used as an alternative strategy to manage refractory GERD.", {"entities": []}], ["However, long-term benefits of this procedure have to be further evaluated in clinical settings.", {"entities": []}], ["This prospective observational study was therefore conducted to evaluate the outcome of patients with refractory GERD 5\u00a0years after the Stretta procedure.", {"entities": []}], ["A total of 152 patients with refractory GERD underwent the Stretta procedure in our department between April 2007 and September 2008.", {"entities": []}], ["They were followed up for 5\u00a0years, during which the primary outcome measures including symptom scores of heartburn, regurgitation, chest pain, cough and asthma and the secondary outcome measures including proton pump inhibitor (PPI) use and patients\u2019 satisfaction were analysed at 6, 12, 24, 36, 48 and 60\u00a0months respectively.", {"entities": [[153, 159, "DISEASE"]]}], ["Of the 152 patients, 138 completed the designated 5-year follow-up and were included in the final analysis.", {"entities": []}], ["At the end of the 5-year follow-up, the symptom scores of heartburn (2.47\u2009\u00b1\u20091.22 vs. 5.86\u2009\u00b1\u20091.52), regurgitation (2.23\u2009\u00b1\u20091.30 vs. 5.56\u2009\u00b1\u20091.65), chest pain (2.31\u2009\u00b1\u20090.76 vs. 4.79\u2009\u00b1\u20091.59), cough (3.14\u2009\u00b1\u20091.43 vs. 6.62\u2009\u00b1\u20091.73) and asthma (3.26\u2009\u00b1\u20091.53 vs. 6.83\u2009\u00b1\u20091.46) were all significantly decreased as compared with the corresponding values before the procedure (P\u2009<\u20090.001).", {"entities": [[226, 232, "DISEASE"]]}], ["After the Stretta procedure, 59 (42.8%) patients achieved complete PPI therapy independence and 104 (75.4%) patients were completely or partially satisfied with the GERD symptom control.", {"entities": []}], ["Moreover, no severe complications were observed except for complaint of abdominal distention in 12 (8.7%) patients after the Stretta procedure.", {"entities": []}], ["The Stretta procedure may achieve an effective and satisfactory long-term symptom control and considerably reduce the reliance on medication without significant adverse effects in adult patients with refractory GERD, thereby having profound clinical implications.", {"entities": []}], ["Federally qualified community health centers (CHCs) and rural health clinics (RHCs) are intended to provide access to care for vulnerable populations.", {"entities": []}], ["While some research has explored the effects of CHCs on population health, little information exists regarding RHC effects.", {"entities": []}], ["We sought to clarify the contribution that CHCs and RHCs may make to the accessibility of primary health care, as measured by county-level rates of hospitalization for ambulatory care sensitive (ACS) conditions.", {"entities": []}], ["We conducted an ecologic analysis of the relationship between facility presence and county-level hospitalization rates, using 2002 discharge data from eight states within the US (579 counties).", {"entities": []}], ["Counties were categorized by facility availability: CHC(s) only, RHC(s) only, both (CHC and RHC), and neither.", {"entities": []}], ["US Agency for Healthcare Research and Quality definitions were used to identify ACS diagnoses.", {"entities": []}], ["Discharge rates were based on the individual's county of residence and were obtained by dividing ACS hospitalizations by the relevant county population.", {"entities": []}], ["We calculated ACS rates separately for children, working age adults, and older individuals, and for uninsured children and working age adults.", {"entities": []}], ["To ensure stable rates, we excluded counties having fewer than 1,000 residents in the child or working age adult categories, or 500 residents among those 65 and older.", {"entities": []}], ["Multivariate Poisson analysis was used to calculate adjusted rate ratios.", {"entities": []}], ["Among working age adults, rate ratio (RR) comparing ACS hospitalization rates for CHC-only counties to those of counties with neither facility was 0.86 (95% Confidence Interval, CI, 0.78\u20130.95).", {"entities": []}], ["Among older adults, the rate ratio for CHC-only counties compared to counties with neither facility was 0.84 (CI 0.81\u20130.87); for counties with both CHC and RHC present, the RR was 0.88 (CI 0.84\u20130.92).", {"entities": []}], ["No CHC/RHC effects were found for children.", {"entities": []}], ["No effects were found on estimated hospitalization rates among uninsured populations.", {"entities": []}], ["Our results suggest that CHCs and RHCs may play a useful role in providing access to primary health care.", {"entities": []}], ["Their presence in a county may help to limit the county's rate of hospitalization for ACS diagnoses, particularly among older people.", {"entities": []}], ["(a) To assess the effects of computed tomography (CT) scanners, scanning conditions, airway size, and phantom composition on airway dimension measurement and (b) to investigate the limitations of accurate quantitative assessment of small airways using CT images.", {"entities": []}], ["An airway phantom, which was constructed using various types of material and with various tube sizes, was scanned using four CT scanner types under different conditions to calculate airway dimensions, luminal area (Ai), and the wall area percentage (WA%).", {"entities": []}], ["To investigate the limitations of accurate airway dimension measurement, we then developed a second airway phantom with a thinner tube wall, and compared the clinical CT images of healthy subjects with the phantom images scanned using the same CT scanner.", {"entities": []}], ["The study using clinical CT images was approved by the local ethics committee, and written informed consent was obtained from all subjects.", {"entities": []}], ["Data were statistically analyzed using one-way ANOVA.", {"entities": []}], ["Errors noted in airway dimension measurement were greater in the tube of small inner radius made of material with a high CT density and on images reconstructed by body algorithm (p<0.001), and there was some variation in error among CT scanners under different fields of view.", {"entities": []}], ["Airway wall thickness had the maximum effect on the accuracy of measurements with all CT scanners under all scanning conditions, and the magnitude of errors for WA% and Ai varied depending on wall thickness when airways of <1.0-mm wall thickness were measured.", {"entities": []}], ["The parameters of airway dimensions measured were affected by airway size, reconstruction algorithm, composition of the airway phantom, and CT scanner types.", {"entities": []}], ["In dimension measurement of small airways with wall thickness of <1.0 mm, the accuracy of measurement according to quantitative CT parameters can decrease as the walls become thinner.", {"entities": []}], ["Snoring can be a representative symptom of a sleep disorder, and thus snoring detection is quite important to improving the quality of an individual\u2019s daily life.", {"entities": [[45, 59, "DISEASE"]]}], ["The purpose of this research is to develop an unconstrained snoring detection technique that can be integrated into a smartphone application.", {"entities": []}], ["In contrast with previous studies, we developed a practical technique for snoring detection during ordinary sleep by using the built-in sound recording system of a smartphone, and the recording was carried out in a standard private bedroom.", {"entities": []}], ["The experimental protocol was designed to include a variety of actions that frequently produce noise (including coughing, playing music, talking, rining an alarm, opening/closing doors, running a fan, playing the radio, and walking) in order to accurately recreate the actual circumstances during sleep.", {"entities": []}], ["The sound data were recorded for 10 individuals during actual sleep.", {"entities": []}], ["In total, 44 snoring data sets and 75 noise datasets were acquired.", {"entities": []}], ["The algorithm uses formant analysis to examine sound features according to the frequency and magnitude.", {"entities": []}], ["Then, a quadratic classifier is used to distinguish snoring from non-snoring noises.", {"entities": []}], ["Ten-fold cross validation was used to evaluate the developed snoring detection methods, and validation was repeated 100 times randomly to improve statistical effectiveness.", {"entities": []}], ["The overall results showed that the proposed method is competitive with those from previous research.", {"entities": []}], ["The proposed method presented 95.07% accuracy, 98.58% sensitivity, 94.62% specificity, and 70.38% positive predictivity.", {"entities": []}], ["Though there was a relatively high false positive rate, the results show the possibility for ubiquitous personal snoring detection through a smartphone application that takes into account data from normally occurring noises without training using preexisting data.", {"entities": []}], ["Kimura's disease (KD) is a rare chronic inflammatory disease of unclear etiology, characterized by subcutaneous nodules, mainly in the head and neck region, frequently associated with regional lymphadenopathy.", {"entities": []}], ["Orbital involvement is infrequent and when it occurs, usually affects the eyelid or the lacrimal gland.", {"entities": []}], ["We report a case of a 44-year-old man that presented with bilateral slowly progressive proptosis that was initially misdiagnosed as Graves\u2019 Ophthalmopathy.", {"entities": []}], ["15 months of worsening proptosis and the development of facial and temporal swelling led to further investigation.", {"entities": []}], ["Computed tomography and magnetic resonance imaging showed enlargement of all recti muscles and diffuse orbital infiltration.", {"entities": []}], ["An orbital biopsy was performed and was consistent with the diagnosis of KD.", {"entities": []}], ["Long term oral corticosteroid showed marked improvement of proptosis and facial swelling.", {"entities": []}], ["This case serves to emphasize that KD should be included in the differential diagnosis of inflammatory diseases of the orbit, even when characterized by predominant involvement of the extraocular muscles.", {"entities": []}], ["The pedigree and genotype data from the Framingham Heart Study were examined for errors.", {"entities": []}], ["Errors in 21 of 329 pedigrees were detected with the program PREST, and of these the errors in 16 pedigrees were resolved.", {"entities": []}], ["Genotyping errors were then detected with SIMWALK2.", {"entities": []}], ["Five Mendelian errors were found following the pedigree corrections.", {"entities": []}], ["Double-recombinant errors were more common, with 142 being detected at mistyping probabilities of 0.25 or greater.", {"entities": []}], ["Recent studies show that formaldehyde participates in DNA demethylation/methylation cycle.", {"entities": []}], ["Emerging evidence identifies that neuronal activity induces global DNA demethylation and re-methylation; and DNA methylation is a critical step for memory formation.", {"entities": []}], ["These data suggest that endogenous formaldehyde may intrinsically link learning-responsive DNA methylation status and memory formation.", {"entities": []}], ["Here, we report that during spatial memory formation process, spatial training induces an initial global DNA demethylation and subsequent re-methylation associated with hippocampal formaldehyde elevation then decline to baseline level in Sprague Dawley rats.", {"entities": []}], ["Scavenging this elevated formaldehyde by formaldehyde-degrading enzyme (FDH), or enhancing DNA demethylation by a DNA demethylating agent, both led to spatial memory deficits by blocking DNA re-methylation in rats.", {"entities": []}], ["Furthermore, we found that the normal adult rats intrahippocampally injected with excess formaldehyde can imitate the aged-related spatial memory deficits and global DNA methylation decline.", {"entities": []}], ["These findings indicate that aging-associated excess formaldheyde contributes to cognitive decline during aging.", {"entities": []}], ["To determine the use of the mucin proteins MUC5B and MUC5AC as prognosis markers for non-small cell lung cancer (NSCLC) carrying epidermal growth factor receptor ( EGFR ) mutations.", {"entities": [[100, 111, "DISEASE"], [105, 111, "DISEASE"], [43, 48, "GENE"], [164, 168, "GENE"]]}], ["Patients who underwent surgical resection at Nagasaki University Hospital and related facilities in Japan between June 1996 and March 2013.", {"entities": []}], ["159 Japanese patients (male: n=103; female: n=56) with NSCLC, who underwent surgical resection ( EGFR -mutant type: n=78, EGFR wild type: n=81).", {"entities": [[97, 101, "GENE"], [122, 126, "GENE"], [97, 101, "GENE"], [122, 126, "GENE"]]}], ["Patients whose tumours expressed MUC5B had significantly longer overall survival and relapse-free survival compared to the MUC5B-negative patients with EGFR mutant NSCLC (p=0.0098 and p=0.0187, respectively).", {"entities": [[33, 38, "GENE"], [123, 128, "GENE"], [152, 156, "GENE"]]}], ["In patients with EGFR wild-type NSCLC, there was no association with MUC5B expression.", {"entities": [[17, 21, "GENE"], [69, 74, "GENE"]]}], ["MUC5AC expression was not different between EGFR mutant and wild-type NSCLC.", {"entities": [[44, 48, "GENE"]]}], ["Present findings indicate that MUC5B, but not MUC5AC, is a novel prognostic biomarker for patients with NSCLC carrying EGFR mutations but not for patients with NSCLC carrying wild-type EGFR .", {"entities": [[31, 36, "GENE"], [119, 123, "GENE"], [185, 189, "GENE"], [119, 123, "GENE"], [185, 189, "GENE"]]}], ["Glycopyrronium bromide has recently been approved as a once daily maintenance inhalation therapy for moderate to severe chronic obstructive pulmonary disease (COPD).", {"entities": [[120, 157, "DISEASE"]]}], ["Efficacy and safety trial data have found rare cases of significant QT prolongation.", {"entities": []}], ["To our knowledge, we describe the first case report of QT prolongation\u00a0>600\u00a0ms with initiation of glycopyrronium bromide in a real world setting.", {"entities": []}], ["A 78-year-old female with moderate COPD recently started on glycopyrronium bromide, presented to Emergency Department (ED) with syncope.", {"entities": []}], ["Her past medical history was significant for a left total mastectomy and she had been on Tamoxifen for 9\u00a0months.", {"entities": []}], ["One day prior to her presentation, she had visited a naturopathic clinic for a vitamin infusion resulting in emesis.", {"entities": []}], ["The following day she continued to feel dizzy and had a witnessed syncopal episode without any reported cardiac or neurological symptoms preceding the event or after regaining consciousness.", {"entities": []}], ["In the emergency department, she reported dizziness and was found to be hypotensive.", {"entities": []}], ["Her symptoms completely resolved with intravenous fluids.", {"entities": []}], ["Lab work was normal however her electrocardiogram (ECG) demonstrated a QTc interval of 603 and 631\u00a0ms (Friderica and Bazett\u2019s respectively) with a normal QT interval on her baseline ECG prior to initiating Tamoxifen.", {"entities": []}], ["She was admitted to the Cardiology service for further work-up of QT prolongation.", {"entities": []}], ["Her syncope was felt to be due to orthostatic hypotension and the QT prolongation secondary to medications, which were both discontinued during her admission.", {"entities": []}], ["After 2\u00a0days, her QT interval normalized consistent with the half-life of Glycopyrronium bromide (13\u201357\u00a0h) compared to Tamoxifen (8\u201314\u00a0days).", {"entities": []}], ["Glycopyrronium bromide is guideline recommended as first line therapy for prevention of exacerbation in moderate to severe COPD however safety data had been limited to select populations.", {"entities": []}], ["This case report highlights the need for future studies to identify high-risk populations at potential risk of life-threatening arrhythmias who may benefit from periodic ECG surveillance.", {"entities": []}], ["Lower urinary tract symptoms (LUTS), which encompass storage, voiding, and postmicturition symptoms, are highly prevalent and recognized globally.", {"entities": []}], ["Based on a nationwide population-based database, this study tests the hypothesis that medical attendance for LUTS is associated with a subsequent increase in the number of outpatient visits and hospitalizations, with differences among medical specialties and age groups.", {"entities": []}], ["Participants were selected from a random population sample of approximately one million people as a representative cohort of National Health Insurance (NHI) enrollees in Taiwan.", {"entities": []}], ["Participants had at least three outpatient service claims with a coding of LUTS during the recruitment period 2001\u20132004.", {"entities": []}], ["Both the LUTS group and non-LUTS control group were monitored for subsequent outpatient visits and hospitalizations, excluding LUTS-related healthcare services, for 2 years following the index date.", {"entities": []}], ["The results were categorized based on medical specialty and age group.", {"entities": []}], ["The outpatient visit rates (no.", {"entities": []}], ["per person-year) and adjusted incidence rate ratios (IRRs) (95% confidence interval (CI) were significantly higher in urology (4.51, 95%CI 4.15\u20134.91) and gynecology (1.82, 95%CI 1.76\u20131.89) for the LUTS group.", {"entities": []}], ["They were also significantly high in other departments, including internal medicine (1.25), general practice (1.13), Chinese medicine (1.77), family medicine (1.19), surgery (1.38), and psychiatry (1.98).", {"entities": []}], ["Similarly, the hospitalization rate (no.", {"entities": []}], ["per 1000 person-year) and adjusted IRRs (95% CI) were significantly higher in urology (5.50, 95% CI\u200a=\u200a4.60\u20136.50) and gynecology (1.60, 95% CI\u200a=\u200a1.35\u20131.90), as well as in internal medicine (1.55) and surgery (1.56), but not in psychiatry (1.12).", {"entities": []}], ["Furthermore, the IRRs differed among 3 age groups.", {"entities": []}], ["A significantly higher number of outpatient visits and hospitalizations were observed for individuals with LUTS, compared to the control group, and the effects differed with the advancement of age.", {"entities": []}], ["This study broadens understanding of LUTS by viewing their impact on healthcare services with multiple and overlapping systems, rather than considering them exclusively as symptoms of traditional diseases of the bladder and urethra.", {"entities": []}], ["The development of Sj\u00f6gren\u2019s syndrome (SjS) is a dynamic and temporal process with a female predilection.", {"entities": [[29, 37, "DISEASE"]]}], ["Following the initial influx of immune cells, T cell clusters develop, accelerating the pathology in the salivary glands.", {"entities": []}], ["Proinflammatory cytokines, IFN-\u03b3 and IL-17A, produced by T cells contribute synergistically to the disease.", {"entities": []}], ["In this study, we examined the sexual dimorphism in cellular infiltrates of the salivary glands by using functional single-cell microengraving analysis.", {"entities": []}], ["Using high-throughput sequencing, we investigated the clonal diversity of the T cell receptors (TCRs) of infiltrating IFN-\u03b3 and IL-17A-producing T cells in male and female SjS-susceptible (SjS Aec1Aec2 mice.", {"entities": []}], ["There were elevated frequencies of IFN-\u03b3 and IL-17A-producing effector T cell populations in female SjS", {"entities": []}], ["After 70 years with no confirmed autochthonous cases of dengue fever in Japan, 19 cases were reported during August\u2013September 2014.", {"entities": []}], ["Dengue virus serotype 1 was detected in 18 patients.", {"entities": []}], ["Phylogenetic analysis of the envelope protein genome sequence from 3 patients revealed 100% identity with the strain from the first patient (2014) in Japan.", {"entities": []}], ["Little is known about the prevalence, predictors and gender differences in hand grip strength of older adults in Africa.", {"entities": []}], ["This study aims to investigate social and health differences in hand grip strength among older adults in a national probability sample of older South Africans who participated in the Study of Global Ageing and Adults Health (SAGE wave 1) in 2008.", {"entities": []}], ["We conducted a national population-based cross-sectional study with a sample of 3840 men and women aged 50 years or older in South Africa.", {"entities": []}], ["The questionnaire included socio-demographic characteristics, health variables, and anthropometric measurements.", {"entities": []}], ["Linear multivariate regression analysis was performed to assess the association of social factors, health variables and grip strength.", {"entities": []}], ["The mean overall hand grip strength was 37.9 kgs for men (mean age 61.1\u00a0years, SD\u2009=\u20099.1) and 31.5 kgs for women (mean age 62.0\u00a0years, SD\u2009=\u20099.7).", {"entities": []}], ["In multivariate analysis among men, greater height, not being underweight and lower functional disability was associated with greater grip strength, and among women, greater height, better cognitive functioning, and lower functional disability were associated with greater grip strength.", {"entities": []}], ["Greater height and lower functional disability were found for both older South African men and women to be significantly associated with grip strength.", {"entities": []}], ["Tea is one of the most consumed beverages worldwide.", {"entities": []}], ["The healthy effects of tea are attributed to a wealthy of different chemical components from tea.", {"entities": []}], ["Thousands of studies on the chemical constituents of tea had been reported.", {"entities": []}], ["However, data from these individual reports have not been collected into a single database.", {"entities": []}], ["The lack of a curated database of related information limits research in this field, and thus a cohesive database system should necessarily be constructed for data deposit and further application.", {"entities": []}], ["The Tea Metabolome database (TMDB), a manually curated and web-accessible database, was developed to provide detailed, searchable descriptions of small molecular compounds found in Camellia spp.", {"entities": []}], ["in the plant Camellia sinensis and compounds in its manufactured products (different kinds of tea infusion).", {"entities": []}], ["TMDB is currently the most complete and comprehensive curated collection of tea compounds data in the world.", {"entities": []}], ["It contains records for more than 1393 constituents found in tea with information gathered from 364 published books, journal articles, and electronic databases.", {"entities": []}], ["It also contains experimental http://pcsb.ahau.edu.cn:8080/TCDB/index.jsp .", {"entities": []}], ["The TMDB is designed to address the broad needs of tea biochemists, natural products chemists, nutritionists, and members of tea related research community.", {"entities": []}], ["The TMDB database provides a solid platform for collection, standardization, and searching of compounds information found in tea.", {"entities": []}], ["As such this database will be a comprehensive repository for tea biochemistry and tea health research community.", {"entities": []}], ["Epidermal Langerhans cells (LCs) play a key role in immune defense mechanisms and in numerous immunological disorders.", {"entities": []}], ["In this report, we show that percutaneous infection of C57BL/6 mice with the helminth parasite Schistosoma mansoni leads to the activation of LCs but, surprisingly, to their retention in the epidermis.", {"entities": []}], ["Moreover, using an experimental model of LC migration induced by tumor necrosis factor (TNF)-\u03b1, we show that parasites transiently impair the departure of LCs from the epidermis and their subsequent accumulation as dendritic cells in the draining lymph nodes.", {"entities": [[88, 91, "GENE"]]}], ["The inhibitory effect is mediated by soluble lipophilic factors released by the parasites and not by host-derived antiinflammatory cytokines, such as interleukin-10.", {"entities": []}], ["We find that prostaglandin (PG)D 2 , but not the other major eicosanoids produced by the parasites, specifically impedes the TNF-\u03b1\u2013triggered migration of LCs through the adenylate cyclase\u2013coupled PGD 2 receptor (DP receptor).", {"entities": [[196, 199, "GENE"]]}], ["Moreover, the potent DP receptor antagonist BW A868C restores LC migration in infected mice.", {"entities": []}], ["Finally, in a model of contact allergen-induced LC migration, we show that activation of the DP receptor not only inhibits LC emigration but also dramatically reduces the contact hypersensitivity responses after challenge.", {"entities": []}], ["Taken together, we propose that the inhibition of LC migration could represent an additional stratagem for the schistosomes to escape the host immune system and that PGD 2 may play a key role in the control of cutaneous immune responses.", {"entities": [[166, 169, "GENE"]]}], ["Both vitamin D deficiency and genetic variants in the vitamin D receptor (VDR) have been reported to associate with delayed response to intensive-phase therapy for pulmonary tuberculosis.", {"entities": [[174, 186, "DISEASE"], [164, 186, "DISEASE"], [74, 77, "GENE"]]}], ["Studies investigating the influence of genetic variants in vitamin D binding protein (DBP) and vitamin D 25-hydroxylase (CYP2R1) on vitamin D status and response to antituberculous therapy are lacking.", {"entities": [[86, 89, "GENE"], [121, 127, "GENE"]]}], ["We conducted a longitudinal study in 260 patients initiating treatment for smear-positive pulmonary tuberculosis in Lahore, Pakistan.", {"entities": [[100, 112, "DISEASE"], [90, 112, "DISEASE"]]}], ["Vitamin D status and genotypes for polymorphisms in VDR (rs2228570, rs731236, rs1544410), DBP (rs7041, rs4588) and CYP2R1 (rs2060793, rs10500804, rs10766197) were determined at baseline.", {"entities": [[52, 55, "GENE"], [90, 93, "GENE"], [115, 121, "GENE"]]}], ["Sputum smear microscopy was performed at 2, 4, 6 and 8\u00a0weeks, and time to sputum smear conversion was estimated for each participant.", {"entities": []}], ["Analyses were conducted to determine demographic, clinical and genetic determinants of baseline vitamin D status and time to sputum smear conversion.", {"entities": []}], ["Profound vitamin D deficiency (serum 25[OH]D\u2009<\u200925\u00a0nmol/L) was highly prevalent at TB diagnosis (present in 54\u00a0% of patients), and was independently associated with female vs. male sex (adjusted OR 2.60, 95\u00a0% CI 1.50 to 4.52, P \u2009=\u20090.001), recruitment in October to March inclusive (adjusted OR 1.75, 95\u00a0% CI 1.00 to 3.04, P \u2009=\u20090.047) and bilateral vs. unilateral disease (adjusted OR 1.89, 95\u00a0% CI 1.49 to 4.52 P \u2009=\u20090.025).", {"entities": []}], ["Profound vitamin D deficiency was also independently associated with impaired response to antituberculous therapy (median time to sputum smear conversion 22.5 vs. 7.5\u00a0days for patients with serum 25[OH]D <25\u00a0nmol/L vs. \u2265 25\u00a0nmol/L, respectively; aHR 4.36, 95\u00a0% CI 3.25 to 6.65, P \u2009<\u20090.001).", {"entities": [[246, 249, "GENE"]]}], ["No polymorphisms in VDR, CYP2R1 and DBP studied associated with either baseline vitamin D status or time to sputum smear conversion.", {"entities": [[20, 23, "GENE"], [25, 31, "GENE"], [36, 39, "GENE"]]}], ["Profound vitamin D deficiency is very common among TB patients in Lahore, Pakistan, and is independently associated with significantly delayed sputum smear conversion.", {"entities": []}], ["Polymorphisms in VDR, CYP2R1 and DBP did not associate with baseline vitamin D status or response to intensive-phase treatment in this patient group.", {"entities": [[17, 20, "GENE"], [22, 28, "GENE"], [33, 36, "GENE"]]}], ["The Mushua Innu of Natuashish, Labrador, Canada seem to have a high rate of childhood eczema.", {"entities": []}], ["Anecdotally this problem seems to be more common now than 20\u00a0years ago.", {"entities": []}], ["There has been speculation that this could be related to food sensitization that may have arisen coincident with a move away from a traditional Innu diet.", {"entities": []}], ["We undertook to assess the prevalence and severity of pediatric eczema in Natuashish (population 792), and investigate the level of sensitization to common food antigens.", {"entities": []}], ["Over a three-month period we performed a population survey of all children in the community from the ages of 2\u201312 inclusive.", {"entities": []}], ["The one-year prevalence of eczema was assessed using the United Kingdom Working Party\u2019s diagnostic criteria, and graded on the Nottingham Severity Scale.", {"entities": []}], ["All children with eczema and twice as many age/sex matched controls were offered complete blood counts, total IgE, and food specific IgE levels for egg white, cow\u2019s milk protein and wheat.", {"entities": []}], ["One hundred and eighty two (95% of the eligible children) were assessed.", {"entities": []}], ["Of the 182 children examined eczema was diagnosed in 30 (16.5%) - 22 females and 8 males.", {"entities": []}], ["The majority of children with eczema (20/30) were classified as being in the moderate and severe category.", {"entities": []}], ["Of the 22 with eczema and 40 controls who consented to venipuncture all but 3 had IgE levels above the lab's reference range.", {"entities": []}], ["Food specific antibody assays showed that 32, 23, and 5 percent of children with eczema were sensitized to egg, milk, and wheat respectively.", {"entities": []}], ["None of the controls were sensitized.", {"entities": []}], ["The children of Natuashish, Labrador have a high rate of eczema, much of it graded as moderate or severe.", {"entities": []}], ["IgE levels were markedly elevated in children with and without eczema, with average values at least ten-fold higher than other populations.", {"entities": []}], ["There is no evidence of an unusual amount of sensitization to egg, milk or wheat.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is a preventable and treatable lung disease characterized by airflow limitation that is not fully reversible.", {"entities": [[76, 88, "DISEASE"]]}], ["In a significant proportion of patients with COPD, reduced lung elastic recoil combined with expiratory flow limitation leads to lung hyperinflation during the course of the disease.", {"entities": []}], ["Development of hyperinflation during the course of COPD is insidious.", {"entities": []}], ["Dynamic hyperinflation is highly prevalent in the advanced stages of COPD, and new evidence suggests that it also occurs in many patients with mild disease, independently of the presence of resting hyperinflation.", {"entities": []}], ["Hyperinflation is clinically relevant for patients with COPD mainly because it contributes to dyspnea, exercise intolerance, skeletal muscle limitations, morbidity, and reduced physical activity levels associated with the disease.", {"entities": []}], ["Various pharmacological and nonpharmacological interventions have been shown to reduce hyperinflation and delay the onset of ventilatory limitation in patients with COPD.", {"entities": []}], ["The aim of this review is to address the more recent literature regarding the pathogenesis, assessment, and management of both static and dynamic lung hyperinflation in patients with COPD.", {"entities": []}], ["We also address the influence of biological sex and obesity and new developments in our understanding of hyperinflation in patients with mild COPD and its evolution during progression of the disease.", {"entities": [[52, 59, "DISEASE"]]}], ["Effective communication of public health messages is a key strategy for health promotion by public health agencies.", {"entities": []}], ["Creating effective health promotion materials requires careful message design and feedback from representatives of target populations.", {"entities": []}], ["This is particularly true when the target audiences are hard to reach as limited English proficiency groups.", {"entities": []}], ["Traditional methods of soliciting feedback\u2014such as focus groups and convenience sample interviews\u2014are expensive and time consuming.", {"entities": []}], ["As a result, adequate feedback from target populations is often insufficient due to the time and resource constraints characteristic to public health.", {"entities": []}], ["To describe a pilot study investigating the use of crowdsourcing technology as a method to gather rapid and relevant feedback on the design of health promotion messages for oral health.", {"entities": []}], ["Our goal was to better describe the demographics of participants responding to a crowdsourcing survey and to test whether crowdsourcing could be used to gather feedback from English-speaking and Spanish-speaking participants in a short period of time and at relatively low costs.", {"entities": []}], ["We developed health promotion materials on pediatric dental health issues in four different formats and in two languages (English and Spanish).", {"entities": []}], ["We then designed an online survey to elicit feedback on format preferences and made it available in both languages via the Amazon Mechanical Turk crowdsourcing platform.", {"entities": []}], ["We surveyed 236 native English-speaking and 163 native Spanish-speaking participants in less than 12 days, at a cost of US $374.", {"entities": []}], ["Overall, Spanish-speaking participants originated from a wider distribution of countries than the overall Latino population in the United States.", {"entities": []}], ["Most participants were in the 18- to 29-year age range and had some college or graduate education.", {"entities": []}], ["Participants provided valuable input for the health promotion material design.", {"entities": []}], ["Our results indicate that crowdsourcing can be an effective method for recruiting and gaining feedback from English-speaking and Spanish-speaking people.", {"entities": []}], ["Compared with traditional methods, crowdsourcing has the potential to reach more diverse populations than convenience sampling, while substantially reducing the time and cost of gathering participant feedback.", {"entities": []}], ["More widespread adoption of this method could streamline the development of effective health promotion materials in multiple languages.", {"entities": []}], ["Breastfeeding-associated inflammatory breast diseases appear especially during the first twelve weeks postpartum and are the most common reason for early cessation of breastfeeding.", {"entities": []}], ["It also becomes increasingly evident that these inflammatory mammary diseases are triggered or perpetuated in a large part by psychosocial stress.", {"entities": []}], ["Immunological processes taking place during this cascade in the mammary gland and consequences for the breastfeed newborn are mostly yet unknown.", {"entities": []}], ["This review summarizes insights from studies on modulation of cytokine levels in breast milk during inflammatory processes like milk stasis and mastitis systematically.", {"entities": [[144, 152, "DISEASE"]]}], ["It also gives an overview on possible pathological effects, which these cytokine changes in the breast milk might have on the newborn.", {"entities": []}], ["Airway inflammation is the most common hallmark of allergic asthma.", {"entities": [[51, 66, "DISEASE"], [60, 66, "DISEASE"]]}], ["Chemokine receptors involved in leukocyte recruitment are closely related to the pathology in asthma.", {"entities": [[94, 100, "DISEASE"]]}], ["CCR9 has been described as a homeostatic and inflammatory chemokine receptor, but its role and that of its ligand CCL25 during lung inflammation remain unknown.", {"entities": [[0, 4, "GENE"], [114, 119, "GENE"]]}], ["To investigate the role of CCR9 as a modulator of airway inflammation, we established an OVA-induced allergic inflammation model in CCR9-deficient mice.", {"entities": [[27, 31, "GENE"], [132, 136, "GENE"]]}], ["Here, we report the expression of CCR9 and CCL25 as early as 6 hours post-OVA challenge in eosinophils and T-lymphocytes.", {"entities": [[34, 38, "GENE"], [43, 48, "GENE"]]}], ["Moreover, in challenged CCR9-deficient mice, cell recruitment was impaired at peribronchial and perivenular levels.", {"entities": []}], ["OVA-administration in CCR9-deficient mice leads to a less inflammatory cell recruitment, which modifies the expression of IL-10, CCL11, and CCL25 at 24 hours after OVA challenge.", {"entities": [[129, 134, "GENE"], [140, 145, "GENE"]]}], ["In contrast, the secretion of IL-4 and IL-5 was not affected in CCR9-deficient mice compared to WT mice.", {"entities": []}], ["These results demonstrate for the first time that CCR9 and CCL25 expressions are induced in the early stages of airway inflammation and they have an important role modulating eosinophils and lymphocytes recruitment at the first stages of inflammatory process, suggesting that they might be a potential target to regulate inflammation in asthma.", {"entities": [[337, 343, "DISEASE"], [50, 54, "GENE"], [59, 64, "GENE"]]}], ["Studies of human patellar and Achilles tendons have shown that primary tendon fibroblasts (tenocytes) not only have the capacity to produce acetylcholine (ACh) but also express muscarinic ACh receptors (mAChRs) through which ACh can exert its effects.", {"entities": []}], ["In patients with tendinopathy (chronic tendon pain) with tendinosis, the tendon tissue is characterised by hypercellularity and angiogenesis, both of which might be influenced by ACh.", {"entities": []}], ["In this study, we have tested the hypothesis that ACh increases the proliferation rate of tenocytes through mAChR stimulation and have examined whether this mechanism operates via the extracellular activation of the epidermal growth factor receptor (EGFR), as shown in other fibroblastic cells.", {"entities": [[250, 254, "GENE"]]}], ["By use of primary human tendon cell cultures, we identified cells expressing vimentin, tenomodulin and scleraxis and found that these cells also contained enzymes related to ACh synthesis and release (choline acetyltransferase and vesicular acetylcholine transporter).", {"entities": []}], ["The cells furthermore expressed mAChRs of several subtypes.", {"entities": []}], ["Exogenously administered ACh stimulated proliferation and increased the viability of tenocytes in vitro.", {"entities": []}], ["When the cells were exposed to atropine (an mAChR antagonist) or the EGFR inhibitor AG1478, the proliferative effect of ACh decreased.", {"entities": [[69, 73, "GENE"]]}], ["Western blot revealed increased phosphorylation, after ACh stimulation, for both EGFR and the extracellular-signal-regulated kinases 1 and 2.", {"entities": [[81, 85, "GENE"]]}], ["Given that tenocytes have been shown to produce ACh and express mAChRs, this study provides evidence of a possible autocrine loop that might contribute to the hypercellularity seen in tendinosis tendon tissue.", {"entities": []}], ["Large-scale and contemporary population-based studies of heart failure incidence are needed to inform resource planning and research prioritisation but current evidence is scarce.", {"entities": []}], ["We aimed to assess temporal trends in incidence and prevalence of heart failure in a large general population cohort from the UK, between 2002 and 2014.", {"entities": []}], ["For this population-based study, we used linked primary and secondary electronic health records of 4 million individuals from the Clinical Practice Research Datalink (CPRD), a cohort that is representative of the UK population in terms of age and sex.", {"entities": []}], ["Eligible patients were aged 16 years and older, had contributed data between Jan 1, 2002, and Dec 31, 2014, had an acceptable record according to CPRD quality control, were approved for CPRD and Hospital Episodes Statistics linkage, and were registered with their general practice for at least 12 months.", {"entities": []}], ["For patients with incident heart failure, we extracted the most recent measurement of baseline characteristics (within 2 years of diagnosis) from electronic health records, as well as information about comorbidities, socioeconomic status, ethnicity, and region.", {"entities": []}], ["We calculated standardised rates by applying direct age and sex standardisation to the 2013 European Standard Population, and we inferred crude rates by applying year-specific, age-specific, and sex-specific incidence to UK census mid-year population estimates.", {"entities": []}], ["We assumed no heart failure for patients aged 15 years or younger and report total incidence and prevalence for all ages (>0 years).", {"entities": []}], ["From 2002 to 2014, heart failure incidence (standardised by age and sex) decreased, similarly for men and women, by 7% (from 358 to 332 per 100\u2008000 person-years; adjusted incidence ratio 0\u00b793, 95% CI 0\u00b791\u20130\u00b794).", {"entities": []}], ["However, the estimated absolute number of individuals with newly diagnosed heart failure in the UK increased by 12% (from 170\u2008727 in 2002 to 190\u2008798 in 2014), largely due to an increase in population size and age.", {"entities": []}], ["The estimated absolute number of prevalent heart failure cases in the UK increased even more, by 23% (from 750\u2008127 to 920\u2008616).", {"entities": []}], ["Over the study period, patient age and multi-morbidity at first presentation of heart failure increased (mean age 76\u00b75 years [SD 12\u00b70] to 77\u00b70 years [12\u00b79], adjusted difference 0\u00b779 years, 95% CI 0\u00b737\u20131\u00b720; mean number of comorbidities 3\u00b74 [SD 1\u00b79] vs 5\u00b74 [2\u00b75]; adjusted difference 2\u00b70, 95% CI 1\u00b79\u20132\u00b71).", {"entities": []}], ["Socioeconomically deprived individuals were more likely to develop heart failure than were affluent individuals (incidence rate ratio 1\u00b761, 95% CI 1\u00b758\u20131\u00b764), and did so earlier in life than those from the most affluent group (adjusted difference \u22123\u00b751 years, 95% CI \u22123\u00b777 to \u22123\u00b725).", {"entities": []}], ["From 2002 to 2014, the socioeconomic gradient in age at first presentation with heart failure widened.", {"entities": []}], ["Socioeconomically deprived individuals also had more comorbidities, despite their younger age.", {"entities": []}], ["Despite a moderate decline in standardised incidence of heart failure, the burden of heart failure in the UK is increasing, and is now similar to the four most common causes of cancer combined.", {"entities": [[177, 183, "DISEASE"]]}], ["The observed socioeconomic disparities in disease incidence and age at onset within the same nation point to a potentially preventable nature of heart failure that still needs to be tackled.", {"entities": []}], ["British Heart Foundation and National Institute for Health Research.", {"entities": []}], ["To analyze hospitalization rates and the proportion of deaths due to ambulatory care-sensitive hospitalizations and to characterize them according to coverage by the Family Health Strategy, a primary health care guidance program.", {"entities": []}], ["An ecological study comprising 853 municipalities in the state of Minas Gerais, under the purview of 28 regional health care units, was conducted.", {"entities": []}], ["We used data from the Hospital Information System of the Brazilian Unified Health System.", {"entities": []}], ["Ambulatory care-sensitive hospitalizations in 2000 and 2010 were compared.", {"entities": []}], ["Population data were obtained from the demographic censuses.", {"entities": []}], ["The number of ambulatory care-sensitive hospitalizations declined from 20.75/1,000 inhabitants [standard deviation (SD) = 10.42) in 2000 to 14.92/thousand inhabitants (SD = 10.04) in 2010 Heart failure was the most frequent cause in both years.", {"entities": []}], ["Hospitalizations rates for hypertension, asthma, and diabetes mellitus, decreased, whereas those for angina pectoris, prenatal and birth disorders, kidney and urinary tract infections, and other acute infections increased.", {"entities": [[27, 39, "DISEASE"], [41, 47, "DISEASE"], [53, 70, "DISEASE"]]}], ["Hospitalization durations and the proportion of deaths due to ambulatory care-sensitive hospitalizations increased significantly.", {"entities": []}], ["Mean hospitalization rates for sensitive conditions were significantly lower in 2010 than in 2000, but no correlation was found with regard to the expansion of the population coverage of the Family Health Strategy.", {"entities": []}], ["Hospitalization rates and proportion of deaths were different between the various health care regions in the years evaluated, indicating a need to prioritize the primary health care with high efficiency and quality.", {"entities": []}], ["SYN-004 (ribaxamase) is a \u03b2-lactamase designed to be orally administered concurrently with intravenous \u03b2-lactam antibiotics, including most penicillins and cephalosporins.", {"entities": []}], ["Ribaxamase's anticipated mechanism of action is to degrade excess \u03b2-lactam antibiotic that is excreted into the small intestine.", {"entities": []}], ["This enzymatic inactivation of excreted antibiotic is expected to protect the gut microbiome from disruption and thus prevent undesirable side effects, including secondary infections such as Clostridium difficile infections, as well as other antibiotic-associated diarrheas.", {"entities": []}], ["In phase 1 clinical studies, ribaxamase was well tolerated compared to a placebo group and displayed negligible systemic absorption.", {"entities": []}], ["The two phase 2a clinical studies described here were performed to confirm the mechanism of action of ribaxamase, degradation of \u03b2-lactam antibiotics in the human intestine, and were therefore conducted in subjects with functioning ileostomies to allow serial sampling of their intestinal chyme.", {"entities": []}], ["Ribaxamase fully degraded ceftriaxone to below the level of quantitation in the intestines of all subjects in both studies.", {"entities": []}], ["Coadministration of oral ribaxamase with intravenous ceftriaxone was also well tolerated, and the plasma pharmacokinetics of ceftriaxone were unchanged by ribaxamase administration.", {"entities": []}], ["Since ribaxamase is formulated as a pH-dependent, delayed-release formulation, the activity of ribaxamase in the presence of the proton pump inhibitor esomeprazole was examined in the second study; coadministration of these drugs did not adversely affect ribaxamase's ability to degrade ceftriaxone excreted into the intestine.", {"entities": []}], ["These studies have confirmed the in vivo mechanism of action of ribaxamase, degradation of \u03b2-lactam antibiotics in the human intestine (registered at ClinicalTrials.gov under NCT02419001 and NCT02473640).", {"entities": []}], ["The objective was to investigate the potential implication of the IL18 gene promoter polymorphisms in the susceptibility to giant-cell arteritis (GCA).", {"entities": [[66, 70, "GENE"], [146, 149, "GENE"]]}], ["In total, 212 patients diagnosed with biopsy-proven GCA were included in this study.", {"entities": [[52, 55, "GENE"]]}], ["DNA from patients and matched controls was obtained from peripheral blood.", {"entities": []}], ["Samples were genotyped for the IL18 -137 G>C (rs187238), the IL18 -607 C>A (rs1946518), and the IL18 -1297 T>C (rs360719) gene polymorphisms with polymerase chain reaction, by using a predesigned TaqMan allele discrimination assay.", {"entities": [[31, 35, "GENE"], [61, 65, "GENE"], [96, 100, "GENE"], [31, 35, "GENE"], [61, 65, "GENE"], [96, 100, "GENE"], [31, 35, "GENE"], [61, 65, "GENE"], [96, 100, "GENE"]]}], ["No significant association between the IL18 -137 G>C polymorphism and GCA was found.", {"entities": [[39, 43, "GENE"], [70, 73, "GENE"]]}], ["However, the IL18 -607 allele A was significantly increased in GCA patients compared with controls (47.8% versus 40.9% in patients and controls respectively; P = 0.02; OR, 1.32; 95% CI, 1.04 to 1.69).", {"entities": [[13, 17, "GENE"], [63, 66, "GENE"]]}], ["It was due to an increased frequency of homozygosity for the IL18 -607 A/A genotype in patients with GCA (20.4%) compared with controls (13.4%) ( IL18 -607 A/A versus IL18 -607 A/C plus IL18 -607 C/C genotypes: P = 0.04; OR, 1.59; 95% CI, 1.02 to 2.46).", {"entities": [[61, 65, "GENE"], [146, 150, "GENE"], [167, 171, "GENE"], [186, 190, "GENE"], [101, 104, "GENE"], [61, 65, "GENE"], [146, 150, "GENE"], [167, 171, "GENE"], [186, 190, "GENE"], [61, 65, "GENE"], [146, 150, "GENE"], [167, 171, "GENE"], [186, 190, "GENE"], [61, 65, "GENE"], [146, 150, "GENE"], [167, 171, "GENE"], [186, 190, "GENE"]]}], ["Also, the IL18 -1297 allele C was significantly increased in GCA patients (30.7%) compared with controls (23.0%) ( P = 0.003; OR, 1.48; 95% CI, 1.13 to 1.95).", {"entities": [[10, 14, "GENE"], [61, 64, "GENE"]]}], ["In this regard, an increased susceptibility to GCA was observed in individuals carrying the IL18 -1297 C/C or the IL18 -1297 C/T genotypes compared with those carrying the IL18 -1297 T/T genotype ( IL18 -1297 C/C plus IL18 -1297 T/C versus IL18 -1297 T/T genotype in GCA patients compared with controls: P = 0.005; OR, 1.61; 95% CI, 1.15 to 2.25).", {"entities": [[47, 50, "GENE"], [267, 270, "GENE"], [92, 96, "GENE"], [114, 118, "GENE"], [172, 176, "GENE"], [198, 202, "GENE"], [218, 222, "GENE"], [240, 244, "GENE"], [92, 96, "GENE"], [114, 118, "GENE"], [172, 176, "GENE"], [198, 202, "GENE"], [218, 222, "GENE"], [240, 244, "GENE"], [92, 96, "GENE"], [114, 118, "GENE"], [172, 176, "GENE"], [198, 202, "GENE"], [218, 222, "GENE"], [240, 244, "GENE"], [92, 96, "GENE"], [114, 118, "GENE"], [172, 176, "GENE"], [198, 202, "GENE"], [218, 222, "GENE"], [240, 244, "GENE"], [92, 96, "GENE"], [114, 118, "GENE"], [172, 176, "GENE"], [198, 202, "GENE"], [218, 222, "GENE"], [240, 244, "GENE"], [92, 96, "GENE"], [114, 118, "GENE"], [172, 176, "GENE"], [198, 202, "GENE"], [218, 222, "GENE"], [240, 244, "GENE"], [47, 50, "GENE"], [267, 270, "GENE"]]}], ["We also found an additive effect of the IL18 -1297 and -607 polymorphisms with TLR4 Asp299Gly polymorphism.", {"entities": [[40, 44, "GENE"], [79, 83, "GENE"]]}], ["The OR for GCA was 1.95 for combinations of genotypes with one or two risk alleles, whereas carriers of three or more risk alleles have an OR of 3.7.", {"entities": [[11, 14, "GENE"]]}], ["Our results show for the first time an implication of IL18 gene-promoter polymorphisms in the susceptibility to biopsy-proven GCA.", {"entities": [[54, 58, "GENE"], [126, 129, "GENE"]]}], ["In addition, an additive effect between the associated IL18 and TLR4 genetic variants was observed.", {"entities": [[55, 59, "GENE"], [64, 68, "GENE"]]}], ["This paper presents a detailed description of an approach designed to investigate the application of the Health Impact Assessment (HIA) framework to assess the potential health impacts of climate change.", {"entities": []}], ["A HIA framework has been combined with key climate change terminology and concepts.", {"entities": []}], ["The fundamental premise of this framework is an understanding of the interactions between people, the environment and climate.", {"entities": []}], ["The diversity and complexity of these interactions can hinder much needed action on the critical health issue of climate change.", {"entities": []}], ["The objectives of the framework are to improve the methodology for understanding and assessing the risks associated with potential health impacts of climate change, and to provide decision-makers with information that can facilitate the development of effective adaptation plans.", {"entities": []}], ["While the process presented here provides guidance with respect to this task it is not intended to be prescriptive.", {"entities": []}], ["As such, aspects of the process can be amended to suit the scope and available resources of each project.", {"entities": []}], ["A series of working tables has been developed to assist in the collation of evidence throughout the process.", {"entities": []}], ["The framework has been tested in a number of locations including Western Australia, Solomon Islands, Vanuatu and Nauru.", {"entities": []}], ["Canine atopic dermatitis is a common pruritic skin disease often treated with allergen immunotherapy (AIT).", {"entities": [[7, 24, "DISEASE"], [46, 58, "DISEASE"], [14, 24, "DISEASE"]]}], ["AIT in dogs traditionally begins with attempting to identify clinically relevant environmental allergens.", {"entities": []}], ["Current allergen testing methodologies and immunotherapy techniques in dogs are not standardized.", {"entities": []}], ["Immunotherapy with a mixture of allergenic extracts selected based on regional aerobiology rather than intradermal tests or serum IgE assays has been described.", {"entities": []}], ["The objective of this study was to evaluate the effectiveness of regionally-specific immunotherapy in dogs with atopic dermatitis.", {"entities": [[112, 129, "DISEASE"], [119, 129, "DISEASE"]]}], ["The medical records of a veterinary dermatology referral clinic were searched for dogs with atopic dermatitis that began regionally-specific subcutaneous immunotherapy from June, 2010 to May, 2013.", {"entities": [[92, 109, "DISEASE"], [99, 109, "DISEASE"]]}], ["An overall assessment of treatment effectiveness (excellent, good, fair, or poor) was assigned based upon changes in pruritus severity, lesion severity, and the reduction in concurrent medication(s) during a follow-up period of at least 270\u00a0days.", {"entities": []}], ["Baseline characteristics that might predict treatment success were analyzed with the Spearman\u2019s correlation and the Kruskal-Wallis tests.", {"entities": []}], ["Of the 286 dogs that began regionally-specific immunotherapy (RESPIT) during a 3 year period, 103 met the inclusion criteria.", {"entities": []}], ["The overall response to RESPIT was classified as excellent in 19%, good in 38%, fair in 25%, and poor in 18% of dogs.", {"entities": []}], ["The response classification correlated significantly with a reduction in pruritus severity ( r \u2009=\u20090.72, p \u2009<\u20090.001) and lesion severity ( r \u2009=\u20090.54, p \u2009<\u20090.001), but not with the dogs\u2019 baseline characteristics.", {"entities": []}], ["Adverse reactions were reported in 7/286 (2.4%) of treated dogs.", {"entities": []}], ["Under the conditions of this study, RESPIT was safe and effective for the treatment of atopic dermatitis in dogs.", {"entities": [[87, 104, "DISEASE"], [94, 104, "DISEASE"]]}], ["ATS/ERS Task Force has highlighted that special attention must be paid when FEV 1 and FVC are concomitantly decreased (<5 1 /FVC ratio is normal (>5 Observational study of routinely collected data selected from our Clinical Database Warehouse.", {"entities": [[76, 79, "GENE"]]}], ["The prevalence of NSP was 841/12 775 tests (6.6%, 95% CI: 6.2 to 7.0%).", {"entities": []}], ["NSP was mainly associated with seven lung diseases: asthma (prevalence of NSP among asthmatics: 12.6%), COPD/emphysema (prevalence 8.6%), bronchiectasis (12.8%), sarcoidosis (10.7%), interstitial pneumonia (4.0%), pulmonary hypertension (8.9%) and bilateral lung transplantation for cystic fibrosis (36.0%).", {"entities": [[224, 236, "DISEASE"], [196, 205, "DISEASE"], [138, 152, "DISEASE"], [283, 298, "DISEASE"], [162, 173, "DISEASE"], [214, 236, "DISEASE"], [52, 58, "DISEASE"]]}], ["LFT measurements were described in 185 patients with NSP and indisputable nonoverlapping causes.", {"entities": []}], ["A moderate defect (FEV 1 : 66\u2009\u00b1\u20099% predicted) with mild lung hyperinflation (FRC: 111\u2009\u00b1\u200927%, RV: 131\u2009\u00b1\u200933% predicted: suggesting distal airway obstruction) was evidenced whatever the underlying cause.", {"entities": [[19, 22, "GENE"]]}], ["A long term stability of NSP was evidenced in 130/185 patients (70% 95% CI: 64 to 77%).", {"entities": []}], ["NSP is observed in asthma, COPD/emphysema, bronchiectasis, sarcoidosis, pulmonary hypertension, interstitial pneumonia and after bilateral lung transplantation and remains stable in the majority of patients.", {"entities": [[82, 94, "DISEASE"], [109, 118, "DISEASE"], [43, 57, "DISEASE"], [59, 70, "DISEASE"], [72, 94, "DISEASE"], [19, 25, "DISEASE"]]}], ["Pulmonary rehabilitation with core components of exercise training and multiprofessional education is an integral part of the management of patients with chronic lung disease.", {"entities": [[162, 174, "DISEASE"]]}], ["International guidelines for individuals with asthma recommend exercise as exercise improves symptoms, indices of cardiopulmonary efficiency, health status and psychosocial outcome.", {"entities": [[46, 52, "DISEASE"]]}], ["However, there is little published evidence evaluating safety and acceptability of exercise training for individuals with severe asthma and there are concerns regarding exercise-induced asthma.", {"entities": [[129, 135, "DISEASE"], [186, 192, "DISEASE"]]}], ["We propose a feasibility study for a multicentre randomised controlled trial (RCT) of asthma-tailored pulmonary rehabilitation (asthma-tailored PR) versus usual care in individuals with severe asthma.", {"entities": [[86, 92, "DISEASE"], [128, 134, "DISEASE"], [193, 199, "DISEASE"]]}], ["The study will be conducted in three stages.", {"entities": []}], ["Adults with severe asthma will be included if they have persistent symptoms despite being at step 4 or 5 of the British Thoracic Society guidelines.", {"entities": [[19, 25, "DISEASE"]]}], ["Stage 1: semistructured interviews will be used in a sample of 20\u201330 individuals with severe asthma to understand the experience and attitudes of this population towards exercise.", {"entities": [[93, 99, "DISEASE"]]}], ["Stage 2: eight focus groups of at least six healthcare professionals involved in the care of patients with severe asthma will be conducted to understand their attitudes towards exercise for this population.", {"entities": [[114, 120, "DISEASE"]]}], ["Stage 3: a small-scale RCT of the proposed multicentre RCT of asthma-tailored PR versus usual care for individuals with severe asthma will be conducted.", {"entities": [[62, 68, "DISEASE"], [127, 133, "DISEASE"]]}], ["The primary outcome measures will be recruitment, retention and adverse event rates.", {"entities": []}], ["Semistructured interviews with participants of stage 3 will be used to identify further barriers or facilitators to participation in PR and the trial.", {"entities": []}], ["Thematic analysis will be used for the interpretation of all interviews.", {"entities": []}], ["The study results will inform the design of a larger multicentre RCT.", {"entities": []}], ["The National Research Ethics Service Committee East Midland approved the study protocol.", {"entities": []}], ["ISRCTN96143888.", {"entities": []}], ["The association between TP53 R72P and/or MDM2 SNP309 polymorphisms and hepatocellular carcinoma (HCC) risk has been widely reported, but results were inconsistent.", {"entities": [[71, 95, "DISEASE"], [86, 95, "DISEASE"], [24, 28, "GENE"], [41, 45, "GENE"]]}], ["To clarify the effects of these polymorphisms on HCC risk, an updated meta-analysis of all available studies was conducted.", {"entities": []}], ["Eligible articles were identified by search of databases including PubMed, Cochrane Library, EMBASE and Chinese Biomedical Literature database (CBM) for the period up to July 2013.", {"entities": []}], ["Data were extracted by two independent authors and pooled odds ratio (OR) with 95% confidence interval (CI) was calculated.", {"entities": []}], ["Metaregression and subgroup analyses were performed to identify the source of heterogeneity.", {"entities": []}], ["Finally, a total of 10 studies including 2,243 cases and 3,615 controls were available for MDM2 SNP309 polymorphism and 14 studies containing 4,855 cases and 6,630 controls were included for TP53 R72P polymorphism.", {"entities": [[91, 95, "GENE"], [191, 195, "GENE"]]}], ["With respect to MDM2 SNP309 polymorphism, significantly increased HCC risk was found in the overall population.", {"entities": [[16, 20, "GENE"]]}], ["In subgroup analysis by ethnicity and hepatitis virus infection status, significantly increased HCC risk was found in Asians, Caucasians, Africans, and HCV positive patients.", {"entities": [[38, 47, "DISEASE"]]}], ["With respect to TP53 R72P polymorphism, no significant association with HCC risk was observed in the overall and subgroup analyses.", {"entities": [[16, 20, "GENE"]]}], ["In the MDM2 SNP309\u2013TP53 R72P interaction analysis, we found that subjects with MDM2 309TT and TP53 Pro/Pro genotype, MDM2 309 TG and TP53 Arg/Pro genotype, and MDM2 309 GG and TP53 Pro/Pro genotype were associated with significantly increased risk of developing HCC as compared with the reference MDM2 309TT and TP53 Arg/Arg genotype.", {"entities": [[7, 11, "GENE"], [79, 83, "GENE"], [117, 121, "GENE"], [160, 164, "GENE"], [297, 301, "GENE"], [7, 11, "GENE"], [79, 83, "GENE"], [117, 121, "GENE"], [160, 164, "GENE"], [297, 301, "GENE"], [19, 23, "GENE"], [94, 98, "GENE"], [133, 137, "GENE"], [176, 180, "GENE"], [312, 316, "GENE"], [7, 11, "GENE"], [79, 83, "GENE"], [117, 121, "GENE"], [160, 164, "GENE"], [297, 301, "GENE"], [126, 128, "GENE"], [19, 23, "GENE"], [94, 98, "GENE"], [133, 137, "GENE"], [176, 180, "GENE"], [312, 316, "GENE"], [7, 11, "GENE"], [79, 83, "GENE"], [117, 121, "GENE"], [160, 164, "GENE"], [297, 301, "GENE"], [19, 23, "GENE"], [94, 98, "GENE"], [133, 137, "GENE"], [176, 180, "GENE"], [312, 316, "GENE"], [7, 11, "GENE"], [79, 83, "GENE"], [117, 121, "GENE"], [160, 164, "GENE"], [297, 301, "GENE"], [19, 23, "GENE"], [94, 98, "GENE"], [133, 137, "GENE"], [176, 180, "GENE"], [312, 316, "GENE"]]}], ["We concluded that MDM2 SNP309 polymorphism may play an important role in the carcinogenesis of HCC.", {"entities": [[18, 22, "GENE"]]}], ["In addition, our findings further suggest that the combination of MDM2 SNP 309 and TP53 Arg72Pro genotypes confers higher risk to develop HCC.", {"entities": [[66, 70, "GENE"], [83, 87, "GENE"]]}], ["Further large and well-designed studies are needed to confirm this association.", {"entities": []}], ["From a public health perspective, a healthier community environment correlates with fewer occurrences of chronic or infectious diseases.", {"entities": []}], ["Our premise is that community health is a non-linear function of environmental and socioeconomic effects that are not normally distributed among communities.", {"entities": []}], ["The objective was to integrate multivariate data sets representing social, economic, and physical environmental factors to evaluate the hypothesis that communities with similar environmental characteristics exhibit similar distributions of disease.", {"entities": []}], ["The SOM algorithm used the intrinsic distributions of 92 environmental variables to classify 511 communities into five clusters.", {"entities": []}], ["SOM determined clusters were reprojected to geographic space and compared with the distributions of several health outcomes.", {"entities": []}], ["ANOVA results indicated that the variability between community clusters was significant with respect to the spatial distribution of disease occurrence.", {"entities": []}], ["Our study demonstrated a positive relationship between environmental conditions and health outcomes in communities using the SOM-GIS method to overcome data and methodological challenges traditionally encountered in public health research.", {"entities": []}], ["Results demonstrated that community health can be classified using environmental variables and that the SOM-GIS method may be applied to multivariate environmental health studies.", {"entities": []}], ["The Global Lung Function Initiative 2012 (GLI) reference values are currently endorsed by several respiratory societies but evaluations of applicability for adults resident in European countries are lacking.", {"entities": []}], ["The aim of this study was to evaluate if the GLI reference values are appropriate for an adult Caucasian Swedish population.", {"entities": []}], ["During 2008\u20132013, clinical examinations including spirometry were performed on general population samples in northern Sweden, in which 501 healthy Caucasian non-smokers were identified.", {"entities": []}], ["Predicted GLI reference values and Z-scores were calculated for each healthy non-smoking subject and the distributions and mean values for FEV 1 , FVC and the FEV 1 /FVC ratio were examined.", {"entities": [[139, 142, "GENE"], [159, 162, "GENE"], [139, 142, "GENE"], [159, 162, "GENE"]]}], ["The prevalence of airway obstruction among these healthy non-smokers was calculated based on the Lower Limit of normal (LLN) criterion (lower fifth percentile) for the FEV 1 /FVC ratio.", {"entities": [[168, 171, "GENE"]]}], ["Thus, by definition, a prevalence of 5% was expected.", {"entities": []}], ["The Z-scores for FEV 1 , FVC and FEV 1 /FVC were reasonably, although not perfectly, normally distributed, but not centred on zero.", {"entities": [[17, 20, "GENE"], [33, 36, "GENE"], [17, 20, "GENE"], [33, 36, "GENE"]]}], ["Both predicted FEV 1 and, in particular, FVC were lower compared to the observed values in the sample.", {"entities": [[15, 18, "GENE"]]}], ["The deviations were greater among women compared to men.", {"entities": []}], ["The prevalence of airway obstruction based on the LLN criterion for the FEV 1 /FVC ratio was 9.4% among women and 2.7% among men.", {"entities": [[72, 75, "GENE"]]}], ["The use of the GLI reference values may produce biased prevalence estimates of airway obstruction in Sweden, especially among women.", {"entities": []}], ["These results demonstrate the importance of validating the GLI reference values in different countries.", {"entities": []}], ["The online version of this article (doi:10.1186/s12890-015-0022-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Rapid Access Outpatient Units (RAOUs) have been suggested as an alternative to hospital inpatient units for the management of some acutely unwell children.", {"entities": []}], ["These units can provide ambulatory care, delivered close to home, and may prevent unnecessary hospital admission.", {"entities": []}], ["There are no qualitative data on the views of primary care practitioners regarding these types of facilities.", {"entities": []}], ["The aim of the study was to explore the opinions of primary care practitioners regarding a newly established RAOU.", {"entities": []}], ["The RAOU was established locally at a district general hospital when inpatient beds were closed and moved to an inpatient centre, based six miles away at the tertiary teaching hospital.", {"entities": []}], ["Qualitative, practice based group interviews with primary care practitioners (general practitioners (GPs), nurse practitioners and practice nurses) on their experiences of the RAOU.", {"entities": []}], ["The data collection consisted of three practice based interviews with 14 participants.", {"entities": []}], ["The interviews were recorded and transcribed verbatim.", {"entities": []}], ["Thematic content analysis was used to evaluate the data.", {"entities": []}], ["There was positive feedback regarding ease of telephone access for referral, location, and the value of a service staffed by senior doctors where children could be observed, investigated and discharged quickly.", {"entities": []}], ["There was confusion regarding the referral criteria for the assessment unit and where to send certain children.", {"entities": []}], ["A majority of the practitioners felt the utility of the RAOU was restricted by its opening hours.", {"entities": []}], ["Most participants felt they lacked sufficient information regarding the remit and facilities of the unit and this led to some uneasiness regarding safety and long term sustainability.", {"entities": []}], ["Practitioners considered that the RAOU offered a rapid senior opinion, flexible short term observation, quick access to investigations and was more convenient for patients.", {"entities": []}], ["There were concerns regarding opening hours, safety of patients and lack of information about the unit's facilities.", {"entities": []}], ["There was confusion about which children should be sent to the unit.", {"entities": []}], ["This study raises questions regarding policy in regard to the organisation of paediatric services.", {"entities": []}], ["It highlights that when establishing alternative services to local inpatient units, continual communication and engagement of primary care is essential if the units are to function effectively.", {"entities": []}], ["Unintentional weight loss (UWL) is common in older age and associated with adverse outcomes including mortality.", {"entities": []}], ["The aim of the present study was to determine psychosocial correlates of UWL.", {"entities": []}], ["Data were derived from a large, nationally representative study of community-dwelling individuals in the second half of life (40 years and over) in Germany in 2014 (n = 7,933).", {"entities": []}], ["Data on UWL were assessed in face-to-face interviews as unintentional loss of more than 5kg (11 pounds) in weight in the past 12 months, and data on psychosocial factors were recorded in self-administered questionnaires.", {"entities": []}], ["Multiple logistic regressions revealed that UWL was positively associated with depressive symptoms and positive affect, whereas it was negatively associated with self-esteem.", {"entities": []}], ["Individuals with UWL were more likely to feel lonely and perceive themselves as socially excluded.", {"entities": []}], ["The findings of important psychosocial correlates of UWL may help to identify individuals at risk for UWL in older age.", {"entities": []}], ["This is in particular important since interventions to treat this phenomenon in older age are available that reduce adverse consequences resulting from UWL.", {"entities": []}], ["Nickel compounds are known to cause respiratory cancer in humans and induce tumors in experimental animals.", {"entities": [[48, 54, "DISEASE"]]}], ["The underlying molecular mechanisms may involve genotoxic effects; however, the data from different research groups are not easy to reconcile.", {"entities": []}], ["Here, we challenge the common premise that direct genotoxic effects are central to nickel carcinogenesis and probably to that of other metals.", {"entities": []}], ["Instead, we propose that it is formation of metal complexes with proteins and other molecules that changes cellular homeostasis and provides conditions for selection of cells with transformed phenotype.", {"entities": []}], ["This is concordant with the major requirement for nickel carcinogenicity, which is prolonged action on the target tissue.", {"entities": []}], ["If DNA is not the main nickel target, is there another unique molecule that can be attacked with carcinogenic consequences?", {"entities": []}], ["Our recent observations indicate that ascorbate may be such a molecule.", {"entities": []}], ["Nickel depletes intracellular ascorbate, which leads to the inhibition of cellular hydroxylases, manifested by the loss of hypoxia-inducible factor (HIF)-1\u03b1 and - 2\u03b1 hydroxylation and hypoxia-like stress.", {"entities": []}], ["Proline hydroxylation is crucial for collagen and extracellular matrix assembly as well as for assembly of other protein molecules that have collagen-like domains, including surfactants and complement.", {"entities": []}], ["Thus, the depletion of ascorbate by chronic exposure to nickel could be deleterious for lung cells and may lead to lung cancer.", {"entities": [[115, 126, "DISEASE"], [120, 126, "DISEASE"]]}], ["Uncontrolled inflammation is one of the leading causes of kidney failure.", {"entities": [[58, 72, "DISEASE"]]}], ["Pro-inflammatory responses can occur in the absence of infection, a process called sterile inflammation.", {"entities": []}], ["Here we show that the purinergic receptor P2Y 14 (GPR105) is specifically and highly expressed in collecting duct intercalated cells (ICs) and mediates sterile inflammation in the kidney.", {"entities": []}], ["P2Y 14 is activated by UDP-glucose, a damage-associated molecular pattern molecule (DAMP) released by injured cells.", {"entities": []}], ["We found that UDP-glucose increases pro-inflammatory chemokine expression in ICs as well as MDCK-C11 cells, and UDP-glucose activates the MEK1/2-ERK1/2 pathway in MDCK-C11 cells.", {"entities": []}], ["These effects were prevented following inhibition of P2Y 14 with the small molecule PPTN.", {"entities": []}], ["Tail vein injection of mice with UDP-glucose induced the recruitment of neutrophils to the renal medulla.", {"entities": []}], ["This study identifies ICs as novel sensors, mediators and effectors of inflammation in the kidney via P2Y 14 .", {"entities": []}], ["Jaagsiekte sheep retrovirus (JSRV) is a unique oncogenic virus with distinctive biological properties.", {"entities": []}], ["JSRV is the only virus causing a naturally occurring lung cancer (ovine pulmonary adenocarcinoma, OPA) and possessing a major structural protein that functions as a dominant oncoprotein.", {"entities": [[82, 96, "DISEASE"], [53, 64, "DISEASE"], [58, 64, "DISEASE"]]}], ["Lung cancer is the major cause of death among cancer patients.", {"entities": [[0, 11, "DISEASE"], [5, 11, "DISEASE"], [46, 52, "DISEASE"]]}], ["OPA can be an extremely useful animal model in order to identify the cells originating lung adenocarcinoma and to study the early events of pulmonary carcinogenesis.", {"entities": [[92, 106, "DISEASE"], [87, 106, "DISEASE"]]}], ["In this study, we demonstrated that lung adenocarcinoma in sheep originates from infection and transformation of proliferating type 2 pneumocytes (termed here lung alveolar proliferating cells, LAPCs).", {"entities": [[41, 55, "DISEASE"], [36, 55, "DISEASE"]]}], ["We excluded that OPA originates from a bronchioalveolar stem cell, or from mature post-mitotic type 2 pneumocytes or from either proliferating or non-proliferating Clara cells.", {"entities": []}], ["We show that young animals possess abundant LAPCs and are highly susceptible to JSRV infection and transformation.", {"entities": []}], ["On the contrary, healthy adult sheep, which are normally resistant to experimental OPA induction, exhibit a relatively low number of LAPCs and are resistant to JSRV infection of the respiratory epithelium.", {"entities": []}], ["Importantly, induction of lung injury increased dramatically the number of LAPCs in adult sheep and rendered these animals fully susceptible to JSRV infection and transformation.", {"entities": []}], ["Furthermore, we show that JSRV preferentially infects actively dividing cell in vitro .", {"entities": []}], ["Overall, our study provides unique insights into pulmonary biology and carcinogenesis and suggests that JSRV and its host have reached an evolutionary equilibrium in which productive infection (and transformation) can occur only in cells that are scarce for most of the lifespan of the sheep.", {"entities": []}], ["Our data also indicate that, at least in this model, inflammation can predispose to retroviral infection and cancer.", {"entities": [[109, 115, "DISEASE"]]}], ["The identification of cells that give origin to cancer is critical in order to design effective therapeutic strategies.", {"entities": [[48, 54, "DISEASE"]]}], ["To this end, the early stages of cancer are the most informative but they are seldom associated with clinical symptoms and therefore pass unnoticed in human patients.", {"entities": [[33, 39, "DISEASE"]]}], ["Studies on animal tumors are invaluable to this research area.", {"entities": []}], ["In this study, we determined the cells originating an infectious lung cancer of sheep (ovine pulmonary adenocarcinoma, OPA) that is similar to some forms of human pulmonary adenocarcinoma.", {"entities": [[103, 117, "DISEASE"], [173, 187, "DISEASE"], [65, 76, "DISEASE"], [70, 76, "DISEASE"]]}], ["OPA is caused by a virus known as Jaagsiekte sheep retrovirus (JSRV).", {"entities": []}], ["We show that OPA is caused by JSRV infection of proliferating type 2 pneumocytes (lung alveolar proliferating cells, LAPCs).", {"entities": []}], ["We show that young animals possess abundant LAPCs and are highly susceptible to JSRV infection while healthy adult sheep exhibit a relatively low number of LAPCs and are resistant to OPA induction.", {"entities": []}], ["However, adult sheep were susceptible to JSRV infection when the presence of LAPCs was stimulated by induction of a mild injury to the respiratory epithelium.", {"entities": []}], ["Thus, our study identifies the cells originating lung adenocarcinoma in OPA and shows that inflammation to the respiratory epithelium can predispose to retrovirus infection and cancer.", {"entities": [[54, 68, "DISEASE"], [49, 68, "DISEASE"], [177, 183, "DISEASE"]]}], ["Mycobacterium neoaurum is rapidly growing mycobacteria that can cause human infections.", {"entities": []}], ["It commonly causes bloodstream infections in immunocompromised hosts, and unlike other mycobacteria species, it rarely causes pulmonary infections.", {"entities": []}], ["We confirmed the first pulmonary infection case in Korea caused by M. neoaurum using full-length 16S rRNA gene sequencing.", {"entities": []}], ["The immune-mediated hepatobiliary diseases, primary biliary cirrhosis and primary sclerosing cholangitis are relatively rare, albeit and account for a significant amount of liver transplant activity and liver-related mortality globally.", {"entities": [[82, 104, "DISEASE"], [44, 69, "DISEASE"], [93, 104, "DISEASE"]]}], ["Precise disease mechanisms are yet to be described although a contributory role of genetic predisposition is firmly established.", {"entities": []}], ["In addition to links with the major histocompatibility complex, a number of associations outside this region harbor additional loci which underscore the fundamental role of breaks in immune tolerance and mucosal immunogenicity in the pathogenesis of autoimmune biliary disease.", {"entities": []}], ["We provide an overview of these key discoveries before discussing putative avenues of therapeutic exploitation based on existing findings.", {"entities": []}], ["Human rhinoviruses (HRVs), in the Enterovirus genus within the family Picornaviridae , are a highly prevalent cause of acute respiratory infection (ARI).", {"entities": []}], ["Enteroviruses are genetically highly variable, and recombination between serotypes is known to be a major contribution to their diversity.", {"entities": []}], ["Recently it was reported that recombination events in HRVs cause the diversity of HRV-C.", {"entities": []}], ["This study analyzed parts of the viral genes spanning the 5\u2032 non- coding region (NCR) through to the viral protein (VP) encoding sequences of 105 HRV field isolates from 51 outpatient cases of Acute Respiratory Infectious Network (ARINET) and 54 inpatient cases of severe lower respiratory infection (SLRI) surveillance, in order to identify recombination in field samples.", {"entities": []}], ["When analyzing parts of the 5\u2032NCR and VP4/VP2 encoding sequences, we found intra- and interspecies recombinants in field strains of HRV-A and -C. Nineteen cases of recombination events (18.1%) were found among 105 field strains.", {"entities": []}], ["For HRV-A, there were five cases (4.8%) of intraspecies recombination events and three cases (2.8%) of interspecies recombination events.", {"entities": []}], ["For HRV-C, there were four cases (3.8%) of intraspecies recombination events and seven cases (6.7%) of interspecies recombination events.", {"entities": []}], ["Recombination events were significantly more frequently observed in the ARINET samples (18 cases) than in the SLRI samples (1 case; P < 0.0001).", {"entities": []}], ["The recombination breakpoints were located in nucleotides (nt) 472\u2013554, which comprise stem-loop 5 in the internal ribosomal entry site (IRES), based on the HRV-B 35 sequence (accession no.", {"entities": []}], ["Our findings regarding genomic recombination in circulating HRV-A and -C strains suggest that recombination might play a role in HRV fitness and could be a possible determinant of disease severity caused by various HRV infections in patients with ARI.", {"entities": []}], ["To investigate the prevalence of clinical anxiety and clinical depression in Chinese young and mid-aged patients with osteonecrosis of the femoral head (ONFH) and to analyze their potential risk factors.", {"entities": [[118, 131, "DISEASE"]]}], ["Two hundred and sixteen Chinese patients with ONFH were consecutively enrolled in this cross-sectional study from January 2010 to December 2010.", {"entities": []}], ["The Zung self-rating anxiety scale (SAS) and the Zung self-rating depression scale (SDS) were used to assess the prevalence of clinical anxiety and clinical depression.", {"entities": [[84, 87, "GENE"]]}], ["An additional questionnaire containing seventeen items of potential risk factors was completed by all patients.", {"entities": []}], ["Binary logistic regression analysis was employed to reveal potential risk factors of anxiety and depression.", {"entities": []}], ["The prevalence of clinical anxiety and clinical depression was 20.4% and 21.8% in Chinese young and middle-aged patients with ONFH, respectively.", {"entities": []}], ["Binary regression analysis showed that independent risk factors correlated with high incidence of clinical anxiety included involved femoral head (OR = 3.168, 95% CI : 1.496 - 6.708) and stages of ONFH (OR IV-V / II = 5.383, 95% CI : 1.664-17.416).", {"entities": []}], ["Independent risk factors correlated with high incidence of depression included gender (OR = 2.853, 95% CI : 1.467-5.778), comorbid diseases (OR = 4.243, 95% CI : 1.940-9.278) and stages of the disease (OR IV-V/II = 16.963, 95% CI : 4.404-65.331).", {"entities": []}], ["Patients with bilateral ONFH are inclined to have clinical anxiety, while female patients and patients with comorbid diseases might tend to get clinical depression.", {"entities": []}], ["Advanced stages of ONFH are independent risk factors for both clinical anxiety and clinical depression.", {"entities": []}], ["Southwest metropolitan Mexico City children are repeatedly exposed to high levels of a complex mixture of air pollutants, including ozone, particulate matter, aldehydes, metals, and nitrogen oxides.", {"entities": []}], ["We explored nasal cell 8-hydroxy-2'-deoxyguanosine (8-OHdG), a major mutagenic lesion producing G-->T transversion mutations, using an immunohistochemical method, and DNA single strand breaks (ssb) using the single cell gel electrophoresis assay as biomarkers of oxidant exposure.", {"entities": [[193, 196, "GENE"]]}], ["Nasal biopsies from the posterior inferior turbinate were examined in children in grades one through five, including 12 controls from a low-polluted coastal town and 87 Mexico City children.", {"entities": []}], ["Each biopsy was divided for the 8-OHdG and DNA ssb assays.", {"entities": [[47, 50, "GENE"]]}], ["There was an age-dependent increase in the percentage of nasal cells with DNA tails > 10 microm in Mexico City children: 19 +/- 9% for control cells, and 43 +/- 4, 50 +/- 16, 56 +/- 17, 60 +/- 17 and 73 +/- 14%, respectively, for first through fifth graders (p < 0.05).", {"entities": []}], ["Nasal ssb were significantly higher in fifth graders than in first graders (p < 0.05).", {"entities": [[6, 9, "GENE"]]}], ["Higher levels (2.3- to 3-fold) of specific nuclear staining for 8-OHdG were observed in exposed children as compared to controls (p < 0.05).", {"entities": []}], ["These results suggest that DNA damage is present in nasal epithelial cells in Mexico City children.", {"entities": []}], ["Persistent oxidative DNA damage may ultimately result in a selective growth of pr eneoplastic nasal initiated cells in this population and the potential for nasal neoplasms may increase with age.", {"entities": []}], ["The combination of 8-OHdG and DNA ssb should be useful for monitoring oxidative damage in people exposed to polluted atmospheres.", {"entities": [[34, 37, "GENE"]]}], ["The autoimmune thyroid diseases (AITD), including Graves\u2019 disease (GD) and Hashimoto\u2019s thyroiditis (HT), are caused by interactions between susceptibility genes and environmental triggers.", {"entities": [[87, 98, "DISEASE"]]}], ["Single nucleotide polymorphisms (SNPs) of Solute carrier family 22, member 4 ( SLC22A4 ) have been shown to be associated with several autoimmune diseases, including Crohn\u2019s disease (CD) and rheumatoid arthritis (RA).", {"entities": [[191, 211, "DISEASE"], [202, 211, "DISEASE"], [79, 86, "GENE"]]}], ["The aim of this study is to investigate whether SNP rs3792876 in the SLC22A4 gene is associated with GD, HT and AITD in a Chinese Han population.", {"entities": [[69, 76, "GENE"]]}], ["In this study, we collected specimens from 553 Chinese Han individuals of 92 AITD pedigrees in 10 cities in Liaoning province, China (80 GD pedigrees, 478 members; 12 HT pedigrees, 75 members).", {"entities": []}], ["SNP rs3792876 was genotyped using the TaqMan allelic discrimination assay.", {"entities": []}], ["Hardy-Weinberg Equilibrium tests were performed among founders of the pedigrees using Haploview software.", {"entities": []}], ["Family-based association tests performed using FBAT software.", {"entities": []}], ["No deviation from Hardy-Weinberg equilibrium was observed ( p \u2009>\u20090.05).", {"entities": []}], ["There were not significant association between the SLC22A4 gene polymorphism (rs3792876) and GD, HT and AITD was found.", {"entities": [[51, 58, "GENE"]]}], ["These results suggest a lack of association between the SLC22A4 gene polymorphism rs3792876 and susceptibility to GD, HT and AITD in a Chinese Han population.", {"entities": [[56, 63, "GENE"]]}], ["Gel-forming mucins are macromolecules produced by goblet cells and responsible for the mucus gel formation.", {"entities": []}], ["Changes in goblet cell density and in gel-forming mucin production have emerged as sensitive indicators for mucosal diseases.", {"entities": []}], ["A Muc5b-GFP tagged reporter mouse was used to assess Muc5b production in mouse tissues by immunofluorescence microscopy and fluorescent activity using stereromicroscopy and probe-based confocal laser endomicroscopy.", {"entities": [[2, 7, "GENE"], [53, 58, "GENE"]]}], ["Muc5b production was followed longitudinally by recording the fluorescent activity in vagina and in embryonic lung explants under stimulation by interleukin 13.", {"entities": [[0, 5, "GENE"]]}], ["We show that the GFP is easily visualized in the mouse adult ear, nose, trachea, gallbladder, and cervix.", {"entities": []}], ["Live Muc5b is also easily monitored in the nasal cavity, trachea and vagina where its production varies during the estrus cycle with a peak at the proestrus phase and in pregnant mice.", {"entities": [[5, 10, "GENE"]]}], ["Explant culture of reporter mouse embryonic whole lung shows that interleukin 13 stimulates Muc5b production.", {"entities": [[92, 97, "GENE"]]}], ["The transgenic Muc5b-GFP mouse is unique and suitable to study the mechanisms that regulate Muc5b production/secretion and mucous cell differentiation by live imaging and can be applied to test drug efficacy in mucosal disease models.", {"entities": [[15, 20, "GENE"], [92, 97, "GENE"]]}], ["Genetic variants at the vitamin D receptor (VDR) locus are associated with asthma and atopy.", {"entities": [[75, 81, "DISEASE"], [44, 47, "GENE"]]}], ["We hypothesized that polymorphisms in other genes of the vitamin D pathway are associated with asthma or atopy.", {"entities": [[95, 101, "DISEASE"]]}], ["Eleven candidate genes were chosen for this study, five of which code for proteins in the vitamin D metabolism pathway ( CYP27A1 , CYP27B1 , CYP2R1 , CYP24A1 , GC ) and six that are known to be transcriptionally regulated by vitamin D ( IL10 , IL1RL1 , CD28 , CD86 , IL8 , SKIIP ).", {"entities": [[121, 128, "GENE"], [131, 138, "GENE"], [141, 147, "GENE"], [150, 157, "GENE"], [160, 162, "GENE"], [237, 241, "GENE"], [244, 250, "GENE"], [253, 257, "GENE"], [260, 264, "GENE"], [267, 270, "GENE"]]}], ["For each gene, we selected a maximally informative set of common SNPs (tagSNPs) using the European-derived (CEU) HapMap dataset.", {"entities": []}], ["A total of 87 SNPs were genotyped in a French-Canadian family sample ascertained through asthmatic probands (388 nuclear families, 1064 individuals) and evaluated using the Family Based Association Test (FBAT) program.", {"entities": []}], ["We then sought to replicate the positive findings in four independent samples: two from Western Canada, one from Australia and one from the USA (CAMP).", {"entities": []}], ["A number of SNPs in the IL10 , CYP24A1 , CYP2R1 , IL1RL1 and CD86 genes were modestly associated with asthma and atopy (p < 0.05).", {"entities": [[102, 108, "DISEASE"], [24, 28, "GENE"], [31, 38, "GENE"], [41, 47, "GENE"], [50, 56, "GENE"], [61, 65, "GENE"]]}], ["Two-gene models testing for both main effects and the interaction were then performed using conditional logistic regression.", {"entities": []}], ["Two-gene models implicating functional variants in the IL10 and VDR genes as well as in the IL10 and IL1RL1 genes were associated with asthma (p < 0.0002).", {"entities": [[135, 141, "DISEASE"], [55, 59, "GENE"], [92, 96, "GENE"], [64, 67, "GENE"], [55, 59, "GENE"], [92, 96, "GENE"], [101, 107, "GENE"]]}], ["In the replicate samples, SNPs in the IL10 and CYP24A1 genes were again modestly associated with asthma and atopy (p < 0.05).", {"entities": [[97, 103, "DISEASE"], [38, 42, "GENE"], [47, 54, "GENE"]]}], ["However, the SNPs or the orientation of the risk alleles were different between populations.", {"entities": []}], ["A two-gene model involving IL10 and VDR was replicated in CAMP, but not in the other populations.", {"entities": [[27, 31, "GENE"], [36, 39, "GENE"]]}], ["A number of genes involved in the vitamin D pathway demonstrate modest levels of association with asthma and atopy.", {"entities": [[98, 104, "DISEASE"]]}], ["Multilocus models testing genes in the same pathway are potentially more effective to evaluate the risk of asthma, but the effects are not uniform across populations.", {"entities": [[107, 113, "DISEASE"]]}], ["Amphetamine analogues are produced by plants in the genus Ephedra and by khat ( Catha edulis ), and include the widely used decongestants and appetite suppressants (1 S ,2 S )-pseudoephedrine and (1 R ,2 S )-ephedrine.", {"entities": []}], ["The production of these metabolites, which derive from L-phenylalanine, involves a multi-step pathway partially mapped out at the biochemical level using knowledge of benzoic acid metabolism established in other plants, and direct evidence using khat and Ephedra species as model systems.", {"entities": []}], ["Despite the commercial importance of amphetamine-type alkaloids, only a single step in their biosynthesis has been elucidated at the molecular level.", {"entities": []}], ["We have employed Illumina next-generation sequencing technology, paired with Trinity and Velvet-Oases assembly platforms, to establish data-mining frameworks for Ephedra sinica and khat plants.", {"entities": []}], ["Sequence libraries representing a combined 200,000 unigenes were subjected to an annotation pipeline involving direct searches against public databases.", {"entities": []}], ["Annotations included the assignment of Gene Ontology (GO) terms used to allocate unigenes to functional categories.", {"entities": []}], ["As part of our functional genomics program aimed at novel gene discovery, the databases were mined for enzyme candidates putatively involved in alkaloid biosynthesis.", {"entities": []}], ["Queries used for mining included enzymes with established roles in benzoic acid metabolism, as well as enzymes catalyzing reactions similar to those predicted for amphetamine alkaloid metabolism.", {"entities": []}], ["Gene candidates were evaluated based on phylogenetic relationships, FPKM-based expression data, and mechanistic considerations.", {"entities": []}], ["Establishment of expansive sequence resources is a critical step toward pathway characterization, a goal with both academic and industrial implications.", {"entities": []}], ["Indacaterol is a novel, inhaled, once-daily, ultra-long-acting \u03b2 2 -agonist for the treatment of chronic obstructive pulmonary disease (COPD).", {"entities": [[97, 134, "DISEASE"]]}], ["This randomized, double-blind study compared the bronchodilator efficacy of indacaterol with that of placebo and tiotropium in patients with moderate-to-severe COPD.", {"entities": []}], ["In an incomplete-block, multi-dose, three-period, crossover design, patients received three of the following four treatments: indacaterol 150 \u03bcg, indacaterol 300 \u03bcg, tiotropium 18 \u03bcg and placebo, each once-daily for 14 days.", {"entities": []}], ["Each treatment period was separated by a 14-day washout.", {"entities": []}], ["Study drug was supplied daily by blinded, third party study personnel to maintain blinding of patients and investigators.", {"entities": []}], ["The primary efficacy variable was trough forced expiratory volume in one second (FEV 1 ) at 24 h post-dose after 14 days.", {"entities": [[81, 84, "GENE"]]}], ["The study was powered to demonstrate non-inferiority of indacaterol to tiotropium for this variable.", {"entities": []}], ["A total of 169 patients were randomized (mean age 65 years); 153 (90.5%) completed.", {"entities": []}], ["Trough FEV 1 after 14 days with indacaterol 150 \u03bcg and 300 \u03bcg was statistically and clinically superior to placebo, with differences (95% CI) of 170 (120-220) and 150 (100-200) mL respectively (both p < 0.001).", {"entities": [[7, 10, "GENE"]]}], ["For this endpoint, both doses of indacaterol not only met the criterion for non-inferiority compared with tiotropium, but also achieved numerically higher values, with differences versus tiotropium of 40 and 30 mL for indacaterol 150 and 300 \u03bcg, respectively.", {"entities": []}], ["At 5 min post-dose on Day 1, the mean FEV 1 for both indacaterol doses was significantly higher than placebo (by 120 and 130 mL for indacaterol 150 and 300 \u03bcg, respectively; p < 0.001) and tiotropium (by 80 mL for both doses; p < 0.001).", {"entities": [[38, 41, "GENE"]]}], ["Adverse events were reported by similar proportions of patients: 31.4%, 29.5%, 28.3% and 28.5% for indacaterol 150 \u03bcg and 300 \u03bcg, tiotropium and placebo treatments, respectively.", {"entities": []}], ["Once-daily indacaterol provided clinically and statistically significant 24-h bronchodilation.", {"entities": []}], ["Indacaterol was at least as effective as tiotropium, with a faster onset of action (within 5 min) on the first day of dosing.", {"entities": []}], ["Indacaterol should prove useful in patients with moderate-to-severe COPD, for whom treatment with one or more classes of long-acting bronchodilator is recommended.", {"entities": []}], ["ClinicalTrials.gov: NCT00615459, EudraCT number: 2007-004071-19", {"entities": []}], ["Placental insufficiency, high altitude pregnancies, maternal obesity/diabetes, maternal undernutrition and stress can result in a poor setting for growth of the developing fetus.", {"entities": [[61, 68, "DISEASE"]]}], ["These adverse intrauterine environments result in physiological changes to the developing heart that impact how the heart will function in postnatal life.", {"entities": []}], ["The intrauterine environment plays a key role in the complex interplay between genes and the epigenetic mechanisms that regulate their expression.", {"entities": []}], ["In this review we describe how an adverse intrauterine environment can influence the expression of miRNAs (a sub-set of non-coding RNAs) and how these changes may impact heart development.", {"entities": []}], ["Potential consequences of altered miRNA expression in the fetal heart include; Hypoxia inducible factor (HIF) activation, dysregulation of angiogenesis, mitochondrial abnormalities and altered glucose and fatty acid transport/metabolism.", {"entities": []}], ["It is important to understand how miRNAs are altered in these adverse environments to identify key pathways that can be targeted using miRNA mimics or inhibitors to condition an improved developmental response.", {"entities": []}], ["GSK233705 is an inhaled, long-acting muscarinic antagonist in development for the treatment of chronic obstructive pulmonary disease (COPD).", {"entities": [[95, 132, "DISEASE"]]}], ["This study was performed to see if the addition of GSK233705 to salmeterol would provide greater bronchodilation than salmeterol or tiotropium alone in COPD.", {"entities": []}], ["In an incomplete-block, three-period, crossover design, dually responsive patients received three of the following five treatments: GSK233705 20 \u03bcg plus salmeterol 50 \u03bcg twice-daily; GSK233705 50 \u03bcg plus salmeterol 50 \u03bcg twice-daily; salmeterol 50 \u03bcg or placebo, each twice-daily; and tiotropium 18 \u03bcg or placebo once-daily for 7 days.", {"entities": []}], ["Each treatment period was separated by a 14-day washout.", {"entities": []}], ["The primary efficacy endpoint was morning (trough) forced expiratory volume in 1 second (FEV 1 ) on Day 8, following 7 days of treatment.", {"entities": [[89, 92, "GENE"]]}], ["Secondary endpoints included pulmonary function, plethysmography, pharmacokinetics of GSK233705 and salmeterol, adverse events (AEs), electrocardiograms (ECGs), vital signs, and laboratory parameters.", {"entities": []}], ["A total of 47 patients were randomized.", {"entities": []}], ["The mean % predicted normal postbronchodilator FEV 1 was 55% at screening.", {"entities": [[47, 50, "GENE"]]}], ["Compared with placebo (n = 24), the adjusted mean change from baseline in trough FEV 1 on Day 8 was 215 mL higher with GSK233705 20 \u03bcg + salmeterol (n = 23) and 203 mL higher with GSK233705 50 \u03bcg + salmeterol (n = 27), whereas with salmeterol (n = 27) and tiotropium (n = 28) the changes were 101 mL and 118 mL higher, respectively.", {"entities": [[81, 84, "GENE"]]}], ["The primary efficacy results were supported by the results from the other secondary lung function assessments.", {"entities": []}], ["AEs were reported by similar proportions of patients across the treatment groups, with headache the most frequently reported treatment-related AE reported by one subject receiving each of GSK233705 20 \u03bcg + salmeterol, tiotropium, and placebo.", {"entities": []}], ["No significant differences were seen in vital signs, ECGs, or laboratory parameters between the groups.", {"entities": []}], ["The addition of GSK233705 to salmeterol in partially reversible COPD patients resulted in greater bronchodilation than salmeterol or tiotropium alone and was well tolerated.", {"entities": []}], ["Diffuse alveolar damage (DAD), which is the histological surrogate for acute respiratory distress syndrome (ARDS), has a multifactorial aetiology.", {"entities": [[98, 106, "DISEASE"]]}], ["Therefore it is possible that the immunopathology differs among the various presentations of DAD.", {"entities": []}], ["The aim of this study is to compare lung immunopathology of viral (influenza A(H1N1)pdm09) to non-viral, extrapulmonary aetiologies in autopsy cases with DAD.", {"entities": [[67, 76, "DISEASE"]]}], ["The lung tissue of 44 patients, was divided in the H1N1 group ( n \u00a0=\u00a015) characterized by severe pulmonary injury due to influenza A(H1N1)pdm09 infection; the ARDS group ( n \u00a0=\u00a013), characterized by patients with DAD due to non-pulmonary causes; and the Control group ( n \u00a0=\u00a016), consisting of patients with non-pulmonary causes of death.", {"entities": [[121, 130, "DISEASE"]]}], ["Immunohistochemistry and image analysis were used to quantify, in the parenchyma and small airways, several immune cell markers.", {"entities": []}], ["Both DAD groups had higher expression of neutrophils and macrophages in parenchyma and small airways.", {"entities": []}], ["However, there was a higher expression of CD4+ and CD8+ T lymphocytes, CD83+ dendritic cells, granzyme A+ and natural killer\u00a0+\u00a0cell density in the lung parenchyma of the H1N1 group ( p \u00a0<\u00a00.05).", {"entities": []}], ["In the small airways, there was a lower cell density of tryptase\u00a0+\u00a0mast cells and dendritic\u00a0+\u00a0cells and an increase of IL-17 in both DAD groups ( p \u00a0<\u00a00.05).", {"entities": []}], ["DAD due to viral A(H1N1)pdm09 is associated with a cytotoxic inflammatory phenotype, with partially divergent responses in the parenchyma relative to the small airways.", {"entities": []}], ["In non-viral DAD, main immune cell alterations were found at the small airway level, reinforcing the role of the small airways in the pathogenesis of the exudative phase of DAD.", {"entities": []}], ["The online version of this article (doi:10.1186/s12931-017-0630-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Several low and middle-income countries are implementing electronic health records (EHR).", {"entities": []}], ["In the near future, EHRs could become an efficient tool to evaluate healthcare performance if appropriate indicators are developed.", {"entities": []}], ["The aims of this study are: a) to develop quality of care indicators (QCIs) for type 2 diabetes (T2DM) in the Mexican Institute of Social Security (IMSS) health system; b) to determine the feasibility of constructing QCIs using the IMSS EHR data; and c) to evaluate the quality of care (QC) provided to IMSS patients with T2DM.", {"entities": []}], ["We used a three-stage mixed methods approach: a) development of QCIs following the RAND-UCLA method; b) EHR data extraction and construction of indicators; c) QC evaluation using EHR data from 25,130 T2DM patients who received care in 2009.", {"entities": []}], ["We developed 18 QCIs, of which 14 were possible to construct using available EHR data.", {"entities": []}], ["QCIs comprised both process of care and health outcomes.", {"entities": []}], ["Several flaws in the EHR design and quality of data were identified.", {"entities": []}], ["The indicators of process and outcomes of care suggested areas for improvement.", {"entities": []}], ["For example, only 13.0% of patients were referred to an ophthalmologist; 3.9% received nutritional counseling; 63.2% of overweight/obese patients were prescribed metformin, and only 23% had HbA1c <7% (or plasma glucose \u2264130\u2009mg/dl).", {"entities": []}], ["EHR data can be used to evaluate QC.", {"entities": []}], ["The results identified both strengths and weaknesses in the electronic information system as well as in the process and outcomes of T2DM care at IMSS.", {"entities": []}], ["This information can be used to guide targeted interventions to improve QC.", {"entities": []}], ["Chronic airway diseases pose a big challenge to health systems in most developing countries, particularly in Sub-Saharan Africa.", {"entities": []}], ["A diagnosis for people with chronic or persistent cough is usually delayed because of individual and health system barriers.", {"entities": []}], ["However, delayed diagnosis and treatment facilitates further transmission, severity of disease with complications and mortality.", {"entities": []}], ["The objective of this study is to assess the cost-effectiveness of the practical approach to lung health strategy, a patient-centred approach for diagnosis and treatment of common respiratory illnesses in primary healthcare settings, as a means of strengthening health systems to improve the quality of management of respiratory diseases.", {"entities": []}], ["Economic evaluation nested in a cluster randomised controlled trial with three arms will be performed.", {"entities": []}], ["Measures of effectiveness and costs for all arms of the study will be obtained from the cluster randomised controlled clinical trial.", {"entities": []}], ["The main outcome measures are a combined rate of major respiratory diseases milestones and process indicators extracted from the practical approach to lung health strategy.", {"entities": []}], ["For analysis, descriptive as well as regression techniques will be used.", {"entities": []}], ["A cost-effectiveness analysis will be performed according to intention-to-treat principle and from a societal perspective.", {"entities": []}], ["Cost-effectiveness ratios will be calculated using bootstrapping techniques.", {"entities": []}], ["We hope to demonstrate the cost-effectiveness of the practical approach to lung health and informal healthcare providers, see an improvement in patients\u2019 quality of life, achieve a reduction in the duration and occurrence of episodes and the chronicity of respiratory diseases, and are able to report a decrease in the social cost.", {"entities": []}], ["If the practical approach to lung health and informal healthcare provider\u2019s interventions are cost-effective, they could be scaled up to all primary healthcare centres.", {"entities": []}], ["PACTR: PACTR201411000910192", {"entities": []}], ["The dominant viral etiologies responsible for acute respiratory infections (ARIs) are poorly understood, particularly among hospitalized children in resource-limited tropical countries where morbidity and mortality caused by ARIs are highest.", {"entities": []}], ["Improved etiological insight is needed to improve clinical management and prevention.", {"entities": []}], ["We conducted a three-year prospective descriptive study of severe respiratory illness among children from 2 months to 13 years of age within the largest referral hospital for infectious diseases in southern Vietnam.", {"entities": []}], ["Molecular detection for 15 viral species and subtypes was performed on three types of respiratory specimens (nose, throat swabs and nasopharyngeal aspirates) using a multiplex RT-PCR kit (Seeplex\u2122 RV detection, Seegene) and additional monoplex real-time RT-PCRs.", {"entities": []}], ["A total of 309 children were enrolled from November 2004 to January 2008.", {"entities": []}], ["Viruses were identified in 72% (222/309) of cases, including respiratory syncytial virus (24%), influenza virus A and B (17%), human bocavirus (16%), enterovirus (9%), human coronavirus (8%), human metapneumovirus (7%), parainfluenza virus 1\u20133 (6%), adenovirus (5%), and human rhinovirus A (4%).", {"entities": [[96, 105, "DISEASE"]]}], ["Co-infections with multiple viruses were detected in 20% (62/309) of patients.", {"entities": []}], ["When combined, diagnostic yields in nose and throat swabs were similar to nasopharyngeal aspirates.", {"entities": []}], ["Similar to other parts in the world, RSV and influenza were the predominant viral pathogens detected in Vietnamese hospitalized children.", {"entities": [[45, 54, "DISEASE"]]}], ["Combined nasal and throat swabs are the specimens of choice for sensitive molecular detection of a broad panel of viral agents.", {"entities": []}], ["Further research is required to better understand the clinical significance of single versus multiple viral coinfections and to address the role of bacterial (co-)infections involved in severe respiratory illness.", {"entities": []}], ["Stress places a metabolic burden on homeostasis and is linked to heightened sympathetic activity, increased energy expenditure and pathology.", {"entities": []}], ["The yogic state is a hypometabolic state that corresponds with mind-body coherence and reduced stress.", {"entities": []}], ["This study aimed to investigate metabolic responses to stress and different yoga practices in regular yoga practitioners (YP), non-yoga practitioners (NY) and metabolic syndrome patients (MS).", {"entities": [[169, 177, "DISEASE"]]}], ["YP (n = 16), NY (n = 15) and MS (n = 15) subjects underwent an experimental protocol that comprised of different 5-minute interventions including mental arithmetic stress test (MAST), alternate nostril breathing (ANB), Kapabhati breathing (KB) and meditation (Med) interspersed with 5\u00a0minutes of quiet resting (neutral condition (NC)).", {"entities": []}], ["During the intervention periods continuous body weight adjusted oxygen consumption (VO2ml/min/kg) was measured using open circuit indirect calorimetry with a canopy hood.", {"entities": []}], ["This is the first study to report oxygen consumption (OC) in yoga practitioners during and after MAST and the first to report both within and between different populations.", {"entities": []}], ["The results were analysed with SPSS 16 using 3X9 mixed factorial ANOVAs.", {"entities": []}], ["The single between-subject factor was group (YP, NY and MS), the single within-subject factor was made up of the nine intervention phases (NC1, MAST, NC2, ANB, NC3, KB, NC4, Med, NC5).", {"entities": []}], ["The results demonstrated that the regular YP group had significantly less OC and greater variability in their OC across all phases compared to the MS group ( p = .003) and NY group ( p = .01).", {"entities": []}], ["All groups significantly raised their OC during the mental arithmetic stress, however the MS group had a significantly blunted post-stress recovery whereas the YP group rapidly recovered back to baseline levels with post stress recovery being greater than either the NY group or MS group.", {"entities": []}], ["Yoga practitioners have greater metabolic variability compared to non-yoga practitioners and metabolic syndrome patients with reduced oxygen requirements during resting conditions and more rapid post-stress recovery.", {"entities": [[103, 111, "DISEASE"]]}], ["OC in metabolic syndrome patients displays significantly blunted post-stress recovery demonstrating reduced metabolic resilience.", {"entities": [[16, 24, "DISEASE"]]}], ["Our results support the findings of previous randomised trials that suggest regular yoga practice may mitigate against the effects of metabolic syndrome.", {"entities": [[144, 152, "DISEASE"]]}], ["ACTRN12614001075673 ; Date of Registration: 07/10/2014.", {"entities": []}], ["The online version of this article (doi:10.1186/1472-6882-14-445) contains supplementary material, which is available to authorized users.", {"entities": []}], ["In epidemiological studies, items about physician-diagnosed COPD are often used.", {"entities": []}], ["There is a lack of validation and standardization of these items.", {"entities": []}], ["In a general population-based study, 1,050 subjects completed a questionnaire and performed spirometry, including forced expiratory volume in 1 second (FEV 1 ) and forced vital capacity (FVC) after inhalation of 400 \u00b5g of salbutamol.", {"entities": [[152, 155, "GENE"]]}], ["COPD was defined as the ratio of FEV 1 /FVC <0.7 after bronchodilation.", {"entities": [[33, 36, "GENE"]]}], ["Physician-diagnosed COPD was defined as an affirmative answer to the single item: \u201cHave you ever had COPD diagnosed by a physician?\u201d, physician-diagnosed COPD/emphysema as an affirmative answer to any of the two single items; \u201cHave you ever had COPD diagnosed by a physician?\u201d or \u201cHave you ever been told by a physician that you have emphysema?\u201d, physician-diagnosed chronic bronchitis as an affirmative answer to; \u201cHave you ever been told by a physician that you have chronic bronchitis?\u201d and physician-diagnosed COPD, emphysema or chronic bronchitis was defined as an affirmative answer to either of the three items above.", {"entities": [[375, 385, "DISEASE"], [477, 487, "DISEASE"], [541, 551, "DISEASE"]]}], ["For the single item about physician-diagnosed COPD, the sensitivity was around 0.11 and the specificity was almost 0.99 in relation to COPD.", {"entities": []}], ["The sensitivity of the combined items about COPD/emphysema in detecting COPD was 0.11 and the specificity was high, 0.985.", {"entities": []}], ["When the items about physician-diagnosed COPD, emphysema or chronic bronchitis were merged as one entity, the sensitivity went up (0.13) and the specificity went down (0.95).", {"entities": [[68, 78, "DISEASE"]]}], ["Items about physician-diagnosed COPD have low sensitivity but a very high specificity, indicating that these items will minimize the proportion of false positives.", {"entities": []}], ["The low sensitivity will underestimate the total burden of COPD in the general population.", {"entities": []}], ["Items about physician-diagnosed COPD may be used in studies of risk factors for COPD, but are not recommended in prevalence studies.", {"entities": []}], ["Pyrexia, algesia and inflammation are associated with several pathological conditions.", {"entities": []}], ["Synthetic drugs available for the treatment of these conditions cause multiple unwanted effects.", {"entities": []}], ["Several studies are ongoing worldwide to find natural healing agents with better safety profile.", {"entities": []}], ["The current study was thus aimed at evaluating antipyretic, analgesic and anti-inflammatory activities of the methanolic extract of whole plant of V. betonicifolia (VBME).", {"entities": []}], ["VBME was employed to assess antipyretic activity in yeast induced hyperthermia.", {"entities": []}], ["Analgesic profile was ascertained in acetic acid induced writhing, hot plat and tail immersion test.", {"entities": []}], ["Nevertheless, the anti-inflammatory activity was tested in carrageenan induced paw edema and histamine induced inflammatory tests.", {"entities": []}], ["BALB/c mice were used at test doses of 100, 200 and 300mg/kg body weight intra peritoneally (i.p).", {"entities": []}], ["In yeast induced pyrexia, VBME demonstrated dose dependently (78.23%) protection at 300mg/kg, similar to standard drug, paracetamol (90%) at 150mg/kg i.p.", {"entities": []}], ["VBME showed a dose dependent analgesia in various pain models i.e.", {"entities": []}], ["acetic acid, hot plat and tail immersion having 78.90%, 69.96% and 68.58% protection respectively at 300mg/kg.", {"entities": []}], ["However, the analgesic action of VBME was completely antagonized by the injection of naloxone like opiate antagonists.", {"entities": []}], ["Similarly carrageenan and histamine induces inflammation was significantly antagonized by VBME, 66.30% and 60.80% respectively at 300mg/kg.", {"entities": []}], ["It is concluded that VBME has marked antipyretic, analgesic and anti-inflammatory activities in various animal models and this strongly supports the ethnopharmacological uses of Viola betonicifolia as antipyretic, analgesic and anti-inflammatory plant.", {"entities": []}], ["This study was aimed at investigating the effect of esmolol on tissue perfusion and the clinical prognosis of patients with severe sepsis.", {"entities": []}], ["Materials and Methods .", {"entities": []}], ["One hundred fifty-one patients with severe sepsis were selected and divided into the esmolol group ( n = 75) or the control group ( n = 76), who received conventional antiseptic shock treatment.", {"entities": []}], ["The esmolol group received a continuous infusion of esmolol via a central venous catheter, and their heart rate (HR) was maintained at 70\u2013100\u2009bpm over 72 hours.", {"entities": [[113, 115, "GENE"]]}], ["The HR of all patients reached the target level within 72 hours of treatment for both groups.", {"entities": [[4, 6, "GENE"]]}], ["The effect of esmolol on PvaCO 2 was only significant at 48 hours ( P < 0.05).", {"entities": []}], ["ScvO 2 increased in the esmolol group and decreased in the control group ( P < 0.01).", {"entities": []}], ["Lac showed a linear downward trend over the treatment time, but the reduction was more significant in the control group at 48 hours ( P < 0.05) between the two groups.", {"entities": []}], ["Kaplan-Meier analysis showed a significantly shorter duration of mechanical ventilation in the esmolol group than in the control group ( P < 0.05).", {"entities": []}], ["Conclusions .", {"entities": []}], ["Esmolol reduced the duration of mechanical ventilation in patients with severe sepsis, with no significant effect on circulatory function or tissue perfusion.", {"entities": []}], ["The objective of this study was to explore effects of khat ( Catha edulis ) on outcome of rodent malaria infection and its anti-plasmodial activities on Plasmodium berghei ANKA ( PbA ).", {"entities": [[97, 104, "DISEASE"]]}], ["Female Swiss albino mice were orally treated with crude khat ( Catha edulis ) extracts (100, 200 and 300\u00a0mg/kg) on a daily basis for 4\u00a0weeks prior to PbA infection.", {"entities": []}], ["Physical, clinical, hematological, biochemical and histo-pathological features of the mice were assessed.", {"entities": []}], ["In addition, in vivo anti-plasmodial activities of khat were evaluated.", {"entities": []}], ["The finding of this study showed that khat use was strongly associated with increment of levels of liver and kidney biomarkers, leucopenia, severe anemia, rise in level of inflammation biomarkers: C-reactive protein (CRP), uric acid (UA), increased monocyte-lymphocyte count ratio (MLCR), manifestation of cerebral malaria symptoms such as ataxia, paralysis and deviation of the head but with no pulmonary edema.", {"entities": [[306, 322, "DISEASE"], [396, 411, "DISEASE"], [315, 322, "DISEASE"], [147, 153, "DISEASE"], [217, 220, "GENE"]]}], ["Significantly lower level of parasitemia (P\u2009<\u20090.05), rectal temperature, but, high level of hemoglobin were observed at the early stage of the PbA infection in khat treated mice than the control.", {"entities": []}], ["With extension of the treatment period, however, drastic increments were observed in parasite load and rectal temperature although there was reduction in hemoglobin (Hb) level.", {"entities": []}], ["Moreover, khat showed poor anti-plasmodial activity with <10% parasite suppression activity and lack protection against major malaria symptoms.", {"entities": [[126, 133, "DISEASE"]]}], ["The significant reduction (P\u2009<\u20090.01) of hematological parameters during PbA infection strengthen the notion that hematological parameters could be good predictors of severe malaria complications in human.", {"entities": [[173, 180, "DISEASE"]]}], ["In mice model treated with khat prior to infection with the rodent malaria parasite, khat was found to worsen manifestation of most malaria complications.", {"entities": [[67, 74, "DISEASE"], [132, 139, "DISEASE"]]}], ["Furthermore, the same plant showed poor in vivo anti-plasmodial activity and protection against major malaria symptoms.", {"entities": [[102, 109, "DISEASE"]]}], ["The enzyme cyclooxygenase (COX) is an enzyme that catalyzes the formation of one of the mediators of inflammation, the prostaglandins.", {"entities": []}], ["Inhibition of COX allegedly can improve inflammation-induced pathological conditions.", {"entities": []}], ["The purpose of the present study was to evaluate the potential of Sargassum sp.", {"entities": []}], ["components, Fucoidan and alginate, as COX inhibitors.", {"entities": []}], ["The study was conducted by means of a computational ( in silico ) method.", {"entities": []}], ["It was performed in two main stages, the docking between COX-1 and COX-2 with Fucoidan, alginate and aspirin (for comparison) and the analysis of the amount of interactions formed and the residues directly involved in the process of interaction.", {"entities": []}], ["Our results showed that both Fucoidan and alginate had an excellent potential as inhibitors of COX-1 and COX-2.", {"entities": []}], ["Fucoidan had a better potential as an inhibitor of COX than alginate.", {"entities": []}], ["COX inhibition was expected to provide a more favorable effect on inflammation-related pathological conditions.", {"entities": []}], ["The active compounds Fucoidan and alginate derived from Sargassum sp.", {"entities": []}], ["were suspected to possess a good potential as inhibitors of COX-1 and COX-2.", {"entities": []}], ["Exposure to ozone has been associated with increased incidence of respiratory morbidity in humans; however the mechanism(s) behind the enhancement of susceptibility are unclear.", {"entities": []}], ["We have previously reported that exposure to episodic ozone during postnatal development results in an attenuated peripheral blood cytokine response to lipopolysaccharide (LPS) that persists with maturity.", {"entities": []}], ["As the lung is closely interfaced with the external environment, we hypothesized that the conducting airway epithelium of neonates may also be a target of immunomodulation by ozone.", {"entities": []}], ["To test this hypothesis, we evaluated primary airway epithelial cell cultures derived from juvenile rhesus macaque monkeys with a prior history of episodic postnatal ozone exposure.", {"entities": []}], ["Innate immune function was measured by expression of the proinflammatory cytokines IL-6 and IL-8 in primary cultures established following in vivo LPS challenge or, in response to in vitro LPS treatment.", {"entities": []}], ["Postnatal ozone exposure resulted in significantly attenuated IL-6 mRNA and protein expression in primary cultures from juvenile animals; IL-8 mRNA was also significantly reduced.", {"entities": []}], ["The effect of antecedent ozone exposure was modulated by in vivo LPS challenge, as primary cultures exhibited enhanced cytokine expression upon secondary in vitro LPS treatment.", {"entities": []}], ["Assessment of potential IL-6-targeting microRNAs miR-149, miR-202, and miR-410 showed differential expression in primary cultures based upon animal exposure history.", {"entities": [[49, 56, "GENE"], [58, 65, "GENE"], [71, 78, "GENE"]]}], ["Functional assays revealed that miR-149 is capable of binding to the IL-6 3\u2032 UTR and decreasing IL-6 protein synthesis in airway epithelial cell lines.", {"entities": [[32, 39, "GENE"]]}], ["Cumulatively, our findings suggest that episodic ozone during early life contributes to the molecular programming of airway epithelium, such that memory from prior exposures is retained in the form of a dysregulated IL-6 and IL-8 response to LPS; differentially expressed microRNAs such as miR-149 may play a role in the persistent modulation of the epithelial innate immune response towards microbes in the mature lung.", {"entities": [[290, 297, "GENE"]]}], ["Recurrent vulvovaginal candidosis (RVVC) is a chronic condition causing discomfort and pain.", {"entities": []}], ["Health status and health-related quality of life (HRQoL) in RVVC were never previously described using validated questionnaires.", {"entities": []}], ["The objective of this study is to describe subjective health status and HRQoL and estimate health state utilities among women with RVVC.", {"entities": []}], ["A cross-sectional online survey was conducted among women who reported having suffered four or more yeast infections over the past 12\u00a0months, in five European countries (France, Germany, Italy, Spain and the UK) and the USA.", {"entities": []}], ["Index scores were derived from the EQ-5D, a questionnaire providing a single index value for health status.", {"entities": []}], ["The SF-36 questionnaire was used for HRQoL assessment.", {"entities": []}], ["Information on disease severity, treatment patterns and productivity was also collected.", {"entities": []}], ["12,834 members of online research panels were contacted.", {"entities": []}], ["Among them, 620 women with RVVC (5%) were selected to complete the full questionnaire.", {"entities": []}], ["The mean EQ-5D index score was 0.70 (95% confidence interval: [0.67, 0.72]) and the difference between women with a yeast infection at the time of questionnaire completion and other respondents was 0.05 (p\u2009=\u20090.47).", {"entities": []}], ["The EQ-5D index score increased significantly with the time since last infection (p\u2009<\u20090.001).", {"entities": []}], ["68% of women reported depression/anxiety problems during acute episode, and 54% outside episodes, compared to less than 20% in general population (p\u2009<\u20090.001).", {"entities": []}], ["All SF-36 domain scores were significantly below general population norms.", {"entities": []}], ["Mental health domains were the most affected.", {"entities": []}], ["The impact on productivity was estimated at 33 lost work hours per year on average, corresponding to estimated costs between \u20ac266/year and \u20ac1,130/year depending on the country.", {"entities": []}], ["Subjective health status and HRQoL during and in between acute inflammatory episodes in women with RVVC are significantly worse than in the general population, despite the use of antifungal therapy.", {"entities": []}], ["The average index score in women with RVVC is comparable to other diseases such as asthma or COPD and worse than diseases such as headache/migraine according to US and UK catalogs of index scores.", {"entities": [[139, 147, "DISEASE"], [83, 89, "DISEASE"]]}], ["The survey also revealed a significant loss of productivity associated with RVVC.", {"entities": []}], ["The unique structure and coding of the Clinical Practice Research Datalink (CPRD) presents challenges for epidemiologic analysis and for comparisons with other databases.", {"entities": []}], ["To address this limitation we sought to transform CPRD into the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM).", {"entities": []}], ["An extraction, transformation and loading process was developed, which detailed source code mappings, Read code domain classification, an imputation algorithm for drug duration and special handling of lifestyle/clinical data.", {"entities": []}], ["Completeness and accuracy of the above elements were assessed.", {"entities": []}], ["A final validation exercise involved replication of a published case\u2013control study that examined use of nonsteroidal anti-inflammatory drugs (NSAIDs) and the risk of first-time acute myocardial infarction (AMI) in raw CPRD data and the CPRD CDM.", {"entities": [[183, 204, "DISEASE"], [177, 204, "DISEASE"]]}], ["All elements of the CPRD CDM transformation were assessed to be of high quality.", {"entities": []}], ["99.9\u00a0% of database condition records and 89.7\u00a0% of database drug records were mapped (majority unmapped drugs were devices and over-the-counter products); 3.1\u00a0% of duration imputations were deemed possibly erroneous and prevalences for selected conditions and drugs across CPRD raw and CDM data were equivalent.", {"entities": []}], ["Results between the replication raw data and CDM study agreed for conditions, demographics and lifestyle data with slight NSAID exposure data loss owing to unmapped drugs.", {"entities": []}], ["CPRD can be accurately transformed into the OMOP CDM with acceptable information loss across drugs, conditions and observations.", {"entities": []}], ["We determined that for a particular use, case CDM structure was adequate and mappings could be improved but did not substantially change the results of our analysis.", {"entities": []}], ["The online version of this article (doi:10.1007/s40264-014-0214-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Neutrophils are important effector cells of antimicrobial immunity in an acute inflammatory response, with a primary role in the clearance of extracellular pathogens.", {"entities": []}], ["However, in respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD), there is excessive infiltration and activation of neutrophils, subsequent production of reactive oxygen species, and release of serine proteases, matrix metalloproteinases, and myeloperoxidase\u2014resulting in collateral damage as the cells infiltrate into the tissue.", {"entities": [[52, 89, "DISEASE"], [41, 47, "DISEASE"]]}], ["Increased neutrophil survival through dysregulated apoptosis facilitates continued release of neutrophil-derived mediators to perpetuate airway inflammation and tissue injury.", {"entities": []}], ["Several target mechanisms have been investigated to address pathologic neutrophil biology and thereby provide a novel therapy for respiratory disease.", {"entities": []}], ["These include neutrophil influx through inhibition of chemokine receptors CXCR2, CXCR1, and PI3K \u03b3 signaling and neutrophil weaponry by protease inhibitors, targeting matrix metalloproteinases and neutrophil serine proteases.", {"entities": [[74, 79, "GENE"], [81, 86, "GENE"]]}], ["In addition, neutrophil function can be modulated using selective PI3K \u03b4 inhibitors.", {"entities": []}], ["This review highlights the latest advances in targeting neutrophils and their function, discusses the opportunities and risks of neutrophil inhibition, and explores how we might better develop future strategies to regulate neutrophil influx and function for respiratory diseases in dire need of novel effective therapies.", {"entities": []}], ["Given increasing demand for emergency care, there is growing concern over the availability of emergency department (ED) and inpatient resources.", {"entities": []}], ["Existing studies of ED bed supply are dated and often overlook hospital capacity beyond ED settings.", {"entities": []}], ["We described recent statewide trends in the capacity of ED and inpatient hospital services from 2005 to 2014.", {"entities": []}], ["Retrospective analysis.", {"entities": []}], ["Using California hospital data, we examined the absolute and per admission changes in ED beds and inpatient beds in all hospitals from 2005 to 2014.", {"entities": []}], ["Our sample consisted of all patients inpatient and outpatient) from 501 hospital facilities over 10-year period.", {"entities": []}], ["We analysed linear trends in the total annual ED visits, ED beds, licensed and staffed inpatient hospital beds and bed types, ED beds per ED visit, and inpatient beds per admission (ED and non-ED).", {"entities": []}], ["Between 2005 and 2014, ED visits increased from 9.8 million to 13.2 million (an increase of 35.0%, p<0.001).", {"entities": []}], ["ED beds also increased (by 29.8%, p<0.001), with an average annual increase of 195.4 beds.", {"entities": []}], ["Despite this growth, ED beds per visit decreased by 3.9%, from 6.0 ED beds per 10 000 ED visits in 2005 to 5.8 beds in 2014 (p=0.01).", {"entities": []}], ["While overall admission numbers declined by 4.9% (p=0.06), inpatient medical/surgical beds per visit grew by 11.3%, from 11.6 medical/surgical beds per 1000 admissions in 2005 to 12.9 beds in 2014 (p<0.001).", {"entities": []}], ["However, there were reductions in psychiatric and chemical dependency beds per admission, by \u221215.3% (p<0.001) and \u221222.4% (p=0.05), respectively.", {"entities": []}], ["These trends suggest that, in its current state, inadequate supply of ED and specific inpatient beds cannot keep pace with growing patient demand for acute care.", {"entities": []}], ["Analysis of ED and inpatient supply should capture dynamic variations in patient demand.", {"entities": []}], ["Our novel \u2018beds pervisit\u2019 metric offers improvements over traditional supply measures.", {"entities": []}], ["Smoking is the leading cause of preventable death worldwide and has been shown to increase the risk of multiple diseases including coronary artery disease (CAD).", {"entities": []}], ["We sought to identify genes whose levels of expression in whole blood correlate with self-reported smoking status.", {"entities": []}], ["Microarrays were used to identify gene expression changes in whole blood which correlated with self-reported smoking status; a set of significant genes from the microarray analysis were validated by qRT-PCR in an independent set of subjects.", {"entities": []}], ["Stepwise forward logistic regression was performed using the qRT-PCR data to create a predictive model whose performance was validated in an independent set of subjects and compared to cotinine, a nicotine metabolite.", {"entities": []}], ["Microarray analysis of whole blood RNA from 209 PREDICT subjects (41 current smokers, 4 quit \u2264 2 months, 64 quit > 2 months, 100 never smoked; NCT00500617) identified 4214 genes significantly correlated with self-reported smoking status.", {"entities": []}], ["qRT-PCR was performed on 1,071 PREDICT subjects across 256 microarray genes significantly correlated with smoking or CAD.", {"entities": []}], ["A five gene (CLDND1, LRRN3, MUC1, GOPC, LEF1) predictive model, derived from the qRT-PCR data using stepwise forward logistic regression, had a cross-validated mean AUC of 0.93 (sensitivity=0.78; specificity=0.95), and was validated using 180 independent PREDICT subjects (AUC=0.82, CI 0.69-0.94; sensitivity=0.63; specificity=0.94).", {"entities": [[21, 26, "GENE"], [28, 32, "GENE"], [34, 38, "GENE"], [40, 44, "GENE"]]}], ["Plasma from the 180 validation subjects was used to assess levels of cotinine; a model using a threshold of 10 ng/ml cotinine resulted in an AUC of 0.89 (CI 0.81-0.97; sensitivity=0.81; specificity=0.97; kappa with expression model = 0.53).", {"entities": []}], ["We have constructed and validated a whole blood gene expression score for the evaluation of smoking status, demonstrating that clinical and environmental factors contributing to cardiovascular disease risk can be assessed by gene expression.", {"entities": []}], ["The variability in the inflammatory burden of the lung in cystic fibrosis (CF) patients together with the variable effect of glucocorticoid treatment led us to hypothesize that glucocorticoid receptor ( GR ) gene polymorphisms may affect glucocorticoid sensitivity in CF and, consequently, may contribute to variations in the inflammatory response.", {"entities": [[58, 73, "DISEASE"]]}], ["We evaluated the association between four GR gene polymorphisms, TthIII , ER22/23EK , N363S and BclI , and disease progression in a cohort of 255 young patients with CF.", {"entities": []}], ["Genotypes were tested for association with changes in lung function tests, infection with Pseudomonas aeruginosa and nutritional status by multivariable analysis.", {"entities": []}], ["A significant non-corrected for multiple tests association was found between BclI genotypes and decline in lung function measured as the forced expiratory volume in one second (FEV 1 ) and the forced vital capacity (FVC).", {"entities": [[177, 180, "GENE"]]}], ["Deterioration in FEV 1 and FVC was more pronounced in patients with the BclI GG genotype compared to the group of patients with BclI CG and CC genotypes (p = 0.02 and p = 0.04 respectively for the entire cohort and p = 0.01 and p = 0.02 respectively for F508del homozygous patients).", {"entities": [[17, 20, "GENE"]]}], ["The BclI polymorphism may modulate the inflammatory burden in the CF lung and in this way influence progression of lung function.", {"entities": []}], ["25-hydroxyvitamin D deficiency is associated with COPD and increased susceptibility to infection in the general population.", {"entities": []}], ["We investigated whether COPD patients deficient in 25-hydroxyvitamin D were more likely to be frequent exacerbators, had reduced outdoor activity and were more susceptible to human rhinovirus (HRV) exacerbations than those with insufficient and normal levels.", {"entities": []}], ["We also investigated whether the frequency of Fok I, Bsm I and Taq I\u03b1 25-hydroxyvitamin D receptor (VDR) polymorphisms differed between frequent and infrequent exacerbators.", {"entities": [[100, 103, "GENE"]]}], ["There was no difference in 25-hydroxyvitamin D levels between frequent and infrequent exacerbators in the summer; medians 44.1nmol/L (29.1 \u2013 68.0) and 39.4nmol/L (22.3 \u2013 59.2) or winter; medians 24.9nmol/L (14.3 \u2013 43.1) and 27.1nmol/L (19.9 \u2013 37.6).", {"entities": []}], ["Patients who spent less time outdoors in the 14 days prior to sampling had lower 25-hydroxyvitamin D levels (p\u2009=\u20090.02).", {"entities": []}], ["Day length was independently associated with 25-hydroxyvitamin D levels (p\u2009=\u20090.02).", {"entities": []}], ["There was no difference in 25-hydroxyvitamin D levels between baseline and exacerbation; medians 36.2nmol/L (IQR 22.4-59.4) and 33.3nmol/L (23.0-49.7); p\u2009=\u20090.43.", {"entities": []}], ["HRV positive exacerbations were not associated with lower 25-hydroxyvitamin D levels at exacerbation than exacerbations that did not test positive for HRV; medians 30.0nmol/L (20.4 \u2013 57.8) and 30.6nmol/L (19.4 \u2013 48.7).", {"entities": []}], ["There was no relationship between exacerbation frequency and any VDR polymorphisms (all p\u2009>\u20090.05).", {"entities": [[65, 68, "GENE"]]}], ["Low 25-hydroxyvitamin D levels in COPD are not associated with frequent exacerbations and do not increase susceptibility to HRV exacerbations.", {"entities": []}], ["Independent of day length, patients who spend less time outdoors have lower 25-hydroxyvitamin D concentration.", {"entities": []}], ["To examine associations between exposure to prenatal smoking and early-life changes in fat mass (FM), fat-free mass (FFM) and anthropometrics.", {"entities": []}], ["We analyzed 670 mother-offspring pairs in the longitudinal Healthy Start study.", {"entities": []}], ["Maternal smoking data were collected during prenatal research visits.", {"entities": []}], ["Offspring body composition and size were measured by air displacement plethysmography at delivery and postnatal follow-up (5 months) visits.", {"entities": []}], ["Comparing exposed and unexposed offspring, exposure to prenatal smoking was significantly associated with reduced neonatal FM ( P = 0.007) and FFM ( P = 0.02).", {"entities": []}], ["In contrast, at 5 months, exposed offspring had comparable FM ( P = 0.61) and FFM ( P = 0.41).", {"entities": []}], ["After subsequent adjustment for birth weight, offspring exposed to prenatal smoking had significantly greater FFM (154.7 g, 0.5, 309.0; P = 0.049) and sum of skinfolds (2.7 mm: 0.06, 5.3; P = 0.04).", {"entities": []}], ["From delivery to follow-up, exposed offspring had significantly greater increases in FFM (156.4 g, 2.8, 310.1; P = 0.046) and sum of skinfolds (2.7 mm, 0.06, 5.3; P = 0.04), even after adjustment for respective delivery measures.", {"entities": []}], ["Exposure to prenatal smoking was significantly associated with rapid postnatal growth, which may increase the offspring\u2019s risk of metabolic diseases.", {"entities": []}], ["A clinical trial of mometasone furoate/formoterol fumarate (MF/F) administered via a metered-dose inhaler in subjects with moderate to very severe chronic obstructive pulmonary disease (COPD) investigated the efficacy and safety of a fixed-dose combination of MF/F.", {"entities": [[147, 184, "DISEASE"]]}], ["This multicenter, double-blind, placebo-controlled trial had a 26-week treatment period and a 26-week safety extension.", {"entities": []}], ["Subjects (n = 1055; \u226540 years) were current or ex- smokers randomized to twice-daily treatment with inhaled MF/F 400/10 \u03bcg, MF/F 200/10 \u03bcg, MF 400 \u03bcg, F 10 \u03bcg, or placebo.", {"entities": []}], ["The coprimary endpoints of the trial were mean changes from baseline in forced expiratory volume in 1 second (FEV 1 ) over 0\u201312 hours (AUC 0\u201312 FEV 1 ) with MF/F versus MF, and in morning predose FEV 1 with MF/F versus F. Key secondary endpoints were quality of life (Saint George\u2019s Respiratory Questionnaire [SGRQ]), symptom-free nights, and partly stable COPD at 26 weeks, as well as time to first COPD exacerbation.", {"entities": [[110, 113, "GENE"], [144, 147, "GENE"], [196, 199, "GENE"], [110, 113, "GENE"], [144, 147, "GENE"], [196, 199, "GENE"], [110, 113, "GENE"], [144, 147, "GENE"], [196, 199, "GENE"]]}], ["Significant improvements in FEV 1 AUC 0\u201312 occurred at endpoint with MF/F 400/10 and MF/F 200/10 versus MF 400 ( P \u2264 0.007).", {"entities": [[28, 31, "GENE"]]}], ["Significant bronchodilation occurred in 5 minutes with MF/F, and serial spirometry demonstrated sustained FEV 1 improvements with MF/F over the treatment period.", {"entities": [[106, 109, "GENE"]]}], ["Significant improvements in morning predose FEV 1 occurred with both MF/F doses, and these effects were further investigated by excluding results for subjects whose morning FEV 1 data were collected >2 days after the last dose of study treatment.", {"entities": [[44, 47, "GENE"], [173, 176, "GENE"], [44, 47, "GENE"], [173, 176, "GENE"]]}], ["Improvements in SGRQ total scores surpassed the minimum clinically important difference of at least 4 units with MF/F 400/10.", {"entities": []}], ["MF/F 400/10 significantly reduced the time-to-first COPD exacerbation.", {"entities": []}], ["Similar proportions of subjects in all five treatment groups reported treatment-emergent adverse events.", {"entities": []}], ["Rates of pneumonia were low (\u22641.0%) across treatment groups.", {"entities": [[9, 18, "DISEASE"]]}], ["MF/F 400/10 \u03bcg twice daily was shown to be an effective therapy for patients with moderate to very severe COPD, and both MF/F 400/10 \u03bcg twice daily and MF/F 200/10 \u03bcg twice daily were well tolerated.", {"entities": []}], ["Although acute bronchitis is quite common, there is relatively limited information regarding the microorganisms that are involved in this illness.", {"entities": [[15, 25, "DISEASE"]]}], ["We performed a prospective study of acute bronchitis at 31 hospitals and clinics in Korea from July 2011 to June 2012.", {"entities": [[42, 52, "DISEASE"]]}], ["Sputum specimens were collected for polymerase chain reaction (PCR) and culture of microorganisms.", {"entities": []}], ["Of the 811 enrolled patients, 291 had acceptable sputum specimens that were included for analysis of the etiologic distribution.", {"entities": []}], ["With multiplex PCR testing, viruses were identified in 36.1% (105/291), most commonly rhinovirus (25.8%) and coronavirus (3.8%).", {"entities": []}], ["Typical bacteria were isolated in 126/291 (43.3%) patients.", {"entities": []}], ["Among these patients Haemophilus influenzae (n = 39) and Streptococcus pneumoniae (n = 30) were isolated most commonly; atypical bacteria were identified in 44 (15.1%) patients.", {"entities": []}], ["Bacteria-only, virus-only, and mixed infections (bacteria plus virus) accounted for 36.7% (98/291), 17.2% (50/291), and 18.9% (55/291) of infections, respectively.", {"entities": []}], ["In particular, 52.4% of patients with viral infection had a concurrent bacterial infection, and rhinovirus was the most common virus in mixed infections (40/55).", {"entities": []}], ["Additionally, infections with typical bacteria were more common in patients with chronic lung disease ( p = 0.029), and typical bacterial infections showed a trend towards a higher prevalence with older age ( p = 0.001).", {"entities": [[89, 101, "DISEASE"]]}], ["Bacteria were associated with almost half of community-acquired acute bronchitis cases.", {"entities": [[70, 80, "DISEASE"]]}], ["Additional studies are required to further illuminate the role of bacteria and to identify patient groups most likely to benefit from antibiotic treatment.", {"entities": []}], ["Anaemia affects 60\u201380\u00a0% of patients admitted to intensive care units (ICUs).", {"entities": []}], ["Allogeneic red blood cell (RBC) transfusions remain the mainstay of treatment for anaemia but are associated with risks and are costly.", {"entities": []}], ["Our objective was to assess the efficacy and safety of iron supplementation by any route, in anaemic patients in adult ICUs.", {"entities": []}], ["Electronic databases (CENTRAL, MEDLINE, EMBASE) were searched through March 2016 for randomized controlled trials (RCT)s comparing iron by any route with placebo/no iron.", {"entities": []}], ["Primary outcomes were red blood cell transfusions and mean haemoglobin concentration.", {"entities": []}], ["Secondary outcomes included mortality, infection, ICU and hospital length of stay, mean difference (MD) in iron biomarkers, health-related quality of life and adverse events.", {"entities": []}], ["Five RCTs recruiting 665 patients met the inclusion criteria; intravenous iron was tested in four of the RCTs.", {"entities": []}], ["There was no difference in allogeneic RBC transfusion requirements (relative risk 0.87, 95\u00a0% confidence interval (CI) 0.70 to 1.07, p \u2009=\u20090.18, five trials) or mean number of RBC units transfused\u00a0(MD -0.45, 95 % CI -1.34 to 0.43, p = 0.32, two trials) in patients receiving or not receiving iron.", {"entities": []}], ["Similarly, there was no difference between groups in haemoglobin at short-term (up to 10\u00a0days) (MD -0.25, 95\u00a0% CI -0.79 to 0.28, p \u2009=\u20090.35, three trials) or mid-term follow up (last measured time point in hospital or end of trial) (MD 0.21, 95\u00a0% CI -0.13 to 0.55, p \u2009=\u20090.23, three trials).", {"entities": []}], ["There was no difference in secondary outcomes of mortality, in-hospital infection, or length of stay.", {"entities": []}], ["Risk of bias was generally low although three trials had high risk of attrition bias; only one trial had low risk of bias across all domains.", {"entities": []}], ["Iron supplementation does not reduce RBC transfusion requirements in critically ill adults, but there is considerable heterogeneity between trials in study design, nature of interventions, and outcomes.", {"entities": []}], ["Well-designed trials are needed to investigate the optimal iron dosing regimens and strategies to identify which patients are most likely to benefit from iron, together with patient-focused outcomes.", {"entities": []}], ["PROSPERO International prospective register of systematic reviews CRD42015016627 .", {"entities": []}], ["Registered 2 March 2015.", {"entities": []}], ["The online version of this article (doi:10.1186/s13054-016-1486-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The mechanisms behind heterologous immunity and non-specific effects of vaccines on mortality are not well understood.", {"entities": []}], ["We examined associations between cytokine responses and subsequent mortality in low-birth-weight infants in Guinea-Bissau.", {"entities": []}], ["A low-birth-weight trial randomized children to Bacille Calmette-Gu\u00e9rin (BCG) at birth or later according to local policy.", {"entities": []}], ["Blood samples were obtained from a sub-group at age 6 weeks.", {"entities": []}], ["Interleukin (IL)-5, IL-10, IL-13, interferon (IFN)-\u03b3, and tumor necrosis factor (TNF)-\u03b1 were measured in whole-blood cell cultures stimulated with lipopolysaccharide (LPS), phytohaemagglutinin (PHA), or purified protein derivative (PPD).", {"entities": [[81, 84, "GENE"]]}], ["The outcome was mortality between bleeding and 1 year of age.", {"entities": []}], ["Non-linear associations between cytokine responses and mortality were examined.", {"entities": []}], ["Cytokine measurements were available from 390 children.", {"entities": []}], ["The mortality rate (MR) was high (6.8/100 person-years-observation (PYO)).", {"entities": []}], ["Both low and high cytokine responses to LPS and PHA were associated with high mortality (MR up to 25/100 PYO in the lowest 10% and 9.2/100 PYO in the highest 10%).", {"entities": []}], ["In BCG-vaccinated children, higher IFN-\u03b3 responses to PPD were associated with better survival (MR ratio\u200a=\u200a0.43 (0.24\u20130.77)).", {"entities": []}], ["Data presented a rare opportunity to explore associations between cytokine responses and mortality.", {"entities": []}], ["Both low and high cytokine responses were associated with high mortality; a balanced response to invading pathogens seems preferable.", {"entities": []}], ["Members of the genus Pseudonocardia have been widely reported and recovered from several ecosystems, such as soil samples and plant samples.", {"entities": []}], ["Pseudonocardia bacteria colonize the microbial communities on the integument of fungus gardening ant species.", {"entities": []}], ["We present the first documented case of Pseudonocardia carboxydivorans isolated in human cerebrospinal fluid (CSF).", {"entities": []}], ["To the best of our knowledge, this is the first report of an human infection by P. carboxydivorans.", {"entities": []}], ["A patient, who suffered a traumatic brain injury a month before, was admitted to this hospital due to gait alteration and cognitive disturbances.", {"entities": []}], ["Culture of cerebrospinal fluid showed ramified, not acid-fast, Gram positive bacilli.", {"entities": []}], ["The bacterium was identified by molecular methods as P. carboxydivorans .", {"entities": []}], ["This is the first documented case of isolating P. carboxydivorans in human CSF in a case of probable meningitis.", {"entities": [[101, 111, "DISEASE"]]}], ["Further research is needed in order to determine its pathogenic role in human infections.", {"entities": []}], ["The clinical benefit of continued supervised maintenance exercise programs following pulmonary rehabilitation in COPD remains unclear.", {"entities": []}], ["This systematic review aimed to synthesize the available evidence on the efficacy of supervised maintenance exercise programs compared to usual care following pulmonary rehabilitation completion on health care use and mortality.", {"entities": []}], ["Electronic databases (MEDLINE, Embase, CINAHL, Cochrane Central Register of Controlled Trials, Web of Science, and PEDro) and trial registers ( ClinicalTrials.gov and Current Controlled Trials) were searched for randomized trials comparing supervised maintenance exercise programs with usual care following pulmonary rehabilitation completion.", {"entities": []}], ["Primary outcomes were respiratory-cause hospital admissions, exacerbations requiring treatment with antibiotics and/or systemic corticosteroids, and mortality.", {"entities": []}], ["Eight trials (790 COPD patients) met the inclusion criteria, six providing data for meta-analysis.", {"entities": []}], ["Continued supervised maintenance exercise compared to usual care following pulmonary rehabilitation completion significantly reduced the risk of experiencing at least one respiratory-cause hospital admission (risk ratio 0.62, 95% confidence interval [CI] 0.47\u20130.81, P <0.001).", {"entities": []}], ["Meta-analyses also suggested that supervised maintenance exercise leads to a clinically important reduction in the rate of respiratory-cause hospital admissions (rate ratio 0.72, 95% CI 0.50\u20131.05, P =0.09), overall risk of an exacerbation (risk ratio 0.79, 95% CI 0.52\u20131.19, P =0.25), and mortality (risk ratio 0.57, 95% CI 0.17\u20131.92, P =0.37).", {"entities": []}], ["In the first systematic review of the area, current evidence demonstrates that continued supervised maintenance exercise compared to usual care following pulmonary rehabilitation reduces health care use in COPD.", {"entities": []}], ["The variance in the quality of the evidence included in this review highlights the need for this evidence to be followed up with further high-quality randomized trials.", {"entities": []}], ["Amyotrophic lateral sclerosis (ALS) is a rare disease causing degeneration of the upper and lower motor neuron.", {"entities": [[12, 29, "DISEASE"]]}], ["Involvement of the bulbar motor neurons often results in fast progressive dysphagia.", {"entities": []}], ["While cortical compensation of dysphagia has been previously shown in stroke patients, this topic has not been addressed in patients suffering from ALS.", {"entities": []}], ["In the present study, we investigated cortical activation during deglutition in two groups of ALS patients with either moderate or severe dysphagia.", {"entities": []}], ["Whole-head MEG was employed on fourteen patients with sporadic ALS using a self-paced swallowing paradigm.", {"entities": []}], ["Data were analyzed by means of time-frequency analysis and synthetic aperture magnetometry (SAM).", {"entities": []}], ["Group analysis of individual SAM data was performed using a permutation test.", {"entities": []}], ["We found a reduction of cortical swallowing related activation in ALS patients compared to healthy controls.", {"entities": []}], ["Additionally a disease-related shift of hemispheric lateralization was observed.", {"entities": []}], ["While healthy subjects showed bilateral cortical activation, the right sensorimotor cortex was predominantly involved in ALS patients.", {"entities": []}], ["Both effects were even stronger in the group of patients with severe dysphagia.", {"entities": []}], ["Our results suggest that bilateral degeneration of the upper motor neuron in the primary motor areas also impairs further adjusted motor areas, which leads to a strong reduction of \u2018swallowing related\u2019 cortical activation.", {"entities": []}], ["While both hemispheres are affected by the degeneration a relatively stronger activation is seen in the right hemisphere.", {"entities": []}], ["This right hemispheric lateralization of volitional swallowing observed in this study may be the only sign of cortical plasticity in dysphagic ALS patients.", {"entities": []}], ["It may demonstrate compensational mechanisms in the right hemisphere which is known to predominantly coordinate the pharyngeal phase of deglutition.", {"entities": []}], ["These results add new aspects to our understanding of the pathophysiology of dysphagia in ALS patients and beyond.", {"entities": []}], ["The compensational mechanisms observed could be relevant for future research in swallowing therapies.", {"entities": []}], ["Guidelines advocate using B-type natriuretic peptides in the diagnostic work-up of suspected heart failure (HF).", {"entities": []}], ["Their main role is to limit echocardiography rates by ruling out HF/LV dysfunction where peptide level is low.", {"entities": []}], ["Recommended rule-out cut points vary between guidelines.", {"entities": []}], ["The utility of B-type natriuretic peptides in the very old (85+) requires further investigation, with optimal cut points yet to be established.", {"entities": []}], ["We examined NT-proBNP's utility, alone and in combination with history of myocardial infarction (MI), as a rule-out test for LV dysfunction in very old people with limiting dyspnoea.", {"entities": [[74, 95, "DISEASE"]]}], ["Design: Cross-sectional analysis.", {"entities": []}], ["Setting: Population-based sample; North-East England.", {"entities": []}], ["Participants: 155 people (aged 87-89) with limiting dyspnoea.", {"entities": []}], ["Measures: Dyspnoea assessed by questionnaire.", {"entities": []}], ["Domiciliary echocardiography performed; LV systolic/diastolic function graded.", {"entities": []}], ["NT-proBNP measured (Roche Diagnostics).", {"entities": []}], ["Receiver operating characteristic analyses examined NT-proBNP's diagnostic accuracy for LV dysfunction.", {"entities": []}], ["AUC for LVEF less than or equal to 50% was poor (0.58, 95% CI 0.49-0.65), but good for LVEF less than or equal to 40% (0.80, 95% CI 0.73-0.86).", {"entities": []}], ["At ESC cut point (125ng/l), few cases of systolic dysfunction were missed (NPV 94-100%, depending on severity), but echocardiography (88%) and false positive rates (56-81 per 100 screened) were high.", {"entities": []}], ["At NICE cut point (400ng/l), echocardiography (51%) and false positive rates (33-45) were lower; exclusionary performance was good for LVEF less than or equal to 40% (1 case missed per 100 screened, 15% of cases; NPV 97%), but poor for LVEF less than or equal to 50% (16 cases missed per 100 screened, 45% of cases; NPV 68%).", {"entities": []}], ["Incorporating isolated moderate/severe diastolic dysfunction into target condition increased the proportion of cases missed (lower NPV), whilst improving case detection.", {"entities": []}], ["Incorporating MI history as an additional referral prompt slightly reduced the number of cases missed at expense of higher echocardiography and false positive rates.", {"entities": []}], ["High echocardiography rates and poor exclusionary performance for mild degrees of systolic dysfunction and for diastolic dysfunction limit NT-proBNP's utility as a rule-out test for LV dysfunction in very old people with limiting dyspnoea.", {"entities": []}], ["Incorporating MI history as an additional echocardiography prompt yields no overall benefit compared to using NT-proBNP level alone.", {"entities": []}], ["The online version of this article (doi:10.1186/1471-2261-14-128) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Tiotropium (Spiriva) is an inhaled muscarinic antagonist for patients with chronic obstructive pulmonary disease (COPD), and is available in two forms: the HandiHaler and the Respimat inhaler.", {"entities": [[75, 112, "DISEASE"]]}], ["The aim of this study was to investigate the handling of and preference for each device immediately after switching from the HandiHaler to the Respimat and 2\u20133 years after the switch.", {"entities": []}], ["The study comprised two surveys.", {"entities": []}], ["A questionnaire was first administered to 57 patients with COPD (male:female 52:5, mean age 73.6\u00b17.1 years) 8 weeks after switching from the HandiHaler (18 \u03bcg) to the Respimat (5 \u03bcg).", {"entities": []}], ["A second similar but simplified questionnaire was administered to 39 of these patients who continued to use the Respimat and were available for follow-up after more than 2 years.", {"entities": []}], ["Pulmonary function was also measured during each period.", {"entities": []}], ["In the first survey, 17.5% of patients preferred the HandiHaler, and 45.6% preferred the Respimat.", {"entities": []}], ["There were no significant changes in pulmonary function or in the incidence of adverse events after the switch.", {"entities": []}], ["In the second survey, performed 2\u20133 years later, the self-assessed handling of the Respimat had significantly improved, and the number of patients who preferred the Respimat had increased to 79.5%.", {"entities": []}], ["The efficacy of the Respimat was similar to that of the HandiHaler.", {"entities": []}], ["This was clear immediately after the switch, even in elderly patients with COPD who were long-term users of the HandiHaler.", {"entities": []}], ["The preference for the Respimat increased with continued use.", {"entities": []}], ["Obesity is a risk factor for the development of certain respiratory diseases, and neonatal overfeeding results in an early onset of obesity in adulthood.", {"entities": [[0, 7, "DISEASE"], [132, 139, "DISEASE"]]}], ["However, the influence of neonatal overfeeding on respiratory diseases has rarely been studied.", {"entities": []}], ["Therefore, this paper is aimed at investigating the effect of neonatal overfeeding on airway responsiveness and inflammation.", {"entities": []}], ["The neonatal overfeeding was induced by reducing litter size to three pups per litter (small litter, SL) in contrast to the normal litter size with ten pups per litter (NL) on postnatal day 3 (P3) in male ICR mice.", {"entities": []}], ["On P21, mice were weaned to standard chow diet.", {"entities": []}], ["Airway responsiveness to methacholine was measured either on P21 or P150.", {"entities": []}], ["Total and classified inflammatory cells in bronchoalveolar lavage fluid (BALF) were counted, lung inflammatory cells were evaluated through staining with hematoxylin & eosin and F4/80 immunohistochemistry; lung fibrosis was evaluated through staining with Masson and \u03b1-SAM immunohistochemistry.", {"entities": []}], ["Leptin levels in serum were measured by RIA; TNF-\u03b1 levels in serum and BALF were quantified by ELISA; mRNA levels of TNF-\u03b1, CTGF and TGF-\u03b21 in lung tissues were measured using real-time PCR.", {"entities": [[124, 128, "GENE"]]}], ["Mice from SL exhibited accelerated body weight gain, impaired glucose tolerance and hyperleptinemia.", {"entities": []}], ["Enhanced airway responsiveness to methacholine was observed in SL mice on P150, but not on P21.", {"entities": []}], ["Pulmonary inflammation was evident in SL mice on P150, as reflected by inflammatory cells especially macrophages around bronchi and interstitium.", {"entities": []}], ["BALF and serum TNF-\u03b1 levels and lung TNF-\u03b1 mRNA expression were significantly increased in SL mice on P150.", {"entities": []}], ["More collagen accumulated surrounding the bronchi on P150; lung mRNA levels of TGF-\u03b21 and CTGF were also increased on P150.", {"entities": [[90, 94, "GENE"]]}], ["In addition to inducing a variety of metabolic defects, neonatal overfeeding enhanced lung inflammation, which may lead to airway remodeling and airway hyperresponsiveness in adulthood.", {"entities": []}], ["This review evaluates current epidemiologic literature on health effects in relation to residence near landfill sites.", {"entities": []}], ["Increases in risk of adverse health effects (low birth weight, birth defects, certain types of cancers) have been reported near individual landfill sites and in some multisite studies, and although biases and confounding factors cannot be excluded as explanations for these findings, they may indicate real risks associated with residence near certain landfill sites.", {"entities": []}], ["A general weakness in the reviewed studies is the lack of direct exposure measurement.", {"entities": []}], ["An increased prevalence of self-reported health symptoms such as fatigue, sleepiness, and headaches among residents near waste sites has consistently been reported in more than 10 of the reviewed papers.", {"entities": []}], ["It is difficult to conclude whether these symptoms are an effect of direct toxicologic action of chemicals present in waste sites, an effect of stress and fears related to the waste site, or an effect of reporting bias.", {"entities": []}], ["Although a substantial number of studies have been conducted, risks to health from landfill sites are hard to quantify.", {"entities": []}], ["There is insufficient exposure information and effects of low-level environmental exposure in the general population are by their nature difficult to establish.", {"entities": []}], ["More interdisciplinary research can improve levels of knowledge on risks to human health of waste disposal in landfill sites.", {"entities": []}], ["Research needs include epidemiologic and toxicologic studies on individual chemicals and chemical mixtures, well-designed single- and multisite landfill studies, development of biomarkers, and research on risk perception and sociologic determinants of ill health.", {"entities": []}], ["Yoga seems to be an effective means to cope with a variety of internal medicine conditions.", {"entities": []}], ["While characteristics of yoga users have been investigated in the general population, little is known about predictors of yoga use and barriers to yoga use in internal medicine patients.", {"entities": []}], ["The aim of this cross-sectional analysis was to identify sociodemographic, clinical, and psychological predictors of yoga use among internal medicine patients.", {"entities": []}], ["A cross-sectional analysis was conducted among all patients being referred to a Department of Internal and Integrative Medicine during a 3-year period.", {"entities": []}], ["It was assessed whether patients had ever used yoga for their primary medical complaint, the perceived benefit, and the perceived harm of yoga practice.", {"entities": []}], ["Potential predictors of yoga use including sociodemographic characteristics, health behavior, internal medicine diagnosis, general health status, mental health, satisfaction with health, and health locus of control were assessed; and associations with yoga use were tested using multiple logistic regression analysis.", {"entities": []}], ["Odds ratios (OR) with 95% confidence intervals (CI) were calculated for significant predictors.", {"entities": []}], ["Of 2486 participants, 303 (12.19%) reported having used yoga for their primary medical complaint.", {"entities": []}], ["Of those, 184 (60.73%) reported benefits and 12 (3.96%) reported harms due to yoga practice.", {"entities": []}], ["Compared to yoga non-users, yoga users were more likely to be 50\u201364 years old (OR\u2009=\u20091.45; 95%CI\u2009=\u20091.05-2.01; P\u2009=\u20090.025); female (OR\u2009=\u20092.45; 95%CI\u2009=\u20091.45-4.02; P\u2009<\u20090.001); and college graduates (OR\u2009=\u20091.61; 95%CI\u2009=\u20091.14-2.27; P\u2009=\u20090.007); and less likely to currently smoke (OR\u2009=\u20090.61; 95%CI\u2009=\u20090.39-0.96; P\u2009=\u20090.031).", {"entities": []}], ["Manifest anxiety (OR\u2009=\u20091.47; 95%CI\u2009=\u20091.06-2.04; P\u2009=\u20090.020); and high internal health locus of control (OR\u2009=\u20091.92; 95%CI\u2009=\u20091.38-2.67; P\u2009<\u20090.001) were positively associated with yoga use, while high external-fatalistic health locus of control (OR\u2009=\u20090.66; 95%CI\u2009=\u20090.47-0.92; P\u2009=\u20090.014) was negatively associated with yoga use.", {"entities": []}], ["Yoga was used for their primary medical complaint by 12.19% of an internal integrative medicine patient population and was commonly perceived as beneficial.", {"entities": []}], ["Yoga use was not associated with the patients\u2019 specific diagnosis but with sociodemographic factors, mental health, and health locus of control.", {"entities": []}], ["To improve adherence to yoga practice, it should be considered that male, younger, and anxious patients and those with low internal health locus of control might be less intrinsically motivated to start yoga.", {"entities": []}], ["Omega-3 fatty acids play critical roles during fetal growth and development with increased intakes associated with improved maternal-fetal outcomes.", {"entities": []}], ["Omega-3 fatty acid intake in Western diets is low, and the impact of socioeconomic factors on omega-3 fatty acid intake in pregnant women and women of childbearing age has not been reported.", {"entities": []}], ["We used the National Health and Nutrition Examination Survey (NHANES) cycles 2003\u20132012 to assess the relationship between omega-3 fatty acid intake and socioeconomic factors in women of childbearing age.", {"entities": []}], ["Out of 7266 eligible participants, 6478 were women of childbearing age, while 788 were identified as pregnant at the time of the survey.", {"entities": []}], ["Mean EPA+DHA intake of the population was 89.0 mg with no significant difference between pregnant and non-pregnant women.", {"entities": []}], ["By univariate and multivariate analyses adjusting for confounders, omega-3 fatty acid intake was significantly associated with poverty-to-income ratio, race, and educational attainment.", {"entities": []}], ["Our results demonstrate that omega-3 fatty acid intake is a concern in pregnant women and women of childbearing age in the United States, and that socioeconomically disadvantaged populations are more susceptible to potential deficiencies.", {"entities": []}], ["Strategies to increase omega-3 fatty acid intake in these populations could have the potential to improve maternal and infant health outcomes.", {"entities": []}], ["Despite extensive evidence that air pollution affects childhood asthma, state-level and national-level tracking of asthma outcomes in relation to air pollution is limited.", {"entities": [[64, 70, "DISEASE"], [115, 121, "DISEASE"]]}], ["Our goals were to evaluate the feasibility of linking the 2001 California Health Interview Survey (CHIS), air monitoring, and traffic data; estimate associations between traffic density (TD) or outdoor air pollutant concentrations and childhood asthma morbidity; and evaluate the usefulness of such databases, linkages, and analyses to Environmental Public Health Tracking (EPHT).", {"entities": [[245, 251, "DISEASE"]]}], ["We estimated TD within 500 feet of residential cross-streets of respondents and annual average pollutant concentrations based on monitoring station measurements.", {"entities": []}], ["We used logistic regression to examine associations with reported asthma symptoms and emergency department (ED) visits/hospitalizations.", {"entities": [[66, 72, "DISEASE"]]}], ["Assignment of TD and air pollution exposures for cross-streets was successful for 82% of children with asthma in Los Angeles and San Diego, California, Counties.", {"entities": [[103, 109, "DISEASE"]]}], ["Children with asthma living in high ozone areas and areas with high concentrations of particulate matter < 10 \u03bcm in aerodynamic diameter experienced symptoms more frequently, and those living close to heavy traffic reported more ED visits/hospitalizations.", {"entities": [[14, 20, "DISEASE"]]}], ["The advantages of the CHIS for asthma EPHT include a large and representative sample, biennial data collection, and ascertainment of important socio-demographic and residential address information.", {"entities": [[31, 37, "DISEASE"]]}], ["Disadvantages are its cross-sectional design, reliance on parental reports of diagnoses and symptoms, and lack of information on some potential confounders.", {"entities": []}], ["Despite limitations, the CHIS provides a useful framework for examining air pollution and childhood asthma morbidity in support of EPHT, especially because later surveys address some noted gaps.", {"entities": [[100, 106, "DISEASE"]]}], ["We plan to employ CHIS 2003 and 2005 data and novel exposure assessment methods to re-examine the questions raised here.", {"entities": []}], ["The analysis of plasma cell-free DNA (cfDNA) is expected to provide useful biomarkers for early diagnosis of non-small-cell lung cancer (NSCLC).", {"entities": [[124, 135, "DISEASE"], [129, 135, "DISEASE"]]}], ["However, it remains unclear whether the intense release of cfDNA into the bloodstream of NSCLC patients results from malignancy or chronic inflammatory response.", {"entities": []}], ["Consequently, the current diagnostic utility of plasma cfDNA quantification has not been thoroughly validated in subjects with chronic respiratory inflammation.", {"entities": []}], ["Here we assess the effect of chronic respiratory inflammation on plasma cfDNA levels and evaluate the potential clinical value of this phenomenon as an early lung cancer diagnostic tool.", {"entities": [[158, 169, "DISEASE"], [163, 169, "DISEASE"]]}], ["We measured plasma cfDNA concentrations in 50 resectable NSCLC patients, 101 patients with chronic respiratory inflammation (chronic obstructive pulmonary disease, sarcoidosis, or asthma) and 40 healthy volunteers using real-time PCR.", {"entities": [[125, 162, "DISEASE"], [164, 175, "DISEASE"], [180, 186, "DISEASE"]]}], ["We found significantly higher plasma cfDNA levels in NSCLC patients than in subjects with chronic respiratory inflammation and healthy individuals ( P <0.0001).", {"entities": []}], ["There were no significant differences in plasma cfDNA levels between patients with chronic respiratory inflammation and healthy volunteers.", {"entities": []}], ["The cutoff point of >2.8\u2009ng\u2009ml We demonstrated that elevated plasma cfDNA levels in NSCLC resulted primarily from tumour development rather than inflammatory response, raising the potential clinical implications for lung cancer screening and early diagnosis.", {"entities": [[216, 227, "DISEASE"], [221, 227, "DISEASE"]]}], ["Further research is necessary to better characterise and identify factors and processes regulating cfDNA levels in the blood under normal and pathological conditions.", {"entities": []}], ["CD1d is a non-classical major histocompatibility class 1-like molecule which primarily presents either microbial or endogenous glycolipid antigens to T cells involved in innate immunity.", {"entities": [[0, 4, "GENE"]]}], ["Natural killer T (NKT) cells and a subpopulation of \u03b3\u03b4 T cells expressing the V\u03b34 T cell receptor (TCR) recognize CD1d.", {"entities": [[114, 118, "GENE"]]}], ["NKT and V\u03b34 T cells function in the innate immune response via rapid activation subsequent to infection and secrete large quantities of cytokines that both help control infection and modulate the developing adaptive immune response.", {"entities": []}], ["T regulatory cells represent one cell population impacted by both NKT and V\u03b34 T cells.", {"entities": []}], ["This review discusses the evidence that NKT cells promote T regulatory cell activation both through direct interaction of NKT cell and dendritic cells and through NKT cell secretion of large amounts of TGF\u03b2, IL-10 and IL-2.", {"entities": []}], ["Recent studies have shown that CD1d-restricted V\u03b34 T cells, in contrast to NKT cells, selectively kill T regulatory cells through a caspase-dependent mechanism.", {"entities": []}], ["V\u03b34 T cell elimination of the T regulatory cell population allows activation of autoimmune CD8+ effector cells leading to severe cardiac injury in a coxsackievirus B3 (CVB3) myocarditis model in mice.", {"entities": [[174, 185, "DISEASE"]]}], ["CD1d-restricted immunity can therefore lead to either immunosuppression or autoimmunity depending upon the type of innate effector dominating during the infection.", {"entities": []}], ["Oman is heading towards heavy industrialisation with rapid establishment of new industrial parks.", {"entities": []}], ["One of these, the Sohar Industrial Zone (SIZ) started to operate in 2006 and includes many industries that potentially affect local air quality and the health status of its surrounding residents.", {"entities": []}], ["The study aim was to assess the health effects in a population of \u226520\u00a0years old, living in the residential area around the SIZ.", {"entities": []}], ["Area-specific health care visits data for acute respiratory diseases (ARD), asthma, conjunctivitis and dermatitis were obtained for the period between January 1, 2006, and December 31, 2010.", {"entities": [[84, 98, "DISEASE"], [76, 82, "DISEASE"], [103, 113, "DISEASE"]]}], ["Exposure was defined as distance from the SIZ to determine high, intermediate, and control exposure zones (\u22645, >5\u201310, and \u226520\u00a0km from the SIZ respectively).", {"entities": []}], ["Generalized additive models were used to model age and gender adjusted monthly health events for the selected diseases, adjusted for age and gender-specific population smoking prevalence.", {"entities": []}], ["The high and intermediate exposure zones were later combined in the models because of their similarity of effects.", {"entities": []}], ["Exposure effect modification by age, gender and socio-economic status (SES) were examined.", {"entities": []}], ["Living within the high and intermediate exposure zones was associated with a greater risk ratio for ARD (RR: 2.02; 95\u00a0% CI: 1.88\u20132.17), asthma (RR: 3.61; 95\u00a0% CI: 2.96\u20134.41), conjunctivitis (RR: 2.83; 95\u00a0% CI: 2.47\u20133.24), and dermatitis (RR: 2.11; 95\u00a0% CI: 1.86\u20132.39), compared to the control exposure zone.", {"entities": [[175, 189, "DISEASE"], [136, 142, "DISEASE"], [226, 236, "DISEASE"]]}], ["Greater exposure effects were observed amongst ages \u226550\u00a0years and lower SES groups.", {"entities": []}], ["This is the first study carried out in Oman to assess the link between environmental exposure and health.", {"entities": []}], ["These findings hope to contribute to building up evidence for environmental health and sustainable development policy in the country.", {"entities": []}], ["The online version of this article (doi:10.1186/s12889-015-1866-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Although previous studies confirmed that steaming and the fermentation process could significantly improve the cognitive-enhancement and neuroprotective effects of Codonopsis lanceolata , the anti-tumor efficacy of steamed C .", {"entities": []}], ["lanceolata (SCL) and what mechanisms are involved remain largely unknown.", {"entities": []}], ["The present study was designed to evaluate the anti-tumor effect in vivo of SCL in H22 tumor-bearing mice.", {"entities": []}], ["The results clearly indicated that SCL could not only inhibit the tumor growth, but also prolong the survival time of H22 tumor-bearing mice.", {"entities": []}], ["Besides, the serum levels of cytokines, such as interferon gamma (IFN-\u03b3), tumor necrosis factor-\u03b1 (TNF-\u03b1), interleukin-6 (IL-6) and interleukin-2 (IL-2), were enhanced by SCL administration.", {"entities": []}], ["The observations of Hoechst 33258 staining demonstrated that SCL was able to induce tumor cell apoptosis.", {"entities": []}], ["Finally, immunohistochemical analysis revealed that SCL treatment significantly increased Bax expression and decreased Bcl-2 and vascular endothelial growth factor (VEGF) expression of H22 tumor tissues in a dose-dependent manner.", {"entities": [[90, 93, "GENE"]]}], ["Moreover, LC/MS analysis of SCL indicated that it mainly contained lobetyolin and six saponins.", {"entities": []}], ["Taken all together, the findings in the present study clearly demonstrated that SCL inhibited the H22 tumor growth in vivo at least partly via improving the immune functions, inducing apoptosis and inhibiting angiogenesis.", {"entities": []}], ["Inhaled corticosteroids (ICSs) are currently used to prevent and treat asthma and recurrent wheezing attacks in children.", {"entities": [[71, 77, "DISEASE"]]}], ["Fluticasone propionate (FP) is one of the most commonly prescribed ICSs because it is considered effective and well tolerated.", {"entities": []}], ["A male infant of approximately 1\u00a0year of age, who was born to parents without relevant clinical problems or family histories including diabetes, was brought to our attention for recurrent wheezing.", {"entities": []}], ["When he was approximately 2\u00a0years old, a regular daily inhaled treatment with FP given using a spacer was prescribed.", {"entities": []}], ["With this therapy, the child obtained good control of his symptoms with no further recurrences, but after approximately 2\u00a0months of treatment he was admitted to the emergency room because he was whining and agitated and exhibited increased diuresis and water intake.", {"entities": []}], ["Laboratory tests revealed hyperglycaemia (181\u00a0mg/dL), mild glycosuria, blood alkalosis (pH\u00a07.49), a bicarbonate level of 31\u00a0mmol/L, a pCO 2 level of 39\u00a0mmHg, a serum sodium level of 135\u00a0mEq/L and a serum potassium level of 3.5\u00a0mEq/L.", {"entities": []}], ["The parents confirmed that the recommended dose of FP had been administered with no increase in the amount of drug.", {"entities": []}], ["The child was immediately treated with endovenous infusion of physiological saline for 24\u00a0h, and his glycaemic levels as well as venous blood gas analysis returned to normal, with an absence of glucose in the urine.", {"entities": []}], ["Oral glucose tolerance test results and glycated haemoglobin levels were normal.", {"entities": []}], ["Monitoring of blood glucose levels before and after meals for three consecutive days did not reveal any further increase above normal levels.", {"entities": []}], ["He was discharged with a diagnosis of transient symptomatic hyperglycaemia during ICS therapy and the suggestion to replace his inhaled FP therapy with oral montelukast.", {"entities": []}], ["Montelukast was continued for 6\u00a0months; during this time, the child did not present any other hyperglycaemia episodes.", {"entities": []}], ["Although there is no evidence of causation, this case report represents an interesting and unusual description of paediatric transient symptomatic hyperglycaemia after treatment with inhaled FP and highlights the importance of considering this potential adverse event and the necessity of informing parents of the possible clinically relevant risks associated with this drug.", {"entities": []}], ["The objective of the study was to assess the effect of changes in mental health status on health-related quality of life (HRQOL) in children and adolescents aged 8 - 18 years.", {"entities": []}], ["A representative sample of Spanish children and adolescents aged 8-18 years completed the self-administered KIDSCREEN-52 questionnaire at baseline and after 3 years.", {"entities": []}], ["Mental health status was measured using the Strengths and Difficulties Questionnaire (SDQ).", {"entities": []}], ["Changes on SDQ scores over time were used to classify respondents in one of 3 categories (improved, stable, worsened).", {"entities": []}], ["Data was also collected on gender, undesirable life events, and family socio-economic status.", {"entities": []}], ["Changes in HRQOL were evaluated using effect sizes (ES).", {"entities": []}], ["A multivariate analysis was performed to identify predictors of poor HRQOL at follow-up.", {"entities": []}], ["Response rate at follow-up was 54% (n = 454).", {"entities": []}], ["HRQOL deteriorated in all groups on most KIDSCREEN dimensions.", {"entities": []}], ["Respondents who worsened on the SDQ showed the greatest deterioration, particularly on Psychological well-being (ES = -0.81).", {"entities": []}], ["Factors most strongly associated with a decrease in HRQOL scores were undesirable life events and worsening SDQ score.", {"entities": []}], ["Changes in mental health status affect children and adolescents' HRQOL.", {"entities": []}], ["Improvements in mental health status protect against poorer HRQOL while a worsening in mental health status is a risk factor for poorer HRQOL.", {"entities": []}], ["Nutritional depletion is an important manifestation of chronic obstructive pulmonary disease (COPD), which has been related to systemic inflammation.", {"entities": [[55, 92, "DISEASE"]]}], ["It remains unclear to what degree airway inflammation contributes to the presence or progression of nutritional depletion.", {"entities": []}], ["To determine whether airway inflammation and lung bacterial colonization are related to nutritional status or predict progressive weight loss and muscle atrophy in patients with COPD.", {"entities": []}], ["Body composition using dual energy X-ray absorptiometry, indices of airway inflammation, and bacterial colonization were measured in 234 COPD patients.", {"entities": []}], ["Systemic inflammation was assessed from serum C reactive protein (CRP) and circulating total and differential leukocyte counts.", {"entities": [[66, 69, "GENE"]]}], ["Nutritional depletion was defined as a body mass index (BMI) less than 21 kg/m Nutritional depletion occurred in 37% of patients.", {"entities": []}], ["Lung function was worsened in patients with nutritional depletion compared to those without (forced expiratory volume in 1 second 1.17 L versus 1.41 L, mean difference 0.24, 95% confidence interval 0.10 to 0.38, P <0.01).", {"entities": []}], ["There were no differences in airway inflammation and bacterial colonization in patients with and without nutritional depletion.", {"entities": []}], ["At baseline, BMI correlated positively with serum CRP (r s =0.14, P =0.04).", {"entities": [[50, 53, "GENE"]]}], ["Change in weight and change in FFM over time could not be predicted from baseline patient characteristics.", {"entities": []}], ["Nutritional depletion and progressive muscle atrophy are not related to airway inflammation or bacterial colonization.", {"entities": []}], ["Overspill of pulmonary inflammation is not a key driver of muscle atrophy in COPD.", {"entities": []}], ["Interleukin (IL)-9, a pleiotropic cytokine produced by the Th2 subset of T lymphocytes has been proposed as product of a candidate gene responsible for asthma.", {"entities": [[152, 158, "DISEASE"]]}], ["Its wide range of biological functions on many cell types involved in the allergic immune response suggests a potentially important role in the complex pathogenesis of asthma.", {"entities": [[168, 174, "DISEASE"]]}], ["To investigate the contributions of IL-9 to airway inflammation and airway hyperresponsiveness in vivo, we created transgenic mice in which expression of the murine IL-9 cDNA was regulated by the rat Clara cell 10 protein promoter.", {"entities": []}], ["Lung selective expression of IL-9 caused massive airway inflammation with eosinophils and lymphocytes as predominant infiltrating cell types.", {"entities": []}], ["A striking finding was the presence of increased numbers of mast cells within the airway epithelium of IL-9\u2013expressing mice.", {"entities": []}], ["Other impressive pathologic changes in the airways were epithelial cell hypertrophy associated with accumulation of mucus-like material within nonciliated cells and increased subepithelial deposition of collagen.", {"entities": []}], ["Physiologic evaluation of IL-9\u2013expressing mice demonstrated normal baseline airway resistance and markedly increased airway hyperresponsiveness to inhaled methacholine.", {"entities": []}], ["These findings strongly support an important role for IL-9 in the pathogenesis of asthma.", {"entities": [[82, 88, "DISEASE"]]}], ["An Aerosol Time-of-Flight Mass Spectrometer (ATOFMS) was used to investigate the size and chemical composition of fine concentrated ambient particles (CAPs) in the size range 0.2\u20132.6 \u03bcm produced by a Versatile Aerosol Concentration Enrichment System (VACES) contained within the Mobile Ambient Particle Concentrator Exposure Laboratory (MAPCEL).", {"entities": [[151, 155, "GENE"]]}], ["The data were collected during a study of human exposure to CAPs, in Edinburgh (UK), in February-March 2004.", {"entities": [[60, 64, "GENE"]]}], ["The air flow prior to, and post, concentration in the VACES was sampled in turn into the ATOFMS, which provides simultaneous size and positive and negative mass spectral data on individual fine particles.", {"entities": []}], ["The particle size distribution was unaltered by the concentrator over the size range 0.2\u20132.6 \u03bcm, with an average enrichment factor during this study of ~5 (after dilution of the final air stream).", {"entities": []}], ["The mass spectra from single particles were objectively grouped into 20 clusters using the multivariate K-means algorithm and then further grouped manually, according to similarity in composition and time sequence, into 8 main clusters.", {"entities": []}], ["The particle ensemble was dominated by pure and reacted sea salt and other coarse inorganic dusts (as a consequence of the prevailing maritime-source climatology during the study), with relatively minor contributions from carbonaceous and secondary material.", {"entities": []}], ["Very minor variations in particle composition were noted pre- and post-particle concentration, but overall there was no evidence of any significant change in particle composition.", {"entities": []}], ["These results confirm, via single particle analysis, the preservation of the size distribution and chemical composition of fine ambient PM in the size range 0.2\u20132.6 \u03bcm after passage through the VACES concentration instrumentation.", {"entities": []}], ["There remains a significant need for development of effective small molecules that can inhibit cytokine-mediated inflammation.", {"entities": []}], ["Phosphoinositide 3 kinase (PI3K) is a direct upstream activator of AKT, and plays a critical role in multiple cell signaling pathways, cell cycle progression, and cell growth, and PI3K inhibitors have been approved or are in clinical development.", {"entities": []}], ["We examined novel PI3Kdelta inhibitors, which are highly selective for the p110delta isoform of in CD3/CD28 stimulated T-cell cytokine production.", {"entities": []}], ["In vitro generated CD4+ T effector cells stimulated in the presence of a PI3Kdelta inhibitor demonstrated a dose-dependent suppression of cytokines produced by Th1, Th2, and Th17 cells.", {"entities": []}], ["This effect was T-cell intrinsic, and we observed similar effects on human PBMCs.", {"entities": []}], ["Th17 cells expressing a constitutively activated form of AKT were resistant to PI3Kdelta inhibition, suggesting that the inhibitor is acting through AKT signaling pathways.", {"entities": []}], ["Additionally, PI3Kdelta inhibition decreased IL-17 production in vivo and decreased neutrophil recruitment to the lung in a murine model of acute pulmonary inflammation.", {"entities": []}], ["These experiments show that targeting PI3Kdelta activity can modulate T-cell cytokine production and reduce inflammation in vivo , suggesting that PI3Kdelta inhibition could have therapeutic potential in treating inflammatory diseases.", {"entities": []}], ["The first wave of the 2009 influenza H1N1 pandemic (H1N1pdm) in Milwaukee, WI has been recognized as the largest reported regional outbreak in the United States.", {"entities": [[27, 36, "DISEASE"]]}], ["The epidemiologic and clinical characteristics of this large first wave outbreak from April 28", {"entities": []}], ["To assess whether sex, education level, and health insurance affect the use of health services among the adult Brazilian population with chronic noncommunicable diseases (NCD).", {"entities": []}], ["Data from a cross-sectional survey were analyzed, the National Health Survey (PNS).", {"entities": []}], ["Frequency of use of services in the population that referred at least one NCD were compared with the frequency from a population that did not report NCD, according to sex, education level, health insurance, and NCD number (1, 2, 3, 4, or more).", {"entities": []}], ["The prevalence and prevalence ratios were calculated crude and adjusted for sex, age, region, and 95% confidence intervals.", {"entities": []}], ["The presence of a noncommunicable disease was associated with increase in hospitalizations in the last 12 months, in 1.7 times (95%CI 1.53\u20131.9).", {"entities": []}], ["Failing to perform usual activities in the last two weeks for health reasons was 3.1 times higher in NCD carriers (95%CI 2.78\u20133.46); while the prevalence of medical consultation in the last 12 months was 1.26 times higher (95%CI 1.24\u20131.28).", {"entities": []}], ["NCD carriers make more use of health services, as well as women, people with higher number of comorbidities, with health insurance, and higher education level.", {"entities": []}], ["NCD carriers make more use of health services, as well as women, people with higher number of comorbidities, with health insurance, and higher education level.", {"entities": []}], ["Exercise interventions improve clinical outcomes of pain and function in adults with knee pain due to osteoarthritis and higher levels of physical activity are associated with lower severity of pain and higher levels of physical functioning in older adults with knee osteoarthritis in cross-sectional studies.", {"entities": [[102, 116, "DISEASE"], [267, 281, "DISEASE"]]}], ["However, to date no studies have investigated if change in physical activity level during exercise interventions can explain clinical outcomes of pain and function.", {"entities": []}], ["This study aimed to investigate if change in physical activity during exercise interventions is associated with future pain and physical function in older adults with knee pain.", {"entities": []}], ["Secondary longitudinal data analyses of a three armed exercise intervention randomised controlled trial.", {"entities": []}], ["Participants were adults with knee pain attributed to osteoarthritis, over the age of 45\u00a0years old ( n \u00a0=\u2009514) from Primary Care Services in the Midlands and Northwest regions of England.", {"entities": [[54, 68, "DISEASE"]]}], ["Crude and adjusted associations between absolute change in physical activity from baseline to 3\u00a0months (measured by the self-report Physical Activity Scale for the Elderly (PASE)) and i) pain ii) physical function (Western Ontario and McMaster Universities Osteoarthritis Index) and iii) treatment response (OMERACT-OARSI responder criteria) at 3 and 6\u00a0months follow-up were investigated using linear and logistic regression.", {"entities": [[257, 271, "DISEASE"]]}], ["Change in physical activity level was not associated with future pain, function or treatment response outcomes in crude or adjusted models at 3 or 6\u00a0months ( P \u00a0>\u20090.05).", {"entities": []}], ["A 10 point increase in PASE was not associated with pain \u03b2\u2009=\u2009\u2212\u20090.01 (\u2212\u20090.05, 0.02), physical function \u03b2\u2009=\u2009\u2212\u20090.09 (\u2212\u20090.19, 0.02) or likelihood (odds ratio) of treatment response 1.02 (0.99, 1.04) at 3\u00a0months adjusting for sociodemographics, clinical covariates and the trial intervention arm.", {"entities": []}], ["Findings were similar for 6\u00a0month outcome models.", {"entities": []}], ["Change in physical activity did not explain future clinical outcomes of pain and function in this study.", {"entities": []}], ["Other factors may be responsible for clinical improvements following exercise interventions.", {"entities": []}], ["However, the PASE may not be sufficiently responsive to measure change in physical activity level.", {"entities": []}], ["We also recommend further investigation into the responsiveness of commonly used physical activity measures.", {"entities": []}], ["( ISRCTN93634563 ).", {"entities": []}], ["Registered 29th September 2011.", {"entities": []}], ["The online version of this article (10.1186/s12891-018-1968-z) contains supplementary material, which is available to authorized users.", {"entities": []}], ["The ongoing spread of tuberculosis (TB) in poor resource countries and the recently increasing incidence in high resource countries lead to the need of updated knowledge for clinicians, particularly for pediatricians.", {"entities": [[22, 34, "DISEASE"]]}], ["The purpose of this article is to provide an overview on the most important peculiarities of TB in children.", {"entities": []}], ["Children are less contagious than adults, but the risk of progression to active disease is higher in infants and children as compared to the subsequent ages.", {"entities": []}], ["Diagnosis of TB in children is more difficult than in adults, because few signs are associated with primary infection, interferon-gamma release assays and tuberculin skin test are less reliable in younger children, M. tuberculosis is more rarely detected in gastric aspirates than in smears in adults and radiological findings are often not specific.", {"entities": [[218, 230, "DISEASE"]]}], ["Treatment of latent TB is always necessary in young children, whereas it is recommended in older children, as well as in adults, only in particular conditions.", {"entities": []}], ["Antimycobacterial drugs are generally better tolerated in children as compared to adults, but off-label use of second-line antimycobacterial drugs is increasing, because of spreading of multidrug resistant TB worldwide.", {"entities": []}], ["Given that TB is a disease which often involves more than one member in a family, a closer collaboration is needed between pediatricians and clinicians who take care of adults.", {"entities": []}], ["Antigen-mediated crosslinking of Immunoglobulin E (IgE) bound to mast cells/basophils via Fc\u03b5RI, the high affinity IgE Fc-receptor, is a well-known trigger of allergy.", {"entities": []}], ["In humans, but not mice, dendritic cells (DCs) also express Fc\u03b5RI that is constitutively occupied with IgE.", {"entities": []}], ["In contrast to mast cells/basophils, the consequences of IgE/Fc\u03b5RI signals for DC function remain poorly understood.", {"entities": []}], ["We show that humanized mice that express Fc\u03b5RI on DCs carry IgE like non-allergic humans and do not develop spontaneous allergies.", {"entities": []}], ["Antigen-specific IgE/Fc\u03b5RI crosslinking fails to induce maturation or production of inflammatory mediators in human DCs and Fc\u03b5RI-humanized DCs.", {"entities": []}], ["Furthermore, conferring expression of Fc\u03b5RI to DCs decreases the severity of food allergy and asthma in disease-relevant models suggesting anti-inflammatory IgE/Fc\u03b5RI signals.", {"entities": [[77, 89, "DISEASE"], [94, 100, "DISEASE"]]}], ["Consistent with the improved clinical parameters in vivo , antigen-specific IgE/Fc\u03b5RI crosslinking on papain or LPS-stimulated DCs inhibits the production of pro-inflammatory cytokines and chemokines.", {"entities": []}], ["Migration assays confirm that the IgE-dependent decrease in cytokine production results in diminished recruitment of mast cell progenitors; providing a mechanistic explanation for the reduced mast cell-dependent allergic phenotype observed in Fc\u03b5RI-humanized mice.", {"entities": []}], ["Our study demonstrates a novel immune regulatory function of IgE and proposes that DC-intrinsic IgE signals serve as a feedback mechanism to restrain allergic tissue inflammation.", {"entities": []}], ["Guidelines continue to be underutilized, and a variety of strategies to improve their use have been suboptimal.", {"entities": []}], ["Modifying guideline features represents an alternative, but untested way to promote their use.", {"entities": []}], ["The purpose of this study was to identify and define features that facilitate guideline use, and examine whether and how they are included in current guidelines.", {"entities": []}], ["A guideline implementability framework was developed by reviewing the implementation science literature.", {"entities": []}], ["We then examined whether guidelines included these, or additional implementability elements.", {"entities": []}], ["Data were extracted from publicly available high quality guidelines reflecting primary and institutional care, reviewed independently by two individuals, who through discussion resolved conflicts, then by the research team.", {"entities": []}], ["The final implementability framework included 22 elements organized in the domains of adaptability, usability, validity, applicability, communicability, accommodation, implementation, and evaluation.", {"entities": []}], ["Data were extracted from 20 guidelines on the management of diabetes, hypertension, leg ulcer, and heart failure.", {"entities": [[70, 82, "DISEASE"]]}], ["Most contained a large volume of graded, narrative evidence, and tables featuring complementary clinical information.", {"entities": []}], ["Few contained additional features that could improve guideline use.", {"entities": []}], ["These included alternate versions for different users and purposes, summaries of evidence and recommendations, information to facilitate interaction with and involvement of patients, details of resource implications, and instructions on how to locally promote and monitor guideline use.", {"entities": []}], ["There were no consistent trends by guideline topic.", {"entities": []}], ["Numerous opportunities were identified by which guidelines could be modified to support various types of decision making by different users.", {"entities": []}], ["New governance structures may be required to accommodate development of guidelines with these features.", {"entities": []}], ["Further research is needed to validate the proposed framework of guideline implementability, develop methods for preparing this information, and evaluate how inclusion of this information influences guideline use.", {"entities": []}], ["Convincing evidences have demonstrated the associations between HHIP and FAM13a polymorphisms and COPD in non-Asian populations.", {"entities": [[64, 68, "GENE"], [73, 79, "GENE"]]}], ["Here genetic variants in HHIP and FAM13a were investigated in Southern Han Chinese COPD.", {"entities": [[25, 29, "GENE"], [34, 40, "GENE"]]}], ["A case-control study was conducted, including 989 cases and 999 controls.", {"entities": []}], ["The associations between SNPs genotypes and COPD were performed by a logistic regression model; for SNPs and COPD-related phenotypes such as lung function, COPD severity, pack-year of smoking, and smoking status, a linear regression model was employed.", {"entities": []}], ["Effects of risk alleles, genotypes, and haplotypes of the 3 significant SNPs in the HHIP gene on FEV 1 /FVC were also assessed in a linear regression model in COPD.", {"entities": [[84, 88, "GENE"], [97, 100, "GENE"]]}], ["The mean FEV 1 /FVC% value was 46.8 in combined COPD population.", {"entities": [[9, 12, "GENE"]]}], ["None of the 8 selected SNPs apparently related to COPD susceptibility.", {"entities": []}], ["However, three SNPs (rs12509311, rs13118928, and rs182859) in HHIP were associated significantly with the FEV 1 /FVC% ( P max = 4.1 \u00d7 10 1 /FVC% ( P = 2.3 \u00d7 10 1 /FVC% ( P = 3.5 \u00d7 10 Genetic variants in HHIP were related with FEV 1 /FVC in COPD.", {"entities": [[62, 66, "GENE"], [203, 207, "GENE"], [106, 109, "GENE"], [226, 229, "GENE"], [122, 125, "GENE"], [62, 66, "GENE"], [203, 207, "GENE"], [106, 109, "GENE"], [226, 229, "GENE"]]}], ["Significant relationships between risk alleles and risk genotypes and FEV 1 /FVC in COPD were also identified.", {"entities": [[70, 73, "GENE"]]}], ["Computational models of gas transport and aerosol deposition frequently utilize idealized models of bronchial tree structure, where airways are considered a network of bifurcating cylinders.", {"entities": []}], ["However, changes in the shape of the lung during respiration affect the geometry of the airways, especially in disease conditions.", {"entities": []}], ["In this study, the internal airway geometry was examined, concentrating on comparisons between mean lung volume (MLV) and total lung capacity (TLC).", {"entities": []}], ["A set of High Resolution CT images were acquired during breath hold on a group of moderate persistent asthmatics at MLV and TLC after challenge with a broncho-constrictor (methacholine) and the airway trees were segmented and measured.", {"entities": []}], ["The airway hydraulic diameter (Dh) was calculated through the use of average lumen area (Ai) and average internal perimeter (Pi) at both lung volumes and was found to be systematically higher at TLC by 13.5\u00b19% on average, with the lower lobes displaying higher percent change in comparison to the lower lobes.", {"entities": []}], ["The average internal diameter (Din) was evaluated to be 12.4\u00b16.8% (MLV) and 10.8\u00b16.3% (TLC) lower than the Dh, for all the examined bronchi, a result displaying statistical significance.", {"entities": []}], ["Finally, the airway distensibility per bronchial segment and per generation was calculated to have an average value of 0.45\u00b10.28, exhibiting high variability both between and within lung regions and generations.", {"entities": []}], ["Mixed constriction/dilation patterns were recorded between the lung volumes, where a number of airways either failed to dilate or even constricted when observed at TLC.", {"entities": []}], ["We conclude that the Dh is higher than Din, a fact that may have considerable effects on bronchial resistance or airway loss at proximal regions.", {"entities": []}], ["Differences in caliber changes between lung regions are indicative of asthma-expression variability in the lung.", {"entities": [[70, 76, "DISEASE"]]}], ["However, airway distensibility at generation 3 seems to predict distensibility more distally.", {"entities": []}], ["It has been estimated that more than 1 million workers in the United States are exposed to cobalt.", {"entities": []}], ["Occupational exposure to A time course transcriptome analysis was performed on A549 human pulmonary cells, leading to the identification of 85 genes which are repressed or induced in response to soluble FBXL2, ZNT1, SLC12A5 ), tumor suppressors or transcription factors ( MAZ, DLG1, MYC, AXL ) and genes linked to the stress response ( UBC, HSPCB, BNIP3L ).", {"entities": [[203, 208, "GENE"], [216, 223, "GENE"], [272, 275, "GENE"], [277, 281, "GENE"], [283, 286, "GENE"], [288, 291, "GENE"], [336, 339, "GENE"], [348, 354, "GENE"]]}], ["We also identified nine genes coding for secreted proteins as candidates for biomarker research.", {"entities": []}], ["Of those, TIMP 2 was found to be down-regulated and this modulation was confirmed, in a dose-dependent manner, at protein level in the supernatant of exposed cells.", {"entities": []}], ["Most of these genes have never been described as related to cobalt stress and provide original hypotheses for further study of the effects of this metal ion on human lung epithelial cells.", {"entities": []}], ["A putative biomarker of cobalt toxicity was identified.", {"entities": []}], ["Antidepressants are one of the most commonly prescribed medications in young and middle-aged adults, but there is relatively little information on their safety across a range of adverse outcomes in this age group.", {"entities": []}], ["This study aimed to assess associations between antidepressant treatment and several adverse outcomes in people aged 20\u201364 years diagnosed with depression.", {"entities": []}], ["We conducted a cohort study in 238,963 patients aged 20\u201364 years registered with practices across the UK contributing to the QResearch primary care database.", {"entities": []}], ["Only patients with a first diagnosis of depression were included.", {"entities": []}], ["Outcomes were falls, fractures, upper gastrointestinal bleed, road traffic accidents, adverse drug reactions and all-cause mortality recorded during follow-up.", {"entities": []}], ["Cox proportional hazards models were used to estimate hazard ratios associated with antidepressant exposure adjusting for potential confounding variables.", {"entities": []}], ["During 5 years of follow-up, 4651 patients had experienced a fall, 4796 had fractures, 1066 had upper gastrointestinal bleeds, 3690 had road traffic accidents, 1058 had experienced adverse drug reactions, and 3181 patients died.", {"entities": []}], ["Fracture rates were significantly increased for selective serotonin reuptake inhibitors (adjusted hazard ratio 1.30, 95% CI 1.21\u20131.39) and other antidepressants (1.28, 1.11\u20131.48) compared with periods when antidepressants were not used.", {"entities": []}], ["All antidepressant drug classes were associated with significantly increased rates of falls.", {"entities": []}], ["Rates of adverse drug reactions were significantly higher for tricyclic and related antidepressants (1.54, 1.25\u20131.88) and other antidepressants (1.61, 1.22\u20132.12) compared with selective serotonin reuptake inhibitors.", {"entities": []}], ["Trazodone was associated with a significantly increased risk of upper gastrointestinal bleed.", {"entities": []}], ["All-cause mortality rates were significantly higher for tricyclic and related antidepressants (1.39, 1.22\u20131.59) and other antidepressants (1.26, 1.08\u20131.47) than for selective serotonin reuptake inhibitors\u00a0over 5 years but not 1 year, and were significantly reduced after 85 or more days of treatment with selective serotonin reuptake inhibitors.", {"entities": []}], ["Mirtazapine was associated with significantly increased mortality rates over 1 and 5 years of follow-up.", {"entities": []}], ["Selective serotonin reuptake inhibitors had higher rates of fracture than tricyclic and related antidepressants but lower mortality and adverse drug reaction rates than the other antidepressant drug classes.", {"entities": []}], ["The association between mirtazapine and increased mortality merits further investigation.", {"entities": []}], ["These risks should be carefully considered and balanced against potential benefits for individual patients when the decision to prescribe an antidepressant is made.", {"entities": []}], ["The online version of this article (10.1186/s12916-018-1022-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Factors increasing the severity of respiratory infections in developing countries are poorly described.", {"entities": []}], ["We report factors associated with severe acute respiratory illness in Yemeni children (266 infected with respiratory syncytial virus and 66 with human metapneumovirus).", {"entities": []}], ["Age, indoor air pollution, and incomplete vaccinations were risk factors and differed from those in industrialized countries.", {"entities": []}], ["Childhood psychotic symptoms are associated with increased rates of schizophrenia, other psychiatric disorders, and suicide attempts in adulthood; thus, elucidating early risk indicators is crucial to target prevention efforts.", {"entities": [[68, 81, "DISEASE"]]}], ["There is considerable discordance for psychotic symptoms between monozygotic twins, indicating that child-specific non-genetic factors must be involved.", {"entities": []}], ["Epigenetic processes may constitute one of these factors and have not yet been investigated in relation to childhood psychotic symptoms.", {"entities": []}], ["Therefore, this study explored whether differences in DNA methylation at age 10 were associated with monozygotic twin discordance for psychotic symptoms at age 12.", {"entities": []}], ["The Environmental Risk (E-Risk) Longitudinal Twin Study cohort of 2,232 children (1,116 twin pairs) was assessed for age-12 psychotic symptoms and 24 monozygotic twin pairs discordant for symptoms were identified for methylomic comparison.", {"entities": []}], ["Children provided buccal samples at ages 5 and 10.", {"entities": []}], ["DNA was bisulfite modified and DNA methylation was quantified using the Infinium HumanMethylation450 array.", {"entities": []}], ["Differentially methylated positions (DMPs) associated with psychotic symptoms were subsequently tested in post-mortem prefrontal cortex tissue from adult schizophrenia patients and age-matched controls.", {"entities": [[154, 167, "DISEASE"]]}], ["Site-specific DNA methylation differences were observed at age 10 between monozygotic twins discordant for age-12 psychotic symptoms.", {"entities": []}], ["Similar DMPs were not found at age 5.", {"entities": []}], ["The top-ranked psychosis-associated DMP (cg23933044), located in the promoter of the C5ORF42 gene, was also hypomethylated in post-mortem prefrontal cortex brain tissue from schizophrenia patients compared to unaffected controls.", {"entities": [[174, 187, "DISEASE"]]}], ["These data tentatively suggest that epigenetic variation in peripheral tissue is associated with childhood psychotic symptoms and may indicate susceptibility to schizophrenia and other mental health problems.", {"entities": [[161, 174, "DISEASE"]]}], ["Host immunity pathways evolve rapidly in response to antagonism by pathogens.", {"entities": []}], ["Microbial infections can also trigger excessive inflammation that contributes to diverse autoimmune disorders including asthma, lupus, diabetes, and arthritis.", {"entities": [[149, 158, "DISEASE"], [120, 126, "DISEASE"]]}], ["Definitive links between immune system evolution and human autoimmune disease remain unclear.", {"entities": []}], ["Here we provide evidence that several components of the type 2 immune response pathway have been subject to recurrent positive selection in the primate lineage.", {"entities": []}], ["Notably, substitutions in the central immune regulator IL13 correspond to a polymorphism linked to asthma susceptibility in humans.", {"entities": [[99, 105, "DISEASE"], [55, 59, "GENE"]]}], ["We also find evidence of accelerated amino acid substitutions as well as gene gain and loss events among eosinophil granule proteins, which act as toxic antimicrobial effectors that promote asthma pathology by damaging airway tissues.", {"entities": [[190, 196, "DISEASE"]]}], ["These results support the hypothesis that evolutionary conflicts with pathogens promote tradeoffs for increasingly robust immune responses during animal evolution.", {"entities": []}], ["Our findings are also consistent with the view that natural selection has contributed to the spread of autoimmune disease alleles in humans.", {"entities": []}], ["Possession of a properly functioning innate immune system in the lung is vital to prevent infections due to the ongoing exposure of the lung to pathogens.", {"entities": []}], ["While mechanisms of pulmonary innate immunity have been well studied, our knowledge of how these systems are altered in disease states, leading to increased susceptibility to infections, is limited.", {"entities": []}], ["One innate immune protein in the lung, the pulmonary collectin SP-D, has been shown to be important in innate immune defense, as well as clearance of allergens and apoptotic cells.", {"entities": []}], ["MMP-9 is a protease with a wide variety of substrates, and has been found to be dysregulated in a myriad of lung diseases ranging from asthma to cystic fibrosis; in many of these conditions, there are decreased levels of SP-D. Our results indicate that MMP-9 is able to cleave SP-D in vitro and this cleavage leads to loss of its innate immune functions, including its abilities to aggregate bacteria and increase phagocytosis by mouse alveolar macrophages.", {"entities": [[145, 160, "DISEASE"], [135, 141, "DISEASE"]]}], ["However, MMP-9-cleaved SP-D was still detected in a solid-phase E. coli LPS-binding assay, while NE-cleaved SP-D was not.", {"entities": []}], ["In addition, MMP-9 seems to cleave SP-D much more efficiently than NE at physiological levels of calcium.", {"entities": []}], ["Previous studies have shown that in several diseases, including cystic fibrosis and asthma, patients have increased expression of MMP-9 in the lungs as well as decreased levels of intact SP-D. As patients suffering from many of the diseases in which MMP-9 is over-expressed can be more susceptible to pulmonary infections, it is possible that MMP-9 cleavage of SP-D may contribute to this phenotype.", {"entities": [[64, 79, "DISEASE"], [84, 90, "DISEASE"]]}], ["Depression in patients with mastocytosis is often reported but its prevalence and characteristics are not precisely described.", {"entities": [[28, 40, "DISEASE"]]}], ["In addition, the impact of therapies targeting mast cells proliferation, differentiation and degranulation on psychic symptoms of depression have never been investigated.", {"entities": []}], ["Our objective was to determine the prevalence and to describe features of depression in a large cohort of mastocytosis patients (n\u200a=\u200a288) and to investigate the therapeutic impact of the protein kinase inhibitor masitinib in depression symptoms.", {"entities": [[106, 118, "DISEASE"]]}], ["The description of depression was based on the analysis of a database with Hamilton scores using Principal Component Analysis (PCA).", {"entities": []}], ["Efficacy of masitinib therapy was evaluated using non parametric Wilcoxon test for paired data within a three months period (n\u200a=\u200a35).", {"entities": []}], ["Our results show that patients with indolent mastocytosis present an elevated prevalence of depression (64%).", {"entities": [[45, 57, "DISEASE"]]}], ["Depression was moderate in 56% but severe in 8% of cases.", {"entities": []}], ["Core symptoms (such as psychic anxiety, depressed mood, work and interests) characterized depression in mastocytosis patients.", {"entities": [[104, 116, "DISEASE"]]}], ["Masitinib therapy was associated with significant improvement (67% of the cases) of overall depression, with 75% of recovery cases.", {"entities": []}], ["Global Quality of Life slightly improved after masitinib therapy and did not predicted depression improvement.", {"entities": []}], ["In conclusion, depression is very frequent in mastocytosis patients and masitinib therapy is associated with the reduction its psychic experiences.", {"entities": [[46, 58, "DISEASE"]]}], ["We conclude that depression in mastocytosis may originate from processes related to mast cells activation.", {"entities": [[31, 43, "DISEASE"]]}], ["Masitinib could therefore be a useful treatment for mastocytosis patients with depression and anxiety symptoms.", {"entities": [[52, 64, "DISEASE"]]}], ["Cigarette smoking contributes to the pathogenesis of chronic obstructive pulmonary disease and lung cancer.", {"entities": [[95, 106, "DISEASE"], [53, 90, "DISEASE"], [100, 106, "DISEASE"]]}], ["Nicotine-derived nitrosamine ketone (NNK) is the most potent carcinogen among cigarette smoking components, and is known to enhance migration of cancer cells.", {"entities": [[145, 151, "DISEASE"]]}], ["However, the effect of NNK on normal human bronchial epithelial cells is not well studied.", {"entities": []}], ["XB130 is a member of actin filament associated protein family and is involved in cell morphology changes, cytoskeletal rearrangement and outgrowth formation, as well as cell migration.", {"entities": []}], ["We hypothesized that XB130 mediates NNK-induced migration of normal human bronchial epithelial cells.", {"entities": []}], ["Our results showed that, after NNK stimulation, XB130 was translocated to the cell periphery and enriched in cell motility-associated structures, such as lamellipodia, in normal human bronchial epithelial BEAS2B cells.", {"entities": []}], ["Moreover, overexpression of XB130 significantly enhanced NNK-induced migration, which requires both the N- and C-termini of XB130.", {"entities": []}], ["Overexpression of XB130 enhanced NNK-induced protein tyrosine phosphorylation and promoted matrix metalloproteinase-14 translocation to cell motility-associated cellular structures after NNK stimulation.", {"entities": []}], ["XB130-mediated NNK-induced cell migration may contribute to airway epithelial repair; however, it may also be involved in cigarette smoking-related chronic obstructive pulmonary disease and lung cancer.", {"entities": [[190, 201, "DISEASE"], [148, 185, "DISEASE"], [195, 201, "DISEASE"]]}], ["As many respiratory viruses are responsible for influenza like symptoms, accurate measures of the disease burden are not available and estimates are generally based on statistical methods.", {"entities": [[48, 57, "DISEASE"]]}], ["The objective of this study was to estimate absenteeism rates and hours lost due to seasonal influenza and compare these estimates with estimates of absenteeism attributable to the two H1N1 pandemic waves that occurred in 2009.", {"entities": [[93, 102, "DISEASE"]]}], ["Key absenteeism variables were extracted from Statistics Canada's monthly labour force survey (LFS).", {"entities": []}], ["Absenteeism and the proportion of hours lost due to own illness or disability were modelled as a function of trend, seasonality and proxy variables for influenza activity from 1998 to 2009.", {"entities": [[152, 161, "DISEASE"]]}], ["Hours lost due to the H1N1/09 pandemic strain were elevated compared to seasonal influenza, accounting for a loss of 0.2% of potential hours worked annually.", {"entities": [[81, 90, "DISEASE"]]}], ["In comparison, an estimated 0.08% of hours worked annually were lost due to seasonal influenza illnesses.", {"entities": [[85, 94, "DISEASE"]]}], ["Absenteeism rates due to influenza were estimated at 12% per year for seasonal influenza over the 1997/98 to 2008/09 seasons, and 13% for the two H1N1/09 pandemic waves.", {"entities": [[25, 34, "DISEASE"], [79, 88, "DISEASE"]]}], ["Employees who took time off due to a seasonal influenza infection took an average of 14 hours off.", {"entities": [[46, 55, "DISEASE"]]}], ["For the pandemic strain, the average absence was 25 hours.", {"entities": []}], ["This study confirms that absenteeism due to seasonal influenza has typically ranged from 5% to 20%, with higher rates associated with multiple circulating strains.", {"entities": [[53, 62, "DISEASE"]]}], ["Absenteeism rates for the 2009 pandemic were similar to those occurring for seasonal influenza.", {"entities": [[85, 94, "DISEASE"]]}], ["Employees took more time off due to the pandemic strain than was typical for seasonal influenza.", {"entities": [[86, 95, "DISEASE"]]}], ["The payment structure for the New Medicine Service (NMS) in England is based on the assumption that 0.5% of prescription items dispensed in community pharmacies are eligible for the service.", {"entities": [[52, 55, "GENE"]]}], ["This assumption is based on a theoretical calculation.", {"entities": []}], ["This study aimed to find out the actual proportion of prescription items eligible for the NMS dispensed in community pharmacies in order to compare this with the theoretical assumption.", {"entities": [[90, 93, "GENE"]]}], ["The study also aimed to investigate whether the proportion of prescription items eligible for the NMS is affected by pharmacies\u2019 proximity to GP practices.", {"entities": [[98, 101, "GENE"]]}], ["The study collected data from eight pharmacies in Nottingham belonging to the same large chain of pharmacies.", {"entities": []}], ["Pharmacies were grouped by distance from the nearest GP practice and sampled to reflect the distribution by distance of all pharmacies in Nottingham.", {"entities": []}], ["Data on one thousand consecutive prescription items were collected from each pharmacy and the number of NMS eligible items recorded.", {"entities": [[104, 107, "GENE"]]}], ["All NHS prescriptions were included in the sample.", {"entities": [[4, 7, "GENE"]]}], ["Data were analysed and proportions calculated with 95% confidence intervals used to compare the study results against the theoretical figure of 0.5% of prescription items being eligible for the NMS.", {"entities": [[194, 197, "GENE"]]}], ["A total of 8005 prescription items were collected (a minimum of 1000 items per pharmacy) of which 17 items were eligible to receive the service.", {"entities": []}], ["The study found that 0.25% (95% confidence intervals: 0.14% to 0.36%) of prescription items were eligible for the NMS which differs significantly from the theoretical assumption of 0.5%.", {"entities": [[114, 117, "GENE"]]}], ["The opportunity rate for the service was lower, 0.21% (95% confidence intervals: 0.10% to 0.32%) of items, as some items eligible for the NMS did not translate into opportunities to offer the service.", {"entities": [[138, 141, "GENE"]]}], ["Of all the prescription items collected in the pharmacies, 28% were collected by patient representatives.", {"entities": []}], ["The results of this study show that the proportion of items eligible for the NMS dispensed in community pharmacies is lower than the Department of Health assumption of 0.5%.", {"entities": [[77, 80, "GENE"]]}], ["This study did not find a significant difference in the rate of NMS opportunities between pharmacies located close to GP practices compared to those further away.", {"entities": [[64, 67, "GENE"]]}], ["Henna is very popular in the United Arab Emirates (UAE); it is part of the culture and traditions.", {"entities": []}], ["Allergy to natural henna is not usual; however the addition of para -phenylenediamine (PPD) to the natural henna increases the risk of allergic contact dermatitis.", {"entities": [[144, 162, "DISEASE"], [135, 162, "DISEASE"], [152, 162, "DISEASE"]]}], ["The objectives of the study were to identify the presence and concentration of PPD in henna available in UAE.", {"entities": []}], ["Fifteen henna salons were selected randomly from three cities in UAE.", {"entities": []}], ["Twenty five henna samples were acquired from these selected salons.", {"entities": []}], ["The presence of PPD in henna samples was determined qualitatively and quantitatively using High Performance Liquid Chromatography (HPLC).", {"entities": []}], ["The study showed that PPD was present in all of the black henna samples at concentrations ranging between 0.4% and 29.5% and higher than that recommended for hair dyes in most of the black henna samples.", {"entities": []}], ["The presence of PPD in the black henna increases the risk of allergic contact dermatitis among users of black henna and a number of cases have already been reported in UAE.", {"entities": [[70, 88, "DISEASE"], [61, 88, "DISEASE"], [78, 88, "DISEASE"]]}], ["Sleep duration holds considerable importance as an indicator of mental/physical health.", {"entities": []}], ["The objective of this study was to investigate the association between sleep duration, mental health, and chronic disease prevalence in Koreans.", {"entities": []}], ["Of 31,596 subjects eligible for the Korean National Health and Nutrition Examination Survey V (2010\u20132012), 17,638 participants who answered items on sleep duration (aged \u226519\u00a0yrs) were analyzed in a cross-sectional study.", {"entities": []}], ["Association between sleep duration, mental health, and chronic disease prevalence was assessed using logistic regression, and adjusted for various socioeconomic and lifestyle characteristics.", {"entities": []}], ["Short or long sleep duration showed correlations with mental health, and items of significance showed gender-specific patterns.", {"entities": []}], ["Women displayed significant associations with stress and depressive symptoms, and men with stress, thoughts of suicide, and psychiatric counseling.", {"entities": []}], ["While stress was related with short sleep duration in both genders, depressive symptoms showed a relationship with long duration in men, and short duration in women.", {"entities": []}], ["Prevalence of any chronic disease was associated with \u22646\u00a0h sleep when adjusted for factors including mental health, and among chronic diseases, cancer and osteoarthritis showed associations with short sleep duration, while diabetes and dyslipidemia were associated with normal sleep duration.", {"entities": [[155, 169, "DISEASE"], [144, 150, "DISEASE"]]}], ["Mental health problems were associated with sleep duration with gender-specific patterns.", {"entities": []}], ["Associations with osteoarthritis, cancer, diabetes, dyslipidemia and abnormal sleep duration persisted after adjustment for mental health.", {"entities": [[18, 32, "DISEASE"], [34, 40, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12889-015-2542-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Recently, we reported that genetic polymorphisms within the human IL18 gene were associated with disease susceptibility to adult-onset Still's disease (AOSD), which is characterized by extraordinarily high serum levels of IL-18.", {"entities": [[66, 70, "GENE"]]}], ["Because high serum IL-18 induction has also been observed in the systemic type of juvenile idiopathic arthritis (JIA), we investigated whether similar genetic skewing is present in this disease.", {"entities": [[102, 111, "DISEASE"]]}], ["Three haplotypes, S01, S02, and S03, composed of 13 genetic polymorphisms covering two distinct promoter regions, were determined for 33 JIA patients, including 17 with systemic JIA, 10 with polyarthritis, and 6 with oligoarthritis.", {"entities": []}], ["Haplotypes were also analyzed for 28 AOSD patients, 164 rheumatoid arthritis (RA) patients, 102 patients with collagen diseases, and 173 healthy control subjects.", {"entities": [[56, 76, "DISEASE"], [67, 76, "DISEASE"]]}], ["The frequency of individuals carrying a diplotype configuration (a combination of two haplotypes) of S01/S01 was significantly higher in the JIA patients, including all subgroups, than in the healthy controls ( P = 0.0045, Fischer exact probability test; odds ratio (OR) = 3.55, 95% confidence interval (CI) = 1.55\u20138.14).", {"entities": []}], ["In patients with systemic JIA, its frequency did not differ statistically from that of normal controls.", {"entities": []}], ["Nevertheless, it is possible that haplotype S01 is associated with the phenotype of high IL-18 production in systemic JIA because the patients carrying S01/S01 showed significantly higher serum IL-18 levels compared with patients with other diplotype configurations ( P = 0.017, Mann-Whitney U test).", {"entities": []}], ["We confirmed that the frequency of the diplotype configuration of S01/S01 was significantly higher in AOSD patients than in healthy control subjects ( P = 0.011, OR = 3.45, 95% CI = 1.42\u20138.36).", {"entities": []}], ["Furthermore, the RA patients were also more predisposed to have S01/S01 ( P = 0.018, OR = 2.00, 95% CI = 1.14\u20133.50) than the healthy control subjects, whereas the patients with collagen diseases did not.", {"entities": []}], ["In summary, the diplotype configuration of S01/S01 was associated with susceptibility to JIA as well as AOSD and RA, and linked to significantly higher IL-18 production in systemic JIA.", {"entities": []}], ["Possession of the diplotype configuration of S01/S01 would be one of the genetic risk factors for susceptibility to arthritis in the Japanese population.", {"entities": [[116, 125, "DISEASE"]]}], ["Surgical or bronchoscopic lung volume reduction (BLVR) techniques can be beneficial for heterogeneous emphysema.", {"entities": []}], ["Post-processing software tools for lobar emphysema quantification are useful for patient and target lobe selection, treatment planning and post-interventional follow-up.", {"entities": []}], ["We aimed to evaluate the inter-software variability of emphysema quantification using fully automated lobar segmentation prototypes.", {"entities": []}], ["66 patients with moderate to severe COPD who underwent CT for planning of BLVR were included.", {"entities": []}], ["Emphysema quantification was performed using 2 modified versions of in-house software (without and with prototype advanced lung vessel segmentation; programs 1 [YACTA v.2.3.0.2] and 2 [YACTA v.2.4.3.1]), as well as 1 commercial program 3 [Pulmo3D VA30A_HF2] and 1 pre-commercial prototype 4 [CT COPD ISP ver7.0]).", {"entities": []}], ["The following parameters were computed for each segmented anatomical lung lobe and the whole lung: lobar volume (LV), mean lobar density (MLD), 15 Segmentation using programs 1, 3 and 4 was unsuccessful in 1 (1%), 7 (10%) and 5 (7%) patients, respectively.", {"entities": []}], ["Program 2 could analyze all datasets.", {"entities": []}], ["The 53 patients with successful segmentation by all 4 programs were included for further analysis.", {"entities": []}], ["For LV, program 1 and 4 showed the largest mean difference of 72 ml and the widest LoA of [-356, 499 ml] ( p <0.05).", {"entities": []}], ["Program 3 and 4 showed the largest mean difference of 4% and the widest LoA of [-7, 14%] for EI ( p <0.001).", {"entities": []}], ["Only a single software program was able to successfully analyze all scheduled data-sets.", {"entities": []}], ["Although mean bias of LV and EV were relatively low in lobar quantification, ranges of disagreement were substantial in both of them.", {"entities": []}], ["For longitudinal emphysema monitoring, not only scanning protocol but also quantification software needs to be kept constant.", {"entities": []}], ["In Uganda, despite a significant public health burden of tuberculosis (TB) in the context of high human immunodeficiency virus (HIV) prevalence, little is known about community knowledge of TB.", {"entities": [[57, 69, "DISEASE"]]}], ["The purpose of this study was to assess and compare knowledge about TB and HIV in the general population of western Uganda and to examine common knowledge gaps and misconceptions.", {"entities": []}], ["We implemented a multi-stage survey design to randomly survey 360 participants from one district in western Uganda.", {"entities": []}], ["Weighted summary knowledge scores for TB and HIV were calculated and multiple linear regression (with knowledge score as the dependant variable) was used to determine significant predictors.", {"entities": []}], ["Six focus group discussions were conducted to supplement survey findings.", {"entities": []}], ["Mean (SD) HIV knowledge score was 58 (12) and TB knowledge score was 33 (15), both scores out of 100.", {"entities": []}], ["The TB knowledge score was statistically significantly (p\u2009<\u20090.001) lower.", {"entities": []}], ["Multivariate regression models included age, sex, marital status, education, residence, and having a friend with HIV/TB as independent variables.", {"entities": []}], ["TB knowledge was predicted by rural residence (coefficient\u2009=\u2009\u22126.27, 95% CI: -11.7 to \u22120.8), and age \u226545 years (coefficient\u2009=\u20097.45, 95% CI: 0.3-14.6).", {"entities": []}], ["HIV knowledge was only predicted by higher education (coefficient\u2009=\u20090.94, 95%CI: 0.3-1.6).", {"entities": []}], ["Focus group participants mentioned various beliefs in the aetiology of TB including sharing cups, alcohol consumption, smoking, air pollution, and HIV.", {"entities": []}], ["Some respondents believed that TB was not curable.", {"entities": []}], ["TB knowledge is low and many misconceptions about TB exist: these should be targeted through health education programs.", {"entities": []}], ["Both TB and HIV-infection knowledge gaps could be better addressed through an integrated health education program on both infections, whereby TB program managers include HIV information and vice versa.", {"entities": []}], ["Ultrafine carbon black (ufCB) can cause proinflammatory response and increase alveolar-capillary permeability.", {"entities": []}], ["However, the mechanism underlying the increased permeability is not well characterized.", {"entities": []}], ["Vascular endothelial growth factor (VEGF) is originally recognized as a vascular permeability factor.", {"entities": []}], ["Oxidative stress generated by hydrogen peroxide (H 2 O 2 ) stimulates VEGF gene expression.", {"entities": []}], ["The purpose of this study was to explore the role of VEGF in ufCB-induced alveolar-capillary permeability.", {"entities": []}], ["Intratracheal instillation of 200 \u03bcg ufCB in mice caused a significant and sustained increase of total proteins in bronchoalveolar lavage (BAL) fluid, with the maximal increase at 21 hr postinstillation.", {"entities": [[183, 185, "GENE"]]}], ["The influx of neutrophils did not significantly increase until 16 hr.", {"entities": [[66, 68, "GENE"]]}], ["It reached the highest level at 21 hr and returned to the basal level by 42 hr.", {"entities": [[35, 37, "GENE"], [76, 78, "GENE"], [35, 37, "GENE"], [76, 78, "GENE"]]}], ["Tumor necrosis factor-\u03b1 was significantly elevated only at 4 hr.", {"entities": [[61, 63, "GENE"]]}], ["ufCB induced significant increases of VEGF in BAL fluid throughout the study period, with the peak increase at 16 hr.", {"entities": [[114, 116, "GENE"]]}], ["The nonsecreted isoform VEGF188 was not altered after 16 hr of exposure to ufCB.", {"entities": [[57, 59, "GENE"]]}], ["Moreover, there was a strong correlation between VEGF and total proteins in BAL fluid ( R p < 0.01).", {"entities": []}], ["In vivo study supported the role of reactive oxygen species (ROSs) in ufCB-induced VEGF release and protein leakage.", {"entities": []}], ["The involvement of ROSs was strengthened by the fact that interventions with N -acetyl-cysteine prevented ufCB-induced generation of ROSs and VEGF in vitro .", {"entities": []}], ["Our study for the first time demonstrates that ufCB induces the production of VEGF, which is associated with the increase of alveolar-capillary permeability.", {"entities": []}], ["The induction of VEGF by ufCB acts through an ROS-dependent pathway.", {"entities": []}], ["We present to you, case of a 10-year-old female with h/o redness, watering since 8 months.", {"entities": []}], ["Her vision was 20/30 in right eye and 20/70 in left eye.", {"entities": []}], ["Conjunctiva had plenty of purulent discharge and palpebral conjunctiva was studded with membranous lesions.", {"entities": []}], ["She was found to have multiple hyperpigmented papulopustular lesions over face, palms and legs.", {"entities": []}], ["She was started with topical moxifloxacin and lubricating drops.", {"entities": []}], ["Patient was followed-up after 15 days.", {"entities": []}], ["At that time her conjunctiva had formation of a woody pseudomembrane.", {"entities": []}], ["Excision of the lesions and skin biopsy was done and sent for hislopathological examination.", {"entities": []}], ["Findings of histopathological examination were suggestive of ligneous conjunctivitis and juvenile colloid milia.", {"entities": [[70, 84, "DISEASE"]]}], ["We have started this patient with long-term cyclosporine drops and tear supplements.", {"entities": []}], ["In next visit, the membrane was resolved.", {"entities": []}], ["Hence, we continued with the same treatment, but again the woody membrane recurred.", {"entities": []}], ["Airway epithelial cells have been demonstrated to be accessory antigen presentation cells (APC) capable of activating T cells and may play an important role in the development of allergic airway inflammation of asthma.", {"entities": [[211, 217, "DISEASE"], [91, 94, "GENE"]]}], ["In asthmatic airways, loss of expression of the adhesion molecule integrin \u03b24 (ITGB4) and an increase in Th2 inflammation bias has been observed in our previous study.", {"entities": [[79, 84, "GENE"]]}], ["Given that ITGB4 is engaged in multiple signaling pathways, we studied whether disruption of ITGB4-mediated cell adhesion may contribute to the adaptive immune response of epithelial cells, including their ability to present antigens, induce the activate and differentiate of T cells.", {"entities": [[11, 16, "GENE"], [93, 98, "GENE"]]}], ["We silenced ITGB4 expression in bronchial epithelial cells with an effective siRNA vector and studied the effects of ITGB4 silencing on the antigen presentation ability of airway epithelial cells.", {"entities": [[12, 17, "GENE"], [117, 122, "GENE"], [12, 17, "GENE"], [117, 122, "GENE"]]}], ["T cell proliferation and cytokine production was investigated after co-culturing with ITGB4-silenced epithelial cells.", {"entities": []}], ["Surface expression of B7 homologs and the major histocompatibility complex (MHC) class II was also detected after ITGB4 was silenced.", {"entities": [[114, 119, "GENE"]]}], ["Our results demonstrated that silencing of ITGB4 resulted in impaired antigen presentation processes and suppressed T cell proliferation.", {"entities": [[43, 48, "GENE"]]}], ["Meanwhile, decrease in Th1 cytokine production and increase in Th17 cytokine production was induced after co-culturing with ITGB4-silenced epithelial cells.", {"entities": []}], ["Moreover, HLA-DR was decreased and the B7 homologs expression was different after ITGB4 silencing.", {"entities": [[82, 87, "GENE"]]}], ["Overall, this study suggested that downregulation of ITGB4 expression in airway epithelial cells could impair the antigen presentation ability of these cells, which further regulate airway inflammation reaction in allergic asthma.", {"entities": [[214, 229, "DISEASE"], [223, 229, "DISEASE"], [53, 58, "GENE"]]}], ["Studies have indicated that people with disabilities die earlier and may experience a poorer health than the general population.", {"entities": []}], ["This study investigated 31 factors related to health and well-being, health behaviour and social relations among Danish adults with activity limitation (AL).", {"entities": []}], ["This study was based on data from the Danish Health and Morbidity Survey (DHMS) 2013 where 25,000 men and women aged 16\u00a0years or older were selected randomly from the adult Danish population.", {"entities": []}], ["A total of 14,265 individuals answered the self-administered questionnaire including 100 questions on health-related quality of life, health behaviour, morbidity, consequences of illness and social relations.", {"entities": []}], ["Based on an international standard question on AL, 888 individuals (6%) were defined as having profound AL and 4180 (29%) as having some AL.", {"entities": []}], ["Multiple logistic regression analyses were used to analyse the associations between activity limitation and 31 indicators of health.", {"entities": []}], ["The results were presented as relative risks 95% confidence intervals.", {"entities": []}], ["Twenty-eight of 31 indicators showed consistently poorer health and well-being, health behaviour and social relations among individuals with AL as compared to individuals without AL.", {"entities": []}], ["The increased relative risks were in a range of 7-661% the risk among individuals without AL.", {"entities": []}], ["An example is obesity where RR (95% CI) was 2.07 (1.82\u20132.37).", {"entities": [[14, 21, "DISEASE"]]}], ["Only contact with internet friends was significantly higher among individuals with AL as compared to individuals with no AL.", {"entities": []}], ["There was no association between alcohol and AL and no association between fast food and some AL.", {"entities": []}], ["Danish adults with AL experience a poorer health and well-being, and have an unhealthier lifestyle and poorer social relations than adults without AL.", {"entities": []}], ["People with activity limitation should be prioritized in public health and efforts done to secure availability and flexibility of health care services and primary prevention programs.", {"entities": []}], ["Policies should address accessibility, availability and affordability of health care and health behaviour among people with activity limitation.", {"entities": []}], ["The online version of this article (doi:10.1186/s12889-017-4532-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Human enterovirus D68 (EV\u2010D68) recently caused an increase in mild\u2010to\u2010severe pediatric respiratory cases in North America and some European countries.", {"entities": []}], ["Even though few of these children presented with acute paralytic disease, direct causal relationship cannot yet be assumed.", {"entities": []}], ["The purposes of this report were to describe the clinical findings of an outbreak of EV\u2010D68 infection in Mexico City and identify the genetic relationship with previously reported strains.", {"entities": []}], ["Between September and December 2014, 126 nasopharyngeal samples (NPS) of hospitalized children <15 years of age with ARI were tested for the presence of respiratory viruses using a multiplex RT\u2010qPCR and EV\u2010D68\u2010specific RT\u2010qPCR.", {"entities": [[65, 68, "GENE"]]}], ["Clinical, epidemiological, and demographic data were collected and associated with symptomatology and viral infections.", {"entities": []}], ["Phylogenetic analyses were performed using VP1 region.", {"entities": []}], ["Enterovirus/rhinovirus infection was detected in 40 patients (31\u00b77%), of which 24 patients were EV\u2010D68\u2010positive.", {"entities": []}], ["EV\u2010D68 infection prevailed over September and October 2014 and was associated with neutrophilia and lymphopenia, and patients were more likely to develop hypoxemia.", {"entities": [[100, 111, "DISEASE"]]}], ["Phylogenetic analyses showed that Mexican EV\u2010D68 belongs to the new B1 clade.", {"entities": []}], ["This is the first EV\u2010D68 outbreak described in Mexico and occurred few weeks after the United States reported similar infections.", {"entities": []}], ["Although EV\u2010D68 belongs to new B1 clade, no neurological affection was observed.", {"entities": []}], ["In Japan and other societies with rapidly aging populations, recurrent pneumonia (RP) is a major clinical problem yet only limited information exists regarding the burden of this disease.", {"entities": [[71, 80, "DISEASE"]]}], ["A prospective study of adult pneumonia was conducted to investigate the incidence of RP and potential risk factors.", {"entities": [[29, 38, "DISEASE"]]}], ["From February 1, 2012 to January 31, 2013, patients aged\u2009\u2265\u200915\u00a0years who were diagnosed with pneumonia were prospectively enrolled in a representative community hospital located in central Japan.", {"entities": [[92, 101, "DISEASE"]]}], ["Patients were followed for one-year to evaluate the recurrence of pneumonia and characteristics associated with RP.", {"entities": [[66, 75, "DISEASE"]]}], ["Cox proportional hazards models were constructed to compute adjusted hazard ratios (aHR) and ascertain risk factors significantly associated with RP.", {"entities": [[84, 87, "GENE"]]}], ["In total, 841 patients with a median age of 73\u00a0years (range 15\u2013101\u00a0years) were enrolled totaling 1,048 person-years of observation with a median follow-up time of 475\u00a0days.", {"entities": []}], ["A total of 137 patients had at least one recurrent episode with an incidence rate of 13.1 per 100 person-years (95% confidence interval: 11.1\u201315.5).", {"entities": []}], ["In multivariate analysis, a past history of pneumonia (aHR 1.95, 95% CI: 1.35\u20132.8), chronic pulmonary disease (aHR 1.86, 1.24\u20132.78) and inhaled corticosteroid usage (aHR 1.78, 1.12\u20132.84) and hypnotic/sedative medication usage (aHR 2.06, 1.28\u20133.31) were identified as independent risk factors for recurrent pneumonia, whereas angiotensin converting enzyme-inhibitors usage was associated with a reduction of the risk of RP (aHR 0.22, 0.05\u20130.91).", {"entities": [[44, 53, "DISEASE"], [306, 315, "DISEASE"], [55, 58, "GENE"], [111, 114, "GENE"], [166, 169, "GENE"], [227, 230, "GENE"], [423, 426, "GENE"], [55, 58, "GENE"], [111, 114, "GENE"], [166, 169, "GENE"], [227, 230, "GENE"], [423, 426, "GENE"], [55, 58, "GENE"], [111, 114, "GENE"], [166, 169, "GENE"], [227, 230, "GENE"], [423, 426, "GENE"], [55, 58, "GENE"], [111, 114, "GENE"], [166, 169, "GENE"], [227, 230, "GENE"], [423, 426, "GENE"], [55, 58, "GENE"], [111, 114, "GENE"], [166, 169, "GENE"], [227, 230, "GENE"], [423, 426, "GENE"]]}], ["The detection of P. aeruginosa was significantly associated with RP even after adjusting for chronic pulmonary diseases (aHR\u2009=\u20092.37).", {"entities": [[121, 124, "GENE"]]}], ["Recurrent pneumonia constitutes a considerable proportion of the pneumonia burden in Japan.", {"entities": [[10, 19, "DISEASE"], [65, 74, "DISEASE"]]}], ["A past history of pneumonia, chronic pulmonary disease, inhaled corticosteroid and hypnotic/sedative medication usage and detection of P. aeruginosa were identified as independent risk factors for recurrent pneumonia and special attention regarding the use of medications in this vulnerable population is needed to reduce the impact of this disease in aging populations.", {"entities": [[18, 27, "DISEASE"], [207, 216, "DISEASE"]]}], ["The online version of this article (doi:10.1186/s12890-016-0359-1) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Recent evidence has highlighted the role of histamine in inflammation.", {"entities": []}], ["Since this monoamine has also been strongly implicated in the pathogenesis of type-1 diabetes, we assessed its effect in the nonobese diabetic (NOD) mouse model.", {"entities": []}], ["To this end, we used mice (inactivated) knocked out for the gene encoding histidine decarboxylase, the unique histamine-forming enzyme, backcrossed on a NOD genetic background.", {"entities": []}], ["We found that the lack of endogenous histamine in NOD HDC \u03b3 in HDC", {"entities": [[54, 57, "GENE"], [63, 66, "GENE"], [54, 57, "GENE"], [63, 66, "GENE"]]}], ["In the context of a warming climate and increasing urbanisation (with the associated urban heat island effect), interest in understanding temperature related health effects is growing.", {"entities": []}], ["Previous reviews have examined how the temperature-mortality relationship varies by geographical location.", {"entities": []}], ["There have been no reviews examining the empirical evidence for changes in population susceptibility to the effects of heat and/or cold over time.", {"entities": []}], ["The objective of this paper is to review studies which have specifically examined variations in temperature related mortality risks over the 20 We searched five electronic databases combining search terms for three main concepts: temperature, health outcomes and changes in vulnerability or adaptation.", {"entities": []}], ["Studies included were those which quantified the risk of heat related mortality with changing ambient temperature in a specific location over time, or those which compared mortality outcomes between two different extreme temperature events (heatwaves) in one location.", {"entities": []}], ["The electronic searches returned 9183 titles and abstracts, of which eleven studies examining the effects of ambient temperature over time were included and six studies comparing the effect of different heatwaves at discrete time points were included.", {"entities": []}], ["Of the eleven papers that quantified the risk of, or absolute heat related mortality over time, ten found a decrease in susceptibility over time of which five found the decrease to be significant.", {"entities": []}], ["The magnitude of the decrease varied by location.", {"entities": []}], ["Only two studies attempted to quantitatively attribute changes in susceptibility to specific adaptive measures and found no significant association between the risk of heat related mortality and air conditioning prevalence within or between cities over time.", {"entities": []}], ["Four of the six papers examining effects of heatwaves found a decrease in expected mortality in later years.", {"entities": []}], ["Five studies examined the risk of cold.", {"entities": []}], ["In contrast to the changes in heat related mortality observed, only one found a significant decrease in cold related mortality in later time periods.", {"entities": []}], ["There is evidence that across a number of different settings, population susceptibility to heat and heatwaves has been decreasing.", {"entities": []}], ["These changes in heat related susceptibility have important implications for health impact assessments of future heat related risk.", {"entities": []}], ["A similar decrease in cold related mortality was not shown.", {"entities": []}], ["Adaptation to heat has implications for future planning, particularly in urban areas, with anticipated increases in temperature due to climate change.", {"entities": []}], ["The online version of this article (doi:10.1186/s12940-016-0102-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Effects of pulmonary rehabilitation (PR) in chronic obstructive pulmonary disease (COPD) patients with severely impaired health status are poorly documented since these patients are usually excluded from clinical trials.", {"entities": [[44, 81, "DISEASE"]]}], ["This retrospective, observational study aims to study the impact of disease on health status and the effects of PR on COPD patients referred to a tertiary center for PR in The Netherlands.", {"entities": []}], ["Between June 2006 and June 2010, 437 patients with COPD were allocated to our intensive, comprehensive PR program.", {"entities": []}], ["Patients participated in this interdisciplinary program for 12 weeks for a weekly average of 20\u201325 hours.", {"entities": []}], ["Before and directly after, several measures of physical performance and health-related quality of life were determined.", {"entities": []}], ["At baseline, most patients (75%) had a Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage of III\u2013IV.", {"entities": []}], ["Peak exercise performance on a cycle ergometer was on average reduced to 43 \u00b1 29 Watt, and health-related quality of life was significantly impaired, with a total score on the St George\u2019s Respiratory Questionnaire (SGRQ) of 66.", {"entities": []}], ["Health-care utilization in the year preceding PR was very high.", {"entities": []}], ["After rehabilitation, all outcome measures improved statistically significantly ( P < 0.001).", {"entities": []}], ["Exercise performance measured with the 6 minute walking distance test improved clinically significantly in 68% of the patients, whereas 75% of the patients showed a clinically meaningful improvement in quality of life as measured with the SGRQ.", {"entities": []}], ["Multiple regression analysis revealed that 19% of the variation in responses on the 6 minute walking distance test and the SGRQ could be explained on the basis of baseline characteristics.", {"entities": []}], ["The present study provides data to indicate that COPD patients may substantially benefit from rehabilitation in a tertiary pulmonary rehabilitation center, despite a severely impaired health status and high level of health-care utilization, in which prior treatment in primary and secondary care have failed to improve health status.", {"entities": []}], ["Individual rehabilitation responses can only partially be predicted on the basis of baseline characteristics.", {"entities": []}], ["Consequently, no firm conclusions can be drawn from this study with respect to the selection of candidates that could be deemed eligible for this rehabilitation program when entering the program.", {"entities": []}], ["High quality protocols facilitate proper conduct, reporting, and external review of clinical trials.", {"entities": []}], ["However, the completeness of trial protocols is often inadequate.", {"entities": []}], ["To help improve the content and quality of protocols, an international group of stakeholders developed the SPIRIT 2013 Statement (Standard Protocol Items: Recommendations for Interventional Trials).", {"entities": []}], ["The SPIRIT Statement provides guidance in the form of a checklist of recommended items to include in a clinical trial protocol.", {"entities": []}], ["This SPIRIT 2013 Explanation and Elaboration paper provides important information to promote full understanding of the checklist recommendations.", {"entities": []}], ["For each checklist item, we provide a rationale and detailed description; a model example from an actual protocol; and relevant references supporting its importance.", {"entities": []}], ["We strongly recommend that this explanatory paper be used in conjunction with the SPIRIT Statement.", {"entities": []}], ["A website of resources is also available ( www.spirit-statement.org ).", {"entities": []}], ["The SPIRIT 2013 Explanation and Elaboration paper, together with the Statement, should help with the drafting of trial protocols.", {"entities": []}], ["Complete documentation of key trial elements can facilitate transparency and protocol review for the benefit of all stakeholders.", {"entities": []}], ["Probiotic food products contain a variety of different bacterial strains and may offer different health effects.", {"entities": []}], ["The objective was to document the prevalence and dosage of probiotic strains in the Canadian food supply and to review the literature investigating these strains in order to understand what health benefits these products may offer.", {"entities": []}], ["The Food Label Information Program was used to identify probiotic-containing products in the food supply.", {"entities": []}], ["PubMed, Web of Science, and Embase were searched for randomized controlled trials that tested the health effects of these strains in humans.", {"entities": []}], ["There were six probiotic strains/strain combinations identified in the food supply.", {"entities": []}], ["Thirty-one studies investigated these strains and found that they are associated with decreased diarrhea and constipation, improved digestive symptoms, glycemic control, antioxidant status, blood lipids, oral health, and infant breastfeeding outcomes, as well as enhanced immunity and support for Helicobacter pylori eradication.", {"entities": [[109, 121, "DISEASE"], [96, 104, "DISEASE"]]}], ["There were a limited number of studies investigating these strains.", {"entities": []}], ["Many studies were funded by the food industry and tested dosages that were up to twenty-five times the dosage found in most food products.", {"entities": []}], ["Probiotic food products could have health benefits not currently reported on their labels.", {"entities": []}], ["However, many dosages are too low to provide the benefits demonstrated in clinical trials.", {"entities": []}], ["Further research is needed to enable more effective use of these functional foods.", {"entities": []}], ["Inflammation is an important and appropriate host response to infection or injury.", {"entities": []}], ["However, dysregulation of this response, with resulting persistent or inappropriate inflammation, underlies a broad range of pathological processes, from inflammatory dermatoses to type 2 diabetes and cancer.", {"entities": [[201, 207, "DISEASE"]]}], ["As such, identifying new drugs to suppress inflammation is an area of intense interest.", {"entities": []}], ["Despite notable successes, there still exists an unmet need for new effective therapeutic approaches to treat inflammation.", {"entities": []}], ["Traditional drug discovery, including structure-based drug design, have largely fallen short of satisfying this unmet need.", {"entities": []}], ["With faster development times and reduced safety and pharmacokinetic uncertainty, drug repositioning \u2013 the process of finding new uses for existing drugs \u2013 is emerging as an alternative strategy to traditional drug design that promises an improved risk-reward trade-off.", {"entities": []}], ["Using a zebrafish in vivo neutrophil migration assay, we undertook a drug repositioning screen to identify unknown anti-inflammatory activities for known drugs.", {"entities": []}], ["By interrogating a library of 1280 approved drugs for their ability to suppress the recruitment of neutrophils to tail fin injury, we identified a number of drugs with significant anti-inflammatory activity that have not previously been characterized as general anti-inflammatories.", {"entities": []}], ["Importantly, we reveal that the ten most potent repositioned drugs from our zebrafish screen displayed conserved anti-inflammatory activity in a mouse model of skin inflammation (atopic dermatitis).", {"entities": [[179, 196, "DISEASE"], [186, 196, "DISEASE"]]}], ["This study provides compelling evidence that exploiting the zebrafish as an in vivo drug repositioning platform holds promise as a strategy to reveal new anti-inflammatory activities for existing drugs.", {"entities": []}], ["The comprehension of unconventional immune functions of tonsillar B cells, their role in tolerance induction and protective immune responses, is crucial to unveil the dynamic interactions of the upper aero digestive tract with polymicrobial commensal flora and pathogens, in health and disease.", {"entities": []}], ["Here, we describe the kinetics of IL10 intracellular expression and compare it with that of cytokines known to be produced by tonsillar B cells.", {"entities": [[34, 38, "GENE"]]}], ["Additionally, we detected a relevant proportion of IL17-expressing tonsillar B cells, which has not previously been reported.", {"entities": []}], ["We immunophenotyped tonsillar IL10-expressing B cells (B10) and observed IL10 production in activated B cells at every developmental stage.", {"entities": [[30, 34, "GENE"], [73, 77, "GENE"]]}], ["Finally, we identified a relationship between decreased B10 percentages, increased proportion of the germinal centre (GC) population and hypertrophied tonsils (HT).", {"entities": [[118, 120, "GENE"]]}], ["Our findings provide greater insight into the role of B10 in GC reactions and characterized their involvement in the pathogenesis of tonsillar dysfunction.", {"entities": [[61, 63, "GENE"]]}], ["The burden of chronic respiratory disease (CRD) is alarming.", {"entities": []}], ["International studies suggest that women with CRD are undersurveyed and underdiagnosed by physicians worldwide.", {"entities": []}], ["It is unclear what the prevalence of CRD is in the general population of Syria, particularly among women, since there has never been a survey on CRD in this nation.", {"entities": []}], ["The purpose of this study was to investigate the impact of different patterns of smoking on CRD in women.", {"entities": []}], ["We extracted data on smoking patterns and outcome in women from the Global Alliance Against Chronic Respiratory Diseases survey.", {"entities": []}], ["Using spirometric measurements before and after the use of inhaled bronchodilators, we tracked the frequency of CRD in females active and passive narghile or cigarette smokers presenting to primary care.", {"entities": []}], ["We administered the questionnaire to 788 randomly selected females seen during 1 week in the fiscal year 2009\u20132010 in 22 primary care centers in six different regions of Syria.", {"entities": []}], ["Inclusion criteria were age >6 years, presenting for any medical complaint.", {"entities": []}], ["In this cross-sectional study, three groups of female subjects were evaluated: active smokers of cigarettes, active smokers of narghiles, and passive smokers of either cigarettes or narghiles.", {"entities": []}], ["These three groups were compared to a control group of female subjects not exposed to active or passive smoking.", {"entities": []}], ["Exposure to active cigarette smoke but not narghile smoke was associated with doctor-diagnosed chronic obstructive pulmonary disease (COPD).", {"entities": [[95, 132, "DISEASE"]]}], ["However, neither cigarette nor narghile active smoking was associated with increased incidence of spirometrically diagnosed COPD.", {"entities": []}], ["Paradoxically, exposure to passive smoking of either cigarettes or narghiles resulted in association with airway obstruction, defined as forced expiratory volume in 1 second (FEV 1 )/forced vital capacity (FVC) < 70% according to the Global initiative for chronic Obstructive Lung Disease criteria; association with FEV 1 < 80% predicted, evidencing moderate to severe GOLD spirometric grade, and doctor-diagnosed COPD.", {"entities": [[175, 178, "GENE"], [316, 319, "GENE"], [175, 178, "GENE"], [316, 319, "GENE"]]}], ["Physicians tend to underdiagnose COPD in women who present to primary care clinics.", {"entities": []}], ["Whereas around 15% of enrolled women had evidence of COPD with FEV 1 /FVC < 70% after bronchodilators, only 4.8% were physician-diagnosed.", {"entities": [[63, 66, "GENE"]]}], ["Asthma did not appear to be a significant spirometric finding in these female subjects, although around 11% had physician-diagnosed asthma.", {"entities": [[0, 6, "DISEASE"], [132, 138, "DISEASE"]]}], ["One limitation is FEV 1 /FVC < 70% could have also resulted from uncontrolled asthma.", {"entities": [[78, 84, "DISEASE"], [18, 21, "GENE"]]}], ["The same limitation has been reported by the Proyecto Latinoamericano de Investigacion en Obstruccion Pulmonar (PLATINO) study.", {"entities": []}], ["Contrary to popular belief in developing countries, women exposed to tobacco smoke, whether active or passive, and whether by cigarettes or narghiles, like men are at increased risk for the development of COPD, although cultural habits and taboos may decrease the risk of active smoking in some women.", {"entities": []}], ["These findings will be considered for country and region strategy for noncommunicable diseases, to overcome underdiagnosis of CRD in women, fight widespread female cigarette and narghile smoking, and promote behavioral research in this field.", {"entities": []}], ["The airborne indoor pollen in a hospital of Badajoz (Spain) was monitored over two years using a personal Burkard sampler.", {"entities": []}], ["The air was sampled in four places indoors\u2014one closed room and one open ward on each of the ground and the third floors\u2014and one place outdoors at the entrance to the hospital.", {"entities": []}], ["The results were compared with data from a continuous volumetric sampler.", {"entities": []}], ["While 32 pollen types were identified, nearly 75% of the total counts were represented by just five of them.", {"entities": []}], ["These were: Quercus , Cupressaceae, Poaceae, Olea , and Plantago .", {"entities": []}], ["The average indoor concentration was 25.2 grains/m", {"entities": []}], ["The pathogenesis of COPD is complex and remains poorly understood.", {"entities": []}], ["The European Respiratory Society Study on Chronic Obstructive Pulmonary Disease (EUROSCOP) investigated long-term effects of budesonide; 18% of the COPD participants were atopic.", {"entities": []}], ["So far effects of atopy on the long-term course of COPD have not been elucidated.", {"entities": []}], ["Factors related to the presence of atopy (positive phadiatop) in 1277 mild-to-moderate COPD patients participating in EUROSCOP were analysed using regression analysis.", {"entities": []}], ["Incidence and remission of respiratory symptoms during 3-year follow-up were analysed using generalised estimating equations models, and association of atopy with lung function decline using linear mixed effects models.", {"entities": []}], ["Independent predisposing factors associated with the presence of atopy were: male gender (OR: 2.21; 95% CI: 1.47\u20133.34), overweight/obese (OR: 1.41; 95% CI: 1.04\u20131.92) and lower age (OR: 0.98; 95% CI: 0.96\u20130.99).", {"entities": []}], ["Atopy was associated with a higher prevalence of cough (OR: 1.71; 95% CI: 1.26\u20132.34) and phlegm (OR: 1.50; 95% CI: 1.10\u20132.03), but not with lung function levels or FEV 1 decline.", {"entities": [[164, 167, "GENE"]]}], ["Atopic COPD patients not treated with budesonide had an increased incidence of cough over time (OR: 1.79, 95% CI: 1.03\u20133.08, p\u2009=\u20090.038), while those treated with budesonide had increased remission of cough (OR: 1.93, 95% CI: 1.11\u20133.37, p\u2009=\u20090.02) compared to non-atopic COPD patients.", {"entities": []}], ["Atopic COPD patients are more likely male, have overweight/obesity and are younger as compared with non-atopic COPD patients.", {"entities": [[59, 66, "DISEASE"]]}], ["Atopy in COPD is associated with an increased incidence and prevalence of respiratory symptoms.", {"entities": []}], ["If atopic COPD patients are treated with budesonide, they more often show remission of symptoms compared to non-atopic COPD patients who are treated with budesonide.", {"entities": []}], ["We recommend including atopy in the diagnostic work-up and management of COPD.", {"entities": []}], ["Although gene-gene interaction, or epistasis, plays a large role in complex traits in model organisms, genome-wide by genome-wide searches for two-way interaction have limited power in human studies.", {"entities": []}], ["We thus used knowledge of a biological pathway in order to identify a contribution of epistasis to autism spectrum disorders (ASDs) in humans, a reverse-pathway genetic approach.", {"entities": []}], ["Based on previous observation of increased ASD symptoms in Mendelian disorders of the Ras/MAPK pathway (RASopathies), we showed that common SNPs in RASopathy genes show enrichment for association signal in GWAS ( P = 0.02).", {"entities": []}], ["We then screened genome-wide for interactors with RASopathy gene SNPs and showed strong enrichment in ASD-affected individuals ( P < 2.2 x 10 GPR141 , in a RASopathy neural cell line.", {"entities": []}], ["We thus used orthogonal approaches to provide strong evidence for a contribution of epistasis to ASDs, confirm a role for the Ras/MAPK pathway in idiopathic ASDs, and to identify a convergent candidate gene that may interact with the Ras/MAPK pathway.", {"entities": []}], ["The contribution of epistasis to human biology and complex trait architecture has been subject to intense debate.", {"entities": []}], ["Despite statistical methods to detect interaction, allele frequencies and study designs have limited our power to address this question.", {"entities": []}], ["Rather than a statistically-motivated approach, we developed a reverse pathway genetic approach to detect epistasis in in autism spectrum disorders (ASDs).", {"entities": []}], ["Instead of traditional pathway analysis\u2014exploiting unbiased genetic results to identify biological pathways important for pathophysiology\u2014we hypothesized that the reverse approach of leveraging a specific biological pathway to uncover novel aspects of genetic architecture could be fruitful.", {"entities": []}], ["We drew on knowledge from Mendelian disorders of the Ras/MAPK pathway (RASopathies) associated with ASD to inform our analyses.", {"entities": []}], ["First, we implemented an epistasis screen in idiopathic ASD for SNPs that interact with the Ras/MAPK pathway, allowing us to detect genome-wide enrichment in epistasis signal as well as specific interacting loci.", {"entities": []}], ["Second, we performed modifier mapping within RASopathies and identified overlapping signals with our first approach.", {"entities": []}], ["Finally, we took the top overlapping region and experimentally demonstrated dysregulated expression in iPSC-derived neural cells from RASopathy subjects.", {"entities": []}], ["Together, our results establish a human genetics motivated reverse-pathway strategy, which can be applied broadly to study epistasis.", {"entities": []}], ["Karmaus et al.", {"entities": []}], ["show that loss of mechanistic target of rapamycin complex 1 (mTORC1) signaling impairs myelopoiesis.", {"entities": []}], ["M-CSF\u2013dependent myelopoiesis requires mTORC1 signaling and anabolic metabolism, which in turn promote expression of M-CSFR and transcription factors PU.1 and IRF8, thereby constituting a feed-forward loop for myelopoiesis.", {"entities": [[158, 162, "GENE"]]}], ["Myelopoiesis is necessary for the generation of mature myeloid cells during homeostatic turnover and immunological insults; however, the metabolic requirements for this process remain poorly defined.", {"entities": []}], ["Here, we demonstrate that myelopoiesis, including monocyte and macrophage differentiation, requires mechanistic target of rapamycin complex 1 (mTORC1) signaling and anabolic metabolism.", {"entities": []}], ["Loss of mTORC1 impaired myelopoiesis under steady state and dampened innate immune responses against Listeria monocytogenes infection.", {"entities": []}], ["Stimulation of hematopoietic progenitors with macrophage colony-stimulating factor (M-CSF) resulted in mTORC1-dependent anabolic metabolism, which in turn promoted expression of M-CSF receptor and transcription factors PU.1 and IRF8, thereby constituting a feed-forward loop for myelopoiesis.", {"entities": [[228, 232, "GENE"]]}], ["Mechanistically, mTORC1 engaged glucose metabolism and initiated a transcriptional program involving Myc activation and sterol biosynthesis after M-CSF stimulation.", {"entities": [[101, 104, "GENE"]]}], ["Perturbation of glucose metabolism or disruption of Myc function or sterol biosynthesis impaired myeloid differentiation.", {"entities": [[52, 55, "GENE"]]}], ["Integrative metabolomic and genomic profiling further identified one-carbon metabolism as a central node in mTORC1-dependent myelopoiesis.", {"entities": []}], ["Therefore, the interplay between mTORC1 signaling and metabolic reprogramming underlies M-CSF\u2013induced myelopoiesis.", {"entities": []}], ["The upper airway is an organ not often investigated.", {"entities": []}], ["Relatively little is known about its complex functions, and misunderstandings abound.", {"entities": []}], ["The paper by Thomachot et al in this issue provides an opportunity to ponder on this important organ.", {"entities": []}], ["Although the main result seems to be negative, the study provides some interesting physiological information on the upper airway and how it works.", {"entities": []}], ["Differences in mortality and health experience across regions are well recognised and UK government policy aims to address this inequality.", {"entities": []}], ["Methods combining life expectancy and health have concentrated on specific areas, such as self-perceived health and dementia.", {"entities": [[116, 124, "DISEASE"]]}], ["Few have looked within country or across different areas of health.", {"entities": []}], ["Self-perceived health, self-perceived functional impairment and cognitive impairment are linked closely to survival, as well as quality of life.", {"entities": []}], ["This paper aims to describe regional differences in healthy life expectancy using a variety of states of health and wellbeing within the MRC Cognitive Function and Ageing Study (MRC CFAS).", {"entities": []}], ["MRC CFAS is a population based study of health in 13,009 individuals aged 65 years and above in five centres using identical study methodology.", {"entities": []}], ["The interviews included self-perceived health and measures of functional and cognitive impairment.", {"entities": []}], ["Sullivan's method was used to combine prevalence rates for cognitive and functional impairment and life expectancy to produce expectation of life in various health states.", {"entities": []}], ["The prevalence of both cognitive and functional impairment increases with age and was higher in women than men, with marked centre variation in functional impairment (Newcastle and Gwynedd highest impairment).", {"entities": []}], ["Newcastle had the shortest life expectancy of all the sites, Cambridgeshire and Oxford the longest.", {"entities": []}], ["Centre differences in self-perceived health tended to mimic differences in life expectancy but this did not hold for cognitive or functional impairment.", {"entities": []}], ["Self-perceived health does not show marked variation with age or sex, but does across centre even after adjustment for impairment burden.", {"entities": []}], ["There is considerable centre variation in self-reported functional impairment but not cognitive impairment.", {"entities": []}], ["Only variation in self-perceived health relates to the ranking of life expectancy.", {"entities": []}], ["These data confirm that quite considerable differences in life experience exist across regions of the UK beyond basic life expectancy.", {"entities": []}], ["The relationship between air pollution and daily mortality for the period 1991-1995 was examined in two Korean cities, Seoul and Ulsan.", {"entities": []}], ["The observed concentrations of sulfur dioxide (SO2; mean = 28.7 ppb), ozone (O3; mean = 29.2 ppb), and total suspended particulates (TSP; mean = 82.3 microg/m3) during the study period were at levels below Korea's current ambient air quality standards.", {"entities": []}], ["Daily death counts were regressed separately in the two cities, using Poisson regression on SO2, O3, and/or TSP controlling for variability in the weather and seasons.", {"entities": []}], ["When considered singly in Poisson regression models controlling for seasonal variations and weather conditions, the nonaccidental mortality associated with a 50-ppb increment in a 3-day moving average of SO2 concentrations, including the concurrent day and the preceding 2 days, was 1.078 [95% confidence interval (CI), 1.057-1.099] for Seoul and 1.051 (CI, 0.991-1.115) for Ulsan.", {"entities": []}], ["The rate ratio was 1.051 (CI, 1.031-1.072) in Seoul and 0.999 (CI, 0.", {"entities": []}], ["961-1.039) in Ulsan per 100 microg/m3 for TSP, and 1.015 (CI, 1.", {"entities": []}], ["005-1.025) in Seoul and 1.020 (0.889-1.170) in Ulsan per 50 ppb for 1-hr maximum O3.", {"entities": []}], ["When TSP was considered simultaneously with other pollutants, the TSP association was no longer significant.", {"entities": []}], ["We observed independent pollution effects on daily mortality even after using various approaches to control for either weather or seasonal variables in the regression model.", {"entities": []}], ["This study demonstrated increased mortality associated with air pollution at both SO2 and O3 levels below the current World Health Organization recommendations.", {"entities": []}], ["Although common in children with tympanostomy tubes, the current incidence of tympanostomy tube otorrhea (TTO) is uncertain.", {"entities": []}], ["TTO is generally a sign of otitis media, when middle ear fluid drains through the tube.", {"entities": [[27, 39, "DISEASE"]]}], ["Predictors for otitis media are therefore suggested to have predictive value for the occurrence of TTO.", {"entities": [[15, 27, "DISEASE"]]}], ["To determine the incidence of TTO and its predictors.", {"entities": []}], ["We performed a cohort study, using a parental web-based questionnaire to retrospectively collect data on TTO episodes and its potential predictors from children younger than 10 years of age with tympanostomy tubes.", {"entities": []}], ["Of the 1,184 children included in analyses (total duration of time since tube placement was 768 person years with a mean of 7.8 months per child), 616 children (52%) experienced one or more episodes of TTO.", {"entities": []}], ["137 children (12%) had TTO within the calendar month of tube placement.", {"entities": []}], ["597 (50%) children had one or more acute TTO episodes (duration <4 weeks) and 46 children (4%) one or more chronic TTO episodes (duration \u22654 weeks).", {"entities": []}], ["146 children (12%) experienced recurrent TTO episodes.", {"entities": []}], ["Accounting for time since tube placement, 67% of children developed one or more TTO episodes in the year following tube placement.", {"entities": []}], ["Young age, recurrent acute otitis media being the indication for tube placement, a recent history of recurrent upper respiratory tract infections and the presence of older siblings were independently associated with the future occurrence of TTO, and can therefore be seen as predictors for TTO.", {"entities": [[27, 39, "DISEASE"]]}], ["Our survey confirms that otorrhea is a common sequela in children with tympanostomy tubes, which occurrence can be predicted by age, medical history and presence of older siblings.", {"entities": []}], ["BACKGROUND: Platelet-activating factor (PAF) seems to be implicated in systemic lupus erythematosus (SLE) patients with associated renal diseases.", {"entities": [[80, 99, "DISEASE"], [71, 99, "DISEASE"]]}], ["AIMS: In this study, we ensured the role of PAF in SLE patients without renal complications.", {"entities": []}], ["METHODS: Blood PAF and acetylhydrolase activity, plasma soluble phospholipase A(2), and the presence of antibodies against PAF were investigated in 17 SLE patients without active nephritis and in 17 healthy controls.", {"entities": [[179, 188, "DISEASE"]]}], ["RESULTS: Blood PAF levels were not different (p=0.45) between SLE patients (6.7+/-2.8 pg/ml) and healthy subjects (9.6+/-3.1 pg/ml).", {"entities": []}], ["Plasma acetylhydrolase activity (the PAF-degrading enzyme) was significantly (p=0.03) elevated in SLE patients (57.8+/-6.4 nmol/min/ml) as compared with controls (37.9+/-2.6 nmol/min/ml).", {"entities": []}], ["Plasma soluble phospholipase A(2) (the key enzyme for PAF formation) was not different (p=0.6) between SLE patients (59.1+/-5.1 U/ml) and controls (54.7+/-2.4 U/ml).", {"entities": []}], ["Antibodies against PAF were detected only in 3/17 SLE patients.", {"entities": []}], ["Flow cytometry analysis did not highlight PAF receptors on circulating leukocytes of SLE patients.", {"entities": []}], ["CONCLUSION: This clinical study highlights no evidence for a putative important role of PAF in SLE patients without active nephritis.", {"entities": [[123, 132, "DISEASE"]]}], ["Pelvic adhesions are found in up to 50% of women with CPP during investigative surgeries and adhesiolysis is often performed as part of their management although the causal or casual association of adhesions, and the clinical benefit of adhesiolysis in the context of CPP is still unclear.", {"entities": []}], ["Our aim was to test the hypothesis of whether laparoscopic adhesiolysis leads to significant pain relief and improvement in quality of life (QoL) in patients with chronic pelvic pain (CPP) and adhesions.", {"entities": []}], ["This was a double-blinded RCT.", {"entities": []}], ["This study was conducted in 2 tertiary referral hospitals in United Kingdom over 4\u00a0years.", {"entities": []}], ["Women with chronic pelvic pain (CPP) were randomized into having laparoscopic adhesiolysis or diagnostic laparoscopy.", {"entities": []}], ["Women were assessed at 0, 3 and 6\u00a0months for Visual analogue scale scores (VAS) and Quality of Life (QoL) measures (SF-12 and EHP-30).", {"entities": []}], ["A total of 92 participants were recruited; 50 qualified to be randomized, with 26 in the adhesiolysis and 24 in the control group.", {"entities": []}], ["The results are expressed in median (interquartile ranges).", {"entities": []}], ["In women who underwent adhesiolysis, there was a significant improvement at 6\u00a0months in VAS scores (-17.5 (-36.0 - -5.0) compared to controls (-1.5 (-15.0 \u2013 4.5; p\u2009=\u20090.048); SF-12 scores physical component score (25.0 (18.8 \u2013 43.8)) compared to controls (6.3 (-6.3 \u2013 18.8); p\u2009=\u20090.021), SF-12 emotional component score 32.5 (4.4 \u2013 48.8) compared to controls -5 (-21.3 \u2013 15.0); p\u2009<\u20090.0074) and EHP-30 emotional well being domain 32.5 (4.4 \u2013 48.8) compared to the controls -5 (-21.3 \u2013 15.0; p\u2009<\u20090.0074).", {"entities": []}], ["This study stopped before recruitment reached the statistically powered sample size due to difficulty with enrollment and lack of continued funding.", {"entities": []}], ["In selected population of women presenting to the gynecological clinic with chronic pelvic pain, adhesiolysis in those who have adhesions may be of benefit in terms of improvement of pain and their quality of life.", {"entities": []}], ["ISRCTN 43852269", {"entities": []}], ["We screened patients with chronic respiratory diseases for microbiological and serological evidences of fungal colonisation; in order to determine its prevalence in this group of patients, examine potential clinical and radiological predictors of fungal colonisation and characterise fungal agents associated with individual diseases.", {"entities": []}], ["BAL samples from 60 consecutive patients were subjected to microscopy and culture for fungal agents.", {"entities": []}], ["Serum samples were analysed for precipitin antibodies to Aspergillus antigen and Candida cytoplasmic antigen.", {"entities": []}], ["Statistical significance in the difference of fungal recovery between patient groups was determined using the Chi-square test.", {"entities": []}], ["The major diagnostic groups included patients with bronchogenic carcinoma (n = 31) and tubercular sequelae (n = 16).", {"entities": [[64, 73, "DISEASE"], [51, 73, "DISEASE"]]}], ["In all, 28 patients (46.7%) were culture-positive, with Candida and Aspergillus being recovered from 14 and 13 patients respectively.", {"entities": []}], ["Twenty-one patients (35%) showed presence of precipitin antibodies.", {"entities": []}], ["Patients with bronchogenic carcinoma showed increased predilection for colonisation with Aspergillus, while Candida was recovered more commonly in tubercular sequelae (p = 0.02).", {"entities": [[27, 36, "DISEASE"], [14, 36, "DISEASE"]]}], ["There was no statistically significant association between culture-positivity and specific risk factors/radiological findings.", {"entities": []}], ["The point-prevalence of fungal colonization was almost 50%.", {"entities": []}], ["The combination of fungal culture and serology helped improve diagnostic sensitivity.", {"entities": []}], ["An interesting predilection was observed for Aspergillus and Candida, to preferentially infect patients with Bronchogenic carcinoma and Tubercular sequelae respectively.", {"entities": [[122, 131, "DISEASE"], [109, 131, "DISEASE"]]}], ["In absence of specific predictors, the possibility of fungal colonization needs to be explored actively in these patients.", {"entities": []}], ["Activated mast cells are present within airway smooth muscle (ASM) bundles in eosinophilic asthma.", {"entities": [[91, 97, "DISEASE"]]}], ["ASM production of the chemokine CXCL10 plays a role in their recruitment.", {"entities": [[32, 38, "GENE"]]}], ["Thus the effects of glucocorticoids (fluticasone, budesonide), long-acting \u03b22-agonists (salmeterol, formoterol) and thiazolidinediones (ciglitazone, rosiglitazone) on CXCL10 production by ASM cells (ASMC) from people with and without asthma were investigated in vitro.", {"entities": [[234, 240, "DISEASE"], [167, 173, "GENE"]]}], ["Confluent serum-deprived cells were treated with the agents before and during cytokine stimulation for 0-24\u2009h. CXCL10 protein/mRNA, I\u03baB-\u03b1 levels and p65 activity were measured using ELISA, RT PCR, immunoblotting and p65 activity assays respectively.", {"entities": [[111, 117, "GENE"]]}], ["Data were analysed using ANOVA followed by Fisher\u2019s post-hoc test.", {"entities": []}], ["Fluticasone and/or salmeterol at 1 and 100\u2009nM inhibited CXCL10 release induced by IL-1\u03b2 and TNF-\u03b1, but not IFN\u03b3 or all three cytokines (cytomix).", {"entities": [[56, 62, "GENE"]]}], ["The latter was also not affected by budesonide and formoterol.", {"entities": []}], ["In asthmatic ASMC low salmeterol, but not formoterol, concentrations increased cytomix-induced CXCL10 release and at 0.01\u2009nM enhanced NF-\u03baB activity.", {"entities": [[95, 101, "GENE"]]}], ["Salmeterol 0.1nM together with fluticasone 0.1 and 10\u2009nM still increased CXCL10 release.", {"entities": [[73, 79, "GENE"]]}], ["The thiazolidinediones ciglitazone and rosiglitazone (at 25 and 100\u2009\u03bcM) inhibited cytomix-induced CXCL10 release but these inhibitory effects were not prevented by the PPAR-g antagonist GW9662.", {"entities": [[98, 104, "GENE"]]}], ["Ciglitazone did not affect early NF-\u03baB activity and CXCL10 mRNA production.", {"entities": [[52, 58, "GENE"]]}], ["Thus the thiazolidinediones inhibited asthmatic ASMC CXCL10 release under conditions when common asthma therapies were ineffective or enhanced it.", {"entities": [[97, 103, "DISEASE"], [53, 59, "GENE"]]}], ["They may provide an alternative strategy to reduce mast cell-ASM interactions and restore normal airway physiology in asthma.", {"entities": [[118, 124, "DISEASE"]]}], ["Relationship between recurrent wheeze and airway function and inflammation in preschool children is not fully known.", {"entities": []}], ["To investigate the relationship between recurrent wheeze and airway inflammation, lung function, airway hyper-reactivity (AHR) and atopy in preschool children.", {"entities": [[122, 125, "GENE"]]}], ["Observational study, comparing forced expiratory volume in 1 s (FEV 1 ), forced vital capacity (FVC) and mid-forced expiratory flow (FEF 25%\u201375% ), dose\u2013response slope (DRS), exhaled nitric oxide (eNO) and atopic sensitisation between children with recurrent wheeze and those without.", {"entities": [[64, 67, "GENE"]]}], ["Population-based, cross-sectional study in Seoul and the Gyeonggi province of Korea conducted as a government-funded programme to perform standardised measurement of the prevalence of allergic diseases, and related factors, in preschool children.", {"entities": []}], ["900 children aged 4\u20136 years.", {"entities": []}], ["eNO, FEV 1 /FVC, FEF 25%\u201375% , DRS, atopic sensitisation and allergic diseases.", {"entities": [[5, 8, "GENE"]]}], ["Children completed the modified International Study of Asthma and Allergies in Childhood questionnaire and underwent eNO assessments, spirometry, methacholine bronchial provocation tests and skin prick tests.", {"entities": []}], ["Recurrent wheeze was defined as having a lifetime wheeze of more than three episodes, based on the questionnaire.", {"entities": []}], ["The frequency of hospitalisation and emergency room visits was also obtained by means of the questionnaire.", {"entities": []}], ["\u2018Current\u2019 wheeze was defined as having symptoms or treatments within the past 12 months.", {"entities": []}], ["The prevalence of recurrent wheeze was 13.4%.", {"entities": []}], ["Children with recurrent wheeze showed a higher prevalence of lifetime or current allergic rhinitis (p=0.01\u2009and p=0.002, respectively) and lifetime atopic dermatitis (p=0.007).", {"entities": [[81, 98, "DISEASE"], [147, 164, "DISEASE"], [90, 98, "DISEASE"], [154, 164, "DISEASE"]]}], ["Children with recurrent wheeze showed lower FEV 1 /FVC (p=0.033) and FEF 25%\u201375% (p=0.004), and higher eNO levels (p=0.013) than those without recurrent wheeze.", {"entities": [[44, 47, "GENE"]]}], ["However, the DRS, prevalence of atopic sensitisation and serum IgE levels were not significantly different between the two groups.", {"entities": []}], ["Recurrent wheeze in preschool children may be associated with airway inflammation and diminished airway function, but not with AHR or atopy.", {"entities": [[127, 130, "GENE"]]}], ["The human voice provides a rich source of information about individual attributes such as body size, developmental stability and emotional state.", {"entities": []}], ["Moreover, there is evidence that female voice characteristics change across the menstrual cycle.", {"entities": []}], ["A previous study reported that women speak with higher fundamental frequency (F0) in the high-fertility compared to the low-fertility phase.", {"entities": []}], ["To gain further insights into the mechanisms underlying this variation in perceived attractiveness and the relationship between vocal quality and the timing of ovulation, we combined hormone measurements and acoustic analyses, to characterize voice changes on a day-to-day basis throughout the menstrual cycle.", {"entities": []}], ["Voice characteristics were measured from free speech as well as sustained vowels.", {"entities": []}], ["In addition, we asked men to rate vocal attractiveness from selected samples.", {"entities": []}], ["The free speech samples revealed marginally significant variation in F0 with an increase prior to and a distinct drop during ovulation.", {"entities": []}], ["Overall variation throughout the cycle, however, precluded unequivocal identification of the period with the highest conception risk.", {"entities": []}], ["The analysis of vowel samples revealed a significant increase in degree of unvoiceness and noise-to-harmonic ratio during menstruation, possibly related to an increase in tissue water content.", {"entities": []}], ["Neither estrogen nor progestogen levels predicted the observed changes in acoustic characteristics.", {"entities": []}], ["The perceptual experiments revealed a preference by males for voice samples recorded during the pre-ovulatory period compared to other periods in the cycle.", {"entities": []}], ["While overall we confirm earlier findings in that women speak with a higher and more variable fundamental frequency just prior to ovulation, the present study highlights the importance of taking the full range of variation into account before drawing conclusions about the value of these cues for the detection of ovulation.", {"entities": []}], ["To investigate the efficacy and safety outcomes of combination therapy used to optimize etanercept treatment in patients with psoriasis treated in real-life clinical practice.", {"entities": [[126, 135, "DISEASE"]]}], ["Data from patients presenting with psoriasis, treated initially with etanercept monotherapy, were analysed retrospectively.", {"entities": [[35, 44, "DISEASE"]]}], ["Patients subsequently treated with combination therapy were further analysed.", {"entities": []}], ["The Psoriasis Area and Severity Index (PASI) score was recorded for all patients receiving comedication; a subjective pain score was recorded in those with psoriatic arthritis receiving comedication after 12, 24 and 48\u2009weeks\u2019 treatment and thereafter at 6-month intervals.", {"entities": [[4, 13, "DISEASE"], [166, 175, "DISEASE"], [156, 175, "DISEASE"]]}], ["From the database of 400 patients treated with etanercept, 37 patients (18 male; 19 female; mean age 59.43\u2009years) underwent combination therapy due to lack of efficacy.", {"entities": []}], ["Patients received mostly short-term (range 4\u201334\u2009weeks) comedication with corticosteroids, cyclosporine, methotrexate, nonsteroidal anti-inflammatory drugs, acitretin or sulphasalazine.", {"entities": []}], ["There were significant reductions in the mean PASI score from baseline at all timepoints.", {"entities": []}], ["There were also significant reductions in the mean pain VAS score from baseline at all timepoints in patients with psoriatic arthritis.", {"entities": [[125, 134, "DISEASE"], [115, 134, "DISEASE"]]}], ["The drug survival rate was 59.6% over a mean duration of 323\u2009weeks of etanercept treatment.", {"entities": []}], ["The safety profile of combination therapy was satisfactory.", {"entities": []}], ["Short-term comedication in combination with etanercept may optimize treatment options and improve long-term drug survival in patients with psoriasis.", {"entities": [[139, 148, "DISEASE"]]}], ["Chronic obstructive pulmonary disease (COPD) is a serious lung disease that severely threatens people\u2019s health.", {"entities": [[58, 70, "DISEASE"]]}], ["This study aimed to investigate the effects of heliox-driven nebulization (HDN) on lung function and arterial blood gases in a COPD rat model.", {"entities": []}], ["Twelve healthy male Wistar rats were selected as controls and 34 rats were used to establish a COPD model induced by lipopolysaccharide.", {"entities": []}], ["Then 6 rats each from the control and model groups were selected for their symptoms to be observed.", {"entities": []}], ["The remaining 6 normal rats were used as control group (group A) and the remaining 28 experimental COPD rats were randomly assigned to 4 groups: experimental COPD group (group B), medical oxygen group (group C), and heliox groups (group D, He/O 2 =63%/37%; group E, He/O 2 =71%/29%).", {"entities": []}], ["The lung function indicators and arterial blood gases were analyzed to evaluate the effects of different driving gases on COPD rats.", {"entities": []}], ["The COPD model was successfully established with slow growth and severe lung dysfunction.", {"entities": []}], ["Inspiratory resistance, expiratory resistance, and forced expiratory volume at 0.10 s (FEV0.10)/FVC were significantly decreased, whereas dynamic lung compliance was significantly increased in groups D and E, compared with the experimental COPD group (group B; P <0.05).", {"entities": []}], ["Meanwhile, compared with the model group, the values of partial pressure of carbon dioxide in arterial blood were significantly higher, whereas the potential of hydrogen values were significantly lower after atomization in groups C and D but not in group E ( P <0.05).", {"entities": []}], ["The obvious increase in arterial oxygen saturation was found only in group E ( P <0.05).", {"entities": []}], ["HDN improved the lung function and arterial blood gas analysis results in experimental COPD rats, with an optimal percentage of He/O 2 =71%/29%.", {"entities": []}], ["In this study, we aimed to determine the association between gastroesophageal reflux disease (GERD) and subsequent coronary heart disease (CHD) development, if any, and to evaluate whether longer use of proton pump inhibitors (PPIs) increases the risk of CHD.", {"entities": [[124, 137, "DISEASE"], [115, 137, "DISEASE"], [61, 92, "DISEASE"]]}], ["Patients diagnosed with GERD between 2000 and 2011 were identified as the study cohort (n = 12,960).", {"entities": []}], ["Patients without GERD were randomly selected from the general population, frequency-matched with the study group according to age, sex, and index year, and evaluated as the comparison cohort (n = 51,840).", {"entities": []}], ["Both cohorts were followed up until the end of 2011 to determine the incidence of CHD.", {"entities": []}], ["The risk of CHD was evaluated in both groups by using Cox proportional hazards regression models.", {"entities": []}], ["The GERD patients had a greater probability of CHD than the cohort without GERD did (log-rank test, P \u200a<\u200a0.001 and 11.8 vs 6.5 per 1000 person-years).", {"entities": []}], ["The GERD cohort had a higher risk of CHD than the comparison cohort did after adjustment for age, sex, hypertension, diabetes, hyperlipidemia, alcohol-related illness, stroke, chronic obstructive pulmonary disease, asthma, biliary stone, anxiety, depression, chronic kidney disease, and cirrhosis (adjusted hazard ratio [aHR]: 1.49, 95% confidence interval [CI]: 1.34\u20131.66).", {"entities": [[103, 115, "DISEASE"], [267, 281, "DISEASE"], [176, 213, "DISEASE"], [215, 221, "DISEASE"], [321, 324, "GENE"]]}], ["The risk of CHD was greater for the patients treated with PPIs for more than 1 year (aHR = 1.67, 95% CI = 1.34\u20132.08) than for those treated with PPIs for <1 year (aHR = 1.56, 95% CI = 1.39\u20131.74).", {"entities": [[85, 88, "GENE"], [163, 166, "GENE"], [85, 88, "GENE"], [163, 166, "GENE"]]}], ["Our population-based cohort study results indicate that GERD was associated with an increased risk of developing CHD, and that PPI use for more than 1 year might increase the risk of CHD.", {"entities": []}], ["A fungal immunomodulatory protein isolated from Flammulina velutipes (FIP-fve) has structural similarity to the variable region of the immunoglobulin heavy chain.", {"entities": []}], ["In the present study, the recombinant bioactive FIP-fve protein with a His-tag in N -terminal of recombinant protein was expressed in transetta (DE3) at a high level under the optimized culturing conditions of 0.2 mM IPTG and 28 \u00b0C.", {"entities": []}], ["The efficiency of the purification was improved with additional ultrasonication to the process of lysozyme lysis.", {"entities": []}], ["The yield of the bioactive FIP-fve protein with 97.1% purity reached 29.1 mg/L with a large quantity for industrial applications.", {"entities": []}], ["Enzyme-linked immunosorbent assay showed a maximum increase in interleukin-2 (IL-2) and gamma interferon (IFN-\u03b3) for the mice serum group of 5 mg/kg body mass ( p < 0.01) with three doses of His-FIP-fve.", {"entities": []}], ["However, the production of IL-4 had no apparent difference compared to the control.", {"entities": []}], ["Fibrosis in peripheral airways is responsible for airflow limitation in chronic obstructive pulmonary disease (COPD).", {"entities": [[72, 109, "DISEASE"]]}], ["Annexin A1 modulates several key biological events during inflammation.", {"entities": []}], ["However, little is known about its role in airway fibrosis in COPD.", {"entities": []}], ["We investigated whether levels of Annexin A1 were upregulated in patients with COPD, and whether it promoted airway fibrosis.", {"entities": []}], ["We quantified serum Annexin A1 levels in never-smokers (n=12), smokers without COPD (n=11), and smokers with COPD (n=22).", {"entities": []}], ["Correlations between Annexin A1 expression and clinical indicators (eg, lung function) were assessed.", {"entities": []}], ["In vitro, human bronchial epithelial (HBE) cells were exposed to cigarette smoke extract (CSE) and Annexin A1 expression was assessed.", {"entities": []}], ["Primary human lung fibroblasts were isolated from patients with COPD and effects of Annexin A1 on fibrotic deposition of lung fibroblasts were evaluated.", {"entities": []}], ["Serum Annexin A1 was significantly higher in patients with Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines stage III or IV than in those with GOLD stages I or II (12.8\u00b10.8 ng/mL versus 9.8\u00b10.7 ng/mL; p =0.016).", {"entities": []}], ["Annexin A1 expression was negatively associated with airflow obstruction (forced expiratory volume in one second % predicted; r =\u22120.72, p <0.001).", {"entities": []}], ["In vitro, Annexin A1 was significantly increased in CSE-exposed HBE cells in a time- and concentration-dependent manner.", {"entities": []}], ["Annexin A1 promoted lung fibroblasts proliferation, migration, differentiation, and collagen deposition via the ERK1/2 and p38 mitogen-activated protein kinase pathways.", {"entities": []}], ["Annexin A1 expression is upregulated in patients with COPD and affects lung fibroblast function.", {"entities": []}], ["However, more studies are needed to clarify the role of Annexin A1 in airway fibrosis of COPD.", {"entities": []}], ["Deep inspirations (DIs) and airway smooth muscle fluidization are two widely studied phenomena in asthma research, particularly for their ability (or inability) to counteract severe airway constriction.", {"entities": [[98, 104, "DISEASE"]]}], ["For example, DIs have been shown effectively to reverse airway constriction in normal subjects, but this is impaired in asthmatics.", {"entities": []}], ["Fluidization is a connected phenomenon, wherein the ability of airway smooth muscle (ASM, which surrounds and constricts the airways) to exert force is decreased by applied strain.", {"entities": []}], ["A maneuver which sufficiently strains the ASM, then, such as a DI, is thought to reduce the force generating capacity of the muscle via fluidization and hence reverse or prevent airway constriction.", {"entities": []}], ["Understanding these two phenomena is considered key to understanding the pathophysiology of asthma and airway hyper-responsiveness, and while both have been extensively studied, the mechanism by which DIs fail in asthmatics remains elusive.", {"entities": [[92, 98, "DISEASE"]]}], ["Here we show for the first time the synergistic interaction between DIs and fluidization which allows the combination to provide near complete reversal of airway closure where neither is effective alone.", {"entities": []}], ["This relies not just on the traditional model of airway bistability between open and closed states, but also the critical addition of previously-unknown oscillatory and chaotic dynamics.", {"entities": []}], ["It also allows us to explore the types of subtle change which can cause this interaction to fail, and thus could provide the missing link to explain DI failure in asthmatics.", {"entities": []}], ["The etiology of small intestinal cancer (SIC) is largely unknown, and there are very few epidemiological studies published to date.", {"entities": [[22, 39, "DISEASE"], [33, 39, "DISEASE"]]}], ["No studies have investigated abdominal adiposity in relation to SIC.", {"entities": []}], ["We investigated overall obesity and abdominal adiposity in relation to SIC in the European Prospective Investigation into Cancer and Nutrition (EPIC), a large prospective cohort of approximately half a million men and women from ten European countries.", {"entities": [[24, 31, "DISEASE"], [122, 128, "DISEASE"]]}], ["Overall obesity and abdominal obesity were assessed by body mass index (BMI), waist circumference (WC), hip circumference (HC), waist-to-hip ratio (WHR), and waist-to-height ratio (WHtR).", {"entities": [[8, 15, "DISEASE"], [30, 37, "DISEASE"]]}], ["Multivariate Cox proportional hazards regression modeling was performed to estimate hazard ratios (HRs) and 95\u00a0% confidence intervals (CIs).", {"entities": []}], ["Stratified analyses were conducted by sex, BMI, and smoking status.", {"entities": []}], ["During an average of 13.9\u00a0years of follow-up, 131 incident cases of SIC (including 41 adenocarcinomas, 44 malignant carcinoid tumors, 15 sarcomas and 10 lymphomas, and 21 unknown histology) were identified.", {"entities": []}], ["WC was positively associated with SIC in a crude model that also included BMI (HR per 5-cm increase\u00a0=\u00a01.20, 95\u00a0% CI 1.04, 1.39), but this association attenuated in the multivariable model (HR 1.18, 95\u00a0% CI 0.98, 1.42).", {"entities": [[79, 81, "GENE"], [189, 191, "GENE"], [79, 81, "GENE"], [189, 191, "GENE"]]}], ["However, the association between WC and SIC was strengthened when the analysis was restricted to adenocarcinoma of the small intestine (multivariable HR adjusted for BMI\u00a0=\u00a01.56, 95\u00a0% CI 1.11, 2.17).", {"entities": [[97, 111, "DISEASE"], [150, 152, "GENE"]]}], ["There were no other significant associations.", {"entities": []}], ["WC, rather than BMI, may be positively associated with adenocarcinomas but not carcinoid tumors of the small intestine.", {"entities": []}], ["Abdominal obesity is a potential risk factor for adenocarcinoma in the small intestine.", {"entities": [[49, 63, "DISEASE"], [10, 17, "DISEASE"]]}], ["The differential diagnosis of altered mental status and behavioral change is very extensive.", {"entities": []}], ["Paraneoplastic limbic encephalitis is a rare cause of cognitive impairment, which should be considered in the differential diagnosis.", {"entities": [[22, 34, "DISEASE"]]}], ["A 64-year-old British Caucasian woman presented to our hospital with a 12-week history of confusion and short-term memory loss.", {"entities": []}], ["She was hyponatremic with a serum sodium level of 128mmol/L.", {"entities": []}], ["Moreover, there was evidence of left hilar prominence on the chest radiograph.", {"entities": []}], ["A thoracic computed tomography scan showed left hilar opacity with confluent lymphadenopathy.", {"entities": []}], ["A percutaneous biopsy confirmed a diagnosis of small cell lung cancer.", {"entities": [[58, 69, "DISEASE"], [63, 69, "DISEASE"]]}], ["There was no radiological evidence of brain metastasis on the computed tomography scan.", {"entities": []}], ["In view of continued cognitive impairment, which was felt to be disproportionate to hyponatremia, a magnetic resonance imaging scan of the brain was undertaken.", {"entities": []}], ["It showed hyperintense signals from both hippocampi, highly suggestive of limbic encephalitis presenting as a paraneoplastic manifestation of small cell lung cancer.", {"entities": [[153, 164, "DISEASE"], [81, 93, "DISEASE"], [158, 164, "DISEASE"]]}], ["She had a significant radiological and clinical response following chemotherapy and radiotherapy.", {"entities": []}], ["This case highlights the importance of considering paraneoplastic syndromes in patients with neurological symptoms in the context of lung malignancy.", {"entities": []}], ["If initial investigations fail to reveal the cause of cognitive impairment in a patient with malignancy, magnetic resonance imaging may be invaluable in the diagnosis of limbic encephalitis.", {"entities": [[177, 189, "DISEASE"]]}], ["The clinical presentation, diagnostic techniques and management of paraneoplastic limbic encephalitis are discussed in this case report.", {"entities": [[89, 101, "DISEASE"]]}], ["Estimate the efficacy of amoxicillin for acute uncomplicated lower-respiratory-tract infection (LRTI) in primary care and demonstrate the use of randomisation-based efficacy estimators.", {"entities": []}], ["Secondary analysis of a two-arm individually-randomised placebo-controlled trial.", {"entities": []}], ["Primary care practices in 12 European countries.", {"entities": []}], ["Patients aged 18 or older consulting with an acute LRTI in whom pneumonia was not suspected by the clinician.", {"entities": [[64, 73, "DISEASE"]]}], ["Amoxicillin (two 500\u2005mg tablets three times a day for 7\u2005days) or matched placebo.", {"entities": []}], ["Clinician-rated symptom severity between days 2\u20134; new/worsening symptoms and presence of side effects at 4-weeks.", {"entities": []}], ["Adherence was captured using self-report and tablet counts.", {"entities": []}], ["2061 participants were randomised to the amoxicillin or placebo group.", {"entities": []}], ["On average, 88% of the prescribed amoxicillin was taken.", {"entities": []}], ["The original analysis demonstrated small increases in both benefits and harms from amoxicillin.", {"entities": []}], ["Minor improvements in the benefits of amoxicillin were observed when an adjustments for adherence were made (mean difference in symptom severity \u22120.08, 95% CI \u22120.17 to 0.01, OR for new/worsening symptoms 0.81, 95% CI 0.66 to 0.98) as well as minor increases in harms (OR for side effects 1.32, 95% CI 1.12 to 1.57).", {"entities": []}], ["Adherence to amoxicillin was high, and the findings from the original analysis were robust to non-adherence.", {"entities": []}], ["Participants consulting to primary care with an acute uncomplicated LRTI can on average expect minor improvements in outcome from taking amoxicillin.", {"entities": []}], ["However, they are also at an increased risk of experiencing side effects.", {"entities": []}], ["Eudract-CT 2007-001586-15 and ISRCTN52261229.", {"entities": []}], ["The trial was registered at EudraCT in 2007 due to an administrative misunderstanding that EudraCT was a suitable registry\u2014which it was not in 2007, but has become since.", {"entities": []}], ["On discovery of this error, the trial was also registered at ISRCTN (January 2009).", {"entities": []}], ["Trial procedures did not change between the two registrations.", {"entities": []}], ["Chronic obstructive pulmonary disease (COPD) is characterized by the abnormal and chronic lung inflammation.", {"entities": []}], ["We hypothesized that lung fibroblasts could contribute to the local inflammation and investigated whether low dose theophylline had a beneficial effect on fibroblasts inflammation.", {"entities": []}], ["Subjects undergoing lobectomy for bronchial carcinoma were enrolled and divided into COPD and control groups according to spirometry.", {"entities": [[44, 53, "DISEASE"]]}], ["Primary human lung fibroblasts were cultured from peripheral lung tissue distant to tumor tissue.", {"entities": []}], ["There was a significant increase in both the mRNA expressions and protein levels for IL-6 and IL-8 in fibroblasts in COPD group, and the values were negatively correlated with lung function ( P < 0.05).", {"entities": []}], ["For COPD fibroblasts, the protein levels of IL-6 and IL-8 decreased from 993.0 \u00b1 738.9\u2009pg/mL to 650.1 \u00b1 421.9\u2009pg/mL ( P = 0.014) and from 703.1 \u00b1 278.0\u2009pg/mL to 492.0 \u00b1 214.9\u2009pg/mL ( P = 0.001), respectively, with 5\u2009 \u03bc g/mL theophylline treatment.", {"entities": []}], ["In addition, theophylline at the dose of 5\u2009 \u03bc g/mL reduced the increased production of IL-6 and IL-8 induced by 1\u2009 \u03bc g/mL LPS in primary human lung fibroblasts.", {"entities": []}], ["Our data suggest that lung fibroblasts participate in the chronic inflammation in COPD by releasing IL-6 and IL-8, and low dose theophylline can alleviate the proinflammatory mediators' production by fibroblasts.", {"entities": []}], ["Of the several factors believed to exacerbate asthmatic symptoms, air pollution and viral infections are considered to be particularly important.", {"entities": []}], ["Although evidence indicates that each of these respiratory insults individually can increase asthma severity in susceptible individuals, we know little about the extent to which exposure to environmental oxidant pollutants can influence the course of respiratory viral infection and its associated inflammation.", {"entities": [[93, 99, "DISEASE"]]}], ["To investigate the interaction of these two stimuli within their common epithelial cell targets in the upper and lower respiratory tracks, we infected primary human nasal epithelial cells and cells of the BEAS-2B line grown at the air-liquid interface with human rhinovirus type 16 (RV16) and exposed them to NO2 (2.0 ppm) or O3 (0.2 ppm) for 3 hr.", {"entities": [[345, 347, "GENE"]]}], ["Independently, RV16, NO2, and O3 rapidly increased release of the inflammatory cytokine interleukin-8 through oxidant-dependent mechanisms.", {"entities": []}], ["The combined effect of RV16 and oxidant ranged from 42% to 250% greater than additive for NO2 and from 41% to 67% for O3.", {"entities": []}], ["We abrogated these effects by treating the cells with the antioxidant N-acetylcysteine.", {"entities": []}], ["Surface expression of intercellular adhesion molecule 1 (ICAM-1) underwent additive enhancement in response to combined stimulation.", {"entities": []}], ["These data indicate that oxidant pollutants can amplify the generation of proinflammatory cytokines by RV16-infected cells and suggest that virus-induced inflammation in upper and lower airways may be exacerbated by concurrent exposure to ambient levels of oxidants commonly encountered the indoor and outdoor environments.", {"entities": []}], ["Diagnosis of allergic rhinitis is primarily based on history, physical examination and allergy testing.", {"entities": [[13, 30, "DISEASE"], [22, 30, "DISEASE"]]}], ["A technique that noninvasively evaluates the soft tissue changes in the nasal mucosa of allergic rhinitis patients has not been defined.", {"entities": [[88, 105, "DISEASE"], [97, 105, "DISEASE"]]}], ["To assess nasal mucosal changes and measure the submucosal fibrosis in allergic rhinitis patients with sonoelastography.", {"entities": [[71, 88, "DISEASE"], [80, 88, "DISEASE"]]}], ["Case control study.", {"entities": []}], ["Eighty-eight turbinates of 44 patients were included in the study.", {"entities": []}], ["There were 23 prick test positive allergic rhinitis patients.", {"entities": [[34, 51, "DISEASE"], [43, 51, "DISEASE"]]}], ["The control group constituted 21 patients.", {"entities": []}], ["The rhinitis quality of life questionnaire and the visual analogue scale were applied to the allergic rhinitis patients.", {"entities": [[93, 110, "DISEASE"], [4, 12, "DISEASE"], [102, 110, "DISEASE"]]}], ["A higher visual analogue scale score indicated more severe allergic rhinitis symptoms.", {"entities": [[59, 76, "DISEASE"], [68, 76, "DISEASE"]]}], ["Sonoelastographic measurements were made from the lateral nasal wall.", {"entities": []}], ["The propagation speed of sound waves was recorded in m/s.", {"entities": []}], ["The presence of asthma and the type of allergic rhinitis (seasonal or perennial) was noted.", {"entities": [[39, 56, "DISEASE"], [48, 56, "DISEASE"], [16, 22, "DISEASE"]]}], ["Ten patients had seasonal allergic rhinitis and thirteen patients had perennial allergic rhinitis.", {"entities": [[26, 43, "DISEASE"], [80, 97, "DISEASE"], [35, 43, "DISEASE"], [89, 97, "DISEASE"]]}], ["Six patients (26.1%) had accompanying asthma along with allergic rhinitis.", {"entities": [[56, 73, "DISEASE"], [65, 73, "DISEASE"], [38, 44, "DISEASE"]]}], ["The median visual analogue scale score was 7 (3-9) in allergic rhinitis patients.", {"entities": [[54, 71, "DISEASE"], [63, 71, "DISEASE"]]}], ["The median symptom duration was 7 (1-24) months.", {"entities": []}], ["The median quality of life questionnaire score was 3.39 (1.68-5.43) points.", {"entities": []}], ["The median sonoelastography scores of allergic rhinitis patients and healthy subjects were 2.38 m/s (0.9-4.47) and 2.42 m/s (1.62-3.50), respectively.", {"entities": [[38, 55, "DISEASE"], [47, 55, "DISEASE"]]}], ["Sonoelastographic measurements of seasonal and perennial allergic rhinitis patients did not differ significantly (p>0.05).", {"entities": [[57, 74, "DISEASE"], [66, 74, "DISEASE"]]}], ["The presence of asthma did not have a significant impact on the elastography measurements (p>0.05).", {"entities": [[16, 22, "DISEASE"]]}], ["However, regression analysis revealed a significant inverse correlation (coefficients: B=0.005, standard error=0.097, beta 0=0.008) between the visual analogue scale and sonoelastography scores (p<0.05).", {"entities": []}], ["Sonoelastography was not suitable as a diagnostic tool in allergic rhinitis.", {"entities": [[58, 75, "DISEASE"], [67, 75, "DISEASE"]]}], ["Reduced sonoelastography scores were measured in more symptomatic patients.", {"entities": []}], ["Higher visual analogue scale scores could be an indicator of disease severity.", {"entities": []}], ["Microalgae have recently attracted considerable interest worldwide, due to their extensive application potential in the renewable energy, biopharmaceutical, and nutraceutical industries.", {"entities": []}], ["Microalgae are renewable, sustainable, and economical sources of biofuels, bioactive medicinal products, and food ingredients.", {"entities": []}], ["Several microalgae species have been investigated for their potential as value-added products with remarkable pharmacological and biological qualities.", {"entities": []}], ["As biofuels, they are a perfect substitute to liquid fossil fuels with respect to cost, renewability, and environmental concerns.", {"entities": []}], ["Microalgae have a significant ability to convert atmospheric CO 2 to useful products such as carbohydrates, lipids, and other bioactive metabolites.", {"entities": []}], ["Although microalgae are feasible sources for bioenergy and biopharmaceuticals in general, some limitations and challenges remain, which must be overcome to upgrade the technology from pilot-phase to industrial level.", {"entities": []}], ["The most challenging and crucial issues are enhancing microalgae growth rate and product synthesis, dewatering algae culture for biomass production, pretreating biomass, and optimizing the fermentation process in case of algal bioethanol production.", {"entities": []}], ["The present review describes the advantages of microalgae for the production of biofuels and various bioactive compounds and discusses culturing parameters.", {"entities": []}], ["Thymoquinone (TQ) has been reported to possess anti-tumor activity in various types of cancer.", {"entities": [[87, 93, "DISEASE"]]}], ["However, its effects and molecular mechanism of action in hepatocellular carcinoma (HCC) are still not completely understood.", {"entities": [[58, 82, "DISEASE"], [73, 82, "DISEASE"]]}], ["We observed that TQ inhibited tumor cell growth in vitro , where treatment with TQ arrested the cell cycle in G1 by upregulating p21 and downregulating cyclinD1 and CDK2 expression; moreover, TQ induced apoptosis by decreasing expression of Bcl-2 and increasing expression of Bax.", {"entities": [[165, 169, "GENE"], [276, 279, "GENE"]]}], ["Simultaneously, TQ demonstrated a suppressive impact on the Notch pathway, where overexpression of NICD1 reversed the inhibitory effect of TQ on cell proliferation, thereby attenuating the repressive effects of TQ on the Notch pathway, cyclinD1, CDK2 and Bcl-2, and also diminishing upregulation of p21 and Bax.", {"entities": [[246, 250, "GENE"], [307, 310, "GENE"]]}], ["In a xenograft model, TQ inhibited HCC growth in nude mice; this inhibitory effect in vivo , as well as of HCC cell growth in vitro , was associated with a discernible decline in NICD1 and Bcl-2 levels and a dramatic rise in p21 expression.", {"entities": []}], ["In conclusion, TQ inhibits HCC cell growth by inducing cell cycle arrest and apoptosis, achieving these effects by repression of the Notch signaling pathway, suggesting that TQ represents a potential preventive or therapeutic agent in HCC patients.", {"entities": []}], ["Allergic rhinitis (AR) is an increasing and common condition affecting many people globally, especially children.", {"entities": [[0, 17, "DISEASE"], [9, 17, "DISEASE"]]}], ["The aim of the study was to investigate the association between the frequency of truck traffic and allergic rhinitis symptoms, rhinoconjunctivitis and hayfever among 13 to 14\u00a0year old school children in Ekurhuleni Metropolitan Municipality, Gauteng Province, South Africa.", {"entities": [[99, 116, "DISEASE"], [108, 116, "DISEASE"]]}], ["In a cross-sectional study design, 3764 children from 16 randomly selected high schools were eligible to participate, 3468 completed the International Study of Asthma and Allergies in Childhood (ISAAC) Phase I questionnaire of which 3424 were suitable for analysis; the overall response rate was 92\u00a0%.", {"entities": []}], ["Data were analysed using multilevel logistic regression analysis.", {"entities": []}], ["The prevalence of self-reported rhinitis ever, current rhinitis rhinoconjunctivitis and hayfever was 52, 40, 21 and 37\u00a0% respectively.", {"entities": [[32, 40, "DISEASE"], [55, 63, "DISEASE"]]}], ["Rhinitis ever, current rhinitis and current rhinoconjunctivitis were significantly associated with the frequency of trucks passing near residences almost all day on weekdays, (OR 1.46 95\u00a0% CI: 1.16\u2009\u2212\u20091.84), (OR 1.60 95\u00a0% CI: 1.24\u20132.02) and (OR 1.42 95\u00a0% CI: 1.09\u20131.84) respectively.", {"entities": [[0, 8, "DISEASE"], [23, 31, "DISEASE"]]}], ["No association was observed between truck traffic and hay fever in the multiple analyses.", {"entities": []}], ["The study shows a high prevalence of allergic rhinitis symptoms amongst children.", {"entities": [[37, 54, "DISEASE"], [46, 54, "DISEASE"]]}], ["The results support the hypothesis that traffic related pollution plays a role in the prevalence of allergic rhinitis symptoms in children residing in the area.", {"entities": [[100, 117, "DISEASE"], [109, 117, "DISEASE"]]}], ["Primary care (PC) patients have difficulties in committing to and incorporating primary prevention and health promotion (PP&HP) activities into their long-term care.", {"entities": [[14, 16, "GENE"], [124, 126, "GENE"]]}], ["We aimed to re-interpret, for the first time, qualitative findings regarding factors affecting PC patients' acceptance of PP&HP activities.", {"entities": [[95, 97, "GENE"], [125, 127, "GENE"]]}], ["A meta-ethnographic synthesis was generated following electronic and manual searches that retrieved 29 articles.", {"entities": []}], ["Papers were reviewed and translated to produce a re-interpretation of the extracted concepts.", {"entities": []}], ["The factors affecting PC patients' receptiveness to PP&HP activities were framed in a four-level ecological model (intrapersonal, interpersonal, institutional and environment and society).", {"entities": [[22, 24, "GENE"], [55, 57, "GENE"]]}], ["Intrapersonal factors (patients' beliefs/attitudes, knowledge, skills, self-concept, motivation and resources) were the most numerous, with almost 25 different factors.", {"entities": []}], ["Public health education to modify erroneous beliefs and values regarding PP&HP could encourage a transition to healthier lifestyles.", {"entities": [[76, 78, "GENE"]]}], ["Health care professionals' abilities to communicate and involve patients in the decision-making process can act as facilitators.", {"entities": []}], ["Biopsychosocial training (with emphasis on communication skills) for health professionals must start with undergraduates.", {"entities": []}], ["Increased consultation time, the use of reminders, follow-up visits and tools for communicating risk and motivating patients could be applied at the intrapersonal level.", {"entities": []}], ["Collaborative care involving other health professionals (nutritionists or psychotherapists) and family and community stakeholders (teachers or gym trainers) was important in developing healthier habits.", {"entities": []}], ["Patients also cited barriers related to the built environment and socioeconomic difficulties that highlighted the need for policies promoting social justice and equity.", {"entities": []}], ["Encouraging PP&HP using social marketing strategies and regulating media to control its impact on health were also cited.", {"entities": [[15, 17, "GENE"]]}], ["Only the perspectives of PC patients in the context of chronic conditions were considered thus limiting extrapolation to other contexts.", {"entities": [[25, 27, "GENE"]]}], ["Several factors affect PP&HP.", {"entities": [[26, 28, "GENE"]]}], ["This must be taken into account when designing PP&HP activities if they are to be successfully implemented and maintained in routine practice.", {"entities": [[50, 52, "GENE"]]}], ["This study aims to investigate the efficacy and safety of neutral macroporous resin hemoperfusion in treating maintenance hemodialysis (MHD) patients with refractory uremic pruritus (RUP).", {"entities": []}], ["Ninety patients were enrolled and were randomly divided into 3 groups: control group, experiment 1 group, and experiment 2 group.", {"entities": []}], ["Clinical symptom scores of skin itching were recorded before and at 4 and 8 weeks after the treatment.", {"entities": []}], ["In addition, serum parathyroid hormone (PTH), calcium (Ca VSA score, modified Duo pruritus score, and CRP: these indices decreased to some extent at 4 and 8 weeks after treatment in the 2 experiment groups, compared with pretreatment ( P \u200a<\u200a0.05); and differences among these 3 groups were statistically significant ( P \u200a<\u200a0.05).", {"entities": [[40, 43, "GENE"], [102, 105, "GENE"]]}], ["PTH, P P \u200a<\u200a0.05); and differences between the control and experiment 1 groups, as well as between the control and experiment 2 groups, were statistically significant ( P \u200a<\u200a0.05).", {"entities": [[0, 3, "GENE"]]}], ["However, the difference between the experiment 1 and experiment 2 groups were not statistically significant ( P \u200a<\u200a0.05).", {"entities": []}], ["The effects of HA330 and HA130 resin hemoperfusion apparatus on secondary hyperparathyroidism and the disorder of calcium and phosphorus metabolism are similar.", {"entities": [[64, 93, "DISEASE"], [74, 93, "DISEASE"]]}], ["The mechanism may be related to its strong adsorption effect, and its capacity to widely remove inflammatory mediators, immune mediators, and endotoxins.", {"entities": []}], ["Intracellular persistence of Staphylococcus aureus favors bacterial spread and chronic infections.", {"entities": []}], ["Here, we provide evidence for the existence of human CD4 S .", {"entities": [[53, 56, "GENE"]]}], ["The analyses showed that pulsing of monocyte-derived dendritic cells (MoDC) with native staphylococcal protein antigens induced release of Th2-associated cytokines and mediators linked to T regulatory cell development (G-CSF, IL-2 and IL-10) from both CD4 S .", {"entities": [[252, 255, "GENE"]]}], ["Nevertheless, delivery of in vitro transcribed mRNA-encoded staphylococcal antigens triggered Th1-biased responses, e.g.", {"entities": []}], ["IFN\u03b3 and TNF release from both na\u00efve and memory T cells.", {"entities": [[9, 12, "GENE"]]}], ["Collectively, our data highlight the potential of mRNA-adjuvanted antigen presentation to enable inflammatory responses, thus overriding the existing Th2/Treg-biased memory T cell response to native S .", {"entities": []}], ["aureus antigens.", {"entities": []}], ["Staphylococcus aureus is deemed one of the most important nosocomial pathogens but, to date, there are no safe and protective vaccines.", {"entities": []}], ["In this study we investigate the nature of the preformed T cell response to S .", {"entities": []}], ["aureus antigens in healthy donors.", {"entities": []}], ["Our data reveal that CD4 S .", {"entities": [[21, 24, "GENE"]]}], ["aureus -specific T cell responses bears the potential to override the tolerogenic bias.", {"entities": []}], ["It favors TNF- and IFN\u03b3-releasing T cells and may, thus, represent an innovative tool in prophylactic and therapeutic vaccine development.", {"entities": []}], ["Individuals claiming a disability benefit after long-term sickness absence, have to undergo medical disability assessments.", {"entities": []}], ["These assessments, often carried out by specialized physicians, can be complicated by wrong expectations or defensive attitudes of disability benefit claimants.", {"entities": []}], ["It is hypothesized that empowerment of these claimants will enhance the physician-patient relationship by shifting claimants from a passive role to a more active and constructive role during disability assessments.", {"entities": []}], ["Furthermore, empowerment of claimants may lead to a more realistic expectation and acceptance of the assessment outcome among claimants and may lead to a more accurate assessment by the physician.", {"entities": []}], ["In a two-armed randomized controlled trial (RCT), 230 claimants will be randomized to either the intervention or control group.", {"entities": []}], ["For the intervention group, an interactive website was designed http://www.wiagesprek.nl using an Intervention Mapping procedure.", {"entities": []}], ["This website was tested during a pilot study among 51 claimants.", {"entities": []}], ["The final version of the website consists of five interactive modules, in which claimants will be prepared and empowered step-by-step, prior to their upcoming disability assessment.", {"entities": []}], ["Other website components are a forum, a personal health record, a personal diary, and information on disability assessment procedures, return to work, and coping with disease and work disability.", {"entities": []}], ["Subjects from the control group will be directed to a website with commonly available information only.", {"entities": []}], ["Approximately two weeks prior to their disability assessment, disability claimants will be recruited through the Dutch Workers Insurance Authority (UWV).", {"entities": []}], ["Outcomes will be assessed at five occasions: directly after recruitment (baseline), prior to disability assessment, directly after disability assessment as well as 6 and 16 weeks after the assessment.", {"entities": []}], ["The study's primary outcome is empowerment, measured with the Vrijbaan questionnaire.", {"entities": []}], ["Secondary outcomes include claimants' satisfaction, perceived justice, coping strategy, and knowledge.", {"entities": []}], ["A process evaluation will also be conducted.", {"entities": []}], ["This study evaluates the effectiveness of an interactive website aimed at empowerment of disability claimants.", {"entities": []}], ["It is hypothesized that by increasing empowerment, the physician-patient relationship may be enhanced and claimants' satisfaction and perceived justice can be improved.", {"entities": []}], ["Results are expected in 2010.", {"entities": []}], ["Relatively few studies have examined the association between air pollution and stroke mortality.", {"entities": []}], ["Inconsistent and inclusive results from existing studies on air pollution and stroke justify the need to continue to investigate the linkage between stroke and air pollution.", {"entities": []}], ["No studies have been done to investigate the association between stroke and greenness.", {"entities": []}], ["The objective of this study was to examine if there is association of stroke with air pollution, income and greenness in northwest Florida.", {"entities": []}], ["Our study used an ecological geographical approach and dasymetric mapping technique.", {"entities": []}], ["We adopted a Bayesian hierarchical model with a convolution prior considering five census tract specific covariates.", {"entities": []}], ["A 95% credible set which defines an interval having a 0.95 posterior probability of containing the parameter for each covariate was calculated from Markov Chain Monte Carlo simulations.", {"entities": []}], ["The 95% credible sets are (-0.286, -0.097) for household income, (0.034, 0.144) for traffic air pollution effect, (0.419, 1.495) for emission density of monitored point source polluters, (0.413, 1.522) for simple point density of point source polluters without emission data, and (-0.289,-0.031) for greenness.", {"entities": []}], ["Household income and greenness show negative effects (the posterior densities primarily cover negative values).", {"entities": []}], ["Air pollution covariates have positive effects (the 95% credible sets cover positive values).", {"entities": []}], ["High risk of stroke mortality was found in areas with low income level, high air pollution level, and low level of exposure to green space.", {"entities": []}], ["Maintaining the patency of the upper airway during breathing is of vital importance.", {"entities": []}], ["The activity of various muscles is related to the patency of the upper airway.", {"entities": []}], ["In the present study, we examined the respiratory motor activity in the efferent nerves innervating the upper airway muscles to determine the movements of the upper airway during respiration under normocapnic conditions (pH = 7.4) and in hypercapnic acidosis (pH = 7.2).", {"entities": []}], ["Experiments were performed on arterially perfused decerebrate rats aged between postnatal days 21\u201335.", {"entities": []}], ["We recorded the efferent nerve activity in a branch of the cervical spinal nerve innervating the infrahyoid muscles (CN), the hypoglossal nerve (HGN), the external branch of the superior laryngeal nerve (SLN), and the recurrent laryngeal nerve (RLN) with the phrenic nerve (PN).", {"entities": [[204, 207, "GENE"]]}], ["Inspiratory nerve discharges were observed in all these nerves under normocapnic conditions.", {"entities": []}], ["The onset of inspiratory discharges in the CN and HGN was slightly prior to those in the SLN and RLN.", {"entities": [[89, 92, "GENE"]]}], ["When the CO 2 concentration in the perfusate was increased from 5% to 8% to prepare for hypercapnic acidosis, the peak amplitudes of the inspiratory discharges in all the recorded nerves were increased.", {"entities": []}], ["Moreover, hypercapnic acidosis induced pre-inspiratory discharges in the CN, HGN, SLN, and RLN.", {"entities": [[82, 85, "GENE"]]}], ["The onset of pre-inspiratory discharges in the CN, HGN, and SLN was prior to that of discharges in the RLN.", {"entities": [[60, 63, "GENE"]]}], ["These results suggest that the securing of the airway that occurs a certain time before dilation of the glottis may facilitate ventilation and improve hypercapnic acidosis.", {"entities": []}], ["Since the development of the World Health Organization (WHO) Air Quality Guidelines for Europe, a large number of epidemiologic studies have been published documenting effects of major air pollutants on health at concentrations below existing guidelines and standards.", {"entities": []}], ["In this review, recent studies are discussed that permit some evaluation of short-term health effects observed at exposure levels lower than the current WHO Guidelines or U.S. Environmental Protection Agency (U.S. EPA) standards.", {"entities": []}], ["Some studies have been conducted at concentration levels that never exceeded existing guidelines or standards.", {"entities": []}], ["Other studies have been conducted at exposure levels sometimes exceeding current guidelines or standards.", {"entities": []}], ["The published analyses of several of these studies permit evaluation of low-level health effects either because analyses were restricted to levels not exceeding the guidelines or graphic analyses were reported suggesting effects at these low levels.", {"entities": []}], ["For ambient ozone, effects on lung function of subjects exercising outdoors have now been documented at 1-hr maximum levels not exceeding 120 micrograms/m3, i.e., half the current U.S. EPA standard.", {"entities": []}], ["One study even suggests that such effects occur at levels below 100 micrograms/m3.", {"entities": []}], ["Several studies are now available documenting effects of particulate air pollution on health in the virtual absence of SO2.", {"entities": []}], ["Effects on mortality and hospital admissions for asthma have been documented at levels not exceeding 100 micrograms/m3, expressed as 24-hr average inhalable particles PM10 concentration.", {"entities": [[49, 55, "DISEASE"]]}], ["Effects on lung function, acute respiratory symptoms, and medication use have been found at 24-hr average PM10 levels not exceeding 115 micrograms/m3.", {"entities": []}], ["When the WHO Air Quality Guidelines and the U.S. EPA standard for PM10 were developed, there were no studies available on health effects of PM10.", {"entities": []}], ["In this review, we include nine studies documenting health effects of measured PM10 at low levels of exposure, indicating that there is now an entirely new epidemiologic database that can be evaluated in the process of revising current guidelines and standards.", {"entities": []}], ["The low levels of exposure at which effects on health were seen underscore the urgent need for such reevaluations.", {"entities": []}], ["Though cupping therapy has been used in China for thousands of years, there has been no systematic summary of clinical research on it.", {"entities": []}], ["This review is to evaluate the therapeutic effect of cupping therapy using evidence-based approach based on all available clinical studies.", {"entities": []}], ["We included all clinical studies on cupping therapy for all kinds of diseases.", {"entities": []}], ["We searched six electronic databases, all searches ended in December 2008.", {"entities": []}], ["We extracted data on the type of cupping and type of diseases treated.", {"entities": []}], ["550 clinical studies were identified published between 1959 and 2008, including 73 randomized controlled trials (RCTs), 22 clinical controlled trials, 373 case series, and 82 case reports.", {"entities": []}], ["Number of RCTs obviously increased during past decades, but the quality of the RCTs was generally poor according to the risk of bias of the Cochrane standard for important outcome within each trials.", {"entities": []}], ["The diseases in which cupping was commonly employed included pain conditions, herpes zoster, cough or asthma, etc.", {"entities": [[102, 108, "DISEASE"], [78, 91, "DISEASE"]]}], ["Wet cupping was used in majority studies, followed by retained cupping, moving cupping, medicinal cupping, etc.", {"entities": []}], ["38 studies used combination of two types of cupping therapies.", {"entities": []}], ["No serious adverse effects were reported in the studies.", {"entities": []}], ["According to the above results, quality and quantity of RCTs on cupping therapy appears to be improved during the past 50 years in China, and majority of studies show potential benefit on pain conditions, herpes zoster and other diseases.", {"entities": [[205, 218, "DISEASE"]]}], ["However, further rigorous designed trials in relevant conditions are warranted to support their use in practice.", {"entities": []}], ["Patients with severe asthma have increased airway remodelling and elevated numbers of circulating fibrocytes with enhanced myofibroblastic differentiation capacity, despite being treated with high doses of corticosteroids, and long acting \u03b2 2 -adrenergic receptor (AR) agonists (LABAs).", {"entities": [[21, 27, "DISEASE"]]}], ["We determined the effect of \u03b2 2 -AR agonists, alone or in combination with corticosteroids, on fibrocyte function.", {"entities": []}], ["Non-adherent non-T cells from peripheral blood mononuclear cells isolated from healthy subjects and patients with non-severe or severe asthma were treated with the \u03b2 2 -AR agonist, salmeterol, in the presence or absence of the corticosteroid dexamethasone.", {"entities": [[135, 141, "DISEASE"]]}], ["The number of fibrocytes (collagen I 2 -AR were determined using flow cytometry.", {"entities": []}], ["The role of cyclic adenosine monophosphate (cAMP) was elucidated using the cAMP analogue 8-bromoadenosine 3\u2032,5\u2032-cyclic monophosphate (8-Br-cAMP) and the phosphodiesterase type IV (PDE4) inhibitor, rolipram.", {"entities": []}], ["Salmeterol reduced the proliferation, myofibroblastic differentiation and CCR7 expression of fibrocytes from healthy subjects and non-severe asthma patients.", {"entities": [[141, 147, "DISEASE"], [74, 78, "GENE"]]}], ["Fibrocytes from severe asthma patients had a lower baseline surface \u03b2 2 -AR expression and were relatively insensitive to salmeterol but not to 8-Br-cAMP or rolipram.", {"entities": [[23, 29, "DISEASE"]]}], ["Dexamethasone increased \u03b2 2 -AR expression and enhanced the inhibitory effect of salmeterol on severe asthma fibrocyte differentiation.", {"entities": [[102, 108, "DISEASE"]]}], ["Fibrocytes from patients with severe asthma are relatively insensitive to the inhibitory effects of salmeterol, an effect which is reversed by combination with corticosteroids.", {"entities": [[37, 43, "DISEASE"]]}], ["The online version of this article (10.1186/s12931-017-0678-7) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Pyrethroid pesticides were applied via ground spraying to residential neighborhoods in New York City during July\u2013September 2000 to control mosquito vectors of West Nile virus (WNV).", {"entities": []}], ["Case reports link pyrethroid exposure to asthma exacerbations, but population-level effects on asthma from large-scale mosquito control programs have not been assessed.", {"entities": [[41, 47, "DISEASE"], [95, 101, "DISEASE"]]}], ["We conducted this analysis to determine whether widespread urban pyrethroid pesticide use was associated with increased rates of emergency department (ED) visits for asthma.", {"entities": [[166, 172, "DISEASE"]]}], ["We recorded the dates and locations of pyrethroid spraying during the 2000 WNV season in New York City and tabulated all ED visits for asthma to public hospitals from October 1999 through November 2000 by date and ZIP code of patients\u2019 residences.", {"entities": [[135, 141, "DISEASE"]]}], ["The association between pesticide application and asthma-related emergency visits was evaluated across date and ZIP code, adjusting for season, day of week, and daily temperature, precipitation, particulate, and ozone levels.", {"entities": [[50, 56, "DISEASE"]]}], ["There were 62,827 ED visits for asthma during the 14-month study period, across 162 ZIP codes.", {"entities": [[32, 38, "DISEASE"]]}], ["The number of asthma visits was similar in the 3-day periods before and after spraying (510 vs. 501, p = 0.78).", {"entities": [[14, 20, "DISEASE"]]}], ["In multivariate analyses, daily rates of asthma visits were not associated with pesticide spraying (rate ratio = 0.92; 95% confidence interval, 0.80\u20131.07).", {"entities": [[41, 47, "DISEASE"]]}], ["Secondary analyses among children and for chronic obstructive pulmonary disease yielded similar null results.", {"entities": [[42, 79, "DISEASE"]]}], ["This analysis shows that spraying pyrethroids for WNV control in New York City was not followed by population-level increases in public hospital ED visit rates for asthma.", {"entities": [[164, 170, "DISEASE"]]}], ["Inflammation of the lower airways is a central feature of chronic obstructive pulmonary disease (COPD).", {"entities": [[58, 95, "DISEASE"]]}], ["Inflammatory responses are associated with an increased expression of a cascade of proteins including cytokines, chemokines, growth factors, enzymes, adhesion molecules and receptors.", {"entities": []}], ["In most cases the increased expression of these proteins is the result of enhanced gene transcription: many of these genes are not expressed in normal cells under resting conditions but they are induced in the inflammatory process in a cell-specific manner.", {"entities": []}], ["Transcription factors regulate the expression of many pro-inflammatory genes and play a key role in the pathogenesis of airway inflammation.", {"entities": []}], ["Many studies have suggested a role for viral infections as a causative agent of COPD exacerbations.", {"entities": []}], ["In this review we will focus our attention on the relationship between common respiratory viral infections and the molecular and inflammatory mechanisms that lead to COPD exacerbation.", {"entities": []}], ["There are sparse and conflicting data regarding the long\u2010term clinical course of atopic dermatitis ( AD ).", {"entities": [[81, 98, "DISEASE"], [88, 98, "DISEASE"]]}], ["Although often described as a childhood disease, newer population\u2010based estimates suggest the prevalence of pediatric and adult disease may be similar.", {"entities": []}], ["Our objective was to determine whether there is a decline in the prevalence of AD in population\u2010based cohorts of patients followed longitudinally beyond childhood.", {"entities": []}], ["We conducted a systematic review and meta\u2010analysis including studies assessing AD prevalence across 3 or more points in time.", {"entities": []}], ["The primary outcome was weighted overall risk difference (percentage decrease in AD prevalence).", {"entities": []}], ["Of 2080 references reviewed, 7 studies with 13\u00a0515 participants were included.", {"entities": []}], ["Participants were assessed at 3\u20106 time points, ranging from age 3\u00a0months to 26\u00a0years.", {"entities": []}], ["The percentage decrease in prevalence after age 12 was 1%, which was not significantly different from zero (95% confidence interval \u22122%\u20105%).", {"entities": []}], ["Similar results were found with other age cut\u2010offs.", {"entities": []}], ["The prevalence of AD in longitudinal birth cohort studies is similar in childhood and adolescence/early adulthood.", {"entities": []}], ["In the UK, people of South Asian origin with asthma experience excess morbidity, with hospitalisation rates three times those of the majority White population and evidence suggests that South Asian children with asthma are more likely to suffer uncontrolled symptoms and hospital admissions with acute asthma compared to White British children.", {"entities": [[45, 51, "DISEASE"], [212, 218, "DISEASE"], [302, 308, "DISEASE"]]}], ["This paper draws on data from The Management and Interventions for Asthma (MIA) study to identify the operation of barriers to optimal care and good asthma control for South Asian children.", {"entities": [[67, 73, "DISEASE"], [149, 155, "DISEASE"], [75, 78, "GENE"]]}], ["The MIA study followed a multi-phase, iterative, participatory design, underpinned by the socio-ecological model.", {"entities": [[4, 7, "GENE"]]}], ["Findings presented here are from face-to face, semi-structured interviews with South Asian (Indian, Pakistani and Bangladeshi origin) parents and carers of a child with asthma ( n \u2009=\u200949).", {"entities": [[169, 175, "DISEASE"]]}], ["Interviews were conducted in English or relevant South Asian languages using specially trained community facilitators.", {"entities": []}], ["Data were transcribed verbatim and analysed according to the principles of interpretive thematic analysis, facilitated by the use of NVivo.", {"entities": []}], ["Seven dimensions of candidacy are identified: identification of candidacy; navigation; the permeability of asthma services; appearances at health services; adjudications; offers and resistance and operating conditions in the local production of candidacy.", {"entities": [[107, 113, "DISEASE"]]}], ["The analysis demonstrates several ways in which a potential lack of alignment between the priorities and competencies of British South Asian families and the organization of health services combine to create vulnerabilities and difficulties in effectively managing childhood asthma.", {"entities": [[275, 281, "DISEASE"]]}], ["Healthcare systems have a responsibility to develop services that are sensitive and appropriate to the needs of their communities.", {"entities": []}], ["In South Asian communities, further efforts are required to raise awareness of symptoms and effectively communicate how, when and where to seek help for children.", {"entities": []}], ["There is a need for improved diagnosis and consistent, effectively communicated information, especially regarding medication.", {"entities": []}], ["Parents made several suggestions for improving services: presentations about asthma at easily accessible community venues; an advice centre or telephone helpline to answer queries; opportunities for sharing experiences with other families; having information provided in South Asian languages; longer GP appointments; extended use of asthma nurses; and better education for healthcare professionals to ensure consistency of care and advice.", {"entities": [[77, 83, "DISEASE"], [334, 340, "DISEASE"]]}], ["S. prolificans has become a major pathogen in immunocompromised patients.", {"entities": []}], ["Scedosporium apiospermum and S. prolificans are fungi of increasing clinical importance, particularly in persons with underlying diseases.", {"entities": []}], ["We reviewed the records of 59 patients in Australia from whom Scedosporium spp.", {"entities": []}], ["were isolated from June 30, 1997, through December 31, 2003.", {"entities": []}], ["S. apiospermum was isolated predominantly from the respiratory tracts of 28 of 31 patients with underlying lung diseases and resulted in 2 infections and 1 death.", {"entities": []}], ["The annual number of S. apiospermum isolates remained constant.", {"entities": []}], ["S. prolificans was isolated from 28 patients only after November 1999.", {"entities": []}], ["Eight patients with acute myeloid leukemia or hematopoietic stem cell transplants had invasive infection; 4 had fungemia and 6 died from infection.", {"entities": [[26, 42, "DISEASE"], [20, 42, "DISEASE"], [34, 42, "DISEASE"]]}], ["S. prolificans caused locally invasive infection in 2 immunocompetent patients and was found in the respiratory tract of 18 patients with underlying respiratory disease but did not cause fungemia or deaths in these patients.", {"entities": []}], ["Scedosporium spp.", {"entities": []}], ["showed distinct clinical and epidemiologic features.", {"entities": []}], ["To assess the long-term pediatric safety of 2 doses of mometasone furoate administered via a dry powder inhaler (MF-DPI) for mild-to-moderate persistent asthma and compare them with that of beclomethasone dipropionate administered via a metered dose inhaler (BDP-MDI) in the treatment of persistent asthma.", {"entities": [[153, 159, "DISEASE"], [299, 305, "DISEASE"]]}], ["Both MF-DPI doses tested are twice the approved pediatric dosage of 100 \u03bcg once-daily (QD) for children aged 4\u201311 years.", {"entities": []}], ["Children (N = 233) aged 4\u201311 years were randomized to 52 weeks of treatment with MF-DPI 200 \u03bcg QD AM, MF-DPI 100 \u03bcg twice daily (BID), or BDP-MDI 168 \u03bcg BID.", {"entities": []}], ["Patients had used inhaled corticosteroids (ICSs) daily for \u2265 30 days before the screening visit and were on stable ICS doses for \u2265 2 weeks before screening.", {"entities": []}], ["The primary safety variable was the incidence of adverse events.", {"entities": []}], ["Secondary safety variables were laboratory tests (including cortisol concentrations), vital signs, and physical examination.", {"entities": []}], ["The incidence of adverse events was similar in all 3 treatment groups.", {"entities": []}], ["The most frequently reported adverse event was upper respiratory tract infection, reported by 47%\u201349% of the MF-DPI-treated patients and 51% of the BPD-treated patients.", {"entities": []}], ["Most adverse events were considered unrelated to study drug.", {"entities": []}], ["The most frequently reported related adverse events were headache (MF-DPI 200 \u03bcg QD AM, 8%; MF-DPI 100 \u03bcg BID, 4%; BDP-MDI 168 \u03bcg BID, 2%) and oral candidiasis (4% in each treatment group).", {"entities": [[143, 159, "DISEASE"], [148, 159, "DISEASE"]]}], ["No clinically relevant changes in laboratory values, including plasma cortisol, vital signs, or physical examinations were noted in any treatment group.", {"entities": []}], ["Both MF-DPI doses were well tolerated, with no unusual or unexpected adverse events or safety concerns, and had a similar adverse event profile to that of BDP-MDI 168 \u03bcg BID.", {"entities": []}], ["The most common method for determining cause of death is certification by physicians based either on available medical records, or where such data are not available, through verbal autopsy (VA).", {"entities": []}], ["The physician-certification approach is costly and inconvenient; however, recent work shows the potential of a computer-based probabilistic model (InterVA) to interpret verbal autopsy data in a more convenient, consistent, and rapid way.", {"entities": []}], ["In this study we validate separately both physician-certified verbal autopsy (PCVA) and the InterVA probabilistic model against hospital cause of death (HCOD) in adults dying in a district hospital on the coast of Kenya.", {"entities": []}], ["Between March 2007 and June 2010, VA interviews were conducted for 145 adult deaths that occurred at Kilifi District Hospital.", {"entities": []}], ["The VA data were reviewed by a physician and the cause of death established.", {"entities": []}], ["A range of indicators (including age, gender, physical signs and symptoms, pregnancy status, medical history, and the circumstances of death) from the VA forms were included in the InterVA for interpretation.", {"entities": []}], ["Cause-specific mortality fractions (CSMF), Cohen's kappa (\u03ba) statistic, receiver operating characteristic (ROC) curves, sensitivity, specificity, and positive predictive values were applied to compare agreement between PCVA, InterVA, and HCOD.", {"entities": []}], ["HCOD, InterVA, and PCVA yielded the same top five underlying causes of adult deaths.", {"entities": []}], ["The InterVA overestimated tuberculosis as a cause of death compared to the HCOD.", {"entities": [[26, 38, "DISEASE"]]}], ["On the other hand, PCVA overestimated diabetes.", {"entities": []}], ["Overall, CSMF for the five major cause groups by the InterVA, PCVA, and HCOD were 70%, 65%, and 60%, respectively.", {"entities": []}], ["PCVA versus HCOD yielded a higher kappa value (\u03ba = 0.52, 95% confidence interval [CI]: 0.48, 0.54) than the InterVA versus HCOD which yielded a kappa (\u03ba) value of 0.32 (95% CI: 0.30, 0.38).", {"entities": []}], ["Overall, (\u03ba) agreement across the three methods was 0.41 (95% CI: 0.37, 0.48).", {"entities": []}], ["The areas under the ROC curves were 0.82 for InterVA and 0.88 for PCVA.", {"entities": []}], ["The observed sensitivities and specificities across the five major causes of death varied from 43% to 100% and 87% to 99%, respectively, for the InterVA/PCVA against the HCOD.", {"entities": []}], ["Both the InterVA and PCVA compared well with the HCOD at a population level and determined the top five underlying causes of death in the rural community of Kilifi.", {"entities": []}], ["We hope that our study, albeit small, provides new and useful data that will stimulate further definitive work on methods of interpreting VA data.", {"entities": []}], ["The prevalence of being overweight and of obesity is increasing worldwide, and is associated with a high risk to health.", {"entities": [[42, 49, "DISEASE"]]}], ["Therefore, the aim of our study was to investigate whether normal weight, overweight and obese subjects of low, middle or high socioeconomic status (SES) differ with regard to their health behavior, health, quality of life, and the use of medical care.", {"entities": []}], ["Data from the Austrian Health Interview Survey (ATHIS) 2006/07, comprising 3 groups of 1,077 individuals, each of whom were normal weight, overweight, or obese, respectively, and matched according to their age, sex and SES, were analyzed concerning health outcomes.", {"entities": []}], ["The results show that subjects with a low SES differ significantly from those of high SES in terms of their health behavior, self-perceived health, levels of impairment, chronic conditions, quality of life, and health care.", {"entities": []}], ["Additionally, obesity in adults is associated with sub-optimal dietary practices and worse health, poorer quality of life and medical care than normal weight and overweight individuals.", {"entities": [[14, 21, "DISEASE"]]}], ["A significant interaction between the weight class and SES was found concerning physical exercise, impairment due to health problems and chronic diseases.", {"entities": []}], ["A low SES has a strong negative impact on health, especially in obese individuals.", {"entities": []}], ["Therefore a continuous target group-oriented, non-discriminatory public health program is required, prioritizing obese subjects with low SES.", {"entities": []}], ["Genotype scores that predict relevant clinical outcomes may detect other disease features and help direct prevention efforts.", {"entities": []}], ["We report data that validate a previously-established v1.0 smoking cessation quit success genotype score and describe striking differences in the score in individuals who display differing developmental trajectories of use of common addictive substances.", {"entities": []}], ["In a cessation study, v1.0 genotype scores predicted ability to quit with p = 0.00056 and area under ROC curve 0.66.", {"entities": []}], ["About 43 vs 13% quit in the upper vs lower genotype score terciles.", {"entities": []}], ["Latent class growth analyses of a developmentally-assessed sample identified three latent classes based on substance use.", {"entities": []}], ["Higher v1.0 scores were associated with a) higher probabilities of participant membership in a latent class that displayed low use of common addictive substances during adolescence (p = 0.0004) and b) lower probabilities of membership in a class that reported escalating use (p = 0.001).", {"entities": []}], ["These results suggest that: a) we have identified genetic predictors of smoking cessation success, b) genetic influences on quit success overlap with those that influence the rate at which addictive substance use is taken up during adolescence and c) individuals at genetic risk for both escalating use of addictive substances and poor abilities to quit may provide especially urgent focus for prevention efforts.", {"entities": []}], ["The clinic-pathological features and outcomes of Chinese patients with antineutrophil cytoplasmic autoantibody (ANCA)-positive eosinophilic granulomatosis with polyangiitis (EGPA) and renal involvement have not been studied.", {"entities": []}], ["Fourteen EGPA patients with renal involvement were included.", {"entities": []}], ["All patients underwent renal biopsy.", {"entities": []}], ["Clinic-pathological features and outcomes were retrospectively analyzed.", {"entities": []}], ["The most common initial symptom of EGPA was asthma (57.1\u00a0%), followed by hemoptysis (21.4\u00a0%), gross hematuria (14.3\u00a0%), and arthritis (7.1\u00a0%).", {"entities": [[124, 133, "DISEASE"], [44, 50, "DISEASE"]]}], ["All patients had positive serum ANCA (anti-MPO in 12, anti-PR3 in 2).", {"entities": []}], ["Elevated eosinophils (median 15\u00a0%, range 10\u201345\u00a0%) were found in all patients.", {"entities": []}], ["The median serum IgE level was 463\u00a0g/L (range 200\u20131000\u00a0g/L).", {"entities": []}], ["All patients presented with renal dysfunction, with a median SCr of 5.4\u00a0mg/dL (range 1.47\u201311\u00a0mg/dL), seven patients (50\u00a0%) required initial renal replacement therapy.", {"entities": []}], ["Thirteen patients showed hematuria and proteinuria (median 1.1\u00a0g/24\u00a0h, range 0.5\u20137.8\u00a0g/24\u00a0h).", {"entities": [[39, 50, "DISEASE"]]}], ["Renal biopsy showed pauci-immune segmental necrotizing glomerulonephritis with crescents in 13 patients and acute interstitial nephritis in one patient.", {"entities": [[55, 73, "DISEASE"], [114, 136, "DISEASE"], [127, 136, "DISEASE"]]}], ["Twelve patients (85.7\u00a0%) showed renal interstitial eosinophil infiltration, among whom three had eosinophilic granuloma.", {"entities": []}], ["Among seven patients (71.4\u00a0%) who required initial dialysis, 5 discontinued dialysis, one died, one received maintenance dialysis after glucocorticoids plus immunosuppressive for induction treatment.", {"entities": []}], ["Twelve patients were followed up for a median of 43.5\u00a0months (range 6\u201383 months), during follow-up, two patients progressed to end-stage renal disease, nine had chronic kidney disease with eGFR\u2009<\u200960\u00a0mL/min, and two patients had normal eGFR.", {"entities": [[169, 183, "DISEASE"], [189, 193, "GENE"], [235, 239, "GENE"], [189, 193, "GENE"], [235, 239, "GENE"]]}], ["Renal involvement in ANCA-positive EGPA could be severe and showed varied renal histology.", {"entities": []}], ["Although intensive immunosuppressive therapy effectively improved the renal function, the long-term renal survival was poor.", {"entities": []}], ["Early diagnosis and treatment are essential to improve long-term renal survival.", {"entities": []}], ["Human immunodeficiency virus (HIV)\u2013related immunosuppression is a major risk factor for influenza illness and severity in Malawian adults.", {"entities": [[88, 97, "DISEASE"]]}], ["Household crowding, food insecurity, and poor sanitation are additional risk factors.", {"entities": []}], ["Influenza preventive strategies should target HIV-infected adults in Africa.", {"entities": [[0, 9, "DISEASE"]]}], ["The impact of human immunodeficiency virus (HIV) infection on influenza incidence and severity in adults in sub-Saharan Africa is unclear.", {"entities": [[62, 71, "DISEASE"]]}], ["Seasonal influenza vaccination is recommended for HIV-infected persons in developed settings but is rarely implemented in Africa.", {"entities": [[9, 18, "DISEASE"]]}], ["We conducted a prospective cohort study to compare the incidence of laboratory-confirmed influenza illness between HIV-infected and HIV-uninfected adults in Blantyre, Malawi.", {"entities": [[89, 98, "DISEASE"]]}], ["In a parallel case-control study, we explored risk factors for severe influenza presentation of severe (hospitalized) lower respiratory tract infection, and mild influenza (influenza-like illness [ILI]).", {"entities": [[70, 79, "DISEASE"], [162, 171, "DISEASE"], [173, 182, "DISEASE"]]}], ["The cohort study enrolled 608 adults, of whom 360 (59%) were HIV infected.", {"entities": []}], ["Between April 2013 and March 2015, 24 of 229 ILI episodes (10.5%) in HIV-infected and 5 of 119 (4.2%) in HIV-uninfected adults were positive for influenza by means of polymerase chain reaction (incidence rate, 46.0 vs 14.5 per 1000 person-years; incidence rate ratio, 2.75; 95% confidence interval, 1.02\u20137.44; P = .03; adjusted for age, sex, household crowding, and food security).", {"entities": [[145, 154, "DISEASE"]]}], ["In the case-control study, influenza was identified in 56 of 518 patients (10.8%) with hospitalized lower respiratory tract infection, and 88 or 642 (13.7%) with ILI.", {"entities": [[27, 36, "DISEASE"]]}], ["The HIV prevalence was 69.6% and 29.6%, respectively, among influenza-positive case patients and controls.", {"entities": [[60, 69, "DISEASE"]]}], ["HIV was a significant risk factor for severe influenza (odds ratio, 4.98; 95% confidence interval, 2.09\u201311.88; P < .001; population-attributable fraction, 57%; adjusted for season, sanitation facility, and food security).", {"entities": [[45, 54, "DISEASE"]]}], ["HIV is an important risk factor for influenza-associated ILI and severe presentation in this high\u2013HIV prevalence African setting.", {"entities": [[36, 45, "DISEASE"]]}], ["Targeted influenza vaccination of HIV-infected African adults should be reevaluated, and the optimal mechanism for vaccine introduction in overstretched health systems needs to be determined.", {"entities": [[9, 18, "DISEASE"]]}], ["Epidemiologists have shown how birth outcomes are generally robust for immigrant Latina mothers, despite often situated in poor households, advanced by their strong prenatal and nutritional practices.", {"entities": []}], ["But little is known about (1) how these protective factors may differ among Latino subgroups, (2) the extent to which birth outcomes, ongoing maternal practices, and family supports advance Latino toddlers\u2019 health and physical growth, and (3) whether the same processes advance toddlers\u2019 early cognitive growth.", {"entities": []}], ["We drew on a national probability sample of 8,114 infants born in 2001, including 1,450 of diverse Latino origins.", {"entities": []}], ["Data come from birth records, maternal interviews when the child was 9 and 24\u00a0months of age, and direct assessments of health status, physical growth, and cognitive proficiencies.", {"entities": []}], ["Descriptive analyses compared Mexican-heritage and other Latino mothers and toddlers relative to middle-class whites.", {"entities": []}], ["Multivariate regression techniques identified predictors of child health, weight, and BMI, as well as cognitive proficiencies at 24\u00a0months.", {"entities": []}], ["Infants of Mexican-heritage or less acculturated Latina mothers displayed robust birth outcomes, compared with other ethnic groups.", {"entities": []}], ["The low incidence of premature births and low birthweight among these mothers continued to advance their cognitive growth through 24\u00a0months of age.", {"entities": []}], ["Yet Latino children overall displayed smaller gains in cognitive proficiencies between 9 and 24\u00a0months, compared with middle-class populations, attributable to Latinas\u2019 lower levels of maternal education, weaker preliteracy practices, and a higher ratio of children per resident adult.", {"entities": []}], ["Health practitioners should recognize that many Latina mothers display healthy prenatal practices and give birth to robust infants.", {"entities": []}], ["But these early protective factors do not necessarily advance early cognitive growth.", {"entities": []}], ["Screening practices, early interventions, and federal policy should become more sensitive to these countervailing dynamics.", {"entities": []}], ["We systematically examined by immune-histology the lungs of some widely used mouse models of asthma.", {"entities": [[93, 99, "DISEASE"]]}], ["These models include sensitization by multiple intraperitoneal injections of soluble ovalbumin (OVA) or of OVA with alum, followed by three intranasal or aerosol challenges 3 days apart.", {"entities": []}], ["Within 24 hours after a single challenge there is fibrinoid necrosis of arterial walls with deposition of immunoglobulin and OVA and infiltration of eosinophilic polymorphonuclear cells that lasts for about 3 days followed by peribronchial B-cell infiltration and slight reversible goblet cell hypertrophy.", {"entities": []}], ["After 2 challenges, severe eosinophilic vasculitis is present at 6 hours, increases by 72 hours and then declines; B-cell proliferation and significant goblet cell hypertrophy and hyperplasia (GCHTH) and bronchial smooth muscle hypertrophy recur more prominently.", {"entities": [[40, 50, "DISEASE"]]}], ["After 3 challenges, there is significantly increased induced bronchus associated lymphoid tissue (iBALT) formation, GCHTH and smooth muscle hypertrophy.", {"entities": []}], ["Elevated levels of Th2 cytokines: IL-4, IL-5 and IL-13, are present in bronchial lavage fluids.", {"entities": []}], ["Sensitized mice have precipitating antibody and positive Arthus skin reactions but also develop significant levels IgE antibody to OVA but only 1 week after challenge.", {"entities": []}], ["We conclude that the asthma like lung lesions induced in these models is preceded by immune complex mediated eosinophilic vasculitis and iBALT formation.", {"entities": [[122, 132, "DISEASE"], [21, 27, "DISEASE"]]}], ["There are elevations of Th2 cytokines that most likely produce bronchial lesions that resemble human asthma.", {"entities": [[101, 107, "DISEASE"]]}], ["However, it is unlikely that mast cell activated atopic mechanisms are responsible as we found only a few presumed mast cells by toluidine blue and metachromatic staining limited to the most proximal part of the main stem bronchus, and none in the remaining main stem bronchus or in the lung periphery.", {"entities": []}], ["Health surveys are a rich source of information on a variety of health issues, including health care.", {"entities": []}], ["This article compares various national and regional surveys in terms of their geographical coverage with respect to the Canadian North, especially their Aboriginal population, and the comparability of the survey contents relating to health care.", {"entities": []}], ["Three surveys were selected as providing some information on health care, with separate estimates for the North and its Aboriginal populations.", {"entities": []}], ["They are the Canadian Community Health Survey (CCHS), Aboriginal Peoples Survey (APS) and the First Nations Regional Health Survey (RHS).", {"entities": []}], ["Different surveys focus on different categories of Aboriginal people, and no single survey has covered all categories of Aboriginal people in the North consistently.", {"entities": []}], ["RHS is targeted at the on-reserve First Nations population only.", {"entities": []}], ["APS and CCHS sample the off-reserve First Nations population as well as M\u00e9tis and Inuit.", {"entities": []}], ["To achieve adequate sample size for North\u2013South comparisons and comparisons among Aboriginal groups within the North, several cycles of the biennial/annual CCHS can be merged, producing a large data set with consistent coverage of topics using comparable questions.", {"entities": []}], ["The content areas of the 3 surveys can be broadly categorized as health status, health determinants and health care.", {"entities": []}], ["Substantial variation exists across surveys in the domains covered.", {"entities": []}], ["There are also changes over time in terms of definitions, questions and even basic concepts.", {"entities": []}], ["The available health care content of the 3 surveys focus on access to different types of health services, contact with different categories of health professionals, unmet health needs and the use of preventive services.", {"entities": []}], ["Many important dimensions of health care are not covered.", {"entities": []}], ["Not all these basic indicators are available for the North or its Aboriginal populations.", {"entities": []}], ["A comprehensive survey of health care in the North with sufficient sample size to provide reliable estimates for its subpopulations \u2013 urban and remote, Aboriginal and non-Aboriginal, and First Nations, Inuit and M\u00e9tis \u2013 would provide useful information to decision-makers and service providers.", {"entities": []}], ["Analytical studies can also be conducted to investigate the correlations and interactions among health status, health determinants and health care and assess whether such relationships differ among the different population groups.", {"entities": []}], ["Initially discovered as an estrogen-responsive gene in breast cancer cell lines, anterior gradient 2 ( AGR2 ) is a developmentally regulated gene belonging to the protein disulfide isomerase (PDI) gene family.", {"entities": [[55, 68, "DISEASE"], [62, 68, "DISEASE"], [103, 107, "GENE"]]}], ["Developmentally, AGR2 is expressed in the mammary gland in an estrogen-dependent manner, and AGR2 knockout and overexpression mouse models indicate that the gene promotes lobuloalveolar development by stimulating cell proliferation.", {"entities": [[17, 21, "GENE"], [93, 97, "GENE"], [17, 21, "GENE"], [93, 97, "GENE"]]}], ["Although AGR2 overexpression alone seems insufficient for breast tumorigenesis in mice, several lines of investigations suggest that AGR2 promotes breast tumorigenesis.", {"entities": [[9, 13, "GENE"], [133, 137, "GENE"], [9, 13, "GENE"], [133, 137, "GENE"]]}], ["Overexpression of AGR2 in several breast cancer cell lines increases cell survival in clonogenic assays and cell proliferation, whereas AGR2 loss of function leads to decreased cell cycle progression and cell death.", {"entities": [[34, 47, "DISEASE"], [41, 47, "DISEASE"], [18, 22, "GENE"], [136, 140, "GENE"], [18, 22, "GENE"], [136, 140, "GENE"]]}], ["In addition, AGR2 was shown to promote metastasis of breast epithelial cells in an in vivo metastasis assay.", {"entities": [[13, 17, "GENE"]]}], ["As a PDI, AGR2 is thought to be involved in the unfolded protein response that alleviates endoplasmic reticulum stress.", {"entities": [[10, 14, "GENE"]]}], ["Since cancer has to overcome proteotoxic stress due to excess protein production, AGR2 may be one of many pro-survival factors recruited to assist in protein folding or degradation or both.", {"entities": [[6, 12, "DISEASE"], [82, 86, "GENE"]]}], ["When AGR2 is secreted, it plays a role in cellular adhesion and dissemination of metastatic tumor cells.", {"entities": [[5, 9, "GENE"]]}], ["In breast cancer, AGR2 expression is associated with estrogen receptor (ER)-positive tumors; its overexpression is a predictor of poor prognosis.", {"entities": [[3, 16, "DISEASE"], [10, 16, "DISEASE"], [18, 22, "GENE"]]}], ["The AGR2 gene is directly targeted by ER-alpha, which is preferentially bound in tumors with poor outcome.", {"entities": [[4, 8, "GENE"]]}], ["Whereas aromatase inhibitor therapy decreases AGR2 expression, tamoxifen acts as an agonist of AGR2 expression in ER-positive tumors, perhaps contributing to tamoxifen resistance.", {"entities": [[46, 50, "GENE"], [95, 99, "GENE"], [46, 50, "GENE"], [95, 99, "GENE"]]}], ["AGR2 is also overexpressed in a subset of ER-negative tumors.", {"entities": [[0, 4, "GENE"]]}], ["Furthermore, AGR2 expression is associated with the dissemination of metastatic breast cancer cells and can be used as a marker to identify circulating tumor cells and metastatic cells in sentinel lymph nodes.", {"entities": [[80, 93, "DISEASE"], [87, 93, "DISEASE"], [13, 17, "GENE"]]}], ["In conclusion, AGR2 is a promising drug target in breast cancer and may serve as a useful prognostic indicator as well as a marker of breast cancer metastasis.", {"entities": [[50, 63, "DISEASE"], [134, 147, "DISEASE"], [57, 63, "DISEASE"], [141, 147, "DISEASE"], [15, 19, "GENE"]]}], ["The Healthy Environments Partnership (HEP) is a community-based participatory research effort investigating variations in cardiovascular disease risk, and the contributions of social and physical environments to those variations, among non-Hispanic black, non-Hispanic white, and Hispanic residents in three areas of Detroit, Michigan.", {"entities": []}], ["Initiated in October 2000 as a part of the National Institute of Environmental Health Sciences\u2019 Health Disparities Initiative, HEP is affiliated with the Detroit Community\u2013Academic Urban Research Center.", {"entities": []}], ["The study is guided by a conceptual model that considers race-based residential segregation and associated concentrations of poverty and wealth to be fundamental factors influencing multiple, more proximate predictors of cardiovascular risk.", {"entities": []}], ["Within this model, physical and social environments are identified as intermediate factors that mediate relationships between fundamental factors and more proximate factors such as physical activity and dietary practices that ultimately influence anthropomorphic and physiologic indicators of cardiovascular risk.", {"entities": []}], ["The study design and data collection methods were jointly developed and implemented by a research team based in community-based organizations, health service organizations, and academic institutions.", {"entities": []}], ["These efforts include collecting and analyzing airborne particulate matter over a 3-year period; census and administrative data; neighborhood observation checklist data to assess aspects of the physical and social environment; household survey data including information on perceived stressors, access to social support, and health-related behaviors; and anthropometric, biomarker, and self-report data as indicators of cardiovascular health.", {"entities": []}], ["Through these collaborative efforts, HEP seeks to contribute to an understanding of factors that contribute to racial and socioeconomic health inequities, and develop a foundation for efforts to eliminate these disparities in Detroit.", {"entities": []}], ["In spite of the strong role of traditional medicine in childcare in the pluralistic healthcare system in Western Africa, little information is known on mothers\u2019 domestic plant knowledge.", {"entities": []}], ["Identifying local perspectives and treatments of children\u2019s illnesses, including folk illnesses, is essential to having a comprehensive understanding of how mothers make healthcare treatment decisions.", {"entities": []}], ["We aimed to identify which infant illnesses Beninese and Gabonese mothers knew to treat with medicinal plants and for which illnesses they sought biomedical care or traditional healers.", {"entities": []}], ["We conducted 81 questionnaires with mothers in B\u00e9nin and Gabon and made 800 botanical specimens of cited medicinal plants.", {"entities": []}], ["We calculated the number of species cited per illness and the proportion of participants knowledgeable on at least one herbal remedy per illness.", {"entities": []}], ["Using qualitative data, we described folk illnesses in each country and summarized responses on preferences for each of the three healthcare options.", {"entities": []}], ["Participants from both countries were most knowledgeable on plants to treat respiratory illnesses, malaria, diarrhea, and intestinal ailments.", {"entities": [[99, 106, "DISEASE"], [108, 116, "DISEASE"]]}], ["Mothers also frequently mentioned the use of plants to encourage children to walk early , monitor the closure of fontanels, and apply herbal enemas.", {"entities": []}], ["Major folk illnesses were atita and ka in B\u00e9nin and la rate and fesses rouges in Gabon.", {"entities": []}], ["Traditional healers were reported to have specialized knowledge of cultural bound illnesses.", {"entities": []}], ["Malaria was frequently cited as an illness for which mothers would directly seek biomedical treatment.", {"entities": [[0, 7, "DISEASE"]]}], ["Mothers largely saw the three systems as complementary, seamlessly switching between different healing options until a remedy was found.", {"entities": []}], ["Folk illnesses were found to give insight into local treatments and may reveal important neglected diseases.", {"entities": []}], ["Due to high reported levels of knowledge on treating top statistical causes of infant mortality and folk illnesses, mothers\u2019 medicinal plant knowledge should be included in the analysis of healthcare-seeking behavior for childcare.", {"entities": []}], ["Chronic diseases are an increasing threat to people\u2019s health and to the sustainability of health organisations.", {"entities": []}], ["Despite the need for routine monitoring systems to assess the impact of chronicity in the population and its evolution over time, currently no single source of information has been identified as suitable for this purpose.", {"entities": []}], ["Our objective was to describe the prevalence of various chronic conditions estimated using routine data recorded by health professionals: diagnoses on hospital discharge abstracts, and primary care prescriptions and diagnoses.", {"entities": []}], ["The ICD-9-CM codes for diagnoses and Anatomical Therapeutic Chemical (ATC) codes for prescriptions were collected for all patients in the Basque Country over 14 years of age (n=1,964,337) for a 12-month period.", {"entities": []}], ["We employed a range of different inputs: hospital diagnoses, primary care diagnoses, primary care prescriptions and combinations thereof.", {"entities": []}], ["Data were collapsed into the morbidity groups specified by the Johns Hopkins Adjusted Clinical Groups (ACGs) Case-Mix System.", {"entities": []}], ["We estimated the prevalence of 12 chronic conditions, comparing the results obtained using the different data sources with each other and also with those of the Basque Health Interview Survey (ESCAV).", {"entities": []}], ["Using the different combinations of inputs, Standardized Morbidity Ratios (SMRs) for the considered diseases were calculated for the list of patients of each general practitioner.", {"entities": []}], ["The variances of the SMRs were used as a measure of the dispersion of the data and were compared using the Brown-Forsythe test.", {"entities": []}], ["The prevalences calculated using prescription data were higher than those obtained from diagnoses and those from the ESCAV, with two exceptions: malignant neoplasm and migraine.", {"entities": [[168, 176, "DISEASE"]]}], ["The variances of the SMRs obtained from the combination of all the data sources (hospital diagnoses, and primary care prescriptions and diagnoses) were significantly lower than those using only diagnoses.", {"entities": []}], ["The estimated prevalence of chronic diseases varies considerably depending of the source(s) of information used.", {"entities": []}], ["Given that administrative databases compile data registered for other purposes, the estimations obtained must be considered with caution.", {"entities": []}], ["In a context of increasingly widespread computerisation of patient medical records, the complementary use of a range of sources may be a feasible option for the routine monitoring of the prevalence of chronic diseases.", {"entities": []}], ["\u2022 Muscarinic receptors increase smooth muscle tone in airways and urinary bladder.", {"entities": []}], ["\u2022 \u03b2-Adrenoceptors relax smooth muscle tone and oppose muscarinic contraction.", {"entities": []}], ["\u2022 Opposition involves transmitter release, signal transduction and receptor expression.", {"entities": []}], ["\u2022 This supports the combined use of muscarinic antagonists and \u03b2-adrenoceptor agonists.", {"entities": []}], ["Muscarinic receptors increase smooth muscle tone in airways and urinary bladder.", {"entities": []}], ["\u03b2-Adrenoceptors relax smooth muscle tone and oppose muscarinic contraction.", {"entities": []}], ["Opposition involves transmitter release, signal transduction and receptor expression.", {"entities": []}], ["This supports the combined use of muscarinic antagonists and \u03b2-adrenoceptor agonists.", {"entities": []}], ["Muscarinic receptor antagonists and \u03b2-adrenoceptor agonists are used in the treatment of obstructive airway disease and overactive bladder syndrome.", {"entities": [[139, 147, "DISEASE"]]}], ["Here we review the pharmacological rationale for their combination.", {"entities": []}], ["Muscarinic receptors and \u03b2-adrenoceptors are physiological antagonists for smooth muscle tone in airways and bladder.", {"entities": []}], ["Muscarinic agonism may attenuate \u03b2-adrenoceptor-mediated relaxation more than other contractile stimuli.", {"entities": []}], ["Chronic treatment with one drug class may regulate expression of the target receptor but also that of the opposing receptor.", {"entities": []}], ["Prejunctional \u03b2 2 -adrenoceptors can enhance neuronal acetylcholine release.", {"entities": []}], ["Moreover, at least in the airways, muscarinic receptors and \u03b2-adrenoceptors are expressed in different locations, indicating that only a combined modulation of both systems may cause dilatation along the entire bronchial tree.", {"entities": []}], ["While all of these factors contribute to a rationale for a combination of muscarinic receptor antagonists and \u03b2-adrenoceptor agonists, the full value of such combination as compared to monotherapy can only be determined in clinical studies.", {"entities": []}], ["Aspergillus moulds exist ubiquitously as spores that are inhaled in large numbers daily.", {"entities": []}], ["Whilst most are removed by anatomical barriers, disease may occur in certain circumstances.", {"entities": []}], ["Depending on the underlying state of the human immune system, clinical consequences can ensue ranging from an excessive immune response during allergic bronchopulmonary aspergillosis to the formation of an aspergilloma in the immunocompetent state.", {"entities": [[169, 182, "DISEASE"], [143, 182, "DISEASE"]]}], ["The severest infections occur in those who are immunocompromised where invasive pulmonary aspergillosis results in high mortality rates.", {"entities": [[90, 103, "DISEASE"]]}], ["The diagnosis of Aspergillus -associated pulmonary disease is based on clinical, radiological, and immunological testing.", {"entities": []}], ["An understanding of the innate and inflammatory consequences of exposure to Aspergillus species is critical in accounting for disease manifestations and preventing sequelae.", {"entities": []}], ["The major components of the innate immune system involved in recognition and removal of the fungus include phagocytosis, antimicrobial peptide production, and recognition by pattern recognition receptors.", {"entities": []}], ["The cytokine response is also critical facilitating cell-to-cell communication and promoting the initiation, maintenance, and resolution of the host response.", {"entities": []}], ["In the following review, we discuss the above areas with a focus on the innate and inflammatory response to airway Aspergillus exposure and how these responses may be modulated for therapeutic benefit.", {"entities": []}], ["The nucleotide-binding and oligomerization domain, leucine-rich repeat (also known as NOD-like receptors, both abbreviated to NLR) family of intracellular pathogen recognition receptors are increasingly being recognized to play a pivotal role in the pathogenesis of a number of rare monogenic diseases, as well as some more common polygenic conditions.", {"entities": []}], ["Bacterial wall constituents and other cellular stressor molecules are recognized by a range of NLRs, which leads to activation of the innate immune response and upregulation of key proinflammatory pathways, such as IL-1\u03b2 production and translocation of nuclear factor-\u03baB to the nucleus.", {"entities": []}], ["These signalling pathways are increasingly being targeted as potential sites for new therapies.", {"entities": []}], ["This review discusses the role played by NLRs in a variety of inflammatory diseases and describes the remarkable success to date of these therapeutic agents in treating some of the disorders associated with aberrant NLR function.", {"entities": []}], ["IRAK-M is an inhibitor of Toll-like receptor signaling that acts by re-directing IRAK-4 activity to TAK1 independent NF-\u03baB activation and by inhibition of IRAK-1/IRAK-2 activity.", {"entities": []}], ["IRAK-M is expressed in monocytes/macrophages and lung epithelial cells.", {"entities": []}], ["Lack of IRAK-M in mice greatly improves the resistance to nosocomial pneumonia and lung tumors, which entices IRAK-M as a potential therapeutic target.", {"entities": [[69, 78, "DISEASE"]]}], ["IRAK-M consists of an N-terminal death domain (DD), a dysfunctional kinase domain and unstructured C-terminal domain.", {"entities": []}], ["Little is known however on IRAK-M\u2019s structure-function relationships.", {"entities": []}], ["Since death domains provide the important interactions of IRAK-1, IRAK-2 and IRAK-4 molecules, we generated a 3D structure model of the human IRAK-M-DD (residues C5-G119) to guide mutagenesis studies and predict protein-protein interaction points.", {"entities": []}], ["First we identified the DD residues involved in the endogenous capacity of IRAK-M to activate NF-\u03baB that is displayed upon overexpression in 293T cells.", {"entities": []}], ["W74 and R97, at distinct interfaces of the IRAK-M-DD, were crucial for this endogenous NF-\u03baB activating capacity, as well as the C-terminal domain (S445-E596) of IRAK-M.", {"entities": []}], ["Resulting anti-inflammatory A20 and pro-inflammatory IL-8 transcription in 293T cells was W74 dependent, while IL-8 protein expression was dependent on R97 and the TRAF6 binding motif at P478.", {"entities": [[164, 169, "GENE"]]}], ["The IRAK-M-DD W74 and R97 binding interfaces are predicted to interact with opposite sides of IRAK-4-DD\u2019s.", {"entities": []}], ["Secondly we identified DD residues important for the inhibitory action of IRAK-M by stable overexpression of mutants in THP-1 macrophages and H292 lung epithelial cells.", {"entities": []}], ["IRAK-M inhibited TLR2/4-mediated cytokine production in macrophages in a manner that is largely dependent on W74.", {"entities": []}], ["R97 was not involved in inhibition of TNF production but was engaged in IL-6 down-regulation by IRAK-M. Protein-interactive residues D19-A23, located in between W74 and R97, were also observed to be crucial for inhibition of TLR2/4 mediated cytokine induction in macrophages.", {"entities": [[38, 41, "GENE"]]}], ["Remarkably, IRAK-M inhibited TLR5 mediated IL-8 production by lung epithelial cells independent of W74 and R97, but dependent on D19-A23 and R70, two surface-exposed regions that harbor predicted IRAK-2-DD interaction points of IRAK-M. IRAK-M employs alternate residues of its DD to inhibit the different inflammatory mediators induced by varying TLRs and cells.", {"entities": [[29, 33, "GENE"]]}], ["The online version of this article (doi:10.1186/s12964-014-0077-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Anticancer therapies that target single signal transduction pathways often fail to prevent proliferation of cancer cells because of overlapping functions and cross-talk between different signaling pathways.", {"entities": [[108, 114, "DISEASE"]]}], ["Recent research has identified that balanced multi-component therapies might be more efficacious than highly specific single component therapies in certain cases.", {"entities": []}], ["Ideally, synergistic combinations can provide 1) increased efficacy of the therapeutic effect 2) reduced toxicity as a result of decreased dosage providing equivalent or increased efficacy 3) the avoidance or delayed onset of drug resistance.", {"entities": []}], ["Therefore, the interest in combinatorial drug discovery based on systems-oriented approaches has been increasing steadily in recent years.", {"entities": []}], ["Here we describe the development of Combinatorial Drug Assembler (CDA), a genomics and bioinformatics system, whereby using gene expression profiling, multiple signaling pathways are targeted for combinatorial drug discovery.", {"entities": [[66, 69, "GENE"]]}], ["CDA performs expression pattern matching of signaling pathway components to compare genes expressed in an input cell line (or patient sample data), with expression patterns in cell lines treated with different small molecules.", {"entities": [[0, 3, "GENE"]]}], ["Then it detects best pattern matching combinatorial drug pairs across the input gene set-related signaling pathways to detect where gene expression patterns overlap and those predicted drug pairs could likely be applied as combination therapy.", {"entities": []}], ["We carried out in vitro validations on non-small cell lung cancer cells and triple-negative breast cancer (TNBC) cells.", {"entities": [[54, 65, "DISEASE"], [92, 105, "DISEASE"], [59, 65, "DISEASE"], [99, 105, "DISEASE"]]}], ["We found two combinatorial drug pairs that showed synergistic effect on lung cancer cells.", {"entities": [[72, 83, "DISEASE"], [77, 83, "DISEASE"]]}], ["Furthermore, we also observed that halofantrine and vinblastine were synergistic on TNBC cells.", {"entities": []}], ["CDA provides a new way for rational drug combination.", {"entities": [[0, 3, "GENE"]]}], ["Together with phExplorer, CDA also provides functional insights into combinatorial drugs.", {"entities": [[26, 29, "GENE"]]}], ["CDA is freely available at http://cda.i-pharm.org .", {"entities": [[0, 3, "GENE"], [34, 37, "GENE"]]}], ["The relationship between airway structural changes (remodeling) and airways hyperresponsiveness (AHR) is unclear.", {"entities": [[97, 100, "GENE"]]}], ["Asthma guidelines suggest treating persistent asthma with inhaled corticosteroids and long acting \u03b2-agonists (LABA).", {"entities": [[0, 6, "DISEASE"], [46, 52, "DISEASE"]]}], ["We examined the link between physiological function and structural changes following treatment fluticasone and salmeterol separately or in combination in a mouse model of allergic asthma.", {"entities": [[171, 186, "DISEASE"], [180, 186, "DISEASE"]]}], ["BALB/c mice were sensitized to intraperitoneal ovalbumin (OVA) followed by six daily inhalation exposures.", {"entities": []}], ["Treatments included 9 daily nebulized administrations of fluticasone alone (6 mg/ml), salmeterol (3 mg/ml), or the combination fluticasone and salmeterol.", {"entities": []}], ["Lung impedance was measured following methacholine inhalation challenge.", {"entities": []}], ["Airway inflammation, epithelial injury, mucus containing cells, and collagen content were assessed 48 hours after OVA challenge.", {"entities": []}], ["Lungs were imaged using micro-CT.", {"entities": []}], ["Treatment of allergic airways disease with fluticasone alone or in combination with salmeterol reduced AHR to approximately na\u00fcve levels while salmeterol alone increased elastance by 39% compared to control.", {"entities": [[103, 106, "GENE"]]}], ["Fluticasone alone and fluticasone in combination with salmeterol both reduced inflammation to near naive levels.", {"entities": []}], ["Mucin containing cells were also reduced with fluticasone and fluticasone in combination with salmeterol.", {"entities": []}], ["Fluticasone alone and in combination with salmeterol reduces airway inflammation and remodeling, but salmeterol alone worsens AHR: and these functional changes are consistent with the concomitant changes in mucus metaplasia.", {"entities": [[126, 129, "GENE"]]}], ["Curcumin (diferuloylmethane) is a yellow pigment present in the spice turmeric ( Curcuma longa ) that has been associated with antioxidant, anti-inflammatory, anticancer, antiviral, and antibacterial activities as indicated by over 6,000 citations.", {"entities": []}], ["In addition, over one hundred clinical studies have been carried out with curcumin.", {"entities": []}], ["One of the major problems with curcumin is perceived to be the bioavailability.", {"entities": []}], ["How curcumin should be delivered in vivo , how bioavailable is it, how well curcumin is absorbed and how it is metabolized, is the focus of this review.", {"entities": []}], ["Various formulations of curcumin that are currently available are also discussed.", {"entities": []}], ["The majority of Polish smokers declare their will to quit smoking and many of them attempt to quit.", {"entities": []}], ["Although morbidity and mortality from tobacco-related diseases are among the highest in the world, there is a lack of comprehensive cessation support for smokers.", {"entities": []}], ["We aimed to investigate how Poles, including the medically ill, cope with quitting cigarettes and what their motivations to quit are.", {"entities": []}], ["Convenience sampling was used for the purpose of the study.", {"entities": []}], ["Individuals attending several health care units were screened for a history of quit attempts.", {"entities": []}], ["Ex-smokers were defined as smoking previously at least one cigarette/day but who have no longer been smoking for at least one month.", {"entities": []}], ["Attempts at quitting were defined as abstaining from cigarettes for at least one day.", {"entities": []}], ["Data on socio-demographics, tobacco use, quitting behaviors and reasons to quit from 618 subjects (385 ex- and 233 current smokers) who fulfilled these criteria were collected with the use of a questionnaire.", {"entities": []}], ["For the comparison of proportions, a chi-square test was used.", {"entities": []}], ["In the entire study population, 77% of smokers attempted to quit smoking on their own and a similar proportion of smokers (76%) used the cold turkey method when quitting.", {"entities": []}], ["Current smokers were more likely than former smokers to use some form of aid (p = 0.0001), mainly nicotine replacement therapy (68%).", {"entities": []}], ["The most important reasons for quitting smoking were: general health concern (57%), personal health problems (32%) and social reasons (32%).", {"entities": []}], ["However, 41% of smokers prompted to quitting by personal health problems related to tobacco smoking did not see the link between the two.", {"entities": []}], ["A small proportion of ex-smokers (3%) abstaining from cigarettes for longer than a year were not confident about their self-efficacy to sustain abstinence further.", {"entities": []}], ["The majority of Polish smokers, including patients with tobacco-related diseases, attempt to quit without smoking cessation assistance, thus there is a need for a broader professional help for them.", {"entities": []}], ["There is also a lack of general information on hazards related to tobacco and further anti-tobacco campaigns in media are needed.", {"entities": []}], ["Finally, former smokers should be given more attention and periodic inquiries regarding the smoking habit are worthwhile.", {"entities": []}], ["The airway muscles from allergen-sensitized animals in vitro show a heightened response to histamine, but not to carbachol.", {"entities": []}], ["This study investigated whether the airway responsiveness to histamine in vivo is comparable to that of methacholine in human subjects with varying degrees of atopy.", {"entities": []}], ["One-hundred-and-sixty-eight consecutive adult asthma patients or volunteers underwent bronchoprovocation tests to both histamine and methacholine after determining their blood eosinophil counts, serum total IgE levels and skin test reactivity to 10 common aeroallergens.", {"entities": [[46, 52, "DISEASE"]]}], ["The responsiveness to histamine was significantly related to that to methacholine (r=0.609, p <0.001), but many individuals with a negative methacholine test response showed a positive response to histamine.", {"entities": []}], ["The histamine-bronchial reactivity index (BRindex) was significantly higher than the methacholine-BRindex in subjects with a positive response to none (n=69, p <0.01) or only one (n=42, p <0.001) of histamine and methacholine, while there was no significant difference in the subjects with positive responses to both of them (n=57).", {"entities": []}], ["The histamine-BRindex was significantly higher than the methacholine-BRindex in the subjects with mild histamine hyperresponsiveness (n=58, 1.28\u00b10.01 vs. 1.20\u00b10.02, respectively, p <0.001).", {"entities": []}], ["Both histamine and methacholine responsiveness was significantly related to the atopy markers.", {"entities": []}], ["However, the histamine-BRindex/methacholine-BRindex ratio of the atopics was not significantly different from that of the non-atopics.", {"entities": []}], ["The airway responsiveness to histamine is comparable to that of methacholine in the subjects with positive responses to both histamine and methacholine, but the airway responsiveness to histamine is greater than that to methacholine in those subjects with mild airway hyperresponsiveness, regardless of atopy.", {"entities": []}], ["Biotransformation of ten \u03b1-haloacetophenones in the growing culture of the strain Rhodotorula rubra KCh 82 has been carried out.", {"entities": []}], ["Nine of the substrates underwent an effective enantioselective reduction to the respective ( R )-alcohols according to Prelog\u2019s rule, with the exception of 2-chloro-1,2-diphenylethan-1-one that was not transformed by this strain.", {"entities": []}], ["The expected reduction proceeded without dehalogenation, leading to the respective ( R )-halohydrins in high yields.", {"entities": []}], ["The use of this biocatalyst yielded ( R )-2-bromo-1-phenyl-ethan-1-ol (enantiomeric excess (ee) = 97%) and its derivatives: 4'-Bromo- (ee = 99%); 4'-Chloro- (ee > 99%); 4'-Methoxy- (ee = 96%); 3'-Methoxy- (ee = 93%); 2'-Methoxy- (ee = 98%).", {"entities": []}], ["There were also obtained and characterized 2,4'-dichloro-, 2,2',4'-trichloro- and 2-chloro-4'-fluoro-phenyetan-1-ol with >99% of enantiomeric excesses.", {"entities": []}], ["Tolerogenic dendritic cells (DCs) have the ability to induce regulatory T cells and play an important role in preventing chronic inflammatory and autoimmune diseases.", {"entities": []}], ["We have identified a novel compound, 14-dehydroergosterol, from Koji, a Japanese traditional food material fermented with fungi.", {"entities": []}], ["14-dehydroergosterol is an ergosterol analogue with a conjugated double bond, but the activity of 14-dehydroergosterol is much higher than that of ergosterol.", {"entities": []}], ["14-dehydroergosterol induces the conversion of murine bone marrow (BM)-derived DCs and differentiated DCs into tolerogenic DCs, in which the production of IL-12 is suppressed and that of IL-10 is increased.", {"entities": []}], ["In a co-culture experiment, DCs treated with 14-dehydroergosterol induced the conversion of na\u00efve CD4-positive T cells into regulatory T cells.", {"entities": []}], ["In a murine model of multiple sclerosis, experimental autoimmune encephalopathy, 14-dehydroergosterol suppressed the clinical score and inflammatory responses of myeloid DCs and T cells to myelin oligodendrocyte glycoprotein.", {"entities": [[21, 39, "DISEASE"]]}], ["14-dehydroergosterol-treated human DCs induced from PBMCs also showed a tolerogenic phenotype.", {"entities": []}], ["This is the first report to identify a novel compound, 14-dehydroergosterol, that induces DCs to convert to a tolerogenic type.", {"entities": []}], ["14-dehydroergosterol is contained in various fermented foods based on Koji, so 14-dehydroergosterol might be a helpful aid to prevent chronic inflammatory and autoimmune diseases.", {"entities": []}], ["Although many nanomaterials are being used in academia, industry and daily life, there is little understanding about the effects of nanoparticles on the reproductive health of vertebral animals, including human beings.", {"entities": []}], ["An experimental study was therefore performed here to explore the effect of calcium phosphate nanoparticles on both steroid hormone production and apoptosis in human ovarian granulosa cells.", {"entities": []}], ["Calcium phosphate nanoparticles uptaking was evaluated by transmission electron microscopy (TEM).", {"entities": []}], ["The cell cycle was assessed with propidium iodide-stained cells (distribution of cells in G0/G1, S, and G2/M phases) by flow cytometry.", {"entities": []}], ["The pattern of cell death (necrosis and apoptosis) was analyzed by flow cytometry with annexin V-FITC/PI staining.", {"entities": []}], ["The expression of mRNAs encoding P450scc, P450arom and StAR were determined by RT-PCR.", {"entities": []}], ["Progesterone and estradiol levels were measured by radioimmunoassay.", {"entities": []}], ["TEM results confirmed that calcium phosphate nanoparticles could enter into granulosa cells, and distributed in the membranate compartments, including lysosome and mitochondria and intracellular vesicles.", {"entities": []}], ["The increased percentage of cells in S phase when cultured with nanoparticles indicated that there was an arrest at the checkpoint from phase S-to-G2/M (from 6.28 +/- 1.55% to 11.18 +/- 1.73%, p < 0.05).", {"entities": []}], ["The increased ratio of S/(G2/M) implied the inhibition of DNA synthesis and/or impairment in the transition of the S progression stage.", {"entities": []}], ["The apoptosis rate of normal granulosa cells was 7.83 +/- 2.67%, the apoptotic rate increased to 16.53 +/- 5.56% (P < 0.05) after the cells were treated with 100 microM calcium phosphate nanoparticles for 48 hours.", {"entities": []}], ["Treatment with calcium phosphate nanoparticles at concentrations of 10-100 microM didn't significantly change either the progesterone or estradiol levels in culture fluid, and the expression levels of mRNAs encoding P450scc, P450arom and StAR after 48 h and 72 h period of treatment.", {"entities": []}], ["Calcium phosphate nanoparticles interfered with cell cycle of cultured human ovarian granulosa cells thus increasing cell apoptosis.", {"entities": []}], ["This pilot study suggested that effects of nanoparticles on ovarian function should be extensively investigated.", {"entities": []}], ["The RAG1/RAG2 endonuclease (\"RAG\") initiates the V(D)J recombination reaction that assembles Ig heavy ( IgH ) and light ( IgL ) chain variable region exons from germline gene segments to generate primary antibody repertoires IgH V(D)J assembly occurs in progenitor (pro-) B cells followed by that of IgL in precursor (pre-) B cells.", {"entities": []}], ["Expression of IgH \u03bc and IgL (Ig\u03ba or Ig\u03bb) chains generates IgM, which is expressed on immature B cells as the B cell antigen-binding receptor (\"BCR\").", {"entities": [[143, 146, "GENE"]]}], ["Rag expression can continue in immature B cells Ig \u03ba V(D)J recombination that replaces the initial V\u03baJ\u03ba exon with one that generates a new specificity Ig \u03bb V(D)J recombination and expression Rag -expressing immature B cell stage helps shape pre-immune BCR repertoires.", {"entities": [[252, 255, "GENE"]]}], ["As the major site of post-natal B cell development, the bone marrow is the principal location of primary Ig repertoire diversification in mice.", {"entities": []}], ["Here, we report that early B cell development also occurs within the mouse intestinal lamina propria (LP), where the associated V(D)J recombination/receptor editing processes modulate primary LP Ig repertoires.", {"entities": []}], ["At weanling age in normally housed mice, the LP contains a population of Rag -expressing B lineage cells that harbor intermediates indicative of ongoing V(D)J recombination and which contain cells with pro-B, pre-B, and editing phenotypes.", {"entities": []}], ["Consistent with LP-specific receptor editing, Rag -expressing LP B-lineage cells have similar V H repertoires, but significantly different V \u03ba repertoires, compared to those of Rag2 -expressing BM counterparts.", {"entities": [[177, 181, "GENE"]]}], ["Moreover, colonization of germ-free mice leads to an increased ratio of Ig \u03bb-expressing versus Ig \u03ba-expressing B cells specifically in the LP.", {"entities": []}], ["We conclude that B cell development occurs in the intestinal mucosa, where it is regulated by extra-cellular signals from commensal microbes that influence gut Ig repertoires.", {"entities": []}], ["Community-associated methicillin-resistant Staphylococcus aureus (MRSA) invasive disease resembled healthcare-associated MRSA disease.", {"entities": []}], ["We compared characteristics of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) skin and soft tissue infections (SSTIs) and CA-MRSA invasive disease identified in Minnesota from 2000 through 2003.", {"entities": []}], ["A total of 586 patients with SSTIs and 65 patients with invasive disease were identified.", {"entities": []}], ["Patients with invasive disease were more likely to be smokers (p = 0.03), and report a history of immunosuppressive therapy (p = 0.03), emphysema (p = 0.011), or injection drug use (p = 0.020) than were SSTI patients.", {"entities": []}], ["Invasive disease isolates were less likely to be susceptible to ciprofloxacin (p = 0.002) and clindamycin (p = 0.001) and more likely to have healthcare-associated pulsed-field gel electrophoresis subtypes than SSTI isolates (p<0.001).", {"entities": []}], ["Patients with invasive disease may have had healthcare exposures that put them at risk of acquiring healthcare-associated MRSA and which were not exclusion criteria in the CA-MRSA case definition.", {"entities": []}], ["Continued surveillance of MRSA is needed to better characterize CA-MRSA infections.", {"entities": []}], ["The Class I cytokine receptors have a wide range of actions, including a major role in the development and function of immune and blood cells.", {"entities": []}], ["However, the evolution of the genes encoding them remains poorly understood.", {"entities": []}], ["To address this we have used bioinformatics to analyze the Class I receptor repertoire in sea squirt ( Ciona intestinalis ) and zebrafish ( Danio rerio ).", {"entities": []}], ["Only two Class I receptors were identified in sea squirt, one with homology to the archetypal GP130 receptor, and the other with high conservation with the divergent orphan receptor CLF-3.", {"entities": []}], ["In contrast, 36 Class I cytokine receptors were present in zebrafish, including representative members for each of the five structural groups found in mammals.", {"entities": []}], ["This allowed the identification of 27 core receptors belonging to the last common ancestor of teleosts and mammals.", {"entities": []}], ["This study suggests that the majority of diversification of this receptor family occurred after the divergence of urochordates and vertebrates approximately 794 million years ago (MYA), but before the divergence of ray-finned from lobe-finned fishes around 476 MYA.", {"entities": []}], ["Since then, only relatively limited lineage-specific diversification within the different Class I receptor structural groups has occurred.", {"entities": []}], ["Nile tilapia Oreochromis niloticus is a freshwater fish but can tolerate a wide range of salinities.", {"entities": []}], ["The mechanism of salinity adaptation at the molecular level was studied using RNA-Seq to explore the molecular pathways in fish exposed to 0, 8, or 16 (practical salinity unit, psu).", {"entities": []}], ["Based on the change of gene expressions, the differential genes unions from freshwater to saline water were classified into three categories.", {"entities": []}], ["In the constant change category (1), steroid biosynthesis, steroid hormone biosynthesis, fat digestion and absorption, complement and coagulation cascades were significantly affected by salinity indicating the pivotal roles of sterol-related pathways in response to salinity stress.", {"entities": []}], ["In the change-then-stable category (2), ribosomes, oxidative phosphorylation, signaling pathways for peroxisome proliferator activated receptors, and fat digestion and absorption changed significantly with increasing salinity, showing sensitivity to salinity variation in the environment and a responding threshold to salinity change.", {"entities": []}], ["In the stable-then-change category (3), protein export, protein processing in endoplasmic reticulum, tight junction, thyroid hormone synthesis, antigen processing and presentation, glycolysis/gluconeogenesis and glycosaminoglycan biosynthesis\u2014keratan sulfate were the significantly changed pathways, suggesting that these pathways were less sensitive to salinity variation.", {"entities": []}], ["This study reveals fundamental mechanism of the molecular response to salinity adaptation in O .", {"entities": []}], ["niloticus , and provides a general guidance to understand saline acclimation in O .", {"entities": []}], ["niloticus .", {"entities": []}], ["Since the development of federal standards for drug approval, the practice of medicine has historically involved the compounding of medications based on a physician\u2019s determination that a US FDA-approved product either did not exist, or could not be used for medical reasons.", {"entities": []}], ["Today, prescriptions for non-FDA-approved compounded drugs may be driven by fanciful and largely unregulated pharmacy advertisements to physicians and patients and/or payer reimbursement policies, thus placing prescribers in the backseat for clinical decision making.", {"entities": []}], ["This article outlines essential differences between FDA-approved drugs and compounded drugs and reasserts the primary medical role of physicians for determining what medical circumstances may necessitate treatment with non-FDA-approved products.", {"entities": []}], ["In addition, liability concerns when prescribing non-FDA-approved drugs are discussed.", {"entities": []}], ["While representing a US perspective, underlying principles apply globally in the setting of magistral and extemporaneous formulations produced outside national regulatory frameworks.", {"entities": []}], ["Circulating osteoprotegerin (OPG) levels are increased in patients with chronic heart failure (HF).", {"entities": []}], ["The diagnostic and prognostic merit of OPG measurement in patients admitted with acute dyspnoea is unknown.", {"entities": []}], ["To evaluate the diagnostic and prognostic value of measuring OPG in patients admitted to hospital with acute dyspnoea.", {"entities": []}], ["OPG was analysed by ELISA in 308 patients admitted due to acute dyspnoea.", {"entities": []}], ["Investigators blinded to OPG results adjudicated the diagnosis for the index hospitalization.", {"entities": []}], ["Clinical outcomes were obtained from hospital records.", {"entities": []}], ["In total, 139 patients (45%) were hospitalized with acute HF.", {"entities": []}], ["OPG levels on hospital admission were higher in patients with acute HF vs. no acute HF, 7.8 (5.5\u201310.4) vs. 5.4 (3.8\u20137.2) pmol/L, p<0.001.", {"entities": []}], ["The area under the receiver operator characteristic curve (ROC AUC) of OPG to discriminate between HF vs. non-HF was 0.695 [95% CI 0.636\u20130.754].", {"entities": []}], ["OPG did not provide incremental information to the ED physician\u2019s prediction or N-terminal pro-B-type natriuretic peptide regarding the diagnosis of acute HF.", {"entities": []}], ["OPG levels (log transformed) were associated with mortality in crude analysis (HR (95% CI) 1.87 (1.34 to 2.61), p<0.001), but this association was attenuated and no longer significant after including established cardiac biomarkers into the model.", {"entities": [[79, 81, "GENE"]]}], ["In patients admitted to hospital with acute dyspnoea, OPG levels are higher in patients with acute HF than in those with dyspnoea from other causes.", {"entities": []}], ["However, OPG does not provide incremental information beyond ED physician assessment for the diagnosis of acute HF or beyond clinical risk variables and established cardiac biomarkers concerning prognosis.", {"entities": []}], ["Macrophages are heterogeneous and can polarize into specific subsets, e.g.", {"entities": []}], ["pro-inflammatory M1-like and re-modelling M2-like macrophages.", {"entities": []}], ["To determine if peritoneal macrophages (PEMs) or bone marrow derived macrophages (BMDMs) resembled aortic macrophages from ApoE\u2212/\u2212 mice, their M1/M2 phenotype, inflammatory status, and lipid metabolism signatures were compared.", {"entities": []}], ["oxLDL accumulation was similar in PEMs and BMDMs.", {"entities": []}], ["On protein expression level, BMDMs showed an M2-like CD206", {"entities": []}], ["Anti-IgE therapy, using recombinant humanized anti-IgE antibodies, is clinically effective in patients with eosinophil-related disorders such as allergic asthma, allergic rhinitis, and chronic urticaria.", {"entities": [[162, 179, "DISEASE"], [193, 202, "DISEASE"], [145, 160, "DISEASE"], [171, 179, "DISEASE"], [154, 160, "DISEASE"]]}], ["Chronic eosinophilic pneumonia tends to respond promptly to systemic corticosteroid therapy, however; relapses are common following corticosteroid tapering.", {"entities": [[0, 30, "DISEASE"], [21, 30, "DISEASE"], [8, 30, "DISEASE"]]}], ["We treated two patients (17- and 19-yr-old males) of chronic eosinophilic pneumonia whose symptoms were cough and dyspnea on exertion.", {"entities": [[53, 83, "DISEASE"], [74, 83, "DISEASE"], [61, 83, "DISEASE"]]}], ["The symptoms were recurrent while tapering off corticosteroid.", {"entities": []}], ["They were treated with anti-IgE antibody without recurrence for 2 yr and 15 months.", {"entities": []}], ["Here, we first describe clinical experience of the 2 cases of chronic eosinophilic pneumonia.", {"entities": [[62, 92, "DISEASE"], [83, 92, "DISEASE"], [70, 92, "DISEASE"]]}], ["Leukotrienes (LTs) belong to the large family of lipid mediators implicated in various inflammatory conditions such as asthma and rheumatoid arthritis.", {"entities": [[130, 150, "DISEASE"], [141, 150, "DISEASE"], [119, 125, "DISEASE"]]}], ["Four distinct types (BLT1, BLT2, CysLT1 and CysLT2) of G-protein-coupled receptors for LTs have been identified.", {"entities": []}], ["Several studies have reported that LTs are involved in inflammatory pain, but the mechanism and the expression of LT receptors in the nociceptive pathway are unknown.", {"entities": [[114, 116, "GENE"]]}], ["We investigated the precise expression of these four types of LT receptors in the adult rat dorsal root ganglion (DRG) using reverse transcription-polymerase reaction (RT-PCR) and radioisotope-labeled in situ hybridization histochemistry (ISHH).", {"entities": [[62, 64, "GENE"]]}], ["We detected mRNAs for BLT1 and CysLT2 in the DRG, but not for BLT2 and CysLT1.", {"entities": []}], ["CysLT2 mRNA was preferentially expressed by small sized DRG neurons (about 36% of total neurons), whereas BLT1 mRNA was expressed by non-neuronal cells.", {"entities": []}], ["Double labeling analysis of CysLT2 with NF-200, calcitonin gene-related peptide (CGRP), isolectin B4 (IB4), transient receptor potential vanilloid subfamily 1 (TRPV1) and P2X3 receptor revealed that many CysLT2-labeled neurons were localized with unmyelinated and non-peptidergic neurons, and interestingly, CysLT2 mRNA heavily co-localized with TRPV1 and P2X3-positive neurons.", {"entities": [[160, 165, "GENE"], [346, 351, "GENE"], [160, 165, "GENE"], [346, 351, "GENE"]]}], ["Intraplantar injection of LTC4, a CysLT2 receptor agonist, itself did not induce the thermal hyperalgesia, spontaneous pain behaviors or swelling of hind paw.", {"entities": []}], ["However, pretreatment of LTC4 remarkably enhanced the painful behaviors produced by alpha, beta-methylene adenosine 5'-triphosphate (\u03b1\u03b2-me-ATP), a P2X3 receptor agonist.", {"entities": []}], ["These data suggests that CysLT2 expressed in DRG neurons may play a role as a modulator of P2X3, and contribute to a potentiation of the neuronal activity following peripheral inflammation.", {"entities": []}], ["Pseudomonas aeruginosa is one of the common colonizing bacteria of the human body and is an opportunistic pathogen frequently associated with respiratory infections.", {"entities": []}], ["Inactivated P. aeruginosa (IPA) have a variety of biological effects against inflammation and allergy.", {"entities": []}], ["Transforming growth factor-\u03b2 (TGF-\u03b2) signaling plays a critical role in the regulation of cell growth, differentiation, and development in a wide range of biological systems.", {"entities": []}], ["The present study was designed to investigate the effects of IPA on TGF-\u03b2/Smad signaling in vivo, using a hypoxia-induced pulmonary hypertension (PH) rat model.", {"entities": [[132, 144, "DISEASE"], [122, 144, "DISEASE"]]}], ["Sprague Dawley rats (n=40) were exposed to 10% oxygen for 21 days to induce PH.", {"entities": []}], ["At the same time, IPA was administered intravenously from day 1 to day 14.", {"entities": []}], ["Mean pulmonary artery pressure (mPAP) and the right ventricle (RV) to left ventricle plus the interventricular septum (LV+S) mass ratio were used to evaluate the development of PH.", {"entities": []}], ["Vessel thickness and density were measured using immunohistochemistry.", {"entities": []}], ["Primary arterial smooth muscle cells (PASMCs) were isolated and the proliferation of PASMCs was assayed by flow cytometry.", {"entities": []}], ["The production of TGF-\u03b21 in cultured supernatant of PASMCs was assayed by ELISA.", {"entities": []}], ["The expression levels of \u03b1-smooth muscle actin (\u03b1-SMA), TGF-\u03b21 and phospho-Smad 2/3 in PASMCs were assayed by western blot.", {"entities": []}], ["Our data indicated that IPA attenuated PH, RV hypertrophy and pulmonary vascular remodeling in rats, which was probably mediated by restraining the hypoxia-induced overactive TGF-\u03b21/Smad signaling.", {"entities": []}], ["In conclusion, IPA is a promising protective treatment in PH due to the inhibiting effects on TGF-\u03b21/Smad 2/3 signaling.", {"entities": []}], ["Children and adolescents with Juvenile Idiopathic Arthritis (JIA) typically have reduced physical activity level and impaired aerobic and anaerobic exercise capacity when compared to their non-JIA counterparts.", {"entities": [[50, 59, "DISEASE"]]}], ["Low intensity exercise regimens appear to be safe in children with JIA and may results in improvements in overall physical function.", {"entities": []}], ["Poor adherence to paediatric rheumatology treatment may lead to negative clinical outcomes and possibly increased disease activity.", {"entities": []}], ["This includes symptoms such as pain, fatigue, quality of life, longer term outcomes including joint damage, as well as increase of healthcare associated costs.", {"entities": []}], ["Low adherence to medications such as methotrexate and biological-drugs remains a significant issue for paediatric rheumatologists, with alarming reports that less than half of the children with JIA are compliant to drug-therapy.", {"entities": []}], ["The recent advances in interactive technology resulting in a variety of wearable user-friendly smart devices may become a key solution to address important questions in JIA clinical management.", {"entities": []}], ["Fully understanding the impact that arthritis and treatment complications have upon individual children and their families has long been a challenge for clinicians.", {"entities": [[36, 45, "DISEASE"]]}], ["Modern interactive technologies can be customised and accessed directly in the hands or wrists of children with JIA.", {"entities": []}], ["These secured networks could be accessible \u2018live\u2019 at anytime and anywhere by the child, parents and clinicians.", {"entities": []}], ["Multidisciplinary teams in paediatric rheumatology may benefit from adopting these technologies to better understand domains such as patient biological parameters, symptoms progression, adherence to drug-therapy, quality of life, and participation in physical activities.", {"entities": []}], ["Most importantly the use of smart devices technologies may also facilitate more timely clinical decisions, improve self-management and parents awareness in the progression of their child\u2019s disease.", {"entities": []}], ["Paediatric rheumatology research could also benefit from the use of these smart devices, as they would allow real-time access to meaningful data to thoroughly understand the disease-patterns of JIA, such as pain and physical activity outcomes.", {"entities": []}], ["Data collection that typically occurs once every 1 or 3\u00a0months in the clinical setting could instead be gathered every week, day, minute or virtually live online.", {"entities": []}], ["Arguably, few limitations in wearing such interactive technologies still exist and require further developments.", {"entities": []}], ["Finally, by embracing and adapting these new and now highly accessible interactive technologies, clinical management and research in paediatric rheumatology may be greatly advanced.", {"entities": []}], ["To prospectively evaluate quantitative airway wall measurements of thin-section CT for the diagnosis of Bronchiolitis Obliterans Syndrome (BOS) following lung transplantation.", {"entities": []}], ["In 141 CT examinations, bronchial wall thickness (WT), the wall area percentage (WA%) calculated as the ratio of the bronchial wall area and the total area (sum of bronchial wall area and bronchial lumen area) and the difference of the WT on inspiration and expiration (WTdiff) were automatically measured in different bronchial generations.", {"entities": []}], ["The measurements were correlated with the lung function parameters.", {"entities": []}], ["WT and WA% in CT examinations of patients with (n\u200a=\u200a25) and without (n\u200a=\u200a116) BOS, were compared using the unpaired t-test and univariate analysis of variance, while also considering the differing lung volumes.", {"entities": []}], ["Measurements could be performed in 2,978 bronchial generations.", {"entities": []}], ["WT, WA%, and WTdiff did not correlate with the lung function parameters (r<0.5).", {"entities": []}], ["The WA% on inspiration was significantly greater in patients with BOS than in patients without BOS, even when considering the dependency of the lung volume on the measurements.", {"entities": []}], ["WT on inspiration and expiration and WA% on expiration did not show significant differences between the groups.", {"entities": []}], ["WA% on inspiration was significantly greater in patients with than in those without BOS.", {"entities": []}], ["However, WA% measurements were significantly dependent on lung volume and showed a high variability, thus not allowing the sole use of bronchial wall measurements to differentiate patients with from those without BOS.", {"entities": []}], ["Previous research suggested that baseline corrected distance visual acuity (CDVA) and maximum keratometry (Kmax) are the predictors for effectiveness of corneal crosslinking (CXL) for keratoconus.", {"entities": [[184, 195, "DISEASE"]]}], ["The aim of this study was to validate the previously determined predictors in a new treatment cohort.", {"entities": []}], ["A prospective cohort of 112 eyes in 90 consecutive patients was used to validate the results of 102 eyes in 79 patients from our previous prospective cohort.", {"entities": []}], ["All patients were treated using epithelium-off corneal CXL in a tertiary hospital setting.", {"entities": []}], ["Primary outcomes were changes in CDVA (LogMAR) and Kmax between baseline and 1-year post-treatment.", {"entities": []}], ["Predictive factors for both outcomes were determined using univariable and multivariable analyses.", {"entities": []}], ["Lower pretreatment CDVA was found to be the sole independent factor predicting an improvement in CDVA 1\u00a0year after CXL (\u03b2 coefficient: \u22120.476, P \u00a0<\u00a00.01).", {"entities": []}], ["Kmax flattening is more likely to take place in eyes with preoperative central cones (\u03b2 coefficient: 0.655, P \u00a0<\u00a00.01).", {"entities": []}], ["These results are consistent with our initial research and indicate high reproducibility in the new cohort.", {"entities": []}], ["The previously postulated prediction model for postoperative CDVA showed limited predictive value in the validation cohort ( R", {"entities": []}], ["Discussing the effects of Ziyinqingre prescription on the level of airway resistance (Rrs), airway response threshold (Dmin), airway conductance (sGrs) and the level of inflammatory cytokines interleukin-4 (IL-4) and interferon-\u03b3 (IFN-\u03b3) of the bronchial hyper-responsiveness (BHR) cough patients.", {"entities": []}], ["84 subjects diagnosed as BHR were randomly divided into 42 Chinese Traditional medicine group and 42 control group.", {"entities": []}], ["The Chinese Traditional Medicine group received Ziyinqingre prescription twice a day and the control group received 10mg Montelukast Sodium tablets once a day for two weeks.", {"entities": []}], ["Observe the clinical symptoms improvement and the changes of the level of the Rrs, Dmin, sGrs and IL-4, IFN-\u03b3.", {"entities": []}], ["After receiving the medicine, the symptoms of the Chinese medicine group were obviously alleviated, the outcome was more satisfied than that of the control group.", {"entities": []}], ["Compared with the control group, the level of Dmin increased and sGrs level decreased more obviously ( P <0.05); the level of IL-4 decreased and IFN^level increased more obviously in the Chinese medicine group ( P <0.05).", {"entities": []}], ["Ziyinqingre prescription can not only improve BHR patients\u2019 symptoms, but reduce the level of bronchial responsiveness, which proved a better curative effect of Chinese medicine.", {"entities": []}], ["The mechanism is probably due to relieving the airway inflammation by keeping the balance between Th1 and Th2 cells.", {"entities": []}], ["Pediatric medical and nursing education lack the environmental health content needed to properly prepare health care professionals to prevent, recognize, manage, and treat environmental exposure\u2013related diseases.", {"entities": []}], ["The need for improvements in health care professionals\u2019 environmental health knowledge has been expressed by leading institutions.", {"entities": []}], ["However, few studies have evaluated the effectiveness of programs that incorporate pediatric environmental health (PEH) into curricula and practice.", {"entities": []}], ["We evaluated the effectiveness of the National Environmental Education Foundation\u2019s (NEEF) Children\u2019s Environmental Health Faculty Champions Initiative, which is designed to build environmental health capacity among pediatric health care professionals.", {"entities": []}], ["Twenty-eight pediatric health care professionals participated in a train-the-trainer workshop, in which they were educated to train other health care professionals in PEH and integrate identified PEH competencies into medical and nursing practice and curricula.", {"entities": []}], ["We evaluated the program using a workshop evaluation tool, action plan, pre- and posttests, baseline and progress assessments, and telephone interviews.", {"entities": []}], ["During the 12 months following the workshop, the faculty champions\u2019 average pretest score of 52% was significantly elevated ( p < 0.0001) to 65.5% on the first posttest and to 71.5% on the second posttest, showing an increase and retention of environmental health knowledge.", {"entities": []}], ["Faculty champions trained 1,559 health care professionals in PEH, exceeding the goal of 280 health care professionals trained.", {"entities": []}], ["Ninety percent of faculty champions reported that PEH had been integrated into the curricula at their institution.", {"entities": []}], ["The initiative was highly effective in achieving its goal of building environmental health capacity among health care professionals.", {"entities": []}], ["The faculty champions model is a successful method and can be replicated in other arenas.", {"entities": []}], ["Cross-reactivity between soybean allergens and bovine caseins has been previously reported.", {"entities": []}], ["In this study we aimed to map epitopes of the major soybean allergen Gly m 5 that are co-recognized by casein specific antibodies, and to identify a peptide responsible for the cross-reactivity.", {"entities": []}], ["Cow's milk protein (CMP)-specific antibodies were used in different immunoassays (immunoblotting, ELISA, ELISA inhibition test) to evaluate the in vitro recognition of soybean proteins (SP).", {"entities": []}], ["Recombinant Gly m 5 (\u03b1), a truncated fragment containing the C-terminal domain (\u03b1-T) and peptides of \u03b1-T were obtained and epitope mapping was performed with an overlapping peptide assay.", {"entities": []}], ["Bioinformatics tools were used for epitope prediction by sequence alignment, and for modelling the cross-recognized soy proteins and peptides.", {"entities": []}], ["The binding of SP to a monoclonal antibody was studied by surface Plasmon resonance (SPR).", {"entities": [[85, 88, "GENE"]]}], ["Finally, the in vivo cross-recognition of SP was assessed in a mouse model of milk allergy.", {"entities": []}], ["Both \u03b1 and \u03b1-T reacted with the different CMP-specific antibodies.", {"entities": []}], ["\u03b1-T contains IgG and IgE epitopes in several peptides, particularly in the peptide named PA.", {"entities": []}], ["Besides, we found similar values of association and dissociation constants between the \u03b1-casein specific mAb and the different milk and soy components.", {"entities": []}], ["The food allergy mouse model showed that SP and PA contain the cross-reactive B and T epitopes, which triggered hypersensitivity reactions and a Th2-mediated response on CMP-sensitized mice.", {"entities": [[4, 16, "DISEASE"]]}], ["Gly m 5 is a cross-reactive soy allergen and the \u03b1-T portion of the molecule contains IgG and IgE immunodominant epitopes, confined to PA, a region with enough conformation to be bound by antibodies.", {"entities": []}], ["These findings contribute to explain the intolerance to SP observed in IgE-mediated CMA patients, primarily not sensitised to SP, as well as it sets the basis to propose a mucosal immunotherapy for milk allergy using this soy peptide.", {"entities": []}], ["A significant number of older asthmatics, more often than in previous ages, have poorly controlled asthma, leading to increased morbidity and mortality.", {"entities": [[99, 105, "DISEASE"]]}], ["On the other hand, current guidelines suggest that most asthmatics can obtain achievement and maintenance of disease control and do not include sections specific to the management of asthma in the elderly so that it is more evident the contrast between poor control of asthma in the elderly and the lack of specific guidance from guidelines on asthma management in older asthmatics.", {"entities": [[183, 189, "DISEASE"], [269, 275, "DISEASE"], [344, 350, "DISEASE"]]}], ["Inhaled corticosteroids are the cornerstone for older asthmatics, eventually with add-on inhaled long-acting beta-agonists; inhaled short acting beta-agonists can be used as rescue medications.", {"entities": []}], ["Triggers exacerbating asthma are similar for all ages, but inhaled viruses and drug interactions have greater clinical significance in the elderly.", {"entities": [[22, 28, "DISEASE"]]}], ["Older asthmatics have an increased likelihood of comorbidities and polypharmacy, with possible worsening of asthma control and reduced treatment adherence.", {"entities": [[108, 114, "DISEASE"]]}], ["Physicians and older asthmatics probably either do not perceive or accept a poor asthma control.", {"entities": [[81, 87, "DISEASE"]]}], ["We conclude that specific instruments addressed to evaluate asthma control in the elderly with concomitant comorbidities and measurements for improving self-management and adherence could assure better disease control in older asthmatics.", {"entities": [[60, 66, "DISEASE"]]}], ["The popular methods for evaluating the initial therapeutic effect (ITE) of noninvasive positive pressure ventilation (NPPV) can only roughly reflect the therapeutic outcome of a patient\u2019s ventilation because they are subjective, invasive and time-delayed.", {"entities": []}], ["In contrast, vibration response imaging (VRI) can monitor the function of a patient\u2019s ventilation over the NPPV therapy in a non-invasive manner.", {"entities": []}], ["This study aimed to investigate the value of VRI in evaluating the ITE of NPPV for patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD).", {"entities": [[119, 156, "DISEASE"]]}], ["Thirty-six AECOPD patients received VRI at three time points: before NPPV treatment (T1), at 15\u2009min of NPPV treatment (T2), and at 15\u2009min after the end of NPPV treatment (T4).", {"entities": []}], ["Blood gas analysis was also performed at T1 and at 2\u2009hours of NPPV treatment (T3).", {"entities": []}], ["Thirty-nine healthy volunteers also received VRI at T1 and T2.", {"entities": []}], ["VRI examination at the time point T2 in either the patients or volunteers did not require any interruption of the on-going NPPV.", {"entities": []}], ["The clinical indices at each time point were compared between the two groups.", {"entities": []}], ["Moreover, correlations between the PaCO 2 changes (T3 vs T1) and abnormal VRI scores (AVRIS) changes (T2 vs T1) were analyzed.", {"entities": []}], ["No significant AVRIS differences were found between T1 and T2 in the healthy controls (8.51\u2009\u00b1\u20093.36 vs. 8.53\u2009\u00b1\u20093.57, P\u2009>\u20090.05).", {"entities": []}], ["The AVRIS, dynamic score, MEF score and EVP score showed a significant decrease in AECOPD patients at T2 compared with T1 (P\u2009<\u20090.05), but a significant increase at T4 compared with T2 (P\u2009<\u20090.05).", {"entities": []}], ["We also found a positive correlation (R 2 changes (T3 vs T1) and AVRIS changes (T2 vs T1).", {"entities": []}], ["VRI is a promising noninvasive tool for evaluating the initial therapeutic effects of NPPV in AECOPD patients and predicting the success of NPPV in the early stage.", {"entities": []}], ["Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most common type of medication used in the treatment of acute pain.", {"entities": []}], ["Ketorolac trometamol (KT) is a nonnarcotic, peripherally acting nonsteroidal anti-inflammatory drug with analgesic effects comparable to certain opioids.", {"entities": []}], ["The aim of this study was to compare the efficacy of KT and naproxen (NA) in the treatment of acute low back pain (LBP) of moderate-to-severe intensity.", {"entities": [[115, 118, "GENE"]]}], ["In this 10-day, Phase III, randomized, double-blind, double-dummy, noninferiority trial, participants with acute LBP of moderate-to-severe intensity as determined through a visual analog scale (VAS) were randomly assigned in a 1:1 ratio to receive sublingual KT 10 mg three times daily or oral NA 250 mg three times daily.", {"entities": [[113, 116, "GENE"]]}], ["From the second to the fifth day of treatment, if patient had VAS >40 mm, increased dosage to four times per day was allowed.", {"entities": []}], ["The primary end point was the reduction in LBP as measured by VAS.", {"entities": [[43, 46, "GENE"]]}], ["We also performed a post hoc superiority analysis.", {"entities": []}], ["KT was not inferior to NA for the reduction in LBP over 5 days of use as measured by VAS scores ( P =0.608 for equality of variance; P =0.321 for equality of means) and by the Roland\u2013Morris Disability Questionnaire ( P =0.180 for equality of variance test; P =0.446 for equality of means) using 95% confidence intervals.", {"entities": [[47, 50, "GENE"]]}], ["The percentage of participants with improved pain relief 60 minutes after receiving the first dose was higher in the KT group (24.2%) than in the NA group (6.5%; P =0.049).", {"entities": []}], ["The most common adverse effects were heartburn, nausea, and vomiting.", {"entities": []}], ["KT is not inferior in efficacy and delivers faster pain relief than NA.", {"entities": []}], ["The transcription factor XBP1 has been linked to the development of highly secretory tissues such as plasma cells and Paneth cells, yet its function in granulocyte maturation has remained unknown.", {"entities": [[25, 29, "GENE"]]}], ["Here we discovered an unexpectedly selective and absolute requirement for XBP1 in eosinophil differentiation without an effect on the survival of basophils or neutrophils.", {"entities": [[74, 78, "GENE"]]}], ["Progenitors of myeloid cells and eosinophils selectively activated the endoribonuclease IRE1\u03b1 and spliced Xbp1 mRNA without inducing parallel endoplasmic reticulum (ER) stress signaling pathways.", {"entities": [[106, 110, "GENE"]]}], ["Without XBP1, nascent eosinophils exhibited massive defects in the post-translational maturation of key granule proteins required for survival, and these unresolvable structural defects fed back to suppress critical aspects of the transcriptional developmental program.", {"entities": [[8, 12, "GENE"]]}], ["Hence, we present evidence that granulocyte subsets can be distinguished by their differential reliance on secretory-pathway homeostasis.", {"entities": []}], ["Preeclampsia ( PE ) is a life\u2010threatening hypertensive disorder of pregnancy associated with autoantibodies, termed AT 1 \u2010 AA , that activate the AT 1 angiotensin receptor.", {"entities": []}], ["Although the pathogenic nature of these autoantibodies has been extensively studied, little is known about the molecular cause of their generation.", {"entities": []}], ["Here we show that tissue transglutaminase ( TG 2), an enzyme that conducts posttranslational modification of target proteins, directly modified the 7\u2010amino acid (7\u2010aa) epitope peptide that localizes to the second extracellular loop of the AT 1 receptor.", {"entities": [[44, 46, "GENE"]]}], ["These findings led us to further discover that plasma transglutaminase activity was induced and contributed to the production of AT 1 \u2010 AA and disease development in an experimental model of PE induced by injection of LIGHT , a tumor necrosis factor superfamily member.", {"entities": []}], ["Key features of PE were regenerated by adoptive transfer of purified IgG from LIGHT \u2010injected pregnant mice and blocked by the 7\u2010amino acid epitope peptide.", {"entities": []}], ["Translating our mouse research to humans, we found that plasma transglutaminase activity was significantly elevated in PE patients and was positively correlated with AT 1 \u2010 AA levels and PE features.", {"entities": []}], ["Overall, we provide compelling mouse and human evidence that elevated transglutaminase underlies AT 1 \u2010 AA production in PE and highlight novel pathogenic biomarkers and innovative therapeutic possibilities for the disease.", {"entities": []}], ["Unconventional natural gas development (UNGD) produces environmental contaminants and psychosocial stressors.", {"entities": []}], ["Despite these concerns, few studies have evaluated the health effects of UNGD.", {"entities": []}], ["We investigated associations between UNGD activity and symptoms in a cross-sectional study in Pennsylvania.", {"entities": []}], ["We mailed a self-administered questionnaire to 23,700 adult patients of the Geisinger Clinic.", {"entities": []}], ["Using standardized and validated questionnaire items, we identified respondents with chronic rhinosinusitis (CRS), migraine headache, and fatigue symptoms.", {"entities": [[115, 123, "DISEASE"]]}], ["We created a summary UNGD activity metric that incorporated well phase, location, total depth, daily gas production and inverse distance\u2013squared to patient residences.", {"entities": []}], ["We used logistic regression, weighted for sampling and response rates, to assess associations between quartiles of UNGD activity and outcomes, both alone and in combination.", {"entities": []}], ["The response rate was 33%.", {"entities": []}], ["Of 7,785 study participants, 1,850 (24%) had current CRS symptoms, 1,765 (23%) had migraine headache, and 1,930 (25%) had higher levels of fatigue.", {"entities": [[83, 91, "DISEASE"]]}], ["Among individuals who met criteria for two or more outcomes, adjusted odds ratios for the highest quartile of UNGD activity compared with the lowest were [OR (95% CI)] 1.49 (0.78, 2.85) for CRS plus migraine, 1.88 (1.08, 3.25) for CRS plus fatigue, 1.95 (1.18, 3.21) for migraine plus fatigue, and 1.84 (1.08, 3.14) for all three outcomes together.", {"entities": [[199, 207, "DISEASE"], [271, 279, "DISEASE"]]}], ["Significant associations were also present in some models of single outcomes.", {"entities": []}], ["This study provides evidence that UNGD is associated with nasal and sinus, migraine headache, and fatigue symptoms in a general population representative sample.", {"entities": [[75, 83, "DISEASE"]]}], ["Tustin AW, Hirsch AG, Rasmussen SG, Casey JA, Bandeen-Roche K, Schwartz BS.", {"entities": []}], ["Associations between unconventional natural gas development and nasal and sinus, migraine headache, and fatigue symptoms in Pennsylvania.", {"entities": [[81, 89, "DISEASE"]]}], ["Environ Health Perspect 125:189\u2013197; http://dx.doi.org/10.1289/EHP281", {"entities": []}], ["Arformoterol tartrate (arformoterol, 15 \u03bcg bid) is a nebulized long-acting \u03b2 2 -agonist approved for maintenance treatment of COPD.", {"entities": []}], ["This was a multicenter, double-blind, randomized, placebo-controlled study.", {"entities": []}], ["Patients (aged \u2265 40 years with baseline FEV 1 \u2264 65% predicted, FEV 1 > 0.50 L, FEV 1 /FVC \u2264 70%, and \u2265 15 pack-year smoking history) received arformoterol (n = 420) or placebo (n = 421) for 1 year.", {"entities": [[40, 43, "GENE"], [63, 66, "GENE"], [79, 82, "GENE"], [40, 43, "GENE"], [63, 66, "GENE"], [79, 82, "GENE"], [40, 43, "GENE"], [63, 66, "GENE"], [79, 82, "GENE"]]}], ["The primary assessment was time from randomization to respiratory death or first COPD exacerbation-related hospitalization.", {"entities": []}], ["Among 841 patients randomized, 103 had \u2265 1 primary event (9.5% vs 15.0%, for arformoterol vs placebo, respectively).", {"entities": []}], ["Patients who discontinued treatment for any reason (39.3% vs 49.9%, for arformoterol vs placebo, respectively) were followed for up to 1 year postrandomization to assess for primary events.", {"entities": []}], ["Fewer patients receiving arformoterol than placebo experienced COPD exacerbation-related hospitalizations (9.0% vs 14.3%, respectively).", {"entities": []}], ["Twelve patients (2.9%) receiving arformoterol and 10 patients (2.4%) receiving placebo died during the study.", {"entities": []}], ["Risk for first respiratory serious adverse event was 50% lower with arformoterol than placebo ( P = .003).", {"entities": []}], ["Numerically more patients on arformoterol (13; 3.1%) than placebo (10; 2.4%) experienced cardiac serious adverse events; however, time-to-first cardiac serious adverse event was not significantly different.", {"entities": []}], ["Improvements in trough FEV 1 and FVC were greater with arformoterol (least-squares mean change from baseline vs placebo: 0.051 L, P = .030 and 0.075 L, P = .018, respectively).", {"entities": [[23, 26, "GENE"]]}], ["Significant improvements in quality of life (overall St. George\u2019s Hospital Respiratory Questionnaire and Clinical COPD Questionnaire) were observed with arformoterol vs placebo ( P < .05).", {"entities": []}], ["Arformoterol demonstrated an approximately 40% lower risk of respiratory death or COPD exacerbation-related hospitalization over 1 year vs placebo.", {"entities": []}], ["Arformoterol was well-tolerated and improved lung function vs placebo.", {"entities": []}], ["ClinicalTrials.gov; No.", {"entities": []}], [": NCT00909779; URL: www.clinicaltrials.gov", {"entities": []}], ["Allium hirtifolium Boiss.", {"entities": []}], ["known as Persian shallot, is a spice used as a traditional medicine in Iran and, Mediterranean region.", {"entities": []}], ["In this study, the chemical composition of the hydromethanolic extract of this plant was analyzed using GC/MS.", {"entities": []}], ["The result showed that 9-hexadecenoic acid, 11,14-eicosadienoic acid, and n-hexadecanoic acid are the main constituents.", {"entities": []}], ["The antibacterial activity of the shallot extract was also examined by disk diffusion and microdilution broth assays.", {"entities": []}], ["It was demonstrated that Persian shallot hydromethanolic extract was effective against 10 different species of pathogenic bacteria including methicillin resistant Staphylococcus aureus (MRSA), methicillin sensitive Staphylococcus aureus (MSSA), Staphylococcus aureus , Staphylococcus epidermidis , Streptococcus pneumoniae , Escherichia coli, Escherichia coli O157:H7, Salmonella typhimurium, Proteus mirabilis , and Klebsiella pneumoniae .", {"entities": []}], ["Specifically, the minimum concentration of the extract which inhibited bacterial growth (MIC values) was 1.88\u2009mg/mL for most of the gram-positive bacteria.", {"entities": []}], ["This concentration was not much different from the concentration that was safe for mammalian cells (1.50\u2009mg/mL) suggesting that the hydromethanolic extract of Persian shallot may be a safe and strong antibacterial agent.", {"entities": []}], ["Geographic Information Systems (GIS) have become an innovative and somewhat crucial tool for analyzing relationships between public health data and environment.", {"entities": []}], ["This study, though focusing on a Local Health Unit of northeastern Italy, could be taken as a benchmark for developing a standardized national data-acquiring format, providing a step-by-step instructions on the manipulation of address elements specific for Italian language and traditions.", {"entities": []}], ["Geocoding analysis was carried out on a health database comprising 268,517 records of the Local Health Unit of Rovigo in the Veneto region, covering a period of 10 years, starting from 2001 up to 2010.", {"entities": []}], ["The Map Service provided by the Environmental Research System Institute (ESRI, Redlands, CA), and ArcMap 10.0 by ESRI The first attempt of geocoding produced a poor quality result, having about 40% of the addresses matched.", {"entities": []}], ["A procedure of manual standardization was performed in order to enhance the quality of the results, consequently a set of guiding principle were expounded which should be pursued for geocoding health data.", {"entities": []}], ["High-level geocoding detail will provide a more precise geographic representation of health related events.", {"entities": []}], ["The main achievement of this study was to outline some of the difficulties encountered during the geocoding of health data and to put forward a set of guidelines, which could be useful to facilitate the process and enhance the quality of the results.", {"entities": []}], ["Public health informatics represents an emerging specialty that highlights on the application of information science and technology to public health practice and research.", {"entities": []}], ["Therefore, this study could draw the attention of the National Health Service to the underestimated problem of geocoding accuracy in health related data for environmental risk assessment.", {"entities": []}], ["Allergic Contact Dermatitis (ACD) is regarded as a T-cell-mediated delayed-type hypersensitivity reaction.", {"entities": [[9, 27, "DISEASE"], [17, 27, "DISEASE"], [29, 32, "GENE"]]}], ["We studied the kinetics of the expression of CS-1 fibronectin, thymus and activation-regulated chemokine (CCL17/ TARC) and different chemokine receptors (CR) in skin biopsies from individuals suffering from back problems, with the antigen responsible of their contact dermatitis and an irrelevant antigen.", {"entities": [[260, 278, "DISEASE"], [268, 278, "DISEASE"]]}], ["Samples were taken at 2, 10, and 48 hours for histological and immunohistochemical studies using monoclonal antibodies against human CS-1 fibronectin, CCL17, CD3, CD68, CD49d, CXCR3, CCR5, and CCR3.", {"entities": [[151, 156, "GENE"], [163, 167, "GENE"], [176, 181, "GENE"], [183, 187, "GENE"], [193, 197, "GENE"]]}], ["At positive antigen stimulated sites there was an early expression of CS-1 fibronectin (2 hours), followed by CCL17 and a later accumulation of alplha4/beta1+ (CD49d), CD3+, CD68+, CXCR3+ and CCR5+ mononuclear cells.", {"entities": [[110, 115, "GENE"]]}], ["At 48 hours, approximately 59 % of infiltrating cells were CXCR3+, 42% CCR5+, and only 14 % CCR3+.", {"entities": []}], ["These results showed for the first time a very early expression of CS-1 fibronectin which preceded production of CCL17 in blood endothelial cells (BCEs) from patients' skin with ACD.", {"entities": [[113, 118, "GENE"], [178, 181, "GENE"]]}], ["The role of these molecules in recruitment of monocytes and effector T cells in ACD is discussed.", {"entities": [[80, 83, "GENE"]]}], ["Folic acid (FA) added to foods during fortification is 70-85% bioavailable compared to 50% of folate occurring naturally in foods.", {"entities": []}], ["Thus, if FA supplements also are taken during pregnancy, both mother and fetus can be exposed to FA exceeding the Institute of Medicine's recommended tolerable upper limit (TUL) of 1,000 micrograms per day (\u03bcg/d) for adult pregnant women.", {"entities": []}], ["The primary objective is to estimate the proportion of women taking folic acid (FA) doses exceeding the TUL before and during pregnancy, and to identify correlates of high FA use.", {"entities": []}], ["During 2005-2008, pre-pregnancy and pregnancy-related data on dietary supplementation were obtained by interviewing 539 pregnant women enrolled at two obstetrics-care facilities in Durham County, North Carolina.", {"entities": []}], ["Before pregnancy, 51% of women reported FA supplementation and 66% reported this supplementation during pregnancy.", {"entities": []}], ["Before pregnancy, 11.9% (95% CI = 9.2%-14.6%) of women reported supplementation with FA doses above the TUL of 1,000 \u03bcg/day, and a similar proportion reported this intake prenatally.", {"entities": []}], ["Before pregnancy, Caucasian women were more likely to take FA doses above the TUL (OR = 2.99; 95% = 1.28-7.00), compared to African American women, while women with chronic conditions were less likely to take FA doses above the TUL (OR = 0.48; 95%CI = 0.21-0.97).", {"entities": []}], ["Compared to African American women, Caucasian women were also more likely to report FA intake in doses exceeding the TUL during pregnancy (OR = 5.09; 95%CI = 2.07-12.49).", {"entities": []}], ["Fifty-one percent of women reported some FA intake before and 66% during pregnancy, respectively, and more than one in ten women took FA supplements in doses that exceeded the TUL.", {"entities": []}], ["Caucasian women were more likely to report high FA intake.", {"entities": []}], ["A study is ongoing to identify possible genetic and non-genotoxic effects of these high doses.", {"entities": []}], ["The impact of the presence and awareness of individual health states on quality of life (HRQoL) is often documented.", {"entities": []}], ["However, the impacts of different health states have rarely been compared amongst each other, whilst quality of life data from Asia are relatively sparse.", {"entities": []}], ["We examined and compared the effects of different health states on quality of life in a Thai population.", {"entities": []}], ["In 2008\u20132009, 5,915 corporate employees were invited to participate in a survey where HRQoL was measured by the Short Form 36 (SF-36) questionnaire.", {"entities": []}], ["The adjusted mean SF-36 scores were calculated for each self-reported illness, number of chronic conditions, lifestyle factors and awareness of diabetes and hypertension.", {"entities": [[157, 169, "DISEASE"]]}], ["The effect sizes (ES) were compared using Cohen's d .", {"entities": []}], ["The response rate was 82% and 4,683 (79.1%) had complete data available for analysis.", {"entities": []}], ["Physical and Mental Component Summary (PCS and MCS) scores decreased as the number of chronic conditions increased monotonically (p<0.0001).", {"entities": []}], ["Diabetes and hypertension negatively influenced PCS (mean score differences \u22120.6 and \u22121.5, p<0.001 respectively) but not MCS, whereas awareness of diabetes and hypertension negatively influenced MCS (\u22122.9 and \u22121.6, p<0.005 respectively) but not PCS.", {"entities": [[13, 25, "DISEASE"], [160, 172, "DISEASE"]]}], ["Arthritis had the largest ES on PCS (\u22120.37), while awareness of diabetes had the largest ES on MCS (\u22120.36).", {"entities": []}], ["CVD moderately affected PCS and MCS (ES \u22120.34 and \u22120.27 respectively).", {"entities": []}], ["Obesity had a negative effect on PCS (ES \u22120.27).", {"entities": []}], ["Exercise positively affected PCS and MCS (ES +0.08 and +0.21 (p<0.01) respectively).", {"entities": []}], ["Health promotion to reduce the prevalence of chronic diseases is important to improve the quality of life in Asian populations.", {"entities": []}], ["Physical activity is an important part of such programs.", {"entities": []}], ["Awareness of diseases may have greater impacts on mental health than having the disease itself.", {"entities": []}], ["This has implications for the evaluation of the cost-benefit of screening and labeling of individuals with pre-disease states.", {"entities": []}], ["To identify molecular characteristics in situ in response to repetitive UVB (ultraviolet-B) irradiation.", {"entities": []}], ["Microarray data from the Gene Expression Omnibus were re-analyzed to identify DEGs (differentially expressed genes) between UVB-irradiated and non-irradiated skin biopsies.", {"entities": []}], ["Enrichment and annotation analyses were performed respectively using DAVID, and TSGene and TAG databases.", {"entities": []}], ["PPIs (protein-protein interactions) were analyzed using STRING, and miRNAs (microRNAs) and TFs (transcription factors) were predicted separately by miRNA-related databases and ENCODE.", {"entities": []}], ["Accordingly, the PPI network and regulatory networks were visualized using Cytoscape, and they were merged together to obtain an integrated network for mining densely connected modules.", {"entities": []}], ["Altogether, 151 up- and 64 down-regulated genes were identified between UVB-irradiated and non-irradiated skin biopsies, among which down-regulated DNAJB4 and SLIT2 were annotated as tumor-suppressors and up-regulated KIT was annotated as an oncogene.", {"entities": [[148, 154, "GENE"], [159, 164, "GENE"]]}], ["The up-regulated DEGs were significantly enriched in biological processes related to pigmentation ( DCT , SOX10 , TYRP1 , TYR , MLPH , KIT and GPR143 ), while the down-regulated DEGs were dramatically related to haemopoiesis and the immune system ( GPR183 , INHBA , PTPRC , PLEK , CD8A and IKZF1 ).", {"entities": [[100, 103, "GENE"], [106, 111, "GENE"], [114, 119, "GENE"], [122, 125, "GENE"], [128, 132, "GENE"], [143, 149, "GENE"], [249, 255, "GENE"], [258, 263, "GENE"], [266, 271, "GENE"], [274, 278, "GENE"], [281, 285, "GENE"], [290, 295, "GENE"]]}], ["Furthermore, many miRNAs were screened for the DEGs, including miR-206 and miR-496 targeting KIT , miR-184 targeting DCT , and highly significant miR-337-5p, miR-21 and miR-16.", {"entities": [[63, 70, "GENE"], [75, 82, "GENE"], [99, 106, "GENE"], [117, 120, "GENE"], [146, 156, "GENE"], [158, 164, "GENE"]]}], ["Additionally, TFs were identified for the DEGs, among which PAX5 and HNF4A targeted MLPH and GPR143 , respectively, while BATF , SPI1 and EP300 jointly target GPR183 , PTPRC and PLEK .", {"entities": [[60, 64, "GENE"], [69, 74, "GENE"], [84, 88, "GENE"], [93, 99, "GENE"], [122, 126, "GENE"], [129, 133, "GENE"], [138, 143, "GENE"], [159, 165, "GENE"], [168, 173, "GENE"], [178, 182, "GENE"]]}], ["The pigmentation and immune system implicated by DEGs, miRNAs and TFs might be important molecular mechanisms in response to UVB irradiation.", {"entities": []}], ["Low maternal dietary vitamin E (but not vitamin C) intake during pregnancy has been associated with increased in vitro cord blood mononuclear cell (CBMC) proliferative responses, childhood wheezing and asthma.", {"entities": [[202, 208, "DISEASE"]]}], ["We investigated whether these associations reflect direct effects of vitamin E by investigating the effects of supplementing CBMC cultures with physiological concentrations of vitamin E. CBMC from seventy neonates were cultured supplemented with either nothing, \u03b1-tocopherol or ascorbic acid.", {"entities": []}], ["Proliferative, IFN-\u03b3, IL-4, IL-10 and TGF-\u03b2 responses were measured.", {"entities": []}], ["In general, vitamin E supplementation was associated with a trend for reduced proliferative responses after stimulation with antigens and house dust mite, and with increased proliferation after stimulation with timothy grass allergen.", {"entities": []}], ["There was a trend for CBMC cultures to exhibit decreased secretion of IFN-\u03b3, IL-10 and IL-4.", {"entities": []}], ["Supplementation with vitamin C had no effect on CBMC proliferation, but increased IFN-\u03b3 and IL-4 production, and decreased IL-10 production.", {"entities": []}], ["In conclusion, in vitro vitamin E and C supplementation of CBMC modifies neonatal immune function, but not in a manner predicted by observational epidemiological studies.", {"entities": []}], ["The observed associations between vitamin E and childhood respiratory disease are complex, and the nature and form of nutritional intervention need to be carefully considered before inclusion in trials.", {"entities": []}], ["Particulate matter (PM) adverse effects on health include lung and heart damage.", {"entities": []}], ["The renin-angiotensin-aldosterone (RAAS) and kallikrein-kinin (KKS) endocrine systems are involved in the pathophysiology of cardiovascular diseases and have been found to impact lung diseases.", {"entities": []}], ["The aim of the present study was to evaluate whether PM exposure regulates elements of RAAS and KKS.", {"entities": []}], ["Sprague\u2013Dawley rats were acutely (3\u00a0days) and subchronically (8\u00a0weeks) exposed to coarse (CP), fine (FP) or ultrafine (UFP) particulates using a particulate concentrator, and a control group exposed to filtered air (FA).", {"entities": [[90, 92, "GENE"]]}], ["We evaluated the mRNA of the RAAS components At1 , At2r and Ace, and of the KKS components B1r , B2r and Klk-1 by RT-PCR in the lungs and heart.", {"entities": []}], ["The ACE and AT 1 R protein were evaluated by Western blot, as were HO-1 and \u03b3GCSc as indicators of the antioxidant response and IL-6 levels as an inflammation marker.", {"entities": []}], ["We performed a binding assay to determinate AT 1 R density in the lung, also the subcellular AT 1 R distribution in the lungs was evaluated.", {"entities": []}], ["Finally, we performed a histological analysis of intramyocardial coronary arteries and the expression of markers of heart gene reprogramming ( Acta1 and Col3a1 ).", {"entities": [[143, 148, "GENE"], [153, 159, "GENE"]]}], ["The PM fractions induced the expression of RAAS and KKS elements in the lungs and heart in a time-dependent manner.", {"entities": []}], ["CP exposure induced Ace mRNA expression and regulated its protein in the lungs.", {"entities": [[0, 2, "GENE"]]}], ["Acute and subchronic exposure to FP and UFP induced the expression of At1r in the lungs and heart.", {"entities": []}], ["All PM fractions increased the AT 1 R protein in a size-dependent manner in the lungs and heart after subchronic exposure.", {"entities": []}], ["The AT 1 R lung protein showed a time-dependent change in subcellular distribution.", {"entities": []}], ["In addition, the presence of AT 1 R in the heart was accompanied by a decrease in HO-1, which was concomitant with the induction of Acta1 and Col3a1 and the increment of IL-6.", {"entities": [[132, 137, "GENE"], [142, 148, "GENE"]]}], ["Moreover, exposure to all PM fractions increased coronary artery wall thickness.", {"entities": []}], ["We demonstrate that exposure to PM induces the expression of RAAS and KKS elements, including AT 1 R, which was the main target in the lungs and the heart.", {"entities": []}], ["To determine the efficacy, tolerability, and safety of an aqueous extract of Costus speciosus ( C. speciosus ) rhizome in pediatric and adult patients suffering from acute pharyngitis and tonsillitis as an alternative to antibiotics use.", {"entities": [[188, 199, "DISEASE"], [172, 183, "DISEASE"]]}], ["This pilot cohort trial was conducted at King Abdulaziz University in Saudi Arabia between May and December 2014, among 15 patients with acute pharyngitis and tonsillitis who were administered nasal drops of aqueous extract of C. speciosus rhizome at a dose of 15-30 drops every 8 hours for 3 days.", {"entities": [[159, 170, "DISEASE"], [143, 154, "DISEASE"]]}], ["The primary outcome measure was the clinical improvement and remission rate within the first 5 days.", {"entities": []}], ["The administration of C. speciosus resulted in an improvement in acute symptoms in 60% of the patients treated within the first 24 hours, and remission rate of 93% by day 5, without any recorded adverse effects.", {"entities": []}], ["This study revealed a significant efficacy of the aqueous extract of C. speciosus rhizome in acute pharyngitis and tonsillitis.", {"entities": [[115, 126, "DISEASE"], [99, 110, "DISEASE"]]}], ["Arginase overexpression contributes to airways hyperresponsiveness (AHR) in asthma.", {"entities": [[76, 82, "DISEASE"], [68, 71, "GENE"]]}], ["Arginase expression is further augmented in cigarette smoking asthmatics, suggesting that it may be upregulated by environmental pollution.", {"entities": []}], ["Thus, we hypothesize that arginase contributes to the exacerbation of respiratory symptoms following exposure to air pollution, and that pharmacologic inhibition of arginase would abrogate the pollution-induced AHR.", {"entities": [[211, 214, "GENE"]]}], ["To investigate the role of arginase in the air pollution-induced exacerbation of airways responsiveness, we employed two murine models of allergic airways inflammation.", {"entities": []}], ["Mice were sensitized to ovalbumin (OVA) and challenged with nebulized PBS (OVA/PBS) or OVA (OVA/OVA) for three consecutive days (sub-acute model) or 12 weeks (chronic model), which exhibit inflammatory cell influx and remodeling/AHR, respectively.", {"entities": []}], ["Twenty-four hours after the final challenge, mice were exposed to concentrated ambient fine particles plus ozone (CAP+O 3 ), or HEPA-filtered air (FA), for 4 hours.", {"entities": []}], ["After the CAP+O 3 exposures, mice underwent tracheal cannulation and were treated with an aerosolized arginase inhibitor ( S -boronoethyl-L-cysteine; BEC) or vehicle, immediately before determination of respiratory function and methacholine-responsiveness using the flexiVent Compared to FA, arginase activity was significantly augmented in the lungs of CAP+O 3 -exposed OVA/OVA mice in both the sub-acute and chronic models.", {"entities": []}], ["Western blotting and immunohistochemical staining revealed that the increased activity was due to arginase 1 expression in the area surrounding the airways in both models.", {"entities": []}], ["Arginase inhibition significantly reduced the CAP+O 3 -induced increase in AHR in both models.", {"entities": [[75, 78, "GENE"]]}], ["This study demonstrates that arginase is upregulated following environmental exposures in murine models of asthma, and contributes to the pollution-induced exacerbation of airways responsiveness.", {"entities": [[107, 113, "DISEASE"]]}], ["Thus arginase may be a therapeutic target to protect susceptible populations against the adverse health effects of air pollution, such as fine particles and ozone, which are two of the major contributors to smog.", {"entities": []}], ["Histamine is detected in high concentrations in the airways during an allergic asthma response.", {"entities": [[70, 85, "DISEASE"], [79, 85, "DISEASE"]]}], ["In a murine model of allergic asthma, JNJ 7777120, an antagonist at the histamine H 4 receptor, reduces asthmatic symptoms, while the histamine H 1 receptor-selective antagonist mepyramine is virtually without effect.", {"entities": [[21, 36, "DISEASE"], [30, 36, "DISEASE"]]}], ["In the present study, we analyzed the effect of combined antagonism at the histamine H 1 and H 4 receptors in a murine asthma model in relation to the timing of their application, i.e.", {"entities": [[119, 125, "DISEASE"]]}], ["sensitization or provocation.", {"entities": []}], ["Asthma was induced in mice by sensitization and provocation with ovalbumin.", {"entities": [[0, 6, "DISEASE"]]}], ["JNJ 7777120 and/or mepyramine were injected subcutaneously either during sensitization or during provocation, and typical asthma parameters were analyzed.", {"entities": [[122, 128, "DISEASE"]]}], ["JNJ 7777120, but not mepyramine, reduced serum concentrations of anti-OVA IgE, inflammatory infiltrations in lung tissue, and eosinophilia in bronchoalveolar-lavage (BAL)-fluids independently of the timing of application.", {"entities": [[126, 138, "DISEASE"]]}], ["Upon application of JNJ 7777120 plus mepyramine in combination during provocation, mepyramine inhibited the effects of JNJ 7777120.", {"entities": []}], ["In contrast, when applied during sensitization, mepyramine enhanced the disease-ameliorating effects of JNJ 7777120.", {"entities": []}], ["Our study indicates that both histamine H 1 and H 4 receptors play important roles in the course of murine experimental asthma.", {"entities": [[120, 126, "DISEASE"]]}], ["Unexpectedly, the contribution of these receptors to the pathogenesis differs between the two phases, sensitization or provocation.", {"entities": []}], ["Since in human asthma, repeated contact to the allergen is not only provocation but also a boost of sensitization, a combined pharmacological targeting of histamine H 1 and H 4 receptors could be taken into consideration as an option for the prevention of asthma and maybe other allergic diseases.", {"entities": [[15, 21, "DISEASE"], [256, 262, "DISEASE"]]}], ["Spinal cord injury (SCI) is a devastating condition with substantial functional and social morbidity.", {"entities": []}], ["Previous research has established that the neuroinflammatory response plays a significant role in cord damage post-SCI.", {"entities": []}], ["However, global immunosuppressive therapies have demonstrated mixed results.", {"entities": []}], ["As a result, more specific therapies modulating inflammation after injury are needed.", {"entities": []}], ["In this regard, research into cytokine signaling has demonstrated that cytokines of the gp130 family including IL-6 and leukemia inhibitory factor (LIF) play key roles in mediating damage to the spinal cord.", {"entities": [[120, 128, "DISEASE"], [148, 151, "GENE"]]}], ["Since members of the gp130 family all share a common signal transduction pathway via the JAK/STAT system, we performed the first study of a relatively new member of the gp130 family, IL-11, in SCI.", {"entities": []}], ["A validated clip-compression mouse model of SCI was used to assess for temporal changes in expression of IL-11 and its receptor, IL-11R\u03b1, post-SCI.", {"entities": []}], ["To elucidate the role of IL-II in the pathophysiology of SCI, we compared differences in locomotor recovery (Basso Mouse Score; CatWalk), electrophysiological spinal cord signaling, histopathology, and the acute inflammatory neutrophil response in IL-11R\u03b1 knockouts with littermate wild-type C57BL/6 mice.", {"entities": []}], ["We found an increase in gene expression of IL-11 in the spinal cord to a peak at twenty-four hours post-SCI with increases in IL-11R\u03b1 gene expression, peaking at seven days post-SCI.", {"entities": []}], ["In spite of clear changes in the temporal expression of both IL-11 and its receptor, we found that there were no significant differences in motor function, electrophysiological signaling, histopathology, or neutrophil infiltration into the spinal cord between wild-type and knockout mice.", {"entities": []}], ["This is the first study to address IL-11 in SCI.", {"entities": []}], ["This study provides evidence that IL-11 signaling may not play as significant a role in SCI as other gp130 cytokines, which will ideally guide future therapy design and the signaling pathways those therapies target.", {"entities": []}], ["The associations between pulmonary diseases (asthma, chronic obstructive pulmonary disease [COPD], and tuberculosis [TB]) and subsequent lung cancer risk have been reported, but few studies have investigated the association with different histologic types of lung cancer.", {"entities": [[137, 148, "DISEASE"], [259, 270, "DISEASE"], [53, 90, "DISEASE"], [103, 115, "DISEASE"], [45, 51, "DISEASE"], [142, 148, "DISEASE"], [264, 270, "DISEASE"]]}], ["Patients newly diagnosed with lung cancer from 2004 to 2008 were identified from the National Health Insurance Research Database in Taiwan.", {"entities": [[30, 41, "DISEASE"], [35, 41, "DISEASE"]]}], ["Histologic types of lung cancer were further confirmed using the Taiwan Cancer Registry Database.", {"entities": [[20, 31, "DISEASE"], [25, 31, "DISEASE"], [72, 78, "DISEASE"]]}], ["Cox proportional hazards regression was used to calculate the hazard ratio (HR) of asthma, COPD, and TB and to estimate the risk of specific types of lung cancer.", {"entities": [[150, 161, "DISEASE"], [83, 89, "DISEASE"], [155, 161, "DISEASE"], [76, 78, "GENE"]]}], ["During the study period, 32,759 cases of lung cancer were identified from 15,219,024 insurants aged 20\u00a0years and older.", {"entities": [[41, 52, "DISEASE"], [46, 52, "DISEASE"]]}], ["In men and women, the adjusted HR estimates of squamous cell carcinoma were respectively 1.37 (95\u00a0% confidence interval [CI], 1.21\u20131.54) and 2.10 (95\u00a0% CI, 1.36\u20133.23) for TB, 1.52 (95\u00a0% CI, 1.42\u20131.64) and 1.50 (95\u00a0% CI, 1.21\u20131.85) for asthma, and 1.66 (95\u00a0% CI, 1.56\u20131.76) and 1.44 (95\u00a0% CI, 1.19\u20131.74) for COPD.", {"entities": [[61, 70, "DISEASE"], [47, 70, "DISEASE"], [235, 241, "DISEASE"], [31, 33, "GENE"]]}], ["Similarly, the adjusted HR estimates of adenocarcinoma were respectively 1.33 (95\u00a0% CI, 1.19\u20131.50) and 1.86 (95\u00a0% CI, 1.57\u20132.19) for TB, 1.13 (95\u00a0% CI, 1.05\u20131.21) and 1.18 (95\u00a0% CI, 1.09\u20131.28) for asthma, and 1.50 (95\u00a0% CI, 1.42\u20131.59) and 1.33 (95\u00a0% CI, 1.25\u20131.42) for COPD.", {"entities": [[40, 54, "DISEASE"], [197, 203, "DISEASE"], [24, 26, "GENE"]]}], ["The HRs of small cell carcinoma were respectively 1.24 (95\u00a0% CI, 1.01\u20131.52) and 2.23 (95\u00a0% CI, 1.17\u20134.25) for TB, 1.51 (95\u00a0% CI, 1.35\u20131.69) and 1.63 (95\u00a0% CI, 1.16\u20132.27) for asthma, and 1.39 (95\u00a0% CI, 1.26\u20131.53) and 1.78 (95\u00a0% CI, 1.33\u20132.39) for COPD.", {"entities": [[22, 31, "DISEASE"], [174, 180, "DISEASE"], [11, 31, "DISEASE"]]}], ["Asthma, COPD, and TB were associated with an increased risk of all major subtypes of lung cancer.", {"entities": [[85, 96, "DISEASE"], [0, 6, "DISEASE"], [90, 96, "DISEASE"]]}], ["The risk was the highest among women with TB.", {"entities": []}], ["Recent studies have identified substantial health disparities between lesbian, gay, and bisexual (LGB) individuals compared to heterosexuals.", {"entities": []}], ["However, possible variation in sexual orientation health disparities by age and according to gender remains largely unexplored.", {"entities": []}], ["To examine physical health disparities between LGB and heterosexual individuals in a general population sample in Sweden, to explore potential age and gender differences in these disparities, and to test potential mechanisms underlying any observed disparities.", {"entities": []}], ["Between 2008 and 2013, 60,922 individuals (16\u201384\u00a0years of age) responded to nationwide population-based health surveys.", {"entities": []}], ["In the sample, 430 (0.7\u00a0%) individuals self-identified as gay/lesbian and 757 (1.3\u00a0%) self-identified as bisexual.", {"entities": []}], ["Logistic and negative binomial regression analyses were used to explore health disparities based on sexual orientation.", {"entities": []}], ["Overall, LGB individuals were more likely to report worse self-rated health as well as more physical health symptoms (e.g., pain, insomnia, dermatitis, tinnitus, intestinal problems) and conditions (e.g., diabetes, asthma, high blood pressure) compared to heterosexuals.", {"entities": [[215, 221, "DISEASE"], [140, 150, "DISEASE"]]}], ["However, these physical health disparities differed by age.", {"entities": []}], ["Disparities were largest among adolescents and young adults and generally smallest in older age groups.", {"entities": []}], ["Health behaviors and elevated reports of exposure to perceived discrimination, victimization, and threats of violence among sexual minorities partially explained the sexual orientation disparities in physical health.", {"entities": []}], ["Age emerged as an important effect modifier of physical health disparities based on sexual orientation.", {"entities": []}], ["Gender-specific findings suggest that sexual orientation disparities persist into adulthood for women but are gradually attenuated for older age groups; in contrast, for men, these disparities disappear starting with young adults.", {"entities": []}], ["These results support a developmental model of minority stress and physical health among LGB individuals.", {"entities": []}], ["A controlled study has been made of the constitutional background of 300 cases of endometrial adenocarcinoma.", {"entities": [[94, 108, "DISEASE"], [82, 108, "DISEASE"]]}], ["The control group was age matched and drawn from the same patient population pool as were the adenocarcinoma cases.", {"entities": [[94, 108, "DISEASE"]]}], ["Endometrial adenocarcinoma was shown to be associated unduly frequently with hypertension, nulliparity and the late age of menopause.", {"entities": [[77, 89, "DISEASE"], [12, 26, "DISEASE"], [0, 26, "DISEASE"]]}], ["No association was found between endometrial adenocarcinoma and obesity, diabetes mellitus, thyroid disease or extragenital malignant disease.", {"entities": [[45, 59, "DISEASE"], [33, 59, "DISEASE"], [64, 71, "DISEASE"], [73, 90, "DISEASE"]]}], ["It is suggested that these results are explicable on the basis that adrenal dysfunction may be an aetiological factor in the development of endometrial adenocarcinoma.", {"entities": [[152, 166, "DISEASE"], [140, 166, "DISEASE"]]}], ["A novel approach based on headspace solid-phase microextraction (HS-SPME) combined with comprehensive two-dimensional gas chromatography\u2013time-of-flight mass spectrometry (GC\u00d7GC\u2013ToFMS) was developed for the simultaneous screening of microbial and mite contamination level in cereals and coffee beans.", {"entities": []}], ["The proposed approach emerges as a powerful tool for the rapid assessment of the microbial contamination level ( ca .", {"entities": []}], ["70 min versus ca .", {"entities": []}], ["72 to 120 h for bacteria and fungi, respectively, using conventional plate counts), and mite contamination ( ca .", {"entities": []}], ["70 min versus ca .", {"entities": []}], ["A full-factorial design was performed for optimization of the SPME experimental parameters.", {"entities": []}], ["The methodology was applied to three types of rice (rough, brown, and white rice), oat, wheat, and green and roasted coffee beans.", {"entities": []}], ["Simultaneously, microbiological analysis of the samples (total aerobic microorganisms, moulds, and yeasts) was performed by conventional plate counts.", {"entities": []}], ["A set of 54 volatile markers was selected among all the compounds detected by GC\u00d7GC\u2013ToFMS.", {"entities": []}], ["Principal Component Analysis (PCA) was applied in order to establish a relationship between potential volatile markers and the level of microbial contamination.", {"entities": []}], ["Methylbenzene, 3-octanone, 2-nonanone, 2-methyl-3-pentanol, 1-octen-3-ol, and 2-hexanone were associated to samples with higher microbial contamination level, especially in rough rice.", {"entities": []}], ["Moreover, oat exhibited a high GC peak area of 2-hydroxy-6-methylbenzaldehyde, a sexual and alarm pheromone for adult mites, which in the other matrices appeared as a trace component.", {"entities": [[31, 33, "GENE"]]}], ["The number of mites detected in oat grains was correlated to the GC peak area of the pheromone.", {"entities": [[65, 67, "GENE"]]}], ["The HS-SPME/GC\u00d7GC\u2013ToFMS methodology can be regarded as the basis for the development of a rapid and versatile method that can be applied in industry to the simultaneous assessment the level of microbiological contamination and for detection of mites in cereals grains and coffee beans.", {"entities": []}], ["Pulmonary artery aneurysms, arterial and venous thrombosis, pulmonary infarction, recurrent pneumonia, bronchiolitis obliterans organized pneumonia, and pleurisy are the main features of pulmonary involvement in Beh\u00e7et disease.", {"entities": [[153, 161, "DISEASE"], [92, 101, "DISEASE"], [138, 147, "DISEASE"], [103, 127, "DISEASE"], [103, 116, "DISEASE"]]}], ["The objective of this study was to investigate the production of B-cell-activating factor of the TNF family (BAFF), an important regulator of B-cell survival and immunoglobulin class-switch recombination, in bronchoalveolar lavage (BAL) fluid from BD patients having pulmonary manifestation.", {"entities": [[97, 100, "GENE"]]}], ["Bronchoalveolar lavage (BAL) was performed in 15 BD patients with pulmonary manifestation and 18 BAL from healthy controls.", {"entities": []}], ["Concentrations of B-cell-active cytokines, including BAFF, IL-6 and IL-13, were measured by using specific ELISA and cytometric bead array assays.", {"entities": []}], ["Levels of BAFF protein were significantly increased in BAL fluid from active BD (109 \u00b1 21.78 pg/mL) compared with those oh healthy controls (4.83 \u00b1 1.75 pg/mL; p < 0.0001).", {"entities": []}], ["In the BAL fluid, BAFF levels were significantly correlated with absolute numbers of total cells (r = 0.823; p < 0.0001), lymphocytes (r = 0.709; p < 0.0001), neutrophils (r = 0.809; p < 0.0001) and macrophages (r = 0.742; p < 0.0001).", {"entities": []}], ["Normalization to albumin indicated that BAFF production occurred locally in the airways.", {"entities": []}], ["BAFF levels were also significantly correlated with the other B-cell-activating cytokines IL-6 ( r = 0.882, p < 0.001) and IL-13 ( r = 0.659, p < 0.001).", {"entities": []}], ["The antigen-induced production of BAFF in the lung of active BD with pulmonary manifestations might contribute to immunoglobulin synthesis by B-cells.", {"entities": []}], ["The cells residing in the lung might affect each other through BAFF.", {"entities": []}], ["The abscopal effect is the effect of radiation therapy at a site distant to the area of irradiation.", {"entities": []}], ["This is not a common event and has not been clearly defined, resulting in few reported cases in the literature.", {"entities": []}], ["We discuss this phenomenon in a patient with hepatocellular carcinoma.", {"entities": [[45, 69, "DISEASE"], [60, 69, "DISEASE"]]}], ["A 63-year-old Japanese man underwent extended right hepatic lobectomy for hepatocellular carcinoma.", {"entities": [[74, 98, "DISEASE"], [89, 98, "DISEASE"]]}], ["During his follow-up examination, a single lung metastasis and a single mediastinal lymph node metastasis were found.", {"entities": []}], ["Trans-catheter arterial embolization was initially attempted to treat the mediastinal tumor, however this approach failed to take effect and carried risks of spinal artery embolism.", {"entities": []}], ["External-beam irradiation, with a dose of 2.25 Gy per fraction, was performed using an antero-posterior parallel-opposed technique (total dose, 60.75 Gy).", {"entities": []}], ["A computed tomography scan performed one month after starting radiotherapy showed a remarkable reduction of the mediastinal lymph node metastasis.", {"entities": []}], ["In addition to this, we observed spontaneous shrinking of the lung metastasis, which was located in the right lower lobe and out of the radiation field.", {"entities": []}], ["No chemotherapy was given during the period.", {"entities": []}], ["There has been no recurrence of either the lung metastasis or the mediastinal lymph node metastasis during a follow-up 10 years after the radiotherapy.", {"entities": []}], ["We observed a rare abscopal effect in a site distant from the area of irradiation.", {"entities": []}], ["Irradiation of the mediastinum resulted in tumor mass regression in the untreated lung tumor.", {"entities": []}], ["Walker et al.", {"entities": []}], ["demonstrate that the transcription factor Bcl11b is expressed in mouse lymphoid ILC2 precursors in the bone marrow and is required for their development.", {"entities": [[42, 48, "GENE"]]}], ["Mice deficient in Bcl11b exhibit a lack of ILC2 development and an expansion of ROR\u03b3t Nippostrongylus brasiliensis worm infection, but can clear Citrobacter rodentium .", {"entities": [[18, 24, "GENE"]]}], ["Group 2 innate lymphoid cells (ILC2s) are often found associated with mucosal surfaces where they contribute to protective immunity, inappropriate allergic responses, and tissue repair.", {"entities": []}], ["Although we know they develop from a common lymphoid progenitor in the bone marrow (BM), the specific lineage path and transcriptional regulators that are involved are only starting to emerge.", {"entities": []}], ["After ILC2 gene expression analysis we investigated the role of Bcl11b, a factor previously linked to T cell commitment, in ILC2 development.", {"entities": [[64, 70, "GENE"]]}], ["Using combined Bcl11b-tom and Id2-gfp reporter mice, we show that Bcl11b is expressed in ILC2 precursors in the BM and maintained in mature ILC2s.", {"entities": [[15, 21, "GENE"], [66, 72, "GENE"]]}], ["In vivo deletion of Bcl11b , by conditional tamoxifen-induced depletion or by Bcl11b fetal liver chimera reconstitution, demonstrates that ILC2s are wholly dependent on Bcl11b for their development.", {"entities": [[20, 26, "GENE"], [78, 84, "GENE"], [169, 175, "GENE"], [20, 26, "GENE"], [78, 84, "GENE"], [169, 175, "GENE"], [20, 26, "GENE"], [78, 84, "GENE"], [169, 175, "GENE"]]}], ["Notably, in the absence of Bcl11b there is a concomitant expansion of the ROR\u03b3t Nippostrongylus brasiliensis infection, we reveal that the absence of Bcl11b leads to impaired worm expulsion, caused by a deficit in ILC2s, whereas Citrobacter rodentium infection is cleared efficiently.", {"entities": [[27, 33, "GENE"], [150, 156, "GENE"], [27, 33, "GENE"], [150, 156, "GENE"]]}], ["These data clearly establish Bcl11b as a new factor in the differentiation of ILC2s.", {"entities": [[29, 35, "GENE"]]}], ["The influenza pandemic that emerged in 2009 provided an unprecedented opportunity to study adaptation of a virus recently acquired from an animal source during human transmission.", {"entities": [[4, 13, "DISEASE"]]}], ["In the United Kingdom, the novel virus spread in three temporally distinct waves between 2009 and 2011.", {"entities": []}], ["Phylogenetic analysis of complete viral genomes showed that mutations accumulated over time.", {"entities": []}], ["Second- and third-wave viruses replicated more rapidly in human airway epithelial (HAE) cells than did the first-wave virus.", {"entities": []}], ["In infected mice, weight loss varied between viral isolates from the same wave but showed no distinct pattern with wave and did not correlate with viral load in the mouse lungs or severity of disease in the human donor.", {"entities": []}], ["However, second- and third-wave viruses induced less alpha interferon in the infected mouse lungs.", {"entities": []}], ["NS1 protein, an interferon antagonist, had accumulated several mutations in second- and third-wave viruses.", {"entities": []}], ["Recombinant viruses with the third-wave NS gene induced less interferon in human cells, but this alone did not account for increased virus fitness in HAE cells.", {"entities": []}], ["Mutations in HA and NA genes in third-wave viruses caused increased binding to \u03b1-2,6-sialic acid and enhanced infectivity in human mucus.", {"entities": []}], ["A recombinant virus with these two segments replicated more efficiently in HAE cells.", {"entities": []}], ["A mutation in PA (N321K) enhanced polymerase activity of third-wave viruses and also provided a replicative advantage in HAE cells.", {"entities": []}], ["Therefore, multiple mutations allowed incremental changes in viral fitness, which together may have contributed to the apparent increase in severity of A(H1N1)pdm09 influenza virus during successive waves.", {"entities": [[165, 174, "DISEASE"]]}], ["IMPORTANCE Although most people infected with the 2009 pandemic influenza virus had mild or unapparent symptoms, some suffered severe and devastating disease.", {"entities": [[64, 73, "DISEASE"]]}], ["The reasons for this variability were unknown, but the numbers of severe cases increased during successive waves of human infection in the United Kingdom.", {"entities": []}], ["To determine the causes of this variation, we studied genetic changes in virus isolates from individual hospitalized patients.", {"entities": []}], ["There were no consistent differences between these viruses and those circulating in the community, but we found multiple evolutionary changes that in combination over time increased the virus's ability to infect human cells.", {"entities": []}], ["These adaptations may explain the remarkable ability of A(H1N1)pdm09 virus to continue to circulate despite widespread immunity and the apparent increase in severity of influenza over successive waves of infection.", {"entities": [[169, 178, "DISEASE"]]}], ["African Americans with low incomes and low literacy levels disproportionately suffer poor health outcomes from many preventable diseases.", {"entities": []}], ["Low functional literacy and low health literacy impede millions of Americans from successfully accessing health information.", {"entities": []}], ["These problems are compounded for African Americans by cultural insensitivity in health materials.", {"entities": []}], ["The Internet could become a useful tool for providing accessible health information to low-literacy and low-income African Americans.", {"entities": []}], ["Optimal health Web sites should include text written at low reading levels and appropriate cultural references.", {"entities": []}], ["More research is needed to determine how African Americans with low literacy skills access, evaluate, prioritize, and value health information on the Internet.", {"entities": []}], ["High levels of serum IgE are considered markers of parasite and helminth exposure.", {"entities": []}], ["In addition, they are associated with allergic disorders, play a key role in anti-tumoral defence, and are crucial mediators of autoimmune diseases.", {"entities": []}], ["Total IgE is a strongly heritable trait.", {"entities": []}], ["In a genome-wide association study (GWAS), we tested 353,569 SNPs for association with serum IgE levels in 1,530 individuals from the population-based KORA S3/F3 study.", {"entities": []}], ["Replication was performed in four independent population-based study samples (total n\u200a=\u200a9,769 individuals).", {"entities": []}], ["Functional variants in the gene encoding the alpha chain of the high affinity receptor for IgE ( FCER1A ) on chromosome 1q23 (rs2251746 and rs2427837) were strongly associated with total IgE levels in all cohorts with P values of 1.85\u00d710 P \u200a=\u200a7.78\u00d710 P \u200a=\u200a1.95\u00d710 RAD50 gene on chromosome 5q31 were consistently associated with IgE levels ( P values 6.28\u00d710 STAT6 was confirmed as susceptibility locus modulating IgE levels.", {"entities": [[97, 103, "GENE"], [264, 269, "GENE"], [358, 363, "GENE"]]}], ["In this first GWAS on total IgE FCER1A was identified and replicated as new susceptibility locus at which common genetic variation influences serum IgE levels.", {"entities": [[32, 38, "GENE"]]}], ["In addition, variants within the RAD50 gene might represent additional factors within cytokine gene cluster on chromosome 5q31, emphasizing the need for further investigations in this intriguing region.", {"entities": [[33, 38, "GENE"]]}], ["Our data furthermore confirm association of STAT6 variation with serum IgE levels.", {"entities": [[44, 49, "GENE"]]}], ["High levels of serum IgE are considered markers of parasite and helminth exposure.", {"entities": []}], ["In addition, they are associated with allergic disorders, play a key role in anti-tumoral defence, and are crucial mediators of autoimmune diseases.", {"entities": []}], ["There is strong evidence that the regulation of serum IgE levels is under a strong genetic control.", {"entities": []}], ["However, despite numerous loci and candidate genes linked and associated with atopy-related traits, very few have been associated consistently with total IgE.", {"entities": []}], ["This study describes the first large-scale, genome-wide scan on total IgE.", {"entities": []}], ["By examining >11,000 German individuals from four independent population-based cohorts, we show that functional variants in the gene encoding the alpha chain of the high affinity receptor for IgE ( FCER1A ) on chromosome 1q23 are strongly associated with total IgE levels.", {"entities": [[198, 204, "GENE"]]}], ["In addition, our data confirm association of STAT6 variation with serum IgE levels, and suggest that variants within the RAD50 gene might represent additional factors within cytokine gene cluster on chromosome 5q31, emphasizing the need for further investigations in this intriguing region.", {"entities": [[45, 50, "GENE"], [121, 126, "GENE"]]}], ["Multimorbidity is a public health problem with high prevalence and important consequences.", {"entities": []}], ["The aim of this paper was to verify the prevalence and distribution of multimorbidity in Brazilian older adults.", {"entities": []}], ["A population-based survey was carried out in 2008 through face-to-face interviews with 1593 older adults (aged 60 or over) living in Bag\u00e9, a medium-sized city in Southern Brazil.", {"entities": []}], ["Multimorbidity was evaluated by 17 morbidities and operationalized according to two cutoff points: 2 or more and 3 or more morbidities.", {"entities": []}], ["Descriptive analysis examined the occurrence of multimorbidity by demographic, socioeconomic and health services variables.", {"entities": []}], ["Observed and expected dyads and triads of diseases were calculated.", {"entities": []}], ["From total sample, 6\u00a0% did not have morbidities.", {"entities": []}], ["Mean morbidity was 3.6.", {"entities": []}], ["Morbidities showing higher prevalence were high blood pressure \u2013 HBP \u2013 (55.3\u00a0%) and spinal column disease (37.4\u00a0%).", {"entities": []}], ["The percent of participants with multimorbidity was 81.3\u00a0% (95 % CI: 79.3; 83.3) for 2 or more morbidities and 64.0\u00a0% (95 % CI: 61.5; 66.4) for 3 or more morbidities.", {"entities": []}], ["In both measures occurrence was higher among women, the more elderly, less socioeconomic status, the bedridden, those who did not have a health private plan, those who used health services and those living in Family Health Strategy catchment areas.", {"entities": []}], ["We found 22 dyads of morbidities with prevalence 10\u00a0% or more and 35 triads with prevalence 5\u00a0% or more.", {"entities": []}], ["The most prevalent observed pair and triplet of morbidities were HBP and spinal column disease (23.6\u00a0%) and HBP, rheumatism/arthritis/arthrosis and spinal column disease (10.6\u00a0%), respectively.", {"entities": [[124, 133, "DISEASE"]]}], ["Multimorbidity frequency was high in the sample studied, in keeping with percentage found in other countries.", {"entities": []}], ["The social inequities identified increase the health system challenges for the management of multimorbidity, requiring a comprehensive and multidimensional care.", {"entities": []}], ["The combinations of diseases can provide initial input to include multimorbidity in Brazilian clinical protocols.", {"entities": []}], ["The genetic factors that give rise to variation in susceptibility to environmental toxins remain largely unexplored.", {"entities": []}], ["Studies on genetic variation in susceptibility to environmental toxins are challenging in human populations, due to the variety of clinical symptoms and difficulty in determining which symptoms causally result from toxic exposure; uncontrolled environments, often with exposure to multiple toxicants; and difficulty in relating phenotypic effect size to toxic dose, especially when symptoms become manifest with a substantial time lag.", {"entities": []}], ["Drosophila melanogaster is a powerful model that enables genome-wide studies for the identification of allelic variants that contribute to variation in susceptibility to environmental toxins, since the genetic background, environmental rearing conditions and toxic exposure can be precisely controlled.", {"entities": []}], ["Here, we used extreme QTL mapping in an outbred population derived from the D .", {"entities": []}], ["melanogaster Genetic Reference Panel to identify alleles associated with resistance to lead and/or cadmium, two ubiquitous environmental toxins that present serious health risks.", {"entities": []}], ["We identified single nucleotide polymorphisms (SNPs) associated with variation in resistance to both heavy metals as well as SNPs associated with resistance specific to each of them.", {"entities": []}], ["The effects of these SNPs were largely sex-specific.", {"entities": []}], ["We applied mutational and RNAi analyses to 33 candidate genes and functionally validated 28 of them.", {"entities": []}], ["We constructed networks of candidate genes as blueprints for orthologous networks of human genes.", {"entities": []}], ["The latter not only provided functional contexts for known human targets of heavy metal toxicity, but also implicated novel candidate susceptibility genes.", {"entities": []}], ["These studies validate Drosophila as a translational toxicogenomics gene discovery system.", {"entities": []}], ["Although physiological effects of environmental toxins are well documented, we know little about the genetic factors that determine individual variation in susceptibility to toxins.", {"entities": []}], ["Such information is difficult to obtain in human populations due to heterogeneity in genetic background and environmental exposure, and the diversity of symptoms and time lag with which they appear after toxic exposure.", {"entities": []}], ["Here, we show that the fruit fly, Drosophila, can serve as a powerful genetic model system to elucidate the genetic underpinnings that contribute to individual variation in resistance to toxicity, using lead and cadmium exposure as an experimental paradigm.", {"entities": []}], ["We identified genes that harbor genetic variants that contribute to individual variation in resistance to heavy metal exposure.", {"entities": []}], ["Furthermore, we constructed genetic networks on which we could superimpose human counterparts of Drosophila genes.", {"entities": []}], ["We were able to place human genes previously implicated in heavy metal toxicity in biological context and identify novel targets for heavy metal toxicity.", {"entities": []}], ["Thus, we demonstrate that based on evolutionary conservation of fundamental biological processes, we can use Drosophila as a powerful translational model for toxicogenomics studies.", {"entities": []}], ["Fungal sensitization is common in severe asthma, but the clinical relevance of this and the relationship with airway colonization by fungi remain unclear.", {"entities": [[41, 47, "DISEASE"]]}], ["The range of fungi that may colonize the airways in asthma is unknown.", {"entities": [[52, 58, "DISEASE"]]}], ["To provide a comprehensive analysis on the range of filamentous fungi isolated in sputum from people with asthma and report the relationship with their clinico-immunological features of their disease.", {"entities": [[106, 112, "DISEASE"]]}], ["We recruited 126 subjects with a diagnosis of asthma, 94% with moderate-severe disease, and 18 healthy volunteers.", {"entities": [[46, 52, "DISEASE"]]}], ["At a single stable visit, subjects underwent spirometry; sputum fungal culture and a sputum cell differential count; skin prick testing to both common aeroallergens and an extended fungal panel; specific IgE to Aspergillus fumigatus .", {"entities": []}], ["Fungi were identified by morphology and species identity was confirmed by sequencing.", {"entities": []}], ["Four patients had allergic bronchopulmonary aspergillosis.", {"entities": [[44, 57, "DISEASE"], [18, 57, "DISEASE"]]}], ["Forty-eight percent of asthma subjects were IgE-sensitized to one fungal allergen and 22% to \u2265 2.", {"entities": [[23, 29, "DISEASE"]]}], ["Twenty-seven different taxa of filamentous fungi were isolated from 54% of their sputa, more than one species being detected in 17%.", {"entities": []}], ["This compared with 3 (17%) healthy controls culturing any fungus ( P < 0.01).", {"entities": []}], ["Aspergillus species were most frequently cultured in isolation followed by Penicillium species.", {"entities": []}], ["Post-bronchodilator FEV 1 (% predicted) in the subjects with asthma was 71(\u00b1 25) in those with a positive fungal culture vs. 83 (\u00b1 25) in those culture-negative, ( P < 0.01).", {"entities": [[61, 67, "DISEASE"], [20, 23, "GENE"]]}], ["Numerous thermotolerant fungi other than A. fumigatus can be cultured from sputum of people with moderate-to-severe asthma; a positive culture is associated with an impaired post-bronchodilator FEV 1 , which might be partly responsible for the development of fixed airflow obstruction in asthma.", {"entities": [[116, 122, "DISEASE"], [288, 294, "DISEASE"], [194, 197, "GENE"]]}], ["Sensitization to these fungi is also common.", {"entities": []}], ["To determine, in the context of primary care preventive health services, the level of importance that Portuguese patients attribute to different preventive activities.", {"entities": []}], ["Cross-sectional study.", {"entities": []}], ["Primary Healthcare, Portugal.", {"entities": []}], ["1000 Portuguese adults selected by a stratified cluster sampling design were invited to participate in a computer-assisted telephone survey.", {"entities": []}], ["Persons with a cognitive or physical disability that hampered the ability to complete a telephone interview and being a nursing home resident or resident in any other type of collective dwelling were excluded.", {"entities": []}], ["Mean level of importance assigned to 20 different medical preventive activities, using a scale of 1\u201310, with 1 corresponding to \u2018no importance for you and your health\u2019 and 10 indicating \u2018very important\u2019.", {"entities": []}], ["The mean level of importance assigned to medical preventive activity was 7.70 (95% CI 7.60 to 7.80).", {"entities": []}], ["Routine blood and urine tests were considered the most important, with an estimated mean of 9.15 (95% CI 9.07 to 9.24), followed by female-specific interventions (Pap smear, mammography and gynaecological and breast ultrasounds), with mean importance ranging from 8.45 (95% CI 8.23 to 8.63) for mammography to 8.56 (95% CI 8.36 to 8.76) for Pap smear.", {"entities": []}], ["Advice regarding alcohol consumption (6.18; 95% CI 5.96 to 6.39) and tobacco consumption (5.99; 95% CI 5.75 to 6.23) were considered much less important.", {"entities": []}], ["Our results reveal that Portuguese patients overestimate the importance of preventive medical activities, tend to give more importance to diagnostic and laboratory tests than to lifestyle measures, do not discriminate tests that are important and evidence-based, and seem not be aware of the individualisation of risk.", {"entities": []}], ["Family physicians should be aware of these optimistic expectations, because these can influence the doctor\u2013patient relationship when discussing these interventions and incorporating personalised risk.", {"entities": []}], ["To examine the association between Type D personality and HbA1c level and to explore the mediating role of medication adherence between them in patients with type 2 diabetes mellitus (T2DM).", {"entities": [[165, 182, "DISEASE"], [158, 182, "DISEASE"]]}], ["330 patients went on to complete a self-report measure of medication adherence and the HbA1c tests.", {"entities": []}], ["Chi-square test, T test, Ordinary Least Square Regression (OLS), and Recentered Influence Function Regression (RIF) were employed.", {"entities": []}], ["Patients with Type D personality had significantly higher HbA1c value ( P < 0.01).", {"entities": []}], ["When Type D personality was operationalized as a categorical variable, SI was associated with HbA1c ( P < 0.01).", {"entities": []}], ["When NA, SI, and their interaction term were entered into regression, all of them were no longer associated with HbA1c level ( P > 0.1).", {"entities": []}], ["On the other hand, when Type D personality was operationalized as a continuous variable, only SI trait was associated with HbA1c level ( P < 0.01).", {"entities": []}], ["When NA, SI, and NA \u00d7 SI term together were entered into regression, only SI was not related to HbA1c level.", {"entities": []}], ["Furthermore, medication adherence had a significant mediation effect between Type D personality and HbA1c, accounting for 54.43% of the total effect.", {"entities": []}], ["Conclusion .", {"entities": []}], ["Type D personality was associated with HbA1c in direct and indirect ways, and medication adherence acted as a mediator role.", {"entities": []}], ["Prompt access to artemesinin-combination therapy (ACT) is not adequate unless the drug is taken according to treatment guidelines.", {"entities": []}], ["Adherence to the treatment schedule is important to preserve efficacy of the drug.", {"entities": []}], ["Although some community based studies have reported fairly high levels of adherence, data on factors influencing adherence to artemether-lumefantrine (AL) treatment schedule remain inadequate.", {"entities": []}], ["This study was carried-out to explore the provider\u2019s instructions to caretakers, caretakers\u2019 understanding of the instructions and how that understanding was likely to influence their practice with regard to adhering to AL treatment schedule.", {"entities": []}], ["A qualitative study was conducted in five villages in Kilosa district, Tanzania.", {"entities": []}], ["In-depth interviews were held with providers that included prescribers and dispensers; and caretakers whose children had just received AL treatment.", {"entities": []}], ["Information was collected on providers\u2019 instructions to caretakers regarding dose timing and how to administer AL; and caretakers\u2019 understanding of providers\u2019 instructions.", {"entities": []}], ["Mismatch was found on providers\u2019 instructions as regards to dose timing.", {"entities": []}], ["Some providers\u2019 (dogmatists) instructions were based on strict hourly schedule (conventional) which was likely to lead to administering some doses in awkward hours and completing treatment several hours before the scheduled time.", {"entities": []}], ["Other providers (pragmatists) based their instruction on the existing circumstances (contextual) which was likely to lead to delays in administering the initial dose with serious treatment outcomes.", {"entities": []}], ["Findings suggest that, the national treatment guidelines do not provide explicit information on how to address the various scenarios found in the field.", {"entities": []}], ["A communication gap was also noted in which some important instructions on how to administer the doses were sometimes not provided or were given with false reasons.", {"entities": []}], ["There is need for a review of the national malaria treatment guidelines to address local context.", {"entities": [[43, 50, "DISEASE"]]}], ["In the review, emphasis should be put on on-the-job training to address practical problems faced by providers in the course of their work.", {"entities": []}], ["Further research is needed to determine the implication of completing AL treatment prior to scheduled time.", {"entities": []}], ["Obesity is now recognised as a worldwide epidemic.", {"entities": [[0, 7, "DISEASE"]]}], ["The recent International Association for the Study of Obesity/International Obesity Taskforce (IASO/IOTF) analysis estimates that approximately 1.0 billion adults are currently overweight and a further 475 million are obese.", {"entities": [[54, 61, "DISEASE"], [76, 83, "DISEASE"]]}], ["Obesity has huge psychosocial impact with obese children and adolescents facing discrimination and stigmatization in many areas of their lives leading to body dissatisfaction, low self-esteem and depression.", {"entities": [[0, 7, "DISEASE"]]}], ["Indeed, obesity is recognised as an important risk factor for the development of several chronic diseases such as hypertension, cancer, asthma and metabolic syndrome.", {"entities": [[114, 126, "DISEASE"], [8, 15, "DISEASE"], [157, 165, "DISEASE"], [136, 142, "DISEASE"], [128, 134, "DISEASE"]]}], ["Chronic low grade systemic inflammation is considered as a hallmark of obesity and may possibly explain the link between obesity and chronic disease, in particular the increased incidence, prevalence and severity of asthma in obese individuals.", {"entities": [[71, 78, "DISEASE"], [121, 128, "DISEASE"], [216, 222, "DISEASE"]]}], ["There is now strong evidence for infiltration of immune and inflammatory cells into adipose tissue that drives systemic inflammation and subsequent end organ damage.", {"entities": []}], ["In addition to adipocytes, the key adipose tissue resident immune cells are macrophages and mast cells.", {"entities": []}], ["Immunometabolism, as an emerging field of investigation, explores the pivotal role of these immune cells in translating immunological changes to metabolic effects in obesity.", {"entities": [[166, 173, "DISEASE"]]}], ["Abundance of free fatty acids, along with other inflammatory cytokines shift the balance of metabolic homeostasis to pro-inflammatory status by influencing the development of inflammatory cell lineage, which, further exhibits distinct functional phenotypes.", {"entities": []}], ["There is emerging evidence for macrophage activation and functional polarization of an anti-inflammatory M 2 phenotype towards a pro-inflammatory M 1 phenotype of macrophages in obese adipose tissue.", {"entities": []}], ["Similarly, studies in both obese humans and murine models reveal the pathognomic presence of an increased number of mast cells in visceral adipose tissue.", {"entities": []}], ["These suggest a possible contribution of mast cells to the unique metabolome of obese asthma.", {"entities": [[86, 92, "DISEASE"]]}], ["This review examines proposed multilevel interactions between metabolic and immune systems in obese asthmatics that underlie the negative effects of obesity and may offer significant therapeutic promise.", {"entities": [[149, 156, "DISEASE"]]}], ["Reactive oxygen species (ROS) have been implicated in the pathogenesis of numerous disease processes.", {"entities": []}], ["Epithelial cells lining the respiratory airways are uniquely vulnerable regarding potential for oxidative damage due to their potential for exposure to both endogenous (e.g., mitochondrial respiration, phagocytic respiratory burst, cellular oxidases) and exogenous (e.g., air pollutants, xenobiotics, catalase negative organisms) oxidants.", {"entities": []}], ["Airway epithelial cells use several nonenzymatic and enzymatic antioxidant mechanisms to protect against oxidative insult.", {"entities": []}], ["Nonenzymatic defenses include certain vitamins and low molecular weight compounds such as thiols.", {"entities": []}], ["The enzymes superoxide dismutase, catalase, and glutatione peroxidase are major sources of antioxidant protection.", {"entities": []}], ["Other materials associated with airway epithelium such as mucus, epithelial lining fluid, and even the basement membrane/extracellular matrix may have protective actions as well.", {"entities": []}], ["When the normal balance between oxidants and antioxidants is upset, oxidant stress ensues and subsequent epithelial cell alterations or damage may be a critical component in the pathogenesis of several respiratory diseases.", {"entities": []}], ["Oxidant stress may profoundly alter lung physiology including pulmonary function (e.g., forced expiratory volumes, flow rates, and maximal inspiratory capacity), mucociliary activity, and airway reactivity.", {"entities": []}], ["ROS may induce airway inflammation; the inflammatory process may serve as an additional source of ROS in airways and provoke the pathophysiologic responses described.", {"entities": []}], ["On a more fundamental level, cellular mechanisms in the pathogenesis of ROS may involve activation of intracellular signaling enzymes including phospholipases and protein kinases stimulating the release of inflammatory lipids and cytokines.", {"entities": []}], ["Respiratory epithelium may be intimately involved in defense against, and pathophysiologic changes invoked by, ROS.", {"entities": []}], ["Multi-walled carbon nanotubes (MWCNTs) are widely used in many disciplines due to their unique physical and chemical properties.", {"entities": []}], ["Therefore, some concerns about the possible human health and environmental impacts of manufactured MWCNTs are rising.", {"entities": []}], ["We hypothesized that instillation of MWCNTs impairs pulmonary function in C57BL/6 mice due to development of lung inflammation and fibrosis.", {"entities": []}], ["MWCNTs were administered to C57BL/6 mice by oropharyngeal aspiration (1, 2, and 4 mg/kg) and we assessed lung inflammation and fibrosis by inflammatory cell infiltration, collagen content, and histological assessment.", {"entities": []}], ["Pulmonary function was assessed using a FlexiVent system and levels of Ccl3, Ccl11, Mmp13 and IL-33 were measured by RT-PCR and ELISA.", {"entities": [[71, 75, "GENE"], [77, 82, "GENE"], [84, 89, "GENE"]]}], ["Mice administered MWCNTs exhibited increased inflammatory cell infiltration, collagen deposition and granuloma formation in lung tissue, which correlated with impaired pulmonary function as assessed by increased resistance, tissue damping, and decreased lung compliance.", {"entities": []}], ["Pulmonary exposure to MWCNTs induced an inflammatory signature marked by cytokine (IL-33), chemokine (Ccl3 and Ccl11), and protease production (Mmp13) that promoted the inflammatory and fibrotic changes observed within the lung.", {"entities": [[102, 106, "GENE"], [111, 116, "GENE"], [144, 149, "GENE"]]}], ["These results further highlight the potential adverse health effects that may occur following MWCNT exposure and therefore we suggest these materials may pose a significant risk leading to impaired lung function following environmental and occupational exposures.", {"entities": []}], ["The use of animals in research and education dates back to the period when humans started to look for ways to prevent and cure ailments.", {"entities": []}], ["Most of present day's drug discoveries were possible because of the use of animals in research.", {"entities": []}], ["The dilemma to continue animal experiments in education and research continues with varied and confusing guidelines.", {"entities": []}], ["However, the animal use and their handling vary in each laboratory and educational institution.", {"entities": []}], ["It has been reported that the animals are being subjected to painful procedures in education and training unnecessarily.", {"entities": []}], ["The extensive use of animals in toxicity studies and testing dermatological preparations has raised concerns about the ways animals are sacrificed for these \u201cirrelevant experiments\u201d.", {"entities": []}], ["On the other side of the coin are scientists who advocate the relevant and judicious use of animals in research so that new discoveries can continue.", {"entities": []}], ["In this review, we discuss the evolution of the use of animals in education and research and how these have been affected in recent times owing to concerns from animal lovers and government regulations.", {"entities": []}], ["A number of computer simulation and other models have been recommended for use as alternatives to use of animals for pharmacology education.", {"entities": []}], ["In this review we also discuss some of these alternatives.", {"entities": []}], ["Previous studies have extensively documented antimicrobial and chemotactic activities of beta-defensins.", {"entities": []}], ["Human beta-defensin-2 (hBD-2) is strongly expressed in lesional psoriatic epidermis, and recently we have shown that high beta-defensin genomic copy number is associated with psoriasis susceptibility.", {"entities": [[175, 184, "DISEASE"]]}], ["It is not known, however, if biologically and pathophysiologically relevant concentrations of hBD-2 protein are present in vivo, which could support an antimicrobial and proinflammatory role of beta-defensins in lesional psoriatic epidermis.", {"entities": []}], ["We found that systemic levels of hBD-2 showed a weak but significant correlation with beta defensin copy number in healthy controls but not in psoriasis patients with active disease.", {"entities": [[143, 152, "DISEASE"]]}], ["In psoriasis patients but not in atopic dermatitis patients, we found high systemic hBD-2 levels that strongly correlated with disease activity as assessed by the PASI score.", {"entities": [[3, 12, "DISEASE"], [33, 50, "DISEASE"], [40, 50, "DISEASE"]]}], ["Our findings suggest that systemic levels in psoriasis are largely determined by secretion from involved skin and not by genomic copy number.", {"entities": [[45, 54, "DISEASE"]]}], ["Modelling of the in vivo epidermal hBD-2 concentration based on the secretion rate in a reconstructed skin model for psoriatic epidermis provides evidence that epidermal hBD-2 levels in vivo are probably well above the concentrations required for in vitro antimicrobial and chemokine-like effects.", {"entities": []}], ["Serum hBD-2 appears to be a useful surrogate marker for disease activity in psoriasis.", {"entities": [[76, 85, "DISEASE"]]}], ["The discrepancy between hBD-2 levels in psoriasis and atopic dermatitis could explain the well known differences in infection rate between these two diseases.", {"entities": [[40, 49, "DISEASE"], [54, 71, "DISEASE"], [61, 71, "DISEASE"]]}], ["In June and July 2016, we identified 8 adults and 17 children with respiratory enterovirus D68 infections.", {"entities": []}], ["Thirteen children required intensive care unit admission because of respiratory insufficiency, and 1 had concomitant acute flaccid myelitis.", {"entities": [[131, 139, "DISEASE"]]}], ["Phylogenetic analysis showed that all of 20 sequences obtained belong to the recently described clade B3.", {"entities": []}], ["The first antenatal clinic (ANC) visit helps to distinguish pregnant women who require standard care, from those with specific problems and so require special attention.", {"entities": []}], ["There are protocols to guide care providers to provide optimal care to women during ANC.", {"entities": []}], ["Our objectives were to determine the level of provider adherence to first antenatal visit guidelines in the Safe Motherhood Protocol (SMP), and assess patient factors that determine complete provider adherence.", {"entities": []}], ["This cross-sectional study is part of a cohort study that recruited women who delivered in eleven health facilities and who had utilized antenatal care services during their pregnancy in the Greater Accra region of Ghana.", {"entities": []}], ["A record review of the first antenatal visit of participants was carried out to assess the level of adherence to the SMP, using a thirteen-point checklist.", {"entities": []}], ["Information on their socio-demographic characteristics and previous pregnancy history was collected using a questionnaire.", {"entities": []}], ["Percentages of adherence levels and baseline characteristics were estimated and cluster-adjusted odds ratios (OR) calculated to identify determinants.", {"entities": []}], ["A total of 948 women who had delivered in eleven public facilities were recruited with a mean age (SD) of 28.2 (5.4) years.", {"entities": []}], ["Overall, complete adherence to guidelines pertained to only 48.1% of pregnant women.", {"entities": []}], ["Providers were significantly more likely to completely adhere to guidelines when caring for multiparous women [OR = 5.43 (1.69\u201317.44), p<0 .", {"entities": []}], ["01 ] but less likely to do so when attending to women with history of previous pregnancy complications [OR = 0.50 (0.33\u20130.75), p<0 .", {"entities": []}], ["Complete provider adherence to first antenatal visit guidelines is low across different facility types in the Greater Accra region of Ghana and is determined by parity and history of previous pregnancy complication.", {"entities": []}], ["Providers should be trained and supported to adhere to the guidelines during provision of care to all pregnant women.", {"entities": []}], ["Tocopherols are lipid soluble antioxidants that exist as eight structurally different isoforms.", {"entities": []}], ["The intake of \u03b3-tocopherol is higher than \u03b1-tocopherol in the average US diet.", {"entities": []}], ["The clinical results of the effects of vitamin E as a cancer preventive agent have been inconsistent.", {"entities": [[54, 60, "DISEASE"]]}], ["All published clinical trials with vitamin E have used \u03b1-tocopherol.", {"entities": []}], ["Recent epidemiological, experimental and molecular studies suggest that \u03b3-tocopherol may be a more potent chemopreventive form of vitamin E compared to the more-studied \u03b1-tocopherol.", {"entities": []}], ["\u03b3-Tocopherol exhibits differences in its ability to detoxify nitrogen dioxide, growth inhibitory effects on selected cancer cell lines, inhibition of neoplastic transformation in embryonic fibroblasts, and inhibition of cyclooxygenase-2 (COX-2) activity in macrophages and epithelial cells.", {"entities": [[117, 123, "DISEASE"]]}], ["Peroxisome proliferator activator receptor \u03b3 (PPAR\u03b3) is a promising molecular target for colon cancer prevention.", {"entities": [[89, 101, "DISEASE"], [95, 101, "DISEASE"]]}], ["Upregulation of PPAR\u03b3 activity is anticarcinogenic through its effects on downstream genes that affect cellular proliferation and apoptosis.", {"entities": []}], ["The thiazolidine class of drugs are powerful PPAR\u03b3 ligands.", {"entities": []}], ["Vitamin E has structural similarity to the thiazolidine, troglitazone.", {"entities": []}], ["In this investigation, we tested the effects of both \u03b1 and \u03b3 tocopherol on the expression of PPAR\u03b3 mRNA and protein in SW 480 colon cancer cell lines.", {"entities": [[126, 138, "DISEASE"], [132, 138, "DISEASE"]]}], ["We also measured the intracellular concentrations of vitamin E in SW 480 colon cancer cell lines.", {"entities": [[73, 85, "DISEASE"], [79, 85, "DISEASE"]]}], ["We have discovered that the \u03b1 and \u03b3 isoforms of vitamin E upregulate PPAR\u03b3 mRNA and protein expression in the SW480 colon cancer cell lines.", {"entities": [[116, 128, "DISEASE"], [122, 128, "DISEASE"]]}], ["\u03b3-Tocopherol is a better modulator of PPAR\u03b3 expression than \u03b1-tocopherol at the concentrations tested.", {"entities": []}], ["Intracellular concentrations increased as the vitamin E concentration added to the media was increased.", {"entities": []}], ["Further, \u03b3-tocopherol-treated cells have higher intracellular tocopherol concentrations than those treated with the same concentrations of \u03b1-tocopherol.", {"entities": []}], ["Our data suggest that both \u03b1 and \u03b3 tocopherol can upregulate the expression of PPAR\u03b3 which is considered an important molecular target for colon cancer chemoprevention.", {"entities": [[139, 151, "DISEASE"], [145, 151, "DISEASE"]]}], ["We show that the expression of PPAR\u03b3 mRNA and protein are increased and these effects are more pronounced with \u03b3-tocopherol.", {"entities": []}], ["\u03b3-Tocopherol's ability to upregulate PPAR\u03b3 expression and achieve higher intracellular concentrations in the colonic tissue may be relevant to colon cancer prevention.", {"entities": [[143, 155, "DISEASE"], [149, 155, "DISEASE"]]}], ["We also show that the intracellular concentrations of \u03b3-tocopherol are several fold higher than \u03b1-tocopherol.", {"entities": []}], ["Further work on other colon cancer cell lines are required to quantitate differences in the ability of these forms of vitamin E to induce apoptosis, suppress cell proliferation and act as PPAR ligands as well as determine their effects in conjunction with other chemopreventive agents.", {"entities": [[22, 34, "DISEASE"], [28, 34, "DISEASE"]]}], ["Upregulation of PPAR\u03b3 by the tocopherols and in particular by \u03b3-tocopherol may have relevance not only to cancer prevention but also to the management of inflammatory and cardiovascular disorders.", {"entities": [[106, 112, "DISEASE"]]}], ["MAVIDOS is a randomised, double-blind, placebo-controlled trial (ISRCTN82927713, registered 2008 Apr 11), funded by Arthritis Research UK, MRC, Bupa Foundation and NIHR.", {"entities": []}], ["Osteoporosis is a major public health problem as a result of associated fragility fractures.", {"entities": [[0, 12, "DISEASE"]]}], ["Skeletal strength increases from birth to a peak in early adulthood.", {"entities": []}], ["This peak predicts osteoporosis risk in later life.", {"entities": [[19, 31, "DISEASE"]]}], ["Vitamin D insufficiency in pregnancy is common (31% in a recent Southampton cohort) and predicts reduced bone mass in the offspring.", {"entities": []}], ["In this study we aim to test whether offspring of mothers supplemented with vitamin D in pregnancy have higher bone mass at birth than those whose mothers were not supplemented.", {"entities": []}], ["Women have their vitamin D status assessed after ultrasound scanning in the twelfth week of pregnancy at 3 trial centres (Southampton, Sheffield, Oxford).", {"entities": []}], ["Women with circulating 25(OH)-vitamin D levels 25-100 nmol/l are randomised in a double-blind design to either oral vitamin D supplement (1000 IU cholecalciferol/day, n = 477) or placebo at 14 weeks (n = 477).", {"entities": []}], ["Questionnaire data include parity, sunlight exposure, dietary information, and cigarette and alcohol consumption.", {"entities": []}], ["At 19 and 34 weeks maternal anthropometry is assessed and blood samples taken to measure 25(OH)-vitamin D, PTH and biochemistry.", {"entities": [[107, 110, "GENE"]]}], ["At delivery venous umbilical cord blood is collected, together with umbilical cord and placental tissue.", {"entities": []}], ["The babies undergo DXA assessment of bone mass within the first 14 days after birth, with the primary outcome being whole body bone mineral content adjusted for gestational age and age.", {"entities": []}], ["Children are then followed up with yearly assessment of health, diet, physical activity and anthropometric measures, with repeat assessment of bone mass by DXA at age 4 years.", {"entities": []}], ["As far as we are aware, this randomised trial is one of the first ever tests of the early life origins hypothesis in human participants and has the potential to inform public health policy regarding vitamin D supplementation in pregnancy.", {"entities": []}], ["It will also provide a valuable resource in which to study the influence of maternal vitamin D status on other childhood outcomes such as glucose tolerance, blood pressure, cardiovascular function, IQ and immunology.", {"entities": []}], ["Evidence sustains a role for the acute-phase protein serum amyloid A (SAA) in carcinogenesis and metastasis, and the protein has been suggested as a marker for tumor progression.", {"entities": []}], ["Nevertheless, the demonstration of a direct activity of SAA on tumor cells is still incipient.", {"entities": []}], ["We have investigated the effect of human recombinant SAA (rSAA) on two human glioma cell lines, A172 and T98G.", {"entities": []}], ["rSAA stimulated the [", {"entities": []}], ["Having a child hospitalized is a stressful event for parents.", {"entities": []}], ["Previous studies have found increased stress in families with children affected by different kinds of pathologies, and analyzed disease related objective variables producing stress.", {"entities": []}], ["However, most of these studies recruited caregivers of children with chronic or serious illnesses, and focused on evaluation of objective environmental stressors and did not consider subjective \"perception\" of stress.", {"entities": []}], ["The aim of this study was to investigate perception of acute stress in caregivers taking care of children without serious physical damage that were hospitalized for short periods.", {"entities": []}], ["Moreover, some variables, such as recreational and school services offered to children, influencing perception of cognitive, physiological and behavioral state relating to the sensation of \"being stressed\" were analyzed.", {"entities": []}], ["This study was realized with a sample of caregivers of children hospitalized for mild acute diseases.", {"entities": []}], ["Research was conducted using two standardized tests, PSM (Psychological Stress Measure) and STAI (State Trait Anxiety Inventory), whose characteristics of reliability and validity had been successfully established.", {"entities": []}], ["Present data showed that caregivers of hospitalized children perceived high levels of stress and anxiety.", {"entities": []}], ["Perception of stress was influenced by the degree of kindred with patients, length of hospitalization, and, notably, participation in some of the activities offered to children, mainly school services.", {"entities": []}], ["Findings showed that child hospitalization is a stressful event for caregivers, even if hospitalization is for middle and transient pathologies.", {"entities": []}], ["Perception of stress was influenced by length of hospitalization, and by degree of kindred.", {"entities": []}], ["Findings even suggest that some services offered to children can modulate caregivers' perception of stress and impact of hospitalization.", {"entities": []}], ["Caregivers whose children used school services describe themselves as less irritable and with higher emotional control compared to other caregivers.", {"entities": []}], ["Considering the importance of education in a child's life, the possibility to continue school activities helped caregivers to feel less under pressure.", {"entities": []}], ["In the light of this finding, amelioration of scholastic activities in pediatric departments may represent a critical point in order to provide a more agreeable hospital stay for children and their caregivers and, as a consequence, improve family involvement in care management.", {"entities": []}], ["Excessive exposure to glucocorticoids causes osteoporosis in children and adults.", {"entities": [[45, 57, "DISEASE"]]}], ["Occlusal disharmony is known to induce an increase in serum corticosteroid levels in murine models, but the influence of occlusal disharmony-induced stress on the bone mass during the growth period has not yet been clarified.", {"entities": []}], ["The purpose of this study was to investigate whether occlusal disharmony-induced stress decreases bone mass.", {"entities": []}], ["Five-week-old C57BL/6J male mice were used.", {"entities": []}], ["A 0.5-mm increase in the vertical height of occlusion was used to induce occlusal disharmony for a period of 7 days.", {"entities": []}], ["Serum corticosterone levels were significantly higher on post-induction day 7, with radiological evidence of osteopenia of the third lumbar vertebra and long bones of the hind limbs.", {"entities": []}], ["Osteopenia was associated with a reduction of the mechanical properties of the tibia and femur, with significant suppression of bone formation parameters and an increase in bone resorption parameters, as evaluated by bone histomorphometric analysis of the tibial/femur metaphysis.", {"entities": []}], ["Our findings at the level of bones were supported by our assessment of serum markers of systemic metabolism.", {"entities": []}], ["Therefore, occlusal disharmony-induced stress may lead to osteopenia and reduce the mechanical strength of bone through an increase in serum glucocorticoid levels in mice.", {"entities": []}], ["The aim of this study was to evaluate central corneal thickness in patients with atopic keratoconjunctivitis.", {"entities": [[88, 108, "DISEASE"]]}], ["The study was conducted in the Atat\u00fcrk University School of Medicine between April 2011 and June 2013.", {"entities": []}], ["The study group included 60 eyes of 30 patients with atopic keratoconjunctivitis.", {"entities": [[60, 80, "DISEASE"]]}], ["Sixty eyes of 30 healthy individuals without any ophthalmic or systemic pathology were used as a control group.", {"entities": []}], ["The central corneal thickness was measured with ultrasonic pachymetry.", {"entities": []}], ["In each group, all subjects included in the study had a best corrected visual acuity (BCVA) of 20/25 or better.", {"entities": []}], ["In the study group past medical histories revealed eczema in 19 patients, asthma in 16, and atopic dermatitis in 15.", {"entities": [[92, 109, "DISEASE"], [74, 80, "DISEASE"], [99, 109, "DISEASE"]]}], ["During clinical examination cicatricial conjunctivitis was noted in 5 patients, giant papillae in 4, symblepharon in 2, and entropion in 2.", {"entities": [[124, 133, "DISEASE"], [40, 54, "DISEASE"]]}], ["The mean central corneal thickness was 523.45\u00b118.03 \u03bcm in the study group (mean age: 37.05\u00b15.7 years) and 540.30\u00b138.91 \u03bcm in the control group (mean age: 36.55\u00b17.1 years), and the difference was statistically significant (p<0.001).", {"entities": []}], ["Evaluation of corneal thickness is important in situations such as corneal refractive surgery and contact lens use, and is an essential parameter in a wide range of ocular disorders, including glaucoma and keratoconus.", {"entities": [[206, 217, "DISEASE"], [193, 201, "DISEASE"]]}], ["Therefore, ophthalmologists should be aware of the low central corneal thickness in patients with atopic keratoconjunctivitis.", {"entities": [[105, 125, "DISEASE"]]}], ["Health status is a prognostic factor included in the assessment of chronic obstructive pulmonary disease (COPD).", {"entities": [[67, 104, "DISEASE"]]}], ["The aim of our study was to examine the associations of clinical factors with change in health status over a 7-year follow-up period.", {"entities": []}], ["In 2005, 970 randomly selected primary and secondary care patients with a COPD diagnosis completed questionnaires including the Clinical COPD Questionnaire (CCQ); and in 2012, 413 completed the CCQ questionnaire again.", {"entities": []}], ["Linear regression used difference in mean total CCQ score between 2005 and 2012 as the dependent variable.", {"entities": []}], ["Independent variables were CCQ score at baseline 2005, sex, age, educational level, body mass index (BMI), smoking status, heart disease, diabetes, depression, number of exacerbations in the previous 6 months, dyspnoea (modified Medical Research Council (mMRC)).", {"entities": [[123, 136, "DISEASE"]]}], ["Health status worsened from mean total CCQ (s.d.)", {"entities": []}], ["2.03 (1.26) in 2005 to 2.16 (1.37) in 2012 ( P =0.011).", {"entities": []}], ["In linear regression with adjustment for baseline CCQ; older age, lower education, higher mMRC and BMI below 25\u2009kg/m P <0.0001).", {"entities": []}], ["A higher level of dyspnoea and lower weight were associated with worse health status in COPD.", {"entities": []}], ["Strategies for decreasing dyspnoea and awareness of the possible increased risk of worsening disease in under- and normal-weight COPD patients are clinically important.", {"entities": []}], ["Indigenous populations have poorer health outcomes compared to their non-Indigenous counterparts.", {"entities": []}], ["The evolution of Indigenous primary health care services arose from mainstream health services being unable to adequately meet the needs of Indigenous communities and Indigenous peoples often being excluded and marginalised from mainstream health services.", {"entities": []}], ["Part of the solution has been to establish Indigenous specific primary health care services, for and managed by Indigenous peoples.", {"entities": []}], ["There are a number of reasons why Indigenous primary health care services are more likely than mainstream services to improve the health of Indigenous communities.", {"entities": []}], ["Their success is partly due to the fact that they often provide comprehensive programs that incorporate treatment and management, prevention and health promotion, as well as addressing the social determinants of health.", {"entities": []}], ["However, there are gaps in the evidence base including the characteristics that contribute to the success of Indigenous primary health care services in providing comprehensive primary health care.", {"entities": []}], ["This systematic scoping review aims to identify the characteristics of Indigenous primary health care service delivery models.", {"entities": []}], ["This systematic scoping review was led by an Aboriginal researcher, using the Joanna Briggs Institute Scoping Review Methodology.", {"entities": []}], ["All published peer-reviewed and grey literature indexed in PubMed, EBSCO CINAHL, Embase, Informit, Mednar, and Trove databases from September 1978 to May 2015 were reviewed for inclusion.", {"entities": []}], ["Studies were included if they describe the characteristics of service delivery models implemented within an Indigenous primary health care service.", {"entities": []}], ["Sixty-two studies met the inclusion criteria.", {"entities": []}], ["Data were extracted and then thematically analysed to identify the characteristics of Indigenous PHC service delivery models.", {"entities": []}], ["Culture was the most prominent characteristic underpinning all of the other seven characteristics which were identified \u2013 accessible health services, community participation, continuous quality improvement, culturally appropriate and skilled workforce, flexible approach to care, holistic health care, and self-determination and empowerment.", {"entities": []}], ["While the eight characteristics were clearly distinguishable within the review, the interdependence between each characteristic was also evident.", {"entities": []}], ["These findings were used to develop a new Indigenous PHC Service Delivery Model, which clearly demonstrates some of the unique characteristics of Indigenous specific models.", {"entities": []}], ["The online version of this article (10.1186/s12992-018-0332-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Chronic progressive external ophthalmoplegia (CPEO) is a relatively common mitochondrial disorder.", {"entities": [[29, 44, "DISEASE"]]}], ["Weakness of the extra-ocular, limb girdle and laryngeal muscles are established clinical features.", {"entities": []}], ["Respiratory muscle involvement however has never been studied systematically, even though respiratory complications are one of the main causes of death.", {"entities": []}], ["We therefore determined the prevalence and nature of respiratory muscle involvement in 23 patients with genetically confirmed CPEO.", {"entities": []}], ["The main finding was decreased respiratory muscle strength, both expiratory (76.8% of predicted, p \u00a0=\u00a00.002) and inspiratory (79.5% of predicted, p \u00a0=\u00a00.004).", {"entities": []}], ["Although the inspiratory vital capacity (92.5% of predicted, p \u00a0=\u00a00.021) and the forced expiratory volume in 1\u00a0s (89.3% of predicted, p \u00a0=\u00a00.002) were below predicted values, both were still within the normal range in the majority of patients.", {"entities": []}], ["Expiratory weakness was associated with a decreased vital capacity (\u03c1\u00a0=\u00a00.502, p \u00a0=\u00a00.015) and decreased peak expiratory flow (\u03c1\u00a0=\u00a00.422, p \u00a0=\u00a00.045).", {"entities": []}], ["Moreover, expiratory muscle strength was lower in patients with limb girdle weakness (62.6\u00a0\u00b1\u00a026.1% of predicted vs. 98.9\u00a0\u00b1\u00a022.5% in patients with normal limb girdle strength, p \u00a0=\u00a00.003), but was not associated with other clinical features, subjective respiratory complaints, disease severity or disease duration.", {"entities": []}], ["Since respiratory involvement in CPEO is associated with severe morbidity and mortality, the present data justify periodic assessment of respiratory functions in all CPEO patients.", {"entities": []}], ["Many in vitro studies have shown that adenosine (Ado) can induce vascular endothelial growth factor (VEGF) mRNA and protein expression and stimulate endothelial proliferation.", {"entities": []}], ["In the present study, we seek to determine whether Ado can increase circulating levels of VEGF protein in the intact human.", {"entities": []}], ["Five outpatients 49.3 \u00b1 6.7 years of age and weighing 88.2 \u00b1 8.5 kg were selected.", {"entities": []}], ["They were given a 6 min intravenous infusion of Ado (0.14 mg kg Plasma VEGF concentration averaged 20.3 \u00b1 2.0 pg ml We conclude from these preliminary findings that intravenous infusion of adenosine can increase plasma levels of VEGF in humans.", {"entities": []}], ["The diagnosis of patients presenting to the emergency department with acute heart failure (AHF) is challenging due to the similarity of AHF symptoms to other conditions such as chronic obstructive pulmonary disease and pneumonia.", {"entities": [[219, 228, "DISEASE"], [177, 214, "DISEASE"]]}], ["Additionally, because AHF is most common in an older population, the presentation of coexistent pathologies further increases the challenge of making an accurate diagnosis and selecting the most appropriate treatment.", {"entities": []}], ["Delays in the diagnosis and treatment of AHF can result in worse outcomes and higher healthcare costs.", {"entities": []}], ["Rapid initiation of treatment is thus necessary for optimal disease management.", {"entities": []}], ["Early treatment decisions for patients with AHF can be guided by risk-stratification models based on initial clinical data, including blood pressure, levels of troponin, blood urea nitrogen, serum creatinine, B-type natriuretic peptide, and ultrasound.", {"entities": []}], ["In this review, we discuss methods for differentiating high-risk and low-risk patients and provide guidance on how treatment decisions can be informed by risk-level assessment.", {"entities": []}], ["Through the use of these approaches, emergency physicians can play an important role in improving patient management, preventing unnecessary hospitalizations, and lowering healthcare costs.", {"entities": []}], ["This review differs from others published recently on the topic of treating AHF by providing a detailed examination of the clinical utility of diagnostic tools for the differentiation of dyspneic patients such as bedside ultrasound, hemodynamic changes, and interrogation of implantable cardiac devices.", {"entities": []}], ["In addition, our clinical guidance on considerations for initial pharmacologic therapy in the undifferentiated patient is provided.", {"entities": []}], ["It is crucial for emergency physicians to achieve an early diagnosis of AHF and initiate therapy in order to reduce morbidity, mortality, and healthcare costs.", {"entities": []}], ["Particle size and surface chemistry are potential determinants of silver nanoparticle (AgNP) respiratory toxicity that may also depend on the lung inflammatory state.", {"entities": []}], ["We compared the effects of intratracheally-administered AgNPs (20nm and 110nm; polyvinylpyrrolidone (PVP) and citrate-capped; 0.1 mg/Kg) in Brown-Norway (BN) and Sprague-Dawley (SD) rats.", {"entities": []}], ["In BN rats, there was both a neutrophilic and eosinophilic response, while in SD rats, there was a neutrophilic response at day 1, greatest for the 20nm citrate-capped AgNPs.", {"entities": []}], ["Eosinophilic cationic protein was increased in bronchoalveolar lavage (BAL) in BN and SD rats on day 1.", {"entities": []}], ["BAL protein and malondialdehyde levels were increased in BN rats at 1 and 7 days, and BAL KC, CCL11 and IL-13 levels at day 1, with increased expression of CCL11 in lung tissue.", {"entities": [[94, 99, "GENE"], [156, 161, "GENE"], [94, 99, "GENE"], [156, 161, "GENE"]]}], ["Pulmonary resistance increased and compliance decreased at day 1, with persistence at day 7.", {"entities": []}], ["The 20nm, but not the 110 nm, AgNPs increased bronchial hyperresponsiveness on day 1, which continued at day 7 for the citrate-capped AgNPs only.", {"entities": []}], ["The 20nm versus the 110 nm size were more proinflammatory in terms of neutrophil influx, but there was little difference between the citrate-capped versus the PVP-capped AgNPs.", {"entities": []}], ["AgNPs can induce pulmonary eosinophilic and neutrophilic inflammation with bronchial hyperresponsiveness, features characteristic of asthma.", {"entities": [[133, 139, "DISEASE"]]}], ["Inflammation is considered to play a central role in a diverse range of disease outcomes associated with exposure to various types of inhalable particulates.", {"entities": []}], ["The initial mechanisms through which particles trigger cellular responses leading to activation of inflammatory responses are crucial to clarify in order to understand what physico-chemical characteristics govern the inflammogenic activity of particulate matter and why some particles are more harmful than others.", {"entities": []}], ["Recent research suggests that molecular triggering mechanisms involved in activation of proinflammatory genes and onset of inflammatory reactions by particles or soluble particle components can be categorized into direct formation of reactive oxygen species (ROS) with subsequent oxidative stress, interaction with the lipid layer of cellular membranes, activation of cell surface receptors, and direct interactions with intracellular molecular targets.", {"entities": []}], ["The present review focuses on the immediate effects and responses in cells exposed to particles and central down-stream signaling mechanisms involved in regulation of proinflammatory genes, with special emphasis on the role of oxidant and non-oxidant triggering mechanisms.", {"entities": []}], ["Importantly, ROS act as a central second-messenger in a variety of signaling pathways.", {"entities": []}], ["Even non-oxidant mediated triggering mechanisms are therefore also likely to activate downstream redox-regulated events.", {"entities": []}], ["Endotoxin, a component of the cell walls of gram-negative bacteria, is a contaminant in organic dusts (house dust) and aerosols.", {"entities": []}], ["In humans, small amounts of endotoxin may cause a local inflammatory response.", {"entities": []}], ["Exhaled nitric oxide (eNO) levels, an inflammation indicator, are associated with the pH values of exhaled breath condensate (EBC).", {"entities": []}], ["This study evaluated seasonal changes on indoor endotoxin concentrations in homes and the relationships between endotoxin exposure and eNO/EBC pH levels for healthy children and children with allergy-related respiratory diseases.", {"entities": []}], ["In total, 34 children with allergy-related respiratory diseases and 24 healthy children were enrolled.", {"entities": []}], ["Indoor air quality measurements and dust sample analysis for endotoxin were conducted once each season inside 58 surveyed homes.", {"entities": []}], ["The eNO, EBC pH levels, and pulmonary function of the children were also determined.", {"entities": []}], ["The highest endotoxin concentrations were on kitchen floors of homes of children with allergy-related respiratory diseases and healthy children, and on bedroom floors of homes of asthmatic children and healthy children.", {"entities": []}], ["Seasonal changes existed in endotoxin concentrations in dust samples from homes of children with allergic rhinitis, with or without asthma, and in EBC pH values among healthy children and those with allergy-related respiratory diseases.", {"entities": [[97, 114, "DISEASE"], [106, 114, "DISEASE"], [132, 138, "DISEASE"]]}], ["Strong relationships existed between endotoxin exposure and EBC pH values in children with allergic rhinitis.", {"entities": [[91, 108, "DISEASE"], [100, 108, "DISEASE"]]}], ["Radiation-induced lung injury (RILI) is a potentially fatal and dose-limiting complication of thoracic radiotherapy.", {"entities": []}], ["This study was to investigate the protective effects of grape seed pro-anthocyanidins (GSPs), an efficient antioxidant and anti-carcinogenic agent, on RILI.", {"entities": []}], ["In our study, it was demonstrated that acute and late RILI was ameliorated after GSPs treatment possibly through suppressing TGF-\u03b21/Smad3/Snail signalling pathway and modulating the levels of cytokines (interferon-\u03b3, IL-4 and IL-13) derived from Th1/Th2 cells.", {"entities": []}], ["In addition, a sustained high level of PGE2 was also maintained by GSPs treatment to limited fibroblast functions.", {"entities": []}], ["As shown by electron spin resonance spectrometry, GSPs could scavenge hydroxyl radical (\u2022OH) in a dose-dependent manner, which might account for the mitigation of lipid peroxidation and consequent apoptosis of lung cells.", {"entities": []}], ["In vitro , GSPs radiosensitized lung cancer cell A549 while mitigating radiation injury on normal alveolar epithelial cell RLE-6TN.", {"entities": [[32, 43, "DISEASE"], [37, 43, "DISEASE"]]}], ["In conclusion, the results showed that GSPs protects mice from RILI through scavenging free radicals and modulating RILI-associated cytokines, suggesting GSPs as a novel protective agent in RILI.", {"entities": []}], ["High antibiotic resistance is described in atypical Mycobacteriosis, mainly by Mycobacterium avium complex (MAC).", {"entities": []}], ["A randomized, double-blind, placebo-controlled clinical trial was carried out in two hospitals to evaluate the effect of interferon (IFN) gamma as immunoadjuvant to chemotherapy on patients with atypical mycobacteria lung disease.", {"entities": [[217, 229, "DISEASE"]]}], ["Patients received placebo or 1 \u00d7 10 Eighteen patients were included in the IFN group and 14 received placebo.", {"entities": []}], ["Groups were homogeneous at entry; average age was 60 years, 75% men, 84% white; MAC infection prevailed (94%).", {"entities": []}], ["At the end of treatment, 72% of patients treated with IFN gamma were evaluated as complete responders, but only 36% in the placebo group.", {"entities": []}], ["The difference was maintained during follow-up.", {"entities": []}], ["A more rapid complete response was obtained in the IFN group (5 months before), with a significantly earlier improvement in respiratory symptoms and pulmonary lesions reduction.", {"entities": []}], ["Disease-related deaths were 35.7% of the patients in the placebo group and only 11.1% in the IFN group.", {"entities": []}], ["Three patients in the IFN group normalized their globular sedimentation rate values.", {"entities": []}], ["Although differences in bacteriology were not significant during the treatment period, some patients in the placebo group converted again to positive during follow-up.", {"entities": []}], ["Significant increments in serum TGF-beta and advanced oxidation protein products were observed in the placebo group but not among IFN receiving patients.", {"entities": []}], ["Treatments were well tolerated.", {"entities": []}], ["Flu-like symptoms predominated in the IFN gamma group.", {"entities": []}], ["No severe events were recorded.", {"entities": []}], ["These data suggest that IFN gamma is useful and well tolerated as adjuvant therapy in patients with pulmonary atypical Mycobacteriosis, predominantly MAC.", {"entities": []}], ["Further wider clinical trials are encouraged.", {"entities": []}], ["Current Controlled Trials ISRCTN70900209.", {"entities": []}], ["The receptor for advanced glycation endproducts (RAGE) is highly expressed in the lung but its physiological functions in this organ is still not completely understood.", {"entities": []}], ["To determine the contribution of RAGE to physiological functions of the lung, we analyzed pulmonary mechanics and structure of wildtype and RAGE deficient (RAGE in vitro conditions.", {"entities": []}], ["Stimulation of interferone-y (IFNy)-activated alveolar macrophages deficient for RAGE with Toll-like receptor (TLR) ligands resulted in significantly decreased release of proinflammatory cytokines and chemokines.", {"entities": []}], ["Exposure to chronic cigarette smoke did not affect emphysema-like changes in lung parenchyma in RAGE", {"entities": []}], ["Active smoking is a major preventable public health problem and an established critical factor for epigenetic modification.", {"entities": []}], ["In this systematic review, we identified 17 studies addressing the association of active smoking exposure with methylation modifications in blood DNA, including 14 recent epigenome-wide association studies (EWASs) and 3 gene-specific methylation studies (GSMSs) on the gene regions identified by EWASs.", {"entities": []}], ["Overall, 1460 smoking-associated CpG sites were identified in the EWASs, of which 62 sites were detected in multiple (\u22653) studies.", {"entities": []}], ["The three most frequently reported CpG sites (genes) in whole blood samples were cg05575921 ( AHRR ), cg03636183 ( F2RL3 ), and cg19859270 ( GPR15 ), followed by other loci within intergenic regions 2q37.1 and 6p21.33 .", {"entities": [[94, 98, "GENE"], [115, 120, "GENE"], [141, 146, "GENE"]]}], ["These significant smoking-related genes were further assessed by specific methylation assays in three GSMSs and reflected not only current but also lifetime or long-term exposure to active smoking.", {"entities": []}], ["In conclusion, this review summarizes the evidences for the use of blood DNA methylation patterns as biomarkers of smoking exposure for research and clinical practice.", {"entities": []}], ["In particular, it provides a reservoir for constructing a smoking exposure index score which could be used to more precisely quantify long-term smoking exposure and evaluate the risks of smoking-induced diseases.", {"entities": []}], ["The online version of this article (doi:10.1186/s13148-015-0148-3) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Inflammation of the prostate is strongly correlated with development of lower urinary tract symptoms and several studies have implicated prostatic fibrosis in the pathogenesis of bladder outlet obstruction.", {"entities": []}], ["It has been postulated that inflammation induces prostatic fibrosis but this relationship has never been tested.", {"entities": []}], ["Here, we characterized the fibrotic response to inflammation in a mouse model of chronic bacterial-induced prostatic inflammation.", {"entities": []}], ["Transurethral instillation of the uropathogenic E. coli into C3H/HeOuJ male mice induced persistent prostatic inflammation followed by a significant increase in collagen deposition and hydroxyproline content.", {"entities": []}], ["This fibrotic response to inflammation was accompanied with an increase in collagen synthesis determined by the incorporation of Col1a1, Col1a2, Col3a1, Mmp2, Mmp9 , and Lox .", {"entities": [[129, 135, "GENE"], [137, 143, "GENE"], [145, 151, "GENE"], [153, 157, "GENE"], [159, 163, "GENE"]]}], ["Correlation analysis revealed a positive correlation of inflammation severity with collagen deposition and immunohistochemical staining revealed that CD45+VIM+ fibrocytes were abundant in inflamed prostates at the time point coinciding with increased collagen synthesis.", {"entities": []}], ["Furthermore, flow cytometric analysis demonstrated an increased percentage of these CD45+VIM+ fibrocytes among collagen type I expressing cells.", {"entities": []}], ["These data show\u2013for the first time\u2013that chronic prostatic inflammation induces collagen deposition and implicates fibrocytes in the fibrotic process.", {"entities": []}], ["This multi-country prospective study of infants aged <1\u00a0year aims to assess the frequency of influenza virus and respiratory syncytial virus (RSV) infections associated with hospitalizations, to describe clinical features and antibody response to infection, and to examine predictors of very severe disease requiring intensive care.", {"entities": [[93, 102, "DISEASE"]]}], ["We are enrolling a hospital-based cohort and a sample of non-ill infants in four countries (Albania, Jordan, Nicaragua, and the Philippines) using a common protocol.", {"entities": []}], ["We are currently starting year 2 of a 2- to 3-year study and will enroll approximately 3,000 infants hospitalized for any acute illness (respiratory or non-respiratory) during periods of local influenza and/or RSV circulation.", {"entities": [[193, 202, "DISEASE"]]}], ["After informed consent and within 24\u00a0h of admission, we collect blood and respiratory specimens and conduct an interview to assess socio-demographic characteristics, medical history, and symptoms of acute illness (onset \u226410\u00a0days).", {"entities": []}], ["Vital signs, interventions, and medications are documented daily through medical record abstraction.", {"entities": []}], ["A follow-up health assessment and collection of convalescent blood occurs 3-5 weeks after enrollment.", {"entities": []}], ["Influenza and RSV infection is confirmed by singleplex real time reverse transcriptase polymerase chain reaction (rRT-PCR) assays.", {"entities": [[0, 9, "DISEASE"]]}], ["Serologic conversion will be assessed comparing acute and convalescent sera using hemagglutination inhibition assay for influenza antibodies and enzyme-linked immunosorbent assay (ELISA) for RSV.", {"entities": [[120, 129, "DISEASE"]]}], ["Concurrent with hospital-based enrollment, respiratory specimens are also being collected (and tested by rRT-PCR) from approximately 1,400 non-ill infants aged <1\u00a0year during routine medical or preventive care.", {"entities": []}], ["The Influenza and RSV in Infants Study (IRIS) promises to expand our knowledge of the frequency, clinical features, and antibody profiles of serious influenza and RSV disease among infants aged <1\u00a0year, quantify the proportion of infections that may be missed by traditional surveillance, and inform decisions about the potential value of existing and new vaccines and other prevention and treatment strategies.", {"entities": [[4, 13, "DISEASE"], [149, 158, "DISEASE"]]}], ["Lactobacillus plantarum WCFS 1 is one of the best studied Lactobacilli, notably as its genome was unravelled over 12\u00a0years ago.", {"entities": []}], ["L.\u00a0plantarum WCFS 1 can be grown to high densities, is amenable to genetic transformation and highly robust with a relatively high survival rate during the gastrointestinal passage.", {"entities": []}], ["In this review, we present and discuss the main insights provided by the functional genomics research on L.\u00a0plantarum WCFS 1 with specific attention for the molecular mechanisms related to its interaction with the human host and its potential to modify the immune system, and induce other health\u2010related benefits.", {"entities": []}], ["Whereas most insight has been gained in mouse and other model studies, only\u00a0five human studies have been reported with L.\u00a0plantarum WCFS 1.", {"entities": []}], ["Hence NCIMB 8826 (the parental strain of L.\u00a0plantarum WCFS 1) in human trials as to capitalize on the wealth of knowledge that is summarized here.", {"entities": []}], ["Mechanistic pathways linking maternal polyunsaturated fatty acid (PUFA) status with gestational length are poorly delineated.", {"entities": []}], ["This study examined whether inflammation and sleep quality serve as mediators, focusing on the antiinflammatory \u03c9-3 docosahexaenoic acid (DHA; 22:6n3) and proinflammatory \u03c9-6 arachidonic acid (AA; 20:4n6).", {"entities": []}], ["Pregnant women ( n = 135) provided a blood sample and completed the Pittsburgh Sleep Quality Index (PSQI) at 20\u201327 weeks gestation.", {"entities": []}], ["Red blood cell (RBC) fatty acid levels were determined by gas chromatography and serum inflammatory markers [interleukin (IL)-6, IL-8, tumor necrosis factor-\u03b1, IL-1\u03b2, and C-reactive protein] by electrochemiluminescence using high sensitivity kits.", {"entities": []}], ["Both higher serum IL-8 (95% CI = 0.10,3.84) and poor sleep (95% CI = 0.03,0.28) served as significant mediators linking lower DHA:AA ratios with shorter gestation.", {"entities": []}], ["Further, a serial mediation model moving from the DHA:AA ratio \u2192 sleep \u2192 IL-8 \u2192 length of gestation was statistically significant (95% CI = 0.02, 0.79).", {"entities": []}], ["These relationships remained after adjusting for depressive symptoms, age, BMI, income, race, and smoking.", {"entities": []}], ["No interactions with race were observed in relation to length of gestation as a continuous variable.", {"entities": []}], ["However, a significant interaction between race and the DHA:AA ratio in predicting preterm birth was observed (p = 0.049); among African Americans only, odds of preterm birth decreased as DHA:AA increased (p = 0.048).", {"entities": []}], ["These data support a role for both inflammatory pathways and sleep quality in linking less optimal RBC PUFA status with shorter gestation in African American and European American women and suggest that African-Americans have greater risk for preterm birth in the context of a low DHA:AA ratio.", {"entities": []}], ["Reduced forced expiratory volume in one second (FEV 1 ) has been linked to non small cell lung cancer (NSCLC).", {"entities": [[90, 101, "DISEASE"], [95, 101, "DISEASE"], [48, 51, "GENE"]]}], ["However, it is unclear whether all or only certain histological subtypes of NSCLC are associated with reduced FEV 1 .", {"entities": [[110, 113, "GENE"]]}], ["Moreover, there is little information on whether gender modifies this relationship.", {"entities": []}], ["Using a large tissue registry, we sought to determine the relationship between FEV 1 and subtypes of NSCLC and determine whether this relationship is modified by gender.", {"entities": [[79, 82, "GENE"]]}], ["We used data from patients who underwent tumor resection for NSCLC at a teaching hospital in Vancouver and had various pre-operative clinical measurements including FEV 1 .", {"entities": [[165, 168, "GENE"]]}], ["We divided the cohort into quartiles of predicted FEV 1 and using both logistic and linear regression modeling techniques determined whether FEV 1 was related to the occurrence of adeno or squamous cell carcinoma in men and women.", {"entities": [[203, 212, "DISEASE"], [189, 212, "DISEASE"], [50, 53, "GENE"], [141, 144, "GENE"], [50, 53, "GENE"], [141, 144, "GENE"]]}], ["There were 610 patients in the study (36% females).", {"entities": []}], ["On average, women were more likely to have adenocarcinoma than were men (72% of all cases of NSCLC in women versus 40% in men; p < 0.001).", {"entities": [[43, 57, "DISEASE"]]}], ["In women, there was no significant relationship between FEV 1 and the risk of any histological subtypes of NSCLC.", {"entities": [[56, 59, "GENE"]]}], ["In men, however, there was an inverse relationship between the risk of adenocarcinoma and FEV 1 such that the lowest quartile of FEV 1 was 47% less likely to have adenocarcinoma compared with the highest FEV 1 quartile (adjusted odds ratio, 0.52; 0.28 to 0.98; p for trend, 0.028).", {"entities": [[71, 85, "DISEASE"], [163, 177, "DISEASE"], [90, 93, "GENE"], [129, 132, "GENE"], [204, 207, "GENE"], [90, 93, "GENE"], [129, 132, "GENE"], [204, 207, "GENE"], [90, 93, "GENE"], [129, 132, "GENE"], [204, 207, "GENE"]]}], ["The reverse was observed for squamous cell carcinoma.", {"entities": [[43, 52, "DISEASE"], [29, 52, "DISEASE"]]}], ["In individuals undergoing lung resection for NSCLC, the risk of adenocarcinoma and squamous cell carcinoma of the lung varies as a function of FEV 1 , independent of smoking intensity in men but not in women.", {"entities": [[64, 78, "DISEASE"], [97, 106, "DISEASE"], [83, 106, "DISEASE"], [143, 146, "GENE"]]}], ["These data indicate that women are much more susceptible to adenocarcinoma than are men especially when they have normal or near normal lung function.", {"entities": [[60, 74, "DISEASE"]]}], ["It may thus be useful to conduct periodic surveillance chest radiographs in asymptomatic female smokers (or ex-smokers) to ascertain peripheral nodules or masses before distant metastases occur since adenocarcinomas tend to metastasize earlier in the disease course than squamous cell carcinomas.", {"entities": []}], ["The aim of this study was to evaluate whether community-based nurse-led continence care interventions are effective in improving outcomes for adult Chinese primary care patients with lower urinary tract symptoms (LUTS).", {"entities": []}], ["A case-controlled intervention study was conducted.", {"entities": []}], ["An intervention group of 360 primary care patients enrolled into a nurse-led continence care programme were recruited by consecutive sampling.", {"entities": []}], ["A control group of 360 primary care patients with LUTS identified by screening were recruited from the waiting rooms of primary care clinics by consecutive sampling.", {"entities": []}], ["Both groups were monitored at baseline and at 12 months.", {"entities": []}], ["Outcome measures included symptom severity, health-related quality of life (HRQOL), self-efficacy, global health and self-reported health service utilization at 12-months.", {"entities": []}], ["The effect of the continence care programme on symptom severity and HRQOL was assessed by the difference-in-difference estimation, using independent t-test and multiple liner regression.", {"entities": []}], ["Chi-square test was used to compare the self-efficacy, global health and self-reported health service utilization between the two groups at 12-months.", {"entities": []}], ["After adjusting for baseline severity and socio-demographics, the intervention group had significant improvements in LUTS severity (P<0.05) and HRQOL (P<0.05).", {"entities": []}], ["Improvements in the amount of urine leakage were not significantly different between the two groups.", {"entities": []}], ["A higher proportion of subjects in the intervention group reported increased self-efficacy (43.48% vs. 66.83%), improved global health condition (17.74% vs. 41.5%), having doctor consultation (18.5% vs. 8.06), having medication due to LUTS (26.50% vs.11.29%) and having non-drug therapy due to LUTS (59.5% vs.9.68%).", {"entities": []}], ["Community-based nurse-led continence care can effectively alleviate symptoms, improve health-related quality of life, and enhance self-efficacy and the global health condition of Chinese male and female primary care patients with LUTS.", {"entities": []}], ["Recent evidence indicates that the adult hematopoietic system is susceptible to diet-induced lineage skewing.", {"entities": []}], ["It is not known whether the developing hematopoietic system is subject to metabolic programming via in utero high-fat diet (HFD) exposure, an established mechanism of adult disease in several organ systems.", {"entities": []}], ["We previously reported substantial losses in offspring liver size with prenatal HFD.", {"entities": []}], ["As the liver is the main hematopoietic organ in the fetus, we asked whether the developmental expansion of the hematopoietic stem and progenitor cell (HSPC) pool is compromised by prenatal HFD and/or maternal obesity.", {"entities": [[209, 216, "DISEASE"]]}], ["We used quantitative assays, progenitor colony formation, flow cytometry, transplantation, and gene expression assays with a series of dietary manipulations to test the effects of gestational high-fat diet and maternal obesity on the day 14.5 fetal liver hematopoietic system.", {"entities": [[219, 226, "DISEASE"]]}], ["Maternal obesity, particularly when paired with gestational HFD, restricts physiological expansion of fetal HSPCs while promoting the opposing cell fate of differentiation.", {"entities": [[9, 16, "DISEASE"]]}], ["Importantly, these effects are only partially ameliorated by gestational dietary adjustments for obese dams.", {"entities": []}], ["Competitive transplantation reveals compromised repopulation and myeloid-biased differentiation of HFD-programmed HSPCs to be a niche-dependent defect, apparent in HFD-conditioned male recipients.", {"entities": []}], ["Fetal HSPC deficiencies coincide with perturbations in genes regulating metabolism, immune and inflammatory processes, and stress response, along with downregulation of genes critical for hematopoietic stem cell self-renewal and activation of pathways regulating cell migration.", {"entities": []}], ["Our data reveal a previously unrecognized susceptibility to nutritional and metabolic developmental programming in the fetal HSPC compartment, which is a partially reversible and microenvironment-dependent defect perturbing stem and progenitor cell expansion and hematopoietic lineage commitment.", {"entities": []}], ["The neutrophil chemoattractant proline-glycine-proline (PGP) is generated from collagen by matrix metalloproteinase-8/9 (MMP-8/9) and prolyl endopeptidase (PE), and it is concomitantly degraded by extracellular leukotriene A 4 hydrolase (LTA 4 H) to limit neutrophilia.", {"entities": [[56, 59, "GENE"], [238, 241, "GENE"]]}], ["Components of cigarette smoke can acetylate PGP, yielding a species (AcPGP) that is resistant to LTA 4 H-mediated degradation and can, thus, support a sustained neutrophilia.", {"entities": [[44, 47, "GENE"], [97, 100, "GENE"]]}], ["In this study, we sought to elucidate if an antiinflammatory system existed to degrade AcPGP that is analogous to the PGP-LTA 4 H axis.", {"entities": []}], ["We demonstrate that AcPGP is degraded through a previously unidentified action of the enzyme angiotensin-converting enzyme (ACE).", {"entities": []}], ["Pulmonary ACE is elevated during episodes of acute inflammation, as a consequence of enhanced vascular permeability, to ensure the efficient degradation of AcPGP.", {"entities": []}], ["Conversely, we suggest that this pathway is aberrant in chronic obstructive pulmonary disease (COPD) enabling the accumulation of AcPGP.", {"entities": [[56, 93, "DISEASE"]]}], ["Consequently, we identify a potentially novel protective role for AcPGP in limiting pulmonary fibrosis and suggest the pathogenic function attributed to ACE in idiopathic pulmonary fibrosis (IPF) to be a consequence of overzealous AcPGP degradation.", {"entities": [[84, 102, "DISEASE"], [171, 189, "DISEASE"], [160, 189, "DISEASE"]]}], ["Thus, AcPGP seemingly has very divergent roles: it is pathogenic in its capacity to drive neutrophilic inflammation and matrix degradation in the context of COPD, but it is protective in its capacity to limit fibrosis in IPF.", {"entities": []}], ["ACE degrades the collagen-derived matrikine, acetylate proline\u2013glycine\u2013proline, to limit pulmonary inflammation and promote repair.", {"entities": []}], ["Rheumatoid arthritis (RA) is the most common autoimmune disorder.", {"entities": [[11, 20, "DISEASE"]]}], ["Loss of Th1/Th2 and Th17/Treg balance has been reported in several inflammatory autoimmune diseases.", {"entities": []}], ["This study was to investigate Th1, Th2, Th17, and Treg differentiation and related cytokines in RA patients.", {"entities": []}], ["The frequencies of Th1, Th2, Th17, and Treg cells in peripheral blood of RA patients ( n = 76) and healthy controls ( n = 18) were determined by flow cytometry.", {"entities": []}], ["Eight serum cytokines were analyzed using cytometric bead array.", {"entities": []}], ["The results demonstrated that RA patients exhibited increased peripheral Th1/Th17 cells and Th1/Th17-related cytokines.", {"entities": []}], ["However, Th1 cells only reached significant difference at advanced stage, but Th17 at all stages, suggesting more important roles in Th17 cells.", {"entities": []}], ["For Th2 and Treg cells, there was a different function pattern in RA progression.", {"entities": []}], ["Although with the increase of DAS28 score, Th2 cell experienced some degree of decrease in RA patients, no significant difference was observed.", {"entities": []}], ["IL-4 and IL-10 showed a significant increase in RA patients.", {"entities": []}], ["These indicated that Th2 cells might exert immunosuppression effects mainly by secreting cytokines.", {"entities": []}], ["Treg cells were found significantly decreased in RA patients, but no difference was observed in TGF- \u03b2 expression, indicating a cell-cell interaction pattern in Treg cell.", {"entities": []}], ["Child maltreatment causes substantial morbidity and mortality in the U.S. Morbidity associated with child maltreatment can reduce health-related quality of life.", {"entities": []}], ["Accurately measuring the reduction in quality of life associated with child maltreatment is essential to the economic evaluation of educational programs and interventions to reduce the incidence of child maltreatment.", {"entities": []}], ["The objective of this study was to review the literature for existing approaches and instruments for measuring quality-of-life for child maltreatment outcomes.", {"entities": []}], ["We reviewed the current literature to identify current approaches to valuing child maltreatment outcomes for economic evaluations.", {"entities": []}], ["We also reviewed available preference-based generic QOL instruments (EQ-5D, HUI, QWB, SF-6D) for appropriateness in measuring change in quality of life due to child maltreatment.", {"entities": []}], ["We did not identify any studies that directly evaluated quality-of-life in maltreated children.", {"entities": []}], ["We identified 4 studies that evaluated quality of life for adult survivors of child maltreatment and 8 studies that measured quality-of-life for pediatric injury not related to child maltreatment.", {"entities": []}], ["No study reported quality-of-life values for children younger than age 3.", {"entities": []}], ["Currently available preference-based QOL instruments (EQ-5D, HUI, QWB, SF-6D) have been developed primarily for adults with the exception of the Health Utilities Index.", {"entities": []}], ["These instruments do not include many of the domains identified as being important in capturing changes in quality of life for child maltreatment, such as potential for growth and development or psychological sequelae specific to maltreatment.", {"entities": []}], ["Recommendations for valuing preference-based quality-of-life for child maltreatment will vary by developmental level and type of maltreatment.", {"entities": []}], ["In the short-term, available multi-attribute utility instruments should be considered in the context of the type of child maltreatment being measured.", {"entities": []}], ["However, if relevant domains are not included in existing instruments or if valuing health for children less than 6 years of age, direct valuation with a proxy respondent is recommended.", {"entities": []}], ["The choice of a proxy respondent is not clear in the case of child maltreatment since the parent may not be a suitable proxy.", {"entities": []}], ["Adult survivors should be considered as appropriate proxies.", {"entities": []}], ["Longer-term research should focus on identifying the key domains for measuring child health and the development of preference-based quality-of-life instruments that are appropriate for valuing child maltreatment outcomes.", {"entities": []}], ["Some gender differences in the progression of human immunodeficiency virus (HIV) infection have been attributed to delayed treatment among women and the social context of poverty.", {"entities": []}], ["Recent economic difficulties have led to multiple service cuts, highlighting the need to identify factors with the most influence on health in order to prioritize scarce resources.", {"entities": []}], ["The aim of this study was to empirically rank factors that longitudinally impact the health status of HIV-infected homeless and unstably housed women.", {"entities": []}], ["Study participants were recruited between 2002 and 2008 from community-based venues in San Francisco, California, and followed over time; marginal structural models and targeted variable importance were used to rank factors by their influence.", {"entities": []}], ["In adjusted analysis, the factor with the strongest effect on overall mental health was unmet subsistence needs (i.e., food, hygiene, and shelter needs), followed by poor adherence to antiretroviral therapy, not having a close friend, and the use of crack cocaine.", {"entities": []}], ["Factors with the strongest effects on physical health and gynecologic symptoms followed similar patterns.", {"entities": []}], ["Within this population, an inability to meet basic subsistence needs has at least as much of an effect on overall health as adherence to antiretroviral therapy, suggesting that advances in HIV medicine will not fully benefit indigent women until their subsistence needs are met.", {"entities": []}], ["COPD often coexists with chronic conditions that may influence disease prognosis.", {"entities": []}], ["We investigated associations between chronic (co)morbidities and exacerbations in primary care COPD patients.", {"entities": []}], ["Retrospective cohort study based on 2012\u20132013 electronic health records from 179 Dutch general practices.", {"entities": []}], ["Comorbidities from patients with physician-diagnosed COPD were categorized according to International Classification of Primary Care (ICPC) codes.", {"entities": []}], ["Chi-squared tests, uni- and multivariable logistic, and Cox regression analyses were used to study associations with exacerbations, defined as oral corticosteroid prescriptions.", {"entities": []}], ["Fourteen thousand six hundred three patients with COPD could be studied (mean age 67 (SD 12) years, 53% male) for two years.", {"entities": []}], ["At baseline 12,826 (88%) suffered from \u22651 comorbidities, 3263 (22%) from \u22655.", {"entities": []}], ["The most prevalent comorbidities were hypertension (35%), coronary heart disease (19%), and osteoarthritis (18%).", {"entities": [[38, 50, "DISEASE"], [67, 80, "DISEASE"], [58, 80, "DISEASE"], [92, 106, "DISEASE"]]}], ["Several comorbidities showed statistically significant associations with frequent (i.e., \u22652/year) exacerbations: heart failure (odds ratio [OR], 95% confidence interval: 1.72; 1.38\u20132.14), blindness & low vision (OR 1.46; 1.21\u20131.75), pulmonary cancer (OR 1.85; 1.28\u20132.67), depression 1.48; 1.14\u20131.91), prostate disorders (OR 1.50; 1.13\u20131.98), asthma (OR 1.36; 1.11\u20131.70), osteoporosis (OR 1.41; 1.11\u20131.80), diabetes (OR 0.80; 0.66\u20130.97), dyspepsia (OR 1.25; 1.03\u20131.50), and peripheral vascular disease (OR 1.20; 1.00\u20131.45).", {"entities": [[437, 446, "DISEASE"], [188, 197, "DISEASE"], [371, 383, "DISEASE"], [484, 500, "DISEASE"], [473, 500, "DISEASE"], [342, 348, "DISEASE"], [243, 249, "DISEASE"]]}], ["From all comorbidity categories, having another chronic respiratory disease beside COPD showed the highest risk for developing a new exacerbation (Cox hazard ratio 1.26; 1.17\u20131.36).", {"entities": []}], ["Chronic comorbidities are highly prevalent in primary care COPD patients.", {"entities": []}], ["Several chronic comorbidities were associated with having frequent exacerbations and increased exacerbation risk.", {"entities": []}], ["This retrospective, population-based cohort study aims to investigate the long-term risk of newly diagnosed dementia in patients discharged for acute respiratory failure that required mechanical ventilation (MV) and intensive care unit (ICU) admission.", {"entities": [[150, 169, "DISEASE"], [108, 116, "DISEASE"]]}], ["From the Taiwan National Health Insurance Research Database, first-time ICU patients using MV between June 1, 1998, and December 31, 2012, were enrolled, and they were followed-up until the earliest onset of one of our two endpoints: a new diagnosis of dementia (primary endpoint), or the end of the study.", {"entities": [[253, 261, "DISEASE"]]}], ["A total of 18,033 patients were enrolled and thirteen hundred eighty-seven patients had been newly diagnosed with dementia (mean onset: 3.2 years post-discharge).", {"entities": [[114, 122, "DISEASE"]]}], ["Patients \u2265 85 years old had the highest risk (multivariate analysis).", {"entities": []}], ["Males had a lower risk than did females in both models (HR: 0.81, 95% CI: 0.72\u20130.9 in model 1; HR: 0.80, 95% CI: 0.72\u20130.89 in model 2).", {"entities": [[56, 58, "GENE"], [95, 97, "GENE"], [56, 58, "GENE"], [95, 97, "GENE"]]}], ["ICU stays > 5 days, hospital stays > 14 days, and more ICU readmissions were associated with a higher risk of developing dementia.", {"entities": [[121, 129, "DISEASE"]]}], ["In conclusion, the long-term risks of a subsequent diagnosis of dementia for acute respiratory failure with MV patients who survive to discharge increase with age and are higher in women than in men.", {"entities": [[83, 102, "DISEASE"], [64, 72, "DISEASE"]]}], ["Additionally, the longer the ICU or hospital stay is, and the more ICU readmissions a patient has, are both significantly associated with developing dementia.", {"entities": [[149, 157, "DISEASE"]]}], ["Obesity is associated with the development of asthma and considerable asthma-related healthcare utilization.", {"entities": [[0, 7, "DISEASE"], [46, 52, "DISEASE"], [70, 76, "DISEASE"]]}], ["To understand the immunological pathways that lead to obesity-associated asthma, we fed mice a high fat diet for 12 weeks, which resulted in obesity and the development of airway hyperreactivity (AHR), a cardinal feature of asthma.", {"entities": [[54, 61, "DISEASE"], [141, 148, "DISEASE"], [73, 79, "DISEASE"], [224, 230, "DISEASE"], [196, 199, "GENE"]]}], ["This AHR depended on innate immunity, since it occurred in obese Rag Il17 Nlrp3 Rag2 Il2r\u03b3", {"entities": [[5, 8, "GENE"], [74, 79, "GENE"], [80, 84, "GENE"]]}], ["Toll-like receptors (TLRs) have significant involvement in Leishmania infection, although little is known about the relationship between these receptors, cytokines and nitric oxide (NO) in patients with visceral leishmaniasis (VL) before or after treatment with anti-leishmanial drugs.", {"entities": [[203, 225, "DISEASE"], [212, 225, "DISEASE"]]}], ["The goal of this study was to evaluate the expression of TLR2 and TLR4 in CD3", {"entities": [[57, 61, "GENE"], [66, 70, "GENE"]]}], ["While the primary method for evaluating diabetic retinopathy involves direct and indirect ophthalmoscopy, various imaging modalities are of significant utility in the screening, evaluation, diagnosis, and treatment of different presentations and manifestations of this disease.", {"entities": [[40, 60, "DISEASE"]]}], ["This manuscript is a review of the important imaging modalities that are used in diabetic retinopathy, including color fundus photography, fluorescein angiography, B-scan ultrasonography, and optical coherence tomography.", {"entities": [[81, 101, "DISEASE"]]}], ["The article will provide an overview of these different imaging techniques and how they can be most effectively used in current practice.", {"entities": []}], ["The number of people on sick-leave started to increase in Sweden and several other European countries towards the end of the 20 Semi-structured interviews with 19 GPs in 17 Primary Health Care settings in four mid-Sweden counties.", {"entities": []}], ["Interview transcripts were analysed with phenomenographic approach aiming to uncover the variation in existing views regarding the respondents' sick-listing commission and practice.", {"entities": []}], ["We found large qualitative differences in the GPs' views on sick-listing.", {"entities": []}], ["The sick-listing commission was experienced to come either from society or from patients, with no responsibility for societal interests, or as an integration of these two views.", {"entities": []}], ["All the GPs were aware of a possible conflict between the interests of society and patients.", {"entities": []}], ["While some expressed feelings of strong conflict, others seemed to have solved the conflict, at least partly, between these two loyalties.", {"entities": []}], ["Some GPs experienced carrying the full responsibility to decide whether a patient would get monetary sick-leave benefits or not and they were not comfortable with this situation.", {"entities": []}], ["Views on the physician's and the patient's responsibility in sick-listing and rehabilitation varied from a passive to an empowering role of the physician.", {"entities": []}], ["GPs expressing a combination of less inclusive views of the different aspects of sick-listing experienced strong conflict and appeared to feel distressed in their sick-listing role.", {"entities": []}], ["Some GPs described how they had changed from less to more inclusive views.", {"entities": []}], ["The clearer understanding of the different views on sick-listing generated in this study can be used in educational efforts to improve physicians' sick-listing practices, benefiting GPs' work situation as well as their patients' well-being.", {"entities": []}], ["The GP's role as a gatekeeper in the social security system needs further exploration.", {"entities": []}], ["Our findings could be used to develop a questionnaire to measure the distribution of different views in a wider population of GPs.", {"entities": []}], ["Chronic disease is by far the leading cause of death worldwide and of increasing concern in low- and middle-income countries, including South Africa, where chronic diseases disproportionately affect the poor living in urban settings.", {"entities": []}], ["The Provincial Government of the Western Cape (PGWC) has prioritized the management of chronic diseases and has developed a policy and framework (Adult Chronic Disease Management Policy 2009) to guide and improve the prevention and management of chronic diseases at a primary care level.", {"entities": []}], ["The aim of this study is to assess the alignment of current primary care practices with the PGWC Adult Chronic Disease Management policy.", {"entities": []}], ["One comprehensive primary care facility in a Cape Town health district was used as a case study.", {"entities": []}], ["Data was collected via semi-structured interviews (n\u200a=\u200a10), focus groups (n\u200a=\u200a8) and document review.", {"entities": []}], ["Participants in this study included clinical staff involved in chronic disease management at the facility and at a provincial level.", {"entities": []}], ["Data previously collected using the Integrated Audit Tool for Chronic Disease Management (part of the PGWC Adult Chronic Disease Management policy) formed the basis of the guide questions used in focus groups and interviews.", {"entities": []}], ["The results of this research indicate a significant gap between policy and its implementation to improve and support chronic disease management at this primary care facility.", {"entities": []}], ["A major factor seems to be poor policy knowledge by clinicians, which contributes to an individual rather than a team approach in the management of chronic disease patients.", {"entities": []}], ["Poor interaction between facility- and community-based services also emerged.", {"entities": []}], ["A number of factors were identified that seemed to contribute to poor policy implementation, the majority of which were staff related and ultimately resulted in a decrease in the quality of patient care.", {"entities": []}], ["Chronic disease policy implementation needs to be improved in order to support chronic disease management at this facility.", {"entities": []}], ["It is possible that similar findings and factors are present at other primary care facilities in Cape Town.", {"entities": []}], ["At a philosophical level, this research highlights the tension between primary health care principles and a diseased-based approach in a primary care setting.", {"entities": []}], ["Iron-catalyzed oxidative stress contributes to lung injury after exposure to various toxins, including cigarette smoke.", {"entities": []}], ["An oxidant/antioxidant imbalance is considered to play a critical role in the pathogenesis of COPD.", {"entities": []}], ["Ferritin is a key protein in iron homeostasis, and its capacity to oxidize and sequester the metal preventing iron prooxidant activity implicates its possible role in the alteration of antioxidant imbalance.", {"entities": []}], ["We investigated the relationship among cigarette smoking, lung function, and serum ferritin concentration in a large cohort representative of the Korean adult population.", {"entities": []}], ["Among 50,405 participants of the Korean National Health and Nutrition Examination Survey from 2010 to 2014, 15,239 adult subjects older than 40 years with serum ferritin levels and spirometric data were selected for this study.", {"entities": []}], ["The mean age was 56.5 years for men (43%) and 56.9 years for women (57%).", {"entities": []}], ["The prevalence of airway obstruction was 13.4%, which was significantly higher in men than in women, and increased in former or current smokers.", {"entities": []}], ["The median levels of serum ferritin were highest in the airway obstruction group, followed by the restrictive pattern group, and lowest in the normal lung function group.", {"entities": []}], ["The median ferritin levels were increased by smoking status and amounts in each spirometric subgroup.", {"entities": []}], ["In multivariable regression analysis, serum ferritin was positively associated with forced expiratory volume in 1 second and forced expiratory volume in 1 second/forced vital capacity, whereas the smoking amount was negatively associated with the adjustment with age, sex, height, and weight.", {"entities": []}], ["Serum ferritin levels were increased in former or current smokers and were increased with smoking amount in all subgroups of participants categorized according to spirometric results.", {"entities": []}], ["The result was also evident in the subgroups divided by obstructive severity.", {"entities": []}], ["While smoking amount was inversely related to lung function, higher levels of serum ferritin were associated with enhanced spirometric results in a representative sample of the general Korean adult population.", {"entities": []}], ["Future prospective studies will be needed to clarify the causality between serum ferritin and lung functions and their role in COPD morbidity.", {"entities": []}], ["Background .", {"entities": []}], ["Aryl hydrocarbon receptor (AhR), a multifunctional regulator that senses and responds to environmental stimuli, plays a role in normal cell development and immune regulation.", {"entities": [[27, 30, "GENE"]]}], ["Recent evidence supports a significant link between environmental exposure and AhR in the development of allergic diseases.", {"entities": [[79, 82, "GENE"]]}], ["We sought to investigate whether AhR plays a role in mediating cockroach allergen-induced allergic immune responses.", {"entities": [[33, 36, "GENE"]]}], ["AhR expression in human lung fibroblasts from asthmatic and healthy individuals and in cockroach extract (CRE) treated human lung fibroblasts (WI-38) was examined.", {"entities": [[0, 3, "GENE"]]}], ["The role of AhR in modulating CRE induced TGF \u03b2 1 production was investigated by using AhR agonist, TCDD, antagonist CH122319, and knockdown of AhR.", {"entities": [[12, 15, "GENE"], [87, 90, "GENE"], [144, 147, "GENE"], [12, 15, "GENE"], [87, 90, "GENE"], [144, 147, "GENE"], [12, 15, "GENE"], [87, 90, "GENE"], [144, 147, "GENE"]]}], ["The role of latent TGF \u03b2 1 binding protein-1 (LTBP1) in mediating TCDD induced active TGF \u03b2 1 release was also examined.", {"entities": [[46, 51, "GENE"]]}], ["AhR expression was higher in airway fibroblasts from asthmatic subjects as compared to healthy controls.", {"entities": [[0, 3, "GENE"]]}], ["AhR in fibroblasts was activated by TCDD with an increased expression of cyp1a1 and cyp1b1.", {"entities": [[0, 3, "GENE"], [73, 79, "GENE"], [84, 90, "GENE"]]}], ["Increased AhR expression was observed in CRE-treated fibroblasts.", {"entities": [[10, 13, "GENE"]]}], ["Importantly, CRE induced TGF \u03b2 1 production in fibroblasts was significantly enhanced by TCDD but inhibited by CH122319.", {"entities": []}], ["Reduced TGF \u03b2 1 production was further confirmed in fibroblasts with AhR knockdown.", {"entities": [[69, 72, "GENE"]]}], ["Moreover, AhR knockdown inhibited CRE induced fibroblast differentiation.", {"entities": [[10, 13, "GENE"]]}], ["Furthermore, TCDD induced active TGF \u03b2 1 release was significantly inhibited by LTBP1 knockdown.", {"entities": [[80, 85, "GENE"]]}], ["Conclusion .", {"entities": []}], ["These results provide evidence for the role of AhR in modulating cockroach allergen-induced immune responses through controlling the active TGF \u03b2 1 release, suggesting a possible synergistic effect between exposure to allergens and environmental chemicals on the development of allergic diseases.", {"entities": [[47, 50, "GENE"]]}], ["The respiratory disease field is changing because of recent advances in our understanding of the airway microbiome.", {"entities": []}], ["Central to this is dysbiosis, an imbalance of microbial communities that can lead to and flag inflammation in the airways.", {"entities": []}], ["The increasing momentum of research in this area holds promise for novel treatment strategies.", {"entities": []}], ["The immunological mechanisms explaining development of an allergy in some individuals and not in others remain incompletely understood.", {"entities": []}], ["Insect bite hypersensitivity (IBH) is a common, seasonal, IgE-mediated, pruritic skin disorder that affects considerable proportions of horses of different breeds, which is caused by bites of the insect Culicoides obsoletus (C. obsoletus) .", {"entities": []}], ["We investigated the allergen-specific immune status of individual horses that had either been diagnosed to be healthy or to suffer of IBH.", {"entities": []}], ["Following intradermal allergen injection, skin biopsies were taken of IBH-affected and healthy ponies and cytokine expression was determined by RT-PCR.", {"entities": []}], ["In addition, allergen-specific antibody titers were measured and cytokine expression of in vitro stimulated, allergen-specific CD4 T-cells was determined.", {"entities": [[127, 130, "GENE"]]}], ["24 hrs after allergen injection, a significant increase in mRNA expression of the type-2 cytokine IL-4 was observed in the skin of IBH-affected Shetland ponies.", {"entities": []}], ["In the skin of healthy ponies, however, an increase in IFN\u03b3 mRNA expression was found.", {"entities": []}], ["Analysis of allergen-specific antibody titers revealed that all animals produced allergen-specific antibodies, and allergen-specific stimulation of CD4 T-cells revealed a significant higher percentage of IFN\u03b3-expressing CD4 T-cells in healthy ponies compared to IBH-affected ponies.", {"entities": [[148, 151, "GENE"], [220, 223, "GENE"], [148, 151, "GENE"], [220, 223, "GENE"]]}], ["These data indicate that horses not affected by IBH, in contrast to the so far established dogma, are not immunologically ignorant but have a Th1-skewed allergen-specific immune response that appears to protect against IBH-associated symptoms.", {"entities": []}], ["To our knowledge this is the first demonstration of a natural situation, in which an allergen-specific immune skewing is protective in an allergic disorder.", {"entities": []}], ["Shewhart control charts have previously been suggested as a process control tool for use in routine linear accelerator (linac) output verifications.", {"entities": []}], ["However, a comprehensive approach to process control has not been investigated for linac output verifications.", {"entities": []}], ["The purpose of this work is to investigate a comprehensive process control approach to linac output constancy quality assurance (QA).", {"entities": []}], ["The RBA\u20103 dose constancy check was used to verify outputs of photon beams and electron beams delivered by a Varian Clinac 21EX linac.", {"entities": []}], ["The data were collected during 2009 to 2010.", {"entities": []}], ["Shewhart\u2010type control charts, exponentially weighted moving average (EWMA) charts, and capability indices were applied to these processes.", {"entities": []}], ["The Shewhart\u2010type individuals chart (X\u2010chart) was used and the number of data points used to calculate the control limits was varied.", {"entities": []}], ["The parameters tested for the EWMA charts (smoothing parameter (\u03bb) and the control limit width (L)) were \u03bb = 0.05 , L = 2.492 ; \u03bb = 0.10 , L = 2.703 ; and \u03bb = 0.20 , L = 2.860 , as well as the number of points used to estimate the initial process mean and variation.", {"entities": []}], ["Lastly, the number of in\u2010control data points used to determine process capability ( C p ) and acceptability ( C pk ) were investigated, comparing the first in\u2010control run to the longest in\u2010control run of the process data.", {"entities": []}], ["C p and C pk values greater than 1.0 were considered acceptable.", {"entities": []}], ["The 95% confidence intervals were reported.", {"entities": []}], ["The X\u2010charts detected systematic errors (e.g., device setup errors).", {"entities": []}], ["In\u2010control run lengths on the X\u2010charts varied from 5 to 30 output measurements (about one to seven months).", {"entities": []}], ["EWMA charts showed in\u2010control runs ranging from 9 to 33 output measurements (about two to eight months).", {"entities": []}], ["The C p and C pk ratios are higher than 1.0 for all energies, except 12 and 20 MeV.", {"entities": []}], ["However, 10 MV and 6, 9, and 16 MeV were in question when considering the 95% confidence limits.", {"entities": []}], ["The X\u2010chart should be calculated using 8\u201312 data points.", {"entities": []}], ["For EWMA chart, using 4 data points is sufficient to calculate the initial mean and variance of the process.", {"entities": []}], ["The EWMA limits should be calculated with \u03bb = 0.10 , L = 2.703 .", {"entities": []}], ["At least 25\u201330 in\u2010control data points should be used to calculate the C p and C pk indices.", {"entities": []}], ["PACS number: 89", {"entities": []}], ["Cardiovascular disease is the main cause of death in Austria.", {"entities": []}], ["However, no systematic information exists regarding characteristics and treatments of contemporary patients with stable coronary artery disease (CAD) in Austria.", {"entities": []}], ["We assembled two retrospective physicians\u2019 databases to describe demographics, clinical profiles, and therapeutic strategies in patients with stable CAD.", {"entities": []}], ["In addition, we compared patient profiles of secondary care internists and hospital-based cardiologists with those of general practitioners in a primary care setting outside of hospital.", {"entities": []}], ["The study population was identified from retrospective chart review of 1020 patients from 106 primary care physicians in Austria (ProCor II registry), and was merged with a previous similar database of 1280 patients under secondary care (ProCor I registry) to yield a total patient number of 2300.", {"entities": []}], ["Female patients with stable CAD were older, had more angina and/or heart failure symptoms, and more depression than males.", {"entities": []}], ["Female gender, type 2 diabetes mellitus, higher CCS class and asthma/COPD were predictors of elevated heart rate, while previous coronary events/revascularization predicted a lower heart rate in multivariate analysis.", {"entities": [[62, 68, "DISEASE"], [22, 39, "DISEASE"], [15, 39, "DISEASE"], [48, 51, "GENE"]]}], ["There were no significant differences with regard to characteristics and management of patients of general practitioners in the primary care setting versus internists in secondary care.", {"entities": []}], ["Characteristics and treatments of unselected patients with stable ischemic heart disease in Austria resemble the pattern of large international registries of stable ischemic heart disease, with the exception that diabetes and systemic hypertension were more prevalent.", {"entities": [[235, 247, "DISEASE"], [66, 88, "DISEASE"], [165, 187, "DISEASE"], [75, 88, "DISEASE"], [174, 187, "DISEASE"]]}], ["Westernized lifestyle and hygienic behavior have contributed to dramatic changes in the human-associated microbiota.", {"entities": []}], ["This particularly relates to indoor activities such as house cleaning.", {"entities": []}], ["We therefore investigated the associations between washing and vacuum cleaning frequency and the gut microbiota composition in a large longitudinal cohort of mothers and their children.", {"entities": []}], ["The gut microbiota composition was determined using 16S ribosomal RNA (rRNA) gene Illumina deep sequencing.", {"entities": []}], ["We found that high vacuum cleaning frequency about twice or more a week was associated with an altered gut microbiota composition both during pregnancy and for 2-year-old children, while there were no associations with house washing frequency.", {"entities": []}], ["In total, six Operational Taxonomic Units (OTUs) showed significant False Discovery Rate (FDR) corrected associations with vacuum cleaning frequency for mothers (two positive and four negative) and five for 2-year-old children (four positive and one negative).", {"entities": []}], ["For mothers and the 2-year-old children, OTUs among the dominant microbiota (average >5\u00a0%) showed correlation to vacuum cleaning frequency, with an increase in Faecalibacterium prausnitzii for mothers ( p \u2009=\u20090.013, FDR corrected), and Blautia sp.", {"entities": []}], ["for 2-year children ( p \u2009=\u20090.012, FDR corrected).", {"entities": []}], ["Bacteria showing significant associations are among the dominant gut microbiota, which may indicate indirect immunomodulation of the gut microbiota possibly through increased allergen (dust mites) exposure as a potential mechanism.", {"entities": []}], ["However, further exploration is needed to unveil mechanistic details.", {"entities": []}], ["The online version of this article (doi:10.1186/s40168-015-0125-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Little is known about the factors which might influence the adherence to a Mediterranean diet in non-Mediterranean European countries.", {"entities": []}], ["Thus, the main purpose of this study was to determine the associations between socioeconomic, psychological, and physical factors on a Mediterranean diet.", {"entities": []}], ["In this cross-sectional study, participants were 14\u201318-year-old adolescents ( N = 3071) from two non-Mediterranean countries: Lithuania ( N = 1863) and Serbia ( N = 1208).", {"entities": []}], ["The dependent variable was Mediterranean diet, and was assessed with the Mediterranean Diet Quality Index for children and adolescents questionnaire.", {"entities": []}], ["Independent variables were gender, body-mass index, self-rated health, socioeconomic status, psychological distress, physical activity, and sedentary behavior.", {"entities": []}], ["The associations between dependent and independent variables were analyzed by using logistic regression.", {"entities": []}], ["Results showed that higher adherence to a Mediterranean diet was associated with higher self-rated health, socioeconomic status, and physical activity, yet low adherence to a Mediterranean diet was associated with being female, having higher body-mass index, psychological distress, and sedentary behavior.", {"entities": []}], ["Our findings suggest that future studies need to explore associations between lifestyle habits\u2014especially in target populations, such as primary and secondary school students.", {"entities": []}], ["Solubility of Tumorigenicity 2 (sST2) is a novel biomarker that better stratifies risk of cardiovascular events (CVE) compared to cardiac troponin T(cTnT) in heart failure.", {"entities": []}], ["We assessed the association of sST2 with the composite outcome of CVE and/or mortality compared to cTnT in kidney transplant candidates.", {"entities": []}], ["200 kidney transplant candidates between 2010 and 2013 were included.", {"entities": []}], ["Elevated sST2 was defined as \u226530ng/ml, cTnT\u22650.01 ng/ml.", {"entities": []}], ["Median age 53 (interquartile range (IQR) 42\u201361) years, 59.7% male and 82.0% white.", {"entities": []}], ["33.5% had history of CVE, 42.5% left ventricular hypertrophy (LVH) and 15.6% positive cardiac stress test.", {"entities": []}], ["Elevated sST2 correlated with male gender, history of prior-transplants, CVE, positive stress test, LVH, elevated cTnT, anemia, hyperphosphatemia, increased CRP and non-transplanted status.", {"entities": [[128, 145, "DISEASE"], [120, 126, "DISEASE"], [157, 160, "GENE"]]}], ["Male gender, history of CVE and LVH were independent determinants of sST2.", {"entities": []}], ["During 28 months (IQR 25.3\u201330), 7.5% died, 13.0% developed CVE and 19.0% developed the composite outcome.", {"entities": []}], ["Elevated sST2 was associated with the composite outcome (hazard ratio = 1.76, CI 1.06\u20132.73, p = 0.029) on univariate analysis but not after adjusting for age, diabetes and cTnT (p = 0.068).", {"entities": []}], ["sST2 did not change the risk prediction model for composite outcome after including age, diabetes, prior history of CVE and elevated cTnT.", {"entities": []}], ["Increased sST2 level is significantly associated with variables associated with CVE in kidney transplant candidates.", {"entities": []}], ["sST2 was associated with increased risk of the composite outcome of CVE and/or death but not independent of cTnT.", {"entities": []}], ["Larger studies are needed to confirm these findings and determine whether sST2 has added value in CV risk stratification in this cohort of patients.", {"entities": []}], ["Gingko biloba has been used for hundreds of years to treat various disorders such as asthma, vertigo, fatigue and, tinnitus or circulatory problems.", {"entities": [[85, 91, "DISEASE"]]}], ["Two of the main extracts are EGb761 and LI 1370.", {"entities": []}], ["Most pharmacological, toxicological and clinical studies have focused on the neuroprotective value of these two main extracts.", {"entities": []}], ["Neuroprotection is a rapidly expanding area of research.", {"entities": []}], ["This area is of particular interest due to the fact that it represents a new avenue of therapy for a frustrating disease that may progress despite optimal treatment.", {"entities": []}], ["One such disease is glaucoma.", {"entities": [[20, 28, "DISEASE"]]}], ["Glaucoma leads to the loss of retinal ganglion cells and their axons but also to tissue remodelling which involves both the optic nerve head and the retina.", {"entities": [[0, 8, "DISEASE"]]}], ["In the retina the astrocytes get activated.", {"entities": []}], ["In addition, the optic nerve gets thinner and the cells of the lateral geniculate ganglion disappear partially.", {"entities": []}], ["On average, ocular blood flow (OBF) is reduced in glaucoma patients in various tissues of the eye.", {"entities": [[50, 58, "DISEASE"]]}], ["Increased intraocular pressure (IOP) is a major risk factor for glaucomatous damage.", {"entities": []}], ["Nevertheless, there is little doubt that other risk factors besides IOP are involved.", {"entities": []}], ["One such risk factor is a primary vascular dysregulation (PVD) occurring in patients with a disturbed autoregulation, another risk factor is oxidative stress.", {"entities": []}], ["Effector CD8 Cyp11a1 promoter in vitro and in vivo in the presence of IL-4.", {"entities": [[13, 20, "GENE"]]}], ["As a result, protein levels and enzymatic activity of CYP11A1, a steroidogenic enzyme regulating CD8 CYP11A1 and VDR polymorphisms may contribute to the predisposition to childhood asthma.", {"entities": [[181, 187, "DISEASE"], [54, 61, "GENE"], [101, 108, "GENE"], [54, 61, "GENE"], [101, 108, "GENE"], [113, 116, "GENE"]]}], ["These data identify a role for 1,25D3 in the molecular programming of CD8 Type 2 CD8", {"entities": []}], ["Difficulties in the acquisition and use of listening, speaking, reading, writing, reasoning or mathematical abilities are present among persons diagnosed with learning disabilities (LDs).", {"entities": []}], ["Previous studies suggest a significant relationship between lead (Pb) exposure and LDs.", {"entities": []}], ["This study evaluated the potential dose-response relationship between blood Pb levels and the risk of LDs.", {"entities": []}], ["This cross-sectional study examined 1411 children (32,788,743 weighted-persons) between 6 and 15 years old from the 2003\u20132004 National Health and Nutrition Examination Survey (NHANES) by analyzing demographics, health related-questions, and laboratory tests using survey logistic and frequency modeling in SAS.", {"entities": []}], ["On a \u00b5g Pb/dL basis, a significant dose-dependent relationship between increasing blood Pb levels and increasing risk of LDs was observed (odds ratio (OR) = 1.21, 95% confidence interval (CI) = 1.03\u20131.43).", {"entities": []}], ["The relationship remained significant when examining covariates such as gender and race (OR = 1.19, 95% CI = 1.00\u20131.40).", {"entities": []}], ["By contrast, no dose-dependence was observed between increasing blood Pb levels and the risk of hay fever in the last year (OR = 0.77, 95% CI = 0.56\u20131.056), a non-plausibly biologically related outcome of blood Pb levels.", {"entities": []}], ["Persons in the 50th\u201375th (12.80%) and 75th\u2013100th (17.14%) percentiles of blood Pb were significantly more likely to have LDs than persons in the 0\u201350th percentile of blood Pb (8.78%).", {"entities": []}], ["An estimated 1 million persons born in the US from 1989 to 1998 developed LDs from elevated blood Pb levels.", {"entities": []}], ["Overall, this study revealed a significant dose-dependent association between increasing childhood blood Pb levels and the risk of a LD diagnosis, but it was not possible to ascribe a direct cause-effect relationship between blood Pb exposure and LD diagnosis.", {"entities": []}], ["Childhood Pb exposure should be considered when evaluating children with LDs, and continuing efforts should be made to reduce Pb exposure.", {"entities": []}], ["Catalase is preferentially expressed in bronchiolar and alveolar epithelial cells, and acts as an endogenous antioxidant enzyme in normal lungs.", {"entities": []}], ["We thus postulated epithelial damage would be associated with a functional deficiency of catalase during the development of lung fibrosis.", {"entities": []}], ["The present study evaluates the expression of catalase mRNA and protein in human interstitial pneumonias and in mouse bleomycin-induced lung injury.", {"entities": []}], ["We examined the degree of bleomycin-induced inflammation and fibrosis in the mice with lowered catalase activity.", {"entities": []}], ["In humans, catalase was decreased at the levels of activity, protein content and mRNA expression in fibrotic lungs (n = 12) compared to control lungs (n = 10).", {"entities": []}], ["Immunohistochemistry revealed a decrease in catalase in bronchiolar epithelium and abnormal re-epithelialization in fibrotic areas.", {"entities": []}], ["In C57BL/6J mice, catalase activity was suppressed along with downregulation of catalase mRNA in whole lung homogenates after bleomycin administration.", {"entities": []}], ["In acatalasemic mice, neutrophilic inflammation was prolonged until 14 days, and there was a higher degree of lung fibrosis in association with a higher level of transforming growth factor-\u03b2 expression and total collagen content following bleomycin treatment compared to wild-type mice.", {"entities": []}], ["Taken together, these findings demonstrate diminished catalase expression and activity in human pulmonary fibrosis and suggest the protective role of catalase against bleomycin-induced inflammation and subsequent fibrosis.", {"entities": [[96, 114, "DISEASE"]]}], ["Asthma is a complex airway allergic disease involving the interplay of various cell types, cytokines, and transcriptional factors.", {"entities": []}], ["Though many factors contribute to disease etiology, the molecular control of disease phenotype and responsiveness is not well understood.", {"entities": []}], ["Here we report an essential role of the matrix attachment region (MAR)-binding protein SMAR1 in regulating immune response during allergic airway disease.", {"entities": []}], ["Conditional knockout of SMAR1 in T cells rendered the mice resistant to eosinophilic airway inflammation against ovalbumin (OVA) allergen with low immunoglobulin E (IgE) and interleukin-5 (IL-5) levels.", {"entities": []}], ["Moreover, a lower IgE/IgG2a ratio and higher interferon-\u03b3 (IFN-\u03b3) response suggested aberrant skewing of T-cell differentiation toward type 1 helper T cell (Th1) response.", {"entities": []}], ["We show that SMAR1 functions as a negative regulator of Th1 and Th17 differentiation by interacting with two potential and similar MAR regions present on the promoters of T-bet and IL-17.", {"entities": []}], ["Thus, we present SMAR1 as a regulator of T-cell differentiation that favors the establishment of Th2 cells by modulating Th1 and Th17 responses.", {"entities": []}], ["The aim of this study was to compare the health effects of shisha smoking with cigarette smoking among male college students in Kuwait.", {"entities": []}], ["This cross-sectional study was conducted on 525 male students in Kuwait from September to October 2013.", {"entities": []}], ["A pretested questionnaire was used for information on demographics and health complaints.", {"entities": []}], ["Peak expiratory flow rate (PEFR) was measured using a portable peak flow meter.", {"entities": []}], ["The outcome variables of health status were compared between smoking shisha, cigarettes, or both, and nonsmoking.", {"entities": []}], ["The prevalence of current smoking was 243 of the 525 students (46%); of them, 52 (10%) were shisha smokers, 69 were (13%) cigarette smokers and 122 (23%) were both shisha and cigarette smokers.", {"entities": []}], ["There were significantly fewer shisha smokers than cigarette smokers with symptoms of persistent cough (4 vs. 13% or 2/52 vs. 15/69; p = 0.007), chest pain (4 vs. 23% or 2/52 vs. 16/69; p = 0.004) and rapid heart rate (12 vs. 28% or 6/52 vs. 19/69; p = 0.04).", {"entities": []}], ["Other complaints, including asthma, respiratory infections, shortness of breath, high blood pressure, increased blood sugar levels and sleep disturbances were similar in the 2 groups.", {"entities": [[28, 34, "DISEASE"]]}], ["Values of PEFR for shisha smokers and cigarette smokers were not significantly different.", {"entities": []}], ["This study produced evidence suggesting that shisha smoking is not safer than cigarette smoking except with regard to complaints such as cough, chest pain and rapid heart rate, and that people who smoke both experience worse health effects in terms of frequent symptoms of respiratory infections, persistent cough, rapid heartbeat and sleep disturbances.", {"entities": []}], ["Synthetic glucocorticoids are potent anti-inflammatory drugs but show dose-dependent metabolic side effects such as the development of insulin resistance and obesity.", {"entities": [[158, 165, "DISEASE"]]}], ["The precise mechanisms involved in these glucocorticoid-induced side effects, and especially the participation of adipose tissue in this are not completely understood.", {"entities": []}], ["We used a combination of transcriptomics, antibody arrays and bioinformatics approaches to characterize prednisolone-induced alterations in gene expression and adipokine secretion, which could underlie metabolic dysfunction in 3T3-L1 adipocytes.", {"entities": []}], ["Several pathways, including cytokine signalling, Akt signalling, and Wnt signalling were found to be regulated at multiple levels, showing that these processes are targeted by prednisolone.", {"entities": []}], ["These results suggest that mechanisms by which prednisolone induce insulin resistance include dysregulation of wnt signalling and immune response processes.", {"entities": []}], ["These pathways may provide interesting targets for the development of improved glucocorticoids.", {"entities": []}], ["Previous studies have shown wide variations in prehospital ambulance care for acute myocardial infarction (AMI) and stroke.", {"entities": [[84, 105, "DISEASE"], [78, 105, "DISEASE"]]}], ["We aimed to evaluate the effectiveness of implementing a Quality Improvement Collaborative (QIC) for improving ambulance care for AMI and stroke.", {"entities": []}], ["We used an interrupted time series design to investigate the effect of a national QIC on change in delivery of care bundles for AMI (aspirin, glyceryl trinitrate [GTN], pain assessment and analgesia) and stroke (face-arm-speech test, blood pressure and blood glucose recording) in all English ambulance services between January 2010 and February 2012.", {"entities": []}], ["Key strategies for change included local quality improvement (QI) teams in each ambulance service supported by a national coordinating expert group that conducted workshops educating staff in QI methods to improve AMI and stroke care.", {"entities": []}], ["Expertise and ideas were shared between QI teams who met together at three national workshops, between QI leads through monthly teleconferences, and between the expert group and participants.", {"entities": []}], ["Feedback was provided to services using annotated control charts.", {"entities": []}], ["We analyzed change over time using logistic regression with three predictor variables: time, gender, and age.", {"entities": []}], ["There were statistically significant improvements in care bundles in nine (of 12) participating trusts for AMI (OR 1.04, 95% CI 1.04, 1.04), nine for stroke (OR 1.06, 95% CI 1.05, 1.07), 11 for either AMI or stroke, and seven for both conditions.", {"entities": []}], ["Overall care bundle performance for AMI increased in England from 43 to 79% and for stroke from 83 to 96%.", {"entities": []}], ["Successful services all introduced provider prompts and individualized or team feedback.", {"entities": []}], ["Other determinants of success included engagement with front-line clinicians, feedback using annotated control charts, expert support, and shared learning between participants and organizations.", {"entities": []}], ["This first national prehospital QIC led to significant improvements in ambulance care for AMI and stroke in England.", {"entities": []}], ["The use of care bundles as measures, clinical engagement, application of quality improvement methods, provider prompts, individualized feedback and opportunities for learning and interaction within and across organizations helped the collaborative to achieve its aims.", {"entities": []}], ["There is mounting evidence that burnout is a risk factor for cardiovascular disease (CVD).", {"entities": []}], ["Stress-related dysregulation of the sympathetic and parasympathetic system and the hypothalamic pituitary adrenal (HPA) axis may explain the enhanced risk for CVD.", {"entities": []}], ["To test this hypothesis, 55 patients (34 males and 21 females) with burnout on sickness absence and 40 healthy participants (16 males and 24 females) were exposed to a psychosocial stressor consisting of mental arithmetic and public speech.", {"entities": []}], ["Physiological variables (i.e., blood pressure, heart rate, cardiac output, vascular resistance, cortisol, and alpha-amylase) were measured.", {"entities": []}], ["Basal levels, reactivity, and recovery were compared between groups.", {"entities": []}], ["In male patients, baseline systolic blood pressure was higher, whereas basal alpha-amylase and cortisol reactivity were lower than in healthy males.", {"entities": []}], ["In female patients, a tendency for lower basal cortisol was found as compared to healthy females.", {"entities": []}], ["Furthermore, reduced basal heart rate variability and a trend for elevated basal cardiac output were observed in both male and female patients.", {"entities": []}], ["Burnout is characterised by dysregulation of the sympathetic and parasympathetic system and the HPA axis, which was more pronounced in males than in females.", {"entities": []}], ["This study further supports burnout as being a risk factor for CVD through dysregulation of the sympathetic and parasympathetic system and the HPA axis.", {"entities": []}], ["The purpose of the present investigation was to develop and evaluate a self-microemulsifying drug delivery system (SMEDDS) for improving the oral absorption of a pranlukast hemihydrate (PLH), a very poorly water-soluble drug.", {"entities": []}], ["An efficient self-microemulsifying vehicle for PLH was selected and optimized using solubility testing and phase diagram construction.", {"entities": []}], ["The formulations were characterized by assessing self-emulsification performance, droplet size analysis, in vitro drug release characteristics and formulation stability studies.", {"entities": []}], ["Optimized formulations for in vitro dissolution and bioavailability assessment were Triethylcitrate (TEC; 10%), Tween 20 (50%), Span 20 (25%), triethanolamine (5%), and benzyl alcohol (10%).", {"entities": []}], ["The SMEDDS readily released the lipid phase to form a fine oil-in-water microemulsion with a narrow distribution size.", {"entities": []}], ["Saturated solubilities of PLH from SMEDDS in water, pH 4.0 and 6.8, were over 150 times greater than that of plain PLH.", {"entities": []}], ["The release of 100% PLH from SMEDDS was considerably greater compared to only 1.12% in simulated intestinal fluid (pH 6.8) from plain PLH after 2 hours.", {"entities": []}], ["The PLH suspension with 0.5% sodium carboxymethylcellulose or 3% PLH-loaded SMEDDS was administrated at a dose of 40 mg/kg as PLH to fasted rats.", {"entities": []}], ["The absorption of PLH from SMEDDS resulted in about a threefold increase in bioavailability compared with plain PLH aqueous suspension.", {"entities": []}], ["Our studies illustrated that the potential use of the new SMEDDS can be used as a possible alternative to oral delivery of a poorly water-soluble drug such as PLH.", {"entities": []}], ["Rhinoviruses (RV) are key triggers in acute asthma exacerbations.", {"entities": [[44, 50, "DISEASE"]]}], ["Previous studies suggest that men suffer from infectious diseases more frequently and with greater severity than women.", {"entities": []}], ["Additionally, the immune response to most infections and vaccinations decreases with age.", {"entities": []}], ["Most immune function studies do not account for such differences, therefore the aim of this study was to determine if the immune response to rhinovirus varies with sex or age.", {"entities": []}], ["Blood mononuclear cells were isolated from 63 healthy individuals and grouped by sex and age (\u226450 years old and \u226552 years old).", {"entities": []}], ["Cells were cultured with rhinovirus 16 at a multiplicity of infection of 1.", {"entities": []}], ["The chemokine IP-10 was measured at 24 h as an index of innate immunity while IFN\u03b3 and IL-13 were measured at 5 days as an index of adaptive immunity.", {"entities": []}], ["Rhinovirus induced IFN\u03b3 and IL-13 was significantly higher in \u226450 year old women than in age matched men (p < 0.02 and p < 0.05) and \u226552 year old women (p < 0.02 and p > 0.005).", {"entities": []}], ["There was no sex or age based difference in rhinovirus induced IP-10 expression.", {"entities": []}], ["Both IFN\u03b3 and IL-13 were negatively correlated with age in women but not in men.", {"entities": []}], ["This study suggests that pre-menopausal women have a stronger adaptive immune response to rhinovirus infection than men and older people, though the mechanisms responsible for these differences remain to be determined.", {"entities": []}], ["Our findings highlight the importance of gender and age balance in clinical studies and in the development of new treatments and vaccines.", {"entities": []}], ["In bronchopulmonary dysplasia (BPD), alveolar septae are thickened with collagen and \u03b1-smooth muscle actin, transforming growth factor (TGF)-\u03b2-positive myofibroblasts.", {"entities": []}], ["Periostin, a secreted extracellular matrix protein, is involved in TGF-\u03b2-mediated fibrosis and myofibroblast differentiation.", {"entities": []}], ["We hypothesized that periostin expression is required for hypoalveolarization and interstitial fibrosis in hyperoxia-exposed neonatal mice, an animal model for this disease.", {"entities": []}], ["We also examined periostin expression in neonatal lung mesenchymal stromal cells and lung tissue of hyperoxia-exposed neonatal mice and human infants with BPD.", {"entities": []}], ["Two-to-three day-old wild-type and periostin null mice were exposed to air or 75% oxygen for 14 days.", {"entities": []}], ["Mesenchymal stromal cells were isolated from tracheal aspirates of premature infants.", {"entities": []}], ["Hyperoxic exposure of neonatal mice increased alveolar wall periostin expression, particularly in areas of interstitial thickening.", {"entities": []}], ["Periostin co-localized with \u03b1-smooth muscle actin, suggesting synthesis by myofibroblasts.", {"entities": []}], ["A similar pattern was found in lung sections of infants dying of BPD.", {"entities": []}], ["Unlike wild-type mice, hyperoxia-exposed periostin null mice did not show larger air spaces or \u03b1-smooth muscle-positive myofibroblasts.", {"entities": []}], ["Compared to hyperoxia-exposed wild-type mice, hyperoxia-exposed periostin null mice also showed reduced lung mRNA expression of \u03b1-smooth muscle actin, elastin, CXCL1, CXCL2 and CCL4.", {"entities": [[160, 165, "GENE"], [167, 172, "GENE"], [177, 181, "GENE"]]}], ["TGF-\u03b2 treatment increased mesenchymal stromal cell periostin expression, and periostin treatment increased TGF-\u03b2-mediated DNA synthesis and myofibroblast differentiation.", {"entities": []}], ["We conclude that periostin expression is increased in the lungs of hyperoxia-exposed neonatal mice and infants with BPD, and is required for hyperoxia-induced hypoalveolarization and interstitial fibrosis.", {"entities": []}], ["Populations living in urban areas experience greater health inequalities as well as higher absolute burdens of illness.", {"entities": []}], ["It is well-established that a range of social and environmental factors determine these differences.", {"entities": []}], ["Less is known about the relative importance of these factors in determining adolescent health within a super diverse urban context.", {"entities": []}], ["A cross-sectional sample of 3,105 adolescent participants aged 11 to 12 were recruited from 25 schools in the London boroughs of Newham, Tower Hamlets, Hackney and Barking & Dagenham.", {"entities": []}], ["Participants completed a pseudo-anonymised paper-based questionnaire incorporating: the Warwick-Edinburgh Mental Well-being Scale used for assessing positive mental well-being, the Short Moods and Feelings Questionnaire based on the DSM III-R criteria for assessment of depressive symptoms, the Youth-Physical Activity Questionnaire and a self-assessment of general health and longstanding illness.", {"entities": []}], ["Prevalence estimates and unadjusted linear models estimate the extent to which positive well-being scores and time spent in physical/sedentary activity vary by socio-demographic and environmental indicators.", {"entities": []}], ["Logistic regression estimated the unadjusted odds of having fair/(very)poor general health, a long standing illness, or depressive symptoms.", {"entities": []}], ["Fully adjusted mixed effects models accounted for clustering within schools and for all socio-demographic and environmental indicators.", {"entities": []}], ["Compared to boys, girls had significantly lower mental well-being and higher rates of depressive symptoms, reported fewer hours physically active and more hours sedentary, and had poorer general health after full adjustment.", {"entities": []}], ["Positive mental well-being was significantly and positively associated with family affluence but the overall relationship between mental health and socioeconomic factors was weak.", {"entities": []}], ["Mental health advantage increased as positive perceptions of the neighbourhood safety, aesthetics, walkability and services increased.", {"entities": []}], ["Prevalence of poor health varied by ethnic group, particularly for depressive symptoms, general health and longstanding illness suggesting differences in the distribution of the determinants of health across ethnic groups.", {"entities": []}], ["During adolescence perceptions of the urban physical environment, along with the social and economic characteristics of their household, are important factors in explaining patterns of health inequality.", {"entities": []}], ["With the advent of high throughput genotyping technology and the information available via projects such as the human genome sequencing and the HapMap project, more and more data relevant to the study of genetics and disease risk will be produced.", {"entities": []}], ["Systematic reviews and meta-analyses of human genome epidemiology studies rely on the ability to identify relevant studies and to obtain suitable data from these studies.", {"entities": []}], ["A first port of call for most such reviews is a search of MEDLINE.", {"entities": []}], ["We examined whether this could be usefully supplemented by identifying databases on the World Wide Web that contain genetic epidemiological information.", {"entities": []}], ["We conducted a systematic search for online databases containing genetic epidemiological information on gene prevalence or gene-disease association.", {"entities": []}], ["In those containing information on genetic association studies, we examined what additional information could be obtained to supplement a MEDLINE literature search.", {"entities": []}], ["We identified 111 databases containing prevalence data, 67 databases specific to a single gene and only 13 that contained information on gene-disease associations.", {"entities": []}], ["Most of the latter 13 databases were linked to MEDLINE, although five contained information that may not be available from other sources.", {"entities": []}], ["There is no single resource of structured data from genetic association studies covering multiple diseases, and in relation to the number of studies being conducted there is very little information specific to gene-disease association studies currently available on the World Wide Web.", {"entities": []}], ["Until comprehensive data repositories are created and utilized regularly, new data will remain largely inaccessible to many systematic review authors and meta-analysts.", {"entities": []}], ["Background: The growing health risks associated with greenhouse gas emissions highlight the need for new energy policies that emphasize efficiency and low-carbon energy intensity.", {"entities": []}], ["Objectives: We assessed the relationships among electricity use, coal consumption, and health outcomes.", {"entities": []}], ["Methods: Using time-series data sets from 41 countries with varying development trajectories between 1965 and 2005, we developed an autoregressive model of life expectancy (LE) and infant mortality (IM) based on electricity consumption, coal consumption, and previous year\u2019s LE or IM.", {"entities": []}], ["Prediction of health impacts from the Greenhouse Gas and Air Pollution Interactions and Synergies (GAINS) integrated air pollution emissions health impact model for coal-fired power plants was compared with the time-series model results.", {"entities": []}], ["Results: The time-series model predicted that increased electricity consumption was associated with reduced IM for countries that started with relatively high IM (> 100/1,000 live births) and low LE (< 57 years) in 1965, whereas LE was not significantly associated with electricity consumption regardless of IM and LE in 1965.", {"entities": []}], ["Increasing coal consumption was associated with increased IM and reduced LE after accounting for electricity consumption.", {"entities": []}], ["These results are consistent with results based on the GAINS model and previously published estimates of disease burdens attributable to energy-related environmental factors, including indoor and outdoor air pollution and water and sanitation.", {"entities": []}], ["Conclusions: Increased electricity consumption in countries with IM < 100/1,000 live births does not lead to greater health benefits, whereas coal consumption has significant detrimental health impacts.", {"entities": []}], ["Italy and Tunisia (Africa for the Romans), facing each other on the opposite sides of the Mediterranean Sea, have been historically linked since the ancient times.", {"entities": []}], ["Over the centuries both countries were mutually dominated so the vestiges and traces of a mutual influence are still present.", {"entities": []}], ["The aim of the present study is to conduct a comparative analysis of the medicinal species present in the respective Floras in order to explore potential analogies and differences in popular phytotherapy that have come out from those reciprocal exchanges having taken place over the centuries The comparative analysis based on the respective floras of both countries takes into consideration the bulk of medicinal species mutually present in Italy and Tunisia, but it focuses on the species growing in areas which are similar in climate.", {"entities": []}], ["The medicinal uses of these species are considered in accordance with the ethnobotanical literature.", {"entities": []}], ["A list of 153 medicinal species belonging to 60 families, present in both floras and used in traditional medicine, was drawn.", {"entities": []}], ["A considerable convergence in therapeutic uses of many species emerged from these data.", {"entities": []}], ["This comparative analysis strengthens the firm belief that ethno-botanical findings represent not only an important shared heritage, developed over the centuries, but also a considerable mass of data that should be exploited in order to provide new and useful knowledge.", {"entities": []}], ["To evaluate the impact that the distribution of emphysema has on clinical and functional severity in patients with COPD.", {"entities": []}], ["The distribution of the emphysema was analyzed in COPD patients, who were classified according to a 5-point visual classification system of lung CT findings.", {"entities": []}], ["We assessed the influence of emphysema distribution type on the clinical and functional presentation of COPD.", {"entities": []}], ["We also evaluated hypoxemia after the six-minute walk test (6MWT) and determined the six-minute walk distance (6MWD).", {"entities": []}], ["Eighty-six patients were included.", {"entities": []}], ["The mean age was 65.2 \u00b1 12.2 years, 91.9% were male, and all but one were smokers (mean smoking history, 62.7 \u00b1 38.4 pack-years).", {"entities": []}], ["The emphysema distribution was categorized as obviously upper lung-predominant (type 1), in 36.0% of the patients; slightly upper lung-predominant (type 2), in 25.6%; homogeneous between the upper and lower lung (type 3), in 16.3%; and slightly lower lung-predominant (type 4), in 22.1%.", {"entities": []}], ["Type 2 emphysema distribution was associated with lower FEV1, FVC, FEV1/FVC ratio, and DLCO.", {"entities": []}], ["In comparison with the type 1 patients, the type 4 patients were more likely to have an FEV1 < 65% of the predicted value (OR = 6.91, 95% CI: 1.43-33.45; p = 0.016), a 6MWD < 350 m (OR = 6.36, 95% CI: 1.26-32.18; p = 0.025), and post-6MWT hypoxemia (OR = 32.66, 95% CI: 3.26-326.84; p = 0.003).", {"entities": []}], ["The type 3 patients had a higher RV/TLC ratio, although the difference was not significant.", {"entities": []}], ["The severity of COPD appears to be greater in type 4 patients, and type 3 patients tend to have greater hyperinflation.", {"entities": []}], ["The distribution of emphysema could have a major impact on functional parameters and should be considered in the evaluation of COPD patients.", {"entities": []}], ["Avaliar o impacto que a distribui\u00e7\u00e3o do enfisema tem na gravidade cl\u00ednica e funcional em pacientes com DPOC.", {"entities": []}], ["A distribui\u00e7\u00e3o do enfisema foi analisada em pacientes com DPOC, que foram classificados de acordo com um sistema de classifica\u00e7\u00e3o visual de cinco pontos a partir de achados de TC de t\u00f3rax.", {"entities": []}], ["Avaliou-se a influ\u00eancia do tipo de distribui\u00e7\u00e3o do enfisema na apresenta\u00e7\u00e3o funcional e cl\u00ednica da DPOC.", {"entities": []}], ["Hipoxemia ap\u00f3s o teste da caminhada de seis minutos (TC6) foi tamb\u00e9m avaliada e a dist\u00e2ncia percorrida (DTC6) foi determinada.", {"entities": []}], ["Foram inclu\u00eddos 86 pacientes.", {"entities": []}], ["A m\u00e9dia de idade foi de 65,2 \u00b1 12,2 anos, 91,9% eram homens, e todos menos um eram fumantes (m\u00e9dia de carga tab\u00e1gica, 62,7 \u00b1 38,4 anos-ma\u00e7o).", {"entities": []}], ["A distribui\u00e7\u00e3o do enfisema foi categorizada como obviamente predominante no pulm\u00e3o superior (tipo 1), em 36,0% dos pacientes; levemente predominante no pulm\u00e3o superior (tipo 2), em 25,6%; homog\u00eaneo entre o pulm\u00e3o superior e inferior (tipo 3), em 16,3%; e levemente predominante no pulm\u00e3o inferior (tipo 4), em 22,1%.", {"entities": []}], ["A distribui\u00e7\u00e3o do enfisema do tipo 2 foi associada a menores valores de VEF1, CVF, rela\u00e7\u00e3o VEF1/CVF e DLCO.", {"entities": []}], ["Em compara\u00e7\u00e3o com os pacientes do tipo 1, os do tipo 4 apresentaram maior probabilidade de ter VEF1 < 65% do previsto (OR = 6,91, IC95%: 1,43-33,45; p = 0,016), DTC6 < 350 m (OR = 6,36, IC95%: 1,26-32,18; p = 0,025),e hipoxemia ap\u00f3s o TC6 (OR = 32,66, IC95%: 3,26-326,84; p = 0,003).", {"entities": []}], ["Os pacientes do tipo 3 tiveram uma rela\u00e7\u00e3o VR/CPT maior, embora sem diferen\u00e7a significativa.", {"entities": []}], ["A gravidade da DPOC parece ser maior nos pacientes do tipo 4, e os do tipo 3 tendem a apresentar maior hiperinsufla\u00e7\u00e3o.", {"entities": []}], ["A distribui\u00e7\u00e3o do enfisema pode ter um impacto importante nos par\u00e2metros funcionais e deve ser considerada na avalia\u00e7\u00e3o de pacientes com DPOC.", {"entities": []}], ["Epithelial remodelling in asthma is characterised by goblet cell hyperplasia and mucus hypersecretion for which no therapies exist.", {"entities": [[26, 32, "DISEASE"]]}], ["Differentiated bronchial air-liquid interface cultures from asthmatic children display high goblet cell numbers.", {"entities": []}], ["Epidermal growth factor and its receptor have been implicated in goblet cell hyperplasia.", {"entities": []}], ["We hypothesised that EGF removal or tyrphostin AG1478 treatment of differentiating air-liquid interface cultures from asthmatic children would result in a reduction of epithelial goblet cells and mucus secretion.", {"entities": [[21, 24, "GENE"]]}], ["In Aim 1 primary bronchial epithelial cells from non-asthmatic (n = 5) and asthmatic (n = 5) children were differentiated under EGF-positive (10ng/ml EGF) and EGF-negative culture conditions for 28 days.", {"entities": [[128, 131, "GENE"], [150, 153, "GENE"], [159, 162, "GENE"]]}], ["In Aim 2, cultures from a further group of asthmatic children (n = 5) were grown under tyrphostin AG1478, a tyrosine kinase inhibitor, conditions.", {"entities": []}], ["All cultures were analysed for epithelial resistance, markers of differentiation using immunocytochemistry, ELISA for MUC5AC mucin secretion and qPCR for MUC5AC mRNA.", {"entities": []}], ["In cultures from asthmatic children the goblet cell number was reduced in the EGF negative group (p = 0.01).", {"entities": [[78, 81, "GENE"]]}], ["Tyrphostin AG1478 treatment of cultures from asthmatic children had significant reductions in goblet cells at 0.2\u03bcg/ml (p = 0.03) and 2\u03bcg/ml (p = 0.003) as well as mucus secretion at 2\u03bcg/ml (p = 0.04).", {"entities": []}], ["We have shown in this preliminary study that through EGF removal and tyrphostin AG1478 treatment the goblet cell number and mucus hypersecretion in differentiating air-liquid interface cultures from asthmatic children is significantly reduced.", {"entities": [[53, 56, "GENE"]]}], ["This further highlights the epidermal growth factor receptor as a potential therapeutic target to inhibit goblet cell hyperplasia and mucus hypersecretion in asthma.", {"entities": [[158, 164, "DISEASE"]]}], ["Reactivation of latent varicella zoster virus, partly due to age-related immunosenescence and immunosuppressive conditions, results in herpes zoster (HZ) and its associated complications.", {"entities": [[135, 148, "DISEASE"]]}], ["The management of the most important complication, post-herpetic neuralgia (PHN), is challenging, particularly in the elderly, and is generally unsatisfactory.", {"entities": []}], ["No previous reviews have reported the incidence of HZ-associated mortality.", {"entities": []}], ["We carried out a systematic literature review to identify studies and databases providing data for HZ-associated mortality in adults aged \u226550\u00a0years in Europe.", {"entities": []}], ["We identified 12 studies: Belgium (1); France (1); Germany (1); the Netherlands (2); Portugal (1); Spain (4) and England/Wales (2) and 4 databases from Europe: France; Germany and England/Wales.", {"entities": []}], ["The incidence was available from eight studies; it was highest in those aged \u226595 in France (19.48/100,000).", {"entities": []}], ["In the European (WHO) database, the overall mortality ranged from 0 to >0.07/100,000.", {"entities": []}], ["The age- and gender-specific HZ mortality rates from the other databases showed that while in younger age groups the HZ mortality rate was higher in males, in older patients the rate was much higher in women.", {"entities": []}], ["The case fatality rate was 2 and 61/100 000 in those 45\u201365 and \u226565\u00a0years, respectively.", {"entities": []}], ["A similar increase with age was seen for the hospital fatality rate; 0.6% in those 45\u201365 years in the UK and 7.1% in those \u226580 in Spain.", {"entities": []}], ["Although the data were sparse and heterogeneous, HZ-associated mortality clearly increases with age.", {"entities": []}], ["In addition, the elderly who develop HZ often have underlying diseases and are at increased risk of functional decline and loss of independence.", {"entities": []}], ["Mortality should be taken into account in health-economics models.", {"entities": []}], ["There is increasing evidence that chronic obstructive pulmonary disease (COPD) is not simply a disease of old age that is largely restricted to heavy smokers, but may be associated with insults to the developing lung during foetal life and the first few years of postnatal life, when lung growth and development are rapid.", {"entities": [[34, 71, "DISEASE"]]}], ["A better understanding of the long-term effects of early life factors, such as intrauterine growth restriction, prenatal and postnatal exposure to tobacco smoke and other pollutants, preterm delivery and childhood respiratory illnesses, on the subsequent development of chronic respiratory disease is imperative if appropriate preventive and management strategies to reduce the burden of COPD are to be developed.", {"entities": []}], ["The extent to which insults to the developing lung are associated with increased risk of COPD in later life depends on the underlying cause, timing and severity of such derangements.", {"entities": []}], ["Suboptimal conditions in utero result in aberrations of lung development such that affected individuals are born with reduced lung function, which tends to remain diminished throughout life, thereby increasing the risk both of wheezing disorders during childhood and subsequent COPD in genetically susceptible individuals.", {"entities": []}], ["If the current trend towards the ever-increasing incidence of COPD is to be reversed, it is essential to minimize risks to the developing lung by improvements in antenatal and neonatal care, and to reduce prenatal and postnatal exposures to environmental pollutants, including passive tobacco smoke.", {"entities": []}], ["Furthermore, adult physicians need to recognize that lung disease is potentially associated with early life insults and provide better education regarding diet, exercise and avoidance of smoking to preserve precious reserves of lung function in susceptible adults.", {"entities": [[53, 65, "DISEASE"]]}], ["This review focuses on factors that adversely influence lung development in utero and during the first 5 years of life, thereby predisposing to subsequent COPD.", {"entities": []}], ["Respiratory syncytial virus (RSV) is an important cause of lower respiratory tract infections in infants.", {"entities": []}], ["A small percentage of the infected infants develops a severe infection, while most of these severely ill patients were previously healthy.", {"entities": []}], ["It remains unclear why these children develop severe RSV infections.", {"entities": []}], ["In this study, we investigate whether pneumococcal nasopharyngeal carriage patterns correlate with mucosal inflammation and severity of disease.", {"entities": []}], ["In total, 105 infants hospitalized with RSV infection were included and recovery samples were taken from 42 patients.", {"entities": []}], ["The presence and density of Streptococcus pneumoniae was determined by RT qPCR to study its relation to viral load, inflammation (MMP-9 and IL-6) and severity of RSV disease.", {"entities": []}], ["We show that pneumococcal presence or absence in the nasopharynx does not correlate with viral load, inflammation or severity of disease.", {"entities": []}], ["However, when pneumococcus is present in patients, a higher nasopharyngeal pneumococcal density was correlated with a higher RSV load, higher MMP-9 levels and a less severe course of disease.", {"entities": []}], ["Our results show correlations between S. pneumoniae density and viral load, inflammation and disease severity, suggesting that pneumococcal density may be an indicator for severity in paediatric RSV disease.", {"entities": []}], ["The online version of this article (doi:10.1186/s12879-016-1454-x) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Maternal smoking during pregnancy is associated with adverse perinatal and postnatal health outcomes.", {"entities": []}], ["The efficacy of nicotine replacement therapies in helping pregnant smokers to quit is not clearly demonstrated; therefore new interventions should be proposed and assessed.", {"entities": []}], ["Financial incentives rewarding abstinence from tobacco smoking is one of the promising options.", {"entities": []}], ["To assess the efficacy of financial incentives on smoking abstinence among French pregnant smokers.", {"entities": []}], ["Participants: pregnant smokers aged \u226518\u2005years, smoking at least five manufactured or three roll-your-own cigarettes per day, and pregnant for <18\u2005weeks of amenorrhoea (WA).", {"entities": []}], ["Setting: participants will be recruited, included and followed-up at monthly face-to-face visits in 16 maternity wards in France.", {"entities": []}], ["Interventions: participants will be randomised to a control or an intervention group.", {"entities": []}], ["After a predefined quit date, participants in the control group will receive \u20ac20 vouchers at the completion of each visit but no financial incentive for smoking abstinence.", {"entities": []}], ["Participants in the intervention group will be rewarded for their abstinence by vouchers on top of the \u20ac20 show-up fee.", {"entities": []}], ["The amount of reward for abstinence will increase as a function of duration of abstinence to stimulate longer periods of abstinence.", {"entities": []}], ["Main outcome measure : complete abstinence from quit date to the last predelivery visit.", {"entities": []}], ["Secondary outcome measures: point prevalence abstinence, time to relapse to smoking, birth weight, fetal growth restriction, preterm birth.", {"entities": []}], ["Main data analysis: outcomes will be analysed on an intention-to-treat (ITT) basis.", {"entities": []}], ["The ITT population is defined as all randomised smoking pregnant women.", {"entities": []}], ["The research protocol was approved by the ethics committee (Comit\u00e9 de Protection des Personnes, CPP) of the Piti\u00e9-Salp\u00eatri\u00e8re Hospital on 15 May 2015, and Amendment No 1 was approved on 13 July 2015.", {"entities": [[81, 84, "GENE"]]}], ["Results will be presented at scientific meetings and published.", {"entities": []}], ["NCT02606227; Pre-results.", {"entities": []}], ["Abdominal aortic aneurysm (AAA) is a leading cause of sudden death in aged people.", {"entities": [[10, 25, "DISEASE"]]}], ["Activation of ubiquitin proteasome system (UPS) plays a critical role in the protein quality control and various diseases.", {"entities": []}], ["However, the functional role of UPS in AAA formation remains unclear.", {"entities": []}], ["In this study, we found that the proteasome activities and subunit expressions in AAA tissues from human and angiotensin II (Ang II)-infused apolipoprotein E knockout (Apo E", {"entities": [[125, 128, "GENE"]]}], ["With the recent widespread use of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA), there have been occasional reports on complications associated with its use.", {"entities": []}], ["Previous reviews on EBUS-TBNA have been limited to studies by skilled operators, thus the results may not always be applicable to recent clinical practice.", {"entities": []}], ["To assess the safety of EBUS-TBNA for the staging and diagnosis of lung cancer in Japan, a nationwide survey on its current usage status and complications associated with its use was conducted by the Japan Society for Respiratory Endoscopy (JSRE).", {"entities": [[67, 78, "DISEASE"], [72, 78, "DISEASE"]]}], ["A questionnaire about EBUS-TBNA performed between January 2011 and June 2012 was mailed to 520 JSRE-accredited facilities.", {"entities": []}], ["Responses were obtained from 455 facilities (87.5%).", {"entities": []}], ["During the study period, EBUS-TBNA was performed in 7,345 cases in 210 facilities (46.2%) using a convex probe ultrasound bronchoscope, for 6,836 mediastinal and hilar lesions and 275 lung parenchymal lesions.", {"entities": []}], ["Ninety complications occurred in 32 facilities.", {"entities": []}], ["The complication rate was 1.23% (95% confidence interval, 0.97%-1.48%), with hemorrhage being the most frequent complication (50 cases, 0.68%).", {"entities": []}], ["Infectious complications developed in 14 cases (0.19%) (Mediastinitis, 7; pneumonia, 4; pericarditis, 1; cyst infection, 1; and sepsis, 1).", {"entities": [[88, 100, "DISEASE"], [74, 83, "DISEASE"]]}], ["Pneumothorax developed in 2 cases (0.03%), one of which required tube drainage.", {"entities": []}], ["Regarding the outcome of the cases with complications, prolonged hospitalization was observed in 14 cases, life-threatening conditions in 4, and death in 1 (severe cerebral infarction) (mortality rate, 0.01%).", {"entities": [[164, 183, "DISEASE"]]}], ["Breakage of the ultrasound bronchoscope occurred in 98 cases (1.33%) in 67 facilities (31.9%), and that of the puncture needle in 15 cases (0.20%) in 8 facilities (3.8%).", {"entities": []}], ["Although the complication rate associated with EBUS-TBNA was found to be low, severe complications, including infectious complications, were observed, and the incidence of device breakage was high.", {"entities": []}], ["Since the use of EBUS-TBNA is rapidly expanding in Japan, an educational program for its safe performance should be immediately established.", {"entities": []}], ["Problems associated with estimation of human exposure to ambient air pollutants are discussed.", {"entities": []}], ["Ideally, we would prefer to have some indication of actual dose.", {"entities": []}], ["For most pollutants this is not presently feasible.", {"entities": []}], ["Specific problems discussed are adequacy of outdoor monitors; the need to correct for exposures and time spent indoors; the need to have particle size distributions described and the chemistry of the particles presented.", {"entities": []}], ["These indicate the need to develop lightweight accurate and reliable personal monitors.", {"entities": []}], ["A growing body of evidence indicates that survivors of intensive care have an impaired quality of life.", {"entities": []}], ["It is not entirely clear from the available literature whether this impairment is a complication of critical illness or a complication of therapy.", {"entities": []}], ["There is little evidence to guide physicians to treatments in the intensive care unit that will minimize the effects of critical illness on these sequelae.", {"entities": []}], ["Although the study by Rublee and colleagues in this issue of Critical Care provides little clinically useful information about the effects of antithrombin III on quality of life, it provides some insight into the challenges that investigators will encounter as we try to incorporate these outcomes into studies of critical illness.", {"entities": []}], ["As the number of randomised controlled trials of medicines for children increases, it becomes progressively more important to understand the experiences of parents who are asked to enrol their child in a trial.", {"entities": []}], ["This paper presents a narrative review of research evidence on parents' experiences of trial recruitment focussing on qualitative research, which allows them to articulate their views in their own words.", {"entities": []}], ["Parents want to do their best for their children, and socially and legally their role is to care for and protect them yet the complexities of the medical and research context can challenge their fulfilment of this role.", {"entities": []}], ["Parents are simultaneously responsible for their child and cherish this role yet they are dependent on others when their child becomes sick.", {"entities": []}], ["They are keen to exercise responsibility for deciding to enter a child in a trial yet can be fearful of making the 'wrong' decision.", {"entities": []}], ["They make judgements about the threat of the child's condition as well as the risks of the trial yet their interpretations often differ from those of medical and research experts.", {"entities": []}], ["Individual parents will experience these and other complexities to a greater or lesser degree depending on their personal experiences and values, the medical situation of their child and the nature of the trial.", {"entities": []}], ["Interactions at the time of trial recruitment offer scope for negotiating these complexities if practitioners have the flexibility to tailor discussions to the needs and situation of individual parents.", {"entities": []}], ["In this way, parents may be helped to retain a sense that they have acted as good parents to their child whatever decision they make.", {"entities": []}], ["Discussing randomised controlled trials and gaining and providing informed consent is challenging.", {"entities": []}], ["The unique position of parents in giving proxy consent for their child adds to this challenge.", {"entities": []}], ["Recognition of the complexities parents face in making decisions about trials suggests lines for future research on the conduct of trials, and ultimately, may help improve the experience of trial recruitment for all parties.", {"entities": []}], ["In vivo phosphorylation of sphingosine analogs with their ensuing binding and activation of their cell-surface sphingosine-1-phosphate receptors is regarded as the main immunomodulatory mechanism of this new class of drugs.", {"entities": []}], ["Prophylactic treatment with sphingosine analogs interferes with experimental asthma by impeding the migration of dendritic cells to draining lymph nodes.", {"entities": [[77, 83, "DISEASE"]]}], ["However, whether these drugs can also alleviate allergic airway inflammation after its onset remains to be determined.", {"entities": []}], ["Herein, we investigated to which extent and by which mechanisms the sphingosine analog AAL-R interferes with key features of asthma in a murine model during ongoing allergic inflammation induced by Dermatophagoides pteronyssinus .", {"entities": [[125, 131, "DISEASE"]]}], ["BALB/c mice were exposed to either D. pteronyssinus or saline, intranasally, once-daily for 10 consecutive days.", {"entities": []}], ["Mice were treated intratracheally with either AAL-R, its pre-phosphorylated form AFD-R, or the vehicle before every allergen challenge over the last four days, i.e.", {"entities": []}], ["after the onset of allergic airway inflammation.", {"entities": []}], ["On day 11, airway responsiveness to methacholine was measured; inflammatory cells and cytokines were quantified in the airways; and the numbers and/or viability of T cells, B cells and dendritic cells were assessed in the lungs and draining lymph nodes.", {"entities": []}], ["AAL-R decreased airway hyperresponsiveness induced by D. pteronyssinus by nearly 70%.", {"entities": []}], ["This was associated with a strong reduction of IL-5 and IL-13 levels in the airways and with a decreased eosinophilic response.", {"entities": []}], ["Notably, the lung CD4 Airway delivery of the non-phosphorylated sphingosine analog, but not its pre-phosphorylated counterpart, is highly efficient at controlling the local T cell response after the onset of allergic airway inflammation.", {"entities": [[18, 21, "GENE"]]}], ["The mechanism appears to involve local induction of lymphocyte apoptosis/necrosis, while mildly affecting dendritic cell and T cell accumulation in draining lymph nodes.", {"entities": []}], ["Phthalates are multifunctional chemicals used in a wide variety of consumer products.", {"entities": []}], ["The aim of this study was to investigate whether levels of urinary phthalate metabolites in urine samples of Austrian mothers and their children were associated with consumer habits and health indicators.", {"entities": []}], ["Within an Austrian biomonitoring survey, urine samples from 50 mother-child pairs of five communities (two-stage random stratified sampling) were analysed.", {"entities": []}], ["The concentrations of 14 phthalate metabolites were determined, and a questionnaire was administered.", {"entities": []}], ["Monoethyl phthalate (MEP), mono-n-butyl phthalate (MnBP), mono-isobutyl phthalate (MiBP), monobenzyl phthalate (MBzP), mono-(2-ethylhexyl) phthalate (MEHP), mono-(2-ethyl-5-hydroxyhexyl) phthalate (5OH-MEHP), mono-(2-ethyl-5-oxohexyl) phthalate (5oxo-MEHP), mono-(5-carboxy-2-ethylpentyl) phthalate (5cx-MEPP), and 3-carboxy-mono-propyl phthalate (3cx-MPP) could be quantified in the majority of samples.", {"entities": []}], ["Significant correlations were found between the use of hair mousse, hair dye, makeup, chewing gum, polyethylene terephthalate (PET) bottles and the diethyl phthalate (DEP) metabolite MEP.", {"entities": []}], ["With regard to health effects, significant associations of MEP in urine with headache, repeated coughing, diarrhoea, and hormonal problems were observed.", {"entities": []}], ["MBzP was associated with repeated coughing and MEHP was associated with itching.", {"entities": []}], ["The second-to-fourth finger length ratio (2D:4D) is an indication of prenatal sex hormone exposure, and has sex-specifically been associated with several lethal illnesses including ischemic heart disease, diverse cancers, and suicide.", {"entities": [[181, 203, "DISEASE"], [190, 203, "DISEASE"]]}], ["Our primary aim was to verify that 2D:4D sex-specifically relates to life expectancy and suicide numbers on a national level (23 countries).", {"entities": []}], ["We also used a hypothesis-free approach to investigate associations with other causes of death [ p value adjustment for multiple hypothesis testing using the false discovery rate procedure (FDR)].", {"entities": []}], ["All parameters were normalized to the national mean (of males and females) and analyzed across nations.", {"entities": []}], ["Normalized male 2D:4D correlated positively with normalized male life expectancy (at birth, r \u00a0=\u00a00.46, p \u00a0=\u00a00.029; at the age of 60, r \u00a0=\u00a00.44, p \u00a0=\u00a00.038) and negatively with normalized male suicide rates ( r \u00a0=\u00a0\u2212\u00a00.49, p \u00a0=\u00a00.017).", {"entities": []}], ["In the exploratory analyses, the normalized male 2D:4D values were negatively associated with the normalized male deaths rates from communicable, maternal, perinatal, and nutritional conditions [ r \u00a0=\u00a0\u2212\u00a00.65, p (FDR)\u00a0=\u00a00.011], respiratory infections [ r \u00a0=\u00a0\u2212\u00a00.69, p (FDR)\u00a0=\u00a00.008], asthma [ r \u00a0=\u00a0\u2212\u00a00.65, p (FDR)\u00a0=\u00a00.011], neurological conditions [ r \u00a0=\u00a0\u2212\u00a00.56, p (FDR)\u00a0=\u00a00.046], and Alzheimer\u2019s disease and other dementias [r\u00a0=\u00a0\u2212\u00a00.59, p (FDR)\u00a0=\u00a00.036].", {"entities": [[283, 289, "DISEASE"]]}], ["The normalized female parameters showed the same cross-national correlations.", {"entities": []}], ["In line with the previous individual level findings, the results suggest that prenatal sex hormone effects are sex-specifically involved in suicide and neurological conditions.", {"entities": []}], ["Moreover, we provide novel national level evidence that prenatal sex hormone priming may sex-specifically influence life expectancy and death risk from respiratory diseases.", {"entities": []}], ["Respiratory sinus arrhythmia (RSA) is related to cardiac vagal outflow and the respiratory pattern.", {"entities": []}], ["Prior infant studies have not systematically examined respiration rate and tidal volume influences on infant RSA or the extent to which infants' breathing is too fast to extract a valid RSA.", {"entities": []}], ["We therefore monitored cardiac activity, respiration, and physical activity in 23 six-month old infants during a standardized laboratory stressor protocol.", {"entities": []}], ["On average, 12.6% (range 0\u201358.2%) of analyzed breaths were too short for RSA extraction.", {"entities": []}], ["Higher respiration rate was associated with lower RSA amplitude in most infants, and lower tidal volume was associated with lower RSA amplitude in some infants.", {"entities": []}], ["RSA amplitude corrected for respiration rate and tidal volume influences showed theoretically expected strong reductions during stress, whereas performance of uncorrected RSA was less consistent.", {"entities": []}], ["We conclude that stress-induced changes of peak-valley RSA and effects of variations in breathing patterns on RSA can be determined for a representative percentage of infant breaths.", {"entities": []}], ["As expected, breathing substantially affects infant RSA and needs to be considered in studies of infant psychophysiology.", {"entities": []}], ["Unprocessed biomass fuel is the primary source of indoor air pollution (IAP) in developing countries.", {"entities": []}], ["The use of biomass fuel has been linked with acute respiratory infections.", {"entities": []}], ["This study assesses sources of variations associated with the level of indoor nitrogen dioxide (NO 2 ).", {"entities": []}], ["This study examines household factors affecting the level of indoor pollution by measuring NO 2 .", {"entities": []}], ["Repeated measurements of NO 2 were made using a passive diffusive sampler.", {"entities": []}], ["A Saltzman colorimetric method using a spectrometer calibrated at 540 nm was employed to analyze the mass of NO 2 on the collection filter that was then subjected to a mass transfer equation to calculate the level of NO 2 for the 24 hours of sampling duration.", {"entities": []}], ["Structured questionnaire was used to collect data on fuel use characteristics.", {"entities": []}], ["Data entry and cleaning was done in EPI INFO version 6.04, while data was analyzed using SPSS version 15.0.", {"entities": []}], ["Analysis of variance, multiple linear regression and linear mixed model were used to isolate determining factors contributing to the variation of NO 2 concentration.", {"entities": []}], ["A total of 17,215 air samples were fully analyzed during the study period.", {"entities": []}], ["Wood and crop were principal source of household energy.", {"entities": []}], ["Biomass fuel characteristics were strongly related to indoor NO 2 concentration in one-way analysis of variance.", {"entities": []}], ["There was variation in repeated measurements of indoor NO 2 over time.", {"entities": []}], ["In a linear mixed model regression analysis, highland setting, wet season, cooking, use of fire events at least twice a day, frequency of cooked food items, and interaction between ecology and season were predictors of indoor NO 2 concentration.", {"entities": []}], ["The volume of the housing unit and the presence of kitchen showed little relevance in the level of NO 2 concentration.", {"entities": []}], ["Agro-ecology, season, purpose of fire events, frequency of fire activities, frequency of cooking and physical conditions of housing are predictors of NO 2 concentration.", {"entities": []}], ["Improved kitchen conditions and ventilation are highly recommended.", {"entities": []}], ["The objective of this study is to investigate whether BCG infection before, during or after sensitization suppresses allergen-induced airway hyperresponsiveness and eosinophilic inflammation in allergic asthma rats, and to determine the required dose of BCG to induce such an inhibition.", {"entities": [[194, 209, "DISEASE"], [203, 209, "DISEASE"]]}], ["Eighty-seven Sprague-Dawley (SD) rats were sensitized and provoked with ovalbumin (OA).", {"entities": []}], ["A pretreatment of 6 x 10(4) or 6 x 10(5) colony forming units (CFUs) of BCG or saline was done at four different times: 3 days before sensitization, at sensitization, 3 days before provocation, or at provocation.", {"entities": []}], ["The assessment of tracheal smooth muscle (TSM) responsiveness to electrical field stimulation or acetylcholine (ACh) and bronchoalveolar lavage (BAL) were performed 1 day after OA provocation.", {"entities": []}], ["Doses of 6 x 10(4) CFUs inhibited TSM sensitivity of rats infected 3 days before sensitization or at sensitization, but not 3 days before provocation or at provocation.", {"entities": []}], ["However, doses of 6 x 10(5) CFUs significantly inhibited not only the airway eosinophilia of rats infected 3 days before sensitization or at sensitization, but also the TSM sensitivity of rats infected 3 days before provocation or at provocation.", {"entities": [[77, 89, "DISEASE"]]}], ["In conclusion, BCG infection suppresses the development of sensitivity of airway smooth muscle and airway eosinophilic inflammation in allergic asthma rats.", {"entities": [[135, 150, "DISEASE"], [144, 150, "DISEASE"]]}], ["Furthermore, a relatively high dose of BCG infection inhibits airway sensitivity, even after allergen sensitization.", {"entities": []}], ["Surgical complexity and related morbidities may affect long\u2010term patient quality of life ( QOL ).", {"entities": []}], ["Aristotle Basic Complexity ( ABC ) score and Risk Adjustment in Congenital Heart Surgery ( RACHS \u20101) category stratify the complexity of pediatric cardiac operations.", {"entities": []}], ["The purpose of this study was to examine the relationship between surgical complexity and QOL and to investigate other demographic and clinical variables that might explain variation in QOL in pediatric cardiac surgical survivors.", {"entities": []}], ["Pediatric Cardiac Quality of Life ( PCQLI ) study participants who had undergone cardiac surgery were included.", {"entities": []}], ["The PCQLI database provided sample characteristics and QOL scores.", {"entities": []}], ["Surgical complexity was defined by the highest ABC raw score or RACHS \u20101 category.", {"entities": []}], ["Relationships among surgical complexity and demographic, clinical, and QOL variables were assessed using ordinary least squares regression.", {"entities": []}], ["A total of 1416 patient\u2013parent pairs were included.", {"entities": []}], ["Although higher ABC scores and RACHS \u20101 categories were associated with lower QOL scores ( P <0.005), correlation with QOL scores was poor to fair ( r =\u22120.10 to \u22120.29) for all groups.", {"entities": []}], ["Ordinary least squares regression showed weak association with R R QOL scores.", {"entities": []}], ["ABC scores and RACHS \u20101 categories are useful tools for morbidity and mortality predictions prior to cardiac surgery and quality of care initiatives but are minimally helpful in predicting a child's or adolescent's long\u2010term QOL scores.", {"entities": []}], ["Further studies are warranted to determine other predictors of QOL variation.", {"entities": []}], ["Obligate intracellular pathogens belonging to the Chlamydiaceae family possess a number of mechanisms by which to manipulate the host cell and surrounding environment.", {"entities": []}], ["Such capabilities include the inhibition of apoptosis, down-regulation of major histocompatability complex (MHC) and CD1/d gene expression, and the acquisition of host-synthesized nutrients.", {"entities": []}], ["It is also documented that a limited number of host-derived macromolecules such as \u03b2-catenin and sphingomyelin accumulate within the inclusion.", {"entities": []}], ["This report provides evidence that immunoglobulin, inherently present in the extracellular environment in vivo and in vitro , enters infected cells and accumulates within the chlamydial inclusion.", {"entities": []}], ["Using epi-fluorescent and confocal microscopy, this selective uptake of Ig is shown to occur among human leukocytes in vivo as well as cells cultured in vitro .", {"entities": []}], ["These findings were confirmed by detection of IgG in the lysate of infected cells by western blot hybridization.", {"entities": []}], ["Sequestered antibodies appear to be present during the entire course of the chlamydial developmental cycle and are distributed throughout this compartment.", {"entities": []}], ["IgG pre-labeled with fluorescein, when added to the supernatant of infected cell cultures, was also imported and readily visualized.", {"entities": []}], ["Accumulation of these molecules within the inclusion and the failure of bovine serum albumin or F(ab') 2 fragments to accumulate in a similar manner suggests the process of entry is specific for intact IgG molecules and not a result of pinocytosis, diffusion, or any other mass endocytic event.", {"entities": []}], ["Sequestration of a host cell-derived protein within the chlamydial inclusion, although unexpected, is not an unprecedented occurrence.", {"entities": []}], ["However, selective accumulation of an exogenous host protein, such as extracellular IgG, has not been previously reported in connection with chlamydial infections.", {"entities": []}], ["The selectivity of this process may indicate that this uptake plays an important role in pathogen physiology or virulence during infection and the phenomenon itself may give rise to novel diagnostic and therapeutic approaches.", {"entities": []}], ["Development of Traditional Chinese Medicine (TCM) syndrome-specific outcome measures is needed for the evaluation of TCM syndrome-specific therapies.", {"entities": [[50, 58, "DISEASE"], [121, 129, "DISEASE"]]}], ["We constructed a Kidney Deficiency Syndrome Questionnaire (KDSQ) for the evaluation of the common TCM syndromes Kidney-Yin Deficiency Syndrome (KDS-Yin) and Kidney-Yang Deficiency Syndrome (KDS-Yang) in middle-aged women with menopausal symptoms.", {"entities": [[35, 43, "DISEASE"], [134, 142, "DISEASE"], [180, 188, "DISEASE"]]}], ["KDS-Yin and KDS-Yang were traditionally defined by expert opinion were validated by exploratory factor analysis (EFA) and structural equation modeling (SEM).", {"entities": []}], ["Content validity was tested by EFA on a sample of 236 women from a seminar and SEM on another sample of 321 women from a postal survey.", {"entities": []}], ["Other psychometric properties were tested on 292 women from the seminar at baseline and two systematically selected sub-samples: 54 who reported no changes in discomforts 11\u201312\u2009days after the baseline and 31 who reported changes in discomforts 67\u201374\u2009days after the baseline.", {"entities": []}], ["All participants completed the KDSQ, the Greene Climacteric Scale and the standard 12-item Short Form Health Survey.", {"entities": []}], ["The EFA and SEM established the measurement models of KDS-Yin and KDS-Yang supporting content validity of the KDSQ.", {"entities": []}], ["Internal consistency was good (Cronbach\u2019s Alpha >0.70).", {"entities": []}], ["Construct validity was supported by theoretically-derived levels of correlation with the established external measures.", {"entities": []}], ["Test\u2013retest reliability was strong (ICC agreement : KDS-Yin, 0.94; KDS-Yang, 0.93).", {"entities": []}], ["The KDSQ was responsive to changes over time as tested by effect size and longitudinal validity.", {"entities": []}], ["The KDSQ was a valid and reliable measure for KDS-Yin and KDS-Yang in Hong Kong Chinese middle-aged women with menopausal symptoms.", {"entities": []}], ["Over the past three decades, the goal of many researchers is analysis of exhaled breath condensate (EBC) as noninvasively obtained sample.", {"entities": []}], ["A total quality in laboratory diagnostic processes in EBC analysis was investigated: pre-analytical (formation, collection, storage of EBC), analytical (sensitivity of applied methods, standardization) and post-analytical (interpretation of results) phases.", {"entities": []}], ["EBC analysis is still used as a research tool.", {"entities": []}], ["Limitations referred to pre-analytical, analytical, and post-analytical phases of EBC analysis are numerous, e.g.", {"entities": []}], ["low concentrations of EBC constituents, single-analyte methods lack in sensitivity, and multi-analyte has not been fully explored, and reference values are not established.", {"entities": []}], ["When all, pre-analytical, analytical and post-analytical requirements are met, EBC biomarkers as well as biomarker patterns can be selected and EBC analysis can hopefully be used in clinical practice, in both, the diagnosis and in the longitudinal follow-up of patients, resulting in better outcome of disease.", {"entities": []}], ["At present, there is no evidence on whether using condition-specific Oral Health-Related Quality of Life (OHRQoL) measures provides more reliable information than generic measures for needs assessment.", {"entities": []}], ["Therefore, the objective was to assess the discriminative ability of one generic and one condition-specific OHRQoL measure, namely, respectively, the short form of the Oral Health Impact Profile (OHIP-14) and the Condition-Specific form of the Oral Impacts on Daily Performances (CS-OIDP) attributed to malocclusion, between adolescents with and without normative need for orthodontic treatment.", {"entities": []}], ["200 16\u201317-year-old adolescents were randomly selected from 957 schoolchildren attending a Sixth Form College in London, United Kingdom.", {"entities": []}], ["The impact of their oral conditions on quality of life during the last 6 months was assessed using two OHRQoL measures; OHIP-14 and OIDP.", {"entities": []}], ["Adolescents were also examined for normative orthodontic treatment need using the Index of Orthodontic Treatment Need (IOTN) and the Dental Aesthetic Index (DAI).", {"entities": []}], ["Discriminative ability was assessed comparing the overall scores and prevalence of oral impacts, calculated using each OHRQoL measure, between adolescents with and without normative need.", {"entities": []}], ["Using the prevalence of oral impacts allowed adjusting for covariates.", {"entities": []}], ["There were significant differences in overall scores for CS-OIDP attributed to malocclusion between adolescents with and without normative need for orthodontic treatment when IOTN or DAI were used to define need (p = 0.029 or 0.011 respectively), and in overall scores for OHIP-14 when DAI, but not IOTN was used to define need (p = 0.029 and 0.080 respectively).", {"entities": []}], ["For the prevalence of impacts, only the prevalence of CS-OIDP attributed to malocclusion differed significantly between adolescents with and without normative need, even after adjusting for covariates (p = 0.017 and 0.049 using IOTN and DAI to define need).", {"entities": []}], ["CS-OIDP attributed to malocclusion was better able than OHIP-14 to discriminate between adolescents with and without normative needs for orthodontic treatment.", {"entities": []}], ["Epidemiological studies have revealed that high consumption of soy products is associated with low incidences of hormone-dependent cancers, including breast and prostate cancer.", {"entities": [[170, 176, "DISEASE"], [161, 176, "DISEASE"]]}], ["Soybeans contain large amounts of isoflavones, such as the genistein and daidzain.", {"entities": []}], ["Previously, it has been demonstrated that genistein, one of the predominant soy isoflavones, can inhibit several steps involved in carcinogenesis.", {"entities": []}], ["It is suggested that genistein possesses pleiotropic molecular mechanisms of action including inhibition of tyrosine kinases, DNA topoisomerase II, 5\u03b1-reductase, galectin-induced G 2 /M arrest, protein histidine kinase, and cyclin-dependent kinases, modulation of different signaling pathways associated with the growth of cancer cells (e.g., NF-\u03baB, Akt, MAPK), etc .", {"entities": [[323, 329, "DISEASE"]]}], ["Moreover, genistein is also a potent inhibitor of angiogenesis.", {"entities": []}], ["Uncontrolled angiogenesis is considered as a key step in cancer growth, invasion, and metastasis.", {"entities": [[57, 63, "DISEASE"]]}], ["Genistein was found to inhibit angiogenesis through regulation of multiple pathways, such as regulation of VEGF, MMPs, EGFR expressions and NF-\u03baB, PI3-K/Akt, ERK1/2 signaling pathways, thereby causing strong antiangiogenic effects.", {"entities": [[119, 123, "GENE"]]}], ["This review focuses on the antiangiogenic properties of soy isoflavonoids and examines their possible underlying mechanisms.", {"entities": []}], ["Workers exposed to organic dusts from concentrated animal feeding operations (CAFOs) are at risk for developing airway inflammatory diseases.", {"entities": []}], ["Available preventative and therapeutic measures for alleviating dust-induced lung disease are inadequate.", {"entities": [[77, 89, "DISEASE"]]}], ["Because omega-3 fatty acids can mitigate inflammatory processes, we aimed to determine whether nutritional supplementation with the omega-3 fatty acid docosahexaenoic acid (DHA) could reduce the airway inflammatory consequences of exposures to organic dust.", {"entities": []}], ["Aqueous extracts of organic dusts from swine CAFOs (ODE) were utilized.", {"entities": []}], ["In DHA-pretreated human bronchial epithelial cells, lung fibroblasts, monocyte cell cultures, and precision-cut murine lung slices, we found that DHA pretreatment dose-dependently decreased ODE-induced inflammatory cytokine production.", {"entities": []}], ["To determine the in vivo significance of DHA, C57BL/6 mice were orally administered DHA for seven days prior to treatment with intranasal ODE or saline inhalations.", {"entities": []}], ["Animals treated with 2 mg DHA demonstrated significant reductions in ODE-induced bronchial alveolar lavage neutrophil influx and pro-inflammatory cytokine/chemokine production compared to mice exposed to ODE alone.", {"entities": []}], ["Collectively, these data demonstrate that DHA affects several lung cells to reduce the airway inflammatory response to organic dust exposures.", {"entities": []}], ["Dietary supplementation with DHA may be an effective therapeutic strategy to reduce the airway inflammatory consequences in individuals exposed to agriculture dust environments.", {"entities": []}], ["Childhood asthma morbidity has been associated with ambient ozone in case-crossover studies.", {"entities": [[10, 16, "DISEASE"]]}], ["Varying effects of ozone by child age and sex, however, have been less explored.", {"entities": []}], ["This study evaluates associations between ozone exposure and asthma emergency department visits and hospitalizations among boys and girls aged 5-17 years in New York City for the 2005-2011 warm season period.", {"entities": [[61, 67, "DISEASE"]]}], ["Time-stratified case-crossover analysis was conducted and, for comparison, time-series analysis controlling for season, day-of-week, same-day and delayed effects of temperature and relative humidity were also performed.", {"entities": []}], ["We found associations between ambient ozone levels and childhood asthma emergency department visits and hospitalizations in New York City, although the relationships varied among boys and girls and by age group.", {"entities": [[65, 71, "DISEASE"]]}], ["For an increase of interquartile range (0.013 ppm) in ozone, there was a 2.9-8.4% increased risk for boys and 5.4-6.5% for girls in asthma emergency department visits; and 8.2% increased risk for girls in hospitalizations.", {"entities": [[132, 138, "DISEASE"]]}], ["Among girls, we observed stronger associations among older children (10-13 and 14-17 year age groups).", {"entities": []}], ["We did not observe significant modification by age for boys.", {"entities": []}], ["Boys exhibited a more prompt response (lag day 1) to ozone than did girls (lag day 3), but significant associations for girls were retained longer, through lag day 6.", {"entities": []}], ["Our study indicates significant variance in associations between short-term ozone concentrations and asthma events by child sex and age.", {"entities": [[101, 107, "DISEASE"]]}], ["Differences in ozone response for boys and girls, before and after puberty, may point towards both social (gendered) and biological (sex-linked) sources of effect modification.", {"entities": []}], ["The online version of this article (doi:10.1186/s12940-015-0010-2) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Both temperature and humidity may independently or jointly contribute to the risk of human rhinovirus (HRV) infections, either through altered survival and spread of viruses in the environment or due to changes in host susceptibility.", {"entities": []}], ["This study examined the relationship between short-term variations in temperature and humidity and the risk of HRV infections in a subarctic climate.", {"entities": []}], ["We conducted a case-crossover study among conscripts ( n = 892) seeking medical attention due to respiratory symptoms during their military training and identified 147 HRV cases by real-time PCR.", {"entities": []}], ["An average temperature, a decline in daily ambient temperature and absolute humidity (AH) during the three preceding days of the onset (hazard period) and two reference periods (a week prior and after the onset) were obtained.", {"entities": []}], ["The average daily temperature preceding HRV infections was \u22129.9 \u00b1 4.9 \u00b0C and the average AH was 2.2 \u00b1 0.9 g/m", {"entities": []}], ["Since the 1980s, severity of illness scoring systems has gained increasing popularity in Intensive Care Units (ICUs).", {"entities": []}], ["Physicians used them for predicting mortality and assessing illness severity in clinical trials.", {"entities": []}], ["The objective of this study was to assess the performance of Simplified Acute Physiology Score 3 (SAPS 3) and its customized equation for Australasia (Australasia SAPS 3, SAPS 3 [AUS]) in predicting clinical prognosis and hospital mortality in emergency ICU (EICU).", {"entities": []}], ["A retrospective analysis of the EICU including 463 patients was conducted between January 2013 and December 2015 in the EICU of Peking University Third Hospital.", {"entities": []}], ["The worst physiological data of enrolled patients were collected within 24 h after admission to calculate SAPS 3 score and predicted mortality by regression equation.", {"entities": []}], ["Discrimination between survivals and deaths was assessed by the area under the receiver operator characteristic curve (AUC).", {"entities": []}], ["Calibration was evaluated by Hosmer-Lemeshow goodness-of-fit test through calculating the ratio of observed-to-expected numbers of deaths which is known as the standardized mortality ratio (SMR).", {"entities": []}], ["A total of 463 patients were enrolled in the study, and the observed hospital mortality was 26.1% (121/463).", {"entities": []}], ["The patients enrolled were divided into survivors and nonsurvivors.", {"entities": []}], ["Age, SAPS 3 score, Acute Physiology and Chronic Health Evaluation Score II (APACHE II), and predicted mortality were significantly higher in nonsurvivors than survivors ( P < 0.05 or P < 0.01).", {"entities": []}], ["The AUC (95% confidence intervals [ CI s]) for SAPS 3 score was 0.836 (0.796\u20130.876).", {"entities": []}], ["The maximum of Youden's index, cutoff, sensitivity, and specificity of SAPS 3 score were 0.526%, 70.5 points, 66.9%, and 85.7%, respectively.", {"entities": []}], ["The Hosmer-Lemeshow goodness-of-fit test for SAPS 3 demonstrated a Chi-square test score of 10.25, P = 0.33, SMR (95% CI ) = 0.63 (0.52\u20130.76).", {"entities": []}], ["The Hosmer-Lemeshow goodness-of-fit test for SAPS 3 (AUS) demonstrated a Chi-square test score of 9.55, P = 0.38, SMR (95% CI ) = 0.68 (0.57\u20130.81).", {"entities": []}], ["Univariate and multivariate analyses were conducted for biochemical variables that were probably correlated to prognosis.", {"entities": []}], ["Eventually, blood urea nitrogen (BUN), albumin, lactate and free triiodothyronine (FT3) were selected as independent risk factors for predicting prognosis.", {"entities": []}], ["The SAPS 3 score system exhibited satisfactory performance even superior to APACHE II in discrimination.", {"entities": []}], ["In predicting hospital mortality, SAPS 3 did not exhibit good calibration and overestimated hospital mortality, which demonstrated that SAPS 3 needs improvement in the future.", {"entities": []}], ["Interpretation of scores from oral health-related quality of life (OHRQoL) instruments, such as the Oral Health Impact Profile (OHIP) is challenging.", {"entities": []}], ["It was the aim of this study to determine how many oral impacts correspond to one point of the 49-item OHIP using a new approach which translates numeric problem counts into the traditionally used ordinal OHIP response categories.", {"entities": []}], ["A sample of 145 consecutively recruited prosthodontic patients seeking treatment or having a routine examination completed the German version of the 49-item OHIP with the original ordinal response format as a self-administered questionnaire.", {"entities": []}], ["In addition, the numerical frequencies of impairment during the previous month were requested in personal interviews.", {"entities": []}], ["Based on a multilevel mixed-effects linear regression, we estimated the mean difference with 95% confidence interval (CI) in numerical frequency between two adjacent ordinal responses.", {"entities": []}], ["A numerical frequency of 15.2 (CI: 14.8 \u2013 15.7) impacts per month corresponded to one OHIP point.", {"entities": []}], ["This translates to approximately one impact every other day in the past month.", {"entities": []}], ["The oral problem count per day that corresponds to one OHIP-49 point can be used to interpret this instrument\u2019s scores in cross-sectional and longitudinal studies.", {"entities": []}], ["This number can help to better understand OHRQoL burden for patients, clinicians, and researchers alike.", {"entities": []}], ["Supplemental Digital Content is Available in the Text.", {"entities": []}], ["To investigate the comparative acute health effects associated with exposures to diesel and 75% biodiesel/25% diesel (B75) blend fuel emissions.", {"entities": []}], ["We analyzed multiple health endpoints in 48 healthy adults before and after exposures to diesel and B75 emissions in an underground mine setting\u2014lung function, lung and systemic inflammation, novel biomarkers of exposure, and oxidative stress were assessed.", {"entities": []}], ["B75 reduced respirable diesel particulate matter by 20%.", {"entities": []}], ["Lung function declined significantly more after exposure to diesel emissions.", {"entities": []}], ["Lung inflammatory cells along with sputum and plasma inflammatory mediators increased significantly to similar levels with both exposures.", {"entities": []}], ["Urinary 8-hydroxydeoxyguanosine, a marker of oxidative stress, was not significantly changed after either exposure.", {"entities": []}], ["Use of B75 lowered respirable diesel particulate matter exposure and some associated acute health effects, although lung and systemic inflammation were not reduced compared with diesel use.", {"entities": []}], ["Functional dyspepsia (FD) is a functional gastrointestinal disorder diagnosed by symptom-based criteria.", {"entities": [[11, 20, "DISEASE"]]}], ["It has been said that duodenal immune activation plays a role in the pathogenesis of FD.", {"entities": []}], ["The primary aims of the study were to compare the total number of duodenal eosinophil and evaluate the eosinophil degranulation rate, number of duodenal degranulated eosinophil and mast cell between patients with FD and healthy subjects.", {"entities": []}], ["We enrolled 96 patients with FD and 24 healthy controls at Sir Run Run Shaw Hospital.", {"entities": []}], ["The total number of eosinophil was comparable in the second portion of duodenum (D2) and duodenal bulb (D1) between patients with FD and healthy controls (all P \u2009>\u20090.05).", {"entities": []}], ["Significant higher eosinophil degranulation positive rate in D2 ( P \u2009=\u20090.003) and a trend towards higher in D1 ( P \u2009=\u20090.084) were observed in patients with FD compared with healthy controls.", {"entities": []}], ["Moreover, the number of duodenal degranulated eosinophil in patients with FD were significantly increased than healthy controls in D1(9.8\u2009\u00b1\u20096.3 vs 2.9\u2009\u00b1\u20092.1 per HPF, P \u2009=\u20090.0002) and a trend towards increase in D2 (10.7\u2009\u00b1\u20097.7 vs 5.3\u2009\u00b1\u20090.9 per HPF, P \u2009=\u20090.077), respectively.", {"entities": []}], ["However, degranulated mast cells in patients with FD were almost same with healthy controls.", {"entities": []}], ["Increased eosinophils degranulation in duodenum play an important role in pathogenesis of FD.", {"entities": []}], ["Breathlessness causes significant burden in our community but the underlying socio-demographic and lifestyle factors that may influence it are not well quantified.", {"entities": []}], ["This study aims to define these predictors of chronic breathlessness at a population level.", {"entities": []}], ["Data were collected from adult South Australians in 2007 and 2008 (n = 5331) as part of a face-to-face, cross-sectional, whole-of-population, multi-stage, systematic area sampling population health survey.", {"entities": []}], ["The main outcome variable was breathlessness in logistic regression models.", {"entities": []}], ["Lifestyle factors examined included smoking history, smoke-free housing, level of physical activity and body mass index (obesity).", {"entities": [[121, 128, "DISEASE"]]}], ["The participation rate was 64.1%, and 11.1% of individuals (15.0% if aged \u226550 years) chronically had breathlessness that limited exertion.", {"entities": []}], ["Significant bivariate associations with chronic breathlessness for the whole population and only those \u226550 included: increasing age; female gender; being separated/divorced/widowed; social disadvantage; smoking status; those without a smoke-free home; low levels of physical activity; and obesity.", {"entities": [[289, 296, "DISEASE"]]}], ["In multi-variate analyses adjusted for age, marital status (p < 0.001), physical activity (p < 0.001), obesity (p < 0.001), gender (p < 0.05) and social disadvantage (p < 0.05) remained significant factors.", {"entities": [[103, 110, "DISEASE"]]}], ["Smoking history was not a significant contributor to the model.", {"entities": []}], ["There is potential benefit in addressing reversible lifestyle causes of breathlessness including high body mass index (obesity) and low levels of physical activity in order to decrease the prevalence of chronic breathlessness.", {"entities": [[119, 126, "DISEASE"]]}], ["Clinical intervention studies for chronic breathlessness should consider stratification by body mass index.", {"entities": []}], ["Staphylococcus aureus is a human commensal bacterium found in the nasal cavity and other body sites.", {"entities": []}], ["Identifying risk factors for S. aureus nasal carriage is of interest, as nasal carriage is a risk factor for subsequent invasive infection.", {"entities": []}], ["We recently investigated the influence of host genetics on S. aureus carriage in Danish middle-aged and elderly twins, which indicated no significant heritability that could account for the observed S. aureus carriage.", {"entities": []}], ["In the present study, we performed a questionnaire-based study of S. aureus colonization on the same cohort of 2,196 Danish middle-aged and elderly twins to identify specific risk factors for S. aureus nasal colonization, including analyzing the paired twins ( n \u2009=\u2009478) that were discordant for S. aureus colonization.", {"entities": []}], ["We found associations between risk factors and S. aureus nasal colonization among middle-aged and elderly twins, including age, male gender, psoriasis, and atopic diseases.", {"entities": [[141, 150, "DISEASE"]]}], ["Also, present living on a farm is clearly associated with S. aureus colonization, while smoking had a borderline statistically significant protective effect.", {"entities": []}], ["The online version of this article (doi:10.1007/s10096-013-1882-0) contains supplementary material, which is available to authorized users.", {"entities": []}], ["Genomic analysis of longevity offers the potential to illuminate the biology of human aging.", {"entities": []}], ["Here, using genome-wide association meta-analysis of 606,059 parents\u2019 survival, we discover two regions associated with longevity ( HLA-DQA1/DRB1 and LPA ).", {"entities": [[150, 153, "GENE"]]}], ["We also validate previous suggestions that APOE , CHRNA3/5 , CDKN2A/B , SH2B3 and FOXO3A influence longevity.", {"entities": [[43, 47, "GENE"], [72, 77, "GENE"]]}], ["Next we show that giving up smoking, educational attainment, openness to new experience and high-density lipoprotein (HDL) cholesterol levels are most positively genetically correlated with lifespan while susceptibility to coronary artery disease (CAD), cigarettes smoked per day, lung cancer, insulin resistance and body fat are most negatively correlated.", {"entities": [[281, 292, "DISEASE"], [286, 292, "DISEASE"]]}], ["We suggest that the effect of education on lifespan is principally mediated through smoking while the effect of obesity appears to act via CAD.", {"entities": [[112, 119, "DISEASE"]]}], ["Using instrumental variables, we suggest that an increase of one body mass index unit reduces lifespan by 7 months while 1 year of education adds 11 months to expected lifespan.", {"entities": []}], ["Variability in human longevity is genetically influenced.", {"entities": []}], ["Using genetic data of parental lifespan, the authors identify associations at HLA-DQA/DRB1 and LPA and find that genetic variants that increase educational attainment have a positive effect on lifespan whereas increasing BMI negatively affects lifespan.", {"entities": [[95, 98, "GENE"]]}], ["Management of asthma can be complicated by both medical and psychiatric conditions, such as gastroesophageal reflux, chronic sinusitis, and anxiety.", {"entities": [[125, 134, "DISEASE"], [14, 20, "DISEASE"]]}], ["When symptoms of asthma are interpreted without regard to such conditions treatment may yield a suboptimal outcome.", {"entities": [[17, 23, "DISEASE"]]}], ["For example, anxiety-associated dyspnea, tachypnea, and chest tightness can be mistakenly interpreted as resulting from an exacerbation of asthma.", {"entities": [[139, 145, "DISEASE"]]}], ["Medical treatment directed only for asthma may thus lead to overuse of asthma medications and increased hospitalizations.", {"entities": [[36, 42, "DISEASE"], [71, 77, "DISEASE"]]}], ["The described case illustrates how a systemic steroid-dependent patient with asthma benefited from receiving care from a pediatric pulmonologist who also was well versed in the diagnosis and treatment of anxiety.", {"entities": [[77, 83, "DISEASE"]]}], ["By using self-hypnosis, the patient was able to reduce her dependence on bronchodilators.", {"entities": []}], ["Following modification of her medical therapy under supervision of the pulmonologist, and regular use of hypnosis, the patient ultimately was weaned off her systemic steroid therapy.", {"entities": []}], ["This report emphasizes that anxiety must be considered as a comorbid condition in the treatment of asthma.", {"entities": [[99, 105, "DISEASE"]]}], ["Self-hypnosis can be a useful skill in the treatment of a patient with anxiety and asthma.", {"entities": [[83, 89, "DISEASE"]]}], ["The annual examination of first graders\u2019 oral health as stipulated by law aimed to reach every child in Rhineland-Palatinate (Germany) in their first year of school.", {"entities": []}], ["We intended to evaluate the first graders\u2019 oral health based on the examination data for 2013/2014.", {"entities": []}], ["Instructed examiners measured the d3mft(deciduous)/D3MFT(permanent) index according to World Health Organization criteria in 25,020 predominantly 6\u20137 year-old first-grade school children.", {"entities": []}], ["Only caries affecting dentin was diagnosed; no radiography or fiber-transillumination was used.", {"entities": []}], ["Out of the d3mft value, the \u201cSignificant Caries Index\u201d (SiC) was calculated.", {"entities": []}], ["This index identifies the dmft score of the third of the population with the highest caries experience.", {"entities": []}], ["Descriptive analysis was performed.", {"entities": []}], ["Out of the the examined children, 60.9\u00a0% were caries free.", {"entities": []}], ["Mean d3mft score was 1.28\u2009\u00b1\u20092.27 while the mean SiC was 3.73\u2009\u00b1\u20092.51.", {"entities": []}], ["A distinctly higher d3mft was found in the decidous molars compared to the front teeth.", {"entities": []}], ["Boys were significantly more caries-experienced than girls ( p \u2009<\u20090.001).", {"entities": []}], ["The results of this study confirm the lasting trend towards decreasing caries prevalence in children starting school found in previous cross-sectional studies.", {"entities": []}], ["This trend was observed in the high-risk group (obtained by SiC) as well as in the entire study population.", {"entities": []}], ["Particular attention in caries prophylaxis should be paid to the primary molars.", {"entities": []}], ["Most studies investigating disability outcomes following injury have examined hospitalised patients.", {"entities": []}], ["It is not known whether variables associated with disability outcomes are similar for injured people who are not hospitalised.", {"entities": []}], ["This paper compares the prevalence of disability 24 months after injury for participants in the Prospective Outcomes of Injury Study who were hospitalised and those non-hospitalised, and also seeks to identify pre-injury and injury-related predictors of disability among hospitalised and non-hospitalised participants.", {"entities": []}], ["Participants, aged 18\u201364 years, were recruited from an injury claims register managed by New Zealand\u2019s no-fault injury compensation insurer after referral by health care professionals.", {"entities": []}], ["A wide range of pre-injury socio-demographic, health and psychosocial characteristics were collected, as well as injury-related characteristics; outcome is assessed using the WHODAS.", {"entities": []}], ["Multivariable models estimating relative risks of disability for hospitalised and non-hospitalised participants were developed using Poisson regression methods.", {"entities": []}], ["Of 2856 participants, analyses were restricted to 2184 (76%) participants for whom both pre-injury and 24 month WHODAS data were available.", {"entities": []}], ["Of these, 25% were hospitalised.", {"entities": []}], ["In both hospitalised and non-hospitalised groups, 13% experience disability (WHODAS\u226510) 24 months after injury; higher than pre-injury (5%).", {"entities": []}], ["Of 28 predictor variables, seven independently placed injured participants in the hospitalised group at increased risk of disability 24 months after injury; eight in the non-hospitalised.", {"entities": []}], ["Only four predictors (pre-injury disability, two or more pre-injury chronic conditions, pre-injury BMI\u226530 and trouble accessing healthcare services) were common to both the hospitalised and non-hospitalised groups.", {"entities": []}], ["There is some evidence to suggest that among the hospitalised group, M\u0101ori have higher risk of disability relative to non-M\u0101ori.", {"entities": []}], ["At 24 months considerable disability is borne, equally, by hospitalised and non-hospitalised groups.", {"entities": []}], ["However, predictors of disability are not necessarily consistent between the hospitalised and non-hospitalised groups, suggesting caution in generalising results from one group to the other.", {"entities": []}], ["Smooth muscle cell migration has been implicated in the development of respiratory and cardiovascular systems; and airway/vascular remodeling.", {"entities": []}], ["Cell migration is a polarized cellular process involving a protrusive cell front and a retracting trailing rear.", {"entities": []}], ["There are three cytoskeletal systems in mammalian cells: the actin cytoskeleton, the intermediate filament network, and microtubules; all of which regulate all or part of the migrated process.", {"entities": []}], ["The dynamic actin cytoskeleton spatially and temporally regulates protrusion, adhesions, contraction, and retraction from the cell front to the rear.", {"entities": []}], ["c-Abl tyrosine kinase plays a critical role in regulating actin dynamics and migration of airway smooth muscle cells and nonmuscle cells.", {"entities": []}], ["Recent studies suggest that intermediate filaments undergo reorganization during migration, which coordinates focal adhesion dynamics, cell contraction, and nucleus rigidity.", {"entities": []}], ["In particular, vimentin intermediate filaments undergo phosphorylation and reorientation in smooth muscle cells, which may regulate cell contraction and focal adhesion assembly/disassembly.", {"entities": []}], ["Motile cells are characterized by a front-rear polarization of the microtubule framework, which regulates all essential processes leading to cell migration through its role in cell mechanics, intracellular trafficking, and signaling.", {"entities": []}], ["This review recapitulates our current knowledge how the three cytoskeletal systems spatially and temporally modulate the migratory properties of cells.", {"entities": []}], ["We also summarize the potential role of migration-associated biomolecules in lung and vascular diseases.", {"entities": []}], ["The \u03b2 common-signaling cytokines interleukin (IL)-3, granulocyte-macrophage colony stimulating factor (GM-CSF) and IL-5 stimulate pro-inflammatory activities of haematopoietic cells via a receptor complex incorporating cytokine-specific \u03b1 and shared \u03b2 common (\u03b2 c , CD131) receptor.", {"entities": []}], ["Evidence from animal models and recent clinical trials demonstrate that these cytokines are critical mediators of the pathogenesis of inflammatory airway disease such as asthma.", {"entities": [[170, 176, "DISEASE"]]}], ["However, no therapeutic agents, other than steroids, that specifically and effectively target inflammation mediated by all 3 of these cytokines exist.", {"entities": []}], ["We employed phage display technology to identify and optimize a novel, human monoclonal antibody (CSL311) that binds to a unique epitope that is specific to the cytokine-binding site of the human \u03b2 c receptor.", {"entities": []}], ["The binding epitope of CSL311 on the \u03b2 c receptor was defined by X-ray crystallography and site-directed mutagenesis.", {"entities": []}], ["CSL311 has picomolar binding affinity for the human \u03b2 c receptor, and at therapeutic concentrations is a highly potent antagonist of the combined activities of IL-3, GM-CSF and IL-5 on primary eosinophil survival in vitro.", {"entities": []}], ["Importantly, CSL311 inhibited the survival of inflammatory cells present in induced sputum from human allergic asthmatic subjects undergoing allergen bronchoprovocation.", {"entities": []}], ["Due to its high potency and ability to simultaneously suppress the activity of all 3 \u03b2 common cytokines, CSL311 may provide a new strategy for the treatment of chronic inflammatory diseases where the human \u03b2 c receptor is central to pathogenesis.", {"entities": []}], ["The coordinates for the \u03b2 c /CSL311 Fab complex structure have been deposited with the RCSB Protein Data Bank (PDB 5DWU).", {"entities": []}], ["Schistosomiasis remains a global public health challenge, with 93% of the \u223c237 million infections occurring in sub-Saharan Africa.", {"entities": [[0, 15, "DISEASE"]]}], ["Though rarely fatal, its recurring nature makes it a lifetime disorder with significant chronic health burdens.", {"entities": []}], ["Much of its negative health impact is due to non-specific conditions such as anemia, undernutrition, pain, exercise intolerance, poor school performance, and decreased work capacity.", {"entities": [[77, 83, "DISEASE"]]}], ["This makes it difficult to estimate the disease burden specific to schistosomiasis using the standard DALY metric.", {"entities": [[67, 82, "DISEASE"]]}], ["In our study, we used Pediatric Quality of Life Inventory (PedsQL), a modular instrument available for ages 2\u201318 years, to assess health-related quality of life (HrQoL) among children living in a Schistosoma haematobium -endemic area in coastal Kenya.", {"entities": []}], ["The PedsQL questionnaires were administered by interview to children aged 5\u201318 years (and their parents) in five villages spread across three districts.", {"entities": []}], ["HrQoL (total score) was significantly lower in villages with high prevalence of S. haematobium (\u22124.0%, p<0.001) and among the lower socioeconomic quartiles (\u22122.0%, p<0.05).", {"entities": []}], ["A greater effect was seen in the psychosocial scales as compared to the physical function scale.", {"entities": []}], ["In moderate prevalence villages, detection of any parasite eggs in the urine was associated with a significant 2.1% (p<0.05) reduction in total score.", {"entities": []}], ["The PedsQL reliabilities were generally high (Cronbach alphas \u22650.70), floor effects were acceptable, and identification of children from low socioeconomic standing was valid.", {"entities": []}], ["We conclude that exposure to urogenital schistosomiasis is associated with a 2\u20134% reduction in HrQoL.", {"entities": [[40, 55, "DISEASE"]]}], ["Further research is warranted to determine the reproducibility and responsiveness properties of QoL testing in relation to schistosomiasis.", {"entities": [[123, 138, "DISEASE"]]}], ["We anticipate that a case definition based on more sensitive parasitological diagnosis among younger children will better define the immediate and long-term HrQoL impact of Schistosoma infection.", {"entities": []}], ["Because urogenital schistosomiasis is a multi-decadal chronic disease that begins in early childhood, and because it is a disease that may affect nearly everyone in endemic communities, its impact on personal health-related quality of life (HrQoL) has been difficult to gauge accurately.", {"entities": [[19, 34, "DISEASE"]]}], ["In order to provide a more precise estimate of schistosomiasis' impact on overall health status, we used a standardized questionnaire, the PedsQL SF15 Inventory, to interview children, aged 5\u201318 years, and their parents, to quantify their reported physical, social, emotional, and scholastic performance status.", {"entities": [[47, 62, "DISEASE"]]}], ["Scores were significantly lower in villages having high Schistosoma prevalence, as compared those having moderate prevalence.", {"entities": []}], ["In adjusting for age, sex, socioeconomic standing, undernutrition, anemia, and hookworm parasites, we found that relative poverty, stunting, wasting, and S. haematobium infection were significant correlates of HrQoL scores, with differential effects in high- and moderate-prevalence communities.", {"entities": [[67, 73, "DISEASE"]]}], ["The greatest differences were noted in the psychosocial domains of performance.", {"entities": []}], ["We conclude that exposure to urogenital schistosomiasis has an overall detrimental effect on HrQoL at a level of 2\u20134% impairment.", {"entities": [[40, 55, "DISEASE"]]}], ["New implementation of better diagnostics for children is expected to refine our estimates of this association, as will follow-up studies of HrQoL following effective individual and community deworming.", {"entities": []}], ["Glycoproteins, glycosphingolipids and polysaccharides exposed at the most external layers of the wall are involved in several types of interactions of fungal cells with the exocellular environment.", {"entities": []}], ["These molecules are fundamental building blocks of organisms, contributing to the structure, integrity, cell growth, differentiation and signaling.", {"entities": []}], ["Several of them are immunologically active compounds with potential as regulators of pathogenesis and the immune response of the host.", {"entities": []}], ["Some of these structures can be specifically recognized by antibodies from patients\u2019 sera, suggesting that they can be also useful in the diagnosis of fungal infections.", {"entities": []}], ["An understanding of the characteristics of smokers who have never tried to quit may be useful to help identify and target these individuals and encourage them to attempt to give up smoking.", {"entities": []}], ["Using national survey data we investigated variables associated with smokers reporting never having tried to quit.", {"entities": []}], ["Using data from the 2007 and 2009 UK Office for National Statistics Opinions and Lifestyle Survey we identified all self-reported current smokers aged 16+.", {"entities": []}], ["The primary outcome was response to the question \u2018have you ever tried to quit smoking?\u2019 Univariable and multivariable logistic regression quantified the association between this outcome and several potential explanatory variables, including age, sex, socioeconomic status, health status, smoking behaviour, and knowledge of the dangers of smoking.", {"entities": []}], ["Desire to quit was the most significant independent predictor of whether a smoker reported never having tried to quit.", {"entities": []}], ["Smokers who reported that their health was good or very good were more likely to report never having tried to quit than those whose health was fair, bad or very bad (OR 1.59, 95% CI 1.05-2.41).", {"entities": []}], ["Smokers who reported that no family members, friends or colleagues had been trying to get them to quit smoking in the last year were more likely to report never having tried to quit than those who reported that someone was trying to persuade them (OR 1.57, 95% CI 1.09-2.28).", {"entities": []}], ["Smokers who hadn\u2019t received any cessation advice from a health professional in the last five years which they considered to be helpful were also more likely to report never having tried to quit.", {"entities": []}], ["Smokers who do not want to quit, who are in good health, whose friends and family are not trying to get them to quit, and who do not report receiving helpful advice to quit from a health professional, are more likely to report never having tried to quit.", {"entities": []}], ["To capture the possible genotypic and phenotypic differences of the 2009 influenza A virus H1N1 pandemic (H1N1pdm) strains circulating in adult hospitalized patients, we isolated and sequenced nine H1N1pdm viruses from patients hospitalized during 2009\u20132010 with severe influenza pneumonia in Kentucky.", {"entities": [[73, 82, "DISEASE"], [270, 279, "DISEASE"], [280, 289, "DISEASE"]]}], ["Each viral isolate was characterized in mice along with two additional H1N1 pandemic strains and one seasonal strain to assess replication and virulence.", {"entities": []}], ["All isolates showed similar levels of replication in nasal turbinates and lung, but varied in their ability to cause morbidity.", {"entities": []}], ["Further differences were identified in cytokine and chemokine responses.", {"entities": []}], ["IL-6 and KC were expressed early in mice infected with strains associated with higher virulence.", {"entities": []}], ["Strains that showed lower pathogenicity in mice had greater IFN\u03b3, MIG, and IL-10 responses.", {"entities": []}], ["A principal component analysis (PCA) of the cytokine and chemokine profiles revealed 4 immune response phenotypes that correlated with the severity of disease.", {"entities": []}], ["A/KY/180/10, which showed the greatest virulence with a rapid onset of disease progression, was compared in additional studies with A/KY/136/09, which showed low virulence in mice.", {"entities": []}], ["Analyses comparing a low (KY/136) versus a high (KY/180) virulent isolate showed a significant difference in the kinetics of infection within the lower respiratory tract and immune responses.", {"entities": []}], ["Notably by 4 DPI, virus titers within the lung, bronchoalveolar lavage fluid (BALf), and cells within the BAL (BALc) revealed that the KY/136 replicated in BALc, while KY/180 replication persisted in lungs and BALc.", {"entities": []}], ["In summary, our studies suggest four phenotypic groups based on immune responses that result in different virulence outcomes in H1N1pdm isolates with a high degree of genetic similarity.", {"entities": []}], ["In vitro studies with two of these isolates suggested that the more virulent isolate, KY/180, replicates productively in macrophages and this may be a key determinant in tipping the response toward a more severe disease progression.", {"entities": []}], ["System lupus erythematosus (SLE) is a multifactorial systemic autoimmune disease with a wide variety of presenting features.", {"entities": [[7, 26, "DISEASE"]]}], ["SLE is believed to result from dysregulated immune responses, loss of tolerance of CD4 T cells and B cells to ubiquitous self-antigens, and the subsequent production of anti-nuclear and other autoreactive antibodies.", {"entities": [[83, 86, "GENE"]]}], ["Recent research has associated lupus development with changes in the dendritic cell (DC) compartment, including altered DC subset frequency and localization, overactivation of mDCs and pDCs, and functional defects in DCs.", {"entities": []}], ["Here we discuss the current knowledge on the role of DC dysfunction in SLE pathogenesis, with the focus on DCs as targets for interventional therapies.", {"entities": []}], ["Human respiratory syncytial virus (RSV) causes severe respiratory disease in infants.", {"entities": []}], ["Airway epithelial cells are the principle targets of RSV infection.", {"entities": []}], ["However, the mechanisms by which it causes disease are poorly understood.", {"entities": []}], ["Most RSV pathogenesis data are derived using laboratory-adapted prototypic strains.", {"entities": []}], ["We hypothesized that such strains may be poorly representative of recent clinical isolates in terms of virus/host interactions in primary human bronchial epithelial cells (PBECs).", {"entities": []}], ["To address this hypothesis, we isolated three RSV strains from infants hospitalized with bronchiolitis and compared them with the prototypic RSV A2 in terms of cytopathology, virus growth kinetics and chemokine secretion in infected PBEC monolayers.", {"entities": [[89, 102, "DISEASE"]]}], ["RSV A2 rapidly obliterated the PBECs, whereas the clinical isolates caused much less cytopathology.", {"entities": []}], ["Concomitantly, RSV A2 also grew faster and to higher titers in PBECs.", {"entities": []}], ["Furthermore, dramatically increased secretion of IP-10 and RANTES was evident following A2 infection compared with the clinical isolates.", {"entities": []}], ["The prototypic RSV strain A2 is poorly representative of recent clinical isolates in terms of cytopathogenicity, viral growth kinetics and pro-inflammatory responses induced following infection of PBEC monolayers.", {"entities": []}], ["Thus, the choice of RSV strain may have important implications for future RSV pathogenesis studies.", {"entities": []}], ["Activator protein 1 (AP-1) (Fos/Jun) is a transcriptional regulator composed of members of the Fos and Jun families of DNA binding proteins.", {"entities": [[28, 31, "GENE"], [95, 98, "GENE"], [32, 35, "GENE"], [103, 106, "GENE"]]}], ["The functions of AP-1 were initially studied in mouse development as well as in the whole organism through conventional transgenic approaches, but also by gene targeting using knockout strategies.", {"entities": []}], ["The importance of AP-1 proteins in disease pathways including the inflammatory response became fully apparent through conditional mutagenesis in mice, in particular when employing gene inactivation in a tissue-specific and inducible fashion.", {"entities": []}], ["Besides the well-documented roles of Fos and Jun proteins in oncogenesis, where these genes can function both as tumor promoters or tumor suppressors, AP-1 proteins are being recognized as regulators of bone and immune cells, a research area termed osteoimmunology.", {"entities": [[37, 40, "GENE"], [45, 48, "GENE"]]}], ["In the present article, we review recent data regarding the functions of AP-1 as a regulator of cytokine expression and an important modulator in inflammatory diseases such as rheumatoid arthritis, psoriasis and psoriatic arthritis.", {"entities": [[176, 196, "DISEASE"], [198, 207, "DISEASE"], [187, 196, "DISEASE"], [222, 231, "DISEASE"], [212, 231, "DISEASE"]]}], ["These new data provide a better molecular understanding of disease pathways and should pave the road for the discovery of new targets for therapeutic applications.", {"entities": []}], ["Lymphangioleiomyomatosis (LAM), a multisystem disease of women, is manifest by the proliferation of smooth muscle-like cells in the lung resulting in cystic lung destruction.", {"entities": []}], ["Women with LAM can also develop renal angiomyolipomas.", {"entities": []}], ["LAM is caused by mutations in the tuberous sclerosis complex genes ( TSC1 or TSC2) , resulting in hyperactive mammalian Target of Rapamycin (mTOR) signaling.", {"entities": [[34, 52, "DISEASE"], [69, 73, "GENE"], [77, 81, "GENE"], [141, 145, "GENE"]]}], ["The mTOR inhibitor, Rapamycin, stabilizes lung function in LAM and decreases the volume of renal angiomyolipomas, but lung function declines and angiomyolipomas regrow when treatment is discontinued, suggesting that factors induced by mTORC1 inhibition may promote the survival of TSC2-deficient cells.", {"entities": [[4, 8, "GENE"]]}], ["Whether microRNA (miRNA, miR) signaling is involved in the response of LAM to mTORC1 inhibition is unknown.", {"entities": []}], ["We identified Rapamycin-dependent miRNA in LAM patient angiomyolipoma-derived cells using two separate screens.", {"entities": [[55, 69, "DISEASE"]]}], ["First, we assayed 132 miRNA of known significance to tumor biology.", {"entities": []}], ["Using a cut-off of >1.5-fold change, 48 microRNA were Rapamycin-induced, while 4 miRs were downregulated.", {"entities": []}], ["In a second screen encompassing 946 miRNA, 18 miRs were upregulated by Rapamycin, while eight were downregulated.", {"entities": []}], ["Dysregulation of miRs 29b, 21, 24, 221, 106a and 199a were common to both platforms and were classified as candidate \u201cRapamiRs.\u201d Validation by qRT-PCR confirmed that these microRNA were increased.", {"entities": []}], ["miR-21, a pro-survival miR, was the most significantly increased by mTOR-inhibition (p<0.01).", {"entities": [[0, 6, "GENE"]]}], ["The regulation of miR-21 by Rapamycin is cell type independent.", {"entities": [[18, 24, "GENE"]]}], ["mTOR inhibition promotes the processing of the miR-21 transcript (pri-miR-21) to a premature form (pre-miR-21).", {"entities": [[0, 4, "GENE"], [47, 53, "GENE"], [70, 76, "GENE"], [103, 109, "GENE"]]}], ["In conclusion, our findings demonstrate that Rapamycin upregulates multiple miRs, including pro-survival miRs, in TSC2-deficient patient-derived cells.", {"entities": []}], ["The induction of miRs may contribute to the response of LAM and TSC patients to Rapamycin therapy.", {"entities": []}], ["Traditional medicinal plant species documentation is very crucial in Ethiopia for biodiversity conservation, bioactive chemical extractions and indigenous knowledge retention.", {"entities": []}], ["Having first observed the inhabitants of Gubalafto District (Northern Ethiopia), the author gathered, recorded, and documented the human traditional medicinal plant species and the associated indigenous knowledge.", {"entities": []}], ["The study was conducted from February 2013 to January 2015 and used descriptive field survey design.", {"entities": []}], ["Eighty-four informants were selected from seven study kebeles (sub-districts) in the District through purposive, snowball, and random sampling techniques.", {"entities": []}], ["Both quantitative and qualitative data were collected through semi-structured interviews, guided field walks, demonstrations, and focus group discussions with the help of guided questions.", {"entities": []}], ["Data were organized and analyzed by descriptive statistics with SPSS version 20 and Microsoft Office Excel 2007.", {"entities": []}], ["A total of 135 medicinal plant species within 120 genera and 64 families were documented.", {"entities": []}], ["Among the species, Ocimum lamiifolium and Rhamnus prinoides scored the highest informant citations and fidelity level value, respectively.", {"entities": []}], ["In the study area, Asteraceae with 8.1% and herbs with 50.4% plant species were the most used sources for their medicinal uses.", {"entities": []}], ["A total of 65 ailments were identified as being treated by traditional medicinal plants, among which stomachache (abdominal health problems) was frequently reported.", {"entities": []}], ["Solanum incanum was reported for the treatment of many of the reported diseases.", {"entities": []}], ["The leaf, fresh parts, and crushed forms of the medicinal plants were the most preferred in remedy preparations.", {"entities": []}], ["Oral application was the highest reported administration for 110 preparations.", {"entities": []}], ["A majority of medicinal plant species existed in the wild without any particular conservation effort.", {"entities": []}], ["Few informants (about 5%) had only brief notes about the traditional medicinal plants.", {"entities": []}], ["Ninety percent of the respondents have learned indigenous medicinal plants knowledge from their family members and friends secretly.", {"entities": []}], ["Orthodox Church schools were found the main place for 65% of healer\u2019s indigenous knowledge origin and experiences.", {"entities": []}], ["Elders, aged between 40 and 84\u00a0years, gave detailed descriptions about traditional medicinal plants.", {"entities": []}], ["Traditional medicinal plants and associated indigenous knowledge are the main systems to maintain human health in Gubalafto District.", {"entities": []}], ["But minimal conservation measures were recorded in the community.", {"entities": []}], ["Thus, in-situ and ex-situ conservation practices and sustainable utilization are required in the District.", {"entities": []}], ["MicroRNAs are post-transcriptional regulators of gene expression that are differentially regulated during development and in inflammatory diseases.", {"entities": []}], ["A role for miRNAs in allergic asthma is emerging and further investigation is required to determine whether they may serve as potential therapeutic targets.", {"entities": [[21, 36, "DISEASE"], [30, 36, "DISEASE"]]}], ["We profiled miRNA expression in murine lungs from an ovalbumin-induced allergic airways disease model, and compared expression to animals receiving dexamethasone treatment and non-allergic controls.", {"entities": []}], ["Our analysis identified 29 miRNAs that were significantly altered during allergic inflammation.", {"entities": []}], ["Target prediction analysis revealed novel genes with altered expression in allergic airways disease and suggests synergistic miRNA regulation of target mRNAs.", {"entities": []}], ["To assess the impacts of one induced miRNA on pathology, we targeted miR-155-5p using a specific antagomir.", {"entities": []}], ["Antagomir administration successfully reduced miR-155-5p expression with high specificity, but failed to alter the disease phenotype.", {"entities": []}], ["Interestingly, further investigation revealed that antagomir delivery has variable efficacy across different immune cell types, effectively targeting myeloid cell populations, but exhibiting poor uptake in lymphocytes.", {"entities": []}], ["Our findings demonstrate that antagomir-based targeting of miRNA function in the lung is highly specific, but highlights cell-specificity as a key limitation to be considered for antagomir-based strategies as therapeutics.", {"entities": []}], ["A conspiracy world view may be a form of mistrust that is typically corrosive to individual and societal well-being.", {"entities": []}], ["Our aim was to establish the correlates of conspiracy thinking in an epidemiologically representative sample.", {"entities": []}], ["US National Comorbidity Survey-Replication (NCS-R) data were analysed from 5645 people who had completed the item \u201cI am convinced there is a conspiracy behind many things in the world.\u201d Results were weighted to be representative of the US adult English speaking household population.", {"entities": []}], ["1618 people (weighted 26.7%) endorsed the conspiracy belief item.", {"entities": []}], ["These individuals were more likely to be: male; currently unmarried; less educated; in a lower income household; outside the labour force; from an ethnic minority group; not attending religious services; taking a weapon outside; and perceiving themselves as of lower social standing compared to others.", {"entities": []}], ["Individuals endorsing the conspiracy belief item had lower levels of physical and psychological well-being, higher levels of suicidal ideation, weaker social networks, less secure attachment style, difficult childhood family experiences, and were more likely to meet criteria for a psychiatric disorder.", {"entities": []}], ["There were no differences between those who endorsed conspiracy beliefs and those who did not in age, importance of religious beliefs in daily life, body mass index, or in having a gun at home.", {"entities": []}], ["Viewing conspiracies in the world is associated with a raised risk of a wide range of adverse circumstances.", {"entities": []}], ["It is a type of cognitive style that requires systematic empirical study, including monitoring of prevalence, tests of causation, and modelling of propagation.", {"entities": []}], ["The genetic make-up of humans and other mammals (such as mice) affects their resistance to influenza virus infection.", {"entities": [[91, 100, "DISEASE"]]}], ["Considering the complexity and moral issues associated with experiments on human subjects, we have only acquired partial knowledge regarding the underlying molecular mechanisms.", {"entities": []}], ["Although influenza resistance in inbred mice has been mapped to several quantitative trait loci (QTLs), which have greatly narrowed down the search for host resistance genes, only few underlying genes have been identified.", {"entities": [[9, 18, "DISEASE"]]}], ["To prioritize a list of promising candidates for future functional investigation, we applied network-based approaches to leverage the information of known resistance genes and the expression profiles contrasting susceptible and resistant mouse strains.", {"entities": []}], ["The significance of top-ranked genes was supported by different lines of evidence from independent genetic associations, QTL studies, RNA interference (RNAi) screenings, and gene expression analysis.", {"entities": []}], ["Further data mining on the prioritized genes revealed the functions of two pathways mediated by tumor necrosis factor (TNF): apoptosis and TNF receptor-2 signaling pathways.", {"entities": [[119, 122, "GENE"], [139, 142, "GENE"], [119, 122, "GENE"], [139, 142, "GENE"]]}], ["We suggested that the delicate balance between TNF\u2019s pro-survival and apoptotic effects may affect hosts\u2019 conditions after influenza virus infection.", {"entities": [[123, 132, "DISEASE"], [47, 50, "GENE"]]}], ["This study considerably cuts down the list of candidate genes responsible for host resistance to influenza and proposed novel pathways and mechanisms.", {"entities": [[97, 106, "DISEASE"]]}], ["Our study also demonstrated the efficacy of network-based methods in prioritizing genes for complex traits.", {"entities": []}], ["The online version of this article (doi:10.1186/1471-2164-14-816) contains supplementary material, which is available to authorized users.", {"entities": []}], ["To examine for a causal relationship between vitamin D and glioma risk we performed an analysis of genetic variants associated with serum 25-hydroxyvitamin D (25(OH)D) levels using Mendelian randomisation (MR), an approach unaffected by biases from confounding.", {"entities": []}], ["Two-sample MR was undertaken using genome-wide association study data.", {"entities": []}], ["Single nucleotide polymorphisms (SNPs) associated with 25(OH)D levels were used as instrumental variables (IVs).", {"entities": []}], ["We calculated MR estimates for the odds ratio (OR) for 25(OH)D levels with glioma using SNP-glioma estimates from 12,488 cases and 18,169 controls, using inverse-variance weighted (IVW) and maximum likelihood estimation (MLE) methods.", {"entities": []}], ["A non-significant association between 25(OH)D levels and glioma risk was shown using both the IVW (OR\u2009=\u20091.21, 95% confidence interval [CI]\u2009=\u20090.90\u20131.62, P \u2009=\u20090.201) and MLE (OR\u2009=\u20091.20, 95% CI\u2009=\u20090.98\u20131.48, P \u2009=\u20090.083) methods.", {"entities": []}], ["In an exploratory analysis of tumour subtype, an inverse relationship between 25(OH)D levels and glioblastoma (GBM) risk was identified using the MLE method (OR\u2009=\u20090.62, 95% CI\u2009=\u20090.43\u20130.89, P \u2009=\u20090.010), but not the IVW method (OR\u2009=\u20090.62, 95% CI\u2009=\u20090.37\u20131.04, P \u2009=\u20090.070).", {"entities": [[97, 109, "DISEASE"]]}], ["No statistically significant association was shown between 25(OH)D levels and non-GBM glioma.", {"entities": []}], ["Our results do not provide evidence for a causal relationship between 25(OH)D levels and all forms of glioma risk.", {"entities": []}], ["More evidence is required to explore the relationship between 25(OH)D levels and risk of GBM.", {"entities": []}], ["Otitis media (OM) is a common childhood disease characterised by middle ear inflammation and effusion.", {"entities": []}], ["Susceptibility to recurrent acute OM (rAOM; \u22653 episodes of AOM in 6 months) and chronic OM with effusion (COME; MEE \u22653 months) is 40\u201370% heritable.", {"entities": []}], ["Few underlying genes have been identified to date, and no genome-wide association study (GWAS) of OM has been reported.", {"entities": []}], ["Data for 2,524,817 single nucleotide polymorphisms (SNPs; 535,544 quality-controlled SNPs genotyped by Illumina 660W-Quad; 1,989,273 by imputation) were analysed for association with OM in 416 cases and 1,075 controls from the Western Australian Pregnancy Cohort (Raine) Study.", {"entities": []}], ["Logistic regression analyses under an additive model undertaken in GenABEL/ProbABEL adjusting for population substructure using principal components identified SNPs at CAPN14 (rs6755194: OR\u200a=\u200a1.90; 95%CI 1.47\u20132.45; P adj-PCA \u200a=\u200a8.3\u00d710 adj-PCA \u200a=\u200a2.2\u00d710 GALNT14 gene.", {"entities": [[168, 174, "GENE"], [253, 260, "GENE"]]}], ["In a gene-based analysis in VEGAS, BPIFA3 (P Gene \u200a=\u200a2\u00d710 BPIFA1 (P Gene \u200a=\u200a1.07\u00d710 BPIFA gene cluster on chromosome 20q11.21 were the top hits.", {"entities": []}], ["In all, 32 genomic regions show evidence of association (P adj-PCA <10 This first discovery GWAS for an OM phenotype has identified CAPN14 and GALNT14 on chromosome 2p23.1 and the BPIFA gene cluster on chromosome 20q11.21 as novel candidate genes which warrant further analysis in cohorts matched more precisely for clinical phenotypes.", {"entities": [[132, 138, "GENE"], [143, 150, "GENE"]]}]]